PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hameed, SS; Hassan, R; Muhammad, FF				Hameed, Shilan S.; Hassan, Rohayanti; Muhammad, Fahmi F.			Selection and classification of gene expression in autism disorder: Use of a combination of statistical filters and a GBPSO-SVM algorithm	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; DATA MINING METHODS; CANCER CLASSIFICATION; SPECTRUM DISORDERS; ACTIVATOR PROTEIN; MICROARRAY; SYSTEM	In this work, gene expression in autism spectrum disorder (ASD) is analyzed with the goal of selecting the most attributed genes and performing classification. The objective was achieved by utilizing a combination of various statistical filters and a wrapper-based geometric binary particle swarm optimization-support vector machine (GBPSO-SVM) algorithm. The utilization of different filters was accentuated by incorporating a mean and median ratio criterion to remove very similar genes. The results showed that the most discriminative genes that were identified in the first and last selection steps included the presence of a repetitive gene (CAPS2), which was assigned as the gene most highly related to ASD risk. The merged gene subset that was selected by the GBPSO-SVM algorithm was able to enhance the classification accuracy.	[Hameed, Shilan S.] Univ Teknol Malaysia, Fac Comp, Dept Comp Sci, Johor Baharu, Malaysia; [Hameed, Shilan S.] Salahaddin Univ, Coll Engn, Dept Software & Informat Engn, Erbil, Kurdistan Regio, Iraq; [Hassan, Rohayanti] Univ Teknol Malaysia, Fac Comp, Dept Software Engn, Johor Baharu, Malaysia; [Muhammad, Fahmi F.] Koya Univ, Fac Sci & Hlth, Dept Phys, Koya, Kurdistan Regio, Iraq	Universiti Teknologi Malaysia; Salahaddin University; Universiti Teknologi Malaysia; Koya University	Muhammad, FF (corresponding author), Koya Univ, Fac Sci & Hlth, Dept Phys, Koya, Kurdistan Regio, Iraq.	fahmi.fariq@koyauniversity.org	Muhammadsharif, Fahmi F./B-3802-2010; Hassan, Rohayanti/M-1203-2015; Hameed, Shilan S./AAQ-9823-2020	Muhammadsharif, Fahmi F./0000-0002-4563-9671; Hassan, Rohayanti/0000-0003-1062-1719; Hameed, Shilan S./0000-0002-8596-644X	UTM Research University Grant Scheme [11H84]; Koya University	UTM Research University Grant Scheme; Koya University	This work was financially supported in part by the UTM Research University Grant Scheme (Vot number 11H84) and in part by Koya University.r The authors are grateful to the Department of Computer Science and Software Engineering of the Universiti Teknologi Malaysia for their administrative support. The authors would also like to express their deepest gratitude for the financial support received under the UTM Research University Grant Scheme (Vot number 11H84).	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Alba E, 2007, 2007 CEC 2007 IEEE C; Alter MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016715; Annavarapu CSR, 2016, EXCLI J, V15, P460, DOI 10.17179/excli2016-481; [Anonymous], 2011, AUTISTIC CHILDREN TH; Ardjani F, 2010, 2010 2ND INTERNATIONAL WORKSHOP ON DATABASE TECHNOLOGY AND APPLICATIONS PROCEEDINGS (DBTA); Bolon-Canedo V, 2014, INFORM SCIENCES, V282, P111, DOI 10.1016/j.ins.2014.05.042; Bridge PD, 1999, J CLIN EPIDEMIOL, V52, P229, DOI 10.1016/S0895-4356(98)00168-1; Cateni S, 2013, MULTIVARIATE ANAL MA; Cervante L, 2012, IEEE C EVOL COMPUTAT; Chen LF, 2012, NEURAL COMPUT APPL, V21, P2087, DOI 10.1007/s00521-011-0632-4; Chen YM, 2010, PATTERN RECOGN LETT, V31, P226, DOI 10.1016/j.patrec.2009.10.013; Christobel M, 2015, SCI WORLD J, V2015; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Das S., 2001, FILTERS WRAPPERS BOO; de Menezes Renee X, 2004, Appl Bioinformatics, V3, P229; De Rubeis S, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0553-1; El-Fishawy P, 2010, PSYCHIAT CLIN N AM, V33, P83, DOI 10.1016/j.psc.2009.12.002; Fisher RA, 1925, MATH P CAMBRIDGE PHI; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Garcia-Nieto J, 2009, INFORM PROCESS LETT, V109, P887, DOI 10.1016/j.ipl.2009.03.029; Gnana DAA, 2016, METHODS, V136; Gonzalez F., 2013, ARXIV13021733; Govindarajan R, 2012, J PHARM BIOALLIED SC, V4, pS310, DOI 10.4103/0975-7406.100283; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Han J, 2012, MOR KAUF D, P1; Hassanien AE, 2013, COMPUT BIOL CHEM, V47, P37, DOI 10.1016/j.compbiolchem.2013.04.007; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; He F, 2012, P INT C 4 EL SYST IN; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Huang JW, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0277-0; Huerta E.B., 2006, WORKSH APPL EV COMP; Huertas C, 2014, INF FUD FUSION 2014; Jirapech-Umpai T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-148; John L. Z., 2010, JR STAT SOC A, V173, P693, DOI DOI 10.1111/J.1467-985X.2010.00646_6.X; Kennedy J, 1997, 1997 COMP CYB SIM 19; Khoshgoftaar T, 2012, MACH LEARN APPL ICML; Krey JF, 2007, CURR OPIN NEUROBIOL, V17, P112, DOI 10.1016/j.conb.2007.01.010; Lai C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-235; Latkowski T, 2015, INT WORK C ART NEUR; Latkowski T, 2015, COMPUT BIOL MED, V56, P82, DOI 10.1016/j.compbiomed.2014.11.004; Latkowski T, 2015, EXPERT SYST APPL, V42, P864, DOI 10.1016/j.eswa.2014.08.043; Lazar C, 2012, IEEE ACM T COMPUT BI, V9, P1106, DOI 10.1109/TCBB.2012.33; Leung MKK, 2016, P IEEE, V104, P176, DOI 10.1109/JPROC.2015.2494198; Li ST, 2008, SOFT COMPUT, V12, P1039, DOI 10.1007/s00500-007-0272-x; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Lin IF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129451; Liu BQ, 2014, PR ELECTROMAGN RES S, P2014; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu B, 2016, MOL GENET GENOMICS, V291, P473, DOI 10.1007/s00438-015-1078-7; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121501; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Moraglio A, 2008, J ARTIFICIAL EVOLUTI, V2008; Muszynski M, 2014, INT J AP MAT COM-POL, V24, P657, DOI 10.2478/amcs-2014-0048; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Rejani Y. I. A., 2009, ARXIV09122314; Sadakata T, 2017, NEUROSCI LETT, V639, P88, DOI 10.1016/j.neulet.2016.12.068; Sadakata T, 2012, FEBS J, V279, P384, DOI 10.1111/j.1742-4658.2011.08431.x; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saha S, 2016, INT J BIOINFORMATICS, V12, P263; Singh RK, 2015, PROCEDIA COMPUT SCI, V50, P52, DOI 10.1016/j.procs.2015.04.060; Sprent P., 2016, APPL NONPARAMETRIC S; Talbi E-G, 2008, COMP SYST APPL 2008; Taniai H, 2008, AM J MED GENET B, V147B, P844, DOI 10.1002/ajmg.b.30740; Teng XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173907; Thurm Audrey, 2012, Dialogues Clin Neurosci, V14, P219; Tran B., 2014, AS PAC C SIM EV LEAR; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Wild C, 2011, WILCOXON RANK SUM TE; Wilinski A, 2012, B POL ACAD SCI-TECH, V60, P461, DOI 10.2478/v10175-012-0058-x; Wing L, 1996, BRIT MED J, V312, P327; Xue B, 2013, IEEE T CYBERNETICS, V43, P1656, DOI 10.1109/TSMCB.2012.2227469; Yoo H, 2015, EXP NEUROBIOL, V24, P257, DOI 10.5607/en.2015.24.4.257; Zhang H, 2016, ICCAD-IEEE ACM INT, DOI 10.1145/2906980.2967032; Zhu L, 2017, IEEE ACM T COMPUTATI	78	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187371	10.1371/journal.pone.0187371	http://dx.doi.org/10.1371/journal.pone.0187371			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095904	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200078
J	Park, JM; Bae, SJ; Yoon, C; Lee, HS; Lee, HW; Ahn, SG; Lee, SA; Jeong, J				Park, Jung Min; Bae, Soong Jun; Yoon, Changik; Lee, Hye Sun; Lee, Hak Woo; Ahn, Sung Gwe; Lee, Seung Ah; Jeong, Joon			Comparison of patients with small (<= 2 cm) breast cancer according to adherence to breast screening program	PLOS ONE			English	Article							FOLLOW-UP; MAMMOGRAPHY; INTERVAL; SURVIVAL; FEATURES; TRIAL	Background We investigated whether adherence to breast screening would yield a clinical benefit even among patients with small breast cancer (>= 2 cm) by comparing differences between those who did and did not adhere to breast screening. Methods Patients who were diagnosed with invasive T1 breast cancer and treated at Gangnam Severance Hospital from January 2006 to June 2014 were included. Of the 632 study patients, 450 and 182 were classified as screen-adherent and non-adherent. Adherence to the breast screening program was defined as the completion of breast screening examinations within 3 years before cancer diagnosis. Recurrence-free survival (RFS) and metastasis-free survival (MFS) were compared between the groups. Propensity score matching were applied to compare survival outcome. Results Adherent patients were more likely to have a lower histologic grade (P< 0.001), high estrogen receptor expression (P = 0.040), and lower HER2-positivity (P = 0.026). The adherent group had more favorable subtypes compared to the non-adherent group, with a greater percentage of Luminal/HER2-negative subtype (66.7% vs. 56.5%) and a lower percentage of HER2 subtype (8.3% vs. 16.7%). The RFS and MFS were significantly better in the adherent group (P = 0.003, 0.010, respectively). In the case-matched cohort, superior survival of the adherent group was maintained. Conclusions Adherence to breast screening in patients with small breast tumors was associated with more favorable tumor biology and better prognosis. Our findings suggest that adherence to breast screening might offer clinical benefits in terms of tumor biology as well as early detection.	[Park, Jung Min; Bae, Soong Jun; Yoon, Changik; Lee, Hak Woo; Ahn, Sung Gwe; Jeong, Joon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea; [Lee, Seung Ah] CHA Univ, CHA Bundang Med Ctr, Dept Surg, Seongnam, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University	Ahn, SG (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea.	asg2004@yuhs.ac		Park, Jung Min/0000-0002-6190-5781; Bae, Soong June/0000-0002-0012-9694; Jeong, Joon/0000-0003-0397-0005; Yoon, Chang Ik/0000-0002-7273-8886; Ahn, Sung Gwe/0000-0002-8778-9686	Basic Science Research Program through NRF - Ministry of Science, ICT, & Future Planning [NRF-2015R1C1A1A02037104]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1520120]	Basic Science Research Program through NRF - Ministry of Science, ICT, & Future Planning; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by the Basic Science Research Program through the NRF, funded by the Ministry of Science, ICT, & Future Planning (NRF-2015R1C1A1A02037104), and grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1520120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Brewster AM, 2011, CANCER PREV RES, V4, P1609, DOI 10.1158/1940-6207.CAPR-10-0361; Burrell HC, 1996, RADIOLOGY, V199, P811, DOI 10.1148/radiology.199.3.8638010; Crosier M, 1999, CLIN CANCER RES, V5, P2682; Dong WL, 2008, CANCER EPIDEM BIOMAR, V17, P1096, DOI 10.1158/1055-9965.EPI-08-0201; Gilliland FD, 2000, J NATL CANCER I, V92, P743, DOI 10.1093/jnci/92.9.743; Groenendijk RPR, 2000, BRIT J CANCER, V82, P381; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Joensuu H, 2004, JAMA-J AM MED ASSOC, V292, P1064, DOI 10.1001/jama.292.9.1064; Klemi PJ, 2003, BREAST, V12, P308, DOI 10.1016/S0960-9776(03)00096-1; Koh VCY, 2015, BREAST CANCER RES TR, V152, P293, DOI 10.1007/s10549-015-3472-6; Lee AKC, 1997, CANCER-AM CANCER SOC, V79, P761, DOI 10.1002/(SICI)1097-0142(19970215)79:4<761::AID-CNCR13>3.3.CO;2-K; Lee EH, 2015, J KOREAN MED ASSOC, V58, P408, DOI 10.5124/jkma.2015.58.5.408; Moody-Ayers SY, 2000, ARCH INTERN MED, V160, P1109, DOI 10.1001/archinte.160.8.1109; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Saadatmand S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4901; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yassin M M, 2003, Asian J Surg, V26, P101, DOI 10.1016/S1015-9584(09)60229-3	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186988	10.1371/journal.pone.0186988	http://dx.doi.org/10.1371/journal.pone.0186988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095835	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200036
J	Wen, JP; Hao, J; Liang, YB; Li, SZ; Cao, K; Lu, XL; Lu, XX; Wang, NL				Wen, Jiangping; Hao, Jie; Liang, Yuanbo; Li, Sizhen; Cao, Kai; Lu, Xilin; Lu, Xinxin; Wang, Ningli			A non-invasive risk score for predicting incident diabetes among rural Chinese people: A village-based cohort study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTIONS; FOLLOW-UP; TYPE-2; POPULATION; PREVALENCE; ADULTS; VALIDATION; PREVENTION; REDUCTION	Objective To develop a new non-invasive risk score for predicting incident diabetes in a rural Chinese population. Methods Data from the Handan Eye Study conducted from 2006-2013 were utilized as part of this analysis. The present study utilized data generated from 4132 participants who were >= 30 years of age. A non-invasive risk model was derived using two-thirds of the sample cohort (selected randomly) using stepwise logistic regression. The model was subsequently validated using data from individuals from the final third of the sample cohort. In addition, a simple point system for incident diabetes was generated according to the procedures described in the Framingham Study. Incident diabetes was defined as follows: (1) fasting plasma glucose (FPG) >= 7.0 mmol/L; or (2) hemoglobin A1c (HbA1c) >= 6.5%; or (3) self-reported diagnosis of diabetes or use of anti-diabetic medications during the follow-up period. Results The simple non-invasive riskscore included age (8 points), Body mass index (BMI) (3 points), waist circumference (WC) (7 points), and family history of diabetes (9 points). The score ranged from 0 to 27 and the area under the receiver operating curve (AUC) of the score was 0.686 in the validation sample. At the optimal cutoff value (which was 9), the sensitivity and specificity were 74.32% and 58.82%, respectively. Conclusions Using information based upon age, BMI, WC, and family history of diabetes, we developed a simple new non-invasive risk score for predicting diabetes onset in a rural Chinese population using information from individuals aged 30 years of age and older. The new risk score proved to be more optimal in the prediction of incident diabetes than most of the existing risk scores developed in Western and Asian countries. This score system will aid in the identification of individuals who are at risk of developing incident diabetes in rural China.	[Wen, Jiangping; Lu, Xinxin] Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, Beijing, Peoples R China; [Hao, Jie; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Liang, Yuanbo] Wenzhou Med Univ, Affiliated Eye Hosp, Clin & Epidemiol Res Ctr, Wenzhou, Peoples R China; [Li, Sizhen] Nanjing Aier Eye Hosp, Nanjing, Jiangsu, Peoples R China; [Cao, Kai] Beijing Inst Ophthalmol, Beijing, Peoples R China; [Lu, Xilin] Handan 3rd Hosp, Dept Lab Med, Handan, Peoples R China	Capital Medical University; Capital Medical University; Wenzhou Medical University	Lu, XX (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, Beijing, Peoples R China.; Wang, NL (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China.	luxinxin2009@126.com; wningli@vip.163.com			National Basic Research Program of China (973 Program); Ministry of Science and Technology of China [2007CB512201]; Foundation of Beijing Tongren Hospital	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Foundation of Beijing Tongren Hospital	This study was financially supported by the National Basic Research Program of China (973 Program), the Ministry of Science and Technology of China (Grant 2007CB512201). Additional support was provided by the Foundation of Beijing Tongren Hospital (Grant 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Gao WG, 2010, DIABETIC MED, V27, P274, DOI 10.1111/j.1464-5491.2010.02943.x; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Glumer C, 2006, DIABETES CARE, V29, P410, DOI 10.2337/diacare.29.02.06.dc05-0945; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Heianza Y, 2012, DIABETOLOGIA, V55, P3213, DOI 10.1007/s00125-012-2712-0; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, pb880, DOI DOI 10.1136/bmj.b880; Kengne AP, 2014, LANCET DIABETES ENDO, V2, P19, DOI 10.1016/S2213-8587(13)70103-7; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Liang YB, 2009, OPHTHAL EPIDEMIOL, V16, P115, DOI 10.1080/09286580902738159; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zhou MG, 2015, DIABETES CARE, V38, P72, DOI 10.2337/dc14-1100; Zhou XH, 2013, DIABETES CARE, V36, P3944, DOI 10.2337/dc13-0593	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186172	10.1371/journal.pone.0186172	http://dx.doi.org/10.1371/journal.pone.0186172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095851	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200014
J	Suparmin, A; Kato, T; Dohra, H; Park, EY				Suparmin, Ahmad; Kato, Tatsuya; Dohra, Hideo; Park, Enoch Y.			Insight into cordycepin biosynthesis of Cordyceps militaris: Comparison between a liquid surface culture and a submerged culture through transcriptomic analysis	PLOS ONE			English	Article							RNA-SEQ; OPTIMIZATION; CULTIVATION; GENOME; HYPERPRODUCTION; BIOCONDUCTOR; EXTRACTION; GENES; TOOL	Cordyceps militaris produces cordycepin, which is known to be a bioactive compound. Currently, cordycepin hyperproduction of C. militaris was carried out in a liquid surface culture because of its low productivity in a submerged culture, however the reason was not known. In this study, 4.92 g/L of cordycepin was produced at the 15th day of C. militaris NBRC 103752 liquid surface culture, but only 1 mg/L was produced in the submerged culture. RNA-Seq was used to clarify the gene expression profiles of the cordycepin biosynthetic pathways of the submerged culture and the liquid surface culture. From this analysis, 1036 genes were shown to be upregulated and 557 genes were downregulated in the liquid surface culture compared with the submerged culture. Specifically, adenylosuccinate synthetase and phosphoribosylaminoimidazole-succinocarboxamide (SAICAR) synthase in purine nucleotide metabolism were significantly upregulated in the liquid surface culture. Thick mycelia formation in the liquid surface culture was found to induce the expression of hypoxia-related genes (GABA shunt, glutamate synthetase precursor, and succinate-semialdehyde dehydrogenase). Cytochrome P450 oxidoreductases containing heme were also found to be significantly enriched, suggesting that a hypoxic condition might be created in the liquid surface culture. These results suggest that hypoxic conditions are more suitable for cordycepin production in the liquid surface culture compared with the submerged culture. Our analysis paves the way for unraveling the cordycepin biosynthesis pathway and for improving cordycepin production in C. militaris.	[Suparmin, Ahmad; Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Grad Sch Integrated Sci & Technol, Dept Agr, Lab Biotechnol,Suruga Ku, Shizuoka, Japan; [Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Green Chem Res Div, Lab Biotechnol,Suruga Ku, Shizuoka, Japan; [Dohra, Hideo] Shizuoka Univ, Res Inst Green Sci & Technol, Instrumental Res Support Off, Suruga Ku, Shizuoka, Japan	Shizuoka University; Shizuoka University; Shizuoka University	Park, EY (corresponding author), Shizuoka Univ, Grad Sch Integrated Sci & Technol, Dept Agr, Lab Biotechnol,Suruga Ku, Shizuoka, Japan.; Park, EY (corresponding author), Shizuoka Univ, Res Inst Green Sci & Technol, Green Chem Res Div, Lab Biotechnol,Suruga Ku, Shizuoka, Japan.	park.enoch@shizuoka.ac.jp	Ahmad, Suparmin/GPC-4767-2022; Ahmad, Suparmin/AGM-3074-2022; Kato, Tatsuya/E-3095-2010; Park, Enoch/AAU-2614-2020	Ahmad, Suparmin/0000-0003-1188-5900; Kato, Tatsuya/0000-0001-7990-2557; Dohra, Hideo/0000-0002-3919-3538; Park, Enoch Y./0000-0002-7840-1424				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chung D, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00381; Das SK, 2008, LETT APPL MICROBIOL, V47, P534, DOI 10.1111/j.1472-765X.2008.02456.x; Fan DD, 2012, BIOCHEM ENG J, V60, P30, DOI 10.1016/j.bej.2011.09.014; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00028; Hillmann F, 2015, CURR GENET, V61, P441, DOI 10.1007/s00294-015-0487-9; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; KREDICH NM, 1961, BIOCHIM BIOPHYS ACTA, V47, P529, DOI 10.1016/0006-3002(61)90546-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leung PH, 2007, J APPL MICROBIOL, V103, P1942, DOI 10.1111/j.1365-2672.2007.03451.x; Llanos A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1224-y; Loraine AE, 2015, METHODS MOL BIOL, V1284, P481, DOI 10.1007/978-1-4939-2444-8_24; Mao XB, 2006, ENZYME MICROB TECH, V38, P343, DOI 10.1016/j.enzmictec.2004.10.010; Mao XB, 2005, PROCESS BIOCHEM, V40, P1667, DOI 10.1016/j.procbio.2004.06.046; Mao XB, 2004, BIOTECHNOL PROGR, V20, P1408, DOI 10.1021/bp049765r; Masuda M, 2006, ENZYME MICROB TECH, V39, P641, DOI 10.1016/j.enzmictec.2005.11.010; Masuda M, 2014, PROCESS BIOCHEM, V49, P181, DOI 10.1016/j.procbio.2013.10.017; Ni H, 2009, J CHROMATOGR B, V877, P2135, DOI 10.1016/j.jchromb.2009.06.009; Park JP, 2001, LETT APPL MICROBIOL, V33, P76, DOI 10.1046/j.1472-765X.2001.00950.x; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sari N, 2016, BIOTECHNOL BIOPROC E, V21, P595, DOI 10.1007/s12257-016-0405-0; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Song JF, 2007, J CHEM TECHNOL BIOT, V82, P1122, DOI 10.1002/jctb.1784; Takaya N, 2009, BIOSCI BIOTECH BIOCH, V73, P1, DOI 10.1271/bbb.80487; Tang YJ, 2003, BIOTECHNOL PROGR, V19, P1842, DOI 10.1021/bp0341592; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yang T, 2016, APPL MICROBIOL BIOT, V100, P743, DOI 10.1007/s00253-015-7047-6; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	41	15	23	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187052	10.1371/journal.pone.0187052	http://dx.doi.org/10.1371/journal.pone.0187052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091925	gold, Green Submitted, Green Published			2022-12-27	WOS:000414229700041
J	Espelt, A; Bosque-Prous, M; Folch, C; Sarasa-Renedo, A; Majo, X; Casabona, J; Brugal, MT				Espelt, Albert; Bosque-Prous, Marina; Folch, Cinta; Sarasa-Renedo, Ana; Majo, Xavier; Casabona, Jordi; Teresa Brugal, M.		REDAN Grp	Is systematic training in opioid overdose prevention effective?	PLOS ONE			English	Article							TAKE-HOME NALOXONE; NONFATAL HEROIN OVERDOSE; INJECTION-DRUG USERS; OPIATE USERS; RISK-FACTORS; KNOWLEDGE; PROGRAMS; DEATH; METAANALYSIS; REGRESSION	The objectives were to analyze the knowledge about overdose prevention, the use of naloxone, and the number of fatal overdoses after the implementation of Systematic Training in Overdose Prevention (STOOP) program. We conducted a quasi-experimental study, and held face-to-face interviews before (n = 725) and after (n = 722) implementation of systematic training in two different samples of people who injected opioids attending harm reduction centers. We asked participants to list the main causes of overdose and the main actions that should be taken when witnessing an overdose. We created two dependent variables, the number of (a) correct and (b) incorrect answers. The main independent variable was Study Group: Intervention Group (IG), Comparison Group (CG), Pre-Intervention Group With Sporadic Training in Overdose Prevention (PREIGS), or Pre-Intervention Group Without Training in Overdose Prevention (PREIGW). The relationship between the dependent and independent variables was assessed using a multivariate Poisson regression analysis. Finally, we conducted an interrupted time series analysis of monthly fatal overdoses before and after the implementation of systematic program during the period 2006 +/- 2015. Knowledge of overdose prevention increased after implementing systematic training program. Compared to the PREIGW, the IG gave more correct answers (IRR = 1.40; 95% CI: 1.33-1.47), and fewer incorrect answers (IRR = 0.33; 95% CI: 0.25-0.44). Forty percent of people who injected opioids who received a naloxone kit had used the kit in response to an overdose they witnessed. These courses increase knowledge of overdose prevention in people who use opioids, give them the necessary skills to use naloxone, and slightly diminish the number of fatal opioid overdoses in the city of Barcelona.	[Espelt, Albert; Bosque-Prous, Marina; Sarasa-Renedo, Ana; Teresa Brugal, M.] Agencia Salut Publ Barcelona, Barcelona, Spain; [Espelt, Albert] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Calle Melchor Fernandez Almagro, Madrid, Spain; [Espelt, Albert] UVicUCC, Fac Ciencies Salut Manresa, Ave Univ, Manresa, Spain; [Espelt, Albert] Univ Autonoma Barcelona, Dept Psicobiol Metodol Ciencies Salut, Campus UAB, Bellaterra, Spain; [Folch, Cinta] Generalitat Catalunya, Ctr Estudis Epidemiol Infecc Transmissio Sexual &, ASPC, Carretera Canyet S-N, Badalona, Spain; [Sarasa-Renedo, Ana] Inst Salud Carlos III, PEAC, Calle Sinesio Delgado, Madrid, Spain; [Majo, Xavier; Casabona, Jordi] Generalitat Catalunya, Dept Salut, Subdireccio Gen Drogodependencies, Carrer Roc Boronat, Barcelona, Spain	Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Autonomous University of Barcelona; Instituto de Salud Carlos III	Espelt, A (corresponding author), Agencia Salut Publ Barcelona, Barcelona, Spain.; Espelt, A (corresponding author), Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Calle Melchor Fernandez Almagro, Madrid, Spain.; Espelt, A (corresponding author), UVicUCC, Fac Ciencies Salut Manresa, Ave Univ, Manresa, Spain.; Espelt, A (corresponding author), Univ Autonoma Barcelona, Dept Psicobiol Metodol Ciencies Salut, Campus UAB, Bellaterra, Spain.	aespelt@umanresa.cat	Brugal, M. Teresa/K-5190-2012; Bosque-Prous, Marina/AAE-1562-2020; Espelt, Albert/G-2281-2014	Brugal, M. Teresa/0000-0003-0580-676X; Bosque-Prous, Marina/0000-0002-8830-8880; Folch, Cinta/0000-0001-8400-2668; Espelt, Albert/0000-0002-8625-4356; Colom Farran, Joan/0000-0001-6861-7865	Spanish Network on Addictive Disorders [RD06/0001/1018, RD12/0028/0018]	Spanish Network on Addictive Disorders	This work was supported by the Spanish Network on Addictive Disorders [grant numbers RD06/0001/1018, and RD12/0028/0018] (http:// www.eng.isciii.es/ISCIII/es/cortenidos/fd-investigacion/fd-ejecucion/fd-centros-participados/centros-participados-redes-retics.shmtl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas-Ibar E, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-33; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Binswanger IA, 2016, ADDICTION, V111, P499, DOI 10.1111/add.13200; Bird SM, 2016, ADDICTION, V111, P883, DOI 10.1111/add.13265; Brugal MT, 2002, ADDICTION, V97, P319, DOI 10.1046/j.1360-0443.2002.00058.x; CEESCAT. SIVES, 2012, SIVES 2012 INT SURV; Clark AK, 2014, J ADDICT MED, V8, P153, DOI 10.1097/ADM.0000000000000034; Darke S, 1996, ADDICTION, V91, P413, DOI 10.1046/j.1360-0443.1996.91341310.x; Darke S, 2003, ADDICTION, V98, P1169, DOI 10.1046/j.1360-0443.2003.00474.x; de la Fuente de Hoz Luis, 2005, Rev Esp Salud Publica, V79, P475, DOI 10.1590/S1135-57272005000400005; EMCDDA, 2013, PREV OV DEATHS EUR; EMCDDA, 2016, 2016 ANN REP STAT DR; Espelt A, NALOXON UBERLEBENSHI; Espelt A, 2015, EUR ADDICT RES, V21, P300, DOI 10.1159/000377626; Frisher M., 2012, PREVENTING OPIOID OV; Galea S, 2006, ADDICT BEHAV, V31, P907, DOI 10.1016/j.addbeh.2005.07.020; Gaston RL, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-26; Gossop M, 1996, BRIT MED J, V313, P402; Green TC, 2008, ADDICTION, V103, P979, DOI 10.1111/j.1360-0443.2008.02182.x; Hilbe J.M., 2014, MODELING COUNT DATA; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Lopez Ma Jose, 2011, Gac Sanit, V25 Suppl 1, P9, DOI 10.1016/S0213-9111(11)70003-6; Majo A X, 2009, ADRECAT GEN CATALUNY; Maldjian L, 2016, SUBST ABUS, V37, P459, DOI 10.1080/08897077.2015.1135850; McAuley A, 2015, INT J DRUG POLICY, V26, P1183, DOI 10.1016/j.drugpo.2015.09.011; McDonald R, 2016, ADDICTION, V111, P1177, DOI 10.1111/add.13326; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Neale J, 2003, ADDICTION, V98, P1171, DOI 10.1046/j.1360-0443.2003.00476.x; Neira-Leon M, 2006, J URBAN HEALTH, V83, P477, DOI 10.1007/s11524-006-9054-5; Neira-Leon M, 2011, INT J DRUG POLICY, V22, P16, DOI 10.1016/j.drugpo.2010.06.003; Rossi C., 1999, INT J DRUG POLICY, V10, P131; Sarasa-Renedo A, 2014, GAC SANIT, V28, P146, DOI 10.1016/j.gaceta.2013.10.012; Seal KH, 2005, J URBAN HEALTH, V82, P303, DOI 10.1093/jurban/jti053; Sherman SG, 2009, INT J DRUG POLICY, V20, P137, DOI 10.1016/j.drugpo.2008.02.004; Strang J, 2008, ADDICTION, V103, P1648, DOI 10.1111/j.1360-0443.2008.02314.x; Strang J, 2015, ADDICTION, V110, P27, DOI 10.1111/add.12904; Tobin KE, 2009, INT J DRUG POLICY, V20, P131, DOI 10.1016/j.drugpo.2008.03.002; Wagner KD, 2010, INT J DRUG POLICY, V21, P186, DOI 10.1016/j.drugpo.2009.01.003; Walley AY, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f174; Warner-Smith M, 2001, ADDICTION, V96, P1113, DOI 10.1046/j.1360-0443.2001.96811135.x; WHO, 1994, MULT STUD INJ RISK H; Williams AV, 2013, DRUG ALCOHOL DEPEN, V132, P383, DOI 10.1016/j.drugalcdep.2013.02.007	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186833	10.1371/journal.pone.0186833	http://dx.doi.org/10.1371/journal.pone.0186833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088247	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900024
J	Hasegawa, D; Ochiai-Shino, H; Onodera, S; Nakamura, T; Saito, A; Onda, T; Watanabe, K; Nishimura, K; Ohtaka, M; Nakanishi, M; Kosaki, K; Yamaguchi, A; Shibahara, T; Azuma, T				Hasegawa, Daigo; Ochiai-Shino, Hiromi; Onodera, Shoko; Nakamura, Takashi; Saito, Akiko; Onda, Takeshi; Watanabe, Katsuhito; Nishimura, Ken; Ohtaka, Manami; Nakanishi, Mahito; Kosaki, Kenjiro; Yamaguchi, Akira; Shibahara, Takahiko; Azuma, Toshifumi			Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction	PLOS ONE			English	Article							CARCINOMA SYNDROME; SIGNALING PATHWAY; HUMAN FIBROBLASTS; SONIC HEDGEHOG; NEVUS SYNDROME; MUTATIONS; DISEASE; FAMILY; BETA; RHABDOMYOSARCOMA	Gorlin syndrome is an autosomal dominant inherited syndrome that predisposes a patient to the formation of basal cell carcinomas, odontogenic keratocysts, and skeletal anomalies. Causative mutations in several genes associated with the sonic hedgehog (SHH) signaling pathway, including PTCH1, have been identified in Gorlin syndrome patients. However, no definitive genotype-phenotype correlations are evident in these patients, and their clinical presentation varies greatly, often leading to delayed diagnosis and treatment. We generated iPSCs from four unrelated Gorlin syndrome patients with loss-of-function mutations in PTCH1 using the Sendai virus vector (SeVdp(KOSM) 302). The patient-derived iPSCs exhibited basic iPSC features, including stem cell marker expression, totipotency, and the ability to form teratomas. GLI1 expression levels were greater in fibroblasts and patient-derived iPSCs than in the corresponding control cells. Patient-derived iPSCs expressed lower basal levels than control iPSCs of the genes encoding the Hh ligands Indian Hedgehog (IHH) and SHH, the Hh acetyltransferase HHAT, Wnt proteins, BMP4, and BMP6. Most of these genes were upregulated in patient-derived iPSCs grown in osteoblast differentiation medium (OBM) and downregulated in control iPSCs cultured in OBM. The expression of GLI1 and GLI2 substantially decreased in both control and patient-derived iPSCs cultured in OBM, whereas GLI3, SHH, and IHH were upregulated in patient-derived iPSCs and downregulated in control iPSCs grown in OBM. Activation of Smoothened by SAG in cells grown in OBM significantly enhanced alkaline phosphatase activity in patient-derived iPSCs compared with control iPSC lines. In summary, patient-derived iPSCs expressed lower basal levels than the control iPSCs of the genes encoding Hh, Wnt, and bone morphogenetic proteins, but their expression of these genes strongly increased under osteogenic conditions. These findings indicate that patient-derived iPSCs are hypersensitive to osteogenic induction. We propose that Hh signaling is constituently active in iPSCs from Gorlin syndrome patients, enhancing their response to osteogenic induction and contributing to disease-associated abnormalities.	[Hasegawa, Daigo; Watanabe, Katsuhito; Shibahara, Takahiko] Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Ochiai-Shino, Hiromi; Onodera, Shoko; Nakamura, Takashi; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo, Japan; [Nishimura, Ken] Univ Tsukuba, Fac Med, Lab Gene Regulat, Ibaraki, Japan; [Ohtaka, Manami; Nakanishi, Mahito] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan; [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo, Japan; [Yamaguchi, Akira; Azuma, Toshifumi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); Keio University; Tokyo Dental College	Azuma, T (corresponding author), Tokyo Dent Coll, Dept Biochem, Tokyo, Japan.; Azuma, T (corresponding author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan.	tazuma@tdc.ac.jp	Onda, Takeshi/V-7114-2019; Nakanishi, Mahito/I-9888-2018; Nishimura, KEN/HGC-6147-2022; Yamaguchi, Akira/AAX-9286-2020	Nakanishi, Mahito/0000-0002-7068-7587; Onda, Takeshi/0000-0003-4722-1954; Onodera, Shoko/0000-0003-0673-3400; Nakamura, Takashi/0000-0002-6124-061X	Japan Society for the Promotion of Science (JSPS), KAKENHI [25462900]; JSPS KAKENHI [25462900, 25861761, 26861686, 26861560, 15K20379, 16K20427, 16K20428]	Japan Society for the Promotion of Science (JSPS), KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/e-grants/index.html), KAKENHI (C) (Grant number 25462900(T.A)) and by JSPS KAKENHI for young scientists (B) (Grant numbers 25861761(H.S), 26861686(S.O), 26861560(A.S), 15K20379(H.S), 16K20427(S.O), and 16K20428(A.S)), http://www.jsps.go.jp/english/e-grants/index.html.; This work was supported by JSPS KAKENHI (C) (Grant number 25462900) and by JSPS KAKENHI for young scientists (B) (Grant numbers 25861761, 26861686, 26861560, 15K20379, 16K20427, and 16K20428). The authors would like to thank Ajinomoto Co Ltd for the technical advices. The authors would like to thank Enago (www.enago.jp) for the English language review.	Alman BA, 2015, NAT REV RHEUMATOL, V11, P552, DOI 10.1038/nrrheum.2015.84; Athar M, 2014, CANCER RES, V74, P4967, DOI 10.1158/0008-5472.CAN-14-1666; Bale AE, 1997, AM J HUM GENET, V60, P10; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Brellier F, 2008, BRIT J DERMATOL, V159, P445, DOI 10.1111/j.1365-2133.2008.08650.x; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Fan Z, 2008, J MED GENET, V45, P303, DOI 10.1136/jmg.2007.055343; Fujii K, 2014, PEDIATR INT, V56, P667, DOI 10.1111/ped.12461; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kato H, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140201; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Konitsiotis AD, 2015, J BIOL CHEM, V290, P3293, DOI 10.1074/jbc.M114.614578; Kurosaka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120821; Li TJ, 2011, J DENT RES, V90, P133, DOI 10.1177/0022034510379016; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Matevossian A, 2015, J BIOL CHEM, V290, P2235, DOI 10.1074/jbc.M114.625764; Matsumoto Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-190; Mizuochi H, 2015, BIOCHEM BIOPH RES CO, V457, P318, DOI 10.1016/j.bbrc.2014.12.108; Naujok O, 2014, STEM CELL REV REP, V10, P480, DOI 10.1007/s12015-014-9509-0; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Ochiai-Shino H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099534; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042855; Onodera S, UNPUB; Pandolfi S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.3; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pastorino L, 2009, AM J MED GENET A, V149A, P1539, DOI 10.1002/ajmg.a.32944; Petrova E, 2015, ONCOGENE, V34, P263, DOI 10.1038/onc.2013.575; Pressey JG, 2011, PEDIATR BLOOD CANCER, V57, P930, DOI 10.1002/pbc.23174; Qualtrough D, 2004, INT J CANCER, V110, P831, DOI 10.1002/ijc.20227; Qualtrough D, 2015, CANCERS, V7, P1885, DOI 10.3390/cancers7030867; Rajurkar M, 2014, ONCOGENE, V33, P5370, DOI 10.1038/onc.2013.480; Shimizu T., 2016, Reproductive Medicine and Biology, V15, P35, DOI 10.1007/s12522-015-0213-9; So PL, 2008, MOL CANCER THER, V7, P1275, DOI 10.1158/1535-7163.MCT-07-2043; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wicking C, 1997, AM J HUM GENET, V60, P21; Wicking Carol, 1997, Current Opinion in Pediatrics, V9, P630, DOI 10.1097/00008480-199712000-00013; Xie JW, 2013, ONCOTARGETS THER, V6, P1425, DOI 10.2147/OTT.S34678; Yang J, 2015, INT J ORAL SCI, V7, P73, DOI 10.1038/ijos.2015.14; Zheng X, 2013, ONCOL REP, V30, P2020, DOI 10.3892/or.2013.2690	48	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186879	10.1371/journal.pone.0186879	http://dx.doi.org/10.1371/journal.pone.0186879			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088246	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900028
J	Liu, ZH; Foo, DCC; Law, WL; Chan, FSY; Fan, JKM; Peng, JS				Liu, Zhong Hui; Foo, Dominic Chi Chung; Law, Wai Lun; Chan, Fion Siu Yin; Fan, Joe King Man; Peng, Jun Sheng			Melanosis coli: Harmless pigmentation? A case-control retrospective study of 657 cases	PLOS ONE			English	Article							BOWEL MOVEMENT FREQUENCY; LAXATIVE USE; COLORECTAL-CANCER; APOPTOSIS; RISK; TOXICITY; ADENOMA; CELLS; WOMEN	Backgrounds and aims The association of melanosis coli with the development of colorectal polyps remains uncertain. Methods From a total of 18263 patients who had received colonoscopy in our hospital, 219 with melanosis coli cases and 438 controls matched by age and sex (at 1:2 ratio) were included in this study. The association of incidence, number, location, and pathology of colorectal neoplasm with grades and distribution of melanosis coli were analyzed. Results Melanosis coli was associated with significantly more colorectal polyps than control, a higher incidence of numerous colorectal polyps (number >= 20) (7.3% vs 0.5%; p < 0.001), and higher number of small colorectal polyps (diameter <= 5 mm; p < 0.01). Patients with melanosis coli had higher incidences of low-grade adenomas (31.1% vs 23.3%, p < 0.05) and non-adenoma polyps (20.1% vs 12.8%, p < 0.05) than the controls. On multivariate analysis, melanosis coli was independently associated with increased detecting rates of low grade adenoma (OR = 1.54; 95%: 1.06-2.23; p < .05), non-adenoma polyp (OR = 1.72; 95%: 1.11-2.70; p < .05) and numerous polyps (OR = 16.2, 95%: 3.66-71.6; p < .05). There was no significant difference in the incidence of high-grade adenomas or adenocarcinomas in the two population groups, but the numbers of these lesions were insufficient to permit firm conclusions. No significant differences in incidence, number, and pathology of colorectal polyps between individuals with melanosis coli of three different grades of severity were found. Melanosis located predominantly in the right colon had an interestingly lower incidence of colonic polyps in right colon than did melanosis located predominantly in the left colon or total colon (8.9% vs. 26.3%, 24.0%, p < 0.05). Patients with melanosis coli had significantly more nonspecific distal ileal ulcers than did controls (8.0% vs 0%, p < 0.001). Conclusion Melanosis coli is associated with a higher incidence and number of colonic non-adenoma polyps and low-grade adenomas, and higher incidence of distal ileal ulcers. Melanosis coli may not be a harmless pigmentation, but a sign of chronic injury of colonic and intestinal mucosa.	[Liu, Zhong Hui; Peng, Jun Sheng] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Surg, Guangzhou, Guangdong, Peoples R China; [Foo, Dominic Chi Chung; Law, Wai Lun; Chan, Fion Siu Yin; Fan, Joe King Man] Univ Hong Kong, Shenzhen Hosp, Dept Surg, Shenzhen, Guangdong, Peoples R China; [Foo, Dominic Chi Chung; Law, Wai Lun; Chan, Fion Siu Yin; Fan, Joe King Man] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; University of Hong Kong; University of Hong Kong	Peng, JS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Surg, Guangzhou, Guangdong, Peoples R China.; Fan, JKM (corresponding author), Univ Hong Kong, Shenzhen Hosp, Dept Surg, Shenzhen, Guangdong, Peoples R China.; Fan, JKM (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	drjoefan@hku.hk; pengsir1010@126.com	Foo, Chi Chung/S-1508-2018; Liu, Zhong-Hui/AAF-5991-2020	Foo, Chi Chung/0000-0001-8849-6597; Liu, Zhong Hui/0000-0002-8604-4818				Blackett JW, 2016, J CLIN GASTROENTEROL; Bockus HL, 1933, J AMER MED ASSOC, V101, P1; Byers RJ, 1997, HISTOPATHOLOGY, V30, P160, DOI 10.1046/j.1365-2559.1997.d01-574.x; Citronberg J, 2014, AM J GASTROENTEROL, V109, P1640, DOI 10.1038/ajg.2014.233; Cruveilheir J, 1835, ANATOMIE PATHOLOGIQU, P1829; Dukas L, 2000, AM J EPIDEMIOL, V151, P958, DOI 10.1093/oxfordjournals.aje.a010139; GHADIALLY FN, 1966, J PATHOL BACTERIOL, V92, P313, DOI 10.1002/path.1700920207; Hung CY, 2012, GASTROENTEROLOGY, V142, pE10, DOI 10.1053/j.gastro.2011.07.032; Kang HW, 2010, AM J GASTROENTEROL, V105, P178, DOI 10.1038/ajg.2009.541; KOSKELA E, 1989, DIS COLON RECTUM, V32, P235, DOI 10.1007/BF02554536; LEE FD, 1993, J CLIN PATHOL, V46, P118, DOI 10.1136/jcp.46.2.118; Ma JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065032; MARSHALL JB, 1995, AM J GASTROENTEROL, V90, P372; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Nusko G, 1997, Z GASTROENTEROL, V35, P313; Nusko G, 2000, GUT, V46, P651, DOI 10.1136/gut.46.5.651; Roberts-Thompson IC, 1999, J GASTROEN HEPATOL, V14, P1047; SENDELBACH LE, 1989, TOXICOLOGY, V57, P227, DOI 10.1016/0300-483X(89)90113-3; SHARP JR, 1980, GASTROENTEROLOGY, V78, P366; STEER HW, 1975, J PATHOL, V115, P199, DOI 10.1002/path.1711150403; van Gorkom BAP, 2001, J PATHOL, V194, P493, DOI 10.1002/path.914; Virchow R., 1847, ARCH PATH ANAT, V1, P379; WALKER NI, 1988, AM J PATHOL, V131, P465; WALKER NI, 1993, PATHOLOGY, V25, P120, DOI 10.3109/00313029309084783; Wang ZC, 2013, J DIGEST DIS, V14, P417, DOI 10.1111/1751-2980.12060; Yoshimoto AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045332; Zhang L., 2015, CHIN J GASTROENTEROL, V24, P257; Zhang XH, 2013, CANCER CAUSE CONTROL, V24, P1015, DOI 10.1007/s10552-013-0176-2; Zhu JK, 2016, ONCOL RES, V24, P137, DOI 10.3727/096504016X14611963142218	29	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186668	10.1371/journal.pone.0186668	http://dx.doi.org/10.1371/journal.pone.0186668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088250	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900020
J	Murray, T; Zeil, J				Murray, Trevor; Zeil, Jochen			Quantifying navigational information: The catchment volumes of panoramic snapshots in outdoor scenes	PLOS ONE			English	Article							INSECT NAVIGATION; DESERT ANTS; LANDMARK NAVIGATION; EXPERIMENTAL ARENAS; LEARNING-WALKS; VIEW; CONTRAST; MEMORY; ROUTES	Panoramic views of natural environments provide visually navigating animals with two kinds of information: they define locations because image differences increase smoothly with distance from a reference location and they provide compass information, because image differences increase smoothly with rotation away from a reference orientation. The range over which a given reference image can provide navigational guidance (its 'catchment area') has to date been quantified from the perspective of walking animals by determining how image differences develop across the ground plane of natural habitats. However, to understand the information available to flying animals there is a need to characterize the 'catchment volumes' within which panoramic snapshots can provide navigational guidance. We used recently developed camera-based methods for constructing 3D models of natural environments and rendered panoramic views at defined locations within these models with the aim of mapping navigational information in three dimensions. We find that in relatively open woodland habitats, catchment volumes are surprisingly large extending for metres depending on the sensitivity of the viewer to image differences. The size and the shape of catchment volumes depend on the distance of visual features in the environment. Catchment volumes are smaller for reference images close to the ground and become larger for reference images at some distance from the ground and in more open environments. Interestingly, catchment volumes become smaller when only above horizon views are used and also when views include a 1 km distant panorama. We discuss the current limitations of mapping navigational information in natural environments and the relevance of our findings for our understanding of visual navigation in animals and autonomous robots.	[Murray, Trevor; Zeil, Jochen] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Murray, T (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	trevor.murray@anu.edu.au			Australian Research Council [DP150101172, DP150102699]	Australian Research Council(Australian Research Council)	The work was supported by Australian Research Council Discovery Project Grants DP150101172 and DP150102699 to Jochen Zeil.	Baddeley B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002336; Baddeley B, 2011, ADAPT BEHAV, V19, P3, DOI 10.1177/1059712310395410; BECKER L, 1958, Z VERGL PHYSIOL, V41, P1; Cheung A, 2008, J EXP PSYCHOL ANIM B, V34, P15, DOI 10.1037/0097-7403.34.1.15; Collett M, 2013, CURR BIOL, V23, pR789, DOI 10.1016/j.cub.2013.07.020; d'Angelo P., 2010, HUGIN PANORAMA PHOTO; Degen J, 2016, CURR BIOL, V26, P2800, DOI 10.1016/j.cub.2016.08.013; Dewar ADM, 2015, BIOSYSTEMS; Dewar ADM, 2014, ADAPT BEHAV, V22, P163, DOI 10.1177/1059712313516132; Fleischmann PN, 2017, J EXP BIOL, V220, P2426, DOI 10.1242/jeb.158147; Fleischmann PN, 2016, J EXP BIOL, V219, P3137, DOI 10.1242/jeb.140459; Gaffin DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122077; Graham P, 2010, CURR BIOL, V20, pR639, DOI 10.1016/j.cub.2010.06.018; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Graham P, 2009, J COMP PHYSIOL A, V195, P681, DOI 10.1007/s00359-009-0443-6; Kollmeier T, 2007, J OPT SOC AM A, V24, P1, DOI 10.1364/JOSAA.24.000001; Mangan M, 2012, BEHAV ECOL, V23, P944, DOI 10.1093/beheco/ars051; Mangan M, 2009, BIOL CYBERN, V101, P307, DOI 10.1007/s00422-009-0338-1; Menzel R, 2015, J COMP PHYSIOL A, V201, P547, DOI 10.1007/s00359-015-0987-6; Moller R, 2002, J THEOR BIOL, V214, P619, DOI 10.1006/jtbi.2001.2484; Muller M, 2010, CURR BIOL, V20, P1368, DOI 10.1016/j.cub.2010.06.035; Narendra A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0683; Philippides A, 2016, C BIOM BIOH SYST, P263; Philippides A, 2011, J EXP BIOL, V214, P445, DOI 10.1242/jeb.046755; Stone T., 2014, ROBOT SCI SYST, V10, P47; Sturzl W, 2008, J EXP PSYCHOL ANIM B, V34, P1, DOI 10.1037/0097-7403.34.1.1; Sturzl W, 2007, BIOL CYBERN, V96, P519, DOI 10.1007/s00422-007-0147-3; Sturzl W, 2016, CURR BIOL, V26, P470, DOI 10.1016/j.cub.2015.12.052; Sturzl W, 2015, J COMP PHYSIOL A, V201, P563, DOI 10.1007/s00359-015-1002-y; Towne WF, 2017, J EXP BIOL; Webb B, 2016, CURR OPIN INSECT SCI, V15, P27, DOI 10.1016/j.cois.2016.02.011; Wystrach A, 2016, J COMP PHYSIOL A, V202, P87, DOI 10.1007/s00359-015-1052-1; Wystrach A, 2012, J EXP BIOL, V215, P44, DOI 10.1242/jeb.059584; Zahedi M, FRACTAL DIMENS UNPUB; Zeil J, 2003, J OPT SOC AM A, V20, P450, DOI 10.1364/JOSAA.20.000450; Zeil J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0034; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008	37	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187226	10.1371/journal.pone.0187226	http://dx.doi.org/10.1371/journal.pone.0187226			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088300	gold, Green Submitted, Green Published			2022-12-27	WOS:000414088900051
J	Sikdar, S; Datta, S; Datta, S				Sikdar, Sinjini; Datta, Somnath; Datta, Susmita			EAMA: Empirically adjusted meta-analysis for large-scale simultaneous hypothesis testing in genomic experiments	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; FALSE DISCOVERY RATE; GENE-EXPRESSION; CLASSIFICATION; ASSOCIATION	Recent developments in high throughput genomic assays have opened up the possibility of testing hundreds and thousands of genes simultaneously. However, adhering to the regular statistical assumptions regarding the null distributions of test statistics in such large-scale multiple testing frameworks has the potential of leading to incorrect significance testing results and biased inference. This problem gets worse when one combines results from different independent genomic experiments with a possibility of ending up with gross false discoveries of significant genes. In this article, we develop a meta-analysis method of combining p-values from different independent experiments involving large-scale multiple testing frameworks, through empirical adjustments of the individual test statistics and p-values. Even though, it is based on various existing ideas, this specific combination is novel and potentially useful. Through simulation studies and real genomic datasets we show that our method outperforms the standard meta-analysis approach of significance testing in terms of accurately identifying the truly significant set of genes.	[Sikdar, Sinjini; Datta, Somnath; Datta, Susmita] Univ Florida, Dept Biostat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Datta, S (corresponding author), Univ Florida, Dept Biostat, Gainesville, FL 32611 USA.	susmita.datta@ufl.edu			NIH [CA 170091-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the research funding from the NIH grant CA 170091-01A1 to Susmita Datta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 1932, STAT METHODS RES WOR; Benidt S, 2015, BIOINFORMATICS, V31, P2131, DOI 10.1093/bioinformatics/btv124; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B., 2015, LOCFDR VIGNETTE COMP; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughey JJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv229; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rousseaux S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005723; Staaf J, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-22; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Tarca AL, 2013, BIOINFORMATICS, V29, P2892, DOI 10.1093/bioinformatics/btt492; Wang XB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-52; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187287	10.1371/journal.pone.0187287	http://dx.doi.org/10.1371/journal.pone.0187287			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088275	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900059
J	Chkhartishvili, N; Chokoshvili, O; Bolokadze, N; Tsintsadze, M; Sharvadze, L; Gabunia, P; Dvali, N; Abutidze, A; Tsertsvadze, T				Chkhartishvili, Nikoloz; Chokoshvili, Otar; Bolokadze, Natalia; Tsintsadze, Maya; Sharvadze, Lali; Gabunia, Pati; Dvali, Natia; Abutidze, Akaki; Tsertsvadze, Tengiz			Late presentation of HIV infection in the country of Georgia: 2012-2015	PLOS ONE			English	Article							EASTERN-EUROPEAN COUNTRY; INJECTING DRUG-USE; ANTIRETROVIRAL THERAPY; COHORT; DEATH; CARE; MORTALITY; INDIVIDUALS; DIAGNOSIS; PEOPLE	Late presentation for HIV care has important individual and population implications. The objective of this study was to explore the problem of late presentation in the country of Georgia. Data on adult persons newly diagnosed with HIV in Georgia between 2012 and 2015 were extracted from the national AIDS Health Information System. Late presenter was defined as a person diagnosed with HIV with a CD4 cell count <350 cells/mm(3) or an AIDS defining illness regardless of the CD4 cell count in the six months after HIV diagnosis. Late presenter with advanced disease was defined as a person diagnosed with HIV with a CD4 cell count <200 cells/mm(3) or an AIDS defining illness, regardless of CD4 cell count in the six months after HIV diagnosis. Among 2267 adults diagnosed with HIV in Georgia in 2012-2015, 1987 (87.6%) had CD4 cell count measured within 6 months of HIV diagnosis and were included in the analysis. Among them 1260 (63.4%) patients were classified as late presenters and 870 (43.8%) as late presenters with advanced disease. The proportion of late presenters declined from 71.1% in 2012 to 55.5% in 2015 (p<0.0001), while presentation late with advanced disease decreased from 56.6% in 2012 to 34.5% in 2015 (p<0.0001). Late presentation was most common among people who inject drugs (77.7%). Overall 186 patients died over the studied period. Mortality was higher both among late presenters (6.74 per 100 person-years vs. 1.08 per 100 person-years, p<0.0001) and late presenters with advanced disease (8.93 per 100 person-years vs. 1.34 per 100 person-years, p<0.0001). High prevalence of late presentation in Georgia reflects insufficiency in HIV testing services. Better testing strategies are needed to improve earlier diagnosis and disease outcomes.	[Chkhartishvili, Nikoloz; Chokoshvili, Otar; Bolokadze, Natalia; Tsintsadze, Maya; Sharvadze, Lali; Gabunia, Pati; Dvali, Natia; Abutidze, Akaki; Tsertsvadze, Tengiz] AIDS & Clin Immunol Res Ctr, Infect Dis, Tbilisi, Georgia; [Sharvadze, Lali; Tsertsvadze, Tengiz] Ivane Javakhishvili Tbilisi State Univ, Tbilisi, Georgia	Ivane Javakhishvili Tbilisi State University	Chkhartishvili, N (corresponding author), AIDS & Clin Immunol Res Ctr, Infect Dis, Tbilisi, Georgia.	nc@aidscenter.ge	Tsertsvadze, Tengiz/GXG-5822-2022; Gabunia, Pati/AAJ-9790-2021; Chokoshvili, Otar/F-7394-2018; Chokoshvili, Otar/AAG-3477-2021	Tsertsvadze, Tengiz/0000-0002-4986-7874; Chokoshvili, Otar/0000-0003-3023-1902; Chokoshvili, Otar/0000-0003-3023-1902; Chkhartishvili, Nikoloz/0000-0002-1309-825X	Infectious Diseases, AIDS and Clinical Immunology Research Center	Infectious Diseases, AIDS and Clinical Immunology Research Center	The work was supported with internal resources of the Infectious Diseases, AIDS and Clinical Immunology Research Center. No external funding was available for this work.; Authors would like to thank all persons involved in the implementation of national HIV programs. This study would not be possible without support provided by Infectious Diseases, AIDS and Clinical Immunology Research Center.	[Anonymous], HIV RISK PREVENTION; [Anonymous], 1993, MMWR RECOMM REP, V41, P1; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Chene G, 2016, INT J EPIDEMIOL; Chkhartishvili N, 2015, HIV MED, V16, P62, DOI 10.1111/hiv.12172; Chkhartishvili N, 2012, LATE HIV DIAGNOSIS G; Chkhartishvili N, 2016, TCM GMJ, V1, P11; Chkhartishvili N, 2014, AIDS RES HUM RETROV, V30, P560, DOI [10.1089/aid.2013.0219, 10.1089/AID.2013.0219]; Degenhardt L, 2014, INT J DRUG POLICY, V25, P53, DOI 10.1016/j.drugpo.2013.08.004; Dickson NP, 2012, HIV MED, V13, P182, DOI 10.1111/j.1468-1293.2011.00959.x; European Centre for Disease Prevention and Control, 2016, HIV AIDS SURV EUR 20; Garriga C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145701; Hachfeld A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20317; Kowalska JD, 2016, HIV MED; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Mocroft, 2015, EUROSURVEILLANCE, V20, P47, DOI [DOI 10.2807/1560-7917.ES.2015.20.47.30070, DOI HTTPS://DOI.ORG/10.2807/1560-7917.ES.2015.20.47.30070]; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Moreno S, 2010, ANTIVIR THER, V15, P9, DOI 10.3851/IMP1523; Murray M, 2012, HIV MED, V13, P89, DOI 10.1111/j.1468-1293.2011.00940.x; O'Connell S, 2016, INT J STD AIDS; Otiashvili D, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0049-2; Raffetti E, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3477-z; Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180; Sobrino-Vegas P, 2016, J INFECTION, V72, P587, DOI 10.1016/j.jinf.2016.01.017; Tsereteli N, 2015, HIV RISK PREVENTION; Tsereteli N, 2014, HIV RISK PREVENTION; Tsertsvadze T, 2009, GUIDELLINES ROUTINE; Tsertsvadze T, 2014, INT J STD AIDS, V25, P913, DOI 10.1177/0956462414525939; UNAIDS, 2016, PREV GAP REP; Weber R, 2015, HIV MED, V16, P137, DOI 10.1111/hiv.12184; Zoufaly A, 2012, HIV MED, V13, P172, DOI 10.1111/j.1468-1293.2011.00958.x	34	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186835	10.1371/journal.pone.0186835	http://dx.doi.org/10.1371/journal.pone.0186835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084276	gold, Green Submitted, Green Published			2022-12-27	WOS:000413910200015
J	Kim, HS; Kim, YY; Oh, JK; Bae, KH				Kim, Hye-Sung; Kim, Young-Youn; Oh, Jeong-Kyu; Bae, Kwang-Hak			Is yogurt intake associated with periodontitis due to calcium?	PLOS ONE			English	Article							DAIRY-PRODUCTS; LACTOBACILLUS-REUTERI; RISK-FACTORS; DISEASE; ADULTS; OLDER	The purpose of this study is to determine whether the lower intakes of yogurt, milk, and calcium are associated with periodontitis in a nationally representative sample of Korean adults. This study comprised 6,150 adults 19 or more years old who took both periodontal examination and nutrition survey. The frequency of yogurt and milk intake was examined with a food frequency questionnaire. The amount of calcium intake was calculated with dietary intakes data gained from complete one-day 24-hour recall interviews. Periodontitis was assessed using the Community Periodontal Index (CPI). Multivariate logistic regression analyses were performed for the whole sample and subgroups with the strata of age, gender, or smoking, in a complex sampling design. Less intake of yogurt was significantly associated with periodontitis (odds ratio [OR] 0.82, 95% confidential interval [CI] 0.70 +/- 0.97), but neither less intake of milk (OR 1.04, 95% CI 0.89 +/- 1.20) nor lower intake of calcium (OR 1.04, 95% CI 0.89 +/- 1.21) was significantly associated with periodontitis. In the subgroup analysis, no difference in the association of yogurt intake with periodontitis was found according to the strata of age, gender, and smoking. In conclusion, periodonitis was significantly associated with the less intake of yogurt among the Korean adults, but the calcium contained in yogurt is not likely to cause it.	[Kim, Hye-Sung; Kim, Young-Youn; Oh, Jeong-Kyu; Bae, Kwang-Hak] Apple tree Dent Hosp, Oral Hlth Sci Res Ctr, Goyang Si, Gyounggi Do, South Korea		Bae, KH (corresponding author), Apple tree Dent Hosp, Oral Hlth Sci Res Ctr, Goyang Si, Gyounggi Do, South Korea.	baekh@snu.ac.kr						Adegboye ARA, 2012, NUTRIENTS, V4, P1219, DOI 10.3390/nu4091219; Al-Zahrani MS, 2006, J PERIODONTOL, V77, P289, DOI 10.1902/jop.2006.050082; Al-Zahrani Mohammad S, 2005, J Int Acad Periodontol, V7, P21; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Albandar JM, 2002, PERIODONTOL 2000, V29, P177, DOI 10.1034/j.1600-0757.2002.290109.x; Genco RJ, 1996, J PERIODONTOL, V67, P1041, DOI 10.1902/jop.1996.67.10s.1041; Hur Inyoung, 2011, Osong Public Health Res Perspect, V2, P192, DOI 10.1016/j.phrp.2011.11.044; Kingman A, 2002, PERIODONTOL 2000, V29, P11, DOI 10.1034/j.1600-0757.2002.290102.x; Korea Center for Disease Control and Prevention, 2010, GUID RAW MAT FORT KO; Korea Center for Disease Control and Prevention, 2010, GUID RAW MAT FORTH K; Korea Centers for Disease Control and Prevention, 2010, SMAPL DES FORTH KOR; Korea Centers for Disease Control and Prevention, 2010, FORTH KOR NAT HLTH N; Korea Centers for Disease Control & Prevention, 2010, STAND OR HLTH SURV K; Korea Health Industry Development Institute (KHIDI), 2019, KOR NAT HLTH NUTR EX; Lee HS, 2009, 2009 14TH OPTOELECTRONICS AND COMMUNICATIONS CONFERENCE (OECC 2009), P9, DOI 10.1109/NUSOD.2009.5297207; Nishida M, 2000, J PERIODONTOL, V71, P1215, DOI 10.1902/jop.2000.71.8.1215; Nishida M, 2000, J PERIODONTOL, V71, P1057, DOI 10.1902/jop.2000.71.7.1057; Petersen PE, 2012, PERIODONTOL 2000, V60, P15, DOI 10.1111/j.1600-0757.2011.00425.x; Shimazaki Y, 2008, J PERIODONTOL, V79, P131, DOI [10.1902/jop.2008.070202, 10.1902/jop.2008.070202 ]; Sookkhee S, 2001, J APPL MICROBIOL, V90, P172, DOI 10.1046/j.1365-2672.2001.01229.x; Tekce M, 2015, J CLIN PERIODONTOL, V42, P363, DOI 10.1111/jcpe.12387; Teughels W, 2013, J CLIN PERIODONTOL, V40, P1025, DOI 10.1111/jcpe.12155; The Korean Nutrition Society, 2010, DIET REF INT KOR 201; Twetman S, 2009, ACTA ODONTOL SCAND, V67, P19, DOI 10.1080/00016350802516170; Van Loan M, 2009, J AM COLL NUTR, V28, p120S, DOI 10.1080/07315724.2009.10719805; WILLIAMS RC, 1990, NEW ENGL J MED, V322, P373, DOI 10.1056/NEJM199002083220606; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19	27	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187258	10.1371/journal.pone.0187258	http://dx.doi.org/10.1371/journal.pone.0187258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084251	gold, Green Published, Green Submitted			2022-12-27	WOS:000413910200042
J	Scibisz, G; Dec, R; Dzwolak, W				Scibisz, Grzegorz; Dec, Robert; Dzwolak, Wojciech			Mellitate: A multivalent anion with extreme charge density causes rapid aggregation and misfolding of wild type lysozyme at neutral pH	PLOS ONE			English	Article							THIOFLAVIN-T; AMYLOID FIBRILS; ACID; PROTEINS; INSULIN; MARS; STABILIZATION; STABILITY; SALT	Due to its symmetric structure and abundance of carboxyl groups, mellitic acid (MA-benzenehexacarboxylic acid) has an uncommon capacity to form highly ordered molecular networks. Dissolved in water, MA dissociates to yield various mellitate anions with pronounced tendencies to form complexes with cations including protonated amines. Deprotonation of MA at physiological pH produces anions with high charge densities (MA(5-) and MA(6-)) whose influence on co-dissolved proteins has not been thoroughly studied. As electrostatic attraction between highly symmetric MA(6-) anions and positively charged low-symmetry globular proteins could lead to interesting self-assembly patterns we have chosen hen egg white lysozyme (HEWL), a basic stably folded globular protein as a cationic partner for mellitate anions to form such hypothetical nanostructures. Indeed, mixing of neutral HEWL and MA solutions does result in precipitation of electrostatic complexes with the stoichiometry dependent on pH. We have studied the self-assembly of HEWL-MA structures using vibrational spectroscopy (infrared absorption and Raman scattering), circular dichroism (CD), atomic force microscopy (AFM). Possible HEWL-MA(6-) molecular docking scenarios were analyzed using computational tools. Our results indicate that even at equimolar ratios (in respect to HEWL), MA(5-) and MA(6-) anions are capable of inducing misfolding and aggregation of the protein upon mild heating which results in non-native intermolecular beta-sheet appearing in the amide I' region of the corresponding infrared spectra. The association process leads to aggregates with compacted morphologies entrapping mellitate anions. The capacity of extremely diluted mellitate anions (i.e. at sub-millimolar concentration range) to trigger aggregation of proteins is discussed in the context of mechanisms of misfolding.	[Scibisz, Grzegorz; Dec, Robert; Dzwolak, Wojciech] Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland	University of Warsaw	Dzwolak, W (corresponding author), Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland.	wdzwolak@chem.umeci.pl		Dzwolak, Wojciech/0000-0002-1407-1497	National Science Centre of Poland [DEC-2011/03/B/ST4/03063]; University of Warsaw [501/64-BST-176309]; EU from European Regional Development Fund under Operational Programme Innovative Economy; EU programme	National Science Centre of Poland(National Science Centre, Poland); University of Warsaw; EU from European Regional Development Fund under Operational Programme Innovative Economy; EU programme	This work was supported by the National Science Centre of Poland, grant no. DEC-2011/03/B/ST4/03063, and in part by University of Warsaw project 501/64-BST-176309. The study was carried out at the Biological and Chemical Research Centre, University of Warsaw, established within the project co-financed by EU from the European Regional Development Fund under the Operational Programme Innovative Economy, 2007-2013, and with the use of CePT infrastructure financed by the same EU programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolvahabi A, 2015, BIOPHYS J, V108, P1199, DOI 10.1016/j.bpj.2015.01.014; Amdursky N, 2012, ACCOUNTS CHEM RES, V45, P1548, DOI 10.1021/ar300053p; Apelblat A, 2006, J PHYS CHEM B, V110, P8893, DOI 10.1021/jp057371s; Azia A, 2009, J MOL BIOL, V393, P527, DOI 10.1016/j.jmb.2009.08.010; Babenko V, 2015, LANGMUIR, V31, P2180, DOI 10.1021/la5048694; Benner SA, 2000, P NATL ACAD SCI USA, V97, P2425, DOI 10.1073/pnas.040539497; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Blanco Y, 2013, ICARUS, V224, P326, DOI 10.1016/j.icarus.2012.06.006; BUCCI E, 1978, J BIOL CHEM, V253, P821; Bye JW, 2014, J PHYS CHEM B, V118, P4282, DOI 10.1021/jp412140v; Chang ESH, 2009, J MOL BIOL, V385, P1257, DOI 10.1016/j.jmb.2008.11.009; Colton IJ, 1997, J AM CHEM SOC, V119, P12701, DOI 10.1021/ja9723491; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Halskau O, 2008, P NATL ACAD SCI USA, V105, P8625, DOI 10.1073/pnas.0709881105; Humphrey SM, 2010, INORG CHEM, V49, P3441, DOI 10.1021/ic902527e; Inabe T, 2005, J MATER CHEM, V15, P1317, DOI 10.1039/b413848a; Jehlicka J, 2006, SPECTROCHIM ACTA A, V65, P229, DOI 10.1016/j.saa.2005.10.036; Johnson BB, 2004, LANGMUIR, V20, P823, DOI 10.1021/la035471o; Karle IL, 2005, J CHEM CRYSTALLOGR, V35, P835, DOI 10.1007/sl0870-005-4554-9; Karle IL, 2009, J CHEM CRYSTALLOGR, V39, P201, DOI 10.1007/s10870-008-9458-z; Kiyotsukuri T, 1995, POLYMER, V36, P5045, DOI 10.1016/0032-3861(96)81634-X; Kvaratskhelia E, 2008, J SOLUTION CHEM, V37, P1063, DOI 10.1007/s10953-008-9292-0; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; MALLETTE MF, 1967, J BACTERIOL, V94, P283, DOI 10.1128/JB.94.2.283-290.1967; McMenimen KA, 2001, J AM CHEM SOC, V123, P6453, DOI 10.1021/ja016043c; Minemawari H, 2009, CRYST GROWTH DES, V9, P4830, DOI 10.1021/cg900655v; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MOZHAEV VV, 1988, EUR J BIOCHEM, V173, P147, DOI 10.1111/j.1432-1033.1988.tb13978.x; NAGATA M, 1995, POLYMER, V36, P2657, DOI 10.1016/0032-3861(95)91214-R; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Park LY, 2003, J AM CHEM SOC, V125, P10586, DOI 10.1021/ja036540o; Piejko M, 2015, J BIOL CHEM, V290, P5947, DOI 10.1074/jbc.M114.608844; Plater MJ, 2015, J CHEM RES, P279, DOI 10.3184/174751915X14303279945021; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Stalport F, 2009, ASTROBIOLOGY, V9, P543, DOI 10.1089/ast.2008.0300; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Stsiapura VI, 2008, J PHYS CHEM B, V112, P15893, DOI 10.1021/jp805822c; Wu LP, 1995, INORG CHIM ACTA, V239, P165, DOI 10.1016/0020-1693(95)04713-1; Zhou T, 2010, J CHROMATOGR A, V1217, P82, DOI 10.1016/j.chroma.2009.11.016; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	43	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187328	10.1371/journal.pone.0187328	http://dx.doi.org/10.1371/journal.pone.0187328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084264	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200051
J	Colas, JT				Colas, Jaron T.			Value-based decision making via sequential sampling with hierarchical competition and attentional modulation	PLOS ONE			English	Article							PERCEPTUAL DECISION; RESPONSE-TIME; EVIDENCE ACCUMULATION; DIFFUSION-MODEL; FACE PERCEPTION; NEURAL BASIS; DIVISIVE NORMALIZATION; CORTICAL MECHANISMS; VISUAL FIXATIONS; VALUE SIGNALS	In principle, formal dynamical models of decision making hold the potential to represent fundamental computations underpinning value-based (i.e., preferential) decisions in addition to perceptual decisions. Sequential-sampling models such as the race model and the drift-diffusion model that are grounded in simplicity, analytical tractability, and optimality remain popular, but some of their more recent counterparts have instead been designed with an aim for more feasibility as architectures to be implemented by actual neural systems. Connectionist models are proposed herein at an intermediate level of analysis that bridges mental phenomena and underlying neurophysiological mechanisms. Several such models drawing elements from the established race, drift-diffusion, feedforward-inhibition, divisive-normalization, and competing-accumulator models were tested with respect to fitting empirical data from human participants making choices between foods on the basis of hedonic value rather than a traditional perceptual attribute. Even when considering performance at emulating behavior alone, more neurally plausible models were set apart from more normative race or drift-diffusion models both quantitatively and qualitatively despite remaining parsimonious. To best capture the paradigm, a novel six-parameter computational model was formulated with features including hierarchical levels of competition via mutual inhibition as well as a static approximation of attentional modulation, which promotes "winner-take-all" processing. Moreover, a meta-analysis encompassing several related experiments validated the robustness of model-predicted trends in humans' value-based choices and concomitant reaction times. These findings have yet further implications for analysis of neurophysiological data in accordance with computational modeling, which is also discussed in this new light.	[Colas, Jaron T.] CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA	California Institute of Technology	Colas, JT (corresponding author), CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	jcolas@caltech.edu		Colas, Jaron/0000-0003-1872-7614	National Science Foundation; Rose Hills Foundation; Gordon and Betty Moore Foundation	National Science Foundation(National Science Foundation (NSF)); Rose Hills Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	I gratefully acknowledge the financial support provided by the National Science Foundation (https://www.nsf.gov/) Graduate Research Fellowship Program, the Rose Hills Foundation (https://www.rosehillsfoundation.org/), and the Gordon and Betty Moore Foundation (https.//www.moore.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P667, DOI 10.1109/TAC.1974.1100707; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; ASHBY FG, 1983, J MATH PSYCHOL, V27, P277, DOI 10.1016/0022-2496(83)90011-1; Balci F, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00056; BARNARD GA, 1946, J ROY STAT SOC B, V8, P1; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, Q J EXP PSYCHOL, V63, P863, DOI 10.1080/17470210903091643; Box G.E., 1987, EMPIRICAL MODEL BUIL; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown S, 2005, PSYCHOL REV, V112, P117, DOI 10.1037/0033-295X.112.1.117; Brown SD, 2008, COGNITIVE PSYCHOL, V57, P153, DOI 10.1016/j.cogpsych.2007.12.002; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; BUNDESEN C, 1993, J MATH PSYCHOL, V37, P446, DOI 10.1006/jmps.1993.1026; BUSEMEYER JR, 1988, J MATH PSYCHOL, V32, P91, DOI 10.1016/0022-2496(88)90042-9; BUSEMEYER JR, 1993, PSYCHOL REV, V100, P432, DOI 10.1037/0033-295X.100.3.432; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Carland MA, 2015, PSYCHON B REV, V22, P1830, DOI 10.3758/s13423-015-0851-2; Chau BKH, 2014, NAT NEUROSCI, V17, P463, DOI 10.1038/nn.3649; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cisek P, 2012, CURR OPIN NEUROBIOL, V22, P927, DOI 10.1016/j.conb.2012.05.007; Cisek P, 2009, J NEUROSCI, V29, P11560, DOI 10.1523/JNEUROSCI.1844-09.2009; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Colas JT, 2017, FRONT PSYCH IN PRESS; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Ditterich J, 2006, EUR J NEUROSCI, V24, P3628, DOI 10.1111/j.1460-9568.2006.05221.x; Ditterich J, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00184; Donkin C, 2009, PSYCHON B REV, V16, P1129, DOI 10.3758/PBR.16.6.1129; Dragalin VP, 1999, IEEE T INFORM THEORY, V45, P2448, DOI 10.1109/18.796383; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Dutilh G, 2016, PSYCHON B REV, V23, P723, DOI 10.3758/s13423-015-0941-1; FANTZ RL, 1961, SCI AM, V204, P66, DOI 10.1038/scientificamerican0561-66; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Forstmann B. U., 2015, INTRO MODEL BASED CO; Forstmann BU, 2011, TRENDS COGN SCI, V15, P272, DOI 10.1016/j.tics.2011.04.002; Frank M. J., 2015, INTRO MODEL BASED CO, P159, DOI DOI 10.1007/978-1-4939-2236-9_8; Frazier PI, 2008, ADV NEURAL INFORM PR, P465; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gossen HH, 1854, ENTWICKELUNG GESETZ; Green DM, 1966, SIGNAL DETECTION THE; GRICE GR, 1972, ATTEN PERCEPT PSYCHO, V12, P103; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanks TD, 2014, ELIFE, V3, DOI 10.7554/eLife.02260; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Harris A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021074; Hawkins GE, 2015, J NEUROSCI, V35, P2476, DOI 10.1523/JNEUROSCI.2410-14.2015; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Henson R, 2006, TRENDS COGN SCI, V10, P64, DOI 10.1016/j.tics.2005.12.005; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Hopf JM, 2006, P NATL ACAD SCI USA, V103, P1053, DOI 10.1073/pnas.0507746103; Houston AI, 2007, BIOLOGY LETT, V3, P365, DOI 10.1098/rsbl.2007.0111; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Hurwicz L., 1972, DECISION ORG VOLUME, P297; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jocham G, 2012, NAT NEUROSCI, V15, P960, DOI 10.1038/nn.3140; JOHNSON DM, 1939, ARCH PSYCHOL, V34, P1; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kelly SP, 2013, J NEUROSCI, V33, P19434, DOI 10.1523/JNEUROSCI.3355-13.2013; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Krajbich I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00193; Krajbich I, 2011, P NATL ACAD SCI USA, V108, P13852, DOI 10.1073/pnas.1101328108; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; LABERGE D, 1962, PSYCHOMETRIKA, V27, P375, DOI 10.1007/BF02289645; Laming DR, 1968, INFORM THEORY CHOICE; Larsen T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0473; Ledberg A, 2007, CEREB CORTEX, V17, P44, DOI 10.1093/cercor/bhj123; Leong YC, 2017, NEURON, V93, P451, DOI 10.1016/j.neuron.2016.12.040; Lewin K., 1935, DYNAMIC THEORY PERS; Lewin K., 1936, PRINCIPLES TOPOLOGIC, DOI [https://doi.org/10.1037/10019-000, DOI 10.1037/10019-000]; Liljeholm M, 2013, J NEUROSCI, V33, P12519, DOI 10.1523/JNEUROSCI.1353-13.2013; Lim SL, 2011, J NEUROSCI, V31, P13214, DOI 10.1523/JNEUROSCI.1246-11.2011; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Liston DB, 2013, J VISION, V13, DOI 10.1167/13.8.1; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Louie K, 2014, J NEUROSCI, V34, P16046, DOI 10.1523/JNEUROSCI.2851-14.2014; Louie K, 2013, P NATL ACAD SCI USA, V110, P6139, DOI 10.1073/pnas.1217854110; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Luce R, 1959, INDIVIDUAL CHOICE BE; Luce RD, 1986, RESPONSE TIMES THEIR; Manohar SG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00711; MARLEY AAJ, 1992, J MATH PSYCHOL, V36, P1, DOI 10.1016/0022-2496(92)90050-H; Mather M, 2013, PERSPECT PSYCHOL SCI, V8, P108, DOI 10.1177/1745691612469037; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McGinty VB, 2016, NEURON, V90, P1299, DOI 10.1016/j.neuron.2016.04.045; McMillen T, 2006, J MATH PSYCHOL, V50, P30, DOI 10.1016/j.jmp.2005.10.003; McNamara JM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0935; Milosavljevic M, 2012, J CONSUM PSYCHOL, V22, P67, DOI 10.1016/j.jcps.2011.10.002; MORTON J, 1964, INT AUDIOL, V3, P216, DOI 10.3109/05384916409074089; Myung IJ, 2000, J MATH PSYCHOL, V44, P190, DOI 10.1006/jmps.1999.1283; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Niwa M, 2008, J NEUROSCI, V28, P4435, DOI 10.1523/JNEUROSCI.5564-07.2008; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; Palminteri S, 2017, TRENDS COGN SCI, V21, P425, DOI 10.1016/j.tics.2017.03.011; Polania R, 2014, NEURON, V82, P709, DOI 10.1016/j.neuron.2014.03.014; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; RAPOPORT A, 1971, J MATH PSYCHOL, V8, P508, DOI 10.1016/0022-2496(71)90005-8; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; RATCLIFF R, 1985, PSYCHOL REV, V92, P212, DOI 10.1037/0033-295X.92.2.212; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Reeves A, 2005, SPATIAL VISION, V18, P73, DOI 10.1163/1568568052801582; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Ricciardi L.M., 1977, DIFFUSION PROCESSES, V14; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Roe RM, 2001, PSYCHOL REV, V108, P370, DOI 10.1037//0033-295X.108.2.370; Roitman JD, 2002, J NEUROSCI, V22, P9475; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schultz W, 2015, PHYSIOL REV, V95, P853, DOI 10.1152/physrev.00023.2014; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shannon C. E., 1949, MATH THEORY COMMUNIC; SHEPARD RN, 1957, PSYCHOMETRIKA, V22, P325, DOI 10.1007/BF02288967; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Simen P, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00183; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; Simion C, 2007, PERCEPT PSYCHOPHYS, V69, P591, DOI 10.3758/BF03193916; Simion C, 2006, VISION RES, V46, P3331, DOI 10.1016/j.visres.2006.04.019; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; STONE M, 1960, PSYCHOMETRIKA, V25, P251, DOI 10.1007/BF02289729; Sullivan N, 2015, PSYCHOL SCI, V26, P122, DOI 10.1177/0956797614559543; Summerfield C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00070; Teichert T, 2016, J NEUROPHYSIOL, V115, P643, DOI 10.1152/jn.00274.2015; Teodorescu AR, 2013, PSYCHOL REV, V120, P1, DOI 10.1037/a0030776; Thura D, 2014, NEURON, V81, P1401, DOI 10.1016/j.neuron.2014.01.031; Thura D, 2012, J NEUROPHYSIOL, V108, P2912, DOI 10.1152/jn.01071.2011; Todd J. W., 1912, ARCH PSYCHOL, V25; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Towal RB, 2013, P NATL ACAD SCI USA, V110, pE3858, DOI 10.1073/pnas.1304429110; TSETSOS K, 2012, FRONT NEUROSCI SWITZ, V6; Tsetsos K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00063; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Usher M, 2004, PSYCHOL REV, V111, P757, DOI 10.1037/0033-295X.111.3.757; van Ravenzwaaij D, 2012, PSYCHOL REV, V119, P201, DOI 10.1037/a0026275; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P3, DOI 10.3758/BF03194023; Waksberg A, 2009, BEHAV ECOL SOCIOBIOL, V63, P461, DOI 10.1007/s00265-008-0681-6; WALD A, 1948, ANN MATH STAT, V19, P326, DOI 10.1214/aoms/1177730197; WALD A, 1945, ANN MATH STAT, V16, P117, DOI 10.1214/aoms/1177731118; Wald A., 1947, SEQUENTIAL ANAL; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Winkel J, 2014, PSYCHON B REV, V21, P777, DOI 10.3758/s13423-013-0551-8; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007; Yang HJ, 2009, ATTEN PERCEPT PSYCHO, V71, P554, DOI 10.3758/APP.71.3.554; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zandbelt B, 2014, P NATL ACAD SCI USA, V111, P2848, DOI 10.1073/pnas.1310577111; Zhang JX, 2010, J MATH PSYCHOL, V54, P322, DOI 10.1016/j.jmp.2010.03.001	168	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186822	10.1371/journal.pone.0186822	http://dx.doi.org/10.1371/journal.pone.0186822			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077746	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000413861200024
J	Kuklik, N; Stausberg, J; Jockel, KH				Kuklik, Nils; Stausberg, Juergen; Joeckel, Karl-Heinz			Adverse drug events in German hospital routine data: A validation of International Classification of Diseases, 10th revision (ICD-10) diagnostic codes	PLOS ONE			English	Article							TRIGGER TOOL; PERFORMANCE	Objective Adverse drug events (ADEs) during hospital stays are a significant problem of healthcare systems. Established monitoring systems lack completeness or are cost intensive. Routinely assigned International Statistical Classification of Diseases and Related Health Problems (ICD) codes could complement existing systems for ADE identification. To analyze the potential of using routine data for ADE detection, the validity of a set of ICD codes was determined focusing on hospital-acquired events. Material and methods The study utilized routine data from four German hospitals covering the years 2014 and 2015. A set of ICD, 10(th) Revision, German Modification (ICD-10-GM) diagnoses coded most frequently in the routine data and identified as codes indicating ADEs was analyzed. Data from psychiatric and psychotherapeutic departments were excluded. Retrospective chart review was performed to calculate positive predictive values (PPV) and sensitivity. Results Of 807 reviewed ADE codes, 91.2% (95%-confidence interval: 89.0, 93.1) were identified as disease in the medical records and 65.1% (61.7, 68.3) were confirmed as ADE. For code groups being predominantly hospital-acquired, 78.5% (73.7, 82.9) were confirmed as ADE, ranging from 68.5% to 94.4% dependent on the ICD code. However, sensitivity of inpatient ADEs was relatively low. 49.7% (45.2, 54.2) of 495 identified hospital-acquired ADEs were coded as disease in the routine data, from which a subgroup of 12.1% (9.4,15.3) was coded as drug-associated disease. Conclusions ICD codes from routine data can provide an important contribution to the development and improvement of ADE monitoring systems. Documentation quality is crucial to further increase the PPV, and actions against under-reporting of ADEs in routine data need to be taken.	[Kuklik, Nils; Stausberg, Juergen; Joeckel, Karl-Heinz] Univ Duisburg Essen, Univ Hosp Essen, IMIBE, Essen, Germany; [Kuklik, Nils] Univ Duisburg Essen, Univ Hosp Essen, IMIBE, Ctr Clin Trials Essen ZKSE, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Kuklik, N (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, IMIBE, Essen, Germany.; Kuklik, N (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, IMIBE, Ctr Clin Trials Essen ZKSE, Essen, Germany.	nils.kuklik@uk-essen.de			Federal Ministry of Education and Research of Germany (Bundesministerium fur Bildung und Forschung, BMBF) [01GY1328]	Federal Ministry of Education and Research of Germany (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF))	NK and KHJ are supported by the Federal Ministry of Education and Research of Germany (Bundesministerium fur Bildung und Forschung, BMBF, grant number 01GY1328, www.bmbf.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azaouagh A, 2008, Pneumologie, V62, P273, DOI 10.1055/s-2008-1038099; Carnevali L, 2013, ANN PHARMACOTHER, V47, P1414, DOI 10.1177/1060028013500939; Forster AJ, 2012, J AM MED INFORM ASSN, V19, P31, DOI 10.1136/amiajnl-2011-000454; Hodge MC, 2017, CAN J DIABETES; Hodgkinson Marisa R., 2009, Journal of Pharmacy Practice and Research, V39, P19; Hoffmann W, 2005, GESUNDHEITSWESEN, V67, P217, DOI 10.1055/s-2004-813850; Hohl CM, 2014, J AM MED INFORM ASSN, V21, P547, DOI 10.1136/amiajnl-2013-002116; Hougland P, 2008, ADV PATIENT SAFETY N, V1; Hougland P, 2006, MED CARE, V44, P629, DOI 10.1097/01.mlr.0000215859.06051.77; Hsu DY, 2016, ALLERGY; Hug BL, 2012, JT COMM J QUAL PATIE, V38, P120, DOI 10.1016/S1553-7250(12)38016-1; Jha AK, 2013, BMJ QUAL SAF, V22, P809, DOI 10.1136/bmjqs-2012-001748; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Lau Iris, 2014, Can J Hosp Pharm, V67, P423; Lopez-Gonzalez E, 2009, DRUG SAFETY, V32, P19, DOI 10.2165/00002018-200932010-00002; Martins ACM, 2014, J CLIN PHARM THER, V39, P609, DOI 10.1111/jcpt.12204; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; Mikkelsen G, 2001, INT J MED INFORM, V63, P123, DOI 10.1016/S1386-5056(01)00152-6; Morimoto T, 2004, QUAL SAF HEALTH CARE, V13, P306, DOI 10.1136/qshc.2004.010611; National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP), 2015, CONT VIEW MED REL HA; Rozich JD, 2003, QUAL SAF HEALTH CARE, V12, P194, DOI 10.1136/qhc.12.3.194; Ruiz E, 2015, EUR J HAEMATOL, V94, P400, DOI 10.1111/ejh.12432; Southern DA, 2016, INT J QUAL HEALTH C, V28, P136, DOI 10.1093/intqhc/mzv099; Stausberg J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-125; Stausberg J, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-134; Stausberg Jurgen, 2005, Adv Skin Wound Care, V18, P140, DOI 10.1097/00129334-200504000-00011; Stergiopoulos S, 2016, DRUG SAFETY, V39, P1117, DOI 10.1007/s40264-016-0455-4; World Health Organization, 2009, CONCEPTUAL FRAMEWORK	28	18	18	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187510	10.1371/journal.pone.0187510	http://dx.doi.org/10.1371/journal.pone.0187510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095926	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200108
J	Somers, CM; Graham, CF; Martino, JA; Frasier, TR; Lance, SL; Gardiner, LE; Poulin, RG				Somers, Christopher M.; Graham, Carly F.; Martino, Jessica A.; Frasier, Timothy R.; Lance, Stacey L.; Gardiner, Laura E.; Poulin, Ray G.			Conservation genetics of the eastern yellow-bellied racer (Coluber constrictor flaviventris) and bullsnake (Pituophis catenifer sayi): River valleys are critical features for snakes at northern range limits	PLOS ONE			English	Article							POPULATION-STRUCTURE; MASSASAUGA RATTLESNAKE; SISTRURUS-CATENATUS; CORONELLA-AUSTRIACA; LANDSCAPE GENETICS; HABITAT SELECTION; BIASED DISPERSAL; F-STATISTICS; MICROSATELLITE; SOFTWARE	On the North American Great Plains, several snake species reach their northern range limit where they rely on sparsely distributed hibernacula located in major river valleys. Independent colonization histories for the river valleys and barriers to gene flow caused by the lack of suitable habitat between them may have produced genetically differentiated snake populations. To test this hypothesis, we used 10 microsatellite loci to examine the population structure of two species of conservation concern in Canada: the eastern yellow-bellied racer (Coluber constrictor flaviventris) and bullsnake (Pituophis catenifer sayi) in 3 major river valleys in southern Saskatchewan. Fixation indices (F-ST) showed that populations in river valleys were significantly differentiated for both species (racers, F-ST = 0.096, P = 0.001; bullsnakes F-ST = 0.045-0.157, P = 0.001). Bayesian assignment (STRUCTURE) and ordination (DAPC) strongly supported genetically differentiated groups in the geographically distinct river valleys. Finer-scale subdivision of populations within river valleys was not apparent based on our data, but is a topic that should be investigated further. Our findings highlight the importance of major river valleys for snakes at the northern extent of their ranges, and raise the possibility that populations in each river valley may warrant separate management strategies.	[Somers, Christopher M.; Graham, Carly F.; Martino, Jessica A.; Gardiner, Laura E.] Univ Regina, Dept Biol, Regina, SK, Canada; [Frasier, Timothy R.] St Marys Univ, Dept Biol, Halifax, NS, Canada; [Lance, Stacey L.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Poulin, Ray G.] Royal Saskatchewan Museum, Regina, SK, Canada	University of Regina; Saint Marys University - Canada; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia	Somers, CM (corresponding author), Univ Regina, Dept Biol, Regina, SK, Canada.	chris.somers@uregina.ca	Somers, Christopher/AAE-6390-2019		Science and Innovation Fund of the province of Saskatchewan; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; University of Regina; Royal Saskatchewan Museum; Saskatchewan Parks; Canadian Museum of Nature; Canadian Wildlife Federation; Agriculture and Agri-food Canada; Environment Canada's Inter-Departmental Recovery Fund; U. S. Department of Energy [DE-FC09-07SR22506]; Parks Canada Agency; Grasslands National Park	Science and Innovation Fund of the province of Saskatchewan; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); University of Regina; Royal Saskatchewan Museum; Saskatchewan Parks; Canadian Museum of Nature; Canadian Wildlife Federation; Agriculture and Agri-food Canada(Agriculture & Agri Food Canada); Environment Canada's Inter-Departmental Recovery Fund; U. S. Department of Energy(United States Department of Energy (DOE)); Parks Canada Agency; Grasslands National Park	We thank the Science and Innovation Fund of the province of Saskatchewan, the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, the University of Regina, the Royal Saskatchewan Museum, Friends of the Royal Saskatchewan Museum, Saskatchewan Parks, the Parks Canada Agency and Grasslands National Park, the Canadian Museum of Nature, the Canadian Wildlife Federation, and Agriculture and Agri-food Canada and Environment Canada's Inter-Departmental Recovery Fund for financial support. This research was partially supported by U. S. Department of Energy under Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation.	Almany GR, 2009, MOL ECOL RESOUR, V9, P1460, DOI 10.1111/j.1755-0998.2009.02759.x; Bernard AM, 2009, CAN J FISH AQUAT SCI, V66, P1617, DOI 10.1139/F09-106; Bronikowski AM, 2000, EVOLUTION, V54, P1760; Clark RW, 2008, MOL ECOL, V17, P719; COSEWIC, 2017, SUMM WILDL SPEC ASS; COSEWIC, 2017, GUID REC REC DES UN; COSEWIC [Committee on the Status of Endangered Wildlife in Canada], 2015, COSEWIC ASS STAT REP; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Dileo MF, 2013, MOL ECOL, V22, P4483, DOI 10.1111/mec.12411; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ernst C.H., 2003, SNAKES US CANADA; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Galarza JA, 2015, BIOL J LINN SOC, V114, P426, DOI 10.1111/bij.12424; Gardiner LE, 2013, J WILDLIFE MANAGE, V77, P975, DOI 10.1002/jwmg.555; Gardiner Laura E., 2011, Blue Jay, V69, P120; Gardiner Laura E., 2011, Blue Jay, V69, P70; Gibbs HL, 2001, J HERED, V92, P173, DOI 10.1093/jhered/92.2.173; Gibbs HL, 1997, MOL ECOL, V6, P1123, DOI 10.1046/j.1365-294X.1997.00284.x; Gosselin T., 2016, STACKR GBS RAD DATA; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harvey DS, 2006, J HERPETOL, V40, P66, DOI 10.1670/89-05A.1; Hofmann S, 2014, J BIOGEOGR, V41, P2162, DOI 10.1111/jbi.12358; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jaeger CP, 2016, ECOL EVOL, V6, P3991, DOI 10.1002/ece3.2159; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Kapfer JM, 2008, COPEIA, P815, DOI 10.1643/CE-07-104; Keogh JS, 2007, BIOL LETTERS, V3, P33, DOI 10.1098/rsbl.2006.0570; Klug PE, 2011, LANDSCAPE ECOL, V26, P281, DOI 10.1007/s10980-010-9554-2; Kwiatkowski MA, 2010, CONSERV GENET RESOUR, V2, P163, DOI 10.1007/s12686-010-9208-3; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Marshall JCJ, 2009, CONSERV GENET, V10, P465, DOI 10.1007/s10592-008-9624-z; Martino JA, 2012, J WILDLIFE MANAGE, V76, P759, DOI 10.1002/jwmg.313; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Meister B, 2010, BIOL J LINN SOC, V101, P51, DOI 10.1111/j.1095-8312.2010.01474.x; Parks Canada Agency, 2010, SPECIES RISK ACT REC; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pernetta AP, 2011, HEREDITY, V107, P231, DOI 10.1038/hdy.2011.7; Prior KA, 1997, CONSERV BIOL, V11, P1147, DOI 10.1046/j.1523-1739.1997.96098.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2014, R LANG ENV STAT COMP; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; Shaffer HB, 2015, ANNU REV ANIM BIOSCI, V3, P113, DOI 10.1146/annurev-animal-022114-110920; Simonov E, 2012, AMPHIBIA-REPTILIA, V33, P273, DOI 10.1163/156853812X642045; Sunny A, 2015, GENETICA, V143, P705, DOI 10.1007/s10709-015-9868-8; Ursenbacher S, 2009, CONSERV GENET, V10, P303, DOI 10.1007/s10592-008-9580-7; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williams KE, 2012, CAN J ZOOL, V90, P304, DOI [10.1139/Z11-136, 10.1139/z11-136]; Wood DA, 2015, CONSERV GENET, V16, P1025, DOI 10.1007/s10592-015-0720-6; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Xuereb ATJ, 2015, CONSERV GENET, V16, P1265, DOI 10.1007/s10592-015-0737-x	54	2	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187322	10.1371/journal.pone.0187322	http://dx.doi.org/10.1371/journal.pone.0187322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095863	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200073
J	Tang, J; Cheng, H; Fang, CM				Tang, Jie; Cheng, Hao; Fang, Changming			The temperature sensitivity of soil organic carbon decomposition is not related to labile and recalcitrant carbon	PLOS ONE			English	Article							MATTER DECOMPOSITION; RESPIRATION; MINERALIZATION; INCUBATION; DEPENDENCE; CLIMATE; Q(10); UNCERTAINTIES; ECOSYSTEMS; VEGETATION	The response of resistant soil organic matter to temperature change is crucial for predicting climate change impacts on C cycling in terrestrial ecosystems. However, the response of the decomposition of different soil organic carbon (SOC) fractions to temperature is still under debate. To investigate whether the labile and resistant SOC components have different temperature sensitivities, soil samples were collected from three forest and two grass land sites, along with a gradient of latitude from 18 degrees 40'to 43 degrees 17'N and elevation from 600 to 3510 m across China, and were incubated under changing temperature (from 12 to 32 degrees C) for at least 260 days. Soil respiration rates were positively related to the content of soil organic carbon and soil microbial carbon. The temperature sensitivity of soil respiration, presented as Q(10) value, varies from 1.93 +/- 0.15 to 2.60 +/- 0.21. During the incubation, there were no significant differences between the Q(10) values of soil samples from different layers of the same site, nor a clear pattern of Q(10) values along with the gradient of latitude. The result of this study does not support current opinion that resistant soil carbon decomposition is more sensitive to temperature change than labile soil carbon.	[Tang, Jie; Cheng, Hao; Fang, Changming] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers & Ecol Engn, Minist Educ, Shanghai, Peoples R China	Fudan University	Fang, CM (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers & Ecol Engn, Minist Educ, Shanghai, Peoples R China.	cmfang@fudan.edu.cn			National Natural Science Foundation of China [40671106, 31070461]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 40671106 and 31070461) (CF has received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Natural Science Foundation of China (40671106, 31070461).	Agren GI, 2000, AMBIO, V29, P55, DOI 10.1639/0044-7447(2000)029[0055:TDOOSO]2.0.CO;2; Agren GI, 2007, SOIL BIOL BIOCHEM, V39, P1794, DOI 10.1016/j.soilbio.2007.02.007; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chen XP, 2010, SOIL BIOL BIOCHEM, V42, P2282, DOI 10.1016/j.soilbio.2010.08.030; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Conen F, 2006, BIOGEOSCI DISCUSS, V3, P1355, DOI DOI 10.5194/bgd-3-1355-2006; Conen F, 2008, SOIL BIOL BIOCHEM, V40, P2703, DOI 10.1016/j.soilbio.2008.07.004; Dalias P, 2001, GLOBAL CHANGE BIOL, V7, P181, DOI 10.1046/j.1365-2486.2001.00386.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Fang C, 2006, BIOGEOSCIENCES, V3, P65, DOI 10.5194/bg-3-65-2006; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fissore C, 2008, GLOBAL CHANGE BIOL, V14, P193, DOI 10.1111/j.1365-2486.2007.01478.x; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Holland EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1137, DOI 10.1029/2000GB001264; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Karhu K, 2010, SOIL BIOL BIOCHEM, V42, P72, DOI 10.1016/j.soilbio.2009.10.002; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; Lenton TM, 2003, GLOBAL CHANGE BIOL, V9, P1333, DOI 10.1046/j.1365-2486.2003.00674.x; Lipson DA, 2007, FEMS MICROBIOL ECOL, V59, P418, DOI 10.1111/j.1574-6941.2006.00240.x; Liski J, 1999, AMBIO, V28, P171; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Niklinska M, 1999, BIOGEOCHEMISTRY, V44, P239, DOI 10.1023/A:1006049204600; Plante AF, 2010, SOIL BIOL BIOCHEM, V42, P1991, DOI 10.1016/j.soilbio.2010.07.022; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2000, SOIL BIOL BIOCHEM, V32, P947, DOI 10.1016/S0038-0717(00)00002-X; Rey A, 2008, EUR J SOIL SCI, V59, P1049, DOI 10.1111/j.1365-2389.2008.01065.x; Townsend AR, 1997, BIOGEOCHEMISTRY, V38, P1, DOI 10.1023/A:1017942918708; Vanhala P, 2007, SOIL BIOL BIOCHEM, V39, P2967, DOI 10.1016/j.soilbio.2007.05.022; Winkler JP, 1996, SOIL BIOL BIOCHEM, V28, P1067, DOI 10.1016/0038-0717(96)00076-4; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	35	13	13	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186675	10.1371/journal.pone.0186675	http://dx.doi.org/10.1371/journal.pone.0186675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095839	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200020
J	Yao, XH; Yan, JW; Ginda, M; Borner, K; Saykin, AJ; Shen, L				Yao, Xiaohui; Yan, Jingwen; Ginda, Michael; Borner, Katy; Saykin, Andrew J.; Shen, Li		Alzheimer's Dis Neuroimaging	Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative	PLOS ONE			English	Article							BIOMARKER CORE; PHENOTYPES; AIMS	Background Alzheimer's disease neuroimaging initiative (ADNI) is a landmark imaging and omics study in AD. ADNI research literature has increased substantially over the past decade, which poses challenges for effectively communicating information about the results and impact of ADNI-related studies. In this work, we employed advanced information visualization techniques to perform a comprehensive and systematic mapping of the ADNI scientific growth and impact over a period of 12 years. Methods Citation information of ADNI-related publications from 01/01/2003 to 05/12/2015 were downloaded from the Scopus database. Five fields, including authors, years, affiliations, sources (journals), and keywords, were extracted and preprocessed. Statistical analyses were performed on basic publication data as well as journal and citations information. Science mapping workflows were conducted using the Science of Science (Sci2) Tool to generate geospatial, topical, and collaboration visualizations at the micro (individual) to macro (global) levels such as geospatial layouts of institutional collaboration networks, keyword co-occurrence networks, and author collaboration networks evolving overtime. Results During the studied period, 996 ADNI manuscripts were published across 233 journals and conference proceedings. The number of publications grew linearly from 2008 to 2015, so did the number of involved institutions. ADNI publications received much more citations than typical papers from the same set of journals. Collaborations were visualized at multiple levels, including authors, institutions, and research areas. The evolution of key ADNI research topics was also plotted over the studied period. Conclusions Both statistical and visualization results demonstrate the increasing attention of ADNI research, strong citation impact of ADNI publications, the expanding collaboration networks among researchers, institutions and ADNI core areas, and the dynamic evolution of ADNI research topics. The visualizations presented here can help improve daily decision making based on a deep understanding of existing patterns and trends using proven and replicable data analysis and visualization methods. They have great potential to provide new insights and actionable knowledge for helping translational research in AD.	[Yao, Xiaohui; Yan, Jingwen; Saykin, Andrew J.; Shen, Li] Indiana Univ, Ctr Neuroimaging, Indianapolis, IN 46204 USA; [Ginda, Michael; Borner, Katy] Indiana Univ, Cyberinfrastruct Network Sci Ctr, Bloomington, IN USA; [Yao, Xiaohui; Yan, Jingwen; Ginda, Michael; Borner, Katy; Saykin, Andrew J.; Shen, Li] Indiana Univ, Network Sci Inst, Bloomington, IN 47405 USA; [Yao, Xiaohui; Yan, Jingwen; Shen, Li] Indiana Univ, Sch Informat & Comp, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Shen, L (corresponding author), Indiana Univ, Ctr Neuroimaging, Indianapolis, IN 46204 USA.; Shen, L (corresponding author), Indiana Univ, Network Sci Inst, Bloomington, IN 47405 USA.; Shen, L (corresponding author), Indiana Univ, Sch Informat & Comp, Indianapolis, IN 46204 USA.	shenli@iu.edu	Shen, Li/AAB-6870-2021	Shen, Li/0000-0002-5443-0503; Ginda, Michael/0000-0002-7500-8096	Project Development Team within Indiana Clinical and Translational Sciences Institute (ICTSI) grant [UL1TR001108]; Alzheimer's disease neuroimaging initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging (NIA) [U01 AG024904, P01 AG039347, RC2 AG036535, R01 AG019771, P30 AG10133, R01 AG042437, R01 AG046171]; National Cancer Institute (NCI) [U01 CA198934]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR001108]; National Library of Medicine (NLM) [R01 LM011360]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R01 EB022574]; Department of Defense (DOD) [W81XWH-12-2-0012, W81XWH-14-2-0151, W81XWH-13-1-0259]; National Collegiate Athletic Association (NCAA) [14132004]; Clinical and Translational Sciences Institute (CTSI) SPARC Program; Indiana University Precision Health Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046171, P30AG010133] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011360] Funding Source: NIH RePORTER	Project Development Team within Indiana Clinical and Translational Sciences Institute (ICTSI) grant; Alzheimer's disease neuroimaging initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Library of Medicine (NLM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Department of Defense (DOD)(United States Department of Defense); National Collegiate Athletic Association (NCAA); Clinical and Translational Sciences Institute (CTSI) SPARC Program; Indiana University Precision Health Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by a Project Development Team within the Indiana Clinical and Translational Sciences Institute (ICTSI) grant UL1TR001108 to LS, AJS and KB. ADNI data collection and sharing for this project was funded by the Alzheimer's disease neuroimaging initiative (ADNI) (National Institutes of Health Grant U01 AG024904 to AJS) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). This work was also partially supported by National Institute on Aging (NIA) grant P01 AG039347, U01 AG024904 to AJS, RC2 AG036535 to AJS, R01 AG019771, P30 AG10133 to AJS, R01 AG042437, and R01 AG046171 to AJS; National Cancer Institute (NCI) grant U01 CA198934; National Center for Advancing Translational Sciences (NCATS) grant UL1 TR001108 to LS; National Library of Medicine (NLM) grant R01 LM011360 to LS; National Institute of Biomedical Imaging and Bioengineering (NIBIB) grant R01 EB022574 to LS; U.S. Department of Defense (DOD) grant W81XWH-14-2-0151 to LS, W81XWH-13-1-0259 to AJS, and W81XWH-12-2-0012 to AJS; National Collegiate Athletic Association (NCAA) grant 14132004 to LS; Clinical and Translational Sciences Institute (CTSI) SPARC Program; and Indiana University Precision Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar E., 2006, Conference on Human Factors in Computing Systems. CHI2006, P791; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], ATLAS KNOWLEDGE ANYO; Bastian M., 2009, 3 INT AAAI C WEBL SO; Borner K, 2015, PLOS ONE, V10; Borner K., 2014, VISUAL INSIGHTS PRAC; Borner K, 2007, ENVIRON PLANN B, V34, P808, DOI 10.1068/b3302t; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Bu┬rner K., 2010, ATLAS SCI VISUALIZIN; Elsevier, 2015, IMP PUBL IPP; Elsevier, 2015, SOURC NORM IMP PAP S; Elsevier, 2015, SCIMAGO J RANK SJR; Elsevier, 2015, SCOPUS; Elsevier, 2015, J METRIC VALUES 1999; Exhibit Team, 2005, PLAC SPAC MAPP SCI; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hughes ME, 2014, JAMA NEUROL, V71, P412, DOI 10.1001/jamaneurol.2013.6225; Huynh D, 2013, OPEN REFINE VERSION; Jack CR, 2015, ALZHEIMERS DEMENT, V11, P740, DOI 10.1016/j.jalz.2015.05.002; Kang JH, 2015, ALZHEIMERS DEMENT, V11, P772, DOI 10.1016/j.jalz.2015.05.003; Liggins C, 2014, ALZHEIMERS DEMENT, V10, P405, DOI 10.1016/j.jalz.2013.12.013; Light RP, 2014, SCIENTOMETRICS, V101, P1535, DOI 10.1007/s11192-014-1238-2; Martin S, 2008, SAND REPORTS, P1; Morris T, 2013, CLUSTERING DEPTHHB M; Morris T, 2015, GEOCODING; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Prince M., WORLD ALZHEIMER REPO; R Core Team, 2015, LANG ENV STAT COMP V; Saykin AJ, 2015, ALZHEIMERS DEMENT, V11, P792, DOI 10.1016/j.jalz.2015.05.009; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Sci2 Team, 2009, SCI CSI SCI2 TOOL; Shaw LM, 2011, ACTA NEUROPATHOL, V121, P597, DOI 10.1007/s00401-011-0808-0; Shen L, 2014, BRAIN IMAGING BEHAV, V8, P183, DOI 10.1007/s11682-013-9262-z; Skupin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058779; Toga AW, 2015, ALZHEIMERS DEMENT, V11, P832, DOI 10.1016/j.jalz.2015.04.004; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Weiner MW, 2017, ALZHEIMERS DEMENT, V13, P561, DOI 10.1016/j.jalz.2016.10.006; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Yao X, 2016, AAIC 17 ALZH ASS INT	39	10	10	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186095	10.1371/journal.pone.0186095	http://dx.doi.org/10.1371/journal.pone.0186095			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095836	Green Published, Green Submitted			2022-12-27	WOS:000414340200013
J	Huang, YT; Chang, YL; Chen, CC; Lai, PY; Chan, CK				Huang, Yu-Ting; Chang, Yu-Lin; Chen, Chun-Chung; Lai, Pik-Yin; Chan, C. K.			Positive feedback and synchronized bursts in neuronal cultures	PLOS ONE			English	Article							TERM SYNAPTIC PLASTICITY; REVERBERATORY ACTIVITY; ACTION-POTENTIALS; NETWORKS; MECHANISMS; DYNAMICS; PATTERNS; DENSITY; CALCIUM; CELLS	Synchronized bursts (SBs) with complex structures are common in neuronal cultures. Although the phenomenon of SBs has been discovered for a long time, its origin is still unclear. Here, we investigate the properties of these SBs in cultures grown on a multi -electrode array. We find that structures of these SBs are related to the different developmental stages of the cultures and these structures can be modified by changing the magnesium concentration in the culture medium; indicating that synaptic mechanism is involved in the generation of SBs. A model based on short term synaptic plasticity (STSP), recurrent connections and astrocytic recycling of neurotransmitters has been developed successfully to understand the observed structures of SBs in experiments. A phase diagram obtained from this model shows that networks exhibiting SBs are in a complex oscillatory state due to large enough positive feedback provided by synaptic facilitation and recurrent connections. In this model, while STSP controls the fast oscillations (similar to 100 ms) within a SB, the astrocytic recycling determines the slow time scale (similar to 10 s) of inter-burst intervals. Our study suggests that glia-neuron interactions can be important in the understanding of the complex dynamics of neuronal networks.	[Huang, Yu-Ting; Lai, Pik-Yin; Chan, C. K.] Natl Cent Univ, Dept Phys, Chungli 320, Taiwan; [Huang, Yu-Ting; Lai, Pik-Yin; Chan, C. K.] Natl Cent Univ, Ctr Complex Syst, Chungli 320, Taiwan; [Huang, Yu-Ting; Chang, Yu-Lin; Chen, Chun-Chung; Chan, C. K.] Acad Sinica, Inst Phys, Taipei 115, Taiwan	National Central University; National Central University; Academia Sinica - Taiwan	Lai, PY; Chan, CK (corresponding author), Natl Cent Univ, Dept Phys, Chungli 320, Taiwan.; Lai, PY; Chan, CK (corresponding author), Natl Cent Univ, Ctr Complex Syst, Chungli 320, Taiwan.; Chan, CK (corresponding author), Acad Sinica, Inst Phys, Taipei 115, Taiwan.	pylai@ncu.phy.edu.tw; ckchan@gate.sinica.edu.tw	Chan, Chi-Keung/AAP-7916-2021; Chen, Chun-Chung/A-5905-2008	Chan, Chi-Keung/0000-0002-1496-1086; Chen, Chun-Chung/0000-0002-7664-8300	MOST of ROC [NSC 100-2923-M-001-008-MY3, 102-2112-M-001-009-MY3]	MOST of ROC	This work has been supported by the MOST of ROC under the grant nos. NSC 100-2923-M-001-008-MY3, 102-2112-M-001-009-MY3 and NCTS of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2000, GLIA, V32, P1; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Baruchi I, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.050901; Biffi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083899; Bisio M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107400; Blitz DM, 2004, NAT REV NEUROSCI, V5, P630, DOI 10.1038/nrn1475; Chiappalone M, 2005, NEUROCOMPUTING, V65, P653, DOI 10.1016/j.neucom.2004.10.094; Cohen E, 2008, BRAIN RES, V1235, P21, DOI 10.1016/j.brainres.2008.06.022; Cortes JM, 2013, P NATL ACAD SCI USA, V110, P16610, DOI 10.1073/pnas.1316071110; Czarnecki A, 2012, EUR J NEUROSCI, V35, P375, DOI 10.1111/j.1460-9568.2011.07966.x; De Pitta M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002293; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gritsun TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043352; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Haydon PG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020438; Hennig MH, 2015, NEURAL INFORM PROCES, P5; Hulata E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198105; Ito D, 2010, NEUROSCIENCE, V171, P50, DOI 10.1016/j.neuroscience.2010.08.038; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; Jia LC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.088101; Johnson SE, 2015, J NEUROPHYSIOL, V113, P2461, DOI 10.1152/jn.00286.2014; Jolivet R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004036; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; MAEDA E, 1995, J NEUROSCI, V15, P6834; Maheswaranathan N, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00015; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Masquelier T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075824; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mi YY, 2017, NEURON, V93, P323, DOI 10.1016/j.neuron.2016.12.004; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Niedringhaus M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057144; Penn Y, 2016, P NATL ACAD SCI USA, V113, P3341, DOI 10.1073/pnas.1515105113; Poli D, 2015, FRONT NEURAL CIRCUIT, P9; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Segev R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118102; Sibille J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00189; Stephens CL, 2012, EXP NEUROL, V234, P20, DOI 10.1016/j.expneurol.2011.12.009; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Vardi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep36228; Volman V, 2007, PHYS BIOL, V4, P91, DOI 10.1088/1478-3975/4/2/003; Voss LJ, 2010, J NEUROSCI METH, V192, P214, DOI 10.1016/j.jneumeth.2010.07.025; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051907; Wilson NR, 2007, J NEUROSCI, V27, P13581, DOI 10.1523/JNEUROSCI.3863-07.2007; Zhan X, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011907	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187276	10.1371/journal.pone.0187276	http://dx.doi.org/10.1371/journal.pone.0187276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091966	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700050
J	Qin, LZ; Li, T; Liu, YH				Qin, Lianzhi; Li, Ting; Liu, Yuhua			High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer	PLOS ONE			English	Article							INTRACELLULAR PH; BREAST-CANCER; MUTATIONS; FAMILY	In this study, we aimed to examine the expression of SLC4A1 1 in ovarian cancer and in normal ovarian tissues, its prognostic value and the possible mechanism of its dysregulation. Bioinformatic analysis was performed by using data from the GEO datasets, the Cancer Genome Atlas-Ovarian Cancer (TCGA-OV) and the Human Protein Atlas (HPA). Results showed that SLC4A11 was upregulated in ovarian cancer compared with normal ovarian epithelial tissues. In patients with primary serous ovarian cancer in TCGA-OV, the cases with lymphatic invasion (N = 133) had significantly higher SLC4A11 expression than those without lymphatic invasion (N = 77) (p = 0.0069). High SLC4A11 expression was consistently associated with worse overall survival (OS). Univariate and multivariate analysis confirmed that high SLC4A1 1 expression was an independent prognostic factor for poor OS in grade 3/4 (G3/G4) tumors (HR = 1.416, 95`)/X1: 1.098-1.824, p = 0.007). 320 out of 578 (55.4%) ovarian cancer cases had SLC4A11 amplification. High methylation group had a significantly lower level of SLC4A1 1 expression. Based on these findings, we infer that high SLC4A1 1 expression is an independent predictor for poor OS in grade 3/4 serous ovarian cancer. Both DNA amplification and hypomethylation contribute to its upregulation in ovarian cancer.	[Qin, Lianzhi] Linyi Cent Hosp, Delivery Room, Linyi, Shandong, Peoples R China; [Li, Ting] Zoucheng Peoples Hosp, Dept Gynecol, Zoucheng, Shandong, Peoples R China; [Liu, Yuhua] Anqiu Peoples Hosp, Dept Obstet, Anqiu, Shandong, Peoples R China		Liu, YH (corresponding author), Anqiu Peoples Hosp, Dept Obstet, Anqiu, Shandong, Peoples R China.	yuhualiu1@foxmail.com						Andersen AP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0098; Asadollahi R, 2010, GYNECOL ONCOL, V118, P81, DOI 10.1016/j.ygyno.2010.03.015; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Boedtkjer E, 2013, INT J CANCER, V132, P1288, DOI 10.1002/ijc.27782; Bowen NJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-71; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gorbatenko A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00130; Kao LY, 2015, AM J PHYSIOL-CELL PH, V308, pC176, DOI 10.1152/ajpcell.00271.2014; Koshiyama M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/934261; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Kwon MJ, 2011, INT J MOL SCI, V12, P983, DOI 10.3390/ijms12020983; Lambros MBK, 2005, J PATHOL, V205, P29, DOI 10.1002/path.1681; Lee S, 2016, ONCOGENE, V35, P2112, DOI 10.1038/onc.2015.273; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; McIntyre A, 2016, CANCER RES, V76, P3744, DOI 10.1158/0008-5472.CAN-15-1862; Ogando DG, 2013, AM J PHYSIOL-CELL PH, V305, pC716, DOI 10.1152/ajpcell.00056.2013; Parks SK, 2015, J CELL PHYSIOL, V230, P1954, DOI 10.1002/jcp.24930; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Patel SP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/475392; Pedersen SF, 2013, CANCER RES, V73, P1658, DOI 10.1158/0008-5472.CAN-12-4188; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; Sanhueza C, 2016, CURR MOL MED, V16, P23, DOI 10.2174/1566524016666151222143437; Sanhueza C, 2017, BBA-MOL BASIS DIS, V1863, P81, DOI 10.1016/j.bbadis.2016.10.013; Shei W, 2013, MOL VIS, V19, P1096; Shimada T, 2017, JPN J CLIN ONCOL, V47, P494, DOI 10.1093/jjco/hyx026; Thornell IM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00166; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vilas GL, 2013, HUM MOL GENET, V22, P4579, DOI 10.1093/hmg/ddt307; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Watanabe T, 2001, GYNECOL ONCOL, V81, P172, DOI 10.1006/gyno.2001.6132	33	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187385	10.1371/journal.pone.0187385	http://dx.doi.org/10.1371/journal.pone.0187385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091960	Green Submitted, gold, Green Published			2022-12-27	WOS:000414229700062
J	Hong, ZL; Lin, F; Xiao, B				Hong, Zhiling; Lin, Fan; Xiao, Bin			A novel Gravity-FREAK feature extraction and Gravity-KLT tracking registration algorithm based on iPhone MEMS mobile sensor in mobile environment	PLOS ONE			English	Article								Based on the traditional Fast Retina Keypoint (FREAK) feature description algorithm, this paper proposed a Gravity-FREAK feature description algorithm based on Micro-electromechanical Systems (MEMS) sensor to overcome the limited computing performance and memory resources of mobile devices and further improve the reality interaction experience of clients through digital information added to the real world by augmented reality technology. The algorithm takes the gravity projection vector corresponding to the feature point as its feature orientation, which saved the time of calculating the neighborhood gray gradient of each feature point, reduced the cost of calculation and improved the accuracy of feature extraction. In the case of registration method of matching and tracking natural features, the adaptive and generic corner detection based on the Gravity-FREAK matching purification algorithm was used to eliminate abnormal matches, and Gravity Kaneda-Lucas Tracking (KLT) algorithm based on MEMS sensor can be used for the tracking registration of the targets and robustness improvement of tracking registration algorithm under mobile environment.	[Hong, Zhiling; Lin, Fan; Xiao, Bin] Xiamen Univ, Software Sch, Xiamen, Fujian, Peoples R China	Xiamen University	Hong, ZL (corresponding author), Xiamen Univ, Software Sch, Xiamen, Fujian, Peoples R China.	hongzl@xmu.edu.cn			National Natural Science Foundation of China [31200769]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Project was supported by the National Natural Science Foundation of China (Grant No. 31200769).; The Project was supported by the National Natural Science Foundation of China (Grant No. 31200769). And the authors would like to thank the anonymous reviewers who helped to improve the quality of the paper.	Alahi A, 2012, PROC CVPR IEEE, P510, DOI 10.1109/CVPR.2012.6247715; [Anonymous], 1992, P 25 HAWAII INT C SY, DOI [10.1109/HICSS.1992.183317, DOI 10.1109/HICSS.1992.183317]; Azuma R, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.963459; Baker S, 2004, INT J COMPUT VISION, V56, P221, DOI 10.1023/B:VISI.0000011205.11775.fd; Bazin J C, 2008, 19 INT C PATT REC IC, P1; Bimber O, 2002, INTERNATIONAL SYMPOSIUM ON MIXED AND AUGMENTED REALITY, PROCEEDINGS, P186, DOI 10.1109/ISMAR.2002.1115088; Capel D P., 2005, EFFECTIVE BAIL OUT T; Chekhlov D., 2007, P IEEE INT C COMP VI, P1, DOI DOI 10.1109/CVPR.2007.383026; Chen Fu-Xing, 2005, Journal of Software, V16, P1431, DOI 10.1360/jos161431; Chum O, 2003, LOCALLY OPTIMIZED RA, P236; Chum O., 2004, P ACCV, V2, P812; Davison AJ, 2007, IEEE T PATTERN ANAL, V29, P1052, DOI 10.1109/TPAMI.2007.1049; Debevec Paul., 2008, ACM SIGGRAPH 2008 CL, P1; Dong SY, 2013, ADV ENG SOFTW, V55, P45, DOI 10.1016/j.advengsoft.2012.09.001; Feiner S, 1997, FIRST INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS - DIGEST OF PAPERS, P74, DOI 10.1109/ISWC.1997.629922; Huynh D.-N. T., 2009, P 2009 ACM SIGGRAPH, P135, DOI DOI 10.1145/1581073.1581095; Jin HL, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P684, DOI 10.1109/ICCV.2001.937588; Kato H., 2002, ARTOOLKIT LIB VISION, P79; Klein G, 2008, LECT NOTES COMPUT SC, V5303, P802, DOI 10.1007/978-3-540-88688-4_59; Klein G, 2009, INT SYM MIX AUGMENT, P83, DOI 10.1109/ISMAR.2009.5336495; Kurz D., 2011, 2011 IEEE International Symposium on Mixed and Augmented Reality, P111, DOI 10.1109/ISMAR.2011.6092376; Kurz D, 2011, PROC CVPR IEEE, P161, DOI 10.1109/CVPR.2011.5995339; Lee JD, 2012, EXPERT SYST APPL, V39, P5286, DOI 10.1016/j.eswa.2011.11.009; Lieberknecht S, 2009, INT SYM MIX AUGMENT, P145, DOI 10.1109/ISMAR.2009.5336487; Lucas B.D., 1981, IJCAI 81 P 7 INT JOI, P674, DOI DOI 10.1109/HPDC.2004.1323531; Mair Elmar, 2010, Computer Vision - ECCV 2010. Proceedings 11th European Conference on Computer Vision, P183, DOI 10.1007/978-3-642-15552-9_14; Nowicki M, 2013, ADV INTELL SYST, V226, P835, DOI 10.1007/978-3-319-00969-8_82; Ohta Yutchi, 2014, MIXED REALITY MERGIN; Pupilli M, 2005, REAL TIME CAMERA TRA; Rosten E, 2006, LECT NOTES COMPUT SC, V3951, P430, DOI 10.1007/11744023_34; Samir C, 2014, IEEE T MED IMAGING, V33, P1035, DOI 10.1109/TMI.2014.2300935; Schnabel R, 2007, COMPUT GRAPH FORUM, V26, P214, DOI 10.1111/j.1467-8659.2007.01016.x; Verykokou S., 2016, LNCS, V10058, P50, DOI [DOI 10.1007/978-3-319-48496-9_5, 10.1007/978-3-319-48496, DOI 10.1007/978-3-319-48496]; Verykokou S, 2014, LECT NOTES COMPUT SC, V8740, P279, DOI 10.1007/978-3-319-13695-0_27; Wagner D, 2003, IEEE INTERNATIONAL AUGMENTED REALITY TOOLKIT WORKSHOP, P14, DOI 10.1109/ART.2003.1320418; Wagner D, 2009, INT SYM MIX AUGMENT, P57, DOI 10.1109/ISMAR.2009.5336497; Wagner D, 2010, IEEE T VIS COMPUT GR, V16, P355, DOI 10.1109/TVCG.2009.99; Wu YZ, 2015, IEEE SENS J, V15, P750, DOI 10.1109/JSEN.2014.2354331; Yang MD, 2013, AUTOMAT CONSTR, V33, P48, DOI 10.1016/j.autcon.2012.09.017; You S, 1999, P IEEE VIRT REAL ANN, P260, DOI 10.1109/VR.1999.756960	40	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186176	10.1371/journal.pone.0186176	http://dx.doi.org/10.1371/journal.pone.0186176			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088228	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900007
J	Arias, JP; Bronfman, NC; Cisternas, PC; Repetto, PB				Pablo Arias, Juan; Bronfman, Nicolas C.; Cisternas, Pamela C.; Repetto, Paula B.			Hazard proximity and risk perception of tsunamis in coastal cities: Are people able to identify their risk?	PLOS ONE			English	Article							CLIMATE-CHANGE; 2014 IQUIQUE; CHILE; EARTHQUAKE; PREPAREDNESS; TRUST	Researchers have previously reported that hazard proximity can influence risk perception among individuals exposed to potential hazards. Understanding this relationship among coastline communities at risk of flood events caused by storms and/or tsunamis, is important because hazard proximity, should be recognized when planning and implementing preparation and mitigation actions against these events. Yet, we are not aware of studies that have examined this relationship among coastline inhabitants facing the risk of a tsunami. Consequently, the aim of this study was to examine the relationship between hazard proximity and perceived risk from tsunamis among coastline inhabitants. Participants were 487 residents of the coastal city of Iquique, Chile. They completed a survey during the spring of 2013 that assessed their perceived risk from several natural and non-natural hazards. We found that hazard proximity maintains a negative relationship with the perception of tsunami risk among coastline inhabitants. While this result confirms the general trend obtained in previous studies, this one is conclusive and significant. In contradiction with previous findings, we found that participants from the highest socioeconomic status reported the highest levels of risk perception. This finding can be explained by the fact that most participants from the highest socioeconomic status live closer to the coastline areas, so their risk perception reflects the place where they live, that is in a tsunami inundation zone. Once again, hazard proximity proved to be a determinant factor of risk perception. Our findings have important implications for the development of plans and programs for tsunami preparedness and mitigation. These indicate that individuals do use environmental cues to evaluate their own risk and can potentially make correct choices when having or not to evacuate. Also suggest that preparedness should incorporate how hazard proximity is recognized by individuals and communities at risk.	[Pablo Arias, Juan; Bronfman, Nicolas C.; Cisternas, Pamela C.] Univ Andres Bello, Engn Sci Dept, Santiago, Chile; [Bronfman, Nicolas C.; Cisternas, Pamela C.; Repetto, Paula B.] Natl Res Ctr Integrated Nat Disaster Management C, Santiago, Chile; [Repetto, Paula B.] Pontificia Univ Catolica Chile, Dept Psychol, Santiago, Chile	Universidad Andres Bello; Pontificia Universidad Catolica de Chile	Bronfman, NC (corresponding author), Univ Andres Bello, Engn Sci Dept, Santiago, Chile.; Bronfman, NC (corresponding author), Natl Res Ctr Integrated Nat Disaster Management C, Santiago, Chile.	nbronfman@unab.cl	Repetto, Paula/ABC-5982-2021; repetto, paula/E-5525-2015	Repetto, Paula/0000-0002-0331-7375; Cisternas, Pamela Carmen/0000-0003-3637-7814	Chile's National Science and Technology Commission (Conicyt) [1130864]; National Research Center for Integrated Natural Disaster Management [CONICYT/FONDAP/15110017]	Chile's National Science and Technology Commission (Conicyt); National Research Center for Integrated Natural Disaster Management	This research was partially funded by Chile's National Science and Technology Commission (Conicyt) through the National Fund for Scientific and Technological Research (Fondecyt, grant 1130864) and by the National Research Center for Integrated Natural Disaster Management CONICYT/FONDAP/15110017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-rousan TM, 2014, AM J PUBLIC HEALTH, V104, P506, DOI 10.2105/AJPH.2013.301559; Alvarez L., 1966, PROYECCION POBLACION; Aranguiz R, 2016, PURE APPL GEOPHYS, V173, P333, DOI 10.1007/s00024-015-1225-4; Arlikatti S, 2006, ENVIRON BEHAV, V38, P226, DOI 10.1177/0013916505277603; Armas I, 2006, RISK ANAL, V26, P1223, DOI 10.1111/j.1539-6924.2006.00810.x; Barberi F, 2008, J VOLCANOL GEOTH RES, V172, P244, DOI 10.1016/j.jvolgeores.2007.12.011; Barrientos S. E., 2007, GEOLOGICAL SOC SPECI, P263, DOI [10.1144/GOCH.10, DOI 10.1144/GOCH.10]; Botzen WJW, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR007743; Brilly M, 2005, NAT HAZARD EARTH SYS, V5, P345, DOI 10.5194/nhess-5-345-2005; Brody SD, 2008, ENVIRON BEHAV, V40, P72, DOI 10.1177/0013916506298800; Brody SD, 2004, RISK ANAL, V24, P1561, DOI 10.1111/j.0272-4332.2004.00550.x; Bronfman NC, 2003, RISK ANAL, V23, P1271, DOI 10.1111/j.0272-4332.2003.00400.x; Bronfman NC, 2015, NAT HAZARDS, P1; Bubeck P, 2012, RISK ANAL, V32, P1481, DOI 10.1111/j.1539-6924.2011.01783.x; Cisternas M, 2005, NATURE, V437, P404, DOI 10.1038/nature03943; CRED, 2018, NAT DIS 2017 LOW MOR; Dillon RL, 2014, RISK ANAL, V34, P1907, DOI 10.1111/risa.12209; Esteban M, 2013, INT J DISAST RISK RE, V5, P84, DOI 10.1016/j.ijdrr.2013.07.002; FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739; FISCHHOFF B, 1982, AM STAT, V36, P240, DOI 10.2307/2683835; Gawande K, 2001, J ENVIRON ECON MANAG, V42, P207, DOI 10.1006/jeem.2000.1155; Grothmann T, 2006, NAT HAZARDS, V38, P101, DOI 10.1007/s11069-005-8604-6; Hayes GP, 2014, NATURE, V512, P295, DOI 10.1038/nature13677; Ho MC, 2008, RISK ANAL, V28, P635, DOI 10.1111/j.1539-6924.2008.01040.x; Johnston D, 2005, NAT HAZARDS, V35, P173, DOI 10.1007/s11069-004-2419-8; Kellens W, 2011, RISK ANAL, V31, P1055, DOI 10.1111/j.1539-6924.2010.01571.x; Kovach R.L, 2004, EARLY EARTHQUAKES AM, P280; Lagos M, 2016, EGU GEN ASS C; Lander J.F., 2003, SCI TSUNAMI HAZARDS, V21, P3; Lay T, 2014, GEOPHYS RES LETT, V41, P3818, DOI 10.1002/2014GL060238; Lindell M., 1983, RISK ANAL, V3, P245, DOI [DOI 10.1111/J.1539-6924.1983.TB01393.X, 10.1111/j.1539-6924.1983.tb01393.x]; Lindell MK, 2008, RISK ANAL, V28, P539, DOI 10.1111/j.1539-6924.2008.01032.x; Lindell MK, 2012, RISK ANAL, V32, P616, DOI 10.1111/j.1539-6924.2011.01647.x; Lindell MK, 2009, RISK ANAL, V29, P1072, DOI 10.1111/j.1539-6924.2009.01243.x; Lindell MK, 2017, COMMUNICATION; MADERTHANER R, 1978, J APPL PSYCHOL, V63, P380, DOI 10.1037/0021-9010.63.3.380; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Miceli R, 2008, J ENVIRON PSYCHOL, V28, P164, DOI 10.1016/j.jenvp.2007.10.006; Myles D., 1985, THE GREAT WAVES; National Seismological Centre, 2016, IMP DESTR EARTHQ 157; O'Neill E., 2016, RISK ANAL; ONEMI, 2014, REC PREP RESP TSUN; Rogers, 1984, LOW PROBABILITY HIGH, P507; Siegrist M, 2000, RISK ANAL, V20, P195, DOI 10.1111/0272-4332.202020; Siegrist M, 2000, RISK ANAL, V20, P713, DOI 10.1111/0272-4332.205064; Siegrist M, 2006, RISK ANAL, V26, P971, DOI 10.1111/j.1539-6924.2006.00792.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P., 2016, PERCEPTION RISK; Tomita T, 2016, COAST ENG J, V58, DOI 10.1142/S0578563416500030; Wachinger G, 2010, WP3 CAPHAZ NET; Wachinger G, 2013, RISK ANAL, V33, P1049, DOI 10.1111/j.1539-6924.2012.01942.x; Williams BL, 1999, RISK ANAL, V19, P1019, DOI 10.1023/A:1007095808381; Zaalberg R, 2009, RISK ANAL, V29, P1759, DOI 10.1111/j.1539-6924.2009.01316.x; Zhang Y, 2010, ENVIRON BEHAV, V42, P597, DOI 10.1177/0013916509334564	54	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186455	10.1371/journal.pone.0186455	http://dx.doi.org/10.1371/journal.pone.0186455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088230	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900013
J	Sun, ZP; de Roos, AM				Sun, Zepeng; de Roos, Andre M.			Seasonal reproduction leads to population collapse and an Allee effect in a stage-structured consumer-resource biomass model when mortality rate increases	PLOS ONE			English	Article							FISH POPULATIONS; MATURATION; SIZE; HISTORY; PREDATION; STATES; RISK	Many populations collapse suddenly when reaching low densities even if they have abundant food conditions, a phenomenon known as an Allee effect. Such collapses can have disastrous consequences, for example, for loss of biodiversity. In this paper, we formulate a stage-structured consumer-resource biomass model in which adults only reproduce at the beginning of each growing season, and investigate the effect of an increasing stage-independent background mortality rate of the consumer. As the main difference with previously studied continuous-time models, seasonal reproduction can result in an Allee effect and consumer population collapses at high consumer mortality rate. However, unlike the mechanisms reported in the literature, in our model the Allee effect results from the time difference between the maturation of juveniles and the reproduction of adults. The timing of maturation plays a crucial role because it not only determines the body size of the individuals at maturation but also influences the duration of the period during which adults can invest in reproductive energy, which together determine the reproductive output at the end of the season. We suggest that there exists an optimal timing of maturation and that consumer persistence is promoted if individuals mature later in the season at a larger body size, rather than maturing early, despite high food availability supporting rapid growth.	[Sun, Zepeng; de Roos, Andre M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Amsterdam	Sun, ZP (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	zepengsun@gmail.com	Sun, Zepeng/P-3663-2016; De Roos, Andre M./A-1590-2008	Sun, Zepeng/0000-0002-9846-4174; De Roos, Andre M./0000-0002-6944-2048	China Scholarship Council; European Research Council under the European Union's Seventh Framework Programme/ERC [322814]	China Scholarship Council(China Scholarship Council); European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC))	ZS is grateful for the support of China Scholarship Council (http://www.csc.edu.cn/). AMdR is supported by funding from the European Research Council (https://erc.europa.eu/) under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement No. 322814. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ZS is grateful for the support of China Scholarship Council. AMdR is supported by funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement No. 322814. We thank Floor Soudijn for helpful discussions and an anonymous reviewer for helpful comments on an earlier version of this article.	Alos J, 2014, MAR ECOL PROG SER, V503, P219, DOI 10.3354/meps10745; Berec L, 2001, AM NAT, V157, P217, DOI 10.1086/318626; Blackburn TM, 2015, MOL ECOL, V24, P1942, DOI 10.1111/mec.13075; Cassey P, 2014, OECOLOGIA, V175, P417, DOI 10.1007/s00442-014-2902-1; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Courchamp F, 2001, ANIM CONSERV, V4, P169, DOI 10.1017/S1367943001001196; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; De Roos AM, 2008, THEOR POPUL BIOL, V73, P47, DOI 10.1016/j.tpb.2007.09.004; De Roos AM, 2008, ECOL LETT, V11, P1, DOI 10.1111/j.1461-0248.2007.01121.x; de Roos AM, 2007, AM NAT, V170, pE59, DOI 10.1086/520119; De Roos AM, 2013, J MATH BIOL, V66, P889, DOI 10.1007/s00285-012-0583-0; Dennis B., 1989, Natural Resource Modeling, V3, P481; DeRoos AM, FINDCURVE C BASED PA; Gascoigne JC, 2004, J APPL ECOL, V41, P801, DOI 10.1111/j.0021-8901.2004.00944.x; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; Good C, 2016, J WORLD AQUACULT SOC, V47, P605, DOI 10.1111/jwas.12342; Grunbaum D, 2003, ECOLOGY, V84, P3265, DOI 10.1890/01-4098; Guill C, 2009, THEOR POPUL BIOL, V76, P168, DOI 10.1016/j.tpb.2009.06.002; Higgins L, 2000, OECOLOGIA, V122, P51, DOI 10.1007/PL00008835; Hutchings JA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0693; Hutchings JA, 2014, ICES J MAR SCI, V71, P2152, DOI 10.1093/icesjms/fst179; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kramer AM, 2010, J ANIM ECOL, V79, P633, DOI 10.1111/j.1365-2656.2009.01657.x; Kuparinen A, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140075; Lever JJ, 2014, ECOL LETT, V17, P350, DOI 10.1111/ele.12236; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; McCallum H, 1996, TRENDS ECOL EVOL, V11, P491, DOI 10.1016/S0169-5347(96)30050-5; McClure CA, 2007, AQUACULTURE, V272, P370, DOI 10.1016/j.aquaculture.2007.08.039; Mooring MS, 2004, J WILDLIFE MANAGE, V68, P519, DOI 10.2193/0022-541X(2004)068[0519:VPRATA]2.0.CO;2; Morita K, 2002, J FISH BIOL, V61, P1230, DOI [10.1006/jfbi.2002.2138, 10.1111/j.1095-8649.2002.tb02467.x]; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Persson L., 2013, MONOGRAPHS POPULATIO, V51; Persson L, 2013, ECOLOGY, V94, P1487, DOI 10.1890/12-1883.1; Roff Derek A., 1992; Schneider JM, 1997, BIOL J LINN SOC, V60, P517; Shimada Y, 2014, PLOS ONE, V6; Soudijn FH, 2017, THEOR ECOL-NETH, V10, P73, DOI 10.1007/s12080-016-0309-9; Stearns S.C., 1992, pi; Sun ZP, 2015, THEOR POPUL BIOL, V103, P60, DOI 10.1016/j.tpb.2015.04.004; Swain DP, 2015, MAR ECOL PROG SER, V519, P165, DOI 10.3354/meps11012	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187338	10.1371/journal.pone.0187338	http://dx.doi.org/10.1371/journal.pone.0187338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088273	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900068
J	Yano, T; Ohira, M; Nakano, R; Tanaka, Y; Ohdan, H				Yano, Takuya; Ohira, Masahiro; Nakano, Ryosuke; Tanaka, Yuka; Ohdan, Hideki			Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; APOPTOSIS-INDUCING LIGAND; T-CELLS; IFN-GAMMA; HEPATOCELLULAR-CARCINOMA; MEDIATED CYTOTOXICITY; CYTOKINE PRODUCTION; TUMOR-METASTASIS; KUPFFER CELLS; ACTIVATION	Liver-resident natural killer (NK) cells express TNF-related apoptosis-inducing ligand (TRAIL), a critical molecule for NK cell-mediated tumor cell killing. We previously reported that TRAIL expression in liver NK cells decreases markedly after hepatectomy; however, the mechanism underlying this drastic alteration remains unknown. In this study, we assessed the role of chemokine signaling in liver-resident NK cells during the perioperative period of hepatectomy. The expression levels of various chemokine receptors on liver-resident NK cells and their associations with TRAIL expression were analyzed by flow cytometry. The expression of various intrahepatic chemokines/cytokines was analyzed after 70% hepatectomy in mice by quantitative RT-PCR and flow cytometry. We further investigated whether polyinosinic-polycytidylic acid (poly I:C)-induced NK cell activation could ameliorate TRAIL expression in the liver after 70% hepatectomy in CXCR3(-/-) and wild-type mice. TRAIL(+)NK cells strongly and exclusively expressed CXCR3, and the expression of its ligand CXCL9 was significantly decreased in the liver after hepatectomy. The kinetics of hepatic CXCL9 expression resembled the changes in hepatic TRAIL(+)NK cells after hepatectomy. Among liver-resident mononuclear cells, CXCL9 was predominantly secreted by macrophages in response to interferon-gamma stimulation. Although the administration of poly I: C, an inducer of interferon-gamma, increased hepatic CXCL9 levels in both CXCR3(-/-) and wildtype mice even after hepatectomy, only wild-type mice exhibited the recovery of TRAIL expression on NK cells. Partial hepatectomy remarkably reduced the proportion of TRAIL-expressing NK cells in the liver via the downregulation of the CXCL9-CXCR3 axis in mice. These findings extend our knowledge of the factors contributing to hepatocellular carcinoma recurrence after hepatectomy.	[Yano, Takuya; Ohira, Masahiro; Nakano, Ryosuke; Tanaka, Yuka; Ohdan, Hideki] Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University	Ohira, M (corresponding author), Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima, Japan.	mohira@hiroshima-u.ac.jp	Ohdan, Hideki/G-4719-2019; Ohira, Masahiro/G-7350-2019; Tanaka, Yuka/G-9580-2019	Ohdan, Hideki/0000-0002-9066-1288; Ohira, Masahiro/0000-0002-5433-5303	Ichino Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Hiroshima University Education and Research Support Foundation; Takeda Science Foundation; Ministry of Education, Science, Sports, and Culture of Japan [KAKENHI JP15K19893]	Ichino Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Hiroshima University Education and Research Support Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Ichino Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, the Hiroshima University Education and Research Support Foundation, Takeda Science Foundation, and a Grant-in-Aid for Scientific Research (KAKENHI JP15K19893 to M.O.) from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi JC, 2014, HEPATOLOGY, V60, P1389, DOI 10.1002/hep.27245; BOUWENS L, 1987, EUR J IMMUNOL, V17, P37, DOI 10.1002/eji.1830170107; Brady J, 2010, J IMMUNOL, V185, P6679, DOI 10.4049/jimmunol.0903354; Carrega P, 2014, J IMMUNOL, V192, P3805, DOI 10.4049/jimmunol.1301889; Curbishley SM, 2005, AM J PATHOL, V167, P887, DOI 10.1016/S0002-9440(10)62060-3; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Knolle PA, 1999, GASTROENTEROLOGY, V116, P1428, DOI 10.1016/S0016-5085(99)70508-1; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Liu Q, 2012, AM J PATHOL, V181, P452, DOI 10.1016/j.ajpath.2012.04.010; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Matsumoto M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7280; Minagawa M, 2000, HEPATOLOGY, V31, P907, DOI 10.1053/he.2000.5850; Miyake T, 2009, J IMMUNOL, V183, P2522, DOI 10.4049/jimmunol.0901500; MORIMOTO H, 1992, CANCER DETECT PREV, V16, P137; Ochi M, 2004, HEPATOLOGY, V39, P1321, DOI 10.1002/hep.20204; Ohdan H, 2003, TRANSPLANTATION, V76, P791, DOI 10.1097/01.TP.0000074603.36553.BD; Ohira M, 2006, TRANSPLANTATION, V82, P1712, DOI 10.1097/01.tp.0000250935.41034.2d; Pak-Wittel MA, 2013, P NATL ACAD SCI USA, V110, pE50, DOI 10.1073/pnas.1220456110; PARK SK, 1971, LANCET, V1, P53; Paul WE, 1999, FUNDAMENTAL IMMUNOLO, P575; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; ROBINSON RA, 1976, JNCI-J NATL CANCER I, V57, P599, DOI 10.1093/jnci/57.3.599; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Suzuki A, 2006, J HEPATOL, V45, P410, DOI 10.1016/j.jhep.2006.04.008; Takahashi M, 1996, J IMMUNOL, V156, P2436; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vujanovic NL, 1996, J IMMUNOL, V157, P1117; Wald O, 2006, J IMMUNOL, V176, P4716, DOI 10.4049/jimmunol.176.8.4716; Watanabe T, 2008, HEPATOL RES, V38, P441, DOI 10.1111/j.1872-034X.2007.00313.x; Wendel M, 2008, CANCER RES, V68, P8437, DOI 10.1158/0008-5472.CAN-08-1440; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186997	10.1371/journal.pone.0186997	http://dx.doi.org/10.1371/journal.pone.0186997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088306	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900035
J	Ahmed, UL; Ying, L; Bashir, MK; Abid, M; Zulfiqar, F				Ahmed, Umar Ljaz; Ying, Liu; Bashir, Muhammad Khalid; Abid, Muhammad; Zulfiqar, Farhad			Status and determinants of small farming households' food security and role of market access in enhancing food security in rural Pakistan	PLOS ONE			English	Article							LOGISTIC-REGRESSION; CLIMATE-CHANGE; PUNJAB; PERCEPTIONS; ADAPTATION; FARMERS; IMPACT; LEVEL	In most of the developing countries, lack of resources and little market accessibility are among the major factors that affect small farming household food security. This study aims to investigate the status of small farming households' food security, and its determinants including the role of market accessibility factors in enhancing food security at household level. In addition, this study also determines the households' perception about different kinds of livelihoods risks. This study is based on a household survey of 576 households conducted through face-to-face interviews using structured interviews in Punjab, Pakistan. Food security status is calculated using dietary intake method. The study findings show that one-fourth of the households are food insecure. The study findings reveal that farm households perceive increase in food prices, crop diseases, lack of irrigation water and increase in health expenses as major livelihood risks. Further, the results of logistic regression show that family size, monthly income, food prices, health expenses and debt are main factors influencing the food security status of rural households. Furthermore, the market accessibility factors (road distance and transportation cost) do significantly affect the small farming household food security. The results suggest that local food security can be enhanced by creating off-farm employment opportunities, improved transportation facilities and road infrastructure.	[Ahmed, Umar Ljaz] Muhammad Nawaz Shareef Univ Agr, Fac Social Sci & Humanities, Dept Agr & Resource Econ, Multan, Pakistan; [Ahmed, Umar Ljaz; Ying, Liu] Huazhong Agr Univ, Coll Econ & Management, Wuhan, Hubei, Peoples R China; [Ying, Liu] Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China; [Bashir, Muhammad Khalid] Univ Agr Faisalabad, Inst Agr & Resource Econ, Faisalabad, Pakistan; [Bashir, Muhammad Khalid] Univ Agr Faisalabad, Agr Policy, USPCAS AFS, Faisalabad, Faisalabad, Pakistan; [Abid, Muhammad] COMSATS Inst Informat Technol, Ctr Climate Res & Dev, Islamabad, Pakistan; [Zulfiqar, Farhad] COMSATS Inst Informat Technol, Dept Econ, Islamabad, Pakistan	Huazhong Agricultural University; Yangtze University; University of Agriculture Faisalabad; University of Agriculture Faisalabad; COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI)	Ying, L (corresponding author), Huazhong Agr Univ, Coll Econ & Management, Wuhan, Hubei, Peoples R China.; Ying, L (corresponding author), Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China.	liuying@mail.hzau.edu.cn	Ahmed, Umar Ijaz/L-8869-2018; Abid, Muhammad/J-8581-2017; Zulfiqar, Farhad/J-8719-2017; Bashir, Muhammad Khalid Khalid/H-9729-2014	Ahmed, Umar Ijaz/0000-0002-1939-2927; Abid, Muhammad/0000-0002-7691-4066; Zulfiqar, Farhad/0000-0002-3945-9172; Bashir, Muhammad Khalid Khalid/0000-0001-5572-2666	Fundamental Research Funds for the Central Universities of China [2662017PY062]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by the Fundamental Research Funds for the Central Universities of China (2662017PY062) - Dr. Liu Ying. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebaw D, 2010, FOOD POLICY, V35, P286, DOI 10.1016/j.foodpol.2010.01.002; Abid M, 2015, EARTH SYST DYNAM, V6, P225, DOI 10.5194/esd-6-225-2015; Abid M, 2016, SCI TOTAL ENVIRON, V547, P447, DOI 10.1016/j.scitotenv.2015.11.125; Abid M, 2011, PAK J AGR SCI, V48, P75; ADB, 2013, FOOD SEC AS PAC; Adeniyi O. R., 2013, African Journal of Food, Agriculture, Nutrition and Development, V13, P8209; Agbola P. O., 2010, ACTA SATECH, V3, P33; Ahmed H, 2012, KAFKAS UNIV VET FAK, V18, pA215; Ahmed U. I., 2015, J ENV AGR SCI, V3, P31; Ahmed U I, 2015, PAKIS J AGRIC RES, V28, P254; Ahmed UI, 2016, J ANIMAL PLANT SCI, V26; Alinovi L., 2009, MEASURING HOUSEHOLD; Babatunde R. O., 2007, Agricultural Journal, V2, P351; Baltenweck I, 2007, J AGR ECON, V58, P536, DOI 10.1111/j.1477-9552.2007.00129.x; Bashir MK, 2013, J ANIM PLANT SCI, V23, P611; Bashir M. K., 2010, World Applied Sciences Journal, V9, P403; Bashir M.K., 2012, 1203 U W AUSTR SCH A; Bashir M K, 2012, 1206 U W AUSTR SCH A; Cafiero C, 2014, ANN NY ACAD SCI, V1331, P230, DOI 10.1111/nyas.12594; Chaudhry S.M., 1997, INTRO STAT THEORY 2; Che J, 2001, Health Rep, V12, P11; FAO, 2009, CROP PROSP FOOD SIT; FAO, 2002, CROPS DROPS MAK BEST; FAO, 2005, STATE FOOD INWORLD; FAO, 1998, RAP PUBLICATION, V1999; FAO & WFP, 2014, STAT FOOD INS WORLD; Gebre G. G., 2012, INTERDISCIPLINARY DE, V10, P173; Gera N, 2004, ASIAN SURV, V44, P353, DOI 10.1525/as.2004.44.3.353; Gittelsohn Joel, 1998, Food and Nutrition Bulletin, V19, P210; GOP, 2011, EC SURV PAK 2010 11; GOP, 2003, EC SURV PAK 2002 03; Government of India, 2014, EC SURV 2013 14; Haile H.K., 2005, WORKING PAPER; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hussain A, 2014, ECOL FOOD NUTR, V53, P119, DOI 10.1080/03670244.2013.792076; IFAD, 2013, MARK OR HOUS FOOD SE; Iram U., 2004, INT J SOC ECON, V31, P753, DOI DOI 10.1108/03068290410546011; Keshaw L, 2006, HOUSEHOLD FOOD SECUR; Khan REA, 2009, NAT C SOC STAB PAK F; Kuwornu J. K. M., 2013, Russian Journal of Agricultural and Socio-Economic Sciences, V1, P26; Maharjan AKL, 2006, INT ASS AGR EC C; Mahmood S, 2014, MEDITERRANEAN J SOCI, V5, P676; Mason R, 2015, AGR HUM VALUES, V32, P539, DOI 10.1007/s10460-014-9568-5; Menard S, 2000, AM STAT, V54, P17, DOI 10.2307/2685605; Miller CM, 2011, FOOD POLICY, V36, P230, DOI 10.1016/j.foodpol.2010.11.020; Minten B, 1999, 26 INT FOOD POL RES; Okwoche VA, 2012, INT J BIOL BIOMOLECU, V6, P1117; Olayemi JK, 1998, INAUGURAL LECT, V167; Peng CYJ, 2002, RES HIGH EDUC, V43, P259, DOI 10.1023/A:1014858517172; Perez-Escamilla R, 2008, REV NUTR, V21, P15; Pinckney TC, 1989, 77 INT FOOD POL RES; Sidhu R. S., 2008, Agricultural Economics Research Review, V21, P91; Singh Archna, 2015, BMC Nutr, V1, P22; Sultana A, 2011, AFR J BUS MANAGE, V5, P12972, DOI 10.5897/AJBM11.1441; Tembo D, 2009, C INT RES FOOD SEC; Zakari S, 2014, SUSTAINABILITY-BASEL, V6, P1191, DOI 10.3390/su6031191; Zulfiqar F, 2014, J FOOD NUTR DISORDER, V3	57	38	39	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0185466	10.1371/journal.pone.0185466	http://dx.doi.org/10.1371/journal.pone.0185466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077719	gold, Green Submitted, Green Published			2022-12-27	WOS:000413861200005
J	Alemayehu, T; Mekasha, A; Abebe, T				Alemayehu, Tinsae; Mekasha, Amha; Abebe, Tamrat			Nasal carriage rate and antibiotic susceptibility pattern of Neisseria meningitidis in healthy Ethiopian children and adolescents: A cross-sectional study	PLOS ONE			English	Article							COLONIZATION	Background Community nasal meningococcal carriage rates are high across Africa. Meningococcal infections are major causes of morbidity and mortality in the continent; especially among children and adolescents. This study aimed to determine the prevalence of nasal carriage and antibiotic susceptibilities of meningococcal isolates from healthy Ethiopian children and adolescents. Method A cross-sectional study was conducted in one of the sub-cities of Addis Ababa, Ethiopia. Nasal swabs were collected and processed for identification, serogrouping and testing susceptibilities for three antibiotics using standard microbiological techniques. Data on epidemiologic risk factors were collected using a structured questionnaire and the magnitude of their association with carriage was assessed using bivariate and multivariate analysis. Result A total of 240 samples were collected (115 from males and 125 from females). The mean age of study participants was 11.1 years. The prevalence of nasal carriage for Neisseria meningitidis was 20.4% (49/240). Carriage was significantly higher among children living under crowded conditions (OR 1.268; 95% CI: 1.186-1.355; p = 0.006). The predominant serogroups were W135-20/49 isolates (40.8%) and C-12/49 isolates (24.5%) and 83.7% of meningococci were sensitive for Ciprofloxacin. In contrast, isolates showed high resistance to Ceftriaxone (69.4%) while only 4.2% were sensitive for Penicillin. Multi-drug resistance was documented for 14.3% of the isolates. Conclusions Meningococcal carriage rate was found to be high with higher rates associated with children and adolescents living in crowded living conditions. Predominant isolates were of serogroup W135 and C and the isolates showed marked susceptibility to Ciprofloxacin and resistance to Ceftriaxone and Penicillin.	[Alemayehu, Tinsae; Mekasha, Amha] Addis Ababa Univ, Dept Pediat & Child Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Abebe, Tamrat] Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Alemayehu, T (corresponding author), Addis Ababa Univ, Dept Pediat & Child Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia.	tigisttinsae@gmail.com		Alemayehu, Tinsae/0000-0003-0699-8433	Office of the Director for Research at the Office of the Vice President for Research and Technology Transfer of the Addis Ababa University;  [6223]	Office of the Director for Research at the Office of the Vice President for Research and Technology Transfer of the Addis Ababa University; 	We would like to acknowledge the Office of the Director for Research at the Office of the Vice President for Research and Technology Transfer of the Addis Ababa University for funding the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant number: 6223; We would like to thank the families of the children enrolled in the study, the data collectors and the administration and teachers of the Major General Hayelom Araya Primary and Junior Secondary school. We would also like to acknowledge the Office of the Director for Research at the Office of the Vice President for Research and Technology Transfer of the Addis Ababa University for funding the study.	Assefa A., 2013, THE J, V1, P2, DOI [10.4172/jidt.1000109, DOI 10.4172/JIDT.1000109]; Bakir M, 2001, EUR J EPIDEMIOL, V17, P1015, DOI 10.1023/A:1020021109462; Basta NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078336; Bogaert D, 2005, CLIN INFECT DIS, V40, P899, DOI 10.1086/428351; British society for antimicrobial chemotherapy, 2015, METH ANT SUSC TEST; Centers for Disease Control and Prevention, 2021, INFL ANT MED SUMM CL; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Clinical & Laboratory Standard Institute, 2016, PERFORMANCE STANDARD; de los Monteros LEED, 2009, SALUD PUBLICA MEXICO, V51, P114, DOI 10.1590/S0036-36342009000200006; Fahimzad A., 2008, Iranian Journal of Clinical Infectious Diseases, V3, P25; Forgor AA, 2005, TROP MED INT HEALTH, V10, P1229, DOI 10.1111/j.1365-3156.2005.01520.x; Gazi H, 2004, ANN ACAD MED SINGAP, V33, P758; Pavlopoulou ID, 2004, CLIN MICROBIOL INFEC, V10, P137, DOI 10.1111/j.1469-0691.2004.00750.x; The MenAfriCar Consortium, 2015, J INFECT DIS, V212, P1298; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; US Department of housing & urban development, 2007, MEAS OV HOUS; World Health Organization, 2003, MANUAL LAB IDENTIFIC	17	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187207	10.1371/journal.pone.0187207	http://dx.doi.org/10.1371/journal.pone.0187207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073269	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400133
J	Lu, MC; Tung, CH; Yang, CC; Wang, CL; Huang, KY; Koo, M; Lai, NS				Lu, Ming-Chi; Tung, Chien-Hsueh; Yang, Chang-Chen; Wang, Chun-Lung; Huang, Kuang-Yung; Koo, Malcolm; Lai, Ning-Sheng			Incident osteoarthritis and osteoarthritis-related joint replacement surgery in patients with ankylosing spondylitis: A secondary cohort analysis of a nationwide, population-based health claims database	PLOS ONE			English	Article							AXIAL SPONDYLOARTHRITIS; ARTHRITIS; CRITERIA	Background Ankylosing spondylitis (AS) might be associated with an increased risk of secondary osteoarthritis. However, there is a lack of studies assessing its impact on osteoarthritis-related surgery. The aim of this secondary cohort study was to investigate the risk of symptomatic osteoarthritis and osteoarthritis-related surgery, including total hip replacement surgery (THRS) and total knee replacement surgery (THRS) in patients with AS. Methods Using the Taiwan's National Health Insurance Research Database, we identified 3,462 patients with AS between 2000 and 2012. A comparison cohort was assembled consisting of five patients without AS, based on frequency matching for sex, 10-year age interval, and index year, for each patient with AS. Both groups were followed until diagnosis of the study outcomes or the end of the follow-up period. Results Male patients with AS exhibited a significantly higher incidence of osteoarthritis (adjusted incidence rate ratio [IRR] 1.43; P< 0.001), THRS (adjusted IRR 12.59; P< 0.001), and TKRS (adjusted IRR 1.89; P=0.036). Moreover, analyses stratified by age group (20-39 years versus 40-80 years) indicated a high IRR (adjusted IRR 27.66; P<.001) for THRS among younger patients with AS. Conclusions Male patients with AS had a significant higher risk of developing osteoarthritis, and receiving THRS and TKRS. Young patients with AS also showed a significant higher risk of receiving THRS.	[Lu, Ming-Chi; Tung, Chien-Hsueh; Huang, Kuang-Yung; Lai, Ning-Sheng] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lu, Ming-Chi; Huang, Kuang-Yung; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yang, Chang-Chen] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Orthoped, Chiayi, Taiwan; [Wang, Chun-Lung] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Pediat, Chiayi, Taiwan; [Koo, Malcolm] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto	Lai, NS (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan.; Lai, NS (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Koo, M (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan.; Koo, M (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	m.koo@utoronto.ca; tzuchilai@gmail.com	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167	Buddhist Tzu Chi Medical Foundation [TCMMP105-01-01, TCMMP105-01-02]	Buddhist Tzu Chi Medical Foundation	This work was supported by Buddhist Tzu Chi Medical Foundation, grant numbers TCMMP105-01-01 and TCMMP105-01-02. The URL of the funding institution is http://www.tzuchimedicalfoundation.org/. NSL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study is based in part on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by the National Health Research Institutes, Taiwan. The interpretation and conclusions contained herein do not represent those of the National Health Insurance Administration, Ministry of Health and Welfare or the National Health Research Institutes, Taiwan. This work was supported by grants from the Buddhist Tzu Chi Medical Foundation (TCMMP105-01-01 andTCMMP105-01-02).	Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; CHOU CT, 1994, J RHEUMATOL, V21, P302; Dakwar E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/1/E2; Das SK, 2008, BEST PRACT RES CL RH, V22, P657, DOI 10.1016/j.berh.2008.07.002; Gorman JD, 2002, NEW ENGL J MED, V346, P1349, DOI 10.1056/NEJMoa012664; Gracey E, 2016, ARTHRITIS RHEUMATOL, V68, P679, DOI 10.1002/art.39464; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Ibn Yacoub Y, 2012, CLIN RHEUMATOL, V31, P293, DOI 10.1007/s10067-011-1819-x; Kristensen LE, 2010, ARTHRIT CARE RES, V62, P1362, DOI 10.1002/acr.20258; Lee W, 2007, ANN RHEUM DIS, V66, P633, DOI 10.1136/ard.2006.060293; Loeser RF, 2013, CURR OPIN RHEUMATOL, V25, P108, DOI 10.1097/BOR.0b013e32835a9428; National Health Insurance Administration Ministry of Health and Welfare Taiwan, NAT HLTH INS TAIW 20; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P770, DOI 10.1136/ard.2009.108217; Saglam Y, 2016, ACTA ORTHOP TRAUMATO, V50, P443, DOI 10.1016/j.aott.2016.06.010; Schafer VS, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-358; Sochart DH, 1997, J BONE JOINT SURG AM, V79A, P1181, DOI 10.2106/00004623-199708000-00010; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Taurog JD, 2016, NEW ENGL J MED, V374, P2563, DOI 10.1056/NEJMra1406182; Thijssen E, 2015, RHEUMATOLOGY, V54, P588, DOI 10.1093/rheumatology/keu464; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Webers C, 2016, RHEUMATOLOGY, V55, P419, DOI 10.1093/rheumatology/kev340; Yucesoy B, 2015, WORK, V50, P261, DOI 10.3233/WOR-131739	22	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187594	10.1371/journal.pone.0187594	http://dx.doi.org/10.1371/journal.pone.0187594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095939	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200122
J	Nocchi, N; Soares, AR; Souto, ML; Fernandez, JJ; Martin, MN; Pereira, RC				Nocchi, N.; Soares, A. R.; Souto, M. L.; Fernandez, J. J.; Martin, M. N.; Pereira, R. C.			Detection of a chemical cue from the host seaweed Laurencia dendroidea by the associated mollusc Aplysia brasiliana	PLOS ONE			English	Article							HALOGENATED METABOLITES; ANTIBACTERIAL ACTIVITY; CHAMIGRANE METABOLITES; RED ALGAE; SEA HARES; MARINE; SESQUITERPENES; DACTYLOMELA; BEHAVIOR; SIGNALS	Chemical cues from sessile hosts can attract mobile and associated organisms and they are also impotant to maintain associations and overall biodiversity, but the identity and molecular structures of these chemicals have been little explored in the marine environment. Secondary metabolites are recognized as possible chemical mediators in the association between species of Laurencia and Aplysia, but the identity of the compounds has not been established. Here, for the first time, we experimentally verify that the sesquiterpene (+)-ela-tol, a compound produced by the red seaweed Laurencia dendroidea, is a chemical cue attracting the associated sea hare Aplysia brasiliana. In addition to revealing the nature of the chemical mediation between these two species, we provide evidence of a chemical cue that allows young individuals of A. brasiliana to live in association with L. dendroidea. This study highlights the importance of chemical cues in Laurencia-Aplysia association.	[Nocchi, N.; Pereira, R. C.] Univ Fed Fluminense, Programa Posgrad Dinamica Oceano & Terra, Campus Praia Vermelha, Niteroi, RJ, Brazil; [Nocchi, N.; Soares, A. R.] Univ Fed Rio de Janeiro, GPNOA, Nucl Ecol & Desenvolvimento Socioambiental Macae, Macae, Brazil; [Souto, M. L.; Fernandez, J. J.; Martin, M. N.] Univ La Laguna, Dept Quim Organ, Ctr Invest Biomed Canarias CIBICAN, Inst Univ Bioorgan Antonio Gonzalez IUBO, Tenerife, Spain	Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidad de la Laguna	Pereira, RC (corresponding author), Univ Fed Fluminense, Programa Posgrad Dinamica Oceano & Terra, Campus Praia Vermelha, Niteroi, RJ, Brazil.; Soares, AR (corresponding author), Univ Fed Rio de Janeiro, GPNOA, Nucl Ecol & Desenvolvimento Socioambiental Macae, Macae, Brazil.	angelica.r.soares@gmail.com; rcrespo@id.uff.br	Fernandez, Jose/L-3343-2014; Fernández, José Javier/AAA-3439-2019; Pereira, Renato Crespo/AAA-7832-2020; Soares, Angelica/AAW-6611-2021; Souto, Maria L/L-5911-2014	Fernandez, Jose/0000-0002-0805-8317; Fernández, José Javier/0000-0002-0805-8317; Soares, Angelica/0000-0001-9126-3778; Souto, Maria L/0000-0001-9123-0749; Pereira, Renato/0000-0001-7576-226X; Nocchi, Nathalia/0000-0001-6811-1581	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Project of the Spain National Plan [CTQ2014-55888-C03-01]; CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Project of the Spain National Plan; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial Support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro and the Project of the Spain National Plan (CTQ2014-55888-C03-01). RCP thanks CNPq for Research Productivity fellowships. M thanks Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for a doctoral fellowship and CNPq for a sandwich doctoral fellowship.r We are grateful to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro and the Project of the Spain National Plan (CTQ2014-55888-C03-01) for financial support. RCP thanks CNPq for Research Productivity fellowships. NN thanks Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for a doctoral fellowship and CNPq for a sandwich doctoral fellowship. We are also grateful to the peer reviewers for the substantial contributions in improving our manuscript.	ALINO PM, 1992, J EXP MAR BIOL ECOL, V164, P209, DOI 10.1016/0022-0981(92)90175-A; [Anonymous], 2016, MAR DRUGS, V14, P1; AUDESIRK TE, 1975, BEHAV BIOL, V15, P45, DOI 10.1016/S0091-6773(75)92066-0; Bansemir A, 2004, CHEM BIODIVERS, V1, P463, DOI 10.1002/cbdv.200490039; BRENNAN MR, 1987, PHYTOCHEMISTRY, V26, P1053, DOI 10.1016/S0031-9422(00)82349-3; Carefoot TH, 2003, J EXP MAR BIOL ECOL, V288, P223, DOI 10.1016/S0022-0981(03)00019-4; COLL JC, 1989, AUST J CHEM, V42, P1591, DOI 10.1071/CH9891591; Da Gama BAP, 2002, BIOFOULING, V18, P13, DOI 10.1080/08927010290017680; Machado FLD, 2011, PLANTA MED, V77, P733, DOI 10.1055/s-0030-1250526; DASILVAMACHADO FL, 2014, J AGARDH MOL, V19, P3181, DOI DOI 10.3390/MOLECULES19033181; Derby CD, 2007, BIOL BULL-US, V213, P274, DOI 10.2307/25066645; Dias T, 2005, J NAT PROD, V68, P1677, DOI 10.1021/np050240y; Diaz-Marrero AR, 2012, J NAT PROD, V75, P115, DOI 10.1021/np200845f; Gavagnin M, 2000, J CHEM ECOL, V26, P1563, DOI 10.1023/A:1005526526884; Gillette R, 2000, P NATL ACAD SCI USA, V97, P3585, DOI 10.1073/pnas.97.7.3585; Ginsburg DW, 2001, MAR ECOL PROG SER, V215, P261, DOI 10.3354/meps215261; Harizani M, 2016, PROG CHEM ORG NAT PR, V102, P91, DOI 10.1007/978-3-319-33172-0_2; Hay Mark E., 1992, P93; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Jimenez-Romero C, 2014, BIOORG MED CHEM LETT, V24, P344, DOI 10.1016/j.bmcl.2013.11.008; Kamio M, 2017, NAT PROD REP, V34, P514, DOI 10.1039/c6np00121a; Kamio M, 2010, ANIM BEHAV, V80, P89, DOI 10.1016/j.anbehav.2010.04.003; Kamiya H, 2006, PROG MOLEC, V43, P215, DOI 10.1007/978-3-540-30880-5_10; KENNEDY DJ, 1988, PHYTOCHEMISTRY, V27, P1761, DOI 10.1016/0031-9422(88)80439-4; Machado FLD, 2014, REV BRAS FARMACOGN, V24, P635, DOI 10.1016/j.bjp.2014.10.009; Machado FLD, 2010, REV BRAS FARMACOGN, V20, P441, DOI 10.1590/S0102-695X2010000300024; Machado FLS, 2016, CHEM BIODIVERS, V13, P845, DOI 10.1002/cbdv.201500246; Mollo E, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00092; Nielsen NPV, 1998, J CHROMATOGR A, V805, P17, DOI 10.1016/S0021-9673(98)00021-1; Nunez-Acuna G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060700; Palaniveloo K, 2014, J APPL PHYCOL, V26, P1199, DOI 10.1007/s10811-013-0127-z; Paradas WC, 2016, PLANT CELL PHYSIOL, V57, P1008, DOI 10.1093/pcp/pcw039; Pennings SC, 2001, CORAL REEFS, V20, P320, DOI 10.1007/s003380100178; PENNINGS SC, 1990, J EXP MAR BIOL ECOL, V142, P43, DOI 10.1016/0022-0981(90)90136-Z; Pereira R. C., 2008, P25, DOI 10.1007/978-3-540-74181-7_2; Pereira RC, 2013, BRAZ J BIOL, V63, P665; Rasher DB, 2015, P NATL ACAD SCI USA, V112, P12110, DOI 10.1073/pnas.1508133112; ROGERS CN, 1995, J EXP MAR BIOL ECOL, V192, P47, DOI 10.1016/0022-0981(95)00057-X; Rogers CN, 2002, MAR ECOL PROG SER, V236, P241, DOI 10.3354/meps236241; Saleh N, 2007, ARTHROPOD-PLANT INTE, V1, P119, DOI 10.1007/s11829-007-9011-6; Salgado LT, 2008, J STRUCT BIOL, V162, P345, DOI 10.1016/j.jsb.2008.01.015; Steiger S, 2010, P R SOC LOND B; Sudatti DB, 2006, J CHEM ECOL, V32, P835, DOI 10.1007/s10886-006-9033-z; Sudatti DB, 2016, BIOCHEM SYST ECOL, V64, P131, DOI 10.1016/j.bse.2015.12.001; Switzer-Dunlap M, 1978, P S SETTL MET MAR IN, P197; Tebben J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10803; Vairappan C.S., 2009, MALAYS J SCI, V28, P269; Vairappan CS, 2003, BIOMOL ENG, V20, P255, DOI 10.1016/S1389-0344(03)00067-4; Vairappan CS, 2001, PHYTOCHEMISTRY, V58, P517, DOI 10.1016/S0031-9422(01)00260-6; Wang BG, 2013, CHEM REV, V113, P3632, DOI 10.1021/cr9002215; Weissburg J., 2015, CHEM ECOLOGY AQUATIC; Wessels M, 2000, J NAT PROD, V63, P920, DOI 10.1021/np9905721; Zimmer RK, 1999, ECOLOGY, V80, P1432, DOI 10.1890/0012-9658(1999)080[1432:REOECS]2.0.CO;2	53	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187126	10.1371/journal.pone.0187126	http://dx.doi.org/10.1371/journal.pone.0187126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095906	Green Submitted, gold, Green Published			2022-12-27	WOS:000414340200047
J	Joshi, S; Wang, W; Khan, SR				Joshi, Sunil; Wang, Wei; Khan, Saeed R.			Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition	PLOS ONE			English	Article							KIDNEY-STONE FORMATION; MATRIX GLA-PROTEIN; RENAL EPITHELIAL-CELLS; TAMM-HORSFALL PROTEIN; MESSENGER-RNA; OXIDATIVE STRESS; TEMPORAL-CHANGES; URINARY BIKUNIN; GENE-EXPRESSION; INHIBITOR	Hyperoxaluria associated with renal deposition of calcium oxalate (CaOx) crystals causes renal injury and inflammation leading to number of diseases including chronic kidney disease (CKD). It is however, not been possible to separate the renal consequences of hyperoxaluria from that of CaOx crystal deposition. We decided to utilize ethylene glycol (EG) model where hyperoxaluria and CaOx crystal deposition can be separated in time. To test our hypothesis, male rats were made hyperoxaluric by administering EG, rats were euthanized and kidneys were extracted on day 14, when occasional crystal is seen in the kidneys and day 28, when all animals have developed renal CaOx crystal deposits. Total RNA was extracted for microarray analysis and genome wide analysis of differentially expressed genes was performed to investigate differences between hyperoxaluria and crystal induced alterations in the kidneys. Immunohistochemical and Hematoxylin and Eosin (H&E) staining was also done for macromolecules with significant role in stone formation. All EG fed rats became hyperoxaluric by day 7, showed a few crystal deposits on day 14, and had heavy crystal deposition by day 28. There were significant changes in the expression of genes encoding for NADPH Oxidases; macromolecular crystallization modulators; genes involved in inflammasome activation; and osteogenic marker genes. Results demonstrate major differences between hyperoxaluria and CaOx crystal induced changes in the kidneys. Injury and inflammation are mainly associated with crystal deposition indicating significant role played by crystal retention.	[Joshi, Sunil; Wang, Wei; Khan, Saeed R.] Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32611 USA; [Khan, Saeed R.] Univ Florida, Dept Urol, Coll Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Khan, SR (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32611 USA.; Khan, SR (corresponding author), Univ Florida, Dept Urol, Coll Med, Gainesville, FL 32611 USA.	Khan@pathology.ufl.edu		Khan, Saeed/0000-0001-6975-5952	National Institutes of Health [R01-DK078602, DK092311]; University of Florida Center for the Study of Lithiasis; University of Florida Open Access Publishing Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078602, R01DK092311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Center for the Study of Lithiasis; University of Florida Open Access Publishing Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grant #RO1-DK078602, DK092311 and University of Florida Center for the Study of Lithiasis. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Jin Yao and Dr. Yijun Sun from the University of Florida's Interdisciplinary Center for Biotechnology Research (ICBR) for running the microarrays and data analyses, Dr. Ammon B. Peck for his advice and suggestions during studies, and Dr. Vineet Sangar from Institute of Systems Biology (ISB), Seattle, WA for providing expert assistance in data analysis and Bioinformatics. Supported by National Institutes of Health grant #RO1-DK078602, DK092311 and University of Florida Center for the Study of Lithiasis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplin JR, 2002, ENDOCRIN METAB CLIN, V31, P927, DOI 10.1016/S0889-8529(02)00030-0; Asselman M, 2003, J AM SOC NEPHROL, V14, P3155, DOI 10.1097/01.ASN.0000099380.18995.F7; Atmani F, 1999, J AM SOC NEPHROL, V10, pS385; Atmani F, 1996, EUR J BIOCHEM, V236, P984, DOI 10.1111/j.1432-1033.1996.00984.x; Canales BK, 2012, NUTRITION, V28, P76, DOI 10.1016/j.nut.2011.03.003; Correa-Rotter R, 1998, J AM SOC NEPHROL, V9, P33; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Gao B, 2010, UROL INT, V85, P237, DOI 10.1159/000314947; Glaros T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034633; Gokhale JA, 2001, J UROLOGY, V166, P1492, DOI 10.1016/S0022-5347(05)65818-1; Grewal JS, 2005, BIOCHEM J, V387, P609, DOI 10.1042/BJ20041465; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; HARDING MA, 1991, DEV BIOL, V146, P483, DOI 10.1016/0012-1606(91)90249-3; Hellmann M, 2012, TRENDS CARDIOVAS MED, V22, P197, DOI 10.1016/j.tcm.2012.07.020; Holmes RP, 2005, J UROLOGY, V174, P943, DOI 10.1097/01.ju.0000169476.85935.e2; Holmes RP, 2000, KIDNEY INT, V57, P1662, DOI 10.1046/j.1523-1755.2000.00010.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HS, 2002, J UROLOGY, V167, P2584, DOI 10.1016/S0022-5347(05)65042-2; Hunter GK, 2013, CALCIF TISSUE INT; Hunter GK, 2009, CELLS TISSUES ORGANS, V189, P44, DOI 10.1159/000151430; Iida S, 1999, J UROLOGY, V162, P1480, DOI 10.1016/S0022-5347(05)68344-9; Iida S, 1999, J AM SOC NEPHROL, V10, P986; Joshi S, 2015, BBA-MOL BASIS DIS, V1852, P2000, DOI 10.1016/j.bbadis.2015.06.020; Joshi S, 2015, J UROLOGY, V193, P1684, DOI 10.1016/j.juro.2014.11.093; Joshi S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/462361; Joshi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047738; Jungers P, 2004, AM J KIDNEY DIS, V44, P799, DOI 10.1053/j.ajkd.2004.08.014; Khan A, 2014, WORLD J UROL, V32, P123, DOI 10.1007/s00345-013-1050-2; Khan SR, 2006, KIDNEY INT, V70, P914, DOI 10.1038/sj.ki.5001699; Khan Saeed R, 2004, Clin Exp Nephrol, V8, P75; Khan SR, 2014, AM J PHYSIOL-RENAL, V306, pF1285, DOI 10.1152/ajprenal.00057.2014; Khan SR, 2013, J UROLOGY, V189, P803, DOI 10.1016/j.juro.2012.05.078; Khan SR, 2012, UROL RES, V40, P95, DOI 10.1007/s00240-011-0448-9; Khan SR, 2011, NEPHROL DIAL TRANSPL, V26, P1778, DOI 10.1093/ndt/gfq692; Khan Saeed R, 2011, Arch Ital Urol Androl, V83, P1; Khan SR, 2010, J UROLOGY, V184, P1189, DOI 10.1016/j.juro.2010.04.065; Khan SR, 1997, WORLD J UROL, V15, P236, DOI 10.1007/BF01367661; Khan SR, 2004, FRONT BIOSCI-LANDMRK, V9, P1450, DOI 10.2741/1347; Khan SR, 1999, J AM SOC NEPHROL, V10, pS457; Khan SR, 2000, MOL UROL, V4, P305; Khand FD, 2002, FREE RADICAL BIO MED, V32, P1339, DOI 10.1016/S0891-5849(02)00846-8; Kleinman JG, 2004, NEPHRON PHYSIOL, V98, P43, DOI DOI 10.1159/000080263; Kohri K, 2012, UROL RES, V40, P623, DOI 10.1007/s00240-012-0514-y; Koul S, 2002, KIDNEY INT, V61, P525, DOI 10.1046/j.1523-1755.2002.00163.x; Koul S, 2014, AM J PHYSIOL-RENAL, V306, pF1039, DOI 10.1152/ajprenal.00462.2013; Koul S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043886; Mandel NS, 2004, J UROLOGY, V171, P1301, DOI 10.1097/01.ju.0000110101.41653.bb; Marengo SR, 2002, J UROLOGY, V167, P2192, DOI 10.1016/S0022-5347(05)65127-0; Miyazawa K, 2009, UROL RES, V37, P27, DOI 10.1007/s00240-008-0164-2; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; Monico CG, 2002, KIDNEY INT, V62, P392, DOI 10.1046/j.1523-1755.2002.00468.x; Moriyama MT, 2001, J UROLOGY, V165, P1687, DOI 10.1016/S0022-5347(05)66394-X; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Okada A, 2010, J BONE MINER RES, V25, P2425, DOI 10.1002/jbmr.158; Okada A, 2009, J BONE MINER RES, V24, P908, DOI [10.1359/JBMR.081245, 10.1359/jbmr.081245]; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rule AD, 2010, J AM SOC NEPHROL, V21, P1641, DOI 10.1681/ASN.2010030253; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; RYALL RL, 2004, NEPHRON PHYSIOL, V98, P37, DOI DOI 10.1159/000080262; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schepers MSJ, 2005, KIDNEY INT, V68, P1543, DOI 10.1111/j.1523-1755.2005.00566.x; Schurgers LJ, 2008, THROMB HAEMOSTASIS, V100, P593, DOI 10.1160/TH08-02-0087; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Stapleton AMF, 1998, BRIT J UROL, V81, P666; Stejskal D, 2008, BJU INT, V101, P1151, DOI 10.1111/j.1464-410X.2007.07432.x; Thamilselvan S, 1997, J UROLOGY, V157, P1059, DOI 10.1016/S0022-5347(01)65141-3; Thamilselvan S, 1999, J AM SOC NEPHROL, V10, pS452; Tsujihata M, 2000, J UROLOGY, V164, P1718, DOI 10.1016/S0022-5347(05)67095-4; Umekawa T, 2004, J AM SOC NEPHROL, V15, P635, DOI 10.1097/01.ASN.0000113321.49771.2D; Umekawa T, 2002, KIDNEY INT, V61, P105, DOI 10.1046/j.1523-1755.2002.00106.x; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; Yasui T, 1999, UROL RES, V27, P255, DOI 10.1007/s002400050119; Zuo J, 2011, NEPHROL DIAL TRANSPL, V26, P1785, DOI 10.1093/ndt/gfr035	74	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185009	10.1371/journal.pone.0185009	http://dx.doi.org/10.1371/journal.pone.0185009			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091707	Green Submitted, Green Published, gold			2022-12-27	WOS:000414229700003
J	Oyeyemi, OT; Odaibo, AB				Oyeyemi, Oyetunde T.; Odaibo, Alexander B.			Maternal urogenital schistosomiasis; monitoring disease morbidity by simple reagent strips	PLOS ONE			English	Article							URINARY SCHISTOSOMIASIS; PREGNANT-WOMEN; HAEMATOBIUM INFECTION; RURAL COMMUNITIES; OGUN STATE; HEMATURIA; QUESTIONNAIRES; DIAGNOSIS; CHILDREN; PROTEINURIA	Background Urine analysis is one of the recommended antenatal guidelines for early diagnosis of pregnancy -associated complications. While in practice, urine analysis by dipstick had been used to provide useful information on other urinary tract infections, its applications for early detection of urogenital schistosomiasis in pregnant women is often times not given due attention in most endemic areas. Our study therefore assessed the performance of some common urinalysis parameters in the diagnosis of maternal urogenital schistosomiasis in endemic rural communities of Nigeria. Methodology/Principal findings The cross-sectional epidemiologic survey of urogenital schistosomiasis was conducted among pregnant women in Yewa North Local Government, Ogun State, Nigeria. The women were microscopically examined for infection with Schistosoma haematobium, visually observed for macrohematuria, and screened for microhematuria and proteinuria using standard urine chemical reagent strips. Of 261 volunteered participants, 19.9% tested positive for S. haematobium infection. The proportion of microhematuria (23.8%) was significantly higher than that of macrohematuria (3.8%) and proteinuria (16.8%) (P<0.05). Microhematuria with sensitivity (82.7%) and specificity (89.0%) was the best diagnostic indicator of urogenital schistosomiasis. Macrohematuria with the least sensitivity (11.8%) was however the most specific (98.1%) for diagnosing urogenital schistosomiasis in pregnant women. Maximum microhematuria sensitivity (100.0%) was observed in women between 15-19 years but sensitivity was consistently low in older age groups. Maximum sensitivity, specificity and predictive values (100.0%) were recorded for microhematuria in first trimester women. Diagnostic efficiency of proteinuria and macrohematuria was also better in the first trimester women except the 25.0% specificity recorded for proteinuria. The overall diagnostic performance of microhematuria and proteinuria was better in secundigravidae. Conclusions/Significance Microhematuria can be used for early detection of urogenital schistosomiasis in endemic areas especially in younger women. However because microhematuria is a condition that occurs during pregnancy and in several other diseases, it is necessary to compliment the diagnosis with other diagnostic tools such as microscopy and serology. Treatment with praziquantel is recommended for the women in their late trimesters after follow up test in order to avert associated adverse pregnancy outcomes.	[Oyeyemi, Oyetunde T.] Univ Med Sci, Dept Biol Sci, Ondo, Ondo State, Nigeria; [Odaibo, Alexander B.] Univ Ibadan, Dept Zool, Ibadan, Oyo State, Nigeria	University of Ibadan	Oyeyemi, OT (corresponding author), Univ Med Sci, Dept Biol Sci, Ondo, Ondo State, Nigeria.	zootund@yahoo.com	Oyeyemi, Oyetunde T./G-7824-2012	Oyeyemi, Oyetunde T./0000-0002-3089-2578				Adegnika AA, 2010, TROP MED INT HEALTH, V15, P1204, DOI 10.1111/j.1365-3156.2010.02598.x; Akinwale Olaoluwa, 2015, Folia Malacologica, V23, P137, DOI 10.12657/folmal.023.009; [Anonymous], 2013, SCHIST PROGR REP 200; Anosike JC, 2001, J HELMINTHOL, V75, P223; Ayele B, 2008, PARASITE, V15, P69, DOI 10.1051/parasite/2008151069; Basra A, 2013, CLIN INFECT DIS, V56, pE68, DOI 10.1093/cid/cis976; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; DANIELLI L, 1987, OBSTET GYNECOL, V69, P446; Eyo JE, 2012, TROP BIOMED, V29, P575; Friedman JF, 2007, TRENDS PARASITOL, V23, P159, DOI 10.1016/j.pt.2007.02.006; Gundersen SG, 1996, ACTA TROP, V62, P281, DOI 10.1016/S0001-706X(96)00029-0; Guyatt H, 1999, TROP MED INT HEALTH, V4, P751, DOI 10.1046/j.1365-3156.1999.00483.x; Jou WW, 1998, SOUTHERN MED J, V91, P266, DOI 10.1097/00007611-199803000-00010; Kapito-Tembo AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000361; Khalid A, 2012, INT J GYNECOL OBSTET, V116, P10, DOI 10.1016/j.ijgo.2011.08.018; King CH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002431; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Koukounari A, 2009, AM J TROP MED HYG, V80, P435, DOI 10.4269/ajtmh.2009.80.435; Krauth SJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1165-y; Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235; Mafe MA, 1997, ACTA TROP, V68, P277, DOI 10.1016/S0001-706X(97)00102-2; Mafe MA, 2000, TROP MED INT HEALTH, V5, P53, DOI 10.1046/j.1365-3156.2000.00508.x; Meurs L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001829; Morenikeji O, 2014, AFR HEALTH SCI, V14, P390, DOI 10.4314/ahs.v14i2.15; MOTT KE, 1983, LANCET, V1, P1005; Ochodo EA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009579.pub2; Poggensee G, 2000, B WORLD HEALTH ORGAN, V78, P542; Rudra P, 2011, BJMP, V4, P433; Salawu OT, 2014, HELMINTHOLOGIA, V51, P337, DOI 10.2478/s11687-014-0250-7; Salawu Oyetunde T, 2016, J Parasit Dis, V40, P93, DOI 10.1007/s12639-014-0454-2; Salawu OT, 2014, J PEDIATR UROL, V10, P88, DOI 10.1016/j.jpurol.2013.06.010; Salawu OT, 2013, AFR J ECOL, V51, P441, DOI 10.1111/aje.12054; Salawu OT, 2013, INT J GYNECOL OBSTET, V122, P1, DOI 10.1016/j.ijgo.2013.01.024; Stothard JR, 2009, T ROY SOC TROP MED H, V103, P325, DOI 10.1016/j.trstmh.2008.12.012; Stothard JR, 2006, ACTA TROP, V97, P219, DOI 10.1016/j.actatropica.2005.11.004; TAYLOR P, 1990, ACTA TROP, V47, P91, DOI 10.1016/0001-706X(90)90071-7; Thigpen MC, 2011, AM J TROP MED HYG, V84, P379, DOI 10.4269/ajtmh.2011.10-0186; Ugbomoiko US, 2010, ANN TROP MED PARASIT, V104, P409, DOI 10.1179/136485910X12743554760469; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Venyo A., 2010, WEBMEDCENTRAL UROL, V1; WILKINS HA, 1979, T ROY SOC TROP MED H, V73, P74, DOI 10.1016/0035-9203(79)90134-2; World Health Organization, REP WHO INF CONS US	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187433	10.1371/journal.pone.0187433	http://dx.doi.org/10.1371/journal.pone.0187433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091946	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700065
J	Zheng, HN; Wang, MY; Zhao, CC; Wu, SL; Yu, PF; Lu, Y; Wang, TD; Ai, YX				Zheng, Hainan; Wang, Mengyun; Zhao, Chengcheng; Wu, Shanli; Yu, Peifeng; Lu, Yan; Wang, Tiedong; Ai, Yongxing			Characterization of the deubiquitination activity and substrate specificity of the chicken ubiquitin-specific protease 1/USP associated factor 1 complex	PLOS ONE			English	Article							FANCONI-ANEMIA PATHWAY; STRENGTH-DEPENDENT CONFORMATIONS; IONIC-STRENGTH; HOMOLOGOUS RECOMBINATION; HALOFERAX-VOLCANII; ENZYME; UAF1; USP1; PROTEINS; AUTOCLEAVAGE	Deubiquitinases (DUBs) are essential regulators of intracellular processes involving ubiquitin (Ub) modification. The human DUB ubiquitin-specific protease 1 (hUSP1) interacts with human USP-associated factor 1 (hUAF1), and helps to regulate processes such as DNA damage repair. Previously, we identified a chicken USP1 homologue (chUSP1) during an investigation into the properties of Marek's disease virus (MDV). However, chUSP1's deubiquitination activity, interaction with chUAF1, and substrate specificity remained unknown. In the present study, we expressed and purified both chUAF1 and chUSP1 with or without putative catalytic core mutations using the Bac-to-Bac system, before investigating their deubiquitination activity and kinetics using various substrates. chUSP1 was shown to interact with chUAF1 both in cellular assays in which the two proteins were co-expressed, and in in vitro assays using purified proteins. Heterodimerization with chUAF1 increased the deubiquitination activity of chUSP1 up to 54-fold compared with chUSP1 alone. The chUSP1 mutants C91S, H603A, and D758A reduced the deubiquitination activity of the chUSP1/chUAF1 complex by 10-, 7-, and 33-fold, respectively, while the C91A and H594A chUSP1 mutants eliminated deubiquitination activity of the chUSP1/chUAF1 complex completely. This suggests that C91 and H594, but not D758, are essential for chUSP1 deubiquitination activity, and that a nucleophilic group at position 91 is needed for the deubiquitination reaction. The chUSP1/chUAF1 complex was found to have distinct substrate preferences; efficient hydrolysis of Ub dimers with K11-, K48-, and K63-linkages was seen, with weaker hydrolysis observed with K6-, K27-, and K33-linkages and no hydrolysis seen with a K29 linkage. Furthermore, other Ub-like substrates were disfavored by the complex. No activity was seen with SUMO1-GST, SUMO2- and SUMO3-dimers, ISG15-Rho, FAT10-Rho, or Ufm1-Rho, and only weak activity was observed with NEDD8-Rho. Overall, the data presented here characterize the activity and substrate preferences of chUSP1, and thus may facilitate future studies on its in vivo role.	[Zheng, Hainan; Wang, Mengyun; Yu, Peifeng; Lu, Yan; Wang, Tiedong; Ai, Yongxing] Jilin Univ, Coll Anim Sci, Changchun, Jilin, Peoples R China; [Zhao, Chengcheng] Jilin Univ, Inst Translat Med, Changchun, Jilin, Peoples R China; [Wu, Shanli] Jilin Univ, Coll Basic Med Sci, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, TD; Ai, YX (corresponding author), Jilin Univ, Coll Anim Sci, Changchun, Jilin, Peoples R China.	wangtd@jlu.edu.cn; aiyx@jlu.edu.cn			National Natural Science Foundation of China [31272528]; Program for New Century Excellent Talents in University of China [NCET-12-0232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (No. 31272528, http://www.nsfc.gov.cn/) and the Program for New Century Excellent Talents in University of China (No. NCET-12-0232, http://www.moe.gov.cn./) YXA is the funding recipient. The funders had no role in study design, collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Buller AR, 2013, P NATL ACAD SCI USA, V110, pE653, DOI 10.1073/pnas.1221050110; Caldwell RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r6; Castaneda CA, 2016, STRUCTURE, V24, P423, DOI 10.1016/j.str.2016.01.007; Chen JJ, 2011, CHEM BIOL, V18, P1390, DOI 10.1016/j.chembiol.2011.08.014; Chen R, 2010, CELL RES, V20, P802, DOI 10.1038/cr.2010.41; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Dharadhar S, 2016, J STRUCT BIOL, V196, P437, DOI 10.1016/j.jsb.2016.09.011; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Ferreira T., 2010, IMAGEJ USER GUIDE IJ; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Kim M, 2016, FEBS LETT, V590, P340, DOI 10.1002/1873-3468.12060; Lehoux M, 2014, J VIROL, V88, P8545, DOI 10.1128/JVI.00379-14; Li H, 2016, MOL CELL, V63, P249, DOI 10.1016/j.molcel.2016.05.031; Liao SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02136; Lindner HA, 2007, VIROLOGY, V362, P245, DOI 10.1016/j.virol.2006.12.035; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Murai J, 2011, MOL CELL BIOL, V31, P2462, DOI 10.1128/MCB.05058-11; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Olazabal-Herrero A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0311-7; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Park E, 2013, MOL CELL BIOL, V33, P4360, DOI 10.1128/MCB.00870-13; Park J, 2003, J VIROL, V77, P9041, DOI 10.1128/JVI.77.16.9041-9051.2003; Park J, 2002, IMMUNITY, V17, P221, DOI 10.1016/S1074-7613(02)00368-0; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Sompallae R, 2008, J VIROL, V82, P10477, DOI 10.1128/JVI.01113-08; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Villamil MA, 2013, CELL BIOCHEM BIOPHYS, V67, P111, DOI 10.1007/s12013-013-9637-1; Villamil MA, 2012, BIOCHEMISTRY-US, V51, P9112, DOI 10.1021/bi300845s; Villamil MA, 2012, BIOCHEMISTRY-US, V51, P2829, DOI 10.1021/bi3000512; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Williams SA, 2011, CELL, V146, P917, DOI 10.1016/j.cell.2011.07.040; Xu DQ, 2012, VIRUS RES, V169, P264, DOI 10.1016/j.virusres.2012.07.002; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang KL, 2011, GENE DEV, V25, P1847, DOI 10.1101/gad.17020911; Ye KQ, 2013, PROTEIN SCI, V22, P1174, DOI 10.1002/pro.2302; Ye Y, 2012, NATURE, V492, P266, DOI 10.1038/nature11722; Yeh HM, 2013, J IMMUNOL, V191, P3328, DOI 10.4049/jimmunol.1300225; Yin JP, 2015, STRUCTURE, V23, P2043, DOI 10.1016/j.str.2015.08.010; Yue W, 2014, CELL RES, V24, P482, DOI 10.1038/cr.2014.20	49	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186535	http://dx.doi.org/10.1371/journal.pone.0186535			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091922	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700022
J	Pazhoohan, S; Raoufy, MR; Javan, M; Hajizadeh, S				Pazhoohan, Saeed; Raoufy, Mohammad Reza; Javan, Mohammad; Hajizadeh, Sohrab			Effect of Rho-kinase inhibition on complexity of breathing pattern in a guinea pig model of asthma	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY HYPERRESPONSIVE RATS; BRONCHIAL SMOOTH-MUSCLE; TIME-SERIES ANALYSIS; CHRONIC INFLAMMATION; FLUCTUATION ANALYSIS; ALLERGIC-ASTHMA; ANTIGEN; FLOW; BRONCHOCONSTRICTION	Asthma represents an episodic and fluctuating behavior characterized with decreased complexity of respiratory dynamics. Several evidence indicate that asthma severity or control is associated with alteration in variability of lung function. The pathophysiological basis of alteration in complexity of breathing pattern in asthma has remained poorly understood. Regarding the point that Rho-kinase is involved in pathophysiology of asthma, in present study we investigated the effect of Rho-kinase inhibition on complexity of respiratory dynamics in a guinea pig model of asthma. Male Dunkin Hartley guinea pigs were exposed to 12 series of inhalations with ovalbumin or saline. Animals were treated by the Rho-kinase inhibitor Y-27632 (1mM aerosols) prior to each allergen challenge. We recorded respiration of conscious animals using whole-body plethysmography. Exposure to ovalbumin induced lung inflammation, airway hyperresponsiveness and remodeling including goblet cell hyperplasia, increase in the thickness of airways smooth muscles and subepithelial collagen deposition. Complexity analysis of respiratory dynamics revealed a dramatic decrease in irregularity of respiratory rhythm representing less complexity in asthmatic guinea pigs. Inhibition of Rho-kinase reduced the airway remodeling and hyperreponsiveness, but had no significant effect on lung inflammation and complexity of respiratory dynamics in asthmatic animals. It seems that airway hyperresponsiveness and remodeling do not significantly affect the complexity of respiratory dynamics. Our results suggest that inflammation might be the probable cause of shift in the respiratory dynamics away from the normal fluctuation in asthma.	[Pazhoohan, Saeed; Raoufy, Mohammad Reza; Javan, Mohammad; Hajizadeh, Sohrab] Tarbiat Modares Univ, Dept Physiol, Fac Med Sci, Tehran, Iran	Tarbiat Modares University	Raoufy, MR; Hajizadeh, S (corresponding author), Tarbiat Modares Univ, Dept Physiol, Fac Med Sci, Tehran, Iran.	raoufy@modares.ac.ir; hajizads@modares.ac.ir	Javan, Mohammad/C-6758-2008; pazhoohan, saeed/Q-2257-2018	Javan, Mohammad/0000-0003-2045-6171; 	Tarbiat Modares University; Iran National Science Foundation (INSF)	Tarbiat Modares University; Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	This work was supported by grants from the Tarbiat Modares University to S. Pazhoohan and Iran National Science Foundation (INSF) to S. Hajizadeh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Benchetrit G, 2000, RESP PHYSIOL, V122, P123, DOI 10.1016/S0034-5687(00)00154-7; BOUSQUET J, 1992, ALLERGY, V47, P3, DOI 10.1111/j.1398-9995.1992.tb02242.x; Chen CY, 2001, J ALLERGY CLIN IMMUN, V108, P557; Chiba Y, 1999, BRIT J PHARMACOL, V127, P597, DOI 10.1038/sj.bjp.0702585; Chiba Y, 2001, BRIT J PHARMACOL, V133, P886, DOI 10.1038/sj.bjp.0704137; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Duan W, 2005, AM J RESP CRIT CARE, V171, P571, DOI 10.1164/rccm.200408-1006OC; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Frey U, 2008, LANCET, V372, P1088, DOI 10.1016/S0140-6736(08)61450-6; Frey U, 2011, J APPL PHYSIOL, V110, P1723, DOI 10.1152/japplphysiol.01297.2010; Gulotta C, 2012, AM J RESP CRIT CARE, V185, P1330, DOI 10.1164/ajrccm.185.12.1330; Htwe SS, 2017, AM J RESP CELL MOL B; HUTSON PA, 1988, AM REV RESPIR DIS, V137, P548, DOI 10.1164/ajrccm/137.3.548; Jain M, 2011, CURR SCI INDIA, V101, P1435; Kaminsky DA, 2017, AM J RESP CRIT CARE, V195, P993, DOI 10.1164/rccm.201601-0076OC; Kasahara DI, 2015, CLIN EXP ALLERGY, V45, P457, DOI 10.1111/cea.12438; Lan B, 2015, AM J PHYSIOL-LUNG C, V308, pL1, DOI 10.1152/ajplung.00222.2014; Lancas T, 2006, J APPL PHYSIOL, V100, P1610, DOI 10.1152/japplphysiol.00828.2005; Lee M, 2009, INT IMMUNOPHARMACOL, V9, P418, DOI 10.1016/j.intimp.2009.01.005; Mangin L, 2008, RESP PHYSIOL NEUROBI, V161, P189, DOI 10.1016/j.resp.2008.02.006; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pigati PA, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0073-4; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Possa SS, 2012, AM J PHYSIOL-LUNG C, V303, pL939, DOI 10.1152/ajplung.00034.2012; Que CL, 2001, J APPL PHYSIOL, V91, P1131, DOI 10.1152/jappl.2001.91.3.1131; Raoufy MR, 2017, AM J RESP CRIT CARE, V196, P247, DOI 10.1164/rccm.201701-0026LE; Raoufy MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147976; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; RighettI RF, 2014, RESP PHYSIOL NEUROBI, V192, P134, DOI 10.1016/j.resp.2013.12.012; Samara Z, 2009, RESP PHYSIOL NEUROBI, V165, P82, DOI 10.1016/j.resp.2008.10.015; SAMMON M, 1994, J APPL PHYSIOL, V77, P2481, DOI 10.1152/jappl.1994.77.5.2481; Sarlus H, 2012, J CELL MOL MED, V16, P2401, DOI 10.1111/j.1582-4934.2012.01556.x; Schaafsma D, 2008, AM J PHYSIOL-LUNG C, V295, pL214, DOI 10.1152/ajplung.00498.2007; Schaafsma D, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-121; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Shirazi AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072854; Smith JC, 2000, RESP PHYSIOL, V122, P131, DOI 10.1016/S0034-5687(00)00155-9; Taki F, 2007, CLIN EXP ALLERGY, V37, P599, DOI 10.1111/j.1365-2222.2007.02693.x; Thamrin C, 2016, AM J RESP CRIT CARE, V194, P1053, DOI 10.1164/rccm.201511-2288PP; Thamrin C, 2011, THORAX, V66, P1036, DOI 10.1136/thx.2010.156489; Thamrin C, 2009, J APPL PHYSIOL, V106, P753, DOI 10.1152/japplphysiol.91588.2008; Tiberio IFLC, 1997, AM J RESP CRIT CARE, V155, P1739, DOI 10.1164/ajrccm.155.5.9154886; van den Aardweg JG, 2002, AM J RESP CRIT CARE, V165, P1041, DOI 10.1164/ajrccm.165.8.2104100; Veiga J, 2011, J APPL PHYSIOL, V111, P412, DOI 10.1152/japplphysiol.00267.2011; Walline CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062222; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; YING S, 1991, Clinical and Experimental Allergy, V21, P745, DOI 10.1111/j.1365-2222.1991.tb03205.x; Yoshida M, 2005, J ALLERGY CLIN IMMUN, V115, P1004, DOI 10.1016/j.jaci.2005.02.003; Zhang H, 2014, GENET MOL RES, V13, P8320, DOI [10.4238/2014.October.20.8, 10.4238/2014.January.22.2]; Zhou H, 2011, CLIN EXP PHARMACOL P, V38, P387, DOI 10.1111/j.1440-1681.2011.05523.x; Zhu M, 2011, EUR RESPIR J, V38, P841, DOI 10.1183/09031936.00125010	55	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187249	10.1371/journal.pone.0187249	http://dx.doi.org/10.1371/journal.pone.0187249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088265	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900054
J	Tian, L; Yang, YQ; Sui, WJ; Hu, Y; Li, HL; Wang, F; Qian, KY; Ji, J; Tao, M				Tian, Li; Yang, Yiqun; Sui, Wenjie; Hu, Yan; Li, Huiling; Wang, Fen; Qian, Keyan; Ji, Juan; Tao, Min			Implementation of evidence into practice for cancer-related fatigue management of hospitalized adult patients using the PARIHS framework	PLOS ONE			English	Article							COLORECTAL-CANCER; CLINICAL-TRIAL; HEALTH-CARE; METAANALYSIS; BREAST; EXERCISE; INTERVENTIONS; SURVIVORS; CRITERIA; PROSTATE	This study aimed to explore an evidence-based nursing practice model of CRF management in hospitalized adult patients using the PARIHS evidence-implementation framework as the theoretical structure to provide guidance for similar nursing practices. The implementation of guideline evidence into clinical practice was conducted on the oncology and radiotherapy wards of a university-affiliated hospital. The process of integrating the guideline into the symptom management system of cancer patients was described. The impact of the evidence implementation was evaluated from three aspects: organizational innovations and outcome measures associated with nurses and with patients pre- and post-evidence implementation. During the implementation of evidence into practice on the wards, a nursing process, health education, a quality control sheet and CRF training courses were established. Through this implementation, compliance with evidence related to CRF increased significantly on the two wards, with that of ward B being higher than that of ward A. Regarding nursing outcomes, nursing knowledge, attitude and behavior scores with respect to CRF nursing care increased substantially after its application on the two wards, and the ward B nurses' scoring was higher than that of the ward A nurses. Qualitative analysis concerning the nurses suggested that leadership, patient concern about CRF management, and the need for professional development were the main motivators of the application, whereas the shortage and mobility of nursing human resources and insufficient communication between doctors and nurses were the main barriers. Additionally, most nurses felt more professional and confident about their work. Regarding patient outcomes, patient knowledge, attitude and behavior scores regarding CRF self-management increased significantly. Patients' post-implementation CRF was alleviated compared with the pre-implementation treatment cycle. The PARIHS framework may provide instructive guidance for the incorporation of evidence into practice, and the process-oriented framework might provide greater operational utility of the application.	[Tian, Li; Yang, Yiqun; Sui, Wenjie; Wang, Fen; Qian, Keyan; Ji, Juan; Tao, Min] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China; [Hu, Yan] Fudan Univ, Sch Nursing, Shanghai, Peoples R China; [Li, Huiling] Soochow Univ, Sch Nursing, Suzhou, Peoples R China	Soochow University - China; Fudan University; Soochow University - China	Li, HL (corresponding author), Soochow Univ, Sch Nursing, Suzhou, Peoples R China.	sdfyytl@163.com		Li, Huiling/0000-0001-9025-436X	Suzhou Science and Technology Development Project [SYS 201526]	Suzhou Science and Technology Development Project	This work was supported by Suzhou Science and Technology Development Project (SYS 201526) to Li Tian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken LM, 2011, AUST CRIT CARE, V24, P244, DOI 10.1016/j.aucc.2011.01.004; Berger AM, 2010, J NATL COMPR CANC NE, V8, P904, DOI 10.6004/jnccn.2010.0067; Bucknall Tracey, 2006, J Healthc Qual, V28, P12; Campbell J, 1998, DEV SCALE ASSESS CAN; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Cramer H, 2014, EUR J CANCER CARE, V23, P3, DOI 10.1111/ecc.12093; Davis DA, 1997, CAN MED ASSOC J, V157, P408; de Nijs EJM, 2008, CANCER NURS, V31, P191, DOI 10.1097/01.NCC.0000305721.98518.7c; Eisinger F, 1999, LANCET, V353, P919, DOI 10.1016/S0140-6736(98)07516-3; Epstein Dana R, 2007, Oncol Nurs Forum, V34, pE51, DOI 10.1188/07.ONF.E51-E59; Fernandez-Lao C, 2012, EUR J CANCER CARE, V21, P233, DOI 10.1111/j.1365-2354.2011.01306.x; Fineout-Overholt E, 2005, J PROF NURS, V21, P335, DOI 10.1016/j.profnurs.2005.10.005; Gong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084391; Grant M, 1998, Oncol Nurs Forum, V25, P1404; Greenhalgh T, 2004, SPREAD GOOD IDEAS SY; Horneber M, 2012, DTSCH ARZTEBL INT, V109, P161, DOI 10.3238/arztebl.2012.0161; Huang Y, 2012, CHIN J MOD NURS, V18, P1412; Jean-Pierre P, 2010, CANCER-AM CANCER SOC, V116, P3513, DOI 10.1002/cncr.25083; Jiang M.Y., 2013, CHIN NURS RES, V27, P420, DOI [DOI 10.3969/J.ISSN.1009-6493.2013.05.018, 10.3969/j.issn.1009]; Kitson A, 1998, QUAL HEALTH CARE, V7, P149, DOI 10.1136/qshc.7.3.149; Kitson A., 2013, IMPLEMENT SCI, V8, P54, DOI DOI 10.1186/1748-5908-8-54; Larkin D, 2014, INT J NURS PRACT, V20, P549, DOI 10.1111/ijn.12211; Lee S, 2014, SUPPORT CARE CANCER, V22, P1429, DOI 10.1007/s00520-014-2161-z; Melnyk Bernadette Mazurek, 2002, Reflect Nurs Leadersh, V28, P22; Minton O, 2008, JNCI-J NATL CANCER I, V100, P1155, DOI 10.1093/jnci/djn250; Mishra SI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008465.pub2; Nicholls M.C., 2014, QUALITATIVE RES PRAC, P177, DOI DOI 10.1186/1745-6215-14-166; OCEBM Levels of evidence working group, 2012, OXFORD 2011 LEVELS E; Oldervoll LM, 2004, EUR J CANCER, V40, P951, DOI 10.1016/j.ejca.2003.12.005; Pearson A, 2005, INT J EVID-BASED HEA, V3, P207, DOI 10.1111/j.1479-6988.2005.00026.x; Garcia VR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004310.pub3; Rycroft-Malone J, 2004, J NURS CARE QUAL, V19, P297, DOI 10.1097/00001786-200410000-00002; Seyidova-Khoshknabi D, 2011, AM J HOSP PALLIAT ME, V28, P119, DOI 10.1177/1049909110381590; Shun S, 2004, POCKET GUIDE MANAGIN, P91; SIGN, 2019, SIGN 50 GUID DEV HDB; Stone P, 2001, J PAIN SYMPTOM MANAG, V22, P1007, DOI 10.1016/S0885-3924(01)00361-X; Su CX, 2014, COMPLEMENT THER MED, V22, P567, DOI 10.1016/j.ctim.2014.04.007; The Joanna Briggs institute levels of evidence and grades of Recommendation Working Party, 2014, SUPP DOC J BRIGGS I; Thompson DS, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-15; Tian L, 2016, ONCOLOGIST, V21, P1349, DOI 10.1634/theoncologist.2015-0537; Tomlinson D, 2014, AM J PHYS MED REHAB, V93, P675, DOI 10.1097/PHM.0000000000000083; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vallance JKH, 2007, J CLIN ONCOL, V25, P2352, DOI 10.1200/JCO.2006.07.9988; Van Belle S, 2005, SUPPORT CARE CANCER, V13, P246, DOI 10.1007/s00520-004-0734-y; Waltz C. F., 2016, MEASUREMENT NURSING, DOI DOI 10.1891/9780826170620; Wils J, 2001, ANN ONCOL, V12, P13, DOI 10.1023/A:1008357725209; Zeng YC, 2014, INTEGR CANCER THER, V13, P193, DOI 10.1177/1534735413510024	47	6	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187257	10.1371/journal.pone.0187257	http://dx.doi.org/10.1371/journal.pone.0187257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088266	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900056
J	Xu, L; Chen, JO; Innes, AL; Li, L; Chiang, CY				Xu, Lin; Chen, Jinou; Innes, Anh L.; Li, Ling; Chiang, Chen-Yuan			Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit	PLOS ONE			English	Article							NATIONAL-SURVEY; TUBERCULOSIS	Objectives China has a high burden of drug-resistant tuberculosis (TB). As irrational use and inadequate dosing of anti-TB drugs may contribute to the epidemic of drug-resistant TB, we assessed the drug types and dosages prescribed in the treatment of TB cases in a representative sample of health care facilities in Yunnan. Methods We applied multistage cluster sampling using probability proportion to size to select 28 counties in Yunnan. Consecutive pulmonary TB patients were enrolled from either the TB centers of Yunnan Center of Disease Control or designated TB hospitals. Outcomes of interest included the regimen used in the treatment of new and retreatment TB patients; and the proportion of patients treated with adequate dosing of anti-TB drugs. Furthermore, we assess whether there has been reduction in the use of fluoroquinolone and second line injectables in Tuberculosis Clinical Centre (TCC) after the training activity in late 2012. Results Of 2390 TB patients enrolled, 582 (24.4%) were prescribed second line anti-TB drugs (18.0% in new cases and 60.9% in retreatment cases); 363(15.2%) prescribed a fluoroquinolone. General hospitals (adjusted odds ratio (adjOR) 1.97, 95% confidence interval (CI) 1.47-2.66), retreatment TB cases (adjOR 4.75, 95% CI 3.59-6.27), smear positive cases (adjOR 1.69, 95% CI 1.22-2.33), and extrapulmonary TB (adjOR 2.59, 95% CI 1.66-4.03) were significantly associated with the use of fluoroquinolones. The proportion of patients treated with fluoroquinolones decreased from 41.4% before 2013 to 13.5% after 2013 (adjOR 0.19, 95% CI 0.12-0.28) in TCC. The proportion of patients with correct, under and over dosages of isoniazid was 88.2%, 1.5%, and 10.4%, respectively; of rifampicin was 50.2%, 46.8%, and 2.9%; of pyrazinamide was 67.6%, 31.7% and 0.7%; and of ethambutol was 41.4%, 57.5%, and 1.0%. Conclusions The prescribing practice of anti-TB drugs was not standardized, findings with significant programmatic implication.	[Xu, Lin; Chen, Jinou] Yunnan Ctr Dis Control, TB Div, Yunnan, Peoples R China; [Innes, Anh L.] FHI 360 Asia Pacific Reg Off, Bangkok, Thailand; [Li, Ling] FHI 360 China, Kunming, Yunnan, Peoples R China; [Chiang, Chen-Yuan] Int Union TB & Lung Dis, Paris, France; [Chiang, Chen-Yuan] Taipei Med Univ, Div Pulm Med, Dept Internal Med, Wan Fang Hosp, Taipei, Taiwan; [Chiang, Chen-Yuan] Taipei Med Univ, Div Pulm Med, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Chiang, CY (corresponding author), Int Union TB & Lung Dis, Paris, France.; Chiang, CY (corresponding author), Taipei Med Univ, Div Pulm Med, Dept Internal Med, Wan Fang Hosp, Taipei, Taiwan.; Chiang, CY (corresponding author), Taipei Med Univ, Div Pulm Med, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan.	cychiang@theunion.org	Chen, Jinou/GQY-7968-2022	Chen, Jinou/0000-0001-6074-2178; Xu, Lin/0000-0003-4512-347X	Yunnan Provincial Health Bureau; United States Agency for International Development (USAID); Yunnan Provincial Health Bureau through the Yunnan Provincial Center for Tuberculosis Research; USAID [AID-486-A-12-00002]	Yunnan Provincial Health Bureau; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Yunnan Provincial Health Bureau through the Yunnan Provincial Center for Tuberculosis Research; USAID(United States Agency for International Development (USAID))	This work was funded by the Yunnan Provincial Health Bureau and the United States Agency for International Development (USAID). Funding from the Yunnan Provincial Health Bureau was provided through the Yunnan Provincial Center for Tuberculosis Research. Funding from USAID was provided through Cooperative Agreement No. AID-486-A-12-00002, titled "Greater Mekong Sub-region Multidrug Resistant Tuberculosis Prevention and Management" and implemented by FHI 360. Views expressed do not necessarily represent the those of USAID or FHI 360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiang CY, 2010, INT J TUBERC LUNG D, V14, P878; Chiang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044133; CUTHBERT R J, 1958, Tubercle, V39, P154, DOI 10.1016/S0041-3879(58)80042-2; Diop AH, 2002, INT J TUBERC LUNG D, V6, P215; Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712; He GX, 2010, INT J TUBERC LUNG D, V14, P884; He GX, 2011, CLIN INFECT DIS, V52, pE153, DOI 10.1093/cid/cir075; Hoa NB, 2012, PUBLIC HEALTH ACTION, V2, P15, DOI [10.5588/pha.11.0024, 10.5588/pha.11.0015]; Norval PY, 2010, INT J TUBERC LUNG D, V14, P795; WALKER W C, 1957, Tubercle, V38, P238; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2011, WHO TECH REP SER, V959, P1; WILLIAMS H, 1958, Tubercle, V39, P201, DOI 10.1016/S0041-3879(58)80068-9; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	15	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187076	10.1371/journal.pone.0187076	http://dx.doi.org/10.1371/journal.pone.0187076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088241	Green Submitted, gold, Green Published			2022-12-27	WOS:000414088900038
J	Suen, LKP; Cheng, HL; Yeung, SKW; Au-Yeung, CH; Lee, JCY; Ho, KKY; Lau, NMY; Ng, CKF; Chan, IWS				Suen, Lorna Kwai Ping; Cheng, Hui Lin; Yeung, Simon Kai Wang; Au-Yeung, Cypher Ho; Lee, Jillianne Chi Yen; Ho, Kathy Kit Ying; Lau, Natalie Ming Yan; Ng, Cristina Ka Fu; Chan, Iris Wai Sze			Qualitative insights into the experiences of living with moderate-to-severe lower urinary tract symptoms among community-dwelling ageing males	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; MALE SEXUAL DYSFUNCTION; SEEKING BEHAVIOR; CHRONIC ILLNESS; MEDICAL-CARE; MEN; HEALTH; LUTS; INDIVIDUALS; ASSOCIATION	Background Lower urinary tract symptoms (LUTS) comprise a highly prevalent chronic condition among the aging male population. Existing literature on the experiences of men with LUTS is scarce given that only a few studies explored medical care-seeking behaviors and coping strategies. The current understanding of the experiences of elderly males with LUTS is considerably limited. Therefore, the present study aimed to identify the experiences of living with moderate-to-severe LUTS among community-dwelling Chinese ageing males and their coping strategies to facilitate the management of LUTS by healthcare providers. Methods and findings A qualitative exploratory design using thematic analysis was used. Semi-structured interviews with 24 Chinese ageing males with moderate-to-severe LUTS were conducted. According to the participants, LUTS adversely affect the physical aspects of their daily lives. Most of them were unwilling to seek social support and were even embarrassed to share this topic with their peers. A range of psychological responses could be observed from the participants that range from regarding the condition as a natural life course to loss of one's self-esteem. Most of the interviewees lacked knowledge and held misconceptions toward LUTS, which prevented them from pursuing medical advice. Most of the participants also sought alternative treatments and developed self-help methods to cope with their symptoms. Conclusion LUTS affects the physical and social aspects of sufferers. The findings of this qualitative study can raise awareness about the life experiences, perceptions, misconceptions, and help-seeking behaviors of Chinese elderly with LUTS. Proper health education and advice can be provided for this population.	[Suen, Lorna Kwai Ping; Cheng, Hui Lin; Yeung, Simon Kai Wang; Au-Yeung, Cypher Ho] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Lee, Jillianne Chi Yen] Tseung Kwan O Hosp, Ambulatory Surg Ctr, Hong Kong, Hong Kong, Peoples R China; [Ho, Kathy Kit Ying] Gleneagles Hong Kong Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Lau, Natalie Ming Yan] Hong Kong Sanat Hosp, Nursing Dept, Hong Kong, Hong Kong, Peoples R China; [Ng, Cristina Ka Fu] Princess Margaret Hosp, Operat Theatre, Hong Kong, Hong Kong, Peoples R China; [Chan, Iris Wai Sze] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Suen, LKP (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	lorna.suen@polu.edu.hk	Suen, Lorna KP/F-5077-2014	Suen, Lorna KP/0000-0002-0126-6674; Cheng, Huilin/0000-0002-6117-3832	School of Nursing, The Hong Kong Polytechnic University [1-ZVD4]	School of Nursing, The Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This project was supported by the Block Grant (1-ZVD4), School of Nursing, The Hong Kong Polytechnic University.	Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Andersson SO, 2004, BJU INT, V94, P327, DOI 10.1111/j.1464-410X.2004.04930.x; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Botelho EM, 2011, QUAL HEALTH RES, V21, P1229, DOI 10.1177/1049732311405682; Boyle P, 2003, BJU INT, V92, P409, DOI 10.1046/j.1464-410X.2003.04369.x; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Coyne KS, 2010, INT J CLIN PRACT, V64, P1260, DOI 10.1111/j.1742-1241.2010.02450.x; CunninghamBurley S, 1996, BRIT J GEN PRACT, V46, P349; de Jong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101320; Elstad EA, 2011, J CLIN NURS, V20, P156, DOI 10.1111/j.1365-2702.2010.03493.x; Fowke JH, 2013, BJU INT, V111, P122, DOI 10.1111/j.1464-410X.2012.11287.x; Frankel SJ, 1998, J CLIN EPIDEMIOL, V51, P677, DOI 10.1016/S0895-4356(98)00044-4; Gannon K, 2004, J HEALTH PSYCHOL, V9, P411, DOI 10.1177/1359105304042350; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hansen BL, 2004, EUR UROL, V46, P229, DOI 10.1016/j.eururo.2004.04.005; Ho CCK, 2011, ASIAN J ANDROL, V13, P537, DOI 10.1038/aja.2010.135; Holmes-Rovner M, 2006, J GEN INTERN MED, V21, P56, DOI 10.1111/j.1525-1497.2005.0280.x; Huang TT, 2009, GERIATR NURS, V30, P28, DOI 10.1016/j.gerinurse.2008.03.006; Hunter DJW, TREATMENT SEEKING BE; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Jacobs-Lawson JM, 2011, CURR PSYCHOL, V30, P173, DOI 10.1007/s12144-011-9108-z; Jeong WS, 2015, INT NEUROUROL J, V19, P286, DOI 10.5213/inj.2015.19.4.286; Kiviniemi K, 1999, J CLIN NURS, V8, P542, DOI 10.1046/j.1365-2702.1999.00305.x; Lammers HA, 2015, J EVAL CLIN PRACT, V21, P931, DOI 10.1111/jep.12407; Lee Eun Hyun, 2005, Taehan Kanho Hakhoe Chi, V35, P1508; Li M, ASIAN MULTINATIONAL; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Noguchi N, 2016, AGING MALE, V19, P168, DOI 10.3109/13685538.2016.1169399; Patton M. Q, QUALITATIVE RES EVAL, V4th; Pinnock C, 1998, AUST NZ J PUBL HEAL, V22, P368, DOI 10.1111/j.1467-842X.1998.tb01393.x; Ramesh A, 2009, ASIAN J PHARM CLIN R, V2, P97; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Russo A, 2016, EXPERT OPIN DRUG SAF, V15, P1661, DOI 10.1080/14740338.2016.1190830; Schulman CC, 2005, EUR UROL SUPPL, V4, P1, DOI 10.1016/j.eursup.2004.10.007; Stebbins R.A, 2001, EXPLORATORY RES SOCI, DOI DOI 10.4135/9781412984249; Taylor J, 2006, BJU INT, V98, P605, DOI 10.1111/j.1464-410X.2006.06377.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wareing M, 2005, J CLIN NURS, V14, P239, DOI 10.1111/j.1365-2702.2004.01003.x; Wein AJ, 2009, BJU INT, V103, P33, DOI 10.1111/j.1464-410X.2009.08447.x; Welch LC, 2011, NURS RES, V60, P165, DOI 10.1097/NNR.0b013e3182159cac; Willams Paora N, 2003, Pac Health Dialog, V10, P71; Wolters R, 2002, BJU INT, V90, P655, DOI 10.1046/j.1464-410X.2002.02996.x; Wong SYS, 2006, J AFFECT DISORDERS, V96, P83, DOI 10.1016/j.jad.2006.05.013; Xianquan S, 2005, J MED FOOD, V8, P413, DOI 10.1089/jmf.2005.8.413; Yan E., 2013, ASIAN J GERONTOL GER, V8, P78; Zhang EQ, 1997, CHINESE MED DIET; Zhang EQ, 1996, HLTH PRESERVATION RE; Zhang H, 2014, INT J NURS PRACT, V20, P530, DOI 10.1111/ijn.12198	48	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187085	10.1371/journal.pone.0187085	http://dx.doi.org/10.1371/journal.pone.0187085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL0OH	29084282	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200030
J	El Bcheraoui, C; Palmisano, EB; Dansereau, E; Schaefer, A; Woldeab, A; Moradi-Lakeh, M; Salvatierra, B; Hernandez-Prado, B; Mokdad, AH				El Bcheraoui, Charbel; Palmisano, Erin B.; Dansereau, Emily; Schaefer, Alexandra; Woldeab, Alexander; Moradi-Lakeh, Maziar; Salvatierra, Benito; Hernandez-Prado, Bernardo; Mokdad, Ali H.			Healthy competition drives success in results-based aid: Lessons from the Salud Mesoamerica Initiative	PLOS ONE			English	Article							FRAMEWORK; KNOWLEDGE	Objectives The Salud Mesoame A rica Initiative (SMI) is a three-operation strategy, and is a pioneer in the world of results-based aid (RBA) in terms of the success it has achieved in improving health system inputs following its initial operation. This success in meeting pre-defined targets is rare in the world of financial assistance for health. We investigated the influential aspects of SMI that could have contributed to its effectiveness in improving health systems, with the aim of providing international donors, bilateral organizations, philanthropies, and recipient countries with new perspectives that can help increase the effectiveness of future assistance for health, specifically in the arena of RBA. Methods Qualitative methods based on the criteria of relevance and effectiveness proposed by the Development Assistance Committee of the Organization for Economic Co-operation and Development. Our methods included document review, key informant interviews, a focus group discussion, and a partnership analysis. Participants A purposive sample of 113 key informants, comprising donors, representatives from the Inter-American Development Bank, ministries of health, technical assistance organizations, evaluation organizations, and health care providers. Results During May-October 2016, we interviewed regarding the relevance and effectiveness of SMI. Themes emerged relative to the topics we investigated, and covered the design and the drivers of success of the initiative. The success is due to 1) the initiative's regional approach, which pressured recipient countries to compete toward meeting targets, 2) a robust and flexible design that incorporated the richness of input from stakeholders at all levels, 3) the design-embedded evaluation component that created a culture of accountability among recipient countries, and 4) the reflective knowledge environment that created a culture of evidence-based decision-making. Conclusions A regional approach involving all appropriate stakeholders, and based on knowledge sharing and embedded evaluation can help ensure the effectiveness of future results-based aid programs for health in global settings.	[El Bcheraoui, Charbel; Palmisano, Erin B.; Dansereau, Emily; Schaefer, Alexandra; Woldeab, Alexander; Moradi-Lakeh, Maziar; Hernandez-Prado, Bernardo; Mokdad, Ali H.] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Salvatierra, Benito] El Colegio Frontera Sur, San Cristobal Casas, Chiapas, Mexico	Institute for Health Metrics & Evaluation; El Colegio de la Frontera Sur (ECOSUR)	El Bcheraoui, C (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA USA.	charbel@uw.edu	Mokdad, Ali H./AAD-1232-2022; Moradi-Lakeh, Maziar/ABC-9793-2021	Mokdad, Ali H./0000-0002-4994-3339; Moradi-Lakeh, Maziar/0000-0001-7381-5305; el bcheraoui, charbel/0000-0003-3117-9966	Bill & Melinda Gates Foundation; Spanish Agency for International Development Cooperation; Carlos Slim Foundation through the Inter-American Development Bank	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Spanish Agency for International Development Cooperation(Spanish Government); Carlos Slim Foundation through the Inter-American Development Bank	All phases of this study were supported by the Bill & Melinda Gates Foundation (www.gatesfoundation.org), the Spanish Agency for International Development Cooperation (www.aecid.es), and the Carlos Slim Foundation (www.salud.cadosslim.org) through the Inter-American Development Bank (www.iadb.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Andrews KM, 2000, J MANAGE STUD, V37, P797, DOI 10.1111/1467-6486.00204; Bovens M, 2007, EUR LAW J, V13, P447, DOI 10.1111/j.1468-0386.2007.00378.x; Christensen PH., 2005, FACILITATING KNOWLED; European Commission, 2013, REG STRAT PAP ASS CE; Gertler PJ, 2011, IMPACT EVALUATION IN PRACTICE, P1, DOI 10.1596/978-0-8213-8541-8; Glaser B.G., 1965, AWARENESS DYING; Grittner, 2013, RESULTS BASED FINANC; Hendriks P, 1999, KNOWL PROCESS MANAG, V6, P91, DOI 10.1002/(SICI)1099-1441(199906)6:23.0.CO;2-M; Inter-American Development Bank, IDB SAL MES 2015 RES; IPE M., 2003, HUM RESOUR DEV REV, V2, P337, DOI [10.1177/1534484303257985, DOI 10.1177/1534484303257985]; Jones P, 1998, INT J TECHNOL MANAGE, V16, P152, DOI 10.1504/IJTM.1998.002651; Klingebiel S, 2014, INT DEV POLICY REV I; Klingebiel S., 2012, RESULTS BASED AID RB; Lam A, 2000, ORGAN STUD, V21, P487, DOI 10.1177/0170840600213001; Mokdad AH, 2017, RESULTS BASED FINANC; NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14; OECD WTO, 2013, BOOST VAL CHAINS VIA; Gutierrez JP, 2011, SALUD PUBLICA MEXICO, V53, pS386, DOI 10.1590/S0036-36342011000900012; Pearson M., 2011, RESULTS BASED AID RE; Perakis R, 2015, 052 CTR GLOB DEV; Salud Mesoamerica Initiative, 2012, RESOURCES; Schwank O., 2012, GLOBAL HLTH INITIATI; Turoldo F, 2009, AM J PUBLIC HEALTH, V99, P1197, DOI 10.2105/AJPH.2007.127514; U.S. Department of State Bureau of European and Eurasian Affairs, 2008, FY 2008 US GOV ASS C; University of Colorado Denver School of Public Affairs, 2015, WHAT IS PARTNER; Weiss L.M., 1999, AC MAN P, V1999, pA1	26	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187107	10.1371/journal.pone.0187107	http://dx.doi.org/10.1371/journal.pone.0187107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077731	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200044
J	Kivelitz, L; Kriston, L; Christalle, E; Schulz, H; Watzke, B; Harter, M; Gotzmann, L; Bailee, H; Zahn, S; Melchior, H				Kivelitz, Laura; Kriston, Levente; Christalle, Eva; Schulz, Holger; Watzke, Birgit; Haerter, Martin; Goetzmann, Lutz; Bailee, Harald; Zahn, Sabine; Melchior, Hanne			Effectiveness of telephone-based aftercare case management for adult patients with unipolar depression compared to usual care: A randomized controlled trial	PLOS ONE			English	Article							MENTAL-DISORDERS; HEALTH-CARE; GERMANY; ANXIETY; SERVICES; IMPROVE; BURDEN; COST	Background Patients with depression often have limited access to outpatient psychotherapy following inpatient treatment. The objective of the study was to evaluate the long-term effectiveness of a telephone-based aftercare case management (ACM) intervention for patients with depression. Methods We performed a prospective randomized controlled trial in four psychotherapeutic inpatient care units with N = 199 patients with major depression or dysthymia (F32.x, F33.x, F34.1, according to the ICD-10). The ACM consisted of six phone contacts at two-week intervals performed by trained and certified psychotherapists. The control group received usual care (UC). The primary outcome was depressive symptom severity (BDI-II) at 9-month follow-up, and secondary outcomes were health-related quality of life (SF-8, EQ-5D), self-efficacy (SWE), and the proportion of patients initiating outpatient psychotherapy. Mixed model analyses were conducted to compare improvements between treatment groups. Results Regarding the primary outcome of symptom severity, the groups did not significantly differ after 3 months (p = .132; ES = -0.23) or at the 9-month follow-up (p = .284; ES = -0.20). No significant differences in health-related quality of life or self-efficacy were found between groups. Patients receiving ACM were more likely to be in outpatient psychotherapy after 3 months (OR: 3.00[1.12-8.07]; p = .029) and 9 months (OR: 4.78 [1.55-14.74]; p = .006) than those receiving UC. Conclusions Although telephone-based ACM did not significantly improve symptom severity, it seems to be a valuable approach for overcoming treatment barriers to the clinical pathways of patients with depression regarding their access to outpatient psychotherapy.	[Kivelitz, Laura; Kriston, Levente; Schulz, Holger; Haerter, Martin; Melchior, Hanne] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Watzke, Birgit] Univ Zurich, Inst Psychol, Clin Psychol & Psychotherapy Res, Zurich, Switzerland; [Goetzmann, Lutz] Segeberg Hosp, Dept Psychosomat Med & Psychotherapy, Bad Segeberg, Bad Segeberg, Germany; [Bailee, Harald] Luisenklin Zentrum Verhaltensmed, Bad Durrheim, Germany; [Zahn, Sabine] MediClin Seepark Klin, Fachklin Psychosomat Med & Psychotherapie, Bad Bodenteich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich	Kivelitz, L (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	l.kivelitz@uke.de	Kriston, Levente/D-1713-2013	Kriston, Levente/0000-0003-0748-264X; Harter, Martin/0000-0001-7443-9890	Germany's Federal Ministry of Education and Research; German Federal Pension Fund as part of the research priority 'Chronic Diseases and Patient Orientation';  [0421-FSCP-Z202]	Germany's Federal Ministry of Education and Research; German Federal Pension Fund as part of the research priority 'Chronic Diseases and Patient Orientation'; 	The study was funded by Germany's Federal Ministry of Education and Research and the German Federal Pension Fund as part of the research priority 'Chronic Diseases and Patient Orientation' (http://www.forschung-patientenoriertierung.de/index.php/home.html). The project was competitively adopted based on a detailed research proposal (grant number: 0421-FSCP-Z202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barekatain M, 2014, J RES MED SCI, V19, P240; Baron S, 2011, PSYCHIAT PRAX, V38, P342, DOI 10.1055/s-0030-1266091; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Christensen H, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-25; Collins KA, 2004, CLIN PSYCHOL REV, V24, P583, DOI 10.1016/j.cpr.2004.06.001; Deck R, 2014, REHABILITATION, V53, P305, DOI 10.1055/s-0034-1384594; DGPPNB KBV AWMF AkdA BPtK BApK DAGSHG DEGAM DGPM DGPs DGRW, S3 GUIDL NAT DIS MAN, DOI [10.6101/AZQ/0002622015, DOI 10.6101/AZQ/0002622015]; Dilling H, 1991, INT CLASS DIS; Ellert U, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1330, DOI 10.1007/s00103-005-1168-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gensichen J, 2006, PSYCHOL MED, V36, P7, DOI 10.1017/S0033291705005568; Gensichen J, 2009, ANN INTERN MED, V151, P369, DOI 10.7326/0003-4819-151-6-200909150-00001; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Grabe HJ, 2009, SOC PSYCH PSYCH EPID, V44, P835, DOI 10.1007/s00127-009-0005-9; Gunther OH, 2007, PSYCHIAT PRAX, V34, P292, DOI 10.1055/s-2006-940066; Harfst T, 2002, Rehabilitation (Stuttg), V41, P407; Jacobi F, 2014, NERVENARZT, V85, P77, DOI 10.1007/s00115-013-3961-y; Jerusalem M., 1999, SKALEN ERFASSUNG LEH; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim SE, 2011, AM J MANAG CARE, V17, pE375; Kivelitz L, 2015, PSYCHIAT PRAX, V42, P424, DOI 10.1055/s-0034-1370306; Kivelitz L, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0469-y; Klesse C, 2007, NERVENARZT, V78, P585, DOI 10.1007/s00115-007-2368-z; Kordy H, 2016, PSYCHOTHER PSYCHOSOM, V85, P91, DOI 10.1159/000441951; Lambert M.J., 2013, BERGIN GARFIELDS HDB, V6th ed., P169; Lange M., 2011, PHYS MED REHAB KUROR, V21, P1; Lehmann S, 2010, GESUNDHEITSWESEN, V72, pE33, DOI 10.1055/s-0029-1242769; Mack S, 2014, INT J METHODS PSYCHI; Margraf J., 1994, MINI DIPS DIAGNOSTIS; Reiser A., 2013, THESIS; Rosen CS, 2013, PSYCHIAT SERV, V64, P13, DOI 10.1176/appi.ps.201200142; Schneider S., 2011, DIPS DIAGNOSTISCHES, DOI 10.1007/978-3-642-15529-1; Schulz H, 2011, KLIN PSYCHOL PSYCHOT, P361; Simon GE, 2009, ARCH GEN PSYCHIAT, V66, P1081, DOI 10.1001/archgenpsychiatry.2009.123; van den Berg N, 2015, PSYCHOTHER PSYCHOSOM, V84, P82, DOI 10.1159/000369468; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186967	10.1371/journal.pone.0186967	http://dx.doi.org/10.1371/journal.pone.0186967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077724	gold, Green Published, Green Accepted			2022-12-27	WOS:000413861200032
J	Azage, M; Kumie, A; Worku, A; Bagtzoglou, AC; Anagnostou, E				Azage, Muluken; Kumie, Abera; Worku, Alemayehu; Bagtzoglou, Amvrossios C.; Anagnostou, Emmanouil			Effect of climatic variability on childhood diarrhea and its high risk periods in northwestern parts of Ethiopia	PLOS ONE			English	Article							PRECIPITATION PRODUCTS; WEATHER VARIABILITY; RELATIVE-HUMIDITY; RAINFALL; TEMPERATURE; DISEASE; VALIDATION; ROTAVIRUS; SURVIVAL; CHOLERA	Background Increasing climate variability as a result of climate change will be one of the public health challenges to control infectious diseases in the future, particularly in sub-Saharan Africa including Ethiopia. Objective To investigate the effect of climate variability on childhood diarrhea (CDD) and identify high risk periods of diarrheal diseases. Methods The study was conducted in all districts located in three Zones (Awi, West and East Gojjam) of Amhara Region in northwestern parts of Ethiopia. Monthly CDD cases for 24 months (from July 2013 to June 2015) reported to each district health office from the routine surveillance system were used for the study. Temperature, rainfall and humidity data for each district were extracted from satellite precipitation estimates and global atmospheric reanalysis. The space-time permutation scan statistic was used to identify high risk periods of CDD. A negative binomial regression was used to investigate the relationship between cases of CDD and climate variables. Statistical analyses were conducted using SaTScan program and StataSE v. 12. Results The monthly average incidence rate of CDD was 11.4 per 1000 (95% CI 10.8-12.0) with significant variation between males [12.5 per 1000 (95% CI 11.9 to 13.2)] and females [10.2 per 1000 (95% CI 9.6 to 10.8)]. The space-time permutation scan statistic identified the most likely high risk period of CDD between March and June 2014 located in Huletej Enese district of East Gojjam Zone. Monthly average temperature and monthly average rainfall were positively associated with the rate of CDD, whereas the relative humidity was negatively associated with the rate of CDD. Conclusions This study found that the most likely high risk period is in the beginning of the dry season. Climatic factors have an association with the occurrence of CDD. Therefore, CDD prevention and control strategy should consider local weather variations to improve programs on CDD.	[Azage, Muluken] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia; [Azage, Muluken] Addis Ababa Univ, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia; [Kumie, Abera; Worku, Alemayehu] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Bagtzoglou, Amvrossios C.; Anagnostou, Emmanouil] Univ Connecticut, Sch Engn, Dept Civil & Environm Engn, Storrs, CT USA	Bahir Dar University; Addis Ababa University; Addis Ababa University; University of Connecticut	Azage, M (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia.; Azage, M (corresponding author), Addis Ababa Univ, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia.	mulukenag@yahoo.com	Bagtzoglou, Amvrossios/AAG-6598-2019; Azage, Muluken/AAF-6515-2020; Kumie, Abera/AAC-8537-2022	Azage, Muluken/0000-0003-3222-0158; Bagtzoglou, Amvrossios/0000-0002-4707-4336	Ethiopian Institute of Water Resources Addis Ababa University; Bahir Dar University; University of Connecticut; USAID	Ethiopian Institute of Water Resources Addis Ababa University; Bahir Dar University; University of Connecticut; USAID(United States Agency for International Development (USAID))	The authors would like to acknowledge Ethiopian Institute of Water Resources Addis Ababa University, Bahir Dar University, the University of Connecticut and USAID for funding this research project and their technical support. The authors would like to thank Amhara National Regional State Health Bureau, Zonal Health Offices of Awi and East and West Gojjam and the District Health Office for their cooperation in providing monthly childhood diarrhea.	Alexander KA, 2013, INT J ENV RES PUB HE, V10, P1202, DOI 10.3390/ijerph10041202; Amhara National Regional State Health Bureau, 2010, ANN REP BAH DAR ETH; Amhara National Regional State Health Bureau, 2012, ANN REP BAH DAR ETH; Amhara National Regional State Health Bureau, 2013, ANN REP BAH DAR ETH; Amhara National Regional State Health Bureau, 2011, ANN REP BAH DAR ETH; Amhara National Regional State Health Bureau, 2009, ANN REP BAH DAR ETH; [Anonymous], 1989, APPL LINEAR REGRESSI; Azage M, 2015, CHILDHOOD DIARRHEA E, V10, P12, DOI DOI 10.1371/J0URNAL.P0NE.0144690; Azage M, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0052-2; Bandyopadhyay S, 2012, APPL GEOGR, V33, P63, DOI 10.1016/j.apgeog.2011.07.017; Bentham G, 2001, INT J BIOMETEOROL, V45, P22, DOI 10.1007/s004840000083; Bureau of Finance and Economic Development of Amhara Region, 2014, POP SIZ AMH REG; Campbell-Lendrum D, 2003, CLIMATE CHANGE HLTH; Cardinal M, 1999, STAT MED, V18, P2025, DOI 10.1002/(SICI)1097-0258(19990815)18:15<2025::AID-SIM163>3.3.CO;2-4; Carlton EJ, 2016, INT J EPIDEMIOL, V45, P117, DOI 10.1093/ije/dyv296; Cheung WH, 2008, INT J CLIMATOL, V28, P1723, DOI 10.1002/joc.1623; Chou WC, 2010, SCI TOTAL ENVIRON, V409, P43, DOI 10.1016/j.scitotenv.2010.09.001; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Deribew A, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0112-2; Derin Y, 2016, J HYDROMETEOROL, V17, P1817, DOI 10.1175/JHM-D-15-0197.1; Dinku T, 2007, INT J REMOTE SENS, V28, P1503, DOI 10.1080/01431160600954688; Estrada F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172201; Ethiopian Demographic Health Survey, 2011, ETH DEM HLTH SURV 20; Farag TH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002280; Fewtrell L, 2011, J FLOOD RISK MANAG, V4, P77, DOI 10.1111/j.1753-318X.2011.01092.x; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hashizume M, 2008, EPIDEMIOLOGY, V19, P103, DOI 10.1097/EDE.0b013e31815c09ea; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Hirpa FA, 2010, J APPL METEOROL CLIM, V49, P1044, DOI 10.1175/2009JAMC2298.1; Hoque BA, 2006, INT J HYG ENVIR HEAL, V209, P451, DOI 10.1016/j.ijheh.2006.04.008; ICPAC and IGAD, 2007, CLIM CHANG HUM DEV A; IJAZ MK, 1985, CAN J MICROBIOL, V31, P681, DOI 10.1139/m85-129; IPCC, 2007, CONTRIBUTION WORKING; Islam MS, 2009, T ROY SOC TROP MED H, V103, P1165, DOI 10.1016/j.trstmh.2009.04.016; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Kelly-Hope LA, 2008, ENVIRON HEALTH PERSP, V116, P7, DOI 10.1289/ehp.9658; Kolstad EW, 2011, ENVIRON HEALTH PERSP, V119, P299, DOI 10.1289/ehp.1002060; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M., 2015, SATSCAN USER GUIDE V; Kulldorff M., 2013, SATSCAN TM SER GUIDE; Levy K, 2009, INT J EPIDEMIOL, V38, P1487, DOI 10.1093/ije/dyn260; Limin W, 2009, 4979 PO RES; Fernandez MAL, 2009, T ROY SOC TROP MED H, V103, P137, DOI 10.1016/j.trstmh.2008.07.017; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; McMichael A. J., 2004, COMP QUANTIFICATION; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Mellander PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068461; MOE K, 1982, ARCH VIROL, V72, P179, DOI 10.1007/BF01348963; Moors E, 2013, SCI TOTAL ENVIRON, V22; Motbainor A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133542; Myers MF, 2000, ADV PARASIT, V47, P309, DOI 10.1016/S0065-308X(00)47013-2; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Onozuka D, 2011, EPIDEMIOL INFECT, V139, P1369, DOI 10.1017/S0950268810002451; Onozuka D, 2010, EPIDEMIOL INFECT, V138, P236, DOI 10.1017/S0950268809990574; Pachauri RK, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, pVII; Pan Y, 2008, EPIDEMIOL INFECT, V136, P421, DOI 10.1017/S095026880700831X; Phung D, 2015, EPIDEMIOL INFECT, V143, P3488, DOI 10.1017/S0950268815000709; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Rogerson P.A., 2001, STAT METHODS GEOGRAP; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Tekleaba S, 2013, PHYS CHEM EARTH PT A; Thiemig V, 2012, J HYDROMETEOROL, V13, P1760, DOI 10.1175/JHM-D-12-032.1; Weaver CG, 2015, NEPHROL DIAL TRANSPL, V30, P1244, DOI 10.1093/ndt/gfv071; WHO, 2008, PROT HLTH CLIM CHANG; Xiao GX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-998; Xie P, 2011, BIAS CORRECTED CMORP; Zeleke T, 2013, THEOR APPL CLIMATOL, V111, P665, DOI 10.1007/s00704-012-0700-4	68	33	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186933	10.1371/journal.pone.0186933	http://dx.doi.org/10.1371/journal.pone.0186933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073259	gold, Green Submitted, Green Published			2022-12-27	WOS:000413845400077
J	Tanaka, SE; Aikawa, T; Takeuchi-Kaneko, Y; Fukuda, K; Kanzaki, N				Tanaka, Suguru E.; Aikawa, Takuya; Takeuchi-Kaneko, Yuko; Fukuda, Kenji; Kanzaki, Natsumi			Artificial induction of third-stage dispersal juveniles of Bursaphelenchusxylophilus using newly established inbred lines	PLOS ONE			English	Article							PINE WOOD NEMATODE; MONOCHAMUS-ALTERNATUS COLEOPTERA; PLANT-PARASITIC NEMATODES; CONTROLLING DAUER FORMATION; N-SP NEMATODA; XYLOPHILUS APHELENCHIDA; ECOLOGICAL SIGNIFICANCE; LARVAL DEVELOPMENT; INTERACTING GENES; NATURAL VARIATION	The pine wood nematode, Bursaphelenchus xylophilus, is the causal agent of pine wilt disease. This nematode has two developmental forms in its life cycle; i.e., the propagative and dispersal forms. The former is the form that builds up its population inside the host pine. The latter is specialized for transport by the vector. This form is separated into two dispersal stages (third and fourth); the third-stage dispersal juvenile (J(III)) is specialized for survival under unfavorable conditions, whereas the fourth-stage juvenile (J(IV)), which is induced by a chemical signal from the carrier Monochamus beetle, is transported to new host pines and invades them. Because of its importance in the disease cycle, molecular and chemical aspects of the J(IV) have been investigated, while the mechanism of J(III) induction has not been sufficiently investigated. In an effort to clarify the J(III) induction process, we established inbred lines of B. xylophilus and compared their biological features. We found that the total number of nematodes (propagation proportion) was negatively correlated with the J(III) emergence proportion, likely because nematode development was arrested at J(III); i.e., they could not develop to adults via the reproductive stage. In addition, J(III) induction seemed to be regulated by a small number of genes because the J(III) induction proportion varied among inbred lines despite the high homozygosity of the parental line. We also demonstrated that J(III) can be artificially induced by the nematode's secreted substances. This is the first report of artificial induction of J(III) in B. xylophilus. The dauer (dispersal) juvenile of the model organism Caenorhabditis elegans corresponds functionally to J(III) of B. xylophilus, and this stage is known to be induced by a chemical signal referred to as daumone, derived from the nematodes' secretion. The artificial induction of JIII suggests the presence of daumone-like material in B. xylophilus.	[Tanaka, Suguru E.; Fukuda, Kenji] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Forest Bot, Bunkyo Ku, Tokyo, Japan; [Aikawa, Takuya] FFPRI, Tohoku Res Ctr, Morioka, Iwate, Japan; [Takeuchi-Kaneko, Yuko] Kyoto Univ, Grad Sch Agr, Lab Terr Microbial Ecol, Sakyo Ku, Kyoto, Japan; [Kanzaki, Natsumi] FFPRI, Kansai Res Ctr, Fushimi Ku, Kyoto, Japan	University of Tokyo; Forestry & Forest Products Research Institute - Japan; Kyoto University; Forestry & Forest Products Research Institute - Japan	Kanzaki, N (corresponding author), FFPRI, Kansai Res Ctr, Fushimi Ku, Kyoto, Japan.	nkanzaki@affrc.go.jp	Fukuda, Kenji/F-9355-2017	Fukuda, Kenji/0000-0002-9980-3107	Japan Society for the Promotion of Science and Environment Research [15H04514, 17H03831, 15J03034]	Japan Society for the Promotion of Science and Environment Research	This study was supported in part by the Grants-in-Aid for Scientific Research (B), Nos. 15H04514 and 17H03831 and Grant-in-Aid for JSPS Research Fellow, No. 15J03034 from the Japan Society for the Promotion of Science and Environment Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 1998, APPL ENTOMOL ZOOL, V33, P231, DOI 10.1303/aez.33.231; Aikawa T, 1998, P 24 INT NEM S DUND, V44, P451; Arakawa Y, 2002, J NEMATOL, V34, P396; Bose N, 2014, CURR BIOL, V24, P1536, DOI 10.1016/j.cub.2014.05.045; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, ORG LETT, V11, P3100, DOI 10.1021/ol901011c; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; Choe A, 2012, CURR BIOL, V22, P772, DOI 10.1016/j.cub.2012.03.024; Felix MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094723; Forge TA, 1996, FUND APPL NEMATOL, V19, P349; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Giblin-Davis Robin M., 1993, P302; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOTTLIEB S, 1994, GENETICS, V137, P107; Hooper D. J., 1986, LAB METHODS WORK PLA, P59; Ishibashi N., 1974, Japanese Journal of Nematology, V4, P1; ISHIBASHI N, 1977, APPL ENTOMOL ZOOL, V12, P293, DOI 10.1303/aez.12.293; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Jia KL, 2002, DEVELOPMENT, V129, P221; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kanzaki N, 2016, NEMATOLOGY, V18, P209, DOI 10.1163/15685411-00002954; Kanzaki N, 2015, NEMATOLOGY, V17, P831, DOI 10.1163/15685411-00002908; Kanzaki N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099241; Kanzaki N, 2013, J PARASITOL, V99, P803, DOI 10.1645/GE-3253.1; Kikuchi T, 2007, MOL BIOCHEM PARASIT, V155, P9, DOI 10.1016/j.molbiopara.2007.05.002; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; KIYOHARA T, 1990, FOREST SCI, V36, P1061; Kiyohara T., 1976, Japanese Journal of Nematology, V6, P56; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; Kiyohara T., 1975, T JPN FOR SOC, V86, P296; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; KONDO E, 1978, APPL ENTOMOL ZOOL, V13, P1; Kosaka H, 2001, EUR J PLANT PATHOL, V107, P667, DOI 10.1023/A:1011954828685; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Maehara N, 2001, NEMATOLOGY, V3, P455, DOI 10.1163/156854101753250782; Maehara N, 1997, FUND APPL NEMATOL, V20, P611; Maehara N, 2016, NEMATOLOGY, V18, P679, DOI 10.1163/15685411-00002983; Mamiya Y, 2004, NEMATOL MONOGR PERSP, V1, P9; Mamiya Y., 1975, Japanese Journal of Nematology., V5, P16; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159, DOI 10.1163/187529272X00395; MAMIYA Y, 1972, Review of Plant Protection Research, V5, P46; MAMIYA Y, 1972, NEMATOLOGICA, V18, P120, DOI 10.1163/187529272X00296; MAMIYA Y, 1979, NEMATOLOGICA, V25, P353, DOI 10.1163/187529279X00091; Mayer MG, 2011, P ROY SOC B-BIOL SCI, V278, P2784, DOI 10.1098/rspb.2010.2760; Morimoto K., 1972, Journal of the Japanese Forestry Society, V54, P177; Mota M.M., 2008, PINE WILT DIS, P33, DOI [10.1371/journal.pone.0067377, DOI 10.1371/JOURNAL.PONE.0067377]; NICKLE WR, 1981, J NEMATOL, V13, P385; Noguez JH, 2012, ACS CHEM BIOL, V7, P961, DOI 10.1021/cb300056q; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; Ogura Nobuo, 2002, Japanese Journal of Nematology, V32, P53, DOI 10.3725/jjn1993.32.2_53; Palomares-Rius JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2085-0; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Ryss A, 2005, NEMATOLOGY, V7, P393, DOI 10.1163/156854105774355581; Sone K, 2011, J FOREST RES-JPN, V16, P82, DOI 10.1007/s10310-010-0212-y; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237; Stamps WT, 2001, NEMATOLOGY, V3, P295, DOI 10.1163/156854101317020213; Stasiuk SJ, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-1; Steiner G, 1934, J AGRIC RES, V48, P0949; Takemoto S, 2007, APPL ENTOMOL ZOOL, V42, P247, DOI 10.1303/aez.2007.247; THOMAS JH, 1993, GENETICS, V134, P1105; Tokushige Y., 1969, Journal of the Japanese Forestry Society, V51, P193; Tomalak M, 2011, NEMATOLOGY, V13, P619, DOI 10.1163/138855410X532168; Viney ME, 2003, DEV GROWTH DIFFER, V45, P389, DOI 10.1046/j.1440-169X.2003.00703.x; VOWELS JJ, 1992, GENETICS, V130, P105; Wang DD, 2013, FOREST PATHOL, V43, P144, DOI 10.1111/efp.12011; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020; Zhao B.G., 2008, PINE WILT DISEASE, P18; Zhao LL, 2014, TRENDS PARASITOL, V30, P299, DOI 10.1016/j.pt.2014.04.007; Zhao LJ, 2013, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2013-56	75	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187127	10.1371/journal.pone.0187127	http://dx.doi.org/10.1371/journal.pone.0187127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073232	gold, Green Submitted, Green Published			2022-12-27	WOS:000413845400117
J	Tiwary, S; Xu, L				Tiwary, Shweta; Xu, Lei			FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells (vol 11, e0147638, 2016)	PLOS ONE			English	Correction													Tiwary, Shweta/I-8076-2019	Tiwary, Shweta/0000-0002-2635-2560				Tiwary S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147638	1	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187388	10.1371/journal.pone.0187388	http://dx.doi.org/10.1371/journal.pone.0187388			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073284	Green Submitted, gold, Green Published			2022-12-27	WOS:000413845400137
J	Budhwani, H; Hearld, KR; Hasbun, J; Charow, R; Rosario, S; Tillotson, L; McGlaughlin, E; Waters, J				Budhwani, Henna; Hearld, Kristine R.; Hasbun, Julia; Charow, Rebecca; Rosario, Santo; Tillotson, Louise; McGlaughlin, Elaine; Waters, John			Transgender female sex workers' HIV knowledge, experienced stigma, and condom use in the Dominican Republic	PLOS ONE			English	Article							MALE PROSTITUTES; RISK BEHAVIORS; PARTNER TYPES; WOMEN; INTERVENTIONS; JAMAICA; BURDEN; DETERMINANTS; INFECTION; HEALTH	Introduction Not only do transgender female sex workers have some of the highest rates of sexually transmitted infections (STI), human immunodeficiency virus (HIV), and experienced stigma, they also have higher likelihood of early sexual debut and some of the lowest levels of educational attainment compared to other stigmatized populations. Some of the most common interventions designed to reduce transmission of HIV and STIs seek to educate high-risk groups on sexual health and encourage condom use across all partner types; however, reaching stigmatized populations, particularly those in resource-limited settings, is particularly challenging. Considering the importance of condom use in stopping the spread of HIV, the aim of this study was two-fold; first to characterize this hard-to-reach population of transgender female sex workers in the Dominican Republic, and second, to assess associations between their HIV knowledge, experienced stigma, and condom use across three partner types. Methods We analyzed self-reported data from the Questionnaire for Transgender Sex Workers (N = 78). Respondents were interviewed at their workplaces. Univariate and bivariate analyses were employed. Fisher Chi-square tests assessed differences in HIV knowledge and experienced stigma by condom use across partner types. Results HIV knowledge was alarmingly low, condom use varied across partner type, and the respondents in our sample had high levels of experienced stigma. Average age of first sexual experience was 13.12 years with a youngest age reported of 7. Dominican Republic statutory rape laws indicate 18 years is the age of consent; thus, many of these transgender women's first sexual encounters would be considered forcible (rape) and constitute a prosecutable crime. On average, respondents reported 8.45 sexual partners in the prior month, with a maximum of 49 partners. Approximately two thirds of respondents used a condom the last time they had sex with a regular partner. This was considerably lower than condom use reported with coercive partners (92.96%) and clients (91.78%). Bivariate analyses revealed two trends: experienced stigma was associated with lower rates of condom use, and lower HIV knowledge was associated with lower rates of condom use. The former provides additional evidence that experienced stigma may become internalized, affecting individual-level behaviors-lowering self-confidence and resilience-making it more difficult to negotiate condom use due to lack of self-efficacy and desire to show trust in one's partner. The latter supports public health research that suggests gaps in HIV knowledge persist and are pronounced in highly stigmatized populations. Discussion The vulnerabilities experienced by transgender persons, particularly in environments that vehemently adhere to conservative ideologies related to sex and gender, are significant and harm this population. These vulnerabilities could potentially be addressed through critically examining of impact of policies that indirectly promote or allow victimization of transgender citizens and subsequently diminish the effectiveness of public health and educational interventions. By taking action through the revocation of such laws, the Dominican Republic has the opportunity to improve overall population health, to protect some of its most stigmatized citizens, and to become the flag bearer of enhanced human rights in the Caribbean and Latin America.	[Budhwani, Henna] Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA; [Hearld, Kristine R.] Univ Alabama Birmingham, Dept Hlth Serv Adm, Birmingham, AL USA; [Hasbun, Julia; Rosario, Santo; Tillotson, Louise] Ctr Orientac & Invest Integral COIN, Calle Arzobispo Merino, Santo Domingo, Dominican Rep; [Charow, Rebecca; Waters, John] Caribbean Vulnerable Commun Coalit CVC, Kingston, Jamaica; [McGlaughlin, Elaine] United Nations Populat Fund UNFPA, Tegucigalpa, Honduras	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; United Nations Population Fund	Budhwani, H (corresponding author), Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA.	budhwani@uab.edu		Budhwani, Henna/0000-0002-6716-9754; Hearld, Kristine/0000-0002-0501-874X; Charow, Rebecca/0000-0002-8553-4006				Bailey A, 2016, ARCH SEX BEHAV, V45, P911, DOI 10.1007/s10508-014-0449-1; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bockting WO, 1998, AIDS CARE, V10, P505, DOI 10.1080/09540129850124028; BOLES J, 1994, SOC SCI MED, V39, P85, DOI 10.1016/0277-9536(94)90168-6; Budhwani H, 2016, INDIAN MED J; Budhwani H, TRANSGENDER IN PRESS; Budhwani H, SUICIDE LIF IN PRESS; Budhwani H, 2016, INT J STD AIDS; Budhwani H, 2016, INT J STD AIDS, V27, P769, DOI 10.1177/0956462415594752; Carrasco M. A., 2016, CULTURE HLTH SEXUALI, V19, P1; Clements K, 1999, TRANSGENDER HIV RISK, P39; Consejo Nacional para el VIH y sida (CONAVIHSIDA), 2012, SEG ENC VIG COMP VIN; De Santis JP, 2009, J ASSOC NURSE AIDS C, V20, P362, DOI 10.1016/j.jana.2009.06.005; Decker MR, 2015, LANCET, V385, P186, DOI 10.1016/S0140-6736(14)60800-X; Duncan J, 2010, SEX TRANSM DIS, V37, P306, DOI 10.1097/OLQ.0b013e3181c6e851; Eisenbraun S, 2010, 2009 COUNTR REP HUM; Eldemire-Shearer D, 2008, W INDIAN MED J, V57, P450; ELIFSON KW, 1993, AM J PUBLIC HEALTH, V83, P79, DOI 10.2105/AJPH.83.1.79; ELIFSON KW, 1993, AM J PUBLIC HEALTH, V83, P260, DOI 10.2105/AJPH.83.2.260; Fazelia P, 2016, STIGMA AND HLTH; Fletcher JB, 2014, ARCH SEX BEHAV, V43, P1651, DOI 10.1007/s10508-014-0368-1; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Krogstad DJ, 2010, AM J TROP MED HYG, V83, P743, DOI 10.4269/ajtmh.2010.10-0014; Lightfoot M, 2005, JAIDS-J ACQ IMM DEF, V38, P61, DOI 10.1097/00126334-200501010-00012; Marshall PA, 2007, ETHICAL CHALLENGES S, V5; Ministry of Health, 2009, SUMM FIND SURV MEN W; MODAN B, 1992, AM J PUBLIC HEALTH, V82, P590, DOI 10.2105/AJPH.82.4.590; Nemoto T, 2014, AIDS CARE, V26, P434, DOI 10.1080/09540121.2013.841832; Noar SM, 2012, ARCH SEX BEHAV, V41, P959, DOI 10.1007/s10508-011-9890-6; Onvomaha Tindana Paulina, 2006, IRB, V28, P1; Opeiario D, 2008, JAIDS-J ACQ IMM DEF, V48, P97, DOI 10.1097/QAI.0b013e31816e3971; Operario D, 2010, JAIDS-J ACQ IMM DEF, V55, pS91, DOI 10.1097/QAI.0b013e3181fbc9ec; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Rathe M., 2010, 10 WORLD HLTH; Reisner SL, 2016, LANCET, V388, P412, DOI 10.1016/S0140-6736(16)00684-X; Rhodes T, 2008, BMJ, V337; Sanders T, 2002, FEM PSYCHOL, V12, P561, DOI 10.1177/0959353502012004016; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Snow Inc. World Professional Association for Transgender Health, 2014, BLUEPR PROV COMPR CA; Tekola F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000482; TIRELLI U, 1988, J ACQ IMMUN DEF SYND, V1, P414; Turan B, 2017, AIDS BEHAV, V21, P283, DOI 10.1007/s10461-016-1451-5; Urada LA, 2013, AIDS BEHAV, V17, P523, DOI 10.1007/s10461-011-0113-x; Wilson EC, 2010, AM J PUBLIC HEALTH, V100, P1500, DOI 10.2105/AJPH.2009.160051; Winter S, 2016, LANCET, V388, P390, DOI 10.1016/S0140-6736(16)00683-8; Winter S, 2016, LANCET, V388, P318, DOI 10.1016/S0140-6736(16)30653-5; Wolff KB, 2007, SEX CULT, V11, P1, DOI 10.1007/s12119-007-9000-z; Wylie K, 2016, LANCET, V388, P401, DOI 10.1016/S0140-6736(16)00682-6; Zulliger R, 2015, JAIDS-J ACQ IMM DEF, V69, P216, DOI 10.1097/QAI.0000000000000590	49	29	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186457	10.1371/journal.pone.0186457	http://dx.doi.org/10.1371/journal.pone.0186457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095843	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200017
J	Hosia, A; Falkenhaug, T; Baxter, EJ; Pages, F				Hosia, Aino; Falkenhaug, Tone; Baxter, Emily J.; Pages, Francesc			Abundance, distribution and diversity of gelatinous predators along the northern Mid-Atlantic Ridge: A comparison of different sampling methodologies	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; ZOOPLANKTON; BIOGEOGRAPHY; CNIDARIANS; JELLYFISH; PATTERNS; RISE; NET	The diversity and distribution of gelatinous zooplankton were investigated along the northern Mid-Atlantic Ridge (MAR) from June to August 2004.Here, we present results from macrozooplankton trawl sampling, as well as comparisons made between five different methodologies that were employed during the MAR-ECO survey. In total, 16 species of hydromedusae, 31 species of siphonophores and four species of scyphozoans were identified to species level from macrozooplankton trawl samples. Additional taxa were identified to higher taxonomic levels and a single ctenophore genus was observed. Samples were collected at 17 stations along the MAR between the Azores and Iceland. A divergence in the species assemblages was observed at the southern limit of the Subpolar Frontal Zone. The catch composition of gelatinous zooplankton is compared between different sampling methodologies including: a macrozooplankton trawl; a Multinet; a ringnet attached to bottom trawl; and optical platforms (Underwater Video Profiler (UVP) & Remotely Operated Vehicle (ROV)). Different sampling methodologies are shown to exhibit selectivity towards different groups of gelatinous zooplankton. Only similar to 21 % of taxa caught during the survey were caught by both the macrozooplankton trawl and the Multinet when deployed at the same station. The estimates of gelatinous zooplankton abundance calculated using these two gear types also varied widely (1.4 +/- 0.9 individuals 1000 m(-3) estimated by the macrozooplankton trawl vs. 468.3 +/- 315.4 individuals 1000 m(-3) estimated by the Multinet (mean +/- s.d.) when used at the same stations (n = 6). While it appears that traditional net sampling can generate useful data on pelagic cnidarians, comparisons with results from the optical platforms suggest that ctenophore diversity and abundance are consistently underestimated, particularly when net sampling is conducted in combination with formalin fixation. The results emphasise the importance of considering sampling methodology both when planning surveys, as well as when interpreting existing data.	[Hosia, Aino] Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway; [Falkenhaug, Tone] Inst Marine Res, Flodevigen, Norway; [Baxter, Emily J.] North West Wildlife Trusts, Plumgarths, Kendal, Cumbria, England; [Pages, Francesc] CSIC, Inst Ciencies Mar, Barcelona, Spain	University of Bergen; Institute of Marine Research - Norway; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Hosia, A (corresponding author), Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway.	aino.hosia@uib.no		Hosia, Aino/0000-0001-7664-6498	Sloan Foundation; Research Council of Norway (RCN) [146994/120]; Norwegian Taxonomy Initiative (NTI) [70184233/HYPNO]; RCN [248799]; NTI [70184215]	Sloan Foundation(Alfred P. Sloan Foundation); Research Council of Norway (RCN)(Research Council of Norway); Norwegian Taxonomy Initiative (NTI); RCN; NTI	This study was an element of MAR-ECO (2001-2010), a field project of the Census of Marine Life, funded by the Sloan Foundation. The Institute of Marine Research and the University of Bergen, Norway, contributed ship-time. More information about MAR-ECO funding can be found at http://www.mar-eco.no/about/sponsers.html. AH has received funding from the Research Council of Norway (RCN, http://www.forskningsradet.no/, project no. 146994/120) at the time of the study, and currently from the Norwegian Taxonomy Initiative (NTI, http://www.biodiversity.no/, project no. 70184233/HYPNO) as well as ForBio Research School funding from the RCN (project no. 248799) and the NTI (project no. 70184215). The external funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS H, 1976, MONOGRAPH OCEANOGRAP, DOI DOI 10.1016/J.POCEAN.2008.03.017; Alamaru A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06505-4; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P1, DOI 10.1016/j.dsr2.2007.10.001; Brodeur RD, 2008, PROG OCEANOGR, V77, P103, DOI 10.1016/j.pocean.2008.03.017; Bucklin A, 2004, MOL PHYLOGENET EVOL, V30, P879, DOI 10.1016/j.ympev.2003.11.002; Bucklin A, 2016, J PLANKTON RES, V38, P393, DOI 10.1093/plankt/fbw023; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Engas A, 1997, FISH RES, V29, P295, DOI 10.1016/S0165-7836(96)00545-0; Eriksen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033050; Gaard E, 2008, DEEP-SEA RES PT II, V55, P59, DOI 10.1016/j.dsr2.2007.09.012; Haddock SHD, 2004, HYDROBIOLOGIA, V530, P549, DOI 10.1007/s10750-004-2653-9; HARBISON GR, 1978, DEEP-SEA RES, V25, P233, DOI 10.1016/0146-6291(78)90590-8; Heino M, 2011, ICES J MAR SCI, V68, P377, DOI 10.1093/icesjms/fsq089; Hosia A, 2008, DEEP-SEA RES PT II, V55, P106, DOI 10.1016/j.dsr2.2007.09.007; Junior MN, 2015, J MARINE SYST, V144, P117, DOI 10.1016/j.jmarsys.2014.11.014; Kramp P. L., 1959, Dana Reports, V46, P1; Letessier TB, 2011, J PLANKTON RES, V33, P1510, DOI 10.1093/plankt/fbr056; Licandro P, 2015, EARTH SYST SCI DATA, V7, P173, DOI 10.5194/essd-7-173-2015; Lindsay Dhugal J., 2015, Bulletin of Plankton Society of Japan, V62, P39; Longhurst AR, 1998, ECOLOGICAL GEOGRAPHY; Oksanen J., 2019, R PACKAGE VERSION, DOI DOI 10.4135/9781412971874.N145; Ortman BD, 2010, DEEP-SEA RES PT II, V57, P2148, DOI 10.1016/j.dsr2.2010.09.017; PURCELL JE, 1988, MAR ECOL PROG SER, V45, P197, DOI 10.3354/meps045197; R Development Core Team, 2009, R LANG ENV STAT COMP; Remsen A, 2004, DEEP-SEA RES PT I, V51, P129, DOI 10.1016/j.dsr.2003.09.008; Rossby T, 1999, DEEP-SEA RES PT II, V46, P139, DOI 10.1016/S0967-0645(98)00095-2; RUSSELL FS, 1970, MEDUSAE BRIT ISLES, V2, DOI DOI 10.1080/17451000902810751; Skjoldal HR, 2013, PROG OCEANOGR, V108, P1, DOI 10.1016/j.pocean.2012.10.006; Soiland H, 2008, DEEP-SEA RES PT II, V55, P29, DOI 10.1016/j.dsr2.2007.09.015; Spalding MD, 2012, OCEAN COAST MANAGE, V60, P19, DOI 10.1016/j.ocecoaman.2011.12.016; Stemmann L, 2008, DEEP-SEA RES PT II, V55, P94, DOI 10.1016/j.dsr2.2007.09.019; Sutton TT, 2008, DEEP-SEA RES PT II, V55, P161, DOI 10.1016/j.dsr2.2007.09.013; TOTTON AK, 1965, SYNOPSIS SIPHONOPHOR, DOI DOI 10.1093/PLANKT/FBR056; *UNESCO, 2009, IOC TECHNICAL SERIES, V84; Vecchione M, 2015, PROG OCEANOGR, V138, P105, DOI 10.1016/j.pocean.2015.08.006; Vecchione M, 2010, MAR BIOL RES, V6, P25, DOI 10.1080/17451000902810751; WENNECK T. L., 2008, DEEP SEA RES 2, V55, P6; WIEBE PH, 1985, MAR BIOL, V87, P313, DOI 10.1007/BF00397811; Youngbluth M, 2008, DEEP-SEA RES PT II, V55, P119, DOI 10.1016/j.dsr2.2007.10.002	39	27	28	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187491	10.1371/journal.pone.0187491	http://dx.doi.org/10.1371/journal.pone.0187491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095891	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000414340200102
J	Klaassen, I; de Vries, EW; Vogels, IMC; van Kampen, AHC; Bosscha, MI; Steel, DHW; Van Noorden, CJF; Lesnik-Oberstein, SY; Schlingemann, RO				Klaassen, Ingeborg; de Vries, Ewout W.; Vogels, Ilse M. C.; van Kampen, Antoine H. C.; Bosscha, Machteld I.; Steel, David H. W.; Van Noorden, Cornelis J. F.; Lesnik-Oberstein, Sarit Y.; Schlingemann, Reinier O.			Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GANGLION-CELL NEURITES; BLOOD-RETINAL BARRIER; ANGIOGENESIS IN-VITRO; EPIRETINAL MEMBRANES; MACULAR EDEMA; OCULAR NEOVASCULARIZATION; BINDING PROTEIN-3; FACTOR EXPRESSION; IGF-I	Purpose To identify the protein profiles in vitreous associated with retinal fibrosis, angiogenesis, and neurite formation in epiretinal fibrovascular membranes (FVMs) in patients with proliferative diabetic retinopathy (PDR). Methods Vitreous samples of 5 non-diabetic control patients with vitreous debris and 7 patients with PDR membranes were screened for 507 preselected proteins using the semi-quantitative RayBio (R) L-series 507 antibody array. From this array, 60 proteins were selected for a custom quantitative antibody array (Raybiotech, Human Quantibody (R) array), analyzing 7 control patients, 8 PDR patients with FVMs, and 5 PDR patients without FVMs. Additionally, mRNA levels of proteins of interest were measured in 10 PDR membranes and 11 idiopathic membranes and in retinal tissues and cells to identify possible sources of protein production. Results Of the 507 proteins screened, 21 were found to be significantly elevated in PDR patients, including neurogenic and angiogenic factors such as neuregulin 1 (NRG1), nerve growth factor receptor (NGFR), placental growth factor (PlGF) and platelet derived growth factor (PDGF). Angiopoietin-2 (Ang2) concentrations were strongly correlated to the degree of fibrosis and the presence of FVMs in patients with PDR. Protein correlation analysis showed PDGF to be extensively co-regulated with other proteins, including thrombospondin-1 and Ang2. mRNA levels of glial-derived and brain/derived neurotrophic factor (GDNF and BDNF) were elevated in PDR membranes. These results were validated in a second study of 52 vitreous samples of 32 PDR patients and 20 control patients. Conclusions This exploratory study reveals protein networks that potentially contribute to neurite outgrowth, angiogenesis and fibrosis in the formation of fibrovascular membranes in PDR. We identified a possible role of Ang2 in fibrosis and the formation of FVMs, and of the neurotrophic factors NRG1, PDGF and GDNF in neurite growth that occurs in all FVMs in PDR.	[Klaassen, Ingeborg; de Vries, Ewout W.; Vogels, Ilse M. C.; Van Noorden, Cornelis J. F.; Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Ocular Angiogenesis Grp, Amsterdam, Netherlands; [Klaassen, Ingeborg; de Vries, Ewout W.; Vogels, Ilse M. C.; Van Noorden, Cornelis J. F.; Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Dept Med Biol, Amsterdam, Netherlands; [van Kampen, Antoine H. C.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Bosscha, Machteld I.] Vrije Univ Amsterdam Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Steel, David H. W.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Steel, David H. W.] Sunderland Eye Infirm, Sunderland, Durham, England; [Lesnik-Oberstein, Sarit Y.] Harley St Eye Clin, London, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Newcastle University - UK	Klaassen, I (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Ocular Angiogenesis Grp, Amsterdam, Netherlands.; Klaassen, I (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biol, Amsterdam, Netherlands.	i.klaassen@amc.uva.nl	Bosscha, Machteld/T-2808-2019; Klaassen, Ingeborg/F-7333-2015; Steel, David/I-8053-2015	Steel, David/0000-0001-8734-3089; de Vries, Ewout/0000-0002-6407-4303; Klaassen, Ingeborg/0000-0003-1695-9403	Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Stichting Blinden-Penning; Stichting Ooglijders; Nederlandse Vereniging ter Verbetering van het Lot der Blinden; MaculaFonds through UitZicht; Stichting Nederlands Oogheelkundig Onderzoek	Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Stichting Blinden-Penning; Stichting Ooglijders; Nederlandse Vereniging ter Verbetering van het Lot der Blinden; MaculaFonds through UitZicht; Stichting Nederlands Oogheelkundig Onderzoek	The study was supported by Landelijke Stichting voor Blinden en Slechtzienden (LSBS), Stichting Blinden-Penning and MaculaFonds that contributed through UitZicht (Grant UitZicht 2011-15), Stichting Ooglijders, Nederlandse Vereniging ter Verbetering van het Lot der Blinden and Stichting Nederlands Oogheelkundig Onderzoek (Grant 2011-03). This study was published with the help of Edward en Marianne Blaauw Fonds voor Oogheelkunde (Edward and Marianne Blaauw Fund for Ophthalmology). The funder provided support in the form of salaries for authors [IK, IMCV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abu El-Asrar AM, 2007, BRIT J OPHTHALMOL, V91, P822, DOI 10.1136/bjo.2006.109876; Abu El-Asrar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065472; Abu El-Asrar AM, 2013, ACTA DIABETOL, V50, P545, DOI 10.1007/s00592-011-0330-9; Bach LA, 2015, J MOL ENDOCRINOL, V54, pR1, DOI 10.1530/JME-14-0215; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; BerminghamMcDonogh O, 1996, DEVELOPMENT, V122, P1427; Biancotto A, 2012, CYTOKINE, V60, P438, DOI 10.1016/j.cyto.2012.05.019; Boulton M, 1997, BRIT J OPHTHALMOL, V81, P228, DOI 10.1136/bjo.81.3.228; Bringmann A, 2009, GRAEF ARCH CLIN EXP, V247, P865, DOI 10.1007/s00417-009-1082-x; Burgos R, 2000, DIABETES CARE, V23, P80, DOI 10.2337/diacare.23.1.80; Chen JX, 2012, AM J PHYSIOL-HEART C, V302, pH1003, DOI 10.1152/ajpheart.00866.2011; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; de Carvalho JER, 2013, INVEST OPHTH VIS SCI, V54, P6489, DOI 10.1167/iovs.13-12374; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Elman MJ, 2015, OPHTHALMOLOGY, V122, P375, DOI 10.1016/j.ophtha.2014.08.047; Fickweiler W, 2016, INVEST OPHTH VIS SCI, V57, P6234, DOI 10.1167/iovs.16-20157; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Franklin SL, 2003, J CLIN ENDOCR METAB, V88, P900, DOI 10.1210/jc.2002-020472; Funa K, 2014, J NEUROIMMUNE PHARM, V9, P168, DOI 10.1007/s11481-013-9479-z; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Guangqi E, 2012, J BIOL CHEM, V287, P3029, DOI 10.1074/jbc.M111.293985; Gulkilik Gokhan, 2010, International Ophthalmology, V30, P697, DOI 10.1007/s10792-010-9403-y; HARRISON AA, 1994, DIABETOLOGIA, V37, P1142, DOI 10.1007/BF00418378; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; HOPKINS KD, 1993, HORM METAB RES, V25, P331, DOI 10.1055/s-2007-1002114; Huang H, 2015, DIABETES, V64, P200, DOI 10.2337/db14-0016; Jarajapu YPR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039398; Kita T, 2015, DIABETES, V64, P3588, DOI 10.2337/db15-0317; Klaassen I, 2015, EXP EYE RES, V133, P37, DOI 10.1016/j.exer.2014.10.016; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; Kuiper EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002675; Lee T, 2003, J VASC SURG, V38, P147, DOI 10.1016/S0741-5214(02)75468-2; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Lewis GP, 2007, BRIT J OPHTHALMOL, V91, P1234, DOI 10.1136/bjo.2006.104612; Li JK, 2015, INT J OPHTHALMOL-CHI, V8, P1202, DOI 10.3980/j.issn.2222-3959.2015.06.22; Liu Z, 2011, PEPTIDES, V32, P1244, DOI 10.1016/j.peptides.2011.04.005; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Loukovaara S, 2014, GRAEF ARCH CLIN EXP, V252, P881, DOI 10.1007/s00417-013-2508-z; Martinez-Zapata MJ, 2014, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD008721.PUB2; Masli S, 2014, CURR EYE RES, V39, P759, DOI 10.3109/02713683.2013.877936; Moon SW, 2009, BIOCHEM BIOPH RES CO, V388, P167, DOI 10.1016/j.bbrc.2009.07.144; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P2001; Nambu H, 2004, GENE THER, V11, P865, DOI 10.1038/sj.gt.3302230; Neely KA, 1998, AM J PATHOL, V153, P665, DOI 10.1016/S0002-9440(10)65607-6; Nishikiori N, 2005, DIABETES CARE, V28, P2588, DOI 10.2337/diacare.28.10.2588; Oberstein SYL, 2008, BRIT J OPHTHALMOL, V92, P981, DOI 10.1136/bjo.2007.132332; Oberstein SYL, 2011, MOL VIS, V17, P1794; Oberstein SYL, 2011, BRIT J OPHTHALMOL, V95, P266, DOI 10.1136/bjo.2010.180679; Ogden TL, 2010, ANN OCCUP HYG, V54, P255, DOI 10.1093/annhyg/mep099; Osaadon P, 2014, EYE, V28, P510, DOI 10.1038/eye.2014.13; Park N, 2012, MOL CELLS, V34, P549, DOI 10.1007/s10059-012-0235-7; Patel JI, 2005, BRIT J OPHTHALMOL, V89, P480, DOI 10.1136/bjo.2004.049940; Pauta M, 2015, LIVER INT, V35, P1383, DOI 10.1111/liv.12505; Pfeiffer A, 1997, DIABETES, V46, pS26, DOI 10.2337/diab.46.2.S26; Pfister F, 2010, ACTA DIABETOL, V47, P59, DOI 10.1007/s00592-009-0099-2; Qian XH, 1997, EXP CELL RES, V235, P403, DOI 10.1006/excr.1997.3681; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Sheibani N, 2000, BIOCHEM BIOPH RES CO, V267, P257, DOI 10.1006/bbrc.1999.1903; Siemerink MJ, 2013, J HISTOCHEM CYTOCHEM, V61, P101, DOI 10.1369/0022155412467635; Simo R, 2012, BRIT J OPHTHALMOL, V96, P1285, DOI 10.1136/bjophthalmol-2012-302005; Simo-Servat O, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/872978; Smith JM, 2015, COCHRANE DB SYST REV, V8; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Snead DRJ, 2008, EYE, V22, P1310, DOI 10.1038/eye.2008.36; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Taguchi M, 2016, J NEUROCHEM, V136, P741, DOI 10.1111/jnc.13427; Umeda N, 2003, OPHTHALMIC RES, V35, P217, DOI 10.1159/000071173; Van Geest RJ, 2012, BRIT J OPHTHALMOL, V96, P587, DOI 10.1136/bjophthalmol-2011-301005; Warren RS, 1996, J BIOL CHEM, V271, P29483, DOI 10.1074/jbc.271.46.29483; Watanabe D, 2005, AM J OPHTHALMOL, V139, P476, DOI 10.1016/j.ajo.2004.10.004; Wisniewska-Kruk J, 2012, EXP EYE RES, V96, P181, DOI 10.1016/j.exer.2011.12.003; Xiao JH, 2009, J NEUROSCI, V29, P4016, DOI 10.1523/JNEUROSCI.3811-08.2009; Zhao B, 2004, MICROVASC RES, V68, P239, DOI 10.1016/j.mvr.2004.07.004; Zhou AY, 2014, WORLD J PEDIATR, V10, P262, DOI 10.1007/s12519-014-0502-0	79	39	41	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187304	10.1371/journal.pone.0187304	http://dx.doi.org/10.1371/journal.pone.0187304			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095861	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200068
J	Ong, M; Bulmer, M; Groening, J; Srinivasan, MV				Ong, Marielle; Bulmer, Michael; Groening, Julia; Srinivasan, Mandyam V.			Obstacle traversal and route choice in flying honeybees: Evidence for individual handedness	PLOS ONE			English	Article							LATERALIZATION; EVOLUTION; ASYMMETRY; FLIGHT; PERFORMANCE; COMPETITION; NAVIGATION; RESPONSES; BEHAVIOR; BIASES	Flying insects constantly face the challenge of choosing efficient, safe and collision-free routes while navigating through dense foliage. We examined the route-choice behavior of foraging honeybees when they encountered a barrier which could be traversed by flying through one of two apertures, positioned side by side. When the bees' choice behavior was averaged over the entire tested population, the two apertures were chosen with equal frequency when they were equally wide. When the apertures were of different width, the bees, on average, showed a preference for the wider aperture, which increased sharply with the difference between the aperture widths. Thus, bees are able to discriminate the widths of oncoming gaps and choose the passage which is presumably safer and quicker to transit. Examination of the behavior of individual bees revealed that, when the two apertures were equally wide, ca. 55% of the bees displayed no side bias in their choices. However, the remaining 45% showed varying degrees of bias, with one half of them preferring the left-hand aperture, and the other half the right-hand aperture. The existence of distinct individual biases was confirmed by measuring the times required by biased bees to transit various aperture configurations: The transit time was longer if a bee's intrinsic bias forced it to engage with the narrower aperture. Our results show that, at the population level, bees do not exhibit 'handedness' in choosing routes; however, individual bees display an idiosyncratic bias that can range from a strong left bias, through zero bias, to a strong right bias. In honeybees, previous studies of olfactory and visual learning have demonstrated clear biases at the population level. To our knowledge, our study is the first to uncover the existence of individually distinct biases in honeybees. We also show how a distribution of biases among individual honeybees can be advantageous in facilitating rapid transit of a group of bees through a cluttered environment, without any centralized decision-making or control.	[Ong, Marielle; Groening, Julia; Srinivasan, Mandyam V.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Ong, Marielle; Bulmer, Michael] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia; [Srinivasan, Mandyam V.] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Srinivasan, MV (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.; Srinivasan, MV (corresponding author), Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia.	m.srinivasan@uq.edu.au		Muthukumarasamy, Srinivasan/0000-0002-2948-6206; Groening, Julia/0000-0003-2857-6290	Australian Research Council (ARC) [DP140100914]	Australian Research Council (ARC)(Australian Research Council)	This study was funded by the Australian Research Council (ARC DP140100914), http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfora G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018903; Anfora G, 2010, BEHAV BRAIN RES, V206, P236, DOI 10.1016/j.bbr.2009.09.023; Baird E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.2988; Bell ATA, 2014, CURR BIOL, V24, pR382, DOI 10.1016/j.cub.2014.03.064; Bell ATA, 2016, THESIS; Bhagavatula PS, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003473; Bibost AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080907; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bisazza A, 2000, NEUROPSYCHOLOGIA, V38, P907, DOI 10.1016/S0028-3932(00)00018-X; Brown C, 2011, BEHAV ECOL, V22, P1201, DOI 10.1093/beheco/arr114; Buchanan SM, 2015, P NATL ACAD SCI USA, V112, P6700, DOI 10.1073/pnas.1500804112; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Crall JD, 2015, J EXP BIOL, V218, P2728, DOI 10.1242/jeb.121293; Dukas R, 2011, ANIM BEHAV, V81, P635, DOI 10.1016/j.anbehav.2010.12.011; Frasnelli E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00939; Frasnelli E, 2012, NEUROSCI BIOBEHAV R, V36, P1273, DOI 10.1016/j.neubiorev.2012.02.006; Frasnelli E, 2010, BEHAV BRAIN RES, V209, P36, DOI 10.1016/j.bbr.2010.01.014; Ghirlanda S, 2004, P ROY SOC B-BIOL SCI, V271, P853, DOI 10.1098/rspb.2003.2669; Ghirlanda S, 2009, PHILOS T R SOC B, V364, P861, DOI 10.1098/rstb.2008.0227; Girling RD, 2007, BEHAVIOUR, V144, P143, DOI 10.1163/156853907779947337; Honicke C, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1267-6; Hook MA, 2008, J COMP PSYCHOL, V122, P41, DOI 10.1037/0735-7036.122.1.41; Kells AR, 2001, J INSECT BEHAV, V14, P47, DOI 10.1023/A:1007897512570; Letzkus P, 2008, BIOL LETTERS, V4, P16, DOI 10.1098/rsbl.2007.0466; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; Lihoreau M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30401; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; LOCK A, 1980, PROC R SOC SER B-BIO, V206, P481, DOI 10.1098/rspb.1980.0009; McGrew WC, 2001, BEHAVIOUR, V138, P329, DOI 10.1163/15685390152032497; Mountcastle AM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0531; Portelli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019486; Robins A, 2006, ANIM BEHAV, V72, P843, DOI 10.1016/j.anbehav.2006.01.022; Robins A, 2006, NEUROBIOL LEARN MEM, V86, P214, DOI 10.1016/j.nlm.2006.03.002; Rogers L.J., 2013, DIVIDED BRAINS; Rogers LJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02045; Rogers LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002340; Rogers LJ, 2002, COMP VERTEBRATE LATE; Ros IG, 2017, INTERFACE FOCUS, V7, DOI 10.1098/rsfs.2016.0093; Rutledge R, 2004, ANIM BEHAV, V67, P327, DOI 10.1016/j.anbehav.2003.07.002; Schiffner I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082670; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; Schnell AK, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00620; Serres JR, 2008, NATURWISSENSCHAFTEN, V95, P1181, DOI 10.1007/s00114-008-0440-6; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; Srinivasan MV, 1996, J EXP BIOL, V199, P237; TAKEDA S, 1993, BIOL BULL-US, V184, P203, DOI 10.2307/1542227; Tobo S, 2012, ECOL RES, V27, P53, DOI 10.1007/s11284-011-0867-7; WATERS NS, 1991, PHYSIOL BEHAV, V50, P853, DOI 10.1016/0031-9384(91)90030-R; Weir AAS, 2004, P ROY SOC B-BIOL SCI, V271, pS344, DOI 10.1098/rsbl.2004.0183	49	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0184343	10.1371/journal.pone.0184343	http://dx.doi.org/10.1371/journal.pone.0184343			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095830	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200001
J	Gumpertz, M; Durodoye, R; Griffith, E; Wilson, A				Gumpertz, Marcia; Durodoye, Raifu; Griffith, Emily; Wilson, Alyson			Retention and promotion of women and underrepresented minority faculty in science and engineering at four large land grant institutions	PLOS ONE			English	Article							REPRESENTATION; GENDER	The current climate on college campuses has brought new urgency to the need to increase faculty diversity. In STEM fields particularly, the dearth of underrepresented minority (URM) and female faculty is severe. The retention and success of African American, Hispanic/Latino, American Indian and female faculty have direct implications for the quality and diversity of the future scientific workforce. Understanding the ways retention patterns differ by discipline and institution is crucial for developing a diverse faculty. This study investigates tenure attainment, retention, and time to promotion to full professor for women and URM faculty. We analyze personnel records for assistant and associate professors hired or appointed from 1992 to 2015 at four large land grant institutions. Representation of women and URM faculty in STEM disciplines increased substantially from 1992 to 2015, but mostly for women and Hispanic faculty and more slowly for black and American Indian faculty.	[Gumpertz, Marcia] North Carolina State Univ, Off Inst Equ & Divers, Raleigh, NC 27695 USA; [Durodoye, Raifu] Virginia Tech, Off Inst Res & Effectiveness, Blacksburg, VA USA; [Gumpertz, Marcia; Griffith, Emily; Wilson, Alyson] North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Durodoye, Raifu] Dover, Delaware Dept Educ, Teacher & Leader Effectiveness Branch, Delaware, OH USA	University of North Carolina; North Carolina State University; Virginia Polytechnic Institute & State University; University of North Carolina; North Carolina State University	Gumpertz, M (corresponding author), North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA.	gumpertz@ncsu.edu		Gumpertz, Marcia/0000-0002-8170-1874				Box-Steffensmeier JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143093; Brown S., CHRONICLE HIGHER ED; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Harocollis A, NY TIMES; Kaminski D, 2012, SCIENCE, V335, P864, DOI 10.1126/science.1214844; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Libresco L., 2015, 538 POLITICS; Llovio L., 2015, RICHMOND TIMES DISPA; Marschke R, 2007, J HIGH EDUC-UK, V78, P1, DOI 10.1353/jhe.2007.0003; Massachusetts Institute of Technology, 2010, REP IN FAC RAC DIV; Moore JS, 2008, FINAL REPORT GENDER; Moreno JoseF., 2006, REVOLVING DOOR UNDER; Myers SL, 2004, AM ECON REV, V94, P296, DOI 10.1257/0002828041301614; National Academy of Sciences (US) National Academy of Engineering (US) and Institute of Medicine (US) Committee on Maximizing the Potential of Women in Academic Science and Engineering, 2007, BIAS BARR FULF POT W; National Science Foundation National Center for Science and Engineering Statistics, 2015, DOCT REC US U 2014; Sabatke S., 2016, HUFFINGTON POST; Taylor LL, 2015, COHORT ANAL RETENTIO; Thomas NR, 2015, PLOS ONE, P10; Turner CSV, 2008, J DIVERS HIGH EDUC, V1, P139, DOI 10.1037/a0012837; Whittaker Joseph A, 2015, J Undergrad Neurosci Educ, V13, pA136; Wong Alia, 2016, ATLANTIC; Xu YHJ, 2008, RES HIGH EDUC, V49, P40, DOI 10.1007/s11162-007-9062-7	23	39	39	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187285	10.1371/journal.pone.0187285	http://dx.doi.org/10.1371/journal.pone.0187285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091958	gold, Green Published, Green Submitted			2022-12-27	WOS:000414229700052
J	Honge, BL; Petersen, MS; Olesen, R; Moller, BK; Erikstrup, C				Honge, Bo Langhoff; Petersen, Mikkel Steen; Olesen, Rikke; Moller, Bjarne Kuno; Erikstrup, Christian			Optimizing recovery of frozen human peripheral blood mononuclear cells for flow cytometry	PLOS ONE			English	Article							CLINICAL-TRIALS; CRYOPRESERVATION; RESPONSES; PBMCS; SUBSETS; VACCINE; OPTIMIZATION; INDIVIDUALS; IMMUNOLOGY; PHENOTYPE	Introduction Live peripheral blood mononuclear cells (PBMCs) can be frozen and thawed for later analyses by adding and removing a cryoprotectant, such as dimethyl sulfoxide (DMSO). Laboratories across the world use various procedures, but published evidence of optimal thawing procedures is scarce. Materials and methods PBMCs were separated from blood collected from healthy Danish blood donors, and stored at-80 degrees C after adding of DMSO. The essential steps in the thawing procedure were modified and performance was evaluated by flow cytometry with respect to the percentage and total yield of viable PMBCs. Results The best-performing washing medium was Roswell Park Memorial Institute (RPMI) 1640 at 37 degrees C with 20% fetal bovine serum. When using 10 mL washing medium in a 15-mL Falcon tube, samples should be centrifuged for at least 10 minutes at 500 g. We failed to detect any differences between the tested methods of mixing PBMCs with washing medium. Likewise, neither the thawing duration nor centrifugation temperature (20 C and 37 degrees C) had any effect. PBMCs could be incubated (rested) for up to eight hours in a 37 degrees C 5% CO2 incubator without affecting cell counts, but incubating PBMCs for 16 hours significantly decreased viability and recovery. In general, high viability was not necessarily associated with high recovery. Conclusion Changing the thawing procedure significantly impacted PBMC viability and live cell recovery. Evaluating both viability and live PBMC recovery are necessary to evaluate method performance. Investigation of differential loss of PBMC subtypes and phenotypic changes during thawing and incubation requires further evaluation.	[Honge, Bo Langhoff; Petersen, Mikkel Steen; Moller, Bjarne Kuno; Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark; [Honge, Bo Langhoff] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Olesen, Rikke] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark	Aarhus University; Aarhus University	Honge, BL (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark.; Honge, BL (corresponding author), Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau.	bohonge@gmail.com	; Honge, Bo Langhoff/H-7017-2014	Olesen, Rikke/0000-0002-5157-080X; Honge, Bo Langhoff/0000-0001-9636-4519; Erikstrup, Christian/0000-0001-6551-6647				Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Brooks-Worrell B, 2011, DIABETES-METAB RES, V27, P737, DOI 10.1002/dmrr.1245; Buhl T, 2012, CANCER IMMUNOL IMMUN, V61, P2021, DOI 10.1007/s00262-012-1262-0; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Disis ML, 2006, J IMMUNOL METHODS, V308, P13, DOI 10.1016/j.jim.2005.09.011; Elkord E, 2009, J IMMUNOL METHODS, V347, P87, DOI 10.1016/j.jim.2009.06.001; Ferreira VD, 2015, CRYOBIOLOGY, V71, P507, DOI 10.1016/j.cryobiol.2015.10.149; Germann A, 2013, CRYOBIOLOGY, V67, P193, DOI 10.1016/j.cryobiol.2013.06.012; Hensley-McBain T, 2014, J IMMUNOL METHODS, V411, P23, DOI 10.1016/j.jim.2014.06.002; Keane KN, 2015, CLIN SCI, V128, P723, DOI 10.1042/CS20140725; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Kloverpris H, 2010, J IMMUNOL METHODS, V356, P70, DOI 10.1016/j.jim.2010.01.014; Kutscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076215; Liseth K, 2005, CYTOTHERAPY, V7, P328, DOI 10.1080/14653240500238251; Lockmann A, 2013, EXP DERMATOL, V22, P358, DOI 10.1111/exd.12123; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; Mata MM, 2014, J IMMUNOL METHODS, V406, P1, DOI 10.1016/j.jim.2014.01.017; Meijerink M, 2011, J IMMUNOL METHODS, V373, P136, DOI 10.1016/j.jim.2011.08.010; Nazarpour R, 2012, INT J MOL CELL MED, V1, P88; Nettenstrom L, 2013, J IMMUNOL METHODS, V387, P81, DOI 10.1016/j.jim.2012.09.014; Pedersen OB, 2012, VOX SANG, V102, P271, DOI 10.1111/j.1423-0410.2011.01553.x; Ramachandran Hari, 2012, Cells, V1, P313, DOI 10.3390/cells1030313; Rasmussen SM, 2015, CYTOM PART B-CLIN CY, V88, P40, DOI 10.1002/cyto.b.21192; Riedhammer C, 2014, MULT SCLER, P53; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P21, DOI 10.1016/j.jim.2014.05.013; Sattui S, 2012, CYTOM PART B-CLIN CY, V82B, P54, DOI 10.1002/cyto.b.20621; Seale AC, 2008, J CLIN LAB ANAL, V22, P153, DOI 10.1002/jcla.20234; Shete A, 2013, J IMMUNOASS IMMUNOCH, V34, P333, DOI 10.1080/15321819.2012.741087; Sputtek A, 2011, CYTOTHERAPY, V13, P481, DOI 10.3109/14653249.2010.529891; Stevens VL, 2007, CANCER EPIDEM BIOMAR, V16, P2160, DOI 10.1158/1055-9965.EPI-07-0604; Truck J, 2014, HUM VACC IMMUNOTHER, V10, P2490, DOI 10.4161/hv.29318; Yang J, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0144-1; Zhang W, 2016, J IMMUNOL METHODS, V431, P31, DOI 10.1016/j.jim.2016.02.004	33	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187440	10.1371/journal.pone.0187440	http://dx.doi.org/10.1371/journal.pone.0187440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091947	gold, Green Published, Green Submitted			2022-12-27	WOS:000414229700066
J	Anderson, GA; Ilcisin, L; Kayima, P; Abesiga, L; Benitez, NP; Ngonzi, J; Ronald, M; Shrime, MG				Anderson, Geoffrey A.; Ilcisin, Lenka; Kayima, Peter; Abesiga, Lenard; Benitez, Noralis Portal; Ngonzi, Joseph; Ronald, Mayanja; Shrime, Mark G.			Out-of-pocket payment for surgery in Uganda: The rate of impoverishing and catastrophic expenditure at a government hospital	PLOS ONE			English	Article							HEALTH-CARE; GLOBAL HEALTH; COUNTRIES; DELIVERY; POLICY; COST; PAY	Background and objectives It is Ugandan governmental policy that all surgical care delivered at government hospitals in Uganda is to be provided to patients free of charge. In practice, however, frequent stock-outs and broken equipment require patients to pay for large portions of their care out of their own pocket. The purpose of this study was to determine the financial impact on patients who undergo surgery at a government hospital in Uganda. Methods Every surgical patient discharged from a surgical ward at a large regional referral hospital in rural southwestern Uganda over a 3-week period in April 2016 was asked to participate. Patients who agreed were surveyed to determine their baseline level of poverty and to assess the financial impact of the hospitalization. Rates of impoverishment and catastrophic expenditure were then calculated. An "impoverishing expense" is defined as one that pushes a household below published poverty thresholds. A "catastrophic expense" was incurred if the patient spent more than 10% of their average annual expenditures. Results We interviewed 295 out of a possible 320 patients during the study period. 46% (CI 40-52%) of our patients met the World Bank's definition of extreme poverty ($1.90/person/day). After receiving surgical care an additional 10 patients faced extreme poverty, and 5 patients were newly impoverished by the World Bank's definition ($3.10/person/day). 31% of patients faced a catastrophic expenditure of more than 10% of their estimated total yearly expenses. 53% of the households in our study had to borrow money to pay for care, 21% had to sell possessions, and 17% lost a job as a result of the patient's hospitalization. Only 5% of our patients received some form of charity. Conclusions and relevance Despite the government's policy to provide "free care," undergoing an operation at a government hospital in Uganda can result in a severe economic burden to patients and their families. Alternative financing schemes to provide financial protection are critically needed.	[Anderson, Geoffrey A.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Anderson, Geoffrey A.; Ilcisin, Lenka; Shrime, Mark G.] Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA; [Kayima, Peter; Benitez, Noralis Portal] Mbarara Univ Sci & Technol, Dept Surg, Mbarara, Uganda; [Abesiga, Lenard; Ngonzi, Joseph; Ronald, Mayanja] Mbarara Univ Sci & Technol, Dept Obstet & Gynecol, Mbarara, Uganda	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mbarara University of Science & Technology; Mbarara University of Science & Technology	Shrime, MG (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA.	Shrime@mail.harvard.edu	Ngonzi, Joseph/AAC-6536-2020	Portal Benitez, Noralis/0000-0002-2801-213X	Doris Duke Charitable Foundation through the Harvard Medical School Doris Duke International Clinical Research Fellow Program; Boston Children's Hospital	Doris Duke Charitable Foundation through the Harvard Medical School Doris Duke International Clinical Research Fellow Program; Boston Children's Hospital	: LI received salary and travel support from the Doris Duke Charitable Foundation through the Harvard Medical School Doris Duke International Clinical Research Fellow Program (http://dorisduke.hms.harvard.edu/home). GAA received salary and travel support from the Massachusetts General Hospital Department of Surgery (http://www.massgeneral.org/surgery/?display=health-care-professionals). MGS receives salary support from the General Electric Foundation Safe Surgery 2020 program (http://safesurgery2020.org) and the Steven C Kletjian Foundation. Salaries of the research assistants and basic study materials were funded through a grant from Boston Children's Hospital (http://www.childrenshospital.org/global-health/about). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD BANK OP DAT; Boukhalfa C, 2016, TROP MED INT HEALTH, V21, P245, DOI 10.1111/tmi.12638; Bruno E, 2017, WORLD J SURG, V41, P1218, DOI 10.1007/s00268-016-3847-9; Chao TE, 2014, LANCET GLOB HEALTH, V2, pE334, DOI 10.1016/S2214-109X(14)70213-X; Cruz M., 2015, ENDING EXTREME POVER; Group TWB, 2016, POV OV; Nguyen H, 2015, LANCET, V385, P50, DOI 10.1016/S0140-6736(15)60845-5; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Nguyen KT, 2012, SOC SCI MED, V74, P724, DOI 10.1016/j.socscimed.2011.10.027; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Lofgren J, 2015, SURGERY, V157, P983, DOI 10.1016/j.surg.2015.01.026; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Museveni HEYK, 2011, STATE NATION ADDRESS, P1; Prinja S, 2015, LANCET, V385, P57, DOI 10.1016/S0140-6736(15)60852-2; Prinja S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137315; Pronyk PM, 2016, LANCET GLOB HEALTH, V4, pE276, DOI 10.1016/S2214-109X(16)00046-2; Raj M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131348; Rose J, 2015, LANCET GLOB HEALTH, V3, pS13, DOI 10.1016/S2214-109X(15)70087-2; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS38, DOI 10.1016/S2214-109X(15)70085-9; Tsai A., 2015, LIVELIHOOD INTERVENT; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Ugandan Bureau of S, 2014, NAT POP HOUS CENS 20; Urua U, 2017, INT J INJ CONTROL SA, P1; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Weiser TG, 2016, B WORLD HEALTH ORGAN, V94, P201, DOI 10.2471/BLT.15.159293; Windisch R, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-25	27	48	48	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187293	10.1371/journal.pone.0187293	http://dx.doi.org/10.1371/journal.pone.0187293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088302	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900061
J	Bernardo, I; Wong, J; Wlodek, ME; Vlahos, R; Soeding, P				Bernardo, Ivan; Wong, James; Wlodek, Mary E.; Vlahos, Ross; Soeding, Paul			Evaluation of right heart function in a rat model using modified echocardiographic views	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ARTERIAL-HYPERTENSION; DYSFUNCTION; STRAIN; COPD; MICE	Echocardiography plays a major role in assessing cardiac function in animal models. We investigated use of a modified parasternal mid right-ventricular (MRV) and right ventricle (RV) outflow (RVOT) view, in assessing RV size and function, and the suitability of advanced 2D-strain analysis. 15 WKY rats were examined using transthoracic echocardiography. The left heart was assessed using standard short and long axis views. For the right ventricle a MRV and RVOT view were used to measure RV chamber and free wall area. 2D-strain analysis was applied to both ventricles using off-line analysis. RV chamber volume was determined by injection of 2% agarose gel, and RV free wall dissected and weighed. Echocardiography measurement was correlated with necropsy findings. The RV mid-ventricular dimension (R1) was 0.42 +/- 0.07cm and the right ventricular outflow tract dimension (R2) was 0.34 +/- 0.06cm, chamber end-diastolic area measurements were 0.38 +/- 0.09cm(2) and 0.29 +/- 0.08cm(2) for MRV and RVOT views respectively. RVOT and MRV chamber area correlated with gel mass. Doppler RV stroke volume was 0.32 +/- 0.08ml, cardiac output (CO) 110 +/- 27 ml.min(-1) and RV free wall contractility assessed using 2D-strain analysis was demonstrated. We have shown that modified MRV and RVOT views can provide detailed assessment of the RV in rodents, with 2D-strain analysis of the RV free wall potentially feasible.	[Bernardo, Ivan; Vlahos, Ross] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia; [Wong, James] Royal Melbourne Hosp, Dept Cardiol, Parkville, Vic, Australia; [Wlodek, Mary E.] Univ Melbourne, Dept Physiol, Parkville, Vic, Australia; [Soeding, Paul] Univ Melbourne, Dept Pharmacol, Cardiovasc Therapeut Unit, Parkville, Vic, Australia; [Soeding, Paul] Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Grattan St, Parkville, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Royal Melbourne Hospital	Vlahos, R (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia.; Soeding, P (corresponding author), Univ Melbourne, Dept Pharmacol, Cardiovasc Therapeut Unit, Parkville, Vic, Australia.; Soeding, P (corresponding author), Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Grattan St, Parkville, Vic, Australia.	ross.vlahos@rmit.edu.au; paulsoeding@bigpond.com	Vlahos, Ross/AAM-3837-2020; wlodek, Mary/A-8939-2019	Vlahos, Ross/0000-0001-8443-7071; wlodek, Mary/0000-0002-8490-9099	NHMRC Australia [APP1084627, 1084627]	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by NHMRC Australia APP1084627.; We thank Ms Chandra Lennie (GE Healthcare) and Mr Andrew Jefferies for technical support, Mr Adrian Cajili for designing the diagrams in Fig 1, and NHMRC Australia (grant 1084627) for funding.	Anderson RH, 2009, CLIN ANAT, V22, P64, DOI 10.1002/ca.20645; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Berger JS, 2004, AM J CARDIOL, V94, P649, DOI 10.1016/j.amjcard.2004.05.034; Bernardo I, 2015, PHARMACOL THERAPEUT, V155, P60, DOI 10.1016/j.pharmthera.2015.08.005; Bhan A, 2014, AM J PHYSIOL-HEART C, V306, pH1371, DOI 10.1152/ajpheart.00553.2013; Bhatt SP, 2013, TRANSL RES, V162, P237, DOI 10.1016/j.trsl.2013.05.001; Brown Lindsay, 2002, Heart Lung Circ, V11, P167, DOI 10.1046/j.1444-2892.2002.00148.x; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Gorcsan J, 2011, J AM COLL CARDIOL, V58, P1401, DOI 10.1016/j.jacc.2011.06.038; Hilde JM, 2013, J AM COLL CARDIOL, V62, P1103, DOI 10.1016/j.jacc.2013.04.091; Hurdman J, 2013, EUR RESPIR J, V41, P1292, DOI 10.1183/09031936.00079512; Jones JE, 2002, AM J PHYSIOL-HEART C, V283, pH364, DOI 10.1152/ajpheart.00979.2001; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Leather HA, 2006, AM J PHYSIOL-HEART C, V290, pH2369, DOI 10.1152/ajpheart.01211.2004; Li YB, 2007, ULTRASOUND MED BIOL, V33, P894, DOI 10.1016/j.ultrasmedbio.2006.12.008; Lindqvist P, 2003, Eur J Echocardiogr, V4, P29, DOI 10.1053/euje.2002.0177; MacNee W, 2010, SEMIN RESP CRIT CARE, V31, P295, DOI 10.1055/s-0030-1254070; PARISI A F, 1979, Clinical Cardiology, V2, P257; Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023; Scherrer-Crosbie M, 1998, CIRCULATION, V98, P1015, DOI 10.1161/01.CIR.98.10.1015; Shehata ML, 2013, RADIOLOGY, V266, P114, DOI 10.1148/radiol.12111599; Slama M, 2003, AM J PHYSIOL-HEART C, V284, pH691, DOI 10.1152/ajpheart.00653.2002; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Tee N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/148501; TRAMARIN R, 1991, EUR HEART J, V12, P103, DOI 10.1093/oxfordjournals.eurheartj.a059855; Vlahos R, 2015, EUR J PHARMACOL, V759, P265, DOI 10.1016/j.ejphar.2015.03.029; Vlahos R, 2014, CLIN SCI, V126, P253, DOI 10.1042/CS20130182; Wright Joanne L, 2010, Expert Rev Respir Med, V4, P723, DOI 10.1586/ers.10.68	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187345	10.1371/journal.pone.0187345	http://dx.doi.org/10.1371/journal.pone.0187345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088272	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900069
J	Rup, B; Alon, S; Amit-Cohen, BC; Almon, EB; Chertkoff, R; Tekoah, Y; Rudd, PM				Rup, Bonita; Alon, Sari; Amit-Cohen, Bat-Chen; Almon, Einat Brill; Chertkoff, Raul; Tekoah, Yoram; Rudd, Pauline M.			Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems - The taliglucerase alfa story	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; N-LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODY; GAUCHER-DISEASE; PEDIATRIC-PATIENTS; HOST ANTIBODIES; GLYCOSYLATION; GLUCOCEREBROSIDASE; RECOMMENDATIONS; EPITOPES	Plants are a promising alternative for the production of biotherapeutics. Manufacturing in-planta adds plant specific glycans. To understand immunogenic potential of these glycans, we developed a validated method to detect plant specific glycan antibodies in human serum. Using this assay, low prevalence of pre-existing anti-plant glycan antibodies was found in healthy humans (13.5%) and in glucocerebrosidase-deficient Gaucher disease (GD) patients (5%). A low incidence (9% in naive patient and none in treatment experienced patients) of induced anti-plant glycan antibodies was observed in GD patients after up to 30 months replacement therapy treatment with taliglucerase alfa, a version of human glucocerebrosidase produced in plant cells. Detailed evaluation of clinical safety and efficacy end-points indicated that anti-plant glycan antibodies did not affect the safety or efficacy of taliglucerase alfa in patients. This study shows the benefit of using large scale human trials to evaluate the immunogenicity risk of plant derived glycans, and indicates no apparent risk related to anti-plant glycan antibodies.	[Rup, Bonita] Bonnie Rup Consulting LLC, Reading, MA USA; [Alon, Sari; Amit-Cohen, Bat-Chen; Almon, Einat Brill; Chertkoff, Raul] Protalix LTD, Prod Dev, Carmiel, Israel; [Tekoah, Yoram] Protalix LTD, Res & Dev, Carmiel, Israel; [Rudd, Pauline M.] Natl Inst Bioproc Res & Training, Dublin, Ireland; [Rudd, Pauline M.] AStar, Bioproc Technol Inst, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI)	Tekoah, Y (corresponding author), Protalix LTD, Res & Dev, Carmiel, Israel.	yoram.tekoah@protalix.com		Rudd, Pauline/0000-0003-3880-0532				Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Aviezer D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004792; Bardor M, 2003, GLYCOBIOLOGY, V13, P427, DOI 10.1093/glycob/cwg024; Bardor M, 1999, TRENDS PLANT SCI, V4, P376, DOI 10.1016/S1360-1385(99)01461-2; Bennett LL, 2013, ANN PHARMACOTHER, V47, P1182, DOI 10.1177/1060028013500469; Brooks SA, 2004, MOL BIOTECHNOL, V28, P241, DOI 10.1385/MB:28:3:241; Campbell MP, 2008, BIOINFORMATICS, V24, P1214, DOI 10.1093/bioinformatics/btn090; Chamberlain Paul D., 2009, V483, P325, DOI 10.1007/978-1-59745-407-0_19; Chargelegue D, 2000, TRANSGENIC RES, V9, P187, DOI 10.1023/A:1008976219939; FAYE L, 1993, ANAL BIOCHEM, V209, P104, DOI 10.1006/abio.1993.1088; [FDA F.a.D. Administration], 2009, GUID IND ASS DEV IMM; Fischer R, 2012, BIOTECHNOL ADV, V30, P434, DOI 10.1016/j.biotechadv.2011.08.007; Foetisch K, 2003, J ALLERGY CLIN IMMUN, V111, P889, DOI 10.1067/mai.2003.173; Fox J. L., 2012, Nature Biotechnology, V30, P472, DOI 10.1038/nbt0612-472; Grabowski GA, 2003, ANNU REV GENOM HUM G, V4, P403, DOI 10.1146/annurev.genom.4.070802.110415; Hemmer W., 2012, ANTICARBOHYDRATE ANT, P181; Jin CS, 2006, GLYCOBIOLOGY, V16, P349, DOI 10.1093/glycob/cwj071; Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111/j.1365-2141.2004.05351.x; Kishnani PS, 2016, MOL GENET METAB, V117, P66, DOI 10.1016/j.ymgme.2015.11.001; KUROSAKA A, 1991, J BIOL CHEM, V266, P4168; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Liu J, 2012, P NATL ACAD SCI USA, V109, P10018, DOI 10.1073/pnas.1200941109; Liu YJ, 2011, J PHARMACOL TOX MET, V64, P238, DOI 10.1016/j.vascn.2011.07.003; Mahler V, 2006, CLIN EXP ALLERGY, V36, P1446, DOI 10.1111/j.1365-2222.2006.02587.x; Mari A, 2002, INT ARCH ALLERGY IMM, V129, P286, DOI 10.1159/000067591; Mari A, 2008, ALLERGY, V63, P891, DOI 10.1111/j.1398-9995.2008.01703.x; MCMANUS MT, 1988, PLANTA, V175, P506, DOI 10.1007/BF00393072; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; Mogues T, 2005, J IMMUNOL METHODS, V300, P1, DOI 10.1016/j.jim.2005.01.022; Pastores GM, 2014, BLOOD CELL MOL DIS, V53, P253, DOI 10.1016/j.bcmd.2014.05.004; Petruccelli S, 2006, PLANT BIOTECHNOL J, V4, P511, DOI 10.1111/j.1467-7652.2006.00200.x; RAMIREZSOTO D, 1991, CARBOHYD RES, V213, P27, DOI 10.1016/S0008-6215(00)90595-0; Rup B, 2015, CLIN EXP IMMUNOL, V181, P385, DOI 10.1111/cei.12652; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Schillberg S, 2003, CELL MOL LIFE SCI, V60, P433, DOI 10.1007/s000180300037; Shaaltiel Y, 2007, PLANT BIOTECHNOL J, V5, P579, DOI 10.1111/j.1467-7652.2007.00263.x; Shaaltiel Y, 2016, NAT BIOTECHNOL, V34, P706, DOI 10.1038/nbt.3556; Shankar G, 2008, J PHARMACEUT BIOMED, V48, P1267, DOI 10.1016/j.jpba.2008.09.020; Tekoah Y, 2004, ARCH BIOCHEM BIOPHYS, V426, P266, DOI 10.1016/j.abb.2004.02.034; Tekoah Y, 2015, PLANT BIOTECHNOL J, V13, P1199, DOI 10.1111/pbi.12428; Tekoah Y, 2013, BIOSCIENCE REP, V33, P771, DOI 10.1042/BSR20130081; van Ree R, 2002, INT ARCH ALLERGY IMM, V129, P189, DOI 10.1159/000066770; WAN LL, 1994, PHYTOCHEMISTRY, V37, P933, DOI 10.1016/S0031-9422(00)89507-2; Ward BJ, 2014, VACCINE, V32, P6098, DOI [10.1016/j.vaccine.2014.08.079, 10.10]; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651; Wuhrer M, 2004, RAPID COMMUN MASS SP, V18, P1741, DOI 10.1002/rcm.1546; Xue L, 2013, AAPS J, V15, P852, DOI 10.1208/s12248-013-9492-4; Xue L, 2010, AAPS J, V12, P98, DOI 10.1208/s12248-009-9165-5; ZIMRAN A, 1995, LANCET, V345, P1479, DOI 10.1016/S0140-6736(95)91038-7; Zimran A, 2015, BLOOD CELL MOL DIS, V54, P9, DOI 10.1016/j.bcmd.2014.10.002; Zimran A, 2011, BLOOD, V118, P5767, DOI 10.1182/blood-2011-07-366955; Zimran A, 2011, BLOOD, V118, P1463, DOI 10.1182/blood-2011-04-308890	52	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186211	10.1371/journal.pone.0186211	http://dx.doi.org/10.1371/journal.pone.0186211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088235	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900008
J	van Vugt, JLA; Buettner, S; Levolger, S; van den Braak, RRJC; Suker, M; Gaspersz, MP; de Bruin, RWF; Verhoef, C; van Eijck, CHC; Bossche, N; Koerkamp, BG; IJzermans, JNM				van Vugt, Jeroen L. A.; Buettner, Stefan; Levolger, Stef; van den Braak, Robert R. J. Coebergh; Suker, Mustafa; Gaspersz, Marcia P.; de Bruin, Ron W. F.; Verhoef, Cornelis; van Eijck, Casper H. C.; Bossche, Niek; Koerkamp, Bas Groot; IJzermans, Jan N. M.			Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract	PLOS ONE			English	Article							COLORECTAL-CANCER; SARCOPENIA; COMPLICATIONS; METAANALYSIS; CACHEXIA; CLASSIFICATION; CHEMOTHERAPY; MORTALITY; RESECTION; TOXICITY	Background Low skeletal muscle mass is associated with poor postoperative outcomes in cancer patients. Furthermore, it is associated with increased healthcare costs in the United States. We investigated its effect on hospital expenditure in a Western-European healthcare system, with universal access. Methods Skeletal muscle mass (assessed on CT) and costs were obtained for patients who underwent curative-intent abdominal cancer surgery. Low skeletal muscle mass was defined based on pre-established cut-offs. The relationship between low skeletal muscle mass and hospital costs was assessed using linear regression analysis and Mann-Whitney U-tests. Results 452 patients were included (median age 65, 61.5% males). Patients underwent surgery for colorectal cancer (38.9%), colorectal liver metastases (27.4%), primary liver tumours (23.2%), and pancreatic/periampullary cancer (10.4%). In total, 45.6% had sarcopenia. Median costs were (sic)2,183 higher in patients with low compared with patients with high skeletal muscle mass ((sic)17,144 versus (sic) 14,961; P<0.001). Hospital costs incrementally increased with lower sex-specific skeletal muscle mass quartiles (P = 0.029). After adjustment for confounders, low skeletal muscle mass was associated with a cost increase of (sic)4,061 (P = 0.015). Conclusion Low skeletal muscle mass was independently associated with increased hospital costs of about (sic)4,000 per patient. Strategies to reduce skeletal muscle wasting could reduce hospital costs in an era of incremental healthcare costs and an increasingly ageing population.	[van Vugt, Jeroen L. A.; Buettner, Stefan; Levolger, Stef; van den Braak, Robert R. J. Coebergh; Suker, Mustafa; Gaspersz, Marcia P.; de Bruin, Ron W. F.; van Eijck, Casper H. C.; Koerkamp, Bas Groot; IJzermans, Jan N. M.] Erasmus MC Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands; [Verhoef, Cornelis] Erasmus MC Univ, Med Ctr, Dept Control & Compliance, Rotterdam, Netherlands; [Bossche, Niek] Erasmus MC Canc Inst, Dept Surg Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	van Vugt, JLA (corresponding author), Erasmus MC Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands.	j.l.a.vanvugt@erasmusmc.nl	van Eijck, casper/K-5983-2019; Suker, Mustafa/AAH-8789-2020; Van Eijck, Casper/ABD-1655-2020; Coebergh, Robert/AAG-2520-2019; Verhoef, Cornelis/ABD-3648-2020; Groot koerkamp, Bas/ABD-1621-2020	Suker, Mustafa/0000-0002-7935-4666; Verhoef, Cornelis/0000-0001-9980-8613; Groot koerkamp, Bas/0000-0003-1917-6973; Coebergh van den Braak, Robert/0000-0001-9310-6629; Buettner, Stefan/0000-0002-0942-127X				[Anonymous], 2016, HEALTHC NETH; Antoun S, 2010, ANN ONCOL, V21, P1594, DOI 10.1093/annonc/mdp605; Buettner S, 2017, SURVIVAL RE IN PRESS; Buttner S, 2017, ACTA CHIR BELG, V117, P181, DOI 10.1080/00015458.2017.1279872; Coebergh JW, 2001, EUR J CANCER, V37, pS217; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dingemans AMC, 2014, EXPERT OPIN INV DRUG, V23, P1655, DOI 10.1517/13543784.2014.942729; DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261, DOI 10.1001/jama.1961.03040420001001; Dunn MA, 2016, AM J GASTROENTEROL; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gani F, 2016, SURGERY, V160, P1162, DOI 10.1016/j.surg.2016.05.002; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Huillard O, 2013, BRIT J CANCER, V108, P1034, DOI 10.1038/bjc.2013.58; Kirk PS, 2015, J SURG RES, V199, P51, DOI 10.1016/j.jss.2015.04.074; Kroneman Madelon, 2016, Health Syst Transit, V18, P1; Lalmahomed ZS, 2017, CELL TISSUE BANK, V18, P425, DOI 10.1007/s10561-017-9613-x; Levolger S, 2017, CLIN NUTR; Levolger S, 2015, J SURG ONCOL, V112, P208, DOI 10.1002/jso.23976; Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350; Mak PHK, 2002, ANAESTH INTENS CARE, V30, P633, DOI 10.1177/0310057X0203000516; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Morak MJM, 2008, ANN SURG, V248, P1031, DOI 10.1097/SLA.0b013e318190c53e; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Rolland Y, 2011, CURR OPIN CLIN NUTR, V14, P15, DOI 10.1097/MCO.0b013e328340c2c2; Shachar SS, 2016, EUR J CANCER, V57, P58, DOI 10.1016/j.ejca.2015.12.030; Sheetz KH, 2013, J AM COLL SURGEONS, V217, P813, DOI 10.1016/j.jamcollsurg.2013.04.042; Snijders HS, 2012, EJSO-EUR J SURG ONC, V38, P1013, DOI 10.1016/j.ejso.2012.07.111; Straatman J, 2015, DIGEST SURG, V32, P150, DOI 10.1159/000371861; Tan BHL, 2015, EJSO-EUR J SURG ONC, V41, P333, DOI 10.1016/j.ejso.2014.11.040; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823; van Vugt JLA, 2016, AM J TRANSPLANT, V16, P2277, DOI 10.1111/ajt.13732; van Vugt JLA, 2017, J CACHEXIA SARCOPENI, V8, P285, DOI 10.1002/jcsm.12158; Vonlanthen R, 2011, ANN SURG, V254, P907, DOI 10.1097/SLA.0b013e31821d4a43; Wang SL, 2016, ANN SURG ONCOL, V23, P556, DOI 10.1245/s10434-015-4887-3; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	39	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186547	10.1371/journal.pone.0186547	http://dx.doi.org/10.1371/journal.pone.0186547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088245	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900015
J	Ishikawa, R; Iwata, M; Taniko, K; Monden, G; Miyazaki, N; Orn, C; Tsujimura, Y; Yoshida, S; Ma, JF; Ishii, T				Ishikawa, Ryo; Iwata, Masahide; Taniko, Kenta; Monden, Gotaro; Miyazaki, Naoya; Orn, Chhourn; Tsujimura, Yuki; Yoshida, Shusaku; Ma, Jian Feng; Ishii, Takashige			Detection of quantitative trait loci controlling grain zinc concentration using Australian wild rice, Oryza meridionalis, a potential genetic resource for biofortification of rice	PLOS ONE			English	Article							DEVELOPING-TISSUES; TRANSPORTER; NODE; TOLERANCE; DIVERSITY; ELEMENTS; OSZIP4; IRON; SSLP; SOIL	Zinc (Zn) is one of the essential mineral elements for both plants and humans. Zn deficiency in human is one of the major causes of hidden hunger, a serious health problem observed in many developing countries. Therefore, increasing Zn concentration in edible part is an important issue for improving human Zn nutrition. Here, we found that an Australian wild rice O. meridionalis showed higher grain Zn concentrations compared with cultivated and other wild rice species. The quantitative trait loci (QTL) analysis was then performed to identify the genomic regions controlling grain Zn levels using backcross recombinant inbred lines derived from O. sativa 'Nipponbare' and O. meridionalis W1627. Four QTLs responsible for high grain Zn were detected on chromosomes 2, 9, and 10. The QTL on the chromosome 9 (named qGZn9), which showed the largest effect on grain Zn concentration was confirmed with the introgression line, which had a W1627 chromosomal segment covering the qGZn9 region in the genetic background of O. sativa 'Nipponbare'. Fine mapping of this QTL resulted in identification of two tightly linked loci, qGZn9a and qGZn9b. The candidate regions of qGZn9a and qGZn9b were estimated to be 190 and 950 kb, respectively. Furthermore, we also found that plants having a wild chromosomal segment covering qGZn9a, but not qGZn9b, is associated with fertility reduction. qGZn9b, therefore, provides a valuable allele for breeding rice with high Zn in the grains.	[Ishikawa, Ryo; Iwata, Masahide; Taniko, Kenta; Monden, Gotaro; Miyazaki, Naoya; Orn, Chhourn; Tsujimura, Yuki; Yoshida, Shusaku; Ishii, Takashige] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan; [Ma, Jian Feng] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Orn, Chhourn] Cambodian Agr Res & Dev Inst, Phnom Penh, Cambodia	Kobe University; Okayama University	Ishikawa, R (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan.	r-ishika@port.kobe-u.ac.jp	Ma, Jianfeng/GZB-0110-2022; Ishii, Takashige/AAG-1486-2021	Ishikawa, Ryo/0000-0003-1848-2493	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan as part of the Joint Research Program at the Institute of Plant Science and Resources, Okayama University, Japan [2513, 2614, 2714, 2811, 2910]; Joint Research Program from the Institute of Plant Science and Resources, Okayama University; National BioResource Project (MEXT, Japan)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan as part of the Joint Research Program at the Institute of Plant Science and Resources, Okayama University, Japan; Joint Research Program from the Institute of Plant Science and Resources, Okayama University; National BioResource Project (MEXT, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan as part of the Joint Research Program implemented at the Institute of Plant Science and Resources, Okayama University, Japan (nos. 2513, 2614, 2714, 2811, and 2910 to R.I.). English URLs of the fund are not available. The Joint Research Program from the Institute of Plant Science and Resources, Okayama University, supported consumables and travel fee for the collaborative research between R.I and J.F.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Sanae Rikiishi and Ms. Akemi Morita (Institute of Plant Science and Resources, Okayama University) for their measurement of rice grain Zn concentrations. We also thank Cristina Castillo for her critical reading of the manuscript. The wild rice accessions used in this study were provided by the National Institute of Genetics (Japan) supported by the National BioResource Project (MEXT, Japan).	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Atwell BJ, 2014, PLANT SCI, V215, P48, DOI 10.1016/j.plantsci.2013.10.007; Bautista NS, 2001, GENES GENET SYST, V76, P71, DOI 10.1266/ggs.76.71; Borrill P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00053; Chen XW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04992-z; Cheng ZQ, 2005, J INTEGR PLANT BIOL, V47, P1260, DOI 10.1111/j.1744-7909.2005.00130.x; Doi K, 2008, CURR OPIN PLANT BIOL, V11, P144, DOI 10.1016/j.pbi.2008.01.008; Ishimaru Y, 2007, J EXP BOT, V58, P2909, DOI 10.1093/jxb/erm147; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; MABERLY GF, 1994, ANNU REV PUBL HEALTH, V15, P277; Menguer PK, 2017, GENET MOL BIOL, V40, P238, DOI [10.1590/1678-4685-gmb-2016-0093, 10.1590/1678-4685-GMB-2016-0093]; Messias RD, 2015, CRIT REV FOOD SCI, V55, P123, DOI 10.1080/10408398.2011.649314; Monna L, 2002, THEOR APPL GENET, V104, P772, DOI 10.1007/s00122-001-0813-0; Moreno-Moyano LT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01463; NG NQ, 1981, BOT J LINN SOC, V82, P327, DOI 10.1111/j.1095-8339.1981.tb00964.x; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Ricachenevsky FK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00974; Roohani N, 2013, J RES MED SCI, V18, P144; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sasaki A, 2015, PLANT J, V84, P374, DOI 10.1111/tpj.13005; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Scafaro AP, 2016, NEW PHYTOL, V211, P899, DOI 10.1111/nph.13963; Scafaro AP, 2012, PHYSIOL PLANTARUM, V146, P99, DOI 10.1111/j.1399-3054.2012.01597.x; Scafaro AP, 2010, J EXP BOT, V61, P191, DOI 10.1093/jxb/erp294; Swamy BPM, 2016, RICE, V9, DOI 10.1186/s12284-016-0122-5; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Velu G, 2014, J CEREAL SCI, V59, P365, DOI 10.1016/j.jcs.2013.09.001; Wang S, 2012, WINDOWS QTL CARTOGRA; Wissuwa M, 2008, PLANT SOIL, V306, P37, DOI 10.1007/s11104-007-9368-4; Xue YF, 2016, ANN BOT-LONDON, V117, P363, DOI 10.1093/aob/mcv182; Yamaji N, 2017, CURR OPIN PLANT BIOL, V39, P18, DOI 10.1016/j.pbi.2017.05.002; Yamaji N, 2014, TRENDS PLANT SCI, V19, P556, DOI 10.1016/j.tplants.2014.05.007; Yamaji N, 2013, PLANT PHYSIOL, V162, P927, DOI 10.1104/pp.113.216564; Zhang QJ, 2014, P NATL ACAD SCI USA, V111, pE4954, DOI 10.1073/pnas.1418307111	39	16	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187224	10.1371/journal.pone.0187224	http://dx.doi.org/10.1371/journal.pone.0187224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077764	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200054
J	Gao, LL; Zhu, XC; Li, C; Cheng, LZ				Gao, Lulu; Zhu, Xicun; Li, Cheng; Cheng, Lizhen			Evaluation of the nitrogen content during the new-shoot-growing stage in apple leaves using two-dimensional correlation spectroscopy	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE SPECTROSCOPY; MINERAL PROSPECTIVITY; FEATURE-SELECTION; DILUTION CURVE; INFORMATION; ALGORITHM; INDICATOR; MOISTURE; MACHINE	The new-shoot-growing stage is an important period of apple tree nutrition distribution. The objective of this study is to provide technical support for apple tree nutrition diagnosis by constructing quantitative evaluation models between the apple leaf nitrogen content during the new-shoot-growing stage and characteristic spectral parameters. The correlation coefficients between the original spectral data and the nitrogen content were calculated. Then, the sensitive bands of the nitrogen content were selected using the theory of two-dimensional (2D) correlation spectroscopy. Finally, partial least squares regression (PLSR) and support vector machine (SVM) evaluation models were established using 2 parameters: Rx (maximum spectral reflectivity in the waveband) and Sx (total spectral reflectivity in the waveband). The results showed that the sensitive bands in the 2D correlation synchronous and asynchronous spectrograms were 537-560 nm and 708-719 nm. The PLSR model can be used to estimate the nitrogen content. Compared with PLSR, SVM provided better modeling and testing results, with a larger coefficient of determination (R-2) and a smaller root-mean-square error (RMSE). The SVM model based on Sx was a good backup method. The calibration R-2 of the model was 0.821, its RMSE was 0.710 g.kg(-1), the validation R-2 was 0.768, and its RMSE was 1.019 g.kg(-1). The SVM model based on 2D correlation spectroscopy can be used to quantitatively estimate the nitrogen content in apple leaves.	[Gao, Lulu; Zhu, Xicun; Li, Cheng; Cheng, Lizhen] Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China; [Zhu, Xicun] Shandong Agr Univ, Key Lab Agr Ecol & Environm, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Zhu, XC (corresponding author), Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China.; Zhu, XC (corresponding author), Shandong Agr Univ, Key Lab Agr Ecol & Environm, Tai An, Shandong, Peoples R China.	zxc@sdau.edu.cn		Li, Cheng/0000-0002-1758-6031	National Natural Science Foundation of China (NSFC) [41671346, 41271369]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This paper was supported by the National Natural Science Foundation of China (NSFC), the fund ID was 41671346 & 41271369.; The authors thank the anonymous reviewers for their constructive comments. What's more, the study was supported by the National Natural Science Foundation of China (NSFC), the fund ID was 41671346 & 41271369.	Abedi M, 2012, COMPUT GEOSCI-UK, V46, P272, DOI 10.1016/j.cageo.2011.12.014; Alchanatis V., 2005, Precision Agriculture, V6, P25, DOI 10.1007/s11119-005-0682-7; Ata-Ul-Karim ST, 2014, FIELD CROP RES, V167, P76, DOI 10.1016/j.fcr.2014.07.010; Bajcsy P, 2004, PHOTOGRAMM ENG REM S, V70, P793, DOI 10.14358/PERS.70.7.793; Chen PF, 2010, REMOTE SENS ENVIRON, V114, P1987, DOI 10.1016/j.rse.2010.04.006; [陈伟 Chen Wei], 2011, [生态学报, Acta Ecologica Sinica], V31, P6877; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; He L, 2016, REMOTE SENS ENVIRON, V174, P122, DOI 10.1016/j.rse.2015.12.007; Hyde JR, 2004, ANAL CHEM, V76, P6197, DOI 10.1021/ac049360l; Ji RongHua, 2014, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V45, P269; Kawamura K, 2010, GRASSL SCI, V56, P205, DOI 10.1111/j.1744-697X.2010.00196.x; KIRK PL, 1950, ANAL CHEM, V22, P354, DOI 10.1021/ac60038a038; Kooistra L, 2003, ANAL CHIM ACTA, V484, P189, DOI 10.1016/S0003-2670(03)00331-3; Lepine LC, 2016, REMOTE SENS ENVIRON, V173, P174, DOI 10.1016/j.rse.2015.11.028; Li MZ., 2006, SPECTRAL ANAL TECHNO; McCarty GW, 2002, SOIL SCI SOC AM J, V66, P640, DOI 10.2136/sssaj2002.0640; Menesatti P, 2010, BIOSYST ENG, V105, P448, DOI 10.1016/j.biosystemseng.2010.01.003; Noda I, 2000, APPL SPECTROSC, V54, P994, DOI 10.1366/0003702001950472; Noda I, 2004, VIB SPECTROSC, V36, P143, DOI 10.1016/j.vibspec.2003.12.016; NODA I, 1993, APPL SPECTROSC, V47, P1329, DOI 10.1366/0003702934067694; Noda I, 2000, APPL SPECTROSC, V54, p236A, DOI 10.1366/0003702001950454; Noda I, 2014, J MOL STRUCT, V1069, P3, DOI 10.1016/j.molstruc.2014.01.025; Noh H, 2012, COMPUT ELECTRON AGR, V83, P52, DOI 10.1016/j.compag.2012.01.014; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Qin J, 2011, T ASABE, V54, P2331, DOI 10.13031/2013.40643; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Rodriguez-Galiano V, 2015, ORE GEOL REV, V71, P804, DOI 10.1016/j.oregeorev.2015.01.001; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Ryu C, 2009, BIOSYST ENG, V104, P465, DOI 10.1016/j.biosystemseng.2009.09.002; Serpico SB, 2001, IEEE T GEOSCI REMOTE, V39, P1360, DOI 10.1109/36.934069; Shinzawa H, 2014, J MOL STRUCT, V1069, P176, DOI 10.1016/j.molstruc.2014.02.013; Song HY, 2014, SPECTROSC SPECT ANAL, V34, P1240, DOI 10.3964/j.issn.1000-0593(2014)05-1240-04; Summers D, 2011, ECOL INDIC, V11, P123, DOI 10.1016/j.ecolind.2009.05.001; Sun Xiao-Ling, 2010, Chinese Journal of Plant Ecology, V34, P989, DOI 10.3773/j.issn.1005-264x.2010.08.012; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xing J, 2005, BIOSYST ENG, V90, P27, DOI 10.1016/j.biosystemseng.2004.08.002; Yang D, 2017, INFRARED PHYS TECHN, V83, P206, DOI 10.1016/j.infrared.2017.05.005; Yao X, 2014, INT J APPL EARTH OBS, V32, P114, DOI 10.1016/j.jag.2014.03.014; Yao X, 2014, EUR J AGRON, V55, P20, DOI 10.1016/j.eja.2013.12.004; Zhang Y, 2015, COMPUT ELECTRON AGR, V112, P20, DOI 10.1016/j.compag.2015.01.006	40	5	5	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186751	10.1371/journal.pone.0186751	http://dx.doi.org/10.1371/journal.pone.0186751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073247	Green Submitted, Green Published, gold			2022-12-27	WOS:000413845400047
J	Hall, JA; Brockman, JA; Davidson, SJ; MacLeay, JM; Jewell, DE				Hall, Jean A.; Brockman, Jeff A.; Davidson, Stephen J.; MacLeay, Jen M.; Jewell, Dennis E.			Increased dietary long-chain polyunsaturated fatty acids alter serum fatty acid concentrations and lower risk of urine stone formation in cats	PLOS ONE			English	Article							KIDNEY-FUNCTION BIOMARKERS; CALCIUM-OXALATE; EICOSAPENTAENOIC ACID; SYMMETRIC DIMETHYLARGININE; COMPUTER-PROGRAM; ARACHIDONIC-ACID; FORMERS; UROLITHIASIS; NEPHROLITHIASIS; SATURATION	The lifespan of cats with non-obstructive kidney stones is shortened compared with healthy cats indicating a need to reduce stone formation and minimize chronic kidney disease. The purpose of this study was to investigate the effects of increasing dietary polyunsaturated fatty acids (PUFA) on urine characteristics. Domestic-short-hair cats (n = 12; mean age 5.6 years) were randomized into two groups and fed one of two dry-cat foods in a cross-over study design. For one week before study initiation, all cats consumed control food that contained 0.07% arachidonic acid (AA), but no eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). Group 1 continued eating control food for 56 days. Group 2 was fed test food for 56 days, which was control food plus fish oil and high-AA oil. Test food contained 0.17% AA, 0.09% EPA and 0.18% DHA. After 56 days, cats were fed the opposite food for another 56 days. At baseline and after each feeding period, serum was analyzed for fatty acid concentrations, and urine for specific gravity, calcium concentration, relative-super-saturation for struvite crystals, and a calcium-oxalate-titrimetric test was performed. After consuming test food, cats had increased (all P<0.001) serum concentrations of EPA (173%), DHA (61%), and AA (35%); decreased urine specific gravity (P = 0.02); decreased urine calcium concentration (P = 0.06); decreased relative-super-saturation for struvite crystals (P = 0.03); and increased resistance to oxalate crystal formation (P = 0.06) compared with cats consuming control food. Oxalate crystal formation was correlated with serum calcium concentration (r = 0.41; P<0.01). These data show benefits for reducing urine stone formation in cats by increasing dietary PUFA.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Brockman, Jeff A.; Davidson, Stephen J.; MacLeay, Jen M.; Jewell, Dennis E.] Hills Pet Nutr, Pet Nutr Ctr, Topeka, KS USA	Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu	Jewell, Dennis/AAS-8563-2020	Hall, Jean/0000-0002-7758-6703; Jewell, Dennis/0000-0003-2305-1014	Pet Nutrition Center, Hill's Pet Nutrition, Topeka, KS	Pet Nutrition Center, Hill's Pet Nutrition, Topeka, KS	The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Topeka, KS (http://www.hilispet.com/our-company.html). The funder provided support in the form of salaries for authors [JAB, SJD, JMM, DEJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams LG, 2013, NEW ZEAL VET J, V61, P212, DOI 10.1080/00480169.2013.775691; Baggio B, 1999, J AM SOC NEPHROL, V10, pS381; Baggio B, 1999, NEPHROL DIAL TRANSPL, V14, P553, DOI 10.1093/ndt/14.3.553; Bartges JW, 1999, VET CLIN N AM-SMALL, V29, P45, DOI 10.1016/S0195-5616(99)50004-1; BUCK AC, 1991, J UROLOGY, V146, P188, DOI 10.1016/S0022-5347(17)37750-9; BUCK AC, 1983, J UROLOGY, V129, P421, DOI 10.1016/S0022-5347(17)52130-8; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Cannon AB, 2007, JAVMA-J AM VET MED A, V231, P570, DOI 10.2460/javma.231.4.570; CLAASSEN N, 1995, PROSTAG LEUKOTR ESS, V53, P13, DOI 10.1016/0952-3278(95)90078-0; Ferraro PM, 2017, J UROL; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gupta M., 2011, INT J RES PHARM CHEM, V1, P793; Hall JA, 2014, VET J, V202, P588, DOI 10.1016/j.tvjl.2014.10.021; Hall JA, 2014, J VET INTERN MED, V28, P1676, DOI 10.1111/jvim.12445; Hall JA, 2013, PLOS ONE, V8; Hall JA, 2006, J NUTR, V136, P2338, DOI 10.1093/jn/136.9.2338; Hall JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174854; Hall JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153654; HOUSER M, 1984, KIDNEY INT, V26, P176, DOI 10.1038/ki.1984.152; Jung H, 2017, WORLD J UROL, V35, P1331, DOI 10.1007/s00345-017-2000-1; Kavanagh JP, 2006, J UROLOGY, V175, P766, DOI 10.1016/S0022-5347(05)00145-X; Kirk CA, 2006, VET THER, V7, P333; Laube N, 2002, J CHEM INF COMP SCI, V42, P633, DOI 10.1021/ci0102620; Laube N, 2000, UROL RES, V28, P274, DOI 10.1007/s002400000124; Lekcharoensuk C, 2001, J AM VET MED ASSOC, V219, P1228, DOI 10.2460/javma.2001.219.1228; Lulich JP, 2013, JAVMA-J AM VET MED A, V243, P1147, DOI 10.2460/javma.243.8.1147; Milosevic D, 1998, J CHEM INF COMP SCI, V38, P646, DOI 10.1021/ci9701087; Moor MB, 2016, AM J PHYSIOL-RENAL, V310, pF1337, DOI 10.1152/ajprenal.00273.2015; Naya Y, 2002, BJU INT, V89, P842, DOI 10.1046/j.1464-410X.2002.02740.x; Ortiz-Alvarado O, 2012, UROLOGY, V79, P282, DOI 10.1016/j.urology.2011.08.022; Osborne CA, 1996, VET CLIN N AM-SMALL, V26, P589, DOI 10.1016/S0195-5616(96)50087-2; OSBORNE CA, 1990, J AM VET MED ASSOC, V196, P1053; Osborne CA, 2009, VET CLIN N AM-SMALL, V39, P183, DOI 10.1016/j.cvsm.2008.09.011; Prezioso D, 2015, ARCH ITAL UROL ANDRO, V87, P105, DOI 10.4081/aiua.2015.2.105; ROBERT M, 1994, BRIT J UROL, V73, P358, DOI 10.1111/j.1464-410X.1994.tb07596.x; Roush JK, 2010, JAVMA-J AM VET MED A, V236, P59, DOI 10.2460/javma.236.1.59; Siener R, 2011, J UROLOGY, V185, P719, DOI 10.1016/j.juro.2010.09.074; SINCLAIR AJ, 1979, LIPIDS, V14, P932, DOI 10.1007/BF02533508; WERNESS PG, 1985, J UROLOGY, V134, P1242, DOI 10.1016/S0022-5347(17)47703-2; Yasui T, 2001, EUR UROL, V39, P580, DOI 10.1159/000052507	41	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187133	10.1371/journal.pone.0187133	http://dx.doi.org/10.1371/journal.pone.0187133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073223	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400119
J	Nobeyama, Y; Watanabe, Y; Nakagawa, H				Nobeyama, Yoshimasa; Watanabe, Yoshinori; Nakagawa, Hidemi			Silencing of G0/G1 switch gene 2 in cutaneous squamous cell carcinoma	PLOS ONE			English	Article							DNA METHYLATION; LUNG-CANCER; PROTEIN; IDENTIFICATION; EXPRESSION; G0S2; HEAD	Background Methylation of a CpG island (CGI; a dense cluster of CpGs) located in the 5' region of a gene suppresses that gene's transcription. The expression of G0/G1 switch gene 2 (G0S2) is potentially associated with tumorigenesis. The aim of this study is to elucidate the methylation status of the CGI located in the 5' region of G0S2 (hereinafter called 5' G0S2 CGI) in cutaneous squamous cell carcinoma (SCC). Methods Quantitative real-time methylation-specific PCR (RT-MSP) and bisulfite sequencing were performed to evaluate the methylation statuses of cutaneous SCC and normal epithelial cell samples. Quantitative real-time reverse transcription-PCR was performed to evaluate RNA expression levels. Immunohistochemical analysis was performed to detect protein expression. Results G0S2 was suppressed in the five SCC cell lines with 5' G0S2 CGI methylation levels of nearly 100.0% and was expressed in the two normal cultured keratinocytes with methylation levels of almost 0.0%. G0S2 was re-expressed in SCC cell lines treated with a demethylating agent. The in vivo methylation levels of 5' G0S2 CGI as determined by RT-MSP varied widely (0.0% to 77.7%) in 17 cutaneous SCC samples and narrowly (0.1% to 7.3%) in 6 normal epidermis samples. Nine cutaneous SCC samples exhibited higher methylation levels than the highest methylation level (7.3%) of the 6 normal epidermis samples. Bisulfite sequencing showed dense methylated CpG sites within 5' G0S2 CGI in these highly methylated cutaneous SCC samples. The methylation levels of the cutaneous SCC samples did not correlate with any clinical parameters investigated or with histopathological grading. Conclusions G0S2 is silenced by aberrant DNA methylation in a subset of cutaneous SCCs.	[Nobeyama, Yoshimasa; Watanabe, Yoshinori; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan	Jikei University	Nobeyama, Y (corresponding author), Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan.	nobederm@jikei.ac.jp		Nobeyama, Yoshimasa/0000-0002-0125-8930				Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Brown VL, 2004, J INVEST DERMATOL, V122, P1284, DOI 10.1111/j.0022-202X.2004.22501.x; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Darr OA, 2015, HEAD NECK-J SCI SPEC, V37, P994, DOI 10.1002/hed.23701; Davidson MR, 2013, J THORAC DIS, V5, pS463, DOI 10.3978/j.issn.2072-1439.2013.08.43; Ehrlich M, 2013, EPIGENOMICS-UK, V5, P553, DOI 10.2217/epi.13.43; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Green AC, 2017, BRIT J DERMATOL, V177, P373, DOI 10.1111/bjd.15324; Harwood CA, 2016, ACTA DERM-VENEREOL, V96, P3, DOI 10.2340/00015555-2181; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kusakabe M, 2010, INT J CANCER, V126, P1895, DOI 10.1002/ijc.24947; Liang JQ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1650-x; Meier K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164742; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; SIDEROVSKI DP, 1990, DNA CELL BIOL, V9, P579, DOI 10.1089/dna.1990.9.579; Takeuchi T, 2002, LAB INVEST, V82, P1023, DOI 10.1097/01.LAB.0000025391.35798.F1; Tokumaru Y, 2004, CANCER RES, V64, P5982, DOI 10.1158/0008-5472.CAN-04-0993; Ushijima T, 2005, CANCER RES, V65, P11; Venza I, 2010, BRIT J DERMATOL, V162, P1093, DOI 10.1111/j.1365-2133.2009.09560.x; Weedon D, 2006, WHO CLASSIFICATION T; Welch C, 2009, CANCER RES, V69, P6782, DOI 10.1158/0008-5472.CAN-09-0128; Yim CY, 2016, CANCER RES, V76, P1204, DOI 10.1158/0008-5472.CAN-15-2265	24	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187047	10.1371/journal.pone.0187047	http://dx.doi.org/10.1371/journal.pone.0187047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073263	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400101
J	Stromvall, K; Lundholm, M; Thysell, E; Bergh, A; Bergstrom, SH				Stromvall, Kerstin; Lundholm, Marie; Thysell, Elin; Bergh, Anders; Bergstrom, Sofia Halin			Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth	PLOS ONE			English	Article							CANCER PROGRESSION; IMMUNE MODULATION; FACTOR RECEPTOR; MICROENVIRONMENT; IMMUNOTHERAPY; NICHE; NEUTROPHILS; CELLS; IMMUNOBIOLOGY; EXPRESSION	The aim of this study was to examine in what ways MatLyLu (MLL) rat prostate tumors with high metastatic capacity influence regional lymph nodes prior to metastatic establishment compared to AT1 rat prostate tumors with low metastatic potential. MLL or AT1 tumor cells were injected into the ventral prostate of immunocompetent rats. Tumor and lymph node morphology, and lymph node mRNA expression of macrophage associated markers, T-cell associated markers, and cytokines were examined over time until the first microscopic signs of metastases (at day 14 for MLL-and at day 28 for AT1-tumors). Already at day 3 after tumor cell injection, when the tumors were extremely small and occupied less than 1% of the prostate volume, MLL-and AT1-tumors provoked different immune responses in both the prostate and the regional lymph nodes. MLL-tumors induced expression of immunosuppressive cytokines, suppressed T-cell accumulation, and directed T-cells towards an immunosuppressive phenotype. AT1-tumors caused a response more similar to that in vehicle-injected animals, with accumulation of T-cells in tumors and regional lymph nodes. Prostate tumors with high metastatic potential were able to precondition regional lymph nodes to subsequent metastatic growth in ways different from tumors with less metastatic potential. This may indicate the existence of a time-window when pre-metastatic changes in regional lymph nodes can aid in the prognostication of locally aggressive and potentially metastatic prostate cancer.	[Stromvall, Kerstin; Lundholm, Marie; Thysell, Elin; Bergh, Anders; Bergstrom, Sofia Halin] Umea Univ, Pathol, Dept Med Biosci, Umea, Sweden	Umea University	Bergstrom, SH (corresponding author), Umea Univ, Pathol, Dept Med Biosci, Umea, Sweden.	sofia.halin@umu.se			Swedish Research Council [Co257301]; Swedish Cancer Foundation [130293]; Lion's Cancer Research Foundation, Umea University; King Gustaf V and Queen Victoria's Foundation of Freemasons	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Lion's Cancer Research Foundation, Umea University; King Gustaf V and Queen Victoria's Foundation of Freemasons	This work was supported by grants from the:Swedish Research Council, http://www.vr.se/, (AB), grant number Co257301; The Swedish Cancer Foundation, https://www.cancerfonden.se/, (AB), grant number 130293; The Lion's Cancer Research Foundation, Umea University, http://www.cancerforskningsfonden.se/, (KS, SHB); King Gustaf V and Queen Victoria's Foundation of Freemasons, https://www.frimurarorden.se/organisation/barmhartighetsverksamhet/frimurarstiftelsen/, (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkova D, 2016, BIOCHEM SOC T, V44, P333, DOI 10.1042/BST20150245; Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141601; Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130076; Anderson KG, 2017, CANCER CELL, V31, P311, DOI 10.1016/j.ccell.2017.02.008; Benezech C, 2014, BLOOD, V123, P3200, DOI 10.1182/blood-2013-03-489286; Bergstrom SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31805; Chin AR, 2016, CLIN CANCER RES, V22, P3725, DOI 10.1158/1078-0432.CCR-16-0028; Cochran AJ, 2006, NAT REV IMMUNOL, V6, P659, DOI 10.1038/nri1919; Cochran AJ, 2015, CANCER J, V21, P39, DOI 10.1097/PPO.0000000000000094; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Deryugina EI, 2014, NEOPLASIA, V16, P771, DOI 10.1016/j.neo.2014.08.013; Di Meo S, 2014, CLIN CANCER RES, V20, P585, DOI 10.1158/1078-0432.CCR-13-2240; Drake CG, 2010, NAT REV IMMUNOL, V10, P580, DOI 10.1038/nri2817; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Fujita K, 2009, CANCER SCI, V100, P1047, DOI 10.1111/j.1349-7006.2009.01146.x; Gannon PO, 2006, PROSTATE, V66, P1710, DOI 10.1002/pros.20466; Garlanda C, 2013, SEMIN IMMUNOL, V25, P408, DOI 10.1016/j.smim.2013.10.019; Grotz TE, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1026504; Hagglof Christina, 2012, Cancers (Basel), V4, P531, DOI 10.3390/cancers4020531; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Ioachim Medeiras, 2009, TUM REACT LYMPH LYMP; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259; Ji RC, 2006, CANCER METAST REV, V25, P677, DOI 10.1007/s10555-006-9026-y; Kim R, 2006, LANCET ONCOL, V7, P1006, DOI 10.1016/S1470-2045(06)70975-5; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kryvenko ON, 2017, CURR OPIN UROL, V27, P191, DOI 10.1097/MOU.0000000000000388; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Lundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925; Mansfield AS, 2011, MODERN PATHOL, V24, P487, DOI 10.1038/modpathol.2010.227; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Motallebnezhad M, 2016, TUMOR BIOL, V37, P1387, DOI 10.1007/s13277-015-4477-9; Munn DH, 2006, CURR OPIN IMMUNOL, V18, P220, DOI 10.1016/j.coi.2006.01.002; NEAVES WB, 1979, TRANSPLANTATION, V27, P127, DOI 10.1097/00007890-197902000-00011; O'Neill ASG, 2013, IMMUNOLOGY, V138, P198, DOI 10.1111/imm.12042; Ohnishi K, 2013, CANCER SCI, V104, P1236, DOI 10.1111/cas.12212; Pal SK, 2015, MOL CANCER THER, V14, P2896, DOI 10.1158/1535-7163.MCT-15-0367; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Pencik J, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14215; Pizzola C, 2016, CURR MOL PHARMACOL, V9, P217, DOI 10.2174/1874467208666150716120551; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Shen MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098259; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Singel KL, 2016, IMMUNOL REV, V273, P329, DOI 10.1111/imr.12459; Sleeman JP, 2015, J MOL MED, V93, P1173, DOI 10.1007/s00109-015-1351-6; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Stromvall K, 2017, PROSTATE; Stromvall K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176679; Turnis ME, 2015, EUR J IMMUNOL, V45, P1892, DOI 10.1002/eji.201344413; Zhang X, 2016, INT J ONCOL, V49, P857, DOI 10.3892/ijo.2016.3616	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187086	10.1371/journal.pone.0187086	http://dx.doi.org/10.1371/journal.pone.0187086			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073272	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400110
J	Abd Rahman, M; Zaki, RA; Sarimin, R; Ariff, MI; Suli, Z; Mahmud, M; Bee, KH; Anthonysamy, C; Rahim, AA; Gill, BS; Deva, SR; Sani, AFA; Romli, EZ; Ghazali, IMM; Yusof, MAM; Lutfi, NA; Shuib, SE; Darus, NM; Bakri, R; Yahya, A				Abd Rahman, Marzilawati; Zaki, Rafdzah Ahmad; Sarimin, Roza; Ariff, Mohd Izhar; Suli, Zailiza; Mahmud, Maimunah; Bee, Ker Hong; Anthonysamy, Cecilia; Rahim, Azahirafairud Abdul; Gill, Balvinder Singh; Deva, Shanti Rudra; Sani, Ana Fizalinda Abdullah; Romli, Erni Zurina; Ghazali, Izzuna Mudla Mohamed; Yusof, Mohd. Aminuddin Mohd.; Lutfi, Nafisah Ahmad; Shuib, Shahril Effendi; Darus, Noormah Mohd; Bakri, Rugayah; Yahya, Abqariyah			Adherence to Clinical Practice Guidelines (CPG) management of dengue infection in adults (revised 2nd edition)	PLOS ONE			English	Article							MALAYSIA	The Malaysian Dengue Clinical Practice Guidelines (CPG) have been developed to provide evidence-based guidance in the management of dengue infections. The use of these guidelines is essential to ensure its recommendations are being practiced. However, the adherence to the guidelines for management of dengue (revised 2nd edition) by healthcare providers still remains unknown. Therefore, the aim of this study was to evaluate the proportion among healthcare providers that adhere to this Dengue CPG. A retrospective cohort study of dengue cases registered from 1 January 2014 to 1 June 2015 was conducted in public hospitals and health clinics in Selangor, Putrajaya and Kuala Lumpur. Adherence to the CPG recommendations were recorded by reviewing patients' case notes. Overall proportion of adherence in clinical components of the recommendation were (7.1 to 100.0% versus 7.7 to 73.8%) in history taking, (6.7 to 100.0% versus 12.3 to 60.0%) in physical examinations, (18.4 to 100.0% versus 23.1 to 83.2%) in assessment of warning signs, (0.6 to 100.0% versus 12.3 to 87.7%) in assessment of haemodynamic status, (60.0 to 100.0% versus 27.7 to 40.0%) in diagnosis, (46.6 to 80.0% versus 52.3%) in case notifications, (73.2 to 100.0% versus 89.2 to 96.9%) in performing specific laboratory investigations and (7.9 to 100.0% versus 21.5%) in monitoring, for outpatient versus inpatient, respectively. Adherence trends were demonstrated to be higher in hospital settings compared to outpatient settings. Adherence to this Dengue CPG varies widely with overall good clinical outcomes observed.	[Abd Rahman, Marzilawati] Hosp Kuala Lumpur, Dept Med, Kuala Lumpur, Malaysia; [Zaki, Rafdzah Ahmad; Ariff, Mohd Izhar; Yahya, Abqariyah] Univ Malaya, Julius Ctr Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur, Malaysia; [Sarimin, Roza; Sani, Ana Fizalinda Abdullah; Romli, Erni Zurina; Ghazali, Izzuna Mudla Mohamed; Yusof, Mohd. Aminuddin Mohd.; Lutfi, Nafisah Ahmad; Shuib, Shahril Effendi; Darus, Noormah Mohd; Bakri, Rugayah] Minist Hlth, Hlth Technol Assessment Sect, Putrajaya, Malaysia; [Suli, Zailiza; Gill, Balvinder Singh] Minist Hlth, Dis Control Div, Putrajaya, Malaysia; [Mahmud, Maimunah] Minist Hlth, Hlth Clin, Jinjang, Malaysia; [Bee, Ker Hong; Deva, Shanti Rudra] Hosp Raja Permaisuri Bainun, Dept Med, Ipoh, Malaysia; [Anthonysamy, Cecilia] Hosp Serdang, Dept Emergency Med, Selangor, Malaysia; [Rahim, Azahirafairud Abdul] Hosp Kuala Lumpur, Dept Anaesthesiol, Kuala Lumpur, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; University of Kuala Lumpur	Yahya, A (corresponding author), Univ Malaya, Julius Ctr Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur, Malaysia.	abqariyah.yahya@um.edu.my	ZAKI, RAFDZAH AHMAD/B-9520-2010; Suli, Zailiza/AAG-4045-2019; Yahya, Abqariyah/B-5638-2017	ZAKI, RAFDZAH AHMAD/0000-0003-2884-5198; Yahya, Abqariyah/0000-0001-9158-415X	University Malaya grants 'Geran Bantuan Kecil Penyelidikan (BKP) Universiti Malaya' [BK029-2014]; University Malaya Research Grant [RP034C15HTM]	University Malaya grants 'Geran Bantuan Kecil Penyelidikan (BKP) Universiti Malaya'; University Malaya Research Grant	This study has been funded by University Malaya grants 'Geran Bantuan Kecil Penyelidikan (BKP) Universiti Malaya' - BK029-2014 and University Malaya Research Grant-RP034C15HTM.	Afzal M, NATURE, V11, P56; Ayyub Muhammad, 2006, J Ayub Med Coll Abbottabad, V18, P9; Azami NAM, 2011, BIOMED CENTRAL, V4, P1; Chew MH, 2012, PAK J MED SCI, V28, P643; Ghosh G, 2013, INT J BIOASSAYS, V02, P1462; Grimshaw J M, 1994, Qual Health Care, V3, P45, DOI 10.1136/qshc.3.1.45; Khalil Muhammad Abdul Mabood, 2014, BMC Res Notes, V7, P473, DOI 10.1186/1756-0500-7-473; Ministry of Health Malaysia, 2010, CLIN PRACT GUID MAN; Mohd-Zaki AH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003159; Mudin RN, 2015, INT MED J MALAYS, V14, P5; Pun R., 2012, KATHMANDU U MED J, V10, P3; Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777; Saqib Muhammad Arif Nadeem, 2014, BMC Res Notes, V7, P205, DOI 10.1186/1756-0500-7-205; World Health Organization, 2009, EP PAND AL DENG GUID	14	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0184559	10.1371/journal.pone.0184559	http://dx.doi.org/10.1371/journal.pone.0184559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095822	gold, Green Submitted, Green Published			2022-12-27	WOS:000414340200002
J	Cho, IYK; Jelinkova, K; Schuetze, M; Vinette, SA; Rahman, S; McCrimmon, A; Dewey, D; Bray, S				Cho, Ivy Y. K.; Jelinkova, Kristina; Schuetze, Manuela; Vinette, Sarah A.; Rahman, Sarah; McCrimmon, Adam; Dewey, Deborah; Bray, Signe			Circumscribed interests in adolescents with Autism Spectrum Disorder: A look beyond trains, planes, and clocks	PLOS ONE			English	Article							REPETITIVE BEHAVIORS; YOUNG-CHILDREN; BRAIN ACTIVITY; INTERVENTION; INTENSE; GENE	Adolescence is a unique developmental period, characterized by physical and emotional growth and significant maturation of cognitive and social skills. For individuals with Autism Spectrum Disorder (ASD), it is also a vulnerable period as cognitive and social skills can deteriorate. Circumscribed interests (Cls), idiosyncratic areas of intense interest and focus, are a core symptom of ASD that may be associated with social development. Yet, relatively little is known about the expression of Cls in adolescents with ASD. Many studies investigating Cls have used images depicting items of special interest; however, it is not clear how images should be customized for adolescent studies. The goal of this study was to gain insight into the types of images that may be appropriate for studies of Cls in adolescents with ASD. To this end, we used a mixed methods design that included, 1) one-on-one interviews with 10 adolescents (4 with ASD and 6 TD), to identify categories of images that were High Autism Interest ('HAI') or High Typically Developing Interest ('HTD'), and 2) an online survey taken by fifty-three adolescents with ASD (42 male) and 135 typically developing (TD) adolescents (55 male) who rated how much they liked 105 'HAI' and 'HTD' images. Although we found a significant interaction between 'HAI' and 'HTD' categories and diagnosis, neither group significantly preferred one category over the other, and only one individual category ('Celebrities') showed a significant group effect, favored by TD adolescents. Males significantly preferred 'HAI' images relative to females, and TD adolescents significantly preferred images with social content relative to adolescents with ASD. Our findings suggest that studies investigating affective or neural responses to Cl-related stimuli in adolescents should consider that stereotypical ASD interests (e.g. trains, gadgets) may not accurately represent individual adolescents with ASD, many of whom show interests that overlap with TD adolescents (e.g. video games).	[Cho, Ivy Y. K.; Jelinkova, Kristina; Vinette, Sarah A.; Bray, Signe] Univ Calgary, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada; [Cho, Ivy Y. K.; Jelinkova, Kristina; Schuetze, Manuela; Vinette, Sarah A.; Rahman, Sarah; Bray, Signe] Univ Calgary, Child & Adolescent Imaging Res CAIR Program, Calgary, AB, Canada; [Cho, Ivy Y. K.; Jelinkova, Kristina; Schuetze, Manuela; Vinette, Sarah A.; Rahman, Sarah; McCrimmon, Adam; Dewey, Deborah; Bray, Signe] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Cho, Ivy Y. K.; Jelinkova, Kristina; Vinette, Sarah A.; Dewey, Deborah; Bray, Signe] Univ Calgary, Cumming Sch Med, Dept Paediat, Calgary, AB, Canada; [Schuetze, Manuela] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Vinette, Sarah A.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Rahman, Sarah] Abil Hub, Calgary, AB, Canada; [Rahman, Sarah] Charleston Area Med Ctr, Dept Psychiat, Charleston, WV USA; [Rahman, Sarah] West Virginia Univ, Charleston Div, Charleston, WV 25304 USA; [McCrimmon, Adam] Univ Calgary, Werklund Sch Educ, Calgary, AB, Canada; [Dewey, Deborah] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of Calgary; University of Toronto; University of Calgary; University of Calgary	Bray, S (corresponding author), Univ Calgary, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada.; Bray, S (corresponding author), Univ Calgary, Child & Adolescent Imaging Res CAIR Program, Calgary, AB, Canada.; Bray, S (corresponding author), Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada.; Bray, S (corresponding author), Univ Calgary, Cumming Sch Med, Dept Paediat, Calgary, AB, Canada.	slbray@ucalgary.ca	Dewey, Deborah/AGK-7348-2022	Dewey, Deborah/0000-0002-1323-5832	SickKids Foundation; Canadian Institute for Health Research-Institute for Human Development Child and Youth Health New Investigator Award [NI14-021]; Sinneave Family Foundation; Alberta Children's Hospital Foundation	SickKids Foundation; Canadian Institute for Health Research-Institute for Human Development Child and Youth Health New Investigator Award(Canadian Institutes of Health Research (CIHR)); Sinneave Family Foundation; Alberta Children's Hospital Foundation	This study was supported by a SickKids Foundation and Canadian Institute for Health Research-Institute for Human Development Child and Youth Health New Investigator Award to SB (https://www.sickkidsfoundation.com/; NI14-021). SB also received financial support from the Sinneave Family Foundation (https:theabilityhub.org/about/the-sinneave-family-foundation/) and the Alberta Children's Hospital Foundation (http://www.childrenshospital.ab.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand M, 2015, J PERS, V83, P229, DOI 10.1111/jopy.12098; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anthony LG, 2013, DEV PSYCHOPATHOL, V25, P643, DOI 10.1017/S0954579413000072; Baker MJ, 1998, J ASSOC PERS SEVERE, V23, P300, DOI 10.2511/rpsd.23.4.300; Baron-Cohen S, 1999, BRIT J PSYCHIAT, V175, P484, DOI 10.1192/bjp.175.5.484; Boyd BA, 2007, J AUTISM DEV DISORD, V37, P1550, DOI 10.1007/s10803-006-0286-8; Boyd BA, 2012, J AUTISM DEV DISORD, V42, P1236, DOI 10.1007/s10803-011-1284-z; Bray S, 2010, J NEUROPHYSIOL, V103, P2506, DOI 10.1152/jn.01030.2009; Carrington S, 2003, FOCUS AUTISM OTHER D, V18, P211, DOI DOI 10.1177/10883576030180040201; Cascio CJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-9; Charlop-Christy MH, 1998, J AUTISM DEV DISORD, V28, P189, DOI 10.1023/A:1026061220171; Constantino J.N., 2012, SOCIAL RESPONSIVENES; Crawford H, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0084-x; Dawson G, 2012, J AM ACAD CHILD PSY, V51, P1150, DOI 10.1016/j.jaac.2012.08.018; Delmonte S, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-7; DeLoache JS, 2007, DEV PSYCHOL, V43, P1579, DOI 10.1037/0012-1649.43.6.1579; Dichter GS, 2012, SOC COGN AFFECT NEUR, V7, P160, DOI 10.1093/scan/nsq095; Dunn L.M., 2009, PEABODY PICTURE VOCA; Franchini M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178859; Gabriels RL, 2005, RES DEV DISABIL, V26, P169, DOI 10.1016/j.ridd.2004.05.003; Gunn KCM, 2016, REV EDUC RES, V86, P408, DOI 10.3102/0034654315604027; Hiller RM, 2016, AUTISM, V20, P75, DOI 10.1177/1362361314568899; Jordan CJ, 2012, INTELLECT DEV DISAB, V50, P391, DOI 10.1352/1934-9556-50.5.391; Joseph RM, 2002, J CHILD PSYCHOL PSYC, V43, P807, DOI 10.1111/1469-7610.00092; Klin A, 2007, RES PRACT PERS SEV D, V32, P89, DOI 10.2511/rpsd.32.2.89; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; KOEGEL RL, 1987, J APPL BEHAV ANAL, V20, P243, DOI 10.1901/jaba.1987.20-243; Krasileva KE, 2017, J AUTISM DEV DISORD, V47, P1073, DOI 10.1007/s10803-017-3030-7; Kuo MH, 2013, AUTISM, V17, P481, DOI 10.1177/1362361311416380; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lin A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00143; Lin A, 2012, SOC COGN AFFECT NEUR, V7, P274, DOI 10.1093/scan/nsr006; Lord C., 2012, AUTISM DIAGNOSTIC OB; McCray AT, 2014, NEUROINFORMATICS, V12, P291, DOI 10.1007/s12021-013-9211-4; Mottron L, 2017, EUR CHILD ADOLES PSY, V26, P815, DOI 10.1007/s00787-017-0955-5; Nelson EE, 2005, PSYCHOL MED, V35, P163, DOI 10.1017/S0033291704003915; Parsons OE, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0132-1; Picci G, 2015, CLIN PSYCHOL SCI, V3, P349, DOI 10.1177/2167702614540646; Sasson NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042457; Sasson NJ, 2008, AUTISM RES, V1, P31, DOI 10.1002/aur.4; Seltzer MM, 2004, MENT RETARD DEV D R, V10, P234, DOI 10.1002/mrdd.20038; Seltzer MM, 2003, J AUTISM DEV DISORD, V33, P565, DOI 10.1023/B:JADD.0000005995.02453.0b; Shattuck PT, 2007, J AUTISM DEV DISORD, V37, P1735, DOI 10.1007/s10803-006-0307-7; South M, 2005, J AUTISM DEV DISORD, V35, P145, DOI 10.1007/s10803-004-1992-8; Staal WG, 2012, J AUTISM DEV DISORD, V42, P885, DOI 10.1007/s10803-011-1312-z; Sutherland R, 2017, AUTISM, V21, P785, DOI 10.1177/1362361316668653; Sy JR, 2016, BEHAV MODIF, V40, P713, DOI 10.1177/0145445515622382; Sykes NH, 2009, EUR J HUM GENET, V17, P1347, DOI 10.1038/ejhg.2009.47; Turner-Brown LM, 2011, AUTISM, V15, P437, DOI 10.1177/1362361310386507; Unruh KE, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00586; Watson KK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01026	52	19	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187414	10.1371/journal.pone.0187414	http://dx.doi.org/10.1371/journal.pone.0187414			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095880	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200084
J	Liu, XY; Lister, DL; Zhao, ZJ; Petrie, CA; Zeng, XS; Jones, PJ; Staff, RA; Pokharia, AK; Bates, J; Singh, RN; Weber, SA; Matuzeviciute, GM; Dong, GH; Li, HM; Lu, HL; Jiang, HE; Wang, JX; Ma, J; Tian, D; Jin, GY; Zhou, LP; Wu, XH; Jones, MK				Liu, Xinyi; Lister, Diane L.; Zhao, Zhijun; Petrie, Cameron A.; Zeng, Xiongsheng; Jones, Penelope J.; Staff, Richard A.; Pokharia, Anil K.; Bates, Jennifer; Singh, Ravindra N.; Weber, Steven A.; Matuzeviciute, Giedre Motuzaite; Dong, Guanghui; Li, Haiming; Lu, Hongliang; Jiang, Hongen; Wang, Jianxin; Ma, Jian; Tian, Duo; Jin, Guiyun; Zhou, Liping; Wu, Xiaohong; Jones, Martin K.			Journey to the east: Diverse routes and variable flowering times for wheat and barley en route to prehistoric China	PLOS ONE			English	Article							FOOD GLOBALIZATION; SOUTH-ASIA; AGRICULTURE; SPREAD; CROPS; ADAPTATION; PATHWAYS; ORIGINS	Today, farmers in many regions of eastern Asia sow their barley grains in the spring and harvest them in the autumn of the same year (spring barley). However, when it was first domesticated in southwest Asia, barley was grown between the autumn and subsequent spring (winter barley), to complete their life cycles before the summer drought. The question of when the eastern barley shifted from the original winter habit to flexible growing schedules is of significance in terms of understanding its spread. This article investigates when barley cultivation dispersed from southwest Asia to regions of eastern Asia and how the eastern spring barley evolved in this context. We report 70 new radiocarbon measurements obtained directly from barley grains recovered from archaeological sites in eastern Eurasia. Our results indicate that the eastern dispersals of wheat and barley were distinct in both space and time. We infer that barley had been cultivated in a range of markedly contrasting environments by the second millennium BC. In this context, we consider the distribution of known haplotypes of a flowering-time gene in barley, Ppd-H1, and infer that the distributions of those haplotypes may reflect the early dispersal of barley. These patterns of dispersal resonate with the second and first millennia BC textual records documenting sowing and harvesting times for barley in central/eastern China.	[Liu, Xinyi] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Lister, Diane L.; Petrie, Cameron A.; Jones, Penelope J.; Bates, Jennifer; Jones, Martin K.] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Zhao, Zhijun] Chinese Acad Social Sci, Inst Archaeol, Beijing, Peoples R China; [Zeng, Xiongsheng] Chinese Acad Sci, Inst Hist Nat Sci, Beijing, Peoples R China; [Staff, Richard A.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Staff, Richard A.] Univ Glasgow, SUERC, E Kilbride, Scotland; [Pokharia, Anil K.] Birbal Sahni Inst Paleobot, Lucknow, Uttar Pradesh, India; [Singh, Ravindra N.] Banaras Hindu Univ, Dept AIHC & Archaeol, Varanasi, Uttar Pradesh, India; [Weber, Steven A.] Washington State Univ, Dept Anthropol, Vancouver, WA USA; [Matuzeviciute, Giedre Motuzaite] Vilnius Univ, Dept Archaeol, Vilnius, Lithuania; [Dong, Guanghui; Li, Haiming] Lanzhou Univ, Key Lab Western Chinas Environm Syst, Lanzhou, Gansu, Peoples R China; [Lu, Hongliang] Sichuan Univ, Dept Archaeol, Chengdu, Sichuan, Peoples R China; [Jiang, Hongen] Univ Chinese Acad Sci, Dept Hist Sci & Archaeometry, Beijing, Peoples R China; [Wang, Jianxin; Ma, Jian; Tian, Duo] Northwest Univ Xian, Sch Cultural Heritage, Xian, Shaanxi, Peoples R China; [Jin, Guiyun] Shandong Univ, Sch Hist & Culture, Jinan, Shandong, Peoples R China; [Zhou, Liping] Peking Univ, Lab Earth Surface Proc, Beijing, Peoples R China; [Wu, Xiaohong] Peking Univ, Sch Archaeol & Museol, Beijing, Peoples R China	Washington University (WUSTL); University of Cambridge; Chinese Academy of Social Sciences; Chinese Academy of Sciences; Institute for the History of Natural Science, CAS; University of Oxford; Scottish Universities Research & Reactor Center; University of Glasgow; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); Banaras Hindu University (BHU); Washington State University; Vilnius University; Lanzhou University; Sichuan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest University Xi'an; Shandong University; Peking University; Peking University	Liu, XY (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.	liuxinyi@wustl.edu	liu, xinyi/GWZ-8739-2022; Wu, Xiaohong/AAH-4348-2020; JIN, GUIYUN/P-4936-2019; Dong, Guanghui/C-5985-2013; Petrie, Cameron/ABB-8528-2021; Singh, Ravindra Nath/AAO-2784-2020; Motuzaite Matuzeviciute, Giedre/AAK-2928-2021; Lu, Hongliang/AAO-1322-2021	Wu, Xiaohong/0000-0002-3819-0829; JIN, GUIYUN/0000-0002-4253-6271; Petrie, Cameron/0000-0002-2926-7230; Singh, Ravindra Nath/0000-0002-1102-4839; Motuzaite Matuzeviciute, Giedre/0000-0001-9069-1551; Staff, Richard/0000-0002-8634-014X; Bates, Jennifer/0000-0002-7100-4741; Jones, Penelope/0000-0002-4880-6711; Dong, Guanghui/0000-0001-8005-759X; Pokharia, Anil/0000-0003-1453-0646	European Research Council [249642]; National Natural Science Foundation of China [41620104007, 41672171]; National Social Science Foundation of China [11AZD116, 14ZDB052]; University of Chinese Academy of Sciences [Y65201YY00]; Department of Science and Technology, New Delhi, India [EMR/2015/000881]; International Center for Energy, Environment and Sustainability (InCEES)	European Research Council(European Research Council (ERC)European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China; University of Chinese Academy of Sciences(Chinese Academy of Sciences); Department of Science and Technology, New Delhi, India(Department of Science & Technology (India)); International Center for Energy, Environment and Sustainability (InCEES)	Financial support was provided by the European Research Council (249642-MKJ), National Natural Science Foundation of China (41620104007-GD and 41672171-HJ), National Social Science Foundation of China (11AZD116-GJ and 14ZDB052-JM), University of Chinese Academy of Sciences (Y65201YY00-HJ), the Department of Science and Technology, New Delhi, India (EMR/2015/000881-AP), and International Center for Energy, Environment and Sustainability (InCEES-XL).r The authors are grateful to Jingang Yang, Xuexiang Chen, Fuqiang Wang, Jixiang Song, Yua-nyuan Gao, Wangdue Shargan, Hui Wang, Meng Ren, Shalini Sharma, George Willcox, Catherine Kneale, Pan Gao and Kexin Liu for assistance in accessing samples and conducting lab work. Financial support was provided by the European Research Council (249642), National Natural Science Foundation of China (41620104007 and 41672171), National Social Science Foundation of China (11AZD116 and 14ZDB052), University of Chinese Academy of Sciences (Y65201YY00), the Department of Science and Technology, New Delhi, India (EMR/2015/000881), and International Center for Energy, Environment and Sustainability (InCEES).	Barton L, 2014, WORLD ARCHAEOL, V46, P775, DOI 10.1080/00438243.2014.953703; Bogaard, 2004, NEOLITHIC FARMING CE, DOI DOI 10.4324/9780203358009; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Chen FH, 2015, SCIENCE, V347, P248, DOI 10.1126/science.1259172; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; d'Alpoim Guedes J, 2014, ARCHAEOL ANTHROP SCI, V6, P255, DOI 10.1007/s12520-013-0153-4; Dodson JR, 2013, QUATERNARY SCI REV, V72, P108, DOI 10.1016/j.quascirev.2013.04.021; Flad R., 2010, HOLOCENE, V17, P555; Frachetti MD, 2012, CURR ANTHROPOL, V53, P2, DOI 10.1086/663692; Frachetti MD, 2010, ANTIQUITY, V84, P993, DOI 10.1017/S0003598X0006703X; Fuller D. Q., 2014, GEN ANTHR, V21, P1, DOI [10.1111/gena.01001, DOI 10.1111/GENA.01001]; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2017, HUMAN DISPERSAL AND SPECIES MOVEMENT: FROM PREHISTORY TO THE PRESENT, P304; Goyal P, 2013, RADIOCARBON, V55, P141; Guedes JAD, 2015, P NATL ACAD SCI USA, V112, P5625, DOI 10.1073/pnas.1423708112; Harris D., 2010, ORIGINS AGR W CENTRA; Harvey E.L, 2006, EARLY AGR COMMUNITIE; Jin G., 2008, JIAOZHOU SHANDONG PR, V22; Jones G, 2012, J ARCHAEOL SCI, V39, P3230, DOI 10.1016/j.jas.2012.05.014; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Jones H, 2016, QUATERN INT, V426, P26, DOI 10.1016/j.quaint.2016.02.029; Jones M, 2011, WORLD ARCHAEOL, V43, P665, DOI 10.1080/00438243.2011.624764; Lister D. L., 2012, VEG HIST ARCHAEOBOT, V22, P439; Lister DL, 2009, J ARCHAEOL SCI, V36, P1092, DOI 10.1016/j.jas.2008.12.012; Liu L, 2012, ARCHAEOLOGY CHINA LA; Liu XY, 2016, QUATERN INT, V426, P107, DOI 10.1016/j.quaint.2016.02.059; Liu XY, 2014, WORLD ARCHAEOL, V46, P661, DOI 10.1080/00438243.2014.953706; Liu XY, 2014, ANTIQUITY, V88, P956, DOI 10.1017/S0003598X00050912; Meadow R. H., 1996, ORIGINS SPREAD AGR P, P390; Miller N., 2003, CENTRAL ASIAN VILLAG, P127; Motuzaite Matuzeviciute G., 2015, QUATERN INT, V137, P35; Newton AC, 2011, FOOD SECUR, V3, P141, DOI 10.1007/s12571-011-0126-3; Petrie CA., 2015, CAMBRIDGE WORLD HIST, V2, P289; Petrie CA, 2010, SHERI KHAN TARAKAI E; Qiu X., 1989, GU WENZI LUNJI; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Spengler R.N., 2014, P R SOC, V281, P1, DOI DOI 10.1098/RSPB.2013.3382; Spengler RN, 2015, J WORLD PREHIST, V28, P215, DOI 10.1007/s10963-015-9087-3; Spengler RN, 2013, ENVIRON ARCHAEOL, V18, P211, DOI 10.1179/1749631413Y.0000000008; Stevens CJ, 2016, HOLOCENE, V26, P1541, DOI 10.1177/0959683616650268; Tengberg M., 1999, VEG HIST ARCHAEOBOT, V8, P3; Tewari R., 2006, PRAGDHARA, V16, P35; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Weber S, 1999, ANTIQUITY, V73, P813, DOI 10.1017/S0003598X00065558; Weber SA., 2003, INDUS ETHNOBIOLOGY N, P175; Weiss E, 2011, CURR ANTHROPOL, V52, pS237, DOI 10.1086/658367; Willcox G., 1991, NEW LIGHT EARLY FARM, P139; ZENG X., 2005, ZHONGGUO YINSHI WENH, V1, P99; Zhao ZJ, 2009, CHIN ARCHAEOL, V9, P1; Zhao ZJ, 2011, CURR ANTHROPOL, V52, pS295, DOI 10.1086/659308; Zhuang YJ, 2017, WORLD ARCHAEOL, V48, P563, DOI 10.1080/00438243.2016.1251850; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	54	61	66	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187405	10.1371/journal.pone.0187405	http://dx.doi.org/10.1371/journal.pone.0187405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FL6FI	29095896	Green Published, Green Accepted, gold			2022-12-27	WOS:000414340200080
J	Yagyu, T; Kumada, M; Nakagawa, T				Yagyu, Takeshi; Kumada, Masahiro; Nakagawa, Tsutomu			Novel risk stratification with time course assessment of in-hospital mortality in patients with acute heart failure	PLOS ONE			English	Article							SOFA SCORE; ASSOCIATION; PREDICTION; GUIDELINES; OUTCOMES; JAPAN; CARE	Background Patients with acute heart failure (AHF) show various clinical courses during hospitalization. We aimed to identify time course predictors of in-hospital mortality and to establish a sequentially assessable risk model. Methods and results We enrolled 1,035 consecutive AHF patients into derivation (n = 597) and validation (n = 438) cohorts. For risk assessments at admission, we utilized Get With the Guidelines-Heart Failure (GWTG-HF) risk scores. We examined significant predictors of in-hospital mortality from 11 variables obtained during hospitalization and developed a risk stratification model using multiple logistic regression analysis. Across both cohorts, 86 patients (8.3%) died during hospitalization. Using backward stepwise selection, we identified five time-course predictors: catecholamine administration, minimum platelet concentration, maximum blood urea nitrogen, total bilirubin, and C-reactive protein levels; and established a time course risk score that could sequentially assess a patient's risk status. The addition of a time course risk score improved the discriminative ability of the GWTG-HF risk score (c-statistics in derivation and validation cohorts: 0.776 to 0.888 [p = 0.002] and 0.806 to 0.902 [p<0.001], respectively). A calibration plot revealed a good relationship between observed and predicted in-hospital mortalities in both cohorts (Hosmer-Lemeshow chi-square statistics: 6.049 [p = 0.642] and 5.993 [p = 0.648], respectively). In each group of initial low-intermediate risk (GWTG-HF risk score<47) and initial high risk (GWTG-HF risk score >47), in-hospital mortality was about 6-to 9-fold higher in the high time course risk score group than in the low-intermediate time course risk score group (initial low-intermediate risk group: 20.3% versus 2.2% [p<0.001], initial high risk group: 57.6% versus 8.5% [p<0.001]). Conclusions A time course assessment related to in-hospital mortality during the hospitalization of AHF patients can clearly categorize a patient's on-going status, and may assist patients and clinicians in deciding treatment options.	[Yagyu, Takeshi; Kumada, Masahiro; Nakagawa, Tsutomu] Toyonaka City Hosp, Dept Cardiol, Toyonaka, Osaka, Japan		Yagyu, T (corresponding author), Toyonaka City Hosp, Dept Cardiol, Toyonaka, Osaka, Japan.	yagyu.takeshi.hp@ncvc.go.jp						Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Abraham WT, 2005, J AM COLL CARDIOL, V46, P57, DOI 10.1016/j.jacc.2005.03.051; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; Cowie MR, 2006, EUR HEART J, V27, P1216, DOI 10.1093/eurheartj/ehi859; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Ferrero P, 2015, INT J CARDIOL, V188, P1, DOI 10.1016/j.ijcard.2015.03.154; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Goodlin SJ, 2009, J AM COLL CARDIOL, V54, P386, DOI 10.1016/j.jacc.2009.02.078; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Lee DS, 2014, CAN J CARDIOL, V30, P312, DOI 10.1016/j.cjca.2014.01.001; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Mozaffarian D, 2016, CIRCULATION, V133, P447, DOI 10.1161/CIR.0000000000000366; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489; Peterson PN, 2010, CIRC-CARDIOVASC QUAL, V3, P25, DOI 10.1161/CIRCOUTCOMES.109.854877; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rahimi K, 2014, JACC-HEART FAIL, V2, P440, DOI 10.1016/j.jchf.2014.04.008; Sato N, 2013, CIRC J, V77, P944, DOI 10.1253/circj.CJ-13-0187; Shinagawa H, 2007, INT HEART J, V48, P195, DOI 10.1536/ihj.48.195; Steel A, 2013, INT J CARDIOL, V167, P280, DOI 10.1016/j.ijcard.2012.09.211; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187410	10.1371/journal.pone.0187410	http://dx.doi.org/10.1371/journal.pone.0187410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095900	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200082
J	Bazzano, AN; Martin, J; Hicks, E; Faughnan, M; Murphy, L				Bazzano, Alessandra N.; Martin, Jane; Hicks, Elaine; Faughnan, Maille; Murphy, Laura			Human-centred design in global health: A scoping review of applications and contexts	PLOS ONE			English	Review							MANAGEMENT; DISEASE; INNOVATION; CARE	Health and wellbeing are determined by a number of complex, interrelated factors. The application of design thinking to questions around health may prove valuable and complement existing approaches. A number of public health projects utilizing human centered design (HCD), or design thinking, have recently emerged, but no synthesis of the literature around these exists. The results of a scoping review of current research on human centered design for health outcomes are presented. The review aimed to understand why and how HCD can be valuable in the contexts of health related research. Results identified pertinent literature as well as gaps in information on the use of HCD for public health research, design, implementation and evaluation. A variety of contexts were identified in which design has been used for health. Global health and design thinking have different underlying conceptual models and terminology, creating some inherent tensions, which could be overcome through clear communication and documentation in collaborative projects. The review concludes with lessons learned from the review on how future projects can better integrate design thinking with global health research.	[Bazzano, Alessandra N.; Faughnan, Maille; Murphy, Laura] Tulane Univ, Taylor Canter Social Innovat & Design Thinking, New Orleans, LA 70118 USA; [Martin, Jane] Creat Social Change, London, England; [Hicks, Elaine; Faughnan, Maille; Murphy, Laura] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA	Tulane University; Tulane University	Bazzano, AN (corresponding author), Tulane Univ, Taylor Canter Social Innovat & Design Thinking, New Orleans, LA 70118 USA.	abazzano@tulane.edu	Hicks, Elaine/X-9821-2019; Bazzano, Alessandra N./U-7703-2019; Martin, Jane/H-7407-2016	Hicks, Elaine/0000-0002-3150-7942; Martin, Jane/0000-0002-7679-8579; Bazzano, Alessandra N./0000-0002-8299-2626				Almon N, 2014, MOVING WELLNESS DESI; Amiri M, 2012, WORK, V41, P1193, DOI 10.3233/WOR-2012-0303-1193; Anderson Stuart, 2008, Health Res Policy Syst, V6, P7, DOI 10.1186/1478-4505-6-7; [Anonymous], 2016, GLOBAL HLTH DALBERG; [Anonymous], 2016, DESIGN F HEALTHCARE; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Bate P., 2007, J APPL BEHAV SCI, V43, P41, DOI [10.1177/0021886306297014, DOI 10.1177/0021886306297014]; Beelen D, 2012, CONTRACEPTION, V86, P174, DOI 10.1016/j.contraception.2012.04.019; Bjerkan J, 2015, INFORM HEALTH SOC CA, V40, P167, DOI 10.3109/17538157.2014.907803; Brown T, 2010, STANFORD SOCIAL INNO, V8, pe4637; Brown T, 2008, HARVARD BUS REV, V86, P84; C S J M, 2014, STANFORD SOCIAL INNO; Cahn PS, 2016, J INTERPROF CARE, V30, P378, DOI 10.3109/13561820.2015.1122582; Catalani C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103205; Cheney Catherine, 2016, DEVEX; Devoe J, 2014, J AMBUL CARE MANAG, V37, P148, DOI 10.1097/JAC.0000000000000016; Fabricant R, 2014, STANFORD SOCIAL INNO; Fahnrich C, 2015, EUROSURVEILLANCE, V20; Foundation KP, 2016, GARF INN CTR 2016; Foundation MC, MAY CLIN CTR INN; Giacomin J, 2014, DES J, V17, P606, DOI 10.2752/175630614X14056185480186; Gough D, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-28; IDEO, 2016, HLTH WELLNESS; International Organization for Standardization, 2010, 92412102010 ISO; Jun GT, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-20; Knoblock-Hahn AL, 2014, J ACAD NUTR DIET, V114, P570, DOI 10.1016/j.jand.2013.11.021; Koehly LM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2483-x; Kolko J., 2015, HARVARD BUSINESS REV; Lin Amy H, 2014, J Int AIDS Soc, V17, P19162, DOI 10.7448/IAS.17.3.19162; Lunze K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0784-9; Manzini E., 2015, DESIGN EVERYBODY DES, Vxiv; Matheson GO, 2015, AM J PREV MED, V48, P472, DOI 10.1016/j.amepre.2014.10.014; Matheson GO, 2013, BRIT J SPORT MED, V47, P1003, DOI 10.1136/bjsports-2013-093034; McCreary L, 2010, HARVARD BUS REV, V88, P92; Moody Louise, 2015, Journal of Medical Engineering & Technology, V39, P395, DOI 10.3109/03091902.2015.1088086; Morrison D, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0177-z; Mummah SA, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0400-z; Norman Cameron D, 2016, JMIR Public Health Surveill, V2, pe18, DOI 10.2196/publichealth.5134; Papi E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007980; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Phills JA, 2008, STANFORD SOC INNOVAT, V6, P34, DOI DOI 10.1111/J.1369-7625.2010.00656.X; Ramos AK, 2016, PROG COMM HLTH PARTN, V10, P311, DOI 10.1353/cpr.2016.0022; Roberts JP, 2016, HEALTHCARE-J DEL SCI, V4, P11, DOI 10.1016/j.hjdsi.2015.12.002; Robinson L, 2009, INT PSYCHOGERIATR, V21, P494, DOI 10.1017/S1041610209008448; Romme AGL, 2004, J COMMUNITY APPL SOC, V14, P495, DOI 10.1002/casp.794; Roy MJ, 2014, SOC SCI MED, V123, P182, DOI 10.1016/j.socscimed.2014.07.031; Sanders EBN., 2008, CODESIGN, V4, P5, DOI [10.1080/15710880701875068, DOI 10.1080/15710880701875068]; Sandhu JS, 2015, AM J PUBLIC HEALTH, V105, pS73, DOI 10.2105/AJPH.2014.302395; Sanematsu H, 2011, J ADOLESCENT HEALTH, V48, pS44, DOI 10.1016/j.jadohealth.2010.11.099; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Seeber L, 2015, CURR DRUG SAF, V10, P31, DOI 10.2174/157488631001150407105400; van de Grift TC, 2016, ACAD MED; van Hoof J, 2015, J Aging Res, V2015, P185054, DOI 10.1155/2015/185054; Vechakul J, 2015, MATERN CHILD HLTH J, V19, P2552, DOI 10.1007/s10995-015-1787-x; Watkins CA, 2014, CAN DESIGN THINKING; Whinnery J, 2016, GLOB HEALTH-SCI PRAC, V4, P336, DOI 10.9745/GHSP-D-16-00022	56	130	130	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186744	http://dx.doi.org/10.1371/journal.pone.0186744			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091935	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700029
J	Fronza, MG; Brod, LMP; Casaril, AM; Sacramento, M; Alves, D; Savegnago, L				Fronza, Mariana G.; Pinto Brod, Lucimar M.; Casaril, Angela Maria; Sacramento, Manoela; Alves, Diego; Savegnago, Lucielli			Computational and biological evidences on the serotonergic involvement of SeTACN antidepressant-like effect in mice	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; FORCED SWIMMING TEST; DIPHENYL DISELENIDE; OXIDATIVE STRESS; 5-HT1A RECEPTOR; MOUSE; SYSTEMS; MODEL; ANTIOXIDANT; TRANSPORTER	A series of phenylselany1-1H-1,2,3-triazole-4-carbonitriles with different substituents were screened for their binding affinity with serotonin transporter (SERT) and dopamine transporter (DAT) by docking molecular. 5-(4methoxphenyI)-1-(2-(phenylselanyl)pheny1)-1H1,2,3-triazole-4-carbonitrile (SeTACN) exhibited the best conformation with SERT even higher than fluoxetine and serotonin, suggesting a competitive inhibition. SeTACN demonstrated additional affinity to other serotonergic receptors involved in antidepressant effects: 5HT1a, 5HT2a and 51-1-13. In another set of experiments, SeTACN led to significant reductions in the immobility time of mice submitted to forced swimming test (FST) in the dose range of 0.1- 20mg/kg, suggesting an antidepressant-like effect. The possible mechanism of action was investigated using serotonergic and dopaminergic antagonists. The antidepressant -like effect of SeTACN (0.1 mg/kg i.g.) was prevented by the pretreatment with WAY100635 (a selective 5HT1a antagonist), ketanserin (a 5HT2a/c antagonist) and ondansetron (a selective 5ht3 antagonist), PCPA (an inhibitor of serotonin synthesis) but not with SCH23390 (dopaminergic D1 antagonist) and sulpiride (D2 antagonist). Sub-effective dose of fluoxetine was able to potentiate the effects of a sub-effective dose of SeTACN in FST. None of the treatments affected locomotor activity in open field test (OFT). These results together, suggest that the SeTACN antidepressant-like effect is mediate, at least in parts, by serotonergic system.	[Fronza, Mariana G.; Pinto Brod, Lucimar M.; Casaril, Angela Maria; Savegnago, Lucielli] Univ Fed Pelotas, Programa Posgrad Biotecnol, GPN, CDTec,UFPeI, Pelotas, RS, Brazil; [Sacramento, Manoela; Alves, Diego] Univ Fed Pelotas, PPGQ, Lab Sintese Organ Limpa LASOL, CCQFA, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas	Savegnago, L (corresponding author), Univ Fed Pelotas, Programa Posgrad Biotecnol, GPN, CDTec,UFPeI, Pelotas, RS, Brazil.	luciellisavegnago@yahoo.com.br	Alves, Diego/G-5273-2012; Savegnago, Lucielli/L-7287-2013; Brod, Lucimar Pinto/AAG-3494-2020; Sacramento, Manoela/AAD-9232-2022; Casaril, Angela Maria/L-5565-2016	Alves, Diego/0000-0002-1074-0294; Savegnago, Lucielli/0000-0003-0494-5610; Casaril, Angela Maria/0000-0003-4994-1891	Coordenagao de Aperfeigoamento Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul [FAPERGS PRONEN 16/25510000240-1]	Coordenagao de Aperfeigoamento Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	The project was supported by Coordenagao de Aperfeigoamento Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS PRONEN 16/25510000240-1).	Anderson G, 2014, CURR PHARM DESIGN, V20, P3812, DOI 10.2174/13816128113196660738; Artigas F, 1996, TRENDS NEUROSCI, V19, P378, DOI 10.1016/S0166-2236(96)10037-0; Artigas F, 2013, PHARMACOL THERAPEUT, V137, P119, DOI 10.1016/j.pharmthera.2012.09.006; Gerzson MFB, 2012, PHARMACOL BIOCHEM BE, V102, P21, DOI 10.1016/j.pbb.2012.03.016; Behr GA, 2012, OXID MED CELL LONGEV, V609, P4; BENTON D, 1991, BIOL PSYCHIAT, V29, P1092, DOI 10.1016/0006-3223(91)90251-G; Benton D, 2002, NUTR NEUROSCI, V5, P363, DOI 10.1080/1028415021000055925; BLIER P, 1987, SYNAPSE, V1, P470, DOI 10.1002/syn.890010511; Blier P, 2003, BIOL PSYCHIAT, V53, P193, DOI 10.1016/S0006-3223(02)01643-8; Bruning CA, 2011, EUR J PHARMACOL, V658, P145, DOI 10.1016/j.ejphar.2011.02.039; Carr GV, 2011, PSYCHOPHARMACOLOGY, V213, P265, DOI [10.1007/s00213-010-1832-9, 10.1007/s00213-010-2097-z]; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; Chang CC, 2015, PSYCHIAT RES, V230, P575, DOI 10.1016/j.psychres.2015.10.006; Colla ARS, 2014, PHARMACOL BIOCHEM BE, V124, P108, DOI 10.1016/j.pbb.2014.05.015; Dale E, 2015, BIOCHEM PHARMACOL, V95, P81, DOI 10.1016/j.bcp.2015.03.011; de Ruyck Jerome, 2016, Adv Appl Bioinform Chem, V9, P1, DOI 10.2147/AABC.S105289; Deng XQ, 2014, EUR J MED CHEM, V73, P217, DOI 10.1016/j.ejmech.2013.12.014; Donato F, 2013, LIFE SCI, V93, P393, DOI 10.1016/j.lfs.2013.07.024; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Gabrielsen M, 2013, CHEM BIOL DRUG DES, V81, P695, DOI 10.1111/cbdd.12116; Gandhimathi A, 2016, J BIOMOL STRUCT DYN, V34, P952, DOI 10.1080/07391102.2015.1062802; Gay BM, 2010, NEUROPHARMACOLOGY, V59, P172, DOI 10.1016/j.neuropharm.2010.05.003; Goldberg JF, 2013, J AFFECT DISORDERS, V144, P176, DOI 10.1016/j.jad.2012.04.037; Gupta D, 2016, NEUROSCI BIOBEHAV R, V64, P311, DOI 10.1016/j.neubiorev.2016.03.001; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Jacobsen JPR, 2012, PHILOS T R SOC B, V367, P2444, DOI 10.1098/rstb.2012.0109; Khan I, 2016, BIOORG CHEM, V68, P41, DOI 10.1016/j.bioorg.2016.07.007; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; Marek GJ, 2003, NEUROPSYCHOPHARMACOL, V28, P402, DOI 10.1038/sj.npp.1300057; Martinez DM, 2014, PHARMACOL BIOCHEM BE, V127, P111, DOI 10.1016/j.pbb.2014.10.010; Massart R, 2012, PHILOS T R SOC B, V367, P2485, DOI 10.1098/rstb.2012.0212; McIntyre RS, 2013, DEPRESS ANXIETY, V30, P515, DOI 10.1002/da.22063; Menard C, 2016, NEUROSCIENCE, V321, P138, DOI 10.1016/j.neuroscience.2015.05.053; Michel TM, 2012, CURR PHARM DESIGN, V18, P5890; Miguel-Hidalgo JJ, 2002, CNS DRUGS, V16, P361, DOI 10.2165/00023210-200216060-00001; Millan MJ, 2004, EUR J PHARMACOL, V500, P371, DOI 10.1016/j.ejphar.2004.07.038; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morrissette DA, 2014, CNS SPECTRUMS, V19, P57, DOI 10.1017/S1092852914000613; Moylan S, 2014, NEUROSCI BIOBEHAV R, V45, P46, DOI 10.1016/j.neubiorev.2014.05.007; Muller LG, 2012, PROG NEURO-PSYCHOPH, V36, P101, DOI 10.1016/j.pnpbp.2011.08.015; Neis VB, 2015, PHARMACOL BIOCHEM BE, V130, P9, DOI 10.1016/j.pbb.2014.12.009; Nutt DJ, 2007, J CLIN PSYCHIAT, V68, P42; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Pesarico AP, 2014, PROG NEURO-PSYCHOPH, V54, P179, DOI 10.1016/j.pnpbp.2014.06.001; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pilar-Cuellar F, 2014, CURR PHARM DESIGN, V20, P3776, DOI 10.2174/13816128113196660736; Brod LMP, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.10.008; Pissurlenkar Raghuvir R. S., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P228; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Praveen C, 2012, J CHEM SCI, V124, P451, DOI 10.1007/s12039-011-0150-z; Pytka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142499; Qin B, 2014, CLIN THER, V36, P1087, DOI 10.1016/j.clinthera.2014.06.001; Quesseveur G, 2013, EXP BRAIN RES, V226, P285, DOI 10.1007/s00221-013-3434-3; Ramezanpour M, 2015, BIOPHYS J, V1, P108; Rantamaki T, 2016, PROG NEURO-PSYCHOPH, V64, P285, DOI 10.1016/j.pnpbp.2015.06.001; Rayman M, 2002, LANCET, V379, P1256; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Salim S, 2014, CURR NEUROPHARMACOL, V12, P140, DOI 10.2174/1570159X11666131120230309; Savegnago L, 2008, PHARMACOL BIOCHEM BE, V88, P418, DOI 10.1016/j.pbb.2007.09.015; Savegnago L, 2016, RSC ADV, V6, P8021, DOI 10.1039/c5ra22445d; Schechter Lee E, 2005, NeuroRx, V2, P590, DOI 10.1602/neurorx.2.4.590; Scorza MC, 2012, BRIT J PHARMACOL, V167, P1021, DOI 10.1111/j.1476-5381.2011.01770.x; Sorensen L, 2012, J BIOL CHEM, V287, P43694, DOI 10.1074/jbc.M112.342212; Sylte I, 2001, EUR J PHARMACOL, V416, P33, DOI 10.1016/S0014-2999(01)00860-3; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; URSINI F, 1987, CHEM PHYS LIPIDS, V44, P255, DOI 10.1016/0009-3084(87)90053-3; Victoria FN, 2014, EUR J PHARMACOL, V742, P131, DOI 10.1016/j.ejphar.2014.09.005; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; World Health Organization, 2012, DEPRESSION GLOBAL PU; Yankelevitch-Yahav R, 2015, J VISUALIZED EXPT JO; Zheng W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120080; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	77	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187445	10.1371/journal.pone.0187445	http://dx.doi.org/10.1371/journal.pone.0187445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091968	gold, Green Submitted, Green Published			2022-12-27	WOS:000414229700067
J	Xu, J; Sun, YX; Wu, TY; Wang, B; Liu, Y; Zhang, JF; Lee, WY; Kang, QL; Chai, YM; Li, G				Xu, Jia; Sun, Yuxin; Wu, Tianyi; Wang, Bin; Liu, Yang; Zhang, Jinfang; Lee, Wayne Yukwai; Kang, Qinglin; Chai, Yimin; Li, Gang			Porcine brain extract promotes osteogenic differentiation of bone marrow derived mesenchymal stem cells and bone consolidation in a rat distraction osteogenesis model	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MANDIBULAR DISTRACTION; MASS; CARTILAGE; TISSUE; BETA; MICE	Distraction osteogenesis (DO) is the gold standard to treat large bone defects, but long consolidation period is a major limitation. Innovative efforts to promote osteogenesis are needed. Porcine brain extract (PBE) was reported to enhance the proliferation and differentiation of multiple primary cells. In this study, we aimed to develop a method for collecting PBE and investigate its effects on osteogenic differentiation of rat bone marrow derived mesenchymal stem cells (rBMSCs) and bone consolidation in a rat DO model. The PBE was collected from neonatal brain tissues of porcine fetus and was used to treat rBMSCs. Following PBE treatment (700 ng/ml), osteogenic differentiation was assessed. Further, we locally injected PBE (7 fag/ml, 100p1) or PBS (100p1) into the gap in a Sprague-Dawley (SD) male rat DO model every three days till termination. X-rays, micro-computed tomography, mechanical testing, histology and immunohischemistry examinations were used to exam the quality of the regenerates. The alkaline phosphatase, calcium deposits, and steogenic markers in the PBE treated rBMSCs were significantly increased. In the rat model, new bone properties of bone volume/total tissue volume and mechanical strength were higher in the PBE treated group. Histological analysis also confirmed more mineralized bone after PBE treatment. The current study reports a standard protocol for PBE collection and demonstrated its positive effects on osteogenic differentiation and bone consolidation in DO. Since the PBE is readily available and very cost effective, PBE may be a potential new biosource to promote bone formation in patients undergo DO treatment.	[Xu, Jia; Wu, Tianyi; Kang, Qinglin; Chai, Yimin] Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Peoples Hosp 6, Shanghai, Peoples R China; [Sun, Yuxin; Wang, Bin; Liu, Yang; Zhang, Jinfang; Lee, Wayne Yukwai; Li, Gang] Chinese Univ Hong Kong, Stem Cells & Regenerat Lab, Dept Orthopaed &Traumatol, Li Ka Shing Inst Hlth Sci,Fac Med,Prince Wales Ho, Shatin, Hong Kong, Peoples R China; [Zhang, Jinfang; Li, Gang] Chinese Univ Hong Kong, Shenzhen Res Inst, CUHK ACC Space Med Ctr, Shenzhen, Peoples R China	Shanghai Jiao Tong University; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Chai, YM (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Peoples Hosp 6, Shanghai, Peoples R China.; Li, G (corresponding author), Chinese Univ Hong Kong, Stem Cells & Regenerat Lab, Dept Orthopaed &Traumatol, Li Ka Shing Inst Hlth Sci,Fac Med,Prince Wales Ho, Shatin, Hong Kong, Peoples R China.; Li, G (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, CUHK ACC Space Med Ctr, Shenzhen, Peoples R China.	ymchai@sjtu.edu.cn; gangli@cuhk.edu.hk	WANG, BIN/O-2346-2019; Li, Gang/J-7830-2018; Lee, Wayne YW/H-8298-2013	WANG, BIN/0000-0002-1348-1494; Li, Gang/0000-0002-3981-2239; Lee, Wayne YW/0000-0002-0486-360X; Kang, Qinglin/0000-0001-9825-0451	National Natural Science Foundation of China [81572122, 81371946, 81430049, 81772322]; Hong Kong Government Research Grant Council, General Research Fund [14119115, 14160917, 9054014 N_CityU102/15, T12-402/17-N]; Hong Kong Innovation Technology Commission Funding [ITS/UIM-305]; China Shenzhen City Science and Technology Bureau [JCYJ20150630165236960]; SMART program, Lui Che Woo Institute of Innovative Medicine; Chinese University of Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Government Research Grant Council, General Research Fund; Hong Kong Innovation Technology Commission Funding; China Shenzhen City Science and Technology Bureau; SMART program, Lui Che Woo Institute of Innovative Medicine; Chinese University of Hong Kong(Chinese University of Hong Kong)	The work was partially supported by grants from National Natural Science Foundation of China (81572122, 81371946, 81430049 and 81772322); Hong Kong Government Research Grant Council, General Research Fund (14119115, 14160917, 9054014 N_CityU102/15 and T12-402/17-N); Hong Kong Innovation Technology Commission Funding (ITS/UIM-305) and grants from China Shenzhen City Science and Technology Bureau (JCYJ20150630165236960). This study was also supported in part by SMART program, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong and the research was made possible by resources donated by Lui Che Woo Foundation Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour A, 2008, BONE, V42, P98, DOI 10.1016/j.bone.2007.08.031; Asawa Y, 2004, J ELECTRON MICROSC, V53, P423, DOI 10.1093/jmicro/dfh057; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Bais MV, 2009, BONE, V45, P254, DOI 10.1016/j.bone.2009.04.239; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Camerino C, 2012, ENDOCRINOLOGY, V153, P5394, DOI 10.1210/en.2012-1378; Carvalho RS, 2004, BONE, V34, P849, DOI 10.1016/j.bone.2003.12.027; Chan CW, 2006, J ORTHOP RES, V24, P2072, DOI 10.1002/jor.20258; Chen Y, 2015, OSTEOARTHR CARTILAGE, V23, P1728, DOI 10.1016/j.joca.2015.05.018; Cruz R, 1998, REV NEUROLOGIA, V26, P551, DOI 10.33588/rn.26152.98025; Duque G, 2011, J BONE MINER RES, V26, P1472, DOI 10.1002/jbmr.350; Duque G, 2009, STEM CELLS, V27, P550, DOI 10.1634/stemcells.2008-0886; El-Alfy B, 2010, INT ORTHOP, V34, P115, DOI 10.1007/s00264-008-0574-3; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Farhadieh RD, 1999, J CRANIOFAC SURG, V10, P80, DOI 10.1097/00001665-199901000-00016; Gonzalez C, 1998, CELL MOL BIOL, V44, P1117; GOSPODAROWICZ D, 1984, P NATL ACAD SCI-BIOL, V81, P6963, DOI 10.1073/pnas.81.22.6963; Hao YJ, 2007, BONE, V41, P631, DOI 10.1016/j.bone.2007.06.006; HARRISON G, 1995, J BONE MINER RES, V10, P568, DOI 10.1002/jbmr.5650100409; He YX, 2011, BONE, V48, P1388, DOI 10.1016/j.bone.2011.03.720; HutterPaier B, 1996, J NEURAL TRANSM-SUPP, P267; Jinatta J., 2009, AM J APPL SCI, V6, P1662, DOI DOI 10.3844/AJASSP.2009.1662.1668; Kode A, 2012, J CLIN INVEST, V122, P3490, DOI 10.1172/JCI64906; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Koroleva VI, 1999, BRAIN RES, V816, P618, DOI 10.1016/S0006-8993(98)01246-3; Lee KH, 2013, J ANIM SCI, V91, P2405, DOI 10.2527/jas.2012-5208; Li G, 1997, J ORTHOP RES, V15, P765, DOI 10.1002/jor.1100150520; Liu Z, 1999, HISTOL HISTOPATHOL, V14, P587, DOI 10.14670/HH-14.587; Ma DY, 2013, J ORTHOP RES, V31, P1082, DOI 10.1002/jor.22336; Masi L, 2012, CLIN CASES MINER BON, V9, P13; McCarthy JG, 2002, PLAST RECONSTR SURG, V110, P1704, DOI 10.1097/00006534-200212000-00013; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Niedzwiedzki T, 2015, J MOL ENDOCRINOL, V55, pR23, DOI 10.1530/JME-15-0067; Ornitz DM, 2001, GENOME BIOL, V2; PALEY D, 1990, CLIN ORTHOP RELAT R, P81; Perrien DS, 2002, J PHARMACOL EXP THER, V303, P904, DOI 10.1124/jpet.102.039636; Srcek VG, 2009, IN VITRO CELL DEV-AN, V45, P28, DOI 10.1007/s11626-008-9148-3; Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276; Sun YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00466-4; Sun YX, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/412327; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Xu LL, 2012, INT J BIOCHEM CELL B, V44, P612, DOI 10.1016/j.biocel.2011.12.018; Yeung HY, 2001, CLIN ORTHOP RELAT R, P219	44	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187362	10.1371/journal.pone.0187362	http://dx.doi.org/10.1371/journal.pone.0187362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091962	Green Submitted, gold, Green Published			2022-12-27	WOS:000414229700060
J	Amorim, JL; Figueiredo, JD; Amaral, ACF; Barros, EGD; Palmero, C; MPalantinos, MA; Ramos, AD; Ferreira, JLP; Silva, JRD; Benjamim, CF; Basso, SL; Nasciutti, LE; Fernandes, PD				Amorim, Jorge Luis; Figueiredo, Janaina de Barros; Fernandes Amaral, Ana Claudia; de Oliveira Barros, Eliane Gouvea; Palmero, Celia; MPalantinos, Maria Athana; Ramos, Aline de Souza; Pinto Ferreira, Jose Luiz; de Andrade Silva, Jefferson Rocha; Benjamim, Claudia Farias; Basso, Silvia Luciane; Nasciutti, Luiz Eurico; Fernandes, Patricia Dias			Wound healing properties of Copaifera paupera in diabetic mice	PLOS ONE			English	Article							MULTIJUGA HAYNE; COPAIBA OILS; EXTRACELLULAR-MATRIX; RETICULATA DUCKE; GROWTH-FACTORS; VENOUS ULCERS; OLEORESIN; RATS; FRACTIONS; CYTOKINES	Copaifera oleoresin is one of the most used natural products in popular medicine all over the world. Among other effects (i.e., anti-inflammatory, antinociceptive, microbicidal) one of the most well-known is its wound healing capacity. However, the mechanism by which the oleoresin presents its effect is still not clear. In this study, our aim was to evaluate the wound healing capacity of oleoresin obtained from Copaifera paupera, its mechanism of action and identify its major components. For these purposes, diabetic Swiss Webster mice were topically treated with oleoresin (100, 150 or 200 mg/kg) for 14 consecutive days after an excision was performed in the back of the mice. Cytokines, wound retraction and histological evaluation were conducted at 3, 7 and 10 days (for cytokines); 0, 3, 7, 10 and 14 days (for wound retraction); and 7 and 14 days (for histological evaluation). Our data indicate that oleoresin significantly reduced production of MCP-1 and TNF-alpha at days 7 and 10 post-excision and increased IL-10 production at both days. All treatments demonstrated an effect similar or higher to that in collagenase-treated mice. Histological evaluations demonstrated that higher dose treatment resulted in better resolution and closure of the wound and higher levels of collagen deposition and indexes of re-epithelialization even when compared with the collagenase-treated group. The treatment with oleoresin from Copaifera paupera demonstrated that it is even better than an ointment routinely used for improvement of wound healing, suggesting this oleoresin as an option for use in diabetic patients.	[Amorim, Jorge Luis; Fernandes, Patricia Dias] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil; [Figueiredo, Janaina de Barros; Benjamim, Claudia Farias] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Fernandes Amaral, Ana Claudia; MPalantinos, Maria Athana; Ramos, Aline de Souza; Pinto Ferreira, Jose Luiz; de Andrade Silva, Jefferson Rocha] Fiocruz MS, Farmanguinhos, Rio De Janeiro, Brazil; [de Oliveira Barros, Eliane Gouvea; Palmero, Celia; Nasciutti, Luiz Eurico] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Interacoes Celulares, Rio De Janeiro, Brazil; [Basso, Silvia Luciane] Univ Fed Amazonas, Dept Quim, Lab Cromatog, Manaus, Amazonas, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal de Amazonas	Fernandes, PD (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil.	patricia.dias@icb.ufrj.br	Fernandes, Patricia Dias/W-1565-2019; Amaral, Ana/Y-7832-2018; SILVA, JEFFERSON RA/A-6845-2008; Benjamim, Claudia/T-5090-2019; Ramos, Aline de Souza/M-1575-2018	Fernandes, Patricia Dias/0000-0001-6870-6745; Benjamim, Claudia/0000-0001-6247-9596; Ramos, Aline de Souza/0000-0002-3478-1904; Fernandes AMARAL, ANA CLAUDIA/0000-0002-2532-471X; SILVA, JEFFERSON/0000-0003-2569-1306; Barros, Janaina/0000-0002-3642-3035; Gouvea de Oliveira Barros, Eliane/0000-0002-0020-6653; Ferreira, Jose Luiz Pinto/0000-0003-1027-9861	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303033/2013-4, 405332/20165]; Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/203.018/2015]; Conselho de Administracao de Pessoal de Ensino Superior (CAPES); FAPEAM (REDEBIO); FAPEAM (PAPAC)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho de Administracao de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEAM (REDEBIO); FAPEAM (PAPAC)	We would like to thank Mr. Alan Minho for technical assistance, Institute Vital Brazil (Niteroi City, Brazil) for mouse donation and Prof. Fabio Boylan (Trinity University, Dublin) for English revision. This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant support and fellowship #303033/2013-4 and 405332/20165 to PDF), Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ, grant support #E-26/203.018/2015 to PDF), Conselho de Administracao de Pessoal de Ensino Superior (CAPES, fellowship to JLA) and FAPEAM (REDEBIO and PAPAC projects, fellowship to SLB).	[Anonymous], [No title captured]; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Comelli E, 2010, ACTA CIR BRAS, V25, P362, DOI 10.1590/S0102-86502010000400012; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Gomes ND, 2008, J ETHNOPHARMACOL, V119, P179, DOI 10.1016/j.jep.2008.06.033; Gomes ND, 2010, J ETHNOPHARMACOL, V128, P177, DOI 10.1016/j.jep.2010.01.005; Gomes NM, 2007, J ETHNOPHARMACOL, V109, P486, DOI 10.1016/j.jep.2006.08.018; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; Herrero-Jauregui C, 2011, CHEM BIODIVERS, V8, P674, DOI 10.1002/cbdv.201000258; HERRICK SE, 1992, AM J PATHOL, V141, P1085; Lee K, 2015, ORIENTAL PHARM EXP M, V15, P1, DOI 10.1007/s13596-014-0159-1; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Martins-da-Silva Regina C. V., 2008, Rodriguésia, V59, P455, DOI 10.1590/2175-7860200859304; Nogueira E. de O., 2012, Brazilian Journal of Veterinary Research and Animal Science, V49, P293, DOI 10.11606/issn.1678-4456.v49i4p293-300; Paiva LAF, 2002, PHYTOTHER RES, V16, P737, DOI 10.1002/ptr.1049; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Ram M, 2015, EUR J PHARMACOL, V764, P9, DOI 10.1016/j.ejphar.2015.06.029; Souza Barbosa PC, 2013, CHEM BIODIVERS, V10, P1350, DOI 10.1002/cbdv.201200356; Tincusi BM, 2002, PLANTA MED, V68, P808, DOI 10.1055/s-2002-34399; Veiga VF, 2007, J ETHNOPHARMACOL, V112, P248, DOI 10.1016/j.jep.2007.03.005; Veiga-Junior VF, 2011, PHYTOTHER RES, V15, P476; Vieira RC, 2008, PESQUISA VET BRASIL, V28, P358, DOI 10.1590/S0100-736X2008000800002; Westphal Fernando Luiz, 2007, Rev. Col. Bras. Cir., V34, P170; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Zoghbi MDB, 2009, J ESSENT OIL RES, V21, P403	25	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187380	10.1371/journal.pone.0187380	http://dx.doi.org/10.1371/journal.pone.0187380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088304	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900078
J	Schumacher, J; Diercke, M; Salmon, M; Czogiel, I; Schumacher, D; Claus, H; Gilsdorf, A				Schumacher, Jakob; Diercke, Michaela; Salmon, Maelle; Czogiel, Irina; Schumacher, Dirk; Claus, Hermann; Gilsdorf, Andreas			Timeliness in the German surveillance system for infectious diseases: Amendment of the infection protection act in 2013 decreased local reporting time to 1 day	PLOS ONE			English	Article							OUTBREAK	Time needed to report surveillance data within the public health service delays public health actions. The amendment to the infection protection act (IfSG) from 29 March 2013 requires local and state public health agencies to report surveillance data within one working day instead of one week. We analysed factors associated with reporting time and evaluated the IfSG amendment. Local reporting time is the time between date of notification and date of export to the state public health agency and state reporting time is time between date of arrival at the state public health agency and the date of export. We selected cases reported between 28 March 2012 and 28 March 2014. We calculated the median local and state reporting time, stratified by potentially influential factors, computed a negative binominal regression model and assessed quality and workload parameters. Before the IfSG amendment the median local reporting time was 4 days and 1 day afterwards. The state reporting time was 0 days before and after. Influential factors are the individual local public health agency, the notified disease, the notification software and the day of the week. Data quality and workload parameters did not change. The IfSG amendment has decreased local reporting time, no relevant loss of data quality or identifiable workload-increase could be detected. State reporting time is negligible. We recommend efforts to harmonise practices of local public health agencies including the exclusive use of software with fully compatible interfaces.	[Schumacher, Jakob; Diercke, Michaela; Salmon, Maelle; Czogiel, Irina; Schumacher, Dirk; Claus, Hermann; Gilsdorf, Andreas] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany	Robert Koch Institute	Schumacher, J (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	jakob.schumacher@web.de		Diercke, Michaela/0000-0002-4678-1813; Schumacher, Jakob/0000-0002-9894-6085; Claus, Hermann/0000-0002-0120-1846; Salmon, Maelle/0000-0002-2815-0399; Gilsdorf, Andreas/0000-0001-8572-2798				Altmann M, 2011, EMERG INFECT DIS, V17, P1906, DOI 10.3201/eid1710.111027; Benzler J, 2014, HYGIENEINSPEKTOR, V2014, P9; Bernard H, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.8.20719; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Faensen D, 2006, Euro Surveill, V11, P100, DOI 10.2807/esm.11.04.00614-en; Freeman R, 2013, J INFECTION, V67, P378, DOI 10.1016/j.jinf.2013.07.021; Jones G, 2014, EUROSURVEILLANCE, V19, P19, DOI 10.2807/1560-7917.ES2014.19.1.20664; Robert Koch Institute, 2015, INFEKTIONSEPIDEMIOLO; Salmon M, 2016, EUROSURVEILLANCE, V21, P47, DOI 10.2807/1560-7917.ES.2016.21.13.30180; Samoff E, 2013, PUBLIC HEALTH REP, V128, P51; The R Foundation for Statistical Computing, FIRE SAFETY; Venables WN., 2002, MODERN APPL STAT S; Wald A, 1939, ANN MATH STAT, V10, P105, DOI 10.1214/aoms/1177732209; Yoo HS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-93	14	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187037	10.1371/journal.pone.0187037	http://dx.doi.org/10.1371/journal.pone.0187037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088243	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900037
J	Cherney, D; Perkins, BA; Lytvyn, Y; Heerspink, H; Rodriguez-Ortie, ME; Mischak, H				Cherney, David; Perkins, Bruce A.; Lytvyn, Yuliya; Heerspink, Hiddo; Rodriguez-Ortie, Maria E.; Mischak, Harald			The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY-DISEASE; MASS-SPECTROMETRY; DIABETES-MELLITUS; DIAGNOSIS; PEPTIDES; PROGRESSION; BIOMARKERS	Treatment with empagliflozin, an inhibitor of the sodium/glucose cotransporter 2 (SGLT2), is associated with slower progression of diabetic kidney disease. In this analysis, we explored the hypothesis that empagliflozin may have an impact on urinary peptides associated with chronic kidney disease (CKD). In this post-hoc, exploratory analysis, we investigated urine samples obtained from 40 patients with uncomplicated type 1 diabetes (T1D) before and after treatment with empagliflozin for 8 weeks to for significant post-therapy changes in urinary peptides. We further assessed the association of these changes with CKD in an independent cohort, and with a previously established urinary proteomic panel, termed CKD273. 107 individual peptides significantly changed after treatment. The majority of the empagliflozin-induced changes were in the direction of "CKD absent" when compare to patients with CKD and controls. A classifier consisting of these 107 peptides scored significantly different in controls, in comparison to CKD patients. However, empagliflozin did not impact the CKD273 classifier. Our data indicate that empagliflozin induces multiple significant changes in the urinary proteomic markers such as mucin and clusterin. The relationship between empagliflozin-induced proteomic changes and clinical outcomes merits further investigation.	[Cherney, David; Lytvyn, Yuliya] Univ Toronto, Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; [Perkins, Bruce A.] Univ Toronto, Univ Hlth Network, Div Endocrinol, Toronto, ON, Canada; [Heerspink, Hiddo] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [Rodriguez-Ortie, Maria E.] Univ Autonoma Madrid, REDinREN, Inst Invest Sanitaria, Fdn Jimenez Diaz,Fdn Renal Inigo Alvarez de Toled, Madrid, Spain; [Mischak, Harald] Mosa Diagnost GmbH, Hannover, Germany; [Mischak, Harald] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Groningen; Autonomous University of Madrid; Fundacion Jimenez Diaz; Modular Open Systems Approach (MOSA) Solutions; University of Glasgow	Mischak, H (corresponding author), Mosa Diagnost GmbH, Hannover, Germany.; Mischak, H (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland.	mischak@mosaiques-diagnostics.com	Heerspink, Hiddo J Lambers/K-3358-2014; Perkins, Bruce A/L-3726-2017	Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Mischak, Harald/0000-0003-0323-0306	Janssen; Boehringer Ingelheim-Eli Lilly; AstraZeneca; Merck; Sanofi; Boehringer Ingelheim	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boehringer Ingelheim-Eli Lilly; AstraZeneca(AstraZeneca); Merck(Merck & Company); Sanofi; Boehringer Ingelheim(Boehringer Ingelheim)	DC has received consulting fees or speaking honorarium or both from Janssen, Boehringer Ingelheim-Eli Lilly, AstraZeneca, Merck, Sanofi, and his institution has received operating funding from Janssen, Boehringer Ingelheim-Eli Lilly, AstraZeneca, Merck. HM is the co-founder and co-owner of Mosaiques Diagnostics. BAP has received fees for continuing medical education events from Janssen and Boehringer Ingelheim, has served as an advisor for Boehringer Ingelheim, and his research institute has received research grants on his behalf from Boehringer Ingelheim. The funder provided support in the form of salaries for author HM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen S, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-29; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Dakna M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-594; Girolami Mark, 2006, Drug Discov Today Technol, V3, P13, DOI 10.1016/j.ddtec.2006.03.010; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kaiser T, 2003, J CHROMATOGR A, V1013, P157, DOI 10.1016/S0021-9673(03)00712-X; Klein J, 2014, ELECTROPHORESIS, V35, P1060, DOI 10.1002/elps.201300327; Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103; Mischak H, 2015, NAT REV NEPHROL, V11, P221, DOI 10.1038/nrneph.2014.247; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2009, J MED BIOCHEM, V28, P223, DOI 10.2478/v10011-009-0020-0; Nkuipou-Kenfack E, 2015, ONCOTARGET, V6, P34106, DOI 10.18632/oncotarget.5896; Pontillo C, 2017, KIDNEY INT IN PRESS; Pontillo C, 2016, NEPHROL DIAL TRANSPL; Pontillo C, 2017, CLIN KIDNEY J, V10, P192, DOI 10.1093/ckj/sfx002; Schanstra JP, 2015, J AM SOC NEPHROL, V26, P1999, DOI 10.1681/ASN.2014050423; Silva S, 2015, AM J CLIN NUTR, V101, P44, DOI 10.3945/ajcn.114.094219; Stalmach A, 2013, ELECTROPHORESIS, V34, P1452, DOI 10.1002/elps.201200708; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Zhang ZH, 2017, STRUCT BOND, V173, P1, DOI 10.1007/430_2016_12; Zimmerli LU, 2008, MOL CELL PROTEOMICS, V7, P290, DOI 10.1074/mcp.M700394-MCP200	26	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186910	10.1371/journal.pone.0186910	http://dx.doi.org/10.1371/journal.pone.0186910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084249	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000413910200018
J	Ebata-Kogure, N; Nozawa, K; Murakami, A; Toyoda, T; Haga, Y; Fujii, K				Ebata-Kogure, Nozomi; Nozawa, Kazutaka; Murakami, Aya; Toyoda, Tetsumi; Haga, Yuri; Fujii, Koichi			Clinical and economic burdens experienced by patients with painful diabetic peripheral neuropathy: An observational study using a Japanese claims database	PLOS ONE			English	Article							INSURED PATIENTS; FOOT CARE; HEALTH; POLYNEUROPATHY; COMPLICATIONS; DIAGNOSIS; COMMUNITY; DISEASE; PEOPLE	Background Diabetic peripheral neuropathy (DPN) may often be painful. Despite the high prevalence of painful DPN (pDPN) among patients with diabetes mellitus (DM), understanding of its clinical and economic burden is limited. This study aimed to describe the clinical and economic burdens faced by patients with pDPN in Japan, and compared them with those experienced by patients with DPN but without painful symptoms (non-pDPN). Methods This retrospective, observational study used data from a large-scale, hospital-based Japanese claims database collected from April 2008 to June 2015. Comorbidities, clinical departments visited, length of hospital stay, and medical costs for the period of +/- 6 months from the diagnosis of pDPN or non-pDPN were described for each group. Glycemic control status was examined for each group for patients with glycated hemoglobin data. Results The data of 8,740 patients with pDPN (mean age 70.0 years, 53.4% male) and 12,592 patients with non-pDPN (mean age 67.7 years, 55.7% male) were analyzed. Patients with pDPN had more comorbidities than patients with non-pDPN; 48.7% and 30.9% of patients in the respective groups had 20 or more comorbidities. The median length of hospital stay was 5 days longer in patients with pDPN. The median total medical costs were higher in patients with pDPN (\517,762) than in patients with non-pDPN (\359,909). Patients with pDPN spent higher median costs for medications, but the costs for glycemic control drugs were similar in both groups. For 3,372 patients with glycated hemoglobin data, glycemic control was similar between the two groups. Conclusion Patients with pDPN experienced greater clinical and economic burdens than patients with non-pDPN, suggesting that patients who develop pDPN may suffer not only from the complications of DM and pain, but also from other comorbid disorders.	[Ebata-Kogure, Nozomi; Nozawa, Kazutaka; Fujii, Koichi] Pfizer Japan, Tokyo, Japan; [Ebata-Kogure, Nozomi; Nozawa, Kazutaka; Fujii, Koichi] Aichi Med Univ, Sch Med, Dept Publ Hlth, Nagakute, Aichi, Japan; [Murakami, Aya; Toyoda, Tetsumi; Haga, Yuri] Clinical Study Support Inc, Nagoya, Aichi, Japan	Pfizer; Aichi Medical University	Ebata-Kogure, N (corresponding author), Pfizer Japan, Tokyo, Japan.; Ebata-Kogure, N (corresponding author), Aichi Med Univ, Sch Med, Dept Publ Hlth, Nagakute, Aichi, Japan.	nozomi.ebata@pfizer.com		Ebata-Kogure, Nozomi/0000-0003-3842-2578; Nozawa, Kazutaka/0000-0003-4245-2657	Pfizer Japan Inc.	Pfizer Japan Inc.(Pfizer)	This study was funded by Pfizer Japan Inc. Pfizer Japan Inc. provided support in the form of salaries for authors NE, KN, and KF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Clinical Study Support, Inc. provided support in the form of salaries for authors AM, TT, and YH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbott CA, 2002, DIABETIC MED, V19, P377, DOI 10.1046/j.1464-5491.2002.00698.x; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Benbow SJ, 1998, QJM-INT J MED, V91, P733, DOI 10.1093/qjmed/91.11.733; Berger A, 2004, J PAIN, V5, P143, DOI 10.1016/j.jpain.2003.12.004; Booya F, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-24; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Callaghan BC, 2012, CURR OPIN NEUROL, V25, P536, DOI 10.1097/WCO.0b013e328357a797; Chang CH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002040; Daousi C, 2004, DIABETIC MED, V21, P976, DOI 10.1111/j.1464-5491.2004.01271.x; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6; Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009; Goto Y., 2002, J JAPAN PHYS ASS, V17, P125; Gregg EW, 2004, DIABETES CARE, V27, P1591, DOI 10.2337/diacare.27.7.1591; Ikeda S, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1264-2; Johnston SS, 2014, PAIN MED, V15, P562, DOI 10.1111/pme.12328; Katz DA, 1998, ARCH INTERN MED, V158, P1099, DOI 10.1001/archinte.158.10.1099; Mayfield JA, 1998, DIABETES CARE, V21, P2161, DOI 10.2337/diacare.21.12.2161; Mehra Maneesha, 2014, J Med Econ, V17, P637, DOI 10.3111/13696998.2014.928639; Ogino Mieko, 2016, Clin Exp Neuroimmunol, V7, P158; Oz SG, 2006, J NATL MED ASSOC, V98, P1598; PELTIER A, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G3440; Sadosky A, 2014, PATIENT, V7, P107, DOI 10.1007/s40271-013-0038-8; Satoh Jo, 2007, Journal of the Japan Diabetes Society, V50, P799; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Suzuki Yoshinori, 2005, Nihon Koshu Eisei Zasshi, V52, P652; Tajima N, 2015, J JPN DIABET SOC, V58, P346; Tajima N, 2003, JAPANESE J JPN DIABE, V46, P301; Tesfaye S, 2011, DIABETES-METAB RES, V27, P629, DOI 10.1002/dmrr.1225; Tsuji M, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/318352; Zhao Y, 2009, CURR MED RES OPIN, V25, P585, DOI 10.1185/03007990802706289 	31	12	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187250	10.1371/journal.pone.0187250	http://dx.doi.org/10.1371/journal.pone.0187250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077757	gold, Green Published, Green Submitted			2022-12-27	WOS:000413861200055
J	Sultana, J; Calabro, M; Garcia-Serna, R; Ferrajolo, C; Crisafulli, C; Mestres, J; Trifiro, G				Sultana, Janet; Calabro, Marco; Garcia-Serna, Ricard; Ferrajolo, Carmen; Crisafulli, Concetta; Mestres, Jordi; Trifiro, Gianluca			Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses	PLOS ONE			English	Review							ACUTE KIDNEY INJURY; ATYPICAL ANTIPSYCHOTICS; ASPIRATION PNEUMONIA; COMPARATIVE SAFETY; ELDERLY-PATIENTS; OLDER-ADULTS; DRUG SAFETY; RISK; CLOZAPINE; MORTALITY	Introduction Antipsychotic (AP) safety has been widely investigated. However, mechanisms underlying AP-associated pneumonia are not well-defined. Aim The aim of this study was to investigate the known mechanisms of AP-associated pneumonia through a systematic literature review, confirm these mechanisms using an independent data source on drug targets and attempt to identify novel AP drug targets potentially linked to pneumonia. Methods A search was conducted in Medline and Web of Science to identify studies exploring the association between pneumonia and antipsychotic use, from which information on hypothesized mechanism of action was extracted. All studies had to be in English and had to concern AP use as an intervention in persons of any age and for any indication, provided that the outcome was pneumonia. Information on the study design, population, exposure, outcome, risk estimate and mechanism of action was tabulated. Public repositories of pharmacology and drug safety data were used to identify the receptor binding profile and AP safety events. Cytoscape was then used to map biological pathways that could link AP targets and off-targets to pneumonia. Results The literature search yielded 200 articles; 41 were included in the review. Thirty studies reported a hypothesized mechanism of action, most commonly activation/inhibition of cholinergic, histaminergic and dopaminergic receptors. In vitro pharmacology data confirmed receptor affinities identified in the literature review. Two targets, thromboxane A2 receptor (TBXA2R) and platelet activating factor receptor (PTAFR) were found to be novel AP target receptors potentially associated with pneumonia. Biological pathways constructed using Cytoscape identified plausible biological links potentially leading to pneumonia downstream of TBXA2R and PTAFR. Conclusion Innovative approaches for biological substantiation of drug-adverse event associations may strengthen evidence on drug safety profiles and help to tailor pharmacological therapies to patient risk factors. cholinergic, histaminergic and dopaminergic receptors. In vitro pharmacology data confirmed receptor affinities identified in the literature review. Two targets, thromboxane A2 receptor (TBXA2R) and platelet activating factor receptor (PTAFR) were found to be novel AP target receptors potentially associated with pneumonia. Biological pathways constructed using Cytoscape identified plausible biological links potentially leading to pneumonia downstream of TBXA2R and PTAFR. Conclusion Innovative approaches for biological substantiation of drug-adverse event associations may strengthen evidence on drug safety profiles and help to tailor pharmacological therapies to patient risk factors.	[Sultana, Janet; Calabro, Marco; Crisafulli, Concetta; Trifiro, Gianluca] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Sultana, Janet; Ferrajolo, Carmen; Trifiro, Gianluca] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Garcia-Serna, Ricard; Mestres, Jordi] Chemotargets SL, Baldiri Reixac Barcelona, PCB, Catalonia, Spain; [Ferrajolo, Carmen] Univ Campania L Vanvitelli, Dept Expt Med, Unit Clin Pharmacol, Campania Reg Ctr Pharmacovigilance & Pharmacoepid, Naples, Italy; [Mestres, Jordi] IMIM Hosp Mar Med Res Inst, Res Grp Syst Pharmacol, Res Program Biomed Informat GRIB, Catalonia, Spain; [Mestres, Jordi] Univ Pompeu Fabra, PRBB, Catalonia, Spain	University of Messina; Erasmus University Rotterdam; Erasmus MC; Universita della Campania Vanvitelli; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University	Trifiro, G (corresponding author), Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy.; Trifiro, G (corresponding author), Erasmus MC, Dept Med Informat, Rotterdam, Netherlands.	trifirog@unime.it	Sultana, Janet/Z-4817-2019; Mestres, Jordi/B-3673-2009	Mestres, Jordi/0000-0002-5202-4501; Calabro, Marco/0000-0003-2082-9855; Sultana, Janet/0000-0001-9622-169X	Italian Health Ministry in the context of the Project "Assessment of the safety of antipsychotic drugs in elderly with dementia: an international, population based study using healthcare databases" [GR-2009-1607316]	Italian Health Ministry in the context of the Project "Assessment of the safety of antipsychotic drugs in elderly with dementia: an international, population based study using healthcare databases"	I have read the journal's policy and the authors of this manuscript have the following competing interests: RGS and JM are employed by Chemotargets SL. The funder provided support in the form of salaries and the materials to conduct part of the present study for authors RGS and JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section. This study was published with financial support from by the Italian Health Ministry in the context of the Project "Assessment of the safety of antipsychotic drugs in elderly with dementia: an international, population based study using healthcare databases" [grant number GR-2009-1607316], of which GT is the grant holder. The Italian Health Ministry did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmawla N, 2009, BRIT J PSYCHIAT, V194, P468, DOI 10.1192/bjp.194.5.468a; Aparasu RR, 2013, ANN PHARMACOTHER, V47, P464, DOI 10.1345/aph.1R510; ARIMURA A, 1993, EUR J PHARMACOL, V231, P13, DOI 10.1016/0014-2999(93)90678-B; Barnett MJ, 2006, J CLIN PSYCHOPHARM, V26, P182, DOI 10.1097/01.jcp.0000203598.43314.34; Bauer-Mehren A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002457; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cyphert JM, 2012, AM J PHYSIOL-LUNG C, V302, pL140, DOI 10.1152/ajplung.00152.2011; Gambassi G, 2015, EXPERT OPIN DRUG SAF, V14, P1, DOI 10.1517/14740338.2015.984684; Garcia-Serna R, 2015, CHEM RES TOXICOL, V28, P1875, DOI 10.1021/acs.chemrestox.5b00260; Gau JT, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-45; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Hatta K, 2014, INT J GERIATR PSYCH, V29, P253, DOI 10.1002/gps.3999; Haupt M, 2006, J CLIN PSYCHOPHARM, V26, P566, DOI 10.1097/01.jcp.0000239796.21826.39; Hinkes R, 1996, J CLIN PSYCHOPHARM, V16, P462, DOI 10.1097/00004714-199612000-00013; Hung GCL, 2016, J CLIN PSYCHIAT, V77, P60, DOI 10.4088/JCP.14m09301; Huybrechts KF, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e977; Huybrechts KF, 2012, J AM GERIATR SOC, V60, P420, DOI 10.1111/j.1532-5415.2011.03853.x; Huybrechts KF, 2011, CAN MED ASSOC J, V183, pE411, DOI 10.1503/cmaj.101406; Iovino F, 2013, CELL MICROBIOL, V15, P870, DOI 10.1111/cmi.12129; Ishida T, 2011, PSYCHIAT CLIN NEUROS, V65, P526, DOI 10.1111/j.1440-1819.2011.02244.x; Jabeen S, 2006, ANN PHARMACOTHER, V40, P559, DOI 10.1345/aph.1G495; Jackson JW, 2015, EPIDEMIOLOGY, V26, P700, DOI 10.1097/EDE.0000000000000321; Jackson JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105376; Jiang YW, 2017, CNS DRUGS, V31, P319, DOI 10.1007/s40263-017-0421-4; Kim D.H, 2017, J AM GERIATR SOC; Kim SJ, 2014, RESP CARE, V59, pE145, DOI 10.4187/respcare.02977; Knol W, 2008, J AM GERIATR SOC, V56, P661, DOI 10.1111/j.1532-5415.2007.01625.x; KRUK J, 1995, J NEUROPSYCH CLIN N, V7, P223; Kuo CJ, 2013, SCHIZOPHRENIA BULL, V39, P648, DOI 10.1093/schbul/sbr202; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Leung J.G, 2016, PSYCHOSOMATICS; LIAM C K, 1990, SMJ Singapore Medical Journal, V31, P182; Liang Chih-Sung, 2011, J Psychiatry Neurosci, V36, pE1, DOI 10.1503/jpn.100133; Lorberbaum T, 2015, CLIN PHARMACOL THER, V97, P151, DOI 10.1002/cpt.2; Majumder S, 2009, NEUROL INDIA, V57, DOI 10.4103/0028-3886.55569; Mehta S, 2015, PHARMACOEPIDEM DR S, V24, P1271, DOI 10.1002/pds.3882; Mestres J, 2008, NAT BIOTECHNOL, V26, P983, DOI 10.1038/nbt0908-983; Nielsen J, 2009, EUR NEUROPSYCHOPHARM, V19, P483, DOI 10.1016/j.euroneuro.2009.03.002; Nose M, 2015, PHARMACOEPIDEM DR S, V24, P812, DOI 10.1002/pds.3804; Patel SS, 2011, THER ADV PSYCHOPHARM, V1, P25, DOI 10.1177/2045125311398284; Patel U, 2002, J NATL MED ASSOC, V94, P279; Pratt N, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-72; Pratt N, 2011, DRUG SAFETY, V34, P567, DOI 10.2165/11588470-000000000-00000; Rafaniello C, 2014, EUR J CLIN PHARMACOL, V70, P187, DOI 10.1007/s00228-013-1588-3; Remez N, 2016, CHEM RES TOXICOL, V29, P637, DOI 10.1021/acs.chemrestox.5b00470; Rizos E, 2013, IN VIVO, V27, P651; Ryan PB, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.52; Ryan PB, 2017, DRUG AGING, V34, P211, DOI 10.1007/s40266-016-0430-x; Schmidinger S, 2014, J CLIN PSYCHOPHARM, V34, P385, DOI 10.1097/JCP.0000000000000124; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Star K, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X532396; Steinberg M, 2012, AM J PSYCHIAT, V169, P900, DOI 10.1176/appi.ajp.2012.12030342; Tolppanen AM, 2016, CHEST, V150, P1233, DOI 10.1016/j.chest.2016.06.004; Trifiro G, 2014, DRUG SAFETY, V37, P501, DOI 10.1007/s40264-014-0170-y; Trifiro Gianluca, 2011, Curr Infect Dis Rep, V13, P262, DOI 10.1007/s11908-011-0175-y; Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006; Trifiro G, 2009, PHARMACOL RES, V59, P1, DOI 10.1016/j.phrs.2008.09.017; van der Maarel-Wierink CD, 2011, J AM MED DIR ASSOC, V12, P344, DOI 10.1016/j.jamda.2010.12.099; Voulgari C, 2015, CASE REP MED, V2015, DOI 10.1155/2015/703218; Wang PS, 2007, J CLIN PSYCHOPHARM, V27, P707, DOI 10.1097/JCP.0b013e31815a882b; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yang SY, 2013, J CLIN PSYCHIAT, V74, pE79, DOI 10.4088/JCP.12m07938	64	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187034	10.1371/journal.pone.0187034	http://dx.doi.org/10.1371/journal.pone.0187034			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077727	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200037
J	Fink, A; Buchmann, N; Tegeler, C; Steinhagen-Thiessen, E; Demuth, I; Doblhammer, G				Fink, Anne; Buchmann, Nikolaus; Tegeler, Christina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja; Doblhammer, Gabriele			Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community dwelling elderly population in Germany	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEUROPSYCHOLOGICAL ASSESSMENT; UNITED-STATES; LIFE-STYLE; DEMENTIA; PREVALENCE; RISK; IMPAIRMENT; TRENDS; METAANALYSIS	Aims/Hypothesis The increasing number of people with dementia and cognitive impairments makes it essential to detect and prevent modifiable risk factors of dementia. This study focuses on type 2 diabetes mellitus, especially on undiagnosed cases and their increased risk of cognitive impairment. Furthermore, the potential of physical activity and social integration to moderate the relation between diabetes and cognitive impairment is assessed. Methods We used cross-sectional data from 1299 participants of the Berlin Aging Study II (BASE-II) aged between 60 to 84 years and performed logistic regression models to analyze the association of diabetes status, physical activity, and cohabitation status with poor cognitive performance. Cognitive performance was measured with the Consortium to Establish a Registry for Alzheimer's Disease (CERAD)-Plus test battery. Results Undiagnosed diabetes (odds ratio (OR) = 2.12, p = 0.031), physical inactivity (OR = 1.43, p = 0.008) and non-cohabiting (OR = 1.58, p = 0.002) were associated with an increased likelihood of poor cognitive performance. The highest odds were observed in participants who suffered from undiagnosed or insulin-dependent diabetes and, in addition, were inactive (undiagnosed diabetes: OR = 3.44, p = 0.003; insulin-dependent diabetes: OR = 6.19, p = 0.019) or lived alone (undiagnosed diabetes: OR = 4.46, p = 0.006; insulin-dependent diabetes: OR = 6.46 p = 0.052). Physical activity and cohabiting appeared to be beneficial. Conclusions/Interpretation Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance. Special attention should be paid to undiagnosed and insulin-dependent diabetes cases, which have a particularly high risk of poor cognitive performance.	[Fink, Anne; Doblhammer, Gabriele] German Ctr Neurodegenerat Dis, Bonn, Germany; [Fink, Anne; Doblhammer, Gabriele] Rostock Ctr Study Demog Change, Rostock, Germany; [Buchmann, Nikolaus; Tegeler, Christina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Charite Univ Med Berlin, Interdisciplinary Metab Ctr, Lipid Clin, Berlin, Germany; [Buchmann, Nikolaus; Tegeler, Christina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Free Univ Berlin, Berlin, Germany; [Buchmann, Nikolaus; Tegeler, Christina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Humboldt Univ, Berlin, Germany; [Buchmann, Nikolaus; Tegeler, Christina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Berlin Inst Hlth, Berlin, Germany; [Buchmann, Nikolaus] Ernst Moritz Arndt Univ Greifswald, Klin & Poliklin Innere Med B, Greifswald, Germany; [Steinhagen-Thiessen, Elisabeth] Ernst Moritz Arndt Univ Greifswald, Bereich Geriatrie Univ Med Greifswald, Greifswald, Germany; [Doblhammer, Gabriele] Univ Rostock, Inst Sociol & Demog, Rostock, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University of Rostock	Fink, A (corresponding author), German Ctr Neurodegenerat Dis, Bonn, Germany.; Fink, A (corresponding author), Rostock Ctr Study Demog Change, Rostock, Germany.; Demuth, I (corresponding author), Charite Univ Med Berlin, Interdisciplinary Metab Ctr, Lipid Clin, Berlin, Germany.; Demuth, I (corresponding author), Free Univ Berlin, Berlin, Germany.; Demuth, I (corresponding author), Humboldt Univ, Berlin, Germany.; Demuth, I (corresponding author), Berlin Inst Hlth, Berlin, Germany.	anne.fink@dzne.de; iljademuth@charite.de	Demuth, Ilja/ABD-5352-2021; Buchmann, Nina/E-6095-2011	Demuth, Ilja/0000-0002-4340-2523; Buchmann, Nina/0000-0003-0826-2980; Buchmann, Nikolaus/0000-0002-4345-3515; Tegeler-Nonnen, Christina/0000-0002-8642-1142	German Federal Ministry of education and Research [BMBF] [16SV5536K]; German Center of Neurodegenerative Diseases (DZNE)	German Federal Ministry of education and Research [BMBF](Federal Ministry of Education & Research (BMBF)); German Center of Neurodegenerative Diseases (DZNE)(Helmholtz Association)	This study was funded by the German Federal Ministry of education and Research [BMBF (grant number #16SV5536K)] and the German Center of Neurodegenerative Diseases (DZNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Torres H, 1998, AM J PUBLIC HEALTH, V88, P1452, DOI 10.2105/AJPH.88.10.1452; Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Arrighi HM, 2010, ALZ DIS ASSOC DIS, V24, P90, DOI 10.1097/WAD.0b013e31819fe7d1; Baker LD, 2015, 8 CLIN TRIALS ALZHEI; Barberger-Gateau P, 2004, DEMENT GERIATR COGN, V18, P330, DOI 10.1159/000080127; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Bertram L, 2014, INT J EPIDEMIOL, V43, P703, DOI 10.1093/ije/dyt018; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chandler MJ, 2005, NEUROLOGY, V65, P102, DOI 10.1212/01.wnl.0000167607.63000.38; Chen L, 2015, METABOLISM, V64, P338, DOI 10.1016/j.metabol.2014.10.018; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Danaei G, 2015, LANCET DIABETES ENDO, V3, P624, DOI 10.1016/S2213-8587(15)00129-1; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Doblhammer G, 2013, GERIATRIC MENTAL HLT, V1, P29, DOI DOI 10.1016/J.GMHC.2013.04.002; Doblhammer G, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0146-x; Doblhammer G, 2015, ALZHEIMERS DEMENT, V11, P291, DOI 10.1016/j.jalz.2014.02.006; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Geda YE, 2010, ARCH NEUROL-CHICAGO, V67, P80, DOI 10.1001/archneurol.2009.297; Gerstorf D, 2016, GERONTOLOGY IN PRESS; Grodstein F, 2001, DIABETES CARE, V24, P1060, DOI 10.2337/diacare.24.6.1060; Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087; Hakansson K, 2009, BMJ, V339; Helmer C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b1690; Heneka MT, 2015, ANN NEUROL, V78, P284, DOI 10.1002/ana.24439; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lytle ME, 2004, ALZ DIS ASSOC DIS, V18, P57, DOI 10.1097/01.wad.0000126614.87955.79; Manton K C, 2005, Adv Gerontol, V16, P30; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Memory Clinic Basel, 2005, CERAD PLUS 2005; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Palta P, 2014, J INT NEUROPSYCH SOC, V20, P278, DOI 10.1017/S1355617713001483; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Seo EH, 2010, AM J GERIAT PSYCHIAT, V18, P801, DOI 10.1097/JGP.0b013e3181cab764; Topolski T. D., 2006, CTR DIS CONTROL PREV, V3, P1; University of Washington Health Promotion Research Center, 2015, PHYS ACT AR YOU ASS; van den Berg E, 2010, DIABETOLOGIA, V53, P58, DOI 10.1007/s00125-009-1571-9; van Gelder BM, 2006, J GERONTOL B-PSYCHOL, V61, pP213, DOI 10.1093/geronb/61.4.P213; Victor C., 2000, REV CLIN GERONTOL, V10, P407, DOI [10.1017/S0959259800104101, DOI 10.1017/S0959259800104101]; World Health Organization, 2017, BOD MASS IND BMI 201; Xu WL, 2009, DIABETOLOGIA, V52, P1031, DOI 10.1007/s00125-009-1323-x	53	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187119	10.1371/journal.pone.0187119	http://dx.doi.org/10.1371/journal.pone.0187119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073237	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400115
J	Naaman, H; Rall, G; Matullo, C; Veksler-Lublinsky, I; Shemer-Avni, Y; Gopas, J				Naaman, Hila; Rall, Glenn; Matullo, Christine; Veksler-Lublinsky, Isana; Shemer-Avni, Yonat; Gopas, Jacob			MiRNA-124 is a link between measles virus persistent infection and cell division of human neuroblastoma cells	PLOS ONE			English	Article							SUBACUTE SCLEROSING-PANENCEPHALITIS; HEPATOCELLULAR-CARCINOMA; NEURONAL DIFFERENTIATION; MESSENGER-RNA; BRAIN-TISSUES; CYCLE ARREST; MICRORNA; EXPRESSION; APOPTOSIS; REPLICATION	Measles virus (MV) infects a variety of lymphoid and non-lymphoid peripheral organs. However, in rare cases, the virus can persistently infect cells within the central nervous system. Although some of the factors that allow MV to persist are known, the contribution of host cell-encoded microRNAs (miRNA) have not been described. MiRNAs are a class of noncoding RNAs transcribed from genomes of all multicellular organisms and some viruses, which regulate gene expression in a sequence-specific manner. We have studied the contribution of host cell-encoded miRNAs to the establishment of MV persistent infection in human neuroblastoma cells. Persistent MV infection was accompanied by differences in the expression profile and levels of several host cell-encoded microRNAs as compared to uninfected cells. MV persistence infection of a human neuroblastoma cell line (UKF-NB-MV), exhibit high miRNA-124 expression, and reduced expression of cyclin dependent kinase 6 (CDK6), a known target of miRNA-124, resulting in slower cell division but not cell death. By contrast, acute MV infection of UKF-NB cells did not result in increased miRNA-124 levels or CDK6 reduction. Ectopic overexpression of miRNA-124 affected cell viability only in UKF-NB-MV cells, causing cell death; implying that miRNA-124 over expression can sensitize cells to death only in the presence of MV persistent infection. To determine if miRNA-124 directly contributes to the establishment of MV persistence, UKF-NB cells overexpressing miRNA-124 were acutely infected, resulting in establishment of persistently infected colonies. We propose that miRNA-124 triggers a CDK6-dependent decrease in cell proliferation, which facilitates the establishment of MV persistence in neuroblastoma cells. To our knowledge, this is the first report to describe the role of a specific miRNA in MV persistence.	[Naaman, Hila; Shemer-Avni, Yonat; Gopas, Jacob] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol & Genet, Beer Sheva, Israel; [Rall, Glenn; Matullo, Christine] Fox Chase Canc Ctr, Blood Cell Dev & Funct, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Veksler-Lublinsky, Isana] Ben Gurion Univ Negev, Software & Informat Syst Engn, Beer Sheva, Israel; [Shemer-Avni, Yonat] Soroka Univ Med Ctr, Clin Virol, Beer Sheva, Israel; [Gopas, Jacob] Soroka Univ Med Ctr, Dept Oncol, Beer Sheva, Israel	Ben Gurion University; Fox Chase Cancer Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Gopas, J (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol & Genet, Beer Sheva, Israel.; Gopas, J (corresponding author), Soroka Univ Med Ctr, Dept Oncol, Beer Sheva, Israel.	jacob@bgu.ac.il	Veksler-Lublinsky, Isana/AAF-2496-2019; AVNI, YONAT SHEMER/F-1772-2012	Veksler-Lublinsky, Isana/0000-0002-4251-6158; Matullo, Christine/0000-0003-1598-7007; Gopas, Jacob/0000-0001-9289-8898	NIH [R03 AI094164-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by NIH R03 AI094164-01A1 to Glenn Rall and Jacob Gopas, https://grants.nih.gov/grants/funding/r03.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Richard H. Holzer Foundation to Jacob Gopas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The American Associates of the Ben Gurion University (AABGU) the Philadelphia Chapter to Hila Naaman, https://aabgu.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACZKO K, 1986, J VIROL, V59, P472, DOI 10.1128/JVI.59.2.472-478.1986; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaskar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018765; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; CATTANEO R, 1993, J VIROL, V67, P1493, DOI 10.1128/JVI.67.3.1493-1502.1993; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; Chiang K, 2013, VIROLOGY, V438, P1, DOI 10.1016/j.virol.2012.12.016; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Cinatl J, 1998, CANCER RES, V58, P367; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Doi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep37163; Engelking O, 1999, J GEN VIROL, V80, P1599, DOI 10.1099/0022-1317-80-7-1599; ESOLEN LM, 1995, J VIROL, V69, P3955, DOI 10.1128/JVI.69.6.3955-3958.1995; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Avila-Bonilla RG, 2017, VIRUS RES, V232, P139, DOI 10.1016/j.virusres.2017.03.005; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Israelow B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6408; Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; KATAYAMA Y, 1995, J GEN VIROL, V76, P3201, DOI 10.1099/0022-1317-76-12-3201; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lawrence DMP, 2000, J VIROL, V74, P1908, DOI 10.1128/JVI.74.4.1908-1918.2000; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Lin WHW, 2012, P NATL ACAD SCI USA, V109, P14989, DOI 10.1073/pnas.1211138109; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; McQuaid S, 1998, J VIROL, V72, P5245, DOI 10.1128/JVI.72.6.5245-5250.1998; McQuaid S, 1997, NEUROPATH APPL NEURO, V23, P218, DOI 10.1111/j.1365-2990.1997.tb01205.x; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Naniche D, 1999, J VIROL, V73, P1894, DOI 10.1128/JVI.73.3.1894-1901.1999; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Patterson JB, 2001, VIROLOGY, V291, P215, DOI 10.1006/viro.2001.1182; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Ponomarev Eugene D, 2011, BMC Res Notes, V4, P517, DOI 10.1186/1756-0500-4-517; Rader J, 2013, CLIN CANCER RES, V19, P6173, DOI 10.1158/1078-0432.CCR-13-1675; Rall GF, 2003, ANNU REV MICROBIOL, V57, P343, DOI 10.1146/annurev.micro.57.030502.090843; Rima BK, 2005, VIRUS RES, V111, P132, DOI 10.1016/j.virusres.2005.04.005; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Schneider-Schaulies J, 1999, J NEUROVIROL, V5, P613, DOI 10.3109/13550289909021290; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Silber J, 2013, NEURO-ONCOLOGY, V15, P83, DOI 10.1093/neuonc/nos281; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Sun Y, 2013, CNS NEUROSCI THER, V19, P813, DOI 10.1111/cns.12142; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Trobaugh DW, 2017, TRENDS MOL MED, V23, P80, DOI 10.1016/j.molmed.2016.11.003; Villanueva RA, 2010, ANTIVIR RES, V88, P119, DOI 10.1016/j.antiviral.2010.07.004; Watanabe M, 1995, J NEUROVIROL, V1, P412, DOI 10.3109/13550289509111034; Wong KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019027; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Yi CH, 2013, CAN J MICROBIOL, V59, P814, DOI 10.1139/cjm-2013-0544; Yis U, 2015, J CHILD NEUROL, V30, P69, DOI 10.1177/0883073814531329; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zou DF, 2014, NEURAL REGEN RES, V9, P1241, DOI 10.4103/1673-5374.135333	64	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187077	10.1371/journal.pone.0187077	http://dx.doi.org/10.1371/journal.pone.0187077			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073265	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400109
J	Weirathmueller, MJ; Stafford, KM; Wilcock, WSD; Hilmo, RS; Dziak, RP; Trehu, AM				Weirathmueller, Michelle J.; Stafford, Kathleen M.; Wilcock, William S. D.; Hilmo, Rose S.; Dziak, Robert P.; Trehu, Anne M.			Spatial and temporal trends in fin whale vocalizations recorded in the NE Pacific Ocean between 2003-2013	PLOS ONE			English	Article							EASTERN TROPICAL PACIFIC; LOW-FREQUENCY WHALE; MID-ATLANTIC OCEAN; BALAENOPTERA-PHYSALUS; CULTURAL TRANSMISSION; NORTHEAST PACIFIC; BLUE WHALE; MEGAPTERA-NOVAEANGLIAE; HUMPBACK WHALES; ACOUSTIC LINK	In order to study the long-term stability of fin whale (Balaenoptera physalus) singing behavior, the frequency and inter-pulse interval of fin whale 20 Hz vocalizations were observed over 10 years from 2003-2013 from bottom mounted hydrophones and seismometers in the northeast Pacific Ocean. The instrument locations extended from 40 degrees N to 48 degrees N and 130 degrees W to 125 degrees W with water depths ranging from 1500-4000 m. The inter-pulse interval (IPI) of fin whale song sequences was observed to increase at a rate of 0.54 seconds/year over the decade of observation. During the same time period, peak frequency decreased at a rate of 0.17 Hz/year. Two primary call patterns were observed. During the earlier years, the more commonly observed pattern had a single frequency and single IPI. In later years, a doublet pattern emerged, with two dominant frequencies and IPIs. Many call sequences in the intervening years appeared to represent a transitional state between the two patterns. The overall trend was consistent across the entire geographical span, although some regional differences exist. Understanding changes in acoustic behavior over long time periods is needed to help establish whether acoustic characteristics can be used to help determine population identity in a widely distributed, difficult to study species such as the fin whale.	[Weirathmueller, Michelle J.; Wilcock, William S. D.; Hilmo, Rose S.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Stafford, Kathleen M.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Dziak, Robert P.] NOAA, Pacific Marine Environm Lab, Newport, OR USA; [Trehu, Anne M.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Weirathmueller, MJ (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	michellejw@gmail.com	Dziak, Robert/AAC-6107-2020	Wilcock, William/0000-0001-7224-7246	U.S. Office of Naval Research [N00014-14-1-0423]; Office of Naval Research [N00014-14-1-0423]	U.S. Office of Naval Research(Office of Naval Research); Office of Naval Research(Office of Naval Research)	This work was supported by Grant Number N00014-14-1-0423 from the U.S. Office of Naval Research (http://www.onr.navy.mil/) (WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The analysis presented in this manuscript was supported by the Office of Naval Research under Award Number N00014-14-1-0423. This is PMEL contribution number 4595. Additional advice and insights were provided by Trevor Branch and Julie Keister via helpful discussions during the analysis and manuscript preparation.	Andrew RK, 2011, J ACOUST SOC AM, V129, P642, DOI 10.1121/1.3518770; Barnes C.R., 2015, SEAFLOOR OBSERVATORI, P415, DOI [10.1007/978-3-642-11374-1_16, DOI 10.1007/978-3-642-11374-1_16]; Berube A M, 2002, FISHERIES SCI, V3, P183; Bracewell RN., 1986, FOURIER TRANSFORM IT; Broughton W. B., 1963, ACOUSTIC BEHAVIOUR A, P3; Buchan SJ, 2014, ENDANGER SPECIES RES, V23, P241, DOI 10.3354/esr00566; Carretta JV, 2015, US PACIFIC MARINE MA, P2014; Castellote M, 2012, MAR MAMMAL SCI, V28, P325, DOI 10.1111/j.1748-7692.2011.00491.x; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Cox C., 1984, Journal of Atmospheric and Oceanic Technology, V1, P237, DOI 10.1175/1520-0426(1984)001<0237:ADSDPG>2.0.CO;2; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; Delaney J. R., 2015, SEAFLOOR OBSERVATORI, P465, DOI [DOI 10.1007/978-3-642-11374-1, 10.1007/978-3-642-11374-1]; Delarue J, 2013, ARCTIC, V66, P159; Delarue J, 2009, J ACOUST SOC AM, V125, P1774, DOI 10.1121/1.3068454; Ding T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066751; Foote AD, 2004, NATURE, V428, P910, DOI 10.1038/428910a; Fujino K., 1960, SCI REP WHALES RES I, V15, P84; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; Gavrilov AN, 2012, J ACOUST SOC AM, V131, P4476, DOI 10.1121/1.4707425; Gavrilov AN, 2011, J ACOUST SOC AM, V130, P3651, DOI 10.1121/1.3651817; Gedamke J, 2010, DEEP-SEA RES PT II, V57, P968, DOI 10.1016/j.dsr2.2008.10.042; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Hatch LT, 2004, THESIS, P160; JENKINS PF, 1978, ANIM BEHAV, V26, P50, DOI 10.1016/0003-3472(78)90007-6; Jones E., SCIPY OPEN SOURCE SC; Koot B., 2015, WINTER BEHAV POPULAT; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; McDonald Mark A., 2009, Endangered Species Research, V9, P13, DOI 10.3354/esr00217; McGill PR, 2003, AM GEOPH UN FALL M 2; McKenna MF, 2012, J ACOUST SOC AM, V132, pEL169, DOI 10.1121/1.4740225; Mellinger DK, 2003, J ACOUST SOC AM, V114, P1108, DOI 10.1121/1.1593066; Mizroch SA, 2009, MAMMAL REV, V39, P193, DOI 10.1111/j.1365-2907.2009.00147.x; Moore SE, 1998, MAR MAMMAL SCI, V14, P617, DOI 10.1111/j.1748-7692.1998.tb00749.x; Morano JL, 2012, J ACOUST SOC AM, V132, P1207, DOI 10.1121/1.4730890; Nieukirk SL, 2012, J ACOUST SOC AM, V131, P1102, DOI 10.1121/1.3672648; Nieukirk SL, 2004, J ACOUST SOC AM, V115, P1832, DOI 10.1121/1.1675816; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; NORTHROP J, 1968, J ACOUST SOC AM, V43, P383, DOI 10.1121/1.1910799; Oleson EM, 2003, MAR MAMMAL SCI, V19, P407; Oleson EM, 2014, PLOS ONE, V9, P1; Parks SE, 2007, J ACOUST SOC AM, V122, P3725, DOI 10.1121/1.2799904; Parks SE, 2009, J ACOUST SOC AM, V125, P1230, DOI 10.1121/1.3050282; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; Rankin S, 2005, J ACOUST SOC AM, V118, P3346, DOI 10.1121/1.2046747; Reilly SB, 2013, BALAENOPTERA PHYSALU, V2013; Rendell L, 2007, MAR ECOL PROG SER, V52, P175; Richerson P.J, 1988, CULTURE EVOLUTIONARY; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Sirovic A, 2013, MAR BIOL, V160, P47, DOI 10.1007/s00227-012-2061-z; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; SLATER PJB, 1986, TRENDS ECOL EVOL, V1, P94, DOI 10.1016/0169-5347(86)90032-7; Soule D. C., 2011, J ACOUST SOC AM, V129, P2638; Soule DC, 2013, J ACOUST SOC AM, V133, P1751, DOI 10.1121/1.4774275; Stafford KM, 2011, MAR MAMMAL SCI, V27, P828, DOI 10.1111/j.1748-7692.2010.00437.x; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stafford KM, 2003, MAR MAMMAL SCI, V19, P682, DOI 10.1111/j.1748-7692.2003.tb01124.x; Stafford KM, 2005, J ACOUST SOC AM, V117, P2724, DOI 10.1121/1.1887005; Stafford KM, 1998, J ACOUST SOC AM, V104, P3616, DOI 10.1121/1.423944; Stafford KM, 1999, MAR MAMMAL SCI, V15, P1258, DOI 10.1111/j.1748-7692.1999.tb00889.x; Stafford KM, 1999, J ACOUST SOC AM, V106, P3687, DOI 10.1121/1.428220; THOMPSON PO, 1992, J ACOUST SOC AM, V92, P3051, DOI 10.1121/1.404201; Toomey DR, 2014, OCEANOGRAPHY, V27, P138, DOI 10.5670/oceanog.2014.49; WATKINS W A, 1981, Scientific Reports of the Whales Research Institute Tokyo, P83; WATKINS W A, 1984, Rit Fiskideildar, V8, P1; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685; WATKINS WA, 1981, DEEP-SEA RES, V28, P577, DOI 10.1016/0198-0149(81)90118-7; Watkins William A., 2000, Oceanography, V13, P62; WEST MJ, 1983, J COMP PSYCHOL, V97, P327, DOI 10.1037/0735-7036.97.4.327; Williams MC, 2011, B SEISMOL SOC AM, V101, P940, DOI 10.1785/0120100198	75	25	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186127	10.1371/journal.pone.0186127	http://dx.doi.org/10.1371/journal.pone.0186127			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073230	Green Submitted, gold, Green Published			2022-12-27	WOS:000413845400014
J	Xu, SS; Sun, F; Ren, LP; Yang, H; Tian, N; Peng, S				Xu, Shuanshuan; Sun, Fen; Ren, Lipeng; Yang, Hong; Tian, Na; Peng, Sha			Resveratrol controlled the fate of porcine pancreatic stem cells through the Wnt/beta-catenin signaling pathway mediated by Sirt1	PLOS ONE			English	Article							GENE-EXPRESSION; BETA-CATENIN; C-MYC; CANCER; P53; IDENTIFICATION; INVOLVEMENT; ACTIVATION; MOLECULE; PROTEIN	Porcine pancreatic stem cells (PSCs) are considered promising transplant materials that may be used to treat diabetes, but some problems, such as insufficient cell number and low differentiation efficiency, should be solved before its clinical application. Resveratrol is a natural polyphenolic compound that can alleviate the complications of diabetes. In this study, we aimed to explore the specific effect of resveratrol on porcine PSCs. We treated porcine PSCs with 10 mu M, 25 mu M resveratrol to explore the effect of resveratrol on porcine PSCs. We found that 10 mu M resveratrol improved the proliferation of porcine PSCs, increased the expression of A-beta-catenin (active beta-catenin), Pcna, C-Myc, Bcl-2 and sirtuin-1 (Sirt1), and decreased the expression of P53, Caspase3. While 25 mu M resveratrol had almost opposite effect compared with 10 mu M resveratrol group. The utilization of Dickkopf-related protein 1 (DKK1, Wnt signaling pathway inhibitor) and nicotinamide (Sirt1 inhibitor) suggested that resveratrol regulated cell proliferation by controlling Wnt signaling pathway and this effect was mediated by Sirt1. Our results further revealed that 10 mu M resveratrol promoted the formation of beta-like cells regulated by Wnt/beta-catenin signal pathway. Relatively low-dose resveratrol could improve porcine PSCs fate. It lays theoretical foundation for diabetes treatment with cell transplantation in future.	[Xu, Shuanshuan; Sun, Fen; Ren, Lipeng; Yang, Hong; Tian, Na; Peng, Sha] Northwest A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Peng, S (corresponding author), Northwest A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, Yangling, Shaanxi, Peoples R China.	pengshacxh@163.com	tian, na/GVR-9226-2022		Northwest AF University [2452015034]; Agricultural Science and Technology Innovation and Key Project of Shaanxi Province [2016NY094]	Northwest AF University; Agricultural Science and Technology Innovation and Key Project of Shaanxi Province	This work was supported by Basal Research Fund of Northwest A&F University, grant number [2452015034], URL http://en.nwsuaf.edu.cn/, and Agricultural Science and Technology Innovation and Key Project of Shaanxi Province [2016NY094], URL http://www.sninfo.gov.cn. The funders were used for study design, data collection and analysis, decision to publish.	Abdelgany Amr, 2005, J RNAi Gene Silencing, V1, P88; Bonora M, 2015, ONCOGENE, V34, P1608, DOI [10.1038/onc.2014.462, 10.1038/onc.2014.96]; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Bruin JE, 2015, STEM CELL REP, V4, P605, DOI 10.1016/j.stemcr.2015.02.011; Cao H, 2011, CELL PROLIFERAT, V44, P19, DOI 10.1111/j.1365-2184.2010.00714.x; Cao H., 2012, SPACECR RECOVER REMO, V3, P7, DOI DOI 10.1371/J0URNAL.P0NE.0031502; Chu Yuankui, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P448; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Ding H, 2016, CARDIOVASC THER, V34, P283, DOI 10.1111/1755-5922.12200; Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236; Fritz RD, 2011, BBA-MOL CELL RES, V1813, P1971, DOI 10.1016/j.bbamcr.2011.02.008; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoffman B, 1998, ONCOGENE, V17, P3351, DOI 10.1038/sj.onc.1202592; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu SX, 2016, CELL PROLIFERAT, V49, P395, DOI 10.1111/cpr.12263; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Jarskog LF, 2004, AM J PSYCHIAT, V161, P109, DOI 10.1176/appi.ajp.161.1.109; Kim YD, 2015, YONSEI MED J, V56, P410, DOI 10.3349/ymj.2015.56.2.410; Kupisiewicz K, 2010, CALCIFIED TISSUE INT, V87, P437, DOI 10.1007/s00223-010-9399-3; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liu BH, 2012, CELL METAB, V16, P738, DOI 10.1016/j.cmet.2012.11.007; Malik MZ, 2015, COMPUT BIOL CHEM, V59, P55, DOI 10.1016/j.compbiolchem.2015.07.014; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Rogers SA, 2007, XENOTRANSPLANTATION, V14, P591, DOI 10.1111/j.1399-3089.2007.00429.x; Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464; Rubinfeld B, 1997, LOSS TUMOR SUPPRESSO, V57, P4624; Sanders TH, 2000, J AGR FOOD CHEM, V48, P1243, DOI 10.1021/jf990737b; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Soleas GJ, 1997, CLIN BIOCHEM, V30, P91, DOI 10.1016/S0009-9120(96)00155-5; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Wang B, 2014, J CELL MOL MED, V18, P1599, DOI 10.1111/jcmm.12312; Wang XF, 2016, CELL BIOL INT, V40, P716, DOI 10.1002/cbin.10610; Xiao M, 2008, SCI CHINA SER C, V51, P779, DOI 10.1007/s11427-008-0109-6; Zhang Ya-hong, 2011, Yaoxue Xuebao, V46, P1332; Zhou Y., 2015, CYBERNETICS IEEE T, VPP, P1; Zhou Y, 2016, ONCOTARGET, V7; Zhou Y, 2015, INT J AEROSPACE ENG, V2015, DOI 10.1155/2015/381478	44	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187159	10.1371/journal.pone.0187159	http://dx.doi.org/10.1371/journal.pone.0187159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073244	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400126
J	Babo, YD; Alemie, GA; Fentaye, FW				Babo, Yohannes Demissie; Alemie, Getahun Asres; Fentaye, Fasil Walelign			Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia	PLOS ONE			English	Article							HIV-1-INFECTED ADULTS; VIROLOGICAL RESPONSES; RECOVERY; SUCCESS	Background Due to the limited availability of viral load testing for treatment outcome monitoring in resource limited settings, identifying predictive factors of antiretroviral treatment failure will help in selecting clients who will benefit most from the targeted use of viral load monitoring. Little is known about the predictors of treatment failure in the study area. This study was conducted to determine factors that predict first-line antiretroviral therapy failure among HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia. For this study, antiretroviral therapy treatment failure was defined as the fulfillment of clinical and/or immunological criteria set by WHO. Methods Case-control study was carried out from November to December 2014. Cases were adult clients who were on failing first line regimen and on active follow up while controls were those adult clients on a non-failing first-line regimen for 36 months and above and on active follow up. Data was entered in to Epi Info version 7 and was exported to SPSS version 20 for analysis. Binary logistic regression model was used to identify predictors of ART failure. Results A total of 59 cases and 245 controls were included in the analysis. Sixty three percent of the participants were females and the median age at ART enrollment was 33 years (IQR; 28, 40). The median baseline CD4 count was not significantly different among cases and controls (105 (IQR = 60-174)vs.131 (IQR = 72.5-189.0); p = 0.301). The median peak CD4 count in the failure group (230 (IQR = 123-387)) was significantly low compared to the non-failure group (463 (IQR = 348.5-577)) [p< 0.001]. High peak CD4count (AOR = 0.993; 95% Cl 0.990, 0.996) and longer duration on ART (AOR = 0.923; 95% Cl 0.893, 0.954) were protective of treatment failure. In addition stavudine based regimen (AOR = 3.47; 95% Cl 1.343,10.555), low baseline BMI (AOR = 2.75; 95% Cl 1.012, 7.457), unemployment (AOR = 4.93; 95% Cl 1.493,16.305) and formal educational level (AOR = 5.15; 95% Cl 1.534,17.276) were independently significant predictors of treatment failure. Conclusions In this setting low peak CD4count, shorter duration on first line ART, d4T based regimen, low baseline BMI, unemployment and formal educational level were significantly associated with increased treatment failure. Retaining patients on their initial first line regimen with appropriate follow up and improving their socioeconomic status through various livelihood initiatives should be strengthened.	[Babo, Yohannes Demissie] Management Sci Hlth, Bahirdar, Ethiopia; [Alemie, Getahun Asres] Univ Gondar, Publ Hlth Inst, Coll Med & Hlth Sci, Gondar, Ethiopia; [Fentaye, Fasil Walelign] Wollo Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia	University of Gondar	Fentaye, FW (corresponding author), Wollo Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia.	fasil.walelign@wu.edu.et		Fentaye, Fasil Walelign/0000-0001-6567-1129	United States Agency for International Development (USAID) [AID-611-A-11-00006]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was made possible by the generous support of the United States Agency for International Development (USAID) under Cooperative Agreement No. AID-611-A-11-00006. The contents are the responsibility of the authors and don't necessarily reflect the views of USAID or the United States Government.	Abdissa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-181; Agarwal A, 2013, J AIDS CLIN RES, V4, P210, DOI [10.4172/2155-6113.1000210, DOI 10.4172/2155-6113.1000210]; Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Amhara HIV/AIDS Prevention and Control Coordination Office, FACTAND FIG; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2012, WORLD J AIDS, DOI DOI 10.4236/WJA.2012.24036; Anude CJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-113; Assefa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-468; Assefa Y, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-81; Bennett DE, 2008, ANTIVIR THER, V13, P1; Cozzi-Lepri A, 2012, HIV MED, V13, P62, DOI 10.1111/j.1468-1293.2011.00943.x; CSA ICF, 2012, ETH DEM HLTH SURV 20; Datay MI, 2010, JAIDS-J ACQ IMM DEF, V54, P489, DOI 10.1097/QAI.0b013e3181d91788; Dragsted UB, 2004, J INFECT DIS, V190, P148, DOI 10.1086/420786; EHNRI, 2013, HIV DRUG RES HIVDR E; Federal HAPCO, 2014, COUNTR PROGR REP HIV; Ferreyra C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049834; FMOH, 2008, GUID MAN OPP INF ANT; Gilks C, 2006, AIDS, V20, P1391; Greig JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071407; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Kassa D, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-18; Khienprasit N, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-42; Kifle M., 2013, FMOH VIR LOAD COST P; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Meriki HD, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-5; Misgena DK, 2011, ETHIOP J HEALTH DEV, V25, P61; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-28; Murri R, 2014, J GEN INTERN MED, V19, P104; Palladino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082718; Palmisano L, 2011, ANN I SUPER SANITA, V47, P44, DOI 10.4415/ANN_11_01_10; Peltzer K, 2013, J HEALTH POPUL NUTR, V31, P150; Penot P, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18646; Prabhakar B, 2011, Indian J Sex Transm Dis AIDS, V32, P94, DOI 10.4103/0253-7184.85412; Rajasekaran S, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000279706.24428.78; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Stafford K, 4 IAS C HIV PATH TRE; Teshome W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115125; UNAIDS, 2016, UNAIDS PREV GAP REP; WHO, 2013, GLOB UPD HIV TREATM; Woldia Hospital, 2014, MONTHL FAC ART REP; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization (WHO), 2012, HIV DRUG RES REP; Yayehirad Alemu Melsew, 2013, Journal of AIDS and Clinical Research, V4, P211	45	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187694	10.1371/journal.pone.0187694	http://dx.doi.org/10.1371/journal.pone.0187694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095936	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200128
J	Lv, Z; Li, SP; Chen, HS				Lv, Zhong; Li, Songpeng; Chen, Huisu			Analytical model for effects of capsule shape on the healing efficiency in self-healing materials	PLOS ONE			English	Article							TOUGHENED EPOXY COMPOSITE; CEMENTITIOUS MATERIALS; FATIGUE CRACKS; REPAIR; MICROCAPSULES; RETARDATION; EMULSION; DOSAGE; AGENT	The fundamental requirement for the autonomous capsule-based self-healing process to work is that cracks need to reach the capsules and break them such that the healing agent can be released. Ignoring all other aspects, the amount of healing agents released into the crack is essential to obtain a good healing. Meanwhile, from the perspective of the capsule shapes, spherical or elongated capsules (hollow tubes/fibres) are the main morphologies used in capsule-based self-healing materials. The focus of this contribution is the description of the effects of capsule shape on the efficiency of healing agent released in capsule-based self-healing material within the framework of the theory of geometrical probability and integral geometry. Analytical models are developed to characterize the amount of healing agent released per crack area from capsules for an arbitrary crack intersecting with capsules of various shapes in a virtual capsule-based self-healing material. The average crack opening distance is chosen to be a key parameter in defining the healing potential of individual cracks in the models. Furthermore, the accuracy of the developed models was verified by comparison to the data from a published numerical simulation study.	[Lv, Zhong; Li, Songpeng] Anhui Univ Technol, Sch Civil Engn & Architecture, Maanshan, Anhui, Peoples R China; [Chen, Huisu] Southeast Univ, Sch Mat Sci & Engn, Jiangsu Key Lab Construct Mat, Nanjing, Jiangsu, Peoples R China	Anhui University of Technology; Southeast University - China	Lv, Z (corresponding author), Anhui Univ Technol, Sch Civil Engn & Architecture, Maanshan, Anhui, Peoples R China.	zhonglv1982@163.com	Chen, Huisu/G-5494-2010	Chen, Huisu/0000-0003-1997-5476; LV, Zhong/0000-0002-3738-252X	National Natural Science Foundation Project of China [51408002, 5131101253]; Anhui Provincial Nature Science Foundation [1608085QE111]; Ministry of Science and Technology of China quot;973 Projectquot; [2015CB655102]	National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Nature Science Foundation; Ministry of Science and Technology of China quot;973 Projectquot;	ZL gratefully acknowledges the financial support from National Natural Science Foundation Project of China (grant no. 51408002), Anhui Provincial Nature Science Foundation (grant no. 1608085QE111). HSC gratefully appreciates the financial support from the Ministry of Science and Technology of China "973 Project" (grant no. 2015CB655102) and National Natural Science Foundation Project of China (grant no. 5131101253).	Bekas DG, 2016, COMPOS PART B-ENG, V87, P92, DOI 10.1016/j.compositesb.2015.09.057; Blaiszik BJ, 2008, COMPOS SCI TECHNOL, V68, P978, DOI 10.1016/j.compscitech.2007.07.021; Bon SAF, 2007, EUR POLYM J, V43, P4839, DOI 10.1016/j.eurpolymj.2007.09.001; Brown EN, 2005, COMPOS SCI TECHNOL, V65, P2474, DOI 10.1016/j.compscitech.2005.04.053; Brown EN, 2005, COMPOS SCI TECHNOL, V65, P2466, DOI 10.1016/j.compscitech.2005.04.020; Hager MD, 2010, ADV MATER, V22, P5424, DOI 10.1002/adma.201003036; Huang H., 2012, 2 INT C MICR REL DUR; Huang HL, 2016, MATER DESIGN, V92, P499, DOI 10.1016/j.matdes.2015.12.091; Karaiskos G, 2016, SMART MATER STRUCT, V25, DOI 10.1088/0964-1726/25/5/055003; Kessler MR, 2001, COMPOS PART A-APPL S, V32, P683, DOI 10.1016/S1359-835X(00)00149-4; Li CM, 2016, COMPOS SCI TECHNOL, V123, P250, DOI 10.1016/j.compscitech.2016.01.001; Li WT, 2017, MATERIALS, V10, DOI 10.3390/ma10060589; Li WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081616; Lucas SS, 2016, J INTEL MAT SYST STR, V27, P2577, DOI 10.1177/1045389X16641205; Lv Z, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/11/115009; Lv Z, 2014, J INTEL MAT SYST STR, V25, P47, DOI 10.1177/1045389X12457250; Lv Z, 2013, COMP MATER SCI, V68, P81, DOI 10.1016/j.commatsci.2012.09.032; Lv Z, 2011, SCI ENG COMPOS MATER, V18, P13, DOI 10.1515/SECM.2011.004; Lv Z, 2011, MATER STRUCT, V44, P987, DOI 10.1617/s11527-010-9681-x; Mookhoek S.D., 2010, THESIS; Nakao W., 2009, SELF HEALING MAT FUN, P183; Prajer M, 2015, COMPOS SCI TECHNOL, V106, P127, DOI 10.1016/j.compscitech.2014.11.013; Russ J.C., 1999, PRACTICAL STEREOLOGY; Santal LA., 1953, INTRO INTEGRAL GEOME, V1198; Tang WC, 2015, CONSTR BUILD MATER, V81, P233, DOI 10.1016/j.conbuildmat.2015.02.054; van der Zwaag S, 2009, PHILOS T R SOC A, V367, P1689, DOI 10.1098/rsta.2009.0020; Van Tittelboom K, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/12/125016; Wang YS, 2015, SCI REP-UK, V5, DOI 10.1038/srep18484; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; Wu G, 2014, J MATER CHEM A, V2, P11614, DOI 10.1039/c4ta01312c; Xiong W, 2015, SCI REP-UK, V5, DOI 10.1038/srep10866; Yuan YC, 2008, MACROMOLECULES, V41, P5197, DOI 10.1021/ma800028d; Zemskov SV, 2011, COMP MATER SCI, V50, P3323, DOI 10.1016/j.commatsci.2011.06.024; Zhang M.Q., 2011, SELF HEALING POLYM P; Zhu DY, 2015, PROG POLYM SCI, V49-50, P175, DOI 10.1016/j.progpolymsci.2015.07.002; Zwaag S.v.d., 2007, SELF HEALING MAT ALT	36	11	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187299	10.1371/journal.pone.0187299	http://dx.doi.org/10.1371/journal.pone.0187299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095862	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200067
J	Sabljic, I; Mestrovic, N; Vukelic, B; Macheroux, P; Gruber, K; Luic, M; Abramic, M				Sabljic, Igor; Mestrovic, Nevenka; Vukelic, Bojana; Macheroux, Peter; Gruber, Karl; Luic, Marija; Abramic, Marija			Crystal structure of dipeptidyl peptidase III from the human gut symbiont Bacteroides thetaiotaomicron	PLOS ONE			English	Article							PROTEIN-STRUCTURE; DOMAIN MOTIONS; REFINEMENT; MECHANISM; ALIGNMENT; REVEALS; INSIGHT; MODE	Bacteroides thetaiotaomicron is a dominant member of the human intestinal microbiome. The genome of this anaerobe encodes more than 100 proteolytic enzymes, the majority of which have not been characterized. In the present study, we have produced and purified recombinant dipeptidyl peptidase 111 (DPP III) from B. thetaiotaomicron for the purposes of biochemical and structural investigations. DPP III is a cytosolic zinc-metallopeptidase of the M49 family, involved in protein metabolism. The biochemical results for B. thetaiotaomicron DPP III from our research showed both some similarities to, as well as certain differences from, previously characterised yeast and human DPP III. The 3D-structure of B. thetaiotaomicron DPP III was determined by X-ray crystallography and revealed a two-domain protein. The ligand-free structure (refined to 2.4 A) was in the open conformation, while in the presence of the hydroxamate inhibitor Tyr-Phe-NHOH, the closed form (refined to 3.3 A) was observed. Compared to the closed form, the two domains of the open form are rotated away from each other by about 28 degrees. A comparison of the crystal structure of B. thetaiotaomicron DPP III with that of the human and yeast enzymes revealed a similar overall fold. However, a significant difference with functional implications was discovered in the upper domain, farther away from the catalytic centre. In addition, our data indicate that large protein flexibility might be conserved in the M49 family.	[Sabljic, Igor; Luic, Marija] Rudjer Boskovic Inst, Div Phys Chem, Zagreb, Croatia; [Mestrovic, Nevenka] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia; [Vukelic, Bojana; Abramic, Marija] Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb, Croatia; [Macheroux, Peter] Graz Univ Technol, Inst Biochem, Graz, Austria; [Gruber, Karl] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria	Rudjer Boskovic Institute; Rudjer Boskovic Institute; Rudjer Boskovic Institute; Graz University of Technology; University of Graz	Sabljic, I (corresponding author), Rudjer Boskovic Inst, Div Phys Chem, Zagreb, Croatia.; Abramic, M (corresponding author), Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb, Croatia.	isabljic@irb.hr; abramic@irb.hr	Macheroux, Peter/AAB-5157-2019; Gruber, Karl/GPP-6706-2022	Macheroux, Peter/0000-0002-0242-454X; Gruber, Karl/0000-0002-3485-9740; Sabljic, Igor/0000-0001-9044-2678	Croatian Ministry of Science, Education and Sport [098-1191344-2938]; European Community's Seventh Framework Programme (FP7) under BioStruct-X [283570]; European Community's Seventh Framework Programme under New Molecular Solutions in Research and Development for Innovative Drugs [lnnoMol-FP7-REGPOT-2012-2013-1, 316289]; Austrian Science Funds (FWF) [W901]; DK "Molecular Enzymology", Austrian Exchange Service (OeAD) within the Scientific & Technological Cooperation (WTZ) [HR 09/2012, HR 06/2016]	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); European Community's Seventh Framework Programme (FP7) under BioStruct-X; European Community's Seventh Framework Programme under New Molecular Solutions in Research and Development for Innovative Drugs; Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); DK "Molecular Enzymology", Austrian Exchange Service (OeAD) within the Scientific & Technological Cooperation (WTZ)	This work has been supported by: Croatian Ministry of Science, Education and Sport (project 098-1191344-2938 to MA; https://mzo.hr/en), the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement no. 283570 to ML; https:/www.biostruct-x.eu), the European Community's Seventh Framework Programme under New Molecular Solutions in Research and Development for Innovative Drugs (lnnoMol-FP7-REGPOT-2012-2013-1, grant agreement number 316289; www.innomol.eu), Austrian Science Funds (FWF) http://www.fwf.ac.at/en/, project: W901 (to KG), DK "Molecular Enzymology", Austrian Exchange Service (OeAD) through grants HR 09/2012 (to PM) and HR 06/2016 (to KG) within the Scientific & Technological Cooperation (WTZ) between Austria and Croatia (https://www.bmbf.de/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMIC M, 1988, BIOL CHEM H-S, V369, P29, DOI 10.1515/bchm3.1988.369.1.29; Abramic M, 2004, PERIOD BIOL, V106, P161; Abramic M, 2015, BIOL CHEM, V396, P359, DOI 10.1515/hsz-2014-0247; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baral PK, 2008, J BIOL CHEM, V283, P22316, DOI 10.1074/jbc.M803522200; Bezerra GA, 2012, P NATL ACAD SCI USA, V109, P6525, DOI 10.1073/pnas.1118005109; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Chen J.M., 2004, HDB PROTEOLYTIC ENZY, P809, DOI 10.1016/B978-0-12-079611-3.50247-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corel Corporation., 2003, CORELDRAW 12; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cvitesic A, 2016, J ENZYM INHIB MED CH, V31, P40, DOI 10.1080/14756366.2016.1186021; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fukasawa K, 1998, BIOCHEM J, V329, P275, DOI 10.1042/bj3290275; Fukasawa K, 1999, BIOCHEMISTRY-US, V38, P8299, DOI 10.1021/bi9904959; Gacesa R, 2015, FREE RADICAL BIO MED, V88, P373, DOI 10.1016/j.freeradbiomed.2015.06.015; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Jajcannin-Jozic N, 2013, BIOL CHEM, V394, P767, DOI 10.1515/hsz-2012-0347; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karacic Z, 2012, BIOL CHEM, V393, P1523, DOI 10.1515/hsz-2012-0181; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23787; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Toole GA, 2016, J BACTERIOL, V198, P2763, DOI 10.1128/JB.00615-16; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Rambaut A, 2012, FIGTREE TREE FIGURE; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Spoljaric J, 2009, BIOORG CHEM, V37, P70, DOI 10.1016/j.bioorg.2009.03.002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vukelic B, 2012, BIOL CHEM, V393, P37, DOI 10.1515/BC-2011-193; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187295	10.1371/journal.pone.0187295	http://dx.doi.org/10.1371/journal.pone.0187295			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095893	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200066
J	Mayfield, AB; Chen, CS; Dempsey, AC				Mayfield, Anderson B.; Chen, Chii-Shiarng; Dempsey, Alexandra C.			Biomarker profiling in reef corals of Tonga's Ha'apai and Vava'u archipelagos	PLOS ONE			English	Article							GENE-EXPRESSION; BUILDING CORAL; POCILLOPORA-DAMICORNIS; ELEVATED-TEMPERATURE; PROTEIN; PHYSIOLOGY; ANTHOZOAN; STRESS; SYSTEM; HEALTH	Given the significant threats towards Earth's coral reefs, there is an urgent need to document the current physiological condition of the resident organisms, particularly the reef building scleractinians themselves. Unfortunately, most of the planet's reefs are understudied, and some have yet to be seen. For instance, the Kingdom of Tonga possesses an extensive reef system, with thousands of hectares of unobserved reefs; little is known about their ecology, nor is there any information on the health of the resident corals. Given such knowledge deficiencies, 59 reefs across three Tongan archipelagos were surveyed herein, and pocilloporid corals were sampled from approximately half of these surveyed sites; 10 molecular-scale response variable were assessed in 88 of the sampled colonies, and 12 colonies were found to be outliers based on employment of a multivariate statistics-based aberrancy detection system. These outliers differed from the statistically normally behaving colonies in having not only higher RNA/DNA ratios but also elevated expression levels of three genes: 1) Symbiodinium zinc-induced facilitator-like 1-like, 2) host coral copper-zinc superoxide dismutase, and 3) host green fluorescent protein-like chromoprotein. Outliers were also characterized by significantly higher variation amongst the molecular response variables assessed, and the response variables that contributed most significantly to colonies being delineated as outliers differed between the two predominant reef coral species sampled, Pocillopora damicornis and P. acuta. These closely related species also displayed dissimilar temporal fluctuation patterns in their molecular physiologies, an observation that may have been driven by differences in their feeding strategies. Future works should attempt to determine whether corals displaying statistically aberrant molecular physiology, such as the 12 Tongan outliers identified herein, are indeed characterized by a diminished capacity for acclimating to the rapid changes in their abiotic milieu occurring as a result of global climate change.	[Mayfield, Anderson B.; Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Mayfield, Anderson B.; Dempsey, Alexandra C.] Khaled bin Sultan Living Oceans Fdn, Annapolis, MD USA; [Mayfield, Anderson B.; Chen, Chii-Shiarng] Taiwan Coral Res Ctr, Pingtung, Taiwan; [Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; National Sun Yat Sen University	Mayfield, AB (corresponding author), Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan.; Mayfield, AB (corresponding author), Khaled bin Sultan Living Oceans Fdn, Annapolis, MD USA.; Mayfield, AB (corresponding author), Taiwan Coral Res Ctr, Pingtung, Taiwan.	andersonblairmayfield@gmail.com		Mayfield, Anderson/0000-0003-0138-7844	Khaled bin Sultan Living Oceans Foundation as part of their Global Reef Expedition	Khaled bin Sultan Living Oceans Foundation as part of their Global Reef Expedition	This work was funded exclusively by the Khaled bin Sultan Living Oceans Foundation as part of their Global Reef Expedition. This included a postdoctoral research fellowship to ABM. The funder had no influence on the interpretation of the data, though one author (ACD) is an employee of the funding institution (a non-profit NGO).	Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Chen WNU, 2016, PEERJ, V4, DOI 10.7717/peerj.2358; Clarke KR, 1994, CHANGE MARINE COMMUN; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; Downs CA, 2005, MAR POLLUT BULL, V51, P558, DOI 10.1016/j.marpolbul.2005.04.017; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Feder M.E., 1996, Society for Experimental Biology Seminar Series, V59, P79; Furla P, 2005, INTEGR COMP BIOL, V45, P595, DOI 10.1093/icb/45.4.595; GATES RD, 1990, CORAL REEFS, V8, P193, DOI 10.1007/BF00265010; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Haydon MJ, 2007, PLANT PHYSIOL, V143, P1705, DOI 10.1104/pp.106.092015; Ho JWK, 2008, BIOINFORMATICS, V24, pI390, DOI 10.1093/bioinformatics/btn142; Hochachka P. W., 2002, BIOCH ADAPTATION; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Huang YCA, 2011, MAR ECOL PROG SER, V423, P83, DOI 10.3354/meps08944; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Liu PJ, 2012, MAR POLLUT BULL, V64, P1129, DOI 10.1016/j.marpolbul.2012.03.031; Mayfield AB, 2013, CORAL REEFS, V32, P909, DOI 10.1007/s00338-013-1067-4; Mayfield AB, 2014, INT J MARINE SCI, V4, P1, DOI DOI 10.5376/IJMS.2014.04.0050; Mayfield AB, 2016, CORAL REEFS ECOSYSTE, P13; Mayfield AB, PLATAX IN PRESS; Mayfield AB, 2007, COMP BIOCHEM PHYS A, V147, P1, DOI 10.1016/j.cbpa.2006.12.042; Mayfield AB, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4030063; Mayfield Anderson B., 2016, Platax, V13, P1; Mayfield AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177267; Mayfield Anderson B., 2015, Platax, V12, P1; Mayfield AB, 2016, MOL ECOL, V25, P5944, DOI 10.1111/mec.13896; Mayfield Anderson B., 2014, Platax, V11, P1; Mayfield Anderson B., 2013, Platax, V10, P1; Mayfield AB, 2014, MOL ECOL, V23, P5816, DOI 10.1111/mec.12982; Mayfield AB, 2014, MAR BIOTECHNOL, V16, P371, DOI 10.1007/s10126-014-9558-z; Mayfield Anderson B., 2012, Platax, V9, P1; Mayfield AB, 2013, MAR ENVIRON RES, V86, P1, DOI 10.1016/j.marenvres.2013.01.004; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; Mayfield AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026529; Mayfield AB, 2010, J EXP MAR BIOL ECOL, V395, P215, DOI 10.1016/j.jembe.2010.09.007; Mayfield AB, 2009, MOL ECOL RESOUR, V9, P462, DOI 10.1111/j.1755-0998.2008.02349.x; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; Rinkevich B, 2005, ENVIRON SCI TECHNOL, V39, P4333, DOI 10.1021/es0482583; Saul S, 2015, REMOTE SENS-BASEL, V7, P15894, DOI 10.3390/rs71215810; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Smith EG, 2013, CORAL REEFS, V32, P463, DOI 10.1007/s00338-012-0994-9; Sokal RR, 1995, BIOMETRY; Traylor-Knowles N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-585; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700	48	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185857	10.1371/journal.pone.0185857	http://dx.doi.org/10.1371/journal.pone.0185857			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091723	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700011
J	Das, A; Ranganathan, V; Umar, D; Thukral, S; George, A; Rath, S; Bal, V				Das, Arundhoti; Ranganathan, Vidya; Umar, Danish; Thukral, Shipra; George, Anna; Rath, Satyajit; Bal, Vineeta			Effector/memory CD4 T cells making either Th1 or Th2 cytokines commonly co-express T-bet and GATA-3	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; IN-VITRO; GENE-EXPRESSION; PHENOTYPE DEVELOPMENT; HELPER-CELLS; EX-VIVO; DIFFERENTIATION; POLARIZATION; RESPONSES; NAIVE	Naive CD4 T (NCD4T) cells post-activation undergo programming for inducible production of cytokines leading to generation of memory cells with various functions. Based on cytokine based polarization of NCD4T cells in vitro, programming for either 'Th1' (interferon-gamma [IFNg]) or 'Th2' (interleukin [IL]-4/5/13) cytokines is thought to occur via mutually exclusive expression and functioning of T-bet or GATA-3 transcription factors (TFs). However, we show that a high proportion of mouse and human memory-phenotype CD4 T (MCD4T) cells generated in vivo which expressed either Th1 or Th2 cytokines commonly co-expressed T-bet and GATA-3. While T-bet levels did not differ between IFNg-expressing and IL-4/5/13-expressing MCD4T cells, GATA-3 levels were higher in the latter. These observations were also confirmed in MCD4T cells from FVB/NJ or aged C57BL/6 or IFNg-deficient mice. While MCD4T cells from these strains showed greater Th2 commitment than those from young C57BL/6 mice, pattern of co-expression of TF was similar. Effector T cells generated in vivo following immunization also showed TF co-expression in Th1 or Th2 cytokine producing cells. We speculated that the difference in TF expression pattern of MCD4T cells generated in vivo and those generated in cytokine polarized cultures in vitro could be due to relative absence of polarizing conditions during activation in vivo. We tested this by NCD4T cell activation in non-polarizing conditions in vitro. Anti-CD3 and anti-CD28-mediated priming of polyclonal NCD4T cells in vitro without polarizing milieu generated cells that expressed either IFNg or IL-4/5/13 but not both, yet both IFNg-and IL-4/5/13-expressing cells showed upregulation of both TFs. We also tested monoclonal T cell populations activated in non-polarizing conditions. TCR-transgenic NCD4T cells primed in vitro by cognate peptide in non-polarizing conditions which expressed either IFNg or IL-4/5/13 also showed a high proportion of cells co-expressing TFs, and their cytokine commitment varied depending on genetic background or priming conditions, without altering pattern of TF co-expression. Thus, the model of mutually antagonistic differentiation programs driven by mutually exclusively expressed T-bet or GATA-3 does not completely explain natural CD4 T cell priming outcomes.	[Das, Arundhoti; Ranganathan, Vidya; Umar, Danish; Thukral, Shipra; George, Anna; Rath, Satyajit; Bal, Vineeta] Natl Inst Immunol, New Delhi, India; [Thukral, Shipra] BD Diagnost, Bd, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Bal, V (corresponding author), Natl Inst Immunol, New Delhi, India.	vineeta@nii.res.in		Bal, Vineeta/0000-0002-8995-2045	Department of Biotechnology, Government of India [BT/PR5138/BRB/10/1064/2012, BT/PR14592/BRB/10/858/2010, BT/PR7012/BRB/1159/2012]; Science and Engineering Research Board, Department of Science and Technology, Government of India [SR/SO/BB-0035/2013, SB/SO/HS/210/2013, SR/SO/HS-0005/2011, EMR/2015/001074]; Council for Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Science and Engineering Research Board, Department of Science and Technology, Government of India; Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by grants from the Department of Biotechnology, Government of India (to A.G. # BT/PR5138/BRB/ 10/1064/2012, to S.R. # BT/PR14592/BRB/10/858/ 2010, to V.B. # BT/PR7012/BRB/1159/2012); the Science and Engineering Research Board, Department of Science and Technology, Government of India (to A.G. # SR/SO/BB-0035/2013, S.R. # SB/SO/HS/210/2013, to V.B. #SR/SO/HS-0005/2011, EMR/2015/001074); and a fellowship from the Council for Scientific and Industrial Research, Government of India to A.D. and D.U. The National Institute of Immunology is supported by the Department of Biotechnology, Government of India. There were no sponsors for this work. Funding agencies had no role in either conceptualization or implementation of the work.	Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Ben-Sasson SZ, 2000, EUR J IMMUNOL, V30, P1308, DOI 10.1002/(SICI)1521-4141(200005)30:5<1308::AID-IMMU1308>3.0.CO;2-I; Bian Y, 2005, INT IMMUNOL, V17, P73, DOI 10.1093/intimm/dxh188; Brewer JP, 1999, AM J RESP CRIT CARE, V160, P1150, DOI 10.1164/ajrccm.160.4.9806034; Califano D, 2014, J CLIN INVEST, V124, P174, DOI 10.1172/JCI70103; Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Corthay A, 2006, SCAND J IMMUNOL, V64, P93, DOI 10.1111/j.1365-3083.2006.01782.x; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Deng YP, 2004, J IMMUNOL, V172, P3437, DOI 10.4049/jimmunol.172.6.3437; Dong C, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.49.pe1; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; Hata M, 2009, IMMUNOL LETT, V126, P29, DOI 10.1016/j.imlet.2009.07.008; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hirata M, 2001, PARASITE IMMUNOL, V23, P271, DOI 10.1046/j.1365-3024.2001.00382.x; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; KELSO A, 1988, P NATL ACAD SCI USA, V85, P9189, DOI 10.1073/pnas.85.23.9189; Lai W, 2011, J IMMUNOL, V187, P133, DOI 10.4049/jimmunol.1002742; Lexberg MH, 2010, EUR J IMMUNOL, V40, P3017, DOI 10.1002/eji.201040539; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohning M, 1999, J IMMUNOL, V162, P3882; McAlees JW, 2015, EUR J IMMUNOL, V45, P1019, DOI 10.1002/eji.201444778; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mudter J, 2003, INFLAMM BOWEL DIS, V9, P332, DOI 10.1097/00054725-200309000-00008; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; O'Garra A, 2016, J IMMUNOL, V196, P4423, DOI 10.4049/jimmunol.1600646; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Owaki T, 2006, J IMMUNOL, V177, P7579, DOI 10.4049/jimmunol.177.11.7579; Park HR, 2011, CELL IMMUNOL, V267, P1, DOI 10.1016/j.cellimm.2010.10.004; Pearson-White S, 2003, MOL CELL BIOL, V23, P5446, DOI 10.1128/MCB.23.15.5446-5459.2003; Peck A, 2010, IMMUNOLOGY, V129, P147, DOI 10.1111/j.1365-2567.2009.03189.x; Peine M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001633; Preusse C, 2012, AM J PATHOL; Rane S, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0106-0; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Rhodes SG, 2002, TRENDS IMMUNOL, V23, P246, DOI 10.1016/S1471-4906(02)02200-7; Rogers PR, 2000, J IMMUNOL, V164, P2955, DOI 10.4049/jimmunol.164.6.2955; ROMAGNANI S, 1991, INT J CLIN LAB RES, V21, P152; Saini AS, 2014, NAT IMMUNOL; Smits HH, 2002, J IMMUNOL, V168, P1710, DOI 10.4049/jimmunol.168.4.1710; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Upadhyay M, 2014, J CELL PHYSL; Wang ZE, 1994, J EXP MED, V179; Wesa A, 2007, J IMMUNOTHER, V30, P75, DOI 10.1097/01.cji.0000211316.15278.6e; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Yagi J, 2006, INT IMMUNOL, V18, P1681, DOI 10.1093/intimm/dxl102; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; YANG DM, 1991, IMMUNOLOGY, V72, P3; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zhu JF, 2010, IMMUNITY, V32, P11, DOI 10.1016/j.immuni.2010.01.001; Zygmunt B, 2011, ADV IMMUNOL, V109, P159, DOI 10.1016/B978-0-12-387664-5.00005-4	63	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0185932	10.1371/journal.pone.0185932	http://dx.doi.org/10.1371/journal.pone.0185932			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088218	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900006
J	Lee, JS; Seo, H; Im, K; Park, SN; Kim, SM; Lee, EK; Kim, JA; Lee, JH; Kwon, S; Kim, M; Koh, I; Hwang, S; Park, HW; Kang, HR; Park, KS; Kim, JH; Lee, DS				Lee, Jee-Soo; Seo, Heewon; Im, Kyongok; Park, Si Nae; Kim, Sung-Min; Lee, Eun Kyoung; Kim, Jung-Ah; Lee, Joon-hee; Kwon, Sunghoon; Kim, Miyoung; Koh, Insong; Hwang, Seungwoo; Park, Heung-Woo; Kang, Hye-Ryun; Park, Kyoung Soo; Kim, Ju Han; Lee, Dong Soon			Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing	PLOS ONE			English	Article							EOSINOPHILIA; MUTATIONS; LEUKEMIA; ABNORMALITIES; NEOPLASMS; DIAGNOSIS; FRAMEWORK; PDGFRB; SIFT	Idiopathic hypereosinophilia (IHE)/idiopathic hypereosinophilic syndrome (IHES) has been defined by a persistent elevation of the blood eosinophil count exceeding 1.5x10(3)/mu L, without evidence of reactive or clonal causes. While T-cell clonality assessment has been recommended for unexplained hypereosinophilia, this approach is not often applied to routine practice in the clinic. We hypothesized that the clonality would exist in a subset of IHE/IHES patients. We aimed to investigate the candidate mutations and T-cell clonality in IHE/IHES and to explore the role of mutations in eosinophil proliferation. We performed targeted capture sequencing for 88 genes using next-generation sequencing, T-cell receptor (TCR) gene rearrangement assays, and pathway network analysis in relation to eosinophil proliferation. By targeted sequencing, 140 variants in 59 genes were identified. Sixteen out of 30 patients (53.3%) harbored at least one candidate mutation. The most frequently affected genes were NOTCH1 (26.7%), SCRIB and STAG2 (16.7%), and SH2B3 (13.3%). Network analysis revealed that our 21 candidate genes (BIRC3, BRD4, CSF3R, DNMT3A, EGR2, EZH2, FAT4, FLT3, GATA2, IKZF, JAK2, MAPK1, MPL, NF1, NOTCH1, PTEN, RB1, RUNX1, TET2, TP53 and WT1) are functionally linked to the eosinophilopoietic pathway. Among the 21 candidate genes, five genes (MAPK1, RUNX1, GATA2, NOTCH1 and TP53) with the highest number of linkages were considered major genes. A TCR assay revealed that four patients (13.3%) had a clonal TCR rearrangement. NOTCH1 was the most frequently mutated gene and was shown to be a common node for eosinophilopoiesis in our network analysis, while the possibility of hidden T cell malignancy was indwelling in the presence of NOTCH1 mutation, though not revealed by aberrant T cell study. Collectively, these results provide new evidence that mutations affecting eosinophilopoiesis underlie a subset of IHE/IHES, and the candidate genes are inferred to act their potential roles in the eosino-philopoietic pathway.	[Lee, Jee-Soo; Kim, Jung-Ah; Lee, Joon-hee; Lee, Dong Soon] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Seo, Heewon; Kim, Ju Han] Seoul Natl Univ, Coll Med, Div Biomed Informat, SNUBI, Seoul, South Korea; [Seo, Heewon; Kim, Ju Han] Seoul Natl Univ, Coll Med, Div Biomed Informat, Syst Biomed Informat Natl Core Res Ctr, Seoul, South Korea; [Im, Kyongok; Park, Si Nae; Kim, Sung-Min; Lee, Eun Kyoung; Lee, Dong Soon] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Kwon, Sunghoon] Seoul Natl Univ, Dept Elect Engn, Seoul, South Korea; [Lee, Jee-Soo; Kim, Miyoung] Hallym Univ, Sacred Heart Hosp, Dept Lab Med, Anyang, South Korea; [Koh, Insong] Hanyang Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Hwang, Seungwoo] KRIBB, Korean Bioinformat Ctr KOBIC, Daejeon, South Korea; [Park, Heung-Woo; Kang, Hye-Ryun; Park, Kyoung Soo] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Hallym University; Hanyang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU)	Lee, DS (corresponding author), Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.; Lee, DS (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	soonlee@snu.ac.kr	Park, Heung-Woo/AAW-7690-2020; Park, Kyong Soo/C-2265-2008	Park, Heung-Woo/0000-0002-6970-3228; Lee, Joon Hee/0000-0002-9649-1371; Seo, Heewon/0000-0001-6218-8609; Park, Kyong Soo/0000-0003-3597-342X	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2014R1A2A1A10052286]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2014R1A2A1A10052286). http://www,nrf.re.kr/index. DSL received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bain BJ, 2010, HAEMATOL-HEMATOL J, V95, P696, DOI 10.3324/haematol.2009.021675; Beer PA, 2010, HAEMATOL-HEMATOL J, V95, P2153, DOI 10.3324/haematol.2010.029306; Bruggemann M, 2007, LEUKEMIA, V21, P215, DOI 10.1038/sj.leu.2404481; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Faderl S, 2011, LEUKEMIAS: PRINCIPLES AND PRACTICE OF THERAPY, pIX; Gotlib J, 2015, AM J HEMATOL, V90, P1078, DOI 10.1002/ajh.24196; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Groenen Patricia J T A, 2008, J Hematop, V1, P97, DOI 10.1007/s12308-008-0013-9; Helbig G, 2009, HAEMATOL-HEMATOL J, V94, P1236, DOI 10.3324/haematol.2008.005447; Hodges E, 2003, J CLIN PATHOL, V56, P1, DOI 10.1136/jcp.56.1.1; Kim N, 2016, J EXPT STROKE TRANSL, V9, P1, DOI DOI 10.4172/1939-067X.1000145; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klion AD, 2015, BLOOD, V126, P1069, DOI 10.1182/blood-2014-11-551614; Koren-Michowitz M, 2013, BRIT J HAEMATOL, V161, P811, DOI 10.1111/bjh.12327; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; Lasho TL, 2011, LEUKEMIA, V25, P1056, DOI 10.1038/leu.2011.45; Leeke B, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-13; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Lykkegaard C, 2015, ONCOTARGET, V6, P40588, DOI 10.18632/oncotarget.5845; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Pardanani A, 2016, LEUKEMIA, V30, P1924, DOI 10.1038/leu.2016.73; Patterer V, 2013, ANN HEMATOL, V92, P759, DOI 10.1007/s00277-013-1695-3; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roufosse F, 2000, BRIT J HAEMATOL, V109, P540, DOI 10.1046/j.1365-2141.2000.02097.x; Sakai R, 2006, INT J HEMATOL, V84, P417, DOI 10.1532/IJH97.06054; Sandberg Y, 2005, J MOL DIAGN, V7, P495, DOI 10.1016/S1525-1578(10)60580-6; SCHMIDT U, 1988, BRIT J HAEMATOL, V68, P175, DOI 10.1111/j.1365-2141.1988.tb06186.x; SHAFFER LG, 2013, ISCN 2013 INT SYSTEM, P140; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simon HU, 1999, NEW ENGL J MED, V341, P1112, DOI 10.1056/NEJM199910073411503; Sulong S, 2009, BLOOD, V113, P100, DOI 10.1182/blood-2008-07-166801; Tefferi A, 2010, MAYO CLIN PROC, V85, P158, DOI 10.4065/mcp.2009.0503; Tenedini E, 2014, LEUKEMIA, V28, P1052, DOI 10.1038/leu.2013.302; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vaklavas C, 2007, LEUKEMIA RES, V31, P691, DOI 10.1016/j.leukres.2006.10.005; Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805; WHO, 2008, WHO CLASSIFICATION T; Wilkinson K, 2003, BLOOD, V102, P4187, DOI 10.1182/blood-2003-04-1150; Xu Chen, 2011, Chin J Cancer, V30, P264; Yamamoto K, 2014, LEUKEMIA LYMPHOMA, V55, P2402, DOI 10.3109/10428194.2014.885516	45	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0185602	10.1371/journal.pone.0185602	http://dx.doi.org/10.1371/journal.pone.0185602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088303	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900003
J	Shimoni, Z; Glick, J; Hermush, V; Froom, P				Shimoni, Zvi; Glick, Joseph; Hermush, Vered; Froom, Paul			Sensitivity of the dipstick in detecting bacteremic urinary tract infections in elderly hospitalized patients	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; DIAGNOSTIC-ACCURACY; OLDER WOMEN; URINALYSIS; COHORT	Background The sensitivity of the dipstick in elderly patients with a suspected urinary tract infection (UTI) is unclear because of the inclusion of patients with urine contamination or asymptomatic bacteriuria in previous studies. Methods We selected consecutive patients aged 65 years or older hospitalized in internal medicine departments with bacteremic UTI (same organism in blood and urine cultures) minimizing misclassifications. The false positive rate was determined in consecutive patients with negative culture results. A positive dipstick was a test result with a trace leukocyte esterase and/or nitrite positivity. Bacteriuria was the growth of at least 10(5) colony-forming units per milliliter of urine. Results Of 20,555 consecutive patients, 228 had a bacteremic UTI, and 4069 a negative culture result. The sensitivity of the dipstick was 96.9% (95% CI-93.7-98.6) with a false positive rate of 42.4% (95% CI, 41.0-43.8) in those with a negative culture result. Conclusions In elderly hospitalized patients with a bacteremic UTI, the dipstick urinalysis is highly sensitive, much higher than reported previously in studies of UTIs in the elderly. It is unclear whether the observed high sensitivity of the dipstick was due to the exclusion of patients with asymptomatic bacteriuria or to spectrum bias. Studies of the clinical utility/disutility of using a negative dipstick to rule out a urinary tract infection are warranted.	[Shimoni, Zvi] Laniado Hosp, Sanz Med Ctr, Dept Internal Med B, Netanya, Israel; [Shimoni, Zvi] Ruth & Bruce Rappaport Sch Med, Haifa, Israel; [Glick, Joseph] Laniado Hosp, Sanz Med Ctr, Cent Lab, Netanya, Israel; [Hermush, Vered] Laniado Hosp, Sanz Med Ctr, Dept Geriatr, Netanya, Israel; [Froom, Paul] Laniado Hosp, Sanz Med Ctr, Dept Clin Util, Netanya, Israel; [Froom, Paul] Tel Aviv Univ, Sch Publ Hlth, Ramat Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University	Froom, P (corresponding author), Laniado Hosp, Sanz Med Ctr, Dept Clin Util, Netanya, Israel.; Froom, P (corresponding author), Tel Aviv Univ, Sch Publ Hlth, Ramat Aviv, Israel.	froomp@gmail.com		Froom, Paul/0000-0001-5126-8590				Chen MC, 2016, ACS NANO, V10, P93, DOI 10.1021/acsnano.5b05043; Clinical and Laboratory Standards Institute, 2011, PHYS NONPH PROV PERF; Detweiler K, 2015, UROL CLIN N AM, V42, P561, DOI 10.1016/j.ucl.2015.07.002; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; Froom P, 2000, CLIN CHEM, V46, P1384; Froom P, 2012, AM J CLIN PATHOL, V137, P486, DOI 10.1309/AJCPLJFSS62YBAWN; Jones CW, 2014, J EMERG MED, V46, P71, DOI 10.1016/j.jemermed.2013.08.042; Juthani-Mehta M, 2007, J AM GERIATR SOC, V55, P1072, DOI 10.1111/j.1532-5415.2007.01217.x; Juthani-Mehta M, 2009, J AM GERIATR SOC, V57, P963, DOI 10.1111/j.1532-5415.2009.02227.x; Kayalp D, 2013, CLIN BIOCHEM, V46, P1285, DOI 10.1016/j.clinbiochem.2013.06.015; Kaye D, 1989, Trans Am Clin Climatol Assoc, V100, P155; Mayo S, 2008, J CLIN LAB ANAL, V22, P262, DOI 10.1002/jcla.20257; Mody L, 2014, JAMA-J AM MED ASSOC, V311, P844, DOI 10.1001/jama.2014.303; MONANE M, 1995, J AM GERIATR SOC, V43, P618, DOI 10.1111/j.1532-5415.1995.tb07194.x; Ouslander JG, 1996, J AM GERIATR SOC, V44, P420, DOI 10.1111/j.1532-5415.1996.tb06414.x; Schroeder AR, 2015, PEDIATRICS, V135, P965, DOI 10.1542/peds.2015-0012; Shimoni Z, 2008, EUR J INTERN MED, V19, P494, DOI 10.1016/j.ejim.2007.04.028; Shimoni Z, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013696; Woodford HJ, 2009, J AM GERIATR SOC, V57, P107, DOI 10.1111/j.1532-5415.2008.02073.x	19	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187381	10.1371/journal.pone.0187381	http://dx.doi.org/10.1371/journal.pone.0187381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088289	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900079
J	Esteve, C; Samson, M; Guilhem, A; Nicolas, B; Leguy-Seguin, V; Berthier, S; Bonnotte, B; Audia, S				Esteve, Clementine; Samson, Maxime; Guilhem, Alexandre; Nicolas, Barbara; Leguy-Seguin, Vanessa; Berthier, Sabine; Bonnotte, Bernard; Audia, Sylvain			Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients	PLOS ONE			English	Article							2ND-LINE TREATMENT; DOUBLE-BLIND; PURPURA; CHILDREN; SPLENECTOMY; ELTROMBOPAG; MANAGEMENT; REMISSION; RITUXIMAB; DISCONTINUATION	Dapsone is recommended as a second line therapy in immune thrombocytopenia (ITP), but is underused because of its potential side effects. The medical charts of 42 ITP patients treated with dapsone (100 mg/day) were retrospectively reviewed in order to assess its efficacy and safety in daily clinical practice. The overall response rate was 54.8% (n = 22, with a complete response in 38.1%) with a median time to response of 29 days (24-41 days). Patients with complete response had shorter disease duration whereas no difference was observed between responders and non-responders regarding age, sex or previous treatments received. Importantly, after dapsone withdrawal, a sustained response was observed in 5 patients, representing 12% of the whole cohort. Twenty percent of patients (n = 8) relapsed on therapy after 8.1 (6.5-13.6) months. Side effects occurred in 31% (n = 13) of patients, and required dapsone withdrawal in 22% (n = 9) or dosage reduction in 10% (n = 4) of the cases. Side effects resolved in all but one case. Overall, these data support dapsone as an interesting second line therapy in ITP, with a good safety and efficacy profile at a low cost.	[Esteve, Clementine; Samson, Maxime; Guilhem, Alexandre; Nicolas, Barbara; Leguy-Seguin, Vanessa; Berthier, Sabine; Bonnotte, Bernard; Audia, Sylvain] Univ Bourgogne Franche Comte, CHU Dijon Bourgogne, Serv Med Interne & Immunol Clin, Ctr Reference Constitutif Cytopenies Autoimmunes, Dijon, France	CHU Dijon Bourgogne	Audia, S (corresponding author), Univ Bourgogne Franche Comte, CHU Dijon Bourgogne, Serv Med Interne & Immunol Clin, Ctr Reference Constitutif Cytopenies Autoimmunes, Dijon, France.	sylvain.audia@u-bourgogne.fr	Bonnotte, Bernard/ABA-2525-2021; Samson, Maxime/ABE-1461-2021; Audia, Sylvain/H-3366-2019	Bonnotte, Bernard/0000-0002-1098-4598; Samson, Maxime/0000-0002-6547-232X; Audia, Sylvain/0000-0003-1772-1392				Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Audia S, 2016, REV MED INTERNE, V37, P43, DOI 10.1016/j.revmed.2015.08.007; Audia S, 2010, REV MED INTERNE, V31, P337, DOI 10.1016/j.revmed.2009.11.008; Bussel JB, 2009, LANCET, V373, P641, DOI 10.1016/S0140-6736(09)60402-5; Vancine-Califani SMC, 2008, PLATELETS, V19, P489, DOI 10.1080/09537100802315110; Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501; Damodar S, 2005, EUR J HAEMATOL, V75, P328, DOI 10.1111/j.1600-0609.2005.00545.x; DURAND JM, 1991, BRIT J HAEMATOL, V78, P460, DOI 10.1111/j.1365-2141.1991.tb04467.x; Dutta T K, 2001, J Assoc Physicians India, V49, P421; Godeau B, 1997, BRIT J HAEMATOL, V97, P336, DOI 10.1046/j.1365-2141.1997.412687.x; GODEAU B, 1993, AM J HEMATOL, V44, P70, DOI 10.1002/ajh.2830440117; Godeau B, 2008, BLOOD, V112, P999, DOI 10.1182/blood-2008-01-131029; HERNANDEZ F, 1995, BRIT J HAEMATOL, V90, P473, DOI 10.1111/j.1365-2141.1995.tb05179.x; Gonzalez-Lopez TJ, 2015, AM J HEMATOL, V90, pE40, DOI 10.1002/ajh.23900; Gonzalez-Lopez TJ, 2015, PLATELETS, V26, P83, DOI 10.3109/09537104.2013.870987; Khellaf M, 2005, HAEMATOLOGICA, V90, P829; Khellaf M, 2014, BLOOD, V124, P3228, DOI 10.1182/blood-2014-06-582346; Khellaf M, 2014, AM J HEMATOL, V89, P194, DOI 10.1002/ajh.23609; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Le Louet H, 1999, AM J HEMATOL, V62, P251, DOI 10.1002/(SICI)1096-8652(199912)62:4<251::AID-AJH10>3.3.CO;2-D; Loustau V, 2015, REV MED INTERNE, V36, P167, DOI 10.1016/j.revmed.2014.07.009; Mahevas M, 2016, BLOOD, V128, P1625, DOI 10.1182/blood-2016-03-704734; Mahevas M, 2014, BRIT J HAEMATOL, V165, P865, DOI 10.1111/bjh.12888; Maloisel F, 2004, AM J MED, V116, P590, DOI 10.1016/j.amjmed.2003.12.024; Meeker ND, 2003, J PEDIAT HEMATOL ONC, V25, P173, DOI 10.1097/00043426-200302000-00019; MOSS C, 1988, BRIT MED J, V297, P266, DOI 10.1136/bmj.297.6643.266; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Newland A, 2016, BRIT J HAEMATOL, V172, P262, DOI 10.1111/bjh.13827; Patel AP, 2015, PLATELETS, V26, P164, DOI 10.3109/09537104.2014.886677; Patel VL, 2012, BLOOD, V119, P5989, DOI 10.1182/blood-2011-11-393975; Provan D, 2003, BRIT J HAEMATOL, V120, P574; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Rodrigo C, 2013, J THROMB HAEMOST, V11, P1946, DOI 10.1111/jth.12371; Sauvetre G, 2015, AM J HEMATOL, V90, pE201, DOI 10.1002/ajh.24068; Vianelli N, 2013, HAEMATOLOGICA, V98, P875, DOI 10.3324/haematol.2012.075648; Zaja F, 2012, AM J HEMATOL, V87, P321, DOI 10.1002/ajh.22266	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187296	10.1371/journal.pone.0187296	http://dx.doi.org/10.1371/journal.pone.0187296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084292	Green Submitted, Green Published, gold			2022-12-27	WOS:000413910200046
J	Gram, M; Erlenwein, J; Petzke, F; Falla, D; Przemeck, M; Emons, MI; Reuster, M; Olesen, SS; Drewes, AM				Gram, Mikkel; Erlenwein, Joachim; Petzke, Frank; Falla, Deborah; Przemeck, Michael; Emons, Miriam I.; Reuster, Michael; Olesen, Soren S.; Drewes, Asbjorn M.			The cortical responses to evoked clinical pain in patients with hip osteoarthritis	PLOS ONE			English	Article							TONIC PAIN; EEG; PERCEPTION; POWER; OSCILLATIONS	Background Experimental models have been used extensively to evaluate pain using e.g., visual analogue scales or electroencephalography (EEG). Stimulation using tonic pain has been shown to better mimic the unpleasantness of chronic pain, but has mainly been evoked by non-clinical stimuli. This study aims to, evaluate the EEG during clinical pain in patients scheduled for total hip replacement with control and resting conditions. Methods The hip scheduled for replacement was moved by the examiner to evoke pain for 30 seconds while recording EEG. The control condition entailed movement of the opposite hip in a similar fashion and holding it for 30 seconds. In addition, EEG was recorded during the resting condition with open eyes. The relative spectral content was calculated from the EEG as well as functional connectivity using phase-lag index for frequency bands delta (1 -4Hz), theta (4-8Hz), alpha (8 -12Hz) and beta (12 -32Hz). A mixed model was used for statistical comparison between the three recording conditions. Results Spectral content differed between conditions in all bands. Functional connectivity differed in delta and theta frequency bands. Post-hoc analysis revealed differences between the painful and control condition in delta, theta and beta for spectral content. Pain during the hip rotation was correlated to the theta (r = -0.24 P = 0.03) and beta (r = 0.25 P = 0.02) content in the EEG. Conclusion EEG differences during hip movements in the affected and unaffected hip appeared in the spectral beta and theta content. This was correlated to the reported pain perceived, pointing towards pain specific brain activity related to clinical pain.	[Gram, Mikkel; Olesen, Soren S.; Drewes, Asbjorn M.] Aalborg Univ Hosp, Mech Sense, Dept Gastroenterol & Hepatol, Aalborg, Denmark; [Gram, Mikkel] Coaze IVS, Aalborg, Denmark; [Erlenwein, Joachim; Petzke, Frank; Falla, Deborah; Emons, Miriam I.; Reuster, Michael] Univ Gottingen, Univ Hosp, Dept Anesthesiol, Pain Clin, Gottingen, Germany; [Przemeck, Michael] Annastift, Dept Anesthesiol & Intens Care, Hannover, Germany; [Drewes, Asbjorn M.] Aalborg Univ Hosp, Clin Inst, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; University of Gottingen; Aalborg University; Aalborg University Hospital	Drewes, AM (corresponding author), Aalborg Univ Hosp, Mech Sense, Dept Gastroenterol & Hepatol, Aalborg, Denmark.; Drewes, AM (corresponding author), Aalborg Univ Hosp, Clin Inst, Aalborg, Denmark.	amd@mech-sensa.com	Drewes, Asbjørn/AAR-7479-2021; Falla, Deborah/ABA-7734-2021	Drewes, Asbjørn/0000-0001-7465-964X; Falla, Deborah/0000-0003-1689-6190; Erlenwein, Joachim/0000-0003-4782-3402	Innovation Fund Denmark - Individuals, Disease and Society [10-092786]	Innovation Fund Denmark - Individuals, Disease and Society	This study was funded from Innovation Fund Denmark - Individuals, Disease and Society, grant number 10-092786 http:// innovationsfonden.dk/en.	Akin M, 2002, J Med Syst, V26, P241, DOI 10.1023/A:1015075101937; BACKONJA M, 1991, ELECTROEN CLIN NEURO, V79, P192, DOI 10.1016/0013-4694(91)90137-S; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; BRESLAU J, 1989, ELECTROEN CLIN NEURO, V72, P281, DOI 10.1016/0013-4694(89)90063-1; Castellanos NP, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00090; Chang PF, 2002, BRAIN RES BULL, V57, P667, DOI 10.1016/S0361-9230(01)00763-8; Downian R, 2008, CLIN NEUROPHYSIOL, V119, P1201, DOI 10.1016/j.clinph.2008.01.019; Drewes AM, 2003, SCAND J GASTROENTERO, V38, P1115, DOI 10.1080/00365520310004399; DUSTMAN RE, 1985, NEUROBIOL AGING, V6, P193, DOI 10.1016/0197-4580(85)90049-1; Gram M, 2015, CLIN NEUROPHYSIOL, V126, P763, DOI 10.1016/j.clinph.2014.07.027; Gross J, 2007, PLOS BIOL, V5, P1168, DOI 10.1371/journal.pbio.0050133; Hardmeier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108648; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Khodayari-Rostamabad A, 2015, ANESTHESIOLOGY, V122, P140, DOI 10.1097/ALN.0000000000000510; Kramer JLK, 2012, J NEUROSCI, V32, P12981, DOI 10.1523/JNEUROSCI.3175-12.2012; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Malver LP, 2014, BRIT J CLIN PHARMACO, V77, P72, DOI 10.1111/bcp.12137; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Nir RR, 2012, CLIN NEUROPHYSIOL, V123, P605, DOI 10.1016/j.clinph.2011.08.006; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Olesen AE, 2012, PHARMACOL REV, V64, P722, DOI 10.1124/pr.111.005447; Olesen SS, 2011, EUR J GASTROEN HEPAT, V23, P418, DOI 10.1097/MEG.0b013e3283457b09; Olesen SS, 2011, SCAND J GASTROENTERO, V46, P988, DOI 10.3109/00365521.2011.579160; RAINVILLE P, 1992, SOMATOSENS MOT RES, V9, P265, DOI 10.3109/08990229209144776; Shao SY, 2012, CLIN NEUROPHYSIOL, V123, P2042, DOI 10.1016/j.clinph.2012.02.084; STEEDMAN SM, 1992, CLIN J PAIN, V8, P204, DOI 10.1097/00002508-199209000-00004; Stormo K, 1998, CURR REV PAIN, V2, P171, DOI DOI 10.1007/S11916-998-0015-4; Zhang ZG, 2012, J NEUROSCI, V32, P7429, DOI 10.1523/JNEUROSCI.5877-11.2012	29	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186400	10.1371/journal.pone.0186400	http://dx.doi.org/10.1371/journal.pone.0186400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084278	Green Published, gold			2022-12-27	WOS:000413910200006
J	Hensel, Z				Hensel, Zach			A plasmid-based Escherichia coli gene expression system with cell-to-cell variation below the extrinsic noise limit	PLOS ONE			English	Article							PROPAGATION; CONSTRUCTION; SIMULATION; MOLECULES; NETWORKS; BINDING; DESIGN; IMAGE	Experiments in synthetic biology and microbiology can benefit from protein expression systems with low cell(to(cell variability (noise) and expression levels precisely tunable across a useful dynamic range. Despite advances in understanding the molecular biology of microbial gene regulation, many experiments employ protein(expression systems exhibiting high noise and nearly all(or(none responses to induction. I present an expression system that incorporates elements known to reduce gene expression noise: negative autoregulation and bicistronic transcription. I show by stochastic simulation that while negative autoregulation can produce a more gradual response to induction, bicistronic expression of a repressor and gene of interest can be necessary to reduce noise below the extrinsic limit. I synthesized a plasmid(based system incorporating these principles and studied its properties in Escherichia coli cells, using flow cytometry and fluorescence microscopy to characterize induction dose(response, induction/repression kinetics and gene expression noise. By varying ribosome binding site strengths, expression levels from 55-10,740 molecules/cell were achieved with noise below the extrinsic limit. Individual strains are inducible across a dynamic range greater than 20(fold. Experimental comparison of different regulatory networks confirmed that bicistronic autoregulation reduces noise, and revealed unexpectedly high noise for a conventional expression system with a constitutively expressed transcriptional repressor. I suggest a hybrid, low(noise expression system to increase the dynamic range.	[Hensel, Zach] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal; [Hensel, Zach] Okinawa Inst Sci & Technol, Deans Res Unit, Okinawa, Japan	Universidade Nova de Lisboa; Okinawa Institute of Science & Technology Graduate University	Hensel, Z (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal.; Hensel, Z (corresponding author), Okinawa Inst Sci & Technol, Deans Res Unit, Okinawa, Japan.	zach.hensel@itqb.unl.pt	Hensel, Zach/G-2941-2015	Hensel, Zach/0000-0002-4348-6229	Microbiologia Molecular, Estrutural e Celular [LISBOA-01-0145-FEDER-007660]; national funds through FCT - Fundacao para a Ciencia e a Tecnologia; Research Unit at the Okinawa Institute of Science and Technology (OIST); FEDER funds through COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI)	Microbiologia Molecular, Estrutural e Celular; national funds through FCT - Fundacao para a Ciencia e a Tecnologia; Research Unit at the Okinawa Institute of Science and Technology (OIST); FEDER funds through COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI)	This work was financially supported by: Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI), by national funds through FCT - Fundacao para a Ciencia e a Tecnologia, and by the Dean's Research Unit at the Okinawa Institute of Science and Technology (OIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by: Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI), by national funds through FCT-Fundacao para a Ciencia e a Tecnologia, and by the Dean's Research Unit at the Okinawa Institute of Science and Technology (GIST). Experiments were done at GIST; data analysis, simulations, additional experiments and paper writing were done at the Instituto de Tecnologia Quimica e Biologica Antonio Xavier. I thank Dr. Eder Zavala (University of Exeter) for his insightful comments on the manuscript.	Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Binder D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160711; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gillespie DT, 1996, PHYS REV E, V54, P2084, DOI 10.1103/PhysRevE.54.2084; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hartvig L, 1996, EMBO J, V15, P4767, DOI 10.1002/j.1460-2075.1996.tb00854.x; Hensel Z, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001591; Hensel Z, 2012, NAT STRUCT MOL BIOL, V19, P797, DOI 10.1038/nsmb.2336; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Kang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029800; Karig DK, 2012, NUCLEIC ACIDS RES, V40, P3763, DOI 10.1093/nar/gkr1191; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lederer T, 1996, BIOCHEMISTRY-US, V35, P7439, DOI 10.1021/bi952683e; Lovdok L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000171; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; POSTLE K, 1984, NUCLEIC ACIDS RES, V12, P4849, DOI 10.1093/nar/12.12.4849; Ray JCJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002672; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sneppen K, 2010, MBIO, V1, DOI 10.1128/mBio.00177-10; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187259	10.1371/journal.pone.0187259	http://dx.doi.org/10.1371/journal.pone.0187259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084263	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200043
J	Kumar, S; Tanti, B; Patil, BL; Mukherjee, SK; Sahoo, L				Kumar, Sanjeev; Tanti, Bhaben; Patil, Basavaprabhu L.; Mukherjee, Sunil Kumar; Sahoo, Lingaraj			RNAi-derived transgenic resistance to Mungbean yellow mosaic India virus in cowpea	PLOS ONE			English	Article							LEAF CURL DISEASE; ENGINEERING RESISTANCE; HAIRPIN RNA; MEDIATED RESISTANCE; GENOMIC COMPONENTS; ADENOSINE KINASE; GEMINIVIRUS AL2; DNA VIRUS; GENE; PLANTS	Cowpea is an important grain legume crop of Africa, Latin America, and Southeast Asia. Leaf curl and golden mosaic diseases caused by Mungbean yellow mosaic India virus (MYMIV) have emerged as most devastating viral diseases of cowpea in Southeast Asia. In this study, we employed RNA interference (RNAi) strategy to control cowpea-infecting MYMIV. For this, we generated transgenic cowpea plants harbouring three different intron hairpin RNAi constructs, containing the AC2, AC4 and fusion of AC2 and AC4 (AC2+AC4) of seven cowpea-infecting begomoviruses. The T-0 and T-1 transgenic cowpea lines of all the three constructs accumulated transgene-specific siRNAs. Transgenic plants were further assayed up to T-1 generations, for resistance to MYMIV using agro-infectious clones. Nearly 100% resistance against MYMIV infection was observed in transgenic lines, expressing AC2-hp and AC2+AC4-hp RNA, when compared with untransformed controls and plants transformed with empty vectors, which developed severe viral disease symptoms within 3 weeks. The AC4-hp RNA expressing lines displayed appearance of milder symptoms after 5 weeks of MYMIV-inoculation. Northern blots revealed a positive correlation between the level of transgene-specific siRNAs accumulation and virus resistance. The MYMIV-resistant transgenic lines accumulated nearly zero or very low titres of viral DNA. The transgenic cowpea plants had normal phenotype with no yield penalty in greenhouse conditions. This is the first demonstration of RNAi-derived resistance to MYMIV in cowpea.	[Kumar, Sanjeev; Sahoo, Lingaraj] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, India; [Kumar, Sanjeev; Tanti, Bhaben] Gauhati Univ, Dept Bot, Gauhati, Assam, India; [Patil, Basavaprabhu L.] ICAR Natl Res Ctr Plant Biotechnol, LBS Ctr, IARI, Pusa Campus, New Delhi, India; [Mukherjee, Sunil Kumar] Indian Agr Res Inst, Div Plant Pathol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Gauhati University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Sahoo, L (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, India.	ls@iitg.ernet.in		Sahoo, Lingaraj/0000-0001-8103-2714; Patil, Basavaprabhu/0000-0002-6023-5894	Department of Biotechnology, Government of India [BT/173/NE/TDP/2011, BT/PR13560/COE/34/44/2015]; DBT	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India)	The work was funded by a research grant to LS and SKM from the Department of Biotechnology, Government of India (BT/173/NE/TDP/2011 and BT/PR13560/COE/34/44/2015). S.K. is grateful to DBT for Research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to CSIRO, Australia for the pHANNIBAL, pKANNIBAL and pART27 vectors. We express our sincere thanks to Prof. Sampa Das, Bose Institute for providing Agrobacterium tumefaciens strain, EHA105 and Center for Application of Molecular Biology to International Agriculture (CAMBIA), Australia for pCAMBIA3300. S.K. is grateful to DBT for Research fellowship.	Alegbejo MD, 2001, J SUSTAIN AGR, V18, P55, DOI 10.1300/J064v18n01_05; Aragao FJL, 1998, MOL BREEDING, V4, P491, DOI 10.1023/A:1009613607559; Bakshi S, 2012, J PLANT GROWTH REGUL; Bakshi S, 2012, PLANT CELL TISS ORG, V110, P77, DOI 10.1007/s11240-012-0132-y; Bakshi S, 2012, PLANT CELL REP, V31, P1093, DOI 10.1007/s00299-012-1230-3; Bakshi S, 2011, PLANT CELL REP, V30, P2281, DOI 10.1007/s00299-011-1133-8; Behura R, 2015, METHODS MOL BIOL, V1223, P255, DOI 10.1007/978-1-4939-1695-5_20; Bendahmane M, 1997, PLANT MOL BIOL, V33, P351, DOI 10.1023/A:1005715805000; Bonfim K, 2007, MOL PLANT MICROBE IN, V20, P717, DOI 10.1094/MPMI-20-6-0717; Chakraborty S, 2008, J GEN VIROL, V89, P818, DOI 10.1099/vir.0.82873-0; Chellappan P, 2004, PLANT MOL BIOL, V56, P601, DOI 10.1007/s11103-004-0147-9; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Cruz ARR, 2014, PLANT PATHOL, V63, P831, DOI 10.1111/ppa.12178; DAY AG, 1991, P NATL ACAD SCI USA, V88, P6721, DOI 10.1073/pnas.88.15.6721; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; FARGETTE D, 1994, PHYTOPATHOLOGY, V84, P91, DOI 10.1094/Phyto-84-91; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Hanley-Bowdoin L, 1999, CRIT REV PLANT SCI, V18, P71, DOI 10.1016/S0735-2689(99)00383-4; Haq QMI, 2010, INDIAN J VIROL, V21, P82, DOI 10.1007/s13337-010-0003-2; Hema M, 2014, ADV VIRUS RES, V90, P431, DOI 10.1016/B978-0-12-801246-8.00009-3; Jeske H, 2009, CURR TOP MICROBIOL, V331, P185; John P, 2008, ARCH VIROL, V153, P1359, DOI 10.1007/s00705-008-0116-8; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; KAREEM KT, 2007, VIROL J, V4, DOI DOI 10.1186/1743-; Kumar S, 2016, WORLD RES J BIOTECHN, V3, P53; Kumar S, 2017, BIOCATAL AGRIC BIOTE, V11, P183, DOI 10.1016/j.bcab.2017.07.004; Langyintuo AS, 2003, FIELD CROP RES, V82, P215, DOI 10.1016/S0378-4290(03)00039-x; Lin CY, 2012, TRANSGENIC RES, V21, P231, DOI 10.1007/s11248-011-9523-9; Malathi VG, 2005, CAN J PLANT PATHOL, V27, P439; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Mendez-Lozano J, 2003, PHYTOPATHOLOGY, V93, P270, DOI 10.1094/PHYTO.2003.93.3.270; Mishra S, 2015, PLANT CELL TISS ORG, V120, P19, DOI 10.1007/s11240-014-0572-7; Mishra S, 2014, MOL BREEDING, V34, P1345, DOI 10.1007/s11032-014-0120-5; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; NENE YL, 1973, PLANT DIS REP, V57, P463; Owor BE, 2011, J GEN VIROL, V92, P2458, DOI 10.1099/vir.0.032862-0; Patil BL, 2016, VIRUS RES, V213, P109, DOI 10.1016/j.virusres.2015.11.011; Patil BL, 2015, VIRUS GENES, V50, P474, DOI 10.1007/s11262-015-1184-y; Patil BL, 2015, MOL PLANT PATHOL, V16, P484, DOI 10.1111/mpp.12205; Patil BL, 2011, MOL PLANT PATHOL, V12, P31, DOI 10.1111/j.1364-3703.2010.00650.x; Pooggin M, 2003, NAT BIOTECHNOL, V21, P131, DOI 10.1038/nbt0203-131b; Praveen S, 2010, TRANSGENIC RES, V19, P45, DOI 10.1007/s11248-009-9291-y; Rahman J, 2012, APPL BIOCHEM BIOTECH, V167, P758, DOI 10.1007/s12010-012-9702-z; Rajeswaran R, 2007, MOL PLANT MICROBE IN, V20, P1545, DOI 10.1094/MPMI-20-12-1545; Ramesh SV, 2007, OLIGONUCLEOTIDES, V17, P251, DOI 10.1089/oli.2006.0063; Renteria-Canett I, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-104; Ribeiro SG, 2007, J VIROL, V81, P1563, DOI 10.1128/JVI.01238-06; Rodriguez-Negrete EA, 2009, J VIROL, V83, P1332, DOI 10.1128/JVI.01474-08; Rouhibakhsh A, 2005, PLANT PATHOL, V54, P259, DOI 10.1111/j.1365-3059.2005.01139.x; Roy A., 2001, Tropical Agricultural Research, V13, P341; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; SAUNDERS K, 1995, J GEN VIROL, V76, P2287, DOI 10.1099/0022-1317-76-9-2287; Shanmugapriya Gnanasekaran, 2015, VirusDisease, V26, P55, DOI 10.1007/s13337-015-0251-2; Shivaprasad PV, 2005, J VIROL, V79, P8149, DOI 10.1128/JVI.79.13.8149-8163.2005; Singh BB, 2005, GEN RESOUR CHROM ENG, V1, P117; Singh BB, 2002, RECENT PROGR COWPEA, P22; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Solleti SK, 2008, J BIOTECHNOL, V135, P97, DOI 10.1016/j.jbiotec.2008.02.008; Solleti SK, 2008, PLANT CELL REP; Sunitha S, 2013, VIRUS GENES, V46, P496, DOI 10.1007/s11262-013-0889-z; Surendranath B, 2005, ARCH VIROL, V150, P1833, DOI 10.1007/s00705-005-0542-9; Szittya G, 2013, CURR TOP MICROBIOL, V371, P153, DOI 10.1007/978-3-642-37765-5_6; THOTTAPPILLY G, 1992, TROP PEST MANAGE, V38, P337; Timko M.P., 2007, PULSES SUGAR TUBER C, V3, P49, DOI DOI 10.1007/978-3-540-34516-9_3; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; Tzfira T, 2006, CURR OPIN BIOTECH, V17, P147, DOI 10.1016/j.copbio.2006.01.009; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vanderschuren H, 2007, PLANT BIOTECHNOL J, V5, P207, DOI 10.1111/j.1467-7652.2006.00217.x; Vanderschuren H, 2009, PLANT MOL BIOL, V70, P265, DOI 10.1007/s11103-009-9472-3; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; VARMA A, 1992, MUNGBEAN YELLOW MOSAIC DISEASE: PROCEEDINGS OF AN INTERNATIONAL WORKSHOP, BANGKOK, THAILAND, 2-3 JULY 1991, P8; Wang H, 2005, J VIROL, V79, P7410, DOI 10.1128/JVI.79.12.7410-7418.2005; Wang H, 2003, PLANT CELL, V15, P3020, DOI 10.1105/tpc.015180; Wang MB, 2000, MOL PLANT PATHOL, V1, P347, DOI 10.1046/j.1364-3703.2000.00038.x; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Zhang P, 2005, PLANT BIOTECHNOL J, V3, P385, DOI 10.1111/j.1467-7652.2005.00132.x; [No title captured]	79	25	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186786	10.1371/journal.pone.0186786	http://dx.doi.org/10.1371/journal.pone.0186786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077738	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200022
J	Lee, HW; Kim, KJ; Jung, KS; Chon, YE; Huh, JH; Park, KH; Chung, JB; Kim, CO; Han, KH; Park, JY				Lee, Hye Won; Kim, Kwang Joon; Jung, Kyu Sik; Chon, Young Eun; Huh, Ji Hye; Park, Kyeong Hye; Chung, Jae Bock; Kim, Chang Oh; Han, Kwang-Hyub; Park, Jun Yong			The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter	PLOS ONE			English	Article							FATTY LIVER-DISEASE; RISK-FACTORS; METABOLIC SYNDROME; MASS; PREVALENCE; DIAGNOSIS; PREDICTORS; ULTRASOUND; ADIPOSITY; FIBROSIS	Background Nonalcoholic fatty liver disease (NAFLD) is closely related with obesity. However, obese subjects, generally represented by high BMI, do not always develop NAFLD. A number of possible causes of NAFLD have been studied, but the exact mechanism has not yet been elucidated. Methods A total of 304 consecutive subjects who underwent general health examinations including abdominal ultrasonography, transient elastography and abdominal fat computed tomography were prospectively enrolled. Significant steatosis was diagnosed by ultrasonography and controlled attenuation parameter (CAP) assessed by transient elastography. Results Visceral fat area (VFA) was significantly related to hepatic steatosis assessed by CAP, whereas body mass index (BMI) was related to CAP only in univariate analysis. In multiple logistic regression analysis, VFA (odds ratio [OR], 1.010; 95% confidence interval [CI], 1.001-1.019; P = 0.028) and triglycerides (TG) (OR, 1.006; 95% CI, 1.001-1.011; P = 0.022) were independent risk factors for significant hepatic steatosis. The risk of significant hepatic steatosis was higher in patients with higher VFA: the OR was 4.838 (P< 0.001; 95% CI, 2.912-8.039) for 100< VFA <= 200 cm(2) and 7.474 (P< 0.001; 95% CI, 2.462-22.693) for VFA > 200 cm(2), compared to patients with a VFA <= 100 cm(2). Conclusions Our data demonstrated that VFA and TG is significantly related to hepatic steatosis assessed by CAP not BMI. This finding suggests that surveillance for subjects with NAFLD should incorporate an indicator of visceral obesity, and not simply rely on BMI.	[Lee, Hye Won; Jung, Kyu Sik; Chung, Jae Bock; Han, Kwang-Hyub; Park, Jun Yong] Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea; [Lee, Hye Won; Jung, Kyu Sik; Chung, Jae Bock; Han, Kwang-Hyub; Park, Jun Yong] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea; [Kim, Kwang Joon; Kim, Chang Oh] Yonsei Univ, Coll Med, Dept Internal Med, Div Geriatr, Seoul, South Korea; [Chon, Young Eun] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Seongman, South Korea; [Huh, Ji Hye] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Endocrinol & Metab, Wonju, South Korea; [Park, Kyeong Hye] Ilsan Hosp, Dept Internal Med, Div Endocrinol & Metab, Natl Hlth Insurance Serv, Goyang, Gyeonggi, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; National Health Insurance Service; NHIS Ilsan Hospital	Park, JY (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea.; Park, JY (corresponding author), Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea.	DRPJY@yuhs.ac	Park, Jun Yong/H-7127-2019	Kim, Chang Oh/0000-0002-0773-5443; Park, Jun Yong/0000-0001-6324-2224; Han, Kwang-Hyub/0000-0003-3960-6539; Lee, Hye Won/0000-0002-3552-3560				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Chon YE, 2013, LIVER INT, V30, P12282; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; FOSTER KJ, 1980, BRIT J RADIOL, V53, P440, DOI 10.1259/0007-1285-53-629-440; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Hsieh SD, 2000, INT J OBESITY, V24, P358, DOI 10.1038/sj.ijo.0801157; Jung SH, 2016, YONSEI MED J, V57, P674, DOI 10.3349/ymj.2016.57.3.674; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Kim D, 2017, CLIN GASTROENTEROL H, V15, P474, DOI 10.1016/j.cgh.2016.08.028; Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169; Lee HW, 2017, DIGEST DIS SCI, V62, P2150, DOI 10.1007/s10620-017-4592-0; Lee HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157358; Lee KK, 2012, YONSEI MED J, V53, P99, DOI 10.3349/ymj.2012.53.1.99; Lin YC, 2010, PEDIATR NEONATOL, V51, P149, DOI 10.1016/S1875-9572(10)60028-9; Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x; Loomis AK, 2016, J CLIN ENDOCR METAB, V101, P945, DOI 10.1210/jc.2015-3444; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Oh H, 2016, CLIN MOL HEPATOL, V22, P327, DOI 10.3350/cmh.2016.0049; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Pang Q, 2015, WORLD J GASTROENTERO, V21, P1650, DOI 10.3748/wjg.v21.i5.1650; Park BJ, 2008, J GASTROEN HEPATOL, V23, P900, DOI 10.1111/j.1440-1746.2007.05212.x; Pickhardt PJ, 2012, AM J ROENTGENOL, V198, P1100, DOI 10.2214/AJR.11.7361; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Ratziu V, 2002, HEPATOLOGY, V35, P1485, DOI 10.1053/jhep.2002.33324; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Sobhonslidsuk A, 2007, WORLD J GASTROENTERO, V13, P3614, DOI 10.3748/wjg.v13.i26.3614; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vongsuvanh R, 2012, J HEPATOL, V57, P392, DOI 10.1016/j.jhep.2012.03.013; Xu CF, 2013, AM J GASTROENTEROL, V108, P1299, DOI 10.1038/ajg.2013.104	35	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187066	10.1371/journal.pone.0187066	http://dx.doi.org/10.1371/journal.pone.0187066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077769	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200040
J	Romero-Ugalde, HM; Le Rolle, V; Bonnet, JL; Henry, C; Belo, A; Mabo, P; Carrault, G; Hernandez, AI				Romero-Ugalde, Hector M.; Le Rolle, Virginie; Bonnet, Jean-Luc; Henry, Christine; Belo, Alain; Mabo, Philippe; Carrault, Guy; Hernandez, Alfredo I.			A novel controller based on state-transition models for closed-loop vagus nerve stimulation: Application to heart rate regulation	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; VENTRICULAR RATE; FAILURE; DESIGN	Vagus nerve stimulation (VNS) is an established adjunctive therapy for pharmacologically refractory epilepsy and depression and is currently in active clinical research for other applications. In current clinical studies, VNS is delivered in an open-loop approach, where VNS parameters are defined during a manual titration phase. However, the physiological response to a given VNS configuration shows significant inter and intra-patient variability and may significantly evolve through time. VNS closed-loop approaches, allowing for the optimization of the therapy in an adaptive manner, may be necessary to improve efficacy while reducing side effects. This paper proposes a generic, closed-loop control VNS system that is able to optimize a number of VNS parameters in an adaptive fashion, in order to keep a control variable within a specified range. Although the proposed control method is completely generic, an example application using the cardiac beat to beat interval (RR) as control variable will be developed in this paper. The proposed controller is based on a state transition model (STM) that can be configured using a partially or a fully-connected architecture, different model orders and different state-transition algorithms. The controller is applied to the adaptive regulation of heart rate and evaluated on 6 sheep, for 13 different targets, using partially-connected STM with 10 states. Also, partially and fully-connected STM defined by 30 states were applied to 7 other sheep for the same 10 targets. Results illustrate the interest of the proposed fully-connected STM and the feasibility of integrating this control system into an implantable neuromodulator.	[Romero-Ugalde, Hector M.; Le Rolle, Virginie; Mabo, Philippe; Carrault, Guy; Hernandez, Alfredo I.] INSERM, U1099, F-35000 Rennes, France; [Romero-Ugalde, Hector M.; Le Rolle, Virginie; Mabo, Philippe; Carrault, Guy; Hernandez, Alfredo I.] Univ Rennes 1, LTSI, F-35000 Rennes, France; [Bonnet, Jean-Luc; Henry, Christine] Sorin CRM SAS, Clamart, France; [Belo, Alain] INSERM, UMR970, Paris Cardiovasc Res Ctr, Paris, France; [Belo, Alain] Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, Paris, France; [Belo, Alain] Paris Descartes Univ, PRES Paris Sorbonne, Paris, France; [Mabo, Philippe] CHU Rennes, Dept Cardiol, F-35000 Rennes, France; [Mabo, Philippe] INSERM, CIC IT 1414, F-35000 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Le Rolle, V (corresponding author), INSERM, U1099, F-35000 Rennes, France.; Le Rolle, V (corresponding author), Univ Rennes 1, LTSI, F-35000 Rennes, France.	virginie.lerolle@univ-rennes1.fr	carrault, guy/ABC-4463-2020; Hernández, Alfredo I/K-4933-2015; Le Rolle, Virginie/AAQ-7010-2020	carrault, guy/0000-0003-1482-2067; Hernández, Alfredo I/0000-0003-0765-2311; Le Rolle, Virginie/0000-0003-1068-5587; Romero Ugalde, Hector Manuel/0000-0002-7614-6474	BPIFRANCE within French "Investments for the future" program - INTENSE project; BPIFRANCE within French "Investments for the future" program INTENSE project	BPIFRANCE within French "Investments for the future" program - INTENSE project; BPIFRANCE within French "Investments for the future" program INTENSE project	This work was supported by BPIFRANCE within the framework of the French "Investments for the future" program (http://investissementsdavenir.bpifrance.fr) - INTENSE project. SORIN CRM SAS did not support financially the project. JLB and CH are employed by SORIN CRM SAS. No other authors received a salary or gratification from SORIN CRM SAS for their contribution to this work. The specific roles of the authors are articulated in the "author contributions" section.; This work was partially supported by BPIFRANCE within the framework of the French "Investments for the future" program INTENSE project.	Akhtar H, 2016, NEUROSCI BULL, V32, P115, DOI 10.1007/s12264-015-0009-2; Andreu D, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026001; BILGUTAY AM, 1968, J THORAC CARDIOV SUR, V56, P71, DOI 10.1016/S0022-5223(19)42875-4; Buschman HP, 2006, NEUROMODULATION, V9, P214, DOI 10.1111/j.1525-1403.2006.00062.x; De Ferrari GM, 2009, IEEE ENG MED BIO, P2037, DOI 10.1109/IEMBS.2009.5334414; Hauptman PJ, 2012, AM HEART J, V163, P954, DOI 10.1016/j.ahj.2012.03.021; Healy S, 2013, CHILD NERV SYST, V29, P2095, DOI 10.1007/s00381-013-2143-3; Kobayashi M, 2013, ANN THORAC SURG, V96, P339, DOI 10.1016/j.athoracsur.2012.12.060; Ojeda D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163734; Pednault E. P. D., 1994, Journal of Logic and Computation, V4, P467, DOI 10.1093/logcom/4.5.467; Premchand RK, 2015, J CARD FAIL; Reiter R., 2001, KNOWLEDGE ACTION LOG; Romer H, 2016, BIOL CYBERN, V110, P247, DOI 10.1007/s00422-015-0672-4; Rousselet L, 2014, IEEE ENG MED BIO, P526, DOI 10.1109/EMBC.2014.6943644; Rychticki F, 2006, SEIZURE-EUR J EPILEP, V15, P483, DOI 10.1016/j.seizure.2006.06.001; Schwartz PJ, 2009, HEART RHYTHM, V6, pS76, DOI 10.1016/j.hrthm.2009.08.012; Tosato M, 2006, MED BIOL ENG COMPUT, V44, P161, DOI 10.1007/s11517-006-0037-1; Ugalde HMR, 2015, I IEEE EMBS C NEUR E, P462, DOI 10.1109/NER.2015.7146659; Ugalde HR, 2014, IEEE ENG MED BIO, P6262, DOI 10.1109/EMBC.2014.6945060; Waninger MS, 2000, PACE, V23, P1239, DOI 10.1111/j.1540-8159.2000.tb00937.x; Zannad F, 2015, EUR HEART J, V36, P425, DOI 10.1093/eurheartj/ehu345; Zhang YH, 2002, AM J PHYSIOL-HEART C, V282, pH1102, DOI 10.1152/ajpheart.00738.2001; Zhou YX, 2010, J BIOMED RES, V24, P107, DOI 10.1016/S1674-8301(10)60018-8	23	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186068	10.1371/journal.pone.0186068	http://dx.doi.org/10.1371/journal.pone.0186068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077707	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200009
J	Zhang, XX; Chen, K; Wu, YD; Wiest, O				Zhang, Xiaoxiao; Chen, Kai; Wu, Yun-Dong; Wiest, Olaf			Protein dynamics and structural waters in bromodomains	PLOS ONE			English	Article							FORCE-FIELD; LYSINE ACETYLATION; HISTONE RECOGNITION; MOLECULAR-DYNAMICS; ATAD2 BROMODOMAIN; INHIBITORS; SIMULATIONS; METABOLISM; LANDSCAPE; PROGRESS	Bromodomains are epigenetic readers of acetylated lysines that are integral parts of histone tails. The 61 bromodomains in humans are structurally highly conserved but specifically bind to widely varying recognition motifs, suggesting that dynamic rather than static factors are responsible for recognition selectivity. To test this hypothesis, the dynamics of the binding sites and structural water molecules of four bromodomains (ATAD2, BAZ2B, BRD2(1) and CREBBP) representing four different subtypes is studied with 1 mu s MD simulations using the RSFF2 force field. The different dynamics of the ZA-loops and BC-loops between the four bromodomains leads to distinct patterns for the opening and closing of the binding pocket. This in turn determines the structural and energetic properties of the structural waters in the binding pocket, suggesting that these waters are not only important for the recognition itself, as has been proposed previously, but also contribute to the selectivity of different bromodomains.	[Zhang, Xiaoxiao; Chen, Kai; Wu, Yun-Dong; Wiest, Olaf] Peking Univ, Lab Computat Chem & Drug Design, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Chen, Kai] South China Univ Technol, Sch Chem & Chem Engn, Key Lab Funct Mol Engn Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Yun-Dong] Peking Univ, Coll Chem & Mol Engn, Beijing, Peoples R China; [Wiest, Olaf] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Peking University; University Town of Shenzhen; South China University of Technology; Peking University; University of Notre Dame	Wiest, O (corresponding author), Peking Univ, Lab Computat Chem & Drug Design, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China.; Wiest, O (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	owiest@nd.edu	Wu, Yun-Dong/G-8463-2013; Chen, Kai/U-9373-2017; Chen, Kai/AAF-4663-2019	Chen, Kai/0000-0003-1012-0383; Chen, Kai/0000-0003-1012-0383; Wiest, Olaf/0000-0001-9316-7720	National Science Foundation of China [NSFC 21133002]; Shenzhen Peacock Program [JCYJ20140509093817689]; Nanshan District [KC2014ZDZJ0026A]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Peacock Program; Nanshan District	This work was supported by National Science Foundation of China (NSFC 21133002), Shenzhen Peacock Program (JCYJ20140509093817689), and Nanshan District (KC2014ZDZJ0026A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the National Science Foundation of China (NSFC 21133002) the Shenzhen Peacock Program (JCYJ20140509093817689) and the Nanshan District (KC2014ZDZJ0026A) for financial support.	Arking DE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002158; Bamborough P, 2015, J MED CHEM, V58, P6151, DOI 10.1021/acs.jmedchem.5b00773; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Chaikuad A, 2014, MEDCHEMCOMM, V5, P1843, DOI 10.1039/c4md00237g; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Chung CW, 2012, J MED CHEM, V55, P576, DOI 10.1021/jm201320w; Crawford TD, 2016, J MED CHEM, V59, P5391, DOI 10.1021/acs.jmedchem.6b00264; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Drouin L, 2015, J MED CHEM, V58, P2553, DOI 10.1021/jm501963e; Ferguson FM, 2014, BIOCHEMISTRY-US, V53, P6706, DOI 10.1021/bi500909d; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Flynn EM, 2015, STRUCTURE, V23, P1801, DOI 10.1016/j.str.2015.08.004; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hewings DS, 2012, J MED CHEM, V55, P9393, DOI 10.1021/jm300915b; Hnilicova J, 2013, MOL BIOL CELL, V24, P3557, DOI 10.1091/mbc.E13-06-0303; Huang DZ, 2014, CHEMMEDCHEM, V9, P573, DOI 10.1002/cmdc.201300156; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jiang F, 2014, J AM CHEM SOC, V136, P9536, DOI 10.1021/ja502735c; Jiang F, 2013, PHYS CHEM CHEM PHYS, V15, P3413, DOI 10.1039/c2cp43633g; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaypee S, 2016, PHARMACOL THERAPEUT, V162, P98, DOI 10.1016/j.pharmthera.2016.01.011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li SX, 2015, J PHYS CHEM LETT, V6, P2127, DOI 10.1021/acs.jpclett.5b00654; Michel J, 2009, J PHYS CHEM B, V113, P13337, DOI 10.1021/jp9047456; Morozumi Y, 2016, J MOL CELL BIOL, V8, P349, DOI 10.1093/jmcb/mjv060; Picaud S, 2015, CANCER RES, V75, P5106, DOI 10.1158/0008-5472.CAN-15-0236; Poncet-Montange G, 2015, BIOCHEM J, V466, P337, DOI 10.1042/BJ20140933; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Revenko AS, 2010, MOL CELL BIOL, V30, P5260, DOI 10.1128/MCB.00484-10; Romero FA, 2016, J MED CHEM, V59, P1271, DOI 10.1021/acs.jmedchem.5b01514; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Steiner S, 2013, FEBS LETT, V587, P2158, DOI 10.1016/j.febslet.2013.05.032; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vidler LR, 2012, J MED CHEM, V55, P7346, DOI 10.1021/jm300346w; Waring MJ, 2016, NAT CHEM BIOL, V12, P1097, DOI [10.1038/NCHEMBIO.2210, 10.1038/nchembio.2210]; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang GT, 2012, J MED CHEM, V55, P7342, DOI 10.1021/jm3011977; Zhou CY, 2015, J CHEM THEORY COMPUT, V11, P5473, DOI 10.1021/acs.jctc.5b00581; Zhou CY, 2015, J PHYS CHEM B, V119, P1035, DOI 10.1021/jp5064676	45	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186570	10.1371/journal.pone.0186570	http://dx.doi.org/10.1371/journal.pone.0186570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077715	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200012
J	Lee, YH; Kim, KN; Heo, DW; Kang, TS; Lee, SB; Kim, CS				Lee, Yeon Hee; Kim, Kyoung Nam; Heo, Dong Won; Kang, Tae Seen; Lee, Sung Bok; Kim, Chang-sik			Difference in patterns of retinal ganglion cell damage between primary open-angle glaucoma and non-arteritic anterior ischaemic optic neuropathy	PLOS ONE			English	Article							NERVE-FIBER LAYER; COHERENCE TOMOGRAPHY; DIAGNOSTIC-ACCURACY; DISC MORPHOLOGY; CIRRUS HD; THICKNESS; TOPOGRAPHY; OPHTHALMOSCOPY; PREVALENCE; COMPLEX	Purpose To compare the patterns of retinal ganglion cell damage between primary open-angle glaucoma (POAG) and non-arteritic anterior ischaemic optic neuropathy (NAION). Methods In total, 35 eyes with unilateral NAION, and 70 age-and average peripapillary retinal nerve fibre layer (RNFL) thickness-matched eyes with POAG, were enrolled as disease groups; 35 unaffected fellow eyes of the NAION, and 70 age-and refractive error-matched normal subjects for the POAG, were enrolled as their control groups, respectively. The peripapillary RNFL thickness and macular ganglion cell plus inner plexiform layer (GCIPL) thickness were compared between the disease groups and their controls, and between the two disease groups. Results Mean RNFL thicknesses at the 1 and 2 o'clock (superonasal) positions were thinner in NAION than in POAG (both p < 0.05). Mean RNFL thickness at 7 o'clock (inferotemporal) was thinner in POAG than in NAION (p = 0.001). Although there was no significant difference between NAION and POAG in average GCIPL thickness, all of the sectoral GCIPL thicknesses were thinner in NAION (all p < 0.05), except in the inferior and inferotemporal sectors. The ranges of the clock-hour RNFL with damage greater than the average RNFL thickness reduction, versus fellow eyes and control eyes, were 7 hours in NAION and 4 hours in POAG. Conclusions The more damaged clock-hour RNFL regions differed between NAION (1 and 2 o'clock) and POAG (7 o'clock). Most sectoral GCIPL thicknesses were thinner in NAION than in POAG.	[Lee, Yeon Hee; Kim, Kyoung Nam; Heo, Dong Won; Kang, Tae Seen; Lee, Sung Bok; Kim, Chang-sik] Chungnam Natl Univ, Sch Med, Dept Ophthalmol, Chungnam Natl Univ Hosp, Daejeon, South Korea	Chungnam National University; Chungnam National University Hospital	Kim, KN (corresponding author), Chungnam Natl Univ, Sch Med, Dept Ophthalmol, Chungnam Natl Univ Hosp, Daejeon, South Korea.	kknace@cnuhco.kr		Kim, Kyoung Nam/0000-0003-3898-3236; LEE, SUNG-BOK/0000-0002-9665-6463; Lee, Yeon-Hee/0000-0003-0993-7548; Kim, Chang-sik/0000-0001-9595-244X				Aggarwal D, 2012, INVEST OPHTH VIS SCI, V53, P4539, DOI 10.1167/iovs.11-9300; Larrea BA, 2014, GRAEF ARCH CLIN EXP, V252, P1839, DOI 10.1007/s00417-014-2697-0; Arnold AC, 2003, J NEURO-OPHTHALMOL, V23, P157, DOI 10.1097/00041327-200306000-00012; Arnold AC, 2002, SEMINARS OPHTHALMOLO; Bowd C, 2006, INVEST OPHTH VIS SCI, V47, P2889, DOI 10.1167/iovs.05-1489; Contreras I, 2007, OPHTHALMOLOGY, V114, P2338, DOI 10.1016/j.ophtha.2007.05.042; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Danesh-Meyer HV, 2010, INVEST OPHTH VIS SCI, V51, P2003, DOI 10.1167/iovs.09-3492; Danesh-Meyer HV, 2001, OPHTHALMOLOGY, V108, P593, DOI 10.1016/S0161-6420(00)00602-3; ELLENBERGER C, 1973, ARCH NEUROL-CHICAGO, V28, P182, DOI 10.1001/archneur.1973.00490210062008; Fard MA, 2016, INVEST OPHTH VIS SCI, V57, P1011, DOI 10.1167/iovs.15-18618; Fiscella RG, 2003, AM J OPHTHALMOL, V136, P18, DOI 10.1016/S0002-9394(03)00102-8; Gerling J, 1998, GRAEF ARCH CLIN EXP, V236, P188, DOI 10.1007/s004170050062; Gonul S, 2013, BRIT J OPHTHALMOLOGY; Hayreh SS, 2005, ARCH OPHTHALMOL-CHIC, V123, P1554, DOI 10.1001/archopht.123.11.1554; HAYREH SS, 1974, BRIT J OPHTHALMOL, V58, P964, DOI 10.1136/bjo.58.12.964; Hood DC, 2008, OPHTHALMOLOGY, V115, P904, DOI 10.1016/j.ophtha.2007.06.001; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Horowitz J, 2010, GRAEF ARCH CLIN EXP, V248, P845, DOI 10.1007/s00417-010-1323-z; HOYT WF, 1962, ARCH OPHTHALMOL-CHIC, V68, P94, DOI 10.1001/archopht.1962.00960030098018; Hwang YH, 2015, CLIN EXP OPHTHALMOL, V43, P720, DOI 10.1111/ceo.12545; Hwang YH, 2012, INVEST OPHTH VIS SCI, V53, P2226, DOI 10.1167/iovs.11-8689; Janz NK, 2001, OPHTHALMOLOGY, V108, P887, DOI 10.1016/S0161-6420(00)00624-2; Jeoung JW, 2013, INVEST OPHTH VIS SCI, V54, P4422, DOI 10.1167/iovs.12-11273; JOHNSON LN, 1994, J NEURO-OPHTHALMOL, V14, P38; JONAS JB, 1993, INVEST OPHTH VIS SCI, V34, P2260; JONAS JB, 1993, OPHTHALMOLOGY, V100, P63; Kim YK, 2016, INVEST OPHTH VIS SCI, V57, P5856, DOI 10.1167/iovs.16-20116; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; OLVER JM, 1990, EYE, V4, P7, DOI 10.1038/eye.1990.3; ONDA E, 1995, AM J OPHTHALMOL, V120, P92, DOI 10.1016/S0002-9394(14)73763-8; Park SB, 2009, ARCH OPHTHALMOL-CHIC, V127, P1603, DOI 10.1001/archophthalmol.2009.296; Quigley H, 1976, T SECTION OPHTHALMOL, V83, P755; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Saito H, 2006, OPHTHALMOLOGY, V113, P1340, DOI 10.1016/j.ophtha.2006.01.072; Seo SJ, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1690256; Suh MH, 2013, GRAEF ARCH CLIN EXP, V251, P2617, DOI 10.1007/s00417-013-2468-3; Suh MH, 2011, AM J OPHTHALMOL, V151, P277, DOI 10.1016/j.ajo.2010.08.033; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Tesser RA, 2003, OPHTHALMOLOGY, V110, P2031, DOI 10.1016/S0161-6420(03)00804-2; TROBE JD, 1980, ARCH OPHTHALMOL-CHIC, V98, P1040, DOI 10.1001/archopht.1980.01020031030003	44	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187093	10.1371/journal.pone.0187093	http://dx.doi.org/10.1371/journal.pone.0187093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073261	Green Submitted, Green Published, gold			2022-12-27	WOS:000413845400112
J	Mast, N; Lin, JB; Anderson, KW; Bjorkhem, I; Pikuleva, IA				Mast, Natalia; Lin, Joseph B.; Anderson, Kyle W.; Bjorkhem, Ingemar; Pikuleva, Irina A.			Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1)	PLOS ONE			English	Article							ACYL-COENZYME; IN-VITRO; PROTEIN-PHOSPHORYLATION; TAU PHOSPHORYLATION; EXCHANGE FACTOR; RAB GTPASES; METABOLISM; 24-HYDROXYLASE; NEURONS; HOMEOSTASIS	Cytochrome P450 46A1 (CYP46A1) converts cholesterol to 24-hydroxycholesterol and thereby controls the major pathways of cholesterol removal from the brain. Cyp46a1(-/-) mice have a reduction in the rate of cholesterol biosynthesis in the brain and significant impairments to memory and learning. To gain insights into the mechanisms underlying Cyp46a1(-/-) phenotype, we used Cyp46a1(-/-) mice and quantified their brain sterol levels and the expression of the genes pertinent to cholesterol homeostasis. We also compared the Cyp46a1(-/-) and wild type brains for protein phosphorylation and ubiquitination. The data obtained enable the following inferences. First, there seems to be a compensatory upregulation in the Cyp46a1(-/-) brain of the pathways of cholesterol storage and CYP46A1-independent removal. Second, transcriptional regulation of the brain cholesterol biosynthesis via sterol regulatory element binding transcription factors is not significantly activated in the Cyp46a1(-/-) brain to explain a compensatory decrease in cholesterol biosynthesis. Third, some of the liver X receptor target genes (Abca1) are paradoxically upregulated in the Cyp46a1(-/-) brain, possibly due to a reduced activation of the small GTPases RAB8, CDC42, and RAC as a result of a reduced phosphorylation of RAB3IP and PAK1. Fourth, the phosphorylation of many other proteins (a total of 146) is altered in the Cyp46a1(-/-) brain, including microtubule associated and neurofilament proteins (the MAP and NEF families) along with proteins related to synaptic vesicles and synaptic neurotransmission (e.g., SLCs, SHANKs, and BSN). Fifth, the extent of protein ubiquitination is increased in the Cyp46a1(-/-) brain, and the affected proteins pertain to ubiquitination (UBE2N), cognition (STX1B and ATP1A2), cytoskeleton function (TUBA1A and YWHAZ), and energy production (ATP1A2 and ALDOA). The present study demonstrates the diverse potential effects of CYP46A1 deficiency on brain functions and identifies important proteins that could be affected by this deficiency.	[Mast, Natalia; Lin, Joseph B.; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Anderson, Kyle W.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Anderson, Kyle W.] Inst Biosci & Biotechnol Res, Rockville, MD USA; [Bjorkhem, Ingemar] Karolinska Inst, Div Clin Chem, Dept Lab Med, Huddinge, Sweden	Case Western Reserve University; National Institute of Standards & Technology (NIST) - USA; Karolinska Institutet	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	iap8@case.edu		Bjorkhem, Ingemar/0000-0002-0575-9425; Lin, Joseph/0000-0001-6667-9018; Anderson, Kyle/0000-0002-2808-3026; Pikuleva, Irina/0000-0001-9742-6232	National Institute of General Medical Sciences [GM062882]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant GM062882 (IAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 2013, J LIPID RES, V54, P1033, DOI 10.1194/jlr.M034124; Anderson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118839; Anderson KW, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9098-1; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Brachet A, 2015, J CELL BIOL, V208, P791, DOI 10.1083/jcb.201407122; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Diaz-Garcia CM, 2017, CELL METAB, V26, P361, DOI 10.1016/j.cmet.2017.06.021; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Djelti F, 2015, BRAIN, V138, P2383, DOI 10.1093/brain/awv166; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Giese KP, 2013, LEARN MEMORY, V20, P540, DOI 10.1101/lm.028449.112; Habegger KM, 2012, ENDOCRINOLOGY, V153, P2130, DOI 10.1210/en.2011-2099; Han J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00005; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Hoang JJ, 2013, BIOCHEM PHARMACOL, V86, P168, DOI 10.1016/j.bcp.2013.04.005; Hodge CD, 2015, ACS CHEM BIOL, V10, P1718, DOI 10.1021/acschembio.5b00222; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jiang W, 2014, DIABETES METAB J, V38, P171, DOI 10.4093/dmj.2014.38.3.171; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Joo Y, 2015, FASEB J, V29, P4133, DOI 10.1096/fj.14-265009; Kinoshita PF, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00195; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Kotti T, 2008, P NATL ACAD SCI USA, V105, P11394, DOI 10.1073/pnas.0805556105; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kumar P, 2015, J ALZHEIMERS DIS, V43, P341, DOI 10.3233/JAD-140933; Kumar R, 2017, GENE, V605, P20, DOI 10.1016/j.gene.2016.12.014; Leal G, 2017, VITAM HORM, V104, P153, DOI 10.1016/bs.vh.2016.10.004; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liao WL, 2008, ANAL BIOCHEM, V377, P55, DOI 10.1016/j.ab.2008.03.016; Lin JB, 2016, J LIPID RES, V57, P258, DOI 10.1194/jlr.M064469; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Luu W, 2013, IUBMB LIFE, V65, P675, DOI 10.1002/iub.1182; Maiga SF, 2014, BIOCHIMIE, V96, P56, DOI 10.1016/j.biochi.2013.08.027; Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897; Mast N, 2017, J BIOL CHEM, V292, P12934, DOI 10.1074/jbc.M117.794909; Mast N, 2017, NEUROPHARMACOLOGY, V123, P465, DOI 10.1016/j.neuropharm.2017.06.026; Mast N, 2017, J BIOL CHEM, V292, P4913, DOI 10.1074/jbc.M116.774760; Mast N, 2014, J BIOL CHEM, V289, P3529, DOI 10.1074/jbc.M113.532846; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Milagre I, 2008, J NEUROCHEM, V106, P835, DOI 10.1111/j.1471-4159.2008.05442.x; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Monteiro P, 2017, NAT REV NEUROSCI, V18, P147, DOI 10.1038/nrn.2016.183; Moutinho M, 2014, MOL NEUROBIOL; Moutinho M, 2016, BBA-MOL CELL BIOL L, V1861, P1911, DOI 10.1016/j.bbalip.2016.09.011; Moutinho M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30928; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Ng EL, 2008, BRAIN RES REV, V58, P236, DOI 10.1016/j.brainresrev.2008.04.006; Nunes MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053394; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Qureshi HY, 2013, BIOCHEMISTRY-US, V52, P6445, DOI 10.1021/bi400442d; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Ren Y, 2003, J NEUROSCI, V23, P3316; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rudrabhatla P, 2014, J ALZHEIMERS DIS, V41, P671, DOI 10.3233/JAD-130794; Saeed AA, 2014, J BIOL CHEM, V289, P23712, DOI 10.1074/jbc.M114.556159; Schroder MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058814; Schuetz G, 2004, J CELL BIOL, V167, P945, DOI 10.1083/jcb.200404108; Semenova G, 2017, BIOCHEM SOC T, V45, P79, DOI 10.1042/BST20160134; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Shafaati M, 2010, J LIPID RES, V51, P318, DOI 10.1194/jlr.M900174-JLR200; Shafaati M, 2009, BIOCHEM BIOPH RES CO, V378, P689, DOI 10.1016/j.bbrc.2008.11.103; Sodero AO, 2012, EMBO J, V31, P1764, DOI 10.1038/emboj.2012.31; Sodero AO, 2011, J NEUROCHEM, V116, P747, DOI 10.1111/j.1471-4159.2010.07079.x; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Teng FYH, 2001, GENOME BIOL, V2; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; TURLEY SD, 1981, J LIPID RES, V22, P551; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; Wang JF, 2015, P NATL ACAD SCI USA, V112, P148, DOI 10.1073/pnas.1412089112; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Waterham HR, 2006, FEBS LETT, V580, P5442, DOI 10.1016/j.febslet.2006.07.027; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	97	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187168	10.1371/journal.pone.0187168	http://dx.doi.org/10.1371/journal.pone.0187168			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073233	Green Submitted, gold, Green Published			2022-12-27	WOS:000413845400129
J	Sans, MB; Perez-Fontan, M; Martinez-Alonso, M; Bajo, A; Betriu, A; Valdivielso, JAM; Fernandez, E				Borras Sans, Mercs; Perez-Fontan, Miguel; Martinez-Alonso, Montserrat; Bajo, Auxiliadora; Betriu, Angels; Valdivielso, Jose A. M.; Fernandez, Elvira		NEFRONA INVESTIGATORS	The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CHRONIC KIDNEY-DISEASE; CAROTID ATHEROSCLEROSIS; HEMODIALYSIS-PATIENTS; RISK-FACTORS; URIC-ACID; MYOCARDIAL-INFARCTION; PERITONEAL-DIALYSIS; PROGNOSTIC VALUE; PREDICTIVE-VALUE	Background There is limited and inconclusive information regarding the influence of the modality of renal replacement therapy on the atherosclerotic burden of patients on dialysis. The aim of this study was to compare the prevalence of asymptomatic atheromatous carotid disease, as also its rate of progression and cardiovascular outcomes, in two matched populations of patients treated with hemodialysis (HD) and peritoneal dialysis (PD). Methods Following a prospective, observational and multicenter design, we compared 237 PD and 237 HD patients without previous cardiovascular disease, included in the NEFRONA study, and matched for age, sex, diabetes and time on dialysis. Carotid ultrasound study was performed at baseline and after two years of follow-up in 6 carotid territories. Atheromatous vascular disease (AVD) progression was defined as any increase in the number of territories with plaques after 2 years. Fatal and non fatal cardiovascular events were also recorded during 36-month of follow-up. Main results At baseline, PD patients presented a worse general cardiovascular risk profile than mHD patients. On the contrary, some markers of prevalent atherosclerotic disease (common carotid intima-media thickness and ankle-brachial index) were more favorable in PD patients. During follow-up, we observed no differences either in the rate of progression of atheromatous vascular disease (OR 1.78, 95% CI 0.80-4.06, p = 0.161) or in the incidence of cardiovascular events (OR 1.51, 95% CI 0.85-2.66, p = 0.159), according to the modality of dialysis. Conclusion Dialysis modality did not impact on atherosclerotic carotid disease progression or cardiovascular outcomes, in two groups of patients treated with PD or HD.	[Borras Sans, Mercs; Fernandez, Elvira] Univ Hosp Arnau Vilanova Lleida, Dept Nephrol, Lleida, Spain; [Borras Sans, Mercs; Martinez-Alonso, Montserrat; Betriu, Angels; Valdivielso, Jose A. M.; Fernandez, Elvira] UDETMA Unitat Deteccio Malalties Aterotrombot, Lleida, Spain; [Borras Sans, Mercs; Martinez-Alonso, Montserrat; Betriu, Angels; Valdivielso, Jose A. M.; Fernandez, Elvira] IRBLleida, REDinREN ISCIII, UDETMA, Vasc & Renal Translat Res Grp, Lleida, Spain; [Perez-Fontan, Miguel] Univ Hosp A Coruna, Dept Nephrol, La Coruna, Spain; [Bajo, Auxiliadora] Univ Hosp La Paz, REDinREN ISCIII, Dept Nephrol, Madrid, Spain	University Hospital Arnau de Vilanova; Complejo Hospitalario Universitario A Coruna; Hospital Universitario La Paz	Sans, MB (corresponding author), Univ Hosp Arnau Vilanova Lleida, Dept Nephrol, Lleida, Spain.; Sans, MB (corresponding author), UDETMA Unitat Deteccio Malalties Aterotrombot, Lleida, Spain.; Sans, MB (corresponding author), IRBLleida, REDinREN ISCIII, UDETMA, Vasc & Renal Translat Res Grp, Lleida, Spain.	mmborras.lleida.ics@gencat.cat	Bajo, Maria A/ABF-6991-2020; Valdivielso, Jose M/B-5673-2009; Perez-Fontán, Miguel/ABG-4064-2020	Bajo, Maria A/0000-0001-7364-557X; Valdivielso, Jose M/0000-0003-1343-0184; Perez-Fontán, Miguel/0000-0001-7027-2296; Borras, Merce/0000-0002-7498-4773	AbbVie	AbbVie(AbbVie)	The NEFRONA study is funded by a research grant from AbbVie. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arroyo D, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-168; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Barrios C, 2015, ATHEROSCLEROSIS, V242, P37, DOI 10.1016/j.atherosclerosis.2015.06.048; Bayes B, 2003, NEPHROL DIAL TRANSPL, V18, P106, DOI 10.1093/ndt/18.1.106; Benedetto FA, 2001, J AM SOC NEPHROL, V12, P2458, DOI 10.1681/ASN.V12112458; Collado S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127344; Covic A, 2010, NEPHROL DIAL TRANSPL, V25, P1757, DOI 10.1093/ndt/gfq206; de La Piedra C, 2008, NEFROLOGIA, V28, P123; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Foley RN, 2003, KIDNEY INT, V63, P1462, DOI 10.1046/j.1523-1755.2003.00860.x; Garcia-Lopez E, 2007, PERITON DIALYSIS INT, V27, pS205; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Iseki K, 2002, KIDNEY INT, V61, P1887, DOI 10.1046/j.1523-1755.2002.00324.x; Johnsen SH, 2007, STROKE, V38, P2873, DOI 10.1161/STROKEAHA.107.487264; Junyent M, 2010, NEFROLOGIA, V30, P119, DOI 10.3265/Nefrologia.pre2010.Jan.10216; Junyent M, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-14; Kilpatrick RD, 2007, J AM SOC NEPHROL, V18, P293, DOI 10.1681/ASN.2006070795; Korevaar JC, 2003, KIDNEY INT, V64, P2222, DOI 10.1046/j.1523-1755.2003.00321.x; Kumral E, 2014, ACTA NEUROL SCAND, V130, P11, DOI 10.1111/ane.12208; Lertdumrongluk P, 2013, AM J NEPHROL, V3, P144; Li Q, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-72; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Maeda S, 2009, ATHEROSCLEROSIS, V204, P549, DOI 10.1016/j.atherosclerosis.2008.09.028; Mutluay R, 2012, ADV THER, V29, P370, DOI 10.1007/s12325-012-0011-2; Neogi T, 2009, J RHEUMATOL, V36, P378, DOI 10.3899/jrheum.080646; Nishizawa Y, 2003, AM J KIDNEY DIS, V41, pS76, DOI 10.1053/ajkd.2003.50090; Nishizawa Y, 1997, KIDNEY INT, V52, pS90; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Oyama J, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0409-2; Sanchez-Alvarez JE, 2010, NEFROLOGIA, V30, P427, DOI 10.3265/Nefrologia.pre2010.Mar.10277; Schneider A, 2013, J RENAL NUTR, V23, P411; Schwaiger JP, 2006, AM J KIDNEY DIS, V47, P888, DOI 10.1053/j.ajkd.2006.01.011; Shi ZQ, 2012, RENAL FAILURE, V34, P1206, DOI 10.3109/0886022X.2012.718954; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Tattersall MC, 2014, STROKE, V45, P3257, DOI 10.1161/STROKEAHA.114.005669; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Yilmaz FM, 2007, CLIN BIOCHEM, V40, P1361, DOI 10.1016/j.clinbiochem.2007.07.017; Zoccali C, 2005, SEMIN NEPHROL, V25, P358, DOI 10.1016/j.semnephrol.2005.05.002	39	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186921	10.1371/journal.pone.0186921	http://dx.doi.org/10.1371/journal.pone.0186921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095847	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200032
J	Buhrmann, C; Popper, B; Aggarwal, BB; Shakibaei, M				Buhrmann, Constanze; Popper, Bastian; Aggarwal, Bharat B.; Shakibaei, Mehdi			Resveratrol downregulates inflammatory pathway activated by lymphotoxin alpha (TNF-beta) in articular chondrocytes: Comparison with TNF-alpha	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; RHEUMATOID-ARTHRITIS SYNOVIUM; GENE-EXPRESSION; SIRT1; APOPTOSIS; CARTILAGE; DIFFERENTIATION; OVEREXPRESSION; OSTEOARTHRITIS	While Lymphotoxin a (TNF-beta), a product of lymphocytes, is known to play a pivotal role in inflammatory joint environment, resveratrol has been shown to possess anti-inflammatory and chondroprotective effects via activation of the histondeacetylase Sirt1. Whether TNF-beta induction of inflammatory pathways in primary human chondrocytes (PCH) can be modulated by resveratrol, was investigated. Monolayer and alginate cultures of PCH were treated with TNF-beta, anti-TNF-beta, nicotinamide (NAM), antisense oligonucleotides against Sirt1 (Sirt1-ASO) and/or resveratrol and co-cultured with T-lymphocytes. We found that resveratrol suppressed, similar to anti-TNF-beta, TNF-beta-induced increased adhesiveness in an inflammatory microenvironment of T-lymphocytes and PCH. In contrast, knockdown of Sirt1 by mRNA abolished the inhibitory effects of resveratrol on the TNF-beta-induced adhesiveness, suggesting the essential role of this enzyme for resveratrol-mediated anti-inflammatory signaling. Similar results were obtained in PCH stimulated with TNF-alpha. Sirt1-ASO, NAM or TNF-beta, similar to T-lymphocytes induced inflammatory microenvironment by down-regulation of cartilage-specific proteins, Sox9, Ki67 and enhanced NF-kappa B-regulated gene products involved in inflammatory and degradative processes in cartilage (MMP-9/-13, COX-2, caspase-3), NF-kappa B activation and its translocation to the nucleus. Moreover, resveratrol reversed the TNF-beta-, NAM-, T-lymphocytes-induced up-regulation of various NF-kappa B-regulated gene products. Down-regulation of Sirt1 by mRNA interference abrogated the effect of resveratrol on TNF-beta-induced effects. Ultrastructural and cell viability assay investigations revealed that resveratrol revoked TNF-beta-induced dose-dependent degradative/apoptotic morphological changes, cell viability and proliferation in PCH. Taken together, suppression of TNF-beta-induced inflammatory microenvironment in PCH by resveratrol/Sirt1 might be a novel therapeutic approach for targeting inflammation during rheumatoid arthritis.	[Buhrmann, Constanze; Shakibaei, Mehdi] Ludwig Maximilians Univ Munchen, Fac Med, Inst Anat, Musculoskeletal Res Grp & Tumour Biol,Chair Veget, Pettenkoferstr 11, Munich, Germany; [Popper, Bastian] Ludwig Maximilian Univ Munich, Biomed Ctr, Dept Anat & Cell Biol, Martinsried, Germany; [Aggarwal, Bharat B.] Inflammat Res Ctr, San Diego, CA USA	University of Munich; University of Munich	Shakibaei, M (corresponding author), Ludwig Maximilians Univ Munchen, Fac Med, Inst Anat, Musculoskeletal Res Grp & Tumour Biol,Chair Veget, Pettenkoferstr 11, Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Buhrmann, Constanze/0000-0002-0786-0463				AGGARWAL BB, 1984, J BIOL CHEM, V259, P686; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Anderson KA, 2014, CELL, V159, DOI 10.1016/j.cell.2014.10.045; BRINGMAN TS, 1987, HYBRIDOMA, V6, P489, DOI 10.1089/hyb.1987.6.489; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477; Buhrmann C, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030145; Buhrmann C, 2014, J BIOL CHEM, V289, P22048, DOI 10.1074/jbc.M114.568790; Buhrmann C, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4393; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Busch F, 2012, J BIOL CHEM, V287, P25770, DOI 10.1074/jbc.M112.355420; Calmon-Hamaty F, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3376; Camins A, 2009, PHARMACEUTICALS, V2, P194, DOI 10.3390/ph2030194; Chalk AM, 2002, BIOINFORMATICS, V18, P1567, DOI 10.1093/bioinformatics/18.12.1567; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; DESCH CE, 1990, BLOOD, V75, P2030; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; Dvir-Ginzberg M., 2016, CURR RHEUMATOL REP, V18; Dvir-Ginzberg M, 2011, ARTHRITIS RHEUM-US, V63, P2363, DOI 10.1002/art.30279; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Fujita N, 2011, J ORTHOP RES, V29, P511, DOI 10.1002/jor.21284; Gabay O, 2013, JOINT BONE SPINE, V80, P613, DOI 10.1016/j.jbspin.2013.01.001; Gabay O, 2013, ARTHRITIS RHEUM-US, V65, P159, DOI 10.1002/art.37750; Gabay O, 2012, ANN RHEUM DIS, V71, P613, DOI 10.1136/ard.2011.200504; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Islam MA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5137431; Jiang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep07456; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim HJ, 2014, BONE JOINT RES, V3, P51, DOI 10.1302/2046-3758.33.2000226; Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Lei M, 2012, EUR J PHARMACOL, V674, P73, DOI 10.1016/j.ejphar.2011.10.015; Li WY, 2015, J ORTHOP RES, V33, P1061, DOI 10.1002/jor.22859; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Matsushita T, 2013, J ORTHOP RES, V31, P531, DOI 10.1002/jor.22268; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meinecke I, 2005, CURR PHARM DESIGN, V11, P563, DOI 10.2174/1381612053381945; MESSER G, 1991, J EXP MED, V173, P209, DOI 10.1084/jem.173.1.209; Mewar D, 2011, BRIT J PHARMACOL, V162, P785, DOI 10.1111/j.1476-5381.2010.01099.x; Moon MH, 2013, OSTEOARTHR CARTILAGE, V21, P470, DOI 10.1016/j.joca.2012.11.017; Niederer F, 2011, ANN RHEUM DIS, V70, P1866, DOI 10.1136/ard.2010.148957; O'Rourke KP, 2008, RHEUMATOL INT, V28, P979, DOI 10.1007/s00296-008-0574-z; Robak T, 1998, EUR CYTOKINE NETW, V9, P145; Schulze-Tanzil G, 2004, OSTEOARTHR CARTILAGE, V12, P448, DOI 10.1016/j.joca.2004.02.007; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shaker OG, 2016, REV BRAS REUMATOL, V56, P414, DOI [10.1016/j.rbr.2016.03.005, 10.1016/j.rbre.2016.04.002]; Shakibaei M, 1997, CELL BIOL INT, V21, P75, DOI 10.1006/cbir.1996.0119; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shakibaei M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1291-0; Shakibaei M, 2010, ANTIOXID REDOX SIGN, V13, P821, DOI 10.1089/ars.2009.3036; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072	62	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186993	10.1371/journal.pone.0186993	http://dx.doi.org/10.1371/journal.pone.0186993			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095837	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200038
J	Hansoti, B; Kelen, GD; Quinn, TC; Whalen, MM; DesRosiers, TT; Reynolds, SJ; Redd, A; Rothman, RE				Hansoti, Bhakti; Kelen, Gabor D.; Quinn, Thomas C.; Whalen, Madeleine M.; DesRosiers, Taylor T.; Reynolds, Steven J.; Redd, Andrew; Rothman, Richard E.			A systematic review of emergency department based HIV testing and linkage to care initiatives in low resource settings	PLOS ONE			English	Review							WESTERN KENYA; NORTHERN INDIA; SOUTH-AFRICA; INFECTION; GUIDELINES; DIAGNOSIS; MEDICINE; DISEASE	Introduction Only 45% of people currently living with HIV infection in sub-Saharan Africa are aware of their HIV status. Unmet testing needs may be addressed by utilizing the Emergency Department (ED) as an innovative testing venue in low and middle-income countries (LMICs). The purpose of this review is to examine the burden of HIV infection described in EDs in LMICs, with a focus on summarizing the implementation of various ED-based HIV testing strategies. Methodology and results We performed a systematic review of Pubmed, Embase, Scopus, Web of Science and the Cochrane Library on June 12, 2016. A three-concept search was employed with emergency medicine (e.g., Emergency department, emergency medical services), HIV/AIDS (e.g., human immunodeficiency virus, acquired immunodeficiency syndrome), and LMIC terms (e.g., developing country, under developed countries, specific country names). The search returned 2026 unique articles. Of these, thirteen met inclusion criteria and were included in the final review. There was a large variation in the reported prevalence of HIV infection in the ED population ranging from to 2.14% in India to 43.3% in Uganda. The proportion HIV positive patients with previously undiagnosed infection ranged from 90% to 65.22%. Conclusion In the United States ED-based HIV testing strategies have been front and center at curbing the HIV epidemic. The limited number of ED-based studies we observed in this study may represent the paucity of HIV testing in this venue in LMICs. All of the studies in this review demonstrated a high prevalence of HIV infection in the ED and an extraordinarily high percentage of previously undiagnosed HIV infection. Although the numbers of published reports are few, these diverse studies imply that in HIV endemic low resource settings EDs carry a large burden of undiagnosed HIV infections and may offer a unique testing venue.	[Hansoti, Bhakti; Kelen, Gabor D.; Whalen, Madeleine M.; DesRosiers, Taylor T.; Rothman, Richard E.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21205 USA; [Quinn, Thomas C.; Reynolds, Steven J.; Redd, Andrew] NIAID, Div Intramural Res, NIH, Baltimore, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA)	Hansoti, B (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21205 USA.	bhansot1@jhmi.edu		Whalen, Madeleine/0000-0002-6480-8733; Reynolds, Steven/0000-0002-5403-2759; Hansoti, Bhakti/0000-0003-0188-9764	NIAID NIH HHS [P30 AI094189] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, P30AI094189] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmad S, 2010, EMERG MED J, V27, P746, DOI 10.1136/emj.2009.085191; American College of Emergency Physicians, 2007, Ann Emerg Med, V50, P209; [Anonymous], 2014, HIV AIDS JUNPO 90 90; Branson BM, 2013, JAIDS-J ACQ IMM DEF, V63, pS117, DOI 10.1097/QAI.0b013e3182986f25; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Christensen A, 2012, INT HEALTH, V4, P185, DOI 10.1016/j.inhe.2012.03.001; Cochrane, 2016, LMIC FILT COCHR EFF; Council S, 2012, NAT STRAT PLAN HIV S; Cox M, 2007, EMERG MED AUSTRALAS, V19, P470, DOI 10.1111/j.1742-6723.2007.01012.x; Devi Pushpa, 2010, Indian J Sex Transm Dis AIDS, V31, P27, DOI 10.4103/0253-7184.68997; Force USPST, 2016, FIN UPD SUMM HUM IMM; Gilks CF, 1998, J ACQ IMMUN DEF SYND, V18, P234, DOI 10.1097/00042560-199807010-00006; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Hardwicke R, 2008, J ASSOC NURSE AIDS C, V19, P211, DOI 10.1016/j.jana.2008.03.005; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Hsieh YH, 2015, ANN EMERG MED, V66, P69, DOI 10.1016/j.annemergmed.2015.01.001; Kelen GD, 2009, ANN EMERG MED, V54, P65, DOI 10.1016/j.annemergmed.2009.03.027; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Maheswaran H, 2012, JAIDS-J ACQ IMM DEF, V59, pE43, DOI 10.1097/QAI.0b013e3182414ed7; Minz RW, 2014, INT J STD AIDS, V25, P341, DOI 10.1177/0956462413507442; Minz RW, 2010, INDIAN J PATHOL MICR, V53, P287, DOI 10.4103/0377-4929.64334; Montoy JCC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6895; Nakanjako D, 2007, AFRICAN HLTH SCI, V7; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; Nowacki AK, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-26; Obermeyer Z, 2015, B WORLD HEALTH ORGAN, V93, P577, DOI 10.2471/BLT.14.148338; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Ranney ML, 2011, EMERG MED J, V28, P927, DOI 10.1136/emj.2010.096412; Rothman RE, 2004, ANN EMERG MED, V44, P31, DOI 10.1016/j.annemergmed.2004.01.016; Rothman RE, 2003, ACAD EMERG MED, V10, P278, DOI 10.1111/j.1553-2712.2003.tb02004.x; Sawe HR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010298; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Teja V D, 2004, Indian J Med Microbiol, V22, P159; Teja VD, 2008, INDIAN J MED MICROBI, V26, P167, DOI 10.4103/0255-0857.40535; UNAIDS, 2014, THE GAP REP; Walensky RP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001101; Wallis LA, 2008, INT J EMERG MED, V1, P69, DOI 10.1007/s12245-008-0033-3; Waxman MJ, 2008, INT J EMERG MED, V1, P317, DOI 10.1007/s12245-008-0065-8; Waxman MJ, 2007, AIDS PATIENT CARE ST, V21, P981, DOI 10.1089/apc.2007.0075	41	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187443	10.1371/journal.pone.0187443	http://dx.doi.org/10.1371/journal.pone.0187443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095899	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200092
J	Riggio, J; Caro, T				Riggio, Jason; Caro, Tim			Structural connectivity at a national scale: Wildlife corridors in Tanzania	PLOS ONE			English	Article							CONSERVATION; LANDSCAPE; MIGRATION; BARRIERS; ROAD	Wildlife corridors can help maintain landscape connectivity but novel methods must be developed to assess regional structural connectivity quickly and cheaply so as to determine where expensive and time-consuming surveys of functional connectivity should occur. We use least-cost methods, the most accurate and up-to-date land conversion dataset for East Africa, and interview data on wildlife corridors, to develop a single, consistent methodology to systematically assess wildlife corridors at a national scale using Tanzania as a case study. Our research aimed to answer the following questions; (i) which corridors may still remain open (i.e. structurally connected) at a national scale, (ii) which have been potentially severed by anthropogenic land conversion (e.g., agriculture and settlements), (iii) where are other remaining potential wildlife corridors located, and (iv) which protected areas with lower forms of protection (e.g., Forest Reserves and Wildlife Management Areas) may act as stepping-stones linking more than one National Park and/or Game Reserve. We identify a total of 52 structural connections between protected areas that are potentially open to wildlife movement, and in so doing add 23 to those initially identified by other methods in Tanzanian Government reports. We find that the vast majority of corridors noted in earlier reports as "likely to be severed" have actually not been cut structurally (21 of 24). Nonetheless, nearly a sixth of all the wildlife corridors identified in Tanzania in 2009 have potentially been separated by land conversion, and a third now pass across lands likely to be converted to human use in the near future. Our study uncovers two reserves with lower forms of protection (Uvinza Forest Reserve in the west and Wami-Mbiki Wildlife Management Area in the east) that act as apparently crucial stepping-stones between National Parks and/or Game Reserves and therefore require far more serious conservation support. Methods used in this study are readily applicable to other nations lacking detailed data on wildlife movements and plagued by inaccurate land cover datasets. Our results are the first step in identifying wildlife corridors at a regional scale and provide a springboard for ground-based follow-up conservation.	[Riggio, Jason; Caro, Tim] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Riggio, J (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	jsriggio@ucdavis.edu	Riggio, Jason/AAT-5937-2020	Riggio, Jason/0000-0002-4988-3794	Explorers Club (Exploration Fund); American Philosophical Society (Lewis amp;amp;amp;amp;amp;amp; Clark Fund); University of California, Davis (Henry A. Jastro Graduate Research Fellowship); University of California, Davis (African Studies Committee Graduate Research Fellowship); University of California, Davis (Department of Wildlife, Fish and Conservation Biologyamp;amp;amp;apos;s Walter); University of California, Davis (Elizabeth Howard Wildlife Management Award); University of California, Davis (Selma Herr Fund for Ornithological Research); American Society of Mammalogists	Explorers Club (Exploration Fund); American Philosophical Society (Lewis amp;amp;amp;amp;amp;amp; Clark Fund); University of California, Davis (Henry A. Jastro Graduate Research Fellowship)(University of California System); University of California, Davis (African Studies Committee Graduate Research Fellowship)(University of California System); University of California, Davis (Department of Wildlife, Fish and Conservation Biologyamp;amp;amp;apos;s Walter); University of California, Davis (Elizabeth Howard Wildlife Management Award); University of California, Davis (Selma Herr Fund for Ornithological Research); American Society of Mammalogists	Research was funded by the Explorers Club (Exploration Fund), American Philosophical Society (Lewis & Clark Fund), University of California, Davis (Henry A. Jastro Graduate Research Fellowship, African Studies Committee Graduate Research Fellowship, and Department of Wildlife, Fish and Conservation Biology's Walter and Elizabeth Howard Wildlife Management Award and Selma Herr Fund for Ornithological Research), and an American Society of Mammalogists Grant-in-Aid of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank TAWIRI, the Wildlife Division, and the Commission for Science and Technology (COSTECH) for permissions (Research Permit # 2013-334-NA-2013-76), and Alex Lobora, Senior Research Officer at TAWIRI, for helpful technical guidance. We thank all of the members of the Wami-Mbiki Society, including Majuka Koira (Chairman), Furaha Mbwilo (Head Protection Officer), Hamadi Mbembe (Driver) and the game scouts and staff stationed at Mkongo Camp; and Jessie Godfrey and four anonymous reviewers for comments on the manuscript. Research was funded by the Explorers Club (Exploration Fund), American Philosophical Society (Lewis & Clark Fund), University of California, Davis (Henry A. Jastro Graduate Research Fellowship, African Studies Committee Graduate Research Fellowship, and Department of Wildlife, Fish and Conservation Biology's Walter and Elizabeth Howard Wildlife Management Award and Selma Herr Fund for Ornithological Research), and an American Society of Mammalogists Grant-in-Aid of Research.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Bartlam-Brooks HLA, 2011, ORYX, V45, P210, DOI 10.1017/S0030605310000414; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier P, 2009, ECOL APPL, V19, P2067, DOI 10.1890/08-1898.1; Belote RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154223; Berger J, 2006, BIOL LETT-UK, V2, P528, DOI 10.1098/rsbl.2006.0508; BirdLife International, 2016, COUNTR PROF TANZ; Caro T, 2014, CURR BIOL, V24, pR722, DOI 10.1016/j.cub.2014.07.007; Caro T, 2009, BIOL CONSERV, V142, P2807, DOI 10.1016/j.biocon.2009.06.011; Cozzi G, 2013, J ANIM ECOL, V82, P707, DOI 10.1111/1365-2656.12039; Crooks K. R., 2006, CONNECTIVITY CONSERV; Davis SD, 1994, CENTRES PLANT DIVERS, V1; Dutta T, 2016, REG ENVIRON CHANGE, V16, P53, DOI 10.1007/s10113-015-0877-z; Epps CW, 2013, MOL ECOL, V22, P1574, DOI 10.1111/mec.12198; Fritz S, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044005; Fritz S, 2010, INT J REMOTE SENS, V31, P2237, DOI 10.1080/01431160902946598; Fynn RWS, 2011, AFR J ECOL, V49, P175, DOI 10.1111/j.1365-2028.2010.01245.x; Gregory AJ, 2014, CONSERV BIOL, V28, P689, DOI 10.1111/cobi.12252; Hannerz F, 2008, INT J REMOTE SENS, V29, P3787, DOI 10.1080/01431160801891762; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Holdo RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016370; Jacobson A, 2015, ENVIRON MODELL SOFTW, V72, P1, DOI 10.1016/j.envsoft.2015.06.011; Jones T., 2009, WILDLIFE CORRIDORS T; Jones T, 2012, TROP CONSERV SCI, V5, P463, DOI 10.1177/194008291200500405; Kavanagh D.M., 2011, LINKAGE MAPPER CONNE; Kiffner C, 2016, J NAT CONSERV, V31, P29, DOI 10.1016/j.jnc.2016.02.006; Kiffner C, 2015, AFR J ECOL, V53, P156, DOI 10.1111/aje.12160; Kikoti AP, 2010, PACHYDERM, P57; Krosby M, 2015, LANDSCAPE ECOL, V30, P2121, DOI 10.1007/s10980-015-0235-z; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Latham J., 2014, FAO GLOBAL LAND COVE; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; McRae B., 2013, NAT CONSERV; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Morrison TA, 2016, BIOL CONSERV, V197, P53, DOI 10.1016/j.biocon.2016.02.034; Morrison TA, 2014, ORYX, V48, P613, DOI 10.1017/S0030605313000537; Mpanduji DG, 2009, AFR J ECOL, V47, P257, DOI 10.1111/j.1365-2028.2008.00958.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nabe-Nielsen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008932; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Ntongani WA, 2010, AFR J ECOL, V48, P880, DOI 10.1111/j.1365-2028.2009.01148.x; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Proctor MF, 2015, J WILDLIFE MANAGE, V79, P544, DOI 10.1002/jwmg.862; Ramiadantsoa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132126; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Roever CL, 2013, BIOL CONSERV, V157, P128, DOI 10.1016/j.biocon.2012.06.025; Rovero Francesco, 2012, Ecological Restoration, V30, P282; Rudnick D.A., 2012, ISSUES ECOL, V16, P1; Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Shannon G, 2016, BIOL REV, V91, P982, DOI 10.1111/brv.12207; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Silveira L, 2014, LANDSCAPE ECOL, V29, P1213, DOI 10.1007/s10980-014-0057-4; TAWIRI, 2010, TANZANIA ELEPHANT MA; TAWIRI (Tanzania Wildlife Research Institute), 2009, POP AB EST SPAT DIST; Van de Perre F, 2014, AFR J ECOL, V52, P448, DOI 10.1111/aje.12139; Vancutsem C, 2013, REMOTE SENS-BASEL, V5, P19, DOI 10.3390/rs5010019; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; Wegmann M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0193; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; Zeller KA, 2011, BIOL CONSERV, V144, P892, DOI 10.1016/j.biocon.2010.12.003	66	32	32	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187407	10.1371/journal.pone.0187407	http://dx.doi.org/10.1371/journal.pone.0187407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095901	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200081
J	Ehm, MG; Aponte, JL; Chiano, MN; Yerges-Armstrong, LM; Johnson, T; Barker, JN; Cook, SF; Gupta, A; Hinds, DA; Li, L; Nelson, MR; Simpson, MA; Tian, C; McCarthy, LC; Rajpal, DK; Waterworth, DM				Ehm, Margaret G.; Aponte, Jennifer L.; Chiano, Mathias N.; Yerges-Armstrong, Laura M.; Johnson, Toby; Barker, Jonathan N.; Cook, Suzanne F.; Gupta, Akanksha; Hinds, David A.; Li, Li; Nelson, Matthew R.; Simpson, Michael A.; Tian, Chao; McCarthy, Linda C.; Rajpal, Deepak K.; Waterworth, Dawn M.			Phenome-wide association study using research participants' self-reported data provides insight into the Th17 and IL-17 pathway	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; IDENTIFIES 3; INDIVIDUALS; EFFICACY; MODERATE; RISK	A phenome-wide association study of variants in genes in the Th17 and IL-17 pathway was performed using self-reported phenotypes and genetic data from 521,000 research participants of 23 and Me. Results replicated known associations with similar effect sizes for auto immune traits illustrating self-reported traits can be a surrogate for clinically assessed conditions. Novel associations controlling for a false discovery rate of 5% included the association of the variant encoding p.11e684Ser in TYK2 with increased risk of tonsillectomy, strep throat occurrences and teen acne, the variant encoding p.Arg381GIn in IL23R with a decrease in dandruff frequency, the variant encoding p.AsplOAsn in TRAF3IP2 with risk of male-pattern balding, and the RORC regulatory variant (rs4845604) with protection from allergies. This approach enabled rapid assessment of association with a wide variety of traits and investigation of traits with limited reported associations to overlay meaningful phenotypic context on the range of conditions being considered for drugs targeting this pathway.	[Ehm, Margaret G.; Yerges-Armstrong, Laura M.; Nelson, Matthew R.; Rajpal, Deepak K.; Waterworth, Dawn M.] GlaxoSmithKline, Target Sci, Collegeville, PA 19426 USA; [Aponte, Jennifer L.; Li, Li] PAREXEL Int, Genom Med, Durham, NC USA; [Chiano, Mathias N.; Johnson, Toby; McCarthy, Linda C.] GlaxoSmithKline, Target Sci, Stevenage, Herts, England; [Barker, Jonathan N.; Simpson, Michael A.] Kings Coll London, Fac Life Sci & Med, Div Genet & Mol Med, London, England; [Cook, Suzanne F.] Suzanne F Cook Epidemiol Associates LLC, Chapel Hill, NC USA; [Gupta, Akanksha] GlaxoSmithKline, Dermatol, Res Triangle Pk, NC USA; [Hinds, David A.; Tian, Chao] 23andMe Inc, Stat Genet, Mountain View, CA USA	GlaxoSmithKline; Parexel International; GlaxoSmithKline; University of London; King's College London; GlaxoSmithKline	Ehm, MG (corresponding author), GlaxoSmithKline, Target Sci, Collegeville, PA 19426 USA.	meg.g.ehm@gsk.com	tian, chao/GYD-3462-2022; Simpson, Michael/F-4737-2011	Simpson, Michael/0000-0002-8539-8753	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	MGE, M NC, LMY-A, TJ, AG, MRN, LCM, DKR, DMW are employees of GlaxoSmithKline. JA is an employee of PAREXEL International. SFC is an employee of Suzanne F Cook Epidemiology Associates LLC. DAH and CT are employees of 23andMe. GlaxoSmithKline funded the study. The funder provided support in the form of salaries for authors [MGE, MNC, LMY-A, TJ, AG, MRN, LCM, DKR, DMW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bartlett HS, 2015, NAT REV DRUG DISCOV, V14, P11, DOI 10.1038/nrd4518; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Chen JJ, 2010, CANCER CONTROL, V17, P58, DOI 10.1177/107327481001700108; Dendrou CA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1974; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Di Meglio P, 2013, J INVEST DERMATOL, V133, P2381, DOI 10.1038/jid.2013.170; Diogo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122271; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Navarini AA, 2014, J INVEST DERMATOL, V134, pS53; Navarini AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5020; Nelson MR, 2016, NAT REV GENET, V17, P197, DOI 10.1038/nrg.2016.12; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; Scott RA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3744; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Targan SR, 2012, GASTROENTEROLOGY, V143, pE26, DOI 10.1053/j.gastro.2012.07.084; Tung JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023473	28	11	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186405	10.1371/journal.pone.0186405	http://dx.doi.org/10.1371/journal.pone.0186405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091937	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700017
J	Kulangara, V; Nair, N; Sivasailam, A; Sasidharan, S; Kollannur, JD; Syam, R				Kulangara, Vinodkumar; Nair, Neetha; Sivasailam, Asok; Sasidharan, Suchithra; Kollannur, Justin Davis; Syam, Radhika			Genotypic and phenotypic beta-lactam resistance and presence of PVL gene in Staphylococci from dry bovine udder	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; PANTON-VALENTINE LEUKOCIDIN; ANTIBIOTIC-RESISTANCE; AUREUS; MASTITIS; IDENTIFICATION; PREVALENCE; MRSA; DIVERSITY; ANIMALS	Dairy cows affected with subclinical mastitis can be sources of virulent, antimicrobial-resistant Staphylococci to humans because of the excretion of the bacteria through their milk. This study focussed on the phenotypic and genotypic antibiotic resistance patterns of Staphylococci isolated from dairy cows in early dry period. Among 96 isolates of Gram positive cocci from 157 cows, 76 were identified as Coagulase Negative Staphylococci and the remaining 20 were Staphylococcus aureus. Typical amplicons of coagulase gene were obtained for all 20 samples of S. aureus with three major coagulase types being identified as giving 627 bp (40%), 910 bp (35%) and 710 bp (25%) long PCR products. The groEL gene was amplified in PCR of all 76 isolates of Coagulase Negative Staphylococci, and incubation of PCR products with restriction enzyme Pvul I yielded three distinct PCR-RFLP fragment patterns bearing resemblance to S. chromogenes and S. hyicus. Highest sensitivity of Coagulase Negative Staphylococci was noted for Azithromycin (92.5%) and the least to Tetracyclines (76.3%), whereas for S. aureus, it was Cefoperazone (95%) and Azithromycin (72.2%) respectively. Phenotypic resistance to Oxacillin (25 isolates), and Cefoxitin (11 isolates) was detected by dilution method with a commercial strip (Ezy MICTM). Genotypic resistance to P-Lactam antibiotics was found in 65 (34 with mecA gene and 31 with blaZ gene) isolates. Eighteen isolates possessed both the genes, with the PVL gene for virulence being detected in five of them. Nine isolates which had mecA gene were phenotypically susceptible to oxacillin while phenotypic resistance to oxacillin was observed in seven isolates that did not have either mecA or blaZ gene. This is the first report of persistent Staphylococcal infections possessing PVL gene and high level of genotypic resistance to p-Lactam antibiotics in small-holder dairy cattle from India.	[Kulangara, Vinodkumar; Nair, Neetha; Sivasailam, Asok; Sasidharan, Suchithra; Kollannur, Justin Davis; Syam, Radhika] Coll Vet & Anim Sci, Dept Vet Epidemiol & Prevent Med, Trichur, Kerala, India; [Sivasailam, Asok] Sree Chithra Tirunal Inst Med Sci & Technol, Dept Biochem, Thiruvananthapuram, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Kulangara, V (corresponding author), Coll Vet & Anim Sci, Dept Vet Epidemiol & Prevent Med, Trichur, Kerala, India.	kvinodkuma@gmail.com		Kulangara, Vinodkumar/0000-0001-9643-7976	Department of Animal Husbandry, Kerala State, India [B2/29226/2010]	Department of Animal Husbandry, Kerala State, India	This research work received funding from only one source. Vinodkumar Kulangara received partial funding for the research project from the Department of Animal Husbandry, Kerala State, India as per order No. B2/29226/2010 dtd 31/03/11 of Director of Animal Husbandry, Kerala State, India, Web site http://www.and.kera.gov.in. All funding sources have been mentioned and there has been no additional funding received for this study. We further declare that no individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Asfour H. A. E., 2011, Global Veterinaria, V6, P39; Badiou C, 2010, J CLIN MICROBIOL, V48, P1384, DOI 10.1128/JCM.02274-09; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Santos OCD, 2008, VET MICROBIOL, V130, P134, DOI 10.1016/j.vetmic.2007.12.009; Ebrahimi A, 2009, IRAN J VET RES, V10, P273; Garcia-Alvarez L, 2012, J ANTIMICROB CHEMOTH, V67, pI37, DOI 10.1093/jac/dks206; Gentilini E, 2000, J DAIRY SCI, V83, P1224, DOI 10.3168/jds.S0022-0302(00)74988-5; Gianneechini R, 2002, ACTA VET SCAND, V43, P221, DOI 10.1186/1751-0147-43-221; Goh SH, 1997, J CLIN MICROBIOL, V35, P3116, DOI 10.1128/JCM.35.12.3116-3121.1997; Haran KP, 2012, J CLIN MICROBIOL, V50, P688, DOI 10.1128/JCM.05214-11; Jones CH, 2006, ANTIMICROB AGENTS CH, V50, P505, DOI 10.1128/AAC.50.2.505-510.2006; Joshi S, 2013, INDIAN J MED RES, V137, P363; Kumar VA, 2013, J CLIN MICROBIOL, V51, P318, DOI 10.1128/JCM.01040-12; Li LP, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0492-8; Loeffler B, 2010, PLOS PATHOG, V6, P1, DOI DOI 10.1371/J0URNAL.PPAT.1000715; Moellering RC, 2012, J ANTIMICROB CHEMOTH, V67, P4, DOI 10.1093/jac/dkr437; Moon JS, 2007, J DAIRY SCI, V90, P1176, DOI 10.3168/jds.S0022-0302(07)71604-1; Morgan M, 2008, J ANTIMICROB CHEMOTH, V62, P1181, DOI 10.1093/jac/dkn405; Olsen JE, 2006, J ANTIMICROB CHEMOTH, V57, P450, DOI 10.1093/jac/dki492; Pajic MJ, 2014, VET ARHIV, V84, P205; Skov R, 2014, J ANTIMICROB CHEMOTH, V69, P133, DOI 10.1093/jac/dkt341; Soares LC, 2012, PESQUI VET BRASIL, V32, P692, DOI 10.1590/S0100-736X2012000800002; Sol J, 2000, J DAIRY SCI, V83, P278, DOI 10.3168/jds.S0022-0302(00)74875-2; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; Sumathi BR, 2008, VET WORLD, V1, P37; Tomazi T, 2014, J CLIN MICROBIOL, V52, P1658, DOI 10.1128/JCM.03032-13; Torres AH, 2009, J VET DIAGN INVEST, V21, P427, DOI 10.1177/104063870902100403; Turutoglu H, 2006, B VET I PULAWY, V50, P41; Unal N, 2012, TROP ANIM HEALTH PRO, V44, P573, DOI 10.1007/s11250-011-9937-7; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047	32	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187277	10.1371/journal.pone.0187277	http://dx.doi.org/10.1371/journal.pone.0187277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091956	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700051
J	Forcella, M; Oldani, M; Epistolio, S; Freguia, S; Monti, E; Fusi, P; Frattini, M				Forcella, Matilde; Oldani, Monica; Epistolio, Samantha; Freguia, Stefania; Monti, Eugenio; Fusi, Paola; Frattini, Milo			Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; HUMAN COLON-CANCER; SIALIDASE NEU3; EXPRESSION; ERLOTINIB; INVOLVEMENT; SUPPRESSION; GEFITINIB; SURVIVAL	Adenocarcinoma of Non-Small Cell Lung Cancer (NSCLC) is a severe disease. Patients carrying EGFR mutations may benefit from EGFR targeted therapies (e.g.: gefitinib). Recently, it has been shown that sialidase NEU3 directly interacts and regulates EGFR. In this work, we investigate the effect of sialidase NEU3 overexpression on EGFR pathways activation and EGFR targeted therapies sensitivity, in a series of lung cancer cell lines. NEU3 overexpression, forced after transfection, does not affect NSCLC cell viability. We demonstrate that NEU3 overexpression stimulates the ERK pathway but this activation is completely abolished by gefitinib treatment. The Akt pathway is also hyper-activated upon NEU3 overexpression, but gefitinib is able only to decrease, and not to abolish, such activation. These findings indicate that NEU3 can act directly on the ERK pathway through EGFR and both directly and indirectly with respect to EGFR on the Akt pathway. Furthermore, we provide evidence that a healthy mucosa cell line (with EGFR wild-type gene sequence) is slightly sensitive to gefitinib, especially in the presence of NEU3 overexpression, thus hypothesizing that NEU3 overexpressing patients may benefit from EGFR targeted therapies also in absence of EGFR point mutations. Overall, the expression of NEU3 may be a novel diagnostic marker in NSCLC because, by its ability to stimulate EGFR downstream pathways with direct and indirect mechanisms, it may help in the identification of patients who can profit from EGFR targeted therapies in absence of EGFR activating mutations or from new combinations of EGFR and Akt inhibitors.	[Forcella, Matilde; Oldani, Monica; Fusi, Paola] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Epistolio, Samantha; Freguia, Stefania; Frattini, Milo] Inst Pathol, Lab Mol Pathol, Locarno, Switzerland; [Monti, Eugenio] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy	University of Milano-Bicocca; University of Brescia	Frattini, M (corresponding author), Inst Pathol, Lab Mol Pathol, Locarno, Switzerland.; Monti, E (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.	eugenio.monti@unibs.it; milo.frattini@ti.ch		MONTI, Eugenio/0000-0002-4742-7445; Fusi, Paola/0000-0002-2746-1742; Epistolio, Samantha/0000-0003-1236-2722; FORCELLA, Matilde/0000-0002-9706-4654	Fondazione Ticinese per la Ricerca contro il Cancro (Tessin Foundation against cancer); Ministero dellIstruzione, dell'Universita e della Ricerca (MIUR) FAR	Fondazione Ticinese per la Ricerca contro il Cancro (Tessin Foundation against cancer); Ministero dellIstruzione, dell'Universita e della Ricerca (MIUR) FAR(Ministry of Education, Universities and Research (MIUR))	This work was supported by Fondazione Ticinese per la Ricerca contro il Cancro (Tessin Foundation against cancer) to MF and partly supported by Ministero dellIstruzione, dell'Universita e della Ricerca (MIUR) FAR and ex-60% funds to PF and EM, respectively. For more information: https://ticino.legacancro.ch/ricerca/, http://hubmiur.pubblica.istruzione.it/web/universita/home.	[Anonymous], 2015, R LANG ENV STAT COMP; Bigi A, 2010, GLYCOBIOLOGY, V20, P148, DOI 10.1093/glycob/cwp156; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Choi YJ, 2010, CANCER CHEMOTH PHARM, V66, P381, DOI 10.1007/s00280-009-1174-7; Coudert B, 2012, ANN ONCOL, V23, P388, DOI 10.1093/annonc/mdr125; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Jiang ZB, 2016, ONCOL REP; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Minguet J, 2016, INT J CANCER, V138, P2549, DOI 10.1002/ijc.29915; Mitsudomi Tetsuya, 2006, Int J Clin Oncol, V11, P190, DOI 10.1007/s10147-006-0583-4; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Mozzi A, 2015, GLYCOBIOLOGY, V25, P855, DOI 10.1093/glycob/cwv026; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Osarogiagbon RU, 2015, TRANSL LUNG CANCER R, V4, P465, DOI 10.3978/j.issn.2218-6751.2015.07.17; Osorio F, 2016, HEAVY ROBUST ESTIMAT; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Rodriguez-Walker M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04488-w; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Siegelin MD, 2014, LAB INVEST, V94, P129, DOI 10.1038/labinvest.2013.147; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Wang SH, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0268-z; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503	32	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187289	10.1371/journal.pone.0187289	http://dx.doi.org/10.1371/journal.pone.0187289			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088281	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900060
J	Ngabonziza, JCS; Diallo, AB; Tagliani, E; Diarra, B; Kadanga, AE; Togo, ACG; Thiam, A; de Rijk, WB; Alagna, R; Houeto, S; Ba, F; Dagnra, AY; Ivan, E; Affolabi, D; Schwoebel, V; Trebucq, A; de Jong, BC; Rigouts, L; Daneau, G				Ngabonziza, Jean Claude Semuto; Diallo, Awa Ba; Tagliani, Elisa; Diarra, Bassirou; Kadanga, Abalo Essosimna; Togo, Antieme Combo George; Thiam, Aliou; de Rijk, Willem Bram; Alagna, Riccardo; Houeto, Sabine; Ba, Fatoumata; Dagnra, Anoumou Yaotse; Ivan, Emil; Affolabi, Dissou; Schwoebel, Valerie; Trebucq, Arnaud; de Jong, Bouke Catherine; Rigouts, Leen; Daneau, Geraldine		Union Short MDR-TB Regimen Study G	Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide	PLOS ONE			English	Article							ASPARTATE DECARBOXYLASE PAND; PNCA GENE-MUTATIONS; DRUG-RESISTANCE; FLUOROQUINOLONES; SUSCEPTIBILITY; TRANSMISSION; MECHANISMS; DIAGNOSIS; LINEAGE	Background Besides inclusion in 1st line regimens against tuberculosis (TB), pyrazinamide (PZA) is used in 2nd line anti-TB regimens, including in the short regimen for multidrug-resistant TB (MDR-TB) patients. Guidelines and expert opinions are contradictory about inclusion of PZA in case of resistance. Moreover, drug susceptibility testing (DST) for PZA is not often applied in routine testing, and the prevalence of resistance is unknown in several regions, including in most African countries. Methods Six hundred and twenty-three culture isolates from rifampicin-resistant (RR) patients were collected in twelve Sub-Saharan African countries. Among those isolates, 71% were from patients included in the study on the Union short-course regimen for MDR-TB in Benin, Burkina Faso, Burundi, Cameroon, Central Africa Republic, the Democratic Republic of the Congo, Ivory Coast, Niger, and Rwanda PZA resistance, and the rest (29%) were consecutive isolates systematically stored from 2014-2015 in Mali, Rwanda, Senegal, and Togo. Besides national guidelines, the isolates were tested for PZA resistance through pncA gene sequencing. Results Over half of these RR-TB isolates (54%) showed a mutation in the pncA gene, with a significant heterogeneity between countries. Isolates with fluoroquinolone resistance (but not with injectable resistance or XDR) were more likely to have concurrent PZA resistance. The pattern of mutations in the pncA gene was quite diverse, although some isolates with an identical pattern of mutations in pncA and other drug-related genes were isolated from the same reference center, suggesting possible transmission of these strains. Conclusion Similar to findings in other regions, more than half of the patients having RR-TB in West and Central Africa present concomitant resistance to PZA. Further investigations are needed to understand the relation between resistance to PZA and resistance to fluoroquinolones, and whether continued use of PZA in the face of PZA resistance provides clinical benefit to the patients.	[Ngabonziza, Jean Claude Semuto; Ivan, Emil] Rwanda Biomed Ctr, Biomed Serv Dept, Natl Reference Lab Div, Kigali, Rwanda; [Ngabonziza, Jean Claude Semuto; de Rijk, Willem Bram; de Jong, Bouke Catherine; Rigouts, Leen; Daneau, Geraldine] Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, Antwerp, Belgium; [Diallo, Awa Ba; Thiam, Aliou] CHNU Aristide le Dantec, Mycobacteriol Unit, Bacteriol Virol Lab, Dakar, Senegal; [Tagliani, Elisa; Alagna, Riccardo] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Emerging Bacterial Pathogens Unit, Milan, Italy; [Diarra, Bassirou; Togo, Antieme Combo George] Univ Sci Tech & Technol Bamako, SEREFO UCRC Program, Bamako, Mali; [Kadanga, Abalo Essosimna; Dagnra, Anoumou Yaotse] Lab Natl Reference Mycobacteries, Lome, Togo; [Houeto, Sabine; Affolabi, Dissou] Lab Reference Mycobacteries, Cotonou, Benin; [Ba, Fatoumata] Lab Reference Mycobacteries, Dakar, Senegal; [Schwoebel, Valerie; Trebucq, Arnaud] Int Union TB & Lung Dis, Paris, France; [Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Daneau, Geraldine] Haute Ecole Francisco Ferrer, Biomed Sect, Brussels, Belgium	Rwanda Biomedical Center; Institute of Tropical Medicine (ITM); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Science & Technology of Bamako; University of Antwerp	Ngabonziza, JCS (corresponding author), Rwanda Biomed Ctr, Biomed Serv Dept, Natl Reference Lab Div, Kigali, Rwanda.; Ngabonziza, JCS (corresponding author), Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, Antwerp, Belgium.	cldsemuto@gmail.com	Tagliani, Elisa/AAN-1955-2020; Ngabonziza, Jean Claude Semuto/ABY-9467-2022; Ngabonziza, Jean Claude S./AFW-4109-2022; de Jong, Bouke/A-3636-2013	Ngabonziza, Jean Claude Semuto/0000-0002-6075-5603; Ngabonziza, Jean Claude S./0000-0002-6075-5603; Daneau, Geraldine/0000-0002-2570-0893; Piubello, Alberto/0000-0002-6937-3126; de Jong, Bouke/0000-0002-1017-4675; Diarra, Bassirou/0000-0002-1795-9379; Alagna, Riccardo/0000-0002-8768-8180	OPEC Fund for International Development (OFID); DGD FA3.3 TB network; EDCTP WANETAM; ERC Starting Grant INTERRUPTB [311725]	OPEC Fund for International Development (OFID); DGD FA3.3 TB network; EDCTP WANETAM; ERC Starting Grant INTERRUPTB	This study was supported by funds from the OPEC Fund for International Development (OFID), DGD FA3.3 TB network, the EDCTP WANETAM plus project, and the ERC Starting Grant INTERRUPTB (311725) to Leen Rigouts and Bouke Catherine de Jong.; this study was supported by funds from the OPEC Fund for International Development (OFID), DGD FA3.3 TB network, the EDCTP WANETAM plus project, and the ERC Starting Grant INTERRUPTB (311725) to Leen Rigouts and Bouke Catherine de Jong.	Alame-Emane AK, 2015, INT J TUBERC LUNG D, V19, P679, DOI 10.5588/ijtld.14.0768; Allana S, 2017, EMERG INFECT DIS, V23, P491, DOI 10.3201/eid2303.161034; Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Bates Matthew, 2016, Int J Mycobacteriol, V5 Suppl 1, pS24, DOI 10.1016/j.ijmyco.2016.10.035; Cabibbe A M, 2016, Int J Mycobacteriol, V5 Suppl 1, pS40, DOI 10.1016/j.ijmyco.2016.09.010; Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11; Chiu Y-C, BMC INFECT DIS; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; den Hertog AL, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv037; Dillon NA, 2014, ANTIMICROB AGENTS CH, V58, P7258, DOI 10.1128/AAC.04028-14; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Fofana MO, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00498-16; Gopal P, 2017, ACS INFECT DIS, V3, P492, DOI 10.1021/acsinfecdis.7b00017; Jonmalung J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-223; Jureen P, 2008, ANTIMICROB AGENTS CH, V52, P1852, DOI 10.1128/AAC.00110-08; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kendall EA, 2015, LANCET RESP MED, V3, P963, DOI 10.1016/S2213-2600(15)00458-0; Kim HJ, 2012, INT J TUBERC LUNG D, V16, P98, DOI 10.5588/ijtld.10.0739; Miotto P, 2015, CHEST, V147, P1135, DOI 10.1378/chest.14-1286; Miotto P, 2014, MBIO, V5, DOI 10.1128/mBio.01819-14; Napiorkowska A, 2014, INT J TUBERC LUNG D, V18, P454, DOI 10.5588/ijtld.13.0457; Nikolayevskyy V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152926; Njire M, 2016, ADV MED SCI-POLAND, V61, P63, DOI 10.1016/j.advms.2015.09.007; Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X; Pierre-Audigier C, 2012, INT J TUBERC LUNG D, V16, P221, DOI 10.5588/ijtld.11.0266; Portugal I, 2004, ANTIMICROB AGENTS CH, V48, P2736, DOI 10.1128/AAC.48.7.2736-2738.2004; Ramirez-Busby SM, 2015, ANTIMICROB AGENTS CH, V59, P5267, DOI 10.1128/AAC.00204-15; Said HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146106; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Shi WL, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.61; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trebucq A., 47 UN WORLD C LUNG H; van Soolingen Dick, 2016, Int J Mycobacteriol, V5 Suppl 1, pS60, DOI 10.1016/j.ijmyco.2016.10.036; Velasquez GE, 2016, ANTIMICROB AGENTS CH, V60, P6766, DOI 10.1128/AAC.00632-16; Verdugo D, 2015, ANTIMICROB AGENTS CH, V59, P6140, DOI 10.1128/AAC.00764-15; Walker TM, 2015, LANCET INFECT DIS, V15, P1193, DOI 10.1016/S1473-3099(15)00062-6; Whitfield MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133869; WHO, 2016, WHO FACT SHEET WORLD; WHO, 2016, SHORT MDR TB REG FEA; Zhang Y, 2015, INT J TUBERC LUNG D, V19, P1276, DOI 10.5588/ijtld.15.0389; Zhang Y, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.18; Zheng XB, 2017, INT J ANTIMICROB AG, V49, P183, DOI 10.1016/j.ijantimicag.2016.10.012; Zignol M, 2016, LANCET INFECT DIS, V16, P1185, DOI 10.1016/S1473-3099(16)30190-6	43	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187211	10.1371/journal.pone.0187211	http://dx.doi.org/10.1371/journal.pone.0187211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088294	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900049
J	Vancura, P; Abdelhadi, S; Csicsely, E; Baba, K; Tosini, G; Iuvone, PM; Spessert, R				Vancura, Patrick; Abdelhadi, Shaima; Csicsely, Erika; Baba, Kenkichi; Tosini, Gianluca; Iuvone, P. Michael; Spessert, Rainer			Gnaz couples the circadian and dopaminergic system to G protein-mediated signaling in mouse photoreceptors	PLOS ONE			English	Article							MAMMALIAN RETINA; PERTUSSIS-TOXIN; ALPHA-SUBUNIT; MELATONIN SYNTHESIS; ADENYLYL-CYCLASE; PINEAL-GLAND; CLOCK GENES; RAT RETINA; CELLS; EXPRESSION	The mammalian retina harbors a circadian clockwork that regulates vision and promotes healthiness of retinal neurons, mainly through directing the rhythmic release of the neuro-hormones dopamine-acting on dopamine D-4 receptors-and melatonin-acting on MT1 and MT2 receptors. The gene Gnaz D a unique Gi/o subfamily member D was seen in the present study to be expressed in photoreceptors where its protein product G alpha(z) shows a daily rhythm in its subcellular localization. Apart from subcellular localization, Gnaz displays a daily rhythm in expression-with peak values at night-in preparations of the whole retina, microdissected photoreceptors and photoreceptor-related pinealocytes. In retina, Gnaz rhythmicity was observed to persist under constant darkness and to be abolished in retina deficient for Clock or dopamine D-4 receptors. Furthermore, circadian regulation of Gnaz was disturbed in the db/db mouse, a model of diabetic retinopathy. The data of the present study suggest that Gnaz links the circadian clockwork-via dopamine acting on D-4 receptors D to G protein-mediated signaling in intact but not diabetic retina.	[Vancura, Patrick; Abdelhadi, Shaima; Csicsely, Erika; Spessert, Rainer] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, Mainz, Germany; [Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Neurosci Inst, Atlanta, GA 30310 USA; [Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Dept Pharmacol & Toxicol, Atlanta, GA 30310 USA; [Iuvone, P. Michael] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	Johannes Gutenberg University of Mainz; Morehouse School of Medicine; Morehouse School of Medicine; Emory University	Vancura, P (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, Mainz, Germany.	p.vancura@uni-mainz.de		Csicsely, Erika/0000-0002-9157-5154	National Institutes of Health [R01EY026291, R01EY004864, P30EY006360, R01EY02711]; NATIONAL EYE INSTITUTE [R01EY004864, R01EY026291, P30EY006360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM116760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by grants from the National Institutes of Health: R01EY026291 to GT, R01EY004864 to PMI, P30EY006360 to PMI, and R01EY02711 to PMI.	Aung MH, 2014, J NEUROSCI, V34, P726, DOI 10.1523/JNEUROSCI.3483-13.2014; Baba K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004302; Baba K, 2009, P NATL ACAD SCI USA, V106, P15043, DOI 10.1073/pnas.0904400106; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; BLATT C, 1988, P NATL ACAD SCI USA, V85, P7642, DOI 10.1073/pnas.85.20.7642; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; Cameron M, 2008, J GENET, V87, P459, DOI 10.1007/s12041-008-0068-5; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; Chan ASL, 2002, CELL SIGNAL, V14, P249, DOI 10.1016/S0898-6568(01)00240-6; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Debruyne J, 2008, J GENET, V87, P437, DOI 10.1007/s12041-008-0066-7; Doi M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10583; Dorenbos R, 2007, VISUAL NEUROSCI, V24, P573, DOI 10.1017/S0952523807070538; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Goldmann T, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-2; Gustincich S, 2004, P NATL ACAD SCI USA, V101, P5069, DOI 10.1073/pnas.0400913101; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; HINTON DR, 1990, J NEUROSCI, V10, P2763; Ho MKC, 2001, ONCOGENE, V20, P1615, DOI 10.1038/sj.onc.1204190; Hollborn M, 2011, MOL VIS, V17, P2738; Hultman R, 2014, MOL CELL NEUROSCI, V58, P53, DOI 10.1016/j.mcn.2013.12.004; Hwang CK, 2013, J NEUROSCI, V33, P14989, DOI 10.1523/JNEUROSCI.2039-13.2013; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Jackson CR, 2011, EUR J NEUROSCI, V34, P57, DOI 10.1111/j.1460-9568.2011.07734.x; JIANG MS, 1991, P NATL ACAD SCI USA, V88, P3907, DOI 10.1073/pnas.88.9.3907; Kamphuis W, 2005, BIOCHEM BIOPH RES CO, V330, P18, DOI 10.1016/j.bbrc.2005.02.118; Kimple ME, 2008, J BIOL CHEM, V283, P4560, DOI 10.1074/jbc.M706481200; Kimple ME, 2012, J BIOL CHEM, V287, P20344, DOI 10.1074/jbc.M112.359745; Kunst S, 2015, INVEST OPHTH VIS SCI, V56, P6084, DOI 10.1167/iovs.15-17503; Kunst S, 2013, J NEUROCHEM, V124, P757, DOI 10.1111/jnc.12089; Leck KJ, 2006, NEUROPHARMACOLOGY, V51, P597, DOI 10.1016/j.neuropharm.2006.05.002; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; McMahon DG, 2014, PROG RETIN EYE RES, V39, P58, DOI 10.1016/j.preteyeres.2013.12.001; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Nir I, 2002, J NEUROSCI, V22, P2063, DOI 10.1523/JNEUROSCI.22-06-02063.2002; OSBORNE NN, 1984, NEUROSCI LETT, V50, P117, DOI 10.1016/0304-3940(84)90472-5; Pozdeyev N, 2008, EUR J NEUROSCI, V27, P2691, DOI 10.1111/j.1460-9568.2008.06224.x; Rath MF, 2013, NEUROCHEM RES, V38, P1100, DOI 10.1007/s11064-012-0906-y; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038985; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sanchez-Blazquez P, 2009, CELL SIGNAL, V21, P1444, DOI 10.1016/j.cellsig.2009.05.003; Sandu C, 2011, EUR J NEUROSCI, V34, P507, DOI 10.1111/j.1460-9568.2011.07772.x; Savaskan E, 2002, J HISTOCHEM CYTOCHEM, V50, P519, DOI 10.1177/002215540205000408; Schneider K, 2010, J NEUROCHEM, V115, P585, DOI 10.1111/j.1471-4159.2010.06953.x; Sengupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024483; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Trojan P, 2008, PROG RETIN EYE RES, V27, P237, DOI 10.1016/j.preteyeres.2008.01.003; van den Buuse M, 2005, PSYCHOPHARMACOLOGY, V183, P358, DOI 10.1007/s00213-005-0181-6; Vancura P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164665; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Yang J, 2002, J BIOL CHEM, V277, P46035, DOI 10.1074/jbc.M208519200; Yang Q, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/757412	65	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187411	10.1371/journal.pone.0187411	http://dx.doi.org/10.1371/journal.pone.0187411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088301	gold, Green Submitted, Green Published			2022-12-27	WOS:000414088900081
J	Stefani, LC; Gutierrez, CD; Castro, SMD; Zimmer, RL; Diehl, FP; Meyer, LE; Caumo, W				Stefani, Luciana Cadore; Gutierrez, Claudia De Souza; de Jezus Castro, Stela Maris; Zimmer, Rafael Leal; Diehl, Felipe Polgati; Meyer, Leonardo Elman; Caumo, Wolnei			Derivation and validation of a preoperative risk model for postoperative mortality (SAMPE model): An approach to care stratification	PLOS ONE			English	Article							SURGICAL MORTALITY; INPATIENT SURGERY; CARDIAC RISK; COMPLICATIONS; PREDICTION; OUTCOMES; IDENTIFICATION; ADJUSTMENT; SURVIVAL; FAILURE	Ascertaining which patients are at highest risk of poor postoperative outcomes could improve care and enhance safety. This study aimed to construct and validate a propensity index for 30-day postoperative mortality. A retrospective cohort study was conducted at Hospital de Clinicas de Porto Alegre, Brazil, over a period of 3 years. A dataset of 13524 patients was used to develop the model and another dataset of 7254 was used to validate it. The primary outcome was 30-day in-hospital mortality. Overall mortality in the development dataset was 2.31% [n = 311; 95% confidence interval: 2.06-2.56%]. Four variables were significantly associated with outcome: age, ASA class, nature of surgery (urgent/emergency vs elective), and surgical severity (major/intermediate/minor). The index with this set of variables to predict mortality in the validation sample (n = 7253) gave an AUROC = 0.9137, 85.2% sensitivity, and 81.7% specificity. This sensitivity cut-off yielded four classes of death probability: class I, <2%; class II, 2-5%; class III, 5-10%; class IV, >10%. Model application showed that, amongst patients in risk class IV, the odds of death were approximately fivefold higher (odds ratio 5.43, 95% confidence interval: 2.82-10.46) in those admitted to intensive care after a period on the regular ward than in those sent to the intensive care unit directly after surgery. The SAMPE (Anaesthesia and Perioperative Medicine Service) model accurately predicted 30-day postoperative mortality. This model allows identification of high-risk patients and could be used as a practical tool for care stratification and rational postoperative allocation of critical care resources.	[Stefani, Luciana Cadore; Caumo, Wolnei] Univ Fed Rio Grande do Sul, Dept Surg, Porto Alegre, RS, Brazil; [Stefani, Luciana Cadore; Gutierrez, Claudia De Souza; Diehl, Felipe Polgati; Meyer, Leonardo Elman; Caumo, Wolnei] HCPA, Anesthesia & Perioperat Med Serv, Porto Alegre, RS, Brazil; [Stefani, Luciana Cadore; Gutierrez, Claudia De Souza; Zimmer, Rafael Leal; Caumo, Wolnei] Univ Fed Rio Grande do Sul, Med Sci Postgrad Program, Porto Alegre, RS, Brazil; [Stefani, Luciana Cadore; Caumo, Wolnei] Hosp Clin Porto Alegre, Lab Pain & Neuromodulat, Porto Alegre, RS, Brazil; [de Jezus Castro, Stela Maris] Univ Fed Rio Grande do Sul, Inst Matemat & Estat UFRGS, Dept Stat, Porto Alegre, RS, Brazil; [Stefani, Luciana Cadore] Hosp Clin Porto Alegre, Serv Anestesia & Med Perioperatoria, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Stefani, LC (corresponding author), Univ Fed Rio Grande do Sul, Dept Surg, Porto Alegre, RS, Brazil.; Stefani, LC (corresponding author), HCPA, Anesthesia & Perioperat Med Serv, Porto Alegre, RS, Brazil.; Stefani, LC (corresponding author), Univ Fed Rio Grande do Sul, Med Sci Postgrad Program, Porto Alegre, RS, Brazil.; Stefani, LC (corresponding author), Hosp Clin Porto Alegre, Lab Pain & Neuromodulat, Porto Alegre, RS, Brazil.; Stefani, LC (corresponding author), Hosp Clin Porto Alegre, Serv Anestesia & Med Perioperatoria, Porto Alegre, RS, Brazil.	lpstefani@hcpa.edu.br	Stefani, Luciana Cadore/AAC-6684-2019; Zimmer, Rafael L/K-6518-2015; caumo, wolnei/Q-8728-2016	Stefani, Luciana Cadore/0000-0002-3038-3108; Caumo, Wolnei/0000-0002-5083-4658	Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE-HCPA) [14-0323]	Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE-HCPA)	This work was supported by the Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE-HCPA- Project 14-0323). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherly A, 2004, AM J SURG, V188, P566, DOI 10.1016/j.amjsurg.2004.07.032; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Boersma E, 2005, AM J MED, V118, P1134, DOI 10.1016/j.amjmed.2005.01.064; Brooks MJ, 2005, BRIT J SURG, V92, P1288, DOI 10.1002/bjs.5058; Cohen ME, 2013, J AM COLL SURGEONS, V217, P336, DOI 10.1016/j.jamcollsurg.2013.02.027; Collett D., 2015, TEXTS STAT SCI, DOI [10.1198/tech.2004.s817, DOI 10.1198/TECH.2004.S817]; Donati A, 2004, BRIT J ANAESTH, V93, P393, DOI 10.1093/bja/aeh210; Elsayed H, 2010, INTERACT CARDIOV TH, V11, P65, DOI 10.1510/icvts.2009.223826; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P339, DOI 10.1016/0895-4356(90)90120-E; Ferraris VA, 2014, JAMA SURG, V149, P1103, DOI 10.1001/jamasurg.2014.1338; Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Glance LG, 2012, ANN SURG, V255, P696, DOI 10.1097/SLA.0b013e31824b45af; Gupta PK, 2011, CIRCULATION, V124, P381, DOI 10.1161/CIRCULATIONAHA.110.015701; Haga Y, 2011, ANN SURG, V253, P194, DOI 10.1097/SLA.0b013e3181f66199; Jakobson T, 2014, MEDICINA-LITHUANIA, V50, P111, DOI 10.1016/j.medici.2014.06.002; Jhanji S, 2008, MORTALITY UTILISATIO, P695; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Kurian A, 2011, DIS COLON RECTUM, V54, P467, DOI 10.1007/DCR.0b013e3182060904; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Merani S, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-43; Moonesinghe SR, 2011, ANESTH ANALG, V112, P891, DOI 10.1213/ANE.0b013e3181e1655b; Ozdemir BA, 2016, BRIT J ANAESTH, V116, P54, DOI 10.1093/bja/aev372; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Protopapa KL, 2014, BRIT J SURG, V101, P1774, DOI 10.1002/bjs.9638; Sankar A, 2014, BRIT J ANAESTH, V113, P424, DOI 10.1093/bja/aeu100; Saunders DI, 2012, BRIT J ANAESTH, V109, P368, DOI 10.1093/bja/aes165; Sepehri A, 2014, J THORAC CARDIOV SUR, V148, P3110, DOI 10.1016/j.jtcvs.2014.07.087; Stonelake S, 2015, ANN MED SURG, V4, P240, DOI 10.1016/j.amsu.2015.07.004; Sutton R, 2002, BRIT J SURG, V89, P763, DOI 10.1046/j.1365-2168.2002.02080.x	30	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187122	10.1371/journal.pone.0187122	http://dx.doi.org/10.1371/journal.pone.0187122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084236	gold, Green Published, Green Submitted			2022-12-27	WOS:000413910200032
J	Zhao, YY; Ding, Y; Hou, XY; Li, FY; Hang, WJ; Yun, XJ				Zhao, Yanyun; Ding, Yong; Hou, Xiangyang; Li, Frank Yonghong; Hang, Wenjun; Yun, Xiangjun			Effects of temperature and grazing on soil organic carbon storage in grasslands along the Eurasian steppe eastern transect	PLOS ONE			English	Article							LAND-USE CHANGE; INNER-MONGOLIA; NITROGEN STORAGE; CLIMATE-CHANGE; FOREST SOILS; STOCKS; DYNAMICS; SEQUESTRATION; FERTILIZATION; ECOSYSTEMS	Soil represents the largest terrestrial organic carbon pool. To address global climate change, it is essential to explore the soil organic carbon storage patterns and their controlling factors. We investigated the soil organic carbon density (SOCD) in 48 grassland sites along the Eurasian steppe eastern transect (ESET) region, which covers the Inner Mongolia grassland subregion and Mongolia grasslands subregion. Specifically, we analyzed the SOCD in the top 30 cm soil layer and its relationships with climatic variables, soil texture, grazing intensity and community biomass productivity. The results showed that the average SOCD of the ESET was 4.74 kg/m(2), and the SOCD of the Inner Mongolia grassland subregion (4.11 kg/m(2)) was significantly lower than that of the Mongolia grassland subregion (5.79 kg/m(2)). Significant negative relationships were found between the SOCD and the mean annual temperature (MAT), mean annual precipitation (MAP) and grazing intensity in the ESET region. The MAT and grazing intensity were identified as the major factors influencing the SOCD in the ESET region; the MAP and MAT were the major factors influencing the SOCD in the Inner Mongolia grassland subregion; and the MAT and soil pH were the major factors influencing the SOCD in the Mongolia grassland subregion.	[Zhao, Yanyun; Li, Frank Yonghong] Inner Mongolia Univ, Sch Ecol & Environm, Mongolia Key Lab Grassland Ecol, Hohhot, Peoples R China; [Ding, Yong; Hou, Xiangyang; Hang, Wenjun; Yun, Xiangjun] Chinese Acad Agr Sci, Grassland Res Inst, Key Lab Grassland Ecol & Restorat, Minist Agr, Hohhot, Peoples R China	Inner Mongolia University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Ministry of Agriculture & Rural Affairs	Hou, XY (corresponding author), Chinese Acad Agr Sci, Grassland Res Inst, Key Lab Grassland Ecol & Restorat, Minist Agr, Hohhot, Peoples R China.	houxy16@126.com	Li, Frank Yonghong/AAN-3093-2020	Li, Frank Yonghong/0000-0002-5137-8017	National Key Technology Support Program [2015BAC02B04]; Natural Science Foundation of Inner Mongolia [2015MS0302]	National Key Technology Support Program(National Key Technology R&D Program); Natural Science Foundation of Inner Mongolia	This study was supported by the National Key Technology Support Program (2015BAC02B04) and the Natural Science Foundation of Inner Mongolia (2015MS0302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Key Technology Support Program (2015BAC02B04) and the Natural Science Foundation of Inner Mongolia (2015MS0302).	Akpa SIC, 2016, GEODERMA, V271, P202, DOI 10.1016/j.geoderma.2016.02.021; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Badgery WB, 2013, SOIL RES, V51, P645, DOI 10.1071/SR12358; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breulmann M, 2016, SCI TOTAL ENVIRON, V545, P30, DOI 10.1016/j.scitotenv.2015.12.050; Cerri CEP, 2003, SOIL SCI SOC AM J, V67, P1879, DOI 10.2136/sssaj2003.1879; Chang XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097140; Chen DM, 2015, LANDSCAPE ECOL, V30, P1669, DOI 10.1007/s10980-014-9996-z; Chen JQ, 2015, BIOSCIENCE, V65, P559, DOI 10.1093/biosci/biv050; Chen YP, 2012, ENVIRON MANAGE, V50, P622, DOI 10.1007/s00267-012-9919-1; Dai EF, 2014, J GEOGR SCI, V24, P1035, DOI 10.1007/s11442-014-1136-9; Dlamini P, 2016, AGR ECOSYST ENVIRON, V221, P258, DOI 10.1016/j.agee.2016.01.026; Dulamsuren C, 2016, GLOBAL CHANGE BIOL, V22, P830, DOI 10.1111/gcb.13127; Follett RF, 2012, J SOIL WATER CONSERV, V67, P331, DOI 10.2489/jswc.67.5.331; Goidts E, 2009, GLOBAL CHANGE BIOL, V15, P2981, DOI 10.1111/j.1365-2486.2009.01940.x; Golluscio RA, 2009, ECOSYSTEMS, V12, P686, DOI 10.1007/s10021-009-9252-6; Groisman PY, 2009, B AM METEOROL SOC, V90, P671, DOI 10.1175/2008BAMS2556.1; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Han F, 2016, INT J REMOTE SENS, V37, P5551, DOI 10.1080/01431161.2016.1230286; He NP, 2014, PEDOSPHERE, V24, P391, DOI 10.1016/S1002-0160(14)60025-4; Hedley CB, 2012, SOIL RES, V50, P18, DOI 10.1071/SR11171; Herold N, 2014, BIOGEOCHEMISTRY, V119, P435, DOI 10.1007/s10533-014-9978-x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobley E, 2015, PLANT SOIL, V390, P111, DOI 10.1007/s11104-015-2380-1; [侯向阳 Hou Xiangyang], 2012, [中国草地学报, Chinese Journal of Grassland], V34, P108; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jung JY, 2011, GEODERMA, V166, P145, DOI 10.1016/j.geoderma.2011.07.023; Kolbl A, 2011, PLANT SOIL, V340, P35, DOI 10.1007/s11104-010-0473-4; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Li CL, 2012, J PLANT NUTR SOIL SC, V175, P339, DOI 10.1002/jpln.201100212; Longbottom TL, 2014, CATENA, V119, P125, DOI 10.1016/j.catena.2014.03.002; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Ma HK, 2016, APPL SOIL ECOL, V108, P128, DOI 10.1016/j.apsoil.2016.08.008; Maillard E, 2017, AGR ECOSYST ENVIRON, V236, P268, DOI 10.1016/j.agee.2016.11.024; Maki A, 2007, J HYDROL, V333, P100, DOI 10.1016/j.jhydrol.2006.07.024; Mao DH, 2015, BIOGEOSCIENCES, V12, P1635, DOI 10.5194/bg-12-1635-2015; Marin-Spiotta E, 2013, GLOBAL ECOL BIOGEOGR, V22, P105, DOI 10.1111/j.1466-8238.2012.00788.x; Martin MP, 2011, BIOGEOSCIENCES, V8, P1053, DOI 10.5194/bg-8-1053-2011; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Mcsherry ME, 2013, GLOBAL CHANGE BIOL, V19, P1347, DOI 10.1111/gcb.12144; Mulder VL, 2015, GLOBAL BIOGEOCHEM CY, V29, P1210, DOI 10.1002/2015GB005178; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Nosrati K., 2013, Journal of Applied Sciences and Environmental Management, V17, P225; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Rabbi SMF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17866; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Senechkin IV, 2014, APPL SOIL ECOL, V73, P148, DOI 10.1016/j.apsoil.2013.09.003; Shary P, 2013, EURASIAN SOIL SCI+, V46, P1076, DOI 10.1134/S1064229313090044; Araujo JKS, 2016, SCI TOTAL ENVIRON, V568, P339, DOI 10.1016/j.scitotenv.2016.06.025; Tavakkoli E, 2015, EUROPEAN J SOIL SCI, V66; Wang J, 2013, LANDSCAPE ECOL, V28, P725, DOI 10.1007/s10980-013-9865-1; Wang SP, 2011, AGR ECOSYST ENVIRON, V142, P329, DOI 10.1016/j.agee.2011.06.002; Wang T, 2016, SOIL TILL RES, V163, P176, DOI 10.1016/j.still.2016.05.015; Wang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33190; Wellock ML, 2011, FOREST ECOL MANAG, V262, P1589, DOI 10.1016/j.foreco.2011.07.007; Wu JG, 2015, LANDSCAPE ECOL, V30, P1579, DOI 10.1007/s10980-015-0209-1; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Yonekura Y, 2013, PLANT SOIL, V372, P683, DOI 10.1007/s11104-013-1763-4	60	17	17	11	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186980	10.1371/journal.pone.0186980	http://dx.doi.org/10.1371/journal.pone.0186980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084243	Green Submitted, Green Published, gold			2022-12-27	WOS:000413910200021
J	Cagnardi, P; Guccione, J; Villa, R; D'Andrea, L; Di Loria, A; Ferrante, MC; Borriello, G; Zicarelli, L; Ciaramella, P				Cagnardi, Petra; Guccione, Jacopo; Villa, Roberto; D'Andrea, Luigi; Di Loria, Antonio; Ferrante, Maria Carmela; Borriello, Giuliano; Zicarelli, Luigi; Ciaramella, Paolo			Clinical efficacy and pharmacokinetics of meloxicam in Mediterranean buffalo calves (Bubalus bubalis)	PLOS ONE			English	Article							DAIRY CALVES; BEEF-CALVES; CASTRATION; PAIN; CATTLE; BEHAVIOR; QUALITY; PLASMA; HEALTH; BULLS	The aims of the investigation were to establish for the first time (i) clinical efficacy and (ii) pharmacokinetic profile of meloxicam intravenously (IV) administered in male Mediterranean buffalo calves after surgical orchiectomy. The study was performed on 10 healthy buffalo calves, between 4 and 5 months old and between 127 and 135 kg of body weight (b.w.). An IV injection of 0.5 mg/kg b.w. of meloxicam was administered in six calves (treated group, TG) immediately after surgery; the other four animals were used as untreated control group (CG). The clinical efficacy of meloxicam was evaluated pre-and post-surgery by monitoring respiratory rate (RR), heart rate (HR), rectal temperature (T degrees C), serum cortisol levels (SCL) and pain score (PS). Significant inter-groups differences were detected at sampling times (T): 4 hour (h) for RR (P<0.05), at T1-4-6-8 h for PS (P<0.05) and at T4-6-8 h for SCL (P < 0.0001). Regarding the mean intra-group values observed pre (T0) and post-surgery (from T15 min to T72 h), significant difference between the groups were found for RR (P<0.01), PS and SCL (P<0.05). The pharmacokinetic profile was best fitted by a two-compartmental model and characterized by a fast distribution half-life and slow elimination half-life (0.09 +/- 0.06 h and 21.51 +/- 6.4 h, respectively) and meloxicam mean concentrations at 96 h was of 0.18 +/- 0.14 mu g/mL. The volume of distribution and clearance values were quite low, but reasonably homogenous among individuals (V-dss 142.31 +/- 55.08 mL/kg and Cl-B 4.38 +/- 0.95 mL/kg/h, respectively). The IV administration of meloxicam in buffalo calves shows encouraging effects represented by significant and prolonged analgesic effects, significant reduction of SCL as well as similar pharmacokinetic profile to bovine calves.	[Cagnardi, Petra; Villa, Roberto] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Guccione, Jacopo; D'Andrea, Luigi; Ferrante, Maria Carmela; Borriello, Giuliano; Zicarelli, Luigi; Ciaramella, Paolo] Univ Napoli Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Di Loria, Antonio] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy	University of Milan; University of Naples Federico II; Magna Graecia University of Catanzaro	Guccione, J (corresponding author), Univ Napoli Federico II, Dept Vet Med & Anim Prod, Naples, Italy.; Di Loria, A (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	jacopo.guccione@unina.it; adiloria@unicz.it		Cagnardi, Petra/0000-0001-6232-4850; GUCCIONE, Jacopo/0000-0002-3390-137X; Borriello, Giuliano/0000-0002-4993-0511; Villa, Roberto/0000-0001-5536-1370				Alberghina D., 2016, Comparative Clinical Pathology, V25, P721, DOI 10.1007/s00580-016-2254-9; ALDughaym AM, 2011, RES J PHARM, V5, P1; [Anonymous], EMACVMPVICH463202200; Busch U, 1998, DRUG METAB DISPOS, V26, P576; Coetzee JF, 2015, J VET PHARMACOL THER, V38, P556, DOI 10.1111/jvp.12215; Coetzee JF, 2012, J ANIM SCI, V90, P1026, DOI 10.2527/jas.2011-4068; Coetzee JF, 2013, VET CLIN N AM-FOOD A, V29, P75, DOI 10.1016/j.cvfa.2012.11.002; Coetzee JF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-153; Coetzee JF, 2009, VET THER, V10; Coetzee JF, 2011, APPL ANIM BEHAV SCI, V135, P192, DOI 10.1016/j.applanim.2011.10.016; Currah JM, 2009, CAN VET J, V50, P375; De la Vibora JB, 2008, VET ANAESTH ANALG, V35, P501; de Oliveira FA, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0200-0; De Rosa G, 2015, J DAIRY SCI, V98, P6886, DOI 10.3168/jds.2015-9350; DellaRocca G, 2014, SEMIOLOGIA CLIN VET, P494; Deneuche AJ, 2004, VET SURG, V33, P650, DOI 10.1111/j.1532-950X.2004.04088.x; Desrosches A, 2005, ANIMAL PRACTICE, V21, P1; EMA, 2011, EMACVMPVICH463202200; EMA, 1997, EMEAMRL23697FINAL; European Commission, 2002, OFFICIAL J, V221, P8; Gandra JR, 2011, LIVEST SCI, V140, P283, DOI 10.1016/j.livsci.2011.04.005; Gao CS, 2006, INT J PHARMACEUT, V322, P104, DOI 10.1016/j.ijpharm.2006.05.035; Gibaldi M, 1982, PHARMACOKINETICS; Giuffrida-Mendoza M, 2015, MEAT SCI, V106, P44, DOI 10.1016/j.meatsci.2015.03.024; Guccione J, 2014, J DAIRY SCI, V97, P2219, DOI 10.3168/jds.2013-7268; Guccione J, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0944-4; Guccione J, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0726-4; Guccione J, 2014, J EQUINE VET SCI, V34, P302, DOI 10.1016/j.jevs.2013.07.001; Heinrich A, 2009, J DAIRY SCI, V92, P540, DOI 10.3168/jds.2008-1424; Heinrich A, 2010, J DAIRY SCI, V93, P2450, DOI 10.3168/jds.2009-2813; Jeunesse EC, 2017, J PHARM EXPT THERAPE, V338, P548; Konigsson K, 2002, J VET MED A, V49, P408, DOI 10.1046/j.1439-0442.2002.00461.x; Kreuder AJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-85; LAM FC, 1985, J PHARM SCI, V74, P229, DOI 10.1002/jps.2600740229; Lees P, 2004, J VET PHARMACOL THER, V27, P479, DOI 10.1111/j.1365-2885.2004.00617.x; LEES P, 2009, VET PHARM THERAPEUTI, P457; McDougall S, 2009, J DAIRY SCI, V92, P4421, DOI 10.3168/jds.2009-2284; Molony V, 1997, J ANIM SCI, V75, P266; Montgomery AA, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-8; Mosher RA, 2012, J VET PHARMACOL THER, V35, P373, DOI 10.1111/j.1365-2885.2011.01331.x; OCKERMAN HW, 1984, J ANIM SCI, V59, P981, DOI 10.2527/jas1984.594981x; Repenning PE, 2013, J ANIM SCI, V91, P4975, DOI 10.2527/jas.2012-6061; Roberts SL, 2015, J ANIM SCI, V93, P4123, DOI 10.2527/jas.2015-9160; ROBERTSON IS, 1994, RES VET SCI, V56, P8, DOI 10.1016/0034-5288(94)90189-9; Saurit AR, 2002, VET RES COMMUN, V26, P49, DOI 10.1023/A:1013305721813; Stewart M, 2009, J DAIRY SCI, V92, P1512, DOI 10.3168/jds.2008-1578; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Toutain PL, 2004, AM J VET RES, V65, P1542, DOI 10.2460/ajvr.2004.65.1542; Voloski FLS, 2016, MEAT SCI, V116, P207, DOI 10.1016/j.meatsci.2016.02.020; Weaver AD, 2005, BOVINE SURGERY AND LAMENESS, 2ND EDITION, P168; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450; Zicarelli L, 2017, BUFFALO (BUBALUS BUBALIS) - PRODUCTION AND RESEARCH, P196	52	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187252	10.1371/journal.pone.0187252	http://dx.doi.org/10.1371/journal.pone.0187252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077759	Green Submitted, Green Published, gold			2022-12-27	WOS:000413861200056
J	Kok, A; van Middelaar, CE; Mostert, PF; van Knegsel, ATM; Kemp, B; de Boer, IJM; Hogeveen, H				Kok, Akke; van Middelaar, Corina E.; Mostert, Pim F.; van Knegsel, Ariette T. M.; Kemp, Bas; de Boer, Imke J. M.; Hogeveen, Henk			Effects of dry period length on production, cash flows and greenhouse gas emissions of the dairy herd: A dynamic stochastic simulation model	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; TEST-DAY MILK; ENERGY-BALANCE; EARLY-LACTATION; SUBSEQUENT LACTATION; TRANSITION COWS; HOLSTEIN HERDS; PROTEIN YIELD; SHORT 35-D; MANAGEMENT	Shortening or omitting the dry period of dairy cows improves metabolic health in early lactation and reduces management transitions for dairy cows. The success of implementation of these strategies depends on their impact on milk yield and farm profitability. Insight in these impacts is valuable for informed decision-making by farmers. The aim of this study was to investigate how shortening or omitting the dry period of dairy cows affects production and cash flows at the herd level, and greenhouse gas emissions per unit of milk, using a dynamic stochastic simulation model. The effects of dry period length on milk yield and calving interval assumed in this model were derived from actual performance of commercial dairy cows over multiple lactations. The model simulated lactations, and calving and culling events of individual cows for herds of 100 cows. Herds were simulated for 5 years with a dry period of 56 (conventional), 28 or 0 days (n = 50 herds each). Partial cash flows were computed from revenues from sold milk, calves, and culled cows, and costs from feed and rearing young-stock. Greenhouse gas emissions were computed using a life cycle approach. A dry period of 28 days reduced milk production of the herd by 3.0% in years 2 through 5, compared with a dry period of 56 days. A dry period of 0 days reduced milk production by 3.5% in years 3 through 5, after a dip in milk production of 6.9% in year 2. On average, dry periods of 28 and 0 days reduced partial cash flows by 1,249 pound and 1,632 pound per herd per year, and increased greenhouse gas emissions by 0.7% and 0.5%, respectively. Considering the potential for enhancing cow welfare, these negative impacts of shortening or omitting the dry period seem justifiable, and they might even be offset by improved health.	[Kok, Akke; van Middelaar, Corina E.; Mostert, Pim F.; de Boer, Imke J. M.] Wageningen Univ & Res, Anim Prod Syst Grp, Wageningen, Netherlands; [Kok, Akke; van Knegsel, Ariette T. M.; Kemp, Bas] Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands; [Hogeveen, Henk] Wageningen Univ & Res, Business Econ Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Kok, A (corresponding author), Wageningen Univ & Res, Anim Prod Syst Grp, Wageningen, Netherlands.; Kok, A (corresponding author), Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands.	akke.kok@wur.nl	van Knegsel, Ariette/AAA-7304-2020; Kok, Akke/I-6202-2019; de Boer, Imke/P-7107-2014	van Knegsel, Ariette/0000-0003-1959-3363; Kok, Akke/0000-0002-6024-5339; de Boer, Imke/0000-0002-0675-7528; Hogeveen, Henk/0000-0002-9443-1412	DairyNL (Zuivel NL); Dutch Ministry of Economic Affairs, as part of the Sustainable Dairy Chain initiative (Duurzame Zuivelketen)	DairyNL (Zuivel NL); Dutch Ministry of Economic Affairs, as part of the Sustainable Dairy Chain initiative (Duurzame Zuivelketen)	This study is financed by DairyNL (Zuivel NL; organization of the Dutch dairy supply chain) and the Dutch Ministry of Economic Affairs (EZ), as part of the Sustainable Dairy Chain initiative (Duurzame Zuivelketen; http://ww.duurzamezuivelketen.nl/en/about-us). The specific project is Customized Dry period lengths (Droogstand op maat; http://www.verantwoordeveehouderij.nl/show/Droogstand-op-maat.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the participating farmers and CRV for providing the data, and Dr. Niels Rutten and Dr. Jan Dijkstra (Wageningen University) for useful discussions. This study is financed by DairyNL (Zuivel NL; organization of the Dutch dairy supply chain) and the Dutch Ministry of Economic Affairs (EZ), as part of the Sustainable Dairy Chain initiative (Duurzame Zuivelketen).	Andersen JB, 2005, J DAIRY SCI, V88, P3530, DOI 10.3168/jds.S0022-0302(05)73038-1; ARNOLD P. T. DIX, 1936, JOUR DAIRY SCI, V19, P257, DOI 10.3168/jds.S0022-0302(36)93061-8; Butler WR, 2003, LIVEST PROD SCI, V83, P211, DOI 10.1016/S0301-6226(03)00112-X; Capuco AV, 1997, J DAIRY SCI, V80, P477, DOI 10.3168/jds.S0022-0302(97)75960-5; Centraal Bureau voor Statistiek, 2016, GEZ VOLW OUD GGEN CB; Chen J, 2015, THERIOGENOLOGY, V84, P1387, DOI 10.1016/j.theriogenology.2015.07.025; Cheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115339; Collard BL, 2000, J DAIRY SCI, V83, P2683, DOI 10.3168/jds.S0022-0302(00)75162-9; CVB, 2012, TAB VEEV 2012 VOED L; De Mol R.M., 2003, EMISSIONS METHANE NI; de Vries JW, 2011, LIFE CYCLE ASSESSMEN; Dong H, 2006, FORESTRY; FrieslandCampina, 2016, JAARV 2016; Garnsworthy PC, 2004, ANIM FEED SCI TECH, V112, P211, DOI 10.1016/j.anifeedsci.2003.10.011; Gerber P.J., 2013, TACKLING CLIMATE CHA, P139; Gumen A, 2005, J DAIRY SCI, V88, P2401, DOI 10.3168/jds.S0022-0302(05)72918-0; Heeren JAH, 2014, LIVEST SCI, V168, P149, DOI 10.1016/j.livsci.2014.08.004; Heuer C, 1999, J DAIRY SCI, V82, P295, DOI 10.3168/jds.S0022-0302(99)75236-7; Inchaisri C, 2010, THERIOGENOLOGY, V74, P835, DOI 10.1016/j.theriogenology.2010.04.008; Ingvartsen KL, 2006, ANIM FEED SCI TECH, V126, P175, DOI 10.1016/j.anifeedsci.2005.08.003; International Dairy Federation, 2015, B INT DAIRY FED, V63; Kopf M, 2014, ANIMAL, V8, P1130, DOI 10.1017/S1751731114001062; Kok A, 2017, J DAIRY SCI, V100, P739, DOI 10.3168/jds.2016-10963; Kok A, 2016, J DAIRY SCI, V99, P2956, DOI 10.3168/jds.2015-10559; Kok A, 2017, APPL ANIM BEHAV SCI, V186, P7, DOI 10.1016/j.applanim.2016.10.017; Kuhn MT, 2005, ANIM RES, V54, P351, DOI 10.1051/animres:2005031; KWIN V, 2014, KWANT INF VEEH 2014; Lesschen JP, 2011, ANIM FEED SCI TECH, V166-67, P16, DOI 10.1016/j.anifeedsci.2011.04.058; Mackenzie SG, 2017, INT J LIFE CYCLE ASS, V22, P128, DOI 10.1007/s11367-016-1161-2; Mostert P F, 2018, Animal, V12, P145, DOI 10.1017/S1751731117001306; Mostert PF, 2017, J CLEAN PRO IN PRESS; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Nor NM, 2014, J DAIRY RES, V81, P1, DOI 10.1017/S0022029913000460; Pinedo PJ, 2014, J DAIRY SCI, V97, P2886, DOI 10.3168/jds.2013-7685; R Core Team, 2016, R FDN STAT COMP; Rastani RR, 2005, J DAIRY SCI, V88, P1004, DOI 10.3168/jds.S0022-0302(05)72768-5; Roberts T, 2012, J DAIRY SCI, V95, P3057, DOI 10.3168/jds.2011-4937; Rutten CJ, 2014, J DAIRY SCI, V97, P6869, DOI 10.3168/jds.2014-7948; RVO (Netherlands Enterprise Agency), 2015, HANDR BEDR EXCR MELK; Santschi DE, 2011, J DAIRY SCI, V94, P4734, DOI 10.3168/jds.2010-3596; Santschi DE, 2011, J DAIRY SCI, V94, P2302, DOI 10.3168/jds.2010-3594; SORENSEN JT, 1993, LIVEST PROD SCI, V33, P77, DOI 10.1016/0301-6226(93)90240-I; Steeneveld W, 2013, J DAIRY SCI, V96, P2988, DOI 10.3168/jds.2012-6297; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; TAMMINGA S, 1994, LIVEST PROD SCI, V40, P139, DOI 10.1016/0301-6226(94)90043-4; Van Es A.J.H., 1975, LIVEST PROD SCI, V2, P95, DOI DOI 10.1016/0301-6226(75)90029-9; van Hoeij RJ, 2017, J DAIRY SCI, V100, P5863, DOI 10.3168/jds.2016-11703; van Knegsel ATM, 2014, J DAIRY SCI, V97, P1499, DOI 10.3168/jds.2013-7391; van Knegsel ATM, 2013, VET J, V198, P707, DOI 10.1016/j.tvjl.2013.10.005; van Middelaar CE, 2014, J DAIRY SCI, V97, P5191, DOI 10.3168/jds.2013-7413; van Middelaar CE, 2013, AGR SYST, V121, P9, DOI 10.1016/j.agsy.2013.05.009; Vellinga T. V., 2013, METHODOLOGY USED FEE; Velthof G., 2011, CALCULATION NITROUS; Vonk J., 2016, METHODOLOGY ESTIMATI, DOI [10.18174/383679, DOI 10.18174/]; Wageningen Economic Research, AGR PRIC; Wageningen Economic Research, EC FARM RES; Watters RD, 2009, J DAIRY SCI, V92, P3081, DOI 10.3168/jds.2008-1294; Weiss F, 2012, AGR ECOSYST ENVIRON, V149, P124, DOI 10.1016/j.agee.2011.12.015; WILMINK JBM, 1987, LIVEST PROD SCI, V16, P335, DOI 10.1016/0301-6226(87)90003-0; Zobel G, 2015, J DAIRY SCI, V98, P8263, DOI 10.3168/jds.2015-9617	60	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187101	10.1371/journal.pone.0187101	http://dx.doi.org/10.1371/journal.pone.0187101			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077739	Green Submitted, gold, Green Published			2022-12-27	WOS:000413861200043
J	Yaya, S; Bishwajit, G; Ekholuenetale, M; Shah, V				Yaya, Sanni; Bishwajit, Ghose; Ekholuenetale, Michael; Shah, Vaibhav			Awareness and utilization of community clinic services among women in rural areas in Bangladesh: A cross-sectional study	PLOS ONE			English	Article							HEALTH-CARE-SEEKING; SOCIODEMOGRAPHIC FACTORS; INEQUALITIES; MORBIDITY; KNOWLEDGE; BEHAVIOR; INDIA	Background In recent years, Bangladesh government has accomplished the ambitious project of establishing hospitals 18,000 Community Health Clinics in sub-districts across the country. Operating under the affiliation of the government hospitals, these community health clinics aim to provide free healthcare services and to increase health-awareness among the extreme poor communities in the rural areas. However, a great proportion of the people are still not well aware of the services offered by the community health clinics. Thus, it is imperative to identify the factors of awareness regarding the community clinics. Research-based evidence is necessary to improve the efficacy and service coverage of community clinics among key population. Methods Cross-sectional data of size 11,673 women aged 15 to 49 years living in rural settings across seven divisions were extracted from the latest Bangladesh Demographic and Health Survey 2014. The main outcome measures of our study were awareness and utilization of Community Clinic Services (CCs). Descriptive statistics were used to present the baseline socio-demographic and economic characteristics; Chi-square test and logistic regression were performed to identify the factors associated with awareness of community clinics. Results About one-third (36.7%) of the women were aware of community clinics. Geographical location, level of education, household wealth status and frequency of reading newspaper were found to be significantly associated with awareness about community clinic services. Services reported to be obtained in the community clinics include family planning, immunization, tetanus, antenatal care, vitamin A, and health care for children and child growth monitoring. In the multivariate logistic regression, the odds of awareness among participants with primary education [p<0.001, AOR = 1.255, 95% CI = 1.107-1.357], secondary qualification [p<0.001, AOR = 1.370, 95% CI = 1.242-1.510] and tertiary [p<0.001, AOR = 1.526, 95% CI = 1.286-1.809] had approximately 23%, 37% and 53% respectively higher odds of awareness when compared to those with no formal education. Compared to the women living in richest households, odds of awareness were approximately 12.5%, 12.8%, 4.5% and 22.4% respectively higher among women reported in poorer, middle, richer and richest household wealth status when compared to poorest wealth status. Conclusion Our findings suggested that policies enhancing improved education could benefit health awareness. Poverty elimination and income generation programs among women are also likely to improve awareness about community health clinics in the target population. Special policy attention is required to address the regional variation of awareness about Community clinics.	[Yaya, Sanni] Univ Ottawa, Sch Int Dev & Global Studies, Ottawa, ON, Canada; [Bishwajit, Ghose] Univ Dhaka, Inst Nutr & Food Sci, Dhaka, Bangladesh; [Ekholuenetale, Michael] Womens Hlth & Act Res Ctr, Benin, Nigeria; [Shah, Vaibhav] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada	University of Ottawa; University of Dhaka; University of Ottawa	Yaya, S (corresponding author), Univ Ottawa, Sch Int Dev & Global Studies, Ottawa, ON, Canada.	sanni.yaya@uOttawa.ca	Ekholuenetale, Michael/AAL-3655-2021; Yaya, Sanni/C-1079-2019	Ekholuenetale, Michael/0000-0002-2372-3020; Yaya, Sanni/0000-0002-4876-6043				Ahmed S, 2011, SOC SCI MED, V72, P1704, DOI 10.1016/j.socscimed.2011.03.031; Ahmed SM, 2000, SOC SCI MED, V51, P361, DOI 10.1016/S0277-9536(99)00461-X; Aktar S., 2012, Bangladesh e-Journal of Sociology, V9, P57; Alim MA, 2014, ENVIRON HEALTH PREV, V19, P126, DOI 10.1007/s12199-013-0364-4; Bazzano AN, 2008, TROP MED INT HEALTH, V13, P123, DOI 10.1111/j.1365-3156.2007.01981.x; Benova L, 2014, J GERONTOL B; Carlton EL, 2011, RURAL REMOTE HEALTH, V11; COMDIS-HSD, 2014, RES DEV EFF SERV DEL; Fan L, 2011, J RURAL HEALTH, V27, P39, DOI 10.1111/j.1748-0361.2010.00313.x; Haque MN, 2009, INTERNET J HLTH, V8, P16; Islam M Ataharul, 2006, Health Care Women Int, V27, P807, DOI 10.1080/07399330600880368; Javali R, 2014, INT J MED SCI PUBLIC, V3, P308; Kempen GIJM, 1999, SOC SCI MED, V49, P143, DOI 10.1016/S0277-9536(99)00129-X; Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mishra SK, 2012, ASIA-PAC J PUBLIC HE, V24, P136, DOI 10.1177/1010539510375842; Normand C, 2012, ASSESSMENT COMMUNITY; Ogunlesi T., 2005, NIGER J PAEDIAT, V32, P40; Ogunlesi TA, 2012, MATERN CHILD HLTH J, V16, P677, DOI 10.1007/s10995-011-0765-1; Ogunlesi TA, 2010, J TROP PEDIATRICS, V56, P379, DOI 10.1093/tropej/fmq009; Ogunlesi TA, 2010, MATERN CHILD HLTH J, V14, P459, DOI 10.1007/s10995-008-0440-3; Rashid SF, 2011, REPROD HEALTH MATTER, V19, P21, DOI 10.1016/S0968-8080(11)37551-9; Saito K, 1997, YALE J BIOL MED, V70, P149; Simsek H, 2013, RELATIONSHIP SOCIOEC; Spleen AM, 2014, J RURAL HEALTH, V30, P79, DOI 10.1111/jrh.12032; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; STARFIELD B, 1994, LANCET, V344, P1129, DOI 10.1016/S0140-6736(94)90634-3; STONE L, 1986, SOC SCI MED, V22, P293, DOI 10.1016/0277-9536(86)90125-5; The DHS Program, 2014, DAT SET ACC APPR PRO; Tsegay Y, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-30; Wamani H, 2005, J TROP PEDIATRICS, V51, P356, DOI 10.1093/tropej/fmi048	32	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187303	10.1371/journal.pone.0187303	http://dx.doi.org/10.1371/journal.pone.0187303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077754	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200057
J	Luo, ZT; Fan, YY; Li, QX; Hang, B; Liu, Y; Li, SB; Qiu, H; Pang, ZW				Luo, Zhiting; Fan, Yingying; Li, Qiuxia; Hang, Bing; Liu, Yang; Li, Shubo; Qiu, Hua; Pang, Zongwen			Isolation, purification and characterization of 5 '-phosphodiesterase from Aspergillus fumigatus	PLOS ONE			English	Article							SAFETY EVALUATION; NUCLEASE P1; HYDROLYSIS; PROTEIN; BARLEY	5'-Phosphodiesterase (5'-PDE) catalyzes the hydrolysis of ribonucleic acid to obtain a mixture of ribonucleotides, such as 5'-guanosine monophosphate and 5'-adenosine monophosphate. In this study, a 5'-PDE was newly isolated and purified from Aspergillus fumigatus. Following purification, this enzyme exhibited a specific activity of 1036.76 U/mg protein, a molecular weight of 9.5 kDa, and an optimal temperature and pH for enzyme activity of 60 degrees C and 5.0, respectively. However, its activity was partially inhibited by Fe3+, Cu2+, and Zn2+, but slightly improved by the presence of K+ and Na+. Additionally, chemical-modification experiments were also applied to investigate the structural information of 5'-PDE, in which the residues containing carboxyl and imidazole groups were essential for enzyme activity based on their localization in the 5'-PDE active site. Furthermore, purified 5'-PDE could specifically catalyze the synthesis of ribonucleotides with a V-max 0.71 mmol/mg.min and a K-M of 13.60 mg/mL.	[Luo, Zhiting; Qiu, Hua] Guangxi Univ, Coll Light Ind & Food Engn, Nanning, Peoples R China; [Fan, Yingying; Li, Qiuxia; Hang, Bing; Liu, Yang; Pang, Zongwen] Guangxi Univ, Coll Life Sci & Technol, Nanning, Peoples R China; [Li, Shubo] Liquor Making Biol Technol & Applicat Key Lab Sic, Zigong, Peoples R China	Guangxi University; Guangxi University	Qiu, H (corresponding author), Guangxi Univ, Coll Light Ind & Food Engn, Nanning, Peoples R China.; Pang, ZW (corresponding author), Guangxi Univ, Coll Life Sci & Technol, Nanning, Peoples R China.	qh0038@163.com; pangzw@gxu.edu.cn			Guangxi Natural Science Foundation [2016GXNSFAA380247]; Liquor Making Biological Technology and Application of key laboratory of Sichuan Province [NJ2016-04]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Liquor Making Biological Technology and Application of key laboratory of Sichuan Province	This research was financially supported by the Guangxi Natural Science Foundation (grant NO. 2016GXNSFAA380247), and the Liquor Making Biological Technology and Application of key laboratory of Sichuan Province (NJ2016-04).	Beluhan S, 2003, BIOTECHNOL LETT, V25, P1099, DOI 10.1023/A:1024144215414; BENAIGES MD, 1990, ENZYME MICROB TECH, V12, P86, DOI 10.1016/0141-0229(90)90078-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burdock GA, 2000, FOOD CHEM TOXICOL, V38, P429, DOI 10.1016/S0278-6915(00)00018-1; Davis BG, 2003, CURR OPIN BIOTECH, V14, P379, DOI 10.1016/S0958-1669(03)00098-3; Deoda AJ, 2003, BIORESOURCE TECHNOL, V88, P245, DOI 10.1016/S0960-8524(02)00267-5; GARCIADIAZ M, 1991, EUR J BIOCHEM, V196, P451, DOI 10.1111/j.1432-1033.1991.tb15836.x; Guoqing Ying, 2004, GUANGZHOU FOOD SCI T, V20, P126; He QT, 2011, KOREAN J CHEM ENG, V28, P544, DOI 10.1007/s11814-010-0404-3; Hu Y.-J., 1985, Acta Phytophysiologica Sinica, V11, P155; Krause U, 1996, AM J PHYSIOL-REG I, V270, pR811, DOI 10.1152/ajpregu.1996.270.4.R811; KUNINAKA A, 1961, AGR BIOL CHEM TOKYO, V25, P693, DOI 10.1080/00021369.1961.10857865; Lan TQ, 2013, BIORESOURCE TECHNOL, V133, P175, DOI 10.1016/j.biortech.2013.01.088; Okado N, 2016, FOOD CHEM TOXICOL, V88, P21, DOI 10.1016/j.fct.2015.12.001; Paolucci-Jeanjean D, 2001, J CHEM TECHNOL BIOT, V76, P273, DOI 10.1002/jctb.380; ROBERTO IC, 1991, BIORESOURCE TECHNOL, V36, P271, DOI 10.1016/0960-8524(91)90234-B; Shi LE, 2009, J MEMBRANE SCI, V345, P217, DOI 10.1016/j.memsci.2009.09.001; Soares AM, 2003, BIOCHEM BIOPH RES CO, V302, P193, DOI 10.1016/S0006-291X(03)00155-4; Steensma A, 2004, FOOD CHEM TOXICOL, V42, P935, DOI 10.1016/j.fct.2004.01.017; TAKETO Y, 1974, JPN J EXP MED, V44, P291; TANAKA H, 1985, BIOTECHNOL BIOENG, V27, P890, DOI 10.1002/bit.260270621; Warnecke JM, 2000, NUCLEIC ACIDS RES, V28, P720, DOI 10.1093/nar/28.3.720; Ying GQ, 2006, PROCESS BIOCHEM, V41, P1276, DOI 10.1016/j.procbio.2005.12.028; Ying QQ, 2007, APPL BIOCHEM BIOTECH, V136, P119, DOI 10.1007/BF02685942	24	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186011	10.1371/journal.pone.0186011	http://dx.doi.org/10.1371/journal.pone.0186011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073277	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400011
J	Seckler, JM; Meyer, NM; Burton, ST; Bates, JN; Gaston, B; Lewis, SJ				Seckler, James M.; Meyer, Nikki M.; Burton, Spencer T.; Bates, James N.; Gaston, Benjamin; Lewis, Stephen J.			Detection of trace concentrations of S-nitrosothiols by means of a capacitive sensor	PLOS ONE			English	Article							NITRIC-OXIDE; BIOLOGICAL-SYSTEMS; CYSTIC-FIBROSIS; NITROSYLATION; PROTEIN; BIOSENSORS; CYSTEINE; NITROSOGLUTATHIONE; PERSPECTIVES; DOPAMINE	Small molecule S-nitrosothiols are a class of endogenous chemicals in the body, which have been implicated in a variety of biological functions. However, the labile nature of NO and the limits of current detection assays have made studying these molecules difficult. Here we present a method for detecting trace concentrations of S-nitrosothiols in biological fluids. Capacitive sensors when coupled to a semiconducting material represent a method for detecting trace quantities of a chemical in complex solutions. We have taken advantage of the semiconducting and chemical properties of polydopamine to construct a capacitive sensor and associated method of use, which specifically senses S-nitrosothiols in complex biological solutions.	[Seckler, James M.; Meyer, Nikki M.; Burton, Spencer T.; Gaston, Benjamin; Lewis, Stephen J.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Bates, James N.] Univ Iowa, Dept Anesthesia, Iowa City, IA 52242 USA; [Gaston, Benjamin] Rainbow Babies & Childrens Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA	Case Western Reserve University; University of Iowa; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Lewis, SJ (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.	sjl78@case.edu		lewis, stephen/0000-0001-7050-0666; Bates, James/0000-0002-6898-9527	National Institutes of Health (NIH) [1 P01 HL128192, 1P01HL101871, 1T32HL125245]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health (NIH) Grants: 1 P01 HL128192, 1P01HL101871, 1T32HL125245.	Ambrico M, 2013, J MATER CHEM C, V1, P1018, DOI 10.1039/c2tc00480a; Anand P, 2014, P NATL ACAD SCI USA, V111, P18572, DOI 10.1073/pnas.1417816112; Bazin I, 2017, BIOSENS BIOELECTRON, V87, P285, DOI 10.1016/j.bios.2016.06.083; Berggren C, 1997, ANAL CHEM, V69, P3651, DOI 10.1021/ac970203e; Carver J, 2005, METHOD ENZYMOL, V396, P95, DOI 10.1016/S0076-6879(05)96010-2; Cha WS, 2009, BIOSENS BIOELECTRON, V24, P2441, DOI 10.1016/j.bios.2008.12.022; Chen JY, 2018, BIOSENS BIOELECTRON, V99, P593, DOI 10.1016/j.bios.2017.08.032; Clarke H.T., 1933, J AM CHEM SOC, V55, P4571, DOI [10.1021/ja01338a041, DOI 10.1021/JA01338A041]; Diers AR, 2014, BBA-GEN SUBJECTS, V1840, P892, DOI 10.1016/j.bbagen.2013.07.026; Doctor A, 2005, P NATL ACAD SCI USA, V102, P5709, DOI 10.1073/pnas.0407490102; Elphinstone RE, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00371-17; Erturk G, 2017, CAPACITIVE BIOSENSOR, V17; Estrela P, 2005, ELECTROCHIM ACTA, V50, P4995, DOI 10.1016/j.electacta.2005.02.075; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; Gaudin V, 2017, BIOSENS BIOELECTRON, V90, P363, DOI 10.1016/j.bios.2016.12.005; GESQUIERE JC, 1990, J CHEM SOC CHEM COMM, P1402, DOI 10.1039/c39900001402; Giuffrida MC, 2017, BIOSENS BIOELECTRON, V90, P174, DOI 10.1016/j.bios.2016.11.045; Gow A, 2007, J CHROMATOGR B, V851, P140, DOI 10.1016/j.jchromb.2007.01.052; Gradinaru I, 2007, MAGNESIUM RES, V20, P254; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JASTRZEBSKA MM, 1990, GEN PHYSIOL BIOPHYS, V9, P373; Koch S, 1999, BIOSENS BIOELECTRON, V14, P413, DOI 10.1016/S0956-5663(99)00008-1; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Lipton AJ, 2001, NATURE, V413, P171, DOI 10.1038/35093117; Marozkina NV, 2015, ANNU REV PHYSIOL, V77, P431, DOI 10.1146/annurev-physiol-021113-170352; Marozkina NV, 2012, BBA-GEN SUBJECTS, V1820, P722, DOI 10.1016/j.bbagen.2011.06.017; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McKinnon WR, 2008, J APPL PHYS, V104, DOI 10.1063/1.3050329; Moya MP, 2002, LANCET, V360, P141, DOI 10.1016/S0140-6736(02)09385-6; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Peng B, 2013, ELECTROANAL, V25, P914, DOI 10.1002/elan.201200445; Pfeiffer F, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00025; Prodromidis MI, 2010, ELECTROCHIM ACTA, V55, P4227, DOI 10.1016/j.electacta.2009.01.081; Qu L, 2009, J COMP NEUROL, V514, P343, DOI 10.1002/cne.22007; Raffay TM, 2016, MOL PHARMACOL, V90, P418, DOI 10.1124/mol.116.104125; Ratner S, 1937, J AM CHEM SOC, V59, P200, DOI 10.1021/ja01280a050; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Schoning MJ, 2002, ANALYST, V127, P1137, DOI 10.1039/b204444g; Sharma S, 2016, ESSAYS BIOCHEM, V60, P9, DOI 10.1042/EBC20150002; Sharma SK, 2017, ANAL BIOCHEM, V535, P1, DOI 10.1016/j.ab.2017.07.019; Shen XM, 1997, CHEM RES TOXICOL, V10, P147, DOI 10.1021/tx960145c; Shinwari MW, 2007, MICROELECTRON RELIAB, V47, P2025, DOI 10.1016/j.microrel.2006.10.003; Singel DJ, 2004, NATURE, V430, P297, DOI 10.1038/430297a; Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/ajrccm.165.7.2105032; Stsiapura VI, 2015, ANAL CHEM, V87, P3345, DOI 10.1021/ac5045143; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Swift HR, 1997, J CHEM SOC PERK T 2, P1933, DOI 10.1039/a702937c; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Thavarajah Rooban, 2012, J Oral Maxillofac Pathol, V16, P400, DOI 10.4103/0973-029X.102496; Tripathi KM, 2016, RSC ADV, V6, P37319, DOI 10.1039/c6ra04030f; Tripathi KM, 2016, NEW J CHEM, V40, P1571, DOI 10.1039/c5nj02037a; Veigas B, 2015, SENSORS-BASEL, V15, P10380, DOI 10.3390/s150510380; Wei Q, 2010, POLYM CHEM-UK, V1, P1430, DOI 10.1039/c0py00215a; Weichsel A, 2005, P NATL ACAD SCI USA, V102, P594, DOI 10.1073/pnas.0406549102; Zaman K, 2014, BIOCHEM BIOPH RES CO, V443, P1257, DOI 10.1016/j.bbrc.2013.12.130	59	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187149	10.1371/journal.pone.0187149	http://dx.doi.org/10.1371/journal.pone.0187149			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073241	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400122
J	Eitas, TK; Stepp, WH; Sjeklocha, L; Long, CV; Riley, C; Callahan, J; Sanchez, Y; Gough, P; Knowlin, L; van Duin, D; Ortiz-Pujols, S; Jones, SW; Maile, R; Hong, Z; Berger, S; Cairns, BA				Eitas, Timothy K.; Stepp, Wesley H.; Sjeklocha, Lucas; Long, Clayton V.; Riley, Caitlin; Callahan, James; Sanchez, Yolanda; Gough, Peter; Knowlin, Laquanda; van Duin, David; Ortiz-Pujols, Shiara; Jones, Samuel W.; Maile, Robert; Hong, Zhi; Berger, Scott; Cairns, Bruce A.			Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2- Related Factor 2 (NRF2) in burn patient immune cells and monocytes (vol 12, e0184164, 2017)	PLOS ONE			English	Correction													van Duin, David/AAH-7085-2019	van Duin, David/0000-0003-4784-3227; Sjeklocha, Lucas/0000-0003-0658-3377; Maile, Robert/0000-0002-9126-4188; Stepp, Wesley/0000-0003-2213-1872				Eitas TK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184164	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187785	10.1371/journal.pone.0187785	http://dx.doi.org/10.1371/journal.pone.0187785			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095909	Green Published, gold			2022-12-27	WOS:000414340200133
J	Le Reste, JY; Nabbe, P; Grasset, AB; Le Floch, B; Grall, P; Derriennic, J; Odorico, M; Lalande, S; le Goff, D; Barais, M; Chiron, B; Lingner, H; Guillou, M; Barraine, P				Le Reste, Jean Yves; Nabbe, Patrice; Grasset, Alice Billot; Le Floch, Bernard; Grall, Pauline; Derriennic, Jeremy; Odorico, Michele; Lalande, Sophie; le Goff, Delphine; Barais, Marie; Chiron, Benoit; Lingner, Heidrun; Guillou, Morgane; Barraine, Pierre			Multimorbid outpatients: A high frequency of FP appointments and/or family difficulties, should alert FPs to the possibility of death or acute hospitalization occurring within six months; A primary care feasibility study	PLOS ONE			English	Article							LONG-TERM-CARE; CHRONIC DISEASES; HEALTH; DEFINITION; PREVALENCE; MEDICINE; LIFE	Background The European General Practitioners Research Network (EGPRN) designed and validated a comprehensive definition of multimorbidity using a systematic literature review and qualitative research throughout Europe. This definition was tested as a model to assess death or acute hospitalization in multimorbid outpatients. ObjectiveTo assess which criteria in the EGPRN concept of multimorbidity could detect outpatients at risk of death or acute hospitalization in a primary care cohort at a 6-month follow-up and to assess whether a large scale cohort with FPs would be feasible. Method Family Physicians included a random sample of multimorbid patients who attended appointments in their offices from July to December 2014. Inclusion criteria were those of the EGPRN definition of Multimorbidity. Exclusion criteria were patients under legal protection and those unable to complete the 2-year follow-up. Statistical analysis was undertaken with uni-and multivariate analysis at a 6-month follow-up using a combination of approaches including both automatic classification and expert decision making. A Multiple Correspondence Analysis (MCA) completed the process with a projection of illustrative variables. A logistic regression was finally performed in order to identify and quantify risk factors for decompensation. Results 19 FPs participated in the study. 96 patients were analyzed. 3 different clusters were identified. MCA showed the central function of psychosocial factors and peaceful versus conflictual relationships with relatives in all clusters. While taking into account the limit of a small cohort, age, frequency of family physician visits and extent of family difficulties were the factors which predicted death or acute hospitalization. Conclusion A large scale cohort seems feasible in primary care. A sense of alarm should be triggered to prevent death or acute hospitalization in multimorbid older outpatients who have frequent family physician visits and who experience family difficulties.	[Le Reste, Jean Yves; Nabbe, Patrice; Grasset, Alice Billot; Le Floch, Bernard; Grall, Pauline; Derriennic, Jeremy; Odorico, Michele; Lalande, Sophie; le Goff, Delphine; Barais, Marie; Chiron, Benoit; Guillou, Morgane; Barraine, Pierre] Univ Bretagne Occidentale, SPURBO, Dept Gen Practice, EA 7479, Brest, France; [Lingner, Heidrun] Allgemein Med Hsch Hannover, Hannover, Germany	Universite de Bretagne Occidentale	Le Reste, JY; Nabbe, P (corresponding author), Univ Bretagne Occidentale, SPURBO, Dept Gen Practice, EA 7479, Brest, France.	lereste@univ-brest.fr; nabbep@univ-brest.fr	barais, marie/H-2888-2018	le reste, jean yves/0000-0003-0883-3595				Almirall Jose, 2013, J Comorb, V3, P4; Bongue Bienvenu, 2016, Soins Gerontol, V21, P24, DOI 10.1016/j.sger.2016.05.006; Brandlmeier P, 1976, ZFA (Stuttgart), V52, P1269; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; DRESS, 2016, COMP INT DEP HOSP; European Academy of Teachers in General Practice (Network within Wonca Europe), 2002, EUR DEF GEN PRACT ME; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Galvin R, 2016, AGE AGEING; Garrido-Elustondo S, 2016, ATEN PRIMARIA; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Hummers-Pradier E, 2010, EUR J GEN PRACT, V16, P174, DOI 10.3109/13814788.2010.504982; Kaufman L, 2005, FINDING GROUPS ORDIN; Le Reste JY, 2016, EUR J GEN PRACT, V22, P159, DOI 10.3109/13814788.2015.1136619; Le Reste JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115796; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P319, DOI 10.1016/j.jamda.2013.01.001; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P132, DOI 10.1016/j.jamda.2012.07.017; Le Reste J, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0337-3; Lee L, 2015, CAN FAM PHYSICIAN, V61, pE148; Lussier MT, 2016, PATIENT EDUC COUNS, V99, P530, DOI 10.1016/j.pec.2015.11.007; Muth C, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0223-1; Muth C, 2014, EUR J GEN PRACT, V20, P139, DOI 10.3109/13814788.2013.839651; Onder G, 2015, EUR J INTERN MED, V26, P157, DOI 10.1016/j.ejim.2015.02.020; PETO V, 1993, FAM PRACT, V10, P207, DOI 10.1093/fampra/10.2.207; SPEECHLEY M, 1991, J AM GERIATR SOC, V39, P46, DOI 10.1111/j.1532-5415.1991.tb05905.x; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van den Bussche H, 2013, J CLIN EPIDEMIOL, V66, P209, DOI 10.1016/j.jclinepi.2012.07.019; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; WHO, 2008, PHARMAFORUM 0121; Wicke FS, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-62; WINOGRAD C H, 1991, Journal of the American Geriatrics Society, V39, p25S	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186931	10.1371/journal.pone.0186931	http://dx.doi.org/10.1371/journal.pone.0186931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095849	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200033
J	Lee, KR; Park, SO; Kim, SY; Hong, DY; Kim, JW; Baek, KJ; Shin, DH; Lee, YH				Lee, Kyeong Ryong; Park, Sang O.; Kim, Sin Young; Hong, Dae Young; Kim, Jong Won; Baek, Kwang Je; Shin, Dong Hyuk; Lee, Young Hwan			Red cell distribution width as a novel marker for predicting high-risk from upper gastrointestinal bleeding patients	PLOS ONE			English	Article							HEMORRHAGE	Background In upper gastrointestinal bleeding (UGIB) patients, early risk stratification allows appropriate therapy that may be helpful for reducing morbidity and mortality. Objectives to evaluate the efficacy of red-cell distribution width (RDW) for prediction of high-risk in UGIB patients. Methods We conducted a clinical retrospective observational study based on data for UGIB patients from 2012 to 2013. The primary outcome was the high-risk UGIB, defined as those who required urgent intervention and/or 30-days mortality. RDW was categorized into four quartiles: Q1 (<12.8%), Q2 (12.9-14.4%), Q3 (14.5-16.5%), and Q4 (>16.6%), and multivariable analysis was performed after adjustment of multiple other risk factor. We also evaluated the efficacy of addition of RDW scores to the Pre-endoscopic Rockall Score (PRS) and the Glasgow Blatchford Score (GBS) scoring system. Results Of 360 UGIB patients, 229 (63.6%) were high risk. In multivariable analysis, Q3 and Q4 were strongly associated with high risk; odds ratio (95% Confidence Interval) was 3.144 (1.250-7.905) and 4.182 (1.483-11.790) respectively (all p< 0.05). For lower GBS score group (< 6), the incidence of high risk was higher in Q4 (30%) and Q3 (20%) than in Q2 (12.5%) and Q1 (11.4%). For lower PRS group (< 2), the incidence of high-risk was higher in Q4 (73.7%) and Q3 (57.1%) than in Q1 (35.4%). Receiver operating characteristic analysis showed higher discrimination power in PRS + RDW (Area Under Curve [AUC] = 0.749) than PRS (AUC = 0.715) alone (p = 0.036). Otherwise GBS + RDW (AUC = 0.873) did not show a significant higher discrimination power than the GBS (AUC = 0.864) alone (p = 0.098). Conclusions For UGIB patients, a high RDW (>14.5%) was strongly associated with high risk UGIB. In practice, the combination of RDW with the PRS scoring indexes may increase the accuracy of risk stratification.	[Lee, Kyeong Ryong; Park, Sang O.; Kim, Sin Young; Hong, Dae Young; Kim, Jong Won; Baek, Kwang Je] Konkuk Univ, Med Ctr, Dept Emergency Med, Sch Med, Seoul, South Korea; [Shin, Dong Hyuk] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Emergency Med, Seoul, South Korea; [Lee, Young Hwan] Soonchunhyang Univ, Bucheon Hosp, Dept Emergency Med, Bucheon, South Korea	Konkuk University; Konkuk University Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University	Park, SO (corresponding author), Konkuk Univ, Med Ctr, Dept Emergency Med, Sch Med, Seoul, South Korea.	empso@kuh.ac.kr		Park, Sang O/0000-0003-2663-9366	Konkuk University	Konkuk University	This paper was supported by Konkuk University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This paper was supported by Konkuk University.	Afsar B, 2013, EUR J INTERN MED, V24, pE25, DOI 10.1016/j.ejim.2012.11.017; Alis R, 2015, CLIN CHEM LAB MED, V53, pE29, DOI 10.1515/cclm-2014-0749; Altintas O, 2017, TURK NEUROSURG, V27, P368, DOI 10.5137/1019-5149.JTN.16136-15.1; Blatchford O, 2000, LANCET, V356, P1318, DOI 10.1016/S0140-6736(00)02816-6; Braun E, 2011, CRIT CARE, V15, DOI 10.1186/cc10355; Cheng Calvino Ka-Wing, 2004, Lab Hematol, V10, P42, DOI 10.1532/LH96.04010; Dabbah S, 2010, AM J CARDIOL, V105, P312, DOI 10.1016/j.amjcard.2009.09.027; Fatemi O, 2013, AM HEART J, V166, P104, DOI 10.1016/j.ahj.2013.04.006; Hampole CV, 2009, AM J CARDIOL, V104, P868, DOI 10.1016/j.amjcard.2009.05.016; Holster IL, 2012, WORLD J GASTROENTERO, V18, P1202, DOI 10.3748/wjg.v18.i11.1202; KARIO K, 1991, CLIN LAB HAEMATOL, V13, P222; LAINE L, 1994, NEW ENGL J MED, V331, P717, DOI 10.1056/NEJM199409153311107; Nable JV, 2016, EMERG MED CLIN N AM, V34, P309, DOI 10.1016/j.emc.2015.12.001; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Paulus Elena M, 2014, Am Surg, V80, P685; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064; Semba RD, 2010, CLIN NUTR, V29, P600, DOI 10.1016/j.clnu.2010.03.001; Shehata HA, 1998, INT J GYNECOL OBSTET, V62, P43, DOI 10.1016/S0020-7292(98)00069-1; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179; van Leerdam ME, 2003, AM J GASTROENTEROL, V98, P1494, DOI 10.1016/S0002-9270(03)00299-5	22	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187158	10.1371/journal.pone.0187158	http://dx.doi.org/10.1371/journal.pone.0187158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095860	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200052
J	Rannou, F; Scotet, V; Marcorelles, P; Monnoyer, R; Le Marechal, C				Rannou, Fabrice; Scotet, Virginie; Marcorelles, Pascale; Monnoyer, Roxane; Le Marechal, Cedric			Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency	PLOS ONE			English	Article							HEART-FAILURE; MAXIMAL EXERCISE; SKELETAL-MUSCLE; MUTANT ALLELE; ADENOSINE; GENE; VARIANT; POLYMORPHISM; SURVIVAL; DISEASE	Purpose Current evidence indicates that the common AMPD1 gene variant is associated with improved survival in patients with advanced heart failure. Whilst adenosine has been recognized to mediate the cardioprotective effect of C34T AMPD1, the precise pathophysiologic mechanism involved remains undefined to date. To address this issue, we used cardio-pulmonary exercise testing data (CPX) from subjects with myoadenylate deaminase (MAD) defects. Methods From 2009 to 2013, all the patients referred in our laboratory to perform a metabolic exercise testing, i.e. a CPX with measurements of muscle metabolites in plasma during and after exercise testing, were prospectively enrolled. Subjects that also underwent an open muscle biopsy for diagnosis purpose were finally included. The metabolic-chronotropic response was assessed by calculating the slope of the linear relationship between the percent heart rate reserve and the percent metabolic reserve throughout exercise. MAD activity was measured using the Fishbein's technique in muscle biopsy sample. The common AMPD1 mutation was genotyped and the AMPD1 gene was sequenced to screen rare variants from blood DNA. Results Sixty-seven patients were included in the study; 5 had complete MAD deficiency, 11 had partial MAD deficiency, and 51 had normal MAD activity. Compared with normal MAD activity subjects, MAD deficient subjects appeared to have a lower-than-expected metabolic-chronotopic response during exercise. The metabolic-chronotropic relationship is more closely correlated with MAD activity in skeletal muscle (Rs = 0.57, p = 5.93E-7, Spearman correlation) than the presence of the common AMPD1 gene variant (Rs = 0.34, p = 0.005). Age-predicted O-2 pulse ratio is significantly increased in MAD deficient subjects, indicating a greater efficiency of the cardiovascular system to deliver O-2 (p< 0.01, Scheffe's post hoc test). Conclusion The metabolic-chronotropic response is decreased in skeletal muscle MAD deficiency, suggesting a biological mechanism by which AMPD1 gene exerts cardiac effect.	[Rannou, Fabrice] CHRU Cavale Blanche, Physiol Dept, EA 4324, Brest, France; [Scotet, Virginie; Monnoyer, Roxane; Le Marechal, Cedric] Inst Natl Sante & Rech Med, UMR 1078, Brest, France; [Marcorelles, Pascale] CHRU Morvan, Dept Pathol, EA LNB 4685, Brest, France	CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Brest	Rannou, F (corresponding author), CHRU Cavale Blanche, Physiol Dept, EA 4324, Brest, France.	fabrice.rannou@chu-brest.fr	Rannou, Fabrice/AAI-1924-2021	Scotet, Virginie/0000-0002-5447-4207; le marechal, cedric/0000-0002-5575-5131; Rannou, Fabrice/0000-0002-6643-0527				Anderson JL, 2000, J AM COLL CARDIOL, V36, P1248, DOI 10.1016/S0735-1097(00)00850-0; Bader DS, 2000, AM J CARDIOL, V85, P767, DOI 10.1016/S0002-9149(99)00859-0; Camarda Sérgio Ricardo de Abreu, 2008, Arq. Bras. Cardiol., V91, P311, DOI 10.1590/S0066-782X2008001700005; Darvish A, 1996, AM J PHYSIOL-HEART C, V271, pH2162, DOI 10.1152/ajpheart.1996.271.5.H2162; DIMARCO JP, 1983, CIRCULATION, V68, P1254, DOI 10.1161/01.CIR.68.6.1254; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; Feng AF, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0608-0; Fischer S, 2005, CLIN NEUROPATHOL, V24, P77; FISHBEIN WN, 1984, ANN NEUROL, V15, P271, DOI 10.1002/ana.410150312; Fishbein WN, 1999, ANN NEUROL, V45, P547, DOI 10.1002/1531-8249(199904)45:4<547::AID-ANA25>3.0.CO;2-L; FISHBEIN WN, 1978, SCIENCE, V200, P545, DOI 10.1126/science.644316; FISHBEIN WN, 1985, BIOCHEM MED METAB B, V33, P158, DOI 10.1016/0006-2944(85)90024-9; Grealy R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145171; Gross M, 2002, NEUROMUSCULAR DISORD, V12, P558, DOI 10.1016/S0960-8966(02)00008-1; Hanisch F, 2008, J NEUROL, V255, P318, DOI 10.1007/s00415-008-0530-6; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Kalsi KK, 2003, CARDIOVASC RES, V59, P678, DOI 10.1016/S0008-6363(03)00497-8; Kirchhof P, 2003, AM J PHYSIOL-HEART C, V285, pH145, DOI 10.1152/ajpheart.01036.2002; Kolek MJ, 2005, J CARD FAIL, V11, P677, DOI 10.1016/j.cardfail.2005.06.437; LEE HT, 1993, AM J PHYSIOL, V265, pH1916, DOI 10.1152/ajpheart.1993.265.6.H1916; Loh E, 1999, CIRCULATION, V99, P1422, DOI 10.1161/01.CIR.99.11.1422; MORISAKI T, 1992, P NATL ACAD SCI USA, V89, P6457, DOI 10.1073/pnas.89.14.6457; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; Oliveira RB, 2011, CLINICS, V66, P203, DOI 10.1590/S1807-59322011000200004; Rannou F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132972; Richard P, 2006, J AM COLL CARDIOL, V48, pA79, DOI 10.1016/j.jacc.2006.09.014; SABINA RL, 1984, J CLIN INVEST, V73, P720, DOI 10.1172/JCI111265; SHUMATE JB, 1979, MUSCLE NERVE, V2, P213, DOI 10.1002/mus.880020309; Sommerschild HT, 2000, ACTA ANAESTH SCAND, V44, P1038, DOI 10.1034/j.1399-6576.2000.440903.x; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tarnopolsky MA, 2006, APPL PHYSIOL NUTR ME, V31, P21, DOI 10.1139/H05-008; Tarnopolsky MA, 2001, J PHYSIOL-LONDON, V533, P881, DOI 10.1111/j.1469-7793.2001.t01-1-00881.x; Toyama K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013151; VALEN PA, 1987, ARTHRITIS RHEUM, V30, P661, DOI 10.1002/art.1780300609; Wasserman K, 2005, PRINCIPLES EXERCISE, P160; Wilkoff Bruce L., 1992, Cardiology Clinics, V10, P705; Yamaya Y, 2002, J APPL PHYSIOL, V92, P162, DOI 10.1152/japplphysiol.00409.2001; Yazaki Y, 2004, J CARD FAIL, V10, P316, DOI 10.1016/j.cardfail.2003.10.008	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187266	10.1371/journal.pone.0187266	http://dx.doi.org/10.1371/journal.pone.0187266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095874	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200064
J	Stegmaier, J; Mikut, R				Stegmaier, Johannes; Mikut, Ralf			Fuzzy-based propagation of prior knowledge to improve large-scale image analysis pipelines	PLOS ONE			English	Article							MICROSCOPY DATA; SEGMENTATION; RECONSTRUCTION; UNCERTAINTY; PLATFORM	Many automatically analyzable scientific questions are well-posed and a variety of information about expected outcomes is available a priori. Although often neglected, this prior knowledge can be systematically exploited to make automated analysis operations sensitive to a desired phenomenon or to evaluate extracted content with respect to this prior knowledge. For instance, the performance of processing operators can be greatly enhanced by a more focused detection strategy and by direct information about the ambiguity inherent in the extracted data. We present a new concept that increases the result quality awareness of image analysis operators by estimating and distributing the degree of uncertainty involved in their output based on prior knowledge. This allows the use of simple processing operators that are suitable for analyzing large-scale spatiotemporal (3D+t) microscopy images without compromising result quality. On the foundation of fuzzy set theory, we transform available prior knowledge into a mathematical representation and extensively use it to enhance the result quality of various processing operators. These concepts are illustrated on a typical bioimage analysis pipeline comprised of seed point detection, segmentation, multiview fusion and tracking. The functionality of the proposed approach is further validated on a comprehensive simulated 3D+t benchmark data set that mimics embryonic development and on large-scale light-sheet microscopy data of a zebrafish embryo. The general concept introduced in this contribution represents a new approach to efficiently exploit prior knowledge to improve the result quality of image analysis pipelines. The generality of the concept makes it applicable to practically any field with processing strategies that are arranged as linear pipelines. The automated analysis of terabyte-scale microscopy data will especially benefit from sophisticated and efficient algorithms that enable a quantitative and fast readout.	[Stegmaier, Johannes; Mikut, Ralf] Karlsruhe Inst Technol, Inst Appl Comp Sci, Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Stegmaier, J (corresponding author), Karlsruhe Inst Technol, Inst Appl Comp Sci, Eggenstein Leopoldshafen, Germany.	johannes.stegmaier@kit.edu	Stegmaier, Johannes/ABA-4230-2021; Mikut, Ralf/A-5949-2013	Stegmaier, Johannes/0000-0003-4072-3759; Mikut, Ralf/0000-0001-9100-5496	German Research Foundation DFG [MI 1315/4, SPP 1736]; Helmholtz Association in the program Biolnterfaces in Technology and Medicine	German Research Foundation DFG(German Research Foundation (DFG)); Helmholtz Association in the program Biolnterfaces in Technology and Medicine	The work was funded by the German Research Foundation DFG (JS, Grant No MI 1315/4, associated with SPP 1736 Algorithms for Big Data) and by the Helmholtz Association in the program Biolnterfaces in Technology and Medicine (RM).	Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Amat F, 2014, NAT METHODS, V11, P951, DOI [10.1038/NMETH.3036, 10.1038/nmeth.3036]; Anchini R, 2007, IEEE T INSTRUM MEAS, V56, P681, DOI 10.1109/TIM.2007.894909; [Anonymous], 2011, ROUGH FUZZY PATTERN; [Anonymous], 2012, FUNDAMENTALS LIGHT M; BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bartschat A, 2016, BIOINFORMATICS, V32, P315, DOI 10.1093/bioinformatics/btv559; Beare R., 2006, INSIGHT J, V1, P1, DOI DOI 10.54294/LF8U75; Bede B, 2013, STUD FUZZ SOFT COMP, V295, P1, DOI 10.1007/978-3-642-35221-8; Bedregal B. R. C., 2006, SCAN 06, P12, DOI DOI 10.1109/SCAN.2006.25; Betta G., 2011, P IEEE INSTR MEAS TE, P1; Betta G, 2012, IEEE IMTC P, P963, DOI 10.1109/I2MTC.2012.6229336; Boskovitz V, 2002, IEEE T FUZZY SYST, V10, P247, DOI 10.1109/91.995125; Bouchon-Meunier B, 2000, INFORM UNCERTAINTY F; Bourgine P, 2010, KYBERNETIKA, V46, P226; Chen JY, 2009, INT EL DEVICES MEET, P1, DOI 10.1109/CLEOE-EQEC.2009.5196326; Coelho LP, 2009, I S BIOMED IMAGING, P518, DOI 10.1109/ISBI.2009.5193098; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; De Santo M, 2004, MEASUREMENT, V36, P347, DOI 10.1016/j.measurement.2004.09.011; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; Jennings J. R., 2008, J NANOMATER, V130, P13364, DOI DOI 10.1177/1947601910383564; Khan A., 2013, STUDIES COMPUTATIONA, V445, P167; Khan AU, 2013, ADV INTELL SYST, V190, P459; Khan Z, 2014, DEVELOPMENT, V141, P2895, DOI 10.1242/dev.107730; Kobitski AY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08601; Kybic J, 2010, IEEE T IMAGE PROCESS, V19, P64, DOI 10.1109/TIP.2009.2030955; Lehmann G, 2010, INSIGHT J, P1; LEVENTON ME, 2000, PROC CVPR IEEE, P316, DOI DOI 10.1109/CVPR.2000.855835; Lou X, 2011, I S BIOMED IMAGING, P1557, DOI 10.1109/ISBI.2011.5872698; Mencattini A, 2010, IEEE T INSTRUM MEAS, V59, P27, DOI 10.1109/TIM.2009.2025686; Mikut R., 2017, ARXIV170403298; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pal S. K., 2001, INT J IMAGE GRAPH, V1, P169, DOI DOI 10.1142/S0219467801000128; Peng HC, 2014, NAT PROTOC, V9, P193, DOI 10.1038/nprot.2014.011; Radojevic M, 2015, I S BIOMED IMAGING, P885, DOI 10.1109/ISBI.2015.7164012; Schiegg M, 2013, IEEE I CONF COMP VIS, P2928, DOI 10.1109/ICCV.2013.364; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schoinochoritis B, 2017, P I MECH ENG B-J ENG, V231, P96, DOI 10.1177/0954405414567522; Stegmaier J., 2012, BIOMED TECH, V57, P458; Stegmaier J., 2016, SCYTHE STONEMAIER GA; Stegmaier J, 2012, P 22 WORKSH COMP INT, P55; Stegmaier J, 2016, P IEEE INT S BIOM IM; Stegmaier J, 2016, AT-AUTOM, V64, P555, DOI 10.1515/auto-2016-0019; Stegmaier J, 2016, DEV CELL, V36, P225, DOI 10.1016/j.devcel.2015.12.028; Stegmaier J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090036; Straehle CN, 2012, PROC CVPR IEEE, P765, DOI 10.1109/CVPR.2012.6247747; Svoboda D, 2012, LECT NOTES COMPUT SC, V7325, P473, DOI 10.1007/978-3-642-31298-4_56; Tizhoosh HR, 2005, PATTERN RECOGN, V38, P2363, DOI 10.1016/j.patcog.2005.02.014; Vu N., 2008, P IEEE COMP SOC C CO, P1; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhou XS, 2005, IEEE T PATTERN ANAL, V27, P115, DOI 10.1109/TPAMI.2005.3; Zimmermann HJ, 2010, WIRES COMPUT STAT, V2, P317, DOI 10.1002/wics.82	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187535	10.1371/journal.pone.0187535	http://dx.doi.org/10.1371/journal.pone.0187535			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095927	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200114
J	Kang, HS; Choi, YS; Park, KH; Hwang, SO				Kang, Hee Seung; Choi, Yong Sung; Park, Kyung Hye; Hwang, Sung Oh			Delta neutrophil index as a promising prognostic marker of emergent surgical intervention for acute diverticulitis in the emergency department	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SIGMOID DIVERTICULITIS; COMPLICATED DIVERTICULITIS; INFLAMMATION MARKERS; PRACTICE PARAMETERS; LYMPHOCYTE RATIO; DISEASE; SEVERITY; SEPSIS; PREDICTION	Background Early identification of patients with acute diverticulitis who require emergent surgical intervention in the emergency department (ED) is important to the physician. Although computed tomography (CT) has an important role in evaluating the severity of diverticulitis, its findings alone may not predict the need for emergent surgical intervention in all patients with acute diverticulitis in the ED. Serum inflammation markers may help to differentiate severity of acute diverticulitis and predict the need for surgical intervention in clinical practice. No information is currently available on the clinical usefulness of the delta neutrophil index (DNI), with respect to the prediction of emergent surgical intervention in patients with acute diverticulitis at the ED. Methods This was a retrospective observational study of consecutive adult patients with acute diverticulitis confirmed by CT in the ED, between January 2014 and December 2016. Recruited patients were divided into two groups: emergent surgical intervention and no surgical intervention. The following laboratory serum parameters were examined in the ED: DNI value, C-reactive protein (CRP) levels, white blood cell count, neutrophil count, and neutrophil-to-lymphocyte ratio (NLR). The patients were also examined for the presence or absence of complications by CT. Results A total of 132 patients were finally included in the study, with the emergent surgical intervention group constituting 52 patients. The median DNI value, CRP levels, neutrophil count, and NLR were significantly higher in the emergent surgical intervention group than in the no surgical intervention group. The area under the curve for predicting emergent surgical intervention, using the DNI was significantly higher than that of CRP levels, neutrophil count, or NLR. Moreover, the combination of initial DNI and CT was most powerful diagnostic modality. Conclusions DNI values measured at the ED combined with CT were good predictors for emergent surgical intervention in acute diverticulitis. If the DNI value is greater than 0.7% and complications in CT are suspected in patients suspected to have acute diverticulitis, the need for emergent surgical intervention should be considered carefully in the ED.	[Kang, Hee Seung; Choi, Yong Sung; Park, Kyung Hye; Hwang, Sung Oh] Yonsei Univ, Wonju Coll Med, Dept Emergency Med, Wonju, South Korea; [Park, Kyung Hye] Yonsei Univ, Wonju Coll Med, Dept Med Educ, Wonju, South Korea	Yonsei University; Yonsei University	Choi, YS (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Emergency Med, Wonju, South Korea.	emyscha@yonsei.ac.kr	Cha, Yong Sung/AEF-1706-2022; Hwang, Sung Oh/AAO-5838-2021	Cha, Yong Sung/0000-0001-9897-4273; Hwang, Sung Oh/0000-0003-4585-3181				Ansari-Lari MA, 2003, AM J CLIN PATHOL, V120, P795, DOI 10.1309/LT30BV9UJJV9CFHQ; Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Cornbleet PJ, 2002, CLIN LAB MED, V22, P101, DOI 10.1016/S0272-2712(03)00069-6; Harris Neil, 2005, Lab Hematol, V11, P62, DOI 10.1532/LH96.04064; Harris Neil, 2005, Lab Hematol, V11, P47, DOI 10.1532/LH96.04075; Hinchey E J, 1978, Adv Surg, V12, P85; Humes DJ, 2009, GASTROENTEROLOGY, V136, P1198, DOI 10.1053/j.gastro.2008.12.054; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; Kaser SA, 2010, WORLD J SURG, V34, P2717, DOI 10.1007/s00268-010-0726-7; Kechagias A, 2014, AM SURGEON, V80, P391; Kim HW, 2012, SCAND J INFECT DIS, V44, P475, DOI 10.3109/00365548.2012.657232; Kircher MF, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781313; Klarenbeek BR, 2012, INT J COLORECTAL DIS, V27, P207, DOI 10.1007/s00384-011-1314-5; Kratz Alexander, 2006, Lab Hematol, V12, P63, DOI 10.1532/LH96.06010; Makela J, 2002, DIS COLON RECTUM, V45, P955, DOI 10.1007/s10350-004-6335-5; Makela JT, 2015, SCAND J GASTROENTERO, V50, P536, DOI 10.3109/00365521.2014.999350; Nizri E, 2014, TECH COLOPROCTOL, V18, P145, DOI 10.1007/s10151-013-1044-5; Park BH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-299; PARKS TG, 1970, BRIT J SURG, V57, P775, DOI 10.1002/bjs.1800571021; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Rafferty J, 2006, DIS COLON RECTUM, V49, P939, DOI 10.1007/s10350-006-0578-2; Reynolds IS, 2017, DIGEST SURG, V34, P227, DOI 10.1159/000450836; ROBERTS P, 1995, DIS COLON RECTUM, V38, P125; Seok Y, 2012, SHOCK, V37, P242, DOI 10.1097/SHK.0b013e3182454acf; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Suppiah A, 2013, J GASTROINTEST SURG, V17, P675, DOI 10.1007/s11605-012-2121-1; Tursi A, 2008, DIGEST DIS SCI, V53, P2474, DOI 10.1007/s10620-007-0161-2; Tursi A, 2010, J CLIN GASTROENTEROL, V44, P702, DOI 10.1097/MCG.0b013e3181dad979; van de Wall BJM, 2013, COLORECTAL DIS, V15, P621, DOI 10.1111/codi.12072; Wasvary H, 1999, AM SURGEON, V65, P632	30	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187629	10.1371/journal.pone.0187629	http://dx.doi.org/10.1371/journal.pone.0187629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091955	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700075
J	Radchenko, T; Brink, A; Siegrist, Y; Kochansky, C; Bateman, A; Fontaine, F; Morettoni, L; Zamora, I				Radchenko, Tatiana; Brink, Andreas; Siegrist, Yves; Kochansky, Christopher; Bateman, Alison; Fontaine, Fabien; Morettoni, Luca; Zamora, Ismael			Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry	PLOS ONE			English	Article							IDENTIFICATION; FUTURE; STABILITY; FRAGMENT; MSE	Interest in using peptide molecules as therapeutic agents due to high selectivity and efficacy is increasing within the pharmaceutical industry. However, most peptide-derived drugs cannot be administered orally because of low bioavailability and instability in the gastrointestinal tract due to protease activity. Therefore, structural modifications peptides are required to improve their stability. For this purpose, several in-silico software tools have been developed such as PeptideCutter or PoPS, which aim to predict peptide cleavage sites for different proteases. Moreover, several databases exist where this information is collected and stored from public sources such as MEROPS and ExPASy ENZYME databases. These tools can help design a peptide drug with increased stability against proteolysis, though they are limited to natural amino acids or cannot process cyclic peptides, for example. We worked to develop a new methodology to analyze peptide structure and amide bond metabolic stability based on the peptide structure (linear/cyclic, natural/unnatural amino acids). This approach used liquid chromatography / high resolution, mass spectrometry to obtain the analytical data from in vitro incubations. We collected experimental data for a set (linear/cyclic, natural/unnatural amino acids) of fourteen peptide drugs and four substrate peptides incubated with different proteolytic media: trypsin, chymotrypsin, pepsin, pancreatic elastase, dipeptidyl peptidase-4 and neprilysin. Mass spectrometry data was analyzed to find metabolites and determine their structures, then all the results were stored in a chemically aware manner, which allows us to compute the peptide bond susceptibility by using a frequency analysis of the metabolic-liable bonds. In total 132 metabolites were found from the various in vitro conditions tested resulting in 77 distinct cleavage sites. The most frequent observed cleavage sites agreed with those reported in the literature. The main advantages of the developed approach are the abilities to elucidate metabolite structure of cyclic peptides and those containing unnatural amino acids, store processed information in a searchable format within a database leading to frequency analysis of the labile sites for the analyzed peptides. The presented algorithm may be useful to optimize peptide drug properties with regards to cleavage sites, stability, metabolism and degradation products in drug discovery.	[Radchenko, Tatiana; Zamora, Ismael] Pompeu Fabra Univ, Barcelona, Spain; [Radchenko, Tatiana; Fontaine, Fabien; Zamora, Ismael] Lead Mol Design SL, Sant Cugat Del Valles, Spain; [Brink, Andreas; Siegrist, Yves] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Pharma Res & Early Dev, Basel, Switzerland; [Kochansky, Christopher; Bateman, Alison] Merck & Co Inc, Pharmacokinet Pharmacodynam & Drug Metab, West Point, PA USA; [Morettoni, Luca] Mol Discovery Ltd, London, England	Pompeu Fabra University; Roche Holding; Merck & Company	Radchenko, T; Zamora, I (corresponding author), Pompeu Fabra Univ, Barcelona, Spain.; Radchenko, T; Zamora, I (corresponding author), Lead Mol Design SL, Sant Cugat Del Valles, Spain.	tatiana.radchenko01@estudiant.upf.edu; ismael.zamora@leadmolecular.com		Brink, Andreas/0000-0001-6927-8252; Zamora, Ismael/0000-0002-7700-0354	Amb el suport de la Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya; La ayuda a Doctorados Industrial del Gobierno de la Generalitat de Catalunya	Amb el suport de la Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); La ayuda a Doctorados Industrial del Gobierno de la Generalitat de Catalunya(Generalitat de Catalunya)	Amb el suport de la Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya. La ayuda a Doctorados Industrial del Gobierno de la Generalitat de Catalunya (http://doctoratsindustrials.gencat.cat/es) funded all travel expenses related to this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Andreas Brink and Yves Siergist are employed by F.Hoffmann-La Roche Ltd. Christopher Kochansky and Alison Bateman are employed by Merck & Co., Inc.. Luca Morettoni is employed by Molecular Discovery Ltd. F. Hoffmann-La Roche Ltd, Merck & Co., Inc., and Molecular Discovery Ltd provided support in the form of salaries for authors AB, YS, CK, AB and LM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'dauthor contributions' section.	Ahlqvist M, 2015, RAPID COMMUN MASS SP, V29, P2083, DOI 10.1002/rcm.7364; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bayden AS, 2015, BIOPOLYMERS, V104, P775, DOI 10.1002/bip.22711; Bonn B, 2010, RAPID COMMUN MASS SP, V24, P3127, DOI 10.1002/rcm.4753; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Brink A, 2016, P 64 ASMS C MASS SPE; Brink A., 2013, DRUG DISCOV TODAY TE, V10, pe207; Brink A, 2014, RAPID COMMUN MASS SP, V28, P2695, DOI 10.1002/rcm.7062; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17, DOI 10.1016/S0166-1280(99)00360-7; Di L, 2015, AAPS J, V17, P134, DOI 10.1208/s12248-014-9687-3; Fontaine F, 2009, CHEMMEDCHEM, V4, P427, DOI 10.1002/cmdc.200800355; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011; Katsila T, 2012, MASS SPECTROM REV, V31, P110, DOI 10.1002/mas.20340; Klingler D, 2012, PROTEOMICS, V12, P587, DOI 10.1002/pmic.201100399; Malm-Erjefalt M, 2010, DRUG METAB DISPOS, V38, P1944, DOI 10.1124/dmd.110.034066; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; Cece-Esencan EN, 2016, RAPID COMMUN MASS SP, V30, P301, DOI 10.1002/rcm.7429; Paiva AA, 2017, BIOANALYSIS, V9, P541, DOI 10.4155/bio-2016-0299; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Song JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033747; Tsomaia N, 2015, EUR J MED CHEM, V94, P459, DOI 10.1016/j.ejmech.2015.01.014; Uhlig T., 2014, EUPA OPEN PROTEOMICS, V4, P58, DOI [10.1016/j.euprot.2014.05.003, DOI 10.1016/J.EUPROT.2014.05.003]; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Xu CX, 2006, DRUG DISCOV TODAY, V11, P595, DOI 10.1016/j.drudis.2006.05.011; Zamora Ismael, 2013, Drug Discov Today Technol, V10, pe199, DOI 10.1016/j.ddtec.2012.10.015; Zelesky V, 2013, BIOANALYSIS, V5, P1165, DOI [10.4155/BIO.13.89, 10.4155/bio.13.89]	35	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186461	10.1371/journal.pone.0186461	http://dx.doi.org/10.1371/journal.pone.0186461			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091918	Green Submitted, Green Published, gold			2022-12-27	WOS:000414229700020
J	Jang, H; Choi, Y; Yoo, I; Han, J; Hong, JS; Kim, YY; Ka, H				Jang, Hwanhee; Choi, Yohan; Yoo, Inkyu; Han, Jisoo; Hong, Jin Su; Kim, Yoo Yong; Ka, Hakhyun			Vitamin D-metabolic enzymes and related molecules: Expression at the maternal-conceptus interface and the role of vitamin D in endometrial gene expression in pigs	PLOS ONE			English	Article							UTERINE ENDOMETRIUM; PORCINE UTERUS; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D-3; CYP24A1 EXPRESSION; D 24-HYDROXYLASE; FETAL INTERFACE; HUMAN-PREGNANCY; DECIDUAL CELLS	Vitamin D is a secosteroid hormone with many varied functions including regulation of blood calcium levels, cell proliferation, immunity, and reproduction in mammals. Vitamin D is activated by 25-hydroxylase (CYP2R1) and 1-alpha-hydroxylase (CYP27B1) and is degraded by 24-hydroxylase (CYP24A1). Vitamin D is transported by vitamin D-binding protein (group-specific component, GC) through the bloodstream and regulates cellular actions by binding to vitamin D receptor (VDR). In this study, we determined the expression and regulation of vitamin D-related molecules and the role of vitamin D at the maternal-conceptus interface in pigs. Vitamin D-metabolizing enzymes CYP2R1, CYP27B1, and CYP24A1, vitamin D binding protein GC, and vitamin D receptor VDR were expressed in the endometrium in a pregnancy stage-specific manner as well as in conceptus and chorioallantoic tissues during pregnancy. VDR protein was localized to endometrial and trophoblastic cells. Concentrations of calcitriol, the active form of vitamin D, in the endometrial tissues were higher during early pregnancy than in mid-to late pregnancy, while plasma concentrations of calcitriol were highest during late pregnancy. Furthermore, calcitriol affected the expression of several genes related to conceptus implantation, vitamin D metabolism, calcium ion regulation, PG metabolism, and calcium-binding proteins in endometrial tissue explants. These results show that CYP2R1, CYP27B1, CYP24A1, GC, and VDR were expressed at the maternal-conceptus interface, endometrial calcitriol levels were regulated during pregnancy, and calcitriol modulated the expression of endometrial genes, suggesting that calcitriol may play an important role in the establishment and maintenance of pregnancy by regulating endometrial function in pigs.	[Jang, Hwanhee; Choi, Yohan; Yoo, Inkyu; Han, Jisoo; Ka, Hakhyun] Yonsei Univ, Dept Biol Sci & Technol, Wonju, South Korea; [Hong, Jin Su; Kim, Yoo Yong] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea	Yonsei University; Seoul National University (SNU)	Ka, H (corresponding author), Yonsei Univ, Dept Biol Sci & Technol, Wonju, South Korea.	hka@yonsei.ac.kr		Hong, Jinsu/0000-0002-3401-3024	Rural Development Administration [PJ01119103]; National Research Foundation - Korean Government, Republic of Korea [NRF-2015R1D1A1A01058356]	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation - Korean Government, Republic of Korea	This work was supported by the BioGreen 21 Program (#PJ01119103), Rural Development Administration, and by the National Research Foundation Grant funded by the Korean Government (#NRF-2015R1D1A1A01058356), Republic of Korea.; This work was supported by the BioGreen 21 Program (#PJ01119103), Rural Development Administration, and by the National Research Foundation Grant funded by the Korean Government (#NRF-2015R1D1A1A01058356), Republic of Korea.	Agic A, 2007, REPROD SCI, V14, P486, DOI 10.1177/1933719107304565; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Barrett H, 2010, BEST PRACT RES CL EN, V24, P527, DOI 10.1016/j.beem.2010.05.010; Bazer FW, 2014, DIFFERENTIATION, V87, P52, DOI 10.1016/j.diff.2013.11.005; Bergada L, 2014, LAB INVEST, V94, P608, DOI 10.1038/labinvest.2014.57; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Braissant O, 1998, BIOCHEMICA, V1, P16; Choi Y, 2014, DOMEST ANIM ENDOCRIN, V47, P1, DOI 10.1016/j.domaniend.2013.12.005; Choi Y, 2012, ASIAN AUSTRAL J ANIM, V25, P44, DOI 10.5713/ajas.2011.11305; Choi Y, 2009, BIOL REPROD, V81, P1122, DOI 10.1095/biolreprod.109.076703; DELVIN EE, 1985, J CLIN ENDOCR METAB, V60, P880, DOI 10.1210/jcem-60-5-880; Diaz L, 2000, J CLIN ENDOCR METAB, V85, P2543, DOI 10.1210/jc.85.7.2543; Du HL, 2005, MOL ENDOCRINOL, V19, P2222, DOI 10.1210/me.2004-0336; El-Atifi M, 2015, NEUROREPORT, V26, P245, DOI 10.1097/WNR.0000000000000328; Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Garlow JE, 2002, BIOL REPROD, V66, P718, DOI 10.1095/biolreprod66.3.718; GEISERT RD, 1982, BIOL REPROD, V27, P957, DOI 10.1095/biolreprod27.4.957; Han J, 2017, BIOL REPROD, V97, P69, DOI 10.1093/biolre/iox074; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Jensen MB, 2014, NAT REV ENDOCRINOL, V10, P175, DOI 10.1038/nrendo.2013.262; Joyce MM, 2007, ENDOCRINOLOGY, V148, P4420, DOI 10.1210/en.2007-0505; Ka H, 2001, ENDOCRINOLOGY, V142, P2303, DOI 10.1210/en.142.6.2303; Ka H, 2009, MOL REPROD DEV, V76, P75, DOI 10.1002/mrd.20935; KACHKACHE M, 1993, FEBS LETT, V333, P83, DOI 10.1016/0014-5793(93)80379-9; Kaeoket K, 2003, J VET MED A, V50, P169, DOI 10.1046/j.1439-0442.2003.00532.x; Kim M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143436; KUMAR R, 1979, J CLIN INVEST, V63, P342, DOI 10.1172/JCI109308; Kwak-Kim J, 2010, AM J REPROD IMMUNOL, V63, P611, DOI 10.1111/j.1600-0897.2010.00847.x; LIN H, 1993, J IMMUNOL, V151, P4562; Liu NQ, 2012, ARCH BIOCHEM BIOPHYS, V523, P37, DOI 10.1016/j.abb.2011.11.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma R, 2012, AM J PHYSIOL-ENDOC M, V303, pE928, DOI 10.1152/ajpendo.00279.2012; Mizwicki MT, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275re4; NESTLER JE, 1987, ENDOCRINOLOGY, V120, P1996, DOI 10.1210/endo-120-5-1996; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; O'Brien KO, 2014, J CLIN ENDOCR METAB, V99, P1348, DOI 10.1210/jc.2013-1366; Pike JW, 2012, ARCH BIOCHEM BIOPHYS, V523, P2, DOI 10.1016/j.abb.2011.12.003; Seo H, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114926; Seo H, 2008, ENDOCRINOLOGY, V149, P6166, DOI 10.1210/en.2008-0354; Shahbazi M, 2011, PLACENTA, V32, P657, DOI 10.1016/j.placenta.2011.06.013; Shin JS, 2010, PLACENTA, V31, P1027, DOI 10.1016/j.placenta.2010.08.015; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2014, MOL CELL ENDOCRINOL, V383, P181, DOI 10.1016/j.mce.2013.12.012; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Song G, 2009, ENDOCRINOLOGY, V150, P936, DOI 10.1210/en.2008-1026; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; Sundaram K, 2014, HORM CANCER-US, V5, P90, DOI 10.1007/s12672-014-0170-5; Tamblyn JA, 2015, J ENDOCRINOL, V224, pR107, DOI 10.1530/JOE-14-0642; Vigano P, 2006, J MOL ENDOCRINOL, V36, P415, DOI 10.1677/jme.1.01946; Vigano P, 2003, PLACENTA, V24, pS56, DOI 10.1016/S0143-4004(03)00137-1; WEISMAN Y, 1979, NATURE, V281, P317, DOI 10.1038/281317a0; White FJ, 2005, BIOL REPROD, V73, P1294, DOI 10.1095/biolreprod.105.045153; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zarnani AH, 2010, FERTIL STERIL, V93, P2738, DOI 10.1016/j.fertnstert.2009.09.045	57	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187221	10.1371/journal.pone.0187221	http://dx.doi.org/10.1371/journal.pone.0187221			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088291	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900050
J	Pickering, EM; Hossain, MA; Mousseau, JP; Swanson, RA; French, RH; Abramson, AR				Pickering, Ethan M.; Hossain, Mohammad A.; Mousseau, Jack P.; Swanson, Rachel A.; French, Roger H.; Abramson, Alexis R.			A cross-sectional study of the temporal evolution of electricity consumption of six commercial buildings	PLOS ONE			English	Article							EMPIRICAL VALIDATION; ENERGY PERFORMANCE; COEFFICIENT; EFFICIENCY; PROGRAMS; RETROFIT	Current approaches to building efficiency diagnoses include conventional energy audit techniques that can be expensive and time consuming. In contrast, virtual energy audits of readily available 15-minute-interval building electricity consumption are being explored to provide quick, inexpensive, and useful insights into building operation characteristics. A cross sectional analysis of six buildings in two different climate zones provides methods for data cleaning, population-based building comparisons, and relationships (correlations) of weather and electricity consumption. Data cleaning methods have been developed to categorize and appropriately filter or correct anomalous data including outliers, missing data, and erroneous values (resulting in < 0.5% anomalies). The utility of a cross-sectional analysis of a sample set of building's electricity consumption is found through comparisons of baseload, daily consumption variance, and energy use intensity. Correlations of weather and electricity consumption 15-minute interval datasets show important relationships for the heating and cooling seasons using computed correlations of a Time-Specific-Averaged-Ordered Variable (exterior temperature) and corresponding averaged variables (electricity consumption)(TSAOV method). The TSAOV method is unique as it introduces time of day as a third variable while also minimizing randomness in both correlated variables through averaging. This study found that many of the pair-wise linear correlation analyses lacked strong relationships, prompting the development of the new TSAOV method to uncover the causal relationship between electricity and weather. We conclude that a combination of varied HVAC system operations, building thermal mass, plug load use, and building set point temperatures are likely responsible for the poor correlations in the prior studies, while the correlation of time-specific-averaged-ordered temperature and corresponding averaged variables method developed herein adequately accounts for these issues and enables discovery of strong linear pair-wise correlation R values. TSAOV correlations lay the foundation for a new approach to building studies, that mitigates plug load interferences and identifies more accurate insights into weather-energy relationship for all building types. Over all six buildings analyzed the TSAOV method reported very significant average correlations per building of 0.94 to 0.82 in magnitude. Our rigorous statistics-based methods applied to 15-minute-interval electricity data further enables virtual energy audits of buildings to quickly and inexpensively inform energy savings measures.	[Pickering, Ethan M.; Hossain, Mohammad A.; Abramson, Alexis R.] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Case Sch Engn, Cleveland, OH 44106 USA; [Mousseau, Jack P.] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Case Sch Engn, Cleveland, OH 44106 USA; [Swanson, Rachel A.; Abramson, Alexis R.] Case Western Reserve Univ, Great Lakes Energy Inst, Case Sch Engn, Cleveland, OH 44106 USA; [French, Roger H.] Case Western Reserve Univ, Dept Mat Sci & Engn, Case Sch Engn, Cleveland, OH 44106 USA; [French, Roger H.] Case Western Reserve Univ, Solar Durabil & Lifetime Extens Ctr, Case Sch Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Pickering, EM (corresponding author), Case Western Reserve Univ, Dept Mech & Aerosp Engn, Case Sch Engn, Cleveland, OH 44106 USA.	pickering@caltech.edu	French, Roger H/E-1986-2011	French, Roger H/0000-0002-6162-0532; Hossain, Mohammad/0000-0002-8059-0789; Pickering, Ethan/0000-0002-4485-6359	Cleveland Foundation; Advanced Research Projects Agency - Energy (ARPA-E) at the U.S. Department of Energy [DE-AR-0000668]; Ohio Third Frontier [Tech 11-060, Tech 12-004]; Advanced Research Projects Agency-Energy (ARPA-E), U.S. Department of Energy [DE-AR-0000668]; agency of the United States Government	Cleveland Foundation; Advanced Research Projects Agency - Energy (ARPA-E) at the U.S. Department of Energy; Ohio Third Frontier; Advanced Research Projects Agency-Energy (ARPA-E), U.S. Department of Energy(United States Department of Energy (DOE)); agency of the United States Government	This research was performed in the SDLE Research Center, established with Ohio Third Frontier funding under award Tech 11-060, Tech 12-004, and the Great Lakes Energy Institute, both at Case Western Reserve University. Funding was provided in part by the Cleveland Foundation (www.clevelandfoundation.org) and supported authors: EMP, MAH, and ARA. Further funding is provided by the Advanced Research Projects Agency - Energy (ARPA-E) at the U.S. Department of Energy with award number DE-AR-0000668 (https//arpa-e.energy.gov/) supporting authors: EMP, MAH, JPM, RAS, RHF, and ARA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was performed in the SDLE Research Center, established with Ohio Third Frontier funding under award Tech 11-060, Tech 12-004, and the Great Lakes Energy Institute, both at Case Western Reserve University.; The information, data, or work presented herein was funded in part by the Advanced Research Projects Agency-Energy (ARPA-E), U.S. Department of Energy, under Award Number DE-AR-0000668.; The information, data, or work presented herein was funded in part by an agency of the United States Government. Neither the United States Government nor any agency thereof, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government or any agency thereof.	[Anonymous], 2002, INT PERFORMANCE MEAS, V1; [Anonymous], 2014, FIN SMALL COMM BUILD; [Anonymous], 2016, US ENERGY USE INTENS; [Anonymous], P HOTCLOUD; [Anonymous], 2016, CLIMATE DATA ONLINE; [Anonymous], 2015, ARPA E OPEN 2015 PRO; [Anonymous], 2015, INT ENERGY OUTLOOK 2; Aste N, 2013, ENERG EFFIC, V6, P407, DOI 10.1007/s12053-012-9168-4; Austin D., ADDRESSING MARKET BA; Briefing US, 2013, INT ENERGY OUTLOOK 2; Charlton N, 2014, INT J FORECASTING, V30, P364, DOI 10.1016/j.ijforecast.2013.07.003; Chirarattananon S, 2003, ENERG CONVERS MANAGE, V44, P743, DOI 10.1016/S0196-8904(02)00082-1; Crawley DB, 2008, BUILD ENVIRON, V43, P661, DOI 10.1016/j.buildenv.2006.10.027; Diez DM, 2015, OPENLNTRO STAT; FELS MF, 1986, ENERG BUILDINGS, V9, P5, DOI 10.1016/0378-7788(86)90003-4; Fels MF, 1995, ADV ART PRISM ANAL H, V12; French RH, 2015, CURR OPIN SOLID ST M, V19, P212, DOI 10.1016/j.cossms.2014.12.008; Gerlach David, 2014, ASHRAE T, V120, pGG1; Haberl JS, P 5 INT C ENH BUILD; Harris J, 2000, ENERG POLICY, V28, P867, DOI 10.1016/S0301-4215(00)00075-6; Hong T., ASIM 2012; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7; Kambatla K, 2014, J PARALLEL DISTR COM, V74, P2561, DOI 10.1016/j.jpdc.2014.01.003; Karkare A, 2014, INTELLIGENT GREEN BU, P1, DOI DOI 10.1109/IGBSG.2014.6835192; Katipamula S, 1998, J SOL ENERG-T ASME, V120, P177, DOI 10.1115/1.2888067; Kavousian A, 2015, ENERG BUILDINGS, V99, P220, DOI 10.1016/j.enbuild.2015.03.052; Kissock J.K., 2003, INVERSE MODELING TOO; Kissock JK, 1998, J SOL ENERG-T ASME, V120, P168, DOI 10.1115/1.2888066; Kissock JK, 2007, UNDERSTANDING IND EN; Kneifel J, 2016, APPL ENERG, V178, P468, DOI 10.1016/j.apenergy.2016.06.013; Lang DT, 2016, RCURL GEN NETWORK HT; Lomas KJ, 1997, ENERG BUILDINGS, V26, P253, DOI 10.1016/S0378-7788(97)00007-8; Manz H, 2006, BUILD ENVIRON, V41, P1784, DOI 10.1016/j.buildenv.2005.07.020; Mirsadeghi M, 2013, APPL THERM ENG, V56, P134, DOI 10.1016/j.applthermaleng.2013.03.003; Novan K, 2017, RESIDENTIAL BUILDING; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; QUAYLE RG, 1980, J APPL METEOROL, V19, P241, DOI 10.1175/1520-0450(1980)019<0241:HDDDAT>2.0.CO;2; Revelle, 2014, PSYCH PROCEDURES PSY, P165; Rhodes JD, 2015, ENERG BUILDINGS, V86, P808, DOI 10.1016/j.enbuild.2014.10.076; RStudio Team, 2015, RSTUDIO INT DEV ENV; Rubel F, 2016, CLIMATE EUROPEAN ALP; Rubel F, 2011, METEOROL Z, V20, P361, DOI 10.1127/0941-2948/2011/0258; Salamanca F, 2010, THEOR APPL CLIMATOL, V99, P331, DOI [10.1007/s00704-009-0142-9, 10.1007/s00704-009-0143-8]; Sever F, 2011, ASHRAE T, V117; Shen B, 2012, ENERG POLICY, V46, P346, DOI 10.1016/j.enpol.2012.03.069; Shumway R. H., 2017, SPRINGER TEXTS STAT; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P219, DOI 10.1177/875647939000600404; Team RC., 2022, LANG ENV STAT COMP; Zhao HX, 2012, RENEW SUST ENERG REV, V16, P3586, DOI 10.1016/j.rser.2012.02.049; Zmeureanu, 2005, 9 INT IBPSA C MONTR, P15	50	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187129	10.1371/journal.pone.0187129	http://dx.doi.org/10.1371/journal.pone.0187129			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088269	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900042
J	Smith, AN; Creighton, JC; Belk, MC				Smith, Ashlee N.; Creighton, J. Curtis; Belk, Mark C.			Why does it take two to tango? Lifetime fitness consequences of parental care in a burying beetle	PLOS ONE			English	Article							NICROPHORUS-VESPILLOIDES COLEOPTERA; REPRODUCTIVE BENEFITS; BIPARENTAL CARE; PATERNAL CARE; BROOD SIZE; BODY-SIZE; COMPETITION; ORBICOLLIS; EVOLUTION; SILPHIDAE	In species that require parental care, each parent can either care for their offspring or leave them in the care of the other parent. For each parent this creates three possible parental care strategies: biparental care, uniparental (male or female) care, and uniparental desertion by either the male or female. The burying beetle, Nicrophorus orbicollis, typically exhibits biparental care of offspring, and thus provides a unique system that allows us to compare the fitness benefits of these parental care strategies in an unconfounded way. In this study, we assess the lifetime fitness of biparental care, uniparental care, and uniparental desertion strategies in both male and female N. orbicollis. Specifically, we tested for increased fitness of the biparental care strategy compared to uniparental care strategies. Second, we test for equality of fitness between uniparental care and uniparental desertion strategies. Surprisingly, biparental care yields lower lifetime fitness for both parents compared to the other two strategies. Also, uniparental care and uniparental desertion strategies yielded equal fitness. The evolution of biparental care in this system is not consistent with the expectation of a mutual fitness benefit. We discuss other potential explanations for the evolution of biparental care in this system.	[Smith, Ashlee N.; Belk, Mark C.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Creighton, J. Curtis] Purdue Univ Calumet, Dept Biol Sci, Hammond, LA 47907 USA	Brigham Young University; Purdue University System; Purdue University	Smith, AN (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	ashleens@byu.edu		Smith, Ashlee/0000-0001-8941-8574	Purdue University Graduate Studies Department; Department of Biological Sciences at Purdue University Northwest	Purdue University Graduate Studies Department; Department of Biological Sciences at Purdue University Northwest	ANS received funding for this research from the Purdue University Graduate Studies Department through a Graduate Research Grant (http://webs. purduecal.edu/gradschool/graduate-research-awards/). JCC received funding for this research from the Department of Biological Sciences at Purdue University Northwest (https:// academics.pnw.edu/biology/).	BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V23, P297, DOI 10.1007/BF00300576; BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V22, P429, DOI 10.1007/BF00294981; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Benowitz KM, 2016, BIOL J LINN SOC, V119, P1082, DOI 10.1111/bij.12830; BERTRAM BCR, 1975, J ZOOL, V177, P463; Boncoraglio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031713; Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Creighton JC, 2015, BEHAV ECOL SOCIOBIOL, V69, P265, DOI 10.1007/s00265-014-1839-z; Creighton JC, 2005, BEHAV ECOL, V16, P1031, DOI 10.1093/beheco/ari084; EGGERT AK, 1992, BEHAV ECOL, V3, P243, DOI 10.1093/beheco/3.3.243; Eggert AK, 2008, P ROY SOC B-BIOL SCI, V275, P2521, DOI 10.1098/rspb.2008.0661; Eggert AK, 2011, ANIM BEHAV, V82, P1227, DOI 10.1016/j.anbehav.2011.09.001; Gross MR, 2005, Q REV BIOL, V80, P37, DOI 10.1086/431023; Hopwood PE, 2015, J EVOLUTION BIOL, V28, P1394, DOI 10.1111/jeb.12664; Hopwood PE, 2013, FUNCT ECOL, V27, P1350, DOI 10.1111/1365-2435.12137; HRDY SB, 1974, FOLIA PRIMATOL, V22, P19; Kvarnemo C, 2006, BEHAV ECOL, V17, P144, DOI 10.1093/beheco/ari097; Lee VE, 2014, BEHAV ECOL, V25, P172, DOI 10.1093/beheco/art101; Muller JK, 2007, BEHAV ECOL, V18, P196, DOI 10.1093/beheco/arl073; Muller JK, 1998, ECOL ENTOMOL, V23, P195, DOI 10.1046/j.1365-2311.1998.00119.x; MULLER JK, 1990, ANIM BEHAV, V40, P491, DOI 10.1016/S0003-3472(05)80529-9; MULLER JK, 1990, BEHAV ECOL SOCIOBIOL, V27, P11, DOI 10.1007/BF00183307; OTRONEN M, 1988, ANN ZOOL FENN, V25, P191; Parker DJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9449; REZNICK D, 1992, TRENDS ECOL EVOL, V7, P42, DOI 10.1016/0169-5347(92)90104-J; Royle NJ, 2016, CURR OPIN BEHAV SCI, V12, P30, DOI 10.1016/j.cobeha.2016.08.004; Safryn SA, 2000, J INSECT BEHAV, V13, P291, DOI 10.1023/A:1007700601095; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; SCOTT MP, 1989, J INSECT BEHAV, V2, P133, DOI 10.1007/BF01053623; SCOTT MP, 1990, BEHAV ECOL SOCIOBIOL, V26, P31, DOI 10.1007/BF00174022; Smiseth PT, 2005, ANIM BEHAV, V69, P551, DOI 10.1016/j.anbehav.2004.06.004; Smith AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143762; Smith AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109165; Thomas LK, 2005, ANIM BEHAV, V69, P275, DOI 10.1016/j.anbehav.2004.03.009; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRUMBO ST, 1991, BEHAVIOUR, V117, P82, DOI 10.1163/156853991X00139; TRUMBO ST, 1990, BEHAV ECOL SOCIOBIOL, V27, P269, DOI 10.1007/BF00164899; Trumbo ST, 2006, ANIM BEHAV, V72, P1159, DOI 10.1016/j.anbehav.2006.05.004	39	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186466	10.1371/journal.pone.0186466	http://dx.doi.org/10.1371/journal.pone.0186466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088220	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900014
J	Wang, MQ; Lee, RJ; Bi, Y; Li, LL; Yan, GD; Lu, JH; Meng, QF; Teng, LS; Xie, J				Wang, Mengqiao; Lee, Robert J.; Bi, Ye; Li, Lianlian; Yan, Guodong; Lu, Jiahui; Meng, Qingfan; Teng, Lesheng; Xie, Jing			Transferrin-conjugated liposomes loaded with novel dihydroquinoline derivatives as potential anticancer agents	PLOS ONE			English	Article							CELLS; DELIVERY; TUMOR	A series of 1,2-dihydroquinoline derivatives were synthesized and evaluated for cytotoxicity in HeLa, Hep G2 and 6HEK-293T cell lines. EEDQ2 was identified as a promising anti-cancer agent with low IC50 in HeLa (18.55 mu g/ml) and Hep G2 (14.53 mu g/ml) cells. For improving the antitumor activity and tumor selectivity of EEDQ2, we prepared transferrin (Tf)-modified liposomes (LPs) to deliver EEDQ2. When HeLa and Hep G2 cells were treated with LP-delivered EEDQ2, the ROS level was significantly enhanced, and mitochondrial membrane potential was reversed. Tf-LPs improved cell uptake of EEDQ2 by about 3.7 times compared with non-targeted LPs. These data suggest that Tf-LPs delivering EEDQ2 is a promising strategy to treat cancer.	[Wang, Mengqiao; Lee, Robert J.; Bi, Ye; Li, Lianlian; Yan, Guodong; Lu, Jiahui; Meng, Qingfan; Teng, Lesheng; Xie, Jing] Jilin Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Lee, Robert J.] Ohio State Univ, Coll Pharm, Div Pharmaceut, 500 W 12Th Ave, Columbus, OH 43210 USA	Jilin University; University System of Ohio; Ohio State University	Teng, LS; Xie, J (corresponding author), Jilin Univ, Coll Life Sci, Changchun, Jilin, Peoples R China.	tenglesheng@jlu.edu.cn; xiejing@jlu.edu.cn		Teng, Lesheng/0000-0003-1623-5384	National Natural Science Foundation of China [81502999]; Jilin Province Science and Technology Development Program [20170414039GH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Province Science and Technology Development Program	This research was supported by the National Natural Science Foundation of China (grant no. 81502999) and Jilin Province Science and Technology Development Program (grant no. 20170414039GH).; The work was funded by National Natural Science Foundation of China (No. 81502999) and Jilin Province Science and Technology Development Program (No. 20170414039GH).	Bekhit AA, 2010, EUR J MED CHEM, V45, P6027, DOI 10.1016/j.ejmech.2010.10.001; Bi Y, 2016, CURR DRUG METAB, V17, P763, DOI 10.2174/1389200217666160619191853; Bondock S, 2007, EUR J MED CHEM, V42, P948, DOI 10.1016/j.ejmech.2006.12.025; Chiu SJ, 2006, J CONTROL RELEASE, V112, P199, DOI 10.1016/j.jconrel.2006.02.011; Ding YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122128; Dressler C, 2006, J FLUORESC, V16, P689, DOI 10.1007/s10895-006-0110-z; Engel A, 2003, PHARM RES-DORDR, V20, P51, DOI 10.1023/A:1022294624256; Eswaran R, 2016, J INORG BIOCHEM, V155, P1, DOI 10.1016/j.jinorgbio.2015.11.007; Gomes CRB, 2010, LETT DRUG DES DISCOV, V7, P353; Hossen MN, 2010, J CONTROL RELEASE, V147, P261, DOI 10.1016/j.jconrel.2010.07.100; Lee HH, 2013, INT J ONCOL, V42, P1036, DOI 10.3892/ijo.2013.1762; Li Z, 2014, COLLOID SURFACE B, V122, P630, DOI 10.1016/j.colsurfb.2014.07.042; Ma XY, 2016, CHEM RES CHINESE U, V32, P634, DOI 10.1007/s40242-016-5481-3; Ma XY, 2016, ANTICANCER RES, V36, P2105; Maitani Y, 2001, J LIPOSOME RES, V11, P115, DOI 10.1081/LPR-100103174; Omar K, 2010, BIOORGAN MED CHEM, V18, P426, DOI 10.1016/j.bmc.2009.10.041; Ottana R, 2005, BIOORG MED CHEM LETT, V15, P3930, DOI 10.1016/j.bmcl.2005.05.093; Panwar P, 2010, INT J NANOMED, V5, P101; Przybylo M, 2016, EUR J PHARM SCI, V85, P39, DOI 10.1016/j.ejps.2016.01.028; Raja DS, 2013, EUR J MED CHEM, V64, P148, DOI 10.1016/j.ejmech.2013.03.040; Rekhert JM, 2008, DRUG DISCOV TODAY, V13, P30, DOI 10.1016/j.drudis.2007.09.003; Szilagyi G, 2006, NEUROSCI LETT, V399, P206, DOI 10.1016/j.neulet.2006.01.071; Ulrich AS, 2002, BIOSCIENCE REP, V22, P129, DOI 10.1023/A:1020178304031; Xu M, 2014, CHROMATOGRAPHIA, V77, P223, DOI 10.1007/s10337-013-2591-7; Yang YH, 2016, J CELL PHYSIOL, V231, P2570, DOI 10.1002/jcp.25349; Zhao CK, 2015, LIFE SCI, V137, P37, DOI 10.1016/j.lfs.2015.07.019; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	27	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186821	10.1371/journal.pone.0186821	http://dx.doi.org/10.1371/journal.pone.0186821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088257	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900023
J	Subsomwong, P; Miftahussurur, M; Uchida, T; Vilaichone, R; Ratanachu-ek, T; Mahachai, V; Yamaoka, Y				Subsomwong, Phawinee; Miftahussurur, Muhammad; Uchida, Tomohisa; Vilaichone, Rathakorn; Ratanachu-ek, Thawee; Mahachai, Varocha; Yamaoka, Yoshio			Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand	PLOS ONE			English	Article							ENDONUCLEASE-REPLACING GENE; ENCODING GLYCOSYLTRANSFERASES; CLINICAL-RELEVANCE; CAGA; INFECTION; METAANALYSIS; JAPANESE; VACA; HRGA; ADENOCARCINOMA	Gastric cancer risk is varied among different regions of Thailand. We examined the characteristics of Helicobacter pylori infection in two regions of Thailand. The H. pylori status of 273 dyspeptic patients (136 from the South and 137 from the North; a low and high incidence of gastric cancer region, respectively) was evaluated, and virulence genotypes (cagA, vacA, hrgA and jhp0562-positive/beta-(1,3) galT) were determined. The overall H. pylori infection rate was 34.1% (93/273). The prevalence was higher in the North than in the South (50.4% vs. 17.6%, P < 0.001) and was significantly higher among individuals with the following characteristics: low income, birthplace in the Northeast or North regions, agricultural employment, or consumption of alcohol or unboiling water. Among these socio-demographic determinants, region was an independent risk factor for H. pylori infection (odds ratio = 6.37). Patients including both H. pylori infected and uninfected cases who lived in the North had significantly more severe histological scores than those in the South. In contrast, among H. pylori-positive cases, patients in the South had significantly more severe histological scores than those in the North. Of the 74 strains cultured, 56.8% carried Western-type cagA, with a higher proportion in the South than in the North (76.2% vs. 49.1%, P = 0.05). In disagreement with the current consensus, patients infected with the Western-type cagA strains had more severe inflammation scores in the antrum than those infected with the East Asian-type cagA strains (P = 0.027). Moreover, Western-type cagA strains induced more severe histological scores in patients from the South than those of either genotype from the North. Other virulence genes had no influence on histological scores. The incidence of gastric cancer in Thailand was different among regions and corresponded to differences in the prevalence of H. pylori infection. More careful follow- up for patients in the South will be required, even if they are infected with H. pylori carrying Western-type cagA.	[Subsomwong, Phawinee; Miftahussurur, Muhammad; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan; [Miftahussurur, Muhammad] Univ Airlangga, Dr Soetomo Teaching Hosp, Fac Med, Gastroenterohepatol Div,Dept Internal Med,Inst Tr, Surabaya, Indonesia; [Miftahussurur, Muhammad; Yamaoka, Yoshio] Baylor Coll Med, Dept Gastroenterol & Hepatol, Houston, TX 77030 USA; [Miftahussurur, Muhammad; Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Hasama Machi, Yufu City, Oita, Japan; [Vilaichone, Rathakorn] Thammasat Univ Hosp, Dept Med, Gastroenterol Unit, Pathum Thani, Thailand; [Ratanachu-ek, Thawee] Rajavithi Hosp, Dept Surg, Bangkok, Thailand; [Mahachai, Varocha] Bangkok Med Ctr, GI & Liver Ctr, Bangkok, Thailand	Oita University; Airlangga University; Baylor College of Medicine; Baylor College of Medicine; Oita University; Thammasat University; Rajavithi Hospital	Yamaoka, Y (corresponding author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan.; Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Gastroenterol & Hepatol, Houston, TX 77030 USA.; Yamaoka, Y (corresponding author), Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.	yyamaoka@oita-u.ac.jp	Miftahussurur, Muhammad/AAB-6151-2021; Vilaichone, Ratha-korn/ABA-1118-2020	Miftahussurur, Muhammad/0000-0003-1415-6033; Subsomwong, Phawinee/0000-0002-9961-9350; Yamaoka, Yoshio/0000-0002-1222-5819	Ministry of Education, Culture, Sports, Science and Technology [25293104, 26640114, 15H02657, 16H05191, 211S0002]; National Institutes of Health [DK62813]; Ministry of Research, Technology and Higher Education of Indonesia for World Class Professor Program [105/D2.3/KP/2017]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Research, Technology and Higher Education of Indonesia for World Class Professor Program	This work was supported by Ministry of Education, Culture, Sports, Science and Technology (25293104, 26640114, 15H02657, 16H05191 and 211S0002) to Yoshio Yamaoka, National Institutes of Health (DK62813) to Yoshio Yamaoka and Ministry of Research, Technology and Higher Education of Indonesia for World Class Professor Program (no. 105/D2.3/KP/2017) to Muhammad Miftahussurur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab H, 2016, J INFECT DEV COUNTR, V10, P245, DOI 10.3855/jidc.7713; Ando T, 2002, CANCER RES, V62, P2385; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atisook K, 2003, HELICOBACTER, V8, P132, DOI 10.1046/j.1523-5378.2003.00134.x; Bakhti SZ, 2015, HELICOBACTER; Basiri Z, 2014, ASIAN PAC J CANCER P, V15, P1575, DOI 10.7314/APJCP.2014.15.4.1575; BLASER MJ, 1995, CANCER RES, V55, P2111; CORREA P, 1992, CANCER RES, V52, P6735; D'Elia L, 2012, CLIN NUTR, V31, P489, DOI 10.1016/j.clnu.2012.01.003; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Elitsur Y, 2009, J CLIN GASTROENTEROL, V43, P147, DOI 10.1097/MCG.0b013e318157e4e7; Figueiredo C, 2002, J NATL CANCER I, V94, P1680, DOI 10.1093/jnci/94.22.1680; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Goh KL, 1997, J GASTROEN HEPATOL, V12, pS29, DOI 10.1111/j.1440-1746.1997.tb00455.x; Graham DY, 2005, GUT, V54, P735, DOI 10.1136/gut.2004.056549; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Jones KR, 2009, J CLIN MICROBIOL, V47, P959, DOI 10.1128/JCM.02330-08; Kim J, 2011, CANCER SCI, V102, P231, DOI 10.1111/j.1349-7006.2010.01770.x; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; Loh YH, 2011, AM J CLIN NUTR, V93, P1053, DOI 10.3945/ajcn.111.012377; Lu H, 2004, DIGEST DIS SCI, V49, P1551, DOI 10.1023/B:DDAS.0000042263.18541.ec; Ma KP, 2017, J PLANT ECOL, V10, P1, DOI 10.1093/jpe/rtw129; Matsuda M, 2011, J GASTROEN HEPATOL, V26, P1451, DOI 10.1111/j.1440-1746.2011.06779.x; Matsuhisa T, 2015, WORLD J GASTROENTERO, V21, P8408, DOI 10.3748/wjg.v21.i27.8408; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Miftahussurur M, 2015, EPIDEMIOL INFECT, V143, P986, DOI 10.1017/S095026881400154X; Miftahussurur M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134216; Mitacek EJ, 2008, NUTR CANCER, V60, P196, DOI 10.1080/01635580701649636; Nguyen LT, 2010, EUR J CLIN MICROBIOL, V29, P651, DOI 10.1007/s10096-010-0909-z; Nguyen TL, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-114; Ogiwara H, 2009, J CLIN MICROBIOL, V47, P3493, DOI 10.1128/JCM.00887-09; Oleastro M, 2010, J CLIN MICROBIOL, V48, P2885, DOI 10.1128/JCM.00401-10; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Rhead JL, 2007, GASTROENTEROLOGY, V133, P926, DOI 10.1053/j.gastro.2007.06.056; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Sahara S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-223; Shiota S, 2014, J MED MICROBIOL, V63, P1189, DOI 10.1099/jmm.0.075275-0; Shiota S, 2010, EXPERT REV GASTROENT, V4, P149, DOI [10.1586/egh.10.7, 10.1586/EGH.10.7]; Sicinschi LA, 2010, CLIN MICROBIOL INFEC, V16, P369, DOI 10.1111/j.1469-0691.2009.02811.x; Suwanrungruang K, 2008, ASIAN PAC J CANCER P, V9, P71; Tanaka M, 2012, HEPATO-GASTROENTEROL, V59, P304, DOI 10.5754/hge10364; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Uchida T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-175; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Vilaichone RK, 2004, HELICOBACTER, V9, P453, DOI 10.1111/j.1083-4389.2004.00260.x; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yamaoka Y, 2014, FUTURE ONCOL, V10, P1487, DOI [10.2217/fon.14.29, 10.2217/FON.14.29]; Yamazaki S, 2005, J CLIN MICROBIOL, V43, P3906, DOI 10.1128/JCM.43.8.3906-3916.2005; Zhang XS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004621	54	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187113	10.1371/journal.pone.0187113	http://dx.doi.org/10.1371/journal.pone.0187113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084246	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000413910200031
J	Ingala, MR; Ravenelle, RE; Monro, JJ; Frank, CL				Ingala, Melissa R.; Ravenelle, Rebecca E.; Monro, Johanna J.; Frank, Craig L.			The effects of epidermal fatty acid profiles, 1-oleoglycerol, and triacylglycerols on the susceptibility of hibernating bats to Pseudogymnoascus destructans	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; SELECTIVE MOBILIZATION; SYNDROME FUNGUS; ADIPOSE-TISSUE; PATHOGEN; ECOLOGY; LIPIDS	White Nose Syndrome (WNS) greatly increases the over-winter mortality of little brown (Myotis lucifugus), Indiana (M. sodalis), northern (M. septentrionalis), and tricolored (Perimyotis subflavus) bats, and is caused by cutaneous infections with Pseudogymnoascus destructans (Pd). Big brown bats (Eptesicus fuscus) are highly resistant to Pd infections. Seven different fatty acids (myristic, pentadecanoic, palmitic, palmitoleic, oleic, and, linoleic acids) occur in the wing epidermis of both M. lucifugus and E. fuscus, 4 of which (myristic, palmitoleic, oleic, and, linoleic acids) inhibit Pd growth. The amounts of myristic and linoleic acids in the epidermis of M. lucifugus decrease during hibernation, thus we predicted that the epidermal fatty acid profile of M. lucifugus during hibernation has a reduced ability to inhibit Pd growth. Laboratory Pd growth experiments were conducted to test this hypothesis. The results demonstrated that the fatty acid profile of M. lucifugus wing epidermis during hibernation has a reduced ability to inhibit the growth of Pd. Additional Pd growth experiments revealed that: a) triacylglycerols composed of known anti-Pd fatty acids do not significantly affect growth, b) pentadecanoic acid inhibits Pd growth, and c) 1-oleoglycerol, which is found in the wing epidermis of E. fuscus, also inhibits the growth of this fungus. Analyses of white adipose from M. lucifugus also revealed the selective retention of oleic and linoleic acids in this tissue during hibernation.	[Ingala, Melissa R.; Ravenelle, Rebecca E.; Frank, Craig L.] Fordham Univ, Dept Biol Sci, Louis Calder Ctr, Armonk, NY 10504 USA; [Monro, Johanna J.] Fordham Univ, Environm Sci Program, Bronx, NY 10458 USA	Fordham University; Fordham University	Frank, CL (corresponding author), Fordham Univ, Dept Biol Sci, Louis Calder Ctr, Armonk, NY 10504 USA.	frank@fordham.edu	Frank, Craig/AFQ-3761-2022	Ingala, Melissa/0000-0002-9866-5646; Frank, Craig/0000-0002-4340-4422	National Science Foundation (US) [IOS-0818222]; NSF [IOS-0818222]	National Science Foundation (US)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by National Science Foundation (US), www.nsf.gov, IOS-0818222.; We thank A. Hicks, C. Herzog, and R.J. Rudd for their generous assistance. A. Davis provided valuable comments and guidance throughout the course of this study. This study was supported by NSF grant IOS-0818222 awarded to C.L.F.	Altieri C, 2009, INT J FOOD SCI TECH, V44, P242, DOI 10.1111/j.1365-2621.2007.01639.x; Ben-Hamo M, 2016, P R SOC B; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; BRACK V, 1985, J MAMMAL, V66, P308, DOI 10.2307/1381243; BUCKNER JS, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P227; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Christie WW., 1992, ADV LIPID METHODOLOG; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Fischer CL, 2014, BBA-MOL CELL BIOL L, V1841, P319, DOI 10.1016/j.bbalip.2013.08.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frank CL, 2002, J MAMMAL, V83, P1013, DOI 10.1644/1545-1542(2002)083&lt;1013:STVIDF&gt;2.0.CO;2; Frank C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095175; Frank CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153535; Frank Craig L., 2012, P271; Gunstone F.D., 1996, FATTY ACID LIPID CHE; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Kellner Amanda M.E., 2005, Northwestern Naturalist, V86, P45, DOI 10.1898/1051-1733(2005)086[0045:DOBICR]2.0.CO;2; KUNZ TH, 1974, ECOLOGY, V55, P693, DOI 10.2307/1934408; Langwig KE, 2015, EMERG INFECT DIS, V21, P1023, DOI 10.3201/eid2106.150123; Leopardi S, 2015, CURR BIOL, V25, pR217, DOI 10.1016/j.cub.2015.01.047; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Mead J. F., 1986, LIPIDS CHEM BIOCH NU; Pannkuk EL, 2014, LIPIDS, V49, P1143, DOI 10.1007/s11745-014-3951-2; Pannkuk EL, 2013, CHEM BIODIVERS, V10, P2122, DOI 10.1002/cbdv.201300319; Price ER, 2013, PHYSIOL BIOCHEM ZOOL, V86, P205, DOI 10.1086/668892; RACLOT T, 1995, J LIPID RES, V36, P2164; Raclot T, 2001, J LIPID RES, V42, P2049; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reynolds DS, 2000, ECOSCIENCE, V7, P10; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Shimozuru M, 2016, COMP BIOCHEM PHYS B, V196, P38, DOI 10.1016/j.cbpb.2016.02.001; Thomas DW, 1995, SYM ZOOL S, P233; Urich K., 1994, COMP ANIMAL BIOCH; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109	37	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187195	10.1371/journal.pone.0187195	http://dx.doi.org/10.1371/journal.pone.0187195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077745	gold, Green Submitted, Green Published			2022-12-27	WOS:000413861200052
J	Fang, WF; Douglas, IS; Chen, YM; Lin, CY; Kao, HC; Fang, YT; Huang, CH; Chang, YT; Huang, KT; Wang, YH; Wang, CC; Lin, MC				Fang, Wen-Feng; Douglas, Ivor S.; Chen, Yu-Mu; Lin, Chiung-Yu; Kao, Hsu-Ching; Fang, Ying-Tang; Huang, Chi-Han; Chang, Ya-Ting; Huang, Kuo-Tung; Wang, Yi-His; Wang, Chin-Chou; Lin, Meng-Chih			Development and validation of immune dysfunction score to predict 28-day mortality of sepsis patients	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; SEPTIC SHOCK; IMMUNOMODULATORY THERAPIES; INDUCED IMMUNOSUPPRESSION; MONOCYTE DEACTIVATION; CLINICAL-CRITERIA; OUTCOMES; MANAGEMENT; SURVIVAL	Background Sepsis-induced immune dysfunction ranging from cytokines storm to immunoparalysis impacts outcomes. Monitoring immune dysfunction enables better risk stratification and mortality prediction and is mandatory before widely application of immunoadjuvant therapies. We aimed to develop and validate a scoring system according to patients' immune dysfunction status for 28-day mortality prediction. Methods A prospective observational study from a cohort of adult sepsis patients admitted to ICU between August 2013 and June 2016 at Kaohsiung Chang Gung Memorial Hospital in Taiwan. We evaluated immune dysfunction status through measurement of baseline plasma Cytokine levels, Monocyte human leukocyte-DR expression by flow cytometry, and stimulated immune response using post LPS stimulated cytokine elevation ratio. An immune dysfunction score was created for 28-day mortality prediction and was validated. Results A total of 151 patients were enrolled. Data of the first consecutive 106 septic patients comprised the training cohort, and of other 45 patients comprised the validation cohort. Among the 106 patients, 21 died and 85 were still alive on day 28 after ICU admission. (mortality rate, 19.8%). Independent predictive factors revealed via multivariate logistic regression analysis included segmented neutrophil-to-monocyte ratio, granulocyte-colony stimulating factor, interleukin-10, and monocyte human leukocyte antigen-antigen D-related levels, all of which were selected to construct the score, which predicted 28-day mortality with area under the curve of 0.853 and 0.789 in the training and validation cohorts, respectively. Conclusions The immune dysfunction scoring system developed here included plasma granulocyte-colony stimulating factor level, interleukin-10 level, serum segmented neutrophil-to-monocyte ratio, and monocyte human leukocyte antigen-antigen D-related expression appears valid and reproducible for predicting 28-day mortality.	[Fang, Wen-Feng; Chen, Yu-Mu; Lin, Chiung-Yu; Kao, Hsu-Ching; Fang, Ying-Tang; Huang, Chi-Han; Chang, Ya-Ting; Huang, Kuo-Tung; Wang, Yi-His; Wang, Chin-Chou; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Kaohsiung, Taiwan; [Fang, Wen-Feng; Wang, Yi-His; Wang, Chin-Chou; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Dept Resp Therapy, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Fang, Wen-Feng; Wang, Chin-Chou] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi, Taiwan; [Douglas, Ivor S.] Univ Colorado, Div Pulm Sci & Crit Care Med, Denver, CO 80202 USA; [Douglas, Ivor S.] Denver Hlth Med Ctr, Denver, CO USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; University of Colorado System; University of Colorado Denver; Denver Health Medical Center	Fang, WF; Lin, MC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Kaohsiung, Taiwan.; Fang, WF; Lin, MC (corresponding author), Chang Gung Univ, Coll Med, Dept Resp Therapy, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan.; Fang, WF (corresponding author), Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi, Taiwan.	wenfeng@cgmh.org.tw; mengchih@adm.cgmh.org.tw	Fang, Wen-Feng/AAT-6296-2021; Douglas, Ivor S/AAC-6245-2021	Fang, Wen-Feng/0000-0003-0350-9059; Douglas, Ivor S/0000-0002-4541-1431; Huang, Chi-Han/0000-0002-3393-1587	Chang Gung Memorial Hospital Grant [CMRPG8B1061, CMRPG8B1062, CMRPG8B1063, CMRPG8C0551, CMRPG8C0052, CMRPG8B1071, CMRPG8B1072, CMRPG8B1073, CMRPG8B1081, CMRPG8B1082, CMRPG8B1083]; Taiwan Ministry of Science and Technology [MOST 104-2314-B-182A-123-]	Chang Gung Memorial Hospital Grant(Chang Gung Memorial Hospital); Taiwan Ministry of Science and Technology	The work is supported in part by grants from the Chang Gung Memorial Hospital Grant (CMRPG8B1061, CMRPG8B1062, CMRPG8B1063, CMRPG8C0551, and CMRPG8C0052 to WF Fang; CMRPG8B1071 to 73 to YH Wang; CMRPG8B1081 to 83 to CC Wang) and a grant from Taiwan Ministry of Science and Technology (MOST 104-2314-B-182A-123-) to WF Fang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; [Anonymous], CRIT CARE MED; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Calfee CS, 2016, AM J RESP CRIT CARE, V194, P137, DOI 10.1164/rccm.201604-0697ED; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Davenport EE, 2016, LANCET RESP MED, V4, P259, DOI 10.1016/S2213-2600(16)00046-1; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Gomez HG, 2014, CRIT CARE MED, V42, P771, DOI 10.1097/CCM.0000000000000100; Hall MW, 2011, INTENS CARE MED, V37, P525, DOI 10.1007/s00134-010-2088-x; Hotchkiss RS, 2015, SCIENCE, V347, P1201, DOI 10.1126/science.aaa8334; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Kox WJ, 2000, INTENS CARE MED, V26, pS124, DOI 10.1007/s001340051129; Kumar S, 2010, INDIAN J PATHOL MICR, V53, P494, DOI 10.4103/0377-4929.68290; Le Bourgeois A, 2016, BIOL BLOOD MARROW TR, V22, P1473, DOI 10.1016/j.bbmt.2016.04.015; Leentjens J, 2013, AM J RESP CRIT CARE, V187, P1287, DOI 10.1164/rccm.201301-0036CP; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2014, CRIT CARE, V18, DOI 10.1186/cc13179; Morris AC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011326; Phua J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3245; Reddy RC, 2001, IMMUNOL RES, V24, P273, DOI 10.1385/IR:24:3:273; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Skrupky LP, 2011, ANESTHESIOLOGY, V115, P1349, DOI 10.1097/ALN.0b013e31823422e8; Sonego F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00155; Tamayo E, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.09.001; van Vught LA, 2016, JAMA-J AM MED ASSOC, V315, P1469, DOI 10.1001/jama.2016.2691; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2006, AM J RESP CRIT CARE, V173, P256, DOI 10.1164/rccm.200510-1604OE; Vincent JL, 2002, CLIN INFECT DIS, V34, P1084, DOI 10.1086/339549; Volk HD, 1996, INTENS CARE MED, V22, pS474, DOI 10.1007/BF01743727; Walsh KB, 2015, STROKE, V46, P2302, DOI 10.1161/STROKEAHA.115.009880	38	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187088	10.1371/journal.pone.0187088	http://dx.doi.org/10.1371/journal.pone.0187088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073262	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400111
J	Kinoshita, T; Nishimura, Y; Nakamura, T; Hashizaki, T; Kojima, D; Kawanishi, M; Uenishi, H; Arakawa, H; Ogawa, T; Kamijo, Y; Kawasaki, T; Tajima, F				Kinoshita, Tokio; Nishimura, Yukihide; Nakamura, Takeshi; Hashizaki, Takamasa; Kojima, Daisuke; Kawanishi, Makoto; Uenishi, Hiroyasu; Arakawa, Hideki; Ogawa, Takahiro; Kamijo, Yoshi-ichiro; Kawasaki, Takashi; Tajima, Fumihiro			Effects of physiatrist and registered therapist operating acute rehabilitation (PROr) in patients with stroke	PLOS ONE			English	Article							FUNCTIONAL INDEPENDENCE MEASURE; RANDOMIZED CONTROLLED-TRIAL; EARLY MOBILIZATION; PHASE-II; AVERT; SCALE; DISABILITY; HANDICAP; OUTCOMES; SAFETY	Objective Clinical evidence suggests that early mobilization of patients with acute stroke improves activity of daily living (ADL). The purpose of this study was to compare the utility of the physiatrist and registered therapist operating acute rehabilitation (PROr) applied early or late after acute stroke. Subjects and methods This study was prospective cohort study, assessment design. Patients with acute stroke (n = 227) admitted between June 2014 and April 2015 were divided into three groups based on the time of start of PROr: within 24 hours (VEM, n = 47), 24-48 hours (EM, n = 77), and more than 48 hours (OM, n = 103) from stroke onset. All groups were assessed for the number of deaths during hospitalization, and changes in the Glasgow Coma Scale (GCS), National Institute of Health Stroke Scale (NIHSS), and Functional Independence Measure (FIM) at hospital discharge. Interventions All patients were assessed by physiatrists, who evaluated the specific needs for rehabilitation, and then referred them to registered physical therapists and occupational therapists to provide early mobilization (longer than one hour per day per patient). Results The number of deaths encountered during the PROr period was 13 (out of 227, 5.7%), including 2 (4.3%) in the VEM group. GCS improved significantly during the hospital stay in all three groups, but the improvement on discharge was significantly better in the VEM group compared with the EM and OM groups. FIM improved significantly in the three groups, and the gains in total FIM and motor subscale were significantly greater in the VEM than the other groups. Conclusions PROr seems safe and beneficial rehabilitation to improve ADL in patients with acute stroke.	[Kinoshita, Tokio; Hashizaki, Takamasa; Kojima, Daisuke; Kawanishi, Makoto; Uenishi, Hiroyasu; Arakawa, Hideki; Ogawa, Takahiro; Kamijo, Yoshi-ichiro; Kawasaki, Takashi; Tajima, Fumihiro] Wakayama Med Univ, Dept Rehabil Med, Wakayama, Japan; [Nishimura, Yukihide] Iwate Med Univ, Dept Rehabil Med, Morioka, Iwate, Japan; [Nakamura, Takeshi] Yokohama City Univ, Sch Med, Dept Rehabil Med, Yokohama, Kanagawa, Japan	Wakayama Medical University; Iwate Medical University; Yokohama City University	Tajima, F (corresponding author), Wakayama Med Univ, Dept Rehabil Med, Wakayama, Japan.	tajibun@gmail.com	Kamijo, Yoshi-ichiro/AAH-2810-2020	Nishimura, Yukihide/0000-0002-5365-1347	JSPS KAKENHI [15K01384]; Japan Society for the Promotion Science (JSPS) [15K01384]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by JSPS KAKENHI Grant Number 15K01384. The URL of Japan Society for the Promotion Science (JSPS) is https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K01384/. The author who received funding is FT.	Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chumney D, 2010, J REHABIL RES DEV, V47, P17, DOI 10.1682/JRRD.2009.08.0140; Cumming TB, 2008, J REHABIL MED, V40, P609, DOI 10.2340/16501977-0226; Cumming TB, 2011, STROKE, V42, P153, DOI 10.1161/STROKEAHA.110.594598; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Greening NJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4315; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Intercollegiat e Stroke Working Party, 2012, NAT CFLIN GUID STROK; Keith R A, 1987, Adv Clin Rehabil, V1, P6; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MAHONEY F I, 1965, Md State Med J, V14, P61; Management of Stroke Rehabilitation Working Group, 2010, VA DOD CLIN PRACT GU; Momosaki R, 2016, GERIATR GERONTOL INT, V16, P963, DOI 10.1111/ggi.12582; Moriki T, 2013, OPEN J THER REHABIL, V01, P1; National Stroke Foundation, 2010, CLIN GUID STROK MAN; Roberts L, 1998, STROKE, V29, P986, DOI 10.1161/01.STR.29.5.986; Sorbello D, 2009, CEREBROVASC DIS, V28, P378, DOI 10.1159/000230712; Tay-Teo K, 2008, CEREBROVASC DIS, V26, P475, DOI 10.1159/000155984; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; The Japan Stoke Society, 2015, JAP GUID MAN STROK; Tyedin K, 2010, DISABIL REHABIL, V32, P875, DOI 10.3109/09638280903349552; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	29	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187099	10.1371/journal.pone.0187099	http://dx.doi.org/10.1371/journal.pone.0187099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073250	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400114
J	Bond, JG; Ramirez-Osorio, A; Marina, CF; Fernandez-Salas, I; Liedo, P; Dor, A; Williams, T				Bond, J. G.; Ramirez-Osorio, A.; Marina, C. F.; Fernandez-Salas, I.; Liedo, P.; Dor, A.; Williams, T.			Efficiency of two larval diets for mass-rearing of the mosquito Aedes aegypti	PLOS ONE			English	Article							ALBOPICTUS DIPTERA-CULICIDAE; DISPERSAL; OUTBREAKS; DISEASE; MALES	Aedes aegypti is a major vector of arboviruses that may be controlled on an area-wide basis using the sterile insect technique (SIT). Larval diet is a major factor in mass-rearing for SIT programs. We compared dietary effects on immature development and adult fitness-related characteristics for an International Atomic Energy Agency (IAEA) diet, developed for rearing Ae. albopictus, and a standardized laboratory rodent diet (LRD), under a 14:10 h (light:dark) photoperiod ("light" treatment) or continuous darkness during larval rearing. Larval development was generally fastest in the IAEA diet, likely reflecting the high protein and lipid content of this diet. The proportion of larvae that survived to pupation or to adult emergence did not differ significantly between diets or light treatments. Insects from the LRD-dark treatment produced the highest proportion of male pupae (93% at 24 h after the beginning of pupation) whereas adult sex ratio from the IAEA diet tended to be more male-biased than that of the LRD diet. Adult longevity did not differ significantly with larval diet or light conditions, irrespective of sex. In other aspects the LRD diet generally performed best. Adult males from the LRD diet were significantly larger than those from the IAEA diet, irrespective of light treatment. Females from the LRD diet had-25% higher fecundity and-8% higher egg fertility compared to those from the IAEA diet. Adult flight ability did not differ between larval diets, and males had a similar number of copulations with wild females, irrespective of larval diet. The LRD diet had lower protein and fat content but a higher carbohydrate and energetic content than the IAEA diet. We conclude that the LRD diet is a low-cost standardized diet that is likely to be suitable for mass-rearing of Ae. aegypti for area-wide SIT-based vector control.	[Bond, J. G.; Ramirez-Osorio, A.; Marina, C. F.; Fernandez-Salas, I.] INSP, CRISP, Tapachula, Chiapas, Mexico; [Liedo, P.; Dor, A.] Colegio Frontera Sur ECOSUR, Tapachula, Chiapas, Mexico; [Williams, T.] Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico	El Colegio de la Frontera Sur (ECOSUR); Instituto de Ecologia - Mexico	Williams, T (corresponding author), Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico.	trevor.inecol@gmail.com	Williams, Trevor/ABG-3961-2020; Liedo, Pablo/E-9313-2010; Dor, Ariane/A-7975-2013; Dor, Ariane/AAQ-7554-2020; Williams, Trevor/F-1447-2011	Liedo, Pablo/0000-0002-0004-1721; Dor, Ariane/0000-0002-3483-9547; Williams, Trevor/0000-0003-3414-3440; Marina Fernandez, Carlos Felix/0000-0002-4804-8949	Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (FOINS-CONACYT) [247673]	Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (FOINS-CONACYT)	The study received financial support from the Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (FOINS-CONACYT) project 247673. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Arrivillaga J, 2004, J VECTOR ECOL, V29, P11; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Balestrino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091914; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699; Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47; Benedict MQ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S4; BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; *CDCP, 2016, SURV CONTR AED AEG A; CHAMBERS GM, 1990, J AM MOSQUITO CONTR, V6, P394; CLEMENTS AN, 1955, J EXP BIOL, V32, P547; Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289; Dyck V.A., 2006, STERILE INSECT TECHN; Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015; Gerberg EJ, 1970, B AM MOSQ CONTROL AS, V5, P1; Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302; Joslyn M.A., 1970, METHODS FOOD ANAL PH; Joy TK, 2010, EXP GERONTOL, V45, P685, DOI 10.1016/j.exger.2010.04.009; Karunamoorthi K, 2013, HEALTH SCOPE, V2, DOI 10.17795/jhealthscope-9840; KLOWDEN MJ, 1986, J INSECT PHYSIOL, V32, P479, DOI 10.1016/0022-1910(86)90009-0; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lee SS, 2013, J THEOR BIOL, V331, P78, DOI 10.1016/j.jtbi.2013.04.014; Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Marina CF, 1999, OECOLOGIA, V119, P383, DOI 10.1007/s004420050799; Mellanby K., 1958, Entomologia Experimentalis et Applicata, V1, P153, DOI 10.1007/BF00291058; NASCI RS, 1991, J MED ENTOMOL, V28, P522, DOI 10.1093/jmedent/28.4.522; OMARDEEN T. A., 1957, BULL ENT RES, V48, P349, DOI 10.1017/S0007485300047180; Parker AG, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P209, DOI 10.1007/1-4020-4051-2_8; Ptitsyn AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-153; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; Rund SSC, 2016, INSECTS, V7, DOI 10.3390/insects7020014; Soekiman S., 1984, ICMR ANN, V4, P143; Souza JA, 2007, COMP BIOCHEM PHYS A, V147, P993, DOI 10.1016/j.cbpa.2007.03.008; TAYLOR B, 1969, J EXP BIOL, V51, P59; THOMAS IM, 1950, AUST J SCI RES SER B, V3, P113, DOI 10.1071/BI9500113; VANHANDEL E, 1988, J AM MOSQUITO CONTR, V4, P374; VANHANDEL E, 1965, J PHYSIOL-LONDON, V181, P478, DOI 10.1113/jphysiol.1965.sp007776; Yee DA, 2012, J MED ENTOMOL, V49, P825, DOI 10.1603/ME11132	41	35	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187420	10.1371/journal.pone.0187420	http://dx.doi.org/10.1371/journal.pone.0187420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095933	Green Submitted, gold, Green Published			2022-12-27	WOS:000414340200086
J	Yoo, YJ; Yang, HK; Kim, N; Hwang, JM				Yoo, Yung Ju; Yang, Hee Kyung; Kim, Namju; Hwang, Jeong-Min			Pediatric orbital wall fractures: Prognostic factors of diplopia and ocular motility limitation	PLOS ONE			English	Article							BLOW-OUT FRACTURES; FLOOR FRACTURES; TRAPDOOR FRACTURE; MUSCLE INVOLVEMENT; CHILDREN; OUTCOMES; REPAIR; SURGERY; ADOLESCENTS; MANAGEMENT	Objectives To investigate the factors affecting recovery of diplopia and limited ocular motility in pediatric patients who underwent surgery for orbital wall fracture. Design Retrospective observational case series. Methods In this retrospective observational case series, 150 pediatric patients (1-18 years old) who were diagnosed with orbital medial wall or floor fracture and underwent corrective surgery between 2004 and 2016 at Seoul National University Bundang Hospital were included. The medical records of patients with orbital medial wall or floor fracture were reviewed, including sex, age, diplopia, ocular motility, preoperative computed tomographic finding, and surgical outcomes. Factors affecting recovery of diplopia and ocular motility limitation were analyzed. Results Of the 150 patients (134 boys; mean age, 14.4 years) who underwent corrective surgery for orbital wall fracture, preoperative binocular diplopia was found in 76 (50.7%) patients and limited ocular motility in 81 (54.0%). Presence of muscle incarceration or severe supraduction limitation delayed the recovery of diplopia. In case of ocular motility limitation, presence of muscle incarceration and retrobulbar hemorrhage were related with the delayed resolution. Multivariate analysis revealed supraduction limitation (Hazard ratio [HR] = 1.74, 95% confidence interval [CI] = 1.19-2.55), larger horizontal orbital floor defects (HR = 1.22, 95% CI = 1.07-1.38), and shorter time interval to first visit (HR = 0.73) as negative prognostic factors for the recovery of diplopia. In addition, muscle incarceration (HR = 3.53, 95% CI = 1.54-8.07) and retrobulbar hemorrhage (HR = 3.77, 95% CI = 1.45-9.82) were found as negative prognostic factors for the recovery of motility limitation. Conclusions Presence of muscle incarceration and retrobulbar hemorrhage, horizontal length of floor fracture, supraduction limitation, and time interval from trauma to first visit were correlated with the surgical outcomes in pediatric orbital wall fracture patients. These results strengthen that the soft tissue damage associated with bony fracture affects the orbital functional unit. When managing children with orbital wall fracture, meticulous physical examination and thorough preoperative computed tomography based evaluation will help physicians to identify damage of orbital functional unit.	[Yoo, Yung Ju] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Grad Sch Med, Dept Ophthalmol, Chunchon, South Korea; [Yang, Hee Kyung; Kim, Namju; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU)	Kim, N; Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	resourceful@hanmail.net; hjm@snu.ac.kr						ANDERSON PJ, 1995, J CRANIO MAXILL SURG, V23, P151, DOI 10.1016/S1010-5182(05)80003-4; Bansagi ZC, 2000, OPHTHALMOLOGY, V107, P829, DOI 10.1016/S0161-6420(00)00015-4; Burnstine MA, 2002, OPHTHALMOLOGY, V109, P1207, DOI 10.1016/S0161-6420(02)01057-6; Carroll SC, 2010, BRIT J OPHTHALMOL, V94, P736, DOI 10.1136/bjo.2008.155143; CONVERSE J M, 1960, Trans Am Acad Ophthalmol Otolaryngol, V64, P676; Cope MR, 1999, BRIT J ORAL MAX SURG, V37, P46, DOI 10.1054/bjom.1998.0382; Dal Canto AJ, 2008, OPHTHAL PLAST RECONS, V24, P437, DOI 10.1097/IOP.0b013e31818aac9b; DEMAN K, 1991, INT J ORAL MAX SURG, V20, P330, DOI 10.1016/S0901-5027(05)80260-7; Egbert JE, 2000, OPHTHALMOLOGY, V107, P1875, DOI 10.1016/S0161-6420(00)00334-1; Gerbino G, 2010, J ORAL MAXIL SURG, V68, P1310, DOI 10.1016/j.joms.2009.12.037; Grant JH, 2002, PLAST RECONSTR SURG, V109, P482, DOI 10.1097/00006534-200202000-00011; Harris GJ, 2006, EYE, V20, P1207, DOI 10.1038/sj.eye.6702384; Hatt SR, 2007, OPHTHALMOLOGY, V114, P2316, DOI 10.1016/j.ophtha.2007.01.033; Hink EM, 2014, OPHTHAL PLAST RECONS, V30, P124, DOI 10.1097/IOP.0000000000000026; Hink Eric M, 2013, Int Ophthalmol Clin, V53, P103, DOI 10.1097/IIO.0b013e31828b7913; Iliff N, 1999, PLAST RECONSTR SURG, V103, P787, DOI 10.1097/00006534-199903000-00004; Jordan DR, 1998, OPHTHALMIC PLAST REC, V14, P379, DOI 10.1097/00002341-199811000-00001; Kwon JH, 2005, ARCH OTOLARYNGOL, V131, P723, DOI 10.1001/archotol.131.8.723; Lee WT, 2009, J CRANIOFAC SURG, V20, P75, DOI 10.1097/SCS.0b013e318190df0d; Neinstein RM, 2012, J PLAST RECONSTR AES, V65, P869, DOI 10.1016/j.bjps.2012.02.004; Park MS, 2012, ARCH PLAST SURG-APS, V39, P204, DOI 10.5999/aps.2012.39.3.204; Shin KH, 2011, J CRANIOFAC SURG, V22, P1426, DOI 10.1097/SCS.0b013e31821cc2cd; Stotland MA, 2011, J CRANIOFAC SURG, V22, P1230, DOI 10.1097/SCS.0b013e31821c0f52; Su Y, 2015, J NANOMATER, V2015, DOI 10.1155/2015/276753; Wachler BSB, 1998, OPHTHALMIC PLAST REC, V14, P17; Wang Ning-Chia, 2010, Chang Gung Med J, V33, P313; Wei LA, 2011, J AAPOS, V15, P173, DOI 10.1016/j.jaapos.2011.02.005; Yang JW, 2015, J CRANIO MAXILL SURG, V43, P444, DOI 10.1016/j.jcms.2015.01.010; Yano H, 2010, J CRANIOFAC SURG, V21, P1072, DOI 10.1097/SCS.0b013e3181e20647; Yoon KC, 2003, J KOREAN MED SCI, V18, P881, DOI 10.3346/jkms.2003.18.6.881; Yu DY, 2016, ANN PLAS SURG, V76, pS91, DOI 10.1097/SAP.0000000000000726	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0184945	10.1371/journal.pone.0184945	http://dx.doi.org/10.1371/journal.pone.0184945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095826	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200004
J	Kawatsu, L; Uchimura, K; Ohkado, A				Kawatsu, Lisa; Uchimura, Kazuhiro; Ohkado, Akihiro			Trend and treatment status of latent tuberculosis infection patients in Japan Analysis of Japan TB Surveillance data	PLOS ONE			English	Article							CONTACT INVESTIGATIONS; TREATMENT COMPLETION	Objective and method Management of latent tuberculosis infection (LTBI) is one of the core elements of End TB Strategy. Japan is one of the few countries in which notification of LTBI is mandatory, yet so far, the data has not been analyzed in detail. We thus conducted a cross-sectional study to examine the trend of LTBI, its treatment outcome and factors predicting treatment non-completion in Japan for the period of 2007 and 2014, using the data from the electronic Japan Tuberculosis Surveillance system. Treatment completion was defined as those whose reason for terminating the treatment was recorded as "treatment completed" and whose treatment duration was 180 days or more. Results During the study period, a total of 50,268 LTBI patients were notified, of which 49,525, who had started treatment, were analyzed for characteristics. 57.5% were females, and 38.5% were aged 25-44 years. As for the job category, healthcare professionals, that is medical doctors, nurses and other healthcare workers, consisted the largest group (30.4%). Overall, the number of LTBI notification has been on an increase, with a large increase observed among those aged 65 years and above. Of the 49,525 patients, the information regarding reason for termination of treatment was available for 46,128 (93.1%). Of them, 33,156 (71.9%) had completed treatment as according to the study definition. The risk factors for not completing LTBI treatment included being aged 65 years and above (adjusted odds ratio [aOR] 1.27, 95% confidence interval [95%Cl] 1.10-1.47), foreign-born (aOR 1.14, 95%Cl 1.02-1.28), healthcare professional (aOR 1.44, 95%Cl 1.24-1.69), full-time and part-time worker (aOR 1.40, 95%Cl, 1.20-1.63) and detected via contact investigation (aOR 1.26, 95%Cl 1.12-1.41). Conclusions Our study results revealed that the treatment completion rate was 71.9%, falling short of the national target of 85%, and also that the treatment duration was recorded as less than 180 days for approximately 20% of those who were reported as having completed treatment. Further studies may be built on ours to explore the reasons for not completing the treatment across different population groups, and identify those who benefit the most, and who has the greatest impact on ending TB, by receiving LTBI treatment.	[Kawatsu, Lisa; Uchimura, Kazuhiro; Ohkado, Akihiro] Japan AntiTB Assoc RIT JATA, Res Inst TB, Dept Epidemiol & Clin Res, Tokyo, Japan		Kawatsu, L (corresponding author), Japan AntiTB Assoc RIT JATA, Res Inst TB, Dept Epidemiol & Clin Res, Tokyo, Japan.	kawatsu@jata.or.jp	Ohkado, Akihiro/HGF-2977-2022		Japan Society for the Promotion of Science [16K09155]; LK	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); LK	This work was supported by grant 16K09155, Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (http:// tutivwtsps.gotp/kgrantsinaid/index.html). Funding was received by LK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, MISSED OPPORTUNITIES, V49, P685; Bock NM, 1999, AM J RESP CRIT CARE, V159, P295, DOI 10.1164/ajrccm.159.1.9807020; Brassard P, 2004, INT J TUBERC LUNG D, V8, P988; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Erkens CGM, 2016, EUR RESPIR J, V47, P1492, DOI 10.1183/13993003.01397-2015; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Ishikawa N, 2010, GUIDELINE TUBERCULOS; Izumi K, 2017, INT J TUBERC LUNG D, V21, P188, DOI 10.5588/ijtld.16.0508; Kasai K, 2015, KEKKAKU, V90, P507; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; Lavigne M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-66; Lobato MN, 2005, CHEST, V127, P1296, DOI 10.1378/chest.127.4.1296; Lobue P, 1993, CHEST, V113, P1184; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Nyamathi AM, 2006, INT J TUBERC LUNG D, V10, P775; Ohkado Akihiro, 2015, Kekkaku, V90, P657; Page KR, 2006, ARCH INTERN MED, V166, P1863, DOI 10.1001/archinte.166.17.1863; Parsyan AE, 2007, J INFECTION, V54, P262, DOI 10.1016/j.jinf.2006.04.010; RamphalNaley L, 1996, AM J INFECT CONTROL, V24, P243, DOI 10.1016/S0196-6553(96)90056-5; Shieh FK, 2006, AM J RESP CRIT CARE, V174, P717, DOI 10.1164/rccm.200510-1667OC; The Prevention Committee and the Treatment Committee of the Japanese Society for Tuberculosis, 2013, TREATMENT GUIDELINE, V88, P497; White MC, 2005, HEALTH EDUC RES, V20, P163, DOI 10.1093/her/cyg109; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organization, 2015, IMPL END TB STRAT ES	26	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.018588	http://dx.doi.org/10.1371/journal.pone.018588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091917				2022-12-27	WOS:000414229700025
J	Auckle, R; Su, BJ; Li, HL; Xu, SL; Xie, MJ; Song, YC; Quddus, MA; Xu, YW; Liu, B; Che, WL				Auckle, Ranshaka; Su, Binjie; Li, Hailing; Xu, Siling; Xie, Mujin; Song, Yangchun; Quddus, Mohammed Abdul; Xu, Yawei; Liu, Ban; Che, Wenliang			Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LOWERING TREATMENT; GUIDANCE; BURDEN; IMPACT	Background Familial hypercholesterolemia (FH), characterized by elevated plasma low-density lipoprotein-cholesterol (LDL-C) levels and premature coronary artery disease (CAD), remains mostly underdiagnosed and undertreated. We investigated the prevalence of clinical FH among Chinese patients with premature ST-segment-elevation myocardial infarction (STEMI) and one-year follow-up on their lipid management and cardiovascular events. Methods Four hundred and ninety-eight premature STEMI patients (363men) were enrolled. FH patients were identified using the Dutch Lipid Clinic Network Criteria. Lipid management and cardiovascular events in all patients were assessed. Results Nineteen patients (3.8%) were diagnosed as definite/probable FH, 211 (42.4%) as possible FH and 268 (53.8%) as unlikely FH. All patients were divided into two main groups: unlikely FH (0-2 points) and possible FH (>= 3 points). Possible FH patients were younger (50.1 years vs. 53.5 years) with higher NT-proBNP level (3014.15 pg/mL vs. 2326.25 pg/mL), occurrence of multi-vessel CAD (37.4% vs. 18.3%), lower LVEF (47% vs. 49%) and more severe Killip classification (Class 3, 20.0% vs. 9.7%). Follow-up data were available for 203 patients from the possible FH group and 243 patients from the unlikely FH group. High intensity statin intake status (%) of possible FH vs. unlikely FH was as follows: 1) on admission: 4.8% vs. 0.4%; 2) at discharge: 10.4% vs. 1.6% and 3) at one year follow-up: 5.4% vs. 0.8%. A significantly low percentage of possible FH patients (18.7% vs. 51.4%) achieved target LDL-C levels. There were no significant differences in MACE defined as a composite of cardiogenic shock or Class IV heart failure, recurrent MI, cardiovascular-related rehospitalization, TLR and CV death between the two groups. However, the proportion of cardiogenic shock or Class IV heart failure was significantly higher in possible FH patients group (5.9% vs. 1.2%). Conclusion Clinical diagnosis of possible FH is common in Chinese patients with premature STEMI. A low proportion of FH patients were prescribed high intensity statins. Despite aggressive cholesterol-lowering drugs, a significantly lower proportion of FH patients achieved LDL-C targets compared to unlikely FH patients. Possible FH patients were younger with a significantly higher occurrence of multi-vessel CAD and impaired cardiac function.	[Auckle, Ranshaka; Su, Binjie; Li, Hailing; Xu, Siling; Xie, Mujin; Song, Yangchun; Quddus, Mohammed Abdul; Xu, Yawei; Liu, Ban; Che, Wenliang] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai, Peoples R China; [Che, Wenliang] Shanghai Tenth Peoples Hosp, Chongming branch, Dept Cardiol, Shanghai, Peoples R China	Tongji University	Liu, B; Che, WL (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai, Peoples R China.; Che, WL (corresponding author), Shanghai Tenth Peoples Hosp, Chongming branch, Dept Cardiol, Shanghai, Peoples R China.	niefei527@163.com; chewenliang@tongji.edu.cn			National Natural Science Foundation of China [81570436]; Foundation of Shanghai Municipal Commission of Health and Family Planning [201640053]; Shanghai Medical Guiding Project [124119a6900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Shanghai Municipal Commission of Health and Family Planning; Shanghai Medical Guiding Project	This study was supported by National Natural Science Foundation of China (81570436), WLC; Foundation of Shanghai Municipal Commission of Health and Family Planning (201640053), WLC; Shanghai Medical Guiding Project (124119a6900), WLC.	Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Bibbins-Domingo K, 2007, JAMA-J AM MED ASSOC, V297, P169, DOI 10.1001/jama.297.2.169; De Backer G, 2015, ATHEROSCLEROSIS, V241, P169, DOI 10.1016/j.atherosclerosis.2015.04.809; de Ferranti SD, 2016, CIRCULATION, V133, P1067, DOI 10.1161/CIRCULATIONAHA.115.018791; Elis A, 2011, AM J CARDIOL, V108, P223, DOI 10.1016/j.amjcard.2011.03.027; Goldberg AC, 2011, J CLIN LIPIDOL, V5, P133, DOI 10.1016/j.jacl.2011.03.001; Goldstein JL, 2001, METABOLIC MOL BASES, P2863; Gumbs PD, 2007, PHARMACOECONOMICS, V25, P187, DOI 10.2165/00019053-200725030-00002; Henderson R, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0256-1; Huijgen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009220; Kawada-Watanabe E, 2017, J CARDIOL, V69, P536, DOI 10.1016/j.jjcc.2016.05.002; Knowles JW, 2014, AM HEART J, V168, P807, DOI 10.1016/j.ahj.2014.09.001; Li S, 2016, J CLIN LIPIDOL, V10, P1344, DOI 10.1016/j.jacl.2016.08.013; Mortensen MB, 2016, J CLIN LIPIDOL, V10, P1145, DOI 10.1016/j.jacl.2016.06.002; Nanchen D, 2015, EUR HEART J, V36, P2438, DOI 10.1093/eurheartj/ehv289; Neefjes LA, 2011, ATHEROSCLEROSIS, V219, P721, DOI 10.1016/j.atherosclerosis.2011.09.052; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Pang J, 2015, J CLIN LIPIDOL, V9, P703, DOI 10.1016/j.jacl.2015.07.005; Pijlman AH, 2010, ATHEROSCLEROSIS, V209, P189, DOI 10.1016/j.atherosclerosis.2009.09.014; Rallidis LS, 2016, ATHEROSCLEROSIS, V249, P17, DOI 10.1016/j.atherosclerosis.2016.03.023; Rerup SA, 2016, AM HEART J, V181, P35, DOI 10.1016/j.ahj.2016.08.001; Shi ZM, 2014, INT J CARDIOL, V174, P834, DOI 10.1016/j.ijcard.2014.04.165; Sjouke B, 2015, EUR HEART J, V36, P560, DOI 10.1093/eurheartj/ehu058; Zhao SP, 2014, ATHEROSCLEROSIS, V233, P707, DOI 10.1016/j.atherosclerosis.2013.12.003	25	13	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186815	10.1371/journal.pone.0186815	http://dx.doi.org/10.1371/journal.pone.0186815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088271	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900021
J	Cafiero-Fonseca, ET; Stawasz, A; Johnson, ST; Sato, R; Bloom, DE				Cafiero-Fonseca, Elizabeth T.; Stawasz, Andrew; Johnson, Sydney T.; Sato, Reiko; Bloom, David E.			The full benefits of adult pneumococcal vaccination: A systematic review	PLOS ONE			English	Review							COST-EFFECTIVENESS ANALYSIS; AT-RISK ADULTS; COMMUNITY-ACQUIRED PNEUMONIA; BUDGET IMPACT ANALYSIS; AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS; ACUTE MYOCARDIAL-INFARCTION; PUBLIC PAYER PERSPECTIVE; OF-THE-LITERATURE; POLYSACCHARIDE VACCINE; CONJUGATE VACCINE	Background Pneumococcal disease causes substantial morbidity and mortality, including among adults. Adult pneumococcal vaccines help to prevent these burdens, but they are underused. Accounting for the full benefits of adult pneumococcal vaccination may promote more rational resource allocation decisions with respect to adult pneumococcal vaccines. Objectives Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we conducted a systematic review to assess the extent to which the literature has empirically captured (e.g., through measurement or modeling) the full benefits of adult pneumococcal vaccination. Methods We systematically searched PubMed and Embase to identify studies published between January 1, 2010 and April 10, 2016 that examine adult pneumococcal vaccination. We included articles if they captured any health or economic benefit of an adult pneumococcal vaccine administered to adults age >= 50 or >= 18 in risk groups. Finally, we summarized the literature by categorizing the types of benefits captured, the perspective taken, and the strength of the evidence presented. Our protocol is number 42016038335 in the PROSPERO International prospective register of systematic reviews. Results We identified 5,857 papers and included 150 studies for analysis. While most capture health gains and healthcare cost savings, far fewer studies consider additional benefit categories, such as productivity gains. However, the studies with a broader approach still exhibit significant limitations; for example, many present only abstracts, while others offer no new measurements. Studies that examine the 13-valent pneumococcal conjugate vaccine focus more on broad economic benefits, but still have limitations. Conclusions This review highlights the need for more robust empirical accounting of the full benefits of adult pneumococcal vaccination. Literature outside this realm indicates that these broad benefits may be substantial. Failing to investigate the full benefits may lead society to undervalue vaccines' contributions and therefore underinvest in their development and adoption.	[Cafiero-Fonseca, Elizabeth T.; Stawasz, Andrew; Johnson, Sydney T.; Bloom, David E.] Data Decis LLC, Waltham, MA 02451 USA; [Cafiero-Fonseca, Elizabeth T.] Massachusetts Gen Phys Org, Performance Anal & Improvement, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Johnson, Sydney T.] Harvard TH Chan Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Sato, Reiko] Pfizer Inc, Global Hlth & Value, Collegeville, PA USA; [Bloom, David E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Pfizer; Harvard University; Harvard T.H. Chan School of Public Health	Cafiero-Fonseca, ET (corresponding author), Data Decis LLC, Waltham, MA 02451 USA.; Cafiero-Fonseca, ET (corresponding author), Massachusetts Gen Phys Org, Performance Anal & Improvement, Massachusetts Gen Hosp, Boston, MA 02114 USA.	efonseca@datafordecisions.net		Cafiero-Fonseca, Elizabeth/0000-0003-4253-293X; Johnson, Sydney/0000-0003-1836-5086	Pfizer Inc.	Pfizer Inc.(Pfizer)	Funding for this systematic review was provided by Pfizer Inc. (http://www.pfizer.com/) to Data for Decisions, LLC. RS, an employee of Pfizer Inc., is a co-author and played a role in study design, analysis, and preparation of the manuscript. Data for Decisions, LLC provided support in the form of compensation for DEB, ECF, AS, and STJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abdallah J, 2014, GASTROENTEROLOGY, V146, pS170; Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Akin L, 2011, HUM VACCINES, V7, P441, DOI 10.4161/hv.7.4.14188; Riofrio MFA, 2012, VALUE HEALTH, V15, pA194; Alvarez C, 2011, CLIN MICROBIOL INFEC, V17, pS243; Alves M, 2013, EUROPEAN RESP J, V42, pP3688; Alvis N, 2010, VALUE HEALTH, V13, pA190, DOI 10.1016/S1098-3015(10)72930-2; Andrews NJ, 2012, VACCINE, V30, P6802, DOI 10.1016/j.vaccine.2012.09.019; [Anonymous], 2010, CLIN GERIATRICS, V18, P13; Arencibia Jimenez M, 2014, ARCH BRONCONEUMOL, V50, P93, DOI DOI 10.1016/J; Arrow K.J., 1965, ASPECTS THEORY RISK; Barnighausen T, 2012, CLIN MICROBIOL INFEC, V18, P70, DOI 10.1111/j.1469-0691.2012.03977.x; Barnighausen T, 2014, P NATL ACAD SCI USA, V111, P12313, DOI 10.1073/pnas.1400475111; Barnighausen T, 2011, VACCINE, V29, P2371, DOI 10.1016/j.vaccine.2010.11.090; Barnighausen T, 2014, INDIAN ACAD PEDIAT T, P563, DOI DOI 10.5005/JP/BOOKS/12311_63; Barnighausen T, 2008, SAMJ S AFR MED J, V98, P842; Barnighausen T, 2014, LANCET GLOB HEALTH, V2, pE251, DOI 10.1016/S2214-109X(13)70170-0; Barnighausen T, 2013, SEMIN IMMUNOL, V25, P104, DOI 10.1016/j.smim.2013.04.010; Barra M., 2013, PREVENAR 13 PREVNAR; Becker-Dreps S, 2015, VACCINE, V33, P222, DOI 10.1016/j.vaccine.2014.10.073; Leandro LB, 2015, VALUE HEALTH, V18, pA240; Blommaert A, 2016, VACCINE, V34, P2106, DOI 10.1016/j.vaccine.2016.03.003; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; Bloom DE, 2017, VACCINE, V35, pA29, DOI 10.1016/j.vaccine.2016.12.001; Bloom DE, 2015, VACCINE, V33, pB52, DOI 10.1016/j.vaccine.2015.02.071; Bloom DE, 2014, J POLIT ECON, V122, P1355, DOI 10.1086/677189; Bloom DE, 2012, APPL ECON, V44, P2777, DOI 10.1080/00036846.2011.566203; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Bloom DE, 2013, MANSONS TROPICAL DIS, P23; Boccalini S, 2013, HUM VACC IMMUNOTHER, V9, P699, DOI 10.4161/hv.23268; Bond TC, 2012, AM J KIDNEY DIS, V60, P959, DOI 10.1053/j.ajkd.2012.04.018; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Bussell SA, 2010, CHEST, V138, p735A; Cai J, 2014, VALUE HEALTH, V17, pA755, DOI 10.1016/j.jval.2014.08.225; Castaneda-Orjuela C, 2011, VACCINE, V29, P7644, DOI 10.1016/j.vaccine.2011.08.006; Castiglia P, 2014, ADV THER, V31, P1011, DOI 10.1007/s12325-014-0157-1; Chan TC, 2012, J AM MED DIR ASSOC, V13, P698, DOI 10.1016/j.jamda.2012.05.009; Chang YC, 2012, J INFECTION, V65, P231, DOI 10.1016/j.jinf.2012.04.014; Chapman KE, 2013, J PUBLIC HEALTH-UK, V35, P558, DOI 10.1093/pubmed/fdt011; Charos A, 2012, HIV MED, V13, P42; Charos A, 2012, CLIN MICROBIOL INFEC, V18, P20; Chen JL, 2014, ADV THER, V31, P392, DOI 10.1007/s12325-014-0115-y; Chiou WY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001022; Cho BH, 2013, VACCINE, V31, P6011, DOI 10.1016/j.vaccine.2013.10.024; Chuck A, 2012, VALUE HEALTH, V15, pA243, DOI 10.1016/j.jval.2012.03.1309; Cimen P, 2015, RESP CARE, V60, P239, DOI 10.4187/respcare.03350; Claes C, 2010, VALUE HEALTH, V13, pA435; Collamati A, 2015, EUROPEAN GERIATRIC M, V6, pS18; Constenla D, 2015, PHARMACOECONOMICS, V33, P1107, DOI 10.1007/s40273-015-0294-7; Coulson E, 2011, ANN RHEUM DIS, V70, P1289, DOI 10.1136/ard.2010.144451; Cruz RB, 2012, VALUE HEALTH, V15, pA394, DOI 10.1016/j.jval.2012.08.1116; de Soarez PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130217; Deogaonkar R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-878; Dhankhar P, 2010, INT J INFECT DIS, V14, pE449, DOI 10.1016/j.ijid.2010.02.616; Dhankhar P, 2010, CLIN THER, V32, P1501, DOI 10.1016/j.clinthera.2010.07.019; Dominguez A, 2010, EUR RESPIR J, V36, P608, DOI 10.1183/09031936.00171309; Dominguez A, 2013, HUM VACC IMMUNOTHER, V9, P865, DOI 10.4161/hv.23090; Esposito S, 2016, HUM VACC IMMUNOTHER, V12, P1777, DOI 10.1080/21645515.2016.1150396; European Medicines Agency, ANN 1 SUMM PROD CHAR; Falkenhorst G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169368; Ferreira CN, 2015, VALUE HEALTH, V18, pA839, DOI 10.1016/j.jval.2015.09.366; Ferreira CN, 2014, VALUE HEALTH, V17, pA667, DOI 10.1016/j.jval.2014.08.2464; Ferreira CN, 2014, VALUE HEALTH, V17, pA270, DOI 10.1016/j.jval.2014.03.1575; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Fujii RK, 2011, VALUE HEALTH, V14, pA279, DOI 10.1016/j.jval.2011.08.262; FUJII RK, 2013, VALUE HEALTH, V16, pA84; FUJII RK, 2012, VALUE HEALTH, V15, pA397; Gilbertson DT, 2011, NEPHROL DIAL TRANSPL, V26, P2934, DOI 10.1093/ndt/gfq853; Gomez-Junyent J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105854; Grzesiowski P, 2012, HUM VACC IMMUNOTHER, V8, P1382, DOI 10.4161/hv.21571; Guijarro P, 2012, VALUE HEALTH, V15, pA389, DOI 10.1016/j.jval.2012.08.1091; Gutierrez Rodriguez M A, 2014, Euro Surveill, V19, P20922, DOI 10.2807/1560-7917.ES2014.19.40.20922; Gutierrez Rodriguez MA, 2012, CLIN MICROBIOL I SS3, V18, P149; Hamborsky Jennifer, 2015, EPIDEMIOLOGY PREVENT; Hanna JN, 2010, MED J AUSTRALIA, V193, P392, DOI 10.5694/j.1326-5377.2010.tb03965.x; Hayslip B, 2005, GERONTOLOGIST, V45, P262, DOI 10.1093/geront/45.2.262; Hechter RC, 2012, VACCINE, V30, P5625, DOI 10.1016/j.vaccine.2012.06.085; Hoshi SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139140; Hsieh MJ, 2013, CHEST, V144, DOI 10.1378/chest.1701603; Htar MTT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177985; Huicochea-Bartelt JL, 2014, VALUE HEALTH, V17, pA277, DOI 10.1016/j.jval.2014.03.1612; Hung IFN, 2010, CLIN INFECT DIS, V51, P1007, DOI 10.1086/656587; Ignatova G, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA3673; Inoue S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000105; Jiang Y, 2012, VALUE HEALTH, V15, pA388, DOI 10.1016/j.jval.2012.08.1086; Jiang Y, 2011, VALUE HEALTH, V14, pA279, DOI 10.1016/j.jval.2011.08.260; Jiang Y, 2011, VALUE HEALTH, V14, pA268, DOI 10.1016/j.jval.2011.08.205; Jiang Y, 2011, EUROPEAN GERIATRIC M, V2, pS85; JIANG Y, 2012, VALUE HEALTH, V15, pA396; Jiang Y, 2014, VALUE HLTH, V17; Jiang Y, 2014, EXPERT REV PHARM OUT, V14, P913, DOI 10.1586/14737167.2014.950232; Jiang YL, 2014, EXPERT REV PHARM OUT, V14, P901, DOI 10.1586/14737167.2014.953932; Jiang YL, 2012, EXPERT REV PHARM OUT, V12, P631, DOI [10.1586/ERP.12.55, 10.1586/erp.12.55]; Jiang YL, 2012, EXPERT REV PHARM OUT, V12, P645, DOI [10.1586/erp.12.54, 10.1586/ERP.12.54]; Jingu D, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA1854; Jit M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0446-9; Kaseer B, 2014, J CARDIOVASCULAR DIS, V5, P20; Kawakami K, 2010, VACCINE, V28, P7063, DOI 10.1016/j.vaccine.2010.08.010; Kotsopoulos N, 2014, VALUE HEALTH, V17, pA680, DOI 10.1016/j.jval.2014.08.2532; Koutsovasilis AG, 2014, DIABETES, V63, pA642; Kraicer-Melamed H, 2016, VACCINE, V34, P1540, DOI 10.1016/j.vaccine.2016.02.024; Kuhlmann A, 2015, VALUE HEALTH, V18, pA584, DOI 10.1016/j.jval.2015.09.1957; Kuhlmann A, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-4; Kupronis BA, 2003, J AM GERIATR SOC, V51, P1520, DOI 10.1046/j.1532-5415.2003.51501.x; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Le Meur JB, 2014, INT J CIRCUMPOL HEAL, V73, DOI 10.3402/ijch.v73.22691; Leventer-Roberts M, 2015, CLIN INFECT DIS, V60, P1472, DOI 10.1093/cid/civ096; Li CH, 2015, J HOSP MED, V10, P287, DOI 10.1002/jhm.2328; Liao WH, 2010, EUR J CLIN MICROBIOL, V29, P489, DOI 10.1007/s10096-010-0873-7; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liguori G, 2014, HUM VACC IMMUNOTHER, V10, P492, DOI 10.4161/hv.26888; Lin CJ, 2013, AM J MANAG CARE, V19, pE30; Luk JKH, 2013, HONG KONG MED J, V19, P518, DOI 10.12809/hkmj133951; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Luyten J, 2016, HEALTH AFFAIR, V35, P212, DOI 10.1377/hlthaff.2015.1088; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mahamat A, 2013, HUM VACC IMMUNOTHER, V9, P128, DOI 10.4161/hv.22550; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; Mankinen PT, 2015, VALUE HEALTH, V18, pA579, DOI 10.1016/j.jval.2015.09.1932; Manzur A, 2011, J AM GERIATR SOC, V59, P1711, DOI 10.1111/j.1532-5415.2011.03541.x; Marbaix S, 2015, VALUE HEALTH, V18, pA584, DOI 10.1016/j.jval.2015.09.1959; Martikainen JA, 2012, VALUE HEALTH, V15, pA388, DOI 10.1016/j.jval.2012.08.1089; Martikainen JA, 2014, J EVAL CLIN PRACT, V20, P333, DOI 10.1111/jep.12131; Maruyama T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1004; Menendez R, 2013, VALUE HEALTH, V16, pA353, DOI 10.1016/j.jval.2013.08.182; Menzies RI, 2014, MED J AUSTRALIA, V200, P112, DOI 10.5694/mja12.11759; Merck, PNEUMOVAX 23 PAT PRO; Michaelidis CI, 2013, J GEN INTERN MED, V28, pS55; Michaelidis CI, 2013, VALUE HEALTH, V16, P311, DOI 10.1016/j.jval.2012.11.009; Ministry of Health of Saudi Arabia, HLTH REQ TRAV SAUD A; Minkler M, 1999, AM J PUBLIC HEALTH, V89, P1384, DOI 10.2105/AJPH.89.9.1384; Mirelman AJ, 2014, B WORLD HEALTH ORGAN, V92, P454, DOI 10.2471/BLT.13.132597; Moberley S, 2010, VACCINE, V28, P2296, DOI 10.1016/j.vaccine.2009.12.066; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; MOLINA JEO, 2013, VALUE HEALTH, V16, pA90; Montserrat-Capdevila J, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0387-6; Nagel J, 2015, SCAND J RHEUMATOL, V44, P271, DOI 10.3109/03009742.2014.984754; Nagel J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0636-z; Nunez SM, 2012, VALUE HEALTH, V15, pA242, DOI 10.1016/j.jval.2012.03.1304; O'Brien M, 2010, INT J INFECT DIS, V14, pE449, DOI 10.1016/j.ijid.2010.02.617; Ochoa-Gondar O, 2014, CLIN INFECT DIS, V58, P909, DOI 10.1093/cid/ciu002; Okapuu JM, 2014, CAN J INFECT DIS MED, V25, P147, DOI 10.1155/2014/510373; Oliveira AKB, 2011, J CLIN IMMUNOL, V31, pS65; Ordonez JE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-172; Molina JEO, 2013, VALUE HEALTH, V16, pA90; Ozawa S, 2016, HEALTH AFFAIR, V35, P199, DOI 10.1377/hlthaff.2015.1086; Porchia BR, 2017, EXPERT REV VACCINES, V16, P93, DOI 10.1080/14760584.2017.1242419; Pradas R, 2011, VALUE HEALTH, V14, pA286, DOI 10.1016/j.jval.2011.08.298; Pradas R, 2011, VALUE HEALTH, V14, pA269, DOI 10.1016/j.jval.2011.08.208; Pradas R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-175; Gonzalez-Moro JMR, 2016, CLIN DRUG INVEST, V36, P41, DOI 10.1007/s40261-015-0345-z; Rosales Statkus ME, 2012, CLIN MICROBIOL INFEC, V18, P149; Rozenbaum MH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6879; Rozenbaum MH, 2010, CLIN THER, V32, P1517, DOI 10.1016/j.clinthera.2010.06.016; Rozenbaum MH, 2010, VALUE HEALTH, V13, pA378; Rudnick W, 2013, VACCINE, V31, P5863, DOI 10.1016/j.vaccine.2013.09.049; Sangil A, 2015, J INFECTION, V71, P422, DOI 10.1016/j.jinf.2015.07.004; Schwartz JL, 2016, HEALTH AFFAIR, V35, P208, DOI 10.1377/hlthaff.2015.1438; Shigayeva A, 2016, CLIN INFECT DIS, V62, P139, DOI 10.1093/cid/civ803; Shiri T, 2017, LANCET GLOB HEALTH, V5, pE51, DOI 10.1016/S2214-109X(16)30306-0; Siemieniuk RA, 2011, CANADIAN J INFECT DI, V22, p20B; Siemieniuk RAC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-314; Slotved HC, 2016, VACCINE, V34, P769, DOI 10.1016/j.vaccine.2015.12.056; Smith KJ, 2012, J GEN INTERN MED, V27, pS150; Smith KJ, 2013, VACCINE, V31, P3950, DOI 10.1016/j.vaccine.2013.06.037; Smith KJ, 2013, AM J PREV MED, V44, P373, DOI 10.1016/j.amepre.2012.11.035; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Smith KJ, 2010, VACCINE, V28, P7620, DOI 10.1016/j.vaccine.2010.09.053; Smith KJ, 2010, AM J MANAG CARE, V16, P200; Soneji S, 2011, PUBLIC HEALTH REP, V126, P259, DOI 10.1177/003335491112600217; Sotiropoulos A, 2015, DIABETES, V64, pA441; Steens A, 2015, EPIDEMICS-NETH, V11, P24, DOI 10.1016/j.epidem.2015.01.001; Stoecker C, 2016, J GEN INTERN MED, V31, P901, DOI 10.1007/s11606-016-3651-0; Timmis JK, 2017, VACCINE, V35, pA57, DOI 10.1016/j.vaccine.2016.11.034; Neto JT, 2011, HUM VACCINES, V7, P1037, DOI 10.4161/hv.7.10.15987; Tsai YH, 2015, VACCINE, V33, P2897, DOI 10.1016/j.vaccine.2015.04.068; Tseng HF, 2010, JAMA-J AM MED ASSOC, V303, P1699, DOI 10.1001/jama.2010.529; United Nations Department of Economic and Social Affairs Population Division, 2015, ESAPWP241 UN, DOI DOI 10.1017/CBO9781107415324.004; van der Putten IM, 2015, BMC PUBLIC HEALTH, V15, P1; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; van Werkhoven CH, 2015, CLIN INFECT DIS, V61, P1835, DOI 10.1093/cid/civ686; Varona JL, 2015, VALUE HEALTH, V18, pA580, DOI 10.1016/j.jval.2015.09.1934; Viasus D, 2011, NEPHROL DIAL TRANSPL, V26, P2899, DOI 10.1093/ndt/gfq798; Vila-Corcoles A, 2012, HUM VACC IMMUNOTHER, V8, P639, DOI [10.4161/hv.18548, 10.4161/hv.19466]; Vila-Corcoles A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-222; Vila-Corcoles A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-73; VISCUSI WK, 1993, J ECON LIT, V31, P1912; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wen YW, 2014, VALUE HEALTH, V17, pA271, DOI 10.1016/j.jval.2014.03.1577; Weycker D, 2012, VACCINE, V30, P5437, DOI 10.1016/j.vaccine.2012.05.076; Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI 10.1016/j.jclinepi.2015.06.005; WHO, INFL SEAS FACT SHEET; Wiemken TL, 2014, VACCINE, V32, P2198, DOI 10.1016/j.vaccine.2014.02.048; Williams E, 2015, J INVEST MED, V63, P438; Williams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1; World Health Organisation, PNEUM DIS; World Health Organization, NUMB DEATHS DUE HIV; World Health Organization, 2012, REP IMM VACC REL IMP; World Health Organization, NUMB MAL DEATHS; Wright L. B., 2013, Trials in Vaccinology, V2, P45, DOI 10.1016/j.trivac.2013.09.004; Wu DBC, 2012, VALUE HEALTH, V15, pA602, DOI 10.1016/j.jval.2012.08.003; Wu WC, 2014, AM HEART J, V168, P713, DOI 10.1016/j.ahj.2014.06.024; Yang HK, 2015, VALUE HEALTH, V18, pA871, DOI 10.1016/j.jval.2015.09.015; Yang HK, 2013, VALUE HEALTH, V16, pA714, DOI 10.1016/j.jval.2013.08.2203; Yang HK, 2013, VALUE HEALTH, V16, pA93, DOI 10.1016/j.jval.2013.03.435; Yilmaz D, 2013, AM J RESP CRIT CARE, V187, pA2182; Zanotti G, 2012, CANADIAN J INFECT DI, V23, p40B; Zigmond J, 2013, VALUE HEALTH, V16, pA73, DOI 10.1016/j.jval.2013.03.331	209	32	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186903	10.1371/journal.pone.0186903	http://dx.doi.org/10.1371/journal.pone.0186903			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088258	Green Submitted, gold, Green Published			2022-12-27	WOS:000414088900031
J	Law, S; Panwar, P; Li, J; Aguda, AH; Jamroz, A; Guido, RVC; Bromme, D				Law, Simon; Panwar, Preety; Li, Jody; Aguda, Adeleke H.; Jamroz, Andrew; Guido, Rafael V. C.; Bromme, Dieter			A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K	PLOS ONE			English	Article							CYSTEINE PROTEASES; MOLECULAR DOCKING; SCORING FUNCTIONS; DRUG DESIGN; PROTEIN; OSTEOPOROSIS; DEGRADATION; OSTEOCLASTS; EXPRESSION; DISCOVERY	Cathepsin K (CatK) is a cysteine protease that plays an important role in mammalian intra and extracellular protein turnover and is known for its unique and potent collagenase activity. Through studies on the mechanism of its collagenase activity, selective ectosteric sites were identified that are remote from the active site. Inhibitors targeting these ectosteric sites are collagenase selective and do not interfere with other proteolytic activities of the enzyme. Potential ectosteric inhibitors were identified using a computational approach to screen the druggable subset of and the entire 281,987 compounds comprising Chemical Repository library of the National Cancer Institute-Developmental Therapeutics Program (NCI-DTP). Compounds were scored based on their affinity for the ectosteric site. Here we compared the scores of three individual molecular docking methods with that of a composite score of all three methods together. The composite docking method was up to five-fold more effective at identifying potent collagenase inhibitors (IC50 < 20 mu M) than the individual methods. Of 160 top compounds tested in enzymatic assays, 28 compounds revealed blocking of the collagenase activity of CatK at 100 mu M. Two compounds exhibited IC50 values below 5 mu M corresponding to a molar protease: inhibitor concentration of < 1:12. Both compounds were subsequently tested in osteoclast bone resorption assays where the most potent inhibitor, 10-[2-[bis(2-hydroxyethyl) amino] ethyl]-7,8-diethylbenzo[g] pteridine-2,4-dione, (NSC-374902), displayed an inhibition of bone resorption with an IC50-value of approximately 300 nM and no cell toxicity effects.	[Law, Simon; Aguda, Adeleke H.; Bromme, Dieter] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Law, Simon; Panwar, Preety; Li, Jody; Jamroz, Andrew; Bromme, Dieter] Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada; [Panwar, Preety; Li, Jody; Jamroz, Andrew; Bromme, Dieter] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC, Canada; [Guido, Rafael V. C.] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Inovacao Biodiversidade & Farmacos, Sao Carlos, SP, Brazil	University of British Columbia; University of British Columbia; University of British Columbia; Universidade de Sao Paulo	Bromme, D (corresponding author), Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC, Canada.; Bromme, D (corresponding author), Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada.; Bromme, D (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC, Canada.	dbromme@dentistry.ubc.ca	Guido, Rafael Victorio Carvalho/A-7450-2009	Guido, Rafael Victorio Carvalho/0000-0002-7187-0818; Jamroz, Andrew/0000-0002-6199-1667; Aguda, Adeleke/0000-0001-5187-3264	Canadian Institutes of Health Research [MOP-89974, MOP-125866]; Natural Sciences & Engineering Research Council of Canada [RGPIN-326803-13]; Canada Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences & Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	The present work was supported by the Canadian Institutes of Health Research [grant numbers MOP-89974, MOP-125866] (CIHR: http://www.cihr-irsc.gc.ca/e/193.html), the Natural Sciences & Engineering Research Council of Canada [grant number RGPIN-326803-13] (NSERC: http://www.nserc-crsng.gc.ca/index_eng.asp), and a Canada Research Chair award (to D.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda AH, 2014, P NATL ACAD SCI USA, V111, P17474, DOI 10.1073/pnas.1414126111; Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; [Anonymous], 2004, NCI YEAST ANT DRUG S; Bromme D, 2016, EXPERT OPIN DRUG DIS, V11, P457, DOI 10.1517/17460441.2016.1160884; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Bromme D, 2002, CURR PHARM DESIGN, V8, P1639, DOI 10.2174/1381612023394179; Bromme D, 2009, EXPERT OPIN INV DRUG, V18, P585, DOI [10.1517/13543780902832661 , 10.1517/13543780902832661]; Carta G, 2007, J CHEM INF MODEL, V47, P1564, DOI 10.1021/ci600471m; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Drake MT, 2017, ENDOCR REV, V38, P325, DOI 10.1210/er.2015-1114; Du X, 2013, J BIOL CHEM, V288, P34871, DOI 10.1074/jbc.M113.510008; Dunstan MS, 2011, J MED CHEM, V54, P6597, DOI 10.1021/jm200416e; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Grinter SZ, 2014, MOLECULES, V19, P10150, DOI 10.3390/molecules190710150; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Houston DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121424; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mullard A, 2016, NAT REV DRUG DISCOV, V15, P669, DOI 10.1038/nrd.2016.207; Ntie-Kang F, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-353; PAN YP, 2002, ABSTR PAP AM CHEM 1, V224, P29531; Panwar P, 2017, MATRIX BIOL; Panwar P, 2017, J BONE MINER RES; Panwar P, 2016, BRIT J PHARMACOL, V173, P396, DOI 10.1111/bph.13383; Rastelli G, 2002, BIOORGAN MED CHEM, V10, P1437, DOI 10.1016/S0968-0896(01)00410-2; Runger TM, 2012, J AM ACAD DERMATOL, V66, pE89, DOI 10.1016/j.jaad.2010.11.033; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma V, 2015, BIOCHEM J, V465, P163, DOI 10.1042/BJ20140809; Soe K, 2010, J BONE MINER RES, V25, P2184, DOI 10.1002/jbmr.113; Spitzer R, 2012, J COMPUT AID MOL DES, V26, P687, DOI 10.1007/s10822-011-9533-y; Sullivan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147230; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Valasani KR, 2014, J CHEM INF MODEL, V54, P902, DOI 10.1021/ci5000196; Yamashita DS, 2000, CURR PHARM DESIGN, V6, P1, DOI 10.2174/1381612003401569; Yamashita DS, 1997, J AM CHEM SOC, V119, P11351, DOI 10.1021/ja972204u; Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200	46	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186869	10.1371/journal.pone.0186869	http://dx.doi.org/10.1371/journal.pone.0186869			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088253	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900027
J	Shannon, R; Donovan-Hall, M; Bruton, A				Shannon, Robert; Donovan-Hall, Maggie; Bruton, Anne			Motivational interviewing in respiratory therapy: What do clinicians need to make it part of routine care? A qualitative study	PLOS ONE			English	Article							ACTIVITY COUNSELING PROGRAM; PHYSICAL-ACTIVITY; COPD; METAANALYSIS; REHABILITATION; SKILLS	Motivational interviewing (MI) is a method for building motivation for behaviour change that has potential for use in respiratory contexts. There is a paucity of published research exploring the feasibility of this intervention from the clinicians' perspective. This study aimed to explore respiratory clinicians' views of MI: Is it perceived as useful? Could it be integrated into practice? What training would be required to make it part of routine care? Nine respiratory clinicians attended a one-day MI workshop and a semi-structured face-to-face interview two weeks later. All interviews were audio-recorded, transcribed verbatim and analysed with thematic analysis. Four main themes are presented-1) MI's suitability for use in respiratory contexts: participants saw potential in using MI to motivate their patients to engage with prescribed respiratory interventions, such as increased physical activity. Those who experimented with new skills post-workshop were encouraged by patient responsiveness and outcomes. 2) MI's relationship with routine clinical practice: some believed they already used elements of MI, but most participants felt MI was fundamentally 'different' to their normal style of working. 3) Implementation issues: additional time would need to be made available to enable an appropriate depth of conversation. 4) Training issues: Participants sensed the complexity of MI could make it difficult to learn and that it would take them time to become competent. On-going supervision was perceived as necessary. One key challenge identified was how to suppress behaviours that are antithetical to MI. These findings lend support to the feasibility of using MI in respiratory contexts such as pulmonary rehabilitation programmes, but highlight implementation and training issues that would need to be overcome. The insights have informed the development of another study, testing the effect of a tailored training package on MI skill, specifically for respiratory clinicians delivering pulmonary rehabilitation programmes.	[Shannon, Robert; Donovan-Hall, Maggie; Bruton, Anne] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Bruton, Anne] Southampton NIHR Biomed Res Ctr, Southampton, Hants, England; [Bruton, Anne] Wessex NIHR CLAHRC, Southampton, Hants, England	University of Southampton	Shannon, R (corresponding author), Univ Southampton, Fac Hlth Sci, Southampton, Hants, England.	R.J.Shannon@soton.ac.uk	Shannon, Rob/GXM-5384-2022	Bruton, Anne/0000-0002-4550-2536; Donovan-Hall, Margaret/0000-0003-3398-845X	Wessex Medical Research [Hope J08]; National Institute for Health Research [SRF-2012-05-120] Funding Source: researchfish	Wessex Medical Research; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Wessex Medical Research (grant number Hope J08) awarded to RS.	Altenburg WA, 2015, RESP MED, V109, P112, DOI 10.1016/j.rmed.2014.10.020; Baer JS, 2004, DRUG ALCOHOL DEPEN, V73, P99, DOI 10.1016/j.drugalcdep.2003.10.001; Bennett-Levy J, 2006, BEHAV COGN PSYCHOTH, V34, P57, DOI 10.1017/S1352465805002420; Benzo R, 2016, AM J RESP CRIT CARE; Benzo R, 2013, J CARDIOPULM REHABIL, V33, P113, DOI 10.1097/HCR.0b013e318284ec67; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Carpenter KM, 2012, J CONSULT CLIN PSYCH, V80, P560, DOI 10.1037/a0028362; Cavalheri V, 2016, RESPIROLOGY, V21, P419, DOI 10.1111/resp.12680; Celli BR, 2015, EUR RESPIR J, V45, P879, DOI 10.1183/09031936.00009015; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; de Blok BMJ, 2006, PATIENT EDUC COUNS, V61, P48, DOI 10.1016/j.pec.2005.02.005; de Roten Y, 2013, J SUBST ABUSE TREAT, V45, P155, DOI 10.1016/j.jsat.2013.02.006; Fischer MJ, 2009, RESP MED, V103, P1564, DOI 10.1016/j.rmed.2008.11.020; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; Holland AE, 2017, THORAX, V72, P57, DOI 10.1136/thoraxjnl-2016-208514; Hospes G, 2009, PATIENT EDUC COUNS, V75, P274, DOI 10.1016/j.pec.2008.10.005; Howitt D, 2016, INTRO QUALITATIVE RE, V3rd; Jones AW, 2017, ERJ OPEN RES, V3; Kruis AL, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5392; Lundahl B, 2013, PATIENT EDUC COUNS, V93, P157, DOI 10.1016/j.pec.2013.07.012; Lundahl BW, 2010, RES SOCIAL WORK PRAC, V20, P137, DOI 10.1177/1049731509347850; Miller W.R., 2013, MOTIVATIONAL INTERVI, V3rd; Miller WR, 2014, CONTEMP CLIN TRIALS, V37, P234, DOI 10.1016/j.cct.2014.01.005; Miller WR, 2009, BEHAV COGN PSYCHOTH, V37, P129, DOI 10.1017/S1352465809005128; Mitchell KE, 2014, EUR RESPIR J, V44, P1538, DOI 10.1183/09031936.00047814; O'Halloran PD, 2014, CLIN REHABIL, V28, P1159, DOI 10.1177/0269215514536210; Panagioti M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-356; Randall CL, 2017, COGN BEHAV PRACT, V24, P296, DOI 10.1016/j.cbpra.2016.05.003; Resnicow K, 2002, HEALTH PSYCHOL, V21, P444, DOI 10.1037//0278-6133.21.5.444; Richards DA., 2015, COMPLEX INTERVENTION, V1, DOI [10.4324/9780203794982, DOI 10.4324/9780203794982]; Rollnick S, 2005, BMJ-BRIT MED J, V331, P961, DOI 10.1136/bmj.331.7522.961; Saunders TJ, 2015, COPD, V12, P539, DOI 10.3109/15412555.2014.995286; Schwalbe CS, 2014, ADDICTION, V109, P1287, DOI 10.1111/add.12558; Steiner M., 2016, PULMONARY REHABILITA; VanBuskirk KA, 2014, J BEHAV MED, V37, P768, DOI 10.1007/s10865-013-9527-4; Yardley L., 2015, QUALITATIVE PSYCHOL, V2nd ed., P257	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187335	10.1371/journal.pone.0187335	http://dx.doi.org/10.1371/journal.pone.0187335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088308	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000414088900067
J	Stack, RJ; Southworth, S; Fisher, BA; Barone, F; Buckley, CD; Rauz, S; Bowman, SJ				Stack, Rebecca J.; Southworth, Sue; Fisher, Benjamin A.; Barone, Francesca; Buckley, Christopher D.; Rauz, Saaeha; Bowman, Simon J.			A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjogren's Syndrome	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; DEPRESSION; SLEEP; ASSOCIATIONS; MANAGEMENT; KNOWLEDGE; ESSPRI; WOMEN	Introduction Primary Sjogren's Syndrome (pSS) affects exocrine glands such as those producing the tear film, leading to dry and painful eyes, but is also associated with fatigue. The experience of fatigue in pSS, and its relationship with sicca symptoms, is poorly understood. Methods Twenty people diagnosed with pSS were recruited to participate in a semi-structured qualitative interview about their symptoms experience. Interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis. Results People with pSS described physical tiredness, mental fatigue and ocular fatigue. Mental fatigue was characterised by difficulties in attention, particularly, the ability to follow conversations and short-term memory problems. Participants linked their experience of fatigue to feeling of depression, frustration, irritation and anxiety, and therefore, fatigue was suggested to have had a large impact on their psychological well-being. People with pSS also described a range of ocular symptoms including pain, dryness, and itching, which were compounded by fatigue. For some, eye fatigue was pervasive, and daily activities involving the eyes such as reading, using the computer and driving were impaired. In some cases, the level of ocular discomfort was so severe it prevented sleep, which in turn impacted on general fatigue levels. Conclusions People with pSS experience fatigue in a range of ways; physical, mental and ocular fatigue were described. Fatigue was suggested to exacerbate other ocular symptoms, posed serious physical limitations and caused psychological distress. Further research into the nature of fatigue and ocular symptoms in pSS is required.	[Stack, Rebecca J.; Southworth, Sue; Fisher, Benjamin A.; Barone, Francesca; Buckley, Christopher D.; Rauz, Saaeha; Bowman, Simon J.] Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England; [Southworth, Sue; Rauz, Saaeha] Birmingham & Midland Eye Ctr, Acad Unit Ophthalmol, Birmingham, W Midlands, England; [Bowman, Simon J.] Univ Hosp Birmingham NHS Fdn Trust, Dept Rheumatol, Birmingham, W Midlands, England; [Stack, Rebecca J.] Nottingham Trent Univ, Div Psychol, Nottingham, England	University of Birmingham; University of Birmingham; Nottingham Trent University	Stack, RJ (corresponding author), Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England.; Stack, RJ (corresponding author), Nottingham Trent Univ, Div Psychol, Nottingham, England.	rebecca.stack@ntu.ac.uk	Stack, Rebecca J/Y-5034-2018; Rauz, Saaeha/ABF-2202-2021; Buckley, Christopher/AAN-6378-2021	Stack, Rebecca J/0000-0002-0516-0228; Buckley, Christopher/0000-0001-6924-6402; Rauz, Saaeha/0000-0003-4627-3496	Queen Elizabeth Hospitals Birmingham Charitable Trust; National Institute for Health Research (NIHR)/Wellcome Trust Birmingham Clinical Research Facility; MRC [MR/M009157/1] Funding Source: UKRI; Medical Research Council [MR/M009157/1] Funding Source: researchfish; Versus Arthritis [21236] Funding Source: researchfish	Queen Elizabeth Hospitals Birmingham Charitable Trust; National Institute for Health Research (NIHR)/Wellcome Trust Birmingham Clinical Research Facility; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This research was supported with funding from the Queen Elizabeth Hospitals Birmingham Charitable Trust (http://www.uhb.nhs.uk/charity.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r OASIS recruitment is supported by the National Institute for Health Research (NIHR)/Wellcome Trust Birmingham Clinical Research Facility. The views expressed are those of the authors(s) and not necessarily those of the NHS, the NIHR or the Department of Health."	Barendregt PJ, 1998, ANN RHEUM DIS, V57, P291, DOI 10.1136/ard.57.5.291; Bjerrum KB, 2000, ACTA OPHTHALMOL SCAN, V78, P1; Goodchild CE, 2010, MUSCULOSKELET CARE, V8, P107, DOI 10.1002/msc.174; Goodchild CE, 2008, MUSCULOSKELET CARE, V6, P31, DOI 10.1002/msc.124; Guest G., 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Irwin MR, 2012, SLEEP, V35, P537, DOI 10.5665/sleep.1742; Karaiskos D, 2010, RHEUMATOLOGY, V49, P1762, DOI 10.1093/rheumatology/keq158; Lee E, 2013, SLEEP, V36, P1685, DOI 10.5665/sleep.3128; Lwin CTT, 2003, SCAND J RHEUMATOL, V32, P33, DOI 10.1080/03009740310000373; Mengshoel AM, 2014, ARTHRIT CARE RES, V66, P1227, DOI 10.1002/acr.22263; Ng WF, 2010, RHEUMATOLOGY, V49, P844, DOI 10.1093/rheumatology/keq009; Repping-Wuts H, 2008, CLIN RHEUMATOL, V27, P1549, DOI 10.1007/s10067-008-0967-0; Repping-Wuts H, 2009, J ADV NURS, V65, P901, DOI 10.1111/j.1365-2648.2008.04904.x; Segal B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-46; Segal B, 2008, ARTHRIT RHEUM-ARTHR, V59, P1780, DOI 10.1002/art.24311; Seror R, 2016, ANN RHEUM DIS, V75, P382, DOI 10.1136/annrheumdis-2014-206008; Seror R, 2015, ANN RHEUM DIS, V74, P859, DOI 10.1136/annrheumdis-2013-204615; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Sorensen I M, 2000, Tidsskr Nor Laegeforen, V120, P794; Stevenson H A, 2004, Gerodontology, V21, P141, DOI 10.1111/j.1741-2358.2004.00027.x; Valtysdottir ST, 2000, J RHEUMATOL, V27, P165; van Leeuwen N, 2015, RHEUMATOLOGY, V54, P776, DOI 10.1093/rheumatology/keu387; Wouters EJM, 2012, ANN RHEUM DIS, V71, P668, DOI 10.1136/ard.2011.154245	24	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187272	10.1371/journal.pone.0187272	http://dx.doi.org/10.1371/journal.pone.0187272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088284	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000414088900057
J	Li, YC; Yang, J; Shi, HW; Li, YJ				Li, Yancang; Yang, Jing; Shi, Huawang; Li, Yijie			Assessment of sustainable urban transport development based on entropy and unascertained measure	PLOS ONE			English	Article							NOISE-POLLUTION; EUROPE	To find a more effective method for the assessment of sustainable urban transport development, the comprehensive assessment model of sustainable urban transport development was established based on the unascertained measure. On the basis of considering the factors influencing urban transport development, the comprehensive assessment indexes were selected, including urban economical development, transport demand, environment quality and energy consumption, and the assessment system of sustainable urban transport development was proposed. In view of different influencing factors of urban transport development, the index weight was calculated through the entropy weight coefficient method. Qualitative and quantitative analyses were conducted according to the actual condition. Then, the grade was obtained by using the credible degree recognition criterion from which the urban transport development level can be determined. Finally, a comprehensive assessment method for urban transport development was introduced. The application practice showed that the method can be used reasonably and effectively for the comprehensive assessment of urban transport development.	[Li, Yancang; Yang, Jing; Shi, Huawang; Li, Yijie] Hebei Univ Engn, Coll Civil Engn, Handan, Peoples R China	Hebei University of Engineering	Shi, HW (corresponding author), Hebei Univ Engn, Coll Civil Engn, Handan, Peoples R China.	stone21st@163.com		Shi, Huawang/0000-0003-2803-247X	Natural Science Foundation of Hebei Province, China [E2012402030]; Program of Selection and Cultivating of Disciplinary Talents of Colleges and Universities in Hebei Province [BR2-206]	Natural Science Foundation of Hebei Province, China(Natural Science Foundation of Hebei Province); Program of Selection and Cultivating of Disciplinary Talents of Colleges and Universities in Hebei Province	The work was supported by the Natural Science Foundation of Hebei Province, China (NO. E2012402030 to YL) and the Program of Selection and Cultivating of Disciplinary Talents of Colleges and Universities in Hebei Province (BR2-206 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowicz R, 2006, ENVIRON MODELL SOFTW, V21, P454, DOI 10.1016/j.envsoft.2004.06.013; Camargo Perez J, 2015, ANN OPER RES, V226, P69, DOI DOI 10.1007/s10479-014-1681-8; Chen TY, 2010, INFORM SCIENCES, V180, P4207, DOI 10.1016/j.ins.2010.07.009; Chen Zu-yun, 2007, MINING SAFETY ENV PR, V34, P75; Eissel D, 2014, AI SOC, V29, P387, DOI 10.1007/s00146-013-0461-3; Jamrah A, 2006, ENVIRON MONIT ASSESS, V120, P499, DOI 10.1007/s10661-005-9077-5; Johansson C, 2009, ATMOS ENVIRON, V43, P4681, DOI 10.1016/j.atmosenv.2008.10.024; Kruger NA, 2012, TRANSPORT RES A-POL, V46, P1741, DOI 10.1016/j.tra.2012.07.002; Liman T., 2003, SUSTAINABLE TRANSPOR; May A, 2017, EUR TRANSP RES REV, V9, DOI 10.1007/s12544-017-0224-1; May T, 2003, DEV SUSTAINABLE URBA; Ministry of Transport of the People's Republic of China, 2012, EV IND SYST CIT ROAD; Naphade M, 2011, COMPUTER, V44, P32, DOI 10.1109/MC.2011.187; Park S, 2016, KSCE J CIV ENG, V20, P1053, DOI 10.1007/s12205-016-1682-z; Qiu D, 2005, CENTRAL S HIGHWAY EN, V30, P171; Shi HW, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3230-1; Thinh N.X., 2002, ENVIRON IMPACT ASSES, V22, P475, DOI [10.1016/S0195-9255(02)00023-9, DOI 10.1016/S0195-9255(02)00023-9]; Trigaux D, 2017, INT J LIFE CYCLE ASS, V22, P938, DOI 10.1007/s11367-016-1190-x; Vardoulakis S, 2002, ATMOS ENVIRON, V36, P1025, DOI 10.1016/S1352-2310(01)00288-6; Wang T, 2009, ATMOS ENVIRON, V43, P5682, DOI 10.1016/j.atmosenv.2009.07.034; Wu J, 2011, EXPERT SYST APPL, V38, P5162, DOI 10.1016/j.eswa.2010.10.046; Xu XD, 2016, KSCE J CIV ENG, V20, P1084, DOI 10.1007/s12205-016-1729-1; Yanyan W., 2012, J TRANSPORT SCI ENG, V28, P82; Zannin PHT, 2002, APPL ACOUST, V63, P351, DOI 10.1016/S0003-682X(01)00052-4; Zito P., 2011, EUR TRANSP RES REV, V3, P179, DOI DOI 10.1007/S12544-011-0059-0	25	13	13	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186893	10.1371/journal.pone.0186893	http://dx.doi.org/10.1371/journal.pone.0186893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084281	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200017
J	Alvarenga, JM; Vieira, CR; Godinho, LB; Campelo, PH; Pitts, JP; Colli, GR				Alvarenga, Julio Miguel; Vieira, Cecilia Rodrigues; Godinho, Leandro Braga; Campelo, Pedro Henrique; Pitts, James Purser; Colli, Guarino Rinaldi			Spatial-temporal dynamics of neotropical velvet ant (Hymenoptera: Mutillidae) communities along a forest-savanna gradient	PLOS ONE			English	Article							BETA-DIVERSITY; WASPS HYMENOPTERA; NATIONAL-PARK; MATO-GROSSO; HISTORICAL BIOGEOGRAPHY; HABITAT HETEROGENEITY; SPECIES-DIVERSITY; BRAZILIAN CERRADO; BEES HYMENOPTERA; WOODY VEGETATION	Understanding how and why biological communities are organized over space and time is a major challenge and can aid biodiversity conservation in times of global changes. Herein, spatial-temporal variation in the structure of velvet ant communities was examined along a forest-savanna gradient in the Brazilian Cerrado to assess the roles of environmental filters and interspecific interactions upon community assembly. Velvet ants were sampled using 25 arrays of Y-shaped pitfall traps with drift fences for one year along an environmental gradient from cerrado sensu stricto (open canopy, warmer, drier) to cerradao (closed canopy, cooler, moister). Dataloggers installed on each trap recorded microclimate parameters throughout the study period. The effects of spatial distances, microclimate parameters and shared ancestry on species abundances and turnover were assessed with canonical correspondence analysis, generalized dissimilarity modelling and variance components analysis. Velvet ant diversity and abundance were higher in the cerrado sensu stricto and early in the wet season. There was pronounced compositional turnover along the environmental gradient, and temporal variation in richness and abundance was stronger than spatial variation. The dry season blooming of woody plant species fosters host abundance and, subsequently, velvet ant captures. Species were taxonomically clustered along the gradient with Sphaeropthalmina (especially Traumatomutilla spp.) and Pseudomethocina more associated, respectively, with cerrado sensu stricto and cerradao. This suggests a predominant role of environmental filters on community assemble, with physiological tolerances and host preferences being shared among members of the same lineages. Induced environmental changes in Cerrado can impact communities of wasps and their hosts with unpredictable consequences upon ecosystem functioning and services.	[Alvarenga, Julio Miguel; Godinho, Leandro Braga] Univ Estado Mato Grosso, Programa Posgrad Ecol & Conservacao, Dept Biol, Nova Xavantina, Mato Grosso, Brazil; [Vieira, Cecilia Rodrigues; Pitts, James Purser] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Campelo, Pedro Henrique] Univ Fed Tocantins, Programa Posgrad Biodiversidade Ecol & Conservaca, Porto Nacl, Tocantins, Brazil; [Colli, Guarino Rinaldi] Univ Brasilia, Dept Zool, Brasilia, DF, Brazil	Universidade do Estado de Mato Grosso; Utah System of Higher Education; Utah State University; Universidade Federal do Tocantins (UFT); Universidade de Brasilia	Vieira, CR (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	ceciliavieira@iclouci.com	Vieira, Cecília R/T-2677-2017; Campelo, Pedro Henrique/GPP-7234-2022; Vieira, Cecilia R/O-4454-2014; Colli, Guarino Rinaldi/A-5368-2008	Vieira, Cecília R/0000-0002-4273-3697; Vieira, Cecilia R/0000-0002-4273-3697; Colli, Guarino Rinaldi/0000-0002-2628-5652; Braga Godinho, Leandro/0000-0001-7653-5720; Alvarenga da Silva, Julio Miguel/0000-0003-2276-3810	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES [1221/13-2, 88881.068430-2014-01]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [457587/2012-1]; Fundacao de Apoio a Pesquisa do Distrito Federal - FAPDF [193.000.456/2011]; United States Agency for International Development, Partnerships for Enhanced Engagement in Research - PEER [PEER NAS/USAID PGA-2000005316]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Distrito Federal - FAPDF(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); United States Agency for International Development, Partnerships for Enhanced Engagement in Research - PEER(United States Agency for International Development (USAID))	This study was supported by the following agencies: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (http://www.capes.gov.br), Award Number: None; Recipient: Julio Miguel Alvarenga, MSc, Award Number: 1221/13-2; Recipient: Cecilia Rodrigues Vieira, MSc, Award Number: 88881.068430-2014-01; Recipient: Guarino Rinaldi Colli, PhD; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (http://www.cnpq.br), Award Number: 457587/2012-1; Recipient: Guarino Rinaldi Colli, PhD; Fundacao de Apoio a Pesquisa do Distrito Federal - FAPDF (http://www.fap.df.gov.br), Award Number: 193.000.456/2011; Recipient: Guarino Rinaldi Colli, PhD; United States Agency for International Development, Partnerships for Enhanced Engagement in Research - PEER (http://sites.nationalacademies.org/PGA/PEER/index.htm), Award Number: PEER NAS/USAID PGA-2000005316; Recipient: Guarino Rinaldi Colli, PhD. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JCS, 2008, GESTAO EDUCACAO AMBI, P23; Albrecht M, 2001, OECOLOGIA, V126, P134, DOI 10.1007/s004420000494; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], THESIS; Aranda R, 2016, ENVIRON ENTOMOL, V45, P1146, DOI 10.1093/ee/nvw098; Auko TH, 2013, BIOTA NEOTROP, V13, P292, DOI 10.1590/S1676-06032013000100028; Batalha MA, 2004, AUST J BOT, V52, P149, DOI 10.1071/BT03098; BELL G, 1989, AM NAT, V133, P553, DOI 10.1086/284935; Bino G, 2013, EVOL ECOL, V27, P1159, DOI 10.1007/s10682-013-9631-5; Bolker BM, 2008, ECOLOGICAL MODELS DA; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brannstrom C, 2008, LAND USE POLICY, V25, P579, DOI 10.1016/j.landusepol.2007.11.008; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brothers D. J., 1993, Hymenoptera of the world: an identification guide to families., P161; Brothers DJ, 2000, INSECT SOC, V47, P201, DOI 10.1007/PL00001704; Brothers DJ, 1999, ZOOL SCR, V28, P233, DOI 10.1046/j.1463-6409.1999.00003.x; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; BULHÃO CLARISSA F., 2002, Braz. J. Bot., V25, P361, DOI 10.1590/S0100-84042002000300012; Burbrink FT, 2015, ECOGRAPHY, V38, P1036, DOI 10.1111/ecog.01148; Buschini MLT, 2008, ACTA ZOOL-STOCKHOLM, V89, P351, DOI 10.1111/j.1463-6395.2008.00325.x; Cardillo M, 2016, GLOBAL ECOL BIOGEOGR, V25, P951, DOI 10.1111/geb.12455; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Crawley M. J., 2013, R BOOK; DEYRUP M, 1986, FLA ENTOMOL, V69, P327, DOI 10.2307/3494937; dos Santos EF, 2014, NEOTROP ENTOMOL, V43, P97, DOI 10.1007/s13744-013-0183-8; EITEN G., 1993, CERRADO CARACTERIZAC, P17; Ellis N, 2012, ECOLOGY, V93, P156, DOI 10.1890/11-0252.1; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fahr J, 2011, ECOGRAPHY, V34, P177, DOI 10.1111/j.1600-0587.2010.05510.x; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2309, DOI 10.1023/A:1021374009951; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Fitzpatrick MC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1201; Gao YL, 2017, ANNU REV ENTOMOL, V62, P165, DOI 10.1146/annurev-ento-031616-035425; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Guerin GR, 2013, ECOGRAPHY, V36, P1086, DOI 10.1111/j.1600-0587.2013.00215.x; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Harms TM, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1288; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HEINRICH B, 1984, J COMP PHYSIOL, V154, P175, DOI 10.1007/BF00684142; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Honaker J, 2011, J STAT SOFTW, V45, P1; Hortal J, 2015, ANNU REV ECOL EVOL S, V46, P523, DOI 10.1146/annurev-ecolsys-112414-054400; INMET, 2017, PAR DIAR EST MET NOV; Jepson W, 2010, ANN ASSOC AM GEOGR, V100, P87, DOI 10.1080/00045600903378960; Kovac H, 2009, J INSECT PHYSIOL, V55, P959, DOI 10.1016/j.jinsphys.2009.06.012; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Laporta GZ, 2014, BMC ECOL, V14, DOI 10.1186/s12898-014-0030-8; Lassau SA, 2005, AUSTRAL ECOL, V30, P179, DOI 10.1111/j.1442-9993.2005.01435.x; Lassau SA, 2007, AUSTRAL ECOL, V32, P656, DOI 10.1111/j.1442-9993.2007.01751.x; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; Leite GLD, 2006, FOREST ECOL MANAG, V236, P286, DOI 10.1016/j.foreco.2006.09.013; Lelej A.S., 2005, P1; Lelej Arkady S., 2008, Zootaxa, V1889, P1; Loader C., 2013, LOCFIT LOCAL REGRESS; Lortie CJ, 2007, J ECOL, V95, P468, DOI 10.1111/j.1365-2745.2007.01231.x; Loyola RD, 2006, NEOTROP ENTOMOL, V35, P41, DOI 10.1590/S1519-566X2006000100006; Luz DR, 2016, REV BRAS ENTOMOL, V60, P302, DOI 10.1016/j.rbe.2016.06.001; Manion G., 2016, GDM FUNCTIONS GEN DI; MANLEY DG, 1983, J GEORGIA ENTOMOL SO, V18, P235; Manley DG, 2007, ZOOTAXA, P1; Maracahipes L, 2011, BIOTA NEOTROP, V11, P133, DOI 10.1590/S1676-06032011000100013; Marimon B. S., 2002, Edinburgh Journal of Botany, V59, P303; Marimon Junior BH, 2005, ACTA BOT BRAS, V19, P913, DOI DOI 10.1590/S0102-33062005000400026; Marris E, 2005, NATURE, V437, P944, DOI 10.1038/437944a; Martin LM, 2015, ECOLOGY, V96, P1042, DOI 10.1890/14-0772.1; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Morato Elder F., 2008, Acta Amaz., V38, P789, DOI 10.1590/S0044-59672008000400025; Nenadic O, 2007, J STAT SOFTW, V20; Nimer E., 1989, CLIMATOLOGIA BRASIL, Vsecond; Nonveiller G., 1990, PARS 18 CATALOGUE MU; Oksanen J., 2019, R PACKAGE VERSION, DOI DOI 10.4135/9781412971874.N145; Oliveira PE, 2000, FLORA, V195, P311; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Parr CL, 2014, TRENDS ECOL EVOL, V29, P205, DOI 10.1016/j.tree.2014.02.004; Penone C, 2014, METHODS ECOL EVOL, V5, P961, DOI 10.1111/2041-210X.12232; da Silva NAP, 2011, REV BRAS ENTOMOL, V55, P79, DOI 10.1590/S0085-56262011000100013; Pilgrim EM, 2008, PAN-PAC ENTOMOL, V84, P57, DOI 10.3956/2007-13.1; Pilgrim EM, 2006, J KANSAS ENTOMOL SOC, V79, P222, DOI 10.2317/0511.09.1; Pinheiro F, 2002, AUSTRAL ECOL, V27, P132, DOI 10.1046/j.1442-9993.2002.01165.x; Polidori C, 2010, J ETHOL, V28, P353, DOI 10.1007/s10164-009-0196-2; Polidori C, 2009, ENTOMOL SCI, V12, P116, DOI 10.1111/j.1479-8298.2009.00311.x; Qian H, 2008, DIVERS DISTRIB, V14, P556, DOI 10.1111/j.1472-4642.2008.00466.x; Quinn G.P., 2002, EXPT DESIGN DATA ANA, DOI 10.1017/cbo9780511806384; Quintero D, 1996, SOUTHWEST ENTOMOL, V21, P205; R Development Core Team, 2009, R LANG ENV STAT COMP; RATTER JA, 1973, PHILOS T R SOC B, V266, P449, DOI DOI 10.1098/RSTB.1973.0053; Ribeiro JF, 2008, CERRADO ECOLOGIA FLO, P153, DOI DOI 10.1023/A:1015819219386; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Ricklefs RE, 2011, PHILOS T R SOC B, V366, P2438, DOI 10.1098/rstb.2011.0066; Rossetti MR, 2013, J INSECT CONSERV, V17, P1137, DOI 10.1007/s10841-013-9594-4; Rosauer DF, 2014, ECOGRAPHY, V37, P21, DOI 10.1111/j.1600-0587.2013.00466.x; Sanders NJ, 2007, J BIOGEOGR, V34, P1632, DOI 10.1111/j.1365-2699.2007.01714.x; Santos GMDM, 2007, NEOTROP ENTOMOL, V36, P180, DOI 10.1590/S1519-566X2007000200002; Schuetzenmeister A, 2016, VCA VARIANCE COMPONE; Silverio DV, 2010, BIOTA NEOTROP, V10, P205, DOI 10.1590/S1676-06032010000300024; SMITH RJ, 1994, AM J PHYS ANTHROPOL, V93, P95, DOI 10.1002/ajpa.1330930107; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Smith TB, 2001, TRENDS ECOL EVOL, V16, P431, DOI 10.1016/S0169-5347(01)02201-7; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; Souza AKP, 2005, REV BRAS ZOOL, V22, P320, DOI DOI 10.1590/S0101-81752005000200004; Stephens PR, 2009, MOL ECOL, V18, P4664, DOI 10.1111/j.1365-294X.2009.04378.x; Tabachnick B. G., 2007, USING MULTIVARIATE S, V5th; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; Vieira CR, 2017, ENVIRON ENTOMOL, V46, P353, DOI 10.1093/ee/nvx046; Vieira CR, 2015, J INSECT CONSERV, V19, P849, DOI 10.1007/s10841-015-9803-4; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; WHITTAKER RH, 1953, ECOL MONOGR, V23, P41, DOI 10.2307/1943519; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Wilson JS, 2012, J BIOGEOGR, V39, P336, DOI 10.1111/j.1365-2699.2011.02580.x; Wilson JS, 2010, WEST N AM NATURALIST, V70, P224, DOI 10.3398/064.070.0209; Zanette LRS, 2004, TROP ZOOL, V17, P145, DOI 10.1080/03946975.2004.10531204; Zhao ZH, 2015, BASIC APPL ECOL, V16, P510, DOI 10.1016/j.baae.2015.06.002	127	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187142	10.1371/journal.pone.0187142	http://dx.doi.org/10.1371/journal.pone.0187142			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077763	Green Submitted, gold, Green Published			2022-12-27	WOS:000413861200049
J	Dai, QL; Liu, DN; Cheng, HY; Li, HH; Yang, JZ				Dai, Qionglin; Liu, Danna; Cheng, Hongyan; Li, Haihong; Yang, Junzhong			Two-frequency chimera state in a ring of nonlocally coupled Brusselators	PLOS ONE			English	Article							OSCILLATORS; NETWORKS	Chimera states, which consist of coexisting domains of spatially coherent and incoherent dynamics, have been intensively investigated in the past decade. In this work, we report a special chimera state, 2-frequency chimera state, in one-dimensional ring of nonlocally coupled Brusselators. In a 2-frequency chimera state, there exist two types of coherent domains and oscillators in different types of coherent domains have different mean phase velocities. We present the stability diagram of 2-frequency chimera state and study the transition between the 2-frequency chimera state and an ordinary 2-cluster chimera state.	[Dai, Qionglin; Liu, Danna; Cheng, Hongyan; Li, Haihong; Yang, Junzhong] Beijing Univ Posts & Telecommun, Sch Sci, Beijing, Peoples R China	Beijing University of Posts & Telecommunications	Yang, JZ (corresponding author), Beijing Univ Posts & Telecommun, Sch Sci, Beijing, Peoples R China.	jzyang@bupt.edu.cn	yang, junzhong J/G-3046-2011; Dai, Qionglin/D-8742-2012	yang, junzhong J/0000-0002-9290-1927; Dai, Qionglin/0000-0001-6120-4689	National Natural Science Foundation of China [11575036, 11505016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grants Nos. 11575036 and 11505016), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.174102; Ghosh S, 2016, EPL-EUROPHYS LETT, V115, DOI 10.1209/0295-5075/115/60005; Glansdorf P, 1971, THERMODYNAMIC THEORY; Gu C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.134101; Hagerstrom AM, 2012, NAT PHYS, V8, P658, DOI [10.1038/nphys2372, 10.1038/NPHYS2372]; Hizanidis J, 2014, INT J BIFURCAT CHAOS, V24, DOI 10.1142/S0218127414500308; Kapitaniak T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06379; Kuramoto Y., 2002, Nonlinear Phenomena in Complex Systems, V5, P380; Laing CR, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066221; Larger L, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.054103; Maistrenko YL, 2014, INT J BIFURCAT CHAOS, V24, DOI 10.1142/S0218127414400148; Maksimenko VA, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052205; Martens EA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.044101; Martens EA, 2013, P NATL ACAD SCI USA, V110, P10563, DOI 10.1073/pnas.1302880110; Olmi S, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.030901; Omelchenko I, 2015, CHAOS, V25, DOI 10.1063/1.4927829; Omelchenko I, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.022917; Omelchenko I, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.224101; Omelchenko I, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.234102; Panaggio MJ, 2015, NONLINEARITY, V28, pR67, DOI 10.1088/0951-7715/28/3/R67; Sakaguchi H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031907; Schmidt L, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.034101; Schmidt L, 2014, CHAOS, V24, DOI 10.1063/1.4858996; Sethia GC, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.144101; Tinsley MR, 2012, NAT PHYS, V8, P662, DOI [10.1038/nphys2371, 10.1038/NPHYS2371]; Viktorov EA, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.224101; Wickramasinghe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080586; Zakharova A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.154101; Zhu Y, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/10009; Zhu Y, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022914	31	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187067	10.1371/journal.pone.0187067	http://dx.doi.org/10.1371/journal.pone.0187067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077732	gold, Green Submitted, Green Published			2022-12-27	WOS:000413861200041
J	De Jong, CN; Saes, L; Klerk, CPW; Van der Klift, M; Cornelissen, JJ; Broers, AEC				De Jong, Cornelis N.; Saes, Lotte; Klerk, Clara P. W.; Van der Klift, Marjolein; Cornelissen, Jan J.; Broers, Annoek E. C.			Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; ACUTE GVHD; MARROW-TRANSPLANTATION; THERAPY; ALPHA; BLOOD	Background Acute graft-versus-host disease (aGVHD) is an important complication of allogeneic stem cell transplantation (alloSCT). High dose glucocorticosteroids, are currently recommended as first-line treatment for grade II-IV aGVHD resulting in overall complete responses (CR) in 40%-50% of patients. No standard second-line regimen has been established. Different options have been reported, including anti-TNF alpha antibodies. Methods We retrospectively reviewed the outcome of 15 patients with steroid-refractory (SR) aGVHD treated with etanercept at our institution. Patients were transplanted for a hematological malignancy and received either a myeloablative or a non-myeloablative conditioning regimen. Prophylaxis of GVHD consisted of cyclosporin A and mycophenolic acid. Results Acute GVHD was diagnosed at a median of 61 days post-transplantation. All patients had grade III aGVHD of the gut. Second-line treatment with etanercept was started at a median of 13 days after initiation of first-line therapy. Overall response rate was 53%, with CR in 3 patients and PR in 5 patients. Median overall survival after initiation of treatment with etanercept was 66 days (range 5-267) for the entire group. Median overall survival was 99 days (range 47-267 days) for responders and 17 days (range 5-66 days) for non-responders (p<0.01). Nevertheless, all patients died. Causes of death were progressive GVHD in 7 patients (47%), infection in 6 patients (40%), cardiac death in 1 patient (6.7%) and relapse in 1 patient (6,7%). Conclusion Second-line treatment with etanercept does induce responses in SR-aGVHD of the gut but appears to be associated with poor long-term survival even in responding patients.	[De Jong, Cornelis N.; Saes, Lotte; Cornelissen, Jan J.; Broers, Annoek E. C.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Klerk, Clara P. W.] Onze Lieve Vrouw Hosp, Dept Hematol & Oncol, Amsterdam, Netherlands; [Van der Klift, Marjolein] Amphia Hosp, Dept Hematol, Breda, Netherlands	Erasmus University Rotterdam; Erasmus MC; Onze Lieve Vrouwe Gasthuis Hospital; Amphia Hospital	De Jong, CN (corresponding author), Erasmus MC, Dept Hematol, Rotterdam, Netherlands.	c.n.dejong@erasmusmc.nl		De Jong, Cornelis/0000-0003-2054-0752				Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Busca A, 2007, AM J HEMATOL, V82, P45, DOI 10.1002/ajh.20752; Deeg HJ, 2007, BLOOD, V109, P4119, DOI 10.1182/blood-2006-12-041889; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Girmenia C, 2014, BIOL BLOOD MARROW TR, V20, P872, DOI 10.1016/j.bbmt.2014.03.004; Jacobson CA, 2012, BIOL BLOOD MARROW TR, V18, P565, DOI 10.1016/j.bbmt.2011.08.018; Kennedy GA, 2006, BONE MARROW TRANSPL, V37, P1143, DOI 10.1038/sj.bmt.1705380; Korngold R, 2003, BIOL BLOOD MARROW TR, V9, P292, DOI 10.1016/S1083-8791(03)00087-9; Levine JE, 2008, BLOOD, V111, P2470, DOI 10.1182/blood-2007-09-112987; MacMillan ML, 2002, BIOL BLOOD MARROW TR, V8, P387, DOI 10.1053/bbmt.2002.v8.pm12171485; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; Murdaca G, 2015, EXPERT OPIN DRUG SAF, V14, P571, DOI 10.1517/14740338.2015.1009036; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; van Groningen LFJ, 2016, BIOL BLOOD MARROW TR, V22, P179, DOI 10.1016/j.bbmt.2015.08.039; WEISDORF D, 1990, BLOOD, V75, P1024, DOI 10.1182/blood.V75.4.1024.1024; Wolff D, 2005, BONE MARROW TRANSPL, V35, P1003, DOI 10.1038/sj.bmt.1704929; Xhaard A, 2012, BIOL BLOOD MARROW TR, V18, P406, DOI 10.1016/j.bbmt.2011.06.012	17	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187184	10.1371/journal.pone.0187184	http://dx.doi.org/10.1371/journal.pone.0187184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073260	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400130
J	Huang, C; Mezencev, R; McDonald, JF; Vannberg, F				Huang, Cai; Mezencev, Roman; McDonald, John F.; Vannberg, Fredrik			Open source machine-learning algorithms for the prediction of optimal cancer drug therapies	PLOS ONE			English	Article							CLASSIFICATION; APOPTOSIS	Precision medicine is a rapidly growing area of modern medical science and open source machine-learning codes promise to be a critical component for the successful development of standardized and automated analysis of patient data. One important goal of precision cancer medicine is the accurate prediction of optimal drug therapies from the genomic profiles of individual patient tumors. We introduce here an open source software platform that employs a highly versatile support vector machine (SVM) algorithm combined with a standard recursive feature elimination (RFE) approach to predict personalized drug responses from gene expression profiles. Drug specific models were built using gene expression and drug response data from the National Cancer Institute panel of 60 human cancer cell lines (NCI-60). The models are highly accurate in predicting the drug responsiveness of a variety of cancer cell lines including those comprising the recent NCI-DREAM Challenge. We demonstrate that predictive accuracy is optimized when the learning dataset utilizes all probeset expression values from a diversity of cancer cell types without pre-filtering for genes generally considered to be "drivers" of cancer onset/progression. Application of our models to publically available ovarian cancer (OC) patient gene expression datasets generated predictions consistent with observed responses previously reported in the literature. By making our algorithm "open source", we hope to facilitate its testing in a variety of cancer types and contexts leading to community-driven improvements and refinements in subsequent applications.	[Huang, Cai; Mezencev, Roman; McDonald, John F.; Vannberg, Fredrik] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Huang, Cai; Mezencev, Roman; McDonald, John F.; Vannberg, Fredrik] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Vannberg, F (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.; Vannberg, F (corresponding author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.	vannberg@gatech.edu	Mezencev, Roman/A-8573-2009; Mezencev, Roman/O-8489-2019	Mezencev, Roman/0000-0003-4361-7628	Rising Tide Foundation	Rising Tide Foundation	Funding was provided by the Rising Tide Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga D, 2001, J AM STAT ASSOC, V96, P1161, DOI 10.1198/016214501753381814; Azuaje F., 2016, BRIEF BIOINFORM; Bedo J, 2006, LECT NOTES COMPUT SC, V4304, P170; Bode AM, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0010-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Clough E, 2016, METHODS MOL BIOL, V1418, P93, DOI 10.1007/978-1-4939-3578-9_5; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gaul DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16351; Geeleher P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107468; Guan W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-259; Gysels E, 2005, SIGNAL PROCESS, V85, P2178, DOI 10.1016/j.sigpro.2005.07.008; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hansen SW, 1999, ANN ONCOL, V10, P51, DOI 10.1023/A:1008359418422; Haverty PM, 2016, NATURE, V533, P333, DOI 10.1038/nature17987; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hsu C. W., 2003, PRACTICAL GUIDE SUPP; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu TG, 2015, J THEOR BIOL, V366, P8, DOI 10.1016/j.jtbi.2014.11.010; Mezencev R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2274-5; Ozols RF, 2006, ANN ONCOL, V17, pV181, DOI 10.1093/annonc/mdj978; Piccolo SR, 2013, P NATL ACAD SCI USA, V110, P17778, DOI 10.1073/pnas.1305823110; Radovic M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1423-9; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saez-Rodriguez J, 2016, NAT REV GENET, V17, P470, DOI 10.1038/nrg.2016.69; Salesse S, 2002, ONCOGENE, V21, P8547, DOI 10.1038/sj.onc.1206082; Wen YJ, 2011, PHARMACOGENET GENOM, V21, P476, DOI 10.1097/FPC.0b013e3283481967	30	45	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186906	10.1371/journal.pone.0186906	http://dx.doi.org/10.1371/journal.pone.0186906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073279	Green Submitted, gold, Green Published			2022-12-27	WOS:000413845400074
J	Sung, MS; Lee, TH; Heo, H; Park, SW				Sung, Mi Sun; Lee, Tae Hee; Heo, Hwan; Park, Sang Woo			Clinical features of superficial and deep peripapillary microvascular density in healthy myopic eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; VISUAL-FIELD PROGRESSION; DISC ROTATION; BLOOD-FLOW; ANGIOGRAPHY; ANGLE; TILT; MICROCIRCULATION; ATROPHY; RETINA	Purpose To evaluate the clinical features of peripapillary microvasculature in myopic eyes and investigate the association between the superficial and deep peripapillary microvascular density and the myopic optic disc characteristics. Materials and methods This cross-sectional study included one hundred and fifty healthy myopic eyes with beta-peripapillary atrophy (beta-PPA). Ovality index, degree of optic disc rotation, and the area of beta-PPA were measured. Superficial and deep peripapillary microvascular density was measured using optical coherence tomography angiography. Logistic regression analysis was performed to look for the factors associated with peripapillary microvascular reduction. Results The mean superficial peripapillary microvascular density was 62.14 +/- 5.47%; 33 (22.0%) participants were found to have decreased microvascular density. Increased axial length (p < 0.001) and decreased average peripapillary retinal nerve fiber layer thickness (p = 0.027) were associated with the superficial peripapillary microvascular reduction. The mean deep peripapillary microvascular density was 73.76 +/- 4.02%; 26 (17.33%) participants were found to have decreased microvascular density. Larger ovality index (p = 0.028) and more inferiorly rotated optic disc (p = 0.021) were associated with the deep peripapillary microvascular reduction. Conclusions Axial elongation was significantly associated with microvascular reduction in the superficial peripapillary retina, whereas it was not associated with deep peripapillary microvascular reduction. The deep peripapillary microvascular density was independently associated with myopic optic disc characteristics such as ovality index and optic disc rotation.	[Sung, Mi Sun; Lee, Tae Hee; Heo, Hwan; Park, Sang Woo] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwangju, South Korea; [Sung, Mi Sun; Lee, Tae Hee; Heo, Hwan; Park, Sang Woo] Chonnam Natl Univ, Med Sch & Hosp, Res Inst Med Sci, Gwangju, South Korea; [Park, Sang Woo] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Park, SW (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwangju, South Korea.; Park, SW (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Res Inst Med Sci, Gwangju, South Korea.; Park, SW (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Scientists, Gwangju, South Korea.	exo70@naver.com			National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A01059630]; National Research Foundation of Korea - Korean government [MSIP-2017M3A9E8023019]	National Research Foundation of Korea - Ministry of Education; National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	This research was supported by the Basic Science Research program through the National Research Foundation of Korea (http://www.nrf.re.kr) funded by the Ministry of Education (NRF-2015R1D1A1A01059630 / Sang Woo Park) and Bio & Medical Technology Development Program of the National Research Foundation of Korea funded by the Korean government (MSIP-2017M3A9E8023019 / Mi Sun Sung). The funding organizations had no role in the design or conduct of this research.	Akagi T, 2016, AM J OPHTHALMOL, V168, P237, DOI 10.1016/j.ajo.2016.06.009; AVETISOV ES, 1977, ANN OPHTHALMOL, V9, P1261; Azemin MZ, 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/783525; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cheung SW, 2000, OPHTHAL PHYSL OPT, V20, P119, DOI 10.1016/S0275-5408(99)00045-9; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P4991, DOI 10.1167/iovs.14-14663; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P595, DOI 10.1016/S1350-9462(01)00005-2; Hosseini H, 2013, AM J OPHTHALMOL, V156, P737, DOI 10.1016/j.ajo.2013.05.036; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Lee EJ, 2016, INVEST OPHTH VIS SCI, V57, P6265, DOI 10.1167/iovs.16-20287; Li M, 2017, AM J OPHTHALMOL, V174, P56, DOI 10.1016/j.ajo.2016.10.018; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Liu WF, 2017, CURR EYE RES, V42, P1308, DOI 10.1080/02713683.2017.1307992; Park HYL, 2015, INVEST OPHTH VIS SCI, V56, P156, DOI 10.1167/iovs.13-12327; Shimada N, 2004, GRAEF ARCH CLIN EXP, V242, P284, DOI 10.1007/s00417-003-0836-0; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Sung MS, 2016, OPHTHALMOLOGY, V123, P1484, DOI 10.1016/j.ophtha.2016.03.040; Sung MS, 2016, OPHTHALMOLOGY, V123, P400, DOI 10.1016/j.ophtha.2015.10.018; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Xu H, 2016, INVEST OPHTH VIS SCI, V57, P4464, DOI 10.1167/iovs.16-19603; Yamada H, 2016, OPHTHALMOLOGY, V123, P542, DOI 10.1016/j.ophtha.2015.10.061; Yang Y, 2016, INVEST OPHTH VIS SCI, V57, P6020, DOI 10.1167/iovs.16-19542; Yarmohammadi A, 2016, OPHTHALMOLOGY, V123, P2498, DOI 10.1016/j.ophtha.2016.08.041	30	21	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187160	10.1371/journal.pone.0187160	http://dx.doi.org/10.1371/journal.pone.0187160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073242	Green Submitted, Green Published, gold			2022-12-27	WOS:000413845400127
J	Zhang, YY; Wang, HB; Wang, YN; Wang, HC; Zhang, S; Hong, JY; Guo, HF; Chen, D; Yang, Y; Zan, LS				Zhang, Ying-Ying; Wang, Hong-Bao; Wang, Ya-Ning; Wang, Hong-Cheng; Zhang, Song; Hong, Jie-Yun; Guo, Hong-Fang; Chen, Dai; Yang, Yang; Zan, Lin-Sen			Transcriptome analysis of mRNA and microRNAs in intramuscular fat tissues of castrated and intact male Chinese Qinchuan cattle	PLOS ONE			English	Article							FALSE DISCOVERY RATE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; PREADIPOCYTE PROLIFERATION; TESTOSTERONE DEFICIENCY; HEPATIC STEATOSIS; LONGISSIMUS-DORSI; GENE-EXPRESSION; PATHWAY; ADIPOGENESIS	Intramuscular fat (IMF) is known to enhance beef palatability and can be markedly increased by castration. However, there is little understanding of the molecular mechanism underlying the IMF deposition after castration of beef cattle. We hypothesize that genetic regulators function differently in IMF from bulls and steers. Therefore, after detecting serum testosterone and lipid parameter, as well as the contents of IMF at 6, 12, 18 and 24 months, we have investigated differentially expressed (DE) microRNAs (miRNAs) and mRNAs in IMF of bulls and steers at 24 months of age in Qinchuan cattle using next-generation sequencing, and then explored the possible biopathways regulating IMF deposition. Serum testosterone levels were significantly decreased in steers, whereas IMF content, serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TGs) were markedly increased in steers. Comparing the results of steers and bulls, 580 upregulated genes and 1,120 downregulated genes in IMF tissues were identified as DE genes correlated with IMF deposition. The upregulated genes were mainly associated with lipid metabolism, lipogenesis and fatty acid transportation signalling pathways, and the downregulated genes were correlated with immune response and intracellular signal transduction. Concurrently, the DE miRNAs D important players in adipose tissue accumulation induced by castration D were also examined in IMF tissues; 52 DE miRNAs were identified. The expression profiles of selected genes and miRNAs were also confirmed by quantitative realtime PCR (qRT-PCR) assays. Using integrated analysis, we constructed the microRNA-target regulatory network which was supported by target validation using the dual luciferase reporter system. Moreover, Ingenuity Pathway Analysis (IPA) software was used to construct a molecular interaction network that could be involved in regulating IMF after castration. The detected molecular network is closely associated with lipid metabolism and adipocyte differentiation, which is supported by functional identification results of bta-let-7i on bovine preadipocytes. These results provided valuable insights into the molecular mechanisms of the IMF phenotype differences between steers and bulls.	[Zhang, Ying-Ying; Wang, Hong-Bao; Wang, Ya-Ning; Wang, Hong-Cheng; Zhang, Song; Hong, Jie-Yun; Guo, Hong-Fang; Zan, Lin-Sen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhang, Ying-Ying; Wang, Hong-Bao; Zan, Lin-Sen] Northwest A&F Univ, Natl Beef Cattle Improvement Ctr, Yangling, Shaanxi, Peoples R China; [Zhang, Ying-Ying] Shanghai Acad Agr Sci, Anim Husb & Vet Res Inst, Shanghai, Peoples R China; [Chen, Dai; Yang, Yang] NovelBio Biopharm Technol Co Ltd, Shanghai, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Shanghai Academy of Agricultural Sciences	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Zan, LS (corresponding author), Northwest A&F Univ, Natl Beef Cattle Improvement Ctr, Yangling, Shaanxi, Peoples R China.	zanlinsen@163.com		Zhang, Ying Ying/0000-0003-4200-2760; Zan, Lin-sen/0000-0001-6644-0250	National Natural Science Foundation of China [31272411, 31501937]; China Postdoctoral Science Foundation [2014M562467]; NovelBio Bio-Pharm Technology Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NovelBio Bio-Pharm Technology Co., Ltd.	This work was supported by the National Natural Science Foundation of China (Grant No. 31272411, https://isisn.nsfc.gov.cn/egrantweb/ index; Grant No. 31501937, https://isisn.nstc.gov. cn/egranhnebanaex), the China Postdoctoral Science Foundation (Grant No. 2014M562467, http://www.chinapostdoctor.org.cn/WebSite/ progra/lnfo_Show.aspx?InfoID=09858058-91c5-417a-9ab0-c4f1f102f8cd). DC and YY received support in the form of salary from the commercial company, NovelBio Bio-Pharm Technology Co., Ltd. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by the National Natural Science Foundation of China (Grant No. 31272411; Grant No. 31501937), the China Postdoctoral Science Foundation (Grant No. 2014M562467). Careful preparation of the final manuscript was carried out by BioMedES Ltd., UK.	Abdel-Aziz HO, 2007, J CANCER RES CLIN, V133, P107, DOI 10.1007/s00432-006-0149-x; Albrecht E, 2011, J ANIM SCI, V89, P4339, DOI 10.2527/jas.2011-4039; Albrecht E, 2010, P 9 WORLD C GEN APPL; An JY, 2013, NUCLEIC ACIDS RES, V41, P727, DOI 10.1093/nar/gks1187; Anderson LA, 2001, J CLIN ENDOCR METAB, V86, P5045, DOI 10.1210/jc.86.10.5045; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-47; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernlohr D. A., 2002, BIOCH LIPIDS LIPOPRO, P263; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; Bong JJ, 2012, MEAT SCI, V91, P284, DOI 10.1016/j.meatsci.2012.02.004; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cai ZW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1283-0; Cai ZW, 2014, J APPL GENET, V55, P259, DOI 10.1007/s13353-014-0194-0; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Clark AL, 2015, J BIOL CHEM, V290, P23162, DOI 10.1074/jbc.M115.672659; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; Duarte MS, 2013, J ANIM SCI, V91, P2938, DOI 10.2527/jas.2012-5892; Floryk D, 2011, MOL CELL ENDOCRINOL, V345, P58, DOI 10.1016/j.mce.2011.07.011; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Garcia E, 1999, J ENDOCRINOL, V161, P89, DOI 10.1677/joe.0.1610089; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Jeong J, 2013, J ANIM SCI, V91, P4692, DOI 10.2527/jas.2012-6089; Jeong J, 2012, J ANIM SCI, V90, P2044, DOI 10.2527/jas.2011-4753; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Keeton JIT, 2003, J AOAC INT, V86, P1193; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kopp C, 2014, INT J MOL SCI, V15, P21401, DOI 10.3390/ijms151121401; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lea-Currie YR, 1999, COMP BIOCHEM PHYS C, V123, P17, DOI 10.1016/S0742-8413(99)00003-1; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-811; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071568; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Mach N, 2009, MEAT SCI, V81, P329, DOI 10.1016/j.meatsci.2008.08.007; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Ogata H, 1998, BIOSYSTEMS, V47, P119, DOI 10.1016/S0303-2647(98)00017-3; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; OPPENHEIMER JH, 1991, J CLIN INVEST, V87, P125, DOI 10.1172/JCI114961; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Peng YD, 2013, INT J BIOCHEM CELL B, V45, P1585, DOI 10.1016/j.biocel.2013.04.029; Pethick DW, 2004, AUST J EXP AGR, V44, P705, DOI 10.1071/EA02165; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; SCHWARTZ Y, 1991, P NATL ACAD SCI USA, V88, P6790, DOI 10.1073/pnas.88.15.6790; Senmaru T, 2013, METABOLISM, V62, P851, DOI 10.1016/j.metabol.2012.12.007; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Tominaga S, 2005, BIOCHEM BIOPH RES CO, V326, P499, DOI 10.1016/j.bbrc.2004.11.056; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1378, DOI 10.1152/ajpendo.00252.2009; Whitsel EA, 2001, AM J MED, V111, P261, DOI 10.1016/S0002-9343(01)00833-6; XU XF, 1990, ENDOCRINOLOGY, V126, P1229, DOI 10.1210/endo-126-2-1229; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; Zhang ZQ, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-29; Zhao CP, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-12; Zhao SM, 2009, LIPIDS, V44, P1029, DOI 10.1007/s11745-009-3356-9; Zheng L, 2010, J GASTROEN HEPATOL, V25, P156, DOI 10.1111/j.1440-1746.2009.05949.x; Zhou YP, 2014, 2014 IEEE VISUAL COMMUNICATIONS AND IMAGE PROCESSING CONFERENCE, P9, DOI 10.1109/VCIP.2014.7051491	74	19	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0185961	10.1371/journal.pone.0185961	http://dx.doi.org/10.1371/journal.pone.0185961			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073274	gold, Green Published			2022-12-27	WOS:000413845400010
J	Smage, SB; Brevik, OJ; Frisch, K; Watanabe, K; Duesund, H; Nylund, A				Smage, Sverre Bang; Brevik, Oyvind Jakobsen; Frisch, Kathleen; Watanabe, Kuninori; Duesund, Henrik; Nylund, Are			Concurrent jellyfish blooms and tenacibaculosis outbreaks in Northern Norwegian Atlantic salmon (Salmo salar)farms	PLOS ONE			English	Article							SEA LICE; SP-NOV; FLEXIBACTER; FLAVOBACTERIA; COLONIZATION; MICROBIOME; PATHOGEN; DISEASE	Tenacibaculosis is an increasing problem in the Norwegian Atlantic salmon aquaculture industry causing significant economic losses. In September 2015, two separate outbreaks of suspected tenacibaculosis occurred at two Atlantic salmon farms in Finnmark County in Northern Norway. The events resulted in major losses of smolts newly transferred into sea-water. Prior to, and during the outbreaks, large numbers of small jellyfish, identified as Dipleurosoma typicum (Boeck) were observed in the vicinity of the farms and inside the net-pens. This study investigates the possible link between the jellyfish, Tenacibaculum spp. and the tenacibaculosis outbreaks. Bacteriology, histology, scanning and transmission electron microscopy, and real-time RT-PCR screening were performed on both fish and jellyfish samples. Based on the findings, Tenacibaculum finnmarkense was found to be the dominant bacteria associated with the tenacibaculosis outbreaks at both sites and that D. typicum is unlikely to be a vector for this fish pathogenic bacterium. However, results do show that the jellyfish caused direct damage to the fish's skin and may have exacerbated the bacterial infection by allowing an entry point for bacteria.	[Smage, Sverre Bang; Brevik, Oyvind Jakobsen; Frisch, Kathleen; Duesund, Henrik] Cermaq Grp AS, Dronning Eufemiasgate 16, Oslo, Norway; [Smage, Sverre Bang; Brevik, Oyvind Jakobsen; Frisch, Kathleen; Watanabe, Kuninori; Nylund, Are] Univ Bergen, Dept Biol, Fish Dis Res Grp, Thormohlensgate 55, Bergen, Norway	University of Bergen	Smage, SB (corresponding author), Cermaq Grp AS, Dronning Eufemiasgate 16, Oslo, Norway.; Smage, SB (corresponding author), Univ Bergen, Dept Biol, Fish Dis Res Grp, Thormohlensgate 55, Bergen, Norway.	sverre.smage@cermaq.com			Research Council of Norway (Norges Forskningsrad) [241364]; Cermaq Norway; Cermaq Group AS	Research Council of Norway (Norges Forskningsrad)(Research Council of Norway); Cermaq Norway; Cermaq Group AS	The study was partially funded by the Research Council of Norway (Norges Forskningsrad) (Project number 241364, https://www.forskningsradet.no/prosjektbanken/#!/project/241364/no). This study was also partially funded by Cermaq Norway (www.Cermaq.no). Neither of these funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Cermaq Group AS received this funding. Cermaq Group AS provided support in the form of salaries for authors [SS, KF, OB, HD], and also played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Two of the authors [KW, AN] are employed by the University of Bergen (UiB); however UiB had no role in study design, data collection or decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Abell GCJ, 2005, FEMS MICROBIOL ECOL, V53, P379, DOI 10.1016/j.femsec.2005.01.008; Alles DL, 2013, MARINE PHYTOPLANKTON; Andersen L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-198; Ardyna M, 2014, GEOPHYS RES LETT, V41, P6207, DOI 10.1002/2014GL061047; Avendano-Herrera R, 2016, TRANSBOUND EMERG DIS, V63, P121, DOI 10.1111/tbed.12464; Bamstedt U, 1998, SARSIA, V83, P79, DOI 10.1080/00364827.1998.10413673; Baxter EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018529; Boeck A, 1866, TILSYNELADENDE BILAT; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Bohorquez J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00245; Bosch-Belmar M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27929; Bruno D.W., 1985, Bulletin of the European Association of Fish Pathologists, V5, P64; Buchan A, 2014, NAT REV MICROBIOL, V12, P686, DOI 10.1038/nrmicro3326; Cornelius PFS, 1995, N W EUROPEAN THECA 1; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Dalpadado P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095273; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Dinasquet J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00302; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eiane Ketil, 2009, P209; Ferguson HW, 2010, J VET DIAGN INVEST, V22, P376, DOI 10.1177/104063871002200305; Fisch C, 2011, BIOL CELL, V103, P249, DOI 10.1042/BC20100139; Fleming NEC, 2013, AQUACULT ENV INTERAC, V4, P263, DOI 10.3354/aei00086; FLINT KP, 1985, J APPL BACTERIOL, V59, P561, DOI 10.1111/j.1365-2672.1985.tb03361.x; Fossa JH, 2003, HAVETS MILJO, P99; Fringuelli E, 2012, J FISH DIS, V35, P579, DOI 10.1111/j.1365-2761.2012.01377.x; Frisch K, 2017, J FISH DIS, DOI 10.1111/jfd.12687; Giovannoni SJ, 1996, P NATL ACAD SCI USA, V93, P7979, DOI 10.1073/pnas.93.15.7979; Gomez-Pereira PR, 2010, ISME J, V4, P472, DOI 10.1038/ismej.2009.142; Habib C, 2014, APPL ENVIRON MICROB, V80, P5503, DOI 10.1128/AEM.01177-14; Hahnke RL, 2013, SYST APPL MICROBIOL, V36, P497, DOI 10.1016/j.syapm.2013.06.006; HANSEN GH, 1992, INT J SYST BACTERIOL, V42, P451, DOI 10.1099/00207713-42-3-451; Haukaas A., 2017, HLTH SITUATION NORWE; Helmholz H, 2010, DEV HYDROBIOL, V212, P223, DOI 10.1007/s10750-010-0216-9; Hoffmann K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00266; Hosteland LTS, 2016, MATTE SLAKTE ECOMERD; Karlsen C, 2017, J FISH DIS, V40, P1645, DOI 10.1111/jfd.12632; Kintner AH, 2012, HYDROZOAN JELLYFISH; Llewellyn MS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43465; Loeng H., 1991, P PRO MAR S POL MAR, V10, P18; Lokesh J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19707; LOTAN A, 1995, NATURE, V375, P456, DOI 10.1038/375456a0; Marcos-Lopez M, 2016, J FISH DIS, V39, P111, DOI 10.1111/jfd.12267; MARISCAL RN, 1974, Z ZELLFORSCH MIK ANA, V147, P149, DOI 10.1007/BF00582789; MARTIN VJ, 1986, BIOL BULL-US, V171, P116, DOI 10.2307/1541910; Merceron M, 1995, EQUINOXE, V56, P6; Mitchell SO, 2011, J FISH DIS, V34, P411, DOI 10.1111/j.1365-2761.2011.01251.x; Nakagawa Y, 2002, J GEN APPL MICROBIOL, V48, P155, DOI 10.2323/jgam.48.155; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Nilsen A, 2017, AQUACULTURE, V466, P41, DOI 10.1016/j.aquaculture.2016.09.009; NYLUND A, 1995, J FISH DIS, V18, P135, DOI 10.1111/j.1365-2761.1995.tb00271.x; Olsen AB, 2011, DIS AQUAT ORGAN, V94, P189, DOI 10.3354/dao02324; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Rahman T, 2014, FISH PATHOL, V49, P121, DOI 10.3147/jsfp.49.121; Riebeek H, 2010, PHYTOPLANKTON BLOOM; Rodger H. D., 2007, Fish Veterinary Journal, P38; Rodger HD, 2011, VET REC, V168, DOI 10.1136/vr.d3020; Rodger HD, 2011, REV FISH BIOL FISHER, V21, P423, DOI 10.1007/s11160-010-9182-6; Russell F.S., 1953, MEDUSAE BRIT ISLES; Rutter T, 2010, MANAGING RISK UNCERT; Schlesinger A, 2009, P ROY SOC B-BIOL SCI, V276, P1063, DOI 10.1098/rspb.2008.1586; Schuett C, 2010, HELGOLAND MAR RES, V64, P205, DOI 10.1007/s10152-009-0179-2; Smage SB, 2016, AQUACULTURE, V464, P178, DOI 10.1016/j.aquaculture.2016.06.030; Smage SB, 2016, ANTON LEEUW INT J G, V109, P273, DOI 10.1007/s10482-015-0630-0; Tamura K., 2013, MEGA6 MOL EVOLUTIONA; Teeling H, 2016, ELIFE, V5, DOI 10.7554/eLife.11888; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Torud B., 2008, Acta Veterinaria Scandinavica, V50, pS7, DOI 10.1186/1751-0147-50-S1-S7; Viver T, 2017, ENVIRON MICROBIOL, V19, P3039, DOI 10.1111/1462-2920.13763; Vold V., 2014, THESIS; WAKABAYASHI H, 1986, INT J SYST BACTERIOL, V36, P396, DOI 10.1099/00207713-36-3-396	75	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187476	10.1371/journal.pone.0187476	http://dx.doi.org/10.1371/journal.pone.0187476			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095885	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000414340200100
J	Zheng, XL; Tang, HW; Zhao, XF; Sun, YM; Jiang, YF; Liu, YH				Zheng, Xiaoli; Tang, Hongwei; Zhao, Xiaofeng; Sun, Yamei; Jiang, Yanfang; Liu, Yonghua			Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p	PLOS ONE			English	Article							GASTRIC-CANCER CELLS; FIZZLED 5 EXPRESSION; LUNG-CANCER; C-MET; HEPATOCELLULAR-CARCINOMA; POOR-PROGNOSIS; PROMOTES; PROLIFERATION; PROGRESSION; MIGRATION	Growing evidences indicated that Long noncoding RNAs (lncRNAs) played important roles in tumor initiation and progression. However, the function and mechnism of lncRNA ferritin heavy chain 1 pseudogene 3 (FTH1P3) remain unknown in uveal melanoma. We showed that the expression level of FTH1P3 was upregulated in uveal melanoma cell lines and tissues. Elevated expression of FTH1P3 promoted uveal melanoma cell proliferation, cell cycle and migration. Moreover, we found that FTH1P3 was a direct target gene of miR-224-5p in uveal melanoma cell. Overexpression of FTH1P3 suppressed miR-224-5p expression and promoted the expression of Rac1 and Fizzled 5, which were the direct target genes of miR-224-5p. Furthermore, we showed that miR-224-5p expression level was downregulated in uveal melanoma cell lines and tissues. FTH1P3 expression was inversely correlated with the miR-224-5p expression in uveal melanoma tissues. Ectopic expression of miR-224-5p decreased uveal melanoma cell proliferation, cell cycle and migration. Elevated expression of FTH1P3 enhanced uveal melanoma cell proliferation and migration by inhibiting miR-224-5p expression. These results suggest that lncRNA FTH1P3 plays a crucial role in uveal melanoma. Investigation of the underlying mechanism may be a target for the treatment of uveal melanoma.	[Zheng, Xiaoli; Tang, Hongwei; Liu, Yonghua] Liaocheng Peoples Hosp, Dept Ophthalmol, Liaocheng, Shandong, Peoples R China; [Zhao, Xiaofeng] Liaocheng Peoples Hosp, Joint Lab Translat Med, Liaocheng, Shandong, Peoples R China; [Sun, Yamei] Shanghai Chinese Acad Sci, Inst Pasteur, Shanghai, Peoples R China; [Jiang, Yanfang] Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun, Jilin, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Jilin University	Zheng, XL (corresponding author), Liaocheng Peoples Hosp, Dept Ophthalmol, Liaocheng, Shandong, Peoples R China.	xiaolizheng1@yeah.net			Jilin Province Science and Technology Agency [20160101037JC, 20170622009JC]	Jilin Province Science and Technology Agency	This study was supported by Jilin Province Science and Technology Agency (No.20160101037JC and 20170622009JC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos PG, 2015, INT J ONCOL, V46, P849, DOI 10.3892/ijo.2014.2775; Deng L, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0136-7; Di Sanzo M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151359; Economou MA, 2008, ACTA OPHTHALMOL, V86, P930, DOI [10.1111/j.1755-3768.2008.01184.x, 10.1111/j.1755-3768.2008.01185.x, 10.1111/j.1755-3768.2008.01182.x]; Fang J, 2016, BIOCHEM BIOPH RES CO, V478, P811, DOI 10.1016/j.bbrc.2016.08.030; Geng S, 2016, J CELL MOL MED, V20, P1611, DOI 10.1111/jcmm.12852; He AB, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0397-9; Huang MD, 2015, J HEMATOL ONCOL, V8, DOI [10.1186/s13045-015-0146-0, 10.1186/s13045-015-0153-1]; Kam Y, 2014, CANCER LETT, V352, P90, DOI 10.1016/j.canlet.2013.02.014; Li C, 2015, AM J TRANSL RES, V7, P1747; Li JQ, 2016, BIOMED PHARMACOTHER, V83, P905, DOI 10.1016/j.biopha.2016.07.057; Li P, 2016, AM J TRANSL RES, V8, P3522; Ling H, 2016, GUT, V65, P977, DOI 10.1136/gutjnl-2015-309372; Liu CB, 2016, AM J TRANSL RES, V8, P4095; Liu F, 2016, ONCOTARGET, V7, P49130, DOI 10.18632/oncotarget.9734; Liu NN, 2012, ONCOL REP, V28, P961, DOI 10.3892/or.2012.1905; Ma L, 2017, ONCOTARGET, V8, P4125, DOI 10.18632/oncotarget.13670; Mallikarjuna K, 2007, CURR EYE RES, V32, P281, DOI 10.1080/02713680601161220; Nie FQ, 2015, MOL CANCER THER, V14, P268, DOI 10.1158/1535-7163.MCT-14-0492; Patel S, 2013, CURR ONCOL REP, V15, P386, DOI 10.1007/s11912-013-0316-6; Pereira PR, 2013, CLIN OPHTHALMOL, V7, P1669, DOI 10.2147/OPTH.S28863; Qiao HP, 2013, ASIAN PAC J CANCER P, V14, P1077, DOI 10.7314/APJCP.2013.14.2.1077; Qiu JJ, 2015, INT J ONCOL, V46, P2497, DOI 10.3892/ijo.2015.2943; Sato T, 2008, CURR ONCOL REP, V10, P431, DOI 10.1007/s11912-008-0066-z; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Song P, 2016, AGING-US, V8, P2948, DOI 10.18632/aging.101103; Sun CC, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.94; Sun CC, 2016, ONCOTARGET, V7, P35960, DOI 10.18632/oncotarget.8482; Sun CC, 2016, ONCOTARGET, V7, P51784, DOI 10.18632/oncotarget.10108; Sun L, 2015, FEBS LETT, V589, P2791, DOI 10.1016/j.febslet.2015.08.007; Sun L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124428; Surriga O, 2013, MOL CANCER THER, V12, P2817, DOI 10.1158/1535-7163.MCT-13-0499; Tian ZZ, 2015, INT J CLIN EXP PATHO, V8, P15138; Topcu-Yilmaz P, 2010, MELANOMA RES, V20, P126, DOI 10.1097/CMR.0b013e328335a916; WANG F, 2016, SCI REP-UK, V6, pNIL1, DOI DOI 10.1038/srep33229; Wang JQ, 2014, BIOMED PHARMACOTHER, V68, P557, DOI 10.1016/j.biopha.2014.04.007; Wang LN, 2016, AM J TRANSL RES, V8, P5219; Xia MM, 2016, PHARMAZIE, V71, P460, DOI 10.1691/ph.2016.6580; Yan DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040967; Yang F, 2013, J CANCER RES CLIN, V139, P437, DOI 10.1007/s00432-012-1324-x; Yonekawa Y, 2012, HEMATOL ONCOL CLIN N, V26, P1169, DOI 10.1016/j.hoc.2012.08.004; Yousef YA, 2014, HEMATOL ONCOL STEM C; Yu QY, 2016, AM J TRANSL RES, V8, P5444; Zhang CZ, 2017, GENE, V607, P47, DOI 10.1016/j.gene.2017.01.009; Zhang SC, 2015, ARCH ORAL BIOL, V60, P1581, DOI 10.1016/j.archoralbio.2015.08.003; Zhou X, 2015, SCI REP-UK, V5, DOI 10.1038/srep15972	46	45	45	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0184746	10.1371/journal.pone.0184746	http://dx.doi.org/10.1371/journal.pone.0184746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095823	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200003
J	Beckers, KF; Schulz, CJ; Childers, GW				Beckers, Kalie F.; Schulz, Christopher J.; Childers, Gary W.			Rapid regrowth and detection of microbial contaminants in equine fecal microbiome samples	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; OPERON COPY NUMBER; GUT MICROBIOTA; STORAGE-CONDITIONS; LARGE-INTESTINE; BACTERIA; SOIL; COMMUNITIES; NUTRITION; REGIONS	Advances have been made to standardize 16S rRNA gene amplicon based studies for inter study comparisons, yet there are many opportunities for systematic error that may render these comparisons improper and misleading. The fecal microbiome of horses has been examined previously, however, no universal horse fecal collection method and sample processing procedure has been established. This study was initialized in large part to ensure that samples collected by different individuals from different geographical areas (i.e., crowd sourced) were not contaminated due to less than optimal sampling or holding conditions. In this study, we examined the effect of sampling the surface of fecal pellets compared to homogenized fecal pellets, and also the effect of time of sampling after defecation on 'bloom' taxa (bloom taxa refers to microbial taxa that can grow rapidly in horse feces post defecation) using v4 16S rRNA amplicon libraries. A total of 1,440,171 sequences were recovered from 65 horse fecal samples yielding a total of 3,422 OTUs at 97% similarity. Sampling from either surface or homogenized feces had no effect on diversity and little effect on microbial composition. Sampling at various time points (0, 2, 4, 6, 12 h) had a significant effect on both diversity and community composition of fecal samples. Alpha diversity (Shannon index) initially increased with time as regrowth taxa were detected in the amplicon libraries, but by 12 h the diversity sharply decreased as the community composition became dominated by a few bloom families, including Bacillaceae, Planococcaeae, and Enterococcaceae, and other families to a lesser extent. The results show that immediate sampling of horse feces must be done in order to ensure accurate representation of horse fecal samples. Also, several of the bloom taxa found in this study are known to occur in human and cattle feces post defecation. The dominance of these taxa in feces shortly after defecation suggests that the feces is an important habitat for these organisms, and horse fecal samples that were improperly stored can be identified by presence of bloom taxa.	[Beckers, Kalie F.; Schulz, Christopher J.; Childers, Gary W.] Southeastern Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA	University of Louisiana System; Southeastern Louisiana University	Schulz, CJ (corresponding author), Southeastern Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA.	cschulz@selu.edu						Aitchison J, 2005, MATH GEOL, V37, P829, DOI 10.1007/s11004-005-7383-7; Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00199-16; Anderson M.J., 2005, PERMUTATIONAL MULTIV; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; ARGENZIO RA, 1975, CORNELL VET, V65, P303; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350; Costa MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0335-7; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dicks LMT, 2014, LIVEST SCI, V160, P69, DOI 10.1016/j.livsci.2013.11.025; Dougal K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01502; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Dougal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077660; Durham AE, 2009, VET CLIN N AM-EQUINE, V25, P67, DOI 10.1016/j.cveq.2008.11.003; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eloe-Fadrosh EA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.32, 10.1038/nmicrobiol.2015.32]; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166523; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Fouhy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119355; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Hale VL, 2015, J MICROBIOL METH, V113, P16, DOI 10.1016/j.mimet.2015.03.021; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hansen Naja C. K., 2015, Microbial Ecology in Health and Disease, V26, P27216, DOI 10.3402/mehd.v26.27216; Hart ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143334; HINTZ HF, 1994, ANNU REV NUTR, V14, P243, DOI 10.1146/annurev.nu.14.070194.001331; Hong HA, 2009, RES MICROBIOL, V160, P375, DOI 10.1016/j.resmic.2009.06.006; Janabi AHD, 2016, J MICROBIOL METH, V129, P14, DOI 10.1016/j.mimet.2016.07.019; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Liu XF, 2014, CURR MICROBIOL, V68, P657, DOI 10.1007/s00284-014-0528-5; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; de Almeida MLM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167108; Murtagh F, 2011, ARXIV111162852011; Nishimoto Y, 2016, GUT; O' Donnell MM, 2013, LETT APPL MICROBIOL, V57, P492, DOI 10.1111/lam.12137; R Development Core Team, 2008, LANG ENV STAT COMP F; Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118; Rodriguez C, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0514-5; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Roller BRK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.160, 10.1038/nmicrobiol.2016.160]; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-179; Stewart Colin S., 1997, P142; Tam NKM, 2006, J BACTERIOL, V188, P2692, DOI 10.1128/JB.188.7.2692-2700.2006; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wong K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00500; Yang B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0992-y; Zhao YP, 2016, ASIAN AUSTRAL J ANIM, V29, P1345, DOI 10.5713/ajas.15.0587	66	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/Journal.pone.0187044	http://dx.doi.org/10.1371/Journal.pone.0187044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091944	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700040
J	Murao, N; Yokoi, N; Honda, K; Han, GR; Hayami, T; Gheni, G; Takahashi, H; Minami, K; Seino, S				Murao, Naoya; Yokoi, Norihide; Honda, Kohei; Han, Guirong; Hayami, Tomohide; Gheni, Ghupurjan; Takahashi, Harumi; Minami, Kohtaro; Seino, Susumu			Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in beta-cell glutamate signaling for incretin-induced insulin secretion	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PHOSPHATE TRANSPORTER; RELEASE; ISLETS; TARGET; ACTS	Incretins (GLP-1 and GIP) potentiate insulin secretion through cAMP signaling in pancreatic beta-cells in a glucose-dependent manner. We recently proposed a mechanistic model of incretin-induced insulin secretion (IIIS) that requires two critical processes: 1) generation of cytosolic glutamate through the malate-aspartate (MA) shuttle in glucose metabolism and 2) glutamate transport into insulin granules by cAMP signaling to promote insulin granule exocytosis. To directly prove the model, we have established and characterized CRISPR/Cas9-engineered clonal mouse beta-cell lines deficient for the genes critical in these two processes: aspartate aminotransferase 1 (AST1, gene symbol Got1), a key enzyme in the MA shuttle, which generates cytosolic glutamate, and the vesicular glutamate transporters (VGLUT1, VGLUT2, and VGLUT3, gene symbol Slc17a7, Slc17a6, and Slc17a8, respectively), which participate in glutamate transport into secretory vesicles. Got1 knockout (KO) (3 -cell lines were defective in cytosolic glutamate production from glucose and showed impaired IIIS. Unexpectedly, different from the previous finding that global Slc17a7K0 mice exhibited impaired IIIS from pancreatic islets, beta-cell specific Slc17a7 KO mice showed no significant impairment in IIIS, as assessed by pancreas perfusion experiment. Single Slc17a7 KO 13 cell lines also retained IIIS, probably due to compensatory upregulation of Slc17a6. Interestingly, triple KO of Slc17a7, Slc17a6, and Slc17a8 diminished IIIS, which was rescued by exogenously introduced wild-type Slc17a7 or Slc17a6 genes. The present study provides direct evidence for the essential roles of AST1 and VGLUTs in beta-cell glutamate signaling for IIIS and also shows the usefulness of the CRISPR/Cas9 system for studying beta-cells by simultaneous disruption of multiple genes.	[Murao, Naoya; Yokoi, Norihide; Honda, Kohei; Han, Guirong; Hayami, Tomohide; Gheni, Ghupurjan; Takahashi, Harumi; Minami, Kohtaro; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Dept Physiol & Cell Biol, Kobe, Hyogo, Japan; [Han, Guirong; Hayami, Tomohide] Kansai Elect Power Med Res Inst, Kobe, Hyogo, Japan; [Han, Guirong] Kobe Univ, Div Med Chem, Dept Biophys, Grad Sch Hlth Sci, Kobe, Hyogo, Japan; [Hayami, Tomohide] Aichi Med Univ, Div Diabet, Dept Internal Med, Nagakute, Aichi, Japan	Kobe University; Kobe University; Aichi Medical University	Yokoi, N; Seino, S (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Dept Physiol & Cell Biol, Kobe, Hyogo, Japan.	yokoi@med.kobe-u.ac.jp; seino@med.kobe-u.ac.jp		Minami, Kohtaro/0000-0003-4698-6250; Yokoi, Norihide/0000-0002-5596-9754	Ministry of Education, Culture, Sports, Science and Technology, Japan; MSD K.K.; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research [15K06800] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MSD K.K.(Merck & Company); Japan Diabetes Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by a research grant from MSD K.K. and a research grant from Japan Diabetes Foundation.	Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; Gras C, 2002, J NEUROSCI, V22, P5442; Hayashi M, 2003, J HISTOCHEM CYTOCHEM, V51, P1375, DOI 10.1177/002215540305101014; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Iwasaki M, 2010, J DIABETES INVEST, V1, P137, DOI 10.1111/j.2040-1124.2010.00026.x; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Naylor J, 2016, BIOCHEM J, V473, P2881, DOI 10.1042/BCJ20160476; Omote H, 2011, BIOCHEMISTRY-US, V50, P5558, DOI 10.1021/bi200567k; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; SIEGEL EG, 1985, DIABETOLOGIA, V28, P857, DOI 10.1007/BF00291078; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tamura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126003; WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338; Yokoi N, 2016, J DIABETES INVEST, V7, P38, DOI 10.1111/jdi.12468	26	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187213	10.1371/journal.pone.0187213	http://dx.doi.org/10.1371/journal.pone.0187213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091932	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700046
J	Lee, S; Kweon, OK; Kim, WH				Lee, Sungin; Kweon, Oh-Kyeong; Kim, Wan Hee			Associations between serum leptin levels, hyperlipidemia, and cholelithiasis in dogs	PLOS ONE			English	Article							BODY CONDITION SCORE; INSULIN-RESISTANCE; GALLBLADDER MOTILITY; DIABETES-MELLITUS; GALLSTONE DISEASE; BILIARY SLUDGE; RISK-FACTOR; OBESE MICE; EXPRESSION; RECEPTOR	Leptin and its receptor play several physiological roles in the canine gallbladder, and the dysregulation of leptin might play a role in the pathogenesis of gallbladder diseases such as gallbladder mucocele. Previous studies revealed a positive association between hyperlipidemia and gallstones in humans. However, the latter is still unclear in dogs with cholelithiasis. In this study, we examined the differences in leptin, leptin receptor, total cholesterol, and triglyceride levels between healthy dogs and dogs with cholelithiasis, and evaluated the correlation between leptin and hyperlipidemia. Twenty-eight healthy dogs and 34 client-owned dogs with cholelithiasis were enrolled in the study. Leptin concentrations and lipid profiles were determined from sera, and leptin and leptin receptor expression levels were quantified in gallbladder tissue. In dogs with cholelithiasis, serum concentrations of leptin (p < 0.001), total cholesterol (p < 0.001), and triglycerides (p < 0.001) were significantly higher compared with those in healthy dogs. Positive correlations were observed between serum leptin and total cholesterol (95% confidence interval (CI) = 0.61-0.89, r = 0.725, p < 0.001), and between leptin and triglycerides (95% CI = 0.63-0.89, r = 0.782, p < 0.001) in the cholelithiasis group. Hypercholesterolemia (Odds Ratio (OR) = 9.720; 95% CI = 1.148-82.318) and hypertriglyceridemia (OR = 12.913; 95% CI = 1.548-107.722) were shown to be risk factors for gallstone disease. In cholelithiasis patients who underwent cholecystectomy, serum leptin levels were significantly higher than in patients that had not undergone surgery (p < 0.001). Leptin and leptin receptor expression was upregulated in the gallbladder tissues of cholelithiasis patients (p < 0.01 and p < 0.001, respectively). These results indicate that increased serum leptin concentrations and hyperlipidemia (hypercholesterolemia or hypertriglyceridemia) are associated with canine cholelithiasis and that homeostatic imbalance of these parameters might affect the pathogenesis of gallstones.	[Kim, Wan Hee] Seoul Natl Univ, Dept Vet Clin Sci, Coll Vet Med, Seoul, South Korea; Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, WH (corresponding author), Seoul Natl Univ, Dept Vet Clin Sci, Coll Vet Med, Seoul, South Korea.	whkim@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B03032499]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B03032499) to Wan Hee Kim.	Bohlender J, 2003, J ENDOCRINOL, V178, P217, DOI 10.1677/joe.0.1780217; Cuevas A, 2004, J AM COLL NUTR, V23, P187, DOI 10.1080/07315724.2004.10719360; de Lartigue G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032967; Ettinger SJ., 2017, TXB VET INTERNAL MED, V39, P1483; Fonfara S, 2011, J VET INTERN MED, V25, P1017, DOI 10.1111/j.1939-1676.2011.00782.x; German AJ, 2009, DOMEST ANIM ENDOCRIN, V37, P214, DOI 10.1016/j.domaniend.2009.07.001; Gielkens HAJ, 1998, J HEPATOL, V28, P595, DOI 10.1016/S0168-8278(98)80282-1; Goldblatt MI, 2002, J GASTROINTEST SURG, V6, P438, DOI 10.1016/S1091-255X(01)00046-4; Gonzaga NC, 2014, J PAEDIATR CHILD H, V50, P707, DOI 10.1111/jpc.12610; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Graewin SJ, 2008, J AM COLL SURGEONS, V206, P503, DOI 10.1016/j.jamcollsurg.2007.09.015; Greene VR, 2013, J VET INTERN MED, V27, P1278, DOI 10.1111/jvim.12169; Haluzik M, 1999, PHYSIOL RES, V48, P363; Hess RS, 2010, VET CLIN N AM-SMALL, V40, P309, DOI 10.1016/j.cvsm.2009.12.001; Ishioka K, 2007, RES VET SCI, V82, P11, DOI 10.1016/j.rvsc.2006.06.002; Jonkers IJAM, 2003, GUT, V52, P109, DOI 10.1136/gut.52.1.109; Kavazarakis E, 2001, METABOLISM, V50, P1091, DOI 10.1053/meta.2001.25606; Kieffer TJ, 1996, RES COMMUN, V224, P522; Kim AY, 2015, J VET SCI, V16, P333, DOI 10.4142/jvs.2015.16.3.333; Kim Jung Mi, 2007, Korean J Gastroenterol, V50, P183; KIRPENSTEIJN J, 1993, J AM VET MED ASSOC, V202, P1137; Krishnamurthy S, 1997, J NUCL MED, V38, P1824; Kutsunai M, 2014, VET J, V199, P76, DOI 10.1016/j.tvjl.2013.10.019; Laflamme D, 1997, CANINE PRACT, V22, P10; Lahm Jose A, 2016, VET MED INT, V2016; Lee S, 2017, J VET INTERN MED, V31, P36, DOI 10.1111/jvim.14612; LEE SP, 1981, J CLIN INVEST, V67, P1712, DOI 10.1172/JCI110209; LEE SP, 1988, GASTROENTEROLOGY, V94, P170, DOI 10.1016/0016-5085(88)90626-9; LEE SP, 1986, GASTROENTEROLOGY, V90, P677, DOI 10.1016/0016-5085(86)91123-6; Lee S, 2016, ACTA HISTOCHEM, V118, P674, DOI 10.1016/j.acthis.2016.09.002; Lerch MM, 2016, GALLSTONE RELATED PA; Lostao MP, 1998, FEBS LETT, V423, P302, DOI 10.1016/S0014-5793(98)00110-0; MAFFEI M, 1995, P NATL ACAD SCI USA, V92, P6957, DOI 10.1073/pnas.92.15.6957; Mazaki-Tovi M, 2010, VET J, V183, P109, DOI 10.1016/j.tvjl.2008.08.017; Nelson R.W., 2014, SMALL ANIMAL INTERNA, V5, P897; Nishii N, 2010, J VET MED SCI, V72, P809, DOI 10.1292/jvms.09-0481; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Park HJ, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-113; Piantedosi D, 2016, VET J, V216, P72, DOI 10.1016/j.tvjl.2016.07.002; Rucinsky R, 2010, J AM ANIM HOSP ASSOC, V46, P215, DOI 10.5326/0460215; Sarac S, 2015, J INT MED RES, V43, P385, DOI 10.1177/0300060514561134; Silha JV, 2003, EUR J ENDOCRINOL, V149, P331, DOI 10.1530/eje.0.1490331; Smelt AHM, 2010, CLIN CHIM ACTA, V411, P1625, DOI 10.1016/j.cca.2010.08.003; Swartz-Basile DA, 2007, AM J PHYSIOL-GASTR L, V293, pG84, DOI 10.1152/ajpgi.00389.2006; Sweeney G, 2001, CELL MOL BIOL, V47, P363; Thomas T, 2000, METABOLISM, V49, P1278, DOI 10.1053/meta.2000.9519; Thrall D. E., 2013, TXB VET DIAGNOSTIC R; Tobias K.M., 2013, VET SURG SMALL ANIMA; Tran KQ, 2003, J GASTROINTEST SURG, V7, P857, DOI 10.1016/S1091-255X(03)00146-X; Tran KQ, 2003, J SURG RES, V113, P56, DOI 10.1016/S0022-4804(03)00157-4; Verkest KR, 2011, DOMEST ANIM ENDOCRIN, V41, P24, DOI 10.1016/j.domaniend.2011.02.001; Wang SN, 2006, EUR J CLIN INVEST, V36, P176, DOI 10.1111/j.1365-2362.2006.01611.x	52	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187315	10.1371/journal.pone.0187315	http://dx.doi.org/10.1371/journal.pone.0187315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088261	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900065
J	Rovelli, C; Poli, A; Galli, L; Cernuschi, M; Tamburini, AM; Racca, S; Tambussi, G; Rolla, S; Albarello, L; Rosati, R; Lazzarin, A; Castagna, A; Nozza, S				Rovelli, Cristina; Poli, Andrea; Galli, Laura; Cernuschi, Massimo; Tamburini, Andrea Marco; Racca, Sara; Tambussi, Giuseppe; Rolla, Serena; Albarello, Luca; Rosati, Riccardo; Lazzarin, Adriano; Castagna, Antonella; Nozza, Silvia			Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; ANYPLEX II HPV28; ANTIRETROVIRAL THERAPY; RISK-FACTORS; HIV; MEN; SEX; COHORT; PREVALENCE; CANCER	Objectives The aim of the study was to determine the prevalence of abnormal cytological findings, high risk (HR)-HPV genotypes and to identify factors associated with an abnormal cytological findings in a cohort of HIV-infected males. Patients and methods Retrospective observational study on HIV-infected male patients who performed screening in the absence of clinical symptoms. Cytological abnormalities were classified as atypical squamous cells of undetermined significance (ASC-US), low-grade(LSIL) or high high-grade squamous intraepithelial lesion (HSIL). Logistic regression models were used to identify predictors of having LSIL/HSIL. Results Among 875 pts, abnormal cytology findings were observed in 254 (29%, 95% CI: 26.1%-32.1%) subjects: 142 (16%) had LSIL and 49 (6%) HSIL. Overall, 581 (66%, 95% CI: 63.2%-69.5%) subjects had >= 1 HR-HPV type and 269 (31%) had >= 2 HR HPV types. Multivariate logistic regression showed that subjects with multiple HR-HPV genotypes (OR = 1.351, 95% CI: 1.005-2.111) and with HPV-16 type (OR = 2.032, 95% CI: 1.313-3.146) were more likely to have LSIL/HSIL in addition to a lower CD4+/CD8+ ratio, a previous diagnosis of syphilis and a positive viral load. In another multivariate model, the presence of multiple HPV types in subjects with HPV-16 type was associated with the highest adjusted OR of having a LSIL/HSIL (OR = 2.598, 95% CI: 1.460-4.624). Conclusions In HIV-infected men, the prevalence of abnormal cytological findings was of 29% and of HR-HPV was 66%. The concomitant presence of HPV-16 and multiple HR genotypes was associated with an increased risk of abnormal cytological findings. These data highlight the importance of screening multiple HPV genotypes in HIV-infected patients.	[Rovelli, Cristina; Rosati, Riccardo; Lazzarin, Adriano; Castagna, Antonella] Univ Vita Salute San Raffaele, Milan, Italy; [Poli, Andrea; Galli, Laura; Cernuschi, Massimo; Tambussi, Giuseppe; Lazzarin, Adriano; Castagna, Antonella; Nozza, Silvia] Ist Sci San Raffaele, Infect Dis Dept, Milan, Italy; [Tamburini, Andrea Marco; Rosati, Riccardo] Ist Sci San Raffaele, Gastrointestinal Surg, Milan, Italy; [Racca, Sara; Rolla, Serena] Ist Sci San Raffaele, Lab Microbiol, Milan, Italy; [Albarello, Luca] Ist Sci San Raffaele, Dept Pathol, Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Nozza, S (corresponding author), Ist Sci San Raffaele, Infect Dis Dept, Milan, Italy.	nozza.silvia@hsr.it	NOZZA, SILVIA/AAC-5445-2022; ALBARELLO, LUCA/AAN-3876-2020; Castagna, Antonella/K-3280-2018; Galli, Laura/B-1161-2016; Tamburini, Andrea/U-2958-2019; LAZZARIN, Adriano/K-3607-2018	ALBARELLO, LUCA/0000-0003-4846-5096; Castagna, Antonella/0000-0002-8338-9714; Tamburini, Andrea/0000-0002-7578-209X; LAZZARIN, Adriano/0000-0003-2551-7754; Galli, Laura/0000-0001-8046-0290; Tambussi, Giuseppe/0000-0002-0604-2960; ROSATI, Riccardo/0000-0002-2608-5749				Berry JM, 2014, INT J CANCER, V134, P1147, DOI 10.1002/ijc.28431; Cancer Research UK, 2014, AN CANC INC STAT; Estrade C, 2014, J CLIN MICROBIOL, V52, P607, DOI 10.1128/JCM.02749-13; Fuchs W, 2016, J EUR ACAD DERMATOL, V30, P995, DOI 10.1111/jdv.13539; Garbuglia AR, 2015, J CLIN VIROL, V72, P49, DOI 10.1016/j.jcv.2015.09.001; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Gonzalez C, 2013, INT J CANCER, V133, P1164, DOI 10.1002/ijc.28102; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Latsuzbaia A, 2016, DIAGN MICR INFEC DIS, V85, P318, DOI 10.1016/j.diagmicrobio.2016.04.011; Muller EE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1706-9; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Nagata N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137434; Northfelt DW, 1996, HEMATOL ONCOL CLIN N, V10, P1177, DOI 10.1016/S0889-8588(05)70392-0; PALEFSKY JM, 1994, J ACQ IMMUN DEF SYND, V7, P599; Richel O, ONE LESION ONE VIRUS; Sahasrabuddhe VV, 2013, J INFECT DIS, V207, P392, DOI 10.1093/infdis/jis694; Schofield AM, 2016, AIDS, V30, P1375, DOI 10.1097/QAD.0000000000001045; Shen-Gunther J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3612-y; Su JR, 2011, P 2011 NAT HIV PREV; Torres M, 2013, J CLIN MICROBIOL, V51, P3512, DOI 10.1128/JCM.01405-13; Zeier MD, 2015, AIDS, V29, P59, DOI 10.1097/QAD.0000000000000512	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186367	10.1371/journal.pone.0186367	http://dx.doi.org/10.1371/journal.pone.0186367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088236	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900010
J	Li, DP; Yu, HF; Lin, QX; Liu, Y				Li, Dongpu; Yu, Hongfei; Lin, Qinxiong; Liu, Yun			Doliroside A from Dolichos falcata Klein suppressing amyloid beta-protein 42 fibrillogenesis: An insight at molecular level	PLOS ONE			English	Article							NEUROTOXICITY; INFLAMMATION; INHIBITORS	A bioactive chemical constituent, doliroside A, from Chinese traditional herbal medicine Dolichos falcata Klein was isolated, purified and identified by 60% ethanol extraction, thin layer chromatography (TLC), high performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy. Molecular interaction mechanism between doliroside and amyloid beta 42 protein was evaluated by thioflavin T fluorescence (ThT), circular dichroism (CD), atomic force microscope (AFM), and differential scanning calorimeter (DSC) from the aspects of kinetics, secondary structure, morphology, and thermodynamics, respectively. Results show that the purity of doliroside A is 99.9% by HPLC, and its chemical structure is identified by 1 H-and 13 C-NMR. Doliroside A is observed to be concentrationdependent inhibiting the fibrillation of A beta 42 with the IC50 value of 26.57 +/- 1.6 mu M. CD and DSC results imply that doliroside A can bind to the nuclei and oligomers of A beta 42 to form a stable complex and suppress A beta 42 fibrillation. AFM images show that doliroside A, after bound to the nuclei and oligomers, redirect A beta 42 into off-pathway, amorphous oligomers. These findings not only provide a full insight into the molecular interaction mechanisms between A beta 42 and doliroside A, but also facilitate the development of new native anti-AD drug of doliroside A compound.	[Li, Dongpu] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China; [Yu, Hongfei; Liu, Yun] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing, Peoples R China; [Lin, Qinxiong] South Cent Univ Nationalities, Pharmaceut Coll, Wuhan, Peoples R China	Tianjin Medical University; Beijing University of Chemical Technology; South Central Minzu University	Liu, Y (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing, Peoples R China.	liuyun@mail.buct.edu.cn		Liu, Yun/0000-0002-7521-3831	Ministry of Finance; Ministry of Education of China; Beijing Municipal Natural Science Foundation [5142013]; Fundamental Research Funds for the Central Universities; South-Central University for Nationalities of China [CZY10014]	Ministry of Finance; Ministry of Education of China(Ministry of Education, China); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); South-Central University for Nationalities of China	This work was funded by the Ministry of Finance and the Ministry of Education of China. Additionally, this work was funded by the Beijing Municipal Natural Science Foundation (5142013 to YL) and the Fundamental Research Funds for the Central Universities, South-Central University for Nationalities of China (CZY10014 to QL). DSC equipments were provided by Prof. Zhaofeng Jiang and Dr. Ping Chang in Beijing Union University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The authors also acknowledge the long-term subsidy mechanism from the Ministry of Finance and the Ministry of Education of China for supporting AFM experiments. Additionally, this work was funded by the Beijing Municipal Natural Science Foundation (5142013) and the Fundamental Research Funds for the Central Universities, South-Central University for Nationalities of China (CZY10014). DSC equipments were provided by Prof. Zhaofeng Jiang and Dr. Ping Chang in Beijing Union University. The funders had no role in study design, data collection and analysis, decision to publish, or preparationof the manuscript. There was no additional external funding received for this study.	Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Barnham KJ, 2008, P NATL ACAD SCI USA, V105, P6813, DOI 10.1073/pnas.0800712105; Bieschke J, 2010, P NATL ACAD SCI US; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Chen LY, 2013, J ETHNOPHARMACOL, V150, P545, DOI 10.1016/j.jep.2013.08.063; Churches QI, 2014, BIOORG MED CHEM LETT, V24, P3108, DOI 10.1016/j.bmcl.2014.05.008; Cohen S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.183001; Du BS, 2014, INT IMMUNOPHARMACOL, V20, P221, DOI 10.1016/j.intimp.2014.02.036; Gao JJ, 2013, INTRACTABLE RARE DIS, V2, P3, DOI 10.5582/irdr.2013.v2.1.3; Ge JF, 2012, NEUROCHEM INT, V61, P1192, DOI 10.1016/j.neuint.2012.08.012; Gervais F, 2007, NEUROBIOL AGING, V28, P537, DOI 10.1016/j.neurobiolaging.2006.02.015; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Joshi P, 2014, CELL DEATH DIFFER, V21, P582, DOI 10.1038/cdd.2013.180; Kam TI, 2014, CELL MOL LIFE SCI, V71, P4803, DOI 10.1007/s00018-014-1706-0; Khallouki F, 2015, FOOD CHEM, V179, P191, DOI 10.1016/j.foodchem.2015.01.103; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Liang Y, 2010, J AM CHEM SOC, V132, P6306, DOI 10.1021/ja910964c; Lin YF, 2003, CHINESE DAI MED COLO, V6, P126; Liu Y, 2015, RSC ADV, V5, P62402, DOI 10.1039/c5ra09608a; Rajasekhar K, 2016, ACS CHEM NEUROSCI, V7, P1300, DOI 10.1021/acschemneuro.6b00175; Rajasekhar K, 2015, CHEM COMMUN, V51, P13434, DOI 10.1039/c5cc05264e; Rajasekhar K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08139; Ruggeri FS, 2015, ANGEW CHEM INT EDIT, V54, P2462, DOI 10.1002/anie.201409050; Ruszkowski P, 2014, MINI-REV ORG CHEM, V11, P307, DOI 10.2174/1570193X1103140915111559; Shimmyo Y, 2008, J NEUROSCI RES, V86, P368, DOI 10.1002/jnr.21476; State Administration of Traditional Chinese Medicine, 2005, CHIN MAT MED VOL DAI, P37; Tian HY, 2009, INTEGRATION CHINESE, P41; Viet MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079151; Wang SH, 2010, J PHYS CHEM B, V114, P11576, DOI 10.1021/jp1001435; Wei H, 2014, EUR J PHARMACOL, V740, P321, DOI 10.1016/j.ejphar.2014.07.023; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100787; Yu H.C., 2000, J CHIN NATL FOLK MED, V6, P339	33	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186590	10.1371/journal.pone.0186590	http://dx.doi.org/10.1371/journal.pone.0186590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084238	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200010
J	Lopez, JE; Jaradeh, K; Silva, E; Aminololama-Shakeri, S; Simpson, PC				Lopez, Javier E.; Jaradeh, Katrin; Silva, Emmanuel; Aminololama-Shakeri, Shadi; Simpson, Paul C.			A method to increase reproducibility in adult ventricular myocyte sizing and flow cytometry: Avoiding cell size bias in single cell preparations	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; GENE-EXPRESSION; IN-VIVO; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; MOUSE HEART; RAT-HEART; CARDIOMYOCYTES; SUBPOPULATION; ACCUMULATION	Rationale Flow cytometry (FCM) of ventricular myocytes (VMs) is an emerging technology in adult cardiac research that is challenged by the wide variety of VM shapes and sizes. Cellular variability and cytometer flow cell size can affect cytometer performance. These two factors of variance limit assay validity and reproducibility across laboratories. Washing and filtering of ventricular cells in suspension are routinely done to prevent cell clumping and minimize data variability without the appropriate standardization. We hypothesize that washing and filtering arbitrarily biases towards sampling smaller VMs than what actually exist in the adult heart. Objective To determine the impact of washing and filtering on adult ventricular cells for cell sizing and FCM. Methods and results Left ventricular cardiac cells in single-cell suspension were harvested from New Zealand White rabbits and fixed prior to analysis. Each ventricular sample was aliquoted before washing or filtering through a 40, 70, 100 or 200 mu m mesh. The outcomes of the study are VM volume by Coulter Multisizer and light-scatter signatures by FCM. Data are presented as mean +/- SD. Myocyte volumes without washing or filtering (NF) served as the "gold standard" within the sample and ranged from 11,017 to 46,926 mu m(3). Filtering each animal sample through a 200 mu m mesh caused no variation in the post-filtration volume (1.01+0.01 fold vs. NF, n = 4 rabbits, p = 0.999) with an intra-assay coefficient of variation (% CV) of <5% for all 4 samples. Filtering each sample through a 40, 70 or 100 mu m mesh invariably reduced the post-filtration volume by 41 +/- 10%, 9.0 +/- 0.8% and 8.8 +/- 0.8% respectively (n = 4 rabbits, p < 0.0001), and increased the %CV (18% to 1.3%). The high light-scatter signature by FCM, a simple parameter for the identification of ventricular myocytes, was measured after washing and filtering. Washing discarded VMs and filtering cells through a 40 or 100 mu m mesh reduced larger VM by 46% or 11% respectively (n = 6 from 2 rabbits, p < 0.001). Conclusion Washing and filtering VM suspensions through meshes 100 mu m or less biases myocyte volumes to smaller sizes, excludes larger cells, and increases VM variability. These findings indicate that validity and reproducibility across laboratories can be compromised unless cell preparation is standardized. We propose no wash prior to fixation and a 200 mu m mesh for filtrations to provide a reproducible standard for VM studies using FCM.	[Lopez, Javier E.; Jaradeh, Katrin; Silva, Emmanuel; Aminololama-Shakeri, Shadi] Univ Calif Davis, Davis, CA 95616 USA; [Simpson, Paul C.] VA Med Ctr, San Francisco, CA USA; [Simpson, Paul C.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California Davis; University of California System; University of California San Francisco	Lopez, JE (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	drjlopez@ucdavis.edu	Silva, Emmanuel/AAI-7244-2021	Silva, Emmanuel/0000-0002-6445-8243	Harold Amos Medical Faculty Development Program from the Robert Wood Johnson Foundation; Harold S. Geneen Charitable Trust Awards Program; National Center for Advancing Translational Sciences, NIH [UL1 TR001860, KL2 TR001859]; NIH [R01 HL31113]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001860, KL2TR001859] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031113] Funding Source: NIH RePORTER; Veterans Affairs [I01BX004314] Funding Source: NIH RePORTER	Harold Amos Medical Faculty Development Program from the Robert Wood Johnson Foundation; Harold S. Geneen Charitable Trust Awards Program; National Center for Advancing Translational Sciences, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported in part by the Harold Amos Medical Faculty Development Program from the Robert Wood Johnson Foundation (J.E.L.), Harold S. Geneen Charitable Trust Awards Program (J.E.L.), the National Center for Advancing Translational Sciences, NIH, grant number UL1 TR001860 and linked award KL2 TR001859 (J.E.L.), and NIH R01 HL31113 (P.C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Alvarez DF, 2010, AM J PHYSIOL-LUNG C, V298, pL127, DOI 10.1152/ajplung.00313.2009; ARMSTRONG SC, 1992, J MOL CELL CARDIOL, V24, P149, DOI 10.1016/0022-2828(92)93151-9; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; CAMPBELL SE, 1991, CIRC RES, V68, P984, DOI 10.1161/01.RES.68.4.984; Chen XW, 2016, CIRC RES, V119, P888, DOI 10.1161/CIRCRESAHA.116.309734; Collins FS, 2014, NATURE, P505; DeLaughter DM, 2016, DEV CELL, V39, P480, DOI 10.1016/j.devcel.2016.10.001; Diez C, 1998, CARDIOVASC RES, V40, P530, DOI 10.1016/S0008-6363(98)00189-8; Finak G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20686; Galbraith DW, 2000, FLOW CYTOMETRY CELL, P293; GERDES AM, 1986, ANAT RECORD, V215, P420, DOI 10.1002/ar.1092150414; Guo YX, 2017, CIRC RES, V120, P1874, DOI 10.1161/CIRCRESAHA.116.310283; Kraft T, 2016, CIRC RES, V119, P992, DOI 10.1161/CIRCRESAHA.116.309804; Lopez JE, 2017, J MOL CELL CARDIOL, V111, P114, DOI 10.1016/j.yjmcc.2017.07.012; Lopez JE, 2011, CIRC RES, V109, P629, DOI 10.1161/CIRCRESAHA.111.243410; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Myagmar BE, 2017, CIRC RES, V120, P1103, DOI 10.1161/CIRCRESAHA.117.310520; NAG AC, 1979, J ANAT, V129, P541; NASH GB, 1979, BIOCHIM BIOPHYS ACTA, V587, P99, DOI 10.1016/0304-4165(79)90224-1; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Pandya K, 2008, P NATL ACAD SCI USA, V105, P13063, DOI 10.1073/pnas.0805120105; Pandya K, 2006, P NATL ACAD SCI USA, V103, P16864, DOI 10.1073/pnas.0607700103; Picot J, 2012, CYTOTECHNOLOGY, V64, P109, DOI 10.1007/s10616-011-9415-0; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Pogwizd SM, 1999, CIRC RES, V85, P1009; POWELL T, 1976, BIOCHEM BIOPH RES CO, V72, P327, DOI 10.1016/0006-291X(76)90997-9; SCHIAFFINO S, 1989, CIRC RES, V64, P937, DOI 10.1161/01.RES.64.5.937; Sirish P, 2013, P NATL ACAD SCI USA, V110, P5618, DOI 10.1073/pnas.1221972110; Sirish P, 2012, J MOL CELL CARDIOL, V52, P264, DOI 10.1016/j.yjmcc.2011.10.012; Strijdom H, 2004, J MOL CELL CARDIOL, V37, P897, DOI 10.1016/j.yjmcc.2004.05.018; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186792	10.1371/journal.pone.0186792	http://dx.doi.org/10.1371/journal.pone.0186792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084228	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200013
J	Schomann, T; Mezzanotte, L; De Groot, JCMJ; Rivolta, MN; Hendriks, SH; Frijns, JHM; Huisman, MA				Schomann, Timo; Mezzanotte, Laura; De Groot, John C. M. J.; Rivolta, Marcelo N.; Hendriks, Sanne H.; Frijns, Johan H. M.; Huisman, Margriet A.			Neuronal differentiation of hair-follicle-bulge-derived stem cells co-cultured with mouse cochlear modiolus explants	PLOS ONE			English	Article							NEURAL CREST; EXTRACELLULAR-MATRIX; OTIC PLACODE; INNER-EAR; MIGRATION; NERVE; GROWTH; REPAIR; REGENERATION; EXPRESSION	Stem-cell-based repair of auditory neurons may represent an attractive therapeutic option to restore sensorineural hearing loss. Hair-follicle-bulge-derived stem cells (HFBSCs) are promising candidates for this type of therapy, because they (1) have migratory properties, enabling migration after transplantation, (2) can differentiate into sensory neurons and glial cells, and (3) can easily be harvested in relatively high numbers. However, HFBSCs have never been used for this purpose. We hypothesized that HFBSCs can be used for cellbased repair of the auditory nerve and we have examined their migration and incorporation into cochlear modiolus explants and their subsequent differentiation. Modiolus explants obtained from adult wild-type mice were cultured in the presence of EF1a-copGFP-transduced HFBSCs, constitutively expressing copepod green fluorescent protein (copGFP). Also, modiolus explants without hair cells were co-cultured with DCX-copGFP-transduced HFBSCs, which demonstrate copGFP upon doublecortin expression during neuronal differentiation. Velocity of HFBSC migration towards modiolus explants was calculated, and after two weeks, co-cultures were fixed and processed for immunohistochemical staining. EF1 alpha-copGFP HFBSC migration velocity was fast: 80.5 +/- 6.1 mu m/h. After arrival in the explant, the cells formed a fascicular pattern and changed their phenotype into an ATOH1-positive neuronal cell type. DCX-copGFP HFBSCs became green-fluorescent after integration into the explants, confirming neuronal differentiation of the cells. These results show that HFBSC-derived neuronal progenitors are migratory and can integrate into cochlear modiolus explants, while adapting their phenotype depending on this micro-environment. Thus, HFBSCs show potential to be employed in cell-based therapies for auditory nerve repair.	[Schomann, Timo; De Groot, John C. M. J.; Hendriks, Sanne H.; Frijns, Johan H. M.; Huisman, Margriet A.] Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, South Holland, Netherlands; [Mezzanotte, Laura] Erasmus MC, Dept Radiol, Opt Mol Imaging Grp, Rotterdam, South Holland, Netherlands; [Rivolta, Marcelo N.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield, S Yorkshire, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Sheffield	Huisman, MA (corresponding author), Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, South Holland, Netherlands.	M.A.Huisman@lumc.nl	Frijns, Johan H.M./H-6249-2011; Schomann, Timo/P-7294-2018	Frijns, Johan H.M./0000-0002-1180-3314; Schomann, Timo/0000-0002-0948-6209; Hendriks, Sanne H/0000-0002-0974-3666; Mezzanotte, Laura/0000-0001-5592-8904	MED-EL (Innsbruck, Austria)	MED-EL (Innsbruck, Austria)	The project is financially supported by grants from MED-EL (Innsbruck, Austria, http://www.medel.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project is financially supported by grants from MED-EL (Innsbruck, Austria). The authors have no other funding, financial relationships, or conflicts of interest to disclose. We greatly acknowledge Yuedan Li (Department of Immunohematology and Blood Transfusion, LUMC, Leiden, the Netherlands) for performing transduction of the HFBSCs and Martijn Rabelink (Department of Molecular Cell Biology, LUMC, Leiden, the Netherlands) for the production of the lentivirus.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2004, P NATL ACAD SCI USA, V101, P13291, DOI 10.1073/pnas.0405250101; Amoh Y, 2008, CELL CYCLE, V7, P1865, DOI 10.4161/cc.7.12.6056; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Baudoin JP, 2008, DEV NEUROSCI-BASEL, V30, P132, DOI 10.1159/000109858; Bhattacharyya S, 2004, CURR OPIN GENET DEV, V14, P520, DOI 10.1016/j.gde.2004.08.002; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Desban N, 2006, J CELL SCI, V119, P3206, DOI 10.1242/jcs.03057; El Seady R, 2008, BIOCHEM BIOPH RES CO, V376, P358, DOI 10.1016/j.bbrc.2008.08.166; Fournier BP, 2016, EUR CELLS MATER, V31, P40, DOI 10.22203/eCM.v031a04; Gho CG, 2016, CYTOTECHNOLOGY, V68, P1849, DOI 10.1007/s10616-015-9938-x; Groves AK, 2014, DEV BIOL, V389, P2, DOI 10.1016/j.ydbio.2013.11.027; Gu SQ, 2016, NUCLEIC ACIDS RES, V44, P5811, DOI 10.1093/nar/gkw497; Huisman Margriet A, 2012, Front Biosci (Schol Ed), V4, P121; Joo S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13043; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Lang HN, 2016, SPRINGER HANDB AUDIT, V52, P229, DOI 10.1007/978-1-4939-3031-9_8; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liu F, 2011, CELL CYCLE, V10, P830, DOI 10.4161/cc.10.5.14969; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Martin I, 2012, STEM CELL REV REP, V8, P1178, DOI 10.1007/s12015-012-9387-2; Mattotti M, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/2/026001; Maxwell GD, 1996, P NATL ACAD SCI USA, V93, P13274, DOI 10.1073/pnas.93.23.13274; Mezzanotte L, 2013, CONTRAST MEDIA MOL I, V8, P505, DOI 10.1002/cmmi.1549; Mii S, 2013, J CELL BIOCHEM, V114, P1674, DOI 10.1002/jcb.24509; Nayagam BA, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt135; Sandulache VC, 2007, TISSUE ENG, V13, P2791, DOI 10.1089/ten.2006.0412; Santi PA, 2016, JARO-J ASSOC RES OTO, V17, P159, DOI 10.1007/s10162-016-0562-z; Schiraldi C, 2012, EUR CELLS MATER, V24, P426, DOI 10.22203/eCM.v024a30; Schomann T, 2016, CONTRAST MEDIA MOL I, V11, P550, DOI 10.1002/cmmi.1717; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Steventon B, 2014, DEV BIOL, V389, P28, DOI 10.1016/j.ydbio.2014.01.021; Streit A, 2002, DEV BIOL, V249, P237, DOI 10.1006/dbio.2002.0739; Su WT, 2013, J BIOMED MATER RES A, V101, P185, DOI 10.1002/jbm.a.34318; Sugawara M, 2007, J COMP NEUROL, V501, P30, DOI 10.1002/cne.21227; Tennstaedt A, 2015, BIOMATERIALS, V44, P143, DOI 10.1016/j.biomaterials.2014.12.038; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Uchugonova A, 2011, CELL CYCLE, V10, P2017, DOI 10.4161/cc.10.12.15895; VERWOERD CDA, 1981, ACTA OTO-LARYNGOL, V91, P431, DOI 10.3109/00016488109138524; Wang LY, 2011, JARO-J ASSOC RES OTO, V12, P407, DOI 10.1007/s10162-011-0264-5; Yashiro M, 2015, CELL CYCLE, V14, P2362, DOI 10.1080/15384101.2015.1042633	45	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187183	10.1371/journal.pone.0187183	http://dx.doi.org/10.1371/journal.pone.0187183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084289	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000413910200038
J	Dong, S; Liu, LS; Ye, XM				Dong, Shuai; Liu, Lishuai; Ye, Xuemin			Linear stability analysis of magnetohydrodynamic duct flows with perfectly conducting walls	PLOS ONE			English	Article							HARTMANN LAYER; RECTANGULAR DUCT; CHANNEL FLOW; INSTABILITY; PERTURBATIONS; AMPLIFICATION; TRANSITION	The stability of magnetohydrodynamic flow in a duct with perfectly conducting walls is investigated in the presence of a homogeneous and constant static magnetic field. The temporal growth and spatial distribution of perturbations are obtained by solving iteratively the direct and adjoint governing equations with respect of perturbations, based on nonmodal stability theory. The effect of the applied magnetic field, as well as the aspect ratio of the duct on the stability of the magnetohydrodynamic duct flow is taken into account. The computational results show that, weak jets appear near the sidewalls at a moderate magnetic field and the velocity of the jet increases with the increase of the intensity of the magnetic field. The duct flow is stable at either weak or strong magnetic field, but becomes unstable at moderate intensity magnetic field, and the stability is invariance with the aspect ratio of the duct. The instability of magnetohydrodynamic duct flow is related with the exponential growth of perturbations evolving on the fully developed jets. Transient growth of perturbations is also observed in the computation and the optimal perturbation is found to be in the form of streamwise vortices and localized within the sidewall layers. By contrast, the Hartmann layer perpendicular to the magnetic field is irrelevant to the stability issue of the magnetohydrodynamic duct flow.	[Dong, Shuai; Liu, Lishuai; Ye, Xuemin] North China Elect Power Univ, Dept Power Engn, Baoding 071003, Peoples R China	North China Electric Power University	Dong, S (corresponding author), North China Elect Power Univ, Dept Power Engn, Baoding 071003, Peoples R China.	shuai.dong@ncepu.edu	Dong, Shuai/D-3936-2017	Dong, Shuai/0000-0002-2099-8555	National Natural Science Foundation of China [11302076]; Natural Science Foundation of Hebei Province [A2014502047]; Fundamental Research Funds for the Central Universities [2014MS111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors would like to thank the support of the National Natural Science Foundation of China (No. 11302076) to SD, the Natural Science Foundation of Hebei Province (No. A2014502047) to SD and the Fundamental Research Funds for the Central Universities (No. 2014MS111) to SD.; The authors would like to thank the support of the National Natural Science Foundation of China (No. 11302076), the Natural Science Foundation of Hebei Province (No. A2014502047) and the Fundamental Research Funds for the Central Universities (No. 2014MS111). The work was carried out at National Supercomputer Center in Tianjin, and the calculations were performed on TianHe-1(A).	Airiau C, 2004, PHYS FLUIDS, V16, P2991, DOI 10.1063/1.1765645; Biau D, 2008, J FLUID MECH, V596, P133, DOI 10.1017/S0022112007009536; Braiden L, 2016, EPL-EUROPHYS LETT, V115, DOI 10.1209/0295-5075/115/44002; BRANOVER H., 1978, MAGNETOHYDRODYNAMIC; BUTLER KM, 1992, PHYS FLUIDS A-FLUID, V4, P1637, DOI 10.1063/1.858386; Davidson PA., 2001, INTRO MAGNETOHYDRODY; Dong S, 2017, J APPL FLUID MECH, V10, P1293, DOI 10.18869/acadpub.jafm.73.242.27310; Dong S, 2015, MAGNETOHYDRODYNAMICS, V51, P225, DOI 10.22364/mhd.51.2.6; Dong S, 2016, EUR J MECH B-FLUID, V60, P209, DOI 10.1016/j.euromechflu.2016.06.008; Gerard-Varet D, 2002, PHYS FLUIDS, V14, P1458, DOI 10.1063/1.1456512; Hartmann J., 1937, KGL DAN VIDENSK SELS, V15, P1; HUNT JCR, 1965, J FLUID MECH, V21, P577, DOI 10.1017/S0022112065000344; Kinet M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.154501; Krasnov D, 2010, J FLUID MECH, V653, P273, DOI 10.1017/S0022112010000273; Krasnov DS, 2004, J FLUID MECH, V504, P183, DOI 10.1017/S0022112004008006; LANDAHL MT, 1980, J FLUID MECH, V98, P243, DOI 10.1017/S0022112080000122; Lingwood RJ, 1999, PHYS FLUIDS, V11, P2058, DOI 10.1063/1.870068; MOLOKOV S., 2007, MAGNETOHYDRODYNAMICS; Moresco P, 2004, J FLUID MECH, V504, P167, DOI 10.1017/S0022112004007992; MULLER U., 2001, MAGNETOFLUIDDYNAMICS; MURGATROYD W, 1953, PHILOS MAG, V44, P1348; Orr W. M., 1907, P ROY IRISH ACAD A, V27, P9; Priede J, 2012, J FLUID MECH, V708, P111, DOI 10.1017/jfm.2012.276; Reddy SC, 1998, J FLUID MECH, V365, P269, DOI 10.1017/S0022112098001323; SCHMID P., 2001, STABILITY TRANSITION; Schmid PJ, 2007, ANNU REV FLUID MECH, V39, P129, DOI 10.1146/annurev.fluid.38.050304.092139; SHERCLIFF JA, 1953, P CAMB PHILOS SOC, V49, P136, DOI 10.1017/S0305004100028139; TATSUMI T, 1990, J FLUID MECH, V212, P437, DOI 10.1017/S002211209000204X; Uhlmann M, 2006, J FLUID MECH, V551, P387, DOI 10.1017/S0022112005008487; Zikanov O, 2014, APPL MECH REV, V66, DOI 10.1115/1.4027198	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186944	10.1371/journal.pone.0186944	http://dx.doi.org/10.1371/journal.pone.0186944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077734	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200028
J	Kaza, N; Raju, SV; Cadillac, JM; Trombley, JA; Rasmussen, L; Tang, LP; Dohm, E; Harrod, KS; Rowe, SM				Kaza, Niroop; Raju, S. Vamsee; Cadillac, Joan M.; Trombley, John A.; Rasmussen, Lawrence; Tang, Liping; Dohm, Erik; Harrod, Kevin S.; Rowe, Steven M.			Use of ferrets for electrophysiologic monitoring of ion transport	PLOS ONE			English	Article							POTENTIAL DIFFERENCE MEASUREMENTS; OBSTRUCTIVE PULMONARY-DISEASE; CYSTIC-FIBROSIS MICE; ANIMAL-MODELS; KNOCKOUT FERRETS; EPITHELIAL-CELLS; CFTR MODULATORS; AIRWAY; ABNORMALITIES; PHENOTYPE	Limited success achieved in translating basic science discoveries into clinical applications for chronic airway diseases is attributed to differences in respiratory anatomy and physiology, poor approximation of pathologic processes, and lack of correlative clinical endpoints between humans and laboratory animal models. Here, we discuss advantages of using ferrets (Mustela putorus furo) as a model for improved understanding of human airway physiology and demonstrate assays for quantifying airway epithelial ion transport in vivo and ex vivo, and establish air-liquid interface cultures of ferret airway epithelial cells as a complementary in vitro model for mechanistic studies. We present data here that establishes the feasibility of measuring these human disease endpoints in ferrets. Briefly, potential difference across the nasal and the lower airway epithelium in ferrets could be consistently assessed, were highly reproducible, and responsive to experimental interventions. Additionally, ferret airway epithelial cells were amenable to primary cell culture methods for in vitro experiments as was the use of ferret tracheal explants as an ex vivo system for assessing ion transport. The feasibility of conducting multiple assessments of disease outcomes supports the adoption of ferrets as a highly relevant model for research in obstructive airway diseases.	[Kaza, Niroop; Raju, S. Vamsee; Rasmussen, Lawrence; Tang, Liping; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kaza, Niroop; Raju, S. Vamsee; Rasmussen, Lawrence; Tang, Liping; Rowe, Steven M.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35487 USA; [Cadillac, Joan M.; Dohm, Erik] Univ Alabama Birmingham, Anim Resources Program, Birmingham, AL USA; [Trombley, John A.; Harrod, Kevin S.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Rowe, SM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.; Rowe, SM (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35487 USA.	smrowe@uab.edu		Harrod, Kevin/0000-0003-0780-9470; Rowe, Steven/0000-0001-9045-0133; Kaza, Niroop/0000-0002-7584-1379; Dohm, Erik/0000-0001-7477-6264	National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK072482]; National Heart, Lung, and Blood Institute [1R01 HL105487, CFF R262]; American Lung Associationm [RG-305752]; Flight Attendants Medical Research Association [YFA130008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135816] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Associationm; Flight Attendants Medical Research Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, Grant P30 DK072482 (SMR), the National Heart, Lung, and Blood Institute grant 1R01 HL105487 (SMR),CFF R262 (SMR), American Lung Associationm, Grant RG-305752 (SVR), Flight Attendants Medical Research Association Grant, Grant YFA130008 (SVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton E, 2016, RANDOMISED DOUBLE BL; Bouvier NM, 2015, CURR OPIN VIROL, V13, P101, DOI 10.1016/j.coviro.2015.06.002; CORRALES RJ, 1986, J APPL PHYSIOL, V61, P1065, DOI 10.1152/jappl.1986.61.3.1065; Davies JC, 2005, AM J RESP CRIT CARE, V171, P1015, DOI 10.1164/rccm.200408-1116OC; Dransfield MT, 2013, CHEST, V144, P498, DOI 10.1378/chest.13-0274; Fisher JT, 2013, AM J RESP CELL MOL, V49, P837, DOI 10.1165/rcmb.2012-0433OC; Fisher JT, 2011, METHODS MOL BIOL, V742, P311, DOI 10.1007/978-1-61779-120-8_19; Flisikowska T, 2014, J APPL GENET, V55, P53, DOI 10.1007/s13353-013-0182-9; Fricker M, 2014, EXPERT OPIN DRUG DIS, V9, P629, DOI 10.1517/17460441.2014.909805; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Gohy ST, 2016, CLIN EXP ALLERGY, V46, P529, DOI 10.1111/cea.12712; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; GRUBB BR, 1994, AM J PHYSIOL, V267, pC293, DOI 10.1152/ajpcell.1994.267.1.C293; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Keiser NW, 2011, CURR OPIN PULM MED, V17, P478, DOI 10.1097/MCP.0b013e32834b14c9; Kent G, 1996, PEDIATR RES, V40, P233, DOI 10.1203/00006450-199608000-00008; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; Mou HM, 2016, CELL STEM CELL, V19, P217, DOI 10.1016/j.stem.2016.05.012; Neuberger T, 2011, METHODS MOL BIOL, V741, P39, DOI 10.1007/978-1-61779-117-8_4; Nikula KJ, 2000, INHAL TOXICOL, V12, P123, DOI 10.1080/089583700750019549; Plourde JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046605; Pyle LC, 2011, AM J PHYSIOL-LUNG C, V301, pL587, DOI 10.1152/ajplung.00465.2010; Radigan KA, 2015, INFECT DRUG RESIST, V8, P311, DOI 10.2147/IDR.S58551; Raju SV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87536; Rowe SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066955; Rowe SM, 2013, CHEST, V144, P200, DOI 10.1378/chest.12-2431; Rowe SM, 2011, METHODS MOL BIOL, V741, P69, DOI 10.1007/978-1-61779-117-8_6; Saussereau EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057317; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; Solomon GM, 2010, CHEST, V138, P919, DOI 10.1378/chest.10-0179; Sun XS, 2014, AM J RESP CELL MOL, V50, P502, DOI 10.1165/rcmb.2013-0261OC; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Tang XX, 2016, J CLIN INVEST, V126, P879, DOI 10.1172/JCI83922; Tuggle KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091253; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vlahos R, 2015, EUR J PHARMACOL, V759, P265, DOI 10.1016/j.ejphar.2015.03.029	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186984	10.1371/journal.pone.0186984	http://dx.doi.org/10.1371/journal.pone.0186984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077751	gold, Green Published, Green Submitted			2022-12-27	WOS:000413861200033
J	Gabriel, BM; Al-Tarrah, M; Alhindi, Y; Kilikevicius, A; Venckunas, T; Gray, SR; Lionikas, A; Ratkevicius, A				Gabriel, Brendan M.; Al-Tarrah, Mustafa; Alhindi, Yosra; Kilikevicius, Audrius; Venckunas, Tomas; Gray, Stuart R.; Lionikas, Arimantas; Ratkevicius, Aivaras			H55N polymorphism is associated with low citrate synthase activity which regulates lipid metabolism in mouse muscle cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; OXIDATION; RESISTANCE; MODEL	The H55N polymorphism in the Cs gene of A/J mice has been linked to low activity of the enzyme in skeletal muscles. The aim of the study was to test this hypothesis and examine effects of low citrate synthase (CS) activity on palmitate metabolism in muscle cells. Results of the study showed that carriers of the wild type (WT) Cs (C57BL/6J and Balb/cByJ mouse strains) had higher CS activity (p< 0.01) than carriers of the A/J variant (B6.A-(rs3676616-D10Utsw1)/KjnB6 and A/J mouse strains) in the heart, liver and gastrocnemius muscle. Furthermore, the recombinant CS protein of WT showed higher CS activity than the A/J variant. In C2C12 muscle cells the shRNA mediated 47% knockdown of CS activity reduced the rate of fatty acid oxidation compared to the control cells. In summary, our results are consistent with the hypothesis that H55N substitution causes a reduction in CS activity. Furthermore, low CS activity interferes with metabolic flexibility of muscle cells.	[Gabriel, Brendan M.; Al-Tarrah, Mustafa; Alhindi, Yosra; Lionikas, Arimantas] Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland; [Gabriel, Brendan M.] Karolinska Inst, Dept Physiol & Pharmacol, Integrat Physiol, Stockholm, Sweden; [Kilikevicius, Audrius; Venckunas, Tomas; Ratkevicius, Aivaras] Lithuanian Sports Univ, Dept Appl Biol & Rehabil, Kaunas, Lithuania; [Gray, Stuart R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Aberdeen; Karolinska Institutet; Lithuanian Sports University; University of Glasgow	Ratkevicius, A (corresponding author), Lithuanian Sports Univ, Dept Appl Biol & Rehabil, Kaunas, Lithuania.	Aivaras.Ratkevicius@lsu.lt	Alhindi, Yosra/AAD-4804-2021; Gabriel, Brendan/AAH-2625-2019; Gray, Stuart/L-2489-2017	Alhindi, Yosra/0000-0002-5725-3522; Gabriel, Brendan/0000-0001-6878-8779; Gray, Stuart/0000-0001-8969-9636	European Social Fund under Global Grant measure Grant [VP1-3.1-SMM-07-K-02-057]; European Foundation for the Study of Diabetes; NHS Grampian Endowment grant; Kuwait Ministry of Health; Saudi Ministry of Higher Education; Wenner-Gren Foundation Postdoctoral Fellowship; Albert Renold Travel Fellowship; Novo Nordisk Foundation Challenge Grant; Saltire scholarship	European Social Fund under Global Grant measure Grant; European Foundation for the Study of Diabetes; NHS Grampian Endowment grant; Kuwait Ministry of Health; Saudi Ministry of Higher Education; Wenner-Gren Foundation Postdoctoral Fellowship; Albert Renold Travel Fellowship; Novo Nordisk Foundation Challenge Grant; Saltire scholarship	This work was supported, in whole or in part, by European Social Fund under the Global Grant measure Grant VP1-3.1-SMM-07-K-02-057 (to A.L.), European Foundation for the Study of Diabetes grant (to T.V.), NHS Grampian Endowment grant (to A.R. and S.R.G.), Kuwait Ministry of Health grant (to M.A.), Saudi Ministry of Higher Education grant (to Y.A.,) as well as Saltire scholarship, Wenner-Gren Foundation Postdoctoral Fellowship, Albert Renold Travel Fellowship and a Novo Nordisk Foundation Challenge Grant (to B.G.).	Blomstrand E, 1997, ACTA PHYSIOL SCAND, V159, P41, DOI 10.1046/j.1365-201X.1997.547327000.x; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Fischer K, 2010, MOL ENDOCRINOL, V24, P1935, DOI 10.1210/me.2010-0005; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Haslbeck M, 2003, J CHROMATOGR B, V786, P127, DOI 10.1016/S1570-0232(02)00716-X; Henique C, 2010, J BIOL CHEM, V285, P36818, DOI 10.1074/jbc.M110.170431; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Houmard JA, 2008, AM J PHYSIOL-REG I, V294, pR1111, DOI 10.1152/ajpregu.00396.2007; Iommarini L, 2015, MITOCHONDRION, V22, P96, DOI 10.1016/j.mito.2015.01.008; Jacobs RA, 2013, EXP PHYSIOL, V98, P908, DOI 10.1113/expphysiol.2012.070037; Jeukendrup AE, 2002, ANN NY ACAD SCI, V967, P217; Johnson KR, 2012, NEUROBIOL AGING, V33, P1720, DOI 10.1016/j.neurobiolaging.2011.05.009; Kilikevicius A, 2013, SCAND J MED SCI SPOR, V23, P657, DOI 10.1111/j.1600-0838.2012.01451.x; KURZ LC, 1995, BIOCHEMISTRY-US, V34, P13278, DOI 10.1021/bi00041a003; Leibowitz SF, 2005, BRAIN RES, V1047, P137, DOI 10.1016/j.brainres.2005.03.047; Lin CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00785; Lipina C, 2013, DIABETES, V62, P3426, DOI 10.2337/db13-0264; Martin-Granados C, 2008, INT J BIOCHEM CELL B, V40, P2315, DOI 10.1016/j.biocel.2008.03.021; Ortenblad N, 2005, BBA-MOL BASIS DIS, V1741, P206, DOI 10.1016/j.bbadis.2005.04.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POGSON CI, 1966, BIOCHEM J, V100, P683, DOI 10.1042/bj1000683; Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE31, DOI 10.1152/ajpendo.00609.2011; Ratkevicius A, 2010, PHYSIOL GENOMICS, V42A, P96, DOI 10.1152/physiolgenomics.00066.2010; Saha AK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1030, DOI 10.1152/ajpendo.1999.276.6.E1030; Vigelso Andreas, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P84; Watt KI, 2010, MUSCLE NERVE, V41, P624, DOI 10.1002/mus.21573	27	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0185789	10.1371/journal.pone.0185789	http://dx.doi.org/10.1371/journal.pone.0185789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095821	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000414340200008
J	Schumacher, LL; Huss, AR; Cochrane, RA; Stark, CR; Woodworth, JC; Bai, JF; Poulsen, EG; Chen, Q; Main, RG; Zhang, JQ; Gauger, PC; Ramirez, A; Derscheid, RJ; Magstadt, DM; Dritz, SS; Jones, CK				Schumacher, Loni L.; Huss, Anne R.; Cochrane, Roger A.; Stark, Charles R.; Woodworth, Jason C.; Bai, Jianfa; Poulsen, Elizabeth G.; Chen, Qi; Main, Rodger G.; Zhang, Jianqiang; Gauger, Phillip C.; Ramirez, Alejandro; Derscheid, Rachel J.; Magstadt, Drew M.; Dritz, Steve S.; Jones, Cassandra K.			Characterizing the rapid spread of porcine epidemic diarrhea virus (PEDV) through an animal food manufacturing facility	PLOS ONE			English	Article							UNITED-STATES; FEED MILLS; SURVIVAL; NOROVIRUS; SURFACES; DISEASE; SWINE	New regulatory and consumer demands highlight the importance of animal feed as a part of our national food safety system. Porcine epidemic diarrhea virus (PEDV) is the first viral pathogen confirmed to be widely transmissible in animal food. Because the potential for viral contamination in animal food is not well characterized, the objectives of this study were to 1) observe the magnitude of virus contamination in an animal food manufacturing facility, and 2) investigate a proposed method, feed sequencing, to decrease virus decontamination on animal food-contact surfaces. A U.S. virulent PEDV isolate was used to inoculate 50 kg swine feed, which was mixed, conveyed, and discharged into bags using pilot-scale feed manufacturing equipment. Surfaces were swabbed and analyzed for the presence of PEDV RNA by quantitative real-time polymerase chain reaction (qPCR). Environmental swabs indicated complete contamination of animal food-contact surfaces (0/40 vs. 48/48, positive baseline samples/total baseline samples, positive subsequent samples/total subsequent samples, respectively; P< 0.05) and near complete contamination of non-animal food-contact surfaces (0/24 vs. 16/18, positive baseline samples/total baseline samples, positive subsequent samples/total subsequent samples, respectively; P< 0.05). Flushing animal food-contact surfaces with low-risk feed is commonly used to reduce cross-contamination in animal feed manufacturing. Thus, four subsequent 50 kg batches of virus-free swine feed were manufactured using the same system to test its impact on decontaminating animal food-contact surfaces. Even after 4 subsequent sequences, animal food-contact surfaces retained viral RNA (28/33 positive samples/total samples), with conveying system being more contaminated than the mixer. A bioassay to test infectivity of dust from animal food-contact surfaces failed to produce infectivity. This study demonstrates the potential widespread viral contamination of surfaces in an animal food manufacturing facility and the difficulty of removing contamination using conventional feed sequencing, which underscores the importance for preventing viruses from entering and contaminating such facilities.	[Schumacher, Loni L.; Bai, Jianfa; Poulsen, Elizabeth G.; Dritz, Steve S.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Huss, Anne R.; Stark, Charles R.] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA; [Cochrane, Roger A.; Woodworth, Jason C.; Jones, Cassandra K.] Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA; [Chen, Qi; Main, Rodger G.; Zhang, Jianqiang; Gauger, Phillip C.; Ramirez, Alejandro; Derscheid, Rachel J.; Magstadt, Drew M.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Huss, Anne R.] BioMatrix Int, Princeton, MN USA	Kansas State University; Kansas State University; Kansas State University; Iowa State University	Jones, CK (corresponding author), Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA.	jonesc@ksu.edu	Derscheid, Rachel/AAV-9043-2021; Bai, Jianfa/M-7830-2019; Gauger, Phillip/AAQ-9806-2021	Bai, Jianfa/0000-0002-0021-3036; Dritz, Steve/0000-0001-6371-0729	National Pork Board [14-273]	National Pork Board	This work was supported by the National Pork Board to JCW, 14-273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120532; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Bowman AS, 2015, VET MICROBIOL, V179, P213, DOI 10.1016/j.vetmic.2015.05.027; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Cochrane R. A, 2015, THESIS; Cochrane RA, 2016, J SWINE HEALTH PROD, V24, P154; Davies PR, 2015, PREV VET MED, V122, P235, DOI 10.1016/j.prevetmed.2015.08.006; de Graaf M, 2016, NAT REV MICROBIOL, V14, P421, DOI 10.1038/nrmicro.2016.48; Dee S, 2014, BMC VET RES, P10; Dee S, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0176-9; Fairchild F, 2005, FEED MANUFACTURING T, P203; GERBA CP, 1984, ADV APPL MICROBIOL, V30, P133, DOI 10.1016/S0065-2164(08)70054-6; Greiner LL, 2016, J SWINE HEALTH PROD, V24, P198; Herrman T., 1995, Kansas State University Swine Day 1995. Report of Progress 746, P127; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; HURST CJ, 1980, APPL ENVIRON MICROB, V40, P1067, DOI 10.1128/AEM.40.6.1067-1079.1980; HURST CJ, 1980, APPL ENVIRON MICROB, V40, P192, DOI 10.1128/AEM.40.2.192-200.1980; Huss AR, 2015, J FOOD PROTECT, V78, P1682, DOI 10.4315/0362-028X.JFP-15-052; Huss AR, 2016, P MIS SEC AM SOC AN; Huss AR, PLOS ONE, V12; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lacroix-Gueu P, 2005, CR BIOL, V328, P1065, DOI 10.1016/j.crvi.2005.09.010; Malek Mark, 2009, Clin Infect Dis, V48, P31, DOI 10.1086/594118; McCoy R. A., 2005, FEED MANUFACTURING T, P620; McDaniel GL, 2005, FEED MANUFACTURING T, P238; Nelson J, 2014, 23 INT PIG VET SOC C; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; Schumacher LL, AM J VET RE IN PRESS; Thomas JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139266; Vasickova P, 2010, FOOD ENVIRON VIROL, V2, P24, DOI 10.1007/s12560-010-9025-6; Vega E, 2008, J FOOD PROTECT, V71, P522, DOI 10.4315/0362-028X-71.3.522; Widdowson MA, 2005, EMERG INFECT DIS, V11, P95, DOI 10.3201/eid1101.040426	33	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187309	10.1371/journal.pone.0187309	http://dx.doi.org/10.1371/journal.pone.0187309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095859	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200069
J	Smith, RL; Tan, JME; Jonker, MJ; Jongejan, A; Buissink, T; Veldhuijzen, S; van Kampen, AHC; Brul, S; van der Spek, H				Smith, Reuben L.; Tan, Josephine M. E.; Jonker, Martijs J.; Jongejan, Aldo; Buissink, Thomas; Veldhuijzen, Steve; van Kampen, Antoine H. C.; Brul, Stanley; van der Spek, Hans			Beyond the polymerase-gamma theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; ANTIVIRAL NUCLEOSIDE ANALOGS; INCREASING OXIDATIVE STRESS; ELEGANS LIFE-SPAN; CAENORHABDITIS-ELEGANS; C. ELEGANS; SUPEROXIDE-PRODUCTION; DNA POLYMERASE; COMPLEX-I; VITAMIN-E	Use of some HIV-1 nucleoside reverse transcriptase inhibitors (NRTI) is associated with severe adverse events. However, the exact mechanisms behind their toxicity has not been fully understood. Mitochondrial dysfunction after chronic exposure to specific NRTIs has predominantly been assigned to mitochondrial polymerase-gamma inhibition by NRTIs. However, an increasing amount of data suggests that this is not the sole mechanism. Many NRTI induced adverse events have been linked to the incurrence of oxidative stress, although the causality of events leading to reactive oxygen species (ROS) production and their role in toxicity is unclear. In this study we show that short-term effects of first generation NRTIs, which are rarely discussed in the literature, include inhibition of oxygen consumption, decreased ATP levels and increased ROS production. Collectively these events affect fitness and longevity of C. elegans through mitohormetic signalling events. Furthermore, we demonstrate that these effects can be normalized by addition of the anti-oxidant N-acetylcysteine (NAC), which suggests that ROS likely influence the onset and severity of adverse events upon drug exposure.	[Smith, Reuben L.; Tan, Josephine M. E.; Buissink, Thomas; Veldhuijzen, Steve; Brul, Stanley; van der Spek, Hans] Univ Amsterdam, SILS, Fac Sci FNWI, Mol Biol & Microbial Food Safety, Amsterdam, Netherlands; [Jonker, Martijs J.] Univ Amsterdam, SILS, Fac Sci FNWI, RNA Biol & Appl Bioinformat, Amsterdam, Netherlands; [Jongejan, Aldo; van Kampen, Antoine H. C.] AMC, Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, Amsterdam, Netherlands; [van Kampen, Antoine H. C.] Univ Amsterdam, SILS, Fac Sci FNWI, Biosyst Data Anal, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Smith, RL (corresponding author), Univ Amsterdam, SILS, Fac Sci FNWI, Mol Biol & Microbial Food Safety, Amsterdam, Netherlands.	r.l.smith@amc.uva.nl		Tan, Josephine M.E./0000-0003-2534-3029				Allard JP, 1998, AIDS, V12, P1653, DOI 10.1097/00002030-199813000-00013; Ames BN, 2010, MECH AGEING DEV, V131, P473, DOI 10.1016/j.mad.2010.04.005; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Anders S., 2014, BIORXIV; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson PL, 2004, CLIN INFECT DIS, V38, P743, DOI 10.1086/381678; Apostolova N, 2011, TRENDS PHARMACOL SCI, V32, P715, DOI 10.1016/j.tips.2011.07.007; Apostolova N, 2011, CURR PHARM DESIGN, V17, P2130, DOI 10.2174/138161211796904731; Back P, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/608478; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112; Baruah A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004097; Blas-Garcia A, 2011, CURR PHARM DESIGN, V17, P4076, DOI 10.2174/138161211798764951; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; Burns AR, 2010, NAT CHEM BIOL, V6, P549, DOI [10.1038/NCHEMBIO.380, 10.1038/nchembio.380]; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cote HCF, 2005, ANTIVIR THER, V10, pM3; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Day Brian J, 2004, Cardiovasc Toxicol, V4, P207, DOI 10.1385/CT:4:3:207; de Boer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126220; de la Asuncion JG, 2004, LIFE SCI, V76, P47, DOI 10.1016/j.lfs.2004.06.020; Droge W, 1999, Curr Opin Clin Nutr Metab Care, V2, P493, DOI 10.1097/00075197-199911000-00011; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hasegawa K, 2007, TOXICOL LETT, V175, P82, DOI 10.1016/j.toxlet.2007.09.013; Holden-Dye L, 2007, ANTHELMINTIC DRUGS; Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655; Hukezalie KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047505; Jiang B, 2007, TOXICOL APPL PHARM, V224, P60, DOI 10.1016/j.taap.2007.06.010; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kline ER, 2009, CARDIOVASC TOXICOL, V9, P1, DOI 10.1007/s12012-008-9029-8; Lagido Cristina, 2008, BMC Physiology, V8, P7, DOI 10.1186/1472-6793-8-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawless J., 2011, STAT MODELS METHODS, P1982; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Lopez O, 2003, BIOMED PHARMACOTHER, V57, P113, DOI 10.1016/S0753-3322(03)00017-9; Lund KC, 2008, TOXICOL APPL PHARM, V226, P94, DOI 10.1016/j.taap.2007.08.015; Lund Kaleb C, 2004, Cardiovasc Toxicol, V4, P217, DOI 10.1385/CT:4:3:217; Luz AL, 2016, MITOCHONDRION, V30, P255, DOI 10.1016/j.mito.2016.08.014; Mallon PWG, 2005, J INFECT DIS, V191, P1686, DOI 10.1086/429697; Manda KR, 2011, FREE RADICAL BIO MED, V50, P801, DOI 10.1016/j.freeradbiomed.2010.12.029; Mandas A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/749575; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Mehta S, 2007, VITAM HORM, V75, P355, DOI 10.1016/s0083-6729(06)75013-0; Milazzo L, 2010, AIDS RES HUM RETROV, V26, P1207, DOI 10.1089/aid.2010.0024; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Miyako K, 1997, J BIOL CHEM, V272, P9605; Mondal Debasis, 2004, Cardiovasc Toxicol, V4, P287, DOI 10.1385/CT:4:3:287; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Munkacsy E, 2014, EXP GERONTOL, V56, P221, DOI 10.1016/j.exger.2014.03.016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nazir A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015312; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; PALMEIRA CM, 1995, BBA-BIOENERGETICS, V1229, P187, DOI 10.1016/0005-2728(94)00202-G; Pan-Zhou XR, 2000, ANTIMICROB AGENTS CH, V44, P496, DOI 10.1128/AAC.44.3.496-503.2000; Patrick L, 1999, Altern Med Rev, V4, P403; Patrick L, 2000, Altern Med Rev, V5, P39; Patrick L, 2000, Altern Med Rev, V5, P290; Pereira LF, 1998, CELL BIOCHEM FUNCT, V16, P173, DOI 10.1002/(SICI)1099-0844(199809)16:3<173::AID-CBF783>3.3.CO;2-W; Pulliam DA, 2013, ANTIOXID REDOX SIGN, V19, P1373, DOI 10.1089/ars.2012.4950; Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Segref A, 2014, CELL METAB, V19, P642, DOI 10.1016/j.cmet.2014.01.016; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Smith Reuben L., 2013, Frontiers in Genetics, V3, P328, DOI 10.3389/fgene.2012.00328; Stankov MV, 2010, ANTIMICROB AGENTS CH, V54, P280, DOI 10.1128/AAC.00914-09; Sun R, 2014, ANTIMICROB AGENTS CH, V58, P6758, DOI 10.1128/AAC.03613-14; Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Valenti D, 2000, INT J MOL MED, V6, P93; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Varghese F, 2015, HUM MOL GENET, P1; Viengchareun S, 2007, ANTIVIR THER, V12, P919; Wang L, 2011, ANTIMICROB AGENTS CH, V55, P2552, DOI 10.1128/AAC.00109-11; Wang XW, 2009, AM J PATHOL, V174, P771, DOI 10.2353/ajpath.2009.080157; Xue SY, 2013, TOXICOL SCI, V134, P323, DOI 10.1093/toxsci/kft105; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055	95	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187424	10.1371/journal.pone.0187424	http://dx.doi.org/10.1371/journal.pone.0187424			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095935	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200087
J	Ushiyama, A; Tajima, A; Ishikawa, N; Asano, A				Ushiyama, Ai; Tajima, Atsushi; Ishikawa, Naoto; Asano, Atsushi			Characterization of the functions and proteomes associated with membrane rafts in chicken sperm	PLOS ONE			English	Article							DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS; PLASMA-MEMBRANE; CHOLESTEROL DEPLETION; ANCHORED PROTEINS; TRITON X-100; MOUSE; MOTILITY; BINDING; IDENTIFICATION	Cellular membranes are heterogeneous, and this has a great impact on cellular function. Despite the central role of membrane functions in multiple cellular processes in sperm, their molecular mechanisms are poorly understood. Membrane rafts are specific membrane domains enriched in cholesterol, ganglioside G(M1), and functional proteins, and they are involved in the regulation of a variety of cellular functions. Studies of the functional characterization of membrane rafts in mammalian sperm have demonstrated roles in sperm-egg binding and the acrosomal reaction. Recently, our biochemical and cell biological studies showed that membrane rafts are present and might play functional roles in chicken sperm. In this study, we isolated membrane rafts from chicken sperm as a detergent-resistant membranes (DRM) floating on a density gradient in the presence of 1% Triton X-100, and characterized the function and proteomes associated with these domains. Biochemical comparison of the DRM between fresh and cryopreserved sperm demonstrated that cryopreservation induces cholesterol loss specifically from membrane rafts, indicating the functional connection with reduced post-thaw fertility in chicken sperm. Furthermore, using an avidin-biotin system, we found that sperm DRM is highly enriched in a 60 KDa single protein able to bind to the inner perivitelline layer. To identify possible roles of membrane rafts, quantitative proteomics, combined with a stable isotope dimethyl labeling approach, identified 82 proteins exclusively or relatively more associated with membrane rafts. Our results demonstrate the functional distinctions between membrane domains and provide compelling evidence that membrane rafts are involved in various cellular pathways inherent to chicken sperm.	[Ushiyama, Ai] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan; [Tajima, Atsushi; Ishikawa, Naoto; Asano, Atsushi] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Asano, A (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan.	asano.atsushi.ft@u.tsukuba.ac.jp			JSPS KAKENHI [15K07761]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	JSPS KAKENHI (Grant number 15K07761 to AA) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral A, 2014, HUM REPROD UPDATE, V20, P40, DOI 10.1093/humupd/dmt046; Asano A, 2016, J POULT SCI, V53, P233, DOI 10.2141/jpsa.0150160; Asano A, 2013, J BIOL CHEM, V288, P28104, DOI 10.1074/jbc.M113.450981; Asano A, 2010, PROTEOMICS, V10, P3494, DOI 10.1002/pmic.201000002; Asano A, 2009, J CELL PHYSIOL, V218, P537, DOI 10.1002/jcp.21623; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; BURROWS W. H., 1937, POULTRY SCI, V16, P19, DOI 10.3382/ps.0160019; Buttke DE, 2006, BIOL REPROD, V74, P889, DOI 10.1095/biolreprod.105.046219; Caballero J, 2012, J CELL PHYSIOL, V227, P3876, DOI 10.1002/jcp.24099; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Edwards IJ, 2013, J NEUROSCI, V33, P9913, DOI 10.1523/JNEUROSCI.5584-12.2013; Evans JP, 2002, HUM REPROD UPDATE, V8, P297, DOI 10.1093/humupd/8.4.297; Foster Leonard J., 2007, V43, P35, DOI 10.1007/978-1-4020-5943-8_4; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Gu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019386; Guyonnet B, 2012, MOL CELL PROTEOMICS, V11, P758, DOI 10.1074/mcp.M112.020339; Hansen GH, 2001, J BIOL CHEM, V276, P32338, DOI 10.1074/jbc.M102667200; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hickey KD, 2012, THERIOGENOLOGY, V77, P1369, DOI 10.1016/j.theriogenology.2011.10.045; HOWARTH B, 1990, POULTRY SCI, V69, P1012, DOI 10.3382/ps.0691012; Hu FZ, 2017, BIOL REPROD, V96, P907, DOI 10.1093/biolre/iox010; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Jimenez T, 2011, P NATL ACAD SCI USA, V108, P644, DOI 10.1073/pnas.1016902108; Khalil MB, 2006, DEV BIOL, V290, P220, DOI 10.1016/j.ydbio.2005.11.030; KIDO S, 1988, POULTRY SCI, V67, P476, DOI 10.3382/ps.0670476; Kocak-Toker N, 2002, INT J ANDROL, V25, P180, DOI 10.1046/j.1365-2605.2002.00346.x; Korrodi-Gregorio L, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-15; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; Labas V, 2014, DATA BRIEF, V1, P37, DOI 10.1016/j.dib.2014.08.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li WP, 2001, J CELL SCI, V114, P1397; Li Y, 2016, J UROLOGY, V195, P1160, DOI 10.1016/j.juro.2015.10.179; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Maehashi E, 2003, J BIOL CHEM, V278, P42050, DOI 10.1074/jbc.M307493200; Mattei V, 2011, MOL BIOL CELL, V22, P4842, DOI 10.1091/mbc.E11-04-0348; Motoyama K, 2009, EUR J PHARM SCI, V38, P249, DOI 10.1016/j.ejps.2009.07.010; MRSNY RJ, 1981, J CELL BIOL, V91, P77; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakamura M, 2005, ELECTROPHORESIS, V49, P77, DOI [10.2198/jelectroph.49.77, DOI 10.2198/JELECTROPH.49.77]; Nixon B, 2008, J CELL PHYSL; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Nixon B, 2011, J CELL PHYSIOL, V226, P2651, DOI 10.1002/jcp.22615; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Onodera R, 2013, INT J PHARMACEUT, V452, P116, DOI 10.1016/j.ijpharm.2013.04.071; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Post H, 2010, INT J ANDROL, V33, P775, DOI 10.1111/j.1365-2605.2009.01022.x; Rashid-Doubell F, 2007, PLACENTA, V28, P139, DOI 10.1016/j.placenta.2005.12.005; Reid AT, 2011, ASIAN J ANDROL, V13, P88, DOI 10.1038/aja.2010.74; Sasanami T, 2011, REPRODUCTION, V142, P267, DOI 10.1530/REP-11-0120; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Selvaraj V, 2006, J CELL PHYSIOL, V206, P636, DOI 10.1002/jcp.20504; Selvaraj V, 2009, J CELL PHYSIOL, V218, P522, DOI 10.1002/jcp.21624; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Skerget S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140650; Sleight SB, 2005, BIOL REPROD, V73, P721, DOI 10.1095/biolreprod.105.041533; TAJIMA A, 1989, J REPROD FERTIL, V85, P1, DOI 10.1530/jrf.0.0850001; Tanphaichitr N, 2015, ASIAN J ANDROL, V17, P574, DOI 10.4103/1008-682X.152817; Thaler CD, 2006, MOL REPROD DEV, V73, P1541, DOI 10.1002/mrd.20540; Nguyen TMD, 2016, FEBS J, V283, P1902, DOI 10.1111/febs.13710; Tokhtaeva E, 2012, J BIOL CHEM, V287, P26115, DOI 10.1074/jbc.M112.370734; Tsai PS, 2007, MOL MEMBR BIOL, V24, P313, DOI 10.1080/09687860701228692; Urayama S, 2008, J BIOL CHEM, V283, P21725, DOI 10.1074/jbc.M802631200; Ushiyama A, 2017, REPROD FERT DE UNPUB; Ushiyama A, 2016, J POULT SCI; van Gestel RA, 2005, MOL HUM REPROD, V11, P583, DOI 10.1093/molehr/gah200; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; Zheng YZ, 2009, J LIPID RES, V50, P988, DOI 10.1194/jlr.M800658-JLR200	76	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186482	10.1317/journal.pone.0186482	http://dx.doi.org/10.1317/journal.pone.0186482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095853				2022-12-27	WOS:000414340200018
J	Yang, XY; Xu, GA; Li, Q; Guo, YH; Zhang, M				Yang, Xinyu; Xu, Guoai; Li, Qi; Guo, Yanhui; Zhang, Miao			Authorship attribution of source code by using back propagation neural network based on particle swarm optimization	PLOS ONE			English	Article							ALGORITHM	Authorship attribution is to identify the most likely author of a given sample among a set of candidate known authors. It can be not only applied to discover the original author of plain text, such as novels, blogs, emails, posts etc., but also used to identify source code programmers. Authorship attribution of source code is required in diverse applications, ranging from malicious code tracking to solving authorship dispute or software plagiarism detection. This paper aims to propose a new method to identify the programmer of Java source code samples with a higher accuracy. To this end, it first introduces back propagation (BP) neural network based on particle swarm optimization (PSO) into authorship attribution of source code. It begins by computing a set of defined feature metrics, including lexical and layout metrics, structure and syntax metrics, totally 19 dimensions. Then these metrics are input to neural network for supervised learning, the weights of which are output by PSO and BP hybrid algorithm. The effectiveness of the proposed method is evaluated on a collected dataset with 3,022 Java files belong to 40 authors. Experiment results show that the proposed method achieves 91.060% accuracy. And a comparison with previous work on authorship attribution of source code for Java language illustrates that this proposed method outperforms others overall, also with an acceptable overhead.	[Yang, Xinyu; Xu, Guoai; Li, Qi; Guo, Yanhui; Zhang, Miao] Beijing Univ Posts & Telecommun, Natl Engn Lab Mobile Network Technol, Beijing, Peoples R China	Beijing University of Posts & Telecommunications	Xu, GA (corresponding author), Beijing Univ Posts & Telecommun, Natl Engn Lab Mobile Network Technol, Beijing, Peoples R China.	xga@bupt.edu.cn			National High Technology Research and Development Program of China (863 Program) [2015AA017202]; National Key Research and Development Program of China - CyberSpace Security Project "Mobile Terminal Key Technologies at a High Security Level" [2017YFB0801903]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Research and Development Program of China - CyberSpace Security Project "Mobile Terminal Key Technologies at a High Security Level"	This work was supported by the National High Technology Research and Development Program of China (863 Program) [grant number 2015AA017202]. It was also supported by the National Key Research and Development Program of China - CyberSpace Security Project "Mobile Terminal Key Technologies at a High Security Level" [grant number 2017YFB0801903]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.r This work was supported by the National High Technology Research and Development Program of China (863 Program) [grant number 2015AA017202]. It was also supported by the National Key Research and Development Program of China - CyberSpace Security Project "Mobile Terminal Key Technologies at a High Security Level" [grant number 2017YFB0801903].	Almasi AD, 2016, NEUROCOMPUTING, V174, P31, DOI 10.1016/j.neucom.2015.02.092; Burrows S., 2007, P TWELTH AUSTR DOC C, P32; Burrows S, 2014, SOFTWARE PRACT EXPER, V44, P1, DOI 10.1002/spe.2146; Burrows S, 2009, LECT NOTES COMPUT SC, V5463, P699, DOI 10.1007/978-3-642-00887-0_61; Caliskan-Islam A, PREPRINT; Caliskan-Islam Aylin, 2015, 24 USENIX SEC S USEN; Ding HB, 2004, J SYST SOFTWARE, V72, P49, DOI 10.1016/S0164-1212(03)00049-9; Frantzeskou G, 2004, HDB RES COMPUTATIONA, P470; Gray A, 1998, 1998 INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING: EDUCATION & PRACTICE, PROCEEDINGS, P252, DOI 10.1109/SEEP.1998.707658; Hayes JH, 2010, SOFTW TEST VERIF REL, V20, P329, DOI 10.1002/stvr.412; Huang JL, 2015, INFORM SOFTWARE TECH, V67, P108, DOI 10.1016/j.infsof.2015.07.004; Illias HA, 2016, MEASUREMENT, V90, P94, DOI 10.1016/j.measurement.2016.04.052; Illias HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129363; Jafrasteh B, 2017, NEUROCOMPUTING, V235, P217, DOI 10.1016/j.neucom.2017.01.016; Kennedy J., 2010, ENCY MACHINE LEARNIN, P760, DOI DOI 10.1007/978-0-387-30164-8_630; Kothari J, 2007, INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY, PROCEEDINGS, P243; Krsul I, 1997, COMPUT SECUR, V16, P233, DOI 10.1016/S0167-4048(97)00005-9; Lange R, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P2082; Lim HI, 2009, INFORM SOFTWARE TECH, V51, P1338, DOI 10.1016/j.infsof.2009.04.011; Longstaff T. A., 1993, Computers & Security, V12, P61, DOI 10.1016/0167-4048(93)90013-U; MacDonell S. G., 2002, J LAW INF SCI, V13, P34; Neme A, 2015, NEUROCOMPUTING, V147, P147, DOI 10.1016/j.neucom.2014.03.064; Pellin B. N., 2000, USING CLASSIFICATION; Ren C, 2014, KNOWL-BASED SYST, V56, P226, DOI 10.1016/j.knosys.2013.11.015; Rosenblum N, 2011, LECT NOTES COMPUT SC, V6879, P172, DOI 10.1007/978-3-642-23822-2_10; Seliya N., 2008, J COMPUTING SCI COLL, V23, P50; Shevertalov M, 2009, 1ST INTERNATIONAL SYMPOSIUM ON SEARCH BASED SOFTWARE ENGINEERING, PROCEEDINGS, P69, DOI 10.1109/SSBSE.2009.18; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Spafford E. H., 1993, Computers & Security, V12, P585, DOI 10.1016/0167-4048(93)90055-A; Tian YB, 2015, HYBRID NEURAL NETWOR; Tian ZZ, 2015, IEEE T SOFTWARE ENG, V41, P1217, DOI 10.1109/TSE.2015.2454508; Wisse W, 2015, DIGIT INVEST, V15, P61, DOI 10.1016/j.diin.2015.09.001; Zhang JR, 2007, APPL MATH COMPUT, V185, P1026, DOI 10.1016/j.amc.2006.07.025	34	16	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187204	10.1371/journal.pone.0187204	http://dx.doi.org/10.1371/journal.pone.0187204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095934	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200056
J	Ballouhey, Q; Richard, L; Fourcade, L; Ben Rhaiem, I; Vallat, JM; Sturtz, F; Bourthoumieu, S				Ballouhey, Quentin; Richard, Laurence; Fourcade, Laurent; Ben Rhaiem, Ines; Vallat, Jean Michel; Sturtz, Franck; Bourthoumieu, Sylvie			Involvement of the enteroendocrine system in intestinal obstruction	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; SMALL-BOWEL OBSTRUCTION; JEJUNOILEAL ATRESIA; INTERSTITIAL-CELLS; MYENTERIC PLEXUS; ENDOCRINE-CELLS; IMMUNE-SYSTEM; RAT MODEL; GUT; INNERVATION	Introduction Intestinal atresia, a rare congenital condition, is often associated with intestinal motility disorders despite adequate neonatal surgery. Previous studies have focused on changes in the enteric nervous system (ENS). We hypothesized that other components of the digestive tract could be involved in this condition. Material and methods In a rat model of surgically-induced intestinal obstruction, a transcriptome analysis was performed to measure the global gene expression. Then, analyzes were focused on genes expressed in ENS and neuroendocrine cells. Rat fetus small intestines at different developmental stages (ED15, ED17, ED19 and ED21, (n = 22)) were studied as controls and compared to the upper and lower segments of small intestines from rat fetuses with surgically induced obstruction (n = 14; ligature at ED18). The gene expression pattern was confirmed by immunohistochemistry, electron microscopy and RT-qPCR. Results From ED15 to ED21, there was a physiological decrease in the gene expression of ENS markers and an increase in that of neuroendocrine genes. Regarding operated embryos, the changes in global gene expression were significantly higher in the proximal segment compared to the distal segment (18% vs. 9%). More precisely, a decrease in ENS gene expression and an increase in neuroendocrine gene expression were observed in the proximal segment compared to controls, indicating an accelerated maturation pattern. Immun ohistochemistry and electron microscopy confirmed these findings. Conclusion Fetal intestinal obstruction seems to induce an accelerated maturation in the proximal segment. Moreover, neuroendocrine cells undergo significant unexpected changes, suggesting that ENS changes could be associated with other changes to induce intestinal motility disorders.	[Ballouhey, Quentin; Richard, Laurence; Fourcade, Laurent; Ben Rhaiem, Ines; Vallat, Jean Michel; Sturtz, Franck; Bourthoumieu, Sylvie] Univ Med, Peripheral Neuropathy EA6309, Limoges, France; [Ballouhey, Quentin; Fourcade, Laurent] Univ Hosp, Dept Pediat Surg, Limoges, France; [Richard, Laurence; Vallat, Jean Michel] Univ Hosp, Dept Neurol, Limoges, France; [Sturtz, Franck] Univ Hosp, Dept Biochem & Mol Genet, Limoges, France; [Bourthoumieu, Sylvie] Univ Hosp, Dept Histol Cytol & Cytogenet, Limoges, France	CHU Limoges; CHU Limoges; CHU Limoges; CHU Limoges	Ballouhey, Q; Bourthoumieu, S (corresponding author), Univ Med, Peripheral Neuropathy EA6309, Limoges, France.; Ballouhey, Q (corresponding author), Univ Hosp, Dept Pediat Surg, Limoges, France.; Bourthoumieu, S (corresponding author), Univ Hosp, Dept Histol Cytol & Cytogenet, Limoges, France.	qballouhey@gmail.com; sylvie.bourthournieu@unilim.fr		/0000-0001-6428-5162	CHU de Limoges, APREL (Appel a projet Recherche Equipes Emergentes et Labellisees) - ARS Limousin	CHU de Limoges, APREL (Appel a projet Recherche Equipes Emergentes et Labellisees) - ARS Limousin	This work was supported by a grant from CHU de Limoges, APREL (Appel a projet Recherche Equipes Emergentes et Labellisees, 2013), funded by ARS Limousin.	Baglaj SM, 2001, J PEDIATR SURG, V36, P1428, DOI 10.1053/jpsu.2001.26392; Bohorquez DV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089881; Burns AJ, 2006, NEUROGASTROENT MOTIL, V18, P876, DOI 10.1111/j.1365-2982.2006.00806.x; Celli J, 2014, EUR J MED GENET, V57, P424, DOI 10.1016/j.ejmg.2014.06.007; Chang IY, 2001, J PHYSIOL-LONDON, V536, P555, DOI 10.1111/j.1469-7793.2001.0555c.xd; Farge E, 2011, CURR TOP DEV BIOL, V95, P243, DOI 10.1016/B978-0-12-385065-2.00008-6; Fiegel HC, 2006, EUR J PEDIATR SURG, V16, P407, DOI 10.1055/s-2006-924750; Fourcade L, 2009, NEUROSCI LETT, V461, P126, DOI 10.1016/j.neulet.2009.06.009; Fourcade LM, 2010, J PEDIATR SURG, V45, P499, DOI 10.1016/j.jpedsurg.2009.07.031; Fu M, 2004, ANAT EMBRYOL, V208, P33, DOI 10.1007/s00429-003-0371-0; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Gaillard D, 1996, PEDIATR PATHOL LAB M, V16, P25, DOI 10.1080/107710496175859; Gershon MD, 1999, HOSP PRACT, V34, P31, DOI 10.3810/hp.1999.07.153; Gfroerer S, 2010, WORLD J GASTROENTERO, V16, P5716, DOI 10.3748/wjg.v16.i45.5716; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; Hao MM, 2013, DEV BIOL, V382, P365, DOI 10.1016/j.ydbio.2012.12.006; Hao MM, 2009, J CELL MOL MED, V13, P1193, DOI 10.1111/j.1582-4934.2009.00813.x; Harrison E, 2013, CURR OPIN PHARMACOL, V13, P941, DOI 10.1016/j.coph.2013.09.012; Hatch J, 2015, DEV DYNAM, V244, P56, DOI 10.1002/dvdy.24178; Hemming V, 2007, PRENATAL DIAG, V27, P1205, DOI 10.1002/pd.1886; Heuckeroth RO, 2006, DEVELOPMENT, V133, P2287, DOI 10.1242/dev.02418; Khen N, 2004, PEDIATR RES, V56, P975, DOI 10.1203/01.PDR.0000145294.11800.71; Khen-Dunlop N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062292; Latorre R, 2016, NEUROGASTROENT MOTIL, V28, P620, DOI 10.1111/nmo.12754; Masumoto K, 1999, J PEDIATR SURG, V34, P1463, DOI 10.1016/S0022-3468(99)90104-5; McKeown SJ, 2001, CELL TISSUE RES, V303, P301, DOI 10.1007/s004410000303; Obata Y, 2016, GASTROENTEROLOGY, V151, P836, DOI 10.1053/j.gastro.2016.07.044; Ozguner IF, 2005, J PEDIATR SURG, V40, P1232, DOI 10.1016/j.jpedsurg.2005.05.032; Ramachandran P, 2007, PEDIATR SURG INT, V23, P1183, DOI 10.1007/s00383-007-2029-0; Salvi EP, 2004, ANAT EMBRYOL, V209, P143, DOI 10.1007/s00429-004-0435-9; Schoenberg RA, 2002, J PEDIATR SURG, V37, P735, DOI 10.1053/jpsu.2002.32267; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Stollman TH, 2009, J PEDIATR SURG, V44, P217, DOI 10.1016/j.jpedsurg.2008.10.043; Tander B, 2010, J PEDIATR SURG, V45, P724, DOI 10.1016/j.jpedsurg.2009.11.010; Vaccaro R, 2009, EUR J HISTOCHEM, V53, P143; von Sochaczewski CO, 2017, J SURG RES, V209, P112, DOI 10.1016/j.jss.2016.09.035; Wang XL, 2013, J PEDIATR SURG, V48, P2084, DOI 10.1016/j.jpedsurg.2013.05.025; Watanabe Y, 2001, J PEDIATR SURG, V36, P474, DOI 10.1053/jpsu.2001.21618; Worthington JJ, 2015, BIOCHEM SOC T, V43, P727, DOI 10.1042/BST20150090	40	2	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186507	10.1371/journal.pone.0186507	http://dx.doi.org/10.1371/journal.pone.0186507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091949	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700021
J	Briceno, B; Coville, A; Gertler, P; Martinez, S				Briceno, Bertha; Coville, Aidan; Gertler, Paul; Martinez, Sebastian			Are there synergies from combining hygiene and sanitation promotion campaigns: Evidence from a large-scale cluster-randomized trial in rural Tanzania	PLOS ONE			English	Article							CHILD UNDERNUTRITION; DIARRHEA; COMMUNITY; INDIA; INTERVENTION; BEHAVIOR; HEALTH; HANDS; WATER; RISK	The current evidence on handwashing and sanitation programs suggests limited impacts on health when at-scale interventions have been tested in isolation. However, no published experimental evidence currently exists that tests the interaction effects between sanitation and handwashing. We present the results of two large-scale, government-led handwashing and sanitation promotion campaigns in rural Tanzania, with the objective of tracing the causal chain from hygiene and sanitation promotion to changes in child health outcomes and specifically testing for potential interaction effects of combining handwashing and sanitation interventions. Methods The study is a factorial cluster-randomized control trial where 181 rural wards from 10 districts in Tanzania were randomly assigned to receive sanitation promotion, handwashing promotion, both interventions together or neither (control). Interventions were rolled out from February 2009 to June 2011 and the endline survey was conducted from May to November 2012, approximately one year after program completion. The sample was composed of households with children under 5 years old in the two largest villages in each ward. Masking was not possible due to the nature of the intervention, but enumerators played no part in the intervention and were blinded to treatment status. The primary outcome of interest was 7-day diarrhea prevalence for children under five. Intermediate outcomes of behavior change including improved latrine construction, levels of open defecation and handwashing with soap were also analyzed. Secondary health outcomes included anemia, height-for-age and weight-for-age of children under 5. An intention-to-treat analysis was used to assess the relationship between the interventions and outcomes of interest. Findings One year after the end of the program, ownership of improved latrines increased from 49.7% to 64.8% (95% CI 57.9%-71.7%) and regular open defecation decreased from 23.1% to 11.1% (95% CI 3.5%-18.7%) in sanitation promotion-only wards. Households in hand washing promotion-only wards showed marginal improvements in handwashing behavior related to food preparation but not at other critical junctures. There were no detectable interaction effects for the combined intervention. The associated cost-per-household gaining access to improved sanitation is estimated to be USD $194. Final effects on child health measured through diarrhea, anemia, stunting and wasting were absent in all treatment groups. Interpretation Although statistically significant, the changes in intermediate outcomes achieved through each intervention in isolation were not large enough to generate meaningful health impacts. With no observable signs of interaction, the combined intervention produced similar results. The study highlights the importance of focusing on intermediate outcomes of take up and behavior change as a critical first step in large-scale programs before realizing the changes in health that sanitation and hygiene interventions aim to deliver.	[Briceno, Bertha] Interamer Dev Bank, Knowledge & Learning Sect, Washington, DC USA; [Coville, Aidan] World Bank, Dev Impact Evaluat Unit, 1818 H St NW, Washington, DC 20433 USA; [Gertler, Paul] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Martinez, Sebastian] Interamer Dev Bank, Off Strateg Planning & Dev Effectiveness, Washington, DC USA	Inter-American Development Bank; The World Bank; University of California System; University of California Berkeley; Inter-American Development Bank	Coville, A (corresponding author), World Bank, Dev Impact Evaluat Unit, 1818 H St NW, Washington, DC 20433 USA.	acoville@worldbank.org		Martinez, Sebastian/0000-0002-7651-6674	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by a grant from the Bill & Melinda Gates Foundation to the Water and Sanitation Program. The funder provided support in the form of salaries for BB and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; Biran A, 2014, LANCET GLOB HEALTH, V2, pE145, DOI 10.1016/S2214-109X(13)70160-8; Briceno B, 2015, J DEV EFFECT, V7, P423, DOI 10.1080/19439342.2015.1105848; Bruhn M, 2008, WORLD BANK POLICY RE; Cameron LA, 2013, WORLD BANK POLICY RE; Chase C, 2012, WORLD BANK POLICY RE; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; Crocker J, 2016, ENVIRON SCI TECHNOL, V50, P6517, DOI 10.1021/acs.est.6b01021; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Dreibelbis R, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010129; Duflo E., 2015, TOILETS CAN WORK SHO; Ejemot R. I., 2009, EVIDENCE BASED CHILD, V4, P893, DOI DOI 10.1002/EBCH.373; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Fuller JA, 2016, AM J TROP MED HYG, P15; Galiani S, 2015, HLTH EC; Garn J. V., 2016, INT J HYGIENE ENV HL; Guiteras R, 2015, SCIENCE, V348, P903, DOI 10.1126/science.aaa0491; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Lavelle MJ, 2015, GLOBAL ENVIRON CHANG, V35, P368, DOI 10.1016/j.gloenvcha.2015.09.021; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; Patil SR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001709; Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8; Ram P., 2010, PRACTICAL GUIDANCE M; Schmidt WP, 2015, LANCET GLOB HEALTH, V3, pE659, DOI 10.1016/S2214-109X(15)00182-5; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; Schriewer A, 2015, AM J TROP MED HYG, V93, P509, DOI 10.4269/ajtmh.14-0824; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO- Unicef, LEV TRENDS CHILD MOR; World Health Organization (WHO), 2013, HAEM CONC DIAGN AN A	32	28	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186228	10.1371/journal.pone.0186228	http://dx.doi.org/10.1371/journal.pone.0186228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091726	gold, Green Published, Green Submitted			2022-12-27	WOS:000414229700012
J	Kerren, A; Kucher, K; Li, YF; Schreiber, F				Kerren, Andreas; Kucher, Kostiantyn; Li, Yuan-Fang; Schreiber, Falk			BioVis Explorer: A visual guide for biological data visualization techniques	PLOS ONE			English	Article								Data visualization is of increasing importance in the Biosciences. During the past 15 years, a great number of novel methods and tools for the visualization of biological data have been developed and published in various journals and conference proceedings. As a consequence, keeping an overview of state-of-the-art visualization research has become increasingly challenging for both biology researchers and visualization researchers. To address this challenge, we have reviewed visualization research especially performed for the Biosciences and created an interactive web-based visualization tool, the BioVis Explorer. BioVis Explorer allows the exploration of published visualization methods in interactive and intuitive ways, including faceted browsing and associations with related methods. The tool is publicly available online and has been designed as community-based system which allows users to add their works easily.	[Kerren, Andreas; Kucher, Kostiantyn] Linnaeus Univ, Dept Comp Sci, Vaxjo, Sweden; [Li, Yuan-Fang; Schreiber, Falk] Monash Univ, Fac Informat Technol, Clayton, Vic, Australia; [Schreiber, Falk] Univ Konstanz, Dept Comp & Informat Sci, Constance, Germany	Linnaeus University; Monash University; University of Konstanz	Kerren, A (corresponding author), Linnaeus Univ, Dept Comp Sci, Vaxjo, Sweden.	andreas.kerren@lnu.se	Li, Yuan-Fang/T-7532-2019; Kerren, Andreas/AAV-9187-2020	Kerren, Andreas/0000-0002-0519-2537; Li, Yuan-Fang/0000-0003-4651-2821	Swedish Research Council (Vetenskapsradet) [20125659]; Discovery Project grant "Visualisation of large, complex networks through small, beautiful diagrams" from Australian Research Council (ARC) [DP140100077]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Discovery Project grant "Visualisation of large, complex networks through small, beautiful diagrams" from Australian Research Council (ARC)	This work was partially supported by the framework grant "The Digitized Society-Past, Present, and Future" from the Swedish Research Council (Vetenskapsradet) [grant number 20125659; https//www.vr.se]. We also acknowledge the support of the Discovery Project grant "Visualisation of large, complex networks through small, beautiful diagrams" from Australian Research Council (ARC) [grant number DP140100077; http.//www.arc.gov.au/discoveryprojects]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner W, 2011, HUM-COMPUT INT-SPRIN, P1, DOI 10.1007/978-0-85729-079-3; Alsallakh B., 2014, PROC EUROGRAPH C VIS, P1, DOI DOI 10.2312/EUROVISSTAR.20141170; Andrews K., 2002, Information Visualization, V1, P166, DOI 10.1057/palgrave.ivs.9500023; Bachmaier C., 2013, HDB GRAPH DRAWING VI, P621; Beck F, 2016, IEEE T VIS COMPUT GR, V22, P180, DOI 10.1109/TVCG.2015.2467757; Beck Fabian, 2014, P STATE ART REPORTS, P83, DOI DOI 10.2312/EUROVISSTAR.20141174; Cvek U, 2011, IEEE INT CONF INF VI, P241, DOI 10.1109/IV.2011.37; Dinkla Kasper, 2012, Tsinghua Science and Technology, V17, P365; Isaacs Katherine E, 2014, EUROVIS 2014, P141; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jusufi I, 2013, INFORM VISUAL, V12, P291, DOI 10.1177/1473871612468880; Kehrer J, 2013, IEEE T VIS COMPUT GR, V19, P495, DOI 10.1109/TVCG.2012.110; Kerren A., 2007, LNCS TUTORIAL, V4417; Kerren A., 2013, APPROACHES INTEGRATI, P173; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kucher K., 2017, COMPUTER GRAPHICS FO; Kucher K, 2015, IEEE PAC VIS SYMP, P117, DOI 10.1109/PACIFICVIS.2015.7156366; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; O'Donoghue SI, 2010, NAT METHODS, V7, pS2, DOI 10.1038/nmeth.f.301; Pavlopoulos GA, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-12; Pretorius AJ, 2016, SURVEY VISUALIZATION; Ropinski T, 2011, COMPUT GRAPH-UK, V35, P392, DOI 10.1016/j.cag.2011.01.011; Schulz HJ, 2011, IEEE COMPUT GRAPH, V31, P11, DOI 10.1109/MCG.2011.103; Secrier M, 2014, BRIEF BIOINFORM, V15, P771, DOI 10.1093/bib/bbt021; Tory M, 2005, IEEE COMPUT GRAPH, V25, P8, DOI 10.1109/MCG.2005.102; Vehlow C., 2015, EUR C VIS EUROVIS ST, DOI [DOI 10.2312/EUROVISSTAR.20151110, 10.2312/eurovisstar.20151110]	27	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187341	10.1371/journal.pone.0187341	http://dx.doi.org/10.1371/journal.pone.0187341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091942	gold, Green Published, Green Submitted			2022-12-27	WOS:000414229700058
J	Yamaguchi, H; Ishida, Y; Hosomichi, J; Suzuki, JI; Hatano, K; Usumi-Fujita, R; Shimizu, Y; Kaneko, S; Ono, T				Yamaguchi, Hiroyuki; Ishida, Yuji; Hosomichi, Jun; Suzuki, Jun-ichi; Hatano, Kasumi; Usumi-Fujita, Risa; Shimizu, Yasuhiro; Kaneko, Sawa; Ono, Takashi			Ultrasound microbubble-mediated transfection of NF-kappa B decoy oligodeoxynucleotide into gingival tissues inhibits periodontitis in rats in vivo	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ATTENUATES NEOINTIMAL FORMATION; TRANSCRIPTION FACTOR DECOY; PLASMID DNA; EPITHELIAL-CELLS; ARTERIAL INJURY; GENE-EXPRESSION; BONE-RESORPTION; CONTRAST AGENTS; ALVEOLAR BONE	Periodontitis is a chronic infectious disease for which the fundamental treatment is to reduce the load of subgingival pathogenic bacteria by debridement. However, previous investigators attempted to implement a nuclear factor kappa B (NF-kappa B) decoy oligodeoxynucleotide (ODN) as a suppressor of periodontitis progression. Although we recently reported the effectiveness of the ultrasound-microbubble method as a tool for transfecting the NF-kappa B decoy ODN into healthy rodent gingival tissue, this technique has not yet been applied to the pathological gingiva of periodontitis animal models. Therefore, the aim of this study was to investigate the effectiveness of the technique in transfecting the NF-kappa B decoy ODN into rats with ligature-induced periodontitis. Micro computed tomography (micro-CT) analysis demonstrated a significant reduction in alveolar bone loss following treatment with the NF-kappa B decoy ODN in the experimental group. RT-PCR showed that NF-kappa B decoy ODN treatment resulted in significantly reduced expression of inflammatory cytokine transcripts within rat gingival tissues. Thus, we established a transcutaneous transfection model of NF-kappa B decoy ODN treatment of periodontal tissues using the ultrasound-microbubble technique. Our findings suggest that the NF-kappa B decoy ODN could be used as a significant suppressor of gingival inflammation and periodontal disease progression.	[Yamaguchi, Hiroyuki; Ishida, Yuji; Hosomichi, Jun; Suzuki, Jun-ichi; Hatano, Kasumi; Usumi-Fujita, Risa; Shimizu, Yasuhiro; Kaneko, Sawa; Ono, Takashi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Orthodont Sci, Tokyo, Japan; [Suzuki, Jun-ichi] Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo	Ishida, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Orthodont Sci, Tokyo, Japan.	yjis.orts@tmd.ac.jp	Ono, Takashi/ABC-4644-2020	Ono, Takashi/0000-0002-8043-660X; YAMAGUCHI, HIROYUKI/0000-0002-3754-6723	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [24792322]; Grants-in-Aid for Scientific Research [16K20639] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported in part by Grants-in-Aid for Scientific Research (24792322) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI). Yuji Ishida, http://www. isps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belibasakis GN, 2007, MICROB PATHOGENESIS, V43, P46, DOI 10.1016/j.micpath.2007.03.001; Bosshardt DD, 2005, J DENT RES, V84, P9, DOI 10.1177/154405910508400102; Brunetti G, 2005, J PERIODONTOL, V76, P1675, DOI 10.1902/jop.2005.76.10.1675; Cheng WC, 2010, J PERIODONTAL RES, V45, P788, DOI 10.1111/j.1600-0765.2010.01301.x; Egashira K, 2008, J GENE MED, V10, P805, DOI 10.1002/jgm.1192; Endoh M, 2002, MOL THER, V5, P501, DOI 10.1006/mthe.2002.0577; Erdemir Ebru Olgun, 2015, Eur J Dent, V9, P60, DOI 10.4103/1305-7456.149644; FECHHEIMER M, 1987, P NATL ACAD SCI USA, V84, P8463, DOI 10.1073/pnas.84.23.8463; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Fujihara R, 2014, J PERIODONTAL RES, V49, P508, DOI 10.1111/jre.12131; Fujihara R, 2013, TUMOR NECROSIS FACTO, V49, P508, DOI DOI 10.1111/JRE.12131; Hatipoglu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128134; HavemosePoulsen A, 1997, CRIT REV ORAL BIOL M, V8, P217, DOI 10.1177/10454411970080020801; Inagaki H, 2006, J VASC RES, V43, P12, DOI 10.1159/000089103; Inoue H, 2014, ULTRASONICS, V54, P874, DOI 10.1016/j.ultras.2013.10.021; Kornman KS, 1997, PERIODONTOL 2000, V14, P33, DOI 10.1111/j.1600-0757.1997.tb00191.x; Kunugiza Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1980; Latanich CA, 2009, J INVEST SURG, V22, P301, DOI 10.1080/08941930903040155; Lee FY, 2011, AAPS PHARMSCITECH, V12, P1110, DOI 10.1208/s12249-011-9681-3; Leow CH, 2015, ULTRASOUND MED BIOL, V41, P2926, DOI 10.1016/j.ultrasmedbio.2015.06.023; LINDHE J, 1984, J CLIN PERIODONTOL, V11, P448, DOI 10.1111/j.1600-051X.1984.tb01344.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/634095; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Morishita R, 2004, CURR OPIN PHARMACOL, V4, P139, DOI 10.1016/j.coph.2003.10.008; Nakamura H, 2002, GENE THER, V9, P1221, DOI 10.1038/sj.gt.3301724; Nakata T, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0303-z; Paefgen V, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00197; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shimizu H, 2009, ANTIOXID REDOX SIGN, V11, P2065, DOI [10.1089/ars.2008.2355, 10.1089/ARS.2008.2355]; Shirasaki H, 2004, CLIN EXP ALLERGY, V34, P945, DOI 10.1111/j.1365-2222.2004.01964.x; STASHENKO P, 1991, J CLIN PERIODONTOL, V18, P548, DOI 10.1111/j.1600-051X.1991.tb00088.x; Stride E, 2009, ULTRASOUND MED BIOL, V35, P861, DOI 10.1016/j.ultrasmedbio.2008.11.010; Sugano M, 2012, INT J PHARMACEUT, V422, P332, DOI 10.1016/j.ijpharm.2011.11.001; Suzuki J, 2010, J AM COLL CARDIOL, V55, P904, DOI 10.1016/j.jacc.2009.09.054; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tamai R, 2005, INFECT IMMUN, V73, P6290, DOI 10.1128/IAI.73.10.6290-6298.2005; Taniyama Y, 2002, CIRCULATION, V105, P1233, DOI 10.1161/hc1002.105228; Taniyama Y, 2006, YAKUGAKU ZASSHI, V126, P1039, DOI 10.1248/yakushi.126.1039; Taubman MA, 2005, J PERIODONTOL, V76, P2033, DOI 10.1902/jop.2005.76.11-S.2033; Toker H, 2008, J PERIODONTOL, V79, P1089, DOI [10.1902/jop.2008.070462, 10.1902/jop.2008.070462 ]; Tomita N, 2000, GENE THER, V7, P1326, DOI 10.1038/sj.gt.3301243; VanWinkelhoff AJ, 1996, PERIODONTOL 2000, V10, P45; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wee JH, 2017, ALLERGY ASTHMA IMMUN, V9, P61, DOI 10.4168/aair.2017.9.1.61; Xu XC, 2015, MOL MED REP, V12, P3494, DOI 10.3892/mmr.2015.3875; Yamaguchi H, 2017, INT J ORAL SCI, V9, P80, DOI 10.1038/ijos.2017.10	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186264	10.1371/journal.pone.0186264	http://dx.doi.org/10.1371/journal.pone.0186264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091721	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700013
J	Hill, LD; Edwards, R; Turner, JR; Argo, YD; Olkhanud, PB; Odsuren, M; Guttikunda, S; Ochir, C; Smith, KR				Hill, L. Drew; Edwards, Rufus; Turner, Jay R.; Argo, Yuma D.; Olkhanud, Purevdorj B.; Odsuren, Munkhtuul; Guttikunda, Sarath; Ochir, Chimedsuren; Smith, Kirk R.			Health assessment of future PM2.5 exposures from indoor, outdoor, and secondhand tobacco smoke concentrations under alternative policy pathways in Ulaanbaatar, Mongolia	PLOS ONE			English	Article							AIR-POLLUTION; SPATIAL VARIABILITY; GLOBAL BURDEN; DISEASE; MORTALITY; RISK; COLD	Introduction Winter air pollution in Ulaanbaatar, Mongolia is among the worst in the world. The health impacts of policy decisions affecting air pollution exposures in Ulaanbaatar were modeled and evaluated under business as usual and two more-strict alternative emissions pathways through 2024. Previous studies have relied on either outdoor or indoor concentrations to assesses the health risks of air pollution, but the burden is really a function of total exposure. This study combined projections of indoor and outdoor concentrations of PM2.5 with population time-activity estimates to develop trajectories of total age-specific PM2.5 exposure for the Ulaanbaatar population. Indoor PM2.5 contributions from secondhand tobacco smoke (SHS) were estimated in order to fill out total exposures, and changes in population and background disease were modeled. The health impacts were derived using integrated exposure-response curves from the Global Burden of Disease Study. Results Annual average population-weighted PM2.5 exposures at baseline (2014) were estimated at 59 mu g/m(3). These were dominated by exposures occurring indoors, influenced considerably by infiltrated outdoor pollution. Under current control policies, exposures increased slightly to 60 mu g/m(3) by 2024; under moderate emissions reductions and under a switch to clean technologies, exposures were reduced from baseline levels by 45% and 80%, respectively. The moderate improvement pathway decreased per capita annual disability-adjusted life year (DALY) and death burdens by approximately 40%. A switch to clean fuels decreased per capita annual DALY and death burdens by about 85% by 2024 with the relative SHS contribution increasing substantially. Conclusion This study demonstrates a way to combine estimated changes in total exposure, background disease and population levels, and exposure-response functions to project the health impacts of alternative policy pathways. The resulting burden analysis highlights the need for aggressive action, including the elimination of residential coal burning and the reduction of current smoking rates.	[Hill, L. Drew; Smith, Kirk R.] Univ Calif Berkeley, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Edwards, Rufus] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Turner, Jay R.] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO USA; [Argo, Yuma D.; Olkhanud, Purevdorj B.; Odsuren, Munkhtuul; Ochir, Chimedsuren] Mongolian Natl Univ Med Sci, Sch Publ Hlth, Ulaanbaatar, Mongolia; [Olkhanud, Purevdorj B.] NHLBI, Sickle Cell Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Guttikunda, Sarath] Desert Res Inst, Div Atmospher Sci, Reno, NV USA	University of California System; University of California Berkeley; University of California System; University of California Irvine; Washington University (WUSTL); Mongolian National University of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Hill, LD (corresponding author), Univ Calif Berkeley, Div Environm Hlth Sci, Berkeley, CA 94720 USA.	drew.hill@berkeley.edu	Hill, Drew/AAO-4930-2020; Ochir, Chimedsuren/AAW-7743-2020	Hill, Drew/0000-0001-8929-3556; Ochir, Chimedsuren/0000-0002-7134-5255; Guttikunda, Sarath/0000-0003-4507-5199; Turner, Jay/0000-0001-7787-6244	Mongolian Ministry of Environment and Green Development through the Clean Air Foundation of Ulaanbaatar; NSF SAGE IGERT at the University of California, Berkeley [DGE-1144885]; Berkeley Air Monitoring Group	Mongolian Ministry of Environment and Green Development through the Clean Air Foundation of Ulaanbaatar; NSF SAGE IGERT at the University of California, Berkeley; Berkeley Air Monitoring Group	The Mongolian Ministry of Environment and Green Development provided funding for this study through the Clean Air Foundation of Ulaanbaatar: https://www.mne.mn/. The NSF SAGE IGERT program (DGE-1144885) at the University of California, Berkeley funded L. Drew Hill during part of the write up and analysis phases of this project. For a short period overlapping the beginning of this study, authors YDA, RE, and JT were partially supported as consultants on a separate project for Social Impact. The specific roles of these authors are articulated in the 'author contributions' section. Some of the publicly available data collected as part of the Social Impact project were used in the current study. Social Impact was not otherwise involved in this study.; Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The authors are grateful to the National Statistics Office of Mongolia and the Statistics Department of Ulaanbaatar, Health Development Center of the Ministry of Health and Sports which provided access to various demographics and health databases. We are grateful to Social Impact and the Millennium Challenge Corporation for their open access databases of household measurements conducted as part of the impact evaluation of the Energy and Environment Projects. We thank Maria Hernandez, Ajay Pillarisetti, Paul Chung, and Alan Hubbard of the University of California, Berkeley and Nick Lam from the University of Illinois for their advice and generous assistance during the project. We acknowledge Boldkhuu Nanzad of the Ministry of Energy of Mongolia for advocating for our research, and appreciate the Berkeley Air Monitoring Group for facilitating financial arrangements. We also acknowledge that the final analysis benefits from comments made by many participants at a workshop presenting preliminary results conducted as part of the impact evaluation of the Energy and Environment Projects. During the peer-review process, a modified version of this paper was included as a chapter in a doctoral dissertation at the University of California, Berkeley. The full dissertation, which includes five total chapters and is titled "A breath of fresher air: improving methods for PM<INF>2.5</INF> exposure assessment from Mongolia to California" by Lawson Andrew Hill, will eventually be available at ProQuest/UMI or the University of California's online repository, "eScholarship."	Alexeeff SE, 2015, J EXPO SCI ENV EPID, V25, P138, DOI 10.1038/jes.2014.40; Allen RW, 2013, AIR QUAL ATMOS HLTH, V6, P137, DOI 10.1007/s11869-011-0154-3; Amarsaikhan D., 2014, J GEOSCI ENV PROT, V2, P123, DOI [10.4236/gep.2014.22017, DOI 10.4236/GEP.2014.22017]; [Anonymous], 2007, NIH CURR SER S; Balakrishnan K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-77; Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Cameron T, 2004, ADVISORY COUNCIL CLE; Chilkhaasuren B, 2010, POPULATION EC ACTIVI; Chowdhury Z, 2013, ATMOS ENVIRON, V67, P161, DOI 10.1016/j.atmosenv.2012.10.041; Davy PK, 2011, ATMOS POLLUT RES, V2, P126, DOI 10.5094/APR.2011.017; Demaio AR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-213; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dore G, 2006, ENVIRONMENT, V48, P10, DOI 10.3200/ENVT.48.6.10-24; Enkhbat U, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020214; Environmental Systems Research Institute, 2012, ARCGIS DESKT REL 10; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Greene L., 2014, IMPACT EVALUATION RE; Greene L, 2014, SOCIAL IMPACT 2012 2; Greene L, 2014, MONGOLIA ENERGY ENV; Guttikunda SK, 2013, AIR QUAL ATMOS HLTH, V6, P357, DOI 10.1007/s11869-012-0187-2; HJI Group Corporation, 2011, MONG UL LOW CARB EN; Japan International Cooperation Agency, 2013, CAP DEV PROJ AIR POL; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Kohn M., 2013, BLOOMBERG BUSINESS; Li TX, 2016, SCI TOTAL ENVIRON, V548, P6, DOI 10.1016/j.scitotenv.2016.01.038; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luo B, 2014, INT J BIOMETEOROL, V58, P185, DOI 10.1007/s00484-013-0641-3; Mongolian Statistical Information Service, 2016, DAT STAT DAT SECT; Nakao M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3481-x; National Statistics Office of Mongolia, 2012, 2010 POP HOUS CENS M; OpenAQ, 2016, US DIPL POST UL DAT; Pillarisetti A, 2016, BROKEN PUMPS AND PROMISES: INCENTIVIZING IMPACT IN ENVIRONMENTAL HEALTH, P147, DOI 10.1007/978-3-319-28643-3_10; Pinto JP, 2004, J AIR WASTE MANAGE, V54, P440, DOI 10.1080/10473289.2004.10470919; R Core Team, 2015, R LANGUAGE ENV STAT; Statistics Department of Ulaanbaatar, 2013, POP HOUS CENS 2012; Ulzii D, 2015, HEAL EFF AIR POLLUT, V1, P67; United Nations Children's Fund, 2016, RED IMP AIR POLL CHI; United Nations Children's Fund Mongolia, 2016, UND ADDR IMP AIR POL; United States Environmental Protection Agency, 1995, EPA454B95003B; United States Environmental Protection Agency, 2006, FED REGISTER, V71, P9866; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; van Donkelaar A, 2015, ENVIRON HEALTH PERSP, V123, P135, DOI 10.1289/ehp.1408646; Warburton D, 2013, ENVIRON RES, V124, P65, DOI 10.1016/j.envres.2013.04.002; WHO, 2014, WHO GUID IND AIR QUA; World Bank, 2011, AIR QUAL AN UL IMPR; World Bank Asia Sustainable and Alternative Energy Program, 2009, MONG HEAT POOR PER U; World Health Organization, 2010, MONG STEPS SURV PREV; World Health Organization Western Pacific Region, 2012, SMOK BANS ALL PUBL A	50	26	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186834	10.1371/journal.pone.0186834	http://dx.doi.org/10.1371/journal.pone.0186834			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088256	gold, Green Published			2022-12-27	WOS:000414088900025
J	Berg, F; Slotte, A; Johannessen, A; Kvamme, C; Clausen, LW; Nash, RDM				Berg, Florian; Slotte, Aril; Johannessen, Arne; Kvamme, Cecilie; Clausen, Lotte Worsoe; Nash, Richard D. M.			Comparative biology and population mixing among local, coastal and offshore Atlantic herring (Clupea harengus) in the North Sea, Skagerrak, Kattegat and western Baltic	PLOS ONE			English	Article							SPAWNING MIGRATION; STOCKS; DIFFERENTIATION; NUMBER; GROWTH; FISH; COD	The population structure of Atlantic herring (Clupea harengus) from 13 local, coastal and offshore areas of the North Sea, Skagerrak, Kattegat and western Baltic (northeast Atlantic) was studied using biological and environmental data from 1970-2015. The objective was to identify distinct populations by comparing variability in the temporal and spatial phenotypic characteristics and evaluate the potential for mixing of populations in time and space. The populations varied in biological characteristics such as mean vertebral counts (VS), growth and maturity ogives. Generalized additive models indicated temporally stable VS in the North Sea and western Baltic, whereas intra-annual temporal variation of VS occurred in other areas. High variability of VS within a population was not affected by environmental factors such as temperature and salinity. Consequently, seasonal VS variability can be explained by the presence or absence of herring populations as they migrate between areas. The three main populations identified in this paper correspond to the three managed stocks in this area: Norwegian spring spawners (NSS), western Baltic spring spawners (WBSS) and North Sea autumn spawners (NSAS). In addition, several local populations were identified in fjords or lakes along the coast, but our analyses could not detect direct mixing of local populations with the three main populations. Our results highlight the importance of recognizing herring dynamics and understanding the mixing of populations as a challenge for management of herring.	[Berg, Florian; Slotte, Aril; Kvamme, Cecilie; Nash, Richard D. M.] IM R, Bergen, Norway; [Berg, Florian; Johannessen, Arne] Univ Bergen, Dept Biol, Bergen, Norway; [Clausen, Lotte Worsoe] Int Council Explorat Sea, HC Andersens Blvd, Copenhagen, Denmark	University of Bergen	Berg, F (corresponding author), IM R, Bergen, Norway.; Berg, F (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	floriane@imr.no	Berg, Florian/M-9678-2014	Berg, Florian/0000-0003-1543-8112; Worsoe Clausen, Lotte/0000-0003-1503-6092; Nash, Richard/0000-0003-0958-149X				Aasen O., 2015, PLOS ONE, V10; Almeland O.W., 2015, PHENOTYPIC PLASTICIT; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 2016, DAT OC HYDR; [Anonymous], 1989, 1989H22 ICES CM; ARO E, 1989, RAP PROCES, V190, P72; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bekkevold D, 2015, ICES J MAR SCI, V72, P1790, DOI 10.1093/icesjms/fsu247; Bekkevold D, 2011, MAR ECOL PROG SER, V442, P187, DOI 10.3354/meps09352; Berg F, 2017, FISH RES, V194, P68, DOI 10.1016/j.fishres.2017.05.009; Bierman SM, 2010, ICES J MAR SCI, V67, P885, DOI 10.1093/icesjms/fsp300; Billerbeck JN, 1997, CAN J FISH AQUAT SCI, V54, P1796, DOI 10.1139/cjfas-54-8-1796; Burke N, 2008, ICES J MAR SCI, V65, P1670, DOI 10.1093/icesjms/fsn177; Clausen LAW, 2015, J FISH BIOL, V86, P228, DOI 10.1111/jfb.12571; CUSHING DH, 1967, J MAR BIOL ASSOC UK, V47, P193, DOI 10.1017/S002531540003366X; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; DQWG, 2016, SAN ANTONIO REPORT; Dragesund O., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V177, P43; Dragesund O, 1997, SARSIA, V82, P97, DOI 10.1080/00364827.1997.10413643; Eggers F, 2015, MAR ECOL PROG SER, V520, P245, DOI 10.3354/meps11103; Eggers F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111985; Groger J, 2001, J APPL ICHTHYOL, V17, P207, DOI 10.1046/j.1439-0426.2001.00254.x; Grohsler T, 2015, J APPL ICHTHYOLOGY; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heath M, 1997, J SEA RES, V38, P413, DOI 10.1016/S1385-1101(97)00045-2; Holst Jens Christian, 2004, P203; HULME TJ, 1995, ICES J MAR SCI, V52, P775, DOI 10.1006/jmsc.1995.0074; Huse G, 2016, CAN J FISH AQUAT SCI, V73, P177, DOI 10.1139/cjfas-2015-0095; Husebo A, 2005, MAR FRESHWATER RES, V56, P763, DOI 10.1071/MF04170; ICES, 2012, REP ICES ADV COMM IC, P1; *ICES, 1998, 1998H2 ICES CM; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Johannessen A, 1995, ECOLOGY OF FJORDS AND COASTAL WATERS, P347; Johansson D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097635; Langard L, 2014, J FISH BIOL, V84, P1202, DOI 10.1111/jfb.12329; Lindsey C.C., 1988, P197; Mariani S, 2005, MAR ECOL PROG SER, V303, P245, DOI 10.3354/meps303245; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Mosegaard H., 1996, ICES COUNCIL M H, V17, P1; Pampoulie C, 2015, MAR ECOL PROG SER, V522, P219, DOI 10.3354/meps11114; Payne MR, 2010, ICES J MAR SCI, V67, P1939, DOI 10.1093/icesjms/fsq036; ROSENBERG R, 1982, FISH RES, V1, P83; Runnstrom S., 1941, QUANTITATIVE INVESTI, V6; Sea North, 2007, ICES J MAR SCI, V64, P377; Slotte A, 1999, J FISH BIOL, V54, P338, DOI 10.1111/j.1095-8649.1999.tb00834.x; Slotte A, 1999, SARSIA, V84, P111, DOI 10.1080/00364827.1999.10420439; Smedbol RK, 2001, J FISH BIOL, V59, P109, DOI 10.1006/jfbi.2001.1765; Stephenson RL, 2009, ICES J MAR SCI, V66, P1733, DOI 10.1093/icesjms/fsp189; Swain DP, 2001, ICES J MAR SCI, V58, P253, DOI 10.1006/jmsc.2000.1007; TANING AV, 1952, BIOL REV, V27, P169, DOI 10.1111/j.1469-185X.1952.tb01392.x; von Bertalanffy L, 1934, ROUX ARCH DEV BIOL, V131, P613, DOI 10.1007/BF00650112; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; ZIJLSTRA JJ, 1969, J CONSEIL, V33, P67	54	12	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187374	10.1371/journal.pone.0187374	http://dx.doi.org/10.1371/journal.pone.0187374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084258	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000413910200053
J	Li, J; Yao, ZY; She, C; Li, J; Ten, B; Liu, C; Lin, SB; Dong, QR; Ren, PG				Li, Jian; Yao, Zhen-yu; She, Chang; Li, Jian; Ten, Bin; Liu, Chang; Lin, Shu-bin; Dong, Qi-Rong; Ren, Pei-Gen			Effects of low-dose X-ray irradiation on activated macrophages and their possible signal pathways	PLOS ONE			English	Article							PARTICLE-INDUCED OSTEOLYSIS; IONIZING-RADIATION; TITANIUM PARTICLES; MODEL; SUPPRESSION; ENDOTOXIN; RESPONSES; IMPLANTS; EFFICACY; CULTURES	Low-dose irradiation (LDI) has been used in clinics to treat human diseases, including chronic inflammation. This study assessed the effects of LDI on the inflammatory response of activated mouse primary peritoneal macrophages, and the underlying signal pathways. Primary peritoneal macrophages were isolated from mice and then incubated with lipopolysaccharide (LPS)-coated Ti microparticles (Ti-positive control) with or without brief exposure to LDI (X-ray, 0.5 Gy) 1 h later (Ti-LDI group) or left untreated in culture medium (Ti-negative control). The macrophages were then subjected to qRT-PCR, Western blot, cell viability CCK-8 assay, and ELISA. qRT-PCR analysis revealed the Ti-LDI group expressed significantly lower levels of IL-1 beta, IL-6, and TNF-alpha mRNA than those of the Ti-positive control group, while the ELISA data showed that Ti-LDI group had significantly lower secretion of IL-1 beta, IL-6, and TNF-alpha proteins. The most significant reduction associated with LDI was the secretion TNF-alpha protein, which barely increased from 13 to 25 h after treatment. Western blot data demonstrated that phosphorylation of p65 and ERK was much lower in the Ti-LDI group than in the controls. The data from the current study suggests that LDI of activated mouse macrophages was associated with significantly lower inflammation responses, compared with non-exposed activated macrophages, which was possibly through inhibition of the NF-kappa B and ERK pathways.	[Li, Jian; She, Chang; Lin, Shu-bin; Dong, Qi-Rong] Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou, Jiangsu, Peoples R China; [Yao, Zhen-yu; Li, Jian; Ten, Bin; Liu, Chang; Ren, Pei-Gen] Chinese Acad Sci, Shenzhen Inst Adv Technol, Dept Translat Med, R&D Ctr, Shenzhen, Guangdong, Peoples R China	Soochow University - China; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Dong, QR (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou, Jiangsu, Peoples R China.; Ren, PG (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Dept Translat Med, R&D Ctr, Shenzhen, Guangdong, Peoples R China.	dqrszgk@163.com; pg.ren@siat.ac.cn			Suzhou Science and Technology Development Project [SYS201621, SYSD2015084]; natural science foundation of Jiangsu Province [BK20160340]	Suzhou Science and Technology Development Project; natural science foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by grants from Suzhou Science and Technology Development Project (Grants NO: SYS201621, SYSD2015084) and the natural science foundation of Jiangsu Province (Grants NO: BK20160340).	Arenas M, 2006, INT J RADIAT ONCOL, V66, P560, DOI 10.1016/j.ijrobp.2006.06.004; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Bitar D, 2015, WORLD J ORTHOP, V6, P172, DOI 10.5312/wjo.v6.i2.172; Cerqueira EMM, 2008, DENTOMAXILLOFAC RAD, V37, P398, DOI 10.1259/dmfr/56848097; Dempsey KE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2201; Ding HF, 2012, J MATER SCI-MATER M, V23, P1055, DOI 10.1007/s10856-012-4574-x; Esteban J, 2008, J CLIN MICROBIOL, V46, P488, DOI 10.1128/JCM.01762-07; Goodman Stuart B, 2013, Instr Course Lect, V62, P201; Joo HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136394; Liebmann A, 2004, STRAHLENTHER ONKOL, V180, P165, DOI 10.1007/s00066-004-1197-2; Lin TH, 2014, ACTA BIOMATER, V10, P3747, DOI 10.1016/j.actbio.2014.04.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodermann B, 2012, INT J RADIAT BIOL, V88, P727, DOI 10.3109/09553002.2012.689464; LUCKEY TD, 1982, HEALTH PHYS, V43, P771, DOI 10.1097/00004032-198212000-00001; Magone K, 2015, ARCH ORTHOP TRAUM SU, V135, P683, DOI 10.1007/s00402-015-2196-8; Misharin AV, 2012, J LEUKOCYTE BIOL, V92, P325, DOI 10.1189/jlb.1111560; Ouyang ZX, 2014, BIOCHEM PHARMACOL, V90, P276, DOI 10.1016/j.bcp.2014.06.009; Pajarinen Jukka, 2014, J Long Term Eff Med Implants, V24, P283; Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603; Sangsliwan T, 2008, RADIAT RES, V170, P776, DOI 10.1667/RR1399.1; Schaue D, 2002, INT J RADIAT BIOL, V78, P567, DOI 10.1080/09553000210126457; Schwarz EM, 2003, J ORTHOPAED RES, V21, P1049, DOI 10.1016/S0736-0266(03)00093-7; Seo SW, 2010, BONE, V46, P695, DOI 10.1016/j.bone.2009.10.032; Shao HG, 2015, BIOMATERIALS, V60, P92, DOI 10.1016/j.biomaterials.2015.04.048; She C, 2016, J ORTHOP RES, V34, P1688, DOI 10.1002/jor.23179; Tsukimoto M, 2009, RADIAT RES, V171, P219, DOI 10.1667/RR1351.1; Xu Y, 2014, BIOCHEM BIOPH RES CO, V453, P362, DOI 10.1016/j.bbrc.2014.09.088; Yang HL, 2016, BIOMATERIALS, V80, P1, DOI 10.1016/j.biomaterials.2015.11.046; Zhou XZ, 2009, ARCH ORTHOP TRAUM SU, V129, P125, DOI 10.1007/s00402-008-0634-6	29	6	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0185854	10.1371/journal.pone.0185854	http://dx.doi.org/10.1371/journal.pone.0185854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077718	gold, Green Published, Green Submitted			2022-12-27	WOS:000413861200007
J	Coignet, MV; Zirpoli, GR; Roberts, MR; Khoury, T; Bandera, EV; Zhu, QQ; Yao, S				Coignet, Marie V.; Zirpoli, Gary Robert; Roberts, Michelle R.; Khoury, Thaer; Bandera, Elisa V.; Zhu, Qianqian; Yao, Song			Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NATURAL MENOPAUSE; AGE; MENARCHE; VARIANTS; LOCI; HERITABILITY; METAANALYSIS; DETERMINANTS; REPLICATION	Reproductive aging phenotypes, including age at menarche (AM) and age at natural menopause (ANM), are well-established risk factors for breast cancer. In recent years, many genetic variants have been identified in association with AM and ANM in genome-wide association studies among European populations. Using data from the Women's Circle of Health Study (WCHS) of 1,307 European-American (EA) and 1,365 African-American (AA) breast cancer cases and controls, we aimed to replicate 53 earlier GWAS variants for AM and ANM in AA and EA groups and to perform analyses on total and net reproductive life-span (TRLS; NRLS). Breast cancer risk was also examined in relation to a polygenic risk score (PRS) for each of the reproductive aging phenotypes. We replicated a number of variants in EA women, including rs7759938 in LIN28B for AM and rs16991615 in MCM8 for ANM; whereas in the AA group, only one SNP (rs2947411 in TMEM18) for AM was directionally consistent and nominally significant. In analysis of TRLS and NRLS, several SNPs were significant, including rs466639 in RXRG that was associated with both phenotypes in both AA and EA groups. None of the PRS was associated with breast cancer risk. Given the paucity of data available among AA populations, our study contributes to the literature of genetics of reproductive aging in AA women and highlights the importance of cross population replication of GWAS variants.	[Coignet, Marie V.; Zirpoli, Gary Robert; Roberts, Michelle R.; Yao, Song] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Zirpoli, Gary Robert] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Roberts, Michelle R.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA; [Khoury, Thaer] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Bandera, Elisa V.] Rutgers Canc Inst New Jersey, Canc Prevent & Control Program, New Brunswick, NJ USA; [Zhu, Qianqian] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Roswell Park Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Roswell Park Cancer Institute	Yao, S (corresponding author), Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA.	song.yao@roswellpark.org		Yao, Song/0000-0001-9442-1313	US National Institutes of Health [R01 CA100598, P01 CA151135, R03 CA192205, P30 CA016056]; US Army Medical Research and Material Command [DAMD-17-01-1-0334]; Roswell Park Cancer Institute Genomics Shared Resource, which is a National Cancer Institute Cancer Center Supported Grant (CCSG) shared resource [P30 CA016056]; National Program of Cancer Registries of the Centers for Disease Control and Prevention [1US58DP003931-01]; Surveillance, Epidemiology, and End Results program of the National Cancer Institute [N01-PC-2010-0027]; State of New Jersey; NATIONAL CANCER INSTITUTE [R03CA192205] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Roswell Park Cancer Institute Genomics Shared Resource, which is a National Cancer Institute Cancer Center Supported Grant (CCSG) shared resource; National Program of Cancer Registries of the Centers for Disease Control and Prevention; Surveillance, Epidemiology, and End Results program of the National Cancer Institute; State of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the US National Institutes of Health (R01 CA100598, P01 CA151135, and R03 CA192205 and P30 CA016056) and US Army Medical Research and Material Command (DAMD-17-01-1-0334). The genotyping work was performed by the Roswell Park Cancer Institute Genomics Shared Resource, which is a National Cancer Institute Cancer Center Supported Grant (CCSG) shared resource (P30 CA016056). The New Jersey State Cancer Registry is supported by the National Program of Cancer Registries of the Centers for Disease Control and Prevention under cooperative agreement 1US58DP003931-01 awarded to the New Jersey Department of Health. The collection of New Jersey cancer incidence data is also supported by the Surveillance, Epidemiology, and End Results program of the National Cancer Institute under contract N01-PC-2010-0027 and the State of New Jersey. The funding agents played no role in the design, collection, analysis, and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	Ambrosone CB, 2009, J ONCOL, V2009, DOI 10.1155/2009/871250; Bandera EV, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-71; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Bromberger JT, 1997, AM J EPIDEMIOL, V145, P124; Carty CL, 2013, HUM REPROD, V28, P1695, DOI 10.1093/humrep/det071; Chen CTL, 2014, HUM MOL GENET, V23, P3327, DOI 10.1093/hmg/ddu041; Chen CTL, 2012, HUM MOL GENET, V21, P1419, DOI 10.1093/hmg/ddr570; Cheng TYD, 2016, CANCER CAUSE CONTROL, V27, P965, DOI 10.1007/s10552-016-0774-x; CRAMER DW, 1995, FERTIL STERIL, V64, P740, DOI 10.1016/S0015-0282(16)57849-2; Day F, 2016, BIORXIV; Day FR, 2017, NAT GENET, V49, P834, DOI 10.1038/ng.3841; de Bruin JP, 2001, HUM REPROD, V16, P2014, DOI 10.1093/humrep/16.9.2014; Delahanty RJ, 2013, HUM REPROD, V28, P1135, DOI 10.1093/humrep/det011; Demerath EW, 2013, HUM MOL GENET, V22, P3329, DOI 10.1093/hmg/ddt181; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Freedman DS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e43; Giner XC, 2015, FASEB J, V29, P4256, DOI 10.1096/fj.14-259804; Gong ZH, 2015, INT J CANCER, V137, P666, DOI 10.1002/ijc.29434; He CY, 2014, MOL CELL ENDOCRINOL, V382, P767, DOI 10.1016/j.mce.2012.05.003; He CY, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3155; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Johnson N, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3662; Karapanou O, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-115; Liu YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000420; MacMahon B, 1966, DATA NATL HLTH SURVE, V11, P1; Mbarek H, 2016, AM J HUM GENET, V98, P898, DOI 10.1016/j.ajhg.2016.03.008; Morabia A, 1998, AM J EPIDEMIOL, V148, P1195, DOI 10.1093/oxfordjournals.aje.a009609; Morris DH, 2010, BRIT J CANCER, V103, P1760, DOI 10.1038/sj.bjc.6605978; Murabito JM, 2005, J CLIN ENDOCR METAB, V90, P3427, DOI 10.1210/jc.2005-0181; Oh H, 2016, BREAST CANCER RES TR, V158, P341, DOI 10.1007/s10549-016-3859-z; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pritchard JK, 2000, GENETICS, V155, P945; Pyun JA, 2014, MENOPAUSE, V21, P522, DOI 10.1097/GME.0b013e3182a433f7; Quan L, 2014, ENDOCR-RELAT CANCER, V21, P853, DOI 10.1530/ERC-14-0250; Rahmani M, 2013, HUM REPROD, V28, P1987, DOI 10.1093/humrep/det106; Ruiz-Narvaez EA, 2011, AM J EPIDEMIOL, V173, P587, DOI 10.1093/aje/kwq401; Shen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058766; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; Spencer KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055258; Spratt DE, 2016, JAMA ONCOL, V2, P1070, DOI 10.1001/jamaoncol.2016.1854; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; Treloar SA, 1998, LANCET, V352, P1084, DOI 10.1016/S0140-6736(05)79753-1; Tu WZ, 2015, J ADOLESCENT HEALTH, V56, P66, DOI 10.1016/j.jadohealth.2014.07.020; van Asselt KM, 2004, FERTIL STERIL, V82, P1348, DOI 10.1016/j.fertnstert.2004.04.047; Yao S, 2013, BREAST CANCER RES TR, V141, P447, DOI 10.1007/s10549-013-2698-4; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162	50	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187205	10.1371/journal.pone.0187205	http://dx.doi.org/10.1371/journal.pone.0187205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073238	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400132
J	Martinelli, I; Ponziani, FR; Maino, A; Bhoori, S; Abbattista, M; Maggi, U; De Feo, TM; Bucciarelli, P; Artoni, A; Longhi, E; Serafini, M; Rossi, G; Mazzaferro, V				Martinelli, Ida; Ponziani, Francesca R.; Maino, Alberto; Bhoori, Sherrie; Abbattista, Maria; Maggi, Umberto; De Feo, Tullia M.; Bucciarelli, Paolo; Artoni, Andrea; Longhi, Elena; Serafini, Marta; Rossi, Giorgio; Mazzaferro, Vincenzo			Thrombosis after liver transplantation for hepatocellular carcinoma	PLOS ONE			English	Article							HEPATIC-ARTERY THROMBOSIS; PORTAL-VEIN THROMBOSIS; VASCULAR COMPLICATIONS; RISK-FACTORS; FOLLOW-UP; SURVIVAL; EXPERIENCE; MANAGEMENT; CRITERIA; COHORT	The influence of thrombosis on the prognosis of patients with hepatocellular carcinoma (HCC) after liver transplantation (LT) and the role of the commonest inherited thrombophilia abnormalities factor V Leiden and prothrombin G20210A in the development of thrombosis are unknown. We investigated a cohort of patients who underwent LT for HCC with the aim to estimate the incidence rate (IR) of thrombosis, its influence on mortality and re-transplantation rates and, in the frame of a nested case-control study, the role of thrombophilia in donors and recipients for the development of thrombosis. Four-hundred and thirty patients underwent LT and were followed for a median of 7.2 years. Twenty-six recipients (6%) developed thrombosis (IR 1.06 [95% CI: 0.71-1.53] per 100 pts-yr). Mortality rate after LT was 3.95 (95% CI: 3.22-4.79) per 100 pts-yr and was not influenced by thrombosis. Re-transplantation was planned for 33 patients and was more common in patients with thrombosis than in those without (HR 2.50 [95% CI: 0.87-7.17]). The risk of thrombosis was 4 times higher in recipients with thrombophilia than in those without (OR 4.23 [95% CI: 0.99-18.04]) and 6 times higher when the analysis was restricted to venous thrombosis (OR 6.26 [95% CI: 1.19-32.85]). The presence of inherited thrombophilia in the donors did not increase the risk of thrombosis of the recipient. In conclusion, thrombosis is a complication of 6% of patients transplanted for HCC and increases the risk of re-transplantation but not of mortality. The risk of thrombosis, particularly venous, is increased in the presence of thrombophilia abnormalities in the recipients.	[Martinelli, Ida; Maino, Alberto; Abbattista, Maria; Bucciarelli, Paolo; Artoni, Andrea] Fdn IRCCS Ca Granda Osped Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Ponziani, Francesca R.; Bhoori, Sherrie; Mazzaferro, Vincenzo] Univ Milan, Liver Surg Transplantat & Gastroenterol, Milan, Italy; [Ponziani, Francesca R.; Bhoori, Sherrie; Mazzaferro, Vincenzo] Ist Nazl Tumori Fdn IRCCS, Milan, Italy; [Maggi, Umberto; Rossi, Giorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hepatobiliary & Liver Transplant Unit, Milan, Italy; [Maggi, Umberto; Rossi, Giorgio] Univ Milan, Milan, Italy; [De Feo, Tullia M.; Longhi, Elena; Serafini, Marta] Fdn IRCCS Ca Granda Osped Maggiore Policlin, NITp, Organ & Tissue Transplant Immunol, Milan, Italy; [Maino, Alberto] Azienda Prov & Serv Sanitari, Dept Internal Med, Trento, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Martinelli, I (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy.	martin@policlinico.mi.it	Mazzaferro, Vincenzo/AAL-4707-2020; Maino, Alberto/H-4486-2019; Abbattista, Maria/AFX-6574-2022; Ponziani, Francesca Romana/E-4136-2016; Rossi, Giorgio/M-3445-2015; Abbattista, Maria/AAQ-2710-2021; MAZZAFERRO, VINCENZO MARIA/C-2726-2017	Maino, Alberto/0000-0001-5909-9189; Abbattista, Maria/0000-0003-3620-3347; Ponziani, Francesca Romana/0000-0002-5924-6238; Rossi, Giorgio/0000-0002-5588-1306; MAZZAFERRO, VINCENZO MARIA/0000-0002-4013-8085; Artoni, Andrea/0000-0003-0625-8320				Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Ayala R, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-130; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Duffy JP, 2007, ANN SURG, V246, P502, DOI 10.1097/SLA.0b013e318148c704; Duffy JP, 2009, J AM COLL SURGEONS, V208, P896, DOI 10.1016/j.jamcollsurg.2008.12.032; Francis JL, 1998, SEMIN THROMB HEMOST, V24, P93, DOI 10.1055/s-2007-995829; Gad EH, 2016, ANN MED SURG, V8, P28, DOI 10.1016/j.amsu.2016.04.021; Heimbach J, 2017, HEPATOLOGY; Itri JN, 2013, ABDOM IMAGING, V38, P1300, DOI 10.1007/s00261-013-0002-z; Jensen MK, 2013, LIVER TRANSPLANT, V19, P315, DOI 10.1002/lt.23583; KORN EL, 1986, STAT MED, V5, P255, DOI 10.1002/sim.4780050306; Kujovich JL, 2011, GENET MED, V13, P1, DOI 10.1097/GIM.0b013e3181faa0f2; Martinelli I, 2014, NAT REV CARDIOL, V11, P140, DOI 10.1038/nrcardio.2013.211; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Pareja E, 2010, TRANSPL P, V42, P2970, DOI 10.1016/j.transproceed.2010.07.063; Pastacaldi S, 2001, LIVER TRANSPLANT, V7, P75, DOI 10.1053/jlts.2001.22040; Petrick JL, 2016, J CLIN ONCOL, V34, P1787, DOI 10.1200/JCO.2015.64.7412; Piardi T, 2016, WORLD J HEPATOL, V8, P36, DOI 10.4254/wjh.v8.i1.36; Ponziani FR, 2014, TRANSPLANT REV-ORLAN, V28, P92, DOI 10.1016/j.trre.2014.01.003; Rabe C, 2001, WORLD J GASTROENTERO, V7, P208; Ravaioli M, 2008, AM J TRANSPLANT, V8, P2547, DOI 10.1111/j.1600-6143.2008.02409.x; Rodriguez-Castro KI, 2012, TRANSPLANTATION, V94, P1145, DOI 10.1097/TP.0b013e31826e8e53; Sieders E, 2000, LIVER TRANSPLANT, V6, P326, DOI 10.1053/lv.2000.6146; Sirchia G, 1998, TRANSPL P, V30, P1735, DOI 10.1016/S0041-1345(98)00409-6; Takahashi Y, 2009, PEDIATR SURG INT, V25, P745, DOI 10.1007/s00383-009-2430-y; Thomassen MCLGD, 2003, HAEMATOLOGICA, V88, P1150; Yao FY, 2008, HEPATOLOGY, V48, P819, DOI 10.1002/hep.22412; Yao FY, 2005, AM J TRANSPLANT, V5, P795, DOI 10.1111/j.1600-6143.2005.00750.x; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186699	10.1371/journal.pone.0186699	http://dx.doi.org/10.1371/journal.pone.0186699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073275	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400041
J	Rahman, S; Choudhury, AA; Khanam, R; Moin, SMI; Ahmed, S; Begum, N; Shoma, NN; Quaiyum, MA; Baqui, AH				Rahman, Sayedur; Choudhury, Aziz Ahmed; Khanam, Rasheda; Moin, Syed Mamun Ibne; Ahmed, Salahuddin; Begum, Nazma; Shoma, Nurun Naher; Quaiyum, Md Abdul; Baqui, Abdullah H.		Projahnmo Study Grp Bangladesh	Effect of a package of integrated demand- and supply-side interventions on facility delivery rates in rural Bangladesh: Implications for large-scale programs	PLOS ONE			English	Article							REDUCING MATERNAL MORTALITY; MIDDLE-INCOME COUNTRIES; JANANI-SURAKSHA-YOJANA; HEALTH VOUCHER SCHEME; ACCESS BARRIERS; CARE; SERVICES; EQUITY; IMPACT; STRATEGIES	Background According to the Bangladesh Demographic and Health Survey 2014, only approximately 37 percent of women deliver in a health facility. Among the eight administrative divisions of Bangladesh, the facility delivery rate is lowest in the Sylhet division (22.6 percent) where we assessed the effect of integrated supply- and demand-side interventions on the facility-based delivery rate. Methods Population-based cohort data of pregnant women from an ongoing maternal and newborn health improvement study being conducted in a population of similar to 120,000 in Sylhet district were used. The study required collection and processing of biological samples immediately after delivery. Therefore, the project assembled various strategies to increase institutional delivery rates. The supply-side intervention included capacity expansion of the health facilities through service provider refresher training, 24/7 service coverage, additions of drugs and supplies, and incentives to the providers. The demand-side component involved financial incentives to cover expenses, a provision of emergency transport, and referral support to a tertiary-level hospital. We conducted a before-and-after observational study to assess the impact of the intervention in a total of 1,861 deliveries between December 2014 and November 2016. Results Overall, implementation of the intervention package was associated with 52.6 percentage point increase in the proportions of facility-based deliveries from a baseline rate of 25.0 percent to 77.6 percent in 24 months. We observed lower rates of institutional deliveries when only supply-side interventions were implemented. The proportion rose to 47.1 percent and continued increasing when the project emphasized addressing the financial barriers to accessing obstetric care in a health facility. Conclusions An integrated supply-and demand-side intervention was associated with a substantial increase in institutional delivery. The package can be tailored to identify which combination of interventions may produce the optimum result and be scaled. Rigorous implementation research studies are needed to draw confident conclusions and to provide information about the costs, feasibility for scale-up and sustainability.	[Rahman, Sayedur; Choudhury, Aziz Ahmed; Moin, Syed Mamun Ibne; Ahmed, Salahuddin; Begum, Nazma; Shoma, Nurun Naher] Johns Hopkins Univ Bangladesh, Dhaka, Bangladesh; [Khanam, Rasheda; Baqui, Abdullah H.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Ctr Maternal & Newborn Hlth, Dept Int Hlth, Baltimore, MD USA; [Quaiyum, Md Abdul] ICDDR B, Dhaka, Bangladesh	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR)	Rahman, S (corresponding author), Johns Hopkins Univ Bangladesh, Dhaka, Bangladesh.	sayedur@jhu.edu	Dangal, Ganesh/O-1989-2017; Khanam, Rasheda/P-8050-2018; Ahmed, Salahuddin/AAH-7005-2020; Rahman, Sayedur/R-2843-2018	Dangal, Ganesh/0000-0002-5834-5525; Khanam, Rasheda/0000-0002-9365-8594; Ahmed, Salahuddin/0000-0001-6771-0638; Rahman, Sayedur/0000-0002-4445-3699	Bill and Melinda Gates Foundation [OPP1054163]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by Bill and Melinda Gates Foundation Award No: OPP1054163. AHB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsana K, 2001, REPROD HEALTH MATTER, V9, P79, DOI 10.1016/S0968-8080(01)90094-1; Agha S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-57; Agha S, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-10; Ahmed S, 2011, SOC SCI MED, V72, P1704, DOI 10.1016/j.socscimed.2011.03.031; Ahmed S, 2011, HEALTH POLICY PLANN, V26, P25, DOI 10.1093/heapol/czq015; Amudhan S, 2013, INT J EPIDEMIOL, V42, P769, DOI 10.1093/ije/dyt071; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020601; Bellows B, 2013, HEALTH POLICY PLANN, V28, P134, DOI 10.1093/heapol/czs030; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; De Allegri M, 2012, J PUBLIC HEALTH POL, V33, P439, DOI 10.1057/jphp.2012.27; Ekirapa-Kiracho E, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S11; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Ensor T, 2014, B WORLD HEALTH ORGAN, V92, P51, DOI 10.2471/BLT.13.122721; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gupta SK, 2012, J HEALTH POPUL NUTR, V30, P464; Hatt L., 2010, EC EVALUATION DEMAND; Hurst TE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0727-5; Islam A., 2014, AM J HLTH RES, V6, P366, DOI [10.11648/j.ajhr.20140206.18, DOI 10.11648/J.AJHR.20140206.18]; Islam Z, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1610-6; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Keya KT, 2014, INT Q COMMUNITY HEAL, V35, P37, DOI 10.2190/IQ.35.1.d; Killingsworth JR, 1999, HEALTH POLICY PLANN, V14, P152, DOI 10.1093/heapol/14.2.152; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Kruk ME, 2008, TROP MED INT HEALTH, V13, P1442, DOI 10.1111/j.1365-3156.2008.02173.x; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Moyer CA, 2014, MATERN CHILD HLTH J, V18, P109, DOI 10.1007/s10995-013-1240-y; Moyer Cheryl A, 2013, Afr J Reprod Health, V17, P30; Mridha MK, 2009, J HEALTH POPUL NUTR, V27, P124; Mullany LC, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-67; Murray SF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-30; Nahar S, 1998, HEALTH POLICY PLANN, V13, P417, DOI 10.1093/heapol/13.4.417; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; Nguyen HTH, 2012, SOC SCI MED, V74, P989, DOI 10.1016/j.socscimed.2011.11.030; NIPORT Mitra and Associates ICF International and ICBBRB, 2012, BANGL MAT MORT HLTH; Parkhurst JO, 2006, J HEALTH POPUL NUTR, V24, P438; Pitchforth E, 2006, QUAL SAF HEALTH CARE, V15, P214, DOI 10.1136/qshc.2005.017285; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Saksena P, 2012, TROP MED INT HEALTH, V17, P23, DOI 10.1111/j.1365-3156.2011.02894.x; Sarker BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146161; Schmidt JO, 2010, HEALTH POLICY, V96, P98, DOI 10.1016/j.healthpol.2010.01.008; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Titaley CR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-485; Tura G, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-18; Van de Poel E, 2014, B WORLD HEALTH ORGAN, V92, P331, DOI 10.2471/BLT.13.129122; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186182	10.1371/journal.pone.0186182	http://dx.doi.org/10.1371/journal.pone.0186182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073229	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400015
J	Hinzpeter, R; Wagner, MW; Wurnig, MC; Seifert, B; Manka, R; Alkadhi, H				Hinzpeter, Ricarda; Wagner, Matthias W.; Wurnig, Moritz C.; Seifert, Burkhardt; Manka, Robert; Alkadhi, Hatem			Texture analysis of acute myocardial infarction with CT: First experience study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; FEATURES; CANCER	Objective To investigate the feasibility and accuracy of texture analysis to distinguish through objective and quantitative image information between healthy and infarcted myocardium with computed tomography (CT). Materials and methods Twenty patients (5 females; mean age 56 +/- 10years) with proven acute myocardial infarction (Ml) and 20 patients (8 females; mean age 42 +/- 15years) with no cardiac abnormalities (hereafter termed controls) underwent contrast-enhanced cardiac CT. Short axis CT images of the left ventricle (LV) were reconstructed at the slice thicknesses 1 mm, 2mm, and 5mm. Two independent, blinded readers segmented the LV in controls and patients. Texture analysis was performed yielding first-level features based on the histogram (variance, skewness, kurtosis, entropy), second-level features based on the gray-level co-occurrence matrix (GLCM) (contrast, correlation, energy and homogeneity), and third-level features based on the gray-level run-length matrix (GLRLM). Results Inter-and intrareader agreement was good to excellent for all histogram (intraclass correlation coefficient (ICC):0.70-0.93) and for all GLCM features (ICC:0.66-0.99), and was variable for the GLRLM features (ICC:-0.12-0.99). Univariate analysis showed significant differences between patients and controls for 2/4 histogram features, 3/4 GLCM and for 6/11 GLRLM features and all assessed slice thicknesses (all,p<0.05). In a multivariate logistic regression model, the single best variable from each level, determined by ROC analysis, was included stepwise. The best model included kurtosis (OR 0.08, 95%CI:0.01-0.65,P = 0.018) and short run high gray-level emphasis (SRHGE, OR 0.97, 95%CI:0.94-0.99,P = 0.007), with an area-under-the-curve (AUC) of 0.90 (95%CI:0.80-0.99). The best results for kurtosis and SRHGE (AUC = 0.78) were obtained at a 5mm slice thickness. A cut-off value of 14.4 for kurtosis+0.013*SRHGE predicted acute Ml with a sensitivity of 95% (specificity 55%). Conclusion Our study illustrates the feasibility of texture analysis for distinguishing healthy from acutely infarcted myocardium with cardiac CT using objective, quantitative features, with most reproducible and accurate results at a short axis slice thickness of 5mm.	[Hinzpeter, Ricarda; Wagner, Matthias W.; Wurnig, Moritz C.; Manka, Robert; Alkadhi, Hatem] Univ Zurich, Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Seifert, Burkhardt] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Manka, Robert] Univ Zurich, Univ Heart Ctr Zurich, Dept Cardiol, Zurich, Switzerland; [Manka, Robert] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Manka, Robert] Swiss Fed Inst Technol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Alkadhi, H (corresponding author), Univ Zurich, Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.	hatem.alkadhi@usz.ch		Seifert, Burkhardt/0000-0002-5829-2478; Wurnig, Moritz/0000-0001-7865-4010				ADAMS DF, 1976, AM J ROENTGENOL, V126, P786, DOI 10.2214/ajr.126.4.786; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Antunes S, 2016, 2016 IEEE 38 ANN INT; Bayanati H, 2015, EUR RADIOL, V25, P480, DOI 10.1007/s00330-014-3420-6; Becker AS, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3669; CHU A, 1990, PATTERN RECOGN LETT, V11, P415, DOI 10.1016/0167-8655(90)90112-F; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Collewet G, 2004, MAGN RESON IMAGING, V22, P81, DOI 10.1016/j.mri.2003.09.001; DASARATHY BV, 1991, PATTERN RECOGN LETT, V12, P497, DOI 10.1016/0167-8655(91)80014-2; Sanchez-Gracian CD, 2016, EUR RADIOL, V26, P3199, DOI 10.1007/s00330-015-4128-y; Dennie C, 2016, QUANT IMAG MED SURG, V6, P6, DOI 10.3978/j.issn.2223-4292.2016.02.01; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Goetti R, 2011, EUR RADIOL, V21, P2091, DOI 10.1007/s00330-011-2149-8; GRAY WR, 1978, CIRCULATION, V58, P497, DOI 10.1161/01.CIR.58.3.497; Guggenbuhl P, 2008, EUR J RADIOL, V67, P514, DOI 10.1016/j.ejrad.2007.08.003; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hodgdon T, 2015, RADIOLOGY, V276, P787, DOI 10.1148/radiol.2015142215; Jin KN, 2016, EUR J RADIOL, V85, P1914, DOI 10.1016/j.ejrad.2016.06.023; Kim H, 2016, INVEST RADIOL, V51, P569, DOI 10.1097/RLI.0000000000000267; Lee H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160188; MacKay JW, 2016, J MAGN RESON IMAGING, V43, P1159, DOI 10.1002/jmri.25088; Mayerhoefer ME, 2009, INVEST RADIOL, V44, P405, DOI 10.1097/RLI.0b013e3181a50a66; Meinel FG, 2014, RADIOLOGY, V270, P708, DOI 10.1148/radiol.13131183; Mendoza DD, 2010, J CARDIOVASC COMPUT, V4, P83, DOI 10.1016/j.jcct.2010.01.019; Mougiakakou SG, 2007, ARTIF INTELL MED, V41, P25, DOI 10.1016/j.artmed.2007.05.002; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Savio SJ, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-60; TAMURA H, 1978, IEEE T SYST MAN CYB, V8, P460, DOI 10.1109/TSMC.1978.4309999; TERPOGOSSIAN MM, 1976, AM J ROENTGENOL, V127, P79, DOI 10.2214/ajr.127.1.79; Thornhill RE., 2014, J CARDIOVASC MAGN R, V16, DOI [10.1186/1532-429X-16-S1-P351, DOI 10.1186/1532-429X-16-S1-P351]; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; von Ballmoos MW, 2011, ANN INTERN MED, V154, P413, DOI 10.7326/0003-4819-154-6-201103150-00007; Wei X., 2007, GRAY LEVEL RUN LENGT; Wibmer A, 2015, EUR RADIOL, V25, P2840, DOI 10.1007/s00330-015-3701-8; Xu D-H, 2004, HEART, V27, P25; Yang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134194	36	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186876	10.1371/journal.pone.0186876	http://dx.doi.org/10.1371/journal.pone.0186876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095833	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200027
J	Maski, K; Steinhart, E; Holbrook, H; Katz, ES; Kapur, K; Stickgold, R				Maski, Kiran; Steinhart, Erin; Holbrook, Hannah; Katz, Eliot S.; Kapur, Kush; Stickgold, Robert			Impaired memory consolidation in children with obstructive sleep disordered breathing	PLOS ONE			English	Article							DECLARATIVE MEMORY; PRESCHOOL-CHILDREN; TUCSON CHILDRENS; APNEA; PERFORMANCE; SPINDLE; RELIABILITY; CHILDHOOD; MORBIDITY; VALIDITY	Memory consolidation is stabilized and even enhanced by sleep (and particularly by 12-15 Hz sleep spindles in NREM stage 2 sleep) in healthy children but it is unclear what happens to these processes when sleep is disturbed by obstructive sleep disordered breathing. This cross-sectional study investigates differences in declarative memory consolidation among children with primary snoring (PS) and obstructive sleep apnea (OSA) compared to controls. We further investigate whether memory consolidation group differences are associated with NREM stage 2 (N2) sigma (12-15 Hz) or NREM slow oscillation (0.5-1 Hz) spectral power bands. In this study, we trained and tested participants on a spatial declarative memory task with cued recall. Retest occurred after a period of daytime wake (Wake) or a night of sleep (Sleep) with in-lab polysomnography. 36 participants ages 5-9 years completed the protocol: 14 with OSA as defined by respiratory disturbance index (RDI) >1/hour, 12 with primary snoring (PS) and 10 controls. OSA participants had poorer overall memory consolidation than controls across Wake and Sleep conditions [OSA: mean =-18.7% (5.8), controls: mean = 1.9% (7.2), t =-2.20, P = 0.04]. In contrast, PS participants and controls had comparable memory consolidation across conditions (t = 0.41; P = 0.38). We did not detect a main effect for condition (Sleep, Wake) or group x condition interaction on memory consolidation. OSA participants had lower N2 sigma power than PS (P = 0.03) and controls (P = 0.004) and N2 sigma power inversely correlated with percentage of time snoring on the study night (r =-0.33, P<0.05). Across all participants, N2 sigma power modestly correlated with memory consolidation in both Sleep (r = 0.37, P = 0.03) and Wake conditions (r = 0.44, P = 0.009). Further observed variable path analysis showed that N2 sigma power mediated the relationship between group and mean memory consolidation across Sleep and Wake states [B-indirect = 6.76(3.5), z = 2.03, P = 0.04]. NREM slow oscillation power did not correlate with memory consolidation. All results retained significance after controlling for age and BMI. In sum, participants with mild OSA had impaired memory consolidation and results were mediated by N2 sigma power. These results suggest that N2 sigma power could serve as biomarker of risk for cognitive dysfunction in children with sleep disordered breathing.	[Maski, Kiran; Steinhart, Erin; Kapur, Kush] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Holbrook, Hannah] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA; [Katz, Eliot S.] Boston Childrens Hosp, Div Resp Dis, Boston, MA USA; [Stickgold, Robert] Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02215 USA; [Stickgold, Robert] Harvard Med Sch, Dept Psychiat, Boston, MA USA	Harvard University; Boston Children's Hospital; University of Vermont; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Maski, K (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.	Kiran.maski@childrens.harvard.edu	Kapur, Kush/AAQ-3437-2020	Kapur, Kush/0000-0001-9022-913X	American Sleep Medicine Foundation Physician Scientist Training Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048832] Funding Source: NIH RePORTER	American Sleep Medicine Foundation Physician Scientist Training Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the American Sleep Medicine Foundation Physician Scientist Training Award to Kiran Maski.	Achenbach TM, 2001, J CONSULT CLIN PSYCH, V69, P699, DOI 10.1037/0022-006X.69.4.699; American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S, V3; Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; Beebe DW, 2010, SLEEP, V33, P1447, DOI 10.1093/sleep/33.11.1447; Beebe DW, 2003, SLEEP, V26, P298, DOI 10.1093/sleep/26.3.298; Biggs SN, 2011, SLEEP MED, V12, P887, DOI 10.1016/j.sleep.2011.07.003; Blunden S, 2000, J CLIN EXP NEUROPSYC, V22, P554, DOI 10.1076/1380-3395(200010)22:5;1-9;FT554; Bourke R, 2011, SLEEP MED, V12, P489, DOI 10.1016/j.sleep.2010.11.010; Bourke RS, 2011, SLEEP MED, V12, P222, DOI 10.1016/j.sleep.2010.08.011; Brockmann PE, 2012, SLEEP BREATH, V16, P23, DOI 10.1007/s11325-011-0480-6; Calhoun SL, 2009, J CLIN SLEEP MED, V5, P228; Chervin RD, 2000, SLEEP MED, V1, P21, DOI 10.1016/S1389-9457(99)00009-X; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Djonlagic I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034106; Gais S, 2002, J NEUROSCI, V22, P6830; Goodwin JL, 2003, SLEEP, V26, P587, DOI 10.1093/sleep/26.5.587; Halbower AC, 2006, PLOS MED, V3, P1391, DOI 10.1371/journal.pmed.0030301; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hoedlmoser K, 2014, SLEEP, V37, P1501, DOI 10.5665/sleep.4000; Holz J, 2012, J SLEEP RES, V21, P612, DOI 10.1111/j.1365-2869.2012.01017.x; Iber C., 2007, AASM MANUAL SCORING; Jackman AR, 2012, SLEEP MED, V13, P621, DOI 10.1016/j.sleep.2012.01.013; Kheirandish-Gozal L, 2010, EUR RESPIR J, V36, P164, DOI 10.1183/09031936.00114209; Kurdziel L, 2013, P NATL ACAD SCI USA, V110, P17267, DOI 10.1073/pnas.1306418110; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; Marcus CL, 2012, PEDIATRICS, V130, P576, DOI 10.1542/peds.2012-1671; Marshall L, 2003, NEUROSCIENCE, V121, P1047, DOI 10.1016/S0306-4522(03)00458-5; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Maski K, 2015, SLEEP DEPENDENT MEMO; Moreira GA, 2005, PEDIATR PULM, V40, P300, DOI 10.1002/ppul.20219; Philby MF, 2017, SCI REP-UK, V7, DOI 10.1038/srep44566; Prehn-Kristensen A, 2011, SLEEP MED, V12, P672, DOI 10.1016/j.sleep.2010.10.010; Rosen CL, 2004, PEDIATRICS, V114, P1640, DOI 10.1542/peds.2004-0103; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Venker CC, 2007, SLEEP BREATH, V11, P217, DOI 10.1007/s11325-007-0103-4; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wilhelm I, 2012, NEUROSCI BIOBEHAV R, V36, P1718, DOI 10.1016/j.neubiorev.2012.03.002; Wilhelm I, 2008, LEARN MEMORY, V15, P373, DOI 10.1101/lm.803708	41	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186915	10.1371/journal.pone.0186915	http://dx.doi.org/10.1371/journal.pone.0186915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095855	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200030
J	Okabe, N; Himi, N; Maruyama-Nakamura, E; Hayashi, N; Narita, K; Miyamoto, O				Okabe, Naohiko; Himi, Naoyuki; Maruyama-Nakamura, Emi; Hayashi, Norito; Narita, Kazuhiko; Miyamoto, Osamu			Rehabilitative skilled forelimb training enhances axonal remodeling in the corticospinal pathway but not the brainstem-spinal pathways after photothrombotic stroke in the primary motor cortex	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; CORTICAL PLASTICITY; ADULT RATS; RECOVERY; TRACT; SYSTEM; REORGANIZATION; LESIONS; TASK; COMPENSATION	Task-specific rehabilitative training is commonly used for chronic stroke patients. Axonal remodeling is believed to be one mechanism underlying rehabilitation-induced functional recovery, and significant roles of the corticospinal pathway have previously been demonstrated. Brainstem-spinal pathways, as well as the corticospinal tract, have been suggested to contribute to skilled motor function and functional recovery after brain injury. However, whether axonal remodeling in the brainstem-spinal pathways is a critical component for rehabilitation-induced functional recovery is not known. In this study, rats were subjected to photothrombotic stroke in the caudal forelimb area of the primary motor cortex and received rehabilitative training with a skilled forelimb reaching task for 4 weeks. After completion of the rehabilitative training, the retrograde tracer Fast blue was injected into the contralesional lower cervical spinal cord. Fast blue-positive cells were counted in 32 brain areas located in the cerebral cortex, hypothalamus, midbrain, pons, and medulla oblongata. Rehabilitative training improved motor performance in the skilled forelimb reaching task but not in the cylinder test, ladder walk test, or staircase test, indicating that rehabilitative skilled forelimb training induced task-specific recovery. In the histological analysis, rehabilitative training significantly increased the number of Fast blue-positive neurons in the ipsilesional rostral forelimb area and secondary sensory cortex. However, rehabilitative training did not alter the number of Fast blue-positive neurons in any areas of the brainstem. These results indicate that rehabilitative skilled forelimb training enhances axonal remodeling selectively in the corticospinal pathway, which suggests a critical role of cortical plasticity, rather than brainstem plasticity, in task-specific recovery after subtotal motor cortex destruction.	[Okabe, Naohiko; Himi, Naoyuki; Maruyama-Nakamura, Emi; Hayashi, Norito; Narita, Kazuhiko; Miyamoto, Osamu] Kawasaki Med Sch, Dept Physiol 2, Kurashiki, Okayama, Japan	Kawasaki Medical School	Okabe, N (corresponding author), Kawasaki Med Sch, Dept Physiol 2, Kurashiki, Okayama, Japan.	n-okabe@med.kawasaki-m.ac.jp			Japan Society for the Promotion of Science [17K01493, 15K16382]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (grant number: 17K01493 and 15K16382) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred RP, 2008, EXP NEUROL, V210, P172, DOI 10.1016/j.expneurol.2007.10.010; Bachmann LC, 2014, J NEUROSCI, V34, P3378, DOI 10.1523/JNEUROSCI.4384-13.2014; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Carmel JB, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00051; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Desrosiers J, 1996, STROKE, V27, P1564, DOI 10.1161/01.STR.27.9.1564; Di Pino G, 2014, NAT REV NEUROL, V10, P597, DOI 10.1038/nrneurol.2014.162; Dobkin BH, 2004, NEUROIMAGE, V23, P370, DOI 10.1016/j.neuroimage.2004.06.008; Esposito MS, 2014, NATURE, V508, P351, DOI 10.1038/nature13023; Filli L, 2014, J NEUROSCI, V34, P13399, DOI 10.1523/JNEUROSCI.0701-14.2014; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Garcia-Alias G, 2015, EXP NEUROL, V266, P112, DOI 10.1016/j.expneurol.2015.01.009; Ghilardi M, 2000, BRAIN RES, V871, P311; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Ishida A, 2016, J NEUROSCI, V36, P455, DOI 10.1523/JNEUROSCI.2399-15.2016; Johansen-Berg H, 2002, BRAIN, V125, P2731, DOI 10.1093/brain/awf282; Jones TA, 2017, NAT REV NEUROSCI, V18, P267, DOI 10.1038/nrn.2017.26; Karhu J, 1999, J NEUROPHYSIOL, V81, P2017, DOI 10.1152/jn.1999.81.5.2017; LAWRENCE DG, 1968, BRAIN, V91, P15, DOI 10.1093/brain/91.1.15; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; Li S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00120; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; MacLellan CL, 2011, NEUROREHAB NEURAL RE, V25, P740, DOI 10.1177/1545968311407517; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Metrot J, 2013, ARCH PHYS MED REHAB, V94, P2283, DOI 10.1016/j.apmr.2013.05.024; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Mitchell EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152176; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Mosberger AC, 2017, CEREB CORTEX; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nakagawa H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.62; Okabe N, 2016, NEUROSCIENCE, V339, P338, DOI 10.1016/j.neuroscience.2016.10.008; Pleger B, 2003, NEURON, V40, P643, DOI 10.1016/S0896-6273(03)00677-9; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Salter K, 2006, J REHABIL MED, V38, P113, DOI 10.1080/16501970500314350; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Siegel CS, 2015, J NEUROSCI, V35, P1443, DOI 10.1523/JNEUROSCI.3713-14.2015; Sommer CJ, 2017, STROKE, V48, P1112, DOI 10.1161/STROKEAHA.116.013324; Starkey ML, 2011, EXP NEUROL, V232, P81, DOI 10.1016/j.expneurol.2011.08.006; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Touvykine B, 2016, NEUROREHAB NEURAL RE, V30, P280, DOI 10.1177/1545968315585356; Wahl AS, 2014, SCIENCE, V344, P1250, DOI 10.1126/science.1253050; Werhahn KJ, 2003, ANN NEUROL, V54, P464, DOI 10.1002/ana.10686; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115	49	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187413	10.1371/journal.pone.0187413	http://dx.doi.org/10.1371/journal.pone.0187413			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095902	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200083
J	Piao, L; Park, H; Jo, CH				Piao, Linfeng; Park, Hyungmin; Jo, Chris Hyunchul			Theoretical prediction and validation of cell recovery rates in preparing platelet-rich plasma through a centrifugation	PLOS ONE			English	Article							RED-BLOOD-CELLS; GROWTH-FACTOR; SEDIMENTATION; SEPARATION; SUSPENSIONS; SURGERY; SYSTEMS; REPAIR; MODEL	In the present study, we propose a theoretical framework to predict the recovery rates of platelets and white blood cells in the process of centrifugal separation of whole blood contained in a tube for the preparation of platelet-rich plasma. Compared to previous efforts to optimize or standardize the protocols of centrifugation, we try to further the physical background (i.e., based on the multiphase flow phenomena) of analysis to develop a universal approach that can be applied to widely different conditions. That is, one-dimensional quasi-linear partial differential equation to describe the centrifugal sedimentation of dispersed phase (red and white blood cells) in continuous phase (plasma) is derived based on the kinematic-wave theory. With the information of whole blood volume and tube geometry considered, it is possible to determine the positions of interfaces between supernatant/suspension and suspension/sediment, i.e., the particle concentration gradient in a tube, for a wide range of centrifugation parameters (time and acceleration). While establishing a theory to predict the recovery rates of the platelet and white blood cell from the pre-determined interface positions, we also propose a new correlation model between the recovery rates of plasma and platelets, which is found to be a function of the whole blood volume, centrifugal time and acceleration, and tube geometry. The present predictions for optimal condition show good agreements with available human clinical data, obtained from different conditions, indicating the universal applicability of our method. Furthermore, the dependence of recovery rates on centrifugal conditions reveals that there exist a different critical acceleration and time for the maximum recovery rate of platelets and white blood cells, respectively. The other parameters such as hematocrit, whole blood volume and tube geometry are also found to strongly affect the maximum recovery rates of blood cells, and finally, as a strategy for increasing the efficiency, we suggest to dilute the whole blood, increase the whole blood volume with a tube geometry fixed.	[Piao, Linfeng; Park, Hyungmin] Seoul Natl Univ, Dept Mech & Aerosp Enginnering, Seoul, South Korea; [Park, Hyungmin] Seoul Natl Univ, Inst Adv Machines & Design, Seoul, South Korea; [Jo, Chris Hyunchul] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Orthoped Surg,Seoul Metropolitan Govt, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, H (corresponding author), Seoul Natl Univ, Dept Mech & Aerosp Enginnering, Seoul, South Korea.; Park, H (corresponding author), Seoul Natl Univ, Inst Adv Machines & Design, Seoul, South Korea.	hminpark@snu.ac.kr	Park, Hyungmin/D-7309-2013	Piao, Linfeng/0000-0001-9094-7940; Park, Hyungmin/0000-0003-3525-8573	Seoul National University Research Grant; National Research Foundation of Korea (NRF) - Korea government (MSIP) via SNU-IAMD [2016R1C1B2012775, 2017R1A4A1015523]	Seoul National University Research Grant; National Research Foundation of Korea (NRF) - Korea government (MSIP) via SNU-IAMD(National Research Foundation of Korea)	This work was supported by the 2016 Seoul National University Research Grant to CHJ and grants (2016R1C1B2012775, 2017R1A4A1015523) to HP through the National Research Foundation of Korea (NRF), funded by the Korea government (MSIP) via SNU-IAMD.r This work was supported by the 2016 Seoul National University Research Grant and grants (2016R1C1B2012775, 2017R1A4A1015523) through the National Research Foundation of Korea (NRF), funded by the Korea government (MSIP) via SNU-IAMD.	Alberts B., 2008, MOL BIOL CEL, V5th ed.; Amable PR, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt218; ANESTIS G, 1983, ING ARCH, V53, P399, DOI 10.1007/BF00533201; Araki J, 2012, TISSUE ENG PART C-ME, V18, P176, DOI [10.1089/ten.tec.2011.0308, 10.1089/ten.TEC.2011.0308]; Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34; BARFORD JP, 1986, BIOTECHNOL BIOENG, V28, P570, DOI 10.1002/bit.260280414; Berres S, 2003, INT J SOLIDS STRUCT, V40, P4965, DOI 10.1016/S0020-7683(03)00249-X; Boswell SG, 2014, AM J SPORT MED, V42, P42, DOI 10.1177/0363546513507566; Bridgman P. W., 1922, DIMENSIONAL ANAL; BROWN RI, 1989, ARTIF ORGANS, V13, P4, DOI 10.1111/j.1525-1594.1989.tb02827.x; Buckingham E, 1914, PHYS REV, V4, P345, DOI 10.1103/PhysRev.4.345; Burger R, 2001, J ENG MATH, V41, P145, DOI 10.1023/A:1011935232049; Burger R, 2001, INT J MINER PROCESS, V63, P115, DOI 10.1016/S0301-7516(01)00038-2; Castillo TN, 2011, AM J SPORT MED, V39, P266, DOI 10.1177/0363546510387517; Cervelli V, 2009, TISSUE ENG PART C-ME, V15, P625, DOI [10.1089/ten.tec.2008.0518, 10.1089/ten.TEC.2008.0518]; Cieslik-Bielecka A, 2009, TRANSFUS APHER SCI, V41, P9, DOI 10.1016/j.transci.2009.05.006; De Gruttola S, 2005, ARTIF ORGANS, V29, P949, DOI 10.1111/j.1525-1594.2005.00164.x; Dhurat Rachita, 2014, J Cutan Aesthet Surg, V7, P189, DOI 10.4103/0974-2077.150734; ENGQUIST B, 1981, MATH COMPUT, V36, P321, DOI 10.1090/S0025-5718-1981-0606500-X; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921; Franco RS, 2013, AM J HEMATOL, V88, P44, DOI 10.1002/ajh.23344; Fromer D, 2002, ARCH APPL MECH, V72, P85, DOI 10.1007/s00419-001-0195-4; Hamid Mohamad Shariff A, 2014, PLoS One, V9, pe90538, DOI 10.1371/journal.pone.0090538; Hammond JW, 2009, AM J SPORT MED, V37, P1135, DOI 10.1177/0363546508330974; Jo CH, 2013, J ORAL IMPLANTOL, V39, P525, DOI 10.1563/AAID-JOI-D-10-00155; Jo CH, 2015, AM J SPORT MED, V43, P2102, DOI 10.1177/0363546515587081; Jo CH, 2012, AM J SPORT MED, V40, P1035, DOI 10.1177/0363546512437525; Jo CH, 2011, AM J SPORT MED, V39, P2082, DOI 10.1177/0363546511413454; KAHN RA, 1976, TRANSFUSION, V16, P162, DOI 10.1046/j.1537-2995.1976.16276155111.x; KYNCH GJ, 1952, T FARADAY SOC, V48, P166, DOI 10.1039/tf9524800166; Leitner GC, 2006, VOX SANG, V91, P135, DOI 10.1111/j.1423-0410.2006.00815.x; Lerche D, 2001, BIORHEOLOGY, V38, P249; Lopez-Vidriero E, 2010, ARTHROSCOPY, V26, P269, DOI 10.1016/j.arthro.2009.11.015; LUEPTOW RM, 1991, J BIOMECH ENG-T ASME, V113, P485, DOI 10.1115/1.2895430; Mazzucco L, 2008, VOX SANG, V94, P202, DOI 10.1111/j.1423-0410.2007.01027.x; McCarrel Taralyn M, 2012, J Bone Joint Surg Am, V94, DOI 10.2106/JBJS.L.00019; Nikolidakis D, 2008, TISSUE ENG PART B-RE, V14, P249, DOI 10.1089/ten.teb.2008.0062; Perez Amanda G M, 2014, ISRN Hematol, V2014, P176060, DOI 10.1155/2014/176060; Perez AGM, 2013, BIORESEARCH OPEN ACC, V2, P307, DOI 10.1089/biores.2013.0015; Persons EL, 1929, J CLIN INVEST, V7, P615, DOI 10.1172/JCI100246; Richardson J.F., 1954, T I CHEM ENG-LOND, V32, P35, DOI DOI 10.1016/S0263-8762(97)80006-8; SARTORY WK, 1975, ANN BIOMED ENG, V3, P13, DOI 10.1007/BF02584486; SARTORY WK, 1977, MATH BIOSCI, V33, P145, DOI 10.1016/0025-5564(77)90069-4; SLICHTER SJ, 1976, BRIT J HAEMATOL, V34, P395, DOI 10.1111/j.1365-2141.1976.tb03586.x; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Ungarish M, 2003, ARCH APPL MECH, V73, P399, DOI 10.1007/s00419-003-0291-8; Walker H. K., 1990, CLIN METHODS HIST PH, V3rd; WALLIS G.B., 2020, ONE DIMENSIONAL 2 PH; Washio T, 1977, P INT JOINT C ART IN, P810; WHELAN J A, 1971, Biorheology, V7, P205; Zimmermann R, 2003, VOX SANG, V85, P283, DOI 10.1111/j.0042-9007.2003.00361.x	52	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187509	10.1371/journal.pone.0187509	http://dx.doi.org/10.1371/journal.pone.0187509			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095890	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200107
J	Zabielski, P; Achnio-Zabielska, AUBO; Wojcik, B; Chabowski, A; Gorski, J				Zabielski, Piotr; Achnio-Zabielska, Agnieszka Urszula B. O.; Wojcik, Beata; Chabowski, Adrian; Gorski, Jan			Effect of plasma free fatty acid supply on the rate of ceramide synthesis in different muscle types in the rat	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; SPHINGOLIPID METABOLISM; INSULIN SENSITIVITY; VENTILATORY MUSCLES; EXERCISE; HEART; DIAPHRAGM; ENDURANCE; HUMANS; RESISTANCE	Ceramide is a key compound in sphingolipid metabolism. Dynamics of ceramide synthesis is important in the several biological processes, such as induction of apoptosis or insulin resistance. So far, its de novo synthesis rate was evaluated indirectly, based on the content of the compound, its intermediates and the activity of respective enzymes. The aim of the present study was to directly measure ceramide synthesis rate (FSR) in different muscle types under varied plasma FFA supply in rat with the use of [U-C-13] palmitate tracer and LC/MS/MS. The experiments were carried out on male Wistar rats, divided into three groups: 1-control, 2-with elevated plasma free fatty acid (FFA) concentration by means of intralipid and heparin, 3-with reduced plasma FFA concentration by means of nicotinic acid. The stable plasma FFA concentration and plasma [U-C-13] palmitate enrichment was maintained for two hours by simultaneous infusion of the tracer and the respective compounds. At the end of the experiment, samples of blood from the abdominal aorta, the heart, diaphragm, soleus and white section of the gastrocnemius were taken. Muscle sphinganine, sphingosine and ceramide content and enrichment and plasma palmitate enrichment was measured with the use of LC/MS/MS. Plasma FFA concentration and composition was measured by means of gas-liquid chromatography. Under basal conditions ceramide FSR in the heart and the diaphragm was higher than in the soleus and the white gastrocnemius. Elevation in the plasma FFA concentration increased the FSR and ceramide content in each muscle, which correlated with increased HOMA-IR. The highest FSR was noted in the heart. Reduction in the plasma FFA concentration decreased ceramide FSR in each muscle type, which was accompanied by marked reduction in HOMA-IR. It is concluded that ceramide FSR depends on both the muscle type and the plasma FFA supply and is correlated with whole body insulin sensitivity under varying plasma FFA supply.	[Zabielski, Piotr; Achnio-Zabielska, Agnieszka Urszula B. O.; Wojcik, Beata; Chabowski, Adrian; Gorski, Jan] Med Univ Bialystok, Dept Physiol, Bialystok, Poland; [Zabielski, Piotr] Med Univ Bialystok, Dept Med Biol, Bialystok, Poland; [Achnio-Zabielska, Agnieszka Urszula B. O.] Med Univ Bialystok, Dept Hyg Epidemiol & Metab Disorders, Bialystok, Poland; [Gorski, Jan] Lomza State Univ Appl Sci, Med Inst, Lomza, Poland	Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok	Zabielski, P (corresponding author), Med Univ Bialystok, Dept Physiol, Bialystok, Poland.; Zabielski, P (corresponding author), Med Univ Bialystok, Dept Med Biol, Bialystok, Poland.	piotr.zabielski@umb.edu.pl	Wójcik, Beata/T-8994-2018; Górski, Jan/T-4828-2018; Blachnio-Zabielsk, Agnieszka U/A-4879-2018; Chabowski, Adrian/T-2225-2018	Wójcik, Beata/0000-0002-9373-9810; Górski, Jan/0000-0001-9886-5069; Blachnio-Zabielsk, Agnieszka U/0000-0002-8055-0576; Chabowski, Adrian/0000-0002-7407-8156	Medical University of Bialystok [N/ST/ZB/16/008/1118, N/ST/ZB/17/002/1118]	Medical University of Bialystok	This work was supported by the Medical University of Bialystok, grant numbers: N/ST/ZB/16/008/1118 and N/ST/ZB/17/002/1118.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; ARIANO MA, 1973, J HISTOCHEM CYTOCHEM, V21, P51, DOI 10.1177/21.1.51; Badin PM, 2013, TRENDS ENDOCRIN MET, V24, P607, DOI 10.1016/j.tem.2013.08.001; Bajaj M, 2002, AM J PHYSIOL-ENDOC M, V283, pE346, DOI 10.1152/ajpendo.00329.2001; Baranowski M, 2008, ACTA PHYSIOL, V192, P519, DOI 10.1111/j.1748-1716.2007.01755.x; Baranowski M, 2007, J PHYSIOL PHARMACOL, V58, P57; Baranowski M, 2011, ADV EXP MED BIOL, V721, P41, DOI 10.1007/978-1-4614-0650-1_3; Blachnio-Zabielska A, 2010, HORM METAB RES, V42, P1, DOI 10.1055/s-0029-1238322; Blachnio-Zabielska A, 2010, J CELL PHYSIOL, V225, P786, DOI 10.1002/jcp.22283; Blachnio-Zabielska AU, 2016, CELL PHYSIOL BIOCHEM, V40, P1207, DOI 10.1159/000453174; Blachnio-Zabielska AU, 2013, J LIPID RES, V54, P1705, DOI 10.1194/jlr.D035006; Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Carpinteiro A, 2008, CANCER LETT, V264, P1, DOI 10.1016/j.canlet.2008.02.020; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chung JO, 2017, DIABETES, V66, P2082, DOI 10.2337/db17-0082; Davitt PM, 2013, J APPL PHYSIOL, V114, P1743, DOI 10.1152/japplphysiol.00095.2013; Dobrzyn A, 2002, AM J PHYSIOL-ENDOC M, V282, pE277, DOI 10.1152/ajpendo.00151.2001; Donati C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00338; Empinado HM, 2014, EUR J HEART FAIL, V16, P519, DOI 10.1002/ejhf.73; Frangioudakis G, 2013, DIABETOLOGIA, V56, P2697, DOI 10.1007/s00125-013-3035-5; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; GOSSELIN LE, 1992, J APPL PHYSIOL, V72, P1506, DOI 10.1152/jappl.1992.72.4.1506; GREEN HJ, 1989, J APPL PHYSIOL, V66, P1914, DOI 10.1152/jappl.1989.66.4.1914; Guo ZK, 1997, J LIPID RES, V38, P1888; Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285; Holmes AG, 2004, J APPL PHYSIOL, V97, P689, DOI 10.1152/japplphysiol.00195.2004; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Kabir MM, 2010, PHYSIOL BEHAV, V101, P22, DOI 10.1016/j.physbeh.2010.04.004; KEENS TG, 1978, J APPL PHYSIOL, V44, P905, DOI 10.1152/jappl.1978.44.6.905; Kelley RC, 2016, HEART FAIL REV; Knapp M, 2011, J PHYSIOL PHARMACOL, V62, P601; Korthuis RJ., 2011, INTEGRATED SYSTEMS P; LEE HB, 1985, J NUCL MED, V26, P72; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lipina C, 2011, DIABETOLOGIA, V54, P1596, DOI 10.1007/s00125-011-2127-3; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Miklosz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085547; MOORE RL, 1982, PFLUG ARCH EUR J PHY, V392, P268, DOI 10.1007/BF00584308; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nawrocki A, 2004, HORM METAB RES, V36, P601, DOI 10.1055/s-2004-825922; Nikolova-Karakashian MN, 2011, ANTIOXID REDOX SIGN, V15, P2501, DOI 10.1089/ars.2011.3940; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Oh YT, 2014, ENDOCRINOLOGY, V155, P923, DOI 10.1210/en.2013-1700; Park TS, 2012, HEART FAIL CLIN, V8, P633, DOI 10.1016/j.hfc.2012.06.003; Persson XMT, 2010, J LIPID RES, V51, P2761, DOI 10.1194/jlr.M008011; Pilegaard H, 2006, DIABETES, V55, P3020, DOI 10.2337/db06-0152; Riboni L, 1997, PROG LIPID RES, V36, P153, DOI 10.1016/S0163-7827(97)00008-8; Russo S B, 2013, Handb Exp Pharmacol, P373, DOI 10.1007/978-3-7091-1511-4_19; Rutherford C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.455; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Serikawa T, 2009, EXP ANIM TOKYO, V58, P333, DOI 10.1538/expanim.58.333; Serlie MJ, 2007, J CLIN ENDOCR METAB, V92, P1524, DOI 10.1210/jc.2006-2347; Straczkowski M, 2004, DIABETES, V53, P1215, DOI 10.2337/diabetes.53.5.1215; SULLIVAN TE, 1978, J APPL PHYSIOL, V44, P358, DOI 10.1152/jappl.1978.44.3.358; TAMAKI N, 1987, EUR J APPL PHYSIOL, V56, P127, DOI 10.1007/BF00640634; Wojcik B, 2015, J PHYSIOL PHARMACOL, V66, P385; Zabielski P, 2017, J ENDOCRINOL, V233, P329, DOI 10.1530/JOE-16-0381; Zhang XJ, 2012, J LIPID RES, V53, P119, DOI 10.1194/jlr.M019901	59	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187136	10.1371/journal.pone.0187136	http://dx.doi.org/10.1371/journal.pone.0187136			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095868	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200048
J	Roy, L; Biswas, TK; Chowdhury, ME				Roy, Lumbini; Biswas, Taposh Kumar; Chowdhury, Mahbub Elahi			Emergency obstetric and newborn care signal functions in public and private facilities in Bangladesh	PLOS ONE			English	Article							SERVICES	Background Signal functions for emergency obstetric and newborn care (EmONC) are the major interventions for averting maternal and neonatal mortalities. Readiness of the facilities is essential to provide all the basic and comprehensive signal functions for EmONC to ensure emergency services from the designated facilities. The study assessed population coverage and availability of EmONC services in public and private facilities in Bangladesh. Methods An assessment was conducted in all the public and private facilities providing obstetric care in to in -patients 24 districts. Data were collected on the performance of signal functions for EmONC from the study facilities in the last three months prior to the date of assessment. Trained data-collectors interviewed the facility managers and key service providers, along with review of records, using contextualized tools. Population coverage of signal functions was assessed by estimating the number of facilities providing the signal functions for EmONC compared to the United Nations requirements. Availability was assessed in terms of the proportion of facilities providing the services by type of facilities and by district. Results Caesarean section (CS) delivery and blood transfusion (BT) services (the two major components of comprehensive EmONC) were respectively available in 6.4 (0.9 public and 5.5 private) and 5.6 (1.3 public and 4.3 private) facilities per 500,000 population. The signal functions for basic EmONC, except two (parental anticonvulsants and assisted vaginal delivery), were available in a minimum of 5 facilities (public and private sectors combined) per 500,000 population. A major inter -district variation in the availability of signal functions was observed in each public- and private -sector facility. Among the various types of facilities, only the public medical college hospitals had all the signal functions. The situation was poor in other public facilities at the district and sub -district levels as well as in private facilities. Conclusions In the public sector, CS delivery and BT services were available in the minimum required number of facilities. However, to ensure basic EmONC services, participation of the private sector is necessary. Public-private partnership should be promoted for nationwide coverage of signal functions for EmONC in Bangladesh.	[Roy, Lumbini; Chowdhury, Mahbub Elahi] Int Ctr Diarrhoeal Dis Res, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Biswas, Taposh Kumar] Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Chowdhury, ME (corresponding author), Int Ctr Diarrhoeal Dis Res, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh.	melahi@icddrb.org	Dangal, Ganesh/O-1989-2017	Dangal, Ganesh/0000-0002-5834-5525; Chowdhury, Mahbub/0000-0001-5690-3303	Global Affairs Canada (GAC); Governments of Bangladesh, Canada, Sweden and the UK	Global Affairs Canada (GAC); Governments of Bangladesh, Canada, Sweden and the UK	This research study was funded by the Global Affairs Canada (GAC) to International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) through the United Nations Population Fund (UNFPA) Bangladesh. icddr,b is also thankful to the Governments of Bangladesh, Canada, Sweden and the UK for providing support to icddr, b's core fund.	Alam B, 2015, INT J GYNECOL OBSTET, V131, P63, DOI 10.1016/j.ijgo.2015.04.041; Alam N, 2016, INT J GYNECOL OBSTET, V135, pS45, DOI 10.1016/j.ijgo.2016.09.003; Associates for Community and Population Research (ACPR), 2001, REV AV US EM OBST CA; Averting Maternal Death and Disability Program (AMDD), NEEDS ASS EM OBST NE; BBS, 2011, POP CENS REP 2011; Chowdhury M. U., 2017, IEEE T POWER SYST, P1; Chowdhury ME, 2014, NEEDS ASSESSMENT STU; Jana Unnayan Sangstha (JUS), 2006, EMOC SERV INV REP 20; National Institute of Population Research and Training (NIPORT), 2012, BANGL MAT MORT HLTH; National Institute of Population Research and Training (NIPORT), 2011, BANGL DEM HLTH SURV; Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; United Nations Children's Fund World Health Organization United Nations Population Fund, GUID MON AV US OBST; University of South Carolina Associates for Community and Population Research, 2011, BANGL HLTH FAC SURV; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, MON EM OBST CAR HDB	17	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187238	10.1371/journal.pone.0187238	http://dx.doi.org/10.1371/journal.pone.0187238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091965	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700049
J	Brylka, LJ; Koppert, S; Babler, A; Kratz, B; Denecke, B; Yorgan, TA; Etich, J; Costa, IG; Brachvogel, B; Boor, P; Schinke, T; Jahnen-Dechent, W				Brylka, Laura J.; Koeppert, Sina; Babler, Anne; Kratz, Beate; Denecke, Bernd; Yorgan, Timur A.; Etich, Julia; Costa, Ivan G.; Brachvogel, Bent; Boor, Peter; Schinke, Thorsten; Jahnen-Dechent, Willi			Post-weaning epiphysiolysis causes distal femur dysplasia and foreshortened hindlimbs in fetuin-A-deficient mice	PLOS ONE			English	Article							CAPITAL FEMORAL EPIPHYSIS; CALCIPROTEIN PARTICLES; GLYCOPROTEIN/FETUIN-A; APATITE FORMATION; GENE-EXPRESSION; HS-GLYCOPROTEIN; CELL SUBSETS; GROWTH-PLATE; BONE; CALCIFICATION	Fetuin-A / alpha(2)-Heremans-Schmid-glycoprotein (gene name Ahsg) is a systemic inhibitor of ectopic calcification. Due to its high affinity for calcium phosphate, fetuin-A is highly abundant in mineralized bone matrix. Foreshortened femora in fetuin-A-deficient Ahsg(-/-) mice indicated a role for fetuin-A in bone formation. We studied early postnatal bone development in fetuin-A-deficient mice and discovered that femora from Ahsg(-/-) mice exhibited severely displaced distal epiphyses and deformed growth plates, similar to the human disease slipped capital femoral epiphysis (SCFE). The growth plate slippage occurred in 70% of Ahsg(-/-) mice of both sexes around three weeks postnatal. At this time point, mice weaned and rapidly gained weight and mobility. Epiphysis slippage never occurred in wildtype and heterozygous Ahsg(+/-) mice. Homozygous fetuin-A-deficient Ahsg(-/-) mice and, to a lesser degree, heterozygous Ahsg(+/-) mice showed lesions separating the proliferative zone from the hypertrophic zone of the growth plate. The hypertrophic growth plate cartilage in long bones from Ahsg(-/-) mice was significantly elongated and V-shaped until three weeks of age and thus prior to the slippage. Genome-wide transcriptome analysis of laser-dissected distal femoral growth plates from 13-day-old Ahsg(-/-) mice revealed a JAK-STAT-mediated inflammatory response including a 550-fold induction of the chemokine Cxcl9. At this stage, vascularization of the elongated growth plates was impaired, which was visualized by immunofluorescence staining. Thus, fetuin-A-deficient mice may serve as a rodent model of growth plate pathologies including SCFE and inflammatory cartilage degradation.	[Brylka, Laura J.; Koeppert, Sina; Babler, Anne; Jahnen-Dechent, Willi] RWTH Aachen Univ Hosp, Biointerface Lab, Helmholtz Inst Biomed Engn, Aachen, Germany; [Kratz, Beate; Denecke, Bernd] RWTH Aachen Univ Hosp, IZKF Genom Facil, Interdisciplinary Ctr Clin Res, Aachen, Germany; [Yorgan, Timur A.; Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Etich, Julia; Brachvogel, Bent] Univ Cologne, Dept Pediat & Adolescent Med, Expt Neonatol, Fac Med, Cologne, Germany; [Etich, Julia; Brachvogel, Bent] Univ Cologne, Ctr Biochem, Med Fac, Cologne, Germany; [Costa, Ivan G.] RWTH Aachen Univ Hosp, IZKF Res Grp Computat Biol & Bioinformat, Interdisciplinary Ctr Clin Res, Aachen, Germany; [Boor, Peter] RWTH Aachen Univ Hosp, Dept Pathol, Aachen, Germany; [Boor, Peter] RWTH Aachen Univ Hosp, Div Nephrol & Immunol, Aachen, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Cologne; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Jahnen-Dechent, W (corresponding author), RWTH Aachen Univ Hosp, Biointerface Lab, Helmholtz Inst Biomed Engn, Aachen, Germany.	willi.jahnen@rwth-aachen.de	Costa, Ivan G./D-5335-2014; Brylka, Laura J/D-7908-2014; Boor, Peter/C-7707-2011; Babler, Anne/AAA-7250-2021	Costa, Ivan G./0000-0003-2890-8697; Brylka, Laura J/0000-0003-4734-9966; Boor, Peter/0000-0001-9921-4284; Etich, Julia/0000-0003-3238-6692; Brachvogel, Bent/0000-0002-3923-0554	Deutsche Forschungsgemeinschaft [JA 562/10, IRTG 1508]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft JA 562/10 and IRTG 1508 to Professor Willi Jahnen-Dechent.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; DICKSON IR, 1975, NATURE, V256, P430, DOI 10.1038/256430a0; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gremse F, 2015, JOVE-J VIS EXP, DOI 10.3791/52770; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Huang B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13885; Jahnen-Dechent W, 2016, BONE, P93; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496; Johnson JS, 2016, J PEDIATR ENDOCR MET, V29, P971, DOI 10.1515/jpem-2016-0023; Karin N, 2016, J LEUKOCYTE BIOL, V99, P857, DOI 10.1189/jlb.2MR0915-441R; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Packialakshmi B, 2015, AVIAN DIS, V59, P349, DOI 10.1637/11082-040715-Review.1; Peck K, 2014, ORTHOP CLIN N AM, V45, P77, DOI 10.1016/j.ocl.2013.09.002; Peterson HA, 2007, EPIPHYSEAL GROWTH PL; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Scharschmidt T, 2009, J BONE JOINT SURG AM, V91A, P366, DOI 10.2106/JBJS.G.00039; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Seto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047338; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; TERMINE JD, 1988, CIBA FDN S, V136, P178; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Westenfeld R, 2009, J AM SOC NEPHROL, V20, P1264, DOI 10.1681/ASN.2008060572; Yuasa K, 2016, GENES CELLS, V21, P25, DOI 10.1111/gtc.12316	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187030	10.1371/journal.pone.0187030	http://dx.doi.org/10.1371/journal.pone.0187030			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088242	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900036
J	Kiat, Y				Kiat, Yosef			Divergent primary moult-A rare moult sequence among Western Palaearctic passerines	PLOS ONE			English	Article							POST-JUVENILE; FEATHER MOLT; BIRDS; GAPS	Wing morphology strongly affects flight performance which may consequently decline during feather moult due to the creation of feather gaps in the wing. Hence, the size and shape of moult-related wing gap may directly affect flight capacity. Here I examined the rare divergent primary moult sequence compared to the more common descendant moult sequence. In the divergent moult, the focus of primary moult is shifted from P-1 (primary feather numbered descendantly) to another primary between P-2 and P-5, and then primaries are moulted in two concurrent waves, one descendant and the other ascendant. The result of this rare moult sequence is the splitting of the wing gap to two smaller gaps. Using a large moult database including 6,763 individuals of 32 Western Palaearctic passerine species, I found evidence of divergent moult only among 27 individuals of 12 species. I examined the speed of wing-feather moult for each individual that moulted divergently compared to a control group of individuals at the same moult stage which moulted following the common descending sequence. The results indicate that the sequence of primary moult and moult speed are correlated. Individuals which moulted divergently moulted their primaries with higher moult speed than descendant moulters. The applicability of this study is weakened by the dearth of moult data, thus making it difficult to draw conclusions for a large range of species. Ornithologists and bird ringers are therefore encouraged to collect more basic moult data during their field study.	[Kiat, Yosef] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Alexander Silberman Inst Life Sci, Edmond J Safra Campus, Jerusalem, Israel	Hebrew University of Jerusalem	Kiat, Y (corresponding author), Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Alexander Silberman Inst Life Sci, Edmond J Safra Campus, Jerusalem, Israel.	yosefkiat@gmail.com		Kiat, Yosef/0000-0002-3485-3517				BAHRMANN U., 1971, BEITR VOGELKDE, V17, P413; Baker K, 1993, IDENTIFICATION GUIDE; BENSCH S, 1993, CONDOR, V95, P305, DOI 10.2307/1369353; Bridge ES, 2011, CONDOR, V113, P1, DOI 10.1525/cond.2011.100228; FRANCIS I S, 1991, Ringing and Migration, V12, P28; Ginn H. B., 1983, MOULT BIRDS BTO GUID; GREEN GH, 1975, BIRD STUDY, V22, P9, DOI 10.1080/00063657509476435; Haukioja E., 1971, ORNIS FENNICA, V48, P1; Hedenstrom A, 2003, J AVIAN BIOL, V34, P324, DOI 10.1111/j.0908-8857.2003.03324.x; Hedenstrom A, 1999, J EXP BIOL, V202, P67; Jenni L., 1994, BIOL MOULT BIRDS; Kelemen Marton, 2000, Ornis Hungarica, V10, P99; Kiat Y, 2016, EVOL ECOL, V30, P783, DOI 10.1007/s10682-016-9838-3; Kiat Y, 2016, J AVIAN BIOL, V47, P47, DOI 10.1111/jav.00717; Lind J, 2001, FUNCT ECOL, V15, P29; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; MARCHETTI K, 1989, BIOL REV, V64, P51, DOI 10.1111/j.1469-185X.1989.tb00638.x; Neto JM, 2006, IBIS, V148, P39, DOI 10.1111/j.1474-919X.2006.00477.x; Newton Ian, 2009, Ringing & Migration, V24, P220; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; Rohwer VG, 2013, AUK, V130, P699, DOI 10.1525/auk.2013.13042; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; STRESEMANN E, 1971, Journal fuer Ornithologie, V112, P373; Stresemann E., 1966, DIE MAUSER DER VOGEL; STRESEMANN VESTA, 1963, JOUR ORNITHOL, V104, P101, DOI 10.1007/BF01677685; Swaddle JP, 1997, CAN J ZOOL, V75, P1135, DOI 10.1139/z97-136; THOMAS D K, 1977, Ringing and Migration, V1, P125; Thompson CW, 1998, AUK, V115, P653, DOI 10.2307/4089414; Williamson K., 1972, British Birds, V65, P50	29	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187282	10.1371/journal.pone.0187282	http://dx.doi.org/10.1371/journal.pone.0187282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088288	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900058
J	Meyers, C; Milici, J; Robison, R				Meyers, Craig; Milici, Janice; Robison, Richard			UVC radiation as an effective disinfectant method to inactivate human papillomaviruses	PLOS ONE			English	Article							MAJOR CAPSID PROTEIN; IN-VITRO; TRANSMISSION; REPLICATION; RISK; SUSCEPTIBILITY; CONTAMINATION; TYPE-16	Endocavitary ultrasound probes are part of a commonly used procedure in the clinical arena. The cavities examined, vaginal canal and cervix, anal canal, and oral cavity are all areas commonly infected with the human papillomavirus (HPV), thus making them susceptible to contamination by HPV. It has been demonstrated that these probes can remain contaminated with high-risk HPV even when approved disinfection protocols have been performed. we have previously shown that HPV is resistant to some high-level disinfectant (HLD). In our present study we analyzed efficacy of using high-level ultra-violet C (UVC) radiation against HPV16 and HPV18 using a hard-surface carrier test. Stocks of infectious authentic HPV16 and HPV18 virions were dried onto carriers with a 5% (v/v) protein soil or 4ppm hard water. Efficacy testing were performed with the automated device, Antigermix S1 device (UVC radiation at 253.7nm) and 0.55% OPA in quadruplicate with matched input, neutralization, and cytotoxicity controls. Hypochlorite was included as a positive control for viral deactivation. Infectivity was determined by the abundance (qRT-PCR) of the spliced E1<^>E4 transcript in infected recipient cells. The automated Antigermix S1 device showed excellent efficacy against HPV16 and HPV18 whereas OPA showed minimal efficacy. While HPV is highly resistant to OPA, high-level UVC radiation offers an effective disinfection practice for ultrasound probes. Our results suggest that healthcare facilities using endocavitary ultrasound probes need to strongly consider disinfection methods that are effective against HPV.	[Meyers, Craig; Milici, Janice] Penn State Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Robison, Richard] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Brigham Young University	Meyers, C (corresponding author), Penn State Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA.	cmeyers@pennstatehealth.psu.edu		Robison, Richard/0000-0002-4324-5169	Germitec France	Germitec France	This work was supported by Germitec France. Germitec is a privately owned company. They provided the funding, the Antigermix 51 device, and in discussion with the corresponding author the basic conceptualization for the study.	BEDELL MA, 1991, J VIROL, V65, P2254, DOI 10.1128/JVI.65.5.2254-2260.1991; Biryukov J, 2015, METHODS MOL BIOL, V1249, P317, DOI 10.1007/978-1-4939-2013-6_24; Casalegno JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048137; Centers for Disease Control, 2008, GUIDELINE DISINFECTI; Conway MJ, 2009, J DENT RES, V88, P307, DOI 10.1177/0022034509333446; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022427; Conway MJ, 2009, VIROLOGY, V393, P295, DOI 10.1016/j.virol.2009.08.010; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; FDA, 2000, GUID IND FDA REV CON; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; Fisher CW, 2012, AM J INFECT CONTROL, V40, P880, DOI 10.1016/j.ajic.2011.11.004; Freitas AC, 2013, CLIN INFECT DIS, V56, P1451, DOI 10.1093/cid/cit066; Hahn HS, 2013, EUR J OBSTET GYN R B, V169, P202, DOI 10.1016/j.ejogrb.2013.02.024; HIGNETT M, 1995, J ASSIST REPROD GEN, V12, P606, DOI 10.1007/BF02212583; Hong Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-109; HUMMEL M, 1992, J VIROL, V66, P6070, DOI 10.1128/JVI.66.10.6070-6080.1992; International ASTM E1053-11, 2011, E105311 INT ASTM; Ishii Y, 2003, VIROLOGY, V308, P128, DOI 10.1016/S0042-6822(02)00099-5; Kac G, 2010, INFECT CONT HOSP EP, V31, P165, DOI 10.1086/649794; Liu ZY, 2016, SEX HEALTH, V13, P10, DOI 10.1071/SH15089; M'Zali F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093368; Ma STC, 2013, EMERG MED J, V30, P472, DOI 10.1136/emermed-2012-201407; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Meyers J, 2014, J ANTIMICROB CHEMOTH, V69, P1546, DOI 10.1093/jac/dku006; Milki AA, 1998, FERTIL STERIL, V69, P409, DOI 10.1016/S0015-0282(97)00571-2; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; Park H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-80; Rooks VJ, 1996, OBSTET GYNECOL, V87, P27, DOI 10.1016/0029-7844(95)00336-3; Rutala W.A., 2019, GUIDELINE DISINFECTI; Rutala WA, 2010, INFECT CONT HOSP EP, V31, P1025, DOI 10.1086/656244; Ryndock E, 2016, J MED VIROL, V88, P1076, DOI 10.1002/jmv.24421; Ryndock EJ, 2015, METHODS MOL BIOL, V1249, P39, DOI 10.1007/978-1-4939-2013-6_3; Ryndock EJ, 2014, EXPERT REV ANTI-INFE, V12, P1165, DOI 10.1586/14787210.2014.959497; Ryndock EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099488; Sabeena S, 2017, J OBSTET GYNAECOL RE, V43, P429, DOI 10.1111/jog.13248; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Smith Elaine M, 2010, Infect Dis Obstet Gynecol, V2010, P326369, DOI 10.1155/2010/326369; Sonnex C, 1999, INT J STD AIDS, V10, P726, DOI 10.1258/0956462991913402; Storment JM, 1997, SOUTHERN MED J, V90, P206, DOI 10.1097/00007611-199702000-00007; Tenti P, 1999, OBSTET GYNECOL, V93, P475, DOI 10.1016/S0029-7844(98)00459-1; Winer RL, 2010, CANCER EPIDEM BIOMAR, V19, P1682, DOI 10.1158/1055-9965.EPI-10-0226	43	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187377	10.1371/journal.pone.0187377	http://dx.doi.org/10.1371/journal.pone.0187377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088277	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900077
J	Monamele, GC; Vernet, MA; Nsaibirni, RFJ; Bigna, JJR; Kenmoe, S; Njankouo, MR; Njouom, R				Monamele, Gwladys C.; Vernet, Marie-Astrid; Nsaibirni, Robert F. J.; Bigna, Jean Joel R.; Kenmoe, Sebastien; Njankouo, Mohamadou Ripa; Njouom, Richard			Associations between meteorological parameters and influenza activity in a subtropical country: Case of five sentinel sites in Yaounde-Cameroon	PLOS ONE			English	Article							SEASONAL INFLUENZA; TRANSMISSION; HUMIDITY; VIRUSES; BURDEN	Influenza is associated with highly contagious respiratory infections. Previous research has found that influenza transmission is often associated with climate variables especially in temperate regions. This study was performed in order to fill the gap of knowledge regarding the relationship between incidence of influenza and three meteorological parameters (temperature, rainfall and humidity) in a tropical setting. This was a retrospective study performed in Yaounde-Cameroon from January 2009 to November 2015. Weekly proportions of confirmed influenza cases from five sentinel sites were considered as dependent variables, whereas weekly values of mean temperature, average relative humidity and accumulated rainfall were considered as independent variables. A univariate linear regression model was used in determining associations between influenza activity and weather covariates. A time-series method was used to predict on future values of influenza activity. The data was divided into 2 parts; the first 71 months were used to calibrate the model, and the last 12 months to test for prediction. Overall, there were 1173 confirmed infections with influenza virus. Linear regression analysis showed that there was no statistically significant association observed between influenza activity and weather variables. Very weak relationships (-0.1 < r < 0.1) were observed. Three prediction models were obtained for the different viral types (overall positive, Influenza A and Influenza B). Model 1 (overall influenza) and model 2 (influenza A) fitted well during the estimation period; however, they did not succeed to make good forecasts for predictions. Accumulated rainfall was the only external covariate that enabled good fit of both models. Based on the stationary R-2, 29.5% and 41.1% of the variation in the series can be explained by model 1 and 2, respectively. This study laid more emphasis on the fact that influenza in Cameroon is characterized by year-round activity. The meteorological variables selected in this study did not enable good forecast of future influenza activity and certainly acted as proxies to other factors not considered, such as, UV radiation, absolute humidity, air quality and wind.	[Monamele, Gwladys C.; Vernet, Marie-Astrid; Nsaibirni, Robert F. J.; Bigna, Jean Joel R.; Kenmoe, Sebastien; Njankouo, Mohamadou Ripa; Njouom, Richard] Ctr Pasteur Cameroun, Natl Influenza Ctr, Yaounde, Cameroon; [Monamele, Gwladys C.] Univ Buea, Dept Microbiol & Parasitol, Buea, Cameroon	Centre Pasteur du Cameroun	Njouom, R (corresponding author), Ctr Pasteur Cameroun, Natl Influenza Ctr, Yaounde, Cameroon.	njouom@pasteur-yaounde.org	Kenmoe, Sebastien/J-9678-2019	Kenmoe, Sebastien/0000-0002-5536-080X	U.S. Department of Health and Human Services (DHHS) via the International Network of Pasteur Institutes [6 DESP060001-01-01]	U.S. Department of Health and Human Services (DHHS) via the International Network of Pasteur Institutes	This work was supported by the U.S. Department of Health and Human Services (DHHS) grant number 6 DESP060001-01-01 via the International Network of Pasteur Institutes to Richard Njouom.; We would like to acknowledge the focal points of the influenza sentinel sites in Yaounde for identification of cases and data collection. We are thankful to Matthieu Schoenhals for editing this manuscript. This work was supported by the U.S. Department of Health and Human Services (DHHS) grant number 6 DESP060001-01-01 via the International Network of Pasteur Institutes.	Alonso WJ, 2015, INFLUENZA OTHER RESP, V9, P101, DOI 10.1111/irv.12308; BUCREP, 2014, RAPP NAT ET POP REG; Caini S, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0155089, 10.1371/journal.pone.0152310]; Chadsuthi S, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/436495; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Emukule GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138708; Fischer WA, 2014, GLOB HEART, V9, P325, DOI 10.1016/j.gheart.2014.08.004; Fuhrmann C, 2010, GEOGR COMPASS, V4, DOI 10.1111/j.1749-8198.2010.00343.x; Heraud JM, 2012, J INFECT DIS, V206, pS5, DOI 10.1093/infdis/jis541; IBM, IBM SPSS FOR 22; Imai C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24413; Khaliq A, 2015, J EPIDEMIOL GLOB HEA, V5, P397, DOI 10.1016/j.jegh.2015.07.007; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Murray EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024042; N'gattia AK, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3503-1; Pica N, 2012, CURR OPIN VIROL, V2, P90, DOI 10.1016/j.coviro.2011.12.003; Soebiyanto RP, 2015, GEOSPATIAL HEALTH, V10, P144, DOI 10.4081/gh.2015.372; Soebiyanto RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134701; Soebiyanto RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100659; Soebiyanto RP, 2010, REMOTE SENSING SPATI, P330; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Tchidjou HK, 2010, J TROP PEDIATRICS, V56, P317, DOI 10.1093/tropej/fmp127; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; WHO, 2014, B WORLD HEALTH ORGAN, V92	27	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186914	10.1371/journal.pone.0186914	http://dx.doi.org/10.1371/journal.pone.0186914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088290	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900032
J	Sittner, A; Bar-David, E; Glinert, I; Ben-Shmuel, A; Weiss, S; Schlomovitz, J; Kobiler, D; Levy, H				Sittner, Assa; Bar-David, Elad; Glinert, Itai; Ben-Shmuel, Amir; Weiss, Shay; Schlomovitz, Josef; Kobiler, David; Levy, Haim			Pathology of wild-type and toxin-independent Bacillus anthracis meningitis in rabbits	PLOS ONE			English	Article							FIBRIN CLOT STRUCTURE; INHALATIONAL ANTHRAX; ANIMAL-MODELS; PATHOGENESIS; PROTECTION; INFECTION; LETHAL; SPORES	Hemorrhagic meningitis is considered a complication of anthrax and was reported in about 50% of deadly cases in humans and non-human primates (NHP). Recently we demonstrated in Guinea pigs and rabbits that 100% of the B. anthracis-infected animals presented histopathology of meningitis at the time of death, some without any sign of hemorrhage. A similar pathology was observed in animals that succumbed following infection with the toxin deficient mutant, thus indicating that anthrax meningitis is a toxin-independent phenomenon. In this manuscript we describe a histopathological study of the B. anthracis infection of the central nervous system (CNS). Though we could find sporadic growth of the bacteria around blood vessels in the cortex, we report that the main infiltration route is the choroid plexus. We found massive destruction of entire sections of the choroid plexus coupled with massive aggregation of bacilli in the ventricles, in close proximity to the parenchyma. The choroid plexus also contained significant amounts of intravascular bacterial aggregates, often enclosed in what appear to be fibrin-like clots. The high concentration of these aggregates in areas of significant tissue destruction combined with the fact that capsular B. anthracis bacteria have a low tendency to adhere to endothelial cells, might suggest that these clots are used as an adherence mechanism by the bacteria. The major histopathological finding is meningitis. We find massive bacterial growth in the meninges without evidence of encephalitis, even when the bacteria emerge from a parenchymal blood vessel. Erythrocytes were present within the meningeal space but no clear vasculitis could be detected. Histology of the brain stem indicates meningitis, edema and hemorrhages that might explain death from suffocation due to direct damage to the respiratory center. All of these processes are toxin-independent, since they were observed following infection with either the wild type strain or the toxin-deficient mutant. Herein, we propose that the first step of anthrax-meningitis is bacterial adhesion to the blood vessels by manipulating coagulation, mainly in the choroid plexus. The trapped bacteria then destroy sections of the choroid plexus, resulting in penetration into the CSF, leading to meningitis and hemorrhage. Death could be the result of increased intracranial pressure and/or damage to the brain stem.	[Sittner, Assa; Bar-David, Elad; Glinert, Itai; Ben-Shmuel, Amir; Weiss, Shay; Schlomovitz, Josef; Kobiler, David; Levy, Haim] Israel Inst Biol Res, Dept Infect Dis, Ness Ziona, Israel		Levy, H (corresponding author), Israel Inst Biol Res, Dept Infect Dis, Ness Ziona, Israel.	haiml@iibr.gov.il		Sittner, Assa/0000-0002-1633-8191				Amaral A, 2004, INTENS CARE MED, V30, P1032, DOI 10.1007/s00134-004-2291-8; Biemond BJ, 1995, THROMB HEAMOST, V73, P8; Dando SJ, 2014, CLIN MICROBIOL REV, V27, P691, DOI 10.1128/CMR.00118-13; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Ebrahimi CM, 2011, INFECT IMMUN, V79, P2510, DOI 10.1128/IAI.00006-11; Ebrahimi CM, 2009, J BACTERIOL, V191, P7165, DOI 10.1128/JB.00903-09; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; Glinert I, 2016, ANTIMICROB AGENTS CH, V60, P4878, DOI 10.1128/AAC.00546-16; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Hendricks Katherine A, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2002.130687; Kobiler D, 2002, INFECT IMMUN, V70, P544, DOI 10.1128/IAI.70.2.544-550.2002; Levy H, 2014, PLOS ONE, V9, P1; Levy H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084947; Levy H, 2012, INFECT IMMUN, V80, P2623, DOI 10.1128/IAI.00244-12; Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012; Loof TG, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00128; McAdow M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002307; Meselson M, 1994, SCIENCE, V266, P7; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; Pillai KS, 2015, HEALTH SECUR, V6, P10; Plotkin AS, 1960, AM J MED, V29, P10; Savransky V, 2013, INFECT IMMUN, V81, P1152, DOI 10.1128/IAI.01289-12; Swartz MN, 2001, NEW ENGL J MED, V345, P6; Twenhafel NA, 2010, VET PATHOL, V47, P819, DOI 10.1177/0300985810378112; van Sorge NM, 2012, FUTURE MICROBIOL, V7, P383, DOI [10.2217/fmb.12.1, 10.2217/FMB.12.1]; Vasconcelos D, 2003, LAB INVEST, V83, P1201, DOI 10.1097/01.LAB.0000080599.43791.01; Weigandt KM, 2012, BIOPHYS J, V103, P2399, DOI 10.1016/j.bpj.2012.10.036; Weiss S, 2006, INFECT IMMUN, V74, P394, DOI 10.1128/IAI.74.1.394-398.2006; Weiss S, 2015, ANTIMICROB AGENTS CH, V59, P7497, DOI 10.1128/AAC.01376-15; Weiss S, 2011, ANTIMICROB AGENTS CH, V55, P1533, DOI 10.1128/AAC.01689-10; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	33	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186613	10.1371/journal.pone.0186613	http://dx.doi.org/10.1371/journal.pone.0186613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088287	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900017
J	Smouse, PE; Banks, SC; Peakall, R				Smouse, Peter E.; Banks, Sam C.; Peakall, Rod			Converting quadratic entropy to diversity: Both animals and alleles are diverse, but some are more diverse than others	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; DISSIMILARITY COEFFICIENTS; ECOLOGICAL COMMUNITIES; INBREEDING AVOIDANCE; POPULATION-GENETICS; SPECIES-DIFFERENCES; FINITE POPULATION; ANTECHINUS-AGILIS; MEDIAN NETWORKS; DISPERSAL	The use of diversity metrics has a long history in population ecology, while population genetic work has been dominated by variance-derived metrics instead, a technical gap that has slowed cross-communication between the fields. Interestingly, Rao's Quadratic Entropy (RQE), comparing elements for 'degrees of divergence', was originally developed for population ecology, but has recently been deployed for evolutionary studies. We here translate RQE into a continuous diversity analogue, and then construct a multiply nested diversity partition for alleles, individuals, populations, and species, each component of which exhibits the behavior of proper diversity metrics, and then translate these components into [0,1] D scaled form. We also deploy non-parametric statistical tests of the among-stratum components and novel tests of the homogeneity of within-stratum diversity components at any hierarchical level. We then illustrate this new analysis with eight nSSR loci and a pair of close Australian marsupial (Antechinus) congeners, using both 'different is different' and 'degree of difference' distance metrics. The total diversity in the collection is larger than that within either species, but most of the within-species diversity is resident within single populations. The combined A. agilis collection exhibits more diversity than does the combined A. stuartii collection, possibly attributable to localized differences in either local ecological disturbance regimes or differential levels of population isolation. Beyond exhibiting different allelic compositions, the two congeners are becoming more divergent for the arrays of allele sizes they possess.	[Smouse, Peter E.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ USA; [Banks, Sam C.] Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT, Australia; [Peakall, Rod] Australian Natl Univ, Res Sch Biol, Acton, ACT, Australia	Rutgers State University New Brunswick; Australian National University; Australian National University	Banks, SC (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT, Australia.	Sam.Banks@anu.edu.au	Peakall, Rod/C-9623-2009; /K-4907-2012	Peakall, Rod/0000-0001-9407-8404; /0000-0003-2415-0057	USDA National Institute of Food and Agriculture [1005333]; New Jersey Agricultural Experiment Station [NJ17160]; Australian Research Council [FT130100043]; USDA	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); New Jersey Agricultural Experiment Station; Australian Research Council(Australian Research Council); USDA(United States Department of Agriculture (USDA))	PES was supported by the USDA National Institute of Food and Agriculture Hatch Project 1005333, and the New Jersey Agricultural Experiment Station, Hatch project NJ17160; SCB was supported by Australian Research Council Future Fellowship FT130100043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; (Fig 1), Bill Sherwin, Oscar Gaggiotti, and a trio of anonymous reviewers for helpful critique on earlier drafts of the manuscript. PES was supported by the USDA and the New Jersey Agricultural Experiment Station, Hatch project NJ17160; SCB was supported by Australian Research Council Future Fellowship FT130100043.	Allen B, 2009, AM NAT, V174, P236, DOI 10.1086/600101; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banks S.C., 2017, ECOGRAPHY; Banks SC, 2014, J ANIM ECOL, V83, P515, DOI 10.1111/1365-2656.12128; Banks SC, 2011, OIKOS, V120, P26, DOI 10.1111/j.1600-0706.2010.18765.x; Banks SC, 2005, BIOL CONSERV, V122, P581, DOI 10.1016/j.biocon.2004.09.013; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Chao A, 2016, METHODS ECOL EVOL, V7, P919, DOI 10.1111/2041-210X.12551; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chiu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100014; COCKBURN A, 1985, ANIM BEHAV, V33, P908, DOI 10.1016/S0003-3472(85)80025-7; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Davies ID, 2016, ECOL EVOL, V6, P1181, DOI 10.1002/ece3.1948; De Bello F, 2010, J VEG SCI, V21, P1992; Dickman CR, 1998, AUST J ZOOL, V46, P1, DOI 10.1071/ZO97036; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Eastman JM, 2011, BIOINFORMATICS, V27, P2437, DOI 10.1093/bioinformatics/btr403; Enard D, 2016, ELIFE, V5, DOI 10.7554/eLife.12469; EXCOFFIER L, 1994, GENETICS, V136, P343; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; Foll M, 2014, AM J HUM GENET, V95, P394, DOI 10.1016/j.ajhg.2014.09.002; Fu YX, 1998, GENETICS, V150, P487; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gonzales E, 2008, AM J BOT, V95, P1254, DOI 10.3732/ajb.2007159; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; Grivet D, 2005, MOL ECOL, V14, P3585, DOI 10.1111/j.1365-294X.2005.02680.x; Grivet D, 2009, MOL ECOL, V18, P3967, DOI 10.1111/j.1365-294X.2009.04326.x; Hardy OJ, 2008, J ECOL, V96, P849, DOI 10.1111/j.1365-2745.2008.01423.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Izsak J, 1995, J ENV ECOL STAT, V2, P213; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; KIMURA M, 1964, GENETICS, V49, P725; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; Lindenmayer DB, 2016, ECOL APPL, V26, P557, DOI 10.1890/15-0575; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Nicotra AB, 2016, MOL ECOL, V25, P2000, DOI 10.1111/mec.13584; Nievergelt CM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030051; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Otter KA, 2001, J AVIAN BIOL, V32, P338, DOI 10.1111/j.0908-8857.2001.320408.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Rao, 1982, SANKHY INDIAN J ST A, V44, P1, DOI DOI 10.1007/S13171-010-0002-9; Rao CR, 2010, SANKHYA SER A, V72, P70, DOI 10.1007/s13171-010-0016-3; Rao C. R., 1986, ENCY STAT SCI, V7, P614; Rao C.R., 1982, UTILITAS MATHEMATICA, V21, P273; Rao C.R., 1982, STAT DECISION THEORY, P235; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; RICHARDSON RH, 1977, GENETICS, V85, P141; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Ricotta C, 2005, ECOL MODEL, V183, P365, DOI 10.1016/j.ecolmodel.2004.08.020; Ricotta C, 2008, J VEG SCI, V19, P229, DOI 10.3170/2008-8-18363; Ricotta C, 2006, THEOR POPUL BIOL, V70, P237, DOI 10.1016/j.tpb.2006.06.003; Ricotta C, 2009, THEOR POPUL BIOL, V76, P299, DOI 10.1016/j.tpb.2009.10.001; Scofield DG, 2012, AM NAT, V180, P719, DOI 10.1086/668202; Scofield DG, 2010, J ECOL, V98, P561, DOI 10.1111/j.1365-2745.2010.01649.x; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sherwin WB, 2010, ENTROPY-SWITZ, V12, P1765, DOI 10.3390/e12071765; Shimatani K, 2001, OIKOS, V93, P135, DOI 10.1034/j.1600-0706.2001.930115.x; SLATKIN M, 1995, GENETICS, V139, P457; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Smouse PE, 2005, HEREDITY, V94, P640, DOI 10.1038/sj.hdy.6800674; Smouse PE, 2015, MOL ECOL RESOUR, V15, P1375, DOI 10.1111/1755-0998.12422; Sokal RR, 1963, PRINCIPLES NUMERICAL; Sork VL, 2015, EVOL ECOL, V29, P927, DOI 10.1007/s10682-015-9769-4; Trumbo DR, 2016, MOL ECOL, V25, P4161, DOI 10.1111/mec.13754; Villeger S, 2008, J ECOL, V96, P845, DOI 10.1111/j.1365-2745.2007.01351.x; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Westerman M, 2016, ZOOL J LINN SOC-LOND, V176, P686, DOI 10.1111/zoj.12323	88	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0185499	10.1371/journal.pone.0185499	http://dx.doi.org/10.1371/journal.pone.0185499			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088229	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900002
J	Chuang, BI; Kuo, LC; Yang, TH; Su, FC; Jou, IM; Lin, WJ; Sun, YN				Chuang, Bo-I; Kuo, Li-Chieh; Yang, Tai-Hua; Su, Fong-Chin; Jou, I-Ming; Lin, Wei-Jr; Sun, Yung-Nien			ocr A medical imaging analysis system for trigger finger using an adaptive texture-based active shape model (ATASM) in ultrasound images	PLOS ONE			English	Article							SONOGRAPHIC APPEARANCE; SEGMENTATION; CLASSIFICATION; PULLEY	Trigger finger has become a prevalent disease that greatly affects occupational activity and daily life. Ultrasound imaging is commonly used for the clinical diagnosis of trigger finger severity. Due to image property variations, traditional methods cannot effectively segment the finger joint's tendon structure. In this study, an adaptive texture-based active shape model method is used for segmenting the tendon and synovial sheath. Adapted weights are applied in the segmentation process to adjust the contribution of energy terms depending on image characteristics at different positions. The pathology is then determined according to the wavelet and co-occurrence texture features of the segmented tendon area. In the experiments, the segmentation results have fewer errors, with respect to the ground truth, than contours drawn by regular users. The mean values of the absolute segmentation difference of the tendon and synovial sheath are 3.14 and 4.54 pixels, respectively. The average accuracy of pathological determination is 87.14%. The segmentation results are all acceptable in data of both clear and fuzzy boundary cases in 74 images. And the symptom classifications of 42 cases are also a good reference for diagnosis according to the expert clinicians' opinions.	[Chuang, Bo-I; Sun, Yung-Nien] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan, Taiwan; [Yang, Tai-Hua; Su, Fong-Chin; Lin, Wei-Jr] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Jou, I-Ming] E Da Hosp, Dept Orthoped, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; E-Da Hospital	Sun, YN (corresponding author), Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan, Taiwan.	ynsun@mail.ncku.edu.tw	Kuo, Li-Chieh/ABC-3826-2021; SU, FONG-CHIN/C-8094-2011	Kuo, Li-Chieh/0000-0001-7728-0096; SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0002-5644-655X; Yang, Tai-Hua/0000-0001-5068-2570	Ministry of Science and Technology, Taiwan, R.O.C. [NSC 101-2221-E-006-059-MY3]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by NSC 101-2221-E-006-059-MY3 from the Ministry of Science and Technology (formally National Science Council), Taiwan, R.O.C. https://www.most.gov.twl. Authors who received the funding: YNS.; The authors would like to express their appreciation for the grant under contract NSC 101-2221-E-006-059-MY3 from the Ministry of Science and Technology, Taiwan, R.O.C.. This work also utilized shared facilities supported by the Medical Device Innovation Center, National Cheng Kung University, Tainan, Taiwan, R.O.C..	Al Rahhal MM, 2016, INFORM SCIENCES, V345, P340, DOI 10.1016/j.ins.2016.01.082; Anavi Y, 2015, IEEE ENG MED BIO, P2940, DOI 10.1109/EMBC.2015.7319008; Casio FA, 2008, MED IMAGE ANAL, V12, P469, DOI 10.1016/j.media.2008.02.001; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen HC, 2012, ULTRASOUND MED BIOL, V38, P811, DOI 10.1016/j.ultrasmedbio.2012.01.025; Christodoulou CI, 2003, IEEE T MED IMAGING, V22, P902, DOI 10.1109/TMI.2003.815066; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Goldberg DE, 1989, GENETIC ALGORITHMS S, DOI DOI 10.1111/J.1365-2486.2009.02080.X; Gong XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141046; Guerini H, 2008, J ULTRAS MED, V27, P1407, DOI 10.7863/jum.2008.27.10.1407; Hamarneh G, 2000, COMPUT CARDIOL, V27, P115, DOI 10.1109/CIC.2000.898469; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He P, 2001, ENG MED BIOL SOC 200, V3, P2712; Huang YL, 2006, NEURAL COMPUT APPL, V15, P164, DOI 10.1007/s00521-005-0019-5; Iakovidis DK, 2010, ARTIF INTELL MED, V50, P33, DOI 10.1016/j.artmed.2010.04.004; Kendall D. G., 1989, STAT SCI, V4, P87, DOI DOI 10.1214/SS/1177012582; Kim ND, 1998, PROCEEDINGS OF THE IEEE-SP INTERNATIONAL SYMPOSIUM ON TIME-FREQUENCY AND TIME-SCALE ANALYSIS, P241, DOI 10.1109/TFSA.1998.721406; Kussul N, 2017, IEEE GEOSCI REMOTE S, V14, P778, DOI 10.1109/LGRS.2017.2681128; Laws KI, 1980, TEXTURED IMAGE SEGME; Liao XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103334; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Medina R, 2005, P ANN INT IEEE EMBS, P3363, DOI 10.1109/IEMBS.2005.1617198; Miyamoto H, 2011, J HAND SURG-AM, V36A, P1486, DOI 10.1016/j.jhsa.2011.05.038; Niu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072988; Padmanabhan K, 1998, MED BIOL ENG COMPUT, V36, P270, DOI 10.1007/BF02522470; Puri M, 2005, MED BIOL ENG COMPUT, V43, P756, DOI 10.1007/BF02430954; Qi Huang, 2004, Canadian Conference on Electrical and Computer Engineering 2004 (IEEE Cat. No.04CH37513), P1269, DOI 10.1109/CCECE.2004.1349629; Ryzewicz M, 2006, J HAND SURG-AM, V31A, P135, DOI 10.1016/j.jhsa.2005.10.013; Santhiyakumari N, 2011, MED BIOL ENG COMPUT, V49, P1299, DOI 10.1007/s11517-011-0800-9; Sato J, 2012, J HAND SURG-AM, V37A, P2012, DOI 10.1016/j.jhsa.2012.06.027; Shen DG, 2003, IEEE T MED IMAGING, V22, P539, DOI 10.1109/TMI.2003.809057; Tsai PY, 2012, ULTRASOUND OBST GYN, V39, P642, DOI 10.1002/uog.10104; Tsiaparas NN, 2011, IEEE T INF TECHNOL B, V15, P130, DOI 10.1109/TITB.2010.2091511; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Zhy Chang-ming, 2008, 2008 International Conference on Computer Science and Software Engineering (CSSE 2008), P795, DOI 10.1109/CSSE.2008.294	36	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187042	10.1371/journal.pone.0187042	http://dx.doi.org/10.1371/journal.pone.0187042			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077737	gold, Green Published, Green Submitted			2022-12-27	WOS:000413861200039
J	Furukawa, K; Tanemura, M; Miyoshi, E; Eguchi, H; Nagano, H; Matsunami, K; Nagaoka, S; Yamada, D; Asaoka, T; Noda, T; Wada, H; Kawamoto, K; Goto, K; Taniyama, K; Mori, M; Doki, Y				Furukawa, Kenta; Tanemura, Masahiro; Miyoshi, Eiji; Eguchi, Hidetoshi; Nagano, Hiroaki; Matsunami, Katsuyoshi; Nagaoka, Satoshi; Yamada, Daisaku; Asaoka, Tadafumi; Noda, Takehiro; Wada, Hiroshi; Kawamoto, Koichi; Goto, Kunihito; Taniyama, Kiyomi; Mori, Masaki; Doki, Yuichiro			A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express alpha-gal epitopes	PLOS ONE			English	Article							ANTI-GAL; DENDRITIC CELLS; PREOPERATIVE CHEMORADIATION; INCREASED IMMUNOGENICITY; COMBINATION THERAPY; IMMUNE-RESPONSES; IN-VITRO; T-CELLS; ADENOCARCINOMA; GEMCITABINE	Objectives Single-agent immunotherapy is ineffective against poorly immunogenic cancers, including pancreatic ductal adenocarcinoma (PDAC). The aims of this study were to demonstrate the feasibility of production of novel autologous tumor lysate vaccines from resected PDAC tumors, and verify vaccine safety and efficacy. Methods Fresh surgically resected tumors obtained from human patients were processed to enzymatically synthesize alpha-gal epitopes on the carbohydrate chains of membrane glycoproteins. Processed membranes were analyzed for the expression of alpha-gal epitopes and the binding of anti-Gal, and vaccine efficacy was assessed in vitro and in vivo. Results Effective synthesis of alpha-gal epitopes was demonstrated after processing of PDAC tumor lysates from 10 different patients, and tumor lysates readily bound an anti-Gal monoclonal antibody. alpha-gal(+) PDAC tumor lysate vaccines elicited strong antibody production against multiple tumor-associated antigens and activated multiple tumor-specific T cells. The lysate vaccines stimulated a robust immune response in animal models, resulting in tumor suppression and a significant improvement in survival without any adverse events. Conclusions Our data suggest that alpha- gal(+) PDAC tumor lysate vaccination may be a practical and effective new immunotherapeutic approach for treating pancreatic cancer.	[Furukawa, Kenta; Tanemura, Masahiro] Osaka Police Hosp, Dept Gastroenterol Surg, Osaka, Japan; [Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Osaka, Japan; [Eguchi, Hidetoshi; Nagaoka, Satoshi; Yamada, Daisaku; Asaoka, Tadafumi; Noda, Takehiro; Wada, Hiroshi; Kawamoto, Koichi; Goto, Kunihito; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg, Osaka, Japan; [Nagano, Hiroaki] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol Breast & Endocrine Surg, Yamaguchi, Japan; [Matsunami, Katsuyoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phamacognosy, Hiroshima, Japan; [Taniyama, Kiyomi] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Kure, Japan; [Taniyama, Kiyomi] Chugoku Canc Ctr, Kure, Japan	Osaka Police Hospital; Osaka University; Osaka University; Yamaguchi University; Hiroshima University	Tanemura, M (corresponding author), Osaka Police Hosp, Dept Gastroenterol Surg, Osaka, Japan.	tanemuram@oph.gr.jp	Matsunami, Katsuyoshi/AHC-4234-2022	Matsunami, Katsuyoshi/0000-0002-8034-0253; Noda, Takehiro/0000-0002-6768-5783	Ministry of Education, Sports and Culture of Japan [16K10618]	Ministry of Education, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Sports and Culture of Japan to M. T. (No. 16K10618).	Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brossart Peter, 1997, Blood, V90, P1594; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen ZC, 2001, GLYCOBIOLOGY, V11, P577, DOI 10.1093/glycob/11.7.577; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Deguchi T, 2010, CANCER RES, V70, P5259, DOI 10.1158/0008-5472.CAN-09-4313; Dodson LF, 2011, IMMUNOTHERAPY-UK, V3, P517, DOI [10.2217/IMT.11.10, 10.2217/imt.11.10]; Eguchi H, 2014, CANCER CHEMOTH PHARM, V73, P309, DOI 10.1007/s00280-013-2357-9; Eguchi H, 2013, HEPATO-GASTROENTEROL, V60, P904, DOI 10.5754/hge12974; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; Fields RC, 1998, P NATL ACAD SCI USA, V95, P9482, DOI 10.1073/pnas.95.16.9482; Galili U, 2003, GYNECOL ONCOL, V90, P100, DOI 10.1016/S0090-8258(03)00148-3; Galili U, 1997, IMMUNOL TODAY, V18, P281, DOI 10.1016/S0167-5699(97)80024-2; Galili U, 2013, IMMUNOLOGY, V140, P1, DOI 10.1111/imm.12110; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Guillerey C, 2015, J CLIN INVEST, V125, P2077, DOI 10.1172/JCI77181; Hartwig W, 2013, LANCET ONCOL, V14, pE476, DOI 10.1016/S1470-2045(13)70172-4; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOFFMAN JP, 1995, AM J SURG, V169, P71, DOI 10.1016/S0002-9610(99)80112-3; Kakizaki A, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1047584; Kobayashi T, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.990793; Koido S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/267539; LaTemple DC, 1998, XENOTRANSPLANTATION, V5, P191, DOI 10.1111/j.1399-3089.1998.tb00027.x; LaTemple DC, 1999, CANCER RES, V59, P3417; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Motta JM, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4753607; Ohigashi H, 2009, ANN SURG, V250, P88, DOI 10.1097/SLA.0b013e3181ad65cc; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Pandolfi F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/894704; Qu CF, 2004, BRIT J CANCER, V91, P2086, DOI 10.1038/sj.bjc.6602232; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Saito H, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1621; Schnurr M, 2002, CANCER RES, V62, P2347; Shen ZH, 1997, J IMMUNOL, V158, P2723; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soares KC, 2012, CANCER J, V18, P642, DOI 10.1097/PPO.0b013e3182756903; Spitz FR, 1997, J CLIN ONCOL, V15, P928, DOI 10.1200/JCO.1997.15.3.928; Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358; Tanemura M, 2013, CANCER SCI, V104, P282, DOI 10.1111/cas.12084; Tanida T, 2015, INT J ONCOL, V46, P78, DOI 10.3892/ijo.2014.2717; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0184901	10.1371/journal.pone.0184901	http://dx.doi.org/10.1371/journal.pone.0184901			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077749	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200002
J	Liu, HW; Chen, YJ; Lai, YC; Huang, CY; Huang, YL; Lin, MT; Han, SY; Chen, CL; Yu, CJ; Lee, PL				Liu, Hsiang-Wen; Chen, Yunn-Jy; Lai, Yi-Chun; Huang, Ching-Yi; Huang, Ya-Ling; Lin, Ming-Tzer; Han, Sung-Ying; Chen, Chi-Ling; Yu, Chong-Jen; Lee, Pei-Lin			Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MAD	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; ORAL APPLIANCE TREATMENT; MANDIBULAR ADVANCEMENT; CONTROLLED TRIAL; BLOOD-PRESSURE; THERAPY; UPDATE; ADHERENCE; OUTCOMES; DISEASE	Introduction This study aimed to determine the effect of combining positive airway pressure (PAP) therapy and mandibular advancement device (MAD) in patients with severe obstructive sleep apnea (OSA) who were pressure intolerant for PAP and were unresponsive to MAD. Methods This retrospective study reviewed the medical records of severe OSA patients with apneahypopnea index (AHI) >= 30/hr who were diagnosed between October 1, 2008 and June 30, 2014. Patients were initially treated with 2 weeks of PAP, and those who were intolerant to high-pressure PAP (>= 15 cm H2O) were switched to 12 weeks of MAD, which is a monobloc designed at 75% of maximum protrusion. Patients who had high residual AHI (>= 15/hr) on MAD underwent 12 weeks of combination therapy (CT) with MAD and CPAP and were enrolled in the present study. Enrolled subjects who completed the 12-week CT were followed-up until June 30, 2016. Results A total of 14 male patients were included. All three treatments effectively reduced AHI, oxygen desaturation index (ODI), and total sleep time with SpO(2) <90% (% TST-SpO(2)<90%) compared to pretreatment values. The residual AHI and ODI on CT was lower than that on MAD or PAP. The residual % TST-SpO(2)<90% was lower than that on MAD and similar to that on PAP. The therapeutic pressure on CT was on average 9.2 cm H2O lower than that on PAP. For the 11 patients who completed CT, only CT reduced ESS compared to pretreatment value. No treatment had significant impact on% slow wave sleep or overnight change of blood pressure. For patients who completed CT, the average usage was 5.9 +/- 1.7 hr/night at 12th week and 6.4 +/- 1.5 hr/night at a median follow-up of 36.5-months. Conclusions Combining MAD and CPAP showed additive effects on reducing AHI and ODI, and lowered the therapeutic pressures.	[Liu, Hsiang-Wen] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yunlin, Taiwan; [Liu, Hsiang-Wen; Lin, Ming-Tzer] Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Chen, Yunn-Jy; Huang, Ching-Yi] Grad Inst Clin Dent, Sch Dent, Dept Dent, Taipei, Taiwan; [Lai, Yi-Chun] Natl Yang Ming Univ Hosp, Dept Internal Med, Ilan, Taiwan; [Huang, Ya-Ling; Yu, Chong-Jen; Lee, Pei-Lin] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Lin, Ming-Tzer] Hsiao Chung Cheng Hosp, Dept Internal Med, New Taipei, Taiwan; [Han, Sung-Ying] Mackay Mem Hosp, Dept Dent, Taipei, Taiwan; [Chen, Chi-Ling] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Lee, Pei-Lin] Natl Taiwan Univ Hosp, Ctr Sleep Disorder, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Mackay Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lee, PL (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Lee, PL (corresponding author), Natl Taiwan Univ Hosp, Ctr Sleep Disorder, Taipei, Taiwan.	leepeilin@ntu.edu.tw	Lee, Pei-Lin/L-5564-2019	Lee, Pei-Lin/0000-0002-6883-9502; Yu, Chong-Jen/0000-0001-5664-9392	Ministry of Science and Technology [MOST 103-2314-B-002-139-MY3, NSC 102-2314-B-002-099]; National Taiwan University [NTU-ERP-104R8951-1, 105R8951-1, 106R880301]; National Taiwan University Hospital [NTUH 105-S2998]; NTU-NTUH-MediaTek Innovative Medical Electronics Research Center	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University(National Taiwan University); National Taiwan University Hospital(National Taiwan University); NTU-NTUH-MediaTek Innovative Medical Electronics Research Center	The study was supported by grants to Prof. Pei-Lin Lee from the Ministry of Science and Technology (project number MOST 103-2314-B-002-139-MY3, NSC 102-2314-B-002-099); National Taiwan University (project number NTU-ERP-104R8951-1, 105R8951-1, 106R880301); National Taiwan University Hospital (NTUH 105-S2998); and NTU-NTUH-MediaTek Innovative Medical Electronics Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarab G, 2010, CLIN ORAL INVEST, V14, P339, DOI 10.1007/s00784-009-0298-9; [Anonymous], 2007, AASM MANUAL SCORING; Barbe F, 2001, ANN INTERN MED, V134, P1015, DOI 10.7326/0003-4819-134-11-200106050-00007; Bloch KE, 2000, AM J RESP CRIT CARE, V162, P246, DOI 10.1164/ajrccm.162.1.9908112; Budhiraja R, 2007, SLEEP, V30, P320; Chai-Coetzer CL, 2013, SLEEP, V36, P1929, DOI 10.5665/sleep.3232; de Vries GE DM, 2016, J DENT SLEEP MED, V3, P6; El-Solh AA, 2002, CHEST, V121, P1541, DOI 10.1378/chest.121.5.1541; El-Solh AA, 2011, SLEEP BREATH, V15, P203, DOI 10.1007/s11325-010-0437-1; Fava C, 2014, CHEST, V145, P762, DOI 10.1378/chest.13-1115; Gotsopoulos H, 2002, AM J RESP CRIT CARE, V166, P743, DOI 10.1164/rccm.200203-208OC; Gozal D, 2008, AM J RESP CRIT CARE, V177, P369, DOI 10.1164/rccm.200608-1190PP; Kaminska M, 2014, CAN RESPIR J, V21, P234, DOI 10.1155/2014/408073; Kato J, 2000, CHEST, V117, P1065, DOI 10.1378/chest.117.4.1065; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Kuo YL, 2015, OTOLARYNG HEAD NECK, V152, P931, DOI 10.1177/0194599815573927; Kushida CA, 2008, J CLIN SLEEP MED, V4, P157; Kushida CA, 2006, SLEEP, V29, P240, DOI 10.1093/sleep/29.2.240; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marklund M, 1998, CHEST, V113, P707, DOI 10.1378/chest.113.3.707; Pelletier-Fleury N, 2001, SLEEP MED, V2, P225, DOI 10.1016/S1389-9457(00)00063-0; Phillips CL, 2013, AM J RESP CRIT CARE, V187, P879, DOI 10.1164/rccm.201212-2223OC; Ramar K, 2015, J CLIN SLEEP MED, V11, P773, DOI 10.5664/jcsm.4858; Sugiura T, 2007, RESPIRATION, V74, P56, DOI 10.1159/000089836; Sutherland K, 2014, J CLIN SLEEP MED, V10, P215, DOI 10.5664/jcsm.3460; Vroegop AVMT, 2012, SLEEP MED, V13, P314, DOI 10.1016/j.sleep.2011.08.005; Walker-Engstrom Marie-Louise, 2003, Sleep Breath, V7, P119, DOI 10.1007/s11325-003-0119-3; Weaver TE, 1997, SLEEP, V20, P278, DOI 10.1093/sleep/20.4.278; Weaver TE, 2007, SLEEP, V30, P711, DOI 10.1093/sleep/30.6.711; Wu C. Y., 2008, THESIS	30	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187032	10.1371/journal.pone.0187032	http://dx.doi.org/10.1371/journal.pone.0187032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073254	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400098
J	Gupta, A; Singh, J; Dufort, I; Robert, C; Dias, FCF; Anzar, M				Gupta, Alisha; Singh, Jaswant; Dufort, Isabelle; Robert, Claude; Dias, Fernanda Caminha Faustino; Anzar, Muhammad			Transcriptomic difference in bovine blastocysts following vitrification and slow freezing at morula stage	PLOS ONE			English	Article							DIFFERENT DEVELOPMENTAL-STAGES; IN-VITRO; GENE-EXPRESSION; MAMMALIAN EMBRYOS; CATTLE EMBRYOS; CRYOPRESERVATION; MOUSE; APOPTOSIS; VIABILITY; SURVIVAL	Cryopreservation is known for its marked deleterious effects on embryonic health. Bovine compact morulae were vitrified or slow-frozen, and post-warm morulae were cultured to the expanded blastocyst stage. Blastocysts developed from vitrified and slow-frozen morulae were subjected to microarray analysis and compared with blastocysts developed from unfrozen control morulae for differential gene expression. Morula to blastocyst conversion rate was higher (P< 0.05) in control (72%) and vitrified (77%) than in slow-frozen (34%) morulae. Total 20 genes were upregulated and 44 genes were downregulated in blastocysts developed from vitrified morulae (fold change >+/- 2, P< 0.05) in comparison with blastocysts developed from control morulae. In blastocysts developed from slow-frozen morulae, 102 genes were upregulated and 63 genes were downregulated (fold change >+/- 1.5, P< 0.05). Blastocysts developed from vitrified morulae exhibited significant changes in gene expression mainly involving embryo implantation (PTGS2, CALB1), lipid peroxidation and reactive oxygen species generation (HSD3B1, AKR1B1, APOA1) and cell differentiation (KRT19, CLDN23). However, blastocysts developed from slow-frozen morulae showed changes in the expression of genes related to cell signaling (SPP1), cell structure and differentiation (DCLK2, JAM2 and VIM), and lipid metabolism (PLA2R1 and SMPD3). In silico comparison between blastocysts developed form vitrified and slow-frozen morulae revealed similar changes in gene expression as between blastocysts developed from vitrified and control morulae. In conclusion, blastocysts developed form vitrified morulae demonstrated better post-warming survival than blastocysts developed from slow-frozen morulae but their gene expression related to lipid metabolism, steroidogenesis, cell differentiation and placentation changed significantly (>2 fold). Slow freezing method killed more morulae than vitrification but those which survived up to blastocyst stage did not express >2 fold change in their gene expression as compared with blastocysts from control morulae.	[Gupta, Alisha; Anzar, Muhammad] Saskatoon Res & Dev Ctr, Agr & Agrifood, Saskatoon, SK, Canada; [Gupta, Alisha; Singh, Jaswant; Dias, Fernanda Caminha Faustino; Anzar, Muhammad] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Saskatoon, SK, Canada; [Dufort, Isabelle; Robert, Claude] Local 2742 Univ Laval, Fac Sci Agr Alimentat Pavillon INAF, Ctr Rech Biol Reprod, Quebec City, PQ, Canada	University of Saskatchewan; Laval University	Anzar, M (corresponding author), Saskatoon Res & Dev Ctr, Agr & Agrifood, Saskatoon, SK, Canada.; Anzar, M (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Saskatoon, SK, Canada.	anzarm@agr.gc.ca		Robert, Claude/0000-0001-9690-8088; Singh, Jaswant/0000-0002-6439-7831; Dias, Fernanda/0000-0001-7944-8518; Anzar, Muhammad/0000-0001-8379-8852	Natural Sciences and Engineering Research Council of Canada (NSERC); Agriculture and Agri-food Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agriculture and Agri-food Canada(Agriculture & Agri Food Canada)	This study was funded by Natural Sciences and Engineering Research Council of Canada (NSERC), and Agriculture and Agri-food Canada to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was funded by Natural Sciences and Engineering Research Council of Canada (NSERC), and Agriculture and Agri-food Canada. Authors are thankful to Dr. Kosala Rajapaksha for his technical help in this study	Abe H, 2002, MOL REPROD DEV, V61, P57, DOI 10.1002/mrd.1131; Abumrad N A, 2000, Curr Opin Clin Nutr Metab Care, V3, P255, DOI 10.1097/00075197-200007000-00003; Aksu DA, 2012, MOL REPROD DEV, V79, P613, DOI 10.1002/mrd.22068; Antunes G, 2010, REPROD DOMEST ANIM, V45, P26, DOI 10.1111/j.1439-0531.2008.01131.x; Anzar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114801; Boisvert WA, 1999, ARTERIOSCL THROM VAS, V19, P525, DOI 10.1161/01.ATV.19.3.525; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bondioli K, 2015, BOVINE REPRODUCTION, P718; BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; Breuiller-Fouche M, 2010, BIOL REPROD, V83, P155, DOI 10.1095/biolreprod.109.080390; Cagnone GLM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094391; Carter F, 2010, BIOL REPROD, V83, P707, DOI 10.1095/biolreprod.109.082354; Carvalho RV, 1996, THERIOGENOLOGY, V45, P489, DOI 10.1016/0093-691X(95)00385-L; CHARPIGNY G, 1988, FEBS LETT, V228, P12, DOI 10.1016/0014-5793(88)80574-X; DELOOS F, 1989, GAMETE RES, V24, P197, DOI 10.1002/mrd.1120240207; Dhali A, 2007, THERIOGENOLOGY, V68, P1292, DOI 10.1016/j.theriogenology.2007.08.030; Dias FCF, 2013, REPRODUCTION, V146, P181, DOI 10.1530/REP-13-0114; Eberhardt DM, 1999, BIOL REPROD, V60, P1483, DOI 10.1095/biolreprod60.6.1483; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8; Gendelman M, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092882; Gilbert I, 2012, REPRODUCTION, V143, P735, DOI 10.1530/REP-11-0460; Godkin JD, 1997, AM J REPROD IMMUNOL, V37, P137; Gupta A, 2016, ANIM REPROD SCI, V164, P162, DOI 10.1016/j.anireprosci.2015.11.026; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Leach L, 2000, PLACENTA, V21, P547, DOI 10.1053/plac.2000.0541; Leao B.C.S., 2014, ZYGOTE, DOI [10.1017/S0967199414000380, DOI 10.1017/S0967199414000380]; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; LEHNJENSEN H, 1983, THERIOGENOLOGY, V19, P263, DOI 10.1016/0093-691X(83)90013-4; Leibo SP, 2008, THERIOGENOLOGY, V69, P37, DOI 10.1016/j.theriogenology.2007.10.006; Leibo SP, 2011, FERTIL STERIL, V96, P269, DOI 10.1016/j.fertnstert.2011.06.065; Leibo S. P., 1981, New technologies in animal breeding, P127; LEIBO SP, 1978, CRYOBIOLOGY, V15, P257, DOI 10.1016/0011-2240(78)90036-6; Li LF, 2012, MOL REPROD DEV, V79, P229, DOI 10.1002/mrd.22018; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Martino NA, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-27; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Mohan M, 2001, MOL REPROD DEV, V60, P289, DOI 10.1002/mrd.1090; Morato R, 2010, REPROD FERT DEVELOP, V22, P1141, DOI 10.1071/RD10013; Mucci N, 2006, THERIOGENOLOGY, V65, P1551, DOI 10.1016/j.theriogenology.2005.08.020; Nedambale TL, 2004, THERIOGENOLOGY, V62, P437, DOI 10.1016/j.theriogenology.2003.10.020; Nedambale TL, 2004, BIOL REPROD, V71, P1671, DOI 10.1095/biolreprod.104.027987; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; POLLARD JW, 1994, THERIOGENOLOGY, V41, P101, DOI 10.1016/S0093-691X(05)80054-8; Prentice JR, 2011, THERIOGENOLOGY, V75, P602, DOI 10.1016/j.theriogenology.2010.09.027; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Rekik W, 2011, MOL REPROD DEV, V78, P226, DOI 10.1002/mrd.21286; Rigotti A, 1999, NEW ENGL J MED, V341, P2011, DOI 10.1056/NEJM199912233412612; Robert C, 2011, MOL REPROD DEV, V78, P651, DOI 10.1002/mrd.21364; ROSENKRANS CF, 1993, BIOL REPROD, V49, P459, DOI 10.1095/biolreprod49.3.459; Saenz-de-Juano MD, 2014, REPROD DOMEST ANIM, V49, P505, DOI 10.1111/rda.12320; Sanchez-Gomez FJ, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00237; Sharkey A, 1998, REV REPROD, V3, P52, DOI 10.1530/revreprod/3.1.52; Shemesh M, 1992, J Physiol Pharmacol, V43, P153; Stinshoff H, 2011, THERIOGENOLOGY, V76, P1433, DOI 10.1016/j.theriogenology.2011.06.013; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Turksen K, 2001, DEV DYNAM, V222, P292, DOI 10.1002/dvdy.1174; Vaiman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065498; Vajta G, 2006, THERIOGENOLOGY, V65, P236, DOI 10.1016/j.theriogenology.2005.09.026; Vajta G, 2006, REPROD BIOMED ONLINE, V12, P779, DOI 10.1016/S1472-6483(10)61091-7; vanWagtendonkdeLeeuw AM, 1997, THERIOGENOLOGY, V48, P1071, DOI 10.1016/S0093-691X(97)00340-3; Vicente JS, 2013, CRYOBIOLOGY, V67, P321, DOI 10.1016/j.cryobiol.2013.09.165; Vigneault C, 2004, BIOL REPROD, V70, P1701, DOI 10.1095/biolreprod.103.022970; Watson AJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD708, DOI 10.2741/Watson; WILMUT I, 1972, J REPROD FERTIL, V31, P513; Yao JB, 2004, PHYSIOL GENOMICS, V19, P84, DOI 10.1152/physiolgenomics.00123.2004; Zander-Fox D, 2013, J ASSIST REPROD GEN, V30, P1091, DOI 10.1007/s10815-013-0056-4	68	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187268	10.1371/journal.pone.0187268	http://dx.doi.org/10.1371/journal.pone.0187268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095916	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200065
J	Smith, CA; Board, TN; Rooney, P; Eagle, MJ; Richardson, SM; Hoyland, JA				Smith, Christopher A.; Board, Tim N.; Rooney, Paul; Eagle, Mark J.; Richardson, Stephen M.; Hoyland, Judith A.			Human decellularized bone scaffolds from aged donors show improved osteoinductive capacity compared to young donor bone (vol 12, e0177416, 2017)	PLOS ONE			English	Correction													Richardson, Stephen/A-4124-2009; Board, Tim/I-9296-2019	Richardson, Stephen/0000-0002-7637-4135; Board, Tim/0000-0002-3295-2087	 [2435];  [MC_PC_14112 v.2]	; 	In the Funding section, the grant numbers are missing. The grant number for the John Charnley Trust is 2435. The grant number for the MRC CIC is MC_PC_14112 v.2.	Smith CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177416	1	10	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187783	10.1371/journal.pone.0187783	http://dx.doi.org/10.1371/journal.pone.0187783			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095911	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200131
J	Stetz, G; Tse, A; Verkhivker, GM				Stetz, Gabrielle; Tse, Amanda; Verkhivker, Gennady M.			Ensemble-based modeling and rigidity decomposition of allosteric interaction networks and communication pathways in cyclin-dependent kinases: Differentiating kinase clients of the Hsp90-Cdc37 chaperone	PLOS ONE			English	Article							HSP90 MOLECULAR CHAPERONE; STRUCTURAL BASIS; PROTEIN-KINASES; COMMUNITY STRUCTURE; WEB SERVER; CONFORMATIONAL DYNAMICS; REGULATORY MECHANISMS; CRYSTAL-STRUCTURE; CDK9/CYCLIN T1; CELL-CYCLE	The overarching goal of delineating molecular principles underlying differentiation of protein kinase clients and chaperone-based modulation of kinase activity is fundamental to understanding activity of many oncogenic kinases that require chaperoning of Hsp70 and Hsp90 systems to attain a functionally competent active form. Despite structural similarities and common activation mechanisms shared by cyclin-dependent kinase (CDK) proteins, members of this family can exhibit vastly different chaperone preferences. The molecular determinants underlying chaperone dependencies of protein kinases are not fully understood as structurally similar kinases may often elicit distinct regulatory responses to the chaperone. The regulatory divergences observed for members of CDK family are of particular interest as functional diversification among these kinases may be related to variations in chaperone dependencies and can be exploited in drug discovery of personalized therapeutic agents. In this work, we report the results of a computational investigation of several members of CDK family (CDK5, CDK6, CDK9) that represented a broad repertoire of chaperone dependencies-from nonclient CDK5, to weak client CDK6, and strong client CDK9. By using molecular simulations of multiple crystal structures we characterized conformational ensembles and collective dynamics of CDK proteins. We found that the elevated dynamics of CDK9 can trigger imbalances in cooperative collective motions and reduce stability of the active fold, thus creating a cascade of favorable conditions for chaperone intervention. The ensemble-based modeling of residue interaction networks and community analysis determined how differences in modularity of allosteric networks and topography of communication pathways can be linked with the client status of CDK proteins. This analysis unveiled depleted modularity of the allosteric network in CDK9 that alters distribution of communication pathways and leads to impaired signaling in the client kinase. According to our results, these network features may uniquely define chaperone dependencies of CDK clients. The perturbation response scanning and rigidity decomposition approaches identified regulatory hotspots that mediate differences in stability and cooperativity of allosteric interaction networks in the CDK structures. By combining these synergistic approaches, our study revealed dynamic and network signatures that can differentiate kinase clients and rationalize subtle divergences in the activation mechanisms of CDK family members. The therapeutic implications of these results are illustrated by identifying structural hotspots of pathogenic mutations that preferentially target regions of the increased flexibility to enable modulation of activation changes. Our study offers a network-based perspective on dynamic kinase mechanisms and drug design by unravelling relationships between protein kinase dynamics, allosteric communications and chaperone dependencies.	[Stetz, Gabrielle; Tse, Amanda; Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Dept Computat & Data Sci, Orange, CA 92866 USA; [Verkhivker, Gennady M.] Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Irvine, CA 92618 USA	Chapman University System; Chapman University; Chapman University System; Chapman University	Verkhivker, GM (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Dept Computat & Data Sci, Orange, CA 92866 USA.; Verkhivker, GM (corresponding author), Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Irvine, CA 92618 USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471				Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Aguilar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041430; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arif A, 2012, BIOCHEM PHARMACOL, V84, P985, DOI 10.1016/j.bcp.2012.06.027; Asamitsu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171727; Asamitsu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119451; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Atilgan C, 2010, BIOPHYS J, V99, P933, DOI 10.1016/j.bpj.2010.05.020; Atilgan C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000544; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Bartova I, 2005, PROTEIN SCI, V14, P445, DOI 10.1110/ps.04959705; Bartova I, 2004, PROTEIN SCI, V13, P1449, DOI 10.1110/ps.03578504; Bartova I, 2008, PROTEIN SCI, V17, P22, DOI 10.1110/ps.072951208; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Baumli S, 2012, STRUCTURE, V20, P1788, DOI 10.1016/j.str.2012.08.011; Besker N, 2014, J BIOMOL STRUCT DYN, V32, P1929, DOI 10.1080/07391102.2013.844080; Bhattacharya D, 2016, NUCLEIC ACIDS RES, V44, pW406, DOI 10.1093/nar/gkw336; Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; Boczek EE, 2015, P NATL ACAD SCI USA, V112, pE3189, DOI 10.1073/pnas.1424342112; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Brown NR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7769; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Bukhtiyarova M, 2007, BIOCHEMISTRY-US, V46, P5687, DOI 10.1021/bi0622221; Camps J, 2009, BIOINFORMATICS, V25, P1709, DOI 10.1093/bioinformatics/btp304; Cao RF, 2017, NUCLEIC ACIDS RES, V45, pD827, DOI 10.1093/nar/gkw1096; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Christensen NJ, 2013, J CHEM THEORY COMPUT, V9, P3210, DOI 10.1021/ct4002152; Chubynsky MV, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041135; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; D'Abramo M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00128; Dahiyat BI, 1997, PROTEIN SCI, V6, P1333, DOI 10.1002/pro.5560060622; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; De Falco G, 2002, ONCOGENE, V21, P7464, DOI 10.1038/sj.onc.1205967; De Vivo M, 2006, PROTEINS, V62, P89, DOI 10.1002/prot.20697; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Di Giovanni C, 2016, EXPERT OPIN INV DRUG, V25, P1215, DOI 10.1080/13543784.2016.1234603; Dutta A, 2015, STRUCTURE, V23, P1692, DOI 10.1016/j.str.2015.07.002; Echalier A, 2014, ACS CHEM BIOL, V9, P1251, DOI 10.1021/cb500135f; Echalier A, 2010, BBA-PROTEINS PROTEOM, V1804, P511, DOI 10.1016/j.bbapap.2009.10.002; Eckl JM, 2015, J BIOL CHEM, V290, P30843, DOI 10.1074/jbc.M115.693150; Emperador A, 2008, BIOPHYS J, V95, P2127, DOI 10.1529/biophysj.107.119115; Emperador A, 2017, J CHEM THEORY COMPUT, V13, P1454, DOI 10.1021/acs.jctc.6b01153; Endicott JA, 2013, BIOCHEM SOC T, V41, P1008, DOI 10.1042/BST20130097; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Eyal E, 2015, BIOINFORMATICS, V31, P1487, DOI 10.1093/bioinformatics/btu847; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD364, DOI 10.1093/nar/gkt1210; Floquet N, 2015, BIOPHYS J, V109, P1179, DOI 10.1016/j.bpj.2015.07.003; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; General IJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003624; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gu JY, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28756; Han YM, 2014, BIOMED REP, V2, P775, DOI 10.3892/br.2014.322; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hespenheide BM, 2002, J MOL GRAPH MODEL, V21, P195, DOI 10.1016/S1093-3263(02)00146-8; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Hu J, 2015, MOL CELL BIOL, V35, P264, DOI 10.1128/MCB.00943-14; Hydbring P, 2016, NAT REV MOL CELL BIO, V17, P280, DOI 10.1038/nrm.2016.27; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1997, J COMPUT PHYS, V137, P346, DOI 10.1006/jcph.1997.5809; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Keramisanou D, 2016, MOL CELL, V62, P260, DOI 10.1016/j.molcel.2016.04.005; Kiel C, 2016, ELIFE, V5, DOI 10.7554/eLife.12814; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Kim J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600663; Kobayashi H, 2014, J BIOL CHEM, V289, P19627, DOI 10.1074/jbc.M113.501148; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002; Kruger DM, 2013, NUCLEIC ACIDS RES, V41, pW340, DOI 10.1093/nar/gkt292; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Lange OF, 2006, J PHYS CHEM B, V110, P22842, DOI 10.1021/jp062548j; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Li HC, 2016, NUCLEIC ACIDS RES, V44, pD415, DOI 10.1093/nar/gkv1236; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lolli G, 2010, CELL CYCLE, V9, P1551, DOI 10.4161/cc.9.8.11195; Lombardi LE, 2016, BIOINFORMATICS, V32, P1235, DOI 10.1093/bioinformatics/btv740; Luo Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep43996; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; Meharena HS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001680; Meireles L, 2011, PROTEIN SCI, V20, P1645, DOI 10.1002/pro.711; Mohanty S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005885; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Oruganty K, 2013, P NATL ACAD SCI USA, V110, P924, DOI 10.1073/pnas.1207104110; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Paladino A, 2015, J CHEM INF MODEL, V55, P1377, DOI 10.1021/acs.jcim.5b00270; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palmieri L, 2013, DRUG DISCOV TODAY, V18, P407, DOI 10.1016/j.drudis.2012.11.009; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2016, BIOPOLYMERS, V105, P594, DOI 10.1002/bip.22835; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Penkler D, 2017, J CHEM INF MODEL, V57, P1359, DOI 10.1021/acs.jcim.6b00775; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Pisani P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154066; Poon RYC, 1997, J BIOL CHEM, V272, P5703, DOI 10.1074/jbc.272.9.5703; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; Rathi PC, 2012, J BIOTECHNOL, V159, P135, DOI 10.1016/j.jbiotec.2012.01.027; Rathi PC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004754; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Roskoski R, 2016, PHARMACOL RES, V107, P249, DOI 10.1016/j.phrs.2016.03.012; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schulze-Gahmen U, 2002, NAT STRUCT BIOL, V9, P177, DOI 10.1038/nsb756; Schulze-Gahmen U, 2013, ELIFE, V2, DOI 10.7554/eLife.00327; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sethi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003046; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shao H, 2013, J MED CHEM, V56, P640, DOI 10.1021/jm301475f; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Sogabe S, 2013, ACS MED CHEM LETT, V4, P201, DOI 10.1021/ml300327z; Srivastava AK, 2014, STRUCTURE, V22, P1735, DOI 10.1016/j.str.2014.09.010; Stetz G, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005299; Stetz G, 2016, J CHEM INF MODEL, V56, P1490, DOI 10.1021/acs.jcim.5b00755; Stetz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143752; Strong TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028100; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Teppa E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-235; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tse A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130203; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Verma S, 2016, BIOCHIMIE, V127, P227, DOI 10.1016/j.biochi.2016.05.018; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Wu P, 2015, PHARMACOL THERAPEUT, V156, P59, DOI 10.1016/j.pharmthera.2015.10.002; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Yang L, 2008, STRUCTURE, V16, P321, DOI 10.1016/j.str.2007.12.011; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Yao XQ, 2016, J BIOL CHEM, V291, P4742, DOI 10.1074/jbc.M115.702605; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10115	172	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186089	10.1371/journal.pone.0186089	http://dx.doi.org/10.1371/journal.pone.0186089			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095844	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200012
J	Vieira, T; Botter, A; Gastaldi, L; Sacco, ICN; Martelli, F; Giacomozzi, C				Vieira, Taian; Botter, Alberto; Gastaldi, Laura; Sacco, Isabel C. N.; Martelli, Francesco; Giacomozzi, Claudia			Textured insoles affect the plantar pressure distribution while elite rowers perform on an indoor rowing machine	PLOS ONE			English	Article							FORCE PRODUCTION; JUNIOR ROWERS; BIOMECHANICS; ADULTS; GAIT; ASYMMETRY; SYMMETRY; FEEDBACK; SYSTEM	Introduction During rowing, foot positioning on the foot stretcher is critical to optimise muscle force transmission and boat propulsion. Following the beneficial effects of textured insoles on gait and balance, this study aims at investigating whether passive stimulation of foot mechanoreceptors induced by these insoles may contribute to improving foot loading pattern and symmetry during indoor rowing. Methods Eleven elite rowers were assessed during controlled training on a standard rowing machine while wearing control, low-density or high-density textured insoles. Plantar pressure and knee and trunk kinematics were measured; performance data were recorded from the machine. Insole effect on kinematic parameters, peak and average values of foot force, contact area and position of centre of pressure was assessed with ANOVA and Bonferroni correction for pair-wise comparisons. Results A main effect was observed for force and contact area, with the high-density insoles providing greatest values (P<0.035). No interaction was observed between side and insole (P>0.190), even though symmetry was higher with high-density insoles. Kinematics (P = 0.800) and rowing performance were not affected by insole type; a consistent though not statistically significant increase in mean travelled distance was observed for denser insoles (P>0.21). Conclusion The high-density textured insoles affected foot loading distribution during indoor rowing. Rowers applied greater foot force and over a greater foot stretcher area with the high-density than the low-density and control insoles. These findings and the methodology applied may be relevant for the understanding and monitoring of rowing performance.	[Vieira, Taian; Botter, Alberto] Politecn Torino, Dept Elect & Telecommun, Lab Engn Neuromuscular Syst & Motor Rehabil, Turin, Italy; [Gastaldi, Laura] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy; [Sacco, Isabel C. N.] Univ Sao Paulo, Sch Med, Lab Biomech Human Movement & Posture, Dept Phys Therapy,Speech,Occupat Therapy, Sao Paulo, Brazil; [Martelli, Francesco; Giacomozzi, Claudia] Italian Natl Inst Hlth, Dept Cardiovasc Dysmetabol & Aging Associated Dis, Rome, Italy	Polytechnic University of Turin; Polytechnic University of Turin; Universidade de Sao Paulo; Istituto Superiore di Sanita (ISS)	Giacomozzi, C (corresponding author), Italian Natl Inst Hlth, Dept Cardiovasc Dysmetabol & Aging Associated Dis, Rome, Italy.	c_giacomozzi@yahoo.com	Sacco, Isabel/T-2630-2019; Vieira, Taian M/A-3818-2013; Botter, Alberto/I-3466-2016; Sacco, Isabel/D-7172-2011; Giacomozzi, Claudia/AAH-1640-2021; Martelli, Francesco/D-8864-2012	Sacco, Isabel/0000-0003-1254-0007; Vieira, Taian M/0000-0002-6239-7301; Botter, Alberto/0000-0002-4797-0667; Sacco, Isabel/0000-0003-1254-0007; Giacomozzi, Claudia/0000-0001-6950-4934; Martelli, Francesco/0000-0002-6963-8331				Aruin AS, 2013, EXP BRAIN RES, V231, P201, DOI 10.1007/s00221-013-3685-z; Barrow JD, 2010, AM J PHYS, V78, P728, DOI 10.1119/1.3318808; Baudouin A, 2002, BRIT J SPORT MED, V36, P396, DOI 10.1136/bjsm.36.6.396; Bourgois J, 2000, BRIT J SPORT MED, V34, P213, DOI 10.1136/bjsm.34.3.213; Buckeridge EM, 2015, SCAND J MED SCI SPOR, V25, pe176, DOI 10.1111/sms.12264; Buckeridge EM, 2014, SPORT BIOMECH, V13, P47, DOI 10.1080/14763141.2013.861013; Busch AC, 2009, COMPUT METH PROG BIO, V94, P15, DOI 10.1016/j.cmpb.2008.08.008; Christiansen E, 1997, SCAND J MED SCI SPOR, V7, P49; Cuijpers LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133527; Elliott B, 2001, SPORT BIOMECH, V1, P1; Evans G, 2016, BRIT J SPORT MED, V50, P266, DOI 10.1136/bjsports-2015-095126; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fohanno V, 2015, SPORT BIOMECH, V14, P310, DOI 10.1080/14763141.2015.1060252; Giacomozzi C, 2010, GAIT POSTURE, V32, P141, DOI 10.1016/j.gaitpost.2010.03.014; Godi M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-95; Hase K, 2002, JSME INT J C-MECH SY, V45, P1073, DOI 10.1299/jsmec.45.1073; Hatton AL, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-11; Hoch MC, 2012, MED SCI SPORT EXER, V44, P666, DOI 10.1249/MSS.0b013e3182390212; Hurkmans HLP, 2006, GAIT POSTURE, V23, P118, DOI 10.1016/j.gaitpost.2005.05.008; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; Kalron A, 2015, PM&R, V7, P17, DOI 10.1016/j.pmrj.2014.08.942; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; Lebel K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118361; Longman D, 2011, INT J SPORTS MED, V32, P606, DOI 10.1055/s-0031-1275301; Ma CC, 2016, GAIT POSTURE, V49, P190, DOI 10.1016/j.gaitpost.2016.07.010; Maurer M, 2011, AM J SPORT MED, V39, P392, DOI 10.1177/0363546510381365; McGregor AH, 2004, INT J SPORTS MED, V25, P465, DOI 10.1055/s-2004-820936; Qiu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083309; Qu XD, 2015, APPL ERGON, V46, P38, DOI 10.1016/j.apergo.2014.06.005; Readi NG, 2015, J MED SCI SPORT, V25; Ritchie C, 2011, GAIT POSTURE, V33, P576, DOI 10.1016/j.gaitpost.2011.01.012; Schaffert N, 2015, J SPORT SCI, V33, P411, DOI 10.1080/02640414.2014.946438; Smith RM, 2002, J SPORT SCI, V20, P783, DOI 10.1080/026404102320675639; Smith TB, 2011, MED SCI SPORT EXER, V43, P2155, DOI 10.1249/MSS.0b013e31821d3f8e; Smoljanovic T, 2009, AM J SPORT MED, V37, P1193, DOI 10.1177/0363546508331205; Soper C, 2004, SPORTS MED, V34, P825, DOI 10.2165/00007256-200434120-00003; Stutchfield BM, 2006, EUR J SPORT SCI, V6, P255, DOI 10.1080/17461390601012678; Trapp R.G., 2004, BASIC CLIN BIOSTATIS, V4th; van Soest AJK, 2016, J SPORTS SCI, P1; Waddington G, 2003, BRIT J SPORT MED, V37, P170, DOI 10.1136/bjsm.37.2.170; Waddington G, 2000, TEXTURED INSOLE EFFE; WATANABE I, 1981, ANN NY ACAD SCI, V374, P855, DOI 10.1111/j.1749-6632.1981.tb30926.x	42	5	5	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187202	10.1371/journal.pone.0187202	http://dx.doi.org/10.1371/journal.pone.0187202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095908	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200055
J	Garbus, I; Romero, JR; Selva, JP; Pasten, MC; Chinestra, C; Carballo, J; Zappacosta, DC; Echenique, V				Garbus, Ingrid; Rodolfo Romero, Jose; Pablo Selva, Juan; Cielo Pasten, Maria; Chinestra, Carolina; Carballo, Jose; Carlos Zappacosta, Diego; Echenique, Viviana			De novo transcriptome sequencing and assembly from apomictic and sexual Eragrostis curvula genotypes	PLOS ONE			English	Article							GENE-EXPRESSION; APOMIXIS; APOSPORY; MARKERS; DISCOVERY; NUCLEAR; RNA	A long-standing goal in plant breeding has been the ability to confer apomixis to agriculturally relevant species, which would require a deeper comprehension of the molecular basis of apomictic regulatory mechanisms. Eragrostis curvula (Schrad.) Nees is a perennial grass that includes both sexual and apomictic cytotypes. The availability of a reference transcriptome for this species would constitute a very important tool toward the identification of genes controlling key steps of the apomictic pathway. Here, we used Roche/454 sequencing technologies to generate reads from inflorescences of E. curvula apomictic and sexual genotypes that were de novo assembled into a reference transcriptome. Near 90% of the 49568 assembled isotigs showed sequence similarity to sequences deposited in the public databases. A gene ontology analysis categorized 27448 isotigs into at least one of the three main GO categories. We identified 11475 SSRs, and several of them were assayed in E curvula germoplasm using SSR-based primers, providing a valuable set of molecular markers that could allow direct allele selection. The differential contribution to each library of the spliced forms of several transcripts revealed the existence of several isotigs produced via alternative splicing of single genes. The reference transcriptome presented and validated in this work will be useful for the identification of a wide range of gene(s) related to agronomic traits of E. curvula, including those controlling key steps of the apomictic pathway in this species, allowing the extrapolation of the findings to other plant species.	[Garbus, Ingrid; Rodolfo Romero, Jose; Pablo Selva, Juan; Cielo Pasten, Maria; Chinestra, Carolina; Carballo, Jose; Carlos Zappacosta, Diego; Echenique, Viviana] Univ Nacl Sur, CONICET, Ctr Recursos Nat Renovables Zona Semiarida CERZOS, Bahia Blanca, Buenos Aires, Argentina; [Garbus, Ingrid] Univ Nacl Sur, Dept Ciencias Salud, Bahia Blanca, Buenos Aires, Argentina; [Pablo Selva, Juan] Univ Nacl Sur, Dept Biol Bioquim & Farm, Bahia Blanca, Buenos Aires, Argentina; [Carlos Zappacosta, Diego; Echenique, Viviana] Univ Nacl Sur, Dept Agron, Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South; National University of the South; National University of the South	Echenique, V (corresponding author), Univ Nacl Sur, CONICET, Ctr Recursos Nat Renovables Zona Semiarida CERZOS, Bahia Blanca, Buenos Aires, Argentina.; Echenique, V (corresponding author), Univ Nacl Sur, Dept Agron, Bahia Blanca, Buenos Aires, Argentina.	echeniq@criba.edu.ar	Echenique, Viviana/GRX-7389-2022	Echenique, Viviana/0000-0003-3755-9062; Garbus, Ingrid/0000-0001-9646-689X; Carballo, Jose/0000-0002-3592-6466	Agenda Nacional de Promocion Cientifica y Tecnologica [PICT 2013 2029]; European Union [645674]; Agencia Nacional de PromociOn Cientifica y Tecnologica (ANPCyT) [PICT 2013-2029, PICT Raices 2014-1243]; Universidad Nacional del Sur (PGI TIR) [CSU-142/14, PGI 24/A199]; CONICET [11220150100963]	Agenda Nacional de Promocion Cientifica y Tecnologica; European Union(European Commission); Agencia Nacional de PromociOn Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad Nacional del Sur (PGI TIR); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funded by Agenda Nacional de Promocion Cientifica y Tecnologica, (http://www.agencia.mincyt.gob.ar/frontendiagencia/fondo/foncyt):) PICT 2013 2029 to I.G. and PICT Ralces 2014 1243 to V.E): Involved in study design, data collection and analysis, experiments development, decision to publish, preparation of the manuscript. Secretaria General de Ciencia y Tecnologia, Universidad Nacional del Sur, (http://www.uns.edu.aricenten id es/40/480#proyectos-grupos-deinvestigacion): PGI - TIR, CSU-142/14 and PGI 24/A199 to V.E: Involved in study design, data collection and analysis, experiments development, decision to publish, preparation of the manuscript. Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://convocatorias.contcet.gov.ar/proyectos-pip/): PIP 11220110100767 to V.E and 11220150100963 to I.G: Involved in study design, data collection and analysis, experiments development, decision to publish, preparation of the manuscript. European Union's Horizon 2020 Research and Innovation Programme (htips://ec europleuiprogram.mes/horizon2020/en/h2020section/fp arie-sklodowska-curieactions) under the Marie Skfodowska-Curie Grant Agreement No 645674: Involved in study design, data collection and ana; Jose Rodolfo Romero passed away before the submission of the final version of this manuscript. Viviana Echenique accepts responsibility for the integrity and validity of the data collected and analyzed. This work was granted by the Agencia Nacional de PromociOn Cientifica y Tecnologica (ANPCyT, PICT 2013-2029 to I.G. and PICT Raices 2014-1243 to V.E), Universidad Nacional del Sur (PGI TIR, CSU-142/14 and PGI 24/A199 to V.E), CONICET (PIPlysis, experiments development, decision to publish, preparation of the manuscript. 11220110100767 to V.E and 11220150100963 to I.G) and the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie Grant Agreement No 645674.	Albertini E, 2001, SEX PLANT REPROD, V14, P213, DOI 10.1007/s00497-001-0116-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barcaccia G, 2013, PLANT REPROD, V26, P159, DOI 10.1007/s00497-013-0222-y; BEKELE E, 1981, ANN BOT-LONDON, V48, P717, DOI 10.1093/oxfordjournals.aob.a086178; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Cannarozzi G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-581; Carman JG, 1997, BIOL J LINN SOC, V61, P51, DOI 10.1006/bijl.1996.0118; Catanach AS, 2006, P NATL ACAD SCI USA, V103, P18650, DOI 10.1073/pnas.0605588103; Cervigni GDL, 2008, PLANT MOL BIOL, V67, P1, DOI 10.1007/s11103-007-9282-4; Chen CX, 2014, MOL GENET GENOMICS, V289, P1147, DOI 10.1007/s00438-014-0875-8; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; Ochogavia AC, 2011, SEX PLANT REPROD, V24, P231, DOI 10.1007/s00497-011-0165-0; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conner JA, 2013, PLANTA, V238, P51, DOI 10.1007/s00425-013-1873-5; Covas G., 1991, PASTO LLORON BIOL MA, P1; Crane C., 2001, FLOWERING APOMIXIS M, P168; Da Maia LC, 2008, INT J PLANT GENOMICS; Galla G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1439-y; Grimanelli D, 1998, HEREDITY, V80, P40, DOI 10.1046/j.1365-2540.1998.00264.x; Grossniklaus U, 2001, PLANT CELL, V13, P1491, DOI 10.1105/tpc.13.7.1491; Hand ML, 2014, GENETICS, V197, P441, DOI 10.1534/genetics.114.163105; Horandl E, 2010, SEX PLANT REPROD, V23, P73, DOI 10.1007/s00497-009-0122-3; Jiang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071054; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; Koltunow A.M., 2013, SEED GENOMICS, P83; Koltunow AM, 2003, ANNU REV PLANT BIOL, V54, P547, DOI 10.1146/annurev.arplant.54.110901.160842; Rodrigo JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175852; Meier M, 2011, AUST J BOT, V59, P253, DOI 10.1071/BT10267; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Noyes RD, 2000, GENETICS, V155, P379; Ortiz JPA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3700-z; Ozias-Akins P, 2007, ANNU REV GENET, V41, P509, DOI 10.1146/annurev.genet.40.110405.090511; Ravishankar KV, 2015, PLANT BREEDING, V134, P247, DOI 10.1111/pbr.12238; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romero J, 2016, BIOL PLANTARUM, V60, P55, DOI 10.1007/s10535-015-0569-z; Roodt-Wilding R, 2006, SYST BIODIVERS, V4, P401, DOI 10.1017/S1477200006002131; Saha MC, 2006, THEOR APPL GENET, V113, P1449, DOI 10.1007/s00122-006-0391-2; Schallau A, 2010, PLANT J, V62, P773, DOI 10.1111/j.1365-313X.2010.04188.x; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Selva J. P., 2012, American Journal of Plant Sciences, V3, P403, DOI 10.4236/ajps.2012.33049; Sharbel TF, 2010, PLANT CELL, V22, P655, DOI 10.1105/tpc.109.072223; Toledo-Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070781; Van Dijk PJ, 1999, HEREDITY, V83, P715, DOI 10.1038/sj.hdy.6886200; Voigt P., 2004, WARM SEASON C4 GRASS, V45, P1027; VOIGT PW, 1976, CROP SCI, V16, P803, DOI 10.2135/cropsci1976.0011183X001600060017x; VOIGT PW, 1971, CROP SCI, V11, P424, DOI 10.2135/cropsci1971.0011183X001100030034x; Watson L., 1992, The grass genera of the world.; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Zappacosta D, 2011, PHYTON-INT J EXP BOT, V80, P211; Zappacosta DC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04423	53	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185595	10.1371/journal.pone.0185595	http://dx.doi.org/10.1371/journal.pone.0185595			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091722	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700008
J	Rozenbaum, AG; Gelband, DS; Stein, M; Mienis, HK; Rabinovich, R				Rozenbaum, Alexis Gabriel; Gelband, Dotan Shaked; Stein, Mordechai; Mienis, Henk K.; Rabinovich, Rivka			First evidence of "ancient deer" (cervid) in the late Miocene Bira Formation, Northern Israel	PLOS ONE			English	Article							EARLY PLIOCENE; MAMMALIA; FRAGMENTATION; ARTIODACTYLA; EVOLUTION; GALILEE; RIFT	Despite the extensive geological and paleontological searches in the south Levant, no terrestrial fauna of late Neogene age was yet reported. Here, we report the first evidence of "ancient deer"-cervid in the late Miocene (Tortonian) lacustrine section of the Bira Formation at Hagal Stream, Jordan Valley, northern Israel. The section comprises rich assemblage of macrofauna fossils, mostly freshwater mollusks. The mammalian bone was discovered among the macrofauna fossils, and is described as an almost complete left humerus of an adult animal identified as an artiodactyls element probably of a cervid. This terrestrial mammal shares similar paleoenvironmental conditions with other contemporaneous localities, where cervids prevailed with bovids and other taxa. It appears that the freshwater lakes provided favorite habitat for the development of the cervids and possibly other mammals. The specific conditions of preservation of the cervid illuminate the role of post depositional processes (taphonomic constrains) in masking terrestrial fauna remains in the region. Accordingly, further efforts will be devoted to unveil the mute part of the southern Levant-east Mediterranean terrestrial faunistic realm at the end of the Miocene.	[Rozenbaum, Alexis Gabriel; Gelband, Dotan Shaked; Stein, Mordechai] Geol Survey Israel, 30 Malkhe Israel, Jerusalem, Israel; [Rozenbaum, Alexis Gabriel; Gelband, Dotan Shaked; Stein, Mordechai; Rabinovich, Rivka] Hebrew Univ Jerusalem, Inst Earth Sci, Edmond J Safra Campus, Jerusalem, Israel; [Mienis, Henk K.; Rabinovich, Rivka] Hebrew Univ Jerusalem, Nat Hist Collect, Edmond J Safra Campus, Jerusalem, Israel	Geological Survey Israel; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rozenbaum, AG (corresponding author), Geol Survey Israel, 30 Malkhe Israel, Jerusalem, Israel.; Rozenbaum, AG (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, Edmond J Safra Campus, Jerusalem, Israel.	alexis.rozenbaum@mail.huji.ac.il	Stein, Mordechai/AAJ-3200-2020	Stein, Mordechai/0000-0002-3126-416X; Rabinovich, Rivka/0000-0002-1343-3134	Israel Science Foundation [683/09]; Ministry of National Infrastructures, Energy and Water Resources grant [213/17/09]	Israel Science Foundation(Israel Science Foundation); Ministry of National Infrastructures, Energy and Water Resources grant	The research was supported by the Israel Science Foundation grant 683/09 and the Ministry of National Infrastructures, Energy and Water Resources grant 213/17/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Amir Sandler and Dr. Ezra Zilberman from the Geological Survey of Israel and Yossi Morag of Gesher Quarries who guided us to the Hagal section. Special thanks to Gali Beiner (ACR), the conservator of The Natural History Collections of the Hebrew University that had speared no effort to expose this unique find and Uzzan who took the photos of the bone. Field assistance by Yaakov Rephael of the Geological Survey of Israel was crucial to the success of this study. We acknowledge Prof. Abraham Starinsky of the Institute of Earth Sciences of the Hebrew University for field discussions. The research was supported by the Israel Science Foundation grant 683/09 and the Ministry of National Infrastructures, Energy and Water Resources grant 213/17/09.	Abbazzi L, 2001, RIV ITAL PALEONTOL S, V107, P107, DOI 10.13130/2039-4942/5426; ABBOTT R. TUCKER, 1958, PROC ACAD NAT SCI PHILADELPHIA, V110, P213; Amr Z.S., 2004, Denisia, V14, P221; Amson E, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1379-7; Ataabadi MM, 2016, PALAEOBIO PALAEOENV, V96, P339, DOI 10.1007/s12549-016-0242-3; AZANZA B, 1995, J PALEONTOL, V69, P1163, DOI 10.1017/S0022336000038142; Azanza B, 2013, PALAEOBIO PALAEOENV, V93, P217, DOI 10.1007/s12549-013-0118-8; Blondel J, 2009, PHYS GEOGRAPHY MEDIT, P139; Bouvrain G, 2007, ANN PALEONTOL, V93, P121, DOI 10.1016/j.annpal.2007.03.001; Boyer DL, 2004, PALAIOS, V19, P372, DOI 10.1669/0883-1351(2004)019<0372:ESOLTS>2.0.CO;2; Braun D, 1992, THESIS; BRETT C E, 1986, Palaios, V1, P207, DOI 10.2307/3514686; Clarke KR, 1994, CHANGE MARINE COMMUN; Cohen A., 1997, GSI297 MIN NAT INFR; Croitor R, 2017, NEUES JAHRB GEOL P-A, V283, P85, DOI 10.1127/njgpa/2017/0630; Dicker T., 1969, J EARTH SCI, V18, P39; Edelman-Furstenberg Y, 2008, PALAEOGEOGR PALAEOCL, V261, P58, DOI 10.1016/j.palaeo.2008.01.004; Flecker R, 2015, EARTH-SCI REV, V150, P365, DOI 10.1016/j.earscirev.2015.08.007; Fortelius M, 2006, PALAEOGEOGR PALAEOCL, V238, P219, DOI 10.1016/j.palaeo.2006.03.042; FREUND R, 1970, PHILOS T R SOC S-A, V267, P107, DOI 10.1098/rsta.1970.0027; FURSICH FT, 1978, LETHAIA, V11, P243, DOI 10.1111/j.1502-3931.1978.tb01231.x; FURSICH FT, 1993, LETHAIA, V26, P327, DOI 10.1111/j.1502-3931.1993.tb01540.x; GARFUNKEL Z, 1989, ISRAEL J EARTH SCI, V38, P51; GARFUNKEL Z, 1981, TECTONOPHYSICS, V80, P81, DOI 10.1016/0040-1951(81)90143-8; Garfunkel Z., 1988, ZOOGEOGRAPHY ISRAEL, P7; Geraads D, 2013, ACTA ZOOL BULGAR, V65, P381; Heintz E., 1970, Memoires Mus natn Hist nat Paris (Sci Terre), V22, P1; Horowitz A., 1974, LATE CENOZOIC STRATI; Horowitz A., 2001, JORDAN RIFT VALLEY; HSU KJ, 1973, NATURE, V242, P240, DOI 10.1038/242240a0; HUDSON J D, 1980, Proceedings of the Geologists' Association, V91, P99; Kafri Uri, 2002, Israel Journal of Earth Sciences, V51, P79, DOI 10.1560/WH4Y-3NNT-TQ2W-1D9D; KANGAS P, 1978, ESTUAR COAST MAR SCI, V6, P409, DOI 10.1016/0302-3524(78)90131-7; Kidwell S.M., 1991, Topics in Geobiology, V9, P115; KIDWELL S M, 1991, Palaios, V6, P426, DOI 10.2307/3514967; Kostopoulos DS, 2006, PALAEONTOGR ABT A, V276, P151; Koufos George D., 2003, Deinsea (Rotterdam), V10, P343; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lopez-Antonanzas R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12871; MALEZ M, 1989, GEOBIOS-LYON, V22, P665, DOI 10.1016/S0016-6995(89)80119-6; MARCUS E, 1985, ISRAEL J EARTH SCI, V34, P1; Marcus E. J, 8411 OIL EXPL INV LT; Pillay D, 2009, J EXP MAR BIOL ECOL, V380, P47, DOI 10.1016/j.jembe.2009.08.016; Pitra C, 2004, MOL PHYLOGENET EVOL, V33, P880, DOI 10.1016/j.ympev.2004.07.013; Raab M, 1997, CARBONATE EVAPORITE, V12, P296, DOI 10.1007/BF03175424; Rabinovich R, 2012, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-94-007-2159-3; Remane A, 1971, BIOL BRACKISH WATER; Rogl F, 1999, GEOL CARPATH, V50, P339; Rogl F., 1984, GEOL J, P171; ROSENFELD A, 1981, ISRAEL J EARTH SCI, V30, P113; Roveri M, 2008, TERRA NOVA, V20, P483, DOI 10.1111/j.1365-3121.2008.00842.x; Rozenbaum AG, 2016, GEOL SOC AM BULL, V128, P1383, DOI 10.1130/B31239.1; Rozenbaum A.G., 2017, THESIS; SCHULMAN N., 1959, BULL RES COUNC ISRAEL SECT G GEO SCI, V8G, P63; Schulman N., 1962, THESIS; Segev A, 2000, TECTONOPHYSICS, V325, P257, DOI 10.1016/S0040-1951(00)00122-0; Shaked-Gelband D, 2017, UNPUB; Shaked-Gelband D, 2012, GSI372012 MIN EN WAT; Shaliv G, 1991, THESIS; Sneh A., 1998, GEOLOGICAL MAP ISRAE; STEIN M, 1992, EARTH PLANET SC LETT, V114, P193, DOI 10.1016/0012-821X(92)90161-N; Stein M, 2014, MOD APPR SOL EARTH S, V6, P279, DOI 10.1007/978-94-017-8872-4_10; Steininger FF, TETHYAN OCEAN PARATE; Tchernov E., 1988, ZOOGEOGRAPHY ISRAEL, P159; Wald R., 2016, THESIS; Zak I., 1967, THESIS; Zilberman E., 2013, ISR GEOL SOC ANN M F, P18; Zuschin M, 2003, EARTH-SCI REV, V63, P33, DOI 10.1016/S0012-8252(03)00014-X	68	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185268	10.1371/Journal.pone.0185268	http://dx.doi.org/10.1371/Journal.pone.0185268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091714	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700005
J	Scott, AJ; Song, EK; Bagby, S; Purkey, A; McCarter, M; Gajdos, C; Quackenbush, KS; Cross, B; Pitts, TM; Tan, AC; Eckhardt, SG; Fenton, H; Arcaroli, J; Messersmith, WA				Scott, Aaron J.; Song, Eun-Kee; Bagby, Stacey; Purkey, Alicia; McCarter, Martin; Gajdos, Csaba; Quackenbush, Kevin S.; Cross, Benjamin; Pitts, Todd M.; Tan, Aik Choon; Eckhardt, S. Gail; Fenton, Hubert; Arcaroli, John; Messersmith, Wells A.			Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; HUMAN-COLON-CARCINOMA; SRC KINASE-ACTIVITY; GROWTH-FACTOR; C-SRC; TYROSINE KINASES; PHASE-I; ACTIVATION; RECEPTOR; BIOMARKERS	Background Dysregulation of the Src pathway has been shown to be important at various stages of cancer. Dasatinib is a potent Src/Abl inhibitor and has demonstrated to have anti-proliferative and anti-invasive activity in many preclinical models. The objective of this study was to determine the anti-tumor activity of dasatinib using in vitro and in vivo preclinical colorectal (CRC) models. Methods CRC cell lines and patient-derived tumor explant (PDX) models were used to investigate the efficacy of dasatinib. We treated 50 CRC cell lines with dasatinib for 72 hours and proliferation was assayed by a sulforhodamine B (SRB) assay; an IC50 <= 0.08 mu mol/L was considered sensitive. We treated 17 patient-derived CRC explants with dasatinib (50 mg/kg/day, administered once-daily) for 28 days to determine in vivo efficacy. Tumor growth inhibition (TGI) >= 50% was considered sensitive. Results We found that 8 out of 50 CRC cell lines reached an IC50 <= 0.08 mu mol/L with dasatinib treatment. In addition, of 17 CRC explants grown in the xenograft mouse model, 2 showed sensitivity to dasatinib. The anti -tumor effects observed in this study were a result of G1 cell cycle arrest as the dasatinib sensitive CRC cell lines exhibited G1 inhibition. Moreover, those CRC cell lines that were responsive (0.08 mu mol/L) to treatment demonstrated a significant baseline increase in Src and FAK gene expression. Conclusion Dasatinib demonstrated significant anti-proliferative activity in a subset of CRC cell lines in vitro, especially in those with increased Src expression at baseline, but only showed modest efficacy in CRC explants. Dasatinib is currently being studied in combination with chemotherapy in patients with advanced CRC, as its use as a single agent appears limited.	[Scott, Aaron J.] Banner Univ, Arizona Canc Ctr, Div Med Oncol, Tucson, AZ 85724 USA; [Song, Eun-Kee] Chonbuk Natl Univ, Med Sch, Jeonju, South Korea; [Bagby, Stacey; Purkey, Alicia; Quackenbush, Kevin S.; Cross, Benjamin; Pitts, Todd M.; Tan, Aik Choon; Arcaroli, John; Messersmith, Wells A.] Univ Colorado Denver, Div Med Oncol, Anschutz Med Campus, Aurora, CO USA; [Bagby, Stacey; Purkey, Alicia; McCarter, Martin; Gajdos, Csaba; Quackenbush, Kevin S.; Cross, Benjamin; Pitts, Todd M.; Tan, Aik Choon; Fenton, Hubert; Arcaroli, John; Messersmith, Wells A.] Univ Colorado, Canc Ctr, Aurora, CO USA; [McCarter, Martin; Gajdos, Csaba] Univ Colorado Denver, Dept Surg, Anschutz Med Campus, Aurora, CO USA; [Eckhardt, S. Gail] Univ Texas Austin, Div Med Oncol, Austin, TX 78712 USA; [Fenton, Hubert] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO USA	Arizona Center Cancer Care; Jeonbuk National University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Austin; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Scott, AJ (corresponding author), Banner Univ, Arizona Canc Ctr, Div Med Oncol, Tucson, AZ 85724 USA.	ajscott@email.arizona.edu	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369; Purkey, Alicia/0000-0002-1865-1421	National Cancer Institute grant [1R01CA152303-01]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grant 1R01CA152303-01. Authors who received funding included WAM, JA. (https://www.cancer.gov/grants-training/grants/funding-opportunities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaroli JJ, 2010, CLIN CANCER RES, V16, P4165, DOI 10.1158/1078-0432.CCR-10-0066; Bagby S, 2016, JOVE-J VIS EXP, DOI 10.3791/54393; BOLEN JB, 1987, ONCOGENE RES, V1, P149; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; COURTNEIDGE SA, 1993, DEVELOPMENT, P57; Demetri GD, 2009, CLIN CANCER RES, V15, P6232, DOI 10.1158/1078-0432.CCR-09-0224; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Ellis LM, 1998, J BIOL CHEM, V273, P1052, DOI 10.1074/jbc.273.2.1052; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Herold CI, 2011, CLIN CANCER RES, V17, P6061, DOI 10.1158/1078-0432.CCR-11-1071; Howlander N, 1975, SEER CANC STAT REV; Kopetz S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-660; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; LaVallee TM, 1998, J CELL BIOL, V141, P1647, DOI 10.1083/jcb.141.7.1647; Levitzki A, 1996, ANTI-CANCER DRUG DES, V11, P175; Lieu C, 2010, J CLIN ONCOLOGY OFFI; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; MARTIN GS, 1970, NATURE, V227, P1021, DOI 10.1038/2271021a0; PARK JS, 1993, ONCOGENE, V8, P2627; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Perez M, 2016, ONCOTARGET, V7, P33111, DOI 10.18632/oncotarget.8880; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Serrels A, 2006, MOL CANCER THER, V5, P3014, DOI 10.1158/1535-7163.MCT-06-0382; Sharma MR, 2012, INVEST NEW DRUG, V30, P1211, DOI 10.1007/s10637-011-9681-x; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Strickler JH, 2014, INVEST NEW DRUG, V32, P330, DOI 10.1007/s10637-013-0042-9; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tsao AS, 2007, MOL CANCER THER, V6, P1962, DOI 10.1158/1535-7163.MCT-07-0052; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zheng X, 2008, INT J CANCER, V122, P1999, DOI 10.1002/ijc.23321	35	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187173	10.1371/journal.pone.0187173	http://dx.doi.org/10.1371/journal.pone.0187173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091939	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700044
J	Kuo, BJ; Vaca, SD; Vissoci, JRN; Staton, CA; Xu, L; Muhumuza, M; Ssenyonjo, H; Mukasa, J; Kiryabwire, J; Nanjula, L; Muhumuza, C; Rice, HE; Grant, GA; Haglund, MM				Kuo, Benjamin J.; Vaca, Silvia D.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.; Xu, Linda; Muhumuza, Michael; Ssenyonjo, Hussein; Mukasa, John; Kiryabwire, Joel; Nanjula, Lydia; Muhumuza, Christine; Rice, Henry E.; Grant, Gerald A.; Haglund, Michael M.			A prospective neurosurgical registry evaluating the clinical care of traumatic brain injury patients presenting to Mulago National Referral Hospital in Uganda	PLOS ONE			English	Article							LOW-INCOME; BURDEN; IMPACT; OUTCOMES	Background Traumatic Brain Injury (TBI) is disproportionally concentrated in low-and middle-income countries (LMICs), with the odds of dying from TBI in Uganda more than 4 times higher than in high income countries (HICs). The objectives of this study are to describe the processes of care and determine risk factors predictive of poor outcomes for TBI patients presenting to Mulago National Referral Hospital (MNRH), Kampala, Uganda. Methods We used a prospective neurosurgical registry based on Research Electronic Data Capture (REDCap) to systematically collect variables spanning 8 categories. Univariate and multivariate analysis were conducted to determine significant predictors of mortality. Results 563 TBI patients were enrolled from 1 June-30 November 2016. 102 patients (18%) received surgery, 29 patients (5.1%) intended for surgery failed to receive it, and 251 patients (45%) received non-operative management. Overall mortality was 9.6%, which ranged from 4.7% for mild and moderate TBI to 55% for severe TBI patients with GCS 3-5. Within each TBI severity category, mortality differed by management pathway. Variables predictive of mortality were TBI severity, more than one intracranial bleed, failure to receive surgery, high dependency unit admission, ventilator support outside of surgery, and hospital arrival delayed by more than 4 hours. Conclusions The overall mortality rate of 9.6% in Uganda for TBI is high, and likely underestimates the true TBI mortality. Furthermore, the wide-ranging mortality (3-82%), high ICU fatality, and negative impact of care delays suggest shortcomings with the current triaging practices. Lack of surgical intervention when needed was highly predictive of mortality in TBI patients. Further research into the determinants of surgical interventions, quality of step-up care, and prolonged care delays are needed to better understand the complex interplay of variables that affect patient outcome. These insights guide the development of future interventions and resource allocation to improve patient outcomes.	[Kuo, Benjamin J.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.; Haglund, Michael M.] Duke Univ, Div Global Neurosurg & Neurol, Durham, NC 27708 USA; [Kuo, Benjamin J.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.; Rice, Henry E.; Haglund, Michael M.] Duke Univ, Global Hlth Inst, Durham, NC 27708 USA; [Kuo, Benjamin J.] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore; [Vaca, Silvia D.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Vaca, Silvia D.; Xu, Linda; Grant, Gerald A.] Stanford Ctr Innovat Global Hlth, Palo Alto, CA USA; [Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Med Ctr, Dept Emergency Med, Durham, NC USA; [Xu, Linda; Grant, Gerald A.] Stanford Univ, Med Ctr, Dept Neurosurg, Palo Alto, CA 94304 USA; [Muhumuza, Michael; Ssenyonjo, Hussein; Mukasa, John; Kiryabwire, Joel; Nanjula, Lydia] Mulago Hosp, Dept Neurosurg, Kampala, Uganda; [Muhumuza, Christine] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Rice, Henry E.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Haglund, Michael M.] Duke Univ, Dept Neurosurg, Med Ctr, Durham, NC 27708 USA	Duke University; Duke University; National University of Singapore; Stanford University; Duke University; Stanford University; Mulago National Referral Hospital; Makerere University; Duke University; Duke University	Haglund, MM (corresponding author), Duke Univ, Div Global Neurosurg & Neurol, Durham, NC 27708 USA.; Haglund, MM (corresponding author), Duke Univ, Global Hlth Inst, Durham, NC 27708 USA.; Haglund, MM (corresponding author), Duke Univ, Dept Neurosurg, Med Ctr, Durham, NC 27708 USA.	michael.haglund@dm.duke.edu		Staton, Catherine/0000-0002-6468-2894; Kuo, Benjamin/0000-0002-3074-2123	Duke Department of Neurosurgery; Duke Division of Global Neurosurgery and Neurology; Duke Global Health Institute; Duke-NUS Medical School; Stanford Medical Scholars Program; FOGARTY INTERNATIONAL CENTER [K01TW010000] Funding Source: NIH RePORTER	Duke Department of Neurosurgery; Duke Division of Global Neurosurgery and Neurology; Duke Global Health Institute; Duke-NUS Medical School; Stanford Medical Scholars Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding was provided by the Duke Department of Neurosurgery, Duke Division of Global Neurosurgery and Neurology, Duke Global Health Institute, Duke-NUS Medical School, and Stanford Medical Scholars Program. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir J, 2017, WORLD NEUROSURG, V101, P651, DOI 10.1016/j.wneu.2017.02.048; Bhalla K, 2009, INJURY PREV, V15, P150, DOI 10.1136/ip.2008.020826; Bhalla K, 2009, PLOS MED, V6, P22, DOI 10.1371/journal.pmed.1000001; CDC, 2016, TRAUMATIC BRAIN INJU; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Di Saverio S, 2014, LANGENBECK ARCH SURG, V399, P109, DOI 10.1007/s00423-013-1143-9; Gagne M, 2017, J TRAUMA ACUTE CARE, V82, P374, DOI 10.1097/TA.0000000000001319; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jayaraman S, 2011, WORLD J SURG, V35, P505, DOI 10.1007/s00268-010-0871-z; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Krishnamoorthy V, 2015, J INTENSIVE CARE, P1; Kwizera Arthur, 2012, BMC Res Notes, V5, P475, DOI 10.1186/1756-0500-5-475; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mwita CC, 2016, J NEUROSCI RURAL PRA, V7, P97, DOI 10.4103/0976-3147.165390; Opondo EA, 2009, ANN AFRICAN SURG, P1; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Staton CA, 2015, INT J INJ CONTROL SA, P1; Tobi KU, 2016, SOUTH AFR J ANAESTH, V22, P135, DOI 10.1080/22201181.2016.1206293; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Ubos. Uganda National Household Survey 2009/ 2010, 2010, UGAUBOSUBOS2012V01, P222; World Health Organization, 2015, INJURY PREV, P318	25	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0182285	10.1371/journal.pone.0182285	http://dx.doi.org/10.1371/journal.pone.0182285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088217	gold, Green Submitted, Green Published			2022-12-27	WOS:000414088900001
J	Sullivan, TJ; Neigel, JE				Sullivan, Timothy J.; Neigel, Joseph E.			Differential host mortality explains the effect of high temperature on the prevalence of a marine pathogen	PLOS ONE			English	Article							CRAB CALLINECTES-SAPIDUS; DINOFLAGELLATE HEMATODINIUM-PEREZI; BLUE-CRAB; INFECTIOUS-DISEASES; THERMAL TOLERANCE; CLIMATE-CHANGE; CORAL DISEASE; SALINITY; ECOLOGY; OCEAN	Infectious diseases threaten marine populations, and the extent of their impacts is often assessed by prevalence of infection (the proportion of infected individuals). Changes in prevalence are often attributed to altered rates of transmission, although the rates of birth, recovery, and mortality also determine prevalence. The parasitic dinoflagellate Hematodinium perezi causes a severe, often fatal disease in blue crabs. It has been speculated that decreases in prevalence associated with high temperatures result from lower rates of infection. We used field collections, environmental sensor data, and high-temperature exposure experiments to investigate the factors that change prevalence of infections in blue crab megalopae (post-larvae). These megalopae migrate from offshore waters, where temperatures are moderate, to marshes where temperatures may be extremely high. Within a few days of arriving in the marsh, the megalopae metamorphose into juvenile crabs. We found a strong negative association between prevalence of Hematodinium infection in megalopae and the cumulative time water temperatures in the marsh exceeded 34 degrees C over the preceding two days. Temperatures this high are known to be lethal for blue crabs, suggesting that higher mortality of infected megalopae could be the cause of reduced prevalence. Experimental exposure of megalopae from the marsh to a temperature of 34 degrees C resulted in higher mortality for infected than uninfected individuals, and decreased the prevalence of infection among survivors from 18% to 3%.	[Sullivan, Timothy J.; Neigel, Joseph E.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Sullivan, Timothy J.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA	University of Louisiana Lafayette; University of Arkansas System; University of Arkansas Fayetteville	Sullivan, TJ (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.; Sullivan, TJ (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	tsulli1988@gmail.com	sullivan, Timothy/AAG-3677-2020		Gulf of Mexico Research Initiative [GRI-013, GoMRI2012-11-523]; University of Louisiana Doctoral Fellowship	Gulf of Mexico Research Initiative; University of Louisiana Doctoral Fellowship	This research was funded by grants from The Gulf of Mexico Research Initiative (gulfresearchinitiative.org) (GRI-013 and GoMRI2012-11-523) awarded to JEN and by a University of Louisiana Doctoral Fellowship to TJS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bree Yednock for sample collection, Jeffery Shields and Joe Pitula for providing DNA from H. perezi, and Ed Chesney for providing lab space, supplies, and guidance for the thermal stress experiments. This research was made possible by grants from The Gulf of Mexico Research Initiative (GRI-013 and GoMRI2012-II-523) and by a University of Louisiana Doctoral Fellowship to T. Sullivan.	Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; Coffey AH, 2012, J PARASITOL, V98, P536, DOI 10.1645/GE-2971.1; COSTLOW JD, 1967, HELGOLAND WISS MEER, V15, P84, DOI 10.1007/BF01618611; COSTLOW JD, 1959, BIOL BULL, V116, P373, DOI 10.2307/1538947; Egan S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00991; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Ford SE, 2007, MAR BIOL, V151, P119, DOI 10.1007/s00227-006-0454-6; Forward RB, 2005, J SHELLFISH RES, V24, P587; Friedman CS, 2009, 623 AL N PAC RES BOA; Gandy R, 2015, DIS AQUAT ORGAN, V113, P235, DOI 10.3354/dao02841; Groner M, 2015, SCIENCE, V347, P1210, DOI 10.1126/science.347.6227.1210-a; Groner ML, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0364; Hallegraeff Gustaaf M., 1997, Aquatic Ecology, V31, P47, DOI 10.1023/A:1009972931195; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hirazawa N, 2003, AQUACULTURE, V223, P1, DOI 10.1016/S0044-8486(03)00167-4; Holland Jr JS, 1971, THESIS; Huchin-Mian JP, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3185-y; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lafferty KD, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P85; LEFFLER CW, 1972, MAR BIOL, V14, P104, DOI 10.1007/BF00373209; Li CW, 2011, PARASITOLOGY, V138, P1924, DOI 10.1017/S0031182011001405; Lycett KA, 2017, DIS AQUAT ORGAN, V124, P169, DOI 10.3354/dao03112; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; Messick GA, 2000, DIS AQUAT ORGAN, V43, P139, DOI 10.3354/dao043139; Metcalf KS, 1995, B MAR SCI, V57, P781; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; POWELL EN, 1992, MAR ECOL-P S Z N I, V13, P243, DOI 10.1111/j.1439-0485.1992.tb00354.x; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Shields JD, 2000, FISH B-NOAA, V98, P139; Shields JD, 2007, BLUE CRAB CALLINECTE, P299; Shields JD, 2007, DIS AQUAT ORGAN, V77, P61, DOI 10.3354/dao01825; Steyer GD, 2003, PROPOSED COAST WIDE, P107; Sullivan TJ, 2016, DIS AQUAT ORGAN, V120, P83, DOI 10.3354/dao03004; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; TAGATZ ME, 1969, T AM FISH SOC, V98, P713, DOI 10.1577/1548-8659(1969)98[713:SROTAA]2.0.CO;2; vanMontfrans J, 1995, B MAR SCI, V57, P834; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120	42	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187128	10.1371/journal.pone.0187128	http://dx.doi.org/10.1371/journal.pone.0187128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084257	Green Submitted, Green Published, gold			2022-12-27	WOS:000413910200033
J	Schellenberg, EG; Poon, J; Weiss, MW				Schellenberg, E. Glenn; Poon, Jaimie; Weiss, Michael W.			Memory for melody and key in childhood	PLOS ONE			English	Article							ABSOLUTE PITCH; UNFAMILIAR MELODIES; ENHANCED MEMORY; WORKING-MEMORY; VOCAL MELODIES; MUSIC; RECOGNITION; AGE; ADOLESCENCE; EXPERIENCE	After only two exposures to previously unfamiliar melodies, adults remember the tunes for over a week and the key for over a day. Here, we examined the development of long-term memory for melody and key. Listeners in three age groups (7- to 8-year-olds, 9- to 11-year-olds, and adults) heard two presentations of each of 12 unfamiliar melodies. After a 10-min delay, they heard the same 12 old melodies intermixed with 12 new melodies. Half of the old melodies were transposed up or down by six semitones from initial exposure. Listeners rated how well they recognized the melodies from the exposure phase. Recognition was better for old than for new melodies, for adults compared to children, and for older compared to younger children. Recognition ratings were also higher for old melodies presented in the same key at test as exposure, and the detrimental effect of the transposition affected all age groups similarly. Although memory for melody improves with age and exposure to music, implicit memory for key appears to be adult-like by 7 years of age.	[Schellenberg, E. Glenn; Poon, Jaimie; Weiss, Michael W.] Univ Toronto Mississauga, Dept Psychol, Mississauga, ON, Canada; [Weiss, Michael W.] Univ Montreal, Dept Psychol, Int Lab Brain Mus & Sound Res, Montreal, PQ, Canada	University of Toronto; University Toronto Mississauga; Universite de Montreal	Schellenberg, EG (corresponding author), Univ Toronto Mississauga, Dept Psychol, Mississauga, ON, Canada.	g.schellenberg@utoronto.ca		Schellenberg, Glenn/0000-0003-3681-6020	Natural Sciences and Engineering Research council of Canada (EGS)	Natural Sciences and Engineering Research council of Canada (EGS)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research council of Canada (EGS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade PE, 2016, PSYCHOL MUSIC; [Anonymous], 1998, ADV INFANCY RES; Bergeson TR, 2002, PSYCHOL SCI, V13, P72, DOI 10.1111/1467-9280.00413; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Bigand E, 2001, COGNITION, V81, pB11, DOI 10.1016/S0010-0277(01)00117-2; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Chin C. S., 2003, PSYCHOL MUSIC, V31, P155, DOI [10.1177/0305735603031002292, DOI 10.1177/0305735603031002292]; Corrigall KA, 2010, MUSIC PERCEPT, V28, P195, DOI 10.1525/mp.2010.28.2.195; Cowan N, 2006, DEV PSYCHOL, V42, P1089, DOI 10.1037/0012-1649.42.6.1089; Cowan N, 2014, EDUC PSYCHOL REV, V26, P197, DOI 10.1007/s10648-013-9246-y; Deutsch D, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P141, DOI 10.1016/B978-0-12-381460-9.00005-5; Dowling WJ, 2008, PERCEPT PSYCHOPHYS, V70, P496, DOI 10.3758/PP.70.3.496; Frieler K., 2013, MUSIC SCI, V17, P334; Halpern AR, 2008, Q J EXP PSYCHOL, V61, P1371, DOI 10.1080/17470210701508038; Halpern AR, 2010, SPRINGER HANDB AUDIT, V36, P233, DOI 10.1007/978-1-4419-6114-3_8; HALPERN AR, 1995, PSYCHOL AGING, V10, P325, DOI 10.1037/0882-7974.10.3.325; Halpern AR, 1998, MUSIC PERCEPT, V15, P335; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Hunter PG, 2011, J EXP CHILD PSYCHOL, V110, P80, DOI 10.1016/j.jecp.2011.04.001; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kail RV, 2007, CHILD DEV, V78, P1760, DOI 10.1111/j.1467-8624.2007.01088.x; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; McAuley JD, 2004, ACTA PSYCHOL, V116, P93, DOI 10.1016/j.actpsy.2004.02.001; McDermott JH, 2012, NEUROSCIENCE OF PREFERENCE AND CHOICE: COGNITIVE AND NEURAL MECHANISMS, P227, DOI 10.1016/B978-0-12-381431-9.00020-6; Newcombe NS, 2007, ADV CHILD DEV BEHAV, V35, P37; Plantinga J, 2005, COGNITION, V98, P1, DOI 10.1016/j.cognition.2004.09.008; Pressley M, 1987, IMAGERY RELATED MNEM, P274; Russo FA, 2003, MUSIC PERCEPT, V21, P119, DOI 10.1525/mp.2003.21.1.119; Saffran JR, 2003, DEVELOPMENTAL SCI, V6, P35, DOI 10.1111/1467-7687.00250; Saffran JR, 2001, DEV PSYCHOL, V37, P74, DOI 10.1037//0012-1649.37.1.74; Schellenberg EG, 2008, MUSIC PERCEPT, V25, P241, DOI 10.1525/MP.2008.25.3.241; Schellenberg EG, 2015, MEM COGNITION, V43, P1021, DOI 10.3758/s13421-015-0519-1; Schellenberg EG, 2014, PSYCHOL RES-PSYCH FO, V78, P84, DOI 10.1007/s00426-013-0483-y; Schellenberg EG, 2010, PSYCHOL MUSIC, V38, P209, DOI 10.1177/0305735609339473; Schellenberg EG, 2005, DEVELOPMENTAL SCI, V8, P551, DOI 10.1111/j.1467-7687.2005.00447.x; Schellenberg EG, 2003, PSYCHOL SCI, V14, P262, DOI 10.1111/1467-9280.03432; Schneider W, 2015, MEMORY DEV EARLY CHI; Slavin S., 2014, PSYSCRIPT 3 VERSION; Stalinski SM, 2010, DEV PSYCHOL, V46, P1799, DOI 10.1037/a0020658; Thelen E., 1998, HDB CHILD PSYCHOL TH, P563; Tillmann B, 2007, COGN NEUROPSYCHOL, V24, P603, DOI 10.1080/02643290701609527; TRAINOR LJ, 1994, PERCEPT PSYCHOPHYS, V56, P125, DOI 10.3758/BF03213891; Trehub SE, 2008, J EXP CHILD PSYCHOL, V100, P40, DOI 10.1016/j.jecp.2008.01.007; Volkova A, 2006, DEVELOPMENTAL SCI, V9, P583, DOI 10.1111/j.1467-7687.2006.00536.x; Weiss MW, 2017, MUSIC PERCEPT, V34, P313, DOI 10.1525/MP.2017.34.3.313; Weiss MW, 2015, Q J EXP PSYCHOL, V68, P866, DOI 10.1080/17470218.2015.1020818; Weiss MW, 2015, DEV PSYCHOL, V51, P370, DOI 10.1037/a0038784; Weiss MW, 2012, PSYCHOL SCI, V23, P1074, DOI 10.1177/0956797612442552; Zelazo PD, 2012, CHILD DEV PERSPECT, V6, P354, DOI 10.1111/j.1750-8606.2012.00246.x	52	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187115	10.1371/journal.pone.0187115	http://dx.doi.org/10.1371/journal.pone.0187115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077726	gold, Green Submitted, Green Published			2022-12-27	WOS:000413861200045
J	Abdin, E; Chong, SA; Vaingankar, JA; Peh, CX; Poon, LY; Rao, S; Verma, S; Subramaniam, M				Abdin, Edimansyah; Chong, Siow Ann; Vaingankar, Janhavi Ajit; Peh, Chao Xu; Poon, Lye Yin; Rao, Sujatha; Verma, Swapna; Subramaniam, Mythily			Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period	PLOS ONE			English	Article							TREATMENT RESPONSE TRAJECTORIES; 1ST-EPISODE PSYCHOSIS; INTERVENTION PROGRAM; GENDER-DIFFERENCES; SOCIAL RECOVERY; OPUS COHORT; SHORT-TERM; SCHIZOPHRENIA; REMISSION; TRIAL	Background Few studies have examined the trajectories of symptom severity in first episode psychosis (FEP) and their impact on functioning. This study aimed to identify discrete trajectories of positive, negative and general psychopathological symptoms and functioning, determine predictors of the identified symptom trajectories and subsequently investigate the relationship between symptom and functioning trajectories over the 2-year follow-up period. Methods Data were extracted from the Singapore Early Psychosis Intervention Programme clinical database. Trajectories of the Positive and Negative Syndrome Scale and Global Assessment of Functioning (GAF) scale over the two-year follow up were modelled using latent class growth curve modelling. Results Two distinct trajectories (early response and stable trajectory and delayed response trajectory) for positive symptoms, four distinct trajectories (early response and stable trajectory, early response and relapse trajectory, slower response and no response trajectory and delayed response trajectory) for negative and general psychopathology symptoms and three distinct trajectories for functioning (high functioning trajectory, moderately stable functioning trajectory and deterioration in functioning trajectory) were identified in our sample. Compared to individuals in the early response and stable trajectory, those in the delayed response trajectory tor positive and negative symptoms, early response and relapse for negative and general psychopathology symptoms and slower response and no response trajectories for general psychopathology symptoms were significantly associated with higher odds of having deterioration in functioning over time. Poor symptom trajectories were also significantly predicted by younger age, male gender, unemployed and economically inactive status, lower education, longer duration of untreated psychosis and diagnosis of schizophrenia spectrum and delusional disorders. Conclusions The results confirm that the symptoms trajectories among patients with FEP are heterogeneous and suggest that a small group of patients may be at higher risk of deterioration in symptom severity and functioning over the 2-year follow-up.	[Abdin, Edimansyah; Chong, Siow Ann; Vaingankar, Janhavi Ajit; Peh, Chao Xu; Subramaniam, Mythily] Inst Mental Hlth, Res Div, Singapore, Singapore; [Poon, Lye Yin; Rao, Sujatha; Verma, Swapna] Inst Mental Hlth, Dept Early Psychosis Intervent, Singapore, Singapore		Abdin, E (corresponding author), Inst Mental Hlth, Res Div, Singapore, Singapore.	edimansyah_abdin@imh.com.sg	Abdin, Edimansyah/E-6451-2011	Abdin, Edimansyah/0000-0002-1016-3298; Peh, Chao Xu/0000-0003-1247-883X	Singapore National Healthcare Group Research Support Scheme	Singapore National Healthcare Group Research Support Scheme	This work was supported in part by the Singapore National Healthcare Group Research Support Scheme grant awarded to the first author. There was no additional external funding received for this study.	Albert N, 2011, SCHIZOPHR RES, V125, P257, DOI 10.1016/j.schres.2010.10.013; Alvarez-Jimenez M, 2012, PSYCHOL MED, V42, P595, DOI 10.1017/S0033291711001504; Austin SF, 2015, SCHIZOPHR RES, V168, P84, DOI 10.1016/j.schres.2015.07.021; Austin SF, 2013, SCHIZOPHR RES, V150, P163, DOI 10.1016/j.schres.2013.07.031; Case M, 2011, PSYCHOL MED, V41, P1291, DOI 10.1017/S0033291710001893; Cechnicki A, 2011, MED SCI MONITOR, V17, pCR277, DOI 10.12659/MSM.881768; Chang WC, 2016, SCHIZOPHR RES, V173, P79, DOI 10.1016/j.schres.2016.03.016; Chang WC, 2011, AUST NZ J PSYCHIAT, V45, P199, DOI 10.3109/00048674.2010.547841; Department of Statistics Singapore, 2016, YB STAT SING; Gee B, 2016, SCHIZOPHR RES, V174, P165, DOI 10.1016/j.schres.2016.04.017; Hodgekins J, 2015, BRIT J PSYCHIAT, V207, P536, DOI 10.1192/bjp.bp.114.153486; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Levine SZ, 2012, SCHIZOPHR RES, V137, P141, DOI 10.1016/j.schres.2012.01.014; Levine SZ, 2011, SCHIZOPHR RES, V126, P184, DOI 10.1016/j.schres.2010.10.026; Levine SZ, 2010, J CLIN PSYCHOPHARM, V30, P446, DOI 10.1097/JCP.0b013e3181e68e80; Levine SZ, 2010, SCHIZOPHRENIA BULL, V36, P624, DOI 10.1093/schbul/sbn120; Melchior H, 2016, PSYCHIAT RES, V238, P228, DOI 10.1016/j.psychres.2016.02.046; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Nagin D. S, 2005, GROUP BASED MODELLIN; Pang S, 2016, EARLY INTERV PSYCHIA, V10, P528, DOI 10.1111/eip.12208; Pelayo-Teran JM, 2014, PSYCHOL MED, V44, P37, DOI 10.1017/S0033291713000330; Piersma HL, 1997, COMMUNITY MENT HLT J, V33, P35, DOI 10.1023/A:1022413110345; Potkin S, 2011, SCHIZOPHR RES, V132, P108, DOI 10.1016/j.schres.2011.07.028; Rabinowitz J, 2007, SCHIZOPHR RES, V91, P254, DOI 10.1016/j.schres.2006.12.013; Schennach R, 2012, SCHIZOPHR RES, V139, P218, DOI 10.1016/j.schres.2012.05.004; Silverstein SM, 2008, CLIN PSYCHOL REV, V28, P1108, DOI 10.1016/j.cpr.2008.03.004; STAFFORD MR, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F185; Thorup A, 2014, EUR PSYCHIAT, V29, P44, DOI 10.1016/j.eurpsy.2012.11.005; Verma S, 2012, East Asian Arch Psychiatry, V22, P114; Verma S, 2012, ACTA PSYCHIAT SCAND, V126, P282, DOI 10.1111/j.1600-0447.2012.01883.x; Verma SK, 2002, SOC PSYCH PSYCH EPID, V37, P326, DOI 10.1007/s00127-002-0553-8; Verma S, 2012, ASIAN J PSYCHIATR, V5, P63, DOI 10.1016/j.ajp.2012.02.001	33	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187141	10.1371/journal.pone.0187141	http://dx.doi.org/10.1371/journal.pone.0187141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095875	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200050
J	Calil, J; Reguero, BG; Zamora, AR; Losada, IJ; Mendez, FJ				Calil, Juliano; Reguero, Borja G.; Zamora, Ana R.; Losada, Inigo J.; Mendez, Fernando J.			Comparative Coastal Risk Index (CCRI): A multidisciplinary risk index for Latin America and the Caribbean	PLOS ONE			English	Article							EXTREME WAVE CLIMATE; VULNERABILITY; CLASSIFICATION; VARIABILITY; MITIGATION; FRAMEWORK; FLOOD	As the world's population grows to a projected 11.2 billion by 2100, the number of people living in low-lying areas exposed to coastal hazards is projected to increase. Critical infrastructure and valuable assets continue to be placed in vulnerable areas, and in recent years, millions of people have been displaced by natural hazards. Impacts from coastal hazards depend on the number of people, value of assets, and presence of critical resources in harm's way. Risks related to natural hazards are determined by a complex interaction between physical hazards, the vulnerability of a society or social-ecological system and its exposure to such hazards. Moreover, these risks are amplified by challenging socioeconomic dynamics, including poorly planned urban development, income inequality, and poverty. This study employs a combination of machine learning clustering techniques (Self Organizing Maps and K-Means) and a spatial index, to assess coastal risks in Latin America and the Caribbean (LAC) on a comparative scale. The proposed method meets multiple objectives, including the identification of hotspots and key drivers of coastal risk, and the ability to process large-volume multidimensional and multivariate datasets, effectively reducing sixteen variables related to coastal hazards, geographic exposure, and socioeconomic vulnerability, into a single index. Our results demonstrate that in LAC, more than 500,000 people live in areas where coastal hazards, exposure (of people, assets and ecosystems) and poverty converge, creating the ideal conditions for a perfect storm. Hotspot locations of coastal risk, identified by the proposed Comparative Coastal Risk Index (CCRI), contain more than 300,00 people and include: El Oro, Ecuador; Sinaloa, Mexico; Usulutan, El Salvador; and Chiapas, Mexico. Our results provide important insights into potential adaptation alternatives that could reduce the impacts of future hazards. Effective adaptation options must not only focus on developing coastal defenses, but also on improving practices and policies related to urban development, agricultural land use, and conservation, as well as ameliorating socioeconomic conditions.	[Calil, Juliano] Middlebury Inst Int Studies, Ctr Blue Econ, Monterey, CA 93940 USA; [Reguero, Borja G.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Reguero, Borja G.] Nature Conservancy, Santa Cruz, CA USA; [Zamora, Ana R.; Mendez, Fernando J.] Univ Cantabria, Santander, Cantabria, Spain; [Losada, Inigo J.] Univ Cantabria, Environm Hydraul Inst IH Cantabria, Santander, Cantabria, Spain	University of California System; University of California Santa Cruz; Nature Conservancy; Universidad de Cantabria; Universidad de Cantabria; IHCantabria - Instituto de Hidraulica Ambiental de la Universidad de Cantabria	Calil, J (corresponding author), Middlebury Inst Int Studies, Ctr Blue Econ, Monterey, CA 93940 USA.	juliano.calil@gmail.com	Losada, Iñigo J/F-9001-2012; Reguero, Borja/L-8621-2014	Losada, Iñigo J/0000-0002-9651-9709; Calil, Juliano/0000-0002-6568-4883; Reguero, Borja/0000-0001-5526-7157				Abeygunawardena Piya, 2002, REDUCING VULNERABILI; Adger W. N., 1999, MITIG ADAPT STRAT GL, V4, P253, DOI [DOI 10.1023/A:1009601904210, 10.1023/A:1009601904210]; Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; [Anonymous], 2014, SEA LEVEL RISE NUISA; [Anonymous], 2009, RISK POVERTY CHANGIN; [Anonymous], 2013, CBS NEWS; [Anonymous], 2010, MULTIPLE PURPOSE HOU; [Anonymous], 2014, ESTIMACION EFECTOS D; [Anonymous], 2015, WORLD POP PROSP 2015; Balk D, 2005, FOOD POLICY, V30, P584, DOI 10.1016/j.foodpol.2005.10.007; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Barcena A, 2012, RIO 20 C NAC UNID DE, P1; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Bjarnadottir S, 2011, NAT HAZARDS, V59, P1055, DOI 10.1007/s11069-011-9817-5; Calil J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132651; Camus P., 2016, OCEAN DYN; Camus P, 2011, COAST ENG, V58, P453, DOI 10.1016/j.coastaleng.2011.02.003; Churchman C.W., 1967, MANAGE SCI, V14, pB, DOI [DOI 10.1287/MNSC.14.4.B141, 10.1287/mnsc.14.4.B141]; Consejo Nacional de Evaluacion de la Politica de Desarrollo Social (CONEVAL), 2016, INF POBR MEX 2014, P144; Cuevas Portilla J, 1998, REV U CRIS COLON, V20, P61; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Cutter SL, 1996, PROG HUM GEOG, V20, P529, DOI 10.1177/030913259602000407; ECLAC, 2011, REG STUD EFF CLIM CH; *ECLAC, 2014, STAT YB LAT AM CAR, DOI DOI 10.1016/J.ECSS.2011.11.041; *ECLAC, 2011, 2 ECLAC; Eisenack K, 2012, MITIG ADAPT STRAT GL, V17, P243, DOI 10.1007/s11027-011-9323-9; Ellis JT, 2015, PERSPECTIVES COASTAL, P1; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Fixler D., 2014, MEASURING EC SUSTAIN, P213; Franco E, 1996, ESTADO SOC GESTION D; Gevrey M, 2006, ECOL MODEL, V197, P361, DOI 10.1016/j.ecolmodel.2006.03.032; Guneralp B, 2015, GLOBAL ENVIRON CHANG, V31, P217, DOI 10.1016/j.gloenvcha.2015.01.002; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Internal Displacement Monitoring Centre (IDMC), 2012, ACT REP 2012 INT DIS, P32; IPCC, 2013, CLIMATE CHANGE 2022; Izaguirre C, 2013, CLIMATIC CHANGE, V119, P277, DOI 10.1007/s10584-013-0712-9; Izaguirre C, 2012, OCEAN MODEL, V59-60, P31, DOI 10.1016/j.ocemod.2012.09.007; Jimenez M, 2012, OCEAN COAST MANAGE, V69, P231, DOI 10.1016/j.ocecoaman.2012.08.017; Juneja S, 2009, DISASTERS POVERTY RI; Kebede AS, 2012, J COASTAL RES, V28, P8, DOI 10.2112/JCOASTRES-D-10-00069.1; KENNARD RW, 1969, TECHNOMETRICS, V11, P137, DOI 10.2307/1266770; Kohonen T., 1998, Neurocomputing, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; Kousky C, 2014, ECOL ECON, V104, P119, DOI 10.1016/j.ecolecon.2014.05.001; KREIMER A, 2000, MANAGING DISASTER RI; Lavel C, 2014, PEOPLE DISPLACED DIS, P65; Ley R, 2011, HYDROL EARTH SYST SC, V15, P2947, DOI 10.5194/hess-15-2947-2011; Loewenberg Samuel, 2010, STRUGGLE HLTH CHIAPA; Losada IJ, 2013, GLOBAL PLANET CHANGE, V104, P34, DOI 10.1016/j.gloplacha.2013.02.006; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Moser CON, 1998, WORLD DEV, V26, P1, DOI 10.1016/S0305-750X(97)10015-8; Moser SC, 2012, ANNU REV ENV RESOUR, V37, P51, DOI 10.1146/annurev-environ-021611-135158; NEUMANN B, 2015, PLOS ONE, V10, DOI DOI 10.1177/0956247807076960; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P229, DOI 10.1016/j.gloenvcha.2004.04.005; OKEEFE P, 1976, NATURE, V260, P566, DOI 10.1038/260566a0; Pasch RJ, 2014, NAT HURRICANE CTR TR; Ramos E, 2012, ESTUAR COAST SHELF S, V112, P105, DOI 10.1016/j.ecss.2011.11.041; Reguero BG, 2015, APPL ENERG, V148, P366, DOI 10.1016/j.apenergy.2015.03.114; Reguero BG, 2013, GLOBAL PLANET CHANGE, V100, P70, DOI 10.1016/j.gloplacha.2012.09.005; Reguero BG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133409; Rueda A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05090-w; Saleemul Huq, 1994, J COASTAL RES, P44; Sen A., 1973, EC INEQUALITY; Slaughter M, 2016, SOCIAL SCI Q, V97, P1267; Small C, 2003, J COASTAL RES, V19, P584; Solidoro C, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003553; Spanger-Siegfried E., 2014, ENCROACHING TIDES SE; Storeygard A, 2008, POPUL SPACE PLACE, V14, P209, DOI 10.1002/psp.484; UNISDR, 2015, 2015 GLOB ASS REP DI; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Villamizar A, 2017, CLIM DEV, V9, P364, DOI 10.1080/17565529.2016.1146120; Vos R., 1999, RESENA HURACAN MANUE, V292, P1; Vos R., 1999, ISS WORKING PAPER SE, V292, P1; Wisner B., 2004, At risk: natural hazards, people's vulnerability and disasters; Zuniga MaE, AG SIGL 21 AM GLOB W; 2013, CLIMATE CHANGE 2013, DOI DOI 10.1073/PNAS.0907765106	76	27	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187011	10.1371/journal.pone.0187011	http://dx.doi.org/10.1371/journal.pone.0187011			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095841	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200040
J	Fryer, TD; Ejaz, S; Jensen-Kondering, U; Williamson, DJ; Sitnikov, S; Sawiak, SJ; Aigbirhio, FI; Hong, YT; Baron, JC				Fryer, Tim D.; Ejaz, Sohail; Jensen-Kondering, Ulf; Williamson, David J.; Sitnikov, Sergey; Sawiak, Stephen J.; Aigbirhio, Franklin I.; Hong, Young T.; Baron, Jean-Claude			Effects of hyperoxia on F-18-fluoro-misonidazole brain uptake and tissue oxygen tension following middle cerebral artery occlusion in rodents: Pilot studies	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ACUTE ISCHEMIC-STROKE; SPONTANEOUSLY HYPERTENSIVE-RAT; SELECTIVE NEURONAL LOSS; ELECTRON-PARAMAGNETIC-RESONANCE; NORMOBARIC HYPEROXIA; HYPOXIC TISSUE; FOCAL ISCHEMIA; BLOOD-FLOW; CARBON-DIOXIDE	Purpose Mapping brain hypoxia is a major goal for stroke diagnosis, pathophysiology and treatment monitoring. F-18-fluoro-misonidazole (FMISO) positron emission tomography (PET) is the gold standard hypoxia imaging method. Normobaric hyperoxia (NBO) is a promising therapy in acute stroke. In this pilot study, we tested the straightforward hypothesis that NBO would markedly reduce FMISO uptake in ischemic brain in Wistar and spontaneously hypertensive rats (SHRs), two rat strains with distinct vulnerability to brain ischemia, mimicking clinical heterogeneity. Methods Thirteen adult male rats were randomized to distal middle cerebral artery occlusion under either 30% O-2 or 100% O-2. FMISO was administered intravenously and PET data acquired dynamically for 3hrs, after which magnetic resonance imaging (MRI) and tetrazolium chloride (TTC) staining were carried out to map the ischemic lesion. Both FMISO tissue uptake at 2-3hrs and FMISO kinetic rate constants, determined based on previously published kinetic modelling, were obtained for the hypoxic area. In a separate group (n = 9), tissue oxygen partial pressure (PtO2) was measured in the ischemic tissue during both control and NBO conditions. Results As expected, the FMISO PET, MRI and TTC lesion volumes were much larger in SHRs than Wistar rats in both the control and NBO conditions. NBO did not appear to substantially reduce FMISO lesion size, nor affect the FMISO kinetic rate constants in either strain. Likewise, MRI and TTC lesion volumes were unaffected. The parallel study showed the expected increases in ischemic cortex PtO2 under NBO, although these were small in some SHRs with very low baseline PtO2. Conclusions Despite small samples, the apparent lack of marked effects of NBO on FMISO uptake suggests that in permanent ischemia the cellular mechanisms underlying FMISO trapping in hypoxic cells may be disjointed from PtO2. Better understanding of FMISO trapping processes will be important for future applications of FMISO imaging.	[Fryer, Tim D.; Jensen-Kondering, Ulf; Williamson, David J.; Sawiak, Stephen J.; Aigbirhio, Franklin I.; Hong, Young T.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Ejaz, Sohail; Jensen-Kondering, Ulf; Sitnikov, Sergey; Baron, Jean-Claude] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England; [Jensen-Kondering, Ulf] Univ Med Ctr Schleswig Holstein, Dept Radiol & Neuroradiol, Kiel, Germany; [Baron, Jean-Claude] Univ Paris 05, Hop St Anne Hosp, Dept Neurol, NSERM,U894, Paris, France	University of Cambridge; University of Cambridge; University of Kiel; Schleswig Holstein University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Baron, JC (corresponding author), Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England.; Baron, JC (corresponding author), Univ Paris 05, Hop St Anne Hosp, Dept Neurol, NSERM,U894, Paris, France.	jean-claucle.baron@inserm.fr	Sawiak, Stephen/I-8944-2012	Sawiak, Stephen/0000-0003-4210-9816; baron, jean-claude/0000-0002-5264-2588	European Union Grant EUSTROKE [Health-F2-2008-2022131]; Medical Research Council [G0600986]; Deutsche Forschungsgemeinschaft [Je 598/1-1]; state of Schleswig-Holstein within the funding programme "Open Access Publikationsfonds"; Medical Research Council [G0001237, G0500874] Funding Source: researchfish; MRC [G0500874, G0001237, G0600986] Funding Source: UKRI	European Union Grant EUSTROKE; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); state of Schleswig-Holstein within the funding programme "Open Access Publikationsfonds"; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	European Union Grant (https://europa.eu) EUSTROKE Health-F2-2008-2022131 provided funding for experiments, consumables, and salaries for S. Ejaz and S. Sitnikov. Medical Research Council (www.mrc.ac.uk) collaborative grant (G0600986) provided funding for DJ Williamson salary, and Deutsche Forschungsgemeinschaft (www.dfg.de): grant Je 598/1-1 provided funding for Ulf Jensen-Kondering fellowship. We acknowledge the financial support by the state of Schleswig-Holstein within the funding programme "Open Access Publikationsfonds".	Alawneh JA, 2014, EUR J NUCL MED MOL I, V41, P736, DOI 10.1007/s00259-013-2581-x; Amenta Francesco, 2010, Italian Journal of Anatomy and Embryology, V115, P13; ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Baron JC, 1999, CEREBROVASC DIS, V9, P193, DOI 10.1159/000015955; BARONE FC, 1992, NEUROSCI BIOBEHAV R, V16, P219, DOI 10.1016/S0149-7634(05)80182-4; Bartlett RM, 2012, J NUCL MED, V53, P1608, DOI 10.2967/jnumed.112.103523; Baskerville TA, 2011, J CEREBR BLOOD F MET, V31, P1799, DOI 10.1038/jcbfm.2011.65; Baskin A, 2015, CURR VASC PHARMACOL, V13, P209, DOI 10.2174/15701611113116660167; Beynon C, 2007, NEUROSCI LETT, V425, P141, DOI 10.1016/j.neulet.2007.07.009; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Brown A T, 2014, Open Neurol J, V8, P27, DOI 10.2174/1874205X01408010027; BUCHAN AM, 1992, STROKE, V23, P273, DOI 10.1161/01.STR.23.2.273; Chan SL, 2016, STROKE, V47, P1618, DOI 10.1161/STROKEAHA.116.013392; COYLE P, 1986, STROKE, V17, P520, DOI 10.1161/01.STR.17.3.520; COYLE P, 1991, BLOOD VESSELS, V28, P183; CROCKARD HA, 1976, J NEUROL SCI, V27, P29, DOI 10.1016/0022-510X(76)90232-X; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DIROCCO RJ, 1993, J CEREBR BLOOD F MET, V13, P755, DOI 10.1038/jcbfm.1993.96; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; DUVERGER D, 1988, J CEREBR BLOOD F MET, V8, P449, DOI 10.1038/jcbfm.1988.86; Ejaz S, 2016, BRAIN, V139, P751, DOI 10.1093/brain/awv391; Ejaz S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00064; Ejaz S, 2015, STROKE, V46, P1084, DOI 10.1161/STROKEAHA.114.007581; Ejaz S, 2013, NEUROBIOL DIS, V51, P120, DOI 10.1016/j.nbd.2012.11.002; Esposito E, 2013, EXP NEUROL, V249, P33, DOI 10.1016/j.expneurol.2013.08.005; Falcao ALE, 2004, ANN NEUROL, V56, P695, DOI 10.1002/ana.20265; Flynn EP, 2002, ANN NEUROL, V52, P566, DOI 10.1002/ana.10322; Fujiwara N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-79; Gratton JA, 1998, STROKE, V29, P690, DOI 10.1161/01.STR.29.3.690; HARRIS RJ, 1987, J CEREBR BLOOD F MET, V7, P599, DOI 10.1038/jcbfm.1987.111; Henninger N, 2007, J CEREBR BLOOD F MET, V27, P1632, DOI 10.1038/sj.jcbfm.9600463; Henninger N, 2013, STROKE, V44, P61, DOI 10.1161/STROKEAHA.112.679084; Henninger N, 2009, J CEREBR BLOOD F MET, V29, P119, DOI 10.1038/jcbfm.2008.104; Hirano T, 1999, NEUROLOGY, V53, P2179, DOI 10.1212/WNL.53.9.2179; HOFFMAN JM, 1987, STROKE, V18, P168, DOI 10.1161/01.STR.18.1.168; Hoffman WE, 1996, SURG NEUROL, V46, P75, DOI 10.1016/0090-3019(96)00049-3; Hoffman WE, 1999, SURG NEUROL, V51, P654, DOI 10.1016/S0090-3019(99)00011-7; Hom S, 2007, AM J PHYSIOL-REG I, V292, pR1881, DOI 10.1152/ajpregu.00761.2005; Hong YT, 2011, J CEREBR BLOOD F MET, V31, P648, DOI 10.1038/jcbfm.2010.141; Hou HH, 2007, PHYSIOL MEAS, V28, P963, DOI 10.1088/0967-3334/28/8/017; Hughes JL, 2012, NEUROIMAGE, V59, P2007, DOI 10.1016/j.neuroimage.2011.10.060; Hughes JL, 2010, NEUROIMAGE, V49, P19, DOI 10.1016/j.neuroimage.2009.08.047; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; Jensen-Kondering U, 2017, INT J STROKE, V12, P752, DOI 10.1177/1747493017706221; Jin XC, 2013, EXP NEUROL, V240, P9, DOI 10.1016/j.expneurol.2012.11.018; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Kang BT, 2014, NEUROSCIENCE, V269, P223, DOI 10.1016/j.neuroscience.2014.03.031; Kim HY, 2005, ANN NEUROL, V57, P571, DOI 10.1002/ana.20430; KINAHAN PE, 1989, IEEE T NUCL SCI, V36, P964, DOI 10.1109/23.34585; Lee GH, 2015, J NEUROIMAGING, V25, P652, DOI 10.1111/jon.12180; Leoni RF, 2011, NEUROIMAGE, V58, P75, DOI 10.1016/j.neuroimage.2011.06.030; Letourneur A, 2012, EXP NEUROL, V233, P264, DOI 10.1016/j.expneurol.2011.10.014; Liang J, 2015, STROKE, V46, P1344, DOI 10.1161/STROKEAHA.114.008599; Liu CS, 2012, STROKE, V43, P220, DOI 10.1161/STROKEAHA.111.625756; Liu SM, 2006, J CEREBR BLOOD F MET, V26, P1274, DOI 10.1038/sj.jcbfm.9600277; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; Markus R, 2004, BRAIN, V127, P1427, DOI 10.1093/brain/awh162; Markus R, 2003, STROKE, V34, P2646, DOI 10.1161/01.STR.0000094422.74023.FF; Markus R, 2002, NEUROIMAGE, V16, P425, DOI 10.1006/nimg.2002.1056; McCabe C, 2009, STROKE, V40, P3864, DOI 10.1161/STROKEAHA.109.559021; Mies G, 1999, J CEREBR BLOOD F MET, V19, P1238, DOI 10.1097/00004647-199911000-00008; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Piert M, 2000, NUCL MED BIOL, V27, P693, DOI 10.1016/S0969-8051(00)00151-7; Piert M, 1999, EUR J NUCL MED, V26, P95, DOI 10.1007/s002590050365; Poli S, 2009, CURR MOL MED, V9, P227, DOI 10.2174/156652409787581619; Read SJ, 2000, ANN NEUROL, V48, P228, DOI 10.1002/1531-8249(200008)48:2<228::AID-ANA13>3.3.CO;2-2; Read SJ, 1998, NEUROLOGY, V51, P1617, DOI 10.1212/WNL.51.6.1617; Reid E, 2012, J CEREBR BLOOD F MET, V32, P1765, DOI 10.1038/jcbfm.2012.69; Rewell SSJ, 2017, J CEREBR BLOOD F MET, V37, P3380, DOI 10.1177/0271678X16688704; Rojas S, 2011, MOL IMAGING BIOL, V13, P558, DOI 10.1007/s11307-010-0371-4; Saita K, 2004, STROKE, V35, P975, DOI 10.1161/01.STR.0000121647.01941.ba; Sarrafzadeh AS, 2010, J CEREBR BLOOD F MET, V30, P36, DOI 10.1038/jcbfm.2009.199; Schirrmacher R, 2016, CEREBROVASC DIS, V41, P139, DOI 10.1159/000442997; Seiffge DJ, 2012, EXP NEUROL, V237, P18, DOI 10.1016/j.expneurol.2012.06.007; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Shin HK, 2014, J NEUROSCI, V34, P15200, DOI 10.1523/JNEUROSCI.1110-14.2014; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Singhal AB, 2007, NEUROL RES, V29, P173, DOI 10.1179/016164107X181815; Spratt NJ, 2006, STROKE, V37, P1862, DOI 10.1161/01.STR.0000226908.93295.9d; Spratt NJ, 2011, J CEREBR BLOOD F MET, V31, P934, DOI 10.1038/jcbfm.2010.174; Spratt NJ, 2009, BRAIN RES, V1288, P135, DOI 10.1016/j.brainres.2009.06.102; Sun L, 2008, STROKE, V39, P1000, DOI 10.1161/STROKEAHA.107.490599; Takasawa M, 2008, STROKE, V39, P1629, DOI 10.1161/STROKEAHA.107.485938; Takasawa M, 2007, J CEREBR BLOOD F MET, V27, P679, DOI 10.1038/sj.jcbfm.9600405; Takasawa M, 2011, EXP NEUROL, V229, P251, DOI 10.1016/j.expneurol.2011.02.005; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Weaver J, 2014, J CEREBR BLOOD F MET, V34, P890, DOI 10.1038/jcbfm.2014.35; Werner P, 2015, J CEREBR BLOOD F MET, V35, P1421, DOI 10.1038/jcbfm.2015.158; Williamson DJ, 2013, NUCL MED BIOL, V40, P338, DOI 10.1016/j.nucmedbio.2012.11.012	94	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187087	10.1371/journal.pone.0187087	http://dx.doi.org/10.1371/journal.pone.0187087			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091934	gold, Green Submitted, Green Published			2022-12-27	WOS:000414229700042
J	Cingolani, A; Lepri, AC; Teofili, L; Galli, L; Mazzotta, V; Baldin, GM; Hohaus, S; Bandera, A; Alba, L; Galizzi, N; Castagna, A; Monforte, AD; Antinori, A				Cingolani, Antonella; Lepri, Alessandro Cozzi; Teofili, Luciana; Galli, Laura; Mazzotta, Valentina; Baldin, Gian Maria; Hohaus, Stefan; Bandera, Alessandra; Alba, Lucia; Galizzi, Nadia; Castagna, Antonella; Monforte, Antonella D'arminio; Antinori, Andrea		ICONA Fdn Study Grp	Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; B-CELL LYMPHOMA; CHEMOTHERAPY PLUS RITUXIMAB; AIDS-RELATED LYMPHOMA; NON-HODGKIN-LYMPHOMA; CART ERA; OUTCOMES; COHORT; CHOP; TRENDS	Objectives to compare overall survival in HIV-associated lymphoma (HIV-L) and lymphoma raising in HIV-negative population (nHIV-L) and to identify predictors of increased risk of death. Methods All HIV+ patients with HIV-associated lymphoma (Hodgkin lymphoma, HL; non-Hodgkin Lymphoma, NHL) observed between 1.2000 and 12.2013 in the ICONA Foundation Study cohort or in three collaborating centres, and, as control group, nHIV-L individuals followed in one of the four collaborating centres over the same time period, were included. Survival estimates were calculated by use of Kaplan-Meier (KM) and multivariable Cox regression models. Results 1,331 pts were included (465 HIV-L, 866 nHIV-L): 909 (68%) NHL, 422 (32%) HL. 3 years-cumulative probability (95% confidence interval, CI) of death was higher in HIV-L compared to nHIV-L in NHL (38% (33-44) vs. 22% (19-26); p<0.001), and HL (22% [15-29] vs. 10% (6-13), p<0.001). Among HL, HIV was associated with an increased risk of death (hazard ratio [HR] = 2.37 [95% CI: 1.24-4.55], p = 0.009) independently of calendar year, age, gender, type of chemotherapy and stage; in NHL, HIV was no longer an independent predictor of death after controlling for rituximab use and IPI (HR = 1.26 (0.97-1.63), p = 0.08). Conclusions Our analysis shows a reduced overall survival in HIV+ patients diagnosed with lymphoma compared to HIV-negative controls. Whereas in HIV people with HL, the increased risk of death was confirmed even after adjustment for main confounders, the association between HIV status and survival in NHL appears to be somewhat attenuated after controlling for more aggressive presentation and lower frequency of rituximab use in HIV-+ people.	[Cingolani, Antonella; Mazzotta, Valentina] Univ Cattolica S Cuore, Fdn Policlin Univ Gemelli, Infect Dis, Rome, Italy; [Lepri, Alessandro Cozzi] UCL, Inst Global Hlth, Ctr Clin Res Epidemiol Modelling & Evaluat CREME, London, England; [Teofili, Luciana; Hohaus, Stefan] Univ Cattolica S Cuore, Fdn Policlin Univ Gemelli, Hematol, Rome, Italy; [Galli, Laura; Galizzi, Nadia; Castagna, Antonella] Ist Sci San Raffaele, Infect Dis, Milan, Italy; [Mazzotta, Valentina; Antinori, Andrea] Natl Inst Infect Dis L Spallanzani, Rome, Italy; [Bandera, Alessandra] Infect Dis San Gerardo Hosp, Monza, Italy; [Monforte, Antonella D'arminio] Univ Milan, San Paolo Hosp, Milan, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of London; University College London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Lazzaro Spallanzani; San Paolo-Polo Universitaria Hospital; University of Milan	Cingolani, A (corresponding author), Univ Cattolica S Cuore, Fdn Policlin Univ Gemelli, Infect Dis, Rome, Italy.	antonella.cingolani@unicatt.it	Mazzotta, Valentina/HHS-2687-2022; Harding, Richard/G-9729-2012; Bandera, Alessandra/AAC-6081-2022; Hohaus, Stefan/K-9718-2016; Teofili, Luciana/K-7278-2016; Antinori, Andrea/K-7125-2016; Galli, Laura/B-1161-2016; Baldin, Gianmaria/A-8562-2019; Castagna, Antonella/K-3280-2018; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019	Mazzotta, Valentina/0000-0002-0240-7504; Teofili, Luciana/0000-0002-7214-1561; Antinori, Andrea/0000-0003-2121-4684; Baldin, Gianmaria/0000-0003-4623-9976; Castagna, Antonella/0000-0002-8338-9714; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; Galli, Laura/0000-0001-8046-0290; BANDERA, ALESSANDRA/0000-0001-9440-4601	BMS; Gilead; Jannsen; MSD; ViiV Italy; Ricerca Corrente degli IRCCS-Ministero della Salute, Roma, Italy	BMS(Bristol-Myers Squibb); Gilead(Gilead Sciences); Jannsen; MSD; ViiV Italy; Ricerca Corrente degli IRCCS-Ministero della Salute, Roma, Italy	ICONA Foundation receives unrestricted grants from BMS, Gilead, Jannsen, MSD, ViiV Italy. National Institute for Infectious Diseases was granted by Ricerca Corrente degli IRCCS-Ministero della Salute, Roma, Italy.; ICONA Foundation receives unrestricted grants from BMS, Gilead, Jannsen, MSD, ViiV Italy; Granted by Ricerca Corrente degli IRCCS-Ministero della Salute, Roma, Italy.	Antinori A, 2001, AIDS, V15, P1483, DOI 10.1097/00002030-200108170-00005; Barta SK, 2015, ANN ONCOL, V26, P958, DOI 10.1093/annonc/mdv036; Barta SK, 2013, BLOOD, V122, P3251, DOI 10.1182/blood-2013-04-498964; Besson C, 2001, BLOOD, V98, P2339, DOI 10.1182/blood.V98.8.2339; Besson C, 2015, CLIN INFECT DIS, V61, P1469, DOI 10.1093/cid/civ627; Borges AH, 2016, CLIN INFECT DIS, V63, P1668, DOI 10.1093/cid/ciw621; Carbone A, 2016, INT J CANCER, V23, P2340; Carbone A, 2009, CURR OPIN HIV AIDS, V4, P3, DOI 10.1097/COH.0b013e32831a722b; Cingolani A, 2010, AIDS, V24, P2408, DOI 10.1097/QAD.0b013e32833db989; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Corona G, 2013, AIDS, P27; Coutinho R, 2014, AIDS, V28, P689, DOI 10.1097/QAD.0000000000000133; Gerard L, 2003, AIDS, V17, P81, DOI 10.1097/00002030-200301030-00011; Gibson Todd M, 2014, AIDS, V28, P2313, DOI 10.1097/QAD.0000000000000428; Gloghini A, 2013, SEMIN CANCER BIOL, V23, P457, DOI 10.1016/j.semcancer.2013.08.004; Gopal S, 2013, JNCI-J NATL CANCER I, V105, P1221, DOI 10.1093/jnci/djt158; Hleyhel M, 2015, INT J CANCER, V137, P2443, DOI 10.1002/ijc.29603; Hoffmann C, 2015, HIV MED, V16, P261, DOI 10.1111/hiv.12200; Hoffmann C, 2003, AIDS, V17, P1521, DOI 10.1097/00002030-200307040-00013; Baptista MJ, 2015, AIDS, V29, P811, DOI 10.1097/QAD.0000000000000624; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Olszewski AJ, 2016, AIDS, V30, P787, DOI 10.1097/QAD.0000000000000986; Pantanowitz L, 2015, SEMIN CANCER BIOL, V34, P52, DOI 10.1016/j.semcancer.2015.06.002; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7	25	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186549	10.1371/journal.pone.0186549	http://dx.doi.org/10.1371/journal.pone.0186549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088223	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900016
J	Tesovnik, T; Cizelj, I; Zorc, M; Citar, M; Bozic, J; Glavan, G; Narat, M				Tesovnik, Tanja; Cizelj, Ivanka; Zorc, Minja; Citar, Manuela; Bozic, Janko; Glavan, Gordana; Narat, Mojca			Immune related gene expression in worker honey bee (Apis mellifera carnica) pupae exposed to neonicotinoid thiamethoxam and Varroa mites (Varroa destructor)	PLOS ONE			English	Article							DEFORMED-WING VIRUS; LARVAE; PESTICIDES; PATHOGEN	Varroa destructor is one of the most common parasites of honey bee colonies and is considered as a possible co-factor for honey bee decline. At the same time, the use of pesticides in intensive agriculture is still the most effective method of pest control. There is limited information about the effects of pesticide exposure on parasitized honey bees. Larval ingestion of certain pesticides could have effects on honey bee immune defense mechanisms, development and metabolic pathways. Europe and America face the disturbing phenomenon of the disappearance of honey bee colonies, termed Colony Collapse Disorder (CCD). One reason discussed is the possible suppression of honey bee immune system as a consequence of prolonged exposure to chemicals. In this study, the effects of the neonicotinoid thiamethoxam on honey bee, Apis mellifera carnica, pupae infested with Varroa destructor mites were analyzed at the molecular level. Varroa-infested and non-infested honey bee colonies received protein cakes with or without thiamethoxam. Nurse bees used these cakes as a feed for developing larvae. Samples of white-eyed and brown-eyed pupae were collected. Expression of 17 immune-related genes was analyzed by real-time PCR. Relative gene expression in samples exposed only to Varroa or to thiamethoxam or simultaneously to both Varroa and thiamethoxam was compared. The impact from the consumption of thiamethoxam during the larval stage on honey bee immune related gene expression in Varroa-infested white-eyed pupae was reflected as down-regulation of spaetzle, AMPs abaecin and defensin-1 and up-regulation of lysozyme-2. In brown-eyed pupae up-regulation of PPOact, spaetzle, hopscotch and basket genes was detected. Moreover, we observed a major difference in immune response to Varroa infestation between white-eyed pupae and brown-eyed pupae. The majority of tested immune-related genes were upregulated only in brown-eyed pupae, while in white-eyed pupae they were downregulated.	[Tesovnik, Tanja; Cizelj, Ivanka; Zorc, Minja; Citar, Manuela; Narat, Mojca] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia; [Bozic, Janko; Glavan, Gordana] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Narat, M (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia.	mojca.narat@bf.uni-lj.si	Zorc, Minja/AGD-6914-2022	Zorc, Minja/0000-0003-3330-7909	Slovenian Research agency (ARRS); Slovenian Ministry of Agriculture, Forestry and Food [L4-5522]	Slovenian Research agency (ARRS)(Slovenian Research Agency - Slovenia); Slovenian Ministry of Agriculture, Forestry and Food	This study was supported by the Slovenian Research agency (ARRS) and Slovenian Ministry of Agriculture, Forestry and Food grant No L4-5522.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; [Anonymous], R LANG ENV STAT COMP; Aronstein K, 2012, AM BEE J, V152, P789; Badiou-Beneteau A, 2012, ECOTOX ENVIRON SAFE, V82, P22, DOI 10.1016/j.ecoenv.2012.05.005; Balasubramanyam MV, 2014, J CHEM BIO PHYS SCI, V4, P361; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Cizelj I, 2016, PESTIC BIOCHEM PHYS, V128, P68, DOI 10.1016/j.pestbp.2015.09.015; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Hillyer JF, 2016, DEV COMP IMMUNOL, V58, P102, DOI 10.1016/j.dci.2015.12.006; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Ilyasov RA, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0013-y; Jefferson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054097; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Koleoglu G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169669; Kuster RD, 2014, J EXP BIOL, V217, P1710, DOI 10.1242/jeb.097766; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Lenth RV, 2016, LEAST SQUARES MEANS, V69, P33, DOI [DOI 10.18637/JSS.V069.I01, DOI 10.1016/j.envexpbot.2017.10.014]; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Novomestky F, 2015, MOMENTS CUMULANTS SK; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ryabov EV, 2016, PEERJ, V4, DOI 10.7717/peerj.1591; Schluns H, 2007, INSECT MOL BIOL, V16, P753, DOI 10.1111/j.1365-2583.2007.00768.x; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Tavares DA, 2015, CHEMOSPHERE, V135, P370, DOI 10.1016/j.chemosphere.2015.04.090; Valanne S, 2007, DEV COMP IMMUNOL, V31, P991, DOI 10.1016/j.dci.2007.01.004; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Villa S, 2000, ECOTOXICOLOGY, V9, P287, DOI 10.1023/A:1026522112328; Wang Y, 2009, EXP PARASITOL, V123, P6, DOI 10.1016/j.exppara.2009.05.017; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	50	28	31	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187079	10.1371/journal.pone.0187079	http://dx.doi.org/10.1371/journal.pone.0187079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088251	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900039
J	Ee, CC; Thuraisingam, S; Pirotta, MV; French, SD; Xue, CC; Teede, HJ				Ee, Carolyn C.; Thuraisingam, Sharmala; Pirotta, Marie V.; French, Simon D.; Xue, Charlie C.; Teede, Helena J.			Expectancy after the first treatment and response to acupuncture for menopausal hot flashes	PLOS ONE			English	Article							MIDDLE-AGED WOMEN; ALTERNATIVE MEDICINE; PLACEBO-RESPONSE; CONTROLLED-TRIAL; NIGHT SWEATS; HEALTH; FLUSHES; COMPLEMENTARY; TRANSITION; PRACTITIONER	Background Evidence on the impact of expectancy on acupuncture treatment response is conflicting. Objectives This secondary analysis of a randomized sham-controlled trial on acupuncture for menopausal hot flashes investigated whether treatment expectancy score was associated with hot flash score at end-of-treatment. Secondary analyses investigated whether there were associations between other pre-specified factors and hot flash score. Study design Women experiencing moderately-severe hot flashes were randomized to receive 10 sessions of real or sham acupuncture over eight weeks. Hot flash score was collected using a seven-day hot flash diary, and expectancy using the modified Credibility and Expectancy Questionnaire immediately after the first treatment. Linear mixed-effects models with random intercepts were used to identify associations between expectancy score and hot flash score at end-of-treatment. Regression was also used to identify associations between prespecified factors of interest and hot flash score. Because there was no difference between real and sham acupuncture for the primary outcome of hot flash score, both arms were combined in the analysis. Results 285 women returned the Credibility and Expectancy Questionnaire, and 283 women completed both expectancy measures. We found no evidence for an association between expectancy and hot flash score at end-of-treatment for individual cases in either acupuncture or sham group. Hot flash scores at end-of-treatment were 8.1 (95% CI, 3.0 to 13.2; P = 0.002) points lower in regular smokers compared to those who had never smoked, equivalent to four fewer moderate hot flashes a day. Conclusion In our study of acupuncture for menopausal hot flashes, higher expectancy after the first treatment did not predict better treatment outcomes. Future research may focus on other determinants of outcomes in acupuncture such as therapist attention. The relationship between smoking and hot flashes is poorly understood and needs further exploration.	[Ee, Carolyn C.] Western Sydney Univ, Natl Inst Complementary Med, Sydney, NSW, Australia; [Ee, Carolyn C.; Thuraisingam, Sharmala; Pirotta, Marie V.] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [French, Simon D.] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada; [French, Simon D.] Macquarie Univ, Dept Chiropract, Fac Sci & Engn, N Ryde, NSW, Australia; [Xue, Charlie C.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia; [Teede, Helena J.] Monash Univ, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia	Western Sydney University; University of Melbourne; Queens University - Canada; Macquarie University; Royal Melbourne Institute of Technology (RMIT); Monash University	Ee, CC (corresponding author), Western Sydney Univ, Natl Inst Complementary Med, Sydney, NSW, Australia.; Ee, CC (corresponding author), Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia.	c.ee@westernsydney.edu.au	Xue, Charlie C/F-1244-2014; Ee, Carolyn/V-5070-2019	Ee, Carolyn/0000-0002-3363-9199; Xue, Charlie/0000-0001-6937-9088; French, Simon/0000-0002-7061-7706	NHMRC; National Health and Medical Research Council, Australia [1004006]; Canadian Chiropractic Research Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Chiropractic Research Foundation	CE was supported by an NHMRC Postgraduate Scholarship, HT by an NHMRC Practitioner Fellowship, MP by an NHMRC Career Development Fellowship. The main study was funded by a Project Grant 1004006 from the National Health and Medical Research Council, Australia (www.nhmrc.gov.au). SDF is supported by a Canadian Chiropractic Research Foundation Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CE was supported by an NHMRC Postgraduate Scholarship, HT by an NHMRC Practitioner Fellowship, MP by an NHMRC Career Development Fellowship. SDF is supported by a Canadian Chiropractic Research Foundation Professorship.	Armour M, 2016, EVID-BASED COMPL ALT, V2016; Avis NE, 2009, MENOPAUSE, V16, P860, DOI 10.1097/gme.0b013e3181a3cdaf; Bair YA, 2008, MENOPAUSE, V15, P32, DOI 10.1097/gme.0b013e31813429d6; Bauml Joshua, 2014, Journal of the National Cancer Institute Monographs, P302, DOI 10.1093/jncimonographs/lgu029; Borud EK, 2009, MENOPAUSE, V16, P484, DOI 10.1097/gme.0b013e31818c02ad; Col NF, 2009, MENOPAUSE, V16, P453, DOI 10.1097/gme.0b013e31818d414e; Colagiuri B, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/857804; Colquhoun D, 2013, ANESTH ANALG, V116, P1360, DOI 10.1213/ANE.0b013e31828f2d5e; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Dodin S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007410.pub2; Duffy OK, 2013, MENOPAUSE, V20, P383, DOI 10.1097/gme.0b013e31827655cf; Ee C, 2016, ANN INTERN MED, V164, P146, DOI 10.7326/M15-1380; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Freeman EW, 2015, PSYCHOSOM MED, V77, P167, DOI 10.1097/PSY.0000000000000143; Greendale GA, 2005, AM J MED, V118, P1411, DOI 10.1016/j.amjmed.2005.10.026; Herber-Gast GCM, 2013, MENOPAUSE, V20, P953, DOI [10.1097/GME.0b013e3182844a7c, 10.1097/gme.0b013e3182844a7c]; Hrobjartsson A, 2011, J CLIN EPIDEMIOL, V64, P1223, DOI 10.1016/j.jclinepi.2011.01.008; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Hunter MS, 2012, BJOG-INT J OBSTET GY, V119, P40, DOI 10.1111/j.1471-0528.2011.03166.x; Kaptchuk TJ, 2009, CULT MED PSYCHIAT, V33, P382, DOI 10.1007/s11013-009-9141-7; Kim KH, 2010, MENOPAUSE, V17, P269, DOI 10.1097/gme.0b013e3181bfac3b; Kumari M, 2005, J CLIN EPIDEMIOL, V58, P719, DOI 10.1016/j.jclinepi.2004.09.016; Linde K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-75; Linde K, 2010, FORSCH KOMPLEMENTMED, V17, P259, DOI 10.1159/000320374; Lund Irene, 2009, Chin Med, V4, P1, DOI 10.1186/1749-8546-4-1; Lundeberg T, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep049; Lundeberg T, 2008, ACUPUNCT MED, V26, P239, DOI 10.1136/aim.26.4.239; MacPherson H, 2003, J ALTERN COMPLEM MED, V9, P869, DOI 10.1089/107555303771952226; MacPherson H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093739; Madsen MV, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3115; Mishra GD, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e402; Nedrow A, 2006, ARCH INTERN MED, V166, P1453, DOI 10.1001/archinte.166.14.1453; Nir Y, 2007, MATURITAS, V56, P383, DOI 10.1016/j.maturitas.2006.11.001; Paterson Charlotte, 2010, Complement Ther Clin Pract, V16, P3, DOI 10.1016/j.ctcp.2009.08.001; Pirotta M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-224; Prady SL, 2015, COMPLEMENT THER MED, V23, P185, DOI 10.1016/j.ctim.2015.01.007; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Price S, 2006, PATIENT EDUC COUNS, V63, P239, DOI 10.1016/j.pec.2005.11.006; Rutherford BR, 2013, AM J PSYCHIAT, V170, P723, DOI 10.1176/appi.ajp.2012.12040474; Rutherford BR, 2010, CURR PSYCHIATRY REV, V6, P1, DOI 10.2174/157340010790596571; Sackett DL, 2007, INT J EPIDEMIOL, V36, P664, DOI 10.1093/ije/dym088; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Stefanopoulou E, 2014, AM J HUM BIOL, V26, P389, DOI 10.1002/ajhb.22530; Thurston RC, 2011, OBSTET GYN CLIN N AM, V38, P489, DOI 10.1016/j.ogc.2011.05.006; van der Sluijs CP, 2007, MENOPAUSE, V14, P397, DOI 10.1097/01.gme.0000236937.36078.f4; van Die MD, 2009, MENOPAUSE, V16, P792, DOI [10.1097/gme.0b013e318199d5e6, 10.1097/GME.0b013e318199d5e6]; Vase L, 2013, PAIN, V154, P1659, DOI 10.1016/j.pain.2013.05.008; White P, 2012, PAIN, V153, P455, DOI 10.1016/j.pain.2011.11.007; Zhang CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140825	49	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186966	10.1371/journal.pone.0186966	http://dx.doi.org/10.1371/journal.pone.0186966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077767	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200031
J	Roberti, G; Manni, G; Riva, I; Hollo, G; Quaranta, L; Agnifili, L; Figus, M; Giammaria, S; Rastelli, D; Oddone, F				Roberti, Gloria; Manni, Gianluca; Riva, Ivano; Hollo, Gabor; Quaranta, Luciano; Agnifili, Luca; Figus, Michele; Giammaria, Sara; Rastelli, Davide; Oddone, Francesco			Detection of central visual field defects in early glaucomatous eyes: Comparison of Humphrey and Octopus perimetry	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETINAL VESSEL TRUNK; DAMAGE; PATTERN; POINTS; MACULA	Purpose To compare the detection rate of central visual field defect (CVFD) between the 30-degree Octopus G1 program (Dynamic strategy) and the HFA 10-2 SITA-Standard test in early glaucoma eyes not showing any CVFD on the HFA 24-2 SITA-Standard test. Methods One eye of 41 early glaucoma patients without CVFD in the central 10 degrees on HFA 24-2 test was tested with both the HFA 10-2 test and the Octopus G1 program 15 minutes apart, in random order. The primary outcome measure was the comparison of CVFD detection rates. Secondary outcome measures comprised the agreement in detecting CVFD, and the comparison of test durations and the numbers of depressed test points outside the central 10-degree area between the HFA 24-2 test and the Octopus G1 program. Results The mean age of the population was 65.2-10.1 years, and the mean deviation with HFA 24-2 was -3.26-2.6 dB. The mean test duration was not significantly different between the tests (p = 0.13). A CVFD was present in 33 (80.4%) HFA 10-2 test and in 23 (56.0%) Octopus G1 tests (p = 0.002). The overall agreement between the HFA 10-2 and Octopus G1 examinations in classifying eyes as having or not having CVFD was moderate (Cohen's kappa 0.47). The Octopus G1 program showed 69.6% sensitivity and 100% specificity to detect CVFD in eyes where the HFA 10-2 test revealed a CVFD. The number of depressed test points (p<5%) outside the central 10 degrees area detected with the Octopus G1 program (19.68-10.6) was significantly higher than that detected with the HFA 24-2 program (11.95-5.5, p<0.001). Conclusion Both HFA 10-2 and Octopus G1programs showed CVFD not present at HFA 24-2 test although the agreement was moderate. The use of a single Octopus G1 examination may represent a practical compromise for the assessment of both central and peripheral visual field up to 30 degrees eccentricity without any additional testing and increasing the total investigation time.	[Roberti, Gloria; Manni, Gianluca; Riva, Ivano; Oddone, Francesco] IRCSS Fdn GB Bietti, Rome, Italy; [Manni, Gianluca; Rastelli, Davide] Univ Roma Tor Vergata, DSCMT, Rome, Italy; [Hollo, Gabor] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Quaranta, Luciano] Univ Brescia, Sect Ophthalmol, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, Brescia, Italy; [Agnifili, Luca] G dAnnunzio Univ Chieti Pescara, Ophthalmol Clin, Dept Med & Aging Sci, Chieti, Italy; [Figus, Michele] Univ Pisa, Dept Neurosci, Pisa, Italy; [Giammaria, Sara] Univ Rome Campus Biomed, Rome, Italy	University of Rome Tor Vergata; Semmelweis University; University of Brescia; G d'Annunzio University of Chieti-Pescara; University of Pisa; University Campus Bio-Medico - Rome Italy	Roberti, G (corresponding author), IRCSS Fdn GB Bietti, Rome, Italy.	gloriaroberti82@gmail.com	Oddone, Francesco/K-8876-2016; Riva, Ivano/B-9860-2019; Giammaria, Sara/AHB-1383-2022; Agnifili, Luca/AAC-6345-2022; Figus, Michele/AAA-9808-2019; Figus, Michele/AAD-6850-2020; roberti, Gloria/K-9058-2016	Oddone, Francesco/0000-0002-2504-0004; Riva, Ivano/0000-0002-7397-2260; Figus, Michele/0000-0003-2243-9033; quaranta, luciano/0000-0002-5462-1713; roberti, Gloria/0000-0001-8788-5785; manni, gianluca/0000-0002-9006-8556	Italian Ministry of Health; Fondazione Roma	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission)	The research for this paper was financially supported by the Italian Ministry of Health and by Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, HUMPHR FIELD AN 2 I; Asaoka R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098525; Bengtsson B, 1997, ACTA OPHTHALMOL SCAN, V75, P368; Blumberg DM, 2017, JAMA OPHTHALMOL, V25; Chen SY, 2015, BRIT J OPHTHALMOL, V99, P1236, DOI 10.1136/bjophthalmol-2014-306431; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; de Moraes CG, 2017, OPHTHALMOLOGY, P1; European Glaucoma Society, 2014, TERM GUID GLAUC; Grillo LM, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.2.15; Hood DC, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.3.5; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P940, DOI 10.1167/iovs.10-5803; Huang HL, 2013, BRIT J OPHTHALMOL, V97, P96, DOI 10.1136/bjophthalmol-2012-302068; MCFADZEAN R, 1994, BRIT J OPHTHALMOL, V78, P185, DOI 10.1136/bjo.78.3.185; Park SC, 2013, OPHTHALMOLOGY, V120, P1546, DOI 10.1016/j.ophtha.2013.01.045; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Racette L., 2016, VISUAL FIELD DIGEST, V6; Sakamoto A, 2010, INVEST OPHTH VIS SCI, V51, P5062, DOI 10.1167/iovs.09-4954; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Traynis I, 2014, JAMA OPHTHALMOL, V132, P291, DOI 10.1001/jamaophthalmol.2013.7656; Wang MY, 2017, AM J OPHTHALMOL, V176, P53, DOI 10.1016/j.ajo.2017.01.001; Wang M, 2009, ARCH OPHTHALMOL-CHIC, V127, P875, DOI 10.1001/archophthalmol.2009.145	22	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186793	10.1371/journal.pone.0186793	http://dx.doi.org/10.1371/journal.pone.0186793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077730	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200023
J	Martin-Guerrero, SM; Munoz-Gamez, JA; Carrasco, MC; Salmeron, J; Martin-Estebane, M; Cuadros, MA; Navascues, J; Martin-Oliva, D				Martin-Guerrero, Sandra M.; Munoz-Gamez, Jose A.; Carrasco, Maria-Carmen; Salmeron, Javier; Martin-Estebane, Maria; Cuadros, Miguel A.; Navascues, Julio; Martin-Oliva, David			Poly(ADP-ribose) polymerases inhibitors prevent early mitochondrial fragmentation and hepatocyte cell death induced by H2O2	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; ADP-RIBOSE POLYMERASE-1; OXIDATIVE STRESS; RAT-LIVER; ANTIOXIDANT STATUS; RESPIRATORY-CHAIN; SOLID TUMORS; DNA-DAMAGE; PHASE-I; DISEASES	Poly(ADP-ribose) polymerases (PARPs) are a family of NAD(+) consuming enzymes that play a crucial role in many cellular processes, most clearly in maintaining genome integrity. Here, we present an extensive analysis of the alteration of mitochondrial morphology and the relationship to PARPs activity after oxidative stress using an in vitro model of human hepatic cells. The following outcomes were observed: reactive oxygen species (ROS) induced by oxidative treatment quickly stimulated PARPs activation, promoted changes in mitochondrial morphology associated with early mitochondrial fragmentation and energy dysfunction and finally triggered apoptotic cell death. Pharmacological treatment with specific PARP-1 (the major NAD(+) consuming poly(ADP-ribose) polymerases) and PARP-1/PARP-2 inhibitors after the oxidant insult recovered normal mitochondrial morphology and, hence, increased the viability of human hepatic cells. As the PARP-1 and PARP-1/PARP-2 inhibitors achieved similar outcomes, we conclude that most of the PARPs effects were due to PARP-1 activation. NAD(+) supplementation had similar effects to those of the PARPs inhibitors. Therefore, PARPs activation and the subsequent NAD+ depletion are crucial events in decreased cell survival (and increased apoptosis) in hepatic cells subjected to oxidative stress. These results suggest that the alterations in mitochondrial morphology and function seem to be related to NAD(+) depletion, and show for the first time that PARPs inhibition abrogates mitochondrial fragmentation. In conclusion, the inhibition of PARPs may be a valuable therapeutic approach for treating liver diseases, by reducing the cell death associated with oxidative stress.	[Martin-Guerrero, Sandra M.; Carrasco, Maria-Carmen; Martin-Estebane, Maria; Cuadros, Miguel A.; Navascues, Julio; Martin-Oliva, David] Univ Granada, Fac Ciencias, Dept Biol Celular, Granada, Spain; [Munoz-Gamez, Jose A.; Salmeron, Javier] Hosp Univ San Cecilio, Inst Invest Biomed IbsGranada, Granada, Spain	University of Granada; Hospital Universitario San Cecilio	Martin-Oliva, D (corresponding author), Univ Granada, Fac Ciencias, Dept Biol Celular, Granada, Spain.	dmoliva@ugr.es	ESTEBANÉ, MARÍA MARTÍN/AAR-5385-2020; Cuadros, Miguel A/L-3954-2014; Martín-Guerrero, Sandra María/P-9333-2018; Martín-Oliva, David/L-8472-2014	ESTEBANÉ, MARÍA MARTÍN/0000-0002-9680-581X; Cuadros, Miguel A/0000-0003-4259-1649; Martín-Guerrero, Sandra María/0000-0003-1489-4757; Martín-Oliva, David/0000-0002-8095-5442; Navascues, Julio/0000-0003-2958-2705	Ministerio de Economia y Competitividad, Spain [BFU2010-19981]; CEI BioTic Granada, Spain [BS9-2015]; Ministerio de Educacion, Cultura y Deporte, Spain [FPU14/02219]	Ministerio de Economia y Competitividad, Spain; CEI BioTic Granada, Spain; Ministerio de Educacion, Cultura y Deporte, Spain	This work was supported by grants from Ministerio de Economia y Competitividad, Spain (BFU2010-19981), CEI BioTic Granada, Spain (BS9-2015) and Ministerio de Educacion, Cultura y Deporte, Spain (FPU14/02219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Avery SV, 2011, BIOCHEM J, V434, P201, DOI 10.1042/BJ20101695; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bai P, 2015, MOL CELL, V58, P947, DOI 10.1016/j.molcel.2015.01.034; Bai P, 2015, TRENDS ENDOCRIN MET, V26, P75, DOI 10.1016/j.tem.2014.11.003; Balmana J, 2014, ANN ONCOL, V25, P1656, DOI 10.1093/annonc/mdu187; Bando I, 2005, J BIOCHEM MOL TOXIC, V19, P154, DOI 10.1002/jbt.20067; Banerjee P, 2013, INDIAN J BIOCHEM BIO, V50, P377; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Berger N.A., 2017, BR J PHARM; Berridge M.V., 1996, BIOCHEMICA, V4, P14, DOI DOI 10.1155/2013/420601; Brunyanszki A, 2016, FREE RADICAL BIO MED, V100, P257, DOI 10.1016/j.freeradbiomed.2016.02.024; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Cortez-Pinto H, 1999, CLIN NUTR, V18, P353, DOI 10.1016/S0261-5614(99)80015-6; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Decker Patrice, 2002, Current Pharmaceutical Biotechnology, V3, P275, DOI 10.2174/1389201023378265; Del Conte G, 2014, BRIT J CANCER, V111, P651, DOI 10.1038/bjc.2014.345; Diani-Moore S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02332-9; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Feng GP, 2002, AM J PHYSIOL-GASTR L, V282, pG825, DOI 10.1152/ajpgi.00467.2001; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Galloway CA, 2012, J GEN PHYSIOL, V139, P455, DOI 10.1085/jgp.201210771; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; GUTIERREZRUIZ MC, 1994, IN VITRO CELL DEV-AN, V30A, P366, DOI 10.1007/BF02634356; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; Hangen E, 2015, MOL CELL, V58, P1001, DOI 10.1016/j.molcel.2015.04.020; Hegedus C, 2014, REDOX BIOL, V2, P978, DOI 10.1016/j.redox.2014.08.003; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Hinoi E, 2006, MOL PHARMACOL, V70, P925, DOI 10.1124/mol.106.024398; Huang K, 2016, J HEPATOL, P30697; Huang Q, 2009, AUTOPHAGY, V5, P273, DOI 10.4161/auto.5.2.7640; Jang KH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.437; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kladna A, 2015, LUMINESCENCE, V30, P1153, DOI 10.1002/bio.2879; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Madan K, 2006, J CLIN GASTROENTEROL, V40, P930, DOI 10.1097/01.mcg.0000212608.59090.08; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Martin-Oliva D, 2011, INVEST OPHTH VIS SCI, V52, P7445, DOI 10.1167/iovs.11-7222; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ozgur E, 2010, INT J RADIAT BIOL, V86, P935, DOI 10.3109/09553002.2010.496029; Pellicciari R, 2008, CHEMMEDCHEM, V3, P914, DOI 10.1002/cmdc.200800010; Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929; Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Pieniazek A, 2013, ADV MED SCI-POLAND, V58, P104, DOI 10.2478/v10039-012-0063-1; Samarghandian S, 2014, INT J CLIN EXP MED, V7, P1449; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Skalitzky DJ, 2003, J MED CHEM, V46, P210, DOI 10.1021/jm0255769; Slimen IB, 2014, INT J HYPERTHER, V30, P513, DOI 10.3109/02656736.2014.971446; Sodhi RK, 2010, VASC PHARMACOL, V53, P77, DOI 10.1016/j.vph.2010.06.003; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Virag L, 1998, J IMMUNOL, V161, P3753; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Wlodkowic D, 2009, METHODS MOL BIOL, V559, P19, DOI 10.1007/978-1-60327-017-5_2; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Yelamos J, 2011, AM J CANCER RES, V1, P328; Yildirim NC, 2010, TURK J BIOCHEM, V35, P138; Yoon SP, 2016, ANAT CELL BIOL, V49, P165, DOI 10.5115/acb.2016.49.3.165; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu TZ, 2011, ANTIOXID REDOX SIGN, V14, P425, DOI 10.1089/ars.2010.3284; Yu-Wai-Man P, 2012, BRAIN, V135, P9, DOI 10.1093/brain/awr352; Zhang LX, 2010, EXP CELL RES, V316, P716, DOI 10.1016/j.yexcr.2009.12.008; Zhu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26322	79	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187130	10.1371/journal.pone.0187130	http://dx.doi.org/10.1371/journal.pone.0187130			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073231	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400118
J	Pinaud, L; Ferrari, ML; Friedman, R; Jehmlich, N; von Bergen, M; Phalipon, A; Sansonetti, PJ; Campbell-Valois, FX				Pinaud, Laurie; Ferrari, Mariana L.; Friedman, Robin; Jehmlich, Nico; von Bergen, Martin; Phalipon, Armelle; Sansonetti, Philippe J.; Campbell-Valois, Francois-Xavier			Identification of novel substrates of Shigella T3SA through analysis of its virulence plasmid-encoded secretome	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; QUANTITATIVE PROTEOMIC ANALYSIS; OUTER-MEMBRANE VESICLES; FLEXNERI IPA INVASINS; ABSOLUTE QUANTIFICATION; INTERCELLULAR SPREAD; BACTERIAL PATHOGENS; SHOTGUN PROTEOMICS; PROTEIN DELIVERY; EPITHELIAL-CELLS	Many human Gram-negative bacterial pathogens express a Type Three Secretion Apparatus (T3SA), including among the most notorious Shigella spp., Salmonella enterica, Yersinia enterocolitica and enteropathogenic Escherichia coli (EPEC). These bacteria express on their surface multiple copies of the T3SA that mediate the delivery into host cells of specific protein substrates critical to pathogenesis. Shigella spp. are Gram-negative bacterial pathogens responsible for human bacillary dysentery. The effector function of several Shigella T3SA substrates has largely been studied but their potential cellular targets are far from having been comprehensively delineated. In addition, it is likely that some T3SA substrates have escaped scrutiny as yet. Indeed, sequencing of the virulence plasmid of Shigella flexneri has revealed numerous open reading frames with unknown functions that could encode additional T3SA substrates. Taking advantage of label-free mass spectrometry detection of proteins secreted by a constitutively secreting strain of S. flexneri, we identified five novel substrates of the T3SA. We further confirmed their secretion through the T3SA and translocation into host cells using beta-lactamase assays. The coding sequences of two of these novel T3SA substrates (Orf13 and Orf131a) have a guanine-cytosine content comparable to those of T3SA components and effectors. The three other T3SA substrates identified (Orf48, Orf86 and Orf176) have significant homology with antitoxin moieties of type II ToxinAntitoxin systems usually implicated in the maintenance of low copy plasmids. While Orf13 and Orf131a might constitute new virulence effectors contributing to S. flexneri pathogenicity, potential roles for the translocation into host cells of antitoxins or antitoxin-like proteins during Shigella infection are discussed.	[Pinaud, Laurie; Ferrari, Mariana L.; Friedman, Robin; Phalipon, Armelle; Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Pinaud, Laurie; Ferrari, Mariana L.; Friedman, Robin; Phalipon, Armelle; Sansonetti, Philippe J.] INSERM, U1202, Paris, France; [Friedman, Robin] Inst Pasteur, Lab Biol Syst, Paris, France; [Friedman, Robin] Inst Pasteur, Ctr Bioinformat Biostat & Biol Integrat, Paris, France; [Jehmlich, Nico; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Mol Syst Biol, Leipzig, Germany; [von Bergen, Martin] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, Leipzig, Germany; [Sansonetti, Philippe J.] Coll France, Chaire Microbiol & Malad Infect, Paris, France; [Campbell-Valois, Francois-Xavier] Univ Ottawa, Fac Sci, Ctr Chem & Synthet Biol, Dept Chem & Biomol Sci, Ottawa, ON, Canada; [Campbell-Valois, Francois-Xavier] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; UDICE-French Research Universities; PSL Research University Paris; College de France; University of Ottawa; University of Ottawa	Campbell-Valois, FX (corresponding author), Univ Ottawa, Fac Sci, Ctr Chem & Synthet Biol, Dept Chem & Biomol Sci, Ottawa, ON, Canada.; Campbell-Valois, FX (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	fcampbel@uottawa.ca	Jehmlich, Nico/B-5403-2009; von Bergen, Martin/D-7960-2011; Campbell-Valois, F-X/AAY-2776-2020; Ferrari, Mariana L./AAL-4396-2021; Jehmlich, Nico/D-9041-2015	Jehmlich, Nico/0000-0002-5638-6868; von Bergen, Martin/0000-0003-2732-2977; Campbell-Valois, F-X/0000-0001-5105-2968; Ferrari, Mariana L./0000-0002-0441-9242; Jehmlich, Nico/0000-0002-5638-6868	Marie Curie fellowship program [141063]; National Science and Engineering Research Council of Canada [RGPIN-2016-05587]; Faculty of Science of the University of Ottawa; French Ministry of Higher Education and Research; French medical research foundation [FDT20150532160, SPF20121226366, SPF20111223288]; European Research Council [339579]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Deutsche Forschungsgemeinschaft [SPP 2002]; European Regional Development Funds (EFRE - Europe funds Saxony); Helmholtz Association	Marie Curie fellowship program(European Commission); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Faculty of Science of the University of Ottawa; French Ministry of Higher Education and Research; French medical research foundation(Fondation pour la Recherche Medicale); European Research Council(European Research Council (ERC)European Commission); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Regional Development Funds (EFRE - Europe funds Saxony); Helmholtz Association(Helmholtz Association)	The following funding organisms supported this study: the Marie Curie fellowship program (grant number 141063, FXCV), the National Science and Engineering Research Council of Canada (grant number RGPIN-2016-05587, FXCV) and the Faculty of Science of the University of Ottawa (FXCV), the French Ministry of Higher Education and Research, the French medical research foundation (grant numbers FDT20150532160, SPF20121226366 and SPF20111223288 to LP, MLF and FXCV, respectively), the European Research Council (grant number 339579 to PJS), the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant number ANR-10-LABX-62-IBEID), and the Deutsche Forschungsgemeinschaft (grant number SPP 2002 to NJ and MvB). PJS is a Senior International Research Scholar of the Howard Hugues Medical Institute. The analytical facilities of the Centre for Chemical Microscopy (ProVIS) at the Helmholtz Centre for Environmental Research are supported by European Regional Development Funds (EFRE - Europe funds Saxony to MvB and NJ) and the Helmholtz Association (to MvB and NJ).	ALLAOUI A, 1993, MOL MICROBIOL, V7, P59, DOI 10.1111/j.1365-2958.1993.tb01097.x; Altindis E, 2015, MBIO, V6, DOI 10.1128/mBio.00075-15; Ashida H, 2007, MOL MICROBIOL, V63, P680, DOI 10.1111/j.1365-2958.2006.05547.x; BENJELLOUNTOUIMI Z, 1995, MOL MICROBIOL, V17, P123, DOI 10.1111/j.1365-2958.1995.mmi_17010123.x; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Burnaevskiy N, 2013, NATURE, V496, P106, DOI 10.1038/nature12004; Burstein D, 2015, MBIO, V6, DOI 10.1128/mBio.00161-15; Campbell-Valois FX, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00028; Campbell-Valois FX, 2014, FEBS LETT, V588, P2428, DOI 10.1016/j.febslet.2014.05.022; Campbell-Valois FX, 2015, MBIO, V6, DOI 10.1128/mBio.02567-14; Campbell-Valois FX, 2014, CELL HOST MICROBE, V15, P177, DOI 10.1016/j.chom.2014.01.005; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cheverton AM, 2016, MOL CELL, V63, P86, DOI 10.1016/j.molcel.2016.05.002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng WY, 2012, MOL CELL PROTEOMICS, V11, P692, DOI 10.1074/mcp.M111.013672; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Dohlich K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003881; Ehsani S, 2009, CURR OPIN MICROBIOL, V12, P24, DOI 10.1016/j.mib.2008.11.007; Faherty CS, 2009, INFECT IMMUN, V77, P5281, DOI 10.1128/IAI.00800-09; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; GOLDBERG MB, 1993, J BACTERIOL, V175, P2189, DOI 10.1128/JB.175.8.2189-2196.1993; Grossmann J, 2010, J PROTEOMICS, V73, P1740, DOI 10.1016/j.jprot.2010.05.011; Hachani A, 2016, CURR OPIN MICROBIOL, V29, P81, DOI 10.1016/j.mib.2015.11.006; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; Kolbe M., 2014, BIOPROTOCOL, V4, pe1302, DOI DOI 10.21769/BI0PR0T0C.1302; Konradt C, 2011, CELL HOST MICROBE, V9, P263, DOI 10.1016/j.chom.2011.03.010; Le Gall T, 2005, MICROBIOL-SGM, V151, P951, DOI 10.1099/mic.0.27639-0; Lee J, 2007, J MOL BIOL, V373, P11, DOI 10.1016/j.jmb.2007.07.037; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Liu X, 2016, J MICROBIOL BIOTECHN; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; McVicker G, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.204; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; OAKS EV, 1985, INFECT IMMUN, V48, P124, DOI 10.1128/IAI.48.1.124-129.1985; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ogawa M, 2003, MOL MICROBIOL, V48, P913, DOI 10.1046/j.1365-2958.2003.03489.x; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Page AL, 2002, MOL MICROBIOL, V43, P1533, DOI 10.1046/j.1365-2958.2002.02835.x; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; Penno C, 2005, MOL MICROBIOL, V56, P204, DOI 10.1111/j.1365-2958.2004.04530.x; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; Pinaud L, 2017, P NATL ACAD SCI USA, V114, P9954, DOI 10.1073/pnas.1707098114; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Santapaola D, 2006, J BACTERIOL, V188, P1620, DOI 10.1128/JB.188.4.1620-1627.2006; Santiago AD, 2016, FRONT MICROBIOL, V7, DOI [10.3382/fmicb.2016.02030, 10.3389/fmicb.2016.02030]; Sayeed S, 2000, J BACTERIOL, V182, P2416, DOI 10.1128/JB.182.9.2416-2421.2000; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sidik S, 2014, G3-GENES GENOM GENET, V4, P2493, DOI 10.1534/g3.114.014381; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Subtil A, 2001, MOL MICROBIOL, V39, P792, DOI 10.1046/j.1365-2958.2001.02272.x; Vander Broek CW, 2015, MOL CELL PROTEOMICS, V14, P905, DOI 10.1074/mcp.M114.044875; Venkatesan MM, 2001, INFECT IMMUN, V69, P3271, DOI 10.1128/IAI.69.5.3271-3285.2001; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84; Zurawski DV, 2008, INFECT IMMUN, V76, P369, DOI 10.1128/IAI.00684-07	68	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186920	10.1371/journal.pone.0186920	http://dx.doi.org/10.1371/journal.pone.0186920			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073283	gold, Green Submitted, Green Published			2022-12-27	WOS:000413845400075
J	Inagaki, K; Yasuda, Y; Ando, M; Kaihan, AB; Hachiya, A; Ozeki, T; Hishida, M; Imaizumi, T; Katsuno, T; Kato, S; Tsuboi, N; Maruyama, S				Inagaki, Koji; Yasuda, Yoshinari; Ando, Masahiko; Kaihan, Ahmad Baseer; Hachiya, Asaka; Ozeki, Takaya; Hishida, Manabu; Imaizumi, Takahiro; Katsuno, Takayuki; Kato, Sawako; Tsuboi, Naotake; Maruyama, Shoichi			Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE; RISK-FACTORS; PULSE THERAPY; PROGNOSIS; CLASSIFICATION; FEATURES; DISEASE; DAMAGE	Background Proteinuria is a powerful prognostic factor for end-stage renal disease in IgA nephropathy (IgAN) patients. However, it is not known whether proteinuria exacerbations are related to seasonal changes. Methods We retrospectively enrolled consecutive patients diagnosed with IgAN by kidney biopsy at our hospital between 2002 and 2014. Proteinuria remission was defined as urinary protein<0.3 g/gCr in two consecutive outpatient urinalyses and exacerbation as urinary protein >= 0.75 g/gCr. Four seasons were defined: spring (March-May), summer (June-August), autumn (September-November), and winter (December-February). We performed a multivariate analysis to identify factors associated with the second remission following a proteinuria exacerbation. Results We analyzed 116 patients. Proteinuria remission and exacerbation occurred in 77, and 43 patients, respectively. The incidence of proteinuria exacerbation was significantly higher in autumn and winter than in spring and summer (p = 0.040). The cumulative second remission rate was significantly higher in patients with autumn and winter proteinuria exacerbation than in patients with spring and summer exacerbations (p = 0.0091). In multivariate analyses, exacerbation onset in autumn and winter (hazard ratio [HR], 3.51; 95% confidence interval [Cl], 1.41-8.74) and intensive therapy (HR, 2.26; 95% Cl, 1.05-4.88) were significantly associated with a second proteinuria remission. Conclusion In IgAN patients in proteinuria remission, proteinuria exacerbation frequently occurred in autumn and winter. Exacerbations occurring in autumn and winter tended to remit early.	[Inagaki, Koji; Yasuda, Yoshinari; Kaihan, Ahmad Baseer; Hachiya, Asaka; Ozeki, Takaya; Hishida, Manabu; Imaizumi, Takahiro; Katsuno, Takayuki; Kato, Sawako; Tsuboi, Naotake; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Inagaki, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan.	inagaki21@med.nagoya-u.ac.jp	Tsuboi, Naotake/L-5960-2019; Kato, Sawako/T-2422-2019	Tsuboi, Naotake/0000-0003-0760-845X; Kato, Sawako/0000-0001-7210-1888	Astellas Pharma; Alexion Pharmaceuticals; Otsuka Pharmaceutical; Kyowa Hakko Kirin; Daiichi-Sankyo; Takeda Pharmaceutical Company; Chugai Pharmaceutical; Dainippon Sumitomo Pharma; Pfizer Japan; Merck Sharp and Dohme; Mochida Pharmaceutical Company; Torii Pharmaceutical; Kissei Pharmaceutical; Novartis Pharma; Kowa Pharmaceutical; Nippon Boehringer Ingelheim; Bristol-Myers Squibb; Mitsubishi Tanabe Pharma Corporation; Teijin Pharma Limited	Astellas Pharma(Astellas Pharmaceuticals); Alexion Pharmaceuticals; Otsuka Pharmaceutical(Otsuka Pharmaceutical); Kyowa Hakko Kirin(Kyowa Kirin Ltd); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Chugai Pharmaceutical; Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Pfizer Japan(Pfizer); Merck Sharp and Dohme(Merck & Company); Mochida Pharmaceutical Company; Torii Pharmaceutical; Kissei Pharmaceutical(Kissei Pharmaceutical Co Ltd); Novartis Pharma; Kowa Pharmaceutical; Nippon Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Teijin Pharma Limited(Teijin Pharma Limited)	Nagoya university nephrology is supported by the following funders; Astellas Pharma, Alexion Pharmaceuticals, Otsuka Pharmaceutical, Kyowa Hakko Kirin, Daiichi-Sankyo, Takeda Pharmaceutical Company, Chugai Pharmaceutical, Dainippon Sumitomo Pharma, Pfizer Japan, Merck Sharp and Dohme, Mochida Pharmaceutical Company, Torii Pharmaceutical, Kissei Pharmaceutical, Novartis Pharma, Kowa Pharmaceutical, Nippon Boehringer Ingelheim, Bristol-Myers Squibb, Mitsubishi Tanabe Pharma Corporation, and Teijin Pharma Limited. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MJ, 2005, AM J KIDNEY DIS, V45, P994, DOI 10.1053/j.ajkd.2005.02.015; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; BRENNAN PJ, 1982, BMJ-BRIT MED J, V285, P919, DOI 10.1136/bmj.285.6346.919; DAMICO G, 1987, Q J MED, V64, P709; Eiro M, 2002, NEPHRON, V90, P432, DOI 10.1159/000054731; Hirano K, 2016, CLIN EXP NEPHROL, V20, P425, DOI 10.1007/s10157-015-1170-7; Kaihan AB, 2017, CLIN EXP NEPHROL; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawamura T, 2014, NEPHROL DIAL TRANSPL, V29, P1546, DOI 10.1093/ndt/gfu020; Kawamura T, 2013, J NEPHROL, V26, P350, DOI 10.5301/jn.5000151; Kim JK, 2012, CLIN J AM SOC NEPHRO, V7, P427, DOI 10.2215/CJN.04820511; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Lin LR, 2016, ARCH MED RES, V47, P25, DOI 10.1016/j.arcmed.2016.01.001; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nam KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101935; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Rauen T, 2015, NEW ENGL J MED, V373, P2225, DOI 10.1056/NEJMoa1415463; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Saeki K, 2014, J HYPERTENS, V32, P1582, DOI 10.1097/HJH.0000000000000232; Sugiyama H, 2011, CLIN EXP NEPHROL, V15, P493, DOI 10.1007/s10157-011-0430-4; SUZUKI S, 1994, LANCET, V343, P12, DOI 10.1016/S0140-6736(94)90875-3; Tatematsu M, 2012, CLIN EXP NEPHROL, V16, P883, DOI 10.1007/s10157-012-0644-0; Toyabe S, 2005, PEDIATR NEPHROL, V20, P470, DOI 10.1007/s00467-004-1780-x; Wada Y, 2012, DIABETIC MED, V29, P506, DOI 10.1111/j.1464-5491.2011.03472.x; Zhang L, 2016, RENAL FAILURE, V38, P799, DOI 10.3109/0886022X.2016.1163153	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187607	10.1371/journal.pone.0187607	http://dx.doi.org/10.1371/journal.pone.0187607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095887	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200123
J	Lee, J; Lee, S; Zhang, HR; Hill, MA; Zhang, CH; Park, Y				Lee, Jonghae; Lee, Sewon; Zhang, Hanrui; Hill, Michael A.; Zhang, Cuihua; Park, Yoonjung			Interaction of IL-6 and TNF-alpha contributes to endothelial dysfunction in type 2 diabetic mouse hearts	PLOS ONE			English	Article							INSULIN-RESISTANCE; NITRIC-OXIDE; INTERLEUKIN-6 IMPAIRS; METABOLIC SYNDROME; OXIDATIVE STRESS; ANGIOTENSIN-II; MICE; OBESITY; RISK; CELLS	Objectives Inflammatory cytokines, such as tumor necrosis factor-a (TNF-alpha) and interleukin-6 (IL-6), are individually considered as important contributors to endothelial dysfunction in obesity and type 2 diabetes (T2D). However, their interactions in coronary arteriole endothelial dysfunction are uncertain. Therefore, this study aimed to determine the effects of TNF-alpha and IL-6 interactions on coronary endothelial dysfunction in experimental T2D. Methods The studies used wild type (WT), diabetic mice (db/db), db/db null for TNF (db(TNF-)/db(TNF-)), and db/db mice treated with neutralizing antibody to IL-6 (anti-IL-6). Endothelium-dependent (acetylcholine [ACh], or luminal flow-induced shear stress) and endothelium-independent (sodium nitroprusside [SNP]) vasodilation of isolated and pressurized coronary arterioles were determined. Quantitative PCR, Western blot, and immunofluorescence staining were utilized for mechanistic studies. Results Relative to WT, arteriolar dilation to both ACh and flow was attenuated in db/db mice and db(TNF-)/db(TNF-). Treatment of db(TNF-)/db(TNF-) and db/db mice with anti-IL-6 improved arteriolar dilation compared to db/db mice. Immunofluorescence staining illustrated localization of IL-6 within the endothelial cells of coronary arterioles. In db/db mice, mRNA and protein expression of IL-6 and superoxide (0 (2)similar to) production were higher, but reduced by anti-IL-6 treatment. Also, in db/db mice, mRNA and protein expression of TNF-alpha suppressed by the anti-IL-6 treatment and the reduced expression of mRNA and protein expression of IL-6 by the genetic deletion of TNF-alpha both supported a reciprocal regulation between TNF-alpha and IL-6. Superoxide dismutase 2 (SOD2) expression and phosphorylation of eNOS (p-eNOS/eNOS) were lower in db/db mice coronary arterioles and were restored in db/db+Anti-IL-6 and db (TNF-)/db (TNF-) mice. Conclusion The interactions between TNF-alpha and IL-6 exacerbate oxidative stress and reduce phosphorylation of eNOS, thereby contributing to coronary endothelial dysfunction in T2D mice.	[Lee, Jonghae; Park, Yoonjung] Univ Houston, Dept Hlth & Human Performance, Houston, TX 77004 USA; [Lee, Sewon; Zhang, Hanrui; Hill, Michael A.; Zhang, Cuihua; Park, Yoonjung] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Lee, Sewon; Zhang, Hanrui; Hill, Michael A.; Zhang, Cuihua] Univ Missouri, Med Pharmacol, Columbia, MO USA; [Lee, Sewon] Incheon Natl Univ, Div Sport Sci, Incheon, South Korea; [Lee, Sewon] Incheon Natl Univ, Sport Sci Inst, Incheon, South Korea; [Zhang, Hanrui] Columbia Univ, Med Ctr, Div Cardiol, Dept Med, New York, NY USA; [Zhang, Cuihua] Univ Missouri, Dept Internal Med, Columbia, MO USA; [Zhang, Cuihua] Univ Missouri, Physiol & Nutr Sci, Columbia, MO USA	University of Houston System; University of Houston; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Incheon National University; Incheon National University; Columbia University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Park, Y (corresponding author), Univ Houston, Dept Hlth & Human Performance, Houston, TX 77004 USA.; Park, Y (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	ypark10@uh.edu	Hill, Michael/AAV-5350-2020; Lee, Sewon/C-8432-2016	Zhang, Hanrui/0000-0001-8655-938X; Hill, Michael/0000-0002-4455-2072; Lee, Sewon/0000-0002-6179-5156	National Heart, Lung, and Blood Institute (NHLBI) [R01-HL077566, R01-HL085119]; American Heart Association Scientist Development Grant [110350047A]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL130574] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (NHLBI, R01-HL077566) to C.Z (Deceased 2011) and M.A.H (http://dalton.missouri.edu/investigators/hillmi.php); National Heart, Lung, and Blood Institute (NHLBI, R01-HL085119) to C.Z and M.A.H; American Heart Association Scientist Development Grant (110350047A) to C.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERKA D, 1989, J IMMUNOL, V143, P3517; Andreozzi F, 2007, MOL CELL BIOL, V27, P2372, DOI 10.1128/MCB.01340-06; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bennet AM, 2003, ATHEROSCLEROSIS, V171, P359, DOI 10.1016/j.atherosclerosis.2003.08.029; Bitar MS, 2005, EUR J PHARMACOL, V511, P53, DOI 10.1016/j.ejphar.2005.01.014; Caballero AE, 2003, OBES RES, V11, P1278, DOI 10.1038/oby.2003.174; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen X., 2015, PLOS ONE, V10; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; DiSanto E, 1997, CYTOKINE, V9, P300, DOI 10.1006/cyto.1996.0169; Donato AJ, 2012, AM J PHYSIOL-HEART C, V303, pH672, DOI 10.1152/ajpheart.00271.2012; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gao X, 2007, ARTERIOSCL THROM VAS, V27, P1269, DOI 10.1161/ATVBAHA.107.142521; Gao X, 2007, CIRCULATION, V115, P245, DOI 10.1161/CIRCULATIONAHA.106.650671; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH2242, DOI 10.1152/ajpheart.00587.2008; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hossain M., 2010, INT J DIABETES MELLI, V2, P165, DOI [10.1016/j.ijdm.2010.08.004, DOI 10.1016/J.IJDM.2010.08.004]; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Kozak AJ, 2005, PROSTAG LEUKOTR ESS, V72, P105, DOI 10.1016/j.plefa.2004.10.007; Li GL, 2007, ENDOCRINOLOGY, V148, P3356, DOI 10.1210/en.2006-1441; Gamez-Mendez AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138609; Meigs James B, 2010, Diabetes Care, V33, P1865, DOI 10.2337/dc10-0641; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR1013, DOI 10.1152/ajpregu.00729.2003; Park Y, 2008, AM J PHYSIOL-HEART C, V295, pH1982, DOI 10.1152/ajpheart.01261.2007; Park Y, 2012, J PHYSIOL-LONDON, V590, P4255, DOI 10.1113/jphysiol.2012.234856; Park Y, 2011, BASIC RES CARDIOL, V106, P111, DOI 10.1007/s00395-010-0129-9; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Picchi A, 2006, CIRC RES, V99, P69, DOI 10.1161/01.RES.0000229685.37402.80; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; San Martin A, 2007, AM J PHYSIOL-HEART C, V292, pH2073, DOI 10.1152/ajpheart.00943.2006; Saura M, 2006, J BIOL CHEM, V281, P30057, DOI 10.1074/jbc.M606279200; SCHINDLER R, 1990, BLOOD, V75, P40; Schrader LI, 2007, ARTERIOSCL THROM VAS, V27, P2576, DOI 10.1161/ATVBAHA.107.153080; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Turner NA, 2007, CARDIOVASC RES, V76, P81, DOI 10.1016/j.cardiores.2007.06.003; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Yang JY, 2009, AM J PHYSIOL-HEART C, V297, pH1208, DOI 10.1152/ajpheart.00396.2009; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0	47	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187189	10.1371/journal.pone.0187189	http://dx.doi.org/10.1371/journal.pone.0187189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095915	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200053
J	Misslin, C; Velasco-Estevez, M; Albert, M; O'Sullivan, SA; Dev, KK				Misslin, Cedric; Velasco-Estevez, Maria; Albert, Marie; O'Sullivan, Sinead A.; Dev, Kumlesh K.			Phospholipase A2 is involved in galactosylsphingosine-induced astrocyte toxicity, neuronal damage and demyelination	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; ARACHIDONIC-ACID; CELL-DEATH; CYTOSOLIC PHOSPHOLIPASE-A(2); GENE-EXPRESSION; GLIAL-CELLS; PSYCHOSINE; RECEPTOR; RELEASE	Krabbe disease is a fatal rare inherited lipid storage disorder affecting 1:100,000 births. This illness is caused by mutations in the gale gene encoding for the enzyme galactosylcerami-dase (GALC). Dysfunction of GALC has been linked to the toxic build-up of the galactolipid, galactosylsphingosine (psychosine), which induces cell death of oligodendrocytes. Previous studies show that phospholipase A2 (PLA2) may play a role in psychosine induce cell death. Here, we demonstrate that non-selective inhibition of cPLA2/sPLA2 and selective inhibition of cPLA2, but not sPLA2, also attenuates psychosine-induced cell death of human astrocytes. This study shows that extracellular calcium is required for psychosine induced cell death, but intracellular calcium release, reactive oxygen species or release of soluble factors are not involved. These findings suggest a cell autonomous effect, at least in human astrocytes. Supporting a role for PLA2 in psychosine-induced cell death of oligodendrocytes and astrocytes, the results show inhibition of PLA2 attenuates psychosine-induced decrease in the expression of astrocyte marker vimentin as well as myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) and the neuronal marker SMI-32 in organotypic slice cultures. These findings provide further mechanistic details of psychosine-induced death of glia and suggest a role for PLA2 in the process. This work also supports the proposal that novel drugs for Krabbe disease may require testing on astrocytes as well as oligodendrocytes for more holistic prediction of pre-clinical and clinical efficacy.	[Misslin, Cedric; Velasco-Estevez, Maria; Albert, Marie; O'Sullivan, Sinead A.; Dev, Kumlesh K.] Trinity Coll Dublin, Sch Med, Drug Dev, Dublin, Ireland; [O'Sullivan, Sinead A.] Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA	Trinity College Dublin; University of Chicago	Dev, KK (corresponding author), Trinity Coll Dublin, Sch Med, Drug Dev, Dublin, Ireland.	devk@tcd.ie	Velasco-Estevez, Maria/AAA-5569-2020	Velasco-Estevez, Maria/0000-0002-2886-122X; Dev, Kumlesh/0000-0003-4274-9119	Trinity College Dublin; Health Research Board; Trinity College Dublin, Ireland; Health Research Board, Ireland; Irish Research Council, Ireland; Irish Research Council;  [GOIPG/2015/2804];  [KEDS-2015-1614];  [HRA-POR-2014-646]	Trinity College Dublin; Health Research Board; Trinity College Dublin, Ireland; Health Research Board, Ireland; Irish Research Council, Ireland; Irish Research Council(Irish Research Council for Science, Engineering and Technology); ; ; 	This work was supported by the Trinity College Dublin, Irish Research Council; GOIPG/2015/2804 (http://research.ie/) and the Health Research Board; KEDS-2015-1614 and HRA-POR-2014-646 (http://www.hrb.ie/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported, in part, by Trinity College Dublin, Ireland, the Health Research Board, Ireland, and the Irish Research Council, Ireland. CM. is an M.Sc. scholar of Trinity College Dublin. M.V.E. is an Irish Research Council PhD Fellow. S.O.S. is a PhD scholar of Trinity College Dublin. We would like to thank Dr. Catherine O 'Sullivan (Trinity College Dublin) for aiding CM. in the earlier parts of this study. The authors declare no competing financial interests.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ABRAMSON SB, 1991, J IMMUNOL, V147, P231; Adam-Vizi V, 2010, J ALZHEIMERS DIS, V20, pS413, DOI 10.3233/JAD-2010-100465; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Becuwe P, 2003, FREE RADICAL BIO MED, V35, P636, DOI 10.1016/S0891-5849(03)00387-3; Benveniste EN, 1997, CHEM IMMUNOL, V69, P31; Bymaster FP, 2001, NEUROPSYCHOPHARMACOL, V25, P871, DOI 10.1016/S0893-133X(01)00298-6; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; CHARLES AC, 1993, GLIA, V7, P134, DOI 10.1002/glia.440070203; CHIU AY, 1991, GLIA, V4, P11, DOI 10.1002/glia.440040103; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Elain G, 2014, GLIA, V62, P725, DOI 10.1002/glia.22637; Formichi P, 2007, J CELL PHYSIOL, V212, P737, DOI 10.1002/jcp.21070; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; Giri S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0798com; Giri S, 2008, J NEUROCHEM, V105, P1820, DOI 10.1111/j.1471-4159.2008.05279.x; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; GRIOT C, 1990, FREE RADICAL RES COM, V11, P181, DOI 10.3109/10715769009088915; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; Haq E, 2003, J NEUROCHEM, V86, P1428, DOI 10.1046/j.1471-4159.2003.01941.x; HAYAKAWA M, 1993, J BIOL CHEM, V268, P11290; Healy LM, 2013, BRIT J PHARMACOL, V169, P1114, DOI 10.1111/bph.12207; HOECK WG, 1993, P NATL ACAD SCI USA, V90, P4475, DOI 10.1073/pnas.90.10.4475; HOLASH JA, 1993, DEV DYNAM, V197, P14, DOI 10.1002/aja.1001970103; Kim C, 2008, BMB REP, V41, P555, DOI 10.5483/BMBRep.2008.41.8.555; Kinloch RA, 2005, EXPERT OPIN THER TAR, V9, P685, DOI 10.1517/14728222.9.4.685; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; LIDDELOW SA, 2017, PLOS ONE, V46, P957, DOI DOI 10.1016/J.IMMUNI.2017.06.006; LIN LL, 1992, J BIOL CHEM, V267, P23451; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; LUZI P, 1995, GENOMICS, V26, P407, DOI 10.1016/0888-7543(95)80230-J; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mronga T, 2004, GLIA, V46, P446, DOI 10.1002/glia.20022; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; O'Sullivan C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0494-x; O'Sullivan C, 2015, J CELL SCI, V128, P3878, DOI 10.1242/jcs.169342; O'Sullivan SA, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0659-7; Ohsawa M, 2013, NEUROSCIENCE, V247, P65, DOI 10.1016/j.neuroscience.2013.05.014; Piomelli D, 1993, CURR OPIN CELL BIOL, V5, P274, DOI 10.1016/0955-0674(93)90116-8; Pritchard AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099444; QIU ZH, 1994, J BIOL CHEM, V269, P19480; Rutkowska A, 2015, GLIA, V63, P341, DOI 10.1002/glia.22757; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; SHEA TB, 1992, J NEUROSCI RES, V31, P309, DOI 10.1002/jnr.490310212; Sheridan GK, 2012, GLIA, V60, P382, DOI 10.1002/glia.22272; Sriram S, 2011, J NEUROIMMUNOL, V239, P13, DOI 10.1016/j.jneuroim.2011.08.012; Sun GY, 2010, NEUROMOL MED, V12, P133, DOI 10.1007/s12017-009-8092-z; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; Suzuki K, 1998, NEUROCHEM RES, V23, P251, DOI 10.1023/A:1022436928925; Tapasi S, 1998, INDIAN J BIOCHEM BIO, V35, P161; Truini A, 2013, J NEUROL, V260, P351, DOI 10.1007/s00415-012-6579-2; Voccoli V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.483; WOLBURG H, 1994, J CELL SCI, V107, P1347; Xu JF, 2003, FREE RADICAL BIO MED, V34, P1531, DOI 10.1016/S0891-5849(03)00152-7; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	60	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187217	10.1371/journal.pone.0187217	http://dx.doi.org/10.1371/journal.pone.0187217			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095858	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200059
J	Shi, HS; Carion, TW; Jiang, YD; Chahine, A; Steinle, JJ; Berger, EA				Shi, Haoshen; Carion, Thomas W.; Jiang, Youde; Chahine, Adam; Steinle, Jena J.; Berger, Elizabeth A.			A regulatory role for beta-adrenergic receptors regarding the resolvin D1 (RvD1) pathway in the diabetic retina	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; DOCOSAHEXAENOIC ACID; TNF-ALPHA; MULLER CELLS; EXPRESSION; MICROGLIA; IGFBP-3; MOUSE; PHOSPHORYLATION; 5-LIPOXYGENASE	Diabetic retinopathy is a visually debilitating disease with limited treatment options available. Compound 49b, a beta-adrenergic receptor agonist, has been demonstrated to effectively reduce disease pathogenesis associated with diabetic retinopathy. While the exact mechanisms are not fully understood, previous studies have determined that it reduces the proinflammatory cytokine, TNF-alpha, and inhibits apoptosis of the retinal microvasculture. As inflammation becomes more recognized in driving disease pathogenesis, so does the regulation by pro-resolving pathways as therapeutic points of intervention. The current study sought to explore whether Compound 49b had any influence on pro-resolving pathways, thus contributing to improved disease outcome. Using in vivo (animal model of type 1 diabetes) and in vitro (retinal endothelial cells, Muller cells, neutrophils/PMN) techniques, it was determined that high glucose lowers pro-resolving lipid mediator, resolvin D1 (RvD1) levels and differentially alters required enzymes, 5-lipoxygenase (5-LOX), 15-LOX-1 and 15-LOX-2. RvD1 receptors formyl peptide receptor 2 (ALX/FPR2) and G-protein coupled receptor 32 (GPR32) were also downregulated in response to hyperglycemic conditions. Moreover, it was observed that beta-adrenergic receptor activation restored high glucose-induced decreases in both enzyme activity and RvD1 levels observed in vivo and in vitro. The current study is the first to describe a regulatory role for beta-adrenergic receptors on pro-resolving pathways.	[Shi, Haoshen; Carion, Thomas W.; Jiang, Youde; Chahine, Adam; Steinle, Jena J.; Berger, Elizabeth A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Steinle, Jena J.; Berger, Elizabeth A.] Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48201 USA	Wayne State University	Berger, EA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.; Berger, EA (corresponding author), Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48201 USA.	eberger@med.wayne.edu	Berger, Elizabeth/W-6893-2019	Berger, Elizabeth/0000-0001-5371-1170; Steinle, Jena/0000-0002-7539-2892	NATIONAL EYE INSTITUTE [P30EY004068, R01EY022330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY022330, P30 EY004068] Funding Source: Medline; NIDDK NIH HHS [P30 DK020572] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albano GD, 2015, J ALLERGY CLIN IMMUN, V135, P1144, DOI 10.1016/j.jaci.2015.02.006; Berger EA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003457; Chen WQ, 2005, INVEST OPHTH VIS SCI, V46, P4342, DOI 10.1167/iovs.05-0601; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Das UN, 2013, NUTRITION, V29, P1, DOI 10.1016/j.nut.2012.02.003; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Jiang YD, 2014, MOL VIS, V20, P872; Johnson JD, 2013, J NEUROIMMUNOL, V254, P161, DOI 10.1016/j.jneuroim.2012.08.007; Joussen AM, 2009, MOL VIS, V15, P1418; Jung TW, 2014, MOL CELL ENDOCRINOL, V391, P30, DOI 10.1016/j.mce.2014.04.012; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kong Y, 2010, J NEUROSCI, V30, P11848, DOI 10.1523/JNEUROSCI.2985-10.2010; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lydic TA, 2009, JALA-J LAB AUTOM, V14, P383, DOI 10.1016/j.jala.2009.07.003; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Opreanu M, 2010, INVEST OPHTH VIS SCI, V51, P3253, DOI 10.1167/iovs.09-4731; Panjala SR, 2011, MOL VIS, V17, P1822; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Steinle JJ, 2007, EXP EYE RES, V84, P118, DOI 10.1016/j.exer.2006.09.006; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684; Walker RJ, 2007, INVEST OPHTH VIS SCI, V48, P5276, DOI 10.1167/iovs.07-0129; Walker RJ, 2011, INVEST OPHTH VIS SCI, V52, P9527, DOI 10.1167/iovs.11-8631; Wang J, 2010, J NEUROIMMUNOL, V223, P77, DOI 10.1016/j.jneuroim.2010.04.006; Werz O, 2002, J BIOL CHEM, V277, P14793, DOI 10.1074/jbc.M111945200; Zhang QH, 2014, MICROVASC RES, V95, P76, DOI 10.1016/j.mvr.2014.07.009; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5376, DOI 10.1167/iovs.13-12497; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	32	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0185383	10.1371/journal.pone.0185383	http://dx.doi.org/10.1371/journal.pone.0185383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095817	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200005
J	Omwenga, EO; Hensel, A; Pereira, S; Shitandi, AA; Goycoolea, FM				Omwenga, Eric Omori; Hensel, Andreas; Pereira, Susana; Shitandi, Alfred Anakalo; Goycoolea, Francisco M.			Antiquorum sensing, antibiofilm formation and cytotoxicity activity of commonly used medicinal plants by inhabitants of Borabu sub-county, Nyamira County, Kenya	PLOS ONE			English	Article							BIOFILM FORMATION; GENE-EXPRESSION; QUORUM; COMMUNICATION; DIGUANYLATE; EXTRACTS	Productions of various bacterial traits like production of virulence factors (e.g. toxins, enzymes), biofilm formation, luminescence among others, have been known to be controlled by quorum sensing (QS), a process that is dependent on chemical signals or autoinducers (Als). Bacteria known to rely on such Als are known to be virulent and tend to be resistant against various antimicrobial agents. Therefore, strategies aimed at the inhibition of QS pathways, are regarded as potential novel therapies in managing bacterial virulence hence reducing their ability to induce infections in humans. In the present study, a portfolio of 25 medicinal plant extracts (ethanol 50% v/v) used in southwestern Kenya were assayed against a transformed E. coliTop 10 reporter QS strain. This biosensor responds to the exogenous addition of 3-oxo-N-hexanoyl homoserine lactone (3OC6HSL) expressing green fluorescent protein (GFP). The large majority of the screened medicinal plants seemed to exhibit toxic effects and almost none of them induced antiquorum sensing (AQS) activity. This could be the consequence of the presence of mixed compounds in the extracts. Elaeodendron buchananii Loes and Acacia gerrardii Benth extracts that seemed to show AQS activity were further proved found to possess mild AQS but with defined antimicrobial activities, and no antibiofilm formation inhibition. Asa control, an E. colipBCA9145 jtk2828:: sfGFP strain that produces constitutively GFP was used and confirmed that none of the two extracts quenched the fluorescence of sfGFP. Cytotoxicity assays with mammalian MDCK cells also did indicate that the selected extracts with putative AQS activity, also reduced the cell viability. Therefore, further studies will be needed to separate and re-test the individual compounds especially from the selected two promising plants.	[Omwenga, Eric Omori] Kisii Univ, Sch Hlth Sci, Kisii, Kenya; [Omwenga, Eric Omori; Pereira, Susana; Goycoolea, Francisco M.] Univ Munster, Inst Plant Biotechnol & Biol, Nanobiotechnol Grp, Munster, Germany; [Hensel, Andreas] Univ Munster, Inst Pharmaceut Biol & Phytochem, Munster, Germany; [Shitandi, Alfred Anakalo] Kisii Univ, Fac Sci Appl, Kisii, Kenya; [Goycoolea, Francisco M.] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England	University of Munster; University of Munster; University of Leeds	Goycoolea, FM (corresponding author), Univ Munster, Inst Plant Biotechnol & Biol, Nanobiotechnol Grp, Munster, Germany.; Goycoolea, FM (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.	fm.goycoolea@gmail.com	Goycoolea, Francisco M./Q-5841-2017	Goycoolea, Francisco M./0000-0001-7949-5429	DAAD [A/13/93803]; NACOSTI - Kenya	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NACOSTI - Kenya	NACOSTI - Kenya sponsored the fieldwork of this project and 90% of the joint scholarship with DAAD awarded to E00 (grant A/13/93803).	Abraham WR, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5010003; Almasoud A, 2016, LWT-FOOD SCI TECHNOL, V66, P560, DOI 10.1016/j.lwt.2015.11.013; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Auchtung JM, 2006, J BACTERIOL, V188, P5273, DOI 10.1128/JB.00300-06; Banskota AH, 2000, J ETHNOPHARMACOL, V72, P239, DOI 10.1016/S0378-8741(00)00252-X; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Corral-Lugo A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaa8271; Even-Tov E, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002386; Gopu V, 2016, RSC ADV, V6, P2592, DOI 10.1039/c5ra20677d; Greenberg EP, 2003, J CLIN INVEST, V112, P1288, DOI 10.1172/JCI200320099; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Jung SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004837; Kaiser M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10048; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; Kareru PG, 2008, AFR J TRADIT COMPLEM, V5, P51; Kumar VP, 2006, J ETHNOPHARMACOL, V107, P182, DOI 10.1016/j.jep.2006.03.013; Lade H, 2014, INT J BIOL SCI, V10, P547, DOI 10.7150/ijbs.9028; Lewis K, 2006, NAT BIOTECHNOL, V24, P1504, DOI 10.1038/nbt1206-1504; Lu LG, 2005, FOODBORNE PATHOG DIS, V2, P242, DOI 10.1089/fpd.2005.2.242; Luo Jing, 2016, Drug Des Devel Ther, V10, P183, DOI 10.2147/DDDT.S97221; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; Mwitari PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065619; Nazzaro F, 2013, INT J MOL SCI, V14, P12607, DOI 10.3390/ijms140612607; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Njeru SN, 2016, J INTERCULT ETHNOPHA, V5, P226, DOI 10.5455/jice.20160416122003; Omwenga EO, 2015, J ETHNOPHARMACOL, V176, P508, DOI 10.1016/j.jep.2015.11.032; Omwenga E. O., 2012, South Asian Journal of Experimental Biology, V2, P217; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peng L, 2005, COLLOID SURFACE B, V45, P108, DOI 10.1016/j.colsurfb.2005.07.014; Qin X, 2016, COLLOID SURFACE B, V149, P358, DOI DOI 10.1016/J.COLSURFB.2016.10.031; Rajamani S, 2008, MOL PLANT MICROBE IN, V21, P1184, DOI 10.1094/MPMI-21-9-1184; Ram Irez-Castillo ML, 2004, LETT, V26, P1301; Reading NC, 2007, J BACTERIOL, V189, P2468, DOI 10.1128/JB.01848-06; Rezk A, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0860-8; Rios JL, 2005, J ETHNOPHARMACOL, V100, P80, DOI 10.1016/j.jep.2005.04.025; Sambanthamoorthy K, 2012, ANTIMICROB AGENTS CH, V56, P5202, DOI 10.1128/AAC.01396-12; Si XR, 2015, APPL MICROBIOL BIOT, V99, P10861, DOI 10.1007/s00253-015-6943-0; Singh S. A., 2010, Journal of Chemical and Pharmaceutical Research, V2, P304; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Sulaiman G. M., 2013, African Journal of Microbiology Research, V7, P1548; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Truchado P, 2015, TRENDS FOOD SCI TECH, V43, P189, DOI 10.1016/j.tifs.2015.02.009; Vila-Sanjurjo C, 2016, BIORXIV; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001	45	16	16	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185722	10.1371/journal.pone.0185722	http://dx.doi.org/10.1371/journal.pone.0185722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091715	Green Published, gold			2022-12-27	WOS:000414229700010
J	Paliwal, D; Joshi, P; Panda, SK				Paliwal, Daizy; Joshi, Prashant; Panda, Subrat Kumar			Hepatitis E Virus (HEV) egress: Role of BST2 (Tetherin) and interferon induced long non coding RNA (IncRNA) BISPR	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ORF3 PROTEIN; CELL-LINES; IN-VIVO; EXPRESSION; RELEASE; BST-2/TETHERIN; GLYCOSYLATION; LOCALIZATION; CYTOSKELETON	Background The biology of Hepatitis E Virus (HEV), a common cause of epidemic and sporadic hepatitis, is still being explored. HEV exits liver through bile, a process which is essential for its natural transmission by feco-oral route. Though the process of this polarised HEV egress is not known in detail, HEV pORF3 and hepatocyte actin cytoskeleton have been shown to play a role. Methods Our transcriptome analysis in Hepatitis E virus (HEV) replicon transfected Huh7 cells at 24 and 72 hrs indicated that at 24hrs, both LncBISPR and BST2, expressed by a bidirectional promoter were highly upregulated whereas at 72 hrs, BST2 expression was comparatively reduced accompanied by normal levels of BISPR. These findings were confirmed by qPCR analysis. Co-localisation of BST2 and HEV pORF2 was confirmed in HEV transfected Huh7 by confocal microscopy. To investigate the role of BISPR/BST2 in HEV life cycle, particularly virus egress, we generated Huh7 cells with-8kb deletion in BISPR gene using Crispr-Cas9 system. The deletion was confirmed by PCR screening, Sanger sequencing and Real time PCR. Virus egress in BISPR Huh7 and Huh7 cells was compared by measuring HEV positive strand RNA copy numbers in cell lysates and culture supernatants at 24 and 72 hrs post HEV replicon transfection and further validated by western blot for HEV pORF2 capsid protein. Results BISPR Huh7 cells showed-8 fold increase in virus egress at 24 hrs compared to Huh7 cells. No significant difference in virus egress was observed at 72hrs. Immunohistochemistry in histologically normal liver and HEV associated acute liver failure revealed BST2 over expression in HEV infected hepatocytes and a dominant canalicular BST2 distribution in normal liver in addition to the cytoplasmic localisation reported in literature. Conclusions These findings lead us to believe that BISPR and BST2 may regulate egress of HEV virions into bile in vivo. This system may also be used to scale up virus production in vitro.	[Paliwal, Daizy; Joshi, Prashant; Panda, Subrat Kumar] All India Inst Med Sci, Dept Pathol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Panda, SK (corresponding author), All India Inst Med Sci, Dept Pathol, New Delhi, India.	subrat@gmail.com		Panda, Subrat Kumar/0000-0003-0761-8631	Department of Biotechnology [BT/PR13335/MED/29/959/2015]; J.C. Bose fellowship granted form Department of Science and Technology, Govt. of India [SR/S2/JCB-05/2007]	Department of Biotechnology; J.C. Bose fellowship granted form Department of Science and Technology, Govt. of India	The present work has been funded by Department of Biotechnology (www.dbtindia.nic.in) (BT/PR13335/MED/29/959/2015) and J.C. Bose fellowship (SR/S2/JCB-05/2007) granted form Department of Science and Technology, Govt. of India (www.dstgov.in) to SKP. Both the funding agencies had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Barriocanal M, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00655; Billcliff PG, 2013, J CELL SCI, V126, P1553, DOI 10.1242/jcs.112953; Dave VP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-128; Devhare PB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26827; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Emerson SU, 2004, J VIROL, V78, P4838, DOI 10.1128/JVI.78.9.4838-4846.2004; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Fujita H, 2012, CURR HIV RES, V10, P321, DOI 10.2174/157016212800792522; GOTO T, 1994, BLOOD, V84, P1922; Graff J, 2008, J VIROL, V82, P1185, DOI 10.1128/JVI.01219-07; Gupta P, 2012, J VIRAL HEPATITIS, V19, pE177, DOI 10.1111/j.1365-2893.2011.01498.x; Homann S, 2011, J VIROL, V85, P10659, DOI 10.1128/JVI.05524-11; Jagya N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087835; Kambara H, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00676; Kapur N, 2012, J VIRAL HEPATITIS, V19, P436, DOI 10.1111/j.1365-2893.2011.01559.x; Kenney SP, 2015, VIROLOGY, V486, P198, DOI 10.1016/j.virol.2015.09.012; Lei QS, 2016, VIRAL IMMUNOL, V29, P105, DOI 10.1089/vim.2015.0107; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Nagashima S, 2011, J GEN VIROL, V92, P2838, DOI 10.1099/vir.0.035378-0; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pan XB, 2013, ANTIVIR RES, V98, P54, DOI 10.1016/j.antiviral.2013.01.009; Panda SK, 2000, J VIROL, V74, P2430, DOI 10.1128/JVI.74.5.2430-2437.2000; Qi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132503; Rehman S, 2008, VIROLOGY, V370, P77, DOI 10.1016/j.virol.2007.07.036; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Surjit M, 2007, J VIROL, V81, P3339, DOI 10.1128/JVI.02039-06; Tanaka T, 2007, J GEN VIROL, V88, P903, DOI 10.1099/vir.0.82535-0; Torresi J, 1999, J GEN VIROL, V80, P1185, DOI 10.1099/0022-1317-80-5-1185; Varma SPK, 2011, J GEN VIROL, V92, P572, DOI 10.1099/vir.0.027714-0; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Yin X, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080229; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997; Zafrullah M, 1999, J VIROL, V73, P4074, DOI 10.1128/JVI.73.5.4074-4082.1999	36	8	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187334	10.1371/journal.pone.0187334	http://dx.doi.org/10.1371/journal.pone.0187334			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091957	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700057
J	Mihelcic, M; Simic, G; Leko, MB; Lavrac, N; Dzeroski, S; Smuc, T				Mihelcic, Matej; Simic, Goran; Leko, Mirjana Babic; Lavrac, Nada; Dzeroski, Saso; Smuc, Tomislav		Alzheimer's Dis Neuroimaging	Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients	PLOS ONE			English	Article							FAS LIGAND; TESTOSTERONE; BRAIN; METAANALYSIS; CLASSIFICATION; PATHOGENESIS; ASSOCIATION; EXPRESSION; DISORDERS; DISCOVERY	Based on a set of subjects and a collection of attributes obtained from the Alzheimer's Disease Neuroimaging Initiative database, we used redescription mining to find interpretable rules revealing associations between those determinants that provide insights about the Alzheimer's disease (AD). We extended the CLUS-RM redescription mining algorithm to a constraint- based redescription mining (CBRM) setting, which enables several modes of targeted exploration of specific, user-constrained associations. Redescription mining enabled finding specific constructs of clinical and biological attributes that describe many groups of subjects of different size, homogeneity and levels of cognitive impairment. We confirmed some previously known findings. However, in some instances, as with the attributes: testosterone, ciliary neurotrophic factor, brain natriuretic peptide, Fas ligand, the imaging attribute Spatial Pattern of Abnormalities for Recognition of Early AD, as well as the levels of leptin and angiopoietin-2 in plasma, we corroborated previously debatable findings or provided additional information about these variables and their association with AD pathogenesis. Moreover, applying redescription mining on ADNI data resulted with the discovery of one largely unknown attribute: the Pregnancy-Associated Protein-A (PAPP-A), which we found highly associated with cognitive impairment in AD. Statistically significant correlations (p <= 0.01) were found between PAPP-A and clinical tests: Alzheimer's Disease Assessment Scale, Clinical Dementia Rating Sum of Boxes, Mini Mental State Examination, etc. The high importance of this finding lies in the fact that PAPP-A is a metalloproteinase, known to cleave insulin-like growth factor binding proteins. Since it also shares similar substrates with A Disintegrin and the Metalloproteinase family of enzymes that act as a-secretase to physiologically cleave amyloid precursor protein (APP) in the non-amyloidogenic pathway, it could be directly involved in the metabolism of APP very early during the disease course. Therefore, further studies should investigate the role of PAPP-A in the development of AD more thoroughly.	[Mihelcic, Matej; Smuc, Tomislav] Rudjer Boskovic Inst, Div Elect, Zagreb, Croatia; [Mihelcic, Matej; Lavrac, Nada; Dzeroski, Saso] Jozef Stefan Int Postgrad Sch, Ljubljana, Slovenia; [Simic, Goran; Leko, Mirjana Babic] Univ Zagreb, Med Sch, Croatian Inst Brain Res, Dept Neurosci, Zagreb, Croatia; [Lavrac, Nada; Dzeroski, Saso] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia	Rudjer Boskovic Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Zagreb; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Smuc, T (corresponding author), Rudjer Boskovic Inst, Div Elect, Zagreb, Croatia.	tomislav.smuc@irb.hr	Šimić, Goran/GZA-9931-2022; Babić Leko, Mirjana/C-3514-2018; Mihelčić, Matej/AAJ-2725-2020; Šimić, Goran/A-9262-2013; Dzeroski, Saso/ABH-2758-2021; Babić Leko, Mirjana/ABG-3331-2021	Babić Leko, Mirjana/0000-0003-4223-4190; Mihelčić, Matej/0000-0002-1023-8413; Šimić, Goran/0000-0002-6339-9261; Dzeroski, Saso/0000-0003-2363-712X; Babić Leko, Mirjana/0000-0003-4223-4190; Smuc, Tomislav/0000-0002-9185-9384	Alzheimer's Disease Neuroimaging Initiative (ADNI) [U01 AG024904]; DOD ADNI [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Slovenian Research Agency; Future and Emerging Technologies EU [604102]; European Commission [612944]; Croatian Science Foundation [9623]; TS and Tau protein hyperphosphorylation, aggregation and trans-synaptic transfer in Alzheimer's disease: cerebrospinal fluid analysis and assessment of potential neuroprotective compounds [IP-2014-09-9730]	Alzheimer's Disease Neuroimaging Initiative (ADNI); DOD ADNI(United States Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Future and Emerging Technologies EU; European Commission(European CommissionEuropean Commission Joint Research Centre); Croatian Science Foundation; TS and Tau protein hyperphosphorylation, aggregation and trans-synaptic transfer in Alzheimer's disease: cerebrospinal fluid analysis and assessment of potential neuroprotective compounds	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from many private pharmaceutical companies and non-profit organizations. The research was partly funded by the Slovenian Research Agency, the Future and Emerging Technologies EU funded Human Brain Project (HBP, grant agreement no. 604102) - NL, SD, the European Commission funded MAESTRA project (Gr. no. 612944) - TS, SD, the Croatian Science Foundation funded projects: Machine Learning Algorithms for Insightful Analysis of Complex Data Structures (grant. no. 9623) - TS and Tau protein hyperphosphorylation, aggregation and trans-synaptic transfer in Alzheimer's disease: cerebrospinal fluid analysis and assessment of potential neuroprotective compounds (grant. no. IP-2014-09-9730) - GS.	Adaszewski S, 2013, NEUROBIOL AGING, V34, P2815, DOI 10.1016/j.neurobiolaging.2013.06.015; Agrawal Rakesh, 1996, ADV KNOWLEDGE DISCOV, P307, DOI DOI 10.1007/978-3-319-31750-2.; Aho T, 2012, J MACH LEARN RES, V13, P2367; Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Arnold SE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.63; Bacher M, 2010, MOL MED, V16, P116, DOI 10.2119/molmed.2009.00123; Bay SD, 2001, DATA MIN KNOWL DISC, V5, P213, DOI 10.1023/A:1011429418057; Blockeel H, 1998, ARTIF INTELL, V101, P285, DOI 10.1016/S0004-3702(98)00034-4; Breiman L., 1984, CLASSIFICATION REGRE; Breskvar M, 2015, P 18 INT INF SOC LIU, P5; Caramelli P, 1999, ACTA NEUROL SCAND, V100, P61, DOI 10.1111/j.1600-0404.1999.tb00724.x; Chang Y.T., 2016, FRONT AGING NEUROSCI, V8, P8; Clarke R, 2014, AM J CLIN NUTR, V100, P657, DOI 10.3945/ajcn.113.076349; Coskun A, 2013, J CARDIOL, V61, P128, DOI 10.1016/j.jjcc.2012.09.007; COX DR, 1957, J AM STAT ASSOC, V52, P543, DOI 10.2307/2281704; Donovan NJ, 2014, AM J GERIAT PSYCHIAT, V22, P1168, DOI 10.1016/j.jagp.2013.03.006; Doraiswamy PM, 2014, MOL PSYCHIATR, V19, P1044, DOI 10.1038/mp.2014.9; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Dukart J, 2013, PSYCHIAT RES-NEUROIM, V212, P230, DOI 10.1016/j.pscychresns.2012.04.007; Ferrer I, 2001, ACTA NEUROPATHOL, V102, P121; Fisher D. H., 1987, Machine Learning, V2, P139, DOI 10.1007/BF00114265; FISHER W, 1958, J AM STAT ASS, V53; Ford AH, 2012, J ALZHEIMERS DIS, V29, P133, DOI 10.3233/JAD-2012-111739; Galbrun Esther, 2012, Statistical Analysis and Data Mining, V5, P284, DOI 10.1002/sam.11145; Galbrun E., 2012, P 18 ACM SIGKDD INT, P1544, DOI DOI 10.1145/2339530.2339776; Galbrun E, 2013, THESIS; Gallo A, 2008, FINDING SUBGROUPS HA, P334; Gamberger D, 2015, LECT NOTES ARTIF INT, V9250, P57, DOI 10.1007/978-3-319-23344-4_6; Gamberger D, 2015, LECT N BIOINFORMAT, V9043, P134, DOI 10.1007/978-3-319-16483-0_13; Gamberger D, 2014, LECT NOTES ARTIF INT, V8777, P87, DOI 10.1007/978-3-319-11812-3_8; Gelernter J, 1997, AM J MED GENET, V74, P497, DOI 10.1002/(SICI)1096-8628(19970919)74:5<497::AID-AJMG8>3.3.CO;2-5; Grammas P, 2011, INT J CLIN EXP PATHO, V4, P616; Grober U, 2013, NUTRIENTS, V5, P5031, DOI 10.3390/nu5125031; Guo LH, 2013, ALZHEIMERS DEMENT, V9, P580, DOI 10.1016/j.jalz.2012.10.002; Heidari Behnam, 2015, Acta Med Iran, V53, P395; Hogervorst E, 2004, EXP GERONTOL, V39, P1633, DOI 10.1016/j.exger.2004.06.019; Hostage CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054483; Hu YS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0252-z; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Juottonen K, 1998, NEUROBIOL AGING, V19, P15, DOI 10.1016/S0197-4580(98)00007-4; Klosgen W., 1996, ADV KNOWLEDGE DISCOV, P249; Kocev D, 2013, PATTERN RECOGN, V46, P817, DOI 10.1016/j.patcog.2012.09.023; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Kondziella D, 2009, NEUROREPORT, V20, P825, DOI 10.1097/WNR.0b013e328326f82f; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Liu X, 2013, NEUROIMAGE, V83, P148, DOI 10.1016/j.neuroimage.2013.06.033; Llano DA, 2013, ALZ DIS ASSOC DIS, V27, P233, DOI 10.1097/WAD.0b013e31826d597a; Lv WS, 2016, MOL NEUROBIOL, V53, P2679, DOI 10.1007/s12035-015-9315-y; Ma C, 2015, BIOMED RES INT, V2015; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marwarha G, 2014, BBA-MOL BASIS DIS, V1842, P1587, DOI 10.1016/j.bbadis.2014.05.015; Marwarha Gurdeep, 2012, Am J Neurodegener Dis, V1, P245; Marwarha G, 2012, CELL SIGNAL, V24, P484, DOI 10.1016/j.cellsig.2011.09.029; Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298; Michalski R. S., 1980, International Journal of Policy Analysis and Information Systems, V4, P219; Mihel M., 2015, P 4 WORKSH NEW FRONT, P86; Mihelcic M, 2017, J INTELL INF SYST, P1, DOI DOI 10.1007/S10844017-04485; Mihelcic M, 2016, LECT NOTES ARTIF INT, V9956, P35, DOI 10.1007/978-3-319-46307-0_3; Mihelcic M, 2017, EXPERT SYST APPL, V68, P196, DOI 10.1016/j.eswa.2016.10.012; Mihelcic M, 2016, LECT NOTES ARTIF INT, V9607, P125, DOI 10.1007/978-3-319-39315-5_9; Papasozomenos SC, 2002, P NATL ACAD SCI USA, V99, P1140, DOI 10.1073/pnas.032646799; Parida L., 2005, REDESCRIPTION MINING, P837; Pearson Karl, 1895, P ROY SOC LONDON, V58, P240, DOI [DOI 10.1098/RSPL.1895.0041, 10.1098/rspl.1895.0041]; Piccart B, 2012, THESIS; Plucinska K, 2016, DIABETES, V65, pA430; R Core Team, 2014, R LANG ENV STAT COMP; Ramakrishnan N., 2004, P 10 ACM SIGKDD INT, DOI DOI 10.1145/1014052.1014083; Risacher SL, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00011; Roberts RO, FRONTIERS NERUOSCIEN, P7; Rosario ER, 2010, BRAIN RES, V1359, P281, DOI 10.1016/j.brainres.2010.08.068; SCHOLZ FW, 1987, J AM STAT ASSOC, V82, P918, DOI 10.2307/2288805; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shipley Sheena M, 2013, Neurol Clin Pract, V3, P305; Simic G, 2016, PROGR NEUROBIOLOGY; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Smith G.E., 2013, MILD COGNITIVE IMPAI; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Song F, 2012, PLOS ONE, V7, P1; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stanley M, 2016, J EXP MED; Stefulj J, 2013, TRANSL NEUROSCI, V4, P349, DOI 10.2478/s13380-013-0136-z; Su JH, 2003, NEUROBIOL DIS, V12, P182, DOI 10.1016/S0969-9961(02)00019-0; Tang SL, 2012, ATHEROSCLEROSIS, V222, P344, DOI 10.1016/j.atherosclerosis.2012.03.005; Thirumangalakudi L, 2006, J ALZHEIMERS DIS, V10, P111; van Leeuwen M, 2015, IEEE T KNOWL DATA EN, V27, P3190, DOI 10.1109/TKDE.2015.2453159; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Wittert G, 2014, ASIAN J ANDROL, V16, P262, DOI 10.4103/1008-682X.122586; Wrobel S, 1997, LECT NOTES ARTIF INT, V1263, P78; Xu D., 2015, ANN DATA SCI, V2, P165, DOI [10.1007/s40745-015-0040-1, DOI 10.1007/S40745-015-0040-1]; Xu J, 2016, CURR ALZHEIMER RES, V13, P215, DOI 10.2174/1567205013666151218145752; Zaki M.J., 2005, P 11 ACM SIGKDD INT, P364, DOI DOI 10.1145/1081870.1081912; Zhao JV, 2016, SCI REPORTS, P6; Zinchenko T., 2014, THESIS	97	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187364	10.1371/journal.pone.0187364	http://dx.doi.org/10.1371/journal.pone.0187364			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088293	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000414088900074
J	Schmidt, K; Butt, J; Mauter, P; Vogel, K; Erles-Kemna, A; Pawlita, M; Nicklas, W				Schmidt, Katja; Butt, Julia; Mauter, Petra; Vogel, Klaus; Erles-Kemna, Andrea; Pawlita, Michael; Nicklas, Werner			Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; STRUCTURAL PROTEIN; CHICKEN ASTROVIRUS; DUCK ASTROVIRUS; GUT MICROBIOTA; CAPSID PROTEIN; VIRUS; GASTROENTERITIS; ANTIBODIES; HEPATITIS	Laboratory mice play a tremendous role in biomedical research in studies on immunology, infection, cancer and therapy. In the course of standardization of mice used in animal experiments, health monitoring constitutes an important instrument towards microbiological standardization. Infections with murine astroviruses (MuAstV) were only recently discovered and are, therefore, still relatively unknown in laboratory animal science. In rodent health monitoring viral infections within a population are commonly assessed in terms of specific antibodies by serological testing, as active infection and excretion of virus is often temporary and can easily be missed. So far only ongoing infections with astroviruses can be detected by PCR. The objective of this work was the development of a sensitive and specific MuAstV multiplex serological assay with a high-throughput capability to be used in routine testing of laboratory mice. Four different MuAstV proteins were recombinantly expressed and used as antigens. The best reacting antigen, the capsid spike protein VP27, was selected and tested with a panel of 400 sera of mice from units with a known MuAstV status. Assay sensitivity and specificity resulted in 98.5% and 100%, respectively, compared to RT-PCR results. Eventually this assay was used to test 5529 serum samples in total, during routine diagnostics at the German Cancer Research Center (DKFZ) in Heidelberg between 2015 and 2017. High sero-prevalence rates of up to 98% were detected in units with open cages indicating that the virus is highly infectious and circulates within these populations virtually infecting all animals regardless of the mouse strain. In addition, data collected from 312 mice purchased from commercial breeders and from 661 mice from 58 research institutes in 15 countries worldwide allowed the conclusion that MuAstV is widespread in contemporary laboratory mouse populations.	[Schmidt, Katja; Mauter, Petra; Vogel, Klaus; Erles-Kemna, Andrea; Nicklas, Werner] German Canc Res Ctr, Ctr Preclin Res, Microbiol Diagnost, Heidelberg, Germany; [Butt, Julia; Pawlita, Michael] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Schmidt, K (corresponding author), German Canc Res Ctr, Ctr Preclin Res, Microbiol Diagnost, Heidelberg, Germany.	katja.schmidt@dkfz-heidelberg.de		Schmidt, Katja/0000-0002-4828-7974	CPR of the DKFZ	CPR of the DKFZ	The authors thank Dr. Daniela Hofler for valuable professional input, Claudia Brandel for the technical support with protein expression, Bernhard Berkus, Elsbeth Schneider and Katrin Gotz for assistance in the diagnostic laboratory, necropsy of animals, sample preparation and documentation, and the animal care technicians at CAL and CPR of the DKFZ for their support and sample taking.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Appleton H, 1975, Lancet, V1, P1297; ASPLIN FD, 1965, VET REC, V77, P487; Bass DM, 1997, J VIROL, V71, P8666, DOI 10.1128/JVI.71.11.8666-8671.1997; BJORKHOLM M, 1995, INT J HEMATOL, V62, P117; Bleich A, 2012, COMP IMMUNOL MICROB, V35, P81, DOI 10.1016/j.cimid.2011.12.006; Bogdanoff WA, 2017, J VIROL, V91, DOI 10.1128/JVI.01859-16; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Compton SR, 2017, J AM ASSOC LAB ANIM, V56, P402; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Banos-Lara MD, 2010, VIROLOGY, V401, P322, DOI 10.1016/j.virol.2010.02.028; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Dong JH, 2011, P NATL ACAD SCI USA, V108, P12681, DOI 10.1073/pnas.1104834108; Dryden KA, 2012, J MOL BIOL, V422, P650, DOI 10.1016/j.jmb.2012.06.029; Farkas T, 2012, VIRUS GENES, V45, P518, DOI 10.1007/s11262-012-0803-0; Fu Y, 2009, J GEN VIROL, V90, P1104, DOI 10.1099/vir.0.008599-0; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geigenmuller U, 2002, J GEN VIROL, V83, P1691, DOI 10.1099/0022-1317-83-7-1691; GOUGH RE, 1984, VET REC, V114, P279, DOI 10.1136/vr.114.11.279-a; Hansen AK, 2014, WORLD J GASTROENTERO, V20, P17727, DOI 10.3748/wjg.v20.i47.17727; HERRMANN JE, 1990, J INFECT DIS, V161, P226, DOI 10.1093/infdis/161.2.226; Hewson KA, 2015, J VIROL METHODS, V221, P106, DOI 10.1016/j.jviromet.2015.04.019; Hsu CC, 2007, LAB ANIMAL, V36, P36, DOI 10.1038/laban0907-36; IMADA T, 1979, AVIAN DIS, V23, P582, DOI 10.2307/1589733; KJELDSBERG E, 1985, ARCH VIROL, V84, P135, DOI 10.1007/BF01310560; Koci MD, 2005, VIRAL IMMUNOL, V18, P11, DOI 10.1089/vim.2005.18.11; Koci MD, 2004, J VIROL, V78, P1564, DOI 10.1128/JVI.78.3.1564-1574.2004; Krishna NK, 2005, VIRAL IMMUNOL, V18, P17, DOI 10.1089/vim.2005.18.17; KURTZ J, 1978, MED MICROBIOL IMMUN, V166, P227, DOI 10.1007/BF02121154; KURTZ JB, 1979, J MED VIROL, V3, P221, DOI 10.1002/jmv.1890030308; Lee A, 2013, AVIAN PATHOL, V42, P434, DOI 10.1080/03079457.2013.822467; MACARTHUR H, 1984, J VIROL, V52, P483, DOI 10.1128/JVI.52.2.483-491.1984; MADELEY CR, 1975, LANCET, V2, P451; MAEDA M, 1979, AVIAN DIS, V23, P589, DOI 10.2307/1589734; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Marvin SA, 2016, J VIROL, V90, P1988, DOI 10.1128/JVI.02367-15; Mendez E, 2004, J VIROL, V78, P8601, DOI 10.1128/JVI.78.16.8601-8608.2004; Mendez E, 2002, J VIROL, V76, P7996, DOI 10.1128/JVI.76.16.7996-8002.2002; Mendez E, 2013, FIELDS VIROLOGY, V1, P609; Mendez E, 2007, J VIROL, V81, P10649, DOI 10.1128/JVI.00785-07; Ng TFF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066937; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Pritchett-Corning KR, 2014, J AM ASSOC LAB ANIM, V53, P633; REYNOLDS DL, 1986, AVIAN DIS, V30, P728, DOI 10.2307/1590577; SANCHEZFAUQUIER A, 1994, VIROLOGY, V201, P312, DOI 10.1006/viro.1994.1296; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Skibinska A, 2015, AVIAN PATHOL, V44, P436, DOI 10.1080/03079457.2015.1084411; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Wang XY, 2011, J VIROL METHODS, V171, P8, DOI 10.1016/j.jviromet.2010.09.015; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12; York RL, 2016, J VIROL, V90, P2254, DOI 10.1128/JVI.02666-15	53	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187174	10.1371/journal.pone.0187174	http://dx.doi.org/10.1371/journal.pone.0187174			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088279	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900044
J	Braun, CK; Kalbitz, M; Halbgebauer, R; Eisele, P; Messerer, DAC; Weckbach, S; Schultze, A; Braumuller, S; Gebhard, F; Huber-Lang, MS				Braun, Christian K.; Kalbitz, Miriam; Halbgebauer, Rebecca; Eisele, Philipp; Messerer, David A. C.; Weckbach, Sebastian; Schultze, Anke; Braumueller, Sonja; Gebhard, Florian; Huber-Lang, Markus S.			Early structural changes of the heart after experimental polytrauma and hemorrhagic shock	PLOS ONE			English	Article							SEPSIS; CARDIOMYOCYTES; CONNEXIN-43; GAP; INFLAMMATION; DYSFUNCTION; EXPRESSION; TRAUMA	Evidence is emerging that systemic inflammation after trauma drives structural and functional impairment of cardiomyocytes and leads to cardiac dysfunction, thus worsening the outcome of polytrauma patients. This study investigates the structural and molecular changes in heart tissue 4 h after multiple injuries with additional hemorrhagic shock using a clinically relevant rodent model of polytrauma. We determined mediators of systemic inflammation (keratinocyte chemoattractant, macrophage chemotactic protein 1), activated complement component C3a and cardiac troponin I in plasma and assessed histological specimen of the mouse heart via standard histomorphology and immunohistochemistry for cellular and subcellular damage and ongoing apoptosis. Further we investigated spatial and quantitative changes of connexin 43 by immunohistochemistry and western blotting. Our results show significantly increased plasma levels of both keratinocyte chemoattractant and cardiac troponin I 4 h after polytrauma and 2 h after induction of hypovolemia. Although we could not detect any morphological changes, immunohistochemical evaluation showed increased level of tissue high-mobility group box 1, which is both a damage-associated molecule and actively released as a danger response signal. Additionally, there was marked lateralization of the cardiac gap-junction protein connexin 43 following combined polytrauma and hemorrhagic shock. These results demonstrate a molecular manifestation of remote injury of cardiac muscle cells in the early phase after polytrauma and hemorrhagic shock with marked disruption of the cardiac gap junction. This disruption of an important component of the electrical conduction system of the heart may lead to arrhythmia and consequently to cardiac dysfunction.	[Braun, Christian K.; Halbgebauer, Rebecca; Eisele, Philipp; Messerer, David A. C.; Schultze, Anke; Braumueller, Sonja; Huber-Lang, Markus S.] Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany; [Kalbitz, Miriam; Gebhard, Florian] Univ Hosp Ulm, Dept Orthoped Trauma Hand Plast & Reconstruct Sur, Ulm, Germany; [Weckbach, Sebastian] Univ Hosp Ulm, Dept Orthoped Surg, Ulm, Germany	Ulm University; Ulm University; Ulm University	Huber-Lang, MS (corresponding author), Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany.	markus.huber-lang@uniklink-ulm.de	Huber-Lang, Markus/AAJ-2209-2020; Braun, Christian K/I-5132-2018; Messerer, David Alexander Christian/AAJ-9965-2021	Braun, Christian K/0000-0002-9854-3251; Messerer, David Alexander Christian/0000-0002-0834-038X; Huber-Lang, Markus/0000-0003-2359-6516	German Research Foundation DFG [CRC 1149]	German Research Foundation DFG(German Research Foundation (DFG))	This study was supported by grants from the German Research Foundation DFG CRC 1149, project A01 and Z02; http://www.dfg.de/en/.	Altmann DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009017; Asavarut Paladd, 2013, Acta Anaesthesiol Taiwan, V51, P28, DOI 10.1016/j.aat.2013.03.007; Atefi G, 2011, FASEB J, V25, P2500, DOI 10.1096/fj.11-183236; Bian B, 2015, EUR J PHARMACOL, V768, P13, DOI 10.1016/j.ejphar.2015.09.023; Celes MRN, 2013, PATHOBIOLOGY, V80, P70, DOI 10.1159/000341640; Celes MRN, 2007, CRIT CARE MED, V35, P2176, DOI 10.1097/01.CCM.0000281454.97901.01; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Denk S, 2017, SHOCK; Fernandez-Cobo M, 1999, CYTOKINE, V11, P216, DOI 10.1006/cyto.1998.0422; Gawande NB, 2014, SHOCK, V42, P211, DOI 10.1097/SHK.0000000000000194; Hoesel LM, 2007, MOL IMMUNOL, V44, P95, DOI 10.1016/j.molimm.2006.06.009; Kalbitz M, 2016, WORLD J SURG; Korff S, 2006, HEART, V92, P987, DOI 10.1136/hrt.2005.071282; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Martins-Marques T, 2015, BIOCHEM J, V467, P231, DOI 10.1042/BJ20141370; McCain ML, 2012, AM J PHYSIOL-HEART C, V302, pH443, DOI 10.1152/ajpheart.01218.2010; Mehta NJ, 2004, INT J CARDIOL, V95, P13, DOI 10.1016/j.ijcard.2003.02.005; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Takasu O, 2013, AM J RESP CRIT CARE, V187, P509, DOI 10.1164/rccm.201211-1983OC; Tao L, 2005, AM J PHYSIOL-HEART C, V288, pH2811, DOI 10.1152/ajpheart.01252.2004; ver Elst KM, 2000, CLIN CHEM, V46, P650; Xia Y, 2009, ACTA PHARMACOL SIN, V30, P928, DOI 10.1038/aps.2009.92; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Yasui K, 2000, CARDIOVASC RES, V48, P68, DOI 10.1016/S0008-6363(00)00145-0; Yin W, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-S1-S6; Zhang CC, 2014, J MOL CELL CARDIOL, V74, P260, DOI 10.1016/j.yjmcc.2014.06.003	27	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187327	10.1371/journal.pone.0187327	http://dx.doi.org/10.1371/journal.pone.0187327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084268	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200050
J	Perez-Parra, S; Chueca, N; Alvarez, M; Pasquau, J; Omar, M; Collado, A; Vinuesa, D; Lozano, AB; Yebra, G; Garcia, F				Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Pasquau, Juan; Omar, Mohamed; Collado, Antonio; Vinuesa, David; Belen Lozano, Ana; Yebra, Gonzalo; Garcia, Federico			High prevalence and diversity of HIV-1 non-B genetic forms due to immigration in southern Spain: A phylogeographic approach	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEWLY-DIAGNOSED PATIENTS; DRUG-RESISTANCE; SPANISH COHORT; SUBTYPE C; TRANSMISSION; SEX; MEN; SURVEILLANCE; EMERGENCE	Phylogenetic studies are a valuable tool to understand viral transmission patterns and the role of immigration in HIV-1 spread. We analyzed the spatio-temporal relationship of different HIV-1 non-B subtype variants over time using phylogenetic analysis techniques. We collected 693 pol (PR+RT) sequences that were sampled from 2005 to 2012 from naive patients in different hospitals in southern Spain. We used REGA v3.0 to classify them into subtypes and recombinant forms, which were confirmed by phylogenetic analysis through maximum likelihood (ML) using RAxML. For the main HIV-1 non-B variants, publicly available, genetically similar sequences were sought using HIV-BLAST. The presence of HIV-1 lineages circulating in our study population was established using ML and Bayesian inference (BEAST v1.7.5) and transmission networks were identified. We detected 165 (23.4%) patients infected with HIV-1 non-B variants: 104 (63%) with recombinant viruses in pol: CRF02_AG (71, 43%), CRF14_BG (8, 4.8%), CRF06_cpx (5, 3%) and nine other recombinant forms (11, 6.7%) and unique recombinants (9, 5.5%). The rest (61, 37%) were infected with non-recombinant subtypes: A1 (30, 18.2%), C (7, [4.2%]), D (3, [1.8%]), F1 (9, 5.5%) and G (12, 7.3%). Most patients infected with HIV-1 non-B variants were men (63%, p < 0.001) aged over 35 (73.5%, p < 0.001), heterosexuals (92.2%, p < 0.001), from Africa (59.5%, p < 0.001) and living in the El Ejido area (62.4%, p < 0.001). We found lineages of epidemiological relevance (mainly within Subtype A1), imported primarily through female sex workers from East Europe. We detected 11 transmission clusters of HIV-1 non-B Sub-types, which included patients born in Spain in half of them. We present the phylogenetic profiles of the HIV-1 non-B variants detected in southern Spain, and explore their putative geographical origins. Our data reveals a high HIV-1 genetic diversity likely due to the import of viral lineages that circulate in other countries. The highly immigrated El Ejido area acts as a gateway through which different subtypes are introduced into other regions, hence the importance of setting up epidemiological control measures to prevent future outbreaks.	[Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Garcia, Federico] Hosp Univ San Cecilio, Serv Microbiol Clin, Campus Salud, Granada, Spain; [Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Garcia, Federico] Inst Invest IBS, Granada, Spain; [Pasquau, Juan] Hosp Virgen Nieves, Serv Infecciosas, Granada, Spain; [Omar, Mohamed] Hosp Ciudad Jaen, Serv Infecciosas, Jaen, Spain; [Collado, Antonio] Hosp Torrecardenas, Serv Med Interna, Almeria, Spain; [Vinuesa, David] Hosp Univ San Cecilio, Serv Infecciosas, Granada, Spain; [Belen Lozano, Ana] Hosp Poniente, Serv Infecciosas, Almeria, Spain; [Yebra, Gonzalo] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland	Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada; Hospital Universitario Virgen de las Nieves; Hospital Torrecardenas; Hospital Universitario San Cecilio; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Garcia, F (corresponding author), Hosp Univ San Cecilio, Serv Microbiol Clin, Campus Salud, Granada, Spain.; Garcia, F (corresponding author), Inst Invest IBS, Granada, Spain.	fegarcia@ugr.es	Chueca, Natalia/T-9734-2019; Garcia, Federico/AAA-3175-2020	Chueca, Natalia/0000-0002-3420-3290; Garcia, Federico/0000-0001-7611-781X; Yebra, Gonzalo/0000-0002-3472-3667; Pasquau, Juan/0000-0001-9409-9205	National Plan of I+D+i [RD12/0017/006]; General Ministry of Evaluation and European; Fund of Regional Development (FEDER); Health Institute Carlos III (ISCIII) [PI12/01053]; Ministry of Health of Andalusia [AC-0082-2013]	National Plan of I+D+i; General Ministry of Evaluation and European; Fund of Regional Development (FEDER); Health Institute Carlos III (ISCIII); Ministry of Health of Andalusia	This work was supported by National Plan of I+D+i (RD12/0017/006), granted to FGG; General Ministry of Evaluation and European, granted to FGG; Fund of Regional Development (FEDER), granted to FGG; Health Institute Carlos III (ISCIII), PI12/01053, granted to FGG; and Ministry of Health of Andalusia (AC-0082-2013), granted to FGG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaeus A, 1997, AIDS, V11, P859, DOI 10.1097/00002030-199707000-00004; Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Alexiev I, 2015, J ANTIMICROB CHEMOTH, V70, P1874, DOI 10.1093/jac/dkv011; Bracho MA, 2014, JAIDS-J ACQ IMM DEF, V65, pE130, DOI 10.1097/01.qai.0000435602.73469.56; Alvarez M, 2003, J MED VIROL, V70, P10, DOI 10.1002/jmv.10368; [Anonymous], TRENDS DRUG RES PREV; Apetrei C, 1998, J VIROL, V72, P3534, DOI 10.1128/JVI.72.5.3534-3538.1998; ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brennan CA, 2006, J MED VIROL, V78, pS24, DOI 10.1002/jmv.20603; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; de Felipe B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-416; De Mendoza C, 2009, AIDS RES HUM RETROV, V25, P967, DOI 10.1089/aid.2008.0166; Delgado E, 2014, 6 C NAC GESIDA 8 REU, P12; Delgado E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143325; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Fernandez-Garcia A, 2009, AIDS RES HUM RETROV, V25, P1187, DOI 10.1089/aid.2009.0140; Garcia F, 2011, ANTIVIR RES, V91, P150, DOI 10.1016/j.antiviral.2011.05.010; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gonzalez-Alba JM, 2011, J VIROL, V85, P10755, DOI 10.1128/JVI.00454-11; Grabowski MK, 2014, CURR OPIN HIV AIDS, V9, P126, DOI 10.1097/COH.0000000000000040; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; Hue S, 2014, AIDS, V28, P1967, DOI 10.1097/QAD.0000000000000383; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Parekh B, 1999, AIDS RES HUM RETROV, V15, P133, DOI 10.1089/088922299311556; Galindo JAP, 2015, J CLIN VIROL, V69, P146, DOI 10.1016/j.jcv.2015.06.094; Perez-Parra S, 2015, ENFERM INFECC MICROB; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Taniguchi Y, 2002, AIDS RES HUM RETROV, V18, P79, DOI 10.1089/088922202753394745; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; Thomson MM, 2012, JAIDS-J ACQ IMM DEF, V59, pE49, DOI 10.1097/QAI.0b013e3182400fc4; Tscherning C, 1998, VIROLOGY, V241, P181, DOI 10.1006/viro.1997.8980; vanHarmelen J, 1997, AIDS, V11, P81, DOI 10.1097/00002030-199701000-00012; Vega Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125699; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11; Yebra G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026757	53	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186928	10.1371/journal.pone.0186928	http://dx.doi.org/10.1371/journal.pone.0186928			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084239	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200019
J	Piotrowski, C; Lede, V; Butthof, A; Kaiser, N; Hirrlinger, PG; Tschop, MH; Schoneberg, T; Bechmann, I				Piotrowski, Carolin; Lede, Vera; Butthof, Anne; Kaiser, Nicole; Hirrlinger, Petra G.; Tschoep, Matthias H.; Schoeneberg, Torsten; Bechmann, Ingo			Open housing drives the expression of immune response genes in the nasal mucosa, but not the olfactory bulb	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; VIRUS; ENCEPHALITIS; MENINGITIS; INFECTION; SPREAD; BRAIN; LISTS; MICE	Nasal mucosa and olfactory bulb are separated by the cribriform plate which is perforated by olfactory nerves. We have previously demonstrated that the cribriform plate is permissive for T cells and monocytes and that viruses can enter the bulb upon intranasal injection by axonal transportation. Therefore, we hypothesized that nasal mucosa and olfactory bulb are equipped to deal with constant infectious threats. To detect genes involved in this process, we compared gene expression in nasal mucosa and bulb of mice kept under specific pathogen free (SPF) conditions to gene expression of mice kept on non-SPF conditions using RNA deep sequencing. We found massive alterations in the expression of immune-related genes of the nasal mucosa, while the bulb did not respond immunologically. The absence of induction of immune-related genes in the olfactory bulb suggests effective defence mechanisms hindering entrance of environmental pathogens beyond the outer arachnoid layer. The genes detected in this study may include candidates conferring susceptibility to meningitis.	[Piotrowski, Carolin; Kaiser, Nicole; Bechmann, Ingo] Univ Leipzig, Inst Anat, Fac Med, Leipzig, Germany; [Lede, Vera; Butthof, Anne; Schoeneberg, Torsten] Univ Leipzig, Rudolf Schonheimer Inst Biochem, Fac Med, Leipzig, Germany; [Hirrlinger, Petra G.] Univ Leipzig, Med Expt Ctr, Fac Med, Leipzig, Germany; [Tschoep, Matthias H.] Helmholtz Ctr Environm Hlth, Munich, Germany	Leipzig University; Leipzig University; Leipzig University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Piotrowski, C (corresponding author), Univ Leipzig, Inst Anat, Fac Med, Leipzig, Germany.	carolin.piotrowski@medizin.uni-leipzig.de			Helmholtz Alliance ICEMED; Medical Faculty of the Universitat Leipzig	Helmholtz Alliance ICEMED; Medical Faculty of the Universitat Leipzig	This project was supported by the Helmholtz Alliance ICEMED. CP received a scholarship of the Medical Faculty of the Universitat Leipzig to perform this work.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Cupovic J, 2016, IMMUNITY, V44, P622, DOI 10.1016/j.immuni.2015.12.022; Detje CN, 2015, J VIROL, V89, P2731, DOI 10.1128/JVI.02044-14; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Goldmann J, 2006, J LEUKOCYTE BIOL, V80, P797, DOI 10.1189/jlb.0306176; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johswich KO, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003509; Kaminski M, 2012, J LEUKOCYTE BIOL, V92, P31, DOI 10.1189/jlb.0511241; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEWANDOWSKI G, 1994, J NEUROIMMUNOL, V55, P23, DOI 10.1016/0165-5728(94)90143-0; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Parra B, 1999, J IMMUNOL, V162, P1641; Perez-Pouchoulen M, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0036-15.2015; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094; SHANKAR V, 1992, J VIROL, V66, P992, DOI 10.1128/JVI.66.2.992-998.1992	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187192	10.1371/journal.pone.0187192	http://dx.doi.org/10.1371/journal.pone.0187192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077773	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200051
J	Joshi, N; Werner, S				Joshi, Natasha; Werner, Sabine			Nrf2 is highly expressed in neutrophils, but myeloid cell-derived Nrf2 is dispensable for wound healing in mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; KEAP1; INFLAMMATION; REPAIR; MACROPHAGES; ACTIVATION	Immune cells of the myeloid lineage are key players in skin wound healing, since they secrete various cytokines and growth factors that orchestrate the repair process. In addition, they are crucial for the defense against invading pathogens through their capacity to produce high levels of reactive oxygen species (ROS). To limit the toxicity of ROS, cells have developed antioxidant defense strategies, including expression of the cytoprotective NRF2 transcription factor. Here we show that murine neutrophils and to a lesser extent macrophages strongly express Nrf2 already when present in the circulation and in particular at the wound site. To determine the role of Nrf2 in neutrophils and macrophages for wound repair, we generated mice with a gain-or loss-of-function of this transcription factor in the myeloid cell lineage. Expression of a constitutively active Nrf2 mutant in myeloid cells did not further enhance the overall Nrf2 activity in these cells due to the already high steady-state activity of endogenous Nrf2. Surprisingly, deletion of Nrf2 in myeloid cells only mildly affected the levels of ROS and the expression of pro-inflammatory cytokines by these cells. In particular, various parameters of wound healing, including wound closure, reepithelialization, wound contraction and the presence of myeloid cells at the wound site were not affected. These results reveal that Nrf2 in myeloid cells is dispensable for wound healing and suggest the presence of additional antioxidant defense strategies of these cells that compensate for the loss of Nrf2, even in the harsh environment of skin wounds.	[Joshi, Natasha; Werner, Sabine] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Otto Stern Weg 7, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Werner, S (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Otto Stern Weg 7, Zurich, Switzerland.	sabine.werner@biol.ethz.ch		Werner, Sabine/0000-0001-7397-8710	Swiss National Science Foundation [PDFMP3_137197/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by Swiss National Science Foundation Grant PDFMP3_137197/1 to SW; http://www.snf.ch.	Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dhall S, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/562625; Dias IHK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066407; Dinkova-Kostova AT, 2017, ARCH BIOCHEM BIOPHYS, V617, P84, DOI 10.1016/j.abb.2016.08.005; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Gerstgrasser A, 2017, J CROHNS COLITIS, V11, P485, DOI 10.1093/ecco-jcc/jjw172; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HEROVICI C, 1963, REV FR ETUD CLIN BIO, V8, P88; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kobayashi E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/529219; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315; Lee LY, 2016, LIVER TRANSPLANT, V22, P1115, DOI 10.1002/lt.24473; Li B, 2014, BIOCHEM BIOPH RES CO, V444, P555, DOI 10.1016/j.bbrc.2014.01.101; Long M, 2016, DIABETES, V65, P780, DOI 10.2337/db15-0564; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Meher AK, 2012, FREE RADICAL BIO MED, V52, P1708, DOI 10.1016/j.freeradbiomed.2012.02.022; Rabbani PS, 2017, BIOMATERIALS, V132, P1, DOI 10.1016/j.biomaterials.2017.04.001; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schafer M, 2015, FREE RADICAL BIO MED, V88, P243, DOI 10.1016/j.freeradbiomed.2015.04.018; Schafer M, 2014, EMBO MOL MED, V6, P442, DOI 10.1002/emmm.201303281; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Soares MA, 2016, DIABETES, V65, P633, DOI 10.2337/db15-0453; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3	33	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187162	10.1371/journal.pone.0187162	http://dx.doi.org/10.1371/journal.pone.0187162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073253	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400128
J	Kashyap, S; Warner, G; Hu, Z; Gao, F; Osman, M; Al Saiegh, Y; Lien, KR; Nath, K; Grande, JP				Kashyap, Sonu; Warner, Gina; Hu, Zeng; Gao, Feng; Osman, Mazen; Al Saiegh, Yousif; Lien, Karen R.; Nath, Karl; Grande, Joseph P.			Cardiovascular phenotype in Smad3 deficient mice with renovascular hypertension	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSMS; RENAL-ARTERY STENOSIS; UNILATERAL URETERAL OBSTRUCTION; TARGETED DISRUPTION; GENETIC DEFICIENCY; FIBROSIS; GROWTH; INFLAMMATION; PROTECTS; INJURY	Renovascular hypertension (RVH) has deleterious effects on both the kidney and the heart. TGF-beta signaling through Smad3 directs tissue fibrosis in chronic injury models. In the 2-kidney 1-clip (2K1C) model of RVH, employing mice on the 129 genetic background, Smad3 deficiency (KO) protects the stenotic kidney (STK) from development of interstitial fibrosis. However, these mice have an increased incidence of sudden cardiac death following 2K1C surgery. The purpose of this study was to characterize the cardiovascular phenotype of these mice. Renal artery stenosis (RAS) was established in Wild-type (WT) and Smad3 KO mice (129 genetic background) by placement of a polytetrafluoroethylene cuff on the right renal artery. Mortality was 25.5% for KO mice with RAS, 4.1% for KO sham mice, 1.2% for WT with RAS, and 1.8% for WT sham mice. Myocardial tissue of mice studied at 3 days following surgery showed extensive myocyte necrosis in KO but not WT mice. Myocyte necrosis was associated with a rapid induction of Ccl2 expression, macrophage influx, and increased MMP-9 activity. At later time points, both KO and WT mice developed myocardial fibrosis. No aortic aneurysms or dissections were observed at any time point. Smad3 KO mice were backcrossed to the C57BL/6J strain and subjected to RAS. Sudden death was observed at 10-14 days following surgery in 62.5% of mice; necropsy revealed aortic dissections as the cause of death. As observed in the 129 mice, the STK of Smad3 KO mice on the C57BL/6J background did not develop significant chronic renal damage. We conclude that the cardiovascular manifestations of Smad3 deficient mice are strain-specific, with myocyte necrosis in 129 mice and aortic rupture in C57BL/6J mice. Future studies will define mechanisms underlying this strain-specific effect on the cardiovascular system.	[Kashyap, Sonu; Hu, Zeng; Osman, Mazen; Lien, Karen R.; Grande, Joseph P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Warner, Gina] Mayo Clin, Dept Anesthesiol, Kogod Aging Ctr, Rochester, MN USA; [Gao, Feng] UT Southwestern Med Sch, Dallas, TX USA; [Al Saiegh, Yousif] Hannover Med Sch, Hannover, Germany; [Nath, Karl; Grande, Joseph P.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hannover Medical School; Mayo Clinic	Grande, JP (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.; Grande, JP (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.	granda.joseph@mayo.edu	Grande, Joseph P./AAG-2128-2020	Grande, Joseph P./0000-0001-5674-1682	NIH/NIAID [R01 AI100911-01]; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK101405] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH/NIAID R01 AI100911-01 (https://projectreporter.nih.gov/project_info_description.cfm?aid=9215631&icde=35145736&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC&pball=) and in part by the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biernacka A, 2015, CIRC-HEART FAIL, V8, P788, DOI 10.1161/CIRCHEARTFAILURE.114.001963; Cardin S, 2014, HYPERTENSION, V64, P1040, DOI 10.1161/HYPERTENSIONAHA.114.04067; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Chen HJ, 2003, AM J PHYSIOL-HEART C, V284, pH1612, DOI 10.1152/ajpheart.00992.2002; Cheng J., 2009, J ORGAN DYSFUNCTION, V5, P182; Cheng JF, 2002, EXP BIOL MED, V227, P943, DOI 10.1177/153537020222701102; Cheng JF, 2009, AM J PHYSIOL-RENAL, V297, pF1055, DOI 10.1152/ajprenal.90439.2008; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Divakaran V, 2009, CIRC-HEART FAIL, V2, P633, DOI 10.1161/CIRCHEARTFAILURE.108.823070; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Grande JP, 2002, EXP BIOL MED, V227, P171, DOI 10.1177/153537020222700304; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; Kalra PA, 2010, KIDNEY INT, V77, P37, DOI 10.1038/ki.2009.406; Kashyap S, 2016, AM J PHYSIOL-RENAL, V310, pF372, DOI 10.1152/ajprenal.00131.2015; Keddis MT, 2010, NEPHROL DIAL TRANSPL, V25, P3615, DOI 10.1093/ndt/gfq269; Kobayashi K, 2005, CIRC RES, V96, P904, DOI 10.1161/01.RES.0000163980.55495.44; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Lucas JA, 2010, AM J PHYSIOL-HEART C, V298, pH424, DOI 10.1152/ajpheart.00529.2009; Nath KA, 2011, AM J PHYSIOL-RENAL, V301, pF436, DOI 10.1152/ajprenal.00162.2011; Police SB, 2009, ARTERIOSCL THROM VAS, V29, P1458, DOI 10.1161/ATVBAHA.109.192658; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rateri DL, 2014, AM J PATHOL, V184, P2586, DOI 10.1016/j.ajpath.2014.05.014; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Tan CK, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000269; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Warner GM, 2012, AM J PHYSIOL-RENAL, V302, pF1455, DOI 10.1152/ajprenal.00645.2011; Weber-Mzell D, 2002, EUR HEART J, V23, P1684, DOI 10.1053/euhj.2002.3314; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187062	10.1371/journal.pone.0187062	http://dx.doi.org/10.1371/journal.pone.0187062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073282	gold, Green Submitted, Green Published			2022-12-27	WOS:000413845400106
J	Xu, Y; Li, N; Lu, MS; Dixon, E; Myers, RP; Jelley, RJ; Quan, HD				Xu, Yuan; Li, Ning; Lu, Mingshan; Dixon, Elijah; Myers, Robert P.; Jelley, Rachel J.; Quan, Hude			The effects of patient cost sharing on inpatient utilization, cost, and outcome	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ELECTRONIC HEALTH RECORDS; RURAL CHINA; PROVIDER PAYMENT; MEDICAL-RECORD; CARE; DEMAND; INSURANCE; VALIDATION; BURDEN	Background Health insurance and provider payment reforms all over the world beg a key empirical question: what are the potential impacts of patient cost-sharing on health care utilization, cost and outcomes? The unique health insurance system and rich electronic medical record (EMR) data in China provides us a unique opportunity to study this topic. Methods Four years (2010 to 2014) of EMR data from one medical center in China were utilized, including 10,858 adult patients with liver diseases. We measured patient cost-sharing using actual reimbursement ratio (RR) which is allowed us to better capture financial incentive than using type of health insurance. A rigorous risk adjustment method was employed with both comorbidities and disease severity measures acting as risk adjustors. Associations between RR and health use, costs and outcome were analyzed by multivariate analyses. Results After risk adjustment, patients with more generous health insurance coverage (higher RR) were found to have longer hospital stay, higher total cost, higher medication cost, and higher ratio of medication to total cost, as well as higher number and likelihood that specific procedures were performed. Conclusion Our study implied that patient cost-sharing affects health care services use and cost. This reflects how patients and physicians respond to financial incentives in the current healthcare system in China, and the responses could be a joint effect of both demand and supply side moral hazard. In order to contain cost and improve efficiency in the system, reforming provide payment and insurance scheme is urgently needed.	[Xu, Yuan; Li, Ning] Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China; [Xu, Yuan; Lu, Mingshan; Dixon, Elijah; Myers, Robert P.; Jelley, Rachel J.; Quan, Hude] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Lu, Mingshan] Univ Calgary, Dept Econ, Calgary, AB, Canada; [Dixon, Elijah] Univ Calgary, Div Gen Surg, Dept Med, Calgary, AB, Canada; [Myers, Robert P.] Univ Calgary, Div Gastroenterol & Hepatol, Dept Med, Liver Unit, Calgary, AB, Canada	Capital Medical University; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Li, N (corresponding author), Capital Med Univ, Beijing YouAn Hosp, Beijing, Peoples R China.	lirungya@ccmu.edu.cn		Xu, Yuan/0000-0003-2100-9437; Quan, Hude/0000-0002-7848-7256	Alberta Health Service (AHS); Libin Cardiovascular Institute of Alberta	Alberta Health Service (AHS); Libin Cardiovascular Institute of Alberta	The authors thank Dr. Guanmin Chen from Alberta Health Service (AHS) and Libin Cardiovascular Institute of Alberta and Dr. Mingfu Liu from Alberta Health Service (AHS) for their supports on data mining and analysis.	Bao XY, 2015, BMJ OPEN GASTROENTER, V2, DOI 10.1136/bmjgast-2015-000051; Borah BJ, 2011, HEALTH ECON, V20, P1025, DOI 10.1002/hec.1757; Chang GM, 2011, MED CARE, V49, P1054, DOI 10.1097/MLR.0b013e318235382b; Devlin SS, 2008, J HLTH EC, V27, P1168; Farinati F, 2012, J HEPATOL, V57, P221, DOI 10.1016/j.jhep.2011.12.022; Ginsburg PB, 2013, HEALTH AFFAIR, V32, P929, DOI 10.1377/hlthaff.2012.1007; Ginsburg PB, 2011, NEW ENGL J MED, V365, P1268, DOI 10.1056/NEJMp1107019; Group NJaTIE, 1993, FREE ALL LESSONS RAN; Huang H, 2015, J EPIDEMIOL, V25, P626, DOI 10.2188/jea.JE20140215; Lei JB, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-96; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liu DH, 2010, INT J MED INFORM, V79, P450, DOI 10.1016/j.ijmedinf.2010.03.002; Liu XQ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007362; Ma J, 2008, HEALTH AFFAIR, V27, P937, DOI 10.1377/hlthaff.27.4.937; MANNING WG, 1987, AM ECON REV, V77, P251; Mort EA, 1996, MED CARE, V34, P783, DOI 10.1097/00005650-199608000-00006; Newhouse J.P., 2000, HDB HLTH EC; Powell-Jackson T, 2015, HEALTH ECON, V24, P755, DOI 10.1002/hec.3060; Remler DK, 2003, HEALTH ECON, V12, P269, DOI 10.1002/hec.725; Roayaie S, 2014, J HEPATOL, V61, P3, DOI 10.1016/j.jhep.2014.04.005; Sada Y, 2016, MED CARE, V54, pE9, DOI 10.1097/MLR.0b013e3182a30373; Tian Z, 2015, AUTOMATED EXTRACTION; Van de Voorde C, 2001, HEALTH ECON, V10, P457, DOI 10.1002/hec.631; Wang H, 2011, HEALTH AFFAIR, V30, P2427, DOI 10.1377/hlthaff.2009.0022; Williamson T, 2014, ANN FAM MED, V12, P367, DOI 10.1370/afm.1644; Winkelmann R, 2004, HEALTH ECON, V13, P1081, DOI 10.1002/hec.868; Xu Y, 2014, J AM MED INFORM ASSN, V21, pE84, DOI 10.1136/amiajnl-2013-001806; Xu Y, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-016-0559-4; Xu Y, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0348-6; Yang G, 2013, LANCET, V381, P1987, DOI DOI 10.1016/S0140-6736(13)61097-1; Yip W, 2014, HEALTH AFFAIR, V33, P502, DOI 10.1377/hlthaff.2013.0702; Yip W, 2009, CHINA ECON REV, V20, P613, DOI 10.1016/j.chieco.2009.08.003; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Yuan SW, 2014, PHARMACOECONOMICS, V32, P265, DOI 10.1007/s40273-013-0079-9; Zhao T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2995-z	35	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187096	10.1371/journal.pone.0187096	http://dx.doi.org/10.1371/journal.pone.0187096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073234	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400113
J	Forghani, A; Milner, TE				Forghani, Ali; Milner, Theodore E.			Origin of directionally tuned responses in lower limb muscles to unpredictable upper limb disturbances	PLOS ONE			English	Article							AUTOMATIC POSTURAL RESPONSES; PERTURBATIONS; STANCE; ARM; LOCOMOTION; PLACEMENT; AMPLITUDE	Unpredictable forces which perturb balance are frequently applied to the body through interaction between the upper limb and the environment. Lower limb muscles respond rapidly to these postural disturbances in a highly specific manner. We have shown that the muscle activation patterns of lower limb muscles are organized in a direction specific manner which changes with lower limb stability. Ankle muscles change their activity within 80 ms of the onset of a force perturbation applied to the hand which is earlier than the onset of changes in ground reaction force, ankle angle or head motion. The latency of the response is sensitive to the perturbation direction. However, neither the latency nor the magnitude of the response is affected by stiffening the arm even though this alters the magnitude and timing of motion of the body segments. Based on the short latency, insensitivity of the change in ankle muscle activation to motion of the body segments but sensitivity to perturbation direction we reason that changes in ankle muscle activation are most likely triggered by sensory signals originating from cutaneous receptors in the hand. Furthermore, evidence that the latency of changes in ankle muscle activation depends on the number of perturbation directions suggests that the neural pathway is not confined to the spinal cord.	[Forghani, Ali] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA USA; [Forghani, Ali; Milner, Theodore E.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada	University of Virginia; McGill University	Milner, TE (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada.	theodore.milner@mcgill.ca		Milner, Theodore/0000-0002-8111-6843	Natural Sciences and Engineering Research Council of Canada [RGPIN-142009-2010]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, RGPIN-142009-2010, http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Funding for this research was provided by the Natural Sciences and Engineering Research Council of Canada RGPIN-142009-2010.	Aruin AS, 2001, EXP BRAIN RES, V138, P458; CORDO PJ, 1982, J NEUROPHYSIOL, V47, P287, DOI 10.1152/jn.1982.47.2.287; DIENER HC, 1984, EXP BRAIN RES, V56, P126; Drew T, 1996, EXP BRAIN RES, V111, P153; Forghani A, 2017, J ELECTROMYOGR KINES, V35, P30, DOI 10.1016/j.jelekin.2017.05.006; Forghani A, 2017, NEUROSCIENCE, V352, P170, DOI 10.1016/j.neuroscience.2017.03.062; Henry SM, 1998, J NEUROPHYSIOL, V80, P1939, DOI 10.1152/jn.1998.80.4.1939; Henry SM, 2001, J NEUROPHYSIOL, V85, P559, DOI 10.1152/jn.2001.85.2.559; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; LEE WA, 1990, EXP BRAIN RES, V82, P304; Lowrey CR, 2017, J NEUROPHYSIOL, V117, P1070, DOI 10.1152/jn.01004.2015; MacKinnon CD, 2000, EXP BRAIN RES, V131, P477, DOI 10.1007/s002219900317; MARSDEN CD, 1981, BRAIN, V104, P513, DOI 10.1093/brain/104.3.513; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Milner TE, 2009, MOTOR CONTROL, V13, P454, DOI 10.1123/mcj.13.4.454; Misiaszek JE, 2016, NEUROSCIENCE, V316, P1, DOI 10.1016/j.neuroscience.2015.12.033; MOORE SP, 1988, EXP BRAIN RES, V73, P648, DOI 10.1007/BF00406624; Remaud A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110004; SHIMAMURA M, 1982, BRAIN RES, V231, P51, DOI 10.1016/0006-8993(82)90006-3; Teng BZ, 2017, EXP BRAIN RES, V235, P2235, DOI 10.1007/s00221-017-4963-y; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; TRAUB MM, 1980, BRAIN, V103, P393, DOI 10.1093/brain/103.2.393	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187006	10.1371/journal.pone.0187006	http://dx.doi.org/10.1371/journal.pone.0187006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095888	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200039
J	Furth, KE; McCoy, AJ; Dodge, C; Walters, JR; Buonanno, A; Delaville, C				Furth, Katrina E.; McCoy, Alex J.; Dodge, Caroline; Walters, Judith R.; Buonanno, Andres; Delaville, Claire			Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus	PLOS ONE			English	Article							NMDA RECEPTOR BLOCKADE; FREQUENCY OSCILLATIONS; COGNITIVE CONTROL; BRAIN RHYTHMS; SCHIZOPHRENIA; CONNECTIVITY; NETWORK; RAT; ANTAGONIST; MEMORY	Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of innervation, the mediodorsal (MD) thalamus, have been hypothesized to contribute to the symptoms of schizophrenia. The NMDAR antagonist ketamine, used to model schizophrenia, elicits a brain state resembling early stage schizophrenia characterized by cognitive deficits and increases in cortical low gamma (40-70 Hz) power. Here we sought to determine how ketamine differentially affects spiking and gamma local field potential (LFP) activity in the rat mPFC and MD thalamus. Additionally, we investigated the ability of drugs targeting the dopamine D4 receptor (D4R) to modify the effects of ketamine on gamma activity as a measure of potential cognitive therapeutic efficacy. Rats were trained to walk on a treadmill to reduce confounds related to hyperactivity after ketamine administration (10 mg/kg s.c.) while recordings were obtained from electrodes chronically implanted in the mPFC and MD thalamus. Ketamine increased gamma LFP power in mPFC and MD thalamus in a similar frequency range, yet did not increase thalamocortical synchronization. Ketamine also increased firing rates and spike synchronization to gamma oscillations in the mPFC but decreased both measures in MD thalamus. Conversely, walking alone increased both firing rates and spike-gamma LFP correlations in both mPFC and MD thalamus. The D4R antagonist alone (L-745,870) had no effect on gamma LFP power during treadmill walking, although it reversed increases induced by the D4R agonist (A-412997) in both mPFC and MD thalamus. Neither drug altered ketamine-induced changes in gamma power or firing rates in the mPFC. However, in MD thalamus, the D4R agonist increased ketamine-induced gamma power and prevented ketamine's inhibitory effect on firing rates. Results provide new evidence that ketamine differentially modulates spiking and gamma power in MD thalamus and mPFC, supporting a potential role for both areas in contributing to ketamine-induced schizophrenia-like symptoms.	[Furth, Katrina E.; McCoy, Alex J.; Dodge, Caroline; Walters, Judith R.; Delaville, Claire] NINDS, Neurophysiol Pharmacol Sect, NIH, Bethesda, MD 20892 USA; [Furth, Katrina E.] Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA; [Furth, Katrina E.; Buonanno, Andres] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Neurobiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Boston University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Furth, KE (corresponding author), NINDS, Neurophysiol Pharmacol Sect, NIH, Bethesda, MD 20892 USA.; Furth, KE (corresponding author), Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA.; Furth, KE (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Neurobiol, NIH, Bethesda, MD 20892 USA.	kfurth@bu.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [ZIA-HD000711]; National Institute of Neurological Disorders and Stroke (NINDS), intramural research programs; Office of Behavioral and Social Sciences Research (OBSSR) Bench-to-Bedside award [NHD15003]; Boston University Graduate Program for Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003117] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke (NINDS), intramural research programs; Office of Behavioral and Social Sciences Research (OBSSR) Bench-to-Bedside award; Boston University Graduate Program for Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful for the generous support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; ZIA-HD000711) and the National Institute of Neurological Disorders and Stroke (NINDS), intramural research programs, and the Office of Behavioral and Social Sciences Research (OBSSR) Bench-to-Bedside award (NHD15003). K.E.F. was supported by university training fellowships from the Boston University Graduate Program for Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors are grateful for the generous support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; ZIA-HD000711) and the National Institute of Neurological Disorders and Stroke (NINDS), intramural research programs, and the Office of Behavioral and Social Sciences Research (OBSSR) Bench-to-Bedside award (NHD15003). The authors also thank Dr. Detlef Vullhorst for his insightful comments on the manuscript. K.E.F. was supported by university training fellowships from the Boston University Graduate Program for Neuroscience.	Abdallah CG, 2015, ANNU REV MED, V66, P509, DOI 10.1146/annurev-med-053013-062946; Alcaraz F, 2016, EUR J NEUROSCI, V44, P1972, DOI 10.1111/ejn.13316; Anderson PM, 2014, INT J NEUROPSYCHOPH, V17, P1895, DOI 10.1017/S1461145714000959; Anderson PM, 2016, CEREB CORTEX; Andersson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040906; Andersson RH, 2012, P NATL ACAD SCI USA, V109, P13118, DOI 10.1073/pnas.1201011109; Anticevic A, 2017, BIOL PSYCHIAT, V81, P818, DOI 10.1016/j.biopsych.2016.12.006; Anticevic A, 2015, BIOL PSYCHIAT, V77, P569, DOI 10.1016/j.biopsych.2014.07.022; Anticevic A, 2014, CEREB CORTEX, V24, P3116, DOI 10.1093/cercor/bht165; Anticevic A, 2014, SCHIZOPHRENIA BULL, V40, P1227, DOI 10.1093/schbul/sbu100; Arnsten AFT, 2000, NEUROPSYCHOPHARMACOL, V23, P405, DOI 10.1016/S0893-133X(00)00133-0; Avila I, 2010, EXP NEUROL, V221, P307, DOI 10.1016/j.expneurol.2009.11.016; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Becker R, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.53; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; Bernaerts P, 2003, BEHAV BRAIN RES, V142, P41, DOI 10.1016/S0166-4328(02)00371-6; Bokil H, 2007, J NEUROSCI METH, V159, P337, DOI 10.1016/j.jneumeth.2006.07.011; Bolkan SS, 2017, NAT NEUROSCI, V20, P987, DOI 10.1038/nn.4568; Brazhnik E, 2016, J NEUROSCI, V36, P4196, DOI 10.1523/JNEUROSCI.3582-15.2016; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cannon J, 2014, EUR J NEUROSCI, V39, P705, DOI 10.1111/ejn.12453; Celada P, 2013, INT J NEUROPSYCHOPH, V16, P2145, DOI 10.1017/S1461145713000643; CHO AK, 1991, PHARMACOL BIOCHEM BE, V39, P947, DOI 10.1016/0091-3057(91)90058-A; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Clinton SM, 2004, SCHIZOPHR RES, V69, P237, DOI 10.1016/j.schres.2003.09.017; Cohen IV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01590-x; Cronenwett WJ, 2010, CURR TOP BEHAV NEURO, V4, P509, DOI 10.1007/7854_2010_55; Dawson N, 2014, NEUROPSYCHOPHARMACOL, V39, P1786, DOI 10.1038/npp.2014.26; Dawson N, 2013, SCHIZOPHRENIA BULL, V39, P366, DOI 10.1093/schbul/sbr144; de la Sallel S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00348; Delaville C, 2015, J NEUROSCI, V35, P6918, DOI 10.1523/JNEUROSCI.0587-15.2015; Demiralp T, 2007, CEREB CORTEX, V17, P1007, DOI 10.1093/cercor/bhl011; Dorph-Petersen KA, 2017, SCHIZOPHR RES, V180, P28, DOI 10.1016/j.schres.2016.08.007; Driesen NR, 2013, NEUROPSYCHOPHARMACOL, V38, P2613, DOI 10.1038/npp.2013.170; Dupre KB, 2016, NEUROBIOL DIS, V86, P1, DOI 10.1016/j.nbd.2015.11.009; Ehrlichman RS, 2009, NEUROSCIENCE, V158, P705, DOI 10.1016/j.neuroscience.2008.10.031; Frohlich J, 2014, J PSYCHOPHARMACOL, V28, P287, DOI 10.1177/0269881113512909; Furth KE, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00102; Gasca-Martinez D, 2010, NEUROSCIENCE, V169, P1672, DOI 10.1016/j.neuroscience.2010.05.048; Gilmour G, 2012, NEUROPHARMACOLOGY, V62, P1401, DOI 10.1016/j.neuropharm.2011.03.015; Giraldo-Chica M, 2017, SCHIZOPHR RES, V180, P58, DOI 10.1016/j.schres.2016.08.005; Gonzalez-Burgos G, 2015, BIOL PSYCHIAT, V77, P1031, DOI 10.1016/j.biopsych.2015.03.010; Govindaiah G, 2010, J NEUROPHYSIOL, V104, P2757, DOI 10.1152/jn.00361.2010; Guidi M, 2015, NEUROBIOL LEARN MEM, V125, P36, DOI 10.1016/j.nlm.2015.07.015; Hakami T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006755; Hoeflich A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv040; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hong LE, 2010, NEUROPSYCHOPHARMACOL, V35, P632, DOI 10.1038/npp.2009.168; Hudson MR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.51; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; Jadi M. P., 2015, BIOL PSYCHIAT; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V142, P78, DOI 10.1007/s002130050865; Jones EG, 1997, SCHIZOPHRENIA BULL, V23, P483, DOI 10.1093/schbul/23.3.483; Jones NC, 2014, INT J NEUROPSYCHOPH, V17, P1671, DOI 10.1017/S1461145714000492; Jones NC, 2012, INT J NEUROPSYCHOPH, V15, P657, DOI 10.1017/S1461145711000848; Kiss Tamas, 2011, Front Psychiatry, V2, P14, DOI 10.3389/fpsyt.2011.00014; Kocsis B, 2014, BRAIN STRUCT FUNCT, P1; Kocsis B, 2013, CNS NEUROSCI THER, V19, P437, DOI 10.1111/cns.12081; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Krystal JH, 2017, BIOL PSYCHIAT, V81, P874, DOI 10.1016/j.biopsych.2017.01.004; Kulikova SP, 2012, EUR J NEUROSCI, V36, P3407, DOI 10.1111/j.1460-9568.2012.08263.x; Lazarewicz MT, 2010, J COGNITIVE NEUROSCI, V22, P1452, DOI 10.1162/jocn.2009.21305; Lee S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00869; Lener MS, 2017, BIOL PSYCHIAT, V81, P886, DOI 10.1016/j.biopsych.2016.05.005; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Lodge D, 2015, BRIT J PHARMACOL, V172, P4254, DOI 10.1111/bph.13222; Lowet E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146443; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; Miller OH, 2016, NEUROPHARMACOLOGY, V100, P17, DOI 10.1016/j.neuropharm.2015.07.028; Minzenberg MJ, 2010, NEUROPSYCHOPHARMACOL, V35, P2590, DOI 10.1038/npp.2010.150; Mitchell AS, 2015, NEUROSCI BIOBEHAV R, V54, P76, DOI 10.1016/j.neubiorev.2015.03.001; Mitchell AS, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00037; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Molina LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085842; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; Murai T, 2014, BEHAV BRAIN RES, V261, P26, DOI 10.1016/j.bbr.2013.11.036; Nakazawa S, 2015, PSYCHOPHARMACOLOGY, V232, P3287, DOI 10.1007/s00213-015-3978-y; Nayak S, 2003, PROG NEURO-PSYCHOPH, V27, P441, DOI 10.1016/S0278-5846(03)00031-9; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Parnaudeau S, 2013, NEURON, V77, P1151, DOI 10.1016/j.neuron.2013.01.038; Pergola G, 2015, NEUROSCI BIOBEHAV R, V54, P57, DOI 10.1016/j.neubiorev.2015.01.013; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; Pinault D, 2008, BIOL PSYCHIAT, V63, P730, DOI 10.1016/j.biopsych.2007.10.006; Pinault D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7040034; Pittman-Polletta BR, 2015, BIOL PSYCHIAT, V77, P1020, DOI 10.1016/j.biopsych.2015.02.005; Popken GJ, 2000, P NATL ACAD SCI USA, V97, P9276, DOI 10.1073/pnas.150243397; Rivolta D, 2015, SCHIZOPHRENIA BULL, V41, P1105, DOI 10.1093/schbul/sbv051; Rondou P, 2010, CELL MOL LIFE SCI, V67, P1971, DOI 10.1007/s00018-010-0293-y; Rosen ZB, 2015, NAT NEUROSCI, V18, P1763, DOI 10.1038/nn.4152; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Sakurai T, 2015, PROG NEUROBIOL, V134, P178, DOI 10.1016/j.pneurobio.2015.09.010; SALT TE, 1988, BRIT J PHARMACOL, V94, P443, DOI 10.1111/j.1476-5381.1988.tb11546.x; Salt TE, 1996, PROG NEUROBIOL, V48, P55, DOI 10.1016/0301-0082(95)00047-X; Santana N, 2011, BIOL PSYCHIAT, V69, P918, DOI 10.1016/j.biopsych.2010.10.030; Shaw AD, 2015, EUR NEUROPSYCHOPHARM, V25, P1136, DOI 10.1016/j.euroneuro.2015.04.012; Sherman SM, 2016, NAT NEUROSCI, V19, P533, DOI 10.1038/nn.4269; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Swanson JM, 1998, MOL PSYCHIATR, V3, P38, DOI 10.1038/sj.mp.4000354; Troyano-Rodriguez E, 2014, BIOL PSYCHIAT, V76, P937, DOI 10.1016/j.biopsych.2014.05.019; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Walther S, 2012, NEUROPSYCHOBIOLOGY, V66, P77, DOI 10.1159/000339456; Watis L, 2008, J NEURAL TRANSM, V115, P493, DOI 10.1007/s00702-007-0859-5; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009; Womelsdorf T, 2014, NAT NEUROSCI, V17, P1031, DOI 10.1038/nn.3764; Wood J, 2012, J NEUROSCI, V32, P3022, DOI 10.1523/JNEUROSCI.6377-11.2012; Woodward ND, 2016, BIOL PSYCHIAT, V79, P1016, DOI 10.1016/j.biopsych.2015.06.026; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Woolley ML, 2008, BEHAV PHARMACOL, V19, P765, DOI 10.1097/FBP.0b013e32831c3b06; Zanos P, 2016, NATURE; Zhang YC, 2014, SCHIZOPHR RES, V153, P129, DOI 10.1016/j.schres.2014.01.023	114	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186732	10.1371/journal.pone.0186732	http://dx.doi.org/10.1371/journal.pone.0186732			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095852	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200022
J	Szakacs, Z; Matrai, P; Hegyi, P; Szabo, I; Vincze, A; Balasko, M; Mosdosi, B; Sarlos, P; Simon, M; Marta, K; Miko, A; Pecsi, D; Demcsak, A; Bajor, J				Szakacs, Zsolt; Matrai, Peter; Hegyi, Peter; Szabo, Imre; Vincze, Aron; Balasko, Marta; Mosdosi, Bernadett; Sarlos, Patrcia; Simon, Maria; Marta, Katalin; Miko, Alexandra; Pecsi, Daniel; Demcsak, Alexandra; Bajor, Judit			Younger age at diagnosis predisposes to mucosal recovery in celiac disease on a gluten-free diet: A meta-analysis	PLOS ONE			English	Article							HISTOLOGICAL FOLLOW-UP; VILLOUS ATROPHY; TRANSGLUTAMINASE ANTIBODIES; DUODENAL BIOPSIES; INTESTINAL-MUCOSA; ADULT PATIENTS; CHILDREN; PREVALENCE; DENSITY; PREDICTORS	Background and aims Persistent intestinal damage is associated with higher complication rates in celiac disease. We aimed to assess the potential modifiers of mucosal recovery. Materials and methods We screened databases (PubMed, Embase, Cochrane Trials, and Web of Science) for papers on celiac disease. Papers discussing (1) celiac patients (2) follow-up biopsy and (3) mucosal recovery after commencement of a gluten-free diet were included. The primary outcome was to produce a comprehensive analysis of complete mucosal recovery (i.e., Marsh 0 on follow-up). We compared children's recovery ratios to those of adults. Patients following a strict gluten-free dietary regimen were included in a subgroup. Summary point estimates, 95% confidence intervals (CIs), and 95% predictive intervals (Pis) were calculated. Heterogeneity was tested with l(2)-statistic. The PROSPERO registration number is CRD42016053482. Results The overall complete mucosal recovery ratio, calculated from 37 observational studies, was 0.36 (Cl: 0.28-0.44, PI:-0.12-0.84; I-2: 98.4%, p<0.01). Children showed higher complete mucosal recovery ratio than adults (p<0.01): 0.65 (Cl: 0.44-0.85, PI:-0.10-1.39; I-2: 96.5%, p<0.01) as opposed to 0.24 (Cl: 0.15-0.33, PI:-0.19-1.08; I-2: 96.3%, p<0.01). In the strict dietary adherence subgroup, complete mucosal recovery ratio was 0.47 (Cl: 0.24-0.70, PI:-0.47-1.41; I-2: 98.8%, p<0.001). On meta-regression, diagnostic villous atrophy (Marsh 3) ratio (-8.97, p<0.01) and male ratio (+6.04, p<0.01) proved to be a significant determinant of complete mucosal recovery, unlike duration of gluten-free diet (+0.01, p = 0.62). The correlation between complete mucosal recovery ratio and age on diagnosis is of borderline that no competing interests exist. significance (-0.03, p = 0.05). Conclusions There is considerable heterogeneity across studies concerning complete mucosal recovery ratios achieved by a gluten-free diet in celiac disease. Several celiac patients fail to achieve complete mucosal recovery even if a strict dietary regimen is followed. Younger age on diagnosis, less severe initial histologic damage and male gender predispose for achieving mucosal recovery.	[Szakacs, Zsolt; Hegyi, Peter; Balasko, Marta; Marta, Katalin; Miko, Alexandra; Pecsi, Daniel] Univ Pecs, Inst Translat Med, Pecs, Hungary; [Matrai, Peter] Univ Pecs, Inst Bioanal, Pecs, Hungary; [Hegyi, Peter] Univ Szeged, Hungarian Acad Sci, Momentum Gastroenterol Multidisciplinary Res Grp, Szeged, Hungary; [Szabo, Imre; Vincze, Aron; Sarlos, Patrcia; Bajor, Judit] Univ Pecs, Dept Internal Med 1st, Div Gastroenterol, Pecs, Hungary; [Mosdosi, Bernadett] Univ Pecs, Dept Paediat, Pecs, Hungary; [Simon, Maria] Univ Pecs, Dept Psychiat & Psychotherapy, Pecs, Hungary; [Demcsak, Alexandra] Univ Szeged, Dept Pediat, Szeged, Hungary	University of Pecs; University of Pecs; Hungarian Academy of Sciences; Szeged University; University of Pecs; University of Pecs; University of Pecs; Szeged University	Szakacs, Z (corresponding author), Univ Pecs, Inst Translat Med, Pecs, Hungary.	szaki92@gmail.com	Sarlos, Patricia/V-6890-2017; Vincze, Aron/A-7048-2011; Mikó, Alexandra/AAE-6190-2020; Pecsi, Daniel/J-7408-2019; Vincze, Aron/J-6724-2019	Sarlos, Patricia/0000-0002-5086-9455; Vincze, Aron/0000-0003-2217-7686; Pecsi, Daniel/0000-0003-0499-6004; Vincze, Aron/0000-0003-2217-7686; Demcsak, Alexandra/0000-0002-5391-6931; Szakacs, Zsolt/0000-0002-7035-941X	Economic Development and Innovation Operative Programme Grant of the National Research, Development and Innovation Office [GINOP 2.3.2-15-2016-00048]; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-3-I, UNKP-17-3-II]	Economic Development and Innovation Operative Programme Grant of the National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); New National Excellence Program of the Ministry of Human Capacities	This work was supported by the Economic Development and Innovation Operative Programme Grant of the National Research, Development and Innovation Office (GINOP 2.3.2-15-2016-00048) STAY ALIVE grant and by the UNKP-17-3-I, UNKP-17-3-II New National Excellence Program of the Ministry of Human Capacities.	Abdulkarim AS, 2002, AM J GASTROENTEROL, V97, P2016; Annibale B, 2001, AM J GASTROENTEROL, V96, P132, DOI 10.1111/j.1572-0241.2001.03463.x; Assiri Asaad M A, 2008, Trop Gastroenterol, V29, P217; BAKER PG, 1975, BRIT MED J, V1, P486, DOI 10.1136/bmj.1.5956.486; Bannister EG, 2014, AM J GASTROENTEROL, V109, P1478, DOI 10.1038/ajg.2014.200; Bardella MT, 2007, HISTOPATHOLOGY, V50, P465, DOI 10.1111/j.1365-2559.2007.02621.x; Baudon JJ, 2005, GASTROEN CLIN BIOL, V29, P1097, DOI 10.1016/S0399-8320(05)82173-6; Bhasin TS, 2010, J CLIN DIAGN RES, V4, P2217; Biagi F, 2012, BRIT J NUTR, V108, P1884, DOI 10.1017/S0007114511007367; Cammarota G, 2007, ENDOSCOPY, V39, P46, DOI 10.1055/s-2006-945044; Capristo E, 2009, J CLIN GASTROENTEROL, V43, P946, DOI 10.1097/MCG.0b013e3181978e4d; Carroccio A, 2008, SCAND J GASTROENTERO, V43, P1315, DOI 10.1080/00365520802200044; Caruso R, 2014, DIGEST LIVER DIS, V46, P323, DOI 10.1016/j.dld.2013.12.005; Casella S, 2012, J AM GERIATR SOC, V60, P1064, DOI 10.1111/j.1532-5415.2012.03997.x; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Ciacci C, 2005, ALIMENT PHARM THERAP, V21, P421, DOI 10.1111/j.1365-2036.2005.02345.x; Ciacci C, 2002, DIGESTION, V66, P178, DOI 10.1159/000066757; Collin P, 2004, GASTROINTEST ENDOSC, V59, P158, DOI 10.1016/S0016-5107(03)01311-7; COLLINS BJ, 1986, J ROY SOC MED, V79, P206, DOI 10.1177/014107688607900406; CONGDON P, 1981, AM J DIS CHILD, V135, P118, DOI 10.1001/archpedi.1981.02130260010004; Corazza GR, 2007, CLIN GASTROENTEROL H, V5, P838, DOI 10.1016/j.cgh.2007.03.019; Corazza GR, 2005, J CLIN PATHOL, V58, P573, DOI 10.1136/jcp.2004.023978; CORAZZA GR, 1994, J INTERN MED, V236, P183, DOI 10.1111/j.1365-2796.1994.tb01281.x; Cuoco L, 1998, SCAND J GASTROENTERO, V33, P401; de Chaisemartin L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136745; Dickey W, 2000, AM J GASTROENTEROL, V95, P712, DOI 10.1111/j.1572-0241.2000.01838.x; Donaldson MR, 2008, J CLIN GASTROENTEROL, V42, P256, DOI 10.1097/MCG.0b013e31802e70b1; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Duerksen DR, 2010, DIGEST DIS SCI, V55, P1026, DOI 10.1007/s10620-009-0813-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elli L, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0361-8; Fine KD, 1997, GASTROENTEROLOGY, V112, P1830, DOI 10.1053/gast.1997.v112.pm9178673; Galli G, 2014, ALIMENT PHARM THER, V40, P639, DOI 10.1111/apt.12893; Ghazzawi Y, 2014, J PEDIATR GASTR NUTR, V59, P229, DOI 10.1097/MPG.0000000000000390; Gorgun J, 2009, VIRCHOWS ARCH, V455, P363, DOI 10.1007/s00428-009-0832-9; Green PHR, 2015, J ALLERGY CLIN IMMUN, V135, P1099, DOI 10.1016/j.jaci.2015.01.044; GREFTE JMM, 1988, J CLIN PATHOL, V41, P886, DOI 10.1136/jcp.41.8.886; Gunther U, 2010, ENDOSCOPY, V42, P197, DOI 10.1055/s-0029-1243937; Gujral N, 2012, WORLD J GASTROENTERO, V18, P6036, DOI 10.3748/wjg.v18.i42.6036; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haere P, 2016, SCAND J GASTROENTERO, V51, P1439, DOI 10.1080/00365521.2016.1218540; Hansen D, 2006, DIABETES CARE, V29, P2452, DOI 10.2337/dc06-0990; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hogberg L, 2003, SCAND J GASTROENTERO, V38, P751, DOI 10.1080/00365520310003318; Hopper AD, 2008, CLIN GASTROENTEROL H, V6, P314, DOI 10.1016/j.cgh.2007.12.008; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Hutchinson JM, 2010, QJM-INT J MED, V103, P511, DOI 10.1093/qjmed/hcq076; Iltanen S, 1999, AUTOIMMUNITY, V29, P179, DOI 10.3109/08916939908998533; Iltanen S, 1999, CLIN EXP IMMUNOL, V117, P51; Kapur G, 2004, J TROP PEDIATRICS, V50, P37, DOI 10.1093/tropej/50.1.37; Karinen H, 2006, SCAND J GASTROENTERO, V41, P191, DOI 10.1080/00365520500206277; Kaukinen K, 2007, ALIMENT PHARM THER, V25, P1237, DOI 10.1111/j.1365-2036.2007.03311.x; Kaukinen K, 2002, EUR J GASTROEN HEPAT, V14, P311, DOI 10.1097/00042737-200203000-00017; Kemppainen TA, 1998, AM J CLIN NUTR, V67, P482, DOI 10.1093/ajcn/67.3.482; Koskinen O, 2010, J CLIN GASTROENTEROL, V44, P483, DOI 10.1097/MCG.0b013e3181b64557; KUMAR PJ, 1988, ARCH DIS CHILD, V63, P916, DOI 10.1136/adc.63.8.916; Lahdenpera A, 2011, SCAND J GASTROENTERO, V46, P538, DOI 10.3109/00365521.2011.551888; Lanzini A, 2009, ALIMENT PHARM THER, V29, P1299, DOI 10.1111/j.1365-2036.2009.03992.x; Lebwohl B, 2014, Aliment Pharmacol Ther, V39, P488, DOI 10.1111/apt.12621; Lebwohl B, 2013, ALIMENT PHARM THER, V37, P332, DOI 10.1111/apt.12164; Lebwohl B, 2015, CLIN GASTROENTEROL H, V13, P1111, DOI 10.1016/j.cgh.2014.11.018; Lebwohl B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117529; Lebwohl B, 2014, J CLIN ENDOCR METAB, V99, P609, DOI 10.1210/jc.2013-3164; Lebwohl B, 2013, ANN INTERN MED, V159, P169, DOI 10.7326/0003-4819-159-3-201308060-00006; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; Leffler DA, 2008, DIGEST DIS SCI, V53, P1573, DOI 10.1007/s10620-007-0055-3; Leffler DA, 2007, CLIN GASTROENTEROL H, V5, P445, DOI 10.1016/j.cgh.2006.12.006; Lichtwark IT, 2014, ALIMENT PHARM THER, V40, P160, DOI 10.1111/apt.12809; Lidums Ilmars, 2011, Clin Transl Gastroenterol, V2, pe4, DOI 10.1038/ctg.2011.3; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Martini S, 2002, CLIN CHEM, V48, P960; MAYER M, 1991, GUT, V32, P881, DOI 10.1136/gut.32.8.881; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McMillan SA, 2001, J CLIN PATHOL, V54, P783, DOI 10.1136/jcp.54.10.783; Metzger MH, 2006, EUR J EPIDEMIOL, V21, P359, DOI 10.1007/s10654-006-9002-4; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; MONTGOMERY AMP, 1988, GUT, V29, P1564, DOI 10.1136/gut.29.11.1564; Murray JA, 2004, AM J CLIN NUTR, V79, P669; Newnham ED, 2016, J GASTROEN HEPATOL, V31, P342, DOI 10.1111/jgh.13060; Nieminen U, 2001, SCAND J GASTROENTERO, V36, P507, DOI 10.1080/003655201750153331; O'Keeffe J, 2001, CLIN EXP IMMUNOL, V125, P376, DOI 10.1046/j.1365-2249.2001.01594.x; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; ODERDA G, 1993, J PEDIATR GASTR NUTR, V16, P172, DOI 10.1097/00005176-199302000-00013; Pekki H, 2015, AM J GASTROENTEROL, V110, P1078, DOI 10.1038/ajg.2015.155; Peraaho M, 2003, ALIMENT PHARM THER, V17, P587, DOI 10.1046/j.1365-2036.2003.01425.x; Raivio T, 2006, ALIMENT PHARM THER, V24, P147, DOI 10.1111/j.1365-2036.2006.02957.x; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Selby WS, 1999, SCAND J GASTROENTERO, V34, P909, DOI 10.1080/003655299750025390; Sharkey LM, 2013, ALIMENT PHARM THER, V38, P1278, DOI 10.1111/apt.12510; SHMERLING DH, 1986, J PEDIATR GASTR NUTR, V5, P565, DOI 10.1097/00005176-198607000-00010; Silvester JA, 2017, GASTROENTEROLOGY; Sjoberg V, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.9; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tuire I, 2012, AM J GASTROENTEROL, V107, P1563, DOI 10.1038/ajg.2012.220; Tursi A, 2006, ENDOSCOPY, V38, P702, DOI 10.1055/s-2006-925178; Uil JJ, 1996, EUR J GASTROEN HEPAT, V8, P219, DOI 10.1097/00042737-199603000-00006; Vahedi K, 2003, AM J GASTROENTEROL, V98, P1079, DOI [10.1016/S0002-9270(02)06006-9, 10.1111/j.1572-0241.2003.07284.x]; Valdimarsson T, 2000, SCAND J GASTROENTERO, V35, P274; VALDIMARSSON T, 1994, SCAND J GASTROENTERO, V29, P457, DOI 10.3109/00365529409096838; Vecsei AKW, 2009, ENDOSCOPY, V41, P123, DOI 10.1055/s-0028-1103484; Vecsei E, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-28; Vivas S, 2009, WORLD J GASTROENTERO, V15, P4775, DOI 10.3748/wjg.15.4775; Volta U, 2008, DIGEST DIS SCI, V53, P1582, DOI 10.1007/s10620-007-0058-0; Wahab PJ, 2002, AM J CLIN PATHOL, V118, P459; Wahab PJ, 2001, JPN J CANCER RES, V92, P279, DOI 10.1111/j.1349-7006.2001.tb01092.x; Wells G.A., 2011, NEWCASTLE OTTAWA SCA; Yachha SK, 2007, J GASTROEN HEPATOL, V22, P1300, DOI 10.1111/j.1440-1746.2007.04929.x; Zanini B, 2012, DIGEST LIVER DIS, V44, P280, DOI 10.1016/j.dld.2011.10.013	112	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187526	10.1371/journal.pone.0187526	http://dx.doi.org/10.1371/journal.pone.0187526			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095937	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000414340200110
J	Zhao, LL; Ru, YF; Liu, M; Tang, JN; Zheng, JF; Wu, B; Gu, YH; Shi, HJ				Zhao, Li-lin; Ru, Yan-fei; Liu, Miao; Tang, Jia-nan; Zheng, Ju-fen; Wu, Bin; Gu, Yi-hua; Shi, Hui-juan			Reproductive effects of cadmium on sperm function and early embryonic development in vitro	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; INDUCED APOPTOSIS; DAMAGE; RAT; EXPOSURE; ZINC; LEAD; FERTILIZATION; DYSFUNCTION; EXPRESSION	Cadmium is a major environmental toxicant that is released into the atmosphere, water and soil in the form of cadmium oxide, cadmium chloride, or cadmium sulfide via industrial activities, such as the manufacturing of batteries and pigments, metal smelting and refining and municipal waste incineration. In the present study, we investigated the effects of cadmium exposure on sperm quality parameters, fertilization capacity and early embryonic development. Our study showed that in vitro incubation of human or mouse sperms with cadmium for a long time (up to 24 hours) could significantly decreased sperm motility in a concentration-and time-dependent manner. Exposure to cadmium in the environment for a short term (30 min) did not affect sperm motility but significantly reduced in vitro fertilization rate. We also evaluated the effects of cadmium at concentrations of 0.625 mu g/ml, and 1.25 mu g/ml on early embryonic development in vitro and observed that the blastocyst formation rate dramatically decreased with increasing cadmium concentration. This finding emphasizes the hazardous effects of cadmium on sperm quality as well as on natural embryo development and raises greater concerns regarding cadmium pollution.	[Zhao, Li-lin; Ru, Yan-fei; Liu, Miao; Tang, Jia-nan; Zheng, Ju-fen; Wu, Bin; Gu, Yi-hua; Shi, Hui-juan] Fudan Univ, Reprod & Dev Inst, SIPPR, Key Lab Reprod Regulat NPFPC, Shanghai, Peoples R China; [Shi, Hui-juan] Shanghai Jiao Tong Univ, Shanghai Key Lab Reprod Med, Shanghai, Peoples R China	Fudan University; Shanghai Jiao Tong University	Gu, YH; Shi, HJ (corresponding author), Fudan Univ, Reprod & Dev Inst, SIPPR, Key Lab Reprod Regulat NPFPC, Shanghai, Peoples R China.; Shi, HJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Reprod Med, Shanghai, Peoples R China.	gu_yihua@hotmail.com; shihuijuan2011@163.com			Ministry of Science and Technology of China [2014CB943104]; Shanghai Municipal Commission of 415 Health and Family Planning [201440002]; Family Planning Project	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Commission of 415 Health and Family Planning; Family Planning Project	This work was supported by the Ministry of Science and Technology of China (2014CB943104) and Family Planning Project, Shanghai Municipal Commission of 415 Health and Family Planning (201440002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Ministry of Science and Technology of China (2014CB943104) and Family Planning Project, Shanghai Municipal Commission of 415 Health and Family Planning (201440002). We thank the Shanghai JIAI Genetics & IVF Institute for their valuable comments on this study.	Abdelrazek HMA, 2016, REPROD BIOL, V16, P300, DOI 10.1016/j.repbio.2016.11.001; Adamkovicova M, 2016, REPROD BIOL ENDOCRIN, V14, DOI 10.1186/s12958-016-0177-6; Adedara IA, 2010, HUM EXP TOXICOL, V29, P801, DOI 10.1177/0960327109360115; Amara S, 2008, J REPROD DEVELOP, V54, P129, DOI 10.1262/jrd.18110; Benoff S, 2000, HUM REPROD UPDATE, V6, P107, DOI 10.1093/humupd/6.2.107; Benoff Susan, 2008, Fertil Steril, V89, pe73, DOI 10.1016/j.fertnstert.2007.12.035; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cilenk KT, 2016, EXP MOL PATHOL, V101, P207, DOI 10.1016/j.yexmp.2016.08.004; Correia S, 2017, J APPL TOXICOL, V37, P159, DOI 10.1002/jat.3333; Da Costa R, 2016, ANDROLOGIA, V48, P464, DOI 10.1111/and.12466; de Freitas ML, 2012, J TOXICOL SCI, V37, P899, DOI 10.2131/jts.37.899; Dorostghoal M, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12762; Gu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070112; Herak-Kramberger CM, 2000, BIOL REPROD, V63, P599, DOI 10.1095/biolreprod63.2.599; Phuc HD, 2017, J APPL TOXICOL, V37, P1046, DOI 10.1002/jat.3455; Huang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050465; Jelks K, 2001, REPROD TOXICOL, V15, P11; Kim J, 2009, TOXICOL LETT, V188, P45, DOI 10.1016/j.toxlet.2009.03.006; Kim K, 2010, J ASSIST REPROD GEN, V27, P463, DOI 10.1007/s10815-010-9437-0; Kudo C, 2004, J NEUROCHEM, V88, P1416, DOI 10.1046/j.1471-4159.2003.02270.x; Lamas CD, 2017, INT J EXP PATHOL, V98, P86, DOI 10.1111/iep.12227; Li XH, 2016, TOXICOLOGY, V357, P52, DOI 10.1016/j.tox.2016.06.003; Liu W, 2014, TOXICOL LETT, V224, P1, DOI 10.1016/j.toxlet.2013.10.009; Lorenzetti S, 2011, ANN I SUPER SANITA, V47, P429, DOI 10.4415/ANN_11_04_16; Martino NA, 2017, REPROD TOXICOL, V69, P132, DOI 10.1016/j.reprotox.2017.02.005; Olszowski T, 2012, ACTA BIOCHIM POL, V59, P475; Oteiza PI, 1999, TOXICOLOGY, V137, P13, DOI 10.1016/S0300-483X(99)00067-0; Pant N, 2015, ANDROLOGIA, V47, P887, DOI 10.1111/and.12342; PARIZEK J, 1957, J ENDOCRINOL, V15, P56, DOI 10.1677/joe.0.0150056; PARIZEK J, 1956, NATURE, V177, P1036; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; SAXENA DK, 1989, RES COMMUN CHEM PATH, V64, P317; Seok SM, 2006, TOXICOL LETT, V165, P212, DOI 10.1016/j.toxlet.2006.04.007; Stojanov T, 1999, MOL HUM REPROD, V5, P116, DOI 10.1093/molehr/5.2.116; Tinkov AA, 2017, SCI TOTAL ENVIRON, V601, P741, DOI 10.1016/j.scitotenv.2017.05.224; Vine MF, 1996, INT J ANDROL, V19, P323, DOI 10.1111/j.1365-2605.1996.tb00523.x; Wang Y.J., 2016, HUM EXP TOXICOL; Yang SH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101703; Yari A, 2016, ANDROLOGIA, V48, P1244, DOI 10.1111/and.12568	39	50	53	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186727	10.1371/journal.pone.0186727	http://dx.doi.org/10.1371/journal.pone.0186727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095856	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200021
J	Adjei, DN; Stronks, K; Adu, D; Snijder, MB; Modesti, PA; Peters, RJG; Vogt, L; Agyemang, C				Adjei, David N.; Stronks, Karien; Adu, Dwomoa; Snijder, Marieke B.; Modesti, Pietro A.; Peters, Ron J. G.; Vogt, Liffert; Agyemang, Charles			Relationship between educational and occupational levels, and Chronic Kidney Disease in a multi-ethnic sample-The HELIUS study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; SOCIOECONOMIC-STATUS; UNITED-STATES; CARDIOVASCULAR-DISEASE; RACIAL-DIFFERENCES; AFRICAN-AMERICAN; ADULT HEALTH; EXCESS RISK; LOW-INCOME; POPULATION	Background Ethnic minority groups in high-income countries are disproportionately affected by Chronic Kidney Disease (CKD) for reasons that are unclear. We assessed the association of educational and occupational levels with CKD in a multi-ethnic population. Furthermore, we assessed to what extent ethnic inequalities in the prevalence of CKD were accounted for by educational and occupational levels. Methods Cross-sectional analysis of baseline data from the Healthy Life in an Urban Setting (HELIUS) study of 21,433 adults (4,525 Dutch, 3,027 South-Asian Surinamese, 4,105 African Surinamese, 2,314 Ghanaians, 3,579 Turks, and 3,883 Moroccans) aged 18 to 70 years living in Amsterdam, the Netherlands. Three CKD outcomes were considered using the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) severity of CKD classification. Comparisons between educational and occupational levels were made using logistic regression analyses. Results After adjustment for sex and age, low-level and middle-level education were significantly associated with higher odds of high to very high-risk of CKD in Dutch (Odds Ratio (OR) 2.10, 95% C.I., 1.37-2.95; OR 1.55, 95% C.I., 1.03-2.34). Among ethnic minority groups, low-level education was significantly associated with higher odds of high to very-high-risk CKD but only in South -Asian Surinamese (OR 1.58, 95% C.I., 1.06-2.34). Similar results were found for the occupational level in relation to CKD risk. Conclusion The lower educational and occupational levels of ethnic minority groups partly accounted for the observed ethnic inequalities in CKD. Reducing CKD risk in ethnic minority populations with low educational and occupational levels may help to reduce ethnic inequalities in CKD and its related complications.	[Adjei, David N.; Stronks, Karien; Snijder, Marieke B.; Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Adjei, David N.] Univ Ghana, Dept Med Lab Sci, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Accra, Ghana; [Adu, Dwomoa] Univ Ghana, Dept Med, Sch Med & Dent, Accra, Ghana; [Adu, Dwomoa] Korle Bu Teaching Hosp, Accra, Ghana; [Modesti, Pietro A.] Univ Florence, Dept Clin & Expt Med, Florence, Italy; [Peters, Ron J. G.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Vogt, Liffert] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Sect Nephrol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Ghana; University of Ghana; University of Florence; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Adjei, DN (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.; Adjei, DN (corresponding author), Univ Ghana, Dept Med Lab Sci, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Accra, Ghana.	dna@chs.edu.gh	Vogt, Liffert/C-3168-2018; Modesti, Pietro Amedeo/B-2638-2012; Nana, David Adjei/AAV-8319-2020	Vogt, Liffert/0000-0002-4585-7505; Modesti, Pietro Amedeo/0000-0002-9511-2173; Nana, David Adjei/0000-0003-2306-5723; Stronks, Karien/0000-0002-0921-2232	Dutch Heart Foundation; Netherlands Organization for Health Research and Development (ZonMw); European Union (Seventh Framework Program [FP7])	Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union (Seventh Framework Program [FP7])	This work was supported by the Dutch Heart Foundation, the Netherlands Organization for Health Research and Development (ZonMw), and the European Union (Seventh Framework Program [FP7]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2015, AM J KIDNEY DIS; Agyemang C, 2016, AM J KIDNEY DIS, V67, P391, DOI 10.1053/j.ajkd.2015.07.023; Agyemang C, 2010, INT J CARDIOL, V141, P266, DOI 10.1016/j.ijcard.2008.12.023; Alebiosu CO, 2005, ETHNIC DIS, V15, P418; Bailey PK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-240; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Bello AK, 2008, CLIN J AM SOC NEPHRO, V3, P1316, DOI 10.2215/CJN.00680208; Bruce MA, 2010, AM J KIDNEY DIS, V55, P1001, DOI 10.1053/j.ajkd.2010.01.016; Crews DC, 2012, AM J KIDNEY DIS, V60, P779, DOI 10.1053/j.ajkd.2012.05.010; DiAngelantonio E, 2007, RENAL FUNCTION RISK; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Fine L, 2005, CARDIOVASCULAR DISOR, P563; Fored CM, 2003, NEPHROL DIAL TRANSPL, V18, P82, DOI 10.1093/ndt/18.1.82; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Geyer S, 2000, J EPIDEMIOL COMMUN H, V54, P299, DOI 10.1136/jech.54.4.299; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Krop JS, 1999, ARCH INTERN MED, V159, P1777, DOI 10.1001/archinte.159.15.1777; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Levin A, 2002, POSTGRAD MED, V111, P53, DOI 10.3810/pgm.2002.04.1168; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Mackenbach JP, 2000, EUR HEART J, V21, P1141, DOI 10.1053/euhj.1999.1990; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; McKay L., 2003, MIGRATION HLTH REV I; Merkin SS, 2007, SOC SCI MED, V65, P809, DOI 10.1016/j.socscimed.2007.04.011; Norris K, 2008, J AM SOC NEPHROL, V19, P1261, DOI 10.1681/ASN.2008030276; NUYTS GD, 1995, LANCET, V346, P7, DOI 10.1016/S0140-6736(95)92648-8; Peralta CA, 2006, J AM SOC NEPHROL, V17, P3491, DOI 10.1681/ASN.2006050493; PERNEGER TV, 1995, ARCH INTERN MED, V155, P1201, DOI 10.1001/archinte.155.11.1201; Richter M, 2009, SOC SCI MED, V69, P396, DOI 10.1016/j.socscimed.2009.05.023; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Shoham DA, 2005, ADV CHRONIC KIDNEY D, V12, P56, DOI 10.1053/j.ackd.2004.10.007; STENGEL B, 1995, INT J EPIDEMIOL, V24, P427, DOI 10.1093/ije/24.2.427; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; van de Mheen H, 1998, INT J EPIDEMIOL, V27, P431, DOI 10.1093/ije/27.3.431; Vart P, 2013, CLIN J AM SOC NEPHRO; Volkova N, 2008, J AM SOC NEPHROL, V19, P356, DOI 10.1681/ASN.2006080934; Ward FL, 2015, HEMODIALYSIS INT; Wedeen RP, 1997, SEMIN NEPHROL; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; White SL, 2008, AM J PUBLIC HEALTH, V98, P1306, DOI 10.2105/AJPH.2007.116020; YOUNG EW, 1994, KIDNEY INT, V45, P907, DOI 10.1038/ki.1994.120	47	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186460	10.1371/journal.pone.0186460	http://dx.doi.org/10.1371/journal.pone.0186460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091928	gold, Green Published			2022-12-27	WOS:000414229700019
J	Halas, M; Klapka, P; Bacik, V; Klobucnik, M				Halas, Marian; Klapka, Pavel; Bacik, Vladimir; Klobucnik, Michel			The spatial equity principle in the administrative division of the Central European countries	PLOS ONE			English	Article							INFRASTRUCTURE INVESTMENTS; INDIVIDUAL ACCESSIBILITY; SPACE-TIME; EFFICIENCY; IMPACTS; INDICATORS; FACILITIES; LOCATION; COHESION; REGIONS	The paper generally builds on the concept of justice in social science. It attempts to interpret this concept in a geographical and particularly in a spatial context. The paper uses the concept of accessibility to define the principle of spatial equity. The main objective of the paper is to propose an approach with which to assess the level of spatial equity in the administrative division of a territory. In order to fulfil this objective the paper theoretically discusses the concept of spatial equity and relates it to other relevant concepts, such as spatial efficiency. The paper proposes some measures of spatial equity and uses the territory of four Central European countries (Austria, the Czech Republic, Hungary, Slovakia) as example of the application of the proposed measures and the corroboration of the proposed approach. The analysis is based on the administrative division of four countries and is carried out at different hierarchical levels as defined by the Nomenclature of Units for Territorial Statistics (NUTS).	[Halas, Marian; Klapka, Pavel] Palacky Univ, Fac Sci, Dept Geog, Olomouc, Czech Republic; [Bacik, Vladimir; Klobucnik, Michel] Comenius Univ, Fac Nat Sci, Dept Human Geog & Demog, Bratislava, Slovakia	Palacky University Olomouc; Comenius University Bratislava	Halas, M (corresponding author), Palacky Univ, Fac Sci, Dept Geog, Olomouc, Czech Republic.	marian.halas@upol.cz	Klapka, Pavel/I-7581-2014; Halas, Marian/F-2138-2010	Klapka, Pavel/0000-0001-9631-9400; Halas, Marian/0000-0002-1335-7055; Bacik, Vladimir/0000-0001-6883-9863	Czech Science Foundation [16-13502S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Czech Science Foundation under Grant "Spatial uncertainty and fuzzy regional systems: identification, analysis and implications of pulsating functional regions" [number 16-13502S] to MH.	BERRY B., 1973, GROWTH CENTRES AM UR; Berry B. J. L., 1964, PAPERS REGIONAL SCI, V13, P147; Bezak A., 1997, GEOGRAFICKE STUDIE, V3, P6; Blazek J, 2011, TEORIE REGIONALNIHO ROZVOJE: NASTIN, KRITIKA, IMPLIKACE, P1; Bretagnolle A, 2009, METHODS SER, V7, P197, DOI 10.1007/978-1-4020-9663-1_7; Brocker J, 2010, TRANSPORT RES B-METH, V44, P795, DOI 10.1016/j.trb.2009.12.008; Bucek J., 2003, REGIONAL CHALLENGE C, P141; Chakraborty J., 1999, T GIS, V3, P239; Dalton AM, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-43; Daskin M. S., 2011, NETWORK DISCRETE LOC; De la Fuente H., 2013, CURR URBAN STUD, V1, P117, DOI [DOI 10.4236/cus.2013.14013, DOI 10.4236/CUS.2013.14013]; Farmer CJQ, 2011, ENVIRON PLANN A, V43, P2723, DOI 10.1068/a44136; Goodall B., 1987, PENGUIN DICT HUMAN G; Gorzelak G, 1992, DILEMAS REGIONAL POL; Gregory D., 2009, DICT HUMAN GEOGRAPHY; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Halas M, 2017, REG STUD, V51, P1568, DOI 10.1080/00343404.2016.1215602; Halas M, 2015, REND LINCEI-SCI FIS, V26, P169, DOI 10.1007/s12210-015-0387-4; HANSEN P, 1985, OPER RES, V33, P1251, DOI 10.1287/opre.33.6.1251; Harvey D., 1996, JUSTICE NATURE GEOGR, V468; Harvey D., 1973, SOCIAL JUSTICE CITY; Haugen K, 2013, TRANSPORT RES A-POL, V49, P10, DOI 10.1016/j.tra.2013.01.001; Haugen K, 2012, PAP REG SCI, V91, DOI 10.1111/j.1435-5957.2011.00374.x; Haynes R, 2003, ENVIRON PLANN A, V35, P1733, DOI 10.1068/a35165; Kim H.M., 2003, J GEOGR SYST, V5, P71, DOI [10.1007/s101090300104, DOI 10.1007/S101090300104]; Klapka P, 2016, MORAV GEOGR REP, V24, P47, DOI 10.1515/mgr-2016-0010; KRAFT S., 2012, ACTA U PALACKIANE OL, V43, P65; Kwan M.-P., 2003, J GEOGR SYST, V5, P1, DOI [DOI 10.1007/S101090300100, 10.1007/s101090300100]; Kwan M. P., 2003, J GEOGR SYST, V5, P129, DOI DOI 10.1007/S101090300107; Kwan MP, 2003, GEOGR ANAL, V35, P341; Kwan MP, 1998, GEOGR ANAL, V30, P191, DOI 10.1111/j.1538-4632.1998.tb00396.x; Liu GW, 2013, INT J APPL MATH STAT, V43, P37; Lopez E, 2008, EUR PLAN STUD, V16, P277, DOI 10.1080/09654310701814629; Martin JC, 2004, REG STUD, V38, P697, DOI 10.1080/003434042000240987; Michniak D., 2015, J MAPS, DOI [10.1080/17445647.2015.1060181, DOI 10.1080/17445647.2015.1060181]; MICHNIAK D., 2003, GEOGRAFICKY CASOPIS, V55, P21; Miller HJ, 2004, ANN ASSOC AM GEOGR, V94, P284, DOI 10.1111/j.1467-8306.2004.09402005.x; Miller HJ, 1999, GEOGR ANAL, V31, P1, DOI 10.1111/j.1538-4632.1999.tb00408.x; Monzon A, 2013, CITIES, V30, P18, DOI 10.1016/j.cities.2011.11.002; Openshaw S., 1984, MODIFIABLE AREAL UNI; Ozkul BD, 2014, REG STUD REG SCI, V1, P32, DOI 10.1080/21681376.2014.887899; Paez A, 2012, J TRANSP GEOGR, V25, P141, DOI 10.1016/j.jtrangeo.2012.03.016; Paez A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-52; Peters D, 2003, EUR PLAN STUD, V11, P317, DOI 10.1080/09654310303638; Prestwich R., 1990, INTRO REGIONAL URBAN; REHAK S., 2009, GEOGRAPHIA MORAVICA, V1, P47; Schonfelder S., 2003, TRANSPORT POLICY, V10, P273, DOI DOI 10.1016/J.TRANPOL.2003.07.002; Smith David M., 1994, GEOGRAPHY SOCIAL JUS; Smith DM, 2000, ENVIRON PLANN A, V32, P1149, DOI 10.1068/a3258; Talen E, 1998, ENVIRON PLANN A, V30, P595, DOI 10.1068/a300595; Unwin D. J., 1996, PROGR HUMAN GEOGRAPH, V20; Witten K, 2003, URBAN STUD, V40, P161, DOI 10.1080/00420980220080221	52	11	11	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187406	10.1371/journal.pone.0187406	http://dx.doi.org/10.1371/journal.pone.0187406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091953	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700063
J	Antonakaki, D; Spiliotopoulos, D; Samaras, CV; Pratikakis, P; Ioannidis, S; Fragopoulou, P				Antonakaki, Despoina; Spiliotopoulos, Dimitris; Samaras, Christos V.; Pratikakis, Polyvios; Ioannidis, Sotiris; Fragopoulou, Paraskevi			Social media analysis during political turbulence	PLOS ONE			English	Article							VISUALIZATION	Today, a considerable proportion of the public political discourse on nationwide elections proceeds in Online Social Networks. Through analyzing this content, we can discover the major themes that prevailed during the discussion, investigate the temporal variation of positive and negative sentiment and examine the semantic proximity of these themes. According to existing studies, the results of similar tasks are heavily dependent on the quality and completeness of dictionaries for linguistic preprocessing, entity discovery and sentiment analysis. Additionally, noise reduction is achieved with methods for sarcasm detection and correction. Here we report on the application of these methods on the complete corpus of tweets regarding two local electoral events of worldwide impact: the Greek referendum of 2015 and the subsequent legislative elections. To this end, we compiled novel dictionaries for sentiment and entity detection for the Greek language tailored to these events. We subsequently performed volume analysis, sentiment analysis, sarcasm correction and topic modeling. Results showed that there was a strong anti-austerity sentiment accompanied with a critical view on European and Greek political actions.	[Antonakaki, Despoina; Samaras, Christos V.; Pratikakis, Polyvios; Ioannidis, Sotiris; Fragopoulou, Paraskevi] FORTH ICS, Iraklion, Crete, Greece; [Spiliotopoulos, Dimitris] Univ Houston, Dept Comp Sci, Houston, TX 77204 USA	University of Houston System; University of Houston	Antonakaki, D (corresponding author), FORTH ICS, Iraklion, Crete, Greece.	despoina@ics.forth.gr	Spiliotopoulos, Dimitris/AAH-8178-2020	Spiliotopoulos, Dimitris/0000-0003-3646-1362; Antonakaki, Despoina/0000-0001-9081-6115	Marie-Curie ITN iSocial - EC [316808]	Marie-Curie ITN iSocial - EC	This work was supported by FP7 Marie-Curie ITN iSocial funded by the EC under grant agreement no 316808 to DA.	[Anonymous], 2011, ASS ADVANCEMENT ARTI, DOI DOI 10.1007/S00247-002-0848-7; [Anonymous], 2012, ASS COMPUTING MACHIN, DOI [DOI 10.1145/2145204, DOI 10.1145/2145204.2145277]; [Anonymous], 2017, SENT STRENGTH DET SH; Antonakaki D., 2017, ANTONAK ELECTIONS ST; Aue Anthony, 2005, P RECENT ADV NATURAL, V1, P2; Barbosa Glivia Angelica Rodrigues, 2012, CHI 2012 HUM FACT CO, P2621, DOI DOI 10.1145/2212776.2223846; Blumenthal M., 2015, WHY POLLS GREECE GOT; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Bollen J., 2009, CORR; Charalampakis B., 2015, P 16 INT C ENG APPL, P17; Charalampakis B, 2016, ENG APPL ARTIF INTEL, V51, P50, DOI 10.1016/j.engappai.2016.01.007; Cheng N, 2011, DIGIT INVEST, V8, P78, DOI 10.1016/j.diin.2011.04.002; Christophides V., 2015, SYNTHESIS LECT SEMAN, V5, P1, DOI DOI 10.2200/S00655ED1V01Y201507WBE013; Cliche M., SARCASM DETECTOR LEA; Conover M. D., 2011, 5 INT AAAI C WEBL SO, DOI DOI 10.1021/JA202932E; Davidov D., 2010, P 14 C COMP NAT LANG, P107; Derczynski L, 2015, INFORM PROCESS MANAG, V51, P32, DOI 10.1016/j.ipm.2014.10.006; Diakopoulos NA, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1195; DwiPrasetyo N, 2015, P 26 ACM C HYP SOC M, pPP149; Eom YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131184; Fan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110184; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Gayo-Avello D., 2012, CORR, Vabs/ 1204. 6441; Gayo-Avello D, 2011, P 5 INT AAAI C WEB S, V5, P490; Golbeck J, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1105; Gonzalez-Ibanez R., 2011, P 49 ANN M ASS COMP, P581; He Y, 2012, 8 INT C LANG RES EV; Hopkins DJ, 2010, AM J POLIT SCI, V54, P229, DOI 10.1111/j.1540-5907.2009.00428.x; Joshi A, 2016, ARXIV161104326; Kollanyi Bence, 2016, COMPPROP DATA MEMO, V4; Lampos V., P 51 ANN M ASS COMP, P993; Liebrecht Christine, 2013, P 4 WORKSH COMP APPR, P29; Livne Avishay, 2011, ICWSM; Lukasik M., 2015, CORR; Maynard D, 2014, LREC 2014 - NINTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P4238; Mejova Y., 2013, P 6 ACM INT C WEB SE, P517, DOI DOI 10.1145/2433396.2433463.; Meng X., 2012, P 18 ACM SIGKDD INT, P379, DOI DOI 10.1145/2339530.2339592; Mikros G. K., 2013, AAAI SPRING S AN MIC; Mohammad SM, 2015, INFORM PROCESS MANAG, V51, P480, DOI 10.1016/j.ipm.2014.09.003; Mutton P, 2003, IEEE INFOR VIS, P300, DOI 10.1109/IV.2003.1217994; O'Connor B, 2010, P INT AAAI C WEBL SO, P993; Pak A, 2010, P 7 INT C LANG RES E; PAPATHEODOROU N, 2013, ID ANN EM PROP VERBS, V8186, P588; Preotiuc-Pietro D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138717; Rahman M., 2016, NETW SYST SEC NSYSS, P1, DOI DOI 10.1109/NSYSS.2016.7400702; Rill S, 2014, KNOWL-BASED SYST, V69, P24, DOI 10.1016/j.knosys.2014.05.008; Riloff Ellen, 2013, P 2013 C EMP METH NA, P704; Shi L, 2012, PREDICTING US PRIMAR; Sievert C., 2014, P WORKSHOP INTERACTI, P63, DOI [10.3115/v1/W14-3110, DOI 10.3115/V1/W14-3110]; Skoric M., 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P2583, DOI 10.1109/HICSS.2012.607; Thelwall M, 2013, J AM SOC INF SCI TEC, V64, P1608, DOI 10.1002/asi.22872; Thelwall M, 2012, J AM SOC INF SCI TEC, V63, P163, DOI 10.1002/asi.21662; Tsakalidis A, 2014, LECT NOTES COMPUT SC, V8787, P168, DOI 10.1007/978-3-319-11746-1_12; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; Wang H., 2012, P ACL 2012 SYST DEM, P115, DOI [10.1145/1935826.1935854, DOI 10.1145/1935826.1935854]; Waugh B, 2013, INFLUENCE DECEPTION	56	19	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186836	10.1371/journal.pone.0186836	http://dx.doi.org/10.1371/journal.pone.0186836			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088263	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900026
J	Rosato, M; Alvarez, I; Feliner, GN; Rossello, JA				Rosato, Marcela; Alvarez, Ines; Nieto Feliner, Gonzalo; Rossello, Josep A.			High and uneven levels of 45S rDNA site-number variation across wild populations of a diploid plant genus (Anacyclus, Asteraceae)	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; GENOME ORGANIZATION; REPETITIVE DNA; EVOLUTION; LOCUS; REARRANGEMENTS; RECOMBINATION; SYSTEMATICS; SPECIATION; AEGILOPS	The nuclear genome harbours hundreds to several thousand copies of ribosomal DNA. Despite their essential role in cellular ribogenesis few studies have addressed intrapopulation, interpopulation and interspecific levels of rDNA variability in wild plants. Some studies have assessed the extent of rDNA variation at the sequence and copy-number level with large sampling in several species. However, comparable studies on rDNA site number variation in plants, assessed with extensive hierarchical sampling at several levels (individuals, populations, species) are lacking. In exploring the possible causes for ribosomal loci dynamism, we have used the diploid genus Anacyclus (Asteraceae) as a suitable system to examine the evolution of ribosomal loci. To this end, the number and chromosomal position of 45S rDNA sites have been determined in 196 individuals from 47 populations in all Anacyclus species using FISH. The 45S rDNA site-number has been assessed in a significant sample of seed plants, which usually exhibit rather consistent features, except for polyploid plants. In contrast, the level of rDNA site-number variation detected in Anacyclus is outstanding in the context of angiosperms particularly regarding populations of the same species. The number of 45S rDNA sites ranged from four to 11, accounting for 14 karyological ribosomal phenotypes. Our results are not even across species and geographical areas, and show that there is no clear association between the number of 45S rDNA loci and the life cycle in Anacyclus. A single rDNA phenotype was detected in several species, but a more complex pattern that included intra-specific and intra-population polymorphisms was recorded in A. homogamos, A. clavatus and A. valentinus, three weedy species showing large and overlapping distribution ranges. It is likely that part of the cytogenetic changes and inferred dynamism found in these species have been triggered by genomic rearrangements resulting from contemporary hybridisation.	[Rosato, Marcela; Rossello, Josep A.] Univ Valencia, Jardin Bot, ICBIBE, Unidad Asociada,CSIC, Valencia, Spain; [Alvarez, Ines; Nieto Feliner, Gonzalo] Real Jardin Bot CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Rossello, JA (corresponding author), Univ Valencia, Jardin Bot, ICBIBE, Unidad Asociada,CSIC, Valencia, Spain.	rossello@uv.es		Nieto Feliner, Gonzalo/0000-0002-7469-4733; Alvarez, Ines/0000-0002-5982-5424	Spanish Ministry of Economy and Competitiveness [CGL2013-49097-C2-1-P]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by funds from the Spanish Ministry of Economy and Competitiveness (Project CGL2013-49097-C2-1-P). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I., 2017, FLORA BERIC IN PRESS, V16; Belyayev A, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-6; Bennetzen JL, 1996, TRENDS MICROBIOL, V4, P347, DOI 10.1016/0966-842X(96)10042-1; Borgen L, 2003, BOT J LINN SOC, V141, P491, DOI 10.1046/j.1095-8339.2003.00147.x; Bustamante FO, 2014, CROP SCI, V54, P617, DOI 10.2135/cropsci2013.05.0325; CARMONA MJ, 1984, PLANT SYST EVOL, V146, P1, DOI 10.1007/BF00984050; Cerbah M, 1999, MOL PLANT MICROBE IN, V12, P947, DOI 10.1094/MPMI.1999.12.11.947; Cronn RC, 1996, J MOL EVOL, V42, P685, DOI 10.1007/BF02338802; Datson PM, 2006, CHROMOSOME RES, V14, P845, DOI 10.1007/s10577-006-1092-z; EHRENDORFER F, 1977, TAXON, V26, P387, DOI 10.2307/1220037; FLAVELL RB, 1986, PHILOS T R SOC B, V312, P227, DOI 10.1098/rstb.1986.0004; Galian JA, 2014, ANN BOT-LONDON, V114, P243, DOI 10.1093/aob/mcu115; Garcia S, 2012, CHROMOSOMA, V121, P389, DOI 10.1007/s00412-012-0368-7; Garnatje T, 2012, GENOME, V55, P529, DOI [10.1139/G2012-041, 10.1139/g2012-041]; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Hanson RE, 1996, CHROMOSOMA, V105, P55, DOI 10.1007/BF02510039; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002167; HUMPHRIES C. J., 1981, NORD J BOT, V1, P83, DOI [DOI 10.1111/J.1756-1051.1981.TB01038.X, 10.1111/j.1756-1051.1981.tb01038.x]; Humphries CJ, 1979, B BRIT MUS NAT HIST, V7, P83; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; KING LM, 1989, EVOLUTION, V43, P1117, DOI 10.1111/j.1558-5646.1989.tb02557.x; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kovarik A, 2008, ANN BOT-LONDON, V101, P815, DOI 10.1093/aob/mcn019; Lai Z, 2005, GENETICS, V171, P291, DOI 10.1534/genetics.105.042242; Lan H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151512; MAGGINI F, 1978, CHROMOSOMA, V66, P173, DOI 10.1007/BF00295138; Oberprieler Christoph, 2004, Willdenowia, V34, P39, DOI 10.3372/wi.34.34102; Olanj N, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0564-8; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; Raskina O, 2004, P NATL ACAD SCI USA, V101, P14818, DOI 10.1073/pnas.0405817101; Raskina O, 2004, CHROMOSOME RES, V12, P153, DOI 10.1023/B:CHRO.0000013168.61359.43; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Roa F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-225; Rosato M, 2008, ANN BOT-LONDON, V102, P15, DOI 10.1093/aob/mcn055; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; SCHWEIZER D, 1976, PLANT SYST EVOL, V126, P107, DOI 10.1007/BF00981668; SOLTIS PS, 1993, MOL PHYLOGENET EVOL, V2, P166, DOI 10.1006/mpev.1993.1017; Torices R, 2013, AN JARDIN BOT MADRID, V70, P48, DOI 10.3989/ajbm.2351; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; Zhong XB, 1996, PLANT MOL BIOL REP, V14, P232, DOI 10.1007/BF02671658	42	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187131	10.1371/journal.pone.0187131	http://dx.doi.org/10.1371/journal.pone.0187131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088249	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900043
J	Campbell, JR; Johnston, JC; Sadatsafavi, M; Cook, VJ; Elwood, RK; Marra, F				Campbell, Jonathon R.; Johnston, James C.; Sadatsafavi, Mohsen; Cook, Victoria J.; Elwood, R. Kevin; Marra, Fawziah			Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada	PLOS ONE			English	Article							LOW-INCIDENCE COUNTRIES; TREATMENT COMPLETION; UNITED-STATES; RANDOMIZED-TRIAL; HEALTH; RIFAMPIN; RISK; DIAGNOSIS; REACTIVATION; IMMIGRANTS	Background The majority of tuberculosis in migrants to Canada occurs due to reactivation of latent TB infection. Risk of tuberculosis in those with latent tuberculosis infection can be significantly reduced with treatment. Presently, only 2.4% of new migrants are flagged for post-landing surveillance, which may include latent tuberculosis infection screening; no other migrants receive routine latent tuberculosis infection screening. To aid in reducing the tuberculosis burden in new migrants to Canada, we determined the cost-effectiveness of using different latent tuberculosis infection interventions in migrants under post-arrival surveillance and in all new migrants. Methods A discrete event simulation model was developed that focused on a Canadian permanent resident cohort after arrival in Canada, utilizing a ten-year time horizon, healthcare system perspective, and 1.5% discount rate. Latent tuberculosis infection interventions were evaluated in the population under surveillance (N = 6100) and the total cohort (N = 260,600). In all evaluations, six different screening and treatment combinations were compared to the base case of tuberculin skin test screening followed by isoniazid treatment only in the population under surveillance. Quality adjusted life years, incident tuberculosis cases, and costs were recorded for each intervention and incremental cost-effectiveness ratios were calculated in relation to the base case. Results In the population under surveillance (N = 6100), using an interferon-gamma release assay followed by rifampin was dominant compared to the base case, preventing 4.90 cases of tuberculosis, a 4.9% reduction, adding 4.0 quality adjusted life years, and saving $353,013 over the ensuing ten-years. Latent tuberculosis infection screening in the total population (N = 260,600) was not cost-effective when compared to the base case, however could potentially prevent 21.8% of incident tuberculosis cases. Conclusions Screening new migrants under surveillance with an interferon-gamma release assay and treating with rifampin is cost saving, but will not significantly impact TB incidence. Universal latent tuberculosis infection screening and treatment is cost-prohibitive. Research into using risk factors to target screening post-landing may provide alternate solutions.	[Campbell, Jonathon R.; Sadatsafavi, Mohsen; Marra, Fawziah] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Johnston, James C.; Cook, Victoria J.; Elwood, R. Kevin] Univ British Columbia, Div Resp Med, Fac Med, Vancouver, BC, Canada; [Johnston, James C.; Cook, Victoria J.; Elwood, R. Kevin] British Columbia Ctr Dis Control, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Marra, F (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.	fawziah@mail.ubc.ca	Sadatsafayi, Mohsen/AAZ-1593-2020; Campbell, Jonathon/AAN-4252-2021	Sadatsafayi, Mohsen/0000-0002-0419-7862; Campbell, Jonathon/0000-0003-2341-2166; , Fawziah/0000-0002-1266-1901				Aldridge RW, 2016, LANCET, V388, P2510, DOI 10.1016/S0140-6736(16)31008-X; Alexander DC, 2009, J CLIN MICROBIOL, V47, P2651, DOI 10.1128/JCM.01946-08; Alsdurf H, 2016, LANCET INFECT DIS, V16, P1269, DOI 10.1016/S1473-3099(16)30216-X; [Anonymous], 2015, CAN FACTS FIG IMM OV; [Anonymous], 2017, GUID EC EV HLTH TECH; [Anonymous], 2017, BCG WORLD ATLAS; [Anonymous], 2016, LIF TABL CAN PROV TE; Ara R, 2010, VALUE HEALTH, V13, P509, DOI 10.1111/j.1524-4733.2010.00700.x; Aspler A, 2010, THORAX, V65, P582, DOI 10.1136/thx.2009.125054; Auguste P, 2016, TUBERCULOSIS, V99, P81, DOI 10.1016/j.tube.2016.04.007; Bauer M, 2015, QUAL LIFE RES, V24, P1337, DOI 10.1007/s11136-014-0858-6; Bettache N, 2012, AM J RESP CRIT CARE, V185, pA6507; Campbell JR, 2015, APPL HEALTH ECON HEA, V13, P325, DOI 10.1007/s40258-015-0183-4; Campbell JR, 2015, MOL DIAGN THER, V19, P107, DOI 10.1007/s40291-015-0135-6; Campbell JR, 2015, MOL DIAGN THER, V19, P9, DOI 10.1007/s40291-014-0125-0; Chan IHY, 2017, LANCET INFECT DIS; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; COMSTOCK GW, 1966, AM REV RESPIR DIS, V93, P171; Dasgupta K, 2000, AM J RESP CRIT CARE, V162, P2079, DOI 10.1164/ajrccm.162.6.2001111; EDWARDS LB, 1971, ARCH ENVIRON HEALTH, V22, P106, DOI 10.1080/00039896.1971.10665820; Fassbender K, 2009, J PAIN SYMPTOM MANAG, V38, P75, DOI 10.1016/j.jpainsymman.2009.04.007; FEREBEE SH, 1963, AM REV RESPIR DIS, V88, P161; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Guo N, 2008, VALUE HEALTH, V11, P1154, DOI 10.1111/j.1524-4733.2008.00355.x; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099; Khan K, 2015, CAN MED ASSOC J, V187, pE473, DOI 10.1503/cmaj.150011; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; Long R, 2002, INT J TUBERC LUNG D, V6, P615; Marra CA, 2008, CHEST, V133, P396, DOI 10.1378/chest.07-1494; Marra F, 2008, INT J TUBERC LUNG D, V12, P1414; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Menzies D, 2008, CAN J PUBLIC HEALTH, V99, P391, DOI 10.1007/BF03405248; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Menzies D, 2011, INDIAN J MED RES, V133, P257; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Oxlade O, 2007, INT J TUBERC LUNG D, V11, P16; Page KR, 2006, ARCH INTERN MED, V166, P1863, DOI 10.1001/archinte.166.17.1863; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; PALMER CE, 1957, AM REV TUBERC PULM, V76, P517; Patel AR, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015108; Pina JM, 2013, EUR J CLIN MICROBIOL, V32, P647, DOI 10.1007/s10096-012-1788-2; Public Health Agency of Canada Canadian Thoracic Society and the Canadian Lung Association, 2013, CANADIAN TUBERCULOSI; Reichman LB, 2004, AM J RESP CRIT CARE, V170, P832, DOI 10.1164/rccm.200405-584PP; Roth D, 2012, BC MED J, V54, P387; Roth DZ, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01546-2016; SALPETER SR, 1993, WESTERN J MED, V159, P560; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Shea KM, 2014, AM J EPIDEMIOL, V179, P216, DOI 10.1093/aje/kwt246; Tan MC, 2008, VALUE HEALTH, V11, P842, DOI 10.1111/j.1524-4733.2008.00334.x; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Walter ND, 2014, AM J RESP CRIT CARE, V189, P88, DOI 10.1164/rccm.201308-1480OC; WHO-UNICEF, 2017, WHO UNICEF EST BCG C; Zammarchi L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1045-3	61	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186778	10.1371/journal.pone.0186778	http://dx.doi.org/10.1371/journal.pone.0186778			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084227	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200012
J	Chng, WBA; Koch, R; Li, XX; Kondo, S; Nagoshi, E; Lemaitre, B				Chng, Wen-bin Alfred; Koch, Rafael; Li, Xiaoxue; Kondo, Shu; Nagoshi, Emi; Lemaitre, Bruno			Transforming Growth Factor beta/Activin signaling in neurons increases susceptibility to starvation	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; DROSOPHILA; SUGAR; EXPRESSION; FRUCTOSE; GLUCOSE; OBESITY	Animals rely on complex signaling network to mobilize its energy stores during starvation. We have previously shown that the sugar-responsive TGF beta/Activin pathway, activated through the TGF beta ligand Dawdle, plays a central role in shaping the post-prandial digestive competence in the Drosophila midgut. Nevertheless, little is known about the TGF beta/Activin signaling in sugar metabolism beyond the midgut. Here, we address the importance of Dawdle (Daw) after carbohydrate ingestion. We found that Daw expression is coupled to dietary glucose through the evolutionarily conserved Mio-Mlx transcriptional complex. In addition, Daw activates the TGF beta/Activin signaling in neuronal populations to regulate triglyceride and glycogen catabolism and energy homeostasis. Loss of those neurons depleted metabolic reserves and rendered flies susceptible to starvation.	[Chng, Wen-bin Alfred; Li, Xiaoxue; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland; [Koch, Rafael; Nagoshi, Emi] Univ Geneva, Dept Genet & Evolut, Sci 3, Geneva, Switzerland; [Kondo, Shu] Natl Inst Genet, Invertebrate Genet Lab, Genet Strains Res Ctr, Mishima, Shizuoka, Japan	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Chng, WBA; Lemaitre, B (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland.	chng.alfred@gmail.com; bruno.lemaitre@epfl.ch	Lemaitre, Bruno/T-8146-2019; Kondo, Shu/AAH-8921-2020	Lemaitre, Bruno/0000-0001-7970-1667; Kondo, Shu/0000-0002-4625-8379; Koch, Rafael/0000-0001-6105-2638; Nagoshi, Emi/0000-0002-6365-4074	Swiss National Fund [3100A0-12079/1]; SNSF [3100A0-12079/1]	Swiss National Fund(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF))	The work is funded by the Swiss National Fund (3100A0-12079/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa RW, 2015, CELL METAB, V21, P323, DOI 10.1016/j.cmet.2015.01.006; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Bai H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003941; Ball GDC, 2005, CAN J DIET PRACT RES, V66, P162, DOI 10.3148/66.3.2005.162; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chng WA, TRENDENDOCRINOLOGY, V28, P131; Chng WBA, 2014, CELL REP, V9, P336, DOI 10.1016/j.celrep.2014.08.064; Collings PJ, 2013, AM J CLIN NUTR, V97, P1020, DOI 10.3945/ajcn.112.045088; Garrido D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004995; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116; Ghosh AC, 2014, P NATL ACAD SCI USA, V111, P5729, DOI 10.1073/pnas.1319116111; Havula E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003438; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jourjine N, 2016, CELL, V166, P855, DOI 10.1016/j.cell.2016.06.046; KANAREK RB, 1982, J NUTR, V112, P1546, DOI 10.1093/jn/112.8.1546; Keller KB, 2003, AM J CRIT CARE, V12, P167, DOI 10.4037/ajcc2003.12.2.167; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Mattila J, 2015, CELL REP, V13, P350, DOI 10.1016/j.celrep.2015.08.081; Musselman LP, 2013, J BIOL CHEM, V288, P8028, DOI 10.1074/jbc.M112.371047; Park S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004555; Pfeiffenberger Cory, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5518; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Serpe M, 2006, DEVELOPMENT, V133, P4969, DOI 10.1242/dev.02711; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Weber K, 2005, GENETICS, V169, P1461, DOI 10.1534/genetics.104.027748; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187054	10.1371/journal.pone.0187054	http://dx.doi.org/10.1371/journal.pone.0187054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084242	Green Submitted, gold, Green Published			2022-12-27	WOS:000413910200028
J	Houshmand-Oeregaard, A; Hjort, L; Kelstrup, L; Hansen, NS; Broholm, C; Gillberg, L; Clausen, TD; Mathiesen, ER; Damm, P; Vaag, A				Houshmand-Oeregaard, Azadeh; Hjort, Line; Kelstrup, Louise; Hansen, Ninna S.; Broholm, Christa; Gillberg, Linn; Clausen, Tine D.; Mathiesen, Elisabeth R.; Damm, Peter; Vaag, Allan			DNA methylation and gene expression of TXNIP in adult offspring of women with diabetes in pregnancy	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; EPIGENOME-WIDE ASSOCIATION; IN-UTERO; MELLITUS; PPARGC1A; GLUCOSE; MUSCLE; BLOOD	Background Fetal exposure to maternal diabetes increases the risk of type 2 diabetes (T2DM), possibly mediated by epigenetic mechanisms. Low blood TXNIP DNA methylation has been associated with elevated glucose levels and risk of T2DM, and increased skeletal muscle TXNIP gene expression was reported in subjects with impaired glucose metabolism or T2DM. Subcutaneous adipose tissue (SAT) and skeletal muscle play a key role in the control of whole body glucose metabolism and insulin action. The extent to which TXNIP DNA methylation levels are decreased and/or gene expression levels increased in SAT or skeletal muscle of a developmentally programmed at-risk population is unknown. Objective and methods The objective of this study was to investigate TXNIP DNA methylation and gene expression in SAT and skeletal muscle, and DNA methylation in blood, from adult offspring of women with gestational diabetes (O-GDM, n = 82) or type 1 diabetes (O-T1DM, n = 67) in pregnancy compared with offspring of women from the background population (O-BP, n = 57). Results SAT TXNIP DNA methylation was increased (p = 0.032) and gene expression decreased (p = 0.001) in O-GDM, but these differences were attenuated after adjustment for confounders. Neither blood/muscle TXNIP DNA methylation nor muscle gene expression differed between groups. Conclusion We found no evidence of decreased TXNIP DNA methylation or increased gene expression in metabolic target tissues of offspring exposed to maternal diabetes. Further studies are needed to confirm and understand the paradoxical SAT TXNIP DNA methylation and gene expression changes in O-GDM subjects.	[Houshmand-Oeregaard, Azadeh; Kelstrup, Louise; Mathiesen, Elisabeth R.; Damm, Peter] Rigshosp, Ctr Pregnant Women Diabet, Dept Obstet, Copenhagen, Denmark; [Houshmand-Oeregaard, Azadeh; Hjort, Line; Hansen, Ninna S.; Broholm, Christa; Gillberg, Linn; Vaag, Allan] Rigshosp, Dept Endocrinol, Diabet & Metab, Copenhagen, Denmark; [Houshmand-Oeregaard, Azadeh; Hjort, Line; Kelstrup, Louise; Hansen, Ninna S.; Clausen, Tine D.; Mathiesen, Elisabeth R.; Damm, Peter; Vaag, Allan] Univ Copenhagen, Inst Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark; [Hjort, Line; Hansen, Ninna S.] Danish Diabet Acad, Danish PhD Sch Mol Metab, Odense, Denmark; [Clausen, Tine D.] Univ Copenhagen, Nordsjaellands Hosp, Dept Gynecol & Obstet, Hillerod, Denmark; [Mathiesen, Elisabeth R.] Rigshosp, Ctr Pregnant Women Diabet, Dept Endocrinol, Copenhagen, Denmark; [Houshmand-Oeregaard, Azadeh] Novo Nordisk AS, Basgvaerd, Denmark; [Vaag, Allan] AstraZeneca, Molndal, Sweden	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Novo Nordisk; AstraZeneca	Houshmand-Oeregaard, A (corresponding author), Rigshosp, Ctr Pregnant Women Diabet, Dept Obstet, Copenhagen, Denmark.; Houshmand-Oeregaard, A (corresponding author), Rigshosp, Dept Endocrinol, Diabet & Metab, Copenhagen, Denmark.; Houshmand-Oeregaard, A (corresponding author), Univ Copenhagen, Inst Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark.; Houshmand-Oeregaard, A (corresponding author), Novo Nordisk AS, Basgvaerd, Denmark.	a.houshmand.oregaard@gmail.com	Gillberg, Linn/A-1417-2017; Clausen, Tine Dalsgaard/X-3720-2019	Gillberg, Linn/0000-0003-0588-1663; Kelstrup, Louise/0000-0003-3994-0377; Damm, Peter/0000-0002-2067-5246; Clausen, Tine Dalsgaard/0000-0001-5585-2153; Hjort, Line/0000-0003-4673-4176; Vaag, Allan Arthur/0000-0002-3690-2191	Danish Council for Strategic Research; Novo Nordisk Foundation; Danish Diabetes Academy; Augustinus Foundation; Danish Diabetes Association; Novo Nordisk Fonden [NNF14OC0009275] Funding Source: researchfish	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Academy; Augustinus Foundation; Danish Diabetes Association; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Council for Strategic Research, the Novo Nordisk Foundation, Danish Diabetes Academy, Augustinus Foundation, Danish Diabetes Association, The A.P. Moller Foundation for the Advancement of Medical Science, European Foundation for the Study of Diabetes (EFSD), and The Research Fund of Rigshospitalet. ERM has received honorarium from Novo Nordisk A/S for talks. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al Muftah WA, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0177-6; [Anonymous], 2006, DEFINITION DIAGNOSIS; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Chambers JC, 2015, LANCET DIABETES ENDO, V3, P526, DOI 10.1016/S2213-8587(15)00127-8; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chong CR, 2014, CARDIOVASC DRUG THER, V28, P347, DOI 10.1007/s10557-014-6538-5; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Dabelea D, 2000, J Matern Fetal Med, V9, P83, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<83::AID-MFM17>3.0.CO;2-O; DAMM P, 1992, AM J OBSTET GYNECOL, V167, P607, DOI 10.1016/S0002-9378(11)91559-2; Damm P, 1998, DAN MED BULL, V45, P495; Dayeh T, 2016, EPIGENETICS-US, V11, P482, DOI 10.1080/15592294.2016.1178418; El Hajj N, 2014, REPRODUCTION, V148, pR111, DOI 10.1530/REP-14-0334; Florath I, 2015, DIABETOLOGIA; Gillberg L, 2014, METABOLISM, V63, P263, DOI 10.1016/j.metabol.2013.10.003; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Houshmand-Oeregaard A, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0338-2; Kelstrup L, 2016, DIABETES, V65, P2900, DOI 10.2337/db16-0227; Koenen TB, 2011, DIABETES, V60, P517, DOI 10.2337/db10-0266; Kulkarni H, 2015, HUM MOL GENET, V24, P5330, DOI 10.1093/hmg/ddv232; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Ruchat SM, 2013, NUTR REV, V71, pS88, DOI 10.1111/nure.12057; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Shalev A, 2014, MOL ENDOCRINOL, V28, P1211, DOI 10.1210/me.2014-1095; Sobngwi E, 2003, LANCET, V361, P1861, DOI 10.1016/S0140-6736(03)13505-2; Soriano-Tarraga C, 2016, HUM MOL GENET, V25, P609, DOI 10.1093/hmg/ddv493; West Nancy A, 2013, Immunometabolism, V1, P1; Zheng J, 2014, BRIT J NUTR, V112, P1850, DOI 10.1017/S0007114514002827	33	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187038	10.1371/journal.pone.0187038	http://dx.doi.org/10.1371/journal.pone.0187038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077742	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200038
J	Mininni, CJ; Zanutto, BS				Mininni, Camilo Juan; Silvano Zanutto, B.			Exploring the limits of learning: Segregation of information integration and response selection is required for learning a serial reversal task	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; TIMING-DEPENDENT PLASTICITY; IN-VIVO; ORBITOFRONTAL CORTEX; SYNAPTIC PLASTICITY; WORKING-MEMORY; NETWORKS; RAT; HIPPOCAMPUS; REWARD	Animals are proposed to learn the latent rules governing their environment in order to maximize their chances of survival. However, rules may change without notice, forcing animals to keep a memory of which one is currently at work. Rule switching can lead to situations in which the same stimulus/response pairing is positively and negatively rewarded in the long run, depending on variables that are not accessible to the animal. This fact raises questions on how neural systems are capable of reinforcement learning in environments where the reinforcement is inconsistent. Here we address this issue by asking about which aspects of connectivity, neural excitability and synaptic plasticity are key for a very general, stochastic spiking neural network model to solve a task in which rules change without being cued, taking the serial reversal task (SRT) as paradigm. Contrary to what could be expected, we found strong limitations for biologically plausible networks to solve the SRT. Especially, we proved that no network of neurons can learn a SRT if it is a single neural population that integrates stimuli information and at the same time is responsible of choosing the behavioural response. This limitation is independent of the number of neurons, neuronal dynamics or plasticity rules, and arises from the fact that plasticity is locally computed at each synapse, and that synaptic changes and neuronal activity are mutually dependent processes. We propose and characterize a spiking neural network model that solves the SRT, which relies on separating the functions of stimuli integration and response selection. The model suggests that experimental efforts to understand neural function should focus on the characterization of neural circuits according to their connectivity, neural dynamics, and the degree of modulation of synaptic plasticity with reward.	[Mininni, Camilo Juan; Silvano Zanutto, B.] Univ Buenos Aires, Inst Ingn Biomed, Buenos Aires, DF, Argentina; [Silvano Zanutto, B.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Mininni, CJ (corresponding author), Univ Buenos Aires, Inst Ingn Biomed, Buenos Aires, DF, Argentina.	mininni@dna.uba.ar		Mininni, Camilo Juan/0000-0002-3862-0454	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2012-1519]; Concejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112 201101 01054]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Concejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by projects PICT 2012-1519 (Agencia Nacional de Promocion Cientifica y Tecnologica, www.agencia. mincyt.gob.ar) and PIP 112 201101 01054 (Concejo Nacional de Investigaciones Cientificas y Tecnicas, www.conicet.gov.ar), granted to BSZ. CJM is supported by a CONICET postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bissonette GB, 2015, BIOL PSYCHIAT, V77, P454, DOI 10.1016/j.biopsych.2014.07.023; Broussard JI, 2016, CELL REP, V14, P1930, DOI 10.1016/j.celrep.2016.01.070; Castane A, 2010, BEHAV BRAIN RES, V210, P74, DOI 10.1016/j.bbr.2010.02.017; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Floresco SB, 2008, BEHAV BRAIN RES, V190, P85, DOI 10.1016/j.bbr.2008.02.008; French R. M., 1992, Connection Science, V4, P365, DOI 10.1080/09540099208946624; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Fusi S, 2007, NAT NEUROSCI, V10, P485, DOI 10.1038/nn1859; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Habenschuss S, 2012, ADV NEURAL INF PROCE, P1; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hertler B, 2009, DOPAMINE MOTOR CORTE, V4; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Izquierdo A, 2017, NEUROSCIENCE, V345, P12, DOI 10.1016/j.neuroscience.2016.03.021; Kappel D, 2017, REWARD BASED STOCHAS; Kappel D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003511; Komischke B, 2002, LEARN MEMORY, V9, P122, DOI 10.1101/lm.44602; Kosaki Y, 2012, BEHAV BRAIN RES, V227, P81, DOI 10.1016/j.bbr.2011.10.039; Liu D, 2014, SCIENCE, V346, P458, DOI 10.1126/science.1256573; MACKINTOSH NJ, 1968, CAN J PSYCHOLOGY, V22, P85, DOI 10.1037/h0082753; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; Myjak J, 2008, STUD MATH, V189, P255, DOI 10.4064/sm189-3-4; Nessler B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003037; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Rueckert E, 2016, SCI REP-UK, V6, DOI 10.1038/srep21142; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Strang CG, 2014, ANIM COGN, V17, P723, DOI 10.1007/s10071-013-0704-1; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wei Y, 2014, J NEUROSCI, V34, P15804, DOI 10.1523/JNEUROSCI.3929-12.2014	37	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186959	10.1371/journal.pone.0186959	http://dx.doi.org/10.1371/journal.pone.0186959			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077735	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200030
J	Ramon-Nunez, LA; Martos, L; Fernandez-Pardo, A; Oto, J; Medina, P; Espana, F; Navarro, S				Ramon-Nunez, Luis A.; Martos, Laura; Fernandez-Pardo, Alvaro; Oto, Julia; Medina, Pilar; Espana, Francisco; Navarro, Silvia			Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation	PLOS ONE			English	Article							CIRCULATING MICRORNAS; NORMALIZATION STRATEGIES; CANCER; SERUM; IDENTIFICATION; EXTRACTION; QUANTIFICATION; SAMPLES; PCR	microRNAs are promising biomarkers in biological fluids in several diseases. Different plasma RNA isolation protocols and carriers are available, but their efficiencies have been scarcely compared. Plasma microRNAs were isolated using a phenol and column-based procedure and a column-based procedure, in the presence or absence of two RNA carriers (yeast RNA and MS2 RNA). We evaluated the presence of PCR inhibitors and the relative abundance of certain microRNAs by qRT-PCR. Furthermore, we analyzed the association between different isolation protocols, the relative abundance of the miRNAs in the sample, the GC content and the free energy of microRNAs. In all microRNAs analyzed, the addition of yeast RNA as a carrier in the different isolation protocols used gave lower raw Cq values, indicating higher microRNA recovery. Moreover, this increase in microRNAs recovery was dependent on their own relative abundance in the sample, their GC content and the free-energy of their own most stable secondary structure. Furthermore, the normalization of microRNA levels by an endogenous microRNA is more reliable than the normalization by plasma volume, as it reduced the difference in microRNA fold abundance between the different isolation protocols evaluated. Our thorough study indicates that a standardization of pre- and analytical conditions is necessary to obtain reproducible inter-laboratory results in plasma microRNA studies.	[Ramon-Nunez, Luis A.; Martos, Laura; Fernandez-Pardo, Alvaro; Oto, Julia; Medina, Pilar; Espana, Francisco; Navarro, Silvia] Hosp Univ & Politecn La Fe, IIS La Fe, Grp Hemostasia Trombosis Arteriosclerosis & Biol, Valencia, Spain	Hospital Universitari i Politecnic La Fe	Ramon-Nunez, LA; Navarro, S (corresponding author), Hosp Univ & Politecn La Fe, IIS La Fe, Grp Hemostasia Trombosis Arteriosclerosis & Biol, Valencia, Spain.	ramon_luinun@gva.es; navarro_silros@gva.es	Medina, Pilar/ABB-7244-2021; ROSALES, SILVIA NAVARRO/G-9263-2016; Ramon, Luis/ABG-7732-2020	Medina, Pilar/0000-0001-9637-5998; ROSALES, SILVIA NAVARRO/0000-0001-6554-1498; Ramon, Luis/0000-0002-5789-4506; Espana, Francisco/0000-0001-7829-2021; Oto, Julia/0000-0003-3963-8661	ISCIII [PI12/00027, RD12/0042/0029, PI14/00512, PI14/00079, FI14/ 00269]; European Social Fund (FEDER); Generalitat Valenciana [PrometeoII/2015/017]	ISCIII(Instituto de Salud Carlos III); European Social Fund (FEDER)(European Social Fund (ESF)European Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This research was supported in part by research Spanish grants from ISCIII (PI12/00027, RD12/0042/0029, PI14/00512, PI14/00079, FI14/ 00269), the European Social Fund (FEDER, "Una manera de hacer Europa"), and the Generalitat Valenciana (PrometeoII/2015/017). PM is a Miguel Servet researcher (FIS-CP09/00065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; [Anonymous], 2011, CELL MOL LIFE SCI, V68, P2667; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051431; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Duy J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1299-5; Eldh M, 2012, MOL IMMUNOL, V50, P278, DOI 10.1016/j.molimm.2012.02.001; Gautam A, 2016, MOL BIOL REP, V43, P1165, DOI 10.1007/s11033-016-4043-6; Gilabert-Estelles J, 2012, CURR MED CHEM, V19, P2406, DOI 10.2174/092986712800269362; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Glynn Claire L, 2013, Microrna, V2, P14; Kim DJ, 2012, J MOL DIAGN, V14, P71, DOI 10.1016/j.jmoldx.2011.09.002; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Leidner RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057841; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv WF, 2015, CLIN LAB, V61, P1953, DOI 10.7754/Clin.Lab.2015.150604; McAlexander Melissa A., 2013, Frontiers in Genetics, V4, P83, DOI 10.3389/fgene.2013.00083; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moret I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082753; Nishiguchi T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/682857; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ramon LA, 2012, HUM REPROD, V27, P3036, DOI 10.1093/humrep/des292; Salehi E, 2015, CLIN RHEUMATOL, V34, P615, DOI 10.1007/s10067-015-2898-x; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Sianou A, 2015, ARCH GYNECOL OBSTET, V292, P271, DOI 10.1007/s00404-015-3660-y; Sidstedt M, 2017, ANAL CHEM, V89, P1642, DOI 10.1021/acs.analchem.6b03746; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Sonkoly E, 2009, INT REV IMMUNOL, V28, P535, DOI 10.3109/08830180903208303; Tan GW, 2015, SCI REP-UK, V5, DOI 10.1038/srep09430; Tang GS, 2015, MED SCI MONITOR, V21, P617, DOI 10.12659/MSM.891028; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang QT, 2002, BIOTECHNIQUES, V33, P788, DOI 10.2144/02334st02; Wang YL, 2015, CLIN GENITOURIN CANC, V13, P261, DOI 10.1016/j.clgc.2015.01.003; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Zorio E., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P82; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187005	10.1371/journal.pone.0187005	http://dx.doi.org/10.1371/journal.pone.0187005			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077772	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200035
J	Paungpin, W; Wiriyarat, W; Chaichoun, K; Tiyanun, E; Sangkachai, N; Changsom, D; Poltep, K; Ratanakorn, P; Puthavathana, P				Paungpin, Weena; Wiriyarat, Witthawat; Chaichoun, Kridsada; Tiyanun, Ekasit; Sangkachai, Nareerat; Changsom, Don; Poltep, Kanaporn; Ratanakorn, Parntep; Puthavathana, Pilaipan			Serosurveillance for pandemic influenza A (H1N1) 2009 virus infection in domestic elephants, Thailand	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PROTEIN A/G CONJUGATE; HEMAGGLUTINATION INHIBITION; NONSPECIFIC INHIBITORS; KAOLIN TREATMENT; IMMUNOGLOBULIN-G; WESTERN-BLOT; ANTIBODIES; SERUM; ANIMALS	The present study conducted serosurveillance for the presence of antibody to pandemic influenza A (H1N1) 2009 virus (H1N1pdm virus) in archival serum samples collected between 2009 and 2013 from 317 domestic elephants living in 19 provinces situated in various parts of Thailand. To obtain the most accurate data, hemagglutination-inhibition (HI) assay was employed as the screening test; and sera with HI antibody titers >= 20 were further confirmed by other methods, including cytopathic effect/hemagglutination based-microneutralization (microNT) and Western blot (WB) assays using H1N1pdm matrix 1 (M1) or hemagglutinin (HA) recombinant protein as the test antigen. Conclusively, the appropriate assays using HI in conjunction with WB assays for HA antibody revealed an overall seropositive rate of 8.5% (27 of 317). The prevalence of antibody to H1N1pdm virus was 2% (4/172) in 2009, 32% (17/53) in 2010, 9% (2/22) in 2011, 12% (1/8) in 2012, and 5% (3/62) in 2013. Notably, these positive serum samples were collected from elephants living in 7 tourist provinces of Thailand. The highest seropositive rate was obtained from elephants in Phuket, a popular tourist beach city. Young elephants had higher seropositive rate than older elephants. The source of H1N1pdm viral infection in these elephants was not explored, but most likely came from close contact with the infected mahouts or from the infected tourists who engaged in activities such as elephant riding and feeding. Nevertheless, it could not be excluded that elephant-to-elephant transmission did occur.	[Paungpin, Weena; Puthavathana, Pilaipan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand; [Paungpin, Weena; Wiriyarat, Witthawat; Chaichoun, Kridsada; Sangkachai, Nareerat; Poltep, Kanaporn; Ratanakorn, Parntep] Mahidol Univ, Fac Vet Sci, Monitoring & Surveillance Ctr Zoonot Dis Wildlife, Salaya, Nakhon Pathom, Thailand; [Tiyanun, Ekasit] Mahidol Univ, Hlth Anim Clin 1, Nakhon Sawan Campus, Nakhon Sawan, Thailand; [Changsom, Don; Puthavathana, Pilaipan] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Salaya, Nakhon Pathom, Thailand; [Puthavathana, Pilaipan] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya, Nakhon Pathom, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Puthavathana, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.; Puthavathana, P (corresponding author), Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Salaya, Nakhon Pathom, Thailand.; Puthavathana, P (corresponding author), Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya, Nakhon Pathom, Thailand.	pilaipan.put@mahidol.ac.th		Paungpin, Weena/0000-0002-3909-2884; POLTEP, KANAPORN/0000-0002-4160-3970; Puthavathana, Pilaipan/0000-0002-5481-9156	Mahidol University under the National Research Universities Initiative	Mahidol University under the National Research Universities Initiative	This work was supported by Mahidol University under the National Research Universities Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Mahidol University under the National Research Universities Initiative. We thank Dr. Sarin Suwanpakdee for a map on location of the study elephants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Adhami BH, 2014, VET PARASITOL, V200, P66, DOI 10.1016/j.vetpar.2013.11.004; ANANTHANARAYAN R, 1960, Bull World Health Organ, V22, P409; ANDERS EM, 1990, P NATL ACAD SCI USA, V87, P4485, DOI 10.1073/pnas.87.12.4485; ANDERSON SG, 1948, AUST J EXP BIOL MED, V26, P403, DOI 10.1038/icb.1948.41; Angkawanish T., 2009, Gajah, V31, P15; Berhane Y, 2010, AVIAN DIS, V54, P1275, DOI 10.1637/9422-061410-Reg.1; Bhide MR, 2004, COMP IMMUNOL MICROB, V27, P191, DOI 10.1016/j.cimid.2003.10.001; Boliar S, 2006, J VET DIAGN INVEST, V18, P264, DOI 10.1177/104063870601800305; Britton AP, 2010, EMERG INFECT DIS, V16, P1043, DOI 10.3201/eid1606.100352; COHEN A, 1959, VIROLOGY, V7, P59, DOI 10.1016/0042-6822(59)90177-1; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Crossley B, 2012, EMERG INFECT DIS, V18, P315, DOI 10.3201/eid1802.111245; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gocnik M, 2008, J GEN VIROL, V89, P958, DOI 10.1099/vir.0.83524-0; Goldstein T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062259; Gu Y, 2015, J VET DIAGN INVEST, V27, P616, DOI 10.1177/1040638715596033; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; HILLEMAN MR, 1953, J IMMUNOL, V71, P110; Howell E., 2013, WHAT ANIMALS CAN TEA; Humphreys AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116318; Iamsirithaworn S., 2011, Siriraj Medical Journal, V63, P64; Inoshima Y, 1999, CLIN DIAGN LAB IMMUN, V6, P388, DOI 10.1128/CDLI.6.3.388-391.1999; Jongcherdchootrakul Kanlaya, 2014, Journal of the Medical Association of Thailand, V97, pS145; Kelly PJ, 1998, COMP IMMUNOL MICROB, V21, P65, DOI 10.1016/S0147-9571(97)80053-7; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; KONNO JIRO, 1958, TOHOKU JOUR EXPTL MED, V67, P391; Krizanova O, 1969, Curr Top Microbiol Immunol, V47, P125; Lair R.C., 1997, GONE ASTRAY CARE MAN; Lerdsamran H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016164; Leyva-Grado VH, 2012, EMERG INFECT DIS, V18, P1135, DOI 10.3201/eid1807.111930; Li DS, 2014, EMERG INFECT DIS, V20, P480, DOI 10.3201/eid2003.131531; Lin DG, 2012, J GEN VIROL, V93, P119, DOI 10.1099/vir.0.037358-0; Lin HT, 2014, JPN J VET RES, V62, P181; LOBMANN M, 1976, J HYG-CAMBRIDGE, V77, P181, DOI 10.1017/S0022172400024608; Louisirirotchanakul S, 2007, J CLIN MICROBIOL, V45, P2284, DOI 10.1128/JCM.00921-07; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nielsen K, 2004, VET MICROBIOL, V101, P123, DOI 10.1016/j.vetmic.2004.02.014; Nymo IH, 2013, J VET DIAGN INVEST, V25, P369, DOI 10.1177/1040638713485073; Panaampon J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036318; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Pereda A, 2010, EMERG INFECT DIS, V16, P304, DOI 10.3201/eid1602.091230; PRITCHETT TJ, 1989, J BIOL CHEM, V264, P9850; RYANPOIRIER KA, 1991, J VIROL, V65, P389, DOI 10.1128/JVI.65.1.389-395.1991; RYANPOIRIER KA, 1993, VIROLOGY, V193, P974, DOI 10.1006/viro.1993.1208; Schaefer JJ, 2012, J VET DIAGN INVEST, V24, P572, DOI 10.1177/1040638712442931; Schmeisser F, 2010, VACCINE, V28, P2442, DOI 10.1016/j.vaccine.2009.12.079; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Schrenzel MD, 2011, EMERG INFECT DIS, V17, P747, DOI [10.3201/eid1706.101355, 10.3201/eid1704.101355]; SPENCE L, 1960, P SOC EXP BIOL MED, V103, P425, DOI 10.3181/00379727-103-25545; Sponseller BA, 2010, EMERG INFECT DIS, V16, P534, DOI 10.3201/eid1603.091737; SUBBARAO EK, 1992, J CLIN MICROBIOL, V30, P996, DOI 10.1128/JCM.30.4.996-999.1992; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thai Elephant Conservation Center, THAIL EL; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Vongchan P, 2013, CHIANG MAI J SCI, V40, P376; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, WHOCDSCSRNCS20025; Zhang DL, 2010, CLIN VACCINE IMMUNOL, V17, P485, DOI 10.1128/CVI.00479-09	58	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186962	10.1371/journal.pone.0186962	http://dx.doi.org/10.1371/journal.pone.0186962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073255	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400080
J	Agrrawal, P; Waggle, D; Sandweiss, DH				Agrrawal, Pankaj; Waggle, Doug; Sandweiss, Daniel H.			Suicides as a response to adverse market sentiment (1980-2016)	PLOS ONE			English	Article							SOCIOLOGICAL LITERATURE; ECONOMIC RECESSION; HEALTH; RATES; CRISIS	Financial crises inflict significant human as well as economic hardship. This paper focuses on the human fallout of capital market stress. Financial stress-induced behavioral changes can manifest in higher suicide and murder-suicide rates. We find that these rates also correlate with the Gross Domestic Product (GDP) growth rate (negatively associated; a-0.25% drop [in the rate of change in annual suicides for a +1 % change in the independent variable]), unemployment rate (positive link; 0.298% increase), inflation rate (positive link; 0.169% increase in suicide rate levels) and stock market returns adjusted for the risk-free T-Bill rate (negative link; -0.047% drop). Suicides tend to rise during periods of economic turmoil, such as the recent Great Recession of 2008. An analysis of Centers for Disease Control and Prevention (CDC) data of more than 2 million non-natural deaths in the US since 1980 reveals a positive correlation with unemployment levels. We find that suicides and murder-suicides associated with adverse market sentiment lag the initial stressor by up to two years, thus opening a policy window for government/public health intervention to reduce these negative outcomes. Both our models explain about 73 to 76% of the variance in suicide rates and rate of change in suicide rates, and deploy a total of four widely available independent variables (lagged and/or transformed). The results are invariant to the inclusion/exclusion of 2008 data over the 1980-2016 time series, the period of our study. The disconnect between rational decision making, induced by cognitive dissonance and severe financial stress can lead to suboptimal outcomes, not only in the area of investing, but in a direct loss of human capital. No economic system can afford such losses. Finance journal articles focus on monetary alpha, which is the return on a portfolio in excess of the benchmark; we think it is important to be aware of the loss of human capital as a consequence of market instability. This study makes one such an attempt.	[Agrrawal, Pankaj] Univ Maine, MaineBusiness Sch, Orono, ME 04469 USA; [Waggle, Doug] Univ West Florida, Dept Accounting & Finance, Pensacola, FL 32514 USA; [Sandweiss, Daniel H.] Univ Maine, Dept Anthropol, Orono, ME USA; [Sandweiss, Daniel H.] Univ Maine, Bryand Global Sci Ctr, Climate Change Inst, Orono, ME USA	University of Maine System; University of Maine Orono; State University System of Florida; University of West Florida; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Agrrawal, P (corresponding author), Univ Maine, MaineBusiness Sch, Orono, ME 04469 USA.	pankaj.agrrawal@maine.edu	Agrrawal, Pankaj/AAM-6317-2020; Sandweiss, Daniel/K-5808-2019	Agrrawal, Pankaj/0000-0002-8617-433X; 				Allegretto Sylvia A., 2011, STATE WORKING AM WEA; [Anonymous], 2011, LANCET, V378, P1440, DOI 10.1016/S0140-6736(11)61633-4; Arora VS, 2015, INT J EPIDEMIOL, V44, P451, DOI 10.1093/ije/dyv069; Bernanke B.S., 2012, US HOUSING MARKET CU; Bowdler Janis, 2010, FORECLOSURE GENERATI; Bureau of Economic Analysis (bea.gov), 2016, GDP DAT FIL; Bureau of Labor Statistics (bls. gov), 2016, UNEMPL DAT FIL; Caner A, 2004, ASSET POVERTY US PER, P76; Catalano R, 2009, NEW ENGL J MED, V360, P749, DOI 10.1056/NEJMp0809122; Center for Research in Security Prices (crsp.com), 2016, 1925 HIST IND GUID S; Centers for Disease Control and Prevention, 2016, WISQARS WEB BAS INJ; Centers for Disease Control and Prevention (CDC), 2016, NAT VIT STAT SYAT SU; Chan CH, 2014, J EPIDEMIOL COMMUN H, V68, P246, DOI 10.1136/jech-2013-202759; Chen CC, 2016, STRESS HEALTH, V32, P607, DOI 10.1002/smi.2677; Coope C, 2014, SOC SCI MED, V117, P76, DOI 10.1016/j.socscimed.2014.07.024; Eliason S, 2009, J AM ACAD PSYCHIATRY, V37, P371; Federal Reserve Bank of St. Louis, 2016, FRED INFL DAT FIL; Jones RW, 2016, HOUSING STUD, V31, P173, DOI 10.1080/02673037.2015.1070795; LEE CMC, 1991, J FINANC, V46, P75, DOI 10.1111/j.1540-6261.1991.tb03746.x; Lee CP, 2002, VALUE HEALTH, V12, P80; Luo FJ, 2011, AM J PUBLIC HEALTH, V101, P1139, DOI 10.2105/AJPH.2010.300010; Mucci N, 2016, NEUROPSYCH DIS TREAT, V12, P983, DOI 10.2147/NDT.S98525; National Center for Health Statistics, 2016, NAMCS DESCR; Norstrom T, 2015, J EPIDEMIOL COMMUN H, V69, P110, DOI 10.1136/jech-2014-204602; Reeves A, 2012, LANCET, V380, P1813, DOI 10.1016/S0140-6736(12)61910-2; Shelton A, 2008, INSIGHTS ISSUES, V9, P1; Spiegel M, 2011, REV FINANC STUD, V24, P1773, DOI 10.1093/rfs/hhr040; STACK S, 1982, DEVIANT BEHAV, V4, P41, DOI 10.1080/01639625.1982.9967602; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P145; Stack S, 2017, SOCIAL SCI J; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Treuhaft S, 2012, FOSTERING EQUITABLE	33	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186913	10.1371/journal.pone.0186913	http://dx.doi.org/10.1371/journal.pone.0186913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095894	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200029
J	Ajima, R; Suzuki, E; Saga, Y				Ajima, Rieko; Suzuki, Emiko; Saga, Yumiko			Pofut1 point-mutations that disrupt O-fucosyltransferase activity destabilize the protein and abolish Notch1 signaling during mouse somitogenesis	PLOS ONE			English	Article							DELTA INTERACTIONS; LIGAND-BINDING; FRINGE; O-FUCOSYL-TRANSFERASE-1; GLYCOSYLATION; SEGMENTATION; ENDOCYTOSIS; DROSOPHILA; RECEPTOR; PATHWAY	The segmental pattern of the vertebrate body is established via the periodic formation of somites from the presomitic mesoderm (PSM). This periodical process is controlled by the cyclic and synchronized activation of Notch signaling in the PSM. Protein O-fucosyltransfer-ase1 (Pofut1), which transfers O-fucose to the EGF domains of the Notch1 receptor, is indispensable for Notch signaling activation. The Drosophila homologue Ofut1 was reported to control Notch localization via two different mechanisms, working as a chaperone for Notch or as a regulator of Notch endocytosis. However, these were found to be independent of O-fucosyltransferase activity because the phenotypes were rescued by Ofut1 mutants lacking O-fucosyltransferase activity. Pofut1 may also be involved in the Notch receptor localization in mice. However, the contribution of enzymatic activity of Pofut1 to the Notch receptor dynamics remains to be elucidated. In order to clarify the importance of the O-fucosyltransferase activity of Pofut1 for Notch signaling activation and the protein localization in the PSM, we established mice carrying point mutations at the 245th a.a. or 370-372th a.a., highly conserved amino-acid sequences whose mutations disrupt the O-fucosyltransferase activity of both Drosophila Ofut1 and mammalian Pofut1, with the CRISPR/Cas9 mediated genome-engineering technique. Both mutants displayed the same severely perturbed somite formation and Notch1 subcellular localization defects as the Pofut1 null mutants. In the mutants, Pofut1 protein, but not RNA, became undetectable by E9.5. Furthermore, both wild-type and mutant Pofut1 proteins were degraded through lysosome dependent machinery. Pofut1 protein loss in the point mutant embryos caused the same phenotypes as those observed in Pofut1 null embryos.	[Ajima, Rieko; Saga, Yumiko] Natl Inst Genet, Genet Strains Res Ctr, Mammalian Dev Lab, Mishima, Shizuoka, Japan; [Ajima, Rieko; Saga, Yumiko] Natl Inst Genet, Mouse Res Supporting Unit, Mishima, Shizuoka, Japan; [Ajima, Rieko; Suzuki, Emiko; Saga, Yumiko] SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Suzuki, Emiko] Natl Inst Genet, Struct Biol Ctr, Gene Network Lab, Mishima, Shizuoka, Japan; [Saga, Yumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo	Ajima, R; Saga, Y (corresponding author), Natl Inst Genet, Genet Strains Res Ctr, Mammalian Dev Lab, Mishima, Shizuoka, Japan.; Ajima, R; Saga, Y (corresponding author), Natl Inst Genet, Mouse Res Supporting Unit, Mishima, Shizuoka, Japan.; Ajima, R; Saga, Y (corresponding author), SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan.; Saga, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.	rajima@nig.ac.jp; ysaga@nig.ac.jp		Suzuki, Emiko/0000-0002-4005-0542	Transdisciplinary Research Integration Center of the Research Organization of Information and Systems	Transdisciplinary Research Integration Center of the Research Organization of Information and Systems	This work was supported by Transdisciplinary Research Integration Center of the Research Organization of Information and Systems (YS).r We thank the Mouse Research Supporting Unit at the National Institute of Genetics for establishing all mutant mice in this study. We are particularly thankful to Dr. Yoshiaki Okamura, Makoto Kiso and Akane Ohishi (National Institute of Genetics, Japan) for technical support. We are grateful to Dr. Yasuyuki Kurihara for generating the monoclonal antibodies used in this study. We are grateful to Dr. Hitoshi Niwa and Dr. Ryoichiro Kageyama for providing reagents. We are grateful to Danelle Wright for editing this manuscript. This work was supported by funding from the Transdisciplinary Research Integration Center of the Research Organization of Information and Systems.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Breton C, 1998, J BIOCHEM, V123, P1000; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Furthauer M, 2009, TRAFFIC, V10, P792, DOI 10.1111/j.1600-0854.2009.00914.x; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hubaud A, 2014, NAT REV MOL CELL BIO, V15, P709, DOI 10.1038/nrm3891; Ishio A, 2015, J BIOL CHEM, V290, P505, DOI 10.1074/jbc.M114.616847; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jorissen E, 2010, CURR TOP DEV BIOL, V92, P201, DOI 10.1016/S0070-2153(10)92006-1; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Le Bras S, 2011, TRAFFIC, V12, P149, DOI 10.1111/j.1600-0854.2010.01126.x; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moretti J, 2013, INT J MOL SCI, V14, P6359, DOI 10.3390/ijms14036359; Muller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088571; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Okubo Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2133; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Saga Y, 2012, CURR OPIN GENET DEV, V22, P331, DOI 10.1016/j.gde.2012.05.004; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Serth K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123776; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Shifley ET, 2008, DEVELOPMENT, V135, P899, DOI 10.1242/dev.006742; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; SUZUKI E, 1994, J ELECTRON MICROSC, V43, P183; Suzuki E, 1995, CELL TECHNOLOGY, V14, P456; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yamamoto S, 2010, CURR TOP DEV BIOL, V92, P165, DOI 10.1016/S0070-2153(10)92005-X	56	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187248	10.1371/journal.pone.0187248	http://dx.doi.org/10.1371/journal.pone.0187248			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095923	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200061
J	Benstoem, C; Moza, A; Meybohm, P; Stoppe, C; Autschbach, R; Devane, D; Goetzenich, A				Benstoem, Carina; Moza, Ajay; Meybohm, Patrick; Stoppe, Christian; Autschbach, Ruediger; Devane, Declan; Goetzenich, Andreas			A core outcome set for adult cardiac surgery trials: A consensus study	PLOS ONE			English	Article							CLINICAL-TRIALS	Background Invasive off-or on-pump cardiac surgery (elective and emergency procedures, excluding transplants are routinely performed to treat complications of ischaemic heart disease. Randomised controlled trials (RCT) evaluate the effectiveness of treatments in the setting of cardiac surgery. However, the impact of RCTs is weakened by heterogeneity in outcome measuring and reporting, which hinders comparison across trials. Core outcome sets (COS, a set of outcomes that should be measured and reported, as a minimum, in clinical trials for a specific clinical field) help reduce this problem. In light of the above, we developed a COS for cardiac surgery effectiveness trials. Methods Potential core outcomes were identified a priori by analysing data on 371 RCTs of 58,253 patients. We reached consensus on core outcomes in an international three-round eDelphi exercise. Outcomes for which at least 60% of the participants chose the response option "no" and less than 20% chose the response option "yes" were excluded. Results Eighty-six participants from 23 different countries involving adult cardiac patients, cardiac surgeons, anaesthesiologists, nursing staff and researchers contributed to this eDelphi. The panel reached consensus on four core outcomes: 1) Measure of mortality, 2) Measure of quality of life, 3) Measure of hospitalisation and 4) Measure of cerebrovascular complication to be included in adult cardiac surgery trials. Conclusion This study used robust research methodology to develop a minimum core outcome set for clinical trials evaluating the effectiveness of treatments in the setting of cardiac surgery. As a next step, appropriate outcome measurement instruments have to be selected.	[Benstoem, Carina; Moza, Ajay; Autschbach, Ruediger; Goetzenich, Andreas] Univ Hosp RWTH Aachen, Dept Thorac & Cardiovasc Surg, Aachen, Germany; [Meybohm, Patrick] Univ Hosp Frankfurt, Dept Anaesthesiol Intens Care & Pain Med, Frankfurt, Germany; [Stoppe, Christian] Univ Hosp RWTH Aachen, Dept Intens Care Med, Aachen, Germany; [Devane, Declan] Natl Univ Ireland Galway, Sch Nursing & Midwifery, Dept Nursing & Midwifery, Galway, Ireland	RWTH Aachen University; RWTH Aachen University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Ollscoil na Gaillimhe-University of Galway	Benstoem, C (corresponding author), Univ Hosp RWTH Aachen, Dept Thorac & Cardiovasc Surg, Aachen, Germany.	cbenstoem@ukaachen.de	Devane, Declan/B-8357-2008	Devane, Declan/0000-0002-9393-7075; Benstoem, Carina/0000-0002-4604-6771	START-Program of the Facully of Medicine, RWTH Aachen [31/15]	START-Program of the Facully of Medicine, RWTH Aachen	This work was supported by the START-Program of the Facully of Medicine, RWTH Aachen [grant number 31/15] to CB and AM.	Benstoem C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122204; Boers M, 2014, J CLIN EPIDEMIOL, V67, P745, DOI 10.1016/j.jclinepi.2013.11.013; Chiarotto A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-511; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Kirkham JJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002148; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; McNair AGK, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002071; Moza A, 2015, TRIALS TRIALS, P1; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; The European Commission, 2016, EUR MED AGENCY SCI M, P1; US Food and Drug Administration, 2017, DRUG DEV TOOLS QUAL, P1; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; World Health Organization, 2016, INT HLTH REG, V3, P1	16	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186772	10.1371/journal.pone.0186772	http://dx.doi.org/10.1371/journal.pone.0186772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095881	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200023
J	Graf, L; Kim, YJ; Cho, GY; Miller, KA; Yoon, HS				Graf, Louis; Kim, Yae Jin; Cho, Ga Youn; Miller, Kathy Ann; Yoon, Hwan Su			Plastid and mitochondrial genomes of Coccophora langsdorfii (Fucales, Phaeophyceae) and the utility of molecular markers	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; SARGASSUM-HORNERI SARGASSACEAE; BROWN-ALGAE; PHYLOGENETIC-RELATIONSHIPS; FUNCTION PREDICTION; CHLOROPLAST GENOME; GENETIC DIVERSITY; PROTEIN-STRUCTURE; COMPLETE SEQUENCE; I-TASSER	Coccophora langsdorfii (Turner) Greville (Fucales) is an intertidal brown alga that is endemic to Northeast Asia and increasingly endangered by habitat loss and climate change. We sequenced the complete circular plastid and mitochondrial genomes of C. langsdorfii. The circular plastid genome is 124,450 bp and contains 139 protein-coding, 28 tRNA and 6 rRNA genes. The circular mitochondrial genome is 35,660 bp and contains 38 protein-coding, 25 tRNA and 3 rRNA genes. The structure and gene content of the C langsdorfii plastid genome is similar to those of other species in the Fucales. The plastid genomes of brown algae in other orders share similar gene content but exhibit large structural recombination. The large in-frame insert in the cox2 gene in the mitochondrial genome of C langsdorfii is typical of other brown algae. We explored the effect of this insertion on the structure and function of the cox2 protein. We estimated the usefulness of 135 plastid genes and 35 mitochondrial genes for developing molecular markers. This study shows that 29 organellar genes will prove efficient for resolving brown algal phylogeny. In addition, we propose a new molecular marker suitable for the study of intraspecific genetic diversity that should be tested in a large survey of populations of C. langsdorfii.	[Graf, Louis; Kim, Yae Jin; Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Cho, Ga Youn] Natl Inst Biol Resources, Incheon, South Korea; [Miller, Kathy Ann] Univ Calif Berkeley, Univ Herbarium, Berkeley, CA 94720 USA	Sungkyunkwan University (SKKU); National Institute of Biological Resources; University of California System; University of California Berkeley	Yoon, HS (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea.	hsyoon2011@skku.edu	Yoon, Hwan Su/A-2974-2013; Yoon, Hwan Su/ABD-7011-2020	Graf, Louis/0000-0001-8276-1687; Yoon, Hwan Su/0000-0001-9507-0105	National Institute of Biological Resources - Ministry of Environment; Collaborative Genome Program - Ministry of Oceans and Fisheries, Korea [20140428]	National Institute of Biological Resources - Ministry of Environment; Collaborative Genome Program - Ministry of Oceans and Fisheries, Korea	This work was supported by the grants from National Institute of Biological Resources funded by the Ministry of Environment and the Collaborative Genome Program (20140428) funded by the Ministry of Oceans and Fisheries, Korea to HSY.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Adams KL, 2001, MOL BIOL EVOL, V18, P2289, DOI 10.1093/oxfordjournals.molbev.a003775; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bi Y, 2015, MITOCHONDRIAL DNA, V1-2; Brodie J, 2009, PHYCOLOGIA, V48, P423, DOI 10.2216/09-21.1; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Burger G, 2000, J MOL BIOL, V297, P365, DOI 10.1006/jmbi.2000.3529; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45; Cho GY, 2006, PHYCOLOGIA, V45, P512, DOI 10.2216/05-48.1; Cho GY, 2004, J PHYCOL, V40, P921, DOI 10.1111/j.1529-8817.2004.03160.x; Cho SM, 2012, BOT MAR, V55, P473, DOI 10.1515/bot-2012-0109; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Graaf RM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-514; Funes S, 2002, SCIENCE, V298, P2155, DOI 10.1126/science.1076003; Gawryluk Ryan M R, 2009, BMC Res Notes, V2, P16, DOI 10.1186/1756-0500-2-16; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Henry RJ, 2013, MOL MARKERS PLANTS, P3; Hilker R, 2012, BIOINFORMATICS, V28, P2509, DOI 10.1093/bioinformatics/bts440; Jackson C, 2017, J PHYCOL, V53, P1, DOI 10.1111/jpy.12465; Janouskovec J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059001; KADENBACH B, 1991, J BIOENERG BIOMEMBR, V23, P321, DOI 10.1007/BF00762225; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; Lee J, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0299-5; Li TY, 2015, MITOCHONDR DNA, V26, P953, DOI 10.3109/19401736.2013.865172; Liu F, 2015, MITOCHONDRIAL DNA, V1-3; Liu Fang, 2014, Biomed Res Int, V2014, P170289, DOI 10.1155/2014/170289; Liu F, 2016, J APPL PHYCOL, V28, P1419, DOI 10.1007/s10811-015-0609-2; Liu F, 2016, MITOCHONDRIAL DNA A, V27, P1468, DOI 10.3109/19401736.2014.953096; Liu F, 2015, CURR GENET, V61, P621, DOI 10.1007/s00294-015-0488-8; Liu F, 2016, MITOCHONDRIAL DNA A, V27, P1158, DOI 10.3109/19401736.2014.936417; Liu F, 2016, MITOCHONDRIAL DNA A, V27, P1129, DOI 10.3109/19401736.2014.933333; Liu F, 2015, J APPL PHYCOL, V27, P1021, DOI 10.1007/s10811-014-0386-3; Liu F, 2015, J APPL PHYCOL, V27, P469, DOI 10.1007/s10811-014-0295-5; Ministry of Environment, 2015, STAT DISTR END SPEC, P344; Oak J.H., 2010, ALGAL FLORA KOREA, P111; Oudot-le Secq MP, 2002, EUR J PHYCOL, V37, P163, DOI 10.1017/S0967026202003542; Oudot-Le Secq MP, 2001, J MOL EVOL, V53, P80, DOI 10.1007/s002390010196; Pecina P, 2004, PHYSIOL RES, V53, pS213; Perez-Martinez X, 2001, J BIOL CHEM, V276, P11302, DOI 10.1074/jbc.M010244200; Qu JQ, 2015, MITOCHONDR DNA, V26, P919, DOI 10.3109/19401736.2013.863290; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sahu Sunil Kumar, 2012, ISRN Mol Biol, V2012, P205049, DOI 10.5402/2012/205049; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Secq MPO, 2006, CURR GENET, V49, P47, DOI 10.1007/s00294-005-0031-4; Silberfeld T, 2014, CRYPTOGAMIE ALGOL, V35, P117, DOI 10.7872/crya.v35.iss2.2014.117; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Smith DR, 2015, GENOME BIOL EVOL, V7, P1227, DOI 10.1093/gbe/evv069; Song HJ, 2016, ALGAE-SEOUL, V31, P137, DOI 10.4490/algae.2016.31.6.5; Stephens TG, 2016, PEERJ, V4, DOI 10.7717/peerj.2038; Szafranski P, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3626-5; Titlyanov E.A., 2016, USEFUL MARINE PLANTS; Uwai SY, 2006, PHYCOLOGIA, V45, P687, DOI 10.2216/05-66.1; Uwai S, 2009, MAR BIOL, V156, P901, DOI 10.1007/s00227-009-1136-y; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Waller RF, 2006, GENE, V383, P33, DOI 10.1016/j.gene.2006.07.003; Wang S, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING, COMMUNICATIONS AND COMPUTING (ICSPCC), P1, DOI 10.1109/INTMAG.2015.7156812; Wang XL, 2013, MAR GENOM, V10, P1, DOI 10.1016/j.margen.2012.12.002; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Wynne MJ, 2014, PHYCOLOGIA, V53, P513, DOI 10.2216/14-055.1; Yang EC, 2012, PROTIST, V163, P217, DOI 10.1016/j.protis.2011.08.001; Yang JH, 2016, MAR GENOM, V28, P17, DOI 10.1016/j.margen.2016.03.003; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yoon HS, 2001, MOL PHYLOGENET EVOL, V21, P231, DOI 10.1006/mpev.2001.1009; Yoshida T., 1998, MARINE ALGAE JAPAN; Yotsukura N, 2010, J APPL PHYCOL, V22, P243, DOI 10.1007/s10811-009-9452-7; Zhang J, 2013, J APPL PHYCOL, V25, P1247, DOI 10.1007/s10811-012-9915-0; Zhang Jing, 2011, Journal of Ocean University of China, V10, P351, DOI 10.1007/s11802-011-1856-8; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140144; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139366; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	81	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187104	10.1371/journal.pone.0187104	http://dx.doi.org/10.1371/journal.pone.0187104			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095864	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200046
J	Jonsson, J; Westman, A; Bruchfeld, J; Sturegard, E; Gaines, H; Schon, T				Jonsson, Jerker; Westman, Anna; Bruchfeld, Judith; Sturegard, Erik; Gaines, Hans; Schon, Thomas			A borderline range for Quantiferon Gold In-Tube results	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; HEALTH-CARE WORKERS; TUBERCULOSIS INFECTION; PLUS; VARIABILITY	Objective Interferon gamma release assays like Quantiferon Gold In-Tube (QFT) are used to identify individuals infected with Mycobacterium tuberculosis. A dichotomous cut-off (0.35 IU/ml) defines a positive QFT without considering test variability. Our objective was to evaluate the introduction of a borderline range under routine conditions. Methods Results of routine QFT samples from Sweden (2009-2014) were collected. A borderline range (0.20-0.99 IU/ml) was introduced in 2010 recommending a follow-up sample. The association between borderline results and incident active TB within 3 to 24 months was investigated through linkage with the national TB-register. Results Using the recommended QFT cut-off, 75.1 % tests were negative, 21.4% positive and 3.5% indeterminate. In total, 9% (3656/40773) were within the borderline range. In follow-up samples, individuals with initial results between 0.20-0.34 IU/ml and 0.35-0.99 IU/ml displayed negative results below the borderline range (<0.20 IU/ml) in 66.1% (230/348) and 42.5% (285/671) respectively, and none developed incident TB. Among 6712 individuals with a positive initial test >0.99 IU/ml, 65 (0.97%) developed incident TB within 3-24 months. Conclusions We recommend retesting of subjects with QFT results in the range 0.20-0.99 IU/ml to enhance reliability and validity of the test. Half of the subjects in the borderline range will be negative at a level<0.20 IU/ml when retested and have a very low risk of developing incident active TB.	[Jonsson, Jerker; Gaines, Hans] Publ Hlth Agcy Sweden, Solna, Sweden; [Jonsson, Jerker; Bruchfeld, Judith; Gaines, Hans] Karolinska Inst, Unit Infect Dis, Dept Med, Stockholm, Sweden; [Westman, Anna] Danderyd Hosp, Dept Infect Dis, Stockholm, Sweden; [Westman, Anna] Karolinska Univ Hosp Lab, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Bruchfeld, Judith; Gaines, Hans] Karolinska Univ Hosp Solna, Dept Infect Dis, Stockholm, Sweden; [Sturegard, Erik] Lund Univ, Dept Translat Med, Infect Dis Res Unit, Lund, Sweden; [Schon, Thomas] Kalmar Cty Hosp, Dept Clin Microbiol & Infect Dis, Kalmar, Sweden; [Schon, Thomas] Linkoping Univ, Dept Clin & Expt Res, Div Med Microbiol, Linkoping, Sweden	Public Health Agency of Sweden; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University; Linkoping University	Schon, T (corresponding author), Kalmar Cty Hosp, Dept Clin Microbiol & Infect Dis, Kalmar, Sweden.; Schon, T (corresponding author), Linkoping Univ, Dept Clin & Expt Res, Div Med Microbiol, Linkoping, Sweden.	tschon@hotmail.com	Jonsson, Jerker/O-6675-2019	Jonsson, Jerker/0000-0003-1383-6176; Schon, Thomas/0000-0003-4849-1286	Swedish Research council [201602043]; Swedish Heart and Lung Foundation (Oscar II Jubilee foundation) [20150236, 20150237]	Swedish Research council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation (Oscar II Jubilee foundation)	This study was funded (all granted to Thomas Schon) by the Swedish Research council, grant 201602043 (www.vr.se) and the Swedish Heart and Lung Foundation (Oscar II Jubilee foundation) grants 20150236 and 20150237 (www3.hjart-lungfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaei Niaz, 2016, J Clin Microbiol, V54, P845, DOI 10.1128/JCM.02803-15; Barcellini L, 2016, EUR RESPIR J, V48, P1411, DOI 10.1183/13993003.00510-2016; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Gamsky TE, 2016, ANN AM THORAC SOC, V13, P660, DOI 10.1513/AnnalsATS.201508-532OC; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Hermansen TS, 2016, THORAX, V71, P652, DOI 10.1136/thoraxjnl-2015-208228; Hoffmann H, 2016, CLIN MICROBIOL INFEC, V22, P701, DOI 10.1016/j.cmi.2016.05.006; Joshi Manish, 2014, Ann Am Thorac Soc, V11, P296, DOI 10.1513/AnnalsATS.201310-378OC; Knierer J, 2017, J OCCUP MED TOXICOL, V12, DOI 10.1186/s12995-016-0148-z; Lewinsohn DM, 2016, CLIN INFECT DIS, P1; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC; Nienhaus A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-9; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Schablon A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115322; Simpson T, 2012, HEART LUNG, V41, P553, DOI 10.1016/j.hrtlng.2012.06.005; Tagmouti Saloua, 2014, Ann Am Thorac Soc, V11, P1267, DOI 10.1513/AnnalsATS.201405-188OC; Thanassi W, 2016, INFECT CONT HOSP EP, V37, P478, DOI 10.1017/ice.2015.324; Welfare TSNBfHa, 2013, NATL SWEDISH RECOMME; Yi LN, 2016, SCI REP-UK, V6, DOI 10.1038/srep30617	23	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187313	10.1371/journal.pone.0187313	http://dx.doi.org/10.1371/journal.pone.0187313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095918	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200071
J	Terrill, JR; Pinniger, GJ; Nair, KV; Grounds, MD; Arthur, PG				Terrill, Jessica R.; Pinniger, Gavin J.; Nair, Keshav V.; Grounds, Miranda D.; Arthur, Peter G.			Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MOUSE MODEL; CYSTEINE DIOXYGENASE; OXIDATIVE STRESS; AMINO-ACIDS; MUSCLE; SUPPLEMENTATION; DYSTROPATHOLOGY; DEFICIENCY; BIOMARKERS	Duchenne Muscular Dystrophy (DMD) is a fatal muscle wasting disease manifested in young boys, for which there is no current cure. We have shown that the amino acid taurine is safe and effective at preventing dystropathology in the mdx mouse model for DMD. This study aimed to establish if treating growing mdx mice with a higher dose of taurine was more effective at improving strength and reducing inflammation and oxidative stress. Mice were treated with a dose of taurine estimated to be 16g/kg/day, in drinking water from 1-6 weeks of age, after which in vivo and ex vivo muscle strength was assessed, as were measures of inflammation, oxidative stress and taurine metabolism. While the dose did decrease inflammation and protein oxidation in dystrophic muscles, there was no improvement in muscle strength (in contrast with benefits observed with the lower dose) and growth of the young mice was significantly restricted. We present novel data that a high taurine dose increases the cysteine content of both mdx liver and plasma, a possible result of down regulation of the taurine synthesis pathway in the liver (which functions to dispose of excess cysteine, which is toxic). These data caution that a high dose of taurine can have adverse effects and may be less efficacious than lower taurine doses. Therefore, monitoring of taurine dosage needs to be considered in future pre-clinical trials, in anticipation of using taurine as a clinical therapy for growing DMD boys (and other conditions).	[Terrill, Jessica R.; Arthur, Peter G.] Univ Western Australia, Sch Mol Sci, Perth, WA, Australia; [Pinniger, Gavin J.; Nair, Keshav V.; Grounds, Miranda D.] Univ Western Australia, Sch Human Sci, Perth, WA, Australia	University of Western Australia; University of Western Australia	Terrill, JR (corresponding author), Univ Western Australia, Sch Mol Sci, Perth, WA, Australia.	jessica.terrill@uwa.edu.au	Arthur, Peter/H-8765-2014; Arthur, Peter/AAD-4594-2020; Pinniger, Gavin/F-1421-2013	Arthur, Peter/0000-0002-1257-8200; Arthur, Peter/0000-0002-1257-8200; Pinniger, Gavin/0000-0002-4400-0817; Terrill, Jessica/0000-0001-5484-5373; Grounds, Miranda/0000-0002-4530-9402	National Health and Medical Research Council (NHMRC) of Australia [APP1065829]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au), grant number APP1065829 (PGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia.	BAGLEY PJ, 1995, J NUTR, V125, P933; Bella DL, 2000, ADV EXP MED BIOL, V483, P71; Biggar WD, 2006, PEDIATR REV, V27, P83, DOI 10.1542/pir.27-3-83; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Capogrosso RF, 2016, PHARMACOL RES, V106, P101, DOI 10.1016/j.phrs.2016.02.016; Cozzoli A, 2011, NEUROPATH APPL NEURO, V37, P243, DOI 10.1111/j.1365-2990.2010.01106.x; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; De Luca A, 2001, BRIT J PHARMACOL, V132, P1047, DOI 10.1038/sj.bjp.0703907; De Luca A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0610-1; De Luca Annamaria, 2012, Acta Myol, V31, P40; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Eppler B, 2001, BIOCHEM PHARMACOL, V62, P29, DOI 10.1016/S0006-2952(01)00647-5; Grounds MD, 2008, CELL MOL LIFE SCI, V65, P1621, DOI 10.1007/s00018-008-7574-8; Grounds MD, 2011, BIOESSAYS, V33, P458, DOI 10.1002/bies.201000136; Hakim CH, 2013, JOVE-J VIS EXP, DOI 10.3791/50183; HARPER AE, 1970, PHYSIOL REV, V50, P428, DOI 10.1152/physrev.1970.50.3.428; HAYES KC, 1980, J NUTR, V110, P2058, DOI 10.1093/jn/110.10.2058; Horvath DM, 2016, AMINO ACIDS, P1; Hu JM, 2000, J VET MED SCI, V62, P693, DOI 10.1292/jvms.62.693; Huxtable R., 2002, TAURINE, V4, P1; JERKINS AA, 1991, AM J PHYSIOL, V261, pE551, DOI 10.1152/ajpendo.1991.261.5.E551; Jerkins AA, 1998, J NUTR, V128, P1890, DOI 10.1093/jn/128.11.1890; Johnson RB, 2015, AQUACULTURE, V445, P79, DOI 10.1016/j.aquaculture.2015.03.030; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Liu Y, 2014, LIVEST SCI, V168, P109, DOI 10.1016/j.livsci.2014.08.014; Manzur AY, 2008, COCHRANE DB SYST REV, V3; Marcinkiewicz J, 2014, AMINO ACIDS, V46, P7, DOI 10.1007/s00726-012-1361-4; Matthews E, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub4; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P5823, DOI 10.1113/jphysiol.2013.263251; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Radley HG, 2007, INT J BIOCHEM CELL B, V39, P469, DOI 10.1016/j.biocel.2006.09.009; Radley-Crabb HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089277; Ramsey KA, 2010, MUSCLE NERVE, V42, P769, DOI 10.1002/mus.21744; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Shao A, 2008, REGUL TOXICOL PHARM, V50, P376, DOI 10.1016/j.yrtph.2008.01.004; Shimizu-Motohashi Y, 2016, AM J TRANSL RES, V8, P2471; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Stipanuk MH, 2004, NEUROCHEM RES, V29, P105, DOI 10.1023/B:NERE.0000010438.40376.c9; Strehle EM, 2015, ARCH DIS CHILD, V100, P1173, DOI 10.1136/archdischild-2014-307962; Terrill JR, 2016, REDOX BIOL, V9, P276, DOI 10.1016/j.redox.2016.08.016; Terrill JR, 2016, J PHYSIOL-LONDON, V594, P3095, DOI 10.1113/JP271418; Terrill JR, 2015, INT J BIOCHEM CELL B, V66, P141, DOI 10.1016/j.biocel.2015.07.016; Terrill JR, 2013, INT J BIOCHEM CELL B, V45, P2097, DOI 10.1016/j.biocel.2013.07.009; Terrill JRP, 2016, PLOS CURR, V8; Ueki I, 2008, CURR PROTOC TOXICOL, V38; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X	48	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187317	10.1371/journal.pone.0187317	http://dx.doi.org/10.1371/journal.pone.0187317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095865	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200072
J	Auracher, J				Auracher, Jan			Sound iconicity of abstract concepts: Place of articulation is implicitly associated with abstract concepts of size and social dominance	PLOS ONE			English	Article							FORMANT FREQUENCIES; FACIAL EXPRESSIONS; SYMBOLISM; EMOTION; COMMUNICATION; SHAPE; CORRESPONDENCES; PERCEPTION; PHONEMES; SADNESS	The concept of sound iconicity implies that phonemes are intrinsically associated with non acoustic phenomena, such as emotional expression, object size or shape, or other perceptual features. In this respect, sound iconicity is related to other forms of cross -modal associations in which stimuli from different sensory modalities are associated with each other due to the implicitly perceived correspondence of their primal features. One prominent example is the association between vowels, categorized according to their place of articulation, and size, with back vowels being associated with bigness and front vowels with smallness. However, to date the relative influence of perceptual and conceptual cognitive processing on this association is not clear. To bridge this gap, three experiments were conducted in which associations between nonsense words and pictures of animals or emotional body postures were tested. In these experiments participants had to infer the relation between visual stimuli and the notion of size from the content of the pictures, while directly perceivable features did not support or even contradicted the predicted association. Results show that implicit associations between articulatory -acoustic characteristics of phonemes and pictures are mainly influenced by semantic features, i.e., the content of a picture, whereas the influence of perceivable features, i.e., size or shape, is overridden. This suggests that abstract semantic concepts can function as an interface between different sensory modalities, facilitating cross -modal associations.	[Auracher, Jan] Max Planck Inst Empir Aesthet, Dept Language & Literature, Frankfurt, Germany		Auracher, J (corresponding author), Max Planck Inst Empir Aesthet, Dept Language & Literature, Frankfurt, Germany.	jan.auracher@aesthetics.mpg.de	Auracher, Jan/ABB-5166-2021	Auracher, Jan/0000-0002-4357-8350	Japanese Society for the Promotion of Science (JSPS) [24520481]	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japanese Society for the Promotion of Science (JSPS, , research project No. 24520481, https://www.isps.go.jp/english/); Researcher: Jan Auracher. Funding was used for technical equipment, software licenses and to pay allowance for participants.	Allott R., 1995, LANGUAGE WURM GLACIA, P15; Amorim MCP, 2005, ANIM BEHAV, V69, P595, DOI 10.1016/j.anbehav.2004.06.016; Aryani A, 2016, PSYCHOL AESTHET CREA, V10, P191, DOI 10.1037/aca0000033; Asano M, 2015, CORTEX, V63, P196, DOI 10.1016/j.cortex.2014.08.025; Auracher J, 2011, DISCOURSE PROCESS, V48, P1, DOI 10.1080/01638531003674894; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BECKER JA, 1988, AM J PSYCHOL, V101, P51, DOI 10.2307/1422792; BIRCH D, 1958, J GEN PSYCHOL, V58, P291, DOI 10.1080/00221309.1958.9920401; Blasi DE, 2016, P NATL ACAD SCI USA, V113, P10818, DOI 10.1073/pnas.1605782113; Colleye O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049179; de Gelder B, 2015, WIRES COGN SCI, V6, P149, DOI 10.1002/wcs.1335; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Eitan Z, 2010, COGNITION, V114, P405, DOI 10.1016/j.cognition.2009.10.013; Elliot AJ, 2013, EMOT REV, V5, P308, DOI 10.1177/1754073913477517; Feinberg DR, 2011, BEHAV ECOL, V22, P1320, DOI 10.1093/beheco/arr134; FONAGY I, 1961, WORD, V17, P194, DOI 10.1080/00437956.1961.11659754; Fox J., 2019, R COMPANION APPL REG; French P. L., 1977, WORD, V28, P305, DOI [DOI 10.1080/00437956.1977.11435647, 10.1080/00437956.1977.11435647]; Gao XQ, 2010, J EXP CHILD PSYCHOL, V105, P98, DOI 10.1016/j.jecp.2009.09.001; Gawronski B, 2006, CONSCIOUS COGN, V15, P485, DOI 10.1016/j.concog.2005.11.007; Greenberg J. H., 1966, WORD, V22, P207, DOI [10.1080/00437956.1966.11435451, DOI 10.1080/00437956.1966.11435451]; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Gregory SW, 2002, SOC PSYCHOL QUART, V65, P298; Gregory SW, 1996, J PERS SOC PSYCHOL, V70, P1231, DOI 10.1037/0022-3514.70.6.1231; Hinton L., 1994, SOUND SYMBOLISM, P1; Hodges-Simeon CR, 2010, HUM NATURE-INT BIOS, V21, P406, DOI 10.1007/s12110-010-9101-5; Imai M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0298; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Jacobs AM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00186; Jakobson R., 1960, STYLE LANG, P350; Kanero J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097905; Kantartzis K, 2011, COGNITIVE SCI, V35, P575, DOI 10.1111/j.1551-6709.2010.01169.x; Klink R. R., 2000, MARKET LETT, V11, P5, DOI DOI 10.1023/A:1008184423824; Knutson B, 1996, J NONVERBAL BEHAV, V20, P165, DOI 10.1007/BF02281954; Kovic V, 2010, COGNITION, V114, P19, DOI 10.1016/j.cognition.2009.08.016; Kraxenberger M, 2014, RIV ITAL FILOS LINGU, V8, P10, DOI 10.4396/20140603; LINDAUER MS, 1990, B PSYCHONOMIC SOC, V28, P151; LINDAUER MS, 1991, METAPHOR SYMB ACT, V6, P183, DOI 10.1207/s15327868ms0603_3; Lockwood G, 2016, J EXP PSYCHOL LEARN, V42, P1274, DOI 10.1037/xlm0000235; Lockwood G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01246; Marks L.E., 1996, METAPHOR SYMBOL, V11, P39, DOI [DOI 10.1207/S15327868MS1101_3, 10.1207/s15327868ms1101_3]; MARKS LE, 1974, AM J PSYCHOL, V87, P173, DOI 10.2307/1422011; Marks LE, 1978, UNITY SENSES INTERRE, VXI; Martino G, 2000, PERCEPTION, V29, P745, DOI 10.1068/p2984; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Menninghaus W, 2014, PSYCHOL AESTHET CREA, V8, P71, DOI 10.1037/a0035309; Miall DS, 2001, POETICS, V29, P55, DOI 10.1016/S0304-422X(00)00025-5; MIRON MS, 1961, J ABNORM SOC PSYCH, V62, P623, DOI 10.1037/h0045212; Monaghan P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0299; Mondloch CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073605; Newman SS, 1933, AM J PSYCHOL, V45, P53, DOI 10.2307/1414186; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Nygaard LC, 2009, COGNITION, V112, P181, DOI 10.1016/j.cognition.2009.04.001; Obermeier C, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00010; Ohala J. J., 1994, SOUND SYMBOLISM, P325, DOI [10.1017/CBO9780511751806.022, DOI 10.1017/CBO9780511751806.022]; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; Oyama T, 1963, PSYCHOLOGIA, V6, P131; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Parise CV, 2012, EXP BRAIN RES, V220, P319, DOI 10.1007/s00221-012-3140-6; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791; Perry LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137147; PLUTCHIK R., 1994, PSYCHOL BIOL EMOTION; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Reay IE, 1994, ENCY LANGUAGE LINGUI, V8, P4064; Revill KP, 2014, BRAIN LANG, V128, P18, DOI 10.1016/j.bandl.2013.11.002; Rubin DC, 2009, MEMORY, V17, P802, DOI 10.1080/09658210903130764; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sapir E, 1929, J EXP PSYCHOL, V12, P225, DOI 10.1037/h0070931; SCHLOSBERG H, 1954, PSYCHOL REV, V61, P81, DOI 10.1037/h0054570; Schmidtke DS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00080; Shrum LJ, 2012, INT J RES MARK, V29, P275, DOI 10.1016/j.ijresmar.2012.03.002; Shrum LJ, 2007, PSYCHOLINGUISTIC PHE, P39; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Sucevic J, 2015, BRAIN LANG, V145, P11, DOI [10.1016/j.bandl.2015.03.011, 10.1016/j.band1.2015.03.011]; Thayer R. E, 1990, BIOPSYCHOLOGY MOOD A; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V80, P86, DOI 10.1037//0022-3514.80.1.86; Tracy JL, 2015, CURR OPIN BEHAV SCI, V3, P25, DOI 10.1016/j.cobeha.2015.01.001; Tsur R, 2006, J PRAGMATICS, V38, P905, DOI 10.1016/j.pragma.2005.12.002; Ultan R., 1978, UNIVERSALS HUMAN LAN, P525; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; von Hornbostel EM, 1931, PFLUG ARCH GES PHYS, V227, P517; WALKER P, 1984, PERCEPTION, V13, P75, DOI 10.1068/p130075; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Westbury C, 2005, BRAIN LANG, V93, P10, DOI 10.1016/j.bandl.2004.07.006; Whissell C, 1999, PERCEPT MOTOR SKILL, V89, P19, DOI 10.2466/PMS.89.5.19-48; Whissell C, 2000, PERCEPT MOTOR SKILL, V91, P617, DOI 10.2466/PMS.91.6.617-648; Wiseman M., 2003, ROMAN JAKOBSONS GEDI, P277; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5	96	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187196	10.1371/journal.pone.0187196	http://dx.doi.org/10.1371/journal.pone.0187196			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FL4VN	29091943	Green Submitted, Green Published, gold			2022-12-27	WOS:000414229700045
J	Bertin, Y; Habouzit, C; Duniere, L; Laurier, M; Durand, A; Duchez, D; Segura, A; Thevenot-Sergentet, D; Baruzzi, F; Chaucheyras-Durand, F; Forano, E				Bertin, Yolande; Habouzit, Chloe; Duniere, Lysiane; Laurier, Marie; Durand, Alexandra; Duchez, David; Segura, Audrey; Thevenot-Sergentet, Delphine; Baruzzi, Federico; Chaucheyras-Durand, Frederique; Forano, Evelyne			Lactobacillus reuteri suppresses E-coli 0157: H7 in bovine ruminal fluid: Toward a pre-slaughter strategy to improve food safety?	PLOS ONE			English	Article							LACTIC-ACID; IN-VITRO; BEEF-CATTLE; GLYCEROL; O157H7; RUMEN; 3-HYDROXYPROPIONALDEHYDE; BACTERIA; SHEEP; DIGESTIBILITY	The bovine gastrointestinal tract (GIT) is the main reservoir for enterohaemorrhagic Escherichia coli (EHEC) responsible for food-borne infections. Therefore, it is crucial to develop strategies, such as EHEC suppression by antagonistic microorganisms, to reduce EHEC survival in the GIT of cattle and to limit shedding and food contamination. Most human derived Lactobacillus reuteri strains produce hydroxypropionaldehyde (HPA), an antimicrobial compound, during anaerobic reduction of glycerol. The capacity of L. reuteriLB1-7, a strain isolated from raw bovine milk, to produce HPA and its antimicrobial activity against an 0157:H7 EHEC strain (FCH6) were evaluated in bovine rumen fluid (RF) under strict anaerobiosis. EHEC was totally suppressed when incubated in RF inoculated with L. reuteri LB1-7 and supplemented with 80 mM glycerol (RF-Glyc80). The addition of LB1-7 or glycerol alone did not modify EHEC survival in RF. Glycerol was converted to HPA (up to 14 mM) by LB1-7 during incubation in RF-Glyc80, and HPA production appeared to be responsible for EHEC suppression. The bactericidal activity of L. reuteriLB1-7, the concentration of glycerol required and the level of HPA produced depended on physiological and ecological environments. In vitro experiments also showed that EHEC inoculated in rumen fluid and exposed to L. reuteri and glycerol had a very limited growth in rectal contents. However, L. reuteri exerted an antimicrobial activity against the rumen endogenous microbiota and perturbed feedstuff degradation in the presence of glycerol. The potential administration of L. reuteri and glycerol in view of application to finishing beef cattle at the time of slaughter is discussed. Further in vivo studies will be important to confirm the efficiency of L. reuteri and glycerol supplementation against EHEC shedding in ruminants.	[Bertin, Yolande; Habouzit, Chloe; Duniere, Lysiane; Laurier, Marie; Durand, Alexandra; Segura, Audrey; Chaucheyras-Durand, Frederique; Forano, Evelyne] Univ Clermont Auvergne, INRA, MEDIS, Clermont Ferrand, France; [Duniere, Lysiane; Chaucheyras-Durand, Frederique] Lallemand SAS, Blagnac, France; [Duchez, David] Univ Blaise Pascal, Polytech Clermont Ferrand, Inst Pascal Axe GePEB, Aubiere, France; [Thevenot-Sergentet, Delphine] VetAgro Sup, Res Grp Bacterial Opportunist Pathogens & Environ, UMR, Ecol Microbienne,CNRS,INRA, Villeurbanne, France; [Thevenot-Sergentet, Delphine] Univ Lyon 1, Villeurbanne, France; [Thevenot-Sergentet, Delphine] VetAgro Sup, Lab Etud Microorganismes Pathogenes, French Lab Shiga Toxin Producing Escherichia Coli, Campus Vet, Marcy Letoile, France; [Baruzzi, Federico] Natl Res Council Italy, Inst Sci Food Prod, Bari, Italy	INRAE; Universite Clermont Auvergne (UCA); Lallemand - France; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR)	Bertin, Y (corresponding author), Univ Clermont Auvergne, INRA, MEDIS, Clermont Ferrand, France.	yolande.bertin@inra.fr	Baruzzi, Federico/I-7276-2013; FORANO, Evelyne/C-9976-2009	FORANO, Evelyne/0000-0002-7450-3466; BARUZZI, FEDERICO/0000-0002-3586-2140	Fonds unique interministeriel [OSEO F1010011M]; European Regional Development Fund [33577]	Fonds unique interministeriel; European Regional Development Fund(European Commission)	This work was supported by Fonds unique interministeriel (OSEO F1010011M) (EF); http://competitivite.gouv.fr/le-lancement-du-10e-appel-a-projets-de-r-d-du-fu/les-resultats-du-10e-appal-a-projets-701.html; European Regional Development Fund (33577) (EF); http:///www.europe-en-auvergne.eu/programme-massif-central.html; Conseil Regional d'Auvergne (CPER T2ANSH) (EF); http://enseignementsup-recherche.gouv.fr/cid72550/le-contrat-de-projets-etat-region-auvergne-2007-2013.html; LALLEMAND SAS provided support in the form of salaries for authors FCD and LD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesogan AT, 2005, ANIM FEED SCI TECH, V119, P333, DOI 10.1016/i.anifeedsci.2004.09.012; Baruzzi F, 2011, APPL MICROBIOL BIOT, V90, P331, DOI 10.1007/s00253-011-3133-6; Bertin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098367; Bertin Y, 2013, ENVIRON MICROBIOL, V15, P610, DOI 10.1111/1462-2920.12019; Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523; Bohle LA, 2010, APPL ENVIRON MICROB, V76, P7306, DOI 10.1128/AEM.01423-10; Brashears MM, 2017, MEAT SCI, V132, P59, DOI 10.1016/j.meatsci.2017.03.015; Brown CA, 1997, APPL ENVIRON MICROB, V63, P27, DOI 10.1128/AEM.63.1.27-32.1997; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Chancey CC, 2013, J FOOD PROTECT, V76, P1778, DOI 10.4315/0362-028X.JFP-12-566; Chaucheyras-Durand F, 2010, BENEF MICROBES, V1, P3, DOI 10.3920/BM2008.1002; Chaucheyras-Durand F, 2006, APPL ENVIRON MICROB, V72, P4136, DOI 10.1128/AEM.02600-05; Damiran D, 2008, ANIM FEED SCI TECH, V141, P15, DOI 10.1016/j.anifeedsci.2007.04.007; Danielsson R, 2014, J DAIRY SCI, V97, P5729, DOI 10.3168/jds.2014-7929; Donkin SS, 2009, J DAIRY SCI, V92, P5111, DOI 10.3168/jds.2009-2201; Eaton KA, 2011, INFECT IMMUN, V79, P185, DOI 10.1128/IAI.00880-10; Elramady MG, 2013, FOODBORNE PATHOG DIS, V10, P661, DOI 10.1089/fpd.2012.1420; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; GARTON GA, 1961, J GEN MICROBIOL, V25, P215, DOI 10.1099/00221287-25-2-215; Goering H.K., 1970, AGR HDB USDA; Gruber SL, 2010, J ANIM SCI, V88, P1148, DOI 10.2527/jas.2009-2183; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; HOBSON PN, 1961, J GEN MICROBIOL, V25, P227, DOI 10.1099/00221287-25-2-227; HOOVER WH, 1991, VET CLIN N AM-FOOD A, V7, P311, DOI 10.1016/S0749-0720(15)30801-X; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Keen JE, 2010, APPL ENVIRON MICROB, V76, P5278, DOI 10.1128/AEM.00400-10; Law D, 2000, J APPL MICROBIOL, V88, P729, DOI 10.1046/j.1365-2672.2000.01031.x; Lomander H, 2012, J DAIRY SCI, V95, P2397, DOI 10.3168/jds.2011-4535; Luongo D, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-298; Luthi-Peng Q, 2002, APPL MICROBIOL BIOT, V60, P73, DOI 10.1007/s00253-002-1099-0; McSweeney S, 2012, 61 FAO; Mosoni P, 2007, J APPL MICROBIOL, V103, P2676, DOI 10.1111/j.1365-2672.2007.03517.x; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Ogawa M, 2001, INT J FOOD MICROBIOL, V68, P135, DOI 10.1016/S0168-1605(01)00465-2; Pandey V, 2015, J INT SOC PREV COMMU, V5, P81, DOI 10.4103/2231-0762.155726; REMOND D, 1993, J ANIM SCI, V71, P2529, DOI 10.2527/1993.7192529x; Rivas L, 2010, APPL ENVIRON MICROB, V76, P7210, DOI 10.1128/AEM.01530-10; Schaefer L, 2010, MICROBIOL-SGM, V156, P1589, DOI 10.1099/mic.0.035642-0; Sperandio V, 2010, GUT MICROBES, V1, P432, DOI 10.4161/gmic.1.6.14177; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Stern MD, 1997, J ANIM SCI, V75, P2256; TALARICO TL, 1989, ANTIMICROB AGENTS CH, V33, P674, DOI 10.1128/AAC.33.5.674; Vaidyanathan H, AMB EXPRESS, P1; Vollenweider S, 2003, J AGR FOOD CHEM, V51, P3287, DOI 10.1021/jf021086d; Vollenweider S, 2010, J AGR FOOD CHEM, V58, P10315, DOI 10.1021/jf1010897; Walker C, 2010, FOODBORNE PATHOG DIS, V7, P249, DOI 10.1089/fpd.2009.0410; White BA, 2014, ANNU REV MICROBIOL, V68, P279, DOI 10.1146/annurev-micro-092412-155618; Wisener LV, 2015, ZOONOSES PUBLIC HLTH, V62, P75, DOI 10.1111/zph.12112	48	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187229	10.1371/journal.pone.0187229	http://dx.doi.org/10.1371/journal.pone.0187229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091926	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700047
J	Johnson, KM; Taslim, C; Saund, RS; Lessnick, SL				Johnson, Kirsten M.; Taslim, Cenny; Saund, Ranajeet S.; Lessnick, Stephen L.			Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma	PLOS ONE			English	Article							DNA-BINDING; FUSION PROTEIN; TRANSCRIPTION FACTOR; MOLECULAR-DYNAMICS; ETS DOMAIN; MECHANISM; ELEMENTS; FAMILY; FLI-1; READ	Ewing sarcoma is a bone malignancy of children and young adults, frequently harboring the EWS/FLI chromosomal translocation. The resulting fusion protein is an aberrant transcription factor that uses highly repetitive GGAA-containing elements (microsatellites) to activate and repress thousands of target genes mediating oncogenesis. However, the mechanisms of EWS/FLI interaction with microsatellites and regulation of target gene expression is not clearly understood. Here, we profile genome-wide protein binding and gene expression. Using a combination of unbiased genome-wide computational and experimental analysis, we define GGAA-microsatellites in a Ewing sarcoma context. We identify two distinct classes of GGAA-microsatellites and demonstrate that EWS/FLI responsiveness is dependent on microsatellite length. At close range "promoter-like" microsatellites, EWS/FLI binding and subsequent target gene activation is highly dependent on number of GGAA-motifs. "Enhancer-like" microsatellites demonstrate length-dependent EWS/FLI binding, but minimal correlation for activated and none for repressed targets. Our data suggest EWS/FLI binds to "promoter-like" and "enhancer-like" microsatellites to mediate activation and repression of target genes through different regulatory mechanisms. Such characterization contributes valuable insight to EWS/FLI transcription factor biology and clarifies the role of GGAA-microsatellites on a global genomic scale. This may provide unique perspective on the role of non-coding DNA in cancer susceptibility and therapeutic development.	[Johnson, Kirsten M.; Lessnick, Stephen L.] Ohio State Univ, Coll Med, Med Scientist Training Program, Columbus, OH 43210 USA; [Johnson, Kirsten M.; Lessnick, Stephen L.] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Johnson, Kirsten M.; Taslim, Cenny; Saund, Ranajeet S.; Lessnick, Stephen L.] Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis, Columbus, OH 43205 USA; [Lessnick, Stephen L.] Ohio State Univ, Coll Med, Div Pediat Hematol Oncol BMT, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Lessnick, SL (corresponding author), Ohio State Univ, Coll Med, Med Scientist Training Program, Columbus, OH 43210 USA.; Lessnick, SL (corresponding author), Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA.; Lessnick, SL (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis, Columbus, OH 43205 USA.; Lessnick, SL (corresponding author), Ohio State Univ, Coll Med, Div Pediat Hematol Oncol BMT, Columbus, OH 43210 USA.	stephen.lessnick@nationwidechildrens.org		Johnson, Kirsten/0000-0003-2388-0621; SAUND, RANAJEET/0000-0001-5501-4387	National Cancer Institute [R01 CA140394, R01 CA183776, F30 CA21058]; High Performance Computing Facility at the Research Institute at Nationwide Children's Hospital; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA183776, R01CA140394, F30CA210588] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); High Performance Computing Facility at the Research Institute at Nationwide Children's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds awarded to S.L.L. from the National Cancer Institute [Grant R01 CA140394 and R01 CA183776], and funds awarded to K.M.J. from the National Cancer Institute [Grant F30 CA21058. This research was supported in part by the High Performance Computing Facility at the Research Institute at Nationwide Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Joanna Groden and Melody Davis for critical reading of the manuscript and members of the laboratory of S.L.L. for helpful discussions. This research was supported in part by the High Performance Computing Facility at the Research Institute at Nationwide Children's Hospital.	BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gangwal Kunal, 2010, Genes Cancer, V1, P177; Gel B, 2016, BIOINFORMATICS, V32, P289, DOI 10.1093/bioinformatics/btv562; Guillon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004932; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Johnson KM, 2017, P NATL ACAD SCI USA, V114, P9870, DOI 10.1073/pnas.1701872114; Kennedy AL, 2015, ONCOTARGET, V6, P30178, DOI 10.18632/oncotarget.4903; Kolde R., 2015, PHEATMAP PRETTY HEAT; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MAO XH, 1994, J BIOL CHEM, V269, P18216; Monument MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104378; Monument MJ, 2012, GENES-BASEL, V3, P444, DOI 10.3390/genes3030444; Morgan M, 2016, BIOCPARALLEL BIOCOND; Obika S, 2003, J MOL BIOL, V331, P345, DOI 10.1016/S0022-2836(03)00726-5; OHNO T, 1993, CANCER RES, V53, P5859; Pages H, 2016, R PACKAGE; Pages H., 2016, BIOSTRINGS STRING OB; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Sankar Savita, 2013, Genes Cancer, V4, P213, DOI 10.1177/1947601913489569; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Sorensen PHB, 1996, SEMIN CANCER BIOL, V7, P3, DOI 10.1006/scbi.1996.0002; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZHU LJ, 2010, BIOMED CENTRAL, V11, DOI DOI 10.1186/1471-2105-11-237	45	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186275	10.1371/journal.pone.0186275	http://dx.doi.org/10.1371/journal.pone.0186275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091716	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700014
J	Choi, M; Ghammraoui, B; Badano, A				Choi, Mina; Ghammraoui, Bahaa; Badano, Aldo			Small-angle X-ray scattering characteristics of mouse brain: Planar imaging measurements and tomographic imaging simulations	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ALZHEIMERS-DISEASE; DIFFRACTION; MYELIN; DIFFUSION; TRANSPORT; TISSUES; MRI	Small-angle x-ray scattering (SAXS) imaging can differentiate tissue types based on their nanoscale molecular structure. However, characterization of the coherent scattering cross-section profile of relevant tissues is needed to optimally design SAXS imaging techniques for a variety of biomedical applications. Reported measured nervous tissue x-ray scattering cross sections under a synchrotron source have had limited agreement. We report a set of x-ray cross-section measurements obtained from planar SAXS imaging of 1 mm thick mouse brain (APP/PS1 wild-type) coronal slices using an 8 keV laboratory x-ray source. Two characteristic peaks were found at 0.96 and 1.60 nm(-1) attributed to myelin. The peak intensities varied by location in the slice. We found that regions of gray matter, white matter, and corpus callosum could be segmented by their increasing intensities of myelin peaks respectively. Measured small-angle x-ray scattering cross sections were then used to define brain tissue scattering properties in a GPU-accelerated Monte Carlo simulation of SAXS computed tomography (CT) using a higher monochromatic x-ray energy (20 keV) to study design trade-offs for noninvasive in vivo SAXS imaging on a small-animal head including radiation dose, signal-to-noise ratio (SNR), and the effect of skull presence on the previous two metrics. Simulation results show the estimated total dose to the mouse head for a single SAXS-CT slice was 149.4 mGy. The pixel SNR was approximately 30.8 for white matter material whether or not a skull was present. In this early-stage proof-of-principle work, we have demonstrated our brain cross-section data and simulation tools can be used to assess optimal instrument parameters for dedicated small-animal SAXS-CT prototypes.	[Choi, Mina; Badano, Aldo] Univ Maryland, Fischell Dept Bioengineering, College Pk, MD 20742 USA; [Choi, Mina; Ghammraoui, Bahaa; Badano, Aldo] CDRH USFDA, Div Imaging Diagnost & Software Reliabil, Off Sci & Engn Labs, Silver Spring, MD 20993 USA	University System of Maryland; University of Maryland College Park	Badano, A (corresponding author), Univ Maryland, Fischell Dept Bioengineering, College Pk, MD 20742 USA.; Badano, A (corresponding author), CDRH USFDA, Div Imaging Diagnost & Software Reliabil, Off Sci & Engn Labs, Silver Spring, MD 20993 USA.	aldo.badano@fda.hhs.gov	Badano, Aldo/G-7786-2012	Badano, Aldo/0000-0003-3712-6670; CHOI, MINA/0000-0002-1695-2271	University of Maryland	University of Maryland	M.C. acknowledges funding by the Fischell Fellowship in Biomedical Engineering at University of Maryland and was also supported by an appointment to the Research Participation Program at the Center for Devices and Radiological Health (CDRH) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S.Department of Energy and the U.S. Food and Drug Administration (FDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Hey-Kyoung Lee at Johns Hopkins University and Christen Welle in DBP/OSEL/CDRH/FDA for supplying mouse brain tissue samples, Christopher Gorini for providing mouse skull samples, and Beom Koo for providing training on the vibratome. M.C. acknowledges funding by the Fischell Fellowship in Biomedical Engineering at University of Maryland and was also supported by an appointment to the Research Participation Program at the Center for Devices and Radiological Health (CDRH) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration (FDA). The mention of commercial products herein is not to be construed as either an actual or implied endorsement of such products by the Department of Health and Human Services. This is a contribution of the US Food and Drug Administration and is not subject to copyright.	Badal A, 2009, MED PHYS, V36, P4878, DOI 10.1118/1.3231824; Bernhardt M, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/19/1/013012; Blanton TN, 1995, POWDER DIFFR, V10, P91, DOI DOI 10.1017/S0885715600014421; Choi M, 2017, APPL PHYS LETT, V110, DOI 10.1063/1.4980133; Choi M, 2016, SPIE MED IMAGING; Choi M, 2016, PROC SPIE, V9788, DOI 10.1117/12.2217408; Choi M, 2016, J APPL CRYSTALLOGR, V49, P188, DOI 10.1107/S1600576715023924; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Dahal E, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa776a; De Felici M, 2008, PHYS MED BIOL, V53, P5675, DOI 10.1088/0031-9155/53/20/007; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Ghammraoui B, 2017, PHYS MED BIOL, V62, P1192, DOI 10.1088/1361-6560/aa5187; Ghammraoui B, 2014, PHYS MED BIOL, V59, P3501, DOI 10.1088/0031-9155/59/13/3501; Gourrier A, 2007, J APPL CRYSTALLOGR, V40, pS78, DOI 10.1107/S0021889807006693; Guiner A., 1955, SMALL ANGLE SCATTERI; HARDING G, 1987, MED PHYS, V14, P515, DOI 10.1118/1.596063; Harding G., 2006, P SPIE; Hubbell JH, 1975, PHYS CHEM REF DATA, V4, P471; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jensen TH, 2011, NEUROIMAGE, V57, P124, DOI 10.1016/j.neuroimage.2011.04.013; Jensen TH, 2011, PHYS MED BIOL, V56, P1717, DOI 10.1088/0031-9155/56/6/012; Kleuker U, 1998, PHYS MED BIOL, V43, P2911, DOI 10.1088/0031-9155/43/10/017; Langkilde AE, 2009, FEBS LETT, V583, P2600, DOI 10.1016/j.febslet.2009.05.040; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Menzel H.-G., 2014, J ICRU, V14, P1, DOI [10.1093/jicru/ndx006, DOI 10.1093/JICRU/NDX006]; Paris O, 2008, BIOINTERPHASES, V3, pFB16, DOI 10.1116/1.2955443; Pauw BR, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/38/383201; Salvat F, 2006, NUCL EN AG WORKSH P; Schroer CG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196062; Silverman DHS, 2002, J NUCL MED, V43, P253; Siu KKW, 2005, NUCL INSTRUM METH A, V548, P140, DOI 10.1016/j.nima.2005.03.081; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stapulionis R, 2008, J IMMUNOL, V180, P3946, DOI 10.4049/jimmunol.180.6.3946; Tartari A, 2002, PHYS MED BIOL, V47, P163, DOI 10.1088/0031-9155/47/1/312; Wilkinson SJ, 2007, PHYS MED BIOL, V52, P2409, DOI 10.1088/0031-9155/52/9/006; Yagi N, 2011, J PHYS CONF SER, V272, DOI 10.1088/1742-6596/272/1/012009; Zhang F, 2010, METALL MATER TRANS A, V41A, P1151, DOI 10.1007/s11661-009-9950-x	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186451	10.1371/journal.pone.0186451	http://dx.doi.org/10.1371/journal.pone.0186451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088259	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900012
J	Rashedi, I; Talele, N; Wang, XH; Hinz, B; Radisic, M; Keating, A				Rashedi, Iran; Talele, Nilesh; Wang, Xing-Hua; Hinz, Boris; Radisic, Milica; Keating, Armand			Collagen scaffold enhances the regenerative properties of mesenchymal stromal cells	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; STEM-CELLS; MECHANICAL STIMULATION; HEART-FAILURE; DIFFERENTIATION; PHENOTYPE; CARDIOMYOCYTES; TISSUE; MSCS; METAANALYSIS	MSCs are widely applied to regenerate heart tissue in myocardial diseases but when grown in standard two-dimensional (2D) cultures exhibit limited potential for cardiac repair and develop fibrogenic features with increasing culture time. MSCs can undergo partial cardiomyogenic differentiation, which improves their cardiac repair capacity. When applied to collagen patches they may improve cardiac tissue regeneration but the mechanisms remain elusive. Here, we investigated the regenerative properties of MSCs grown in a collagen scaffold as a three-dimensional (3D) culture system, and performed functional analysis using an engineered heart tissue (EHT) model. We showed that the expression of cardiomyocyte-specific proteins by MSCs co-cultured with rat neonatal cardiomyocytes was increased in collagen patches versus conventional cultures. MSCs in 3D collagen patches were less fibrogenic, secreted more cardiotrophic factors, retained anti-apoptotic and immunomodulatory function, and responded less to TLR4 ligand lipopolysaccharide (LPS) stimulation. EHT analysis showed no effects by MSCs on cardiomyocyte function, whereas control dermal fibroblasts abrogated the beating of cardiac tissue constructs. We conclude that 3D collagen scaffold improves the cardioprotective effects of MSCs by enhancing the production of trophic factors and modifying their immune modulatory and fibrogenic phenotype. The improvement in myocardial function by MSCs after acquisition of a partial cardiac cell-like phenotype is not due to enhanced MSC contractility. A better understanding of the mechanisms of MSC-mediated tissue repair will help to further enhance the therapeutic potency of MSCs.	[Rashedi, Iran; Radisic, Milica; Keating, Armand] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Rashedi, Iran; Wang, Xing-Hua; Keating, Armand] Univ Hlth Network, Cell Therapy Program, Toronto, ON, Canada; [Talele, Nilesh; Hinz, Boris] Univ Toronto, Lab Tissue Repair & Regenerat, Matrix Dynam Grp, Fac Dent, Toronto, ON, Canada; [Wang, Xing-Hua; Keating, Armand] Univ Hlth Network, Krembil Res Inst, Arthrit Program, Toronto, ON, Canada; [Keating, Armand] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Rashedi, I (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.; Rashedi, I (corresponding author), Univ Hlth Network, Cell Therapy Program, Toronto, ON, Canada.	i.rashedi@utoronto.ca	Talele, Nilesh Prakash/GRE-5860-2022	Talele, Nilesh Prakash/0000-0003-2758-8599; Keating, Armand/0000-0002-7676-6059	University Health Network; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation	University Health Network; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation	This work was supported in part by the Cell Therapy Program at University Health Network and by the Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation to AK.	Astudillo P, 2014, CURR MOL MED, V14, P209, DOI 10.2174/1566524014666140128105352; Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647; Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; Dengler J, 2011, BIOTECHNOL BIOENG, V108, P704, DOI 10.1002/bit.22987; Duggal S, 2009, TISSUE ENG PT A, V15, P1763, DOI 10.1089/ten.tea.2008.0306; Figeac F, 2014, STEM CELLS, V32, P216, DOI 10.1002/stem.1560; Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386; Follin B., 2016, TISSUE ENG B; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI 10.1089/ten.TEC.2009.0432; Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652; Guan JJ, 2011, BIOMATERIALS, V32, P5568, DOI 10.1016/j.biomaterials.2011.04.038; Guo L, 2014, STEM CELLS DEV, V23, P978, DOI 10.1089/scd.2013.0338; Gyongyosi M, 2015, CIRC RES, V116, P1346, DOI 10.1161/CIRCRESAHA.116.304346; Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040; Jung JP, 2016, BIORESEARCH OPEN ACC, V5, P37, DOI 10.1089/biores.2015.0044; Kang K, J AM COLL CARDIOLOGY; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kim DH, 2009, J BIOSCI BIOENG, V108, P63, DOI 10.1016/j.jbiosc.2009.02.008; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Koninckx R, 2009, CYTOTHERAPY, V11, P778, DOI 10.3109/14653240902988818; Li CX, 2017, NAT MATER, V16, P379, DOI [10.1038/nmat4780, 10.1038/NMAT4780]; Lin X, 2013, CELL TISSUE RES, V352, P523, DOI 10.1007/s00441-013-1576-z; Majd H, 2009, STEM CELLS, V27, P200, DOI 10.1634/stemcells.2008-0674; Maureira P, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-93; Modarressi A, 2010, J INVEST DERMATOL, V130, P2818, DOI 10.1038/jid.2010.224; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nguyen LT, ENHANCED OSTEOGENIC; Okura H, 2010, TISSUE ENG PART C-ME, V16, P417, DOI [10.1089/ten.tec.2009.0362, 10.1089/ten.TEC.2009.0362]; Potapova IA, 2008, AM J PHYSIOL-HEART C, V295, pH2257, DOI 10.1152/ajpheart.00219.2008; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Rangappa S, 2003, J THORAC CARDIOV SUR, V126, P124, DOI 10.1016/S0022-5223(03)00074-6; Rashedi I, 2017, STEM CELLS, V35, P265, DOI 10.1002/stem.2485; Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329; Serrao GW, 2012, TISSUE ENG PT A, V18, P1322, DOI [10.1089/ten.tea.2011.0278, 10.1089/ten.TEA.2011.0278]; Shafy A, 2013, EUR J CARDIO-THORAC, V43, P1211, DOI 10.1093/ejcts/ezs480; Shah N, 2014, CELL BIOCHEM FUNCT, V32, P309, DOI 10.1002/cbf.3027; Song H, 2010, P NATL ACAD SCI USA, V107, P3329, DOI 10.1073/pnas.0905729106; Talele NP, 2015, STEM CELL REP, V4, P1016, DOI 10.1016/j.stemcr.2015.05.004; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Wang WJ, 2009, BIOMATERIALS, V30, P2705, DOI 10.1016/j.biomaterials.2009.01.030; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Yannarelli G, 2014, STEM CELL REV REP, V10, P304, DOI 10.1007/s12015-013-9483-y; Yeh HY, 2012, BIOMATERIALS, V33, P8943, DOI 10.1016/j.biomaterials.2012.08.069; Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191; Yoon J, 2005, ACTA CARDIOL, V60, P277, DOI 10.2143/AC.60.3.2005005; Young PP, 2015, TRANSFUSION, V55, P441, DOI 10.1111/trf.12826; Yuan T, 2011, J BIOMED MATER RES A, V98A, P332, DOI 10.1002/jbm.a.33121; Zhao XY, 2014, STEM CELLS, V32, P521, DOI 10.1002/stem.1543	54	38	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187348	10.1371/journal.pone.0187348	http://dx.doi.org/10.1371/journal.pone.0187348			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088264	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900070
J	Wilson, TS; Sleeter, BM; Cameron, DR				Wilson, Tamara S.; Sleeter, Benjamin M.; Cameron, D. Richard			Mediterranean California's water use future under multiple scenarios of developed and agricultural land use change	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; PROTECTED AREAS; COVER; IMPACTS; TRENDS; TEMPERATURE; VARIABILITY; SNOWPACK; DROUGHT; CLIMATE	With growing demand and highly variable inter-annual water supplies, California's water use future is fraught with uncertainty. Climate change projections, anticipated population growth, and continued agricultural intensification, will likely stress existing water supplies in coming decades. Using a state-and-transition simulation modeling approach, we examine a broad suite of spatially explicit future land use scenarios and their associated county-level water use demand out to 2062. We examined a range of potential water demand futures sampled from a 20-year record of historical (1992-2012) data to develop a suite of potential future land change scenarios, including low/high change scenarios for urbanization and agriculture as well as "lowest of the low" and "highest of the high" anthropogenic use. Future water demand decreased 8.3 billion cubic meters (Bm(3)) in the lowest of the low scenario and decreased 0.8 Bm(3) in the low agriculture scenario. The greatest increased water demand was projected for the highest of the high land use scenario (+9.4 Bm(3)), high agricultural expansion (+4.6 Bm(3)), and high urbanization (+2.1 Bm(3)) scenarios. Overall, these scenarios show agricultural land use decisions will likely drive future demand more than increasing municipal and industrial uses, yet improved efficiencies across all sectors could lead to potential water use savings. Results provide water managers with information on diverging land use and water use futures, based on historical, observed land change trends and water use histories.	[Wilson, Tamara S.] US Geol Survey, Western Geog Sci Ctr, Menlo Pk, CA 94025 USA; [Sleeter, Benjamin M.] US Geol Survey, Western Geog Sci Ctr, Tacoma, WA USA; [Cameron, D. Richard] Nature Conservancy, San Francisco, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Nature Conservancy	Wilson, TS (corresponding author), US Geol Survey, Western Geog Sci Ctr, Menlo Pk, CA 94025 USA.	tswilson@usgs.gov		Wilson, Tamara/0000-0001-7399-7532	US Geological Survey; USGS	US Geological Survey(United States Geological Survey); USGS(United States Geological Survey)	This research was supported by the US Geological Survey's Climate and Land Use Research and Development Program and the USGS Land Change Science Program.r This research was supported by the US Geological Survey's Climate and Land Use Research and Development Program, the USGS Land Change Science Program. We are grateful for the detailed and thoughtful peer review provided by Dr. Kristin Byrd of the U.S. Geological Survey as well as our anonymous peer reviewers.	[Anonymous], 2016, PROT AR DAT US PAD U; Ault TR, 2014, J CLIMATE, V27, P7529, DOI 10.1175/JCLI-D-12-00282.1; Averyt K, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015001; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Bierwagen BG, P NATL ACAD SCI, V107, P20887; Brown EG, 2016, B3716D EX DEP; Brown EG, 2015, B2915 EX DEP; Byrd KB, 2015, LANDSCAPE ECOL, V30, P729, DOI 10.1007/s10980-015-0159-7; California Department of Conservation, 2017, FARML MON MAPP PROGR; California Department of Conservation, 2011, WILL ACT LANDS; California Department of Conservation, FARML MAPP MON PROGR; Calzia P.J., 2012, 1794A30 US GEOL SURV, P303; Cameron DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103468; Cameron DR, 2007, CALIFORNIA RANGELAND; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Daniel C, 2016, METHODS ECOL EVOL; Daniel C.J., 2011, P 1 LANDSC STAT AND, P5; Daniel CJ, ST SIM STATE AND TRA; De Girolamo AM, 2012, LAND USE POLICY, V29, P691, DOI 10.1016/j.landusepol.2011.11.005; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Gallant AL, 2004, ENVIRON MANAGE, V34, pS89, DOI 10.1007/s00267-003-0145-3; Geological Society of America, 2016, CAL ALM BOOM HAS RAM; GreenInfo Network, 2016, CAL PROT AR DAT; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Gude PH, 2007, ECOL APPL, V17, P1004, DOI 10.1890/05-1108; Hamilton CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055737; Hamlet AF, 2005, J CLIMATE, V18, P4545, DOI 10.1175/JCLI3538.1; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Howitt R, 2015, EC ANAL 2015 DROUGHT, P31; Januchowski-Hartley SR, 2016, DIVERS DISTRIB; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Klein G, 2015, CEC7002005001SF, P1; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Kroodsma D. A., 2006, ECOLOGICAL APPL, V16, P1975; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Li XC, 2016, SCI BULL, V61, P1651, DOI 10.1007/s11434-016-1148-1; Lund JR, 2016, SAN FRANC ESTUARY WA, V14; Mann ML, 2014, LAND USE POLICY, V41, P438, DOI 10.1016/j.landusepol.2014.06.020; Martinuzzi S, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00376.1; Martinuzzi S, 2015, ECOSYSTEMS, V18, P1332, DOI 10.1007/s10021-015-9901-x; Martinuzzi S, 2015, BIOL CONSERV, V184, P446, DOI 10.1016/j.biocon.2015.02.015; Martinuzzi S, 2015, ECOL APPL, V25, P160, DOI 10.1890/13-2078.1; Maupin MA, ESTIMATED USE WATER, P56; McCabe GJ, 2005, J HYDROMETEOROL, V6, P476, DOI 10.1175/JHM428.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Mueller, 2015, FALLOWED AREA MAPPIN; National Atlas of the United States, 2005, GRAYSC CONT US SHAD; National Fire Protection Association, 2012, 285 NFPA, P1; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Pierce DW, 2013, CLIM DYNAM, V40, P839, DOI 10.1007/s00382-012-1337-9; Radeloff VC, 2012, ECOL APPL, V22, P1036, DOI 10.1890/11-0306.1; Richey AS, 2015, WATER RESOUR RES, V51, P5217, DOI 10.1002/2015WR017349; Rounsevell MDA, 2006, AGR ECOSYST ENVIRON, V114, P57, DOI 10.1016/j.agee.2005.11.027; Scanlon BR, 2012, P NATL ACAD SCI USA, V109, P9320, DOI 10.1073/pnas.1200311109; Sleeter BM, 2015, AIMS ENVIRON SCI, V2, P577, DOI 10.3934/environsci.2015.3.577; Sleeter BM, 2012, GLOBAL ENVIRON CHANG, V22, P896, DOI 10.1016/j.gloenvcha.2012.03.008; Sleeter BM, 2011, ENVIRON MONIT ASSESS, V173, P251, DOI 10.1007/s10661-010-1385-8; Sohl TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112251; Sohl TL, 2014, ECOL APPL, V24, P1015, DOI 10.1890/13-1245.1; Sohl TL, 2012, AGR ECOSYST ENVIRON, V153, P1, DOI 10.1016/j.agee.2012.02.019; Sohl TL, 2004, PHOTOGRAMM ENG REM S, V70, P439, DOI 10.14358/PERS.70.4.439; State of California, 2013, STAT COUNT TOT POP P; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Swain DL, 2015, GEOPHYS RES LETT; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; U.S. Department of Agriculture, 1994, 1992 CENS AGR CAL ST; U.S. Department of Agriculture, 2009, GEOGR AR SER, V1; U.S. Department of Agriculture, 2004, GEOGR AR SER, V1; U.S. Department of Agriculture, 1997, 1997 CENS AGR CAL ST, V1; U.S. Department of Agriculture, 2014, GEOGR AR SER, V1; United States Department of Agriculture (USDA) NASS (NASS). USDA National Agricultural Statistics Service, 2011, CAL CROPL DAT LAYER; US Census Bureau, 2013, STAT COUNT QUICKF; van Vliet MTH, 2012, NAT CLIM CHANGE, V2, P676, DOI [10.1038/nclimate1546, 10.1038/NCLIMATE1546]; Verburg PH, 2006, AGR ECOSYST ENVIRON, V114, P1, DOI 10.1016/j.agee.2005.11.023; Vogelmann JE, 2001, PHOTOGRAMM ENG REM S, V67, P650; Wear D. N., 2011, SRS141; Wilson TS, 2015, AIMS ENVIRON SCI, V2, P282, DOI 10.3934/environsci.2015.2.282; Wilson TS, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/5/054018; Wilson TS, 2014, LAND-BASEL, V3, P362, DOI 10.3390/land3020362; Wilson TS, 2014, REG ENVIRON CHANGE, P1; Woodhouse CA, 2010, P NATL ACAD SCI USA, V107, P21283, DOI 10.1073/pnas.0911197107; Yigzaw W, 2016, EARTHS FUTURE; Zhi-Liang Zhu, 2012, USGS NUMBERED SERIES, V1797, DOI [10.3133/pp1797, DOI 10.3133/PP1797]	83	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187181	10.1371/journal.pone.0187181	http://dx.doi.org/10.1371/journal.pone.0187181			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088254	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900046
J	Lin, GHY; Chai, V; Lee, V; Dodge, K; Truong, T; Wong, M; Johnson, LD; Linderoth, E; Pang, XL; Winston, J; Petrova, PS; Uger, RA; Viller, NN				Lin, Gloria H. Y.; Chai, Vien; Lee, Vivian; Dodge, Karen; Truong, Tran; Wong, Mark; Johnson, Lisa D.; Linderoth, Emma; Pang, Xinli; Winston, Jeff; Petrova, Penka S.; Uger, Robert A.; Viller, Natasja N.			TTI-621 (SIRP alpha Fc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; HIGH-AFFINITY IGG; GAMMA-RI; LUNG-CANCER; RECEPTOR; ACTIVATION; SURVIVAL; BINDING; PROGRESSION; ANTIBODY	Tumor-associated macrophages (TAMs) are heterogeneous and can adopt a spectrum of activation states between pro-inflammatory and pro-tumorigenic in response to the microenvironment. We have previously shown that TTI-621, a soluble SIRP alpha Fc fusion protein that blocks the CD47 "do-not-eat" signal, promotes tumor cell phagocytosis by IFN-gamma-primed macrophages. To assess the impact of CD47 blockade on diverse types of macrophages that are found within the tumor microenvironment, six different polarized human macrophage subsets (M(-), M(IFN gamma), M(IFN-gamma+LPS), M(IL-4), M(HAGG+IL-1 beta), M(IL-10 + TGF beta)) with distinct cell surface markers and cytokine profiles were generated. Blockade of CD47 using TTI-621 significantly increased phagocytosis of lymphoma cells by all macrophage subsets, with M(IFN-gamma), M(IFN-gamma+LPS) and M(IL-10 + TGF beta) macrophages having the highest phagocytic response. TTI-621-mediated phagocytosis involves macrophage expression of both the low-and high-affinity Fc gamma receptors II (CD32) and I (CD64), respectively. Moreover, macrophages with lower phagocytic capabilities (M(-), M(IL-4), M(HAGG + IL-1 beta)) could readily be re-polarized into highly phagocytic macrophages using various cytokines or TLR agonists. In line with the in vitro study, we further demonstrate that TTI-621 can trigger phagocytosis of tumor cells by diverse subsets of isolated mouse TAMs ex vivo. These data suggest that TTI-621 may be efficacious in triggering the destruction of cancer cells by a diverse population of TAMs found in vivo and support possible combination approaches to augment the activity of CD47 blockade.	[Lin, Gloria H. Y.; Chai, Vien; Lee, Vivian; Dodge, Karen; Truong, Tran; Wong, Mark; Johnson, Lisa D.; Linderoth, Emma; Pang, Xinli; Winston, Jeff; Petrova, Penka S.; Uger, Robert A.; Viller, Natasja N.] Trillium Therapeut Inc, Mississauga, ON, Canada		Uger, RA (corresponding author), Trillium Therapeut Inc, Mississauga, ON, Canada.	bob@trilliumtherapeutics.com	Johnson, Lisa DS/E-4218-2013	Johnson, Lisa DS/0000-0002-2019-6560	Trillium Therapeutics Inc.	Trillium Therapeutics Inc.	The authors received no specific funding for this work. Trillium Therapeutics Inc. provided support in the form of salaries for GHYL, VC, VL, KD, TT, MW, LDJ, EL, XP, JW, PSP, RAU and NNV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bevaart L, 2006, CANCER RES, V66, P1261, DOI 10.1158/0008-5472.CAN-05-2856; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; DOUGHERTY GJ, 1987, EUR J IMMUNOL, V17, P1453, DOI 10.1002/eji.1830171011; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Kim DW, 2008, BRIT J CANCER, V98, P1118, DOI 10.1038/sj.bjc.6604256; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; KURLANDER RJ, 1983, J IMMUNOL, V131, P140; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nagelkerke SQ, 2014, BLOOD, V124, P3709, DOI 10.1182/blood-2014-05-576835; Nagorsen D, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-62; Petrova PS, 2017, CLIN CANCER RES, V23, P1068, DOI 10.1158/1078-0432.CCR-16-1700; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quatromoni JG, 2012, AM J TRANSL RES, V4, P376; Redlich S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-71; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sato T, 2011, IMMUNOL RES, V51, P170, DOI 10.1007/s12026-011-8262-6; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Squadrito ML, 2011, MOL ASPECTS MED, V32, P123, DOI 10.1016/j.mam.2011.04.005; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; van der Poel CE, 2010, BLOOD, V116, P5327, DOI 10.1182/blood-2010-04-280214; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Zhang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153550; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	35	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187262	10.1371/journal.pone.0187262	http://dx.doi.org/10.1371/journal.pone.0187262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084248	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200044
J	Liu, HW; Zhang, L; Meng, AH; Zhang, JB; Xie, MM; Qin, YH; Faulk, DC; Zhang, BH; Yang, SS; Qiu, L				Liu, Huawei; Zhang, Lei; Meng, Aihua; Zhang, Junbiao; Xie, Miaomiao; Qin, Yaohong; Faulk, Dylan Chase; Zhang, Baohong; Yang, Shushen; Qiu, Li			Isolation and molecular identification of endophytic diazotrophs from seeds and stems of three cereal crops	PLOS ONE			English	Article							LENGTH-POLYMORPHISM ANALYSIS; SP-NOV; GENES; AMPLIFICATION; BACTERIUM; RHIZOBIA; SEQUENCE; STRAINS; RATES	Ten strains of endophytic diazotroph were isolated and identified from the plants collected from three different agricultural crop species, wheat, rice and maize, using the nitrogen-free selective isolation conditions. The nitrogen-fixing ability of endophytic diazotroph was verified by the nifH-PCR assay that showed positive nitrogen fixation ability. These identified strains were classified by 879F-RAPD and 16S rRNA sequence analysis. RAPD analyses revealed that the 10 strains were clustered into seven 879F-RAPD groups, suggesting a clonal origin. 16S rRNA sequencing analyses allowed the assignment of the 10 strains to known groups of nitrogen-fixing bacteria, including organisms from the genera Paenibacillus, Enterobacter, Klebsiella and Pantoea. These representative genus are not endophytic diazotrophs in the conventional sense. They may have obtained nitrogen fixation ability through lateral gene transfer, however, the evolutionary forces of lateral gene transfer are not well known. Molecular identification results from 16S rRNA analyses were also confirmed by morphological and biochemical data. The test strains SH6A and MZB showed positive effect on the growth of plants.	[Liu, Huawei; Meng, Aihua; Zhang, Junbiao; Xie, Miaomiao; Qin, Yaohong; Yang, Shushen] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Zhang, Lei; Qiu, Li] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Faulk, Dylan Chase; Zhang, Baohong] East Carolina Univ, Dept Biol, Greenville, NC USA	Northwest A&F University - China; Northwest A&F University - China; University of North Carolina; East Carolina University	Yang, SS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Qiu, L (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	yangshushen2002@163.com; qiuli525@nwsuaf.edu.cn			National Natural Science Foundation of China [31071870, 30700489]; International Cooperation and Exchanges Project of Shaanxi Province [2015KW-028]; Northwest AF University [2452015033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchanges Project of Shaanxi Province; Northwest AF University	This work was partially supported by National Natural Science Foundation of China (31071870,30700489), International Cooperation and Exchanges Project of Shaanxi Province (2015KW-028), and Fundamental Research Funds of Northwest A&F University (2452015033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by National Natural Science Foundation of China (31071870,30700489), International Cooperation and Exchanges Project of Shaanxi Province (2015KW-028), and Fundamental Research Funds of Northwest A&F University (2452015033).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bakhoum N, 2015, MICROB ECOL, V69, P641, DOI 10.1007/s00248-014-0507-1; Baldani JI, 1997, SOIL BIOL BIOCHEM, V29, P911, DOI 10.1016/S0038-0717(96)00218-0; Balows A, 1992, HDB BIOL BACTERIA EC; Bellagamba F, 2001, J AGR FOOD CHEM, V49, P3775, DOI 10.1021/jf0010329; Bezdicek DF, 1988, MICROORGANISMS ACTIO; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Chanway CP, 2014, ADVANCES IN BIOLOGY AND ECOLOGY OF NITROGEN FIXATION, P3, DOI 10.5772/57532; Cleenwerck I, 2002, INT J SYST EVOL MICR, V52, P1551, DOI 10.1099/00207713-52-5-1551; Davidson E., 2007, REACTIVE NITROGEN EN; Diouf D, 2010, J APPL MICROBIOL, V108, P818, DOI 10.1111/j.1365-2672.2009.04500.x; James EK, 1998, CRIT REV PLANT SCI, V17, P77, DOI 10.1016/S0735-2689(98)00357-8; Janarthine SRS, 2011, AFR J MICROBIOL RES, V5, P4455, DOI 10.5897/AJMR10.188; JOSEY DP, 1979, J APPL BACTERIOL, V46, P343, DOI 10.1111/j.1365-2672.1979.tb00830.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LAGUERRE G, 1994, APPL ENVIRON MICROB, V60, P56, DOI 10.1128/AEM.60.1.56-63.1994; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Patil BS, 2015, CATAL TODAY, V256, P49, DOI 10.1016/j.cattod.2015.05.005; Peng GX, 2009, INT J SYST EVOL MICR, V59, P1650, DOI 10.1099/ijs.0.65484-0; Rivas R, 2006, PLANT SOIL, V287, P23, DOI 10.1007/s11104-006-9062-y; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valverde A, 2006, INT J SYST EVOL MICR, V56, P2631, DOI 10.1099/ijs.0.64402-0; VANROSSUM D, 1995, APPL ENVIRON MICROB, V61, P1599, DOI 10.1128/AEM.61.4.1599-1609.1995; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Vos M, 2015, TRENDS MICROBIOL, V23, P598, DOI 10.1016/j.tim.2015.07.006; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989	30	14	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187383	10.1371/journal.pone.0187383	http://dx.doi.org/10.1371/journal.pone.0187383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084254	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200055
J	Miura, N; Omodaka, K; Kimura, K; Matsumoto, A; Kikawa, T; Takahashi, S; Takada, N; Takahashi, H; Maruyama, K; Akiba, M; Yuasa, T; Nakazawa, T				Miura, Naoki; Omodaka, Kazuko; Kimura, Koudai; Matsumoto, Akiko; Kikawa, Tsutomu; Takahashi, Seri; Takada, Naoko; Takahashi, Hidetoshi; Maruyama, Kazuichi; Akiba, Masahiro; Yuasa, Tetsuya; Nakazawa, Toru			Evaluation of retinal nerve fiber layer defect using wide-field en-face swept-source OCT images by applying the inner limiting membrane flattening	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FREE FUNDUS PHOTOGRAPHY; NORMAL-TENSION GLAUCOMA; OPEN-ANGLE GLAUCOMA; PROGRESSION; THICKNESS; DAMAGE; WORLDWIDE; PEOPLE; NUMBER	Purpose The assessment of retinal nerve fiber layer defects (RNFLDs) is a useful part of glaucoma care. Here, we obtained en-face images of retinal layers below the inner limiting membrane (ILM) with swept source-optical coherence tomography (SS-OCT), and measured RNFLD angle with new software. Methods This study included 105 eyes of 105 normal tension glaucoma (NTG) patients (age, 59.8 +/- 13.2). Exclusion criteria were best-corrected visual acuity < 0.5, axial length > 28 mm, nonglaucoma ocular disease, and systemic disease affecting the visual field. We obtained 12 x 9 mm 3D volume scans centered on the macula with SS-OCT (DRI OCT-1, Topcon), and from these scans, created 3 averaged en-face images, each comprising 7 horizontal enface images (total thickness: 18.2 mu m). We labeled these averaged images, according to their depth below the ILM, as en-face images 1 (shallowest), 2 (middle) and 3 (deepest). In each image, a circle was drawn centered on the disc, with a radius of half the distance between the centers of the disc and macula. The investigator marked points where the edge of the RNFLD intersected this circle, and RNFLD angle (RNFLDA) was calculated with new software. Finally, we analyzed the association between RNFLDA, cpRNFLT, weighted RGC count (wrgc) and Humphrey field analyzer (HFA)-measured mean deviation (MD) and hemifield total deviation (TD), both overall and in each hemifield. Results En-face image 2 had the highest interclass reproducibility for measuring RNFLDA (intrarater intraclass correlation coefficient (ICC): 0.988, inter-rater ICC: 0.962). The correlation coefficients with RNFLDA were: HFA MD, -0.60; superior TD, -0.73; inferior TD, -0.69; overall cpRNFLT, -0.27; superior hemifield cpRNFLT, -0.39; and inferior hemifield cpRNFLT, -0.53 (all p< 0.001). Conclusions RNFLDA measured in SS-OCT images had high reproducibility and was correlated to glaucoma severity. Our new method may be a valuable future part of glaucoma care.	[Miura, Naoki; Omodaka, Kazuko; Takahashi, Seri; Takada, Naoko; Takahashi, Hidetoshi; Maruyama, Kazuichi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Kimura, Koudai; Yuasa, Tetsuya] Yamagata Univ, Grad Sch Sci & Engn, Yamagata, Japan; [Matsumoto, Akiko; Kikawa, Tsutomu; Akiba, Masahiro] Topcon Corp, Tokyo, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan	Tohoku University; Yamagata University; Topcon Corporation; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp	Maruyama, Kazuichi/GRX-8129-2022	Maruyama, Kazuichi/0000-0001-6283-5466	joint research fund of Topcon Corporation; JST grants from JSPS KAKENHI [26293372, 26670751]; JST Center for Revitalization Promotion	joint research fund of Topcon Corporation; JST grants from JSPS KAKENHI; JST Center for Revitalization Promotion	Tsutomu Kikawa, Akiko Matsumoto, and Masahiro Akiba are employed by Topcon Corporation, a commercial entity. This paper was supported in part by joint research fund of Topcon Corporation, JST grants from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (T.N. 26293372), and for Exploratory Research (T.N. 26670751), and by the JST Center for Revitalization Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 1999, AUTOMATED STATIC PER; Badala F, 2007, AM J OPHTHALMOL, V144, P724, DOI 10.1016/j.ajo.2007.07.010; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Harwerth RS, 2010, PROG RETIN EYE RES, V29, P249, DOI 10.1016/j.preteyeres.2010.02.001; Hood DC, 2015, INVEST OPHTH VIS SCI, V56, P6208, DOI 10.1167/iovs.15-17259; Hood DC, 2014, INVEST OPHTH VIS SCI, V55, P632, DOI 10.1167/iovs.13-13130; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Hwang JM, 2006, J GLAUCOMA, V15, P223, DOI 10.1097/01.ijg.0000212218.96932.f7; Hwang YH, 2014, CURR EYE RES, V39, P1099, DOI 10.3109/02713683.2014.900805; Jeong JH, 2014, ACTA OPHTHALMOL, V92, pE185, DOI 10.1111/aos.12277; Leung CKS, 2012, OPHTHALMOLOGY, V119, P1858, DOI 10.1016/j.ophtha.2012.03.044; Mardin CY, 2001, CURR OPIN OPHTHALMOL, V12, P100, DOI 10.1097/00055735-200104000-00004; Medeiros FA, 2012, AM J OPHTHALMOL, V154, P814, DOI 10.1016/j.ajo.2012.04.022; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Naithani P, 2007, INVEST OPHTH VIS SCI, V48, P3138, DOI 10.1167/iovs.06-1407; Nitta K, 2011, J GLAUCOMA, V20, P189, DOI 10.1097/IJG.0b013e3181e0799c; Omodaka K, 2015, CURR EYE RES, V40, P744, DOI 10.3109/02713683.2014.956371; Omodaka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122347; Park HY Lopilly, 2013, AM J OPHTHALMOL; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; TUULONEN A, 1993, OPHTHALMOLOGY, V100, P587; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0185573	10.1371/journal.pone.0185573	http://dx.doi.org/10.1371/journal.pone.0185573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077716	gold, Green Submitted, Green Published			2022-12-27	WOS:000413861200006
J	Keustermans, G; van der Heijden, LB; Boer, B; Scholman, R; Nuboer, R; Pasterkamp, G; Prakken, B; de Jager, W; Kalkhoven, E; Janse, AJ; Schipper, HS				Keustermans, Genoveva; van der Heijden, Laila B.; Boer, Berlinda; Scholman, Rianne; Nuboer, Roos; Pasterkamp, Gerard; Prakken, Berent; de Jager, Wilco; Kalkhoven, Eric; Janse, Arieke J.; Schipper, Henk S.			Differential adipokine receptor expression on circulating leukocyte subsets in lean and obese children	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; ADIPONECTIN RECEPTORS; T-CELLS; CARDIOVASCULAR-DISEASE; CHILDHOOD OBESITY; LEPTIN; INFLAMMATION; RESPONSES; DYSFUNCTION; ACTIVATION	Background Childhood obesity prevalence has increased worldwide and is an important risk factor for type 2 diabetes (T2D) and cardiovascular disease (CVD). The production of inflammatory adipokines by obese adipose tissue contributes to the development of T2D and CVD. While levels of circulating adipokines such as adiponectin and leptin have been established in obese children and adults, the expression of adiponectin and leptin receptors on circulating immune cells can modulate adipokine signalling, but has not been studied so far. Here, we aim to establish the expression of adiponectin and leptin receptors on circulating immune cells in obese children pre and post-lifestyle intervention compared to normal weight control children. Methods 13 obese children before and after a 1-year lifestyle intervention were compared with an age and sex-matched normal weight control group of 15 children. Next to routine clinical and biochemical parameters, circulating adipokines were measured, and flow cytometric analysis of adiponectin receptor 1 and 2 (AdipoR1, AdipoR2) and leptin receptor expression on peripheral blood mononuclear cell subsets was performed. Results Obese children exhibited typical clinical and biochemical characteristics compared to controls, including a higher BMI-SD, blood pressure and circulating leptin levels, combined with a lower insulin sensitivity index (QUICKI). The 1-year lifestyle intervention resulted in stabilization of their BMI-SD. Overall, circulating leukocyte subsets showed distinct adipokine receptor expression profiles. While monocytes expressed high levels of all adipokine receptors, NK and iNKT cells predominantly expressed AdipoR2, and B-lymphocytes and CD4(+) and CD8(+) T-lymphocyte subsets expressed AdipoR2 as well as leptin receptor. Strikingly though, leukocyte subset numbers and adipokine receptor expression profiles were largely similar in obese children and controls. Obese children showed higher naive B-cell numbers, and pre-intervention also higher numbers of immature transition B-cells and intermediate CD14(++) CD16(+) monocytes combined with lower total monocyte numbers, compared to controls. Furthermore, adiponectin receptor 1 expression on nonclassical CD14(+) CD16(++) monocytes was consistently upregulated in obese children pre-intervention, compared to controls. However, none of the differences in leukocyte subset numbers and adipokine receptor expression profiles between obese children and controls remained significant after multiple testing correction. Conclusions First, the distinct adipokine receptor profiles of circulating leukocyte subsets may partly explain the differential impact of adipokines on leukocyte subsets. Second, the similarities in adipokine receptor expression profiles between obese children and normal weight controls suggest that adipokine signaling in childhood obesity is primarily modulated by circulating adipokine levels, instead of adipokine receptor expression.	[Keustermans, Genoveva; Boer, Berlinda; Scholman, Rianne; Prakken, Berent; de Jager, Wilco; Schipper, Henk S.] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [van der Heijden, Laila B.; Janse, Arieke J.] Hosp Gelderse Vallei, Div Pediat, Ede, Netherlands; [Nuboer, Roos] Meander Med Ctr, Div Pediat, Amersfoort, Netherlands; [Pasterkamp, Gerard] Univ Med Ctr Utrecht, Dept Expt Cardiol, Utrecht, Netherlands; [Prakken, Berent; Schipper, Henk S.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat, Utrecht, Netherlands; [Kalkhoven, Eric] Univ Med Ctr Utrecht, Mol Canc Res, Utrecht, Netherlands; [Kalkhoven, Eric] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Schipper, Henk S.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Cardiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Gelderse Vallei Hospital; Meander Medisch Centrum; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Schipper, HS (corresponding author), Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands.; Schipper, HS (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat, Utrecht, Netherlands.; Schipper, HS (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Cardiol, Utrecht, Netherlands.	h.s.schippor-3@umcutrecht.nl		de Jager, Wilco/0000-0002-0014-0682; van der Heijden, Laila/0000-0002-4292-8128; Schipper, Henk/0000-0003-1997-8060	Dutch Heart Foundation; UMC Utrecht Vascular Prevention Project; Wilhelmina Childrens Hospital Research Fund; Fellowship Clinical Research Talent of the University Medical Center Utrecht; Technology Foundation STW (Stichting voor de Technische Wetenschappen);  [01C-102]; ReumaFonds [LLP-10] Funding Source: researchfish	Dutch Heart Foundation(Netherlands Heart Foundation); UMC Utrecht Vascular Prevention Project; Wilhelmina Childrens Hospital Research Fund; Fellowship Clinical Research Talent of the University Medical Center Utrecht; Technology Foundation STW (Stichting voor de Technische Wetenschappen); ; ReumaFonds	This research was performed within the framework of the Center for Translational Molecular Medicine (CTMM; www.ctmm.nl), project Circulating Cells (grant 01C-102), and supported by the Dutch Heart Foundation, the UMC Utrecht Vascular Prevention Project and the Wilhelmina Childrens Hospital Research Fund. Henk Schipper was supported by a Fellowship Clinical Research Talent of the University Medical Center Utrecht. Genoveva Keustermans was supported by the Technology Foundation STW (Stichting voor de Technische Wetenschappen).	Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Alberti L, 2007, DIABETES OBES METAB, V9, P344, DOI 10.1111/j.1463-1326.2006.00614.x; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Berg KE, 2012, CIRC-CARDIOVASC GENE, V5, P122, DOI 10.1161/CIRCGENETICS.111.960385; Bonomini M, 2016, VASC PHARMACOL, V77, P28, DOI 10.1016/j.vph.2015.10.007; Cipolletta D, 2014, IMMUNOLOGY, V142, P517, DOI 10.1111/imm.12262; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Fan W, 2016, VACCINE, V34, P4835, DOI 10.1016/j.vaccine.2016.08.027; Frasca D, 2016, OBESITY, V24, P615, DOI 10.1002/oby.21383; Lima LCF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00304; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kollias A, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-14; Kosaraju R, 2017, J IMMUNOL; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nave H, 2008, ENDOCRINOLOGY, V149, P3370, DOI 10.1210/en.2007-1516; Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001; Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pang TTL, 2008, ANN NY ACAD SCI, V1150, P143, DOI 10.1196/annals.1447.021; Procaccini C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00332; Reis BS, 2015, J IMMUNOL, V194, P5253, DOI 10.4049/jimmunol.1402996; Rourke JL, 2013, OBES REV, V14, P245, DOI 10.1111/obr.12009; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Saucillo DC, 2014, J IMMUNOL, V192, P136, DOI 10.4049/jimmunol.1301158; Schipper HS, 2012, DIABETOLOGIA, V55, P2800, DOI 10.1007/s00125-012-2641-y; Schipper HS, 2010, CLIN CHEM, V56, P1320, DOI 10.1373/clinchem.2010.146118; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Tian L, 2012, ATHEROSCLEROSIS, V221, P66, DOI 10.1016/j.atherosclerosis.2011.12.014; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Tsiotra PC, 2000, METABOLISM, V49, P1537, DOI 10.1053/meta.2000.18519; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; van Hoek E, 2016, HLTH PROMOT INT; van Stijn CMW, 2015, FASEB J, V29, P636, DOI 10.1096/fj.14-253831; Weber C, 2016, THROMB HAEMOSTASIS, V116, P626, DOI 10.1160/TH16-02-0091; Yamauchi T, 2014, BEST PRACT RES CL EN, V28, P15, DOI 10.1016/j.beem.2013.09.003; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187068	10.1371/journal.pone.0187068	http://dx.doi.org/10.1371/journal.pone.0187068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073286	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400107
J	Clarencon, F; Bardinet, E; Martinerie, J; Pelbarg, V; Champfleur, NMD; Gupta, R; Tollard, E; Soto-Ares, G; Ibarrola, D; Schmitt, E; Tourdias, T; Degos, V; Yelnik, J; Dormont, D; Puybasset, L; Galanaud, D				Clarencon, Frederic; Bardinet, Eric; Martinerie, Jacques; Pelbarg, Vincent; Champfleur, Nicolas Menjot dDe; Gupta, Rajiv; Tollard, Eleonore; Soto-Ares, Gustavo; Ibarrola, Danielle; Schmitt, Emmanuelle; Tourdias, Thomas; Degos, Vincent; Yelnik, Jerome; Dormont, Didier; Puybasset, Louis; Galanaud, Damien		Neuro Imaging Coma Emergence	Lesions in deep gray nuclei after severe traumatic brain injury predict neurologic outcome	PLOS ONE			English	Article							VEGETATIVE STATE; AXONAL INJURY; PROGNOSTIC VALUE; BASAL GANGLIA; HEAD-INJURY; CORPUS-CALLOSUM; WHITE-MATTER; MRI; STEM; NEUROPATHOLOGY	Purpose This study evaluates the correlation between injuries to deep gray matter nuclei, as quanti-tated by lesions in these nuclei on MR T2 Fast Spin Echo (T2 FSE) images, with 6-month neurological outcome after severe traumatic brain injury (TBI). Materials and methods Ninety-five patients (80 males, mean age = 36.7y) with severe TBI were prospectively enrolled. All patients underwent a MR scan within the 45 days after the trauma that included a T2 FSE acquisition. A 3D deformable atlas of the deep gray matter was registered to this sequence; deep gray matter lesions (DGML) were evaluated using a semi-quantitative classification scheme. The 6-month outcome was dichotomized into unfavorable (death, vegetative or minimally conscious state) or favorable (minimal or no neurologic deficit) outcome. Results Sixty-six percent of the patients (63/95) had both satisfactory registration of the 3D atlas on T2 FSE and available clinical follow-up. Patients without DGML had an 89% chance (P = 0.0016) of favorable outcome while those with bilateral DGML had an 80% risk of unfavorable outcome (P = 0.00008). Multivariate analysis based on DGML accurately classified patients with unfavorable neurological outcome in 90.5% of the cases. Conclusion Lesions in deep gray matter nuclei may predict long-term outcome after severe TBI with high sensitivity and specificity.	[Clarencon, Frederic; Dormont, Didier; Galanaud, Damien] Hop La Pitie Salpetriere, Dept Neuroradiol, Paris, France; [Clarencon, Frederic; Degos, Vincent; Dormont, Didier; Puybasset, Louis; Galanaud, Damien] Paris VI Univ Pierre & Marie Curie, Paris, France; [Bardinet, Eric; Martinerie, Jacques] CNRS, UMR 7225, Inst Cerveau & Moelle Epiniere ICM, Paris, France; [Pelbarg, Vincent] Brain & Spine Inst ICM, IHU A ICM, Bioinformat & Biostat Plateform, Paris, France; [Champfleur, Nicolas Menjot dDe] Guy de Chauliac Univ Hosp, Dept Neuroradiol, Montpellier, France; [Gupta, Rajiv] Massachusetts Gen Hosp, Dept Neuroradiol, Boston, MA 02114 USA; [Tollard, Eleonore] Rouen Univ Hosp, Dept Neuroradiol, Rouen, France; [Soto-Ares, Gustavo] Roger Salengro Hosp, Dept Neuroradiol, Lille, France; [Ibarrola, Danielle] Pierre Wertheimer Neurol & Neurosurg Hosp, CERMEP, Bron, France; [Schmitt, Emmanuelle] Nancy Univ Hosp, Dept Neuroradiol, Nancy, France; [Tourdias, Thomas] Bordeaux Univ Hosp, Dept Neuroradiol, Bordeaux, France; [Degos, Vincent; Puybasset, Louis] Paris VI Univ, Pitie Salpetriere Hosp, Neurosurg Intens Care Unit, Paris, France; [Yelnik, Jerome] Paris VI Univ, Pitie Salpetriere Hosp, INSERM, U679, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Harvard University; Massachusetts General Hospital; CHU de Rouen; Universite de Lille - ISITE; CHU Lille; CHU de Nancy; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Clarencon, F (corresponding author), Hop La Pitie Salpetriere, Dept Neuroradiol, Paris, France.; Clarencon, F (corresponding author), Paris VI Univ Pierre & Marie Curie, Paris, France.	fredclare5@msn.com	Tourdias, Thomas/K-1209-2019; IBARROLA, Danielle/GRR-7305-2022	Tourdias, Thomas/0000-0002-7151-6325; IBARROLA, Danielle/0000-0001-8999-8740; PUYBASSET, Louis/0000-0002-6849-1825; YELNIK, Jerome/0000-0003-4814-708X	Projet Hospitalier de Recherche Clinique (PHRC) [P051061]	Projet Hospitalier de Recherche Clinique (PHRC)	This work has been funded by the Projet Hospitalier de Recherche Clinique (PHRC) #P051061.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Comoglu S, 2001, Australas Radiol, V45, P357, DOI 10.1046/j.1440-1673.2001.00937.x; de la Cueva L, 2006, Rev Esp Med Nucl, V25, P89, DOI 10.1157/13086250; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Graham DI, 2005, PROG BRAIN RES, V150, P445, DOI 10.1016/S0079-6123(05)50031-1; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Hopkins RO, 2006, BRAIN INJURY, V20, P273, DOI 10.1080/02699050500488181; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Laouchedi M, 2015, J NEURORADIOLOGY, V42, P202, DOI 10.1016/j.neurad.2014.03.001; Masuzawa H, 1997, NEUROL SURG TOKYO, V25, P689; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Patrick PD, 2007, BRAIN INJURY, V21, P63, DOI 10.1080/02699050601111401; Rosi J, 2017, J CLIN NEUROSCI, V42, P122, DOI 10.1016/j.jocn.2017.03.012; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Shakir A, 2016, J NEUROIMAGING, V26, P103, DOI 10.1111/jon.12286; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Su E, 2016, FRONTIERS NEUROSCIEN; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Vapnik V., 1998, STAT LEARNING THEORY; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Xu WW, 2016, WORLD NEUROSURG, V94, P167, DOI 10.1016/j.wneu.2016.06.123; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Yuan L, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150129	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186641	10.1371/journal.pone.0186641	http://dx.doi.org/10.1371/journal.pone.0186641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095850	Green Submitted, gold, Green Published			2022-12-27	WOS:000414340200019
J	del Priore, L; Pigozzi, MI				del Priore, Lucia; Ines Pigozzi, Maria			Broad-scale recombination pattern in the primitive bird Rhea americana (Ratites, Palaeognathae)	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; CROSSING-OVER; SYNAPTONEMAL COMPLEXES; EQUAL RECOMBINATION; AXIAL EQUALIZATION; AVIAN GENOME; ZEBRA FINCH; CHROMOSOMES; EVOLUTION; NODULES	Birds have genomic and chromosomal features that make them an attractive group to analyze the evolution of recombination rate and the distribution of crossing over. Yet, analyses are biased towards certain species, especially domestic poultry and passerines. Here we analyze for the first time the recombination rate and crossover distribution in the primitive ratite bird, Rhea americana (Rheiformes, Palaeognathae). Using a cytogenetic approach for in situ mapping of crossovers we found that the total genetic map is 3050 cM with a global recombination rate of 2.1 cM/Mb for female rheas. In the five largest macrobivalents there were 3 or more crossovers in most bivalents. Recombination rates for macrobivalents ranges between 1.8-2.1 cM/Mb and the physical length of their synaptonemal complexes is highly predictive of their genetic lengths. The crossover rate at the pseudoautosomal region is 2.1 cM/Mb, similar to those of autosomal pairs 5 and 6 and only slightly higher compared to other macroautosomes. It is suggested that the presence of multiple crossovers on the largest macrobivalents is a feature common to many avian groups, irrespective of their position throughout phylogeny. These data provide new insights to analyze the heterogeneous recombination landscape of birds.	[del Priore, Lucia; Ines Pigozzi, Maria] Univ Buenos Aires, INBIOMED Inst Invest Biomed UBA CONICET, Fac Med, Buenos Aires, DF, Argentina	University of Buenos Aires	Pigozzi, MI (corresponding author), Univ Buenos Aires, INBIOMED Inst Invest Biomed UBA CONICET, Fac Med, Buenos Aires, DF, Argentina.	mpigozzi@fmed.uba.ar	Pigozzi, Maria/AAT-1751-2020	Pigozzi, Maria/0000-0002-3105-0073	Universidad de Buenos Aires, UBACyT [003]; ANPCyT, BID-PICT [0059]	Universidad de Buenos Aires, UBACyT(University of Buenos Aires); ANPCyT, BID-PICT	This study was supported by Universidad de Buenos Aires, UBACyT 2014-2017 No 003 (http://www.uba.ar/secyt/) and ANPCyT, BID-PICT 2013 No 0059 (http://www.agencia.mincyt.gob.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 2003, GENETICS, V165, P849; Anderson LK, 1999, GENETICS, V151, P1569; Anderson LK, 2014, P NATL ACAD SCI USA, V111, P13415, DOI 10.1073/pnas.1406846111; Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Backstrom N, 2010, GENOME RES, V20, P485, DOI 10.1101/gr.101410.109; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Basheva EA, 2008, CHROMOSOME RES, V16, P709, DOI 10.1007/s10577-008-1221-y; Calderon PL, 2006, CHROMOSOME RES, V14, P605, DOI 10.1007/s10577-006-1059-0; Capilla L, 2016, CYTOGENET GENOME RES, V150, P1, DOI 10.1159/000452822; Christidis L., 1990, ANIMAL CYTOGENETICS; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; de Villena FPM, 2001, MAMM GENOME, V12, P318, DOI 10.1007/s003350020005; del Priore L, 2016, GENETICA, V144, P625, DOI 10.1007/s10709-016-9922-1; del Priore L, 2015, CHROMOSOME RES, V23, P199, DOI 10.1007/s10577-014-9448-2; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dumont BL, 2008, EVOLUTION, V62, P276, DOI 10.1111/j.1558-5646.2007.00278.x; Dumont BL, 2017, GENETICS, V205, P155, DOI 10.1534/genetics.116.192690; Duroc Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004674; Elferink MG, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-11; Ellegren H, 2013, ANNU REV ECOL EVOL S, V44, P239, DOI 10.1146/annurev-ecolsys-110411-160327; Ellegren H, 2010, TRENDS ECOL EVOL, V25, P283, DOI 10.1016/j.tree.2009.12.004; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Grelon M, 2016, CR BIOL, V339, P247, DOI 10.1016/j.crvi.2016.04.003; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Hansson B, 2010, HEREDITY, V104, P67, DOI 10.1038/hdy.2009.107; Hulten M, 2006, GENETIC MAPS DIRECT; Hulten M, 2001, GENETIC MAPPING COMP; Jaari S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-1; Janes DE, 2009, J HERED, V100, P125, DOI 10.1093/jhered/esn065; Kawakami T, 2017, MOL ECOL, P1; Kawakami T, 2014, MOL ECOL, V23, P4035, DOI 10.1111/mec.12810; Link J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003261; Maceira NO, 2016, PEQUENAS CADENAS VAL; Mary N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099123; Mezard C, 2015, TRENDS GENET, V31, P393, DOI 10.1016/j.tig.2015.03.008; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nishida-Umehara C, 2007, CHROMOSOME RES, V15, P721, DOI 10.1007/s10577-007-1157-7; Pigozzi MI, 2016, CYTOGENET GENOME RES, V150, P128, DOI 10.1159/000453541; Pigozzi MI, 2005, CHROMOSOMA, V114, P403, DOI 10.1007/s00412-005-0025-5; Pigozzi MI, 1999, GENOME, V42, P308, DOI 10.1139/gen-42-2-308; Pigozzi MI, 2001, CYTOGENET CELL GENET, V95, P129, DOI 10.1159/000059334; Pigozzi MI, 1997, CHROMOSOME RES, V5, P421, DOI 10.1023/A:1018404610973; Pigozzi MI, 1999, GENOME, V42, P315, DOI 10.1139/gen-42-2-315; Pigozzi MI, 2016, CYTOGENETIC GENOME R; RAHN MI, 1986, CYTOGENET CELL GENET, V43, P187, DOI 10.1159/000132319; Rodionov AV, 1992, GENETIKA, V28; Schmid M, 2005, CYTOGENET GENOME RES, V109, P415, DOI 10.1159/000084205; Schmid M, 2017, CYTOGENET GENOME RES, V151, P216, DOI 10.1159/000464268; Segura J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1945; Singhal S, 2015, SCIENCE, V350, P928, DOI 10.1126/science.aad0843; SOLARI AJ, 1993, CYTOGENET CELL GENET, V64, P268, DOI 10.1159/000133591; SOLARI AJ, 1992, CYTOGENET CELL GENET, V59, P52, DOI 10.1159/000133199; Stack SM, 2017, GENETICS, V205, P1101, DOI 10.1534/genetics.116.196089; STOCK AD, 1982, CYTOGENET CELL GENET, V34, P136, DOI 10.1159/000131802; Sumner AT., 2003, CHROMOSOMES ORG FUNC; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Torgasheva AA, 2017, CYTOGENET GENOME RES, V151, P27, DOI 10.1159/000458741; van Oers K, 2014, HEREDITY, V112, P307, DOI 10.1038/hdy.2013.107; Yazdi HP, 2014, MOL BIOL EVOL, V31, P1444, DOI 10.1093/molbev/msu101; Zhang LX, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003608; Zhou Q, 2014, SCIENCE, V346, P1332, DOI 10.1126/science.1246338; Zlotina A, 2012, CHROMOSOME RES, V20, P1017, DOI 10.1007/s10577-012-9319-7	63	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187549	10.1371/journal.pone.0187549	http://dx.doi.org/10.1371/journal.pone.0187549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095930	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200116
J	Lee, CK; Ma, KT; Hong, YJ; Kim, CY				Lee, Chang Kyu; Ma, Kyoung Tak; Hong, Young Jae; Kim, Chan Yun			Long-term clinical outcomes of Ahmed valve implantation in patients with refractory glaucoma	PLOS ONE			English	Article							DIFFERENT BIOMATERIALS; CONGENITAL GLAUCOMA; PEDIATRIC GLAUCOMA; DRAINAGE DEVICES; FOLLOW-UP; SURGERY; TRABECULECTOMY; EXPERIENCE; MANAGEMENT; SILICONE	Purpose To evaluate the long-term efficacy of intraocular pressure (IOP) reduction and complications of Ahmed Glaucoma Valve (AGV) implantation in patients with refractory glaucoma. Design Retrospective study. Subjects The study involved 302 refractory glaucoma patients who underwent AGV implantation and had a minimum follow-up of 6 months between March 1995 and December 2013. Methods An operation was defined as successful when (1) the postoperative IOP remained between 5 and 21 mmHg and was reduced 30% compared to the baseline IOP with or without medication, (2) there was no loss of light perception or vision-threatening severe complications, and (3) no additional filtering or aqueous drainage surgery was required. Clinical records were reviewed. Main outcome measures IOP, anti-glaucoma medications, and complications Results The mean follow-up period was 62.25 months (range, 6 to 190 months). The cumulative probability of success was 89% at 6 months, 81 % at 1 year, 66% at 3 years, 44% at 10 years, and 26% at 15 years. IOP was reduced from a mean of 32.2 +/- 10.5 mmHg to 18.6 +/- 9.1 mmHg at 1 month, 15.2 +/- 7.0 mmHg at 6 months, and 14.2 +/- 3.5 mmHg at 15 years. Surgical failures were significantly increased when preoperative IOP was high, and when severe complications occurred after AGV implantation (P< 0.05). Conclusion AGV implantation was successful for IOP control in patients with refractive glaucoma in the long term. However, the success rate of surgery decreased over time. Preoperative high IOP and severe complications related to the operation were significant risk factors for failure.	[Lee, Chang Kyu] Univ Ulsan, Coll Med, Dept Ophthalmol, Ulsan Univ Hosp, Ulsan, South Korea; [Ma, Kyoung Tak] Jeil Eye Clin, Suwon, South Korea; [Hong, Young Jae] Nune Eye Hosp, Seoul, South Korea; [Kim, Chan Yun] Yonsei Univ, Inst Vis Res, Dept Ophthalmol, Coll Med, Seoul, South Korea	University of Ulsan; Ulsan University Hospital; Yonsei University; Yonsei University Health System	Kim, CY (corresponding author), Yonsei Univ, Inst Vis Res, Dept Ophthalmol, Coll Med, Seoul, South Korea.	kcyeye@yuhs.ac		Lee, Chang Kyu/0000-0002-4023-232X; Kim, Chan Yun/0000-0002-8373-9999				Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1968, DOI 10.1016/S0161-6420(98)91049-1; Ayyala RS, 2002, OPHTHALMIC SURG LAS, V33, P94; Ayyala RS, 2000, ARCH OPHTHALMOL-CHIC, V118, P1081, DOI 10.1001/archopht.118.8.1081; Ayyala RS, 1999, ARCH OPHTHALMOL-CHIC, V117, P233; COLEMAN AL, 1995, AM J OPHTHALMOL, V120, P23, DOI 10.1016/S0002-9394(14)73755-9; Da Mata A, 1999, OPHTHALMOLOGY, V106, P2168, DOI 10.1016/S0161-6420(99)90500-6; Das JC, 2005, EYE, V19, P183, DOI 10.1038/sj.eye.6701447; Gedde SJ, 2010, AM J OPHTHALMOL, V149, P875, DOI 10.1016/j.ajo.2010.02.016; Gedde SJ, 2009, AM J OPHTHALMOL, V148, P670, DOI 10.1016/j.ajo.2009.06.018; Heuer DK, 2001, J GLAUCOMA, V10, P493, DOI 10.1097/00061198-200112000-00010; Huang MC, 1999, AM J OPHTHALMOL, V127, P27, DOI 10.1016/S0002-9394(98)00394-8; Ishida K, 2006, OPHTHALMOLOGY, V113, P1320, DOI 10.1016/j.ophtha.2006.04.020; Law SK, 2005, OPHTHALMOLOGY, V112, P1514, DOI 10.1016/j.ophtha.2005.04.012; Lee EK, 2009, AM J OPHTHALMOL, V148, P361, DOI 10.1016/j.ajo.2009.04.016; Lima FE, 2004, J GLAUCOMA, V13, P233, DOI 10.1097/00061198-200406000-00011; Mandal AK, 1997, OPHTHALMOLOGY, V104, P996, DOI 10.1016/S0161-6420(97)30195-X; Minckler DS, 2008, OPHTHALMOLOGY, V115, P1089, DOI 10.1016/j.ophtha.2008.03.031; Morad Y, 2003, AM J OPHTHALMOL, V135, P821, DOI 10.1016/S0002-9394(02)02274-2; Nguyen QH, 2009, CURR OPIN OPHTHALMOL, V20, P122, DOI 10.1097/ICU.0b013e32831da828; Nouri-Mahdavi K, 2003, AM J OPHTHALMOL, V136, P1001, DOI 10.1016/S0002-9394(03)00630-5; Ou Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P1436, DOI 10.1001/archophthalmol.2009.267; Schwartz Kenneth, 2004, Curr Opin Ophthalmol, V15, P119, DOI 10.1097/00055735-200404000-00011; Souza C, 2007, AM J OPHTHALMOL, V144, P893, DOI 10.1016/j.ajo.2007.07.035; Syed HM, 2004, J GLAUCOMA, V13, P38, DOI 10.1097/00061198-200402000-00008; Tanimoto SA, 2006, CURR OPIN OPHTHALMOL, V17, P132, DOI 10.1097/01.icu.0000193091.60185.27; Topouzis F, 1999, AM J OPHTHALMOL, V128, P198, DOI 10.1016/S0002-9394(99)00080-X; Tsai JC, 2003, OPHTHALMOLOGY, V110, P1814, DOI 10.1016/S0161-6420(03)00574-8; Wilson MR, 2003, AM J OPHTHALMOL, V136, P464, DOI 10.1016/S0002-9394(03)00239-3; Zhu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121608	29	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187533	10.1371/journal.pone.0187533	http://dx.doi.org/10.1371/journal.pone.0187533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095931	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200113
J	Wang, X; Sun, BB; Liu, BY; Fu, YP; Zheng, P				Wang, Xun; Sun, Beibei; Liu, Boyang; Fu, Yaping; Zheng, Pan			A novel method for multifactorial bio-chemical experiments design based on combinational design theory	PLOS ONE			English	Article							NEURAL P SYSTEMS; OPTIMIZATION; EXISTENCE; ALGORITHM	Experimental design focuses on describing or explaining the multifactorial interactions that are hypothesized to reflect the variation. The design introduces conditions that may directly affect the variation, where particular conditions are purposely selected for observation. Combinatorial design theory deals with the existence, construction and properties of systems of finite sets whose arrangements satisfy generalized concepts of balance and/or symmetry. In this work, borrowing the concept of "balance" in combinatorial design theory, a novel method for multifactorial bio-chemical experiments design is proposed, where balanced templates in combinational design are used to select the conditions for observation. Balanced experimental data that covers all the influencing factors of experiments can be obtianed for further processing, such as training set for machine learning models. Finally, a software based on the proposed method is developed for designing experiments with covering influencing factors a certain number of times.	[Wang, Xun; Sun, Beibei] China Univ Petr, Coll Comp & Commun Engn, Qingdao 266580, Shandong, Peoples R China; [Liu, Boyang] China Univ Petr, State Owned Asset & Lab Management Dept, Qingdao 266580, Shandong, Peoples R China; [Fu, Yaping] Qingdao Univ, Inst Complex Sci, Qingdao 266071, Shandong, Peoples R China; [Zheng, Pan] Swinburne Univ Technol, Fac Engn Comp & Sci, Sarawak Campus, Kuching 93350, Malaysia	China University of Petroleum; China University of Petroleum; Qingdao University; Swinburne University of Technology; Swinburne University of Technology Sarawak	Fu, YP (corresponding author), Qingdao Univ, Inst Complex Sci, Qingdao 266071, Shandong, Peoples R China.; Zheng, P (corresponding author), Swinburne Univ Technol, Fac Engn Comp & Sci, Sarawak Campus, Kuching 93350, Malaysia.	fuyaping@qdu.edu.cn; pzheng@swiburne.edu.my	Zheng, Pan/A-5435-2009	Zheng, Pan/0000-0002-6067-626X	National Natural Science Foundation of China [61402187, 61502535, 61572522, 61572523, 61672033, 61672248]; China Postdoctoral Science Foundation funded project [2016M592267]; PetroChina Innovation Foundation [2016D-5007-0305]; Fundamental Research Funds for the Central Universities [R1607005A]; Natural Science Foundation of Shandong Province [ZR2015FM022]; Key Research and Development Program of Shandong Province [2017GGX10147]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); PetroChina Innovation Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Key Research and Development Program of Shandong Province	This work was supported by National Natural Science Foundation of China (61402187, 61502535,61572522,61572523,61672033 and 61672248) to XW, China Postdoctoral Science Foundation funded project (2016M592267) to XW, PetroChina Innovation Foundation (2016D-5007-0305) to PZ, Fundamental Research Funds for the Central Universities (R1607005A) to BL, Natural Science Foundation of Shandong Province (ZR2015FM022) to XW, Key Research and Development Program of Shandong Province (2017GGX10147) to BS.r This work was supported by National Natural Science Foundation of China (61402187, 61502535, 61572522, 61572523, 61672033 and 61672248), China Postdoctoral Science Foundation funded project (2016M592267), PetroChina Innovation Foundation (2016D-5007-0305), Fundamental Research Funds for the Central Universities (Rl607005A), Key Research and Development Program of Shandong Province (2017GGX10147), Natural Science Foundation of Shandong Province (ZR2015FM022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation ofthe manuscript.	Ahmadi M, 2005, J HAZARD MATER, V123, P187, DOI 10.1016/j.jhazmat.2005.03.042; Assmus Edvard F., 1994, DESIGNS THEIR CODES, V103; Balsa-Canto E, 2008, IET SYST BIOL, V2, P163, DOI 10.1049/iet-syb:20070069; Banga JR, 2008, ESSAYS BIOCHEM, V45, P195, DOI 10.1042/BSE0450195; Beth T., 1999, DESIGN THEORY, V69; Chen B, 2017, NEUROCOMPUTING; Chen X, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1725-6; Cox G. M., 1957, EXPT DESIGNS; Fu ZJ, 2017, IEEE T INF FOREN SEC, V12, P1874, DOI 10.1109/TIFS.2017.2692728; Gu B, 2015, IEEE T NEUR NET LEAR, V26, P1403, DOI 10.1109/TNNLS.2014.2342533; Hall M., 1998, COMBINATORIAL THEORY, V71; Iyssedal J., 2008, ENCY STAT QUALITY RE; Kazdin A. E., 1982, SINGLE CASE EXPT DES; Khuri AI, 2010, WIRES COMPUT STAT, V2, P128, DOI 10.1002/wics.73; Kleijnen JPC, 2017, EUR J OPER RES, V256, P1, DOI 10.1016/j.ejor.2016.06.041; Krishnan SS, 2013, IEEE ACM T NETWORK, V21, P2001, DOI 10.1109/TNET.2013.2281542; Li Z, 2016, BIOMED RES INT, V2016; Liu Q, 2016, SECUR COMMUN NETW, V9, P4002, DOI 10.1002/sec.1582; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Ma TH, 2015, COMPUTING, V97, P1165, DOI 10.1007/s00607-015-0453-x; Martinez-Cantin R, 2014, J MACH LEARN RES, V15, P3735; Montgomery D.C., 2021, DESIGN ANAL EXPT, V10th ed; Moore EH, 2013, DIFFERENCE SETS CONN, V67; Shen J, 2017, IEEE T INF FOREN SEC, V12, P2402, DOI 10.1109/TIFS.2017.2705620; Shi XL, 2016, NANOSCALE, V8, P14785, DOI 10.1039/c6nr02695h; Shi XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108856; Shi XM, 2015, J NANOMATER, V2015, DOI [10.1155/2015/140716, 10.1155/2015/905210]; Song T, 2016, IEEE T NANOBIOSCI, V15, P666, DOI 10.1109/TNB.2016.2598879; Song T, 2015, NEURAL PROCESS LETT, V42, P199, DOI 10.1007/s11063-014-9352-y; Song T, 2015, NEUROCOMPUTING, V151, P1439, DOI 10.1016/j.neucom.2014.10.044; Song T, 2014, NEURAL COMPUT APPL, V24, P1833, DOI 10.1007/s00521-013-1397-8; Stanley JC, 2015, EXPT QUASIEXPERIMENT; Tian Y, 2017, IEEE T EVOL IN PRESS; Tobias R., 2007, OPTIMUM EXPT DESIGNS, V34; Tso R, 2017, INT C INT INF HID MU, P267; Wang X, 2010, J STAT PLAN INFER, V140, P3243, DOI 10.1016/j.jspi.2010.04.022; Wang X, 2009, J STAT PLAN INFER, V139, P4200, DOI 10.1016/j.jspi.2009.06.004; Wang X, 2017, ROM J INF SCI TECH, V20, P32; Wang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep27624; Wang X, 2014, J COMPUT BIOL, V21, P320, DOI 10.1089/cmb.2013.0054; Xia ZH, 2016, IEEE T INF FOREN SEC, V11, P2594, DOI 10.1109/TIFS.2016.2590944; Xia ZH, 2016, IEEE T PARALL DISTR, V27, P340, DOI 10.1109/TPDS.2015.2401003; Xu J, 2016, IEEE T NEUR NET LEAR, V27, P1405, DOI 10.1109/TNNLS.2016.2555845; Xue Y, 2018, SOFT COMPUT, V22, P2935, DOI 10.1007/s00500-017-2547-1; Yang YD, 2017, METHODS MOL BIOL, V1484, P55, DOI 10.1007/978-1-4939-6406-2_6; Zeng XX, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005420; Zhang L, 2017, IEEE T CYBERNETICS, V47, P2703, DOI 10.1109/TCYB.2017.2711038; Zhang X., 2016, IEEE T EVOL IN PRESS; Zhang XY, 2017, IEEE COMPUT INTELL M, V12, P43, DOI 10.1109/MCI.2017.2708578; Zou Q, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0353-5	50	2	2	0	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186853	10.1371/journal.pone.0186853	http://dx.doi.org/10.1371/journal.pone.0186853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095845	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200026
J	Abir, T; Ogbo, FA; Stevens, GJ; Page, AN; Milton, AH; Agho, KE				Abir, Tanvir; Ogbo, Felix Akpojene; Stevens, Garry John; Page, Andrew Nicolas; Milton, Abul Hasnat; Agho, Kingsley Emwinyore			The impact of antenatal care, iron-folic acid supplementation and tetanus toxoid vaccination during pregnancy on child mortality in Bangladesh	PLOS ONE			English	Article							NEONATAL-MORTALITY; RURAL BANGLADESH; INFANT-MORTALITY; INTERVENTIONS; IMMUNIZATION; STILLBIRTHS; OUTCOMES; TRENDS	Background Appropriate antenatal care (ANC) is an important preventive public health intervention to ensure women's and newborn health outcomes. The study aimed to investigate the impact of ANC, iron folic acid (IFA) supplementation and tetanus toxoid (TT) vaccination during pregnancy on child mortality in Bangladesh. Method A cross-sectional study of three datasets from the Bangladesh Demographic and Health Surveys for the years 2004, 2007 and 2011 were pooled and used for the analyses. A total weighted sample of 16,721 maternal responses (5,364 for 2004; 4,872 for 2007 and 6,485 for 2011) was used. Multivariate logistic models that adjusted for cluster and sampling weights were used to examine the impact of ANC, IFA supplementation and TT vaccination during pregnancy on the death of a child aged 0-28 days (neonatal), 1-11 months (post neonatal) and 12-59 months (child). Results Multivariable analyses revealed that the odds of postnatal and under -5 mortality was lower in mothers who had ANC [Odds Ratio (OR) = 0.60, 95% confidence interval (95% CI): 0.43-0.85], IFA supplementation [OR = 0.66, 95% CI: (0.45-0.98)] and >= 2 TT vaccinations (OR = 0.43, 95% CI: 0.49-0.78) for post -natal mortality; and for under -5 mortality, any form of ANC (OR = 0.69, 95% CI: 0.51-0.93), IFA supplementation (OR = 0.67, 95% CI: 0.48-0.94) and >= 2 TT vaccinations (OR = 0.50, 95% CI: 0.36-0.69). When combined, TT vaccination with IFA supplementation, and TT vaccination without IFA supplementation were protective across all groups. Conclusion The study found that ANC, IFA supplementation, and TT vaccination during pregnancy reduced the likelihood of child mortality in Bangladesh. The findings suggest that considerable gains in improving child survival could be achieved through ensuring universal coverage of ANC, promoting TT vaccination during pregnancy and IFA supplementation among pregnant women in Bangladesh.	[Abir, Tanvir; Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Ogbo, Felix Akpojene; Page, Andrew Nicolas] Western Sydney Univ, Sch Med, THRI, Penrith, NSW, Australia; [Stevens, Garry John] Western Sydney Univ, Sch Social Sci & Psychol, HADRI, Penrith, NSW, Australia; [Milton, Abul Hasnat] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, CCEB, Callaghan, NSW, Australia	Western Sydney University; Western Sydney University; Western Sydney University; University of Newcastle	Agho, KE (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	k.agho@westernsydeny.edu.au	Agho, Kingsley/AAW-5622-2021; ABIR, TANVIR/AAG-4161-2021; Agho, Kingsley/AAE-9971-2020	Agho, Kingsley/0000-0003-4111-3207; Stevens, Garry/0000-0002-3556-4098				Abir T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006722; Alam N, 2000, J BIOSOC SCI, V32, P229, DOI 10.1017/S0021932000002297; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 2017, SUST DEV KNOWL PLATF; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; BLACK RE, 1980, B WORLD HEALTH ORGAN, V58, P927; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Chai F, 2004, INT J EPIDEMIOL, V33, P551, DOI 10.1093/ije/dyh073; Curtis SL, 1995, ASSESSMENT QUALITY D, P1459; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Ezeh OK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006779; Gitta Sheba N, 2006, MMWR Suppl, V55, P25; Hill K, 2006, DEMOGR RES, V14, P429, DOI 10.4054/DemRes.2006.14.18; Hyder AA, 2014, J HEALTH POPUL NUTR, V32, P564; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Khan AA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-322; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Mahy M., 2003, CHILDHOOD MORTALITY; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; *MIN HLTH FAM WELF, 2015, SUCC FACT WOM CHILDR; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; Nutrition International, WOM NEWB SURV HLTH B; Ogbo FA, 2016, PAEDIATR PERINAT EP, V30, P346, DOI 10.1111/ppe.12293; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Rahman AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112308; Rahman A, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-016-0078-5; Ronsmans C, 2008, PAEDIATR PERINAT EP, V22, P269, DOI 10.1111/j.1365-3016.2008.00939.x; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048891; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; TALL F, 1991, B SOC PATHOL EXOT, V84, P558; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Titaley CR, 2010, B WORLD HEALTH ORGAN, V88, P500, DOI 10.2471/BLT.09.065813; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; West KP, 2014, JAMA-J AM MED ASSOC, V312, P2649, DOI 10.1001/jama.2014.16819; World Health Organisation, 2005, WORLD HLTH REP MAK E; Zeng L, 2008, BMJ-BRIT MED J, P337	42	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187090	10.1371/journal.pone.0187090	http://dx.doi.org/10.1371/journal.pone.0187090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091923	Green Submitted, Green Published, gold			2022-12-27	WOS:000414229700043
J	Matias, WR; Julceus, FE; Abelard, C; Mayo-Smith, LM; Franke, MF; Harris, JB; Ivers, LC				Matias, Wilfredo R.; Julceus, Fabrice E.; Abelard, Cademil; Mayo-Smith, Leslie M.; Franke, Molly F.; Harris, Jason B.; Ivers, Louise C.			Laboratory evaluation of immunochromatographic rapid diagnostic tests for cholera in Haiti	PLOS ONE			English	Article							VIBRIO-CHOLERAE; DIPSTICK TEST; KIT; OUTBREAK; DIARRHEA	Background Rapid diagnostic tests (RDT) for cholera are promising tools for detecting cholera in areas with limited laboratory infrastructure. However, evidence on the characteristics of the many available RDTs is scarce, and their use has been limited by suboptimal performance. We evaluated the performance characteristics of three cholera RDTs from Span Diagnostics, Artron Laboratories, and Standard Diagnostics in a regional laboratory in Haiti. Methodology/Principal findings We retrospectively reviewed records from May 2014 to October 2015 of a laboratory-based surveillance program for Vibrio cholerae atHipital Saint-Nicolas in Saint-Marc, Haiti. We compared the results of 511 Crystal VC, 129 Artron and 451 SD Bioline RDTs to bacterial culture as the gold standard. Of 905 cultures, 477 (52.7%) were positive for V. cholerae 01, of which 27.7% were serotype Inaba. No cultures grew V. cholerae 0139. Sensitivity and specificity of Crystal VC were 98.6% (95%Cl: 96.5%-99.6%) and 71.1% (95%Cl: 64.7%76.9%), respectively. Artron demonstrated a sensitivity of 98.6% (95%Cl: 92.7%-100%) and specificity of 69.1% (95%Cl: 55.2%-80.9%). SD Bioline demonstrated a sensitivity of 81.1% (95%Cl: 75.6%-85.8%) and specificity of 92.8% (95%Cl: 88.4%-95.9%). Crystal VC and Artron frequently showed false positive O139 bands, whereas none were seen with SD Bioline. Conclusions/Significance There is significant variation in the performance of different cholera diagnostic RDTs. Artron and Crystal VC RDTs have high sensitivity and low specificity, while SD Bioline RDT has low to moderate sensitivity and high specificity when performed by laboratory technicians in Haiti. Study limitations included its retrospective design. The suboptimal characteristics of these tests limit their use as clinical point-of-care tests; however, they may be useful in outbreak response, surveillance, and research in resource-limited settings.	[Matias, Wilfredo R.; Franke, Molly F.; Ivers, Louise C.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Matias, Wilfredo R.; Ivers, Louise C.] Partners Hlth, Boston, MA USA; [Julceus, Fabrice E.; Abelard, Cademil] Zanmi Lasante, Pont Tambour, St Marc, Haiti; [Mayo-Smith, Leslie M.; Harris, Jason B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Harris, Jason B.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Ivers, Louise C.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Matias, WR; Ivers, LC (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA.; Matias, WR; Ivers, LC (corresponding author), Partners Hlth, Boston, MA USA.; Ivers, LC (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.	vmatias@partners.org; livers@pih.org	Matias, Wilfredo/AAD-5159-2019; Ivers, Louise C/Q-4164-2018; Franke, Molly/AAK-7559-2020; Harris, Jason/ABF-2684-2020	Ivers, Louise C/0000-0003-2314-9230; Franke, Molly/0000-0002-4890-5728; Harris, Jason/0000-0003-3642-5126; Julceus, Emmanuel Fabrice/0000-0001-6505-9159; Matias, Wilfredo/0000-0002-5371-1354	National Institutes of Health [NIAID R01 A1099243]; Abundance Foundation (LCI); Global Health Research Core of the Department of Global Health and Social Medicine (MFF); Madison Enteric Diseases Laboratory fund; Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at Harvard Medical School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abundance Foundation (LCI); Global Health Research Core of the Department of Global Health and Social Medicine (MFF); Madison Enteric Diseases Laboratory fund; Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at Harvard Medical School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institutes of Health, (NIAID R01 A1099243; to JBH, LCI and MFF), the Abundance Foundation (LCI), the Global Health Research Core of the Department of Global Health and Social Medicine (MFF), and the Madison Enteric Diseases Laboratory fund. WRM was supported in part by the Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at Harvard Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005045; Alam M, 2010, J CLIN MICROBIOL, V48, P3918, DOI 10.1128/JCM.00616-10; ALBERT MJ, 1995, J CLIN MICROBIOL, V33, P3119, DOI 10.1128/JCM.33.12.3119-3123.1995; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ansaruzzaman M, 1999, J MED MICROBIOL, V48, P873, DOI 10.1099/00222615-48-9-873; Boncy J, 2013, DIAGN MICR INFEC DIS, V76, P521, DOI 10.1016/j.diagmicrobio.2013.03.010; Chen WX, 2014, CLIN BIOCHEM, V47, P448, DOI 10.1016/j.clinbiochem.2013.12.022; Debes AK, 2016, AM J TROP MED HYG, V94, P537, DOI 10.4269/ajtmh.15-0496; Dick MH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001845; George CM, 2014, TROP MED INT HEALTH, V19, P301, DOI 10.1111/tmi.12252; Harris JR, 2009, TROP MED INT HEALTH, V14, P1117, DOI 10.1111/j.1365-3156.2009.02335.x; HASAN JAK, 1995, J CLIN MICROBIOL, V33, P2935, DOI 10.1128/JCM.33.11.2935-2939.1995; HASAN JAK, 1994, J CLIN MICROBIOL, V32, P249, DOI 10.1128/JCM.32.1.249-252.1994; Kalluri P, 2006, TROP MED INT HEALTH, V11, P49, DOI 10.1111/j.1365-3156.2005.01539.x; Keddy KH, 2013, J INFECT DIS, V208, pS23, DOI 10.1093/infdis/jit196; Koski-Karell V, 2016, RISK MANAG HEALTHC P, V9, DOI 10.2147/RMHP.S75919; Lesmana M, 1997, J CLIN MICROBIOL, V35, P1856, DOI 10.1128/JCM.35.7.1856-1858.1997; Ley B, 2012, PLOS ONE, V7, P3; Mukherjee P, 2010, JPN J INFECT DIS, V63, P234; Ontweka LN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168257; Page AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037360; QADRI F, 1995, J CLIN MICROBIOL, V33, P732, DOI 10.1128/JCM.33.3.732-734.1995; Sinha A, 2012, INDIAN J MED RES, V135, P523; Steenland MW, 2013, AM J TROP MED HYG, V89, P641, DOI 10.4269/ajtmh.13-0307; WHO, 2013, PREV CONTR CHOL OUTB; World Health Organization, 2016, INT HLTH REG, V3, P1	26	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186710	http://dx.doi.org/10.1371/journal.pone.0186710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091945	Green Submitted, gold, Green Published			2022-12-27	WOS:000414229700028
J	Heffner, MA; Genetos, DC; Christiansen, BA				Heffner, Mollie A.; Genetos, Damian C.; Christiansen, Blaine A.			Bone adaptation to mechanical loading in a mouse model of reduced peripheral sensory nerve function	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; FEMALE C57BL/6 MICE; IN-VIVO; SUBSTANCE-P; CORTICAL BONE; CAPSAICIN; NEURONS; RESORPTION; RAT; INNERVATION	Underlying mechanisms contributing to the imbalance in bone turnover during osteoporosis remain only partially explained. Reduced sensory nerve function may contribute to this imbalance, as sensory neuropeptides affect the activity of osteoblasts and osteoclasts in vivo, especially during bone adaptation. In this study, we investigated bone adaptation in mice following two weeks of tibial compression (peak magnitude 3 N or 7 N). To induce decreased sensory nerve function, mice were treated with capsaicin as neonates. We hypothesized that decreased sensory nerve function would diminish the adaptation of bone to mechanical loading, assessed with mu CT and dynamic histomorphometry. We found that tibial compression induced significant changes in cortical microarchitecture that depended on compression magnitude and location along the length of the tibia; in contrast, there was no effect of loading on trabecular bone of the tibial metaphysis. Tibial compression significantly increased periosteal, and decreased endosteal, bone formation. Contrary to our initial hypothesis, capsaicin-treated mice generally displayed a similar, if not larger, adaptive response to mechanical loading, including greater increases in bone mineral content and mineral apposition rate. To integrate mechanical loading of bone with sensory nerve activation, we examined whether concentration of the neuropeptides calcitonin gene-related peptide (CGRP) and substance P (SP) in bone were affected following 1 or 5 days of 5 N tibial compression or hindlimb unloading. We found that 1 day of tibial compression significantly increased CGRP concentrations in bone, and hindlimb unloading also exhibited a trend toward increased CGRP in bone. These results may suggest a role of sensory nerves in the bone adaptation response to the mechanical environment, though this remains unclear.	[Heffner, Mollie A.] Univ Calif Davis, Mouse Biol Program, Davis, CA 95616 USA; [Genetos, Damian C.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Christiansen, Blaine A.] Univ Calif Davis, Med Ctr, Dept Orthopaed Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Christiansen, BA (corresponding author), Univ Calif Davis, Med Ctr, Dept Orthopaed Surg, Sacramento, CA 95817 USA.	bchristiansen@ucdavis.edu	Genetos, Damian C/A-6480-2012; Genetos, Damian/AAF-5953-2021	Genetos, Damian/0000-0002-8599-2867; Christiansen, Blaine/0000-0002-0105-6458	Department of Defense Congressionally Directed Medical Research Programs [PR110178]	Department of Defense Congressionally Directed Medical Research Programs(United States Department of Defense)	Research reported in this publication was supported by the Department of Defense Congressionally Directed Medical Research Programs, under Award Number PR110178. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Baron R, 1983, PROCESSING UNDECALCI, P13; Brodt M. D, 2010, J BONE MINER RES; Carriero A, 2014, J BIOMECH, V47, P2490, DOI 10.1016/j.jbiomech.2014.03.035; Christiansen BA, 2012, OSTEOARTHR CARTILAGE, V20, P773, DOI 10.1016/j.joca.2012.04.014; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; DSOUZA SM, 1986, ENDOCRINOLOGY, V119, P58, DOI 10.1210/endo-119-1-58; Elefteriou F, 2005, CELL MOL LIFE SCI, V62, P2339, DOI 10.1007/s00018-005-5175-3; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Guo TZ, 2014, J PAIN, V15, P1033, DOI 10.1016/j.jpain.2014.07.004; HaraIrie F, 1996, BONE, V18, P29, DOI 10.1016/8756-3282(95)00425-4; Heffner MA, 2014, J MUSCULOSKEL NEURON, V14, P1; HILL EL, 1991, NEUROSCIENCE, V44, P747, DOI 10.1016/0306-4522(91)90094-5; HOLZER P, 1991, PHARMACOL REV, V43, P143; Imai S, 1997, J ORTHOP RES, V15, P133, DOI 10.1002/jor.1100150120; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Jimenez-Andrade JM, 2009, NEUROSCIENCE, V162, P1244, DOI 10.1016/j.neuroscience.2009.05.065; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; KAR S, 1989, CELL TISSUE RES, V255, P451; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Konttinen YT, 1996, ACTA ORTHOP SCAND, V67, P632, DOI 10.3109/17453679608997772; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Main RP, 2010, J BIOMECH, V43, P2689, DOI 10.1016/j.jbiomech.2010.06.019; Mihara K, 2004, BRIT J DERMATOL, V151, P335, DOI 10.1111/j.1365-2133.2004.06036.x; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Mori T, 1999, BIOCHEM BIOPH RES CO, V262, P418, DOI 10.1006/bbrc.1999.1220; NAGY JI, 1983, J NEUROSCI, V3, P399; Nakano T, 2008, ACTA DERM-VENEREOL, V88, P449, DOI 10.2340/00015555-0479; Offley SC, 2005, J BONE MINER RES, V20, P257, DOI 10.1359/JBMR.041108; Patel TK, 2014, J BIOMECH, V47, P451, DOI 10.1016/j.jbiomech.2013.10.052; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; ROOS BA, 1986, ENDOCRINOLOGY, V118, P46, DOI 10.1210/endo-118-1-46; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; SCADDING JW, 1980, J ANAT, V131, P471; Serre CM, 1999, BONE, V25, P623, DOI 10.1016/S8756-3282(99)00215-X; Spencer GJ, 2004, FEBS LETT, V559, P6, DOI 10.1016/S0014-5793(04)00053-5; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; TAMURA T, 1992, J CELL PHYSIOL, V153, P6, DOI 10.1002/jcp.1041530103; TIPPINS JR, 1984, NEUROPEPTIDES, V4, P425, DOI 10.1016/0143-4179(84)90118-5; Wang LP, 2009, BONE, V45, P309, DOI 10.1016/j.bone.2009.04.203; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; YAMAMOTO I, 1986, CALCIFIED TISSUE INT, V38, P339, DOI 10.1007/BF02555747	44	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187354	10.1371/journal.pone.0187354	http://dx.doi.org/10.1371/journal.pone.0187354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088267	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900071
J	Lee, H; Chung, H; Ko, H; Jeong, C; Noh, SE; Kim, C; Lee, J				Lee, Hooseok; Chung, Heewon; Ko, Hoon; Jeong, Changwon; Noh, Se-Eung; Kim, Chul; Lee, Jinseok			Dedicated cardiac rehabilitation wearable sensor and its clinical potential	PLOS ONE			English	Article							MAXIMAL HEART-RATE; FUNCTIONAL-CAPACITY; INTERVENTION; ELECTRONICS; ADHERENCE; AGE	We describe a wearable sensor developed for cardiac rehabilitation (CR) exercise. To effectively guide CR exercise, the dedicated CR wearable sensor (DCRW) automatically recommends the exercise intensity to the patient by comparing heart rate (HR) measured in real time with a predefined target heart rate zone (THZ) during exercise. The CR exercise includes three periods: pre-exercise, exercise with intensity guidance, and post-exercise. In the pre-exercise period, information such as THZ, exercise type, exercise stage order, and duration of each stage are set up through a smartphone application we developed for iPhones and Android devices. The set-up information is transmitted to the DCRW via Bluetooth communication. In the period of exercise with intensity guidance, the DCRW continuously estimates HR using a reflected pulse signal in the wrist. To achieve accurate HR measurements, we used multichannel photo sensors and increased the chances of acquiring a clean signal. Subsequently, we used singular value decomposition (SVD) for de-noising. For the median and variance of RMSEs in the measured HRs, our proposed method with DCRW provided lower values than those from a single channel-based method and template-based multiple-channel method for the entire exercise stage. In the post-exercise period, the DCRW transmits all the measured HR data to the smartphone application via Bluetooth communication, and the patient can monitor his/her own exercise history.	[Lee, Hooseok; Chung, Heewon; Ko, Hoon; Jeong, Changwon; Lee, Jinseok] Wonkwang Univ, Dept Biomed Engn, Coll Med, Iksan, South Korea; [Noh, Se-Eung] Wonkwang Univ, Dept Rehabil Med, Coll Med, Iksan, South Korea; [Kim, Chul] Inje Univ, Med Coll, Sanggye Paik Hosp, Dept Rehabil Med, Seoul, South Korea	Wonkwang University; Wonkwang University; Inje University	Lee, J (corresponding author), Wonkwang Univ, Dept Biomed Engn, Coll Med, Iksan, South Korea.	gonasago@wku.ac.kr	Lee, Jinseok/AAV-7182-2021; Lee, Jinseok/GRR-6086-2022; Ko, Hoon/J-4612-2013	Lee, Jinseok/0000-0002-8580-490X; Lee, Jinseok/0000-0002-8580-490X; Ko, Hoon/0000-0002-4604-1735	National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future Planning [NRF-2016R1D1A1B03934938, NRF-2015M3A9D7067215]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future Planning	This study was partially supported by a by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT &Future Planning: NRF-2016R1D1A1B03934938 and NRF-2015M3A9D7067215. (J.L both). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboy M, 2005, IEEE T BIO-MED ENG, V52, P1662, DOI 10.1109/TBME.2005.855725; Allen Jerilyn K, 2003, J Cardiovasc Nurs, V18, P150; [Anonymous], 1952, EXPT STUDIES PHYS WO; Arena R, 2012, CIRCULATION, V125, P1321, DOI 10.1161/CIR.0b013e318246b1e5; Arrigo I, 2008, EUR J CARDIOV PREV R, V15, P306, DOI 10.1097/HJR.0b013e3282f40e01; Baldasseroni S, 2016, J AM GERIATR SOC, V64, P1640, DOI 10.1111/jgs.14239; Blackwell D., 2015, TABLES SUMMARY HLTH; de la Cuerda RC, 2012, REV ESP CARDIOL, V65, P72, DOI [10.1016/j.recesp.2011.07.016, 10.1016/j.rec.2011.07.015]; Chang JS, 2017, IEEE J EM SEL TOP C, V7, P7, DOI 10.1109/JETCAS.2017.2673863; Cheng T, 2015, ADV MATER, V27, P3349, DOI 10.1002/adma.201405864; Chung H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161268; Dalal HM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5631; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; Giallauria F, 2016, MONALDI ARCH CHEST D, V66; Gulati M, 2010, CIRCULATION, V122, P130, DOI 10.1161/CIRCULATIONAHA.110.939249; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Jolly K, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11350; Lavie CJ, 2009, EXERCISE TRAINING CA, P373; Lee J, 2013, IEEE T BIO-MED ENG, V60, P203, DOI 10.1109/TBME.2012.2208112; Lewinter C, 2015, EUR J PREV CARDIOL, V22, P1504, DOI 10.1177/2047487314559853; Mackinnon LT, 2003, XERCISE MANAGEMENT C; Maddison R, 2015, EUR J PREV CARDIOL, V22, P701, DOI 10.1177/2047487314535076; Medicine ACoS, 2013, ACSMS GUID EX TEST P; Noonan V, 2000, PHYS THER, V80, P782, DOI 10.1093/ptj/80.8.782; Pasquali SK, 2003, AM HEART J, V145, P445, DOI 10.1067/mhj.2003.172; Roy SJ, 2009, VALIDATION MAXIMAL H; Sarela A, 2009, HOME BASED CARE MODE, P1; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Warren KM, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030342; Whaley M H, 1997, J Cardiopulm Rehabil, V17, P261, DOI 10.1097/00008483-199707000-00007; WHO, CARD DIS CVDS	31	12	14	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187108	10.1371/journal.pone.0187108	http://dx.doi.org/10.1371/journal.pone.0187108			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088260	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900040
J	Guazzo, RA; Helble, TA; D'Spain, GL; Weller, DW; Wiggins, SM; Hildebrand, JA				Guazzo, Regina A.; Helble, Tyler A.; D'Spain, Gerald L.; Weller, David W.; Wiggins, Sean M.; Hildebrand, John A.			Migratory behavior of eastern North Pacific gray whales tracked using a hydrophone array	PLOS ONE			English	Article							ESCHRICHTIUS-ROBUSTUS; HUMPBACK WHALES; PATTERNS; SOUNDS; SEA	Eastern North Pacific gray whales make one of the longest annual migrations of any mammal, traveling from their summer feeding areas in the Bering and Chukchi Seas to their wintering areas in the lagoons of Baja California, Mexico. Although a significant body of knowledge on gray whale biology and behavior exists, little is known about their vocal behavior while migrating. In this study, we used a sparse hydrophone array deployed offshore of central California to investigate how gray whales behave and use sound while migrating. We detected, localized, and tracked whales for one full migration season, a first for gray whales. We verified and localized 10,644 gray whale M3 calls and grouped them into 280 tracks. Results confirm that gray whales are acoustically active while migrating and their swimming and acoustic behavior changes on daily and seasonal time scales. The seasonal timing of the calls verifies the gray whale migration timing determined using other methods such as counts conducted by visual observers. The total number of calls and the percentage of calls that were part of a track changed significantly over both seasonal and daily time scales. An average calling rate of 5.7 calls/whale/day was observed, which is significantly greater than previously reported migration calling rates. We measured a mean speed of 1.6 m/s and quantified heading, direction, and water depth where tracks were located. Mean speed and water depth remained constant between night and day, but these quantities had greater variation at night. Gray whales produce M3 calls with a root mean square source level of 156.9 dB re 1 mu Pa at 1 m. Quantities describing call characteristics were variable and dependent on site-specific propagation characteristics.	[Guazzo, Regina A.; D'Spain, Gerald L.; Wiggins, Sean M.; Hildebrand, John A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Helble, Tyler A.] SPAWAR Syst Ctr Pacific, San Diego, CA USA; [Weller, David W.] NOAA, Southwest Fisheries Sci Ctr, La Jolla, CA USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Naval Information Warfare Center Pacific; National Oceanic Atmospheric Admin (NOAA) - USA	Guazzo, RA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	rguazzo@ucsd.edu	Guazzo, Regina/S-5372-2019	Guazzo, Regina/0000-0002-6482-2965; Hildebrand, John/0000-0002-5418-9799	Science, Mathematics and Research for Transformation Defense Scholarship for Service Program - ASD/R&E (Assistant Secretary of Defense for Research and Education) [PE0601120D8Z, N00244-09-1-0081]; U.S. Army Corps of Engineers by the U.S. Navy's Pacific Fleet through the Cooperative Ecosystem Studies Units;  [W9126G-15-2-003]	Science, Mathematics and Research for Transformation Defense Scholarship for Service Program - ASD/R&E (Assistant Secretary of Defense for Research and Education); U.S. Army Corps of Engineers by the U.S. Navy's Pacific Fleet through the Cooperative Ecosystem Studies Units; 	RAG received a fellowship from the Science, Mathematics and Research for Transformation Defense Scholarship for Service Program funded by ASD/R&E (Assistant Secretary of Defense for Research and Education), Defense - Wide / PE0601120D8Z National Defense Education Program (NDEP) / BA-1, Basic Research, Grant Number N00244-09-1-0081 (https://smart.asee.org/). JAH received a grant from the U.S. Army Corps of Engineers using funds provided by the U.S. Navy's Pacific Fleet through the Cooperative Ecosystem Studies Units. The authors would specifically like to thank Chip Johnson from Pacific Fleet. Grant Number W9126G-15-2-003. (http://vwfw.cesu.psu.edu/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2000, MAR MAMMAL SCI, V16, P530, DOI 10.1111/j.1748-7692.2000.tb00949.x; Crane NL, 1996, J ACOUST SOC AM, V100, P1878, DOI 10.1121/1.416006; CUMMINGS WC, 1968, J ACOUST SOC AM, V44, P1278, DOI 10.1121/1.1911259; Dalheim ME, 1987, BIOACOUSTICS GRAY WH; Durban JW, 2017, SCA17GW06 INT WHAL C; FISH JF, 1974, MAR FISH REV, V36, P38; Gilmore RM, 1960, SPECIAL SCI REPORTS, V342, piv; Helble TA, 2015, J ACOUST SOC AM, V137, P11, DOI 10.1121/1.4904505; Helble TA, 2013, J ACOUST SOC AM, V134, P2556, DOI 10.1121/1.4816581; Helble TA, 2012, J ACOUST SOC AM, V131, P2682, DOI 10.1121/1.3685790; HUBBS CL, 1967, CALIF FISH GAME, V53, P23; Laake JL, 2009, NMFSAFSC203 US DEP C; Mate B, 2010, SC62BRG21 INT WHAL C; Mate Bruce R., 2003, Journal of Cetacean Research and Management, V5, P155; Moore SE, 2001, MAR MAMMAL SCI, V17, P954, DOI 10.1111/j.1748-7692.2001.tb01310.x; Munger LM, 2008, MAR MAMMAL SCI, V24, P795, DOI 10.1111/j.1748-7692.2008.00219.x; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; Perryman WL, 1999, MAR MAMMAL SCI, V15, P426, DOI 10.1111/j.1748-7692.1999.tb00811.x; Perryman WL, 2002, MAR MAMMAL SCI, V18, P121, DOI 10.1111/j.1748-7692.2002.tb01023.x; Perryman WL, 2010, SC62BRG1 INT WHAL CO; PETROCHENKO SP, 1991, SOV PHYS ACOUST+, V37, P622; Poole M.M., 1984, P389; Reilly SB, 2008, IUCN RED LIST THREAT; Rice D. W. W., 1971, AM SOC MAMMAL, DOI DOI 10.5962/BHL.TITLE.39537; Rugh D.J., 1984, P225; Rugh DJ, 2008, MAR MAMMAL SCI, V24, P864, DOI 10.1111/j.1748-7692.2008.00215.x; RUGH DJ, 1990, MAR MAMMAL SCI, V6, P109, DOI 10.1111/j.1748-7692.1990.tb00233.x; Scammon C.M., 1874, MARINE MAMMALS N W C; Shelden Kim E. W., 2002, Journal of Cetacean Research and Management, V4, P53; Sumich J., 2014, E ROBUSTUS BIOL HUMA; SUMICH JL, 1983, CAN J ZOOL, V61, P647, DOI 10.1139/z83-086; Urick R. J., 1967, PRINCIPLES UNDERWATE; Wiggins Sean M., 2007, International Symposium on Underwater Technology 2007. International Workshop on Scientific Use of Submarine Cables and Related Technologies 2007, P551; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161; Woodward PM, 1964, INT SERIES MONOGRAPH, V3	36	20	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0185585	10.1371/journal.pone.0185585	http://dx.doi.org/10.1371/journal.pone.0185585			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084266	Green Submitted, Green Published, gold			2022-12-27	WOS:000413910200002
J	Meyer-Rath, G; Johnson, LF; Pillay, Y; Blecher, M; Brennan, AT; Long, L; Moultrie, H; Sanne, I; Fox, MP; Rosen, S				Meyer-Rath, Gesine; Johnson, Leigh F.; Pillay, Yogan; Blecher, Mark; Brennan, Alana T.; Long, Lawrence; Moultrie, Harry; Sanne, Ian; Fox, Matthew P.; Rosen, Sydney			Changing the South African national antiretroviral therapy guidelines: The role of cost modelling	PLOS ONE			English	Article							OUTCOMES	Background We were tasked by the South African Department of Health to assess the cost implications to the largest ART programme in the world of adopting sets of ART guidelines issued by the World Health Organization between 2010 and 2016. Methods Using data from large South African ART clinics (n = 24,244 patients), projections of patients in need of ART, and cost data from bottom-up cost analyses, we constructed a populationlevel health-state transition model with 6-monthly transitions between health states depending on patients' age, CD4 cell count/percentage, and, for adult first-line ART, time on treatment. Findings For each set of guidelines, the modelled increase in patient numbers as a result of prevalence and uptake was substantially more than the increase resulting from additional eligibility. Under each set of guidelines, the number of people on ART was projected to increase by 31 -133% over the next seven years, and cost by 84-175%, while increased eligibility led to 1 - 26% more patients, and 1-17% higher cost. The projected increases in treatment cost due to the 2010 and the 2015 WHO guidelines could be offset in their entirety by the introduction of cost-saving measures such as opening the drug tenders for international competition and task-shifting. Under universal treatment, annual costs of the treatment programme will decrease for the first time from 2024 onwards. Conclusions Annual budgetary requirements for ART will continue to increase in South Africa until universal treatment is taken to full scale. Model results were instrumental in changing South African ART guidelines, more than tripling the population on treatment between 2009 and 2017, and reducing the per-patient cost of treatment by 64%.	[Meyer-Rath, Gesine; Brennan, Alana T.; Fox, Matthew P.; Rosen, Sydney] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Meyer-Rath, Gesine; Brennan, Alana T.; Long, Lawrence; Sanne, Ian; Fox, Matthew P.; Rosen, Sydney] Univ Witwatersrand, HE2RO, Dept Med, Fac Hlth Sci, Johannesburg, South Africa; [Johnson, Leigh F.] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Pillay, Yogan] Natl Dept Hlth, Pretoria, South Africa; [Blecher, Mark] Natl Treasury, Pretoria, South Africa; [Moultrie, Harry] Univ Witwatersrand, Wits RHI, Fac Hlth Sci, Johannesburg, South Africa; [Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Clin HIV Res Unit, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Boston University; University of Witwatersrand; University of Cape Town; University of Witwatersrand; University of Witwatersrand; Boston University	Meyer-Rath, G (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA.; Meyer-Rath, G (corresponding author), Univ Witwatersrand, HE2RO, Dept Med, Fac Hlth Sci, Johannesburg, South Africa.	gesine@bu.edu	Sanne, Ian/ABH-2231-2020; Fox, Matthew/K-2004-2019; Moultrie, Harry/AFV-0903-2022; Moultrie, Harry/H-1842-2014	Moultrie, Harry/0000-0001-9722-0699; Moultrie, Harry/0000-0001-9722-0699; Rosen, Sydney/0000-0002-6560-2964; Long, Lawrence/0000-0003-4986-4988; Brennan, Alana/0000-0002-7746-0668	American people through the United States Agency for International Development (USAID) [674-A-00-09-00018-00, GHS-A-00-03-00020, AID 674-A-12-00029, 674-A-00-02-00018]; National Institute of Allergy and Infectious Diseases [K01A1083097]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083097] Funding Source: NIH RePORTER	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Associate Cooperative Agreement No. 674-A-00-09-00018-00 under Country Research Activity Leader Award No. GHS-A-00-03-00020 and under award number AID 674-A-12-00029 (G.M.-R.'s, L. L.'s and S.R.'s time), and Cooperative Agreement 674-A-00-02-00018 to Right to Care (A.B.'s and M. F.'s time). M.F. was also supported by K01A1083097 from the National Institute of Allergy and Infectious Diseases. We are grateful for the support of the members of the original Costing Task Team convened by the South African National Department of Health, the staff of the two sites providing cohort data, and to staff at USAID South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, S AFRICA GLOBAL AIDS; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2010, COUNTR PROGR REP DEC; [Anonymous], 2011, STAT M S AFR NAT AID; [Anonymous], 2016, HLTH DEP BUDG VOT 20; Bango F, TROP MED INT HLTH, V21, P1115; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Cleary S, 2009, 5 INT AIDS SOC C 200; Department of Health, 2010, CLIN GUID MAN HIV AI; Department of Health & South African National AIDS Council, 2016, S AFR HIV TB INV CAS; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Meyer-Rath G, 2013, JAIDS-J ACQ IMM DEF, V62, P322, DOI 10.1097/QAI.0b013e31827e8785; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; South African National Department of Health, 2018, GUIDELINES IMPLEMENT; WHO, 2010, ANT THER HIV INF AD; WHO, 2016, CONGUID UANT DRU; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2009, RAP ADV ANT THER HIV	19	38	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186557	10.1371/journal.pone.0186557	http://dx.doi.org/10.1371/journal.pone.0186557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084275	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200008
J	Chen, MC; Kunselman, AR; Stetter, CM; Hannush, SB; Roberts, BW				Chen, Michael C.; Kunselman, Allen R.; Stetter, Christy M.; Hannush, Sadeer B.; Roberts, Benjamin W.			Corneal transplantation at Tenwek Hospital, Kenya, East Africa: Analysis of outcomes and associated patient socioeconomic characteristics	PLOS ONE			English	Article							PENETRATING KERATOPLASTY; GRAFT-SURVIVAL	Purpose To review the graft survival rate, visual outcomes, and patient demographics of primary penetrating keratoplasty performed at Tenwek Hospital, a mission hospital in rural Kenya. Methods A retrospective review was performed of the clinical records of patients who underwent primary penetrating keratoplasty for optical purposes from January 2012 to October 2014. The graft survival rates were constructed using the Kaplan-Meier method, and the effect of clinical and socioeconomic characteristics on time to graft failure were examined using Cox regression models. Results 118 patients met the inclusion criteria. The most common indication for surgery was keratoconus (66.1%), followed by corneal scar (22.0%). Despite all patients giving a verbal commitment to do so, 40 patients (33.9%) failed to make it to followup one year postoperatively. Graft survival at one year, inclusive of all indications, was 85.8%. Of the different indications, keratoconus had the highest one-year graft survival rate of 89.9%. Compared to the preoperative uncorrected visual acuity, 85.3% achieved an improvement at one year. Compared to patients who had completed college or university, the risk of developing graft failure was 4.7 times higher among patients with less education (P = 0.01). Conclusions Corneal transplantation at Tenwek Hospital can be performed with a reasonable chance of success at one year, particularly in cases of keratoconus and in patients with higher educational backgrounds. Adherence to followup recommendations proves to be a challenge in this patient population. Additional studies of larger patient populations with longer follow up periods in similar settings may be helpful in informing appropriate patient selection and maximizing successful outcomes of corneal transplantation in low-resource settings.	[Chen, Michael C.] Penn State Coll Med, Penn State Eye Ctr, Hershey, PA 17033 USA; [Chen, Michael C.; Roberts, Benjamin W.] Tenwek Hosp, Bomet, Bomet County, Kenya; [Kunselman, Allen R.; Stetter, Christy M.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Hannush, Sadeer B.] Wills Eye Hosp & Res Inst, Philadelphia, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Jefferson University	Chen, MC (corresponding author), Penn State Coll Med, Penn State Eye Ctr, Hershey, PA 17033 USA.; Chen, MC (corresponding author), Tenwek Hosp, Bomet, Bomet County, Kenya.	mchen3@pennstatehealth.psu.edu		Chen, Michael/0000-0001-5178-4632				CAMERON JA, 1989, OPHTHALMOLOGY, V96, P1615; Chua PY, 2013, OPHTHALMOLOGY, V120, P2436, DOI 10.1016/j.ophtha.2013.07.050; Dandona L, 1997, BRIT J OPHTHALMOL, V81, P726, DOI 10.1136/bjo.81.9.726; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-7; De Smedt S, 2011, AM J TROP MED HYG, V85, P711, DOI 10.4269/ajtmh.2011.11-0291; Education Policy and Data Center, 2014, 360 FHI ED POL DAT C; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Hayilu D, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0345-7; Huang C, 2009, CORNEA, V28, P1003, DOI 10.1097/ICO.0b013e3181a186c0; International Labour Office, 2012, INT STANDARD CLASSIF; Joshi SA, 2012, INDIAN J OPHTHALMOL, V60, P15, DOI 10.4103/0301-4738.91337; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Mukhtar S, 2017, INT OPHTHALMOL; Oliva MS, 2012, INDIAN J OPHTHALMOL, V60, P423, DOI 10.4103/0301-4738.100540; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Pineda R, 2015, CORNEA, V34, pS35, DOI 10.1097/ICO.0000000000000567; Rashid ZA, 2016, MIDDLE EAST AFR J OP, V23, P283, DOI 10.4103/0974-9233.194074; ROSNER B, 1982, BIOMETRICS, V38, P105, DOI 10.2307/2530293; Tabin GC, 2004, CORNEA, V23, P589, DOI 10.1097/01.ico.0000121712.36593.0d; Tan DTH, 2008, OPHTHALMOLOGY, V115, P975, DOI 10.1016/j.ophtha.2007.08.049; Wagoner MD, 2009, CORNEA, V28, P882, DOI 10.1097/ICO.0b013e31819b00d8; WILLIAMS KA, 1992, OPHTHALMOLOGY, V99, P403; Yorston D, 1996, BRIT J OPHTHALMOL, V80, P890, DOI 10.1136/bjo.80.10.890	23	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187026	10.1371/journal.pone.0187026	http://dx.doi.org/10.1371/journal.pone.0187026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077728	Green Submitted, Green Published, gold			2022-12-27	WOS:000413861200036
J	Zhang, JH; Sun, XQ; Zhu, R; Li, M; Miao, W				Zhang, Jiang-Hua; Sun, Xiao-Qing; Zhu, Rui; Li, Ming; Miao, Wang			Solving an emergency rescue materials problem under the joint reserves mode of government and framework agreement suppliers	PLOS ONE			English	Article							LOCATION	Emergency rescue material reserves are vital for the success of emergency rescue activities. In this study, we consider a situation where a government owned distribution center and framework agreement suppliers jointly store emergency rescue materials. Using a scenario-based approach to represent demand uncertainty, we propose a comprehensive transportation pattern for the following supply chain: "suppliers-government distribution center-disaster area." Using a joint reserves model that includes the government and framework agreement suppliers, we develop a non-linear mathematic model that determines the choices of the framework suppliers, the corresponding optimal commitment quantities, and the quantity of materials that are stored at a government distribution center. Finally, we use IBM ILOG CPLEX to solve the numerical examples to verify the effectiveness of the mode and perform sensitivity analyses on the relevant parameters.	[Zhang, Jiang-Hua; Sun, Xiao-Qing; Zhu, Rui; Li, Ming] Shandong Univ, Sch Management, Jinan, Shandong, Peoples R China; [Miao, Wang] Qilu Univ Technol, Sch Business Adm, Jinan, Shandong, Peoples R China	Shandong University; Qilu University of Technology	Zhang, JH (corresponding author), Shandong Univ, Sch Management, Jinan, Shandong, Peoples R China.; Miao, W (corresponding author), Qilu Univ Technol, Sch Business Adm, Jinan, Shandong, Peoples R China.	zhangjianghua@sdu.edu.cn; Miao2015sd@glu.edu.cn	Zhang, Jianghua/AAL-4343-2021	Zhang, Jianghua/0000-0002-6734-3492	National Natural Science Foundation of China (NSFC) [71571111, 71201093]; Shandong Provincial Water Conservancy Research and Technology Extension Project [SDSLKY201604]; Independent Innovation Foundation of Shandong University; Fundamental Research Funds of Shandong University; Qilu Young Scholars of Shandong University; Tang Scholars of Shandong University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shandong Provincial Water Conservancy Research and Technology Extension Project; Independent Innovation Foundation of Shandong University; Fundamental Research Funds of Shandong University; Qilu Young Scholars of Shandong University; Tang Scholars of Shandong University	This paper was partially supported by the National Natural Science Foundation of China (NSFC) (Grant No. 71571111, 71201093), Shandong Provincial Water Conservancy Research and Technology Extension Project (Grant No. SDSLKY201604), and the Independent Innovation Foundation of Shandong University and the Fundamental Research Funds of Shandong University. The authors also would like to thank the Qilu Young Scholars and Tang Scholars of Shandong University for financial and technical support.	Alfredsson P, 1999, MANAGE SCI, V45, P1416, DOI 10.1287/mnsc.45.10.1416; Balcik B, 2008, INT J LOGIST-RES APP, V11, P101, DOI 10.1080/13675560701561789; Balcik B, 2014, PROD OPER MANAG, V23, P1028, DOI 10.1111/poms.12098; Beamon B.M., 2006, INT J LOGIST-RES APP, V9, P1, DOI DOI 10.1080/13675560500453667; Campbell AM, 2011, EUR J OPER RES, V209, P156, DOI 10.1016/j.ejor.2010.08.029; Das R, 2014, EUR J OPER RES, V235, P616, DOI 10.1016/j.ejor.2013.12.042; Davis LB, 2013, INT J PROD ECON, V141, P561, DOI 10.1016/j.ijpe.2012.09.012; Dekle J, 2005, INTERFACES, V35, P133, DOI 10.1287/inte.1050.0127; Ertem MA, 2010, INT J PHYS DISTR LOG, V40, P202, DOI 10.1108/09600031011035092; Garrido RA, 2015, TRANSPORT RES E-LOG, V75, P18, DOI 10.1016/j.tre.2014.12.002; Lang TE, 2016, ADV OPER RES, V2016, DOI 10.1155/2016/1285406; Lee YH, 2007, INT J PROD ECON, V106, P115, DOI 10.1016/j.ijpe.2006.05.007; Mohammadi R, 2015, APPL MATH MODELLING; Ozbay K, 2007, TRANSP RES RECORD, P63, DOI 10.3141/2022-08; Ozguven EE, 2013, TRANSPORT RES C-EMER, V29, P171, DOI 10.1016/j.trc.2011.08.012; Perez-Rodriguez N, 2016, TRANSPORT SCI, V50, P1261, DOI 10.1287/trsc.2014.0565; Qiu BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139132; Rawls CG, 2010, TRANSPORT RES B-METH, V44, P521, DOI 10.1016/j.trb.2009.08.003; Sheu JB, 2007, TRANSPORT RES E-LOG, V43, P687, DOI 10.1016/j.tre.2006.04.004; Tagaras G, 2002, PROD OPER MANAG, V11, P183, DOI 10.1111/j.1937-5956.2002.tb00490.x; Taskin S, 2010, INT J PROD ECON, V126, P66, DOI 10.1016/j.ijpe.2009.10.008; TOREGAS C, 1971, OPER RES, V19, P1363, DOI 10.1287/opre.19.6.1363; Ukkusuri SV, 2008, TRANSPORT RES REC, P18, DOI 10.3141/2089-03; Wang J, 2009, OPT EXPRESS, V17, P10573, DOI 10.1364/OE.17.010573; Widener MJ, 2011, J TRANSP GEOGR, V19, P821, DOI 10.1016/j.jtrangeo.2010.10.006	25	7	8	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186747	10.1371/journal.pone.0186747	http://dx.doi.org/10.1371/journal.pone.0186747			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077722	Green Submitted, gold, Green Published			2022-12-27	WOS:000413861200020
J	Miliu, A; Lebrun, M; Braun-Breton, C; Lamarque, MH				Miliu, Alexandra; Lebrun, Maryse; Braun-Breton, Catherine; Lamarque, Mauld H.			Shelph2, a bacterial-like phosphatase of the malaria parasite Plasmodium falciparum, is dispensable during asexual blood stage	PLOS ONE			English	Article							PROTEIN-KINASE; CELL INVASION; TYROSINE; PHOSPHORYLATION; EGRESS; CYCLE	During the erythrocytic cycle of the malaria parasite Plasmodium falciparum, egress and invasion are essential steps finely controlled by reversible phosphorylation. In contrast to the growing number of kinases identified as key regulators, phosphatases have been poorly studied, and calcineurin is the only one identified so far to play a role in invasion. PfShelph2, a bacterial-like phosphatase, is a promising candidate to participate in the invasion process, as it was reported to be expressed late during the asexual blood stage and to reside within an apical compartment, yet distinct from rhoptry bulb, micronemes, or dense granules. It was also proposed to play a role in the control of the red blood cell membrane deformability at the end of the invasion process. However, genetic studies are still lacking to support this hypothesis. Here, we take advantage of the CRISPR-Cas9 technology to tag shelph2 genomic locus while retaining its endogenous regulatory regions. This new strain allows us to follow the endogenous PfShelph2 protein expression and location during asexual blood stages. We show that PfShelph2 apical location is also distinct from the rhoptry neck or exonemes. We further demonstrate PfShelph2 dispensability during the asexual blood stage by generating PfShelph2-KO parasites using CRISPR-Cas9 machinery. Analyses of the mutant during the course of the erythrocytic development indicate that there are no detectable phenotypic consequences of Pfshelph2 genomic deletion. As this lack of phenotype might be due to functional redundancy, we also explore the likelihood of PfShelph1 (PfShelph2 paralog) being a compensatory phosphatase. We conclude that despite its cyclic expression profile, PfShelph2 is a dispensable phosphatase during the Plasmodium falciparum asexual blood stage, whose function is unlikely substituted by PfShelph1.	[Miliu, Alexandra; Lebrun, Maryse; Braun-Breton, Catherine; Lamarque, Mauld H.] Univ Montpellier, CNRS, DIMNP, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Lamarque, MH (corresponding author), Univ Montpellier, CNRS, DIMNP, Montpellier, France.	mauld.lamarque@umontpellier.fr	Lebrun, Maryse/I-7728-2016	Lebrun, Maryse/0000-0002-0962-0156; Miliu, Alexandra/0000-0002-1363-8658	Laboratoire d'Excellence (LabEx) (ParaFrap) [ANR-11-LABX-0024, ANR-10-LABX-12-01]	Laboratoire d'Excellence (LabEx) (ParaFrap)	This research was supported by the Laboratoire d'Excellence (LabEx) (ParaFrap ANR-11-LABX-0024 and ANR-10-LABX-12-01)-ML and CBB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; Andreeva AV, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-47; Aniweh Y, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12747; [Anonymous], 2016, WORLD MALARIA REPORT; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Doerig C, 2009, PARASITE, V16, P169, DOI 10.1051/parasite/2009163169; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Fernandez-Pol S, 2013, EUKARYOT CELL, V12, P1179, DOI 10.1128/EC.00027-13; Ferru E, 2011, BLOOD, V117, P5998, DOI 10.1182/blood-2010-11-317024; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Guttery DS, 2014, CELL HOST MICROBE, V16, P128, DOI 10.1016/j.chom.2014.05.020; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hopp CS, 2012, MICROBES INFECT, V14, P831, DOI 10.1016/j.micinf.2012.04.011; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ito D, 2011, PARASITOL INT, V60, P132, DOI 10.1016/j.parint.2011.01.001; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Koch M, 2017, P NATL ACAD SCI USA, V114, P4225, DOI 10.1073/pnas.1620843114; Kutuzov MA, 2012, FUNCT INTEGR GENOMIC, V12, P11, DOI 10.1007/s10142-011-0254-z; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Pantaleo A, 2010, PROTEOMICS, V10, P3469, DOI 10.1002/pmic.201000269; Pantaleo A, 2010, J PROTEOMICS, V73, P445, DOI 10.1016/j.jprot.2009.08.011; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; Paul AS, 2015, CELL HOST MICROBE, V18, P49, DOI 10.1016/j.chom.2015.06.003; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; ROGER N, 1988, MOL BIOCHEM PARASIT, V27, P135, DOI 10.1016/0166-6851(88)90033-3; Santos JM, 2017, CELL HOST MICROBE, V21, P731, DOI 10.1016/j.chom.2017.05.006; SAUL A, 1982, B WORLD HEALTH ORGAN, V60, P755; Sisquella X, 2017, ELIFE, V6, DOI [10.7554/eLife.21083, 10.7554/elife.21083]; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Tsuruta H, 1999, J BIOCHEM-TOKYO, V125, P690, DOI 10.1093/oxfordjournals.jbchem.a022338; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhao X, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-490; Zuccala ES, 2016, SCI REP-UK, V6, DOI 10.1038/srep19766	47	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187073	10.1371/journal.pone.0187073	http://dx.doi.org/10.1371/journal.pone.0187073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073264	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400108
J	Ramirez-Briones, E; Rodriguez-Macias, R; Salcedo-Perez, E; Martinez-Gallardo, N; Tiessen, A; Molina-Torres, J; Delano-Frier, JP; Zanudo-Hernandez, J				Ramirez-Briones, Ernesto; Rodriguez-Macias, Ramon; Salcedo-Perez, Eduardo; Martinez-Gallardo, Norma; Tiessen, Axel; Molina-Torres, Jorge; Delano-Frier, John P.; Zanudo-Hernandez, Julia			Seasonal variation in non-structural carbohydrates, sucrolytic activity and secondary metabolites in deciduous and perennial Diospyros species sampled in Western Mexico	PLOS ONE			English	Article							SUCROSE-PHOSPHATE SYNTHASE; TEMPERATE FOREST; STARCH SYNTHESIS; LEAF-AREA; PHOTOSYNTHESIS; LEAVES; TREES; L.; STORAGE; PLANTS	This study was performed to test the working hypothesis that the primary determinants influencing seasonal driven modifications in carbon mobilization and other key biochemical parameters in leaves of poorly known Diospyros digyna (Ddg; semi-domesticated; perennial) and D. rekoi (Dre; undomesticated; deciduous) trees are determined by environmental growing conditions, agronomic management and physiological plasticity. Thus, biochemical changes in leaves of both trees were recorded seasonally during two successive fruiting years. Trees were randomly sampled in Western Mexico habitats with differing soil quality, climatic conditions, luminosity, and cultivation practices. Leaves of Ddg had consistently higher total chlorophyll contents (C-T) that, unexpectedly, peaked in the winter of 2015. In Dre, the highest leaf C-T values recorded in the summer of 2015 inversely correlated with low average luminosity and high Chl a/Chlb ratios. The seasonal C-T variations in Dre were congruent with varying luminosity, whereas those in Ddg were probably affected by other factors, such as fluctuating leaf protein contents and the funneling of light energy to foliar nonstructural carbohydrates (NSCs) accumulation, which were consistently higher than those detected in Dre leaves. Seasonal foliar NSC fluctuations in both species were in agreement with the carbon (C) demands of flowering, fruiting and/or leaf regrowth. Seasonal changes in foliar hexose to sucrose (Hex/Suc) ratios coincided with cell wall invertase activity in both species. In Dre, high Hex/Suc ratios in spring leaves possibly allowed an accumulation of phenolic acids, not observed in Ddg. The above results supported the hypothesis proposed by showing that leaf responses to changing environmental conditions differ in perennial and deciduous Diospyros trees, including a dynamic adjustment of NSCs to supply the C demands imposed by reproduction, leaf regrowth and, possibly, stress.	[Ramirez-Briones, Ernesto; Rodriguez-Macias, Ramon; Zanudo-Hernandez, Julia] Ctr Univ Ciencias Biol & Agr, Camino Ing La Venta Astillero, Zapopan, Jalisco, Mexico; [Salcedo-Perez, Eduardo] Ctr Univ Ciencias Exactas & Ingn, Camino Ing La Venta Astillero, Zapopan, Jalisco, Mexico; [Martinez-Gallardo, Norma; Tiessen, Axel; Molina-Torres, Jorge; Delano-Frier, John P.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Irapuato, Libramiento Norte Carretera Irapuato Leon Kilomet, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Zanudo-Hernandez, J (corresponding author), Ctr Univ Ciencias Biol & Agr, Camino Ing La Venta Astillero, Zapopan, Jalisco, Mexico.; Delano-Frier, JP (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Irapuato, Libramiento Norte Carretera Irapuato Leon Kilomet, Guanajuato, Mexico.	jdelano@ira.cinvestav.mx; zhj27487@cucba.udg.mx	Délano-Frier, John/B-5768-2015; Hernández, Julia Zañudo/ABB-8655-2021; Tiessen, Axel/AAF-2113-2020; Torres, Jorge Molina/B-9325-2019; Rodríguez, Ramón/W-9275-2019; Tiessen, Axel/D-5959-2011	Tiessen, Axel/0000-0001-5572-4274; Tiessen, Axel/0000-0001-5572-4274; Molina Torres, Jorge/0000-0003-2371-0307; Ramirez-Briones, Ernesto/0000-0002-1428-2542	National Council for Science and Technology (Conacyt, Mexico) [212253]	National Council for Science and Technology (Conacyt, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the National Council for Science and Technology (Conacyt, Mexico) granted a postgraduate scholarship to ERB (code No. 212253). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Acknowledgment is due to The National Council for Science and Technology (Conacyt, Mexico) for the postgraduate scholarship granted to ERB (code No. 212253).	AKAO S, 1981, J JPN SOC HORTIC SCI, V50, P1, DOI 10.2503/jjshs.50.1; [Anonymous], [No title captured]; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bazot S, 2013, TREES-STRUCT FUNCT, V27, P1023, DOI 10.1007/s00468-013-0853-5; BLACK CC, 1987, PHYSIOL PLANTARUM, V69, P387, DOI 10.1111/j.1399-3054.1987.tb04305.x; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUINSMA J, 1961, BIOCHIM BIOPHYS ACTA, V52, P576, DOI 10.1016/0006-3002(61)90418-8; Brunetti C, 2013, INT J MOL SCI, V14, P3540, DOI 10.3390/ijms14023540; Cabrera HM, 2002, REV CHIL HIST NAT, V75, P625; Cao KF, 2000, CAN J BOT, V78, P1245, DOI 10.1139/cjb-78-10-1245; Carvalho S, 2014, PHYTOCHEMISTRY, V99, P86, DOI 10.1016/j.phytochem.2013.12.004; Chang XM, 2008, ENVIRON EXP BOT, V63, P216, DOI 10.1016/j.envexpbot.2007.10.017; Chen T, 2012, ACTA PHYSIOL PLANT, V34, P173, DOI 10.1007/s11738-011-0815-8; Da Silva D, 2014, ANN BOT-LONDON, V114, P643, DOI 10.1093/aob/mcu033; Danyagri G, 2014, ENVIRON EXP BOT, V107, P64, DOI 10.1016/j.envexpbot.2014.05.010; DUGGER W. M. JR., 1969, Proceedings 1st int. Citrus Symp., Univ. California, Riverside 1968., V1, P339; Fajardo A, 2013, ANN BOT-LONDON, V112, P623, DOI 10.1093/aob/mct127; Feng YL, 2008, PHYSIOL PLANTARUM, V133, P318, DOI 10.1111/j.1399-3054.2008.01072.x; García Díaz Roger, 2015, Rev. Mex. Cienc. Agríc, V6, P187; GarciaPlazaola JI, 1997, J EXP BOT, V48, P1667, DOI 10.1093/jexbot/48.314.1667; Geigenberger P, 1998, PLANTA, V205, P428, DOI 10.1007/s004250050340; Ghasemzadeh A, 2010, INT J MOL SCI, V11, P3885, DOI 10.3390/ijms11103885; Goldschmidt EE, 1977, CITRUS FLOWERING FRU, P63; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Gond V, 1999, TREE PHYSIOL, V19, P673; Gough CM, 2010, FORESTS, V1, P65, DOI 10.3390/f1010065; Grant RH, 1997, INT J BIOMETEOROL, V40, P26, DOI 10.1007/s004840050014; Hallik L, 2012, PLANT BIOLOGY, V14, P88, DOI 10.1111/j.1438-8677.2011.00472.x; Hartmann T, 2000, J EXP BOT, V51, P1077, DOI 10.1093/jexbot/51.347.1077; Hauch S, 1998, PLANTA, V207, P266, DOI 10.1007/s004250050482; Hoch G, 2003, PLANT CELL ENVIRON, V26, P1067, DOI 10.1046/j.0016-8025.2003.01032.x; Ibrahim MH, 2012, INT J MOL SCI, V13, P15321, DOI 10.3390/ijms131115321; Jackson J. E., 1980, Horticultural Reviews, V2, P208; Kalberer SR, 2006, PLANT SCI, V171, P3, DOI 10.1016/j.plantsci.2006.02.013; Kerner R, 2014, J PROTEOMICS, V109, P417, DOI 10.1016/j.jprot.2014.05.021; Kitajima K, 2003, PLANT CELL ENVIRON, V26, P857, DOI 10.1046/j.1365-3040.2003.01017.x; Komatsu A, 2002, J EXP BOT, V53, P61, DOI 10.1093/jexbot/53.366.61; Kong DX, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2147-1; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kull O, 1998, FUNCT ECOL, V12, P472, DOI 10.1046/j.1365-2435.1998.00214.x; Li N, 2016, ECOL INDIC, V62, P22, DOI 10.1016/j.ecolind.2015.11.017; LOESCHER WH, 1990, HORTSCIENCE, V25, P274, DOI 10.21273/HORTSCI.25.3.274; Ma ZQ, 2010, HORTSCIENCE, V45, P863, DOI 10.21273/HORTSCI.45.6.863; Marra FP, 2009, TREE PHYSIOL, V29, P1095, DOI 10.1093/treephys/tpp053; Palacio S, 2007, ENVIRON EXP BOT, V59, P34, DOI 10.1016/j.envexpbot.2005.10.003; Percival D, 2012, CAN J PLANT SCI, V92, P1135, DOI [10.4141/CJPS2011-205, 10.4141/cjps2011-205]; Pimienta-Barrios E, 2005, ANN BOT-LONDON, V95, P363, DOI 10.1093/aob/mci034; Proietti P., 1990, Acta Horticulturae, P215; Reig C, 2015, J PLANT PHYSIOL, V177, P51, DOI 10.1016/j.jplph.2014.12.016; Reig C, 2013, J PLANT GROWTH REGUL, V32, P281, DOI 10.1007/s00344-012-9296-2; RYUGO KAY, 1959, PROC AMER SOC HORT SCI, V74, P130; Rzedowski J, 1991, ACTA BOT MEX, V14, P3, DOI [DOI 10.21829/ABM14.1991.611, 10.21829/abm14.1991.611]; SCHOLES JD, 1994, NEW PHYTOL, V126, P213, DOI 10.1111/j.1469-8137.1994.tb03939.x; Schrader S, 2002, J PLANT PHYSIOL, V159, P833, DOI 10.1078/0176-1617-00730; SEMARNAT, 2002, NOM021SEMARNAT200; SHIMIZU T, 1978, J JPN SOC HORTIC SCI, V46, P465, DOI 10.2503/jjshs.46.465; Tauzin AS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00293; Teo G, 2006, P NATL ACAD SCI USA, V103, P18842, DOI 10.1073/pnas.0605873103; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Vemmos SN, 2013, SCI HORTIC-AMSTERDAM, V160, P198, DOI 10.1016/j.scienta.2013.05.036; Wallnofer B., 2007, ANN NATHIST MUS B, V108, P207; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; Wright DP, 1998, PLANT CELL ENVIRON, V21, P209, DOI 10.1046/j.1365-3040.1998.00280.x; Wyka TP, 2016, TREE PHYSIOL, V36, P536, DOI 10.1093/treephys/tpv108; Xiao XH, 2014, FEBS J, V281, P291, DOI 10.1111/febs.12595; Zhang HY, 2014, TREES-STRUCT FUNCT, V28, P77, DOI 10.1007/s00468-013-0931-8; Zhang S, 2015, J PROTEOMICS, V126, P263, DOI 10.1016/j.jprot.2015.06.019; Zhou R, 2003, J AM SOC HORTIC SCI, V128, P113, DOI 10.21273/JASHS.128.1.0113	70	9	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e018723	10.1371/journal.pone.0187235	http://dx.doi.org/10.1371/journal.pone.0187235			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073239	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400135
J	Mwesigwa, J; Achan, J; Di Tanna, GL; Affara, M; Jawara, M; Worwui, A; Hamid-Adiamoh, M; Kanuteh, F; Ceesay, S; Bousema, T; Drakeley, C; Grietens, KP; Lindsay, SW; Van Geertruyden, JP; D'Alessandro, U				Mwesigwa, Julia; Achan, Jane; Di Tanna, Gian Luca; Affara, Muna; Jawara, Musa; Worwui, Archibald; Hamid-Adiamoh, Majidah; Kanuteh, Fatoumatta; Ceesay, Sainey; Bousema, Teun; Drakeley, Chris; Grietens, Koen Peeters; Lindsay, Steve W.; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto			Residual malaria transmission dynamics varies across The Gambia despite high coverage of control interventions	PLOS ONE			English	Article							REAL-TIME PCR; PLASMODIUM-FALCIPARUM; ANOPHELES-GAMBIAE; INSECTICIDE RESISTANCE; PARASITEMIA; DENSITY; IMPACT; INFECTIVITY; CARRIAGE; PATTERNS	Over the last decades, malaria has declined substantially in The Gambia but its transmission has not been interrupted. In order to better target control interventions, it is essential to understand the dynamics of residual transmission. This prospective cohort study was conducted between June 2013 and April 2014 in six pairs of villages across The Gambia. Blood samples were collected monthly during the transmission season (June-December) from all residents aged >6 months (4,194 individuals) and then in April (dry season). Entomological data were collected monthly throughout the malaria transmission season. Ownership of Long-Lasting Insecticidal Nets was 71.5% (2766/3869). Incidence of malaria infection and clinical disease varied significantly across the country, with the highest values in eastern (1.7/PYAR) than in central (0.2/PYAR) and western (0.1/PYAR) Gambia. Malaria infection at the beginning of the transmission season was significantly higher in individuals who slept outdoors (HR = 1.51, 95% Cl: 1.02-2.23, p = 0.04) and in those who had travelled outside the village (HR = 2.47, 95% Cl: 1.83-3.34, p<0.01). Sub-patent infections were more common in older children (HR = 1.35, 95% Cl: 1.04-1.6, p<0.01) and adults (HR = 1.53, 95% Cl: 1.23-1.89, p<0.01) than in younger children. The risk of clinical malaria was significantly higher in households with at least one infected individual at the beginning of the transmission season (HR = 1.76, p<0.01). Vector parity was significantly higher in the eastern part of the country, both in the south (90.7%, 117/129, p<0.01) and the north bank (81.1%, 227/280, p<0.01), than in the western region (41.2%, 341/826), indicating higher vector survival. There is still significant residual malaria transmission across The Gambia, particularly in the eastern region. Additional interventions able to target vectors escaping Long-Lasting Insecticidal Nets and indoor residual spraying are needed to achieve malaria elimination.	[Mwesigwa, Julia; Achan, Jane; Affara, Muna; Jawara, Musa; Worwui, Archibald; Kanuteh, Fatoumatta; Ceesay, Sainey; D'Alessandro, Umberto] Med Res Council Unit Gambia, Banjul, Gambia; [Mwesigwa, Julia; Van Geertruyden, Jean-Pierre] Univ Antwerp, Fac Med & Hlth Sci, Dept Global Hlth, Antwerp, Belgium; [Di Tanna, Gian Luca] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England; [Hamid-Adiamoh, Majidah] Univ Ghana, Dept Biochem Cell & Mol Biol, West African Ctr Cell Biol Infect Pathogens, Accra, Ghana; [Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Drakeley, Chris; D'Alessandro, Umberto] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Grietens, Koen Peeters] Univ Amsterdam, Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	University of London; London School of Hygiene & Tropical Medicine; University of Antwerp; University of London; Queen Mary University London; University of Ghana; Radboud University Nijmegen; University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM); University of Amsterdam; Nagasaki University; Durham University	D'Alessandro, U (corresponding author), Med Res Council Unit Gambia, Banjul, Gambia.; D'Alessandro, U (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	udalessandro@mrc.gm	Bousema, Teun/N-3574-2014; Peeters Grietens, Koen/G-7028-2019; Van geertruyden, Jean-Pierre/K-6425-2014; Di Tanna, Gian Luca/AAF-2352-2019; Van geertruyden, Jean-Pierre/S-3254-2019	Bousema, Teun/0000-0003-2666-094X; Peeters Grietens, Koen/0000-0001-6570-9887; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Di Tanna, Gian Luca/0000-0002-5470-3567; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Mwesigwa, Julia/0000-0003-2452-3677; Lindsay, Steve/0000-0002-3461-9050	UK Medical Research Council (MRC); UK Department for International Development (DFID) under MRC/DFID Concordat [MC_EX_MR/J002364/1]; Medical Research Council [MR/J002364/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under MRC/DFID Concordat(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is funded The UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement. Grant number MC_EX_MR/J002364/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyasingha RR, 2017, GUIDELINES ENTOMOLOG; [Anonymous], 2011, HAEM CONC DIAGN AN A; Babiker HA, 2013, DRUG RESIST UPDATE, V16, P1, DOI 10.1016/j.drup.2013.02.001; Bejon P, 2014, ELIFE, V3, DOI 10.7554/eLife.02130; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Betson M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-187; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014114; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Ceesay S, 2017, DETECTION PLASMODIUM; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, CONTINUED DECLINE MA; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Cucunuba ZM, 2008, MEM I OSWALDO CRUZ, V103, P668, DOI 10.1590/S0074-02762008000700007; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Gnanguenon V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-444; Hamad AA, 2000, PARASITOLOGY, V120, P447, DOI 10.1017/S0031182099005818; IYENGAR R, 1962, B WORLD HEALTH ORGAN, V27, P223; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kleinschmidt I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0782-4; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Lindblade KA, 2006, J MED ENTOMOL, V43, P428, DOI 10.1093/jmedent/43.2.428; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; LINDSAY SW, 1993, T ROY SOC TROP MED H, V87, P45, DOI 10.1016/0035-9203(93)90175-P; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; Nourein AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016948; Nwakanma D, 2008, INT J PARASITOL, V38, P219, DOI 10.1016/j.ijpara.2007.07.003; Okebe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110926; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Opondo KO, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1203-z; Ototo EN, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0763-7; Ouedraogo AL, 2015, CLIN INFECT DIS, V60, P357, DOI 10.1093/cid/ciu797; Quinones ML, 1997, MED VET ENTOMOL, V11, P71, DOI 10.1111/j.1365-2915.1997.tb00292.x; Republic of The Gambia, 2014, GAMB NAT HLTH STRAT; RepublicofTheGambia, 2009, MALCONTR GAMB STRAT; RepublicofTheGambia, 2009, MAL CONTR GAMB START; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Sissoko MS, 2015, AM J TROP MED HYG, V93, P790, DOI 10.4269/ajtmh.14-0765; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351; Thomson M, 1996, SOC SCI MED, V43, P101, DOI 10.1016/0277-9536(95)00346-0; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X; van Eijk AM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1120-1; Walldorf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134061; White G B, 1969, BLOOD FEEDING HABITS; WHO, 2016, WORLD MAL REP 2016; WIRTZ RA, 1987, J MED ENTOMOL, V24, P433, DOI 10.1093/jmedent/24.4.433; World Health Organization, 2014, CONTR RES MAL PAR TR	58	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187059	10.1371/journal.pone.0187059	http://dx.doi.org/10.1371/journal.pone.0187059			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095834	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000414340200041
J	Yang, D; Krois, CR; Huang, P; Wang, JS; Min, J; Yoo, HS; Deng, YH; Napoli, JL				Yang, Di; Krois, Charles R.; Huang, Priscilla; Wang, Jinshan; Min, Jin; Yoo, Hong Sik; Deng, Yinghua; Napoli, Joseph L.			Raldh1 promotes adiposity during adolescence independently of retinal signaling	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1A1; DIET-INDUCED OBESITY; ACID RECEPTOR-ALPHA; VITAMIN-A; BINDING-PROTEIN; STEM-CELLS; ADIPOCYTE DIFFERENTIATION; ACTIVATED RECEPTOR; 3T3-F442A CELLS; 3T3-L1 CELLS	All-frans-retinoic acid (RA) inhibits adipogenesis in established preadipocyte cell lines. Dosing pharmacological amounts of RA reduces weight gain in mice fed a high-fat diet, i.e. counteracts diet-induced obesity (DIO). The aldehyde dehydrogenase Raldh1 (Aldhla1) functions as one of three enzymes that converts the retinol metabolite retinal into RA, and one of many proteins that contribute to RA homeostasis. Female Raldh1-ablated mice resist DIO. This phenotype contrasts with ablations of other enzymes and binding-proteins that maintain RA homeostasis, which gain adiposity. The phenotype observed prompted the conclusion that loss of Raldh1 causes an increase in adipose tissue retinal, and therefore, retinal functions independently of RA to prevent DIO. A second deduction proposed that low nM concentrations of RA stimulate adipogenesis, in contrast to higher concentrations. Using peer-reviewed LC/MS/MS assays developed and validated for quantifying tissue RA and retinal, we show that endogenous retinal and RA concentrations in adipose tissues from Raldh1-null mice do not correlate with the phenotype. Moreover, male Raldh1-null mice resist weight gain regardless of dietary fat content. Resistance to weight gain occurs during adolescence in both sexes. We show that RA concentrations as low as 1 nM, i.e. in the sub-physiological range, impair adipogenesis of embryonic fibroblasts from wild-type mice. Embryonic fibroblasts from Raldh1-null mice resist differentiating into adipocytes, but retain ability to generate RA. These fibroblasts remain sensitive to an RA receptor pan-agonist, and are not affected by an RA receptor pan-antagonist. Thus, the data do not support the hypothesis that retinal itself represses weight gain and adipogenesis independently of RA. Instead, the data indicate that Raldh1 functions as a retinal and atRA-independent promoter of adiposity during adolescence, and enhances adiposity through pre-adipocyte cell autonomous actions.	[Yang, Di; Krois, Charles R.; Huang, Priscilla; Wang, Jinshan; Min, Jin; Yoo, Hong Sik; Deng, Yinghua; Napoli, Joseph L.] Univ Calif Berkeley, Grad Program Metab Biol Nutrit Sci & Toxicol, Berkeley, CA 94720 USA; [Krois, Charles R.] Minnesota State Univ, Mankato, MN USA; [Huang, Priscilla] Midwestern Univ, Arizona Coll Osteopath Med, Glendale, AZ USA; [Wang, Jinshan] Bayer Pharmaceut, Berkeley, CA USA; [Min, Jin] Nova Southeastern Univ, Coll Osteopath Med, Oakland, CA USA; [Deng, Yinghua] Hubei Univ Educ, Wuhan, Hubei, Peoples R China	University of California System; University of California Berkeley; Minnesota State Colleges & Universities; Minnesota State University Mankato; Midwestern University; Bayer AG; Bayer Healthcare Pharmaceuticals; Nova Southeastern University; Hubei University Education	Napoli, JL (corresponding author), Univ Calif Berkeley, Grad Program Metab Biol Nutrit Sci & Toxicol, Berkeley, CA 94720 USA.	jna@berkeley.edu	Yoo, Hong Sik/HDN-7624-2022	Napoli, Joseph/0000-0003-3223-4752	National Institutes of Health USA [DK30875, AA30888, DK102014]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112754, R01DK102014] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health USA, DK30875, JLN; National Institutes of Health USA, AA30888, JLN; National Institutes of Health USA, DK102014, JLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2014, MOL CELL BIOL, V34, P3076, DOI 10.1128/MCB.00185-14; Arnold SLM, 2015, BIOCHEM PHARMACOL, V95, P177, DOI 10.1016/j.bcp.2015.03.001; Bateman OA, 2003, BIOCHEMISTRY-US, V42, P4349, DOI 10.1021/bi027367w; Berry DC, 2012, DIABETES, V61, P1112, DOI 10.2337/db11-1620; Berry DC, 2010, J BIOL CHEM, V285, P15324, DOI 10.1074/jbc.M110.110635; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Dawson M. I., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P199, DOI 10.2174/1568011043352975; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; Everts HB, 2013, J INVEST DERMATOL, V133, P325, DOI 10.1038/jid.2012.393; Green AC, 2017, EXP CELL RES, V350, P284, DOI 10.1016/j.yexcr.2016.12.007; Grunblatt E, 2016, J NEURAL TRANSM, V123, P83, DOI 10.1007/s00702-014-1320-1; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hisada K, 2013, J BONE MINER METAB, V31, P53, DOI 10.1007/s00774-012-0385-x; Jette C, 2004, J BIOL CHEM, V279, P34397, DOI 10.1074/jbc.M314021200; Jeyakumar SM, 2006, OBESITY, V14, P52, DOI 10.1038/oby.2006.7; KAMEI Y, 1994, LIFE SCI, V55, pPL307, DOI 10.1016/0024-3205(94)90073-6; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kedishvili Natalia Y, 2016, Subcell Biochem, V81, P127; Kent T, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.131458; Kim JI, 2015, SCIENCE, V350, P102, DOI 10.1126/science.aac4690; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; Lin SC, 2010, P NATL ACAD SCI USA, V107, P9234, DOI 10.1073/pnas.0910430107; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; MCCAMMON DK, 1993, MOL CELL ENDOCRINOL, V91, P177, DOI 10.1016/0303-7207(93)90270-T; McLaren DS, 2012, WORLD REV NUTR DIET, V103, P33; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Moreb JS, 2008, CURR STEM CELL RES T, V3, P237, DOI 10.2174/157488808786734006; Muccio DD, 1996, J MED CHEM, V39, P3625, DOI 10.1021/jm9603126; Muenzner M, 2013, MOL CELL BIOL, V33, P4068, DOI 10.1128/MCB.00221-13; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Noy N, 2013, ADIPOCYTE, V2, P184, DOI 10.4161/adip.23489; Obrochta KM, 2015, J BIOL CHEM, V290, P7259, DOI 10.1074/jbc.M114.609313; Obrochta KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099435; PAIRAULT J, 1987, J CELL PHYSIOL, V132, P279, DOI 10.1002/jcp.1041320212; Penzes P, 1997, BBA-PROTEIN STRUCT M, V1342, P175, DOI 10.1016/S0167-4838(97)00102-7; PEREIRA F, 1991, BIOCHEM BIOPH RES CO, V175, P831, DOI 10.1016/0006-291X(91)91640-X; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Reeves PG, 1997, J NUTR, V127, pS838; Reichert B, 2011, MOL ENDOCRINOL, V25, P799, DOI 10.1210/me.2010-0465; Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Romeo RD, 2016, NEUROSCI BIOBEHAV R, V70, P206, DOI 10.1016/j.neubiorev.2016.05.020; ROSS AC, 1994, ADV EXP MED BIOL, V352, P187; SAFONOVA I, 1994, MOL CELL ENDOCRINOL, V104, P201, DOI 10.1016/0303-7207(94)90123-6; SATO M, 1980, BIOCHEM BIOPH RES CO, V95, P1839, DOI 10.1016/S0006-291X(80)80113-6; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Sladek NE, 1999, CURR PHARM DESIGN, V5, P607; SOPRANO DR, 1995, ANNU REV NUTR, V15, P111, DOI 10.1146/annurev.nu.15.070195.000551; SOPRANO DR, 1993, TOXICOL APPL PHARM, V122, P159, DOI 10.1006/taap.1993.1183; STONE RL, 1990, DIFFERENTIATION, V45, P119, DOI 10.1111/j.1432-0436.1990.tb00465.x; Sun SY, 2000, J BIOL CHEM, V275, P17149, DOI 10.1074/jbc.M000527200; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Wang C, 2011, J BIOL CHEM, V286, P6542, DOI 10.1074/jbc.M110.198382; Wang JS, 2015, ANAL BIOCHEM, V484, P162, DOI 10.1016/j.ab.2015.05.016; WILLHITE CC, 1984, TOXICOL APPL PHARM, V74, P397, DOI 10.1016/0041-008X(84)90293-X; YOSHIDA A, 1993, ADV EXP MED BIOL, V328, P37; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	66	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187669	10.1371/journal.pone.0187669	http://dx.doi.org/10.1371/journal.pone.0187669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095919	gold, Green Submitted, Green Published			2022-12-27	WOS:000414340200127
J	Gonias, SL; Karimi-Mostowfi, N; Murray, SS; Mantuano, E; Gilder, AS				Gonias, Steven L.; Karimi-Mostowfi, Nicki; Murray, Sarah S.; Mantuano, Elisabetta; Gilder, Andrew S.			Expression of LDL receptor-related proteins (LRPs) in common solid malignancies correlates with patient survival	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; MYELIN-ASSOCIATED GLYCOPROTEIN; SCAVENGER RECEPTORS; CANCER GENOMICS; BETA-CATENIN; MEGALIN; TUMORIGENESIS; PROGRESSION; ASSOCIATION; METASTASIS	LDL receptor-related proteins (LRPs) are transmembrane receptors involved in endocytosis, cell-signaling, and trafficking of other cellular proteins. Considerable work has focused on LRPs in the fields of vascular biology and neurobiology. How these receptors affect cancer progression in humans remains largely unknown. Herein, we mined provisional data-bases in The Cancer Genome Atlas (TCGA) to compare expression of thirteen LRPs in ten common solid malignancies in patients. Our first goal was to determine the abundance of LRP mRNAs in each type of cancer. Our second goal was to determine whether expression of LRPs is associated with improved or worsened patient survival. In total, data from 4,629 patients were mined. In nine of ten cancers studied, the most abundantly expressed LRP was LRP1; however, a correlation between LRP1 mRNA expression and patient survival was observed only in bladder urothelial carcinoma. In this malignancy, high levels of LRP1 mRNA were associated with worsened patient survival. High levels of LDL receptor (LDLR) mRNA were associated with decreased patient survival in pancreatic adenocarcinoma. High levels of LRP10 mRNA were associated with decreased patient survival in hepatocellular carcinoma, lung adenocarcinoma, and pancreatic adenocarcinoma. LRP2 was the only LRP for which high levels of mRNA expression correlated with improved patient survival. This correlation was observed in renal clear cell carcinoma. Insights into LRP gene expression in human cancers and their effects on patient survival should guide future research.	[Gonias, Steven L.; Karimi-Mostowfi, Nicki; Murray, Sarah S.; Mantuano, Elisabetta; Gilder, Andrew S.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Mantuano, Elisabetta] Sapienza Univ Rome, Dept Expt Med, Rome, Italy	University of California System; University of California San Diego; Sapienza University Rome	Gonias, SL (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	sgonias@ucsd.edu			NIH [R01 HL136395]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by NIH grant R01 HL136395 to Steven L Gonias. The sponsor had no role in the study design, collection and analysis of data, or the decision to publish.	Andersen RK, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12352; Auderset L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2108495; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Boucher R, 2008, HISTOCHEM CELL BIOL, V130, P315, DOI 10.1007/s00418-008-0436-5; Brodeur J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-31; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen S, 2007, J CELL SCI, V120, P4009, DOI 10.1242/jcs.013946; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ge S, 2017, AM J CANCER RES, V7, P1540; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Guillaumond F, 2015, P NATL ACAD SCI USA, V112, P2473, DOI 10.1073/pnas.1421601112; Hoang BH, 2004, INT J CANCER, V109, P106, DOI 10.1002/ijc.11677; Holt SK, 2008, CLIN CANCER RES, V14, P3823, DOI 10.1158/1078-0432.CCR-07-4566; Huang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044301; Jeong YH, 2010, BIOCHEM BIOPH RES CO, V392, P495, DOI 10.1016/j.bbrc.2010.01.049; Jeong YH, 2010, BIOCHEM BIOPH RES CO, V391, P1110, DOI 10.1016/j.bbrc.2009.12.033; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Lane-Donovan C, 2017, J LIPID RES, V58, P1036, DOI 10.1194/jlr.R075507; Lee JD, 2016, EXP THER MED, V12, P2974, DOI 10.3892/etm.2016.3722; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lindner I, 2010, CANCER RES, V70, P277, DOI 10.1158/0008-5472.CAN-09-1462; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Mantuano E, 2016, P NATL ACAD SCI USA, V113, P1369, DOI 10.1073/pnas.1515480113; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Montel V, 2007, CANCER RES, V67, P9817, DOI 10.1158/0008-5472.CAN-07-0683; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; Ren DN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7906; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Schuetz AN, 2005, J MOL DIAGN, V7, P206, DOI 10.1016/S1525-1578(10)60547-8; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Sugiyama T, 2000, BIOCHEMISTRY-US, V39, P15817, DOI 10.1021/bi001583s; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Van Gool B, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00271; Vasseur S, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1033586; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126	50	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186649	10.1371/journal.pone.0186649	http://dx.doi.org/10.1371/journal.pone.0186649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088295	Green Submitted, gold, Green Published			2022-12-27	WOS:000414088900019
J	Grasso, G; Deriu, MA; Patrulea, V; Borchard, G; Moller, M; Danani, A				Grasso, Gianvito; Deriu, Marco Agostino; Patrulea, Viorica; Borchard, Gerrit; Moller, Michael; Danani, Andrea			Free energy landscape of siRNA-polycation complexation: Elucidating the effect of molecular geometry, polymer flexibility, and charge neutralization	PLOS ONE			English	Article							DYNAMICS SIMULATIONS; GENE DELIVERY; IN-VIVO; DNA; EXCHANGE; PROTEIN; BINDING; POLY(ETHYLENIMINE); POLYETHYLENIMINE; METADYNAMICS	The success of medical threatments with DNA and silencing interference RNA is strongly related to the design of efficient delivery technologies. Cationic polymers represent an attractive strategy to serve as nucleic-acid carriers with the envisioned advantages of efficient complexation, low cost, ease of production, well-defined size, and low polydispersity index. However, the balance between efficacy and toxicity (safety) of these polymers is a challenge and in need of improvement. With the aim of designing more effective polycationic-based gene carriers, many parameters such as carrier morphology, size, molecular weight, surface chemistry, and flexibility/rigidity ratio need to be taken into consideration. In the present work, the binding mechanism of three cationic polymers (polyarginine, polylysine and polyethyleneimine) to a model siRNA target is computationally investigated at the atomistic level. In order to better understand the polycationic carrier-siRNA interactions, replica exchange molecular dynamic simulations were carried out to provide an exhaustive exploration of all the possible binding sites, taking fully into account the siRNA flexibility together with the presence of explicit solvent and ions. Moreover, well-tempered metadynamics simulations were employed to elucidate how molecular geometry, polycation flexibility, and charge neutralization affect the siRNA-polycations free energy landscape in term of low-energy binding modes and unbinding free energy barriers. Significant differences among polymer binding modes have been detected, revealing the advantageous binding properties of polyarginine and polylysine compared to polyethyleneimine.	[Grasso, Gianvito; Deriu, Marco Agostino; Danani, Andrea] USI, Ist Dalle Molle Studi Sull Intelligenza Artificia, SUPSI, Ctr Galleria 2, Manno, Switzerland; [Patrulea, Viorica; Borchard, Gerrit; Moller, Michael] Univ Geneva, Sch Pharmaceut Sci, Rue Michel Servet 1, Geneva, Switzerland	Universita della Svizzera Italiana; University of Geneva	Danani, A (corresponding author), USI, Ist Dalle Molle Studi Sull Intelligenza Artificia, SUPSI, Ctr Galleria 2, Manno, Switzerland.	andrea.danani@idsia.ch	Patrulea, Viorica/AFM-9063-2022; Deriu, Marco Agostino Agostino/GPW-8179-2022; Patrulea, Viorica/P-4334-2019	Deriu, Marco Agostino Agostino/0000-0003-1918-1772; Patrulea, Viorica/0000-0003-3906-2041; Danani, Andrea/0000-0001-6578-5089; Grasso, Gianvito/0000-0002-7761-222X	Swiss National Foundation [200021_157033]; Swiss National Supercomputing Centre (CSCS)	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss National Supercomputing Centre (CSCS)	This work was supported by the Swiss National Foundation project "Novel micellar drug carrier systems for gene therapies" (project ID 200021_157033). This work was also supported by the Swiss National Supercomputing Centre (CSCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshamsan A, 2009, MOL PHARMACEUT, V6, P121, DOI 10.1021/mp8000815; [Anonymous], 2010, BIOPHYS J, V99, P201; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker NA, 2004, POISSON BOLTZMANN ME, P94, DOI [10.1016/S0076-6879(04)83005-2, DOI 10.1016/S0076-6879(04)83005-2]; Baptista AM, 2002, J CHEM PHYS, V117, P4184, DOI 10.1063/1.1497164; Barducci A, 2011, WIRES COMPUT MOL SCI, V1, P826, DOI 10.1002/wcms.31; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bergonzo C, 2014, J CHEM THEORY COMPUT, V10, P492, DOI 10.1021/ct400862k; Bertschinger M, 2006, J CONTROL RELEASE, V116, P96, DOI 10.1016/j.jconrel.2006.09.006; Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen CY, 2011, BIOPHYS J, V101, P1139, DOI 10.1016/j.bpj.2011.07.016; Choosakoonkriang S, 2003, J PHARM SCI-US, V92, P1710, DOI 10.1002/jps.10437; Coletta A, 2013, NUCLEIC ACIDS RES, V41, P9977, DOI 10.1093/nar/gkt790; Denschlag R, 2009, CHEM PHYS LETT, V473, P193, DOI 10.1016/j.cplett.2009.03.053; Deriu MA, 2016, PROTEINS, V84, P666, DOI 10.1002/prot.25017; Deriu MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108677; DeRouchey J, 2013, BIOCHEMISTRY-US, V52, P3000, DOI 10.1021/bi4001408; Di Leva FS, 2014, NUCLEIC ACIDS RES, V42, P5447, DOI 10.1093/nar/gku247; Dlugosz M, 2004, CHEM PHYS, V302, P161, DOI 10.1016/j.chemphys.2004.03.031; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elder RM, 2011, BIOMACROMOLECULES, V12, P3870, DOI 10.1021/bm201113y; Furini S, 2014, J PHYS CHEM B, V118, P13059, DOI 10.1021/jp505885j; Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Granata D, 2013, P NATL ACAD SCI USA, V110, P6817, DOI 10.1073/pnas.1218350110; Grasso G, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-016-0173-y; Grasso G, 2016, PROTEINS, V84, P52, DOI 10.1002/prot.24954; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HUD NV, 1994, BIOCHEMISTRY-US, V33, P7528, DOI 10.1021/bi00190a005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jere D, 2009, EXPERT OPIN DRUG DEL, V6, P827, DOI 10.1517/17425240903029183; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khandogin J, 2005, BIOPHYS J, V89, P141, DOI 10.1529/biophysj.105.061341; Kondinskaia DA, 2016, J PHYS CHEM B, V120, P6546, DOI 10.1021/acs.jpcb.6b03779; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Lee J, 2014, J CHEM THEORY COMPUT, V10, P2738, DOI 10.1021/ct500175m; Lee MS, 2004, PROTEINS, V56, P738, DOI 10.1002/prot.20128; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lingenheil M, 2009, CHEM PHYS LETT, V478, P80, DOI 10.1016/j.cplett.2009.07.039; Liu X, 2014, NANOSCALE; Lu J, 2012, ACS NANO, V6, P944, DOI 10.1021/nn204536e; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Maiti PK, 2006, NANO LETT, V6, P2478, DOI 10.1021/nl061609m; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mongan J, 2005, CURR OPIN STRUC BIOL, V15, P157, DOI 10.1016/j.sbi.2005.02.002; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Mukherjee G, 2011, J COMPUT CHEM, V32, P893, DOI 10.1002/jcc.21671; Mullen PM, 2000, BBA-GEN SUBJECTS, V1523, P103, DOI 10.1016/S0304-4165(00)00104-5; Nagaya J, 1996, BIOPHYS CHEM, V60, P45, DOI 10.1016/0301-4622(95)00143-3; Navarro G, 2015, MOL PHARMACEUT, V12, P301, DOI 10.1021/mp5007213; Nguyen PH, 2005, PROTEINS, V61, P795, DOI 10.1002/prot.20696; Ouyang DF, 2010, J PHYS CHEM B, V114, P9220, DOI 10.1021/jp911906e; Pavan GM, 2012, CURR MED CHEM, V19, P4929; Pavan Giovanni M, 2011, Curr Drug Discov Technol, V8, P314; Pavan GM, 2011, RSC ADV, V1, P1677, DOI 10.1039/c1ra00472g; Pavan GM, 2010, BIOMACROMOLECULES, V11, P721, DOI 10.1021/bm901298t; Pavan GM, 2009, J AM CHEM SOC, V131, P9686, DOI 10.1021/ja901174k; Perez-Villa A, 2016, NUCLEIC ACIDS RES, V44, P2975, DOI 10.1093/nar/gkv1378; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; SUH J, 1994, BIOORG CHEM, V22, P318, DOI 10.1006/bioo.1994.1025; Sun CB, 2012, J PHYS CHEM B, V116, P2405, DOI 10.1021/jp211716v; Sun CB, 2011, BIOPHYS J, V100, P2754, DOI 10.1016/j.bpj.2011.04.045; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tomalia DA, 2010, SOFT MATTER, V6, P456, DOI 10.1039/b917370f; Toy R, 2014, NANOMEDICINE-UK, V9, P121, DOI 10.2217/nnm.13.191; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Vargiu AV, 2008, NUCLEIC ACIDS RES, V36, P5910, DOI 10.1093/nar/gkn561; Veiseh O, 2011, BIOMATERIALS, V32, P5717, DOI 10.1016/j.biomaterials.2011.04.039; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wiseman JW, 2003, GENE THER, V10, P1654, DOI 10.1038/sj.gt.3302050; Yoo J, 2016, NUCLEIC ACIDS RES, V44, P2036, DOI 10.1093/nar/gkw081; Zerze GH, 2015, J CHEM THEORY COMPUT, V11, P2776, DOI 10.1021/acs.jctc.5b00047; Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79; Zhou W, 2006, BRIT J CANCER, V95, P164, DOI 10.1038/sj.bjc.6603234; Zhou YL, 2004, SPECTROCHIM ACTA A, V60, P377, DOI 10.1016/S1386-1425(03)00243-9; Ziebarth J, 2009, BIOPHYS J, V97, P1971, DOI 10.1016/j.bpj.2009.03.069; Ziebarth JD, 2017, J PHYS CHEM B, V121, P1941, DOI 10.1021/acs.jpcb.6b10775; Ziebarth JD, 2010, BIOMACROMOLECULES, V11, P29, DOI 10.1021/bm900842d	91	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186816	10.1371/journal.pone.0186816	http://dx.doi.org/10.1371/journal.pone.0186816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088239	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900022
J	Laurence, J; Elhadad, S; Robison, T; Terry, H; Varshney, R; Woolington, S; Ghafoory, S; Choi, ME; Ahamed, J				Laurence, Jeffrey; Elhadad, Sonia; Robison, Tyler; Terry, Hunter; Varshney, Rohan; Woolington, Sean; Ghafoory, Shahrouz; Choi, Mary E.; Ahamed, Jasimuddin			HIV protease inhibitor-induced cardiac dysfunction and fibrosis is mediated by platelet-derived TGF-beta 1 and can be suppressed by exogenous carbon monoxide	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; OXIDATIVE STRESS; ARTERIAL INFLAMMATION; INSULIN-RESISTANCE; INFECTION; AUTOPHAGY; KIDNEY; ACTIVATION; BETA	Human immunodeficiency virus (HIV) infection is an independent risk factor for cardiovascular disease. This risk is magnified by certain antiretrovirals, particularly the protease inhibitor ritonavir, but the pathophysiology of this connection is unknown. We postulated that a major mechanism for antiretroviral-associated cardiac disease is pathologic fibrosis linked to platelet activation with release and activation of transforming growth factor (TGF)-beta 1, and that these changes could be modeled in a murine system. We also sought to intervene utilizing inhaled carbon monoxide (CO) as proof-of-concept for therapeutics capable of regulating TGF-beta 1 signaling and collagen autophagy. We demonstrate decreased cardiac function indices, including cardiac output, ejection fraction and stroke volume, and prominent cardiac fibrosis, in mice exposed to pharmacological doses of ritonavir. Cardiac output and fibrosis correlated with plasma TGF-beta 1 levels. Mice with targeted deletion of TGF-beta 1 in megakaryocytes/platelets (PF4CreTgfb1(flox/flox)) were partially protected from ritonavir-induced cardiac dysfunction and fibrosis. Inhalation of low dose CO (250ppm), used as a surrogate for upregulation of inducible heme oxygenase/endogenous CO pathways, suppressed ritonavir-induced cardiac fibrosis. This occurred in association with modulation of canonical (Smad2) and non-canonical (p38) TGF-beta 1 signaling pathways. In addition, CO treatment suppressed the M1 pro-inflammatory subset of macrophages and increased M2c regulatory cells in the hearts of RTV-exposed animals. The effects of CO were dependent upon autophagy as CO did not mitigate ritonavir-induced fibrosis in autophagy-deficient LC3(-/-) mice. These results suggest that platelet-derived TGF-beta 1 contributes to ritonavir-associated cardiac dysfunction and fibrosis, extending the relevance of our findings to other antiretrovirals that also activate platelets. The anti-fibrotic effects of CO are linked to alterations in TGF-beta 1 signaling and autophagy, suggesting a proof-of-concept for novel interventions in HIV/antiretroviral therapy-mediated cardiovascular disease.	[Laurence, Jeffrey; Elhadad, Sonia; Terry, Hunter] Weill Cornell Med Coll, Div Hematol & Med Oncol, New York, NY USA; [Robison, Tyler; Varshney, Rohan; Woolington, Sean; Ghafoory, Shahrouz; Ahamed, Jasimuddin] Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Biol Res Program, Dept Biochem & Mol Biol,OMRF, Oklahoma City, OK 73104 USA; [Choi, Mary E.] WCMC, Div Nephrol & Hypertens, New York, NY USA	Cornell University; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ahamed, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Biol Res Program, Dept Biochem & Mol Biol,OMRF, Oklahoma City, OK 73104 USA.	ahamedj@omrf.org	Elhadad, Sonia/GRF-6466-2022	Elhadad, Sonia/0000-0002-0139-6487; Ahamed, Jasimuddin/0000-0001-6455-0296	NIH [R21 HL125044, R01 HL123605]; COBRA; Angelo Donghia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114731] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRA; Angelo Donghia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R21 HL125044 (J.L. and J.A.) and R01 HL123605 (J.A.), a COBRA grant to OMRF, and the Angelo Donghia Foundation (J.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2017, ANTIOXIDANT IN PRESS; Ahamed J, 2008, BLOOD, V112, P3650, DOI 10.1182/blood-2008-04-151753; Ahamed J, 2016, AIDS, V30, P535, DOI 10.1097/QAD.0000000000000982; Andre L, 2010, AM J RESP CRIT CARE, V181, P587, DOI 10.1164/rccm.200905-0794OC; Angeles Pajares Maria, 2016, Anales de la Real Academia Nacional de Farmacia, V82, P231; [Anonymous], 2012, NAT REV MOL CELL BIO, V13, P616; Burdo T.H., 2015, J CLIN CELL IMMUNOL, V6, DOI [10.4172/2155-9899.1000333, DOI 10.4172/2155-9899.1000333]; Cipriani S, 2013, CIRCULATION, V127, P2114, DOI 10.1161/CIRCULATIONAHA.113.001278; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Duprez DA, 2011, AIDS, V25, P651, DOI 10.1097/QAD.0b013e32834404a1; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Estes JD, 2015, J INFECT DIS, V211, P744, DOI 10.1093/infdis/jiu519; Fakruddin JM, 2003, J BIOL CHEM, V278, P48251, DOI 10.1074/jbc.M304676200; Fernandez D, 2015, AASLD; Freiberg MS, 2017, JAMA CARDIOL, V2, P536, DOI 10.1001/jamacardio.2017.0264; Gaggin HK, 2013, BBA-MOL BASIS DIS, V1832, P2442, DOI 10.1016/j.bbadis.2012.12.014; Gibellini L, 2012, AIDS, V26, P2017, DOI 10.1097/QAD.0b013e328359b8be; Hemkens LG, 2014, EUR HEART J, V35, P1373, DOI 10.1093/eurheartj/eht528; Hsue PY, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004427; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Jerico C, 2006, STROKE, V37, P812, DOI 10.1161/01.STR.0000204037.26797.7f; Kim JH, 2006, J AM SOC NEPHROL, V17, P1373, DOI 10.1681/ASN.2005091001; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Li Gang, 2006, Chinese Medical Sciences Journal, V21, P175; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Lipshultz SE, 2013, JAMA PEDIATR, V167, P520, DOI 10.1001/jamapediatrics.2013.1206; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Lu JY, 2013, KIDNEY INT, V84, P745, DOI 10.1038/ki.2013.135; Lumadue JA, 1996, AM J CLIN PATHOL, V106, P795; Mak IT, 2013, AM J PHYSIOL-REG I, V305, pR1102, DOI 10.1152/ajpregu.00268.2013; Mancini D, TRANSL RES IN PRESS; Marconi VC, 2017, C RETR OPP INF SEATT; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; Mayne E, 2012, JAIDS-J ACQ IMM DEF, V59, P340, DOI 10.1097/QAI.0b013e3182439355; Meyer A, 2012, BLOOD, V119, P1064, DOI 10.1182/blood-2011-09-377648; Patel K, 2014, CIRCULATION, V129, P1204, DOI 10.1161/CIRCULATIONAHA.113.001978; Peers C, 2012, J MOL CELL CARDIOL, V52, P359, DOI 10.1016/j.yjmcc.2011.05.013; Reyskens KMSE, 2014, BBA-MOL BASIS DIS, V1842, P256, DOI 10.1016/j.bbadis.2013.11.019; Reyskens KMSE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073347; Ryom L, 2017, C RETR OPP INF SEATT; Satchell CS, 2011, J INFECT DIS, V204, P1202, DOI 10.1093/infdis/jir509; Shannon RP, 2000, CIRCULATION, V101, P185, DOI 10.1161/01.CIR.101.2.185; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Sureshbabu A, 2016, AM J PHYSIOL-RENAL, V310, pF596, DOI 10.1152/ajprenal.00365.2015; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Tawakol A, 2017, JAMA CARDIOL, V2, P163, DOI 10.1001/jamacardio.2016.4728; Taylor N, 2017, JAIDS-J ACQ IMM DEF, V75, pE13, DOI 10.1097/qai.0000000000001223; van der Heijden WA, 2017, C RETR OPP INF SEATT; WAHL SM, 1991, J EXP MED, V173, P981, DOI 10.1084/jem.173.4.981; Walker JA, 2014, AIDS RES HUM RETROV, V30, P685, DOI [10.1089/AID.2013.0268, 10.1089/aid.2013.0268]; Wang L, 2008, AM J PHYSIOL-RENAL, V294, pF508, DOI 10.1152/ajprenal.00306.2007; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yin MT, 2010, J CLIN ENDOCR METAB, V95, P620, DOI 10.1210/jc.2009-0708; Zanni MV, 2016, JAMA CARDIOL, V1, P474, DOI 10.1001/jamacardio.2016.0846; Zhou ZH, 2005, AM J PATHOL, V166, P27, DOI 10.1016/S0002-9440(10)62229-8	57	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187185	10.1371/journal.pone.0187185	http://dx.doi.org/10.1371/journal.pone.0187185			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088262	Green Published, gold			2022-12-27	WOS:000414088900047
J	Lee, YH; Kweon, SS; Choi, JS; Nam, HS; Park, KS; Choi, SW; Ryu, SY; Oh, SH; Shin, MH				Lee, Young-Hoon; Kweon, Sun-Seog; Choi, Jin-Su; Nam, Hae-Sung; Park, Kyeong-Soo; Choi, Seong-Woo; Ryu, So-Yeon; Oh, Su-Hyun; Shin, Min-Ho			Association of serum vitamin D and parathyroid hormone with subclinical atherosclerotic phenotypes: The Dong-gu Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; 25-HYDROXYVITAMIN D; ARTERIAL STIFFNESS; POSTMENOPAUSAL WOMEN; 25-OH-VITAMIN D; D DEFICIENCY; ALL-CAUSE; RISK; EVENTS	Background Although previous studies reported an association between serum vitamin D and parathyroid hormone (PTH) with carotid atherosclerosis or arterial stiffness, these were inconsistent. We examined the independent association between serum vitamin D and PTH with multiple subclinical markers of atherosclerosis. Methods A total of 8,217 subjects who participated in the Dong-gu Study in Korea were included in the final analysis. The carotid artery structure, including intima-media thickness (IMT), plaques, and luminal diameter, was evaluated using a high-resolution B-mode ultrasound. The brachial-ankle pulse wave velocity (baPWV) was determined using an automatic waveform analysis device, and the mean of the left and right baPWV was used. Results The PTH concentration was positively associated with carotid luminal diameter and baPWV, but not with carotid IMT and plaques. The mean carotid luminal diameter of individuals with PTH levels in the second, third, and fourth quartiles was significantly larger compared with those in the first quartile (P-trend < 0.01). The mean baPWV of individuals with PTH levels in the fourth quartile was significantly greater than those with PTH levels in the first quartile (P-trend = 0.01). However, there was no significant association between vitamin D and any atherosclerotic phenotypes, including carotid IMT, plaques, luminal diameter, and baPWV. Conclusion This suggests that PTH might affect the development of atherosclerosis by altering vascular compliance.	[Lee, Young-Hoon] Wonkwang Univ, Sch Med, Dept Prevent Med, Iksan, Jeonbuk, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Sch Med, Inst Wonkwang Med Sci, Iksan, Jeonbuk, South Korea; [Lee, Young-Hoon] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Iksan, Jeonbuk, South Korea; [Kweon, Sun-Seog; Choi, Jin-Su; Oh, Su-Hyun; Shin, Min-Ho] Chonnam Natl Univ, Med Sch, Dept Prevent Med, Hwasun, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Jeonnam Reg Canc Ctr, Hwasun Hosp, Hwasun, South Korea; [Nam, Hae-Sung] Chungnam Natl Univ, Sch Med, Dept Prevent Med, Daejeon, South Korea; [Park, Kyeong-Soo] Seonam Univ, Coll Med, Dept Prevent Med, Namwon, Jeonbuk, South Korea; [Choi, Seong-Woo; Ryu, So-Yeon] Chosun Univ, Med Sch, Dept Prevent Med, Gwangju, South Korea	Wonkwang University; Wonkwang University; Wonkwang University; Chonnam National University; Chonnam National University; Chungnam National University; Seonam University; Chosun University	Shin, MH (corresponding author), Chonnam Natl Univ, Med Sch, Dept Prevent Med, Hwasun, South Korea.	mhshinx@paran.com	Kweon, Sun-Seog/AAZ-4732-2021	Kweon, Sun-Seog/0000-0003-2378-8550; Lee, Young-Hoon/0000-0003-1367-025X; Oh, Su-Hyun/0000-0002-6373-8833; Nam, Hae-Sung/0000-0003-0911-4576; Shin, Min-Ho/0000-0002-2217-5624	Wonkwang University [WKU-2017]	Wonkwang University	This study was supported by Wonkwang University in 2017 (WKU-2017).	Al Mheid I, 2011, J AM COLL CARDIOL, V58, P186, DOI 10.1016/j.jacc.2011.02.051; Baldassarre D, 2012, J AM COLL CARDIOL, V60, P1489, DOI 10.1016/j.jacc.2012.06.034; Bjorkman M, 2009, ARCH GERONTOL GERIAT, V48, P160, DOI 10.1016/j.archger.2007.12.005; Blondon M, 2013, ARTERIOSCL THROM VAS, V33, P2639, DOI 10.1161/ATVBAHA.113.301781; Bosworth C, 2013, CLIN ENDOCRINOL, V79, P429, DOI 10.1111/cen.12163; Bots ML, 2005, STROKE, V36, P762, DOI 10.1161/01.STR.0000158924.71069.94; Brondum-Jacobsen P, 2015, INT J EPIDEMIOL, V44, P651, DOI 10.1093/ije/dyv078; Brown Spandana J, 2017, Methodist Debakey Cardiovasc J, V13, P49, DOI 10.14797/mdcj-13-2-49; Carrelli AL, 2011, STROKE, V42, P2240, DOI 10.1161/STROKEAHA.110.608539; Choi HS, 2008, INT J CLIN PRACT, V62, P1352, DOI 10.1111/j.1742-1241.2008.01801.x; CROUSE JR, 1994, STROKE, V25, P1354, DOI 10.1161/01.STR.25.7.1354; Ekmekci H, 2017, DIS MARKERS, V2017; Giallauria F, 2012, J CLIN ENDOCR METAB, V97, P3717, DOI 10.1210/jc.2012-1584; Hagstrom E, 2009, CIRCULATION, V119, P2765, DOI 10.1161/CIRCULATIONAHA.108.808733; Judd SE, 2009, AM J MED SCI, V338, P40, DOI 10.1097/MAJ.0b013e3181aaee91; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Knox S, 2012, ATHEROSCLEROSIS, V223, P437, DOI 10.1016/j.atherosclerosis.2012.05.001; Kruger IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054554; Kweon SS, 2014, INT J EPIDEMIOL, V43, P558, DOI 10.1093/ije/dys244; Labropoulos N, 1998, AM J SURG, V176, P140, DOI 10.1016/S0002-9610(98)00135-4; Leone N, 2008, ARTERIOSCL THROM VAS, V28, P1392, DOI 10.1161/ATVBAHA.108.164582; Lerstad G, 2017, EUR J ENDOCRINOL, V176, P625, DOI 10.1530/EJE-16-1037; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim S, 2012, J CLIN ENDOCR METAB, V97, P169, DOI 10.1210/jc.2011-1580; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mannami T, 2000, STROKE, V31, P2958, DOI 10.1161/01.STR.31.12.2958; Matsuoka O, 2005, BIOMED PHARMACOTHER, V59, pS40, DOI 10.1016/S0753-3322(05)80008-3; Meng FB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004810; Michos ED, 2009, CALCIFIED TISSUE INT, V84, P195, DOI 10.1007/s00223-008-9209-3; Mozos I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/109275; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; Pirro M, 2012, J ATHEROSCLER THROMB, V19, P924, DOI 10.5551/jat.13128; Prati P, 2008, STROKE, V39, P2470, DOI 10.1161/STROKEAHA.107.511584; Qi L, 2017, ARTERIOSCLER THROMB; Reis JP, 2009, ATHEROSCLEROSIS, V207, P585, DOI 10.1016/j.atherosclerosis.2009.05.030; Semba RD, 2010, EUR J CLIN NUTR, V64, P203, DOI 10.1038/ejcn.2009.140; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Tomaschitz A, 2012, CARDIOVASC RES, V94, P10, DOI 10.1093/cvr/cvs092; Tomiyama H, 2005, CIRC J, V69, P815, DOI 10.1253/circj.69.815; Valcour A, 2012, J CLIN ENDOCR METAB, V97, P3989, DOI 10.1210/jc.2012-2276; van Ballegooijen AJ, 2013, J CLIN ENDOCR METAB, V98, pE638, DOI 10.1210/jc.2012-4007; Veloudi P, 2016, PULSE, V4, P193, DOI 10.1159/000452742; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186421	10.1371/journal.pone.0186421	http://dx.doi.org/10.1371/journal.pone.0186421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088221	gold, Green Submitted, Green Published			2022-12-27	WOS:000414088900011
J	Zhang, JY; Cheng, X; Jin, Q; Su, XQ; Li, ML; Yan, CC; Jiao, XY; Li, DH; Lin, Y; Cai, YP				Zhang, Jinyun; Cheng, Xi; Jin, Qing; Su, Xueqiang; Li, Manli; Yan, Chongchong; Jiao, Xiaoyu; Li, Daihui; Lin, Yi; Cai, Yongping			Comparison of the transcriptomic analysis between two Chinese white pear (Pyrus bretschneideri Rehd.) genotypes of different stone cells contents	PLOS ONE			English	Article							LIGNIN BIOSYNTHESIS; SYRINGYL LIGNIN; PROFILING REVEALS; ARABIDOPSIS; GENES; LIGNIFICATION; ANNOTATION; BLAST2GO; ANATOMY; PATHWAY	Stone cell content is thought to be one of the key determinants for fruit quality in pears. However, the molecular mechanism of stone cell development remains poorly understood. In this study, we found that the stone cell clusters (SCCs) distribution and area in 'Dangshan Su' (with abundant stone cells) were higher as compared to 'Lianglizaosu' (low stone cell content bud sport of 'Dangshan Su') based on the histochemical staining, and the correlations of lignin content with stone cell content and SCC area was significant. The fruits of 'Dangshan Su' and 'Lianglizaosu' at three different developmental stages (23 and 55 days after flowering and mature) were sampled for comparative transcriptome analysis to explore the metabolic pathways associated with stone cell development. A total of 42444 unigenes were obtained from two varieties, among which 7203 differentially expressed genes (DEGs) were identified by comparison of the six transcriptomes. Specifically, many DEGs associated with lignin biosynthesis were identified, including coumaroylquinate 3-monooxygenase (C3H), shikimate O-hydroxycinnamoyltransferase (HCT), ferulate 5-hydroxylase (F5H), cinnamyl alcohol dehydrogenase (CAD) and peroxidase (POD), as well as genes related to carbon metabolism, such as sorbitol dehydrogenase-like (SDH-like) and ATP-dependent 6-phosphofructokinase (ATP-PFK). At the peak of the stone cell content (55 days after flowering), the expression level of these genes in 'Dangshan Su' was significantly increased compared with 'Lianglizaosu', indicating that these genes were closely related to stone cell development. We validated the transcriptional levels of 33 DEGs using quantitative realtime polymerase chain reaction (qRT-PCR) analysis. The results were consistent with the transcriptome analysis, indicating the reliability of transcriptome data. In addition, subcellular localization analysis of three DEGs in lignin synthesis (PbC3H, PbF5H and PbPOD) revealed that these proteins are mainly distributed in the cell membrane and cytoplasm. These results provide new insights into the molecular mechanism of stone cell formation.	[Zhang, Jinyun; Cheng, Xi; Jin, Qing; Su, Xueqiang; Li, Manli; Jiao, Xiaoyu; Li, Daihui; Lin, Yi; Cai, Yongping] Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Zhang, Jinyun; Yan, Chongchong] Anhui Acad Agr Sci, Hort Inst, Hefei, Anhui, Peoples R China	Anhui Agricultural University; Anhui Academy of Agricultural Sciences	Cai, YP (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China.	ypcaiah@163.com		Cheng, Xi/0000-0002-5669-7092; Zhang, Jinyun/0000-0002-4169-194X	National Natural Science Foundation of China [31640068]; Anhui Agricultural University; Graduate School of Anhui Agricultural University [2017yjs-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Agricultural University; Graduate School of Anhui Agricultural University	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/), Award Number 31640068 (Grant Recipient: Yongping Cai); and Postgraduate Student's Innovation Fund of Anhui Agricultural University (http://yisc.ahau.edu.cn/web/index.aspx), Graduate School of Anhui Agricultural University, Award Number 2017yjs-32 (Grant Recipient: Xi Cheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barakate A, 2011, PLANT CELL, V23, P4492, DOI 10.1105/tpc.111.089037; Barros J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.50, 10.1038/nplants.2016.50]; Barros J, 2015, ANN BOT-LONDON, V115, P1053, DOI 10.1093/aob/mcv046; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; Bomati EK, 2005, PLANT CELL, V17, P1598, DOI 10.1105/tpc.104.029983; Brahem M, 2017, CARBOHYD POLYM, V156, P152, DOI 10.1016/j.carbpol.2016.09.019; Cai YP, 2010, SCI HORTIC-AMSTERDAM, V125, P374, DOI 10.1016/j.scienta.2010.04.029; Cao YP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01874; Carocha V, 2015, NEW PHYTOL, V206, P1297, DOI 10.1111/nph.13313; Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; CHENG X, 2016, GENET MOL RES, V15; Cheng X, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2794040; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dima O, 2015, PLANT CELL, V27, P695, DOI 10.1105/tpc.114.134643; Escamilla-Trevino LL, 2006, PHYTOCHEMISTRY, V67, P1651, DOI 10.1016/j.phytochem.2006.05.022; Eudes A, 2014, CURR OPIN BIOTECH, V26, P189, DOI 10.1016/j.copbio.2014.01.002; Fernandez-Perez F, 2015, J PLANT PHYSIOL, V175, P86, DOI 10.1016/j.jplph.2014.11.006; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Jin Q, 2013, SCI HORTIC-AMSTERDAM, V155, P123, DOI 10.1016/j.scienta.2013.03.020; Kumar M, 2016, J EXP BOT, V67, P515, DOI 10.1093/jxb/erv533; Le Roy J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00735; Li LG, 2001, PLANT CELL, V13, P1567, DOI 10.1105/tpc.13.7.1567; Li SB, 2012, BIOCHEM GENET, V50, P978, DOI 10.1007/s10528-012-9537-x; Li Z, 2016, SCI BULL, V61, P838, DOI 10.1007/s11434-016-1061-7; Lim EK, 2001, J BIOL CHEM, V276, P4344, DOI 10.1074/jbc.M007263200; Liu CJ, 2012, MOL PLANT, V5, P304, DOI 10.1093/mp/ssr121; Liu Y, 2016, J HORTIC SCI BIOTECH, V91, P227, DOI 10.1080/14620316.2016.1142359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mitra PP, 2014, JOVE-J VIS EXP, DOI 10.3791/51381; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nii N, 2008, J HORTIC SCI BIOTECH, V83, P148, DOI 10.1080/14620316.2008.11512362; Pascual MB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01030; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Rueda-Lopez M, 2015, PHYSIOL PLANTARUM, V155, P369, DOI 10.1111/ppl.12381; Schweighofer A, 2007, PLANT CELL, V19, P2213, DOI 10.1105/tpc.106.049585; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Seifert GJ, 2002, CURR BIOL, V12, P1840, DOI 10.1016/S0960-9822(02)01260-5; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Syros T, 2004, J PLANT PHYSIOL, V161, P69, DOI 10.1078/0176-1617-00938; Tao ST, 2009, PLANT SCI, V176, P413, DOI 10.1016/j.plantsci.2008.12.011; Thevenin J, 2011, MOL PLANT, V4, P70, DOI 10.1093/mp/ssq045; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vicentini R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134909; Wagner A, 2015, P NATL ACAD SCI USA, V112, P6218, DOI 10.1073/pnas.1411926112; Wang JP, 2015, P NATL ACAD SCI USA, V112, P8481, DOI 10.1073/pnas.1510473112; Wang Y, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00220, 10.3389/fpls.2013.00314]; Wang YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083675; Wang ZG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00455; Wei SW, 2016, SCI HORTIC-AMSTERDAM, V206, P33, DOI 10.1016/j.scienta.2016.04.019; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Wu Tao, 2012, African Journal of Agricultural Research, V7, P3701; Xu YL, 2009, DANGSHANSULI; Yan CC, 2014, SCI HORTIC-AMSTERDAM, V174, P142, DOI 10.1016/j.scienta.2014.05.018; Yang HJ, 2007, PLANT PHYSIOL, V145, P135, DOI 10.1104/pp.107.100800; Yang SL, 2015, PLANT GROWTH REGUL, V76, P127, DOI 10.1007/s10725-014-9982-0; Yoon J, 2015, J INTEGR PLANT BIOL, V57, P902, DOI 10.1111/jipb.12422; Zhao ShuGang, 2013, Journal of Food, Agriculture & Environment, V11, P937	61	34	35	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187114	10.1371/journal.pone.0187114	http://dx.doi.org/10.1371/journal.pone.0187114			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088238	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900041
J	Kim, A; Sung, JH; Bang, JH; Cho, SW; Lee, J; Sim, CS				Kim, Ahra; Sung, Joo Hyun; Bang, Jin-Hee; Cho, Seung Woo; Lee, Jiho; Sim, Chang Sun			Effects of self-reported sensitivity and road-traffic noise levels on the immune system	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; LOW-FREQUENCY NOISE; KILLER T-CELLS; NKT CELLS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; EXPOSURE; STRESS; HEALTH; CORTISOL	Sensitivity to noise, particularly road traffic noise, can increase cortisol levels and result in changes in immune system biomarkers. Therefore, continuous exposure to noise can have an effect on immune function, hormonal levels, and cardiovascular function, leading to hypertension and stress. The purpose of this study was to investigate the changes in stress-and immune system-related biomarkers according to the self-reported sensitivity to noise and exposure to road traffic noise, to ultimately determine the potential effects of noise on health. A survey was conducted through questionnaire (ISO/TS 15666) sent to 172 female subjects in Korea, including 128 from Ulsan and 44 from Seoul. The average noise level was calculated, and blood samples were collected for measurements of cortisol levels, Natural killer (NK)/Natural killer T (NKT) cell populations, and NK cell activity (through measurements of interleukin-12 (IL-12) and interferon-gamma (INF-gamma) concentrations). Multivariate linear regression analysis of the measured biomarkers according to the road traffic noise level and self-reported noise sensitivity was conducted adjusting for the effects of age, alcohol status, smoking status, regular exercise, and residence period. IL-12 levels increased, whereas the NKT cell population decreased with increasing noise levels. The results further suggested that cortisol levels are more influenced by the subject's sensitivity to noise than to the level of chronic road traffic noise. Therefore, noise appears to have the largest effect on IL-12 levels as well as the population and activity of NKT cells. In conclusion, our results suggest that low-level road traffic noise and sensitivity to noise can affect health by causing changes in the immune response through mechanisms other than increased cortisol.	[Kim, Ahra; Bang, Jin-Hee] Univ Ulsan, Environm Hlth Ctr, Coll Med, Ulsan, South Korea; [Sung, Joo Hyun] Gyeongsang Natl Univ, Dept Occupat & Environm Med, Changwon Hosp, Sch Med, Chang Won, South Korea; [Cho, Seung Woo; Lee, Jiho; Sim, Chang Sun] Univ Ulsan, Dept Occupat & Environm Med, Ulsan Univ Hosp, Coll Med, Ulsan, South Korea	University of Ulsan; Gyeongsang National University; University of Ulsan; Ulsan University Hospital	Sim, CS (corresponding author), Univ Ulsan, Dept Occupat & Environm Med, Ulsan Univ Hosp, Coll Med, Ulsan, South Korea.	zzz0202@naver.com	; Sim, Chang Sun/P-8600-2014	Sung, Joo Hyun/0000-0001-9043-1127; Sim, Chang Sun/0000-0003-0841-1413	Korea Ministry of Environment (MOE); Korea Ministry of Environment [2014001350001]	Korea Ministry of Environment (MOE)(Ministry of Environment (ME), Republic of Korea); Korea Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This study was funded by the Korea Ministry of Environment (MOE) as "the Environmental Health Action Program" to CSS and JHS received funding from Korea Ministry of Environment, grant number: 2014001350001 (URL: http://www.me.go.kr/home/web/main.do). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JD, 2011, UOJM, V1, P13; [Anonymous], 2003, 15666 ISOTS; Babisch W, 2011, NOISE HEALTH, V13, P201, DOI 10.4103/1463-1741.80148; Belojevic Goran, 2002, Noise Health, V4, P33; Bendokiene I, 2011, NOISE HEALTH, V13, P371, DOI 10.4103/1463-1741.90288; Beutel ME, 2016, PLOS ONE, V19; Bluhm GL, 2007, OCCUP ENVIRON MED, V64, P122, DOI 10.1136/oem.2005.025866; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chidrawar Shivani M, 2006, Immun Ageing, V3, P10, DOI 10.1186/1742-4933-3-10; Di GQ, 2013, NOISE HEALTH, V15, P217, DOI 10.4103/1463-1741.113506; Diana J, 2009, EUR J IMMUNOL, V39, P3283, DOI 10.1002/eji.200939800; Duggal NA, 2015, AGE, V37, DOI 10.1007/s11357-015-9748-2; Eriksson C, 2012, NOISE HEALTH, V14, P140, DOI 10.4103/1463-1741.99864; Fouladi DB, 2012, NOISE HEALTH, V14, P184, DOI 10.4103/1463-1741.99894; Hartono, 2010, UNIVERSA MED, V29, P153; Hazeldine J, 2013, AGEING RES REV, V12, P1069, DOI 10.1016/j.arr.2013.04.003; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Ising H, 2004, Noise Health, V6, P21; Jennifer AJ, 2012, PLOS PATHOG, V8; Joshi S K, 2003, Kathmandu Univ Med J (KUMJ), V1, P177; KJELLBERG A, 1990, SCAND J WORK ENV HEA, V16, P29, DOI 10.5271/sjweh.1825; LeBlanc J, 2007, PHYSIOL BEHAV, V91, P208, DOI 10.1016/j.physbeh.2007.02.011; LEVY SM, 1991, NAT IMMUN CELL GROW, V10, P289; Ljunggren HG, NATURE REV IMMUNOLOG, V7, P329; Marks A, 2007, Noise Health, V9, P1; Mattner J, 2013, CURR OPIN IMMUNOL, V25, P697, DOI 10.1016/j.coi.2013.09.008; Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327; Melamed Samuel, 1999, Noise Health, V1, P49; Meyer T, 2017, ANTIOXID REDOX SIGNA; Munzel T, 2016, EUR HEART J, V37, P2844, DOI 10.1093/eurheartj/ehw314; Munzel T, 2017, EUR HEART J; OHRSTROM E, 1988, J SOUND VIB, V122, P277, DOI 10.1016/S0022-460X(88)80354-7; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Passchier-Vermeer W, 2000, ENVIRON HEALTH PERSP, V108, P123, DOI 10.1289/ehp.00108s1123; Rickard AJ, 2009, J MOL ENDOCRINOL, V42, P449, DOI 10.1677/JME-08-0144; Sagiyama K, 2004, CLIN EXP IMMUNOL, V135, P56, DOI 10.1111/j.1365-2249.2004.02340.x; Schmidt F, 2015, CLIN RES CARDIOL, V104, P23, DOI 10.1007/s00392-014-0751-x; Selander J, 2009, ENVIRON HEALTH PERSP, V117, P1713, DOI 10.1289/ehp.0900933; Spreng M., 2000, Noise Health, V2, P59; Stansfeld S. A., 2000, Noise Health, V2, P1; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; van Kamp I, 2013, NOISE HEALTH, V15, P153, DOI 10.4103/1463-1741.112361; van Kempen EEMM, 2002, ENVIRON HEALTH PERSP, V110, P307, DOI 10.1289/ehp.02110307; Vienneau D, 2015, ENVIRON RES, V138, P372, DOI 10.1016/j.envres.2015.02.023; Waye KP, 2003, LIFE SCI, V72, P863, DOI 10.1016/S0024-3205(02)02336-6; Waye KP, 2002, LIFE SCI, V70, P745, DOI 10.1016/S0024-3205(01)01450-3; WHO, 2011, BURDEN DIS ENV NOISE; Wu L, 2009, CURR MOL MED, V9, P4, DOI 10.2174/156652409787314534; Yoshida T, 1997, J SOUND VIB, V205, P517, DOI 10.1006/jsvi.1997.1020	49	27	27	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187084	10.1371/journal.pone.0187084	http://dx.doi.org/10.1371/journal.pone.0187084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084230	gold, Green Published			2022-12-27	WOS:000413910200029
J	Radziwon-Balicka, A; Degn, M; Johansson, SE; Warfvinge, K; Edvinsson, L				Radziwon-Balicka, Aneta; Degn, Matilda; Johansson, Sara E.; Warfvinge, Karin; Edvinsson, Lars			A novel multicolor flow-cytometry application for quantitative detection of receptors on vascular smooth muscle cells	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; TISSUES	There is a need to develop new techniques for quantitative measurement of receptors expression on particular vasculature cells types. Here, we describe and demonstrate a novel method to measure quantitatively and simultaneously the expression of endothelin B receptor (ETB) on vascular smooth muscle cells (VSMC). We isolated cells from male rat tissues such as: brain pial, brain intraparenchymal and retina vessels. To analyze solid tissues, a single-cell suspension was prepared by a combined mechanic and enzymatic process. The cells were stained with Fixable Viability Dye, followed by fixation, permeabilization and antibodies staining. The expression of ETB receptors on VSMC was measured by flow-cytometry and visualized by fluorescence microscopy. We obtained a high percentage of viable cells 87.6% +/- 1.5% pial; 84.6% +/- 4.3% parenchymal and 90.6% +/- 4% retina after isolation of single cells. We performed a quantitative measurement of ETB receptor expression on VSMC and we identified two subpopulations of VSMC based on their expression of smooth muscle cells marker SM22a. The results obtained from pial vessels are statistically significant (38.4% +/- 4% vs 9.8% +/- 3.32%) between the two subpopulations of VSMC. The results obtained from intraparenchymal and retina vessels were not statistically significant. By specific gating on two subpopulations, we were able to quantify the expression of ETB receptors. The two subpopulation expressed the same level of ETB receptor (p = 0.45; p = 0.3; p = 0.42) in pial, parenchymal and retina vessels, respectively. We applied our method to the animals after induction of subarachnoid hemorrhage (SAH). There was statistically significant expression of ETB receptor (p = 0.02) on VSMC between sham 61.4% +/- 4% and SAH 77.4% +/- 4% rats pial vessels. The presented technique is able to quantitatively and selectively measure the level of protein expression on VSMC. The entire technique is optimized for rat tissue; however the protocol can also be adapted for other species.	[Radziwon-Balicka, Aneta; Degn, Matilda; Johansson, Sara E.; Warfvinge, Karin; Edvinsson, Lars] Rigshosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Warfvinge, Karin; Edvinsson, Lars] Lund Univ, Div Expt Vasc Res, Dept Clin Sci, Lund, Sweden	Rigshospitalet; Lund University	Radziwon-Balicka, A (corresponding author), Rigshosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark.	arad0002@regionh.dk	Radziwon-Balicka, Aneta/AAA-3787-2021	Degn, Matilda/0000-0003-3093-3525; Radziwon-Balicka, Aneta/0000-0002-5123-5710; Edvinsson, Lars/0000-0002-1805-1346	Lundbeck Foundation Denmark; Swedish Research Council (Forskningsradet om Halsa, Arbetsliv och Valfard) [5958]; Lundbeck Foundation [R59-2010-5404] Funding Source: researchfish	Lundbeck Foundation Denmark(Lundbeckfonden); Swedish Research Council (Forskningsradet om Halsa, Arbetsliv och Valfard); Lundbeck Foundation(Lundbeckfonden)	This work is supported by a financial support from the Lundbeck Foundation Denmark (Grant of Excellence to LE, 2011-2016) and the Swedish Research Council (Forskningsradet om Halsa, Arbetsliv och Valfard, grant no 5958 to LE).	Adhikari N, 2015, J CARDIOVASC TRANSL, V8, P158, DOI 10.1007/s12265-015-9616-6; Ansar S, 2007, AM J PHYSIOL-HEART C, V293, pH3750, DOI 10.1152/ajpheart.00857.2007; Brindley David, 2011, J Tissue Eng, V2011, P620247, DOI 10.4061/2011/620247; Donnenberg VS, 2013, CYTOM PART A, V83A, P141, DOI 10.1002/cyto.a.22156; Edvinsson L, 2011, ACTA PHYSIOL, V203, P209, DOI 10.1111/j.1748-1716.2010.02227.x; Edvinsson L., 2002, CEREBRAL BLOOD FLOW, V2nd ed; HEAD RJ, 1980, BLOOD VESSELS, V17, P173; Navone SE, 2013, NAT PROTOC, V8, P1680, DOI 10.1038/nprot.2013.107; Povlsen GK, 2015, J CEREBR BLOOD F MET, V35, P329, DOI 10.1038/jcbfm.2014.205; Povlsen GK, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-34; Qasaimeh MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep45681; Saladin K., 2015, UNITY FORM FUNCTION; Schwartz A, 2002, J RES NATL INST STAN, V107, P83, DOI 10.6028/jres.107.009; Spray S, 2016, ACTA PHYSL OXF; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Weber SC, 2011, PEDIATR RES, V70, P236, DOI 10.1203/PDR.0b013e318225f748	16	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186504	10.1371/journal.pone.0186504	http://dx.doi.org/10.1371/journal.pone.0186504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084284	gold, Green Published, Green Submitted			2022-12-27	WOS:000413910200007
J	Hagbom, M; Novak, D; Ekstrom, M; Khalid, Y; Andersson, M; Lindh, M; Nordgren, J; Svensson, L				Hagbom, Marie; Novak, Daniel; Ekstrom, Malin; Khalid, Younis; Andersson, Maria; Lindh, Magnus; Nordgren, Johan; Svensson, Lennart			Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; ORAL ONDANSETRON; EMERGENCY-DEPARTMENT; CHILDREN; DIARRHEA; PATHOGENESIS; SEROTONIN; INFECTION; DEXAMETHASONE; BACTERIAL	Background Rotavirus and norovirus cause acute gastroenteritis with severe diarrhoea and vomiting, symptoms that may lead to severe dehydration and death. The objective of this randomized double-blinded placebo-controlled study was to investigate whether ondansetron, a serotonin receptor antagonist could attenuate rotavirus-and norovirus-induced vomiting and diarrhoea, which would facilitate oral rehydration and possibly accelerate recovery and reduce need for hospitalization. Methods Children with acute gastroenteritis, aged 6 months to 16 years where enrolled (n = 104) and randomized to one single oral dose (0.15mg/kg) of ondansetron (n = 52) or placebo (n = 52). The number of diarrhoea and vomiting episodes during the 24 hours following treatment was reported as well as the number of days with symptoms. Pathogens in faeces were diagnosed by real-time PCR. Outcome parameters were analyzed for rotavirus-and noroviruspositive children. Results One dose of oral ondansetron reduced duration of rotavirus clinical symptoms (p = 0.014), with a median of two days. Furthermore, ondansetron reduced diarrhea episodes, most pronounced in children that had been sick for more than 3 days before treatment (p = 0.028). Conclusion Ondansetron may be a beneficial treatment for children with rotavirus gastroenteritis.	[Hagbom, Marie; Nordgren, Johan; Svensson, Lennart] Linkoping Univ, Dept Clin & Expt Med, Div Mol Virol, Med Fac, Linkoping, Sweden; [Novak, Daniel; Ekstrom, Malin; Khalid, Younis] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Emergency Dept, Gothenburg, Sweden; [Andersson, Maria; Lindh, Magnus] Univ Gothenburg, Inst Biomed, Dept Infect Dis, Sect Clin Virol, Gothenburg, Sweden; [Svensson, Lennart] Karolinska Inst, Dept Med, Stockholm, Sweden	Linkoping University; Queen Silvia Children's Hospital; Sahlgrenska University Hospital; University of Gothenburg; Karolinska Institutet	Svensson, L (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Mol Virol, Med Fac, Linkoping, Sweden.; Svensson, L (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	lennart.svensson@liu.se	svensson, lennart/K-6163-2019	Hagbom, Marie/0000-0002-9770-4623; Novak, Daniel/0000-0002-7892-7880	Swedish Research Council [320301]; Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the research funder Swedish Research Council (LS) 320301, URL: http://www.vr.se/. This study is an academic study; professor Lennart Svensson is the sponsor and he is supported by the Swedish Research Council.	Bialowas S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159660; Camilleri M, 2009, CURR OPIN ENDOCRINOL, V16, P53, DOI 10.1097/MED.0b013e32831e9c8e; Chen CC, 2012, J PEDIATR GASTR NUTR, V55, P541, DOI 10.1097/MPG.0b013e318262a718; Chow CM, 2010, CLIN EXP GASTROENTER, V3, P97; Cohen Ira Todd, 2007, Ther Clin Risk Manag, V3, P333, DOI 10.2147/tcrm.2007.3.2.333; Cubeddu LX, 1997, ALIMENT PHARM THERAP, V11, P185, DOI 10.1046/j.1365-2036.1997.97269000.x; Elfving K, 2014, J CLIN MICROBIOL, V52, P916, DOI 10.1128/JCM.02697-13; Fayyaz Mohammad, 2008, Ther Clin Risk Manag, V4, P41; Freedman SB, 2006, NEW ENGL J MED, V354, P1698, DOI 10.1056/NEJMoa055119; Garsed K, 2014, GUT, V63, P1617, DOI 10.1136/gutjnl-2013-305989; Gershon MD, 2004, ALIMENT PHARM THER, V20, P3, DOI 10.1111/j.1365-2036.2004.02180.x; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Hagbom M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002115; Istrate C, 2014, J VIROL, V88, P3161, DOI 10.1128/JVI.02927-13; Kabayiza JC, 2014, PEDIATR INFECT DIS J, V33, P1037, DOI 10.1097/INF.0000000000000448; Ko G, 2006, J MED VIROL, V78, P825, DOI 10.1002/jmv.20630; Kordasti S, 2004, GUT, V53, P952, DOI 10.1136/gut.2003.033563; Kutukculer N, 1997, J PEDIATR GASTR NUTR, V25, P556, DOI 10.1097/00005176-199711000-00014; Lundgren O, 2000, SCIENCE, V287, P491, DOI 10.1126/science.287.5452.491; Lundgren O, 2001, MICROBES INFECT, V3, P1145, DOI 10.1016/S1286-4579(01)01475-7; Mangel AW, 1999, ALIMENT PHARM THERAP, V13, P77, DOI 10.1046/j.1365-2036.1999.00010.x; Marchetti F, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-15; Morris AP, 2001, AM J PHYSIOL-GASTR L, V281, pG303, DOI 10.1152/ajpgi.2001.281.2.G303; Oldak E, 2012, EUR J CLIN MICROBIOL, V31, P417, DOI 10.1007/s10096-011-1321-z; Olver I, 1996, ANN ONCOL, V7, P945, DOI 10.1093/oxfordjournals.annonc.a010798; Patel RI, 1997, ANESTH ANALG, V85, P538, DOI 10.1097/00000539-199709000-00011; Podewils Laura Jean, 2004, Semin Pediatr Infect Dis, V15, P155, DOI 10.1053/j.spid.2004.05.008; Puustinen L, 2012, EPIDEMIOL INFECT, V140, P268, DOI 10.1017/S0950268811000549; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Ramsook C, 2002, ANN EMERG MED, V39, P397, DOI 10.1067/mem.2002.122706; Reeves JJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e62; Roslund G, 2008, ANN EMERG MED, V52, P22, DOI 10.1016/j.annemergmed.2007.09.010; SCHWELLA N, 1994, BONE MARROW TRANSPL, V13, P169; Spiller R, 2002, BRIT J CLIN PHARMACO, V54, P11, DOI 10.1046/j.1365-2125.2002.01612.x; Stork CM, 2006, ACAD EMERG MED, V13, P1027, DOI 10.1197/j.aem.2006.05.018; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; UHNOO I, 1986, ARCH DIS CHILD, V61, P732, DOI 10.1136/adc.61.8.732; UHNOO I, 1986, J CLIN MICROBIOL, V23, P551, DOI 10.1128/JCM.23.3.551-555.1986; UHNOO I, 1986, J INFECTION, V13, P73, DOI 10.1016/S0163-4453(86)92348-0; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Yilmaz HL, 2009, ALIMENT PHARM THER, V31, P82, DOI 10.1111/j.1365-2036.2009.04145.x	41	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186824	10.1371/journal.pone.0186824	http://dx.doi.org/10.1371/journal.pone.0186824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077725	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200025
J	Nemoto, K; Oka, H; Fukuda, H; Yamakawa, Y				Nemoto, Kiyotaka; Oka, Hiroki; Fukuda, Hiroki; Yamakawa, Yoshinori			MRI-based Brain Healthcare Quotients: A bridge between neural and behavioral analyses for keeping the brain healthy	PLOS ONE			English	Article							BODY-MASS INDEX; VOXEL-BASED MORPHOMETRY; GRAY-MATTER VOLUME; ALZHEIMERS-DISEASE; SOCIAL-STATUS; YOUNG-ADULTS; LATE-LIFE; SCHIZOPHRENIA; METAANALYSIS; FEASIBILITY	Neurological and psychiatric disorders are a burden on social and economic resources. Therefore, maintaining brain health and preventing these disorders are important. While the physiological functions of the brain are well studied, few studies have focused on keeping the brain healthy from a neuroscientific viewpoint. We propose a magnetic resonance imaging (MRI)-based quotient for monitoring brain health, the Brain Healthcare Quotient (BHQ), which is based on the volume of gray matter (GM) and the fractional anisotropy (FA) of white matter (WM). We recruited 144 healthy adults to acquire structural neuro-imaging data, including T1-weighted images and diffusion tensor images, and data associated with both physical (BMI, blood pressure, and daily time use) and social (subjective socioeconomic status, subjective well-being, post-materialism and Epicureanism) factors. We confirmed that the BHQ was sensitive to an age-related decline in GM volume and WM integrity. Further analysis revealed that the BHQ was critically affected by both physical and social factors. We believe that our BHQ is a simple yet highly sensitive, valid measure for brain health research that will bridge the needs of the scientific community and society and help us lead better lives in which we stay healthy, active, and sharp.	[Nemoto, Kiyotaka] Univ Tsukuba, Div Clin Med, Dept Neuropsychiat, Fac Med, Tsukuba, Ibaraki, Japan; [Oka, Hiroki; Fukuda, Hiroki; Yamakawa, Yoshinori] Govt Japan, Cabinet Off, ImPACT Program, Council Sci Technol & Innovat,Chiyoda Ku, Tokyo, Japan	University of Tsukuba	Yamakawa, Y (corresponding author), Govt Japan, Cabinet Off, ImPACT Program, Council Sci Technol & Innovat,Chiyoda Ku, Tokyo, Japan.	yamakawa@bi-lab.org	Nemoto, Kiyotaka/C-4987-2013	Nemoto, Kiyotaka/0000-0001-8623-9829; yamakawa, yoshinori/0000-0002-7995-1794	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	This work was funded by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan).	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Alves GS, 2017, CURR ALZHEIMER RES, V14, P61, DOI 10.2174/1567205013666160603010203; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bosc M, 1997, EUROPEAN NEUROPSYCHO; Demakakos P, 2008, SOC SCI MED, V67, P330, DOI 10.1016/j.socscimed.2008.03.038; Ecker C, 2015, LANCET NEUROL, V14, P1121, DOI 10.1016/S1474-4422(15)00050-2; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Erickson KI, 2014, NEUROBIOL AGING, V35, pS20, DOI 10.1016/j.neurobiolaging.2014.03.034; Fennema-Notestine C, 2007, NEUROINFORMATICS, V5, P235, DOI 10.1007/s12021-007-9003-9; Gunstad J, 2008, INT J NEUROSCI, V118, P1582, DOI 10.1080/00207450701392282; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; INGLEHART R, 1971, AM POLIT SCI REV, V65, P991, DOI 10.2307/1953494; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Lewis GJ, 2012, J COGNITIVE NEUROSCI, V24, P1657, DOI 10.1162/jocn_a_00239; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; Meda SA, 2008, SCHIZOPHR RES, V101, P95, DOI 10.1016/j.schres.2008.02.007; Menary K, 2013, INTELLIGENCE, V41, P597, DOI 10.1016/j.intell.2013.07.010; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; O'Brien C, 2015, TODAYS GERIATRIC MED, V8, P1; Ogawa W., 2015, HLTH EVAL PROMOT, V42, P301, DOI [10.7143/jhep.42.301, DOI 10.7143/JHEP.42.301]; Ohtani T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112691; Pardoe H, 2008, NEUROIMAGE, V42, P611, DOI 10.1016/j.neuroimage.2008.05.007; Peterson C., 2006, PRIMER POSITIVE PSYC, DOI DOI 10.1016/j.compedu.2004.08.013; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Segall JM, 2009, SCHIZOPHRENIA BULL, V35, P82, DOI 10.1093/schbul/sbn150; Seligman M., 2002, HDB POSITIVE PSYCHOL, V2, P3; Sheehan D, 1996, INT CLIN PSYCHOPHARM; Shimoji K, 2013, DIABETES CARE, V36, P696, DOI 10.2337/dc12-0666; Smith SM, 2015, NAT NEUROSCI, V18, P1565, DOI 10.1038/nn.4125; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23; Weingarten CP, 2015, NEUROSCI BIOBEHAV R, V59, P16, DOI 10.1016/j.neubiorev.2015.09.007; WHO, WHAT AR NEUR DIS; Yamakawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004360; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	47	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187137	10.1371/journal.pone.0187137	http://dx.doi.org/10.1371/journal.pone.0187137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077756	gold, Green Published, Green Submitted			2022-12-27	WOS:000413861200048
J	Sorensen, BM; Houben, AJHM; Berendschot, TTJM; Schouten, JSAG; Kroon, AA; van der Kallen, CJH; Henry, RMA; Koster, A; Dagnelie, PC; Schaper, NC; Schram, MT; Stehouwer, CDA				Sorensen, Ben M.; Houben, Alfons J. H. M.; Berendschot, Tos T. J. M.; Schouten, Jan S. A. G.; Kroon, Abraham A.; van der Kallen, Carla J. H.; Henry, Ronald M. A.; Koster, Annemarie; Dagnelie, Pieter C.; Schaper, Nicolaas C.; Schram, Miranda T.; Stehouwer, Coen D. A.			Cardiovascular risk factors as determinants of retinal and skin microvascular function: The Maastricht Study	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; BLOOD-PRESSURE; NITRIC-OXIDE; INSULIN-RESISTANCE; VESSEL DIAMETER; OPTIC-NERVE; AGE; OBESITY; FLOW; PATHOLOGY	Objective Microvascular dysfunction is an important underlying mechanism of microvascular diseases. Determinants (age, sex, hypertension, dyslipidemia, hyperglycemia, obesity, and smoking) of macrovascular diseases affect large-artery endothelial function. These risk factors also associate with microvascular diseases. We hypothesized that they are also determinants of microvascular (endothelial) function. Methods In The Maastricht Study, a type 2 diabetes-enriched population-based cohort study (n = 1991, 51% men, aged 59.7 +/- 8.2 years), we determined microvascular function as flicker light-induced retinal arteriolar %-dilation and heat-induced skin %-hyperemia. Multiple linear regression analyses were used to assess the associations of cardiovascular risk factors (age, sex, waist circumference, total-to-high-density lipoprotein (HDL) cholesterol ratio, fasting plasma glucose (FPG), 24-h systolic blood pressure, and cigarette smoking) with retinal and skin microvascular function. Results In multivariate analyses, age and FPG were inversely associated with retinal and skin microvascular function (regression coefficients per standard deviation (SD) were -0.11SD (95% CI: -0.15;-0.06) and -0.12SD (-0.17;-0.07) for retinal arteriolar %-dilation and -0.10SD (-0.16;-0.05) and -0.11SD (-0.17;-0.06) for skin %-hyperemia, respectively. Men and current smokers had -0.43SD (-0.58;-0.27) and -0.32SD (-0.49;-0.15) lower skin %-hyperemia, respectively. 24-h systolic blood pressure, waist circumference, and total-to-HDL cholesterol ratio were not statistically significantly associated with these microvascular functions. Conclusions Associations between cardiovascular risk factors and retinal and skin microvascular function show a pattern that is partly similar to the associations between cardiovascular risk factors and macrovascular function. Impairment of microvascular function may constitute a pathway through which an adverse cardiovascular risk factor pattern may increase risk of diseases that are partly or wholly of microvascular origin.	[Sorensen, Ben M.; Houben, Alfons J. H. M.; Kroon, Abraham A.; van der Kallen, Carla J. H.; Henry, Ronald M. A.; Dagnelie, Pieter C.; Schaper, Nicolaas C.; Schram, Miranda T.; Stehouwer, Coen D. A.] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Sorensen, Ben M.; Houben, Alfons J. H. M.; Kroon, Abraham A.; van der Kallen, Carla J. H.; Henry, Ronald M. A.; Schaper, Nicolaas C.; Schram, Miranda T.; Stehouwer, Coen D. A.] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands; [Berendschot, Tos T. J. M.; Schouten, Jan S. A. G.] Maastricht Univ, Univ Eye Clin Maastricht, Med Ctr, Maastricht, Netherlands; [Henry, Ronald M. A.; Schram, Miranda T.] Maastricht Univ, Heart & Vasc Ctr, Med Ctr, Maastricht, Netherlands; [Koster, Annemarie; Dagnelie, Pieter C.; Schaper, Nicolaas C.] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands; [Koster, Annemarie] Maastricht Univ, Dept Social Med, Maastricht, Netherlands; [Dagnelie, Pieter C.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University; Maastricht University	Stehouwer, CDA (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.; Stehouwer, CDA (corresponding author), Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands.	cda.stehouwer@mumc.nl	Berendschot, Tos TJM/M-8509-2016; Stehouwer, Coen/AAB-3435-2021; Koster, Annemarie/E-7438-2010; Houben, Alfons J/C-1913-2014; Schaper, Nicolaas C/E-7112-2014	Berendschot, Tos TJM/0000-0002-8101-939X; Koster, Annemarie/0000-0003-1583-7391; Stehouwer, Coen/0000-0001-8752-3223; Schram, Miranda/0000-0001-8113-7604; schaper, nicolaas/0000-0002-2128-8029; Kroon, Abraham/0000-0001-7750-8249; van der Kallen, Carla/0000-0003-1468-8793	European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs [310.041]; Stichting De Weijerhorst (Maastricht, the Netherlands); Pearl String Initiative Diabetes (Amsterdam, the Netherlands); CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Perimed (Jarfalla, Sweden); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)	European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Stichting De Weijerhorst (Maastricht, the Netherlands)(Netherlands Government); Pearl String Initiative Diabetes (Amsterdam, the Netherlands)(Netherlands Government); CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Perimed (Jarfalla, Sweden); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)(Netherlands Government)	This study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 310.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands), Perimed (Jarfalla, Sweden), and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands) and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Arora S, 1998, J VASC SURG, V27, P1141, DOI 10.1016/S0741-5214(98)70016-3; Buysschaert M, 2015, ENDOCRINE, V48, P371, DOI 10.1007/s12020-014-0436-2; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Chen SM, 2011, HEART VESSELS, V26, P2, DOI 10.1007/s00380-010-0017-0; Cheung N, 2007, HYPERTENSION, V50, P617, DOI 10.1161/HYPERTENSIONAHA.107.091926; Chilelli NC, 2013, NUTR METAB CARDIOVAS, V23, P913, DOI 10.1016/j.numecd.2013.04.004; Cracowski JL, 2011, MICROCIRCULATION, V18, P356, DOI 10.1111/j.1549-8719.2011.00098.x; de Jongh RT, 2004, CIRCULATION, V109, P2529, DOI 10.1161/01.CIR.0000129772.26647.6F; De Silva TM, 2016, CELL MOL NEUROBIOL, V36, P241, DOI 10.1007/s10571-015-0308-1; Falsini B, 2002, INVEST OPHTH VIS SCI, V43, P2309; Fitzmaurice G, 2000, NUTRITION, V16, P313, DOI 10.1016/S0899-9007(99)00293-2; Francischetti EA, 2011, MICROVASC RES, V81, P325, DOI 10.1016/j.mvr.2011.01.002; Fraser-Bell S, 2017, CLIN EXP OPHTHALMOL, V45, P45, DOI 10.1111/ceo.12905; Garhofer G, 2011, MICROVASC RES, V82, P351, DOI 10.1016/j.mvr.2011.07.001; Gupta A, 2015, OMICS, V19, P733, DOI 10.1089/omi.2015.0128; Hashimoto S, 2015, DIABETES, V64, P876, DOI 10.2337/db14-0432; Henriksson P, 2014, MICROCIRCULATION, V21, P587, DOI 10.1111/micc.12137; Houben A, 2017, J AM SOC NEPHROL; IJzerman RG, 2003, EUR J CLIN INVEST, V33, P536, DOI 10.1046/j.1365-2362.2003.01179.x; Ijzerman RG, 2003, CLIN SCI, V104, P247, DOI 10.1042/CS20020318; Irving RJ, 2002, CARDIOVASC RES, V53, P271, DOI 10.1016/S0008-6363(01)00450-3; Jia GH, 2016, DIABETES, V65, P2118, DOI 10.2337/dbi16-0026; Jonk AM, 2007, PHYSIOLOGY, V22, P252, DOI 10.1152/physiol.00012.2007; Kellogg DL, 1999, J APPL PHYSIOL, V86, P1185, DOI 10.1152/jappl.1999.86.4.1185; Knottnerus ILH, 2009, CEREBROVASC DIS, V27, P519, DOI 10.1159/000212672; Kubli S, 2000, J CARDIOVASC PHARM, V36, P640, DOI 10.1097/00005344-200011000-00014; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lee JF, 2016, HEART, V102, P278, DOI 10.1136/heartjnl-2015-308403; Lim M, 2013, MICROCIRCULATION, V20, P257, DOI 10.1111/micc.12026; Minson CT, 2001, J APPL PHYSIOL, V91, P1619, DOI 10.1152/jappl.2001.91.4.1619; Montero D, 2015, J HYPERTENS, V33, P445, DOI 10.1097/HJH.0000000000000446; Muris DMJ, 2014, J HYPERTENS, V32, P2439, DOI 10.1097/HJH.0000000000000348; Muris DMJ, 2013, REV ENDOCR METAB DIS, V14, P29, DOI 10.1007/s11154-012-9231-7; Nagel E, 2006, OPHTHALMOLOGE, V103, P114, DOI 10.1007/s00347-005-1254-y; Nagel E, 2004, INVEST OPHTH VIS SCI, V45, P1486, DOI 10.1167/iovs.03-0667; Ogueta SB, 1999, INVEST OPHTH VIS SCI, V40, P1906; Parekh A, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5010005; Puissant C, 2014, J Mal Vasc, V39, P47, DOI 10.1016/j.jmv.2013.11.004; Reimann M, 2015, ATHEROSCLEROSIS SUPP, V18, P1, DOI 10.1016/j.atherosclerosissup.2015.02.001; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; Santos M, 2012, J NEUROL SCI, V322, P46, DOI 10.1016/j.jns.2012.05.048; Schram MT, 2014, EUR J EPIDEMIOL, V29, P439, DOI 10.1007/s10654-014-9889-0; Seshadri S, 2016, ACTA OPHTHALMOL, V94, pE35, DOI 10.1111/aos.12786; Seshadri S, 2015, ACTA OPHTHALMOL, V93, pE266, DOI 10.1111/aos.12594; Smith AR, 2006, ARCH BIOCHEM BIOPHYS, V454, P100, DOI 10.1016/j.abb.2006.02.017; Sorensen BM, 2016, CIRCULATION, V134, P1339, DOI 10.1161/CIRCULATIONAHA.116.023446; Tsao CW, 2015, INT J EPIDEMIOL, V44, P1800, DOI 10.1093/ije/dyv337; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Witte DR, 2005, J AM COLL CARDIOL, V45, P1987, DOI 10.1016/j.jacc.2005.02.073; Yang SH, 2005, CNS NEUROL DISORD-DR, V4, P169, DOI 10.2174/1568007053544174; Zafrani L, 2015, AM J KIDNEY DIS, V66, P1083, DOI 10.1053/j.ajkd.2015.06.019	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187324	10.1371/journal.pone.0187324	http://dx.doi.org/10.1371/journal.pone.0187324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077770	Green Submitted, gold, Green Published			2022-12-27	WOS:000413861200058
J	Scott, I; Umair, S; Savoian, MS; Simpson, HV				Scott, Ian; Umair, Saleh; Savoian, Matthew S.; Simpson, Heather V.			Abomasal dysfunction and cellular and mucin changes during infection of sheep with larval or adult Teladorsagia circumcincta	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; HAEMONCHUS-CONTORTUS LARVAE; OSTERTAGIA-CIRCUMCINCTA; EXCRETORY/SECRETORY PRODUCTS; PARIETAL-CELLS; EPITHELIAL-CELLS; GASTRIC-MUCOSA; NIPPOSTRONGYLUS-BRASILIENSIS; IMMUNE EXCLUSION; PRIMARY CULTURES	This is the first integrated study of the effects on gastric secretion, inflammation and fundic mucins after infection with L3 T. circumcincta and in the very early period following transplantation of adult worms. At 3 months-of-age, 20 Coopworth lambs were infected intraruminally with 35,000 L3; infected animals were killed on Days 5, 10, 15, 20 and 30 postinfection and 6 controls on either Day 0 or 30 post-infection. Another 15 Romney cross lambs received 10,000 adult worms at 4-5 months-of-age though surgically-implanted abomasal cannulae and were killed after 6, 12, 24 and 72 hours; uninfected controls were also killed at 72 hours. Blood was collected at regular intervals from all animals for measurement of serum gastrin and pepsinogen and abomasal fluid for pH measurement from cannulated sheep. Tissues collected at necropsy were fixed in Bouin's fluid for light microscopy, immunocytochemistry and mucin staining and in Karnovsky's fluid for electron microscopy. Nodules around glands containing developing larvae were seen on Day 5 p.i., but generalised effects on secretion occurred only after parasite emergence and within hours after transplantation of adult worms. After L3 infection, there were maximum worm burdens on Days 10-15 post-infection, together with peak tissue eosinophilia, inhibition of gastric acid secretion, hypergastrinaemia,hyperpepsinogenaemia, loss of parietal cells, enlarged gastric pits containing less mucin and increased numbers of mucous neck cells. After adult transplantation, serum pepsinogen was significantly increased after 9 hours and serum gastrin after 18 hours. Parallel changes in host tissues and the numbers of parasites in the abomasal lumen suggest that luminal parasites, but not those in the tissues, are key drivers of the pathophysiology and inflammatory response in animals exposed to parasites for the first time. These results are consistent with initiation of the host response by parasite chemicals diffusing across the surface epithelium, possibly aided by components of ES products which increased permeability. Parietal cells appear to be a key target, resulting in secondary increases in serum gastrin, pit elongation, loss of surface mucins and inhibition of chief cell maturation. Inflammation occurs in parallel, and could either cause the pathology or exacerbate the direct effects of ES products.	[Scott, Ian; Simpson, Heather V.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Umair, Saleh] AgResearch Ltd, Hopkirk Res Inst, Palmerston North, New Zealand; [Savoian, Matthew S.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Massey University; AgResearch - New Zealand; Massey University	Simpson, HV (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	H.V.Simpson@massey.ac.nz			Meat and Wool New Zealand [96MU 25/1.1]; Massey University Research Fund; C. Alma Baker Trust; E. & C. Thoms Bequest	Meat and Wool New Zealand; Massey University Research Fund; C. Alma Baker Trust; E. & C. Thoms Bequest	This work received support from Meat and Wool New Zealand (96MU 25/1.1 Development of alternative methods of parasite control), Massey University Research Fund, C. Alma Baker Trust, E. & C. Thoms Bequest. These funders provided support for research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr S. Umair is employed by AgResearch Ltd., who provided his salary and some research materials for his contribution to mucin histology, but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; ANDERSON N, 1981, PARASITOLOGY, V82, P401, DOI 10.1017/S0031182000066932; ARMOUR J, 1966, AM J VET RES, V27, P1267; BADO A, 1994, YALE J BIOL MED, V67, P113; Balic A, 2000, VET IMMUNOL IMMUNOP, V75, P109, DOI 10.1016/S0165-2427(00)00189-6; Balic A, 2006, PARASITE IMMUNOL, V28, P107, DOI 10.1111/j.1365-3024.2006.00816.x; BEAUCHAMP RD, 1989, J CLIN INVEST, V84, P1017, DOI 10.1172/JCI114223; Behm CA, 2000, PARASITOL TODAY, V16, P202, DOI 10.1016/S0169-4758(99)01620-8; Bredemeyer AJ, 2009, DEV BIOL, V325, P211, DOI 10.1016/j.ydbio.2008.10.025; Canfield V, 1996, P NATL ACAD SCI USA, V93, P2431, DOI 10.1073/pnas.93.6.2431; CHEN MC, 1993, AM J PHYSIOL, V264, pG390, DOI 10.1152/ajpgi.1993.264.2.G390; CHRISTIE MG, 1970, J COMP PATHOL, V80, P89, DOI 10.1016/0021-9975(70)90035-6; COURTNEY CH, 1984, INT J PARASITOL, V14, P377, DOI 10.1016/0020-7519(84)90092-4; DEMPSEY PJ, 1992, GASTROENTEROLOGY, V103, P1950, DOI 10.1016/0016-5085(92)91455-D; Forstner G, 1982, MUCUS HLTH DISEASE, P199; Fox JG, 1996, GASTROENTEROLOGY, V110, P155, DOI 10.1053/gast.1996.v110.pm8536852; FOX MT, 1989, RES VET SCI, V46, P280, DOI 10.1016/S0034-5288(18)31160-3; FOX MT, 1988, VET REC, V122, P136, DOI 10.1136/vr.122.6.136; FOX MT, 1987, INT J PARASITOL, V17, P1181, DOI 10.1016/0020-7519(87)90170-6; FOX MT, 1993, RES VET SCI, V54, P384, DOI 10.1016/0034-5288(93)90140-B; FRYKLUND J, 1988, AM J PHYSIOL, V254, pG399, DOI 10.1152/ajpgi.1988.254.3.G399; Haag E, 2005, PARASITOL RES, V95, P155, DOI 10.1007/s00436-004-1274-6; Hagen SJ, 1997, AM J PHYSIOL-CELL PH, V272, pC48, DOI 10.1152/ajpcell.1997.272.1.C48; HANSKY J, 1969, LANCET, V2, P1388; Hashimoto K, 2009, PARASITE IMMUNOL, V31, P457, DOI 10.1111/j.1365-3024.2009.01123.x; Hasnain SZ, 2013, INT J BIOCHEM CELL B, V45, P364, DOI 10.1016/j.biocel.2012.10.011; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Hersey SJ, 1987, PHYSL GASTROINTESTIN, P947; Hertzberg H, 2000, VET J, V159, P238, DOI 10.1053/tvjl.1999.0475; Hertzberg H, 1999, P 17 INT C WAAVP COP, V199, P202; Hoang VC, 2010, VET PARASITOL, V171, P354, DOI 10.1016/j.vetpar.2010.04.007; Hoang VC, 2010, VET PARASITOL, V170, P253, DOI 10.1016/j.vetpar.2010.02.014; HOLMES PH, 1971, RES VET SCI, V12, P265; Huber A, 2005, PARASITOL RES, V96, P290, DOI 10.1007/s00436-005-1321-y; Ingham A, 2008, INT J PARASITOL, V38, P431, DOI 10.1016/j.ijpara.2007.07.012; ISHIKAWA N, 1994, IMMUNOLOGY, V81, P480; JENNINGS FW, 1966, AM J VET RES, V27, P1249; JOHNSON LR, 1976, GASTROENTEROLOGY, V71, P599; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; KARAM SM, 1994, AM J PHYSIOL, V266, pG745, DOI 10.1152/ajpgi.1994.266.4.G745; Karam SM, 2001, HISTOL HISTOPATHOL, V16, P469, DOI 10.14670/HH-16.469; KLESIUS PH, 1985, INT J PARASITOL, V15, P517, DOI 10.1016/0020-7519(85)90047-5; Lawton DEB, 1996, INT J PARASITOL, V26, P1063, DOI 10.1016/S0020-7519(96)00100-2; Lawton DEB, 2002, VET PARASITOL, V104, P243, DOI 10.1016/S0304-4017(01)00628-8; Lehmann FS, 1996, AM J PHYSIOL-GASTR L, V270, pG783, DOI 10.1152/ajpgi.1996.270.5.G783; LEHY T, 1972, AM J DIG DIS, V17, P887, DOI 10.1007/BF02239527; Li P, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-22; Li QT, 1996, J BIOL CHEM, V271, P3671, DOI 10.1074/jbc.271.7.3671; LI QT, 1995, J BIOL CHEM, V270, P15777, DOI 10.1074/jbc.270.26.15777; Li RW, 2009, VET PARASITOL, V165, P281, DOI 10.1016/j.vetpar.2009.07.008; MCKELLAR Q, 1986, RES VET SCI, V40, P367, DOI 10.1016/S0034-5288(18)30552-6; MCLEAY LM, 1973, PARASITOLOGY, V66, P241, DOI 10.1017/S0031182000045182; Meeusen ENT, 2000, PARASITOL TODAY, V16, P95, DOI 10.1016/S0169-4758(99)01607-5; Merkelbach P, 2002, VET PARASITOL, V104, P217, DOI 10.1016/S0304-4017(01)00635-5; Mihi B, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-121; MILLER HRP, 1983, RES VET SCI, V35, P357, DOI 10.1016/S0034-5288(18)32033-2; MILLER HRP, 1984, VET IMMUNOL IMMUNOP, V6, P167, DOI 10.1016/0165-2427(84)90051-5; Miyazaki Y, 1999, GASTROENTEROLOGY, V116, P78, DOI 10.1016/S0016-5085(99)70231-3; Moradpour N, 2013, PARASITOLOGY, V140, P1762, DOI 10.1017/S0031182013001042; MURAYAMA Y, 1995, GASTROENTEROLOGY, V109, P1051, DOI 10.1016/0016-5085(95)90562-6; MURRAY M, 1970, RES VET SCI, V11, P417; NEWLANDS GFJ, 1990, J COMP PATHOL, V102, P433, DOI 10.1016/S0021-9975(08)80164-8; NICHOLLS CD, 1988, RES VET SCI, V45, P124, DOI 10.1016/S0034-5288(18)30907-X; NICHOLLS CD, 1987, J COMP PATHOL, V97, P299, DOI 10.1016/0021-9975(87)90094-6; Ohning GV, 1996, AM J PHYSIOL-GASTR L, V271, pG470, DOI 10.1152/ajpgi.1996.271.3.G470; OTA H, 1992, HISTOCHEM J, V24, P86, DOI 10.1007/BF01082444; Prinz C, 1997, GASTROENTEROLOGY, V112, P364, DOI 10.1053/gast.1997.v112.pm9024290; Przemeck S, 2005, PARASITOL RES, V95, P213, DOI 10.1007/s00436-004-1280-8; Rehman ZU, 2016, VET PARASITOL, V221, P104, DOI 10.1016/j.vetpar.2016.03.017; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rinaldi M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-61; ROBERT A, 1991, LIFE SCI, V48, P123, DOI 10.1016/0024-3205(91)90405-Z; ROSS J G, 1971, Journal of Helminthology, V45, P1, DOI 10.1017/S0022149X00006878; Rowe A, 2009, VET PARASITOL, V161, P76, DOI 10.1016/j.vetpar.2008.12.023; RUTTEN MJ, 1993, AM J PHYSIOL, V265, pG361, DOI 10.1152/ajpgi.1993.265.2.G361; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Scott I, 1998, INT J PARASITOL, V28, P1383, DOI 10.1016/S0020-7519(98)00111-8; Scott I, 2000, VET PARASITOL, V89, P79, DOI 10.1016/S0304-4017(00)00188-6; SCOTT I, 1995, RES VET SCI, V59, P234, DOI 10.1016/0034-5288(95)90009-8; Serrano MT, 1997, GUT, V40, P42, DOI 10.1136/gut.40.1.42; SHARP R, 1995, DEVELOPMENT, V121, P149; Simcock DC, 1999, INT J PARASITOL, V29, P1053, DOI 10.1016/S0020-7519(99)00065-X; Simpson HV, 2009, VET PARASITOL, V165, P256, DOI 10.1016/j.vetpar.2009.07.030; Simpson HV, 2009, VET PARASITOL, V163, P73, DOI 10.1016/j.vetpar.2009.03.049; Simpson HV, 1999, NEW ZEAL VET J, V47, P20, DOI 10.1080/00480169.1999.36102; Simpson HV, 1997, INT J PARASITOL, V27, P825, DOI 10.1016/S0020-7519(97)00037-4; SIMPSON HV, 1993, COMP BIOCHEM PHYS A, V104, P461, DOI 10.1016/0300-9629(93)90447-C; Simpson HV, 2016, VET PARASITOL; SOMMERVILLE RI, 1953, NATURE, V171, P482, DOI 10.1038/171482a0; SOMMERVILLE RI, 1954, AUST J AGR RES, V5, P130, DOI 10.1071/AR9540130; SPICER SS, 1965, J HISTOCHEM CYTOCHEM, V13, P211, DOI 10.1177/13.3.211; STAFFORD KJ, 1994, NEW ZEAL VET J, V42, P30, DOI 10.1080/00480169.1994.35778; Sundler F, 1989, GASTROENTERLOLOGY, V96, P723; Taylor M. A., 2007, VET PARASITOL, V3rd; Tsubokawa D, 2009, EXP PARASITOL, V123, P319, DOI 10.1016/j.exppara.2009.08.008; Tsutsui S, 1997, BIOCHEM BIOPH RES CO, V235, P520, DOI 10.1006/bbrc.1997.6824; Turner DG, 2008, VET IMMUNOL IMMUNOP, V122, P138, DOI 10.1016/j.vetimm.2007.11.002; Van De Walle J, 2010, TOXICOL IN VITRO, V24, P1441, DOI 10.1016/j.tiv.2010.04.002; Weigert N, 1996, GASTROENTEROLOGY, V110, P147, DOI 10.1053/gast.1996.v110.pm8536851; Wildblood LA, 2005, VET IMMUNOL IMMUNOP, V107, P57, DOI 10.1016/j.vetimm.2005.03.010; Yamauchi J, 2006, APMIS, V114, P270, DOI 10.1111/j.1600-0463.2006.apm_353.x; Yanaoka K, 2008, CANCER EPIDEM BIOMAR, V17, P838, DOI 10.1158/1055-9965.EPI-07-2762	104	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186752	10.1371/journal.pone.0186752	http://dx.doi.org/10.1371/journal.pone.0186752			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073245	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400048
J	Diallo, AO; Soeters, HM; Yameogo, I; Sawadogo, G; Ake, F; Lingani, C; Wang, X; Bita, A; Fall, A; Sangare, L; Ouedraogo-Traore, R; Medah, I; Bicaba, B; Novak, RT				Diallo, Alpha Oumar; Soeters, Heidi M.; Yameogo, Issaka; Sawadogo, Guetawende; Ake, Flavien; Lingani, Clement; Wang, Xin; Bita, Andre; Fall, Amadou; Sangare, Lassana; Ouedraogo-Traore, Rasmata; Medah, Isaie; Bicaba, Brice; Novak, Ryan T.		MenAfriNet Consortium	Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign	PLOS ONE			English	Article							MENINGOCOCCAL CONJUGATE VACCINE; REAL-TIME PCR; PSA-TT; SURVEILLANCE; CARRIAGE; IMPACT; ASSAYS; NIGER; BELT	Background Historically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics in sub-Saharan Africa. In 2010, Burkina Faso became the first country to implement a national meningococcal serogroup A conjugate vaccine (MACV) campaign. We analyzed nationwide meningitis surveillance data from Burkina Faso for the 5 years following MACV introduction. Methods We examined Burkina Faso's aggregate reporting and national laboratory-confirmed case-based meningitis surveillance data from 2011-2015. We calculated incidence (cases per 100,000 persons), and described reported NmA cases. Results In 2011-2015, Burkina Faso reported 20,389 cases of suspected meningitis. A quarter (4,503) of suspected meningitis cases with cerebrospinal fluid specimens were laboratory-confirmed as either S. pneumoniae (57%), N. meningitidis (40%), or H. influenzae (2%). Average adjusted annual national incidence of meningococcal meningitis was 3.8 (range: 2.0-10.2 annually) and was highest among infants aged<1 year (8.4). N. meningitidis serogroup W caused the majority (64%) of meningococcal meningitis among all age groups. Only six confirmed NmA cases were reported in 2011-2015. Five cases were in children who were too young (n = 2) or otherwise not vaccinated (n = 3) during the 2010 MACV mass vaccination campaign; one case had documented MACV receipt, representing the first documented MACV failure. Conclusions Meningococcal meningitis incidence in Burkina Faso remains relatively low following MACV introduction. However, a substantial burden remains and NmA transmission has persisted. MACV integration into routine childhood immunization programs is essential to ensure continued protection.	[Diallo, Alpha Oumar; Soeters, Heidi M.; Wang, Xin; Novak, Ryan T.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Soeters, Heidi M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Yameogo, Issaka; Sawadogo, Guetawende; Medah, Isaie; Bicaba, Brice] Minist Sante, Direct Lutte Maladie, Ouagadougou, Burkina Faso; [Ake, Flavien] CDC Fdn, Ouagadougou, Burkina Faso; [Lingani, Clement; Bita, Andre; Fall, Amadou] AFRO Intercountry Support Team West Afr, World Hlth Org, Ouagadougou, Burkina Faso; [Sangare, Lassana] Ctr Hosp Univ Yalgado Ouedraogo, Ouagadougou, Burkina Faso; [Ouedraogo-Traore, Rasmata] Ctr Hosp Univ Pediat Charles Gaulle, Ouagadougou, Burkina Faso	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Diallo, AO; Soeters, HM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.; Soeters, HM (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.	adiallo@cdc.gov; hmsoeters@cdc.gov	Soeters, Heidi/H-3271-2019	Soeters, Heidi/0000-0002-9415-9340; Diallo, Alpha Oumar/0000-0002-4819-0806	Bill & Melinda Gates Foundation [OPP1084298]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Grant Number OPP1084298. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2015, J INFECT DIS, V212, P1298, DOI 10.1093/infdis/jiv211; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P57; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P561; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Centers for Disease Control and Prevention (U.S.) World Health Organization, 2011, LAB METHODS DIAGNOSI; Colombini A, 2015, CLIN INFECT DIS, V61, pS473, DOI 10.1093/cid/civ600; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Djingarey MH, 2015, CLIN INFECT DIS, V61, pS434, DOI 10.1093/cid/civ551; Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073; Funk Anna, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Idoko OT, 2015, CLIN INFECT DIS, V61, pS416, DOI 10.1093/cid/civ596; Kambire D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166384; Karachaliou A, 2015, CLIN INFECT DIS, V61, pS594, DOI 10.1093/cid/civ508; Kretz CB, 2016, EMERG INFECT DIS, V22, P1762, DOI 10.3201/eid2210.160468; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; LaForce FM, 2017, HUMAN VACCIN IMMUNOT; Lingani C, 2015, CLIN INFECT DIS, V61, pS410, DOI 10.1093/cid/civ597; MacNeil JR, 2014, EMERG INFECT DIS, V20, P394, DOI 10.3201/eid2003.131407; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; PATH, 2017, MAP AFR MEN BELT; Sambo L, 2015, CLIN INFECT DIS, V61, pS387, DOI 10.1093/cid/civ490; Sidikou F, 2016, LANCET INFECT DIS, V16, P1288, DOI 10.1016/S1473-3099(16)30253-5; Tapia MD, 2015, CLIN INFECT DIS, V61, pS514, DOI 10.1093/cid/civ672; Tartof S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063605; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; WHO, 1998, WHO PRACT GUID; [World Health Organization Africa WHOIST-W], 2016, MENINGITIS WEEKLY B; World Health Organization, 2010, TECHN GUID INT DIS S	30	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187466	10.1371/journal.pone.0187466	http://dx.doi.org/10.1371/journal.pone.0187466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095907	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200096
J	Kim, BR; Kwon, YW; Park, GT; Choi, EJ; Seo, JK; Jang, IH; Kim, SC; Ko, HC; Lee, SC; Kim, JH				Kim, Ba Reun; Kwon, Yang Woo; Park, Gyu Tae; Choi, Eun Jung; Seo, Jeong Kon; Jang, Il Ho; Kim, Seung-Chul; Ko, Hyun-Chang; Lee, Sang Chul; Kim, Jae Ho			Identification of a novel angiogenic peptide from periostin	PLOS ONE			English	Article							BREAST-CANCER; FASCICLIN-I; GROWTH; EXPRESSION; CELL; PROTEIN; DOMAIN; MODEL	Angiogenic peptides have therapeutic potential for the treatment of chronic ischemic diseases. Periostin, an extracellular matrix protein expressed in injured tissues, promotes angiogenesis and tissue repair. We previously reported that in vivo administration of both recombinant full-length protein and the first FAS I domain of periostin alleviated peripheral artery occlusive disease by stimulating the migration of humane endothelial colony forming cells (ECFCs) and subsequent angiogenesis. In the present study, we ascertained the peptide sequence responsible for the periostin-induced angiogenesis. By serial deletion mapping of the first FAS I domain, we identified a peptide sequence (amino acids 142-151) of periostin for stimulation of chemotactic migration, adhesion, proliferation and endothelial tube formation of human ECFCs in vitro. Chemotactic migration of ECFCs induced by the periostin peptide was blocked by pre-incubation with an anti-beta 5 integrin neutralizing antibody. Treatment of ECFCs with the periostin peptide led to phosphorylation of both AKT and ERK, and pretreatment of ECFCs with the MEK-ERK pathway inhibitor U0126 or the PI3K-AKT pathway inhibitors, LY294002 or Wortmannin, blocked the periostin peptide-stim-ulated migration of ECFCs. These results suggest that the synthetic periostin peptide can be applied for stimulating angiogenic and therapeutic potentials of ECFCs.	[Kim, Ba Reun; Kwon, Yang Woo; Park, Gyu Tae; Choi, Eun Jung; Kim, Jae Ho] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, South Korea; [Seo, Jeong Kon] Ulsan Natl Inst Sci & Technol, UNIST Cent Res Facil, Ulsan, South Korea; [Jang, Il Ho] Pusan Natl Univ, Sch Dent, Dept Oral Biochem & Mol Biol, Yangsan, South Korea; [Kim, Seung-Chul] Pusan Natl Univ, Sch Med, Dept Obstet & Gynecol, Yangsan, South Korea; [Ko, Hyun-Chang] Pusan Natl Univ, Sch Med, Dept Dermatol, Yangsan, South Korea; [Lee, Sang Chul] KRIBB, Funct Genom Res Ctr, Daejeon, South Korea; [Kim, Jae Ho] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Ulsan National Institute of Science & Technology (UNIST); Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Pusan National University; Pusan National University Hospital	Kim, JH (corresponding author), Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, South Korea.; Kim, JH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea.	jhkimst@pusan.ac.kr	Ko, Hyun-chang/ABF-7418-2021; Kim, Seung-Chul/D-9216-2018	Ko, Hyun-chang/0000-0002-3459-5474; Kim, Seung-Chul/0000-0002-8174-9931; Kim, Jae Ho/0000-0003-4323-4790; Jang, Il Ho/0000-0002-0820-3035	MRC program [NRF-2015R1A5A2009656]; programs of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012M3A9C7050184, NRF-2015M3A9C6030280]	MRC program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); programs of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the MRC program (NRF-2015R1A5A2009656) and by the programs of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012M3A9C7050184;NRF-2015M3A9C6030280). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Braund Rhiannon, 2007, Current Drug Delivery, V4, P195; Buchwald H, 2014, SURG OBES RELAT DIS, V10, P780, DOI 10.1016/j.soard.2014.01.032; Field S, 2016, INT J CANCER, V138, P1959, DOI 10.1002/ijc.29946; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gillan L, 2002, CANCER RES, V62, P5358; Giordano C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00063; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kim BR, 2014, BBA-MOL BASIS DIS, V1842, P1324, DOI 10.1016/j.bbadis.2014.05.004; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Lee YJ, 2013, MOL THER, V21, P1004, DOI 10.1038/mt.2013.30; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; Padhi A, 2014, TUBERCULOSIS, V94, P363, DOI 10.1016/j.tube.2014.03.011; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Robinson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087648; ROESEL JF, 1995, J SURG RES, V58, P449, DOI 10.1006/jsre.1995.1071; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Zhu M, 2010, GYNECOL ONCOL, V119, P337, DOI 10.1016/j.ygyno.2010.07.008	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187464	10.1371/journal.pone.0187464	http://dx.doi.org/10.1371/journal.pone.0187464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095886	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200095
J	Silva, FH; Veiga, FJR; Mora, AG; Heck, RS; De Oliveira, CC; Gambero, A; Franco-Penteado, CF; Antunes, E; Gardner, JD; Priviero, FBM; Claudino, MA				Silva, Fabio Henrique; Reis Veiga, Frederico Jose; Mora, Aline Goncalves; Heck, Rodrigo Sader; De Oliveira, Caroline Candida; Gambero, Alessandra; Franco-Penteado, Carla Fernanda; Antunes, Edson; Gardner, Jason D.; Marinho Priviero, Fernanda Bruschi; Claudino, Mario Angelo			A novel experimental model of erectile dysfunction in rats with heart failure using volume overload	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; SYMPATHETIC-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; CORPUS CAVERNOSUM; PENILE ERECTION; SMOOTH-MUSCLE; UP-REGULATION; EXPRESSION	Background Patients with heart failure (HF) display erectile dysfunction (ED). However, the pathophysiology of ED during HF remains poorly investigated. Objective This study aimed to characterize the aortocaval fistula (ACF) rat model associated with HF as a novel experimental model of ED. We have undertaken molecular and functional studies to evaluate the alterations of the nitric oxide (NO) pathway, autonomic nervous system and oxidative stress in the penis. Methods Male rats were submitted to ACF for HF induction. Intracavernosal pressure in anesthetized rats was evaluated. Concentration-response curves to contractile (phenylephrine) and relaxant agents (sodium nitroprusside; SNP), as well as to electrical field stimulation (EFS), were obtained in the cavernosal smooth muscle (CSM) strips from sham and HF rats. Protein expression of endothelial NO synthase (eNOS) and neuronal NO synthase (nNOS) and phosphodiestarese-5 in CSM were evaluated, as well as NOX2 (gp91 (phox)) and superoxide dismutase (SOD) mRNA expression. SOD activity and thiobarbituric acid reactive substances (TBARs) were also performed in plasma. Results HF rats display erectile dysfunction represented by decreased ICP responses compared to sham rats. The neurogenic contractile responses elicited by EFS were greater in CSM from the HF group. Likewise, phenylephrine-induced contractions were greater in CSM from HF rats. Nitrergic response induced by EFS were decreased in the cavernosal tissue, along with lower eNOS, nNOS and phosphodiestarese-5 protein expressions. An increase of NOX2 and SOD mRNA expression in CSM and plasma TBARs of HF group were detected. Plasma SOD activity was decreased in HF rats. Conclusion ED in HF rats is associated with decreased NO bioavailability in erectile tissue due to eNOS/nNOS dowregulation and NOX2 upregulation, as well as hypercontractility of the penis. This rat model of ACF could be a useful tool to evaluate the molecular alterations of ED associated with HF.	[Silva, Fabio Henrique; Franco-Penteado, Carla Fernanda] Univ Estadual Campinas, Fac Med Sci, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil; [Reis Veiga, Frederico Jose; Mora, Aline Goncalves; Heck, Rodrigo Sader; De Oliveira, Caroline Candida; Gambero, Alessandra; Marinho Priviero, Fernanda Bruschi; Claudino, Mario Angelo] Sao Francisco Univ, Med Sch, Lab Multidisciplinary Res, Braganca Paulista, SP, Brazil; [Antunes, Edson] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil; [Gardner, Jason D.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, Baton Rouge, LA 70803 USA	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Louisiana State University System; Louisiana State University; Louisiana State University Health Sciences Center at Shreveport	Claudino, MA (corresponding author), Sao Francisco Univ, Med Sch, Lab Multidisciplinary Res, Braganca Paulista, SP, Brazil.	mario.claudino@usf.edu.br	Priviero, Fernanda/E-2193-2012; SILVA, FABIO HENRIQUE/AAZ-8140-2020; Claudino, Mário A/D-5367-2014; Silva, Fábio/D-5412-2013	Priviero, Fernanda/0000-0002-6022-2081; Silva, Fábio/0000-0003-3374-5570; Claudino, Mario Angelo/0000-0002-3590-9607; Gambero, Alessandra/0000-0002-4862-4328	Sao Paulo Research Foundation (FAPESP) [2011/21095-4]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106392] Funding Source: NIH RePORTER	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Sao Paulo Research Foundation (FAPESP) (www.fapesp.br), Grant number: 2011/21095-4.	Abassi ZA, 1997, CIRCULATION, V96, P3655; Abassi Z, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/729497; Alcaino H, 2008, EUR J HEART FAIL, V10, P646, DOI 10.1016/j.ejheart.2008.05.008; Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; Bivalacqua TJ, 2003, J ANDROL, V24, pS17; Bohm M, 2010, CIRCULATION, V121, P1439, DOI 10.1161/CIRCULATIONAHA.109.864199; Bradley JM, 2013, J APPL PHYSIOL, V115, P1099, DOI 10.1152/japplphysiol.00343.2013; Burnett Arthur L, 2006, J Clin Hypertens (Greenwich), V8, P53; Carneiro FS, 2010, J SEX MED, V7, P3620, DOI 10.1111/j.1743-6109.2010.02000.x; Champion HC, 2005, P NATL ACAD SCI USA, V102, P1661, DOI 10.1073/pnas.0407183102; Chirinos JA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004133; Cho KI, 2014, INT J MOL SCI, V15, P14803, DOI 10.3390/ijms150814803; Claudino MA, 2011, LIFE SCI, V88, P272, DOI 10.1016/j.lfs.2010.11.018; Claudino MA, 2010, UROLOGY, V75, P961, DOI 10.1016/j.urology.2009.05.098; da Silva FH, 2013, INT J IMPOT RES, V25, P69, DOI 10.1038/ijir.2012.35; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Dworakowski R, 2008, J AM COLL CARDIOL, V51, P1349, DOI 10.1016/j.jacc.2007.12.033; Francis B, 2004, J CARDIOVASC PHARM, V44, pS54, DOI 10.1097/01.fjc.0000166214.42791.f2; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Gardner JD, 2010, AM J PHYSIOL-HEART C, V298, pH497, DOI 10.1152/ajpheart.00336.2009; Hebert K, 2008, INT J IMPOT RES, V20, P507, DOI 10.1038/ijir.2008.35; Hebert K, 2010, J SEX MED, V7, P3991, DOI 10.1111/j.1743-6109.2010.01954.x; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; Jaarsma T, 1996, HEART LUNG, V25, P262, DOI 10.1016/S0147-9563(96)80061-6; Jin LM, 2008, J SEX MED, V5, P544, DOI 10.1111/j.1743-6109.2007.00733.x; KOWALUK EA, 1992, J PHARMACOL EXP THER, V262, P916; Koyama T, 2010, HYPERTENS RES, V33, P485, DOI 10.1038/hr.2010.48; Landmesser U, 2002, CIRCULATION, V106, P3073, DOI 10.1161/01.CIR.0000041431.57222.AF; Leite LN, 2017, EUR J PHARMACOL, V804, P82, DOI 10.1016/j.ejphar.2017.03.024; Lin CS, 2002, INT J IMPOT RES, V14, P15, DOI 10.1038/sj.ijir.3900802; Lynch SM, 1997, ARTERIOSCL THROM VAS, V17, P2975, DOI 10.1161/01.ATV.17.11.2975; Metra M, 2017, LANCET LOND ENGL; Musicki B, 2017, ANDROLOGY-US, V5, P294, DOI 10.1111/andr.12313; Musicki B, 2016, ANDROLOGY-US, V4, P977, DOI 10.1111/andr.12218; Musicki B, 2015, J SEX MED, V12, P2233, DOI 10.1111/jsm.13069; Nagalla KT, 2012, EXP BIOL MED, V237, P24, DOI 10.1258/ebm.2011.011180; Parajuli N, 2014, CLIN SCI, V127, P331, DOI 10.1042/CS20130787; Patel KP, 1996, BRAIN RES, V734, P109, DOI 10.1016/S0006-8993(96)00620-8; PIERUZZI F, 1995, CIRCULATION, V92, P3105, DOI 10.1161/01.CIR.92.10.3105; Polidori MC, 2002, FREE RADICAL BIO MED, V32, P148, DOI 10.1016/S0891-5849(01)00782-1; Rodrigues FL, 2016, LIFE SCI, V145, P9, DOI 10.1016/j.lfs.2015.12.005; Sharma NM, 2011, CARDIOVASC RES, V92, P348, DOI 10.1093/cvr/cvr217; Silva FH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166291; Silva FH, 2014, AM J PHYSIOL-HEART C, V307, pH1393, DOI 10.1152/ajpheart.00708.2013; Silva FH, 2013, J SEX MED, V10, P960, DOI 10.1111/jsm.12063; Silva FH, 2016, J PHARM EXP THER; Toque HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072277; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Westlake C, 1999, J HEART LUNG TRANSPL, V18, P1133, DOI 10.1016/S1053-2498(99)00084-4; Zhang DY, 2014, CARDIOL CLIN, V32, P33, DOI 10.1016/j.ccl.2013.09.010; Zhang Q, 2011, INT J ANDROL, V34, P225, DOI 10.1111/j.1365-2605.2010.01083.x; Zhou R, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12241	56	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187083	10.1371/journaL.pone.0187083	http://dx.doi.org/10.1371/journaL.pone.0187083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095897	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200045
J	Wilunda, C; Dall'Oglio, G; Scanagatta, C; Segafredo, G; Lukhele, BW; Takahashi, R; Putoto, G; Manenti, F; Betran, AP				Wilunda, Calistus; Dall'Oglio, Giovanni; Scanagatta, Chiara; Segafredo, Giulia; Lukhele, Bhekumusa Wellington; Takahashi, Risa; Putoto, Giovanni; Manenti, Fabio; Betran, Ana Pilar			Changing the role of traditional birth attendants in Yirol West County, South Sudan	PLOS ONE			English	Article							INTERVIEWS; PERSPECTIVE; ENOUGH	Effective from May 2014, community-based traditional birth attendants (TBAs) in Yirol West County, South Sudan, were directed to start referring all women in labour to health facilities for childbirth instead of assisting them in the villages. This study aimed to understand the degree of integration of TBAs in the health system, to reveal the factors influencing the integration, and to explore the perceived solutions to the challenges faced by TBAs. A qualitative study utilising 11 focus group discussions with TBAs, 6 focus group discussions with women, and 18 key informant interviews with members of village health committees, staff of health facilities, and staff of the County Health Department was conducted. Data were analysed using qualitative content analysis. The study found that many TBAs were referring women to health facilities for delivery, but some were still attending to deliveries at home. Facilitators of the adoption of the new role by TBAs were: acceptance of the new TBAs' role by the community, women and TBAs, perceptions about institutional childbirth and risks of home childbirth, personal commitment and motivation by some TBAs, a good working relationship between community-based TBAs and health facility staff, availability of incentives for women at health facilities, and training of TBAs. Challenges of integrating TBAs in the health system included, among others, communication problems between TBAs and health care facilities, delays in seeking care by women, insecurity, lack of materials and supplies for TBAs, health system constraints, insufficient incentives for TBAs, long distances to health facilities and transportation problems. This study has revealed encouraging developments in TBAs' integration in the formal health system in Yirol West. However, there is need to address the challenges faced by TBAs in assuming their new role in order to sustain the integration.	[Wilunda, Calistus] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan; [Dall'Oglio, Giovanni] Doctors Africa CUAMM, Rumbek, South Sudan; [Scanagatta, Chiara; Segafredo, Giulia; Putoto, Giovanni; Manenti, Fabio] Doctors Africa CUAMM, Padua, Italy; [Lukhele, Bhekumusa Wellington] Kyoto Univ, Grad Sch Med, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Lukhele, Bhekumusa Wellington] Kyoto Univ, Sch Publ Hlth, Kyoto, Japan; [Takahashi, Risa] Tenri Hlth Care Univ, Fac Hlth Care, Dept Nursing Sci, Tenri, Nara, Japan; [Betran, Ana Pilar] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, Geneva, Switzerland	Kyoto University; Kyoto University; Kyoto University; The World Bank; United Nations Population Fund; World Health Organization	Wilunda, C (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan.	calistuswilunda@yahoo.co.uk	Dangal, Ganesh/O-1989-2017; Putoto, Giovanni/ABG-2069-2020	Dangal, Ganesh/0000-0002-5834-5525; Wilunda, Calistus/0000-0002-6606-6534; Lukhele, Bhekumusa Wellington/0000-0001-6429-638X	Doctors with Africa CUAMM	Doctors with Africa CUAMM	This study was funded by Doctors with Africa CUAMM as part of a project to improve maternal health services in Yirol West County, South Sudan.	Bisika Thomas, 2008, East Afr J Public Health, V5, P103; Byrne A, 2011, INT J GYNECOL OBSTET, V115, P127, DOI 10.1016/j.ijgo.2011.06.019; Coenen M, 2012, QUAL LIFE RES, V21, P359, DOI 10.1007/s11136-011-9943-2; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Gabrysch S, 2009, B WORLD HEALTH ORGAN, V87, P724, DOI 10.2471/BLT.08.057794; Glenton C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010414.pub2; Green A, 2014, LANCET, V384, P1252, DOI 10.1016/S0140-6736(14)61755-4; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Hagaman AK, 2017, FIELD METHOD, V29, P23, DOI 10.1177/1525822X16640447; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kirchberger I, 2009, DIABETIC MED, V26, P700, DOI 10.1111/j.1464-5491.2009.02762.x; Kitui JE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1307-7; Kruske S, 2004, J MIDWIFERY WOM HEAL, V49, P306, DOI 10.1016/j.jmwh.2004.01.005; Low LK, 2006, MIDWIFERY, V22, P78, DOI 10.1016/j.midw.2005.03.005; Ministry of Health, 2009, BAS PACK HLTH NUTR S; Mullany LC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000317; Pyone T, 2014, INT J GYNECOL OBSTET, V127, P41, DOI 10.1016/j.ijgo.2014.04.009; Saravanan S, 2010, J HEALTH MANAG, V12, P93, DOI 10.1177/097206341001200201; Sibley L, 2004, SOC SCI MED, V59, P1757, DOI 10.1016/j.socscimed.2004.02.009; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Sibley LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460.pub3; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNICEF, 2015, TRACK PROGR MAT NEWB; United Nations Children's Fund (UNICEF) World Health Organization International Bank for Reconstruction and Development/The World Bank, 2020, LEVELS TRENDS CHILD; United Nations Department of Economic and Social Affairs, 2015, SUST DEV GOALS KNOWL; WHO, 2004, MAK PREGN SAF CRIT R; WHO, 2010, REPR HLTH STRAT ACC; Wilunda C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-259; World Health Organization, 2012, WHO REC OPT HLTH WOR; World Health Organization, 1992, TRAD BORTH ATT JOINT; YADAV H, 1987, SMJ Singapore Medical Journal, V28, P520	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0185726	10.1371/journal.pone.0185726	http://dx.doi.org/10.1371/journal.pone.0185726			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095824	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200007
J	Neubauer, G; Pilacka, L; Zielinski, P; Gromadzka, J				Neubauer, Grzegorz; Pilacka, Lucyna; Zielinski, Piotr; Gromadzka, Jadwiga			Population-level body condition correlates with productivity in an arctic wader, the dunlin Calidris alpina, during post-breeding migration	PLOS ONE			English	Article							RED KNOTS; FUEL DEPOSITION; HABITAT QUALITY; SHOREBIRDS; INCUBATION; ARRIVAL; LATITUDES; PATTERNS; WEATHER; SEGREGATION	Weather and predation constitute the two main factors affecting the breeding success of those Arctic waders whose productivity is highly variable over the years. We tested whether reproductive success is associated with the post-breeding condition of adults, in which in `good' years (with warm weather, plentiful food and low predation pressure) the condition of breeders and their productivity is high. To verify this hypothesis, we used a 10-year dataset comprising 20,792 dunlins Calidris alpina, trapped during migration at a stopover site on the southern Baltic Sea shore. Males were consistently in a slightly worse condition than females, likely due to male-biased parental investment in brood rearing. Annual productivity indices were positively correlated with the respective condition indices of breeders from the Eurasian Arctic, indicating that in 'good' years, despite great effort spent on reproduction, breeders leave the breeding grounds in better condition. The pattern did not hold for 1992: productivity was low, but the average condition of adults during migration was the highest noted over the decade. We suggest that the delayed effect of the Mount Pinatubo eruption in the Philippines in 1991, could be responsible for the unexpected high condition of Arctic breeders in 1992. High population-level average condition, coupled with the low productivity could stem from severe weather caused by the volcano eruption a year before and strong predation pressure, which in turn lead to a reduced investment in reproduction. The importance of large-scale episodic phenomena, like this volcano eruption, may blur the statistical associations of wildlife with local environmental drivers.	[Neubauer, Grzegorz; Pilacka, Lucyna; Zielinski, Piotr; Gromadzka, Jadwiga] Polish Acad Sci, Museum & Inst Zool, Ornithol Stn, Nadwislanska 108, Gdansk, Poland; [Neubauer, Grzegorz] Wroclaw Univ, Lab Forest Biol, Ul Sienkiewicza 21, Wroclaw, Poland	Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; University of Wroclaw	Pilacka, L (corresponding author), Polish Acad Sci, Museum & Inst Zool, Ornithol Stn, Nadwislanska 108, Gdansk, Poland.	pilacka@miiz.waw.pl		Neubauer, Grzegorz/0000-0003-2123-0780	Research Grants of National Science Centre (Poland) [NCN2012/07/B/NZ8/02810 LP GN PZ]; Museum and Institute of Zoology, Polish Academy of Sciences JG	Research Grants of National Science Centre (Poland); Museum and Institute of Zoology, Polish Academy of Sciences JG	This work was supported by Research Grants of National Science Centre (Poland) no. NCN2012/07/B/NZ8/02810 LP GN PZ, https://www.ncn.gov.pli?language=en;Ornithological Station, Museum and Institute of Zoology, Polish Academy of Sciences JG, http://www.stornit.gda.pi/index_en.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon-Rotman Y, 2015, OIKOS, V124, P861, DOI 10.1111/oik.01730; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Barton K., 2015, MUMIN MULTIMODEL INF; Battley PF, 2002, THESIS; Beale CM, 2006, IBIS, V148, P405, DOI 10.1111/j.1474-919X.2006.00556.x; Blomqvist S, 2002, OECOLOGIA, V133, P146, DOI 10.1007/s00442-002-1017-2; Borowik OA, 1999, AUK, V116, P1107, DOI 10.2307/4089689; Boyd H, 2001, ARDEA, V89, P301; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Choi CY, 2011, J FIELD ORNITHOL, V82, P202, DOI 10.1111/j.1557-9263.2011.00323.x; Choi CY, 2009, ARDEA, V97, P61, DOI 10.5253/078.097.0108; Clark Jacquie A., 2004, Wader Study Group Bulletin, V104, P51; Cramp S, 1983, HDB BIRDS EUROPE MID, V3; del Hoyo J, 1996, HDB BIRDS WORLD, P3; Duriez O, 2012, OIKOS, V121, P862, DOI 10.1111/j.1600-0706.2012.20326.x; Engelmoer M., 1998, GEOGRAPHICAL VARIATI, DOI DOI 10.1007/978-94-011-5016-3; Ganter B, 2000, ARCTIC, V53, P289; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; GREENWOOD J G, 1984, Ringing and Migration, V5, P35; Gromadzka J., 1998, International Wader Studies, V10, P88; Gromadzka J., 1986, Var Fagelvarld Supplement, P51; Gromadzka J., 1985, Wader Study Group Bulletin, P32; GROMADZKA J, 1989, ORNIS SCAND, V20, P132, DOI 10.2307/3676881; Gromadzka J., 1998, WADER STUDY GR B, V10, P85; Gunnarsson TG, 2006, J ANIM ECOL, V75, P1119, DOI 10.1111/j.1365-2656.2006.01131.x; Gunnarsson TG, 2017, IBIS, V159, P467, DOI 10.1111/ibi.12449; Harrison XA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077783; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; HOLMES RT, 1966, CONDOR, V68, P3, DOI 10.2307/1365173; Jamieson SE, 2011, J ORNITHOL, V152, P1013, DOI 10.1007/s10336-011-0691-4; JEHL JR, 1970, ECOLOGY, V52, P169; Klaassen M, 2001, NATURE, V413, P794, DOI 10.1038/35101654; Klaassen M, 2003, AVIAN MIGRATION, P237; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Lappo E.G., 1998, International Wader Studies, V10, P152; Lehikoinen A, 2016, ORNIS FENNICA, V93, P31; Lopes RJ, 2008, DIVERS DISTRIB, V14, P732, DOI 10.1111/j.1472-4642.2008.00480.x; Lopes RJ, 2006, J ORNITHOL, V147, P385, DOI 10.1007/s10336-005-0048-y; Marthinsen G, 2007, BIOL J LINN SOC, V92, P713, DOI 10.1111/j.1095-8312.2007.00931.x; Meissner W., 2007, WADER STUDY GR B, V115, P16; Meissner Wlodzimierz, 1995, Notatki Ornitologiczne, V36, P205; Meissner W, 2015, ARDEOLA, V62, P335; Meissner W, 2015, J ORNITHOL, V156, P47, DOI 10.1007/s10336-014-1132-y; Meissner Wlodzimierz, 2009, Wader Study Group Bulletin, V116, P35; Meissner Wlodzimierz, 2006, Ring, V28, P33; Meissner Wlodzimierz, 2005, Wader Study Group Bulletin, V108, P53; Meissner W, 2008, ORNIS FENNICA, V85, P135; Meltofte H., 2007, MEDDELELSER GRONLAND, V59; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Morrison RIG, 2005, CONDOR, V107, P449, DOI 10.1650/7614; Morrison RIG, 2004, AUK, V121, P333, DOI 10.1642/0004-8038(2004)121[0333:UOBSIS]2.0.CO;2; Morrissette M, 2010, OIKOS, V119, P1181, DOI 10.1111/j.1600-0706.2009.18079.x; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Newton I, 2010, MIGRATION ECOLOGY BI; Nol E, 1997, CONDOR, V99, P389, DOI 10.2307/1369945; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; O'Connor CM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00388.1; Ockendon N, BIOL LET, V2013; PIENKOWSKI MW, 1979, BIRD STUDY, V26, P134, DOI 10.1080/00063657909476632; Piersma T, 2002, INTEGR COMP BIOL, V42, P51, DOI 10.1093/icb/42.1.51; Prater AJ, 1977, GUIDE IDENTIFICATION, P380; Reneerkens Jeroen, 2005, Wader Study Group Bulletin, V106, P12; Robinson Robert A., 2005, Wader Study Group Bulletin, V106, P17; Sandercock BK, 1998, J FIELD ORNITHOL, V69, P235; Schamel D, 2003, W SANDP WORKSH JAN; Shepherd PCF, 2001, CONDOR, V103, P352, DOI 10.1650/0010-5422(2001)103[0352:SRODWA]2.0.CO;2; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; SOIKKELI M, 1967, Annales Zoologici Fennici, V4, P158; Soloviev MY, 1997, J ORNITHOL, V138, P271, DOI 10.1007/BF01651552; Stearns S.C., 1992, pi; SUMMERS RW, 1987, BIRD STUDY, V34, P161, DOI 10.1080/00063658709476955; Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180; Tomkovich Pavel S., 1994, Wader Study Group Bulletin, V75, P20; Tulp I, 2006, J AVIAN BIOL, V37, P207, DOI 10.1111/j.2006.0908-8857.03519.x; Tulp I, 2002, IBIS, V144, P122, DOI 10.1046/j.0019-1019.2001.00014.x; Tulp I, 2008, ARCTIC, V61, P48; Tulp I, 2009, AUK, V126, P155, DOI 10.1525/auk.2009.07181; Tulp I, 2009, POLAR BIOL, V32, P481, DOI 10.1007/s00300-008-0543-8; Wennerberg L, 2001, MOL ECOL, V10, P1111, DOI 10.1046/j.1365-294X.2001.01256.x; Wennerberg L, 1999, IBIS, V141, P391, DOI 10.1111/j.1474-919X.1999.tb04408.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur A. F., 2014, BEGINNERS GUIDE GEN; Zuur AF, BEGINNERS GUIDE GEN, V2; Zuur Alain F., 2009, P1	85	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187370	10.1371/journal.pone.0187370	http://dx.doi.org/10.1371/journal.pone.0187370			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091970	Green Submitted, Green Published, gold			2022-12-27	WOS:000414229700061
J	Christie, MP; Hu, SH; Whitten, AE; Rehman, A; Jarrott, RJ; King, GJ; Collins, BM; Martin, JL				Christie, Michelle P.; Hu, Shu-Hong; Whitten, Andrew E.; Rehman, Asma; Jarrott, Russell J.; King, Gordon J.; Collins, Brett M.; Martin, Jennifer L.			Revisiting interaction specificity reveals neuronal and adipocyte Munc18 membrane fusion regulatory proteins differ in their binding interactions with partner SNARE Syntaxins	PLOS ONE			English	Article							SYNAPTIC VESICLE DOCKING; N-PEPTIDE; COMPLEX; MODE	The efficient delivery of cellular cargo relies on the fusion of cargo-carrying vesicles with the correct membrane at the correct time. These spatiotemporal fusion events occur when SNARE proteins on the vesicle interact with cognate SNARE proteins on the target membrane. Regulatory Munc18 proteins are thought to contribute to SNARE interaction specificity through interaction with the SNARE protein Syntaxin. Neuronal Munc18a interacts with Syntaxin1 but not Syntaxin4, and adipocyte Munc18c interacts with Syntaxin4 but not Syntaxin1. Here we show that this accepted view of specificity needs revision. We find that Munc18c interacts with both Syntaxin4 and Syntaxin1, and appears to bind "noncognate" Syntaxin1 a little more tightly than Syntaxin4. Munc18a binds Syntaxin1 and Syntaxin4, though it interacts with its cognate Syntaxin1 much more tightly. We also observed that when bound to non-cognate Munc18c, Syntaxin1 captures its neuronal SNARE partners SNAP25 and VAMP2, and Munc18c can bind to pre-formed neuronal SNARE ternary complex. These findings reveal that Munc18a and Munc18c bind Syntaxins differently. Munc18c relies principally on the Syntaxin N-peptide interaction for binding Syntaxin4 or Syntaxin1, whereas Munc18a can bind Syntaxin1 tightly whether or not the Syntaxin1 N-peptide is present. We conclude that Munc18a and Munc18c differ in their binding interactions with Syntaxins: Munc18a has two tight binding modes/sites for Syntaxins as defined previously but Munc18c has just one that requires the N-peptide. These results indicate that the interactions between Munc18 and Syntaxin proteins, and the consequences for in vivo function, are more complex than can be accounted for by binding specificity alone.	[Christie, Michelle P.; Hu, Shu-Hong; Whitten, Andrew E.; Rehman, Asma; Jarrott, Russell J.; King, Gordon J.; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld, Australia; [Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Div Cell Biol & Mol Med, St Lucia, Qld, Australia; [Martin, Jennifer L.] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Christie, Michelle P.] St Vincents Inst, Fitzroy, Vic, Australia; [Hu, Shu-Hong; Jarrott, Russell J.] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Whitten, Andrew E.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW, Australia; [Rehman, Asma] Dulbecco Telethon Inst, Genoa, Italy	University of Queensland; University of Queensland; Griffith University; St. Vincent's Institute of Medical Research; Griffith University; Australian Nuclear Science & Technology Organisation; Fondazione Telethon; Dulbecco Telethon Institute (DTI)	Christie, MP; Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld, Australia.; Christie, MP (corresponding author), St Vincents Inst, Fitzroy, Vic, Australia.	mchristie@svi.edu.au; jlm@griffith.edu.au	Martin, Jennifer L./A-6039-2010; Rehman, Asma/X-4632-2018; Collins, Brett/J-1563-2014	Martin, Jennifer L./0000-0002-9225-8863; Whitten, Andrew/0000-0001-8856-3120; Christie, Michelle/0000-0002-7001-3400; Rehman, Asma/0000-0002-0653-9053; Collins, Brett/0000-0002-6070-3774; Jarrott, Russell/0000-0003-4326-1203	Australian National Health and Medical Research Council (NHMRC) [535921]; NHMRC Peter Doherty Fellowship [569864]; NHMRC Career Development Fellowship [APP1061574]; Australian Research Council Laureate Fellowship [FL0992138]; NHMRC Fellowship [455829];  [1066069];  [1080995]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Laureate Fellowship(Australian Research Council); NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ; 	This work was supported by the Australian National Health and Medical Research Council (NHMRC, www.nhmrc.gov.au) through program grant 535921 (to JLM) and then project grants 1066069 and 1080995 (to AEW and JLM). AEW was supported by an NHMRC Peter Doherty Fellowship (569864); BMC by an NHMRC Career Development Fellowship (APP1061574); JLM by an Australian Research Council (www.arc.gov.au) Laureate Fellowship (FL0992138) and then NHMRC Fellowship (455829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Burkhardt P, 2011, P NATL ACAD SCI USA, V108, P15264, DOI 10.1073/pnas.1106189108; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Christie MP, 2012, P NATL ACAD SCI USA, V109, P9816, DOI 10.1073/pnas.1116975109; Colbert KN, 2013, P NATL ACAD SCI USA, V110, P12637, DOI 10.1073/pnas.1303753110; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Genc O, 2014, ELIFE, V3, DOI 10.7554/eLife.01715; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Li YS, 2017, WIREL COMMUN MOB COM, P1, DOI 10.1155/2017/8056126; Lou XC, 2015, J BIOL CHEM, V290, P10535, DOI 10.1074/jbc.M114.631341; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rehman A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183366; Rehman A, 2014, IUCRJ, V1, P505, DOI 10.1107/S2052252514020727; Rehman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083499; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Spessott WA, 2017, P NATL ACAD SCI USA, V114, pE2176, DOI 10.1073/pnas.1617981114; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Togneri J, 2006, P NATL ACAD SCI USA, V103, P17730, DOI 10.1073/pnas.0605448103; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhang YX, 2015, J BIOL CHEM, V290, P10518, DOI 10.1074/jbc.M114.630772	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187302	10.1371/journal.pone.0187302	http://dx.doi.org/10.1371/journal.pone.0187302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088285	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900063
J	Lamb, LE; Janicki, JJ; Bartolone, SN; Peters, KM; Chancellor, MB				Lamb, Laura E.; Janicki, Joseph J.; Bartolone, Sarah N.; Peters, Kenneth M.; Chancellor, Michael B.			Development of an interstitial cystitis risk score for bladder permeability	PLOS ONE			English	Article							URINE MARKERS; INTERLEUKIN-6; PREVALENCE; SYMPTOMS; SERUM	Background Interstitial cystitis/bladder pain syndrome (IC) is a multifactorial syndrome of severe pelvic and genitalia pain and compromised urinary function; a subset of IC patients present with Hunner's lesions or ulcers on their bladder walls (UIC). UIC is diagnosed by cystoscopy, which may be quite painful. The objective of this study was to determine if a calculated Bladder Permeability Defect Risk Score (BP-RS) based on non-invasive urinary cytokines could discriminate UIC patients from controls and IC patients without Hunner's ulcers. Methods A national crowdsourcing effort targeted IC patients and age-matched controls to provide urine samples. Urinary cytokine levels for GRO, IL-6, and IL-8 were determined using a Luminex assay. Results We collected 448 urine samples from 46 states consisting of 153 IC patients (147 female, 6 male), of which 54 UIC patients (50 females, 4 male), 159 female controls, and 136 male controls. A defined BP-RS was calculated to classify UIC, or a bladder permeability defect etiology, with 89% validity. Conclusions The BP-RS Score quantifies UIC risk, indicative of a bladder permeability defect etiology in a subset of IC patients. The Bladder Permeability Defect Risk Score is the first validated urine biomarker assay for interstitial cystitis/bladder pain syndrome.	[Lamb, Laura E.; Bartolone, Sarah N.; Peters, Kenneth M.; Chancellor, Michael B.] Beaumont Hlth Syst, Dept Urol, Royal Oak, MI 48073 USA; [Lamb, Laura E.; Peters, Kenneth M.; Chancellor, Michael B.] Oakland Univ, William Beaumont Sch Med, Rochester Hills, MI 48309 USA; [Janicki, Joseph J.] Underact Bladder Fdn, Pittsburgh, PA USA	Beaumont Health; Oakland University	Chancellor, MB (corresponding author), Beaumont Hlth Syst, Dept Urol, Royal Oak, MI 48073 USA.; Chancellor, MB (corresponding author), Oakland Univ, William Beaumont Sch Med, Rochester Hills, MI 48309 USA.	Michael.Chancellor@Beaumont.Org		Chancellor, Michael/0000-0001-9480-8972; Lamb, Laura/0000-0003-0386-4165; Bartolone, Sarah/0000-0001-9040-7055	Taubman Research Fund; Interstitial Cystitis Association (ICA)	Taubman Research Fund; Interstitial Cystitis Association (ICA)	This work is supported by the Taubman Research Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the interstitial cystitis community that contributed to this study and the Interstitial Cystitis Association (ICA; http://www.ichelp.org/) for assistance with participant recruitment and supporting IC research. We also acknowledge Andrew Vereecke and Lynn Paul for helping with the execution of the IP4IC study.	Belknap S, 2015, DRUGS, V75, P2057, DOI 10.1007/s40265-015-0504-9; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Bourgeois FT, 2007, J AM MED INFORM ASSN, V14, P765, DOI 10.1197/jamia.M2134; Cao EH, 2003, BIOTECHNOL BIOENG, V82, P684, DOI 10.1002/bit.10612; Chen MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061901; Clemens JQ, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-57; Daniels NA, 2007, J NATL MED ASSOC, V99, P509; Davidoff R, 1997, J UROLOGY, V157, P1980, DOI 10.1016/S0022-5347(01)64914-0; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Erickson DR, 1997, J UROLOGY, V158, P790, DOI 10.1016/S0022-5347(01)64317-9; Erickson DR, 2002, J UROLOGY, V167, P2461, DOI 10.1016/S0022-5347(05)65005-7; GEISER T, 1993, J BIOL CHEM, V268, P15419; Hanno PM, 2015, J UROLOGY, V193, P1545, DOI 10.1016/j.juro.2015.01.086; Hanno Philip M, 2002, Rev Urol, V4 Suppl 1, pS3; Herrington W, 2016, CLIN J AM SOC NEPHRO, V11, P1794, DOI 10.2215/CJN.13341215; Hurst RE, 2015, TRANSL ANDROL UROL, V4, P563, DOI 10.3978/j.issn.2223-4683.2015.10.03; Keay S, 1998, UROLOGY, V52, P974, DOI 10.1016/S0090-4295(98)00488-9; Keay SK, 2001, UROLOGY, V57, P9, DOI 10.1016/S0090-4295(01)01127-X; Kuo HC, 2014, INT J UROL, V21, P34, DOI 10.1111/iju.12311; Lamale LM, 2006, UROLOGY, V68, P702, DOI 10.1016/j.urology.2006.04.033; Lee JW, 2005, COMPUT STAT DATA AN, V48, P869, DOI 10.1016/j.csda.2004.03.017; LOTZ M, 1994, J UROLOGY, V152, P869, DOI 10.1016/S0022-5347(17)32594-6; Maeda D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143316; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Ogawa T, 2010, J UROLOGY, V183, P1206, DOI 10.1016/j.juro.2009.11.007; Parker KS, 2016, EBIOMEDICINE, V7, P167, DOI 10.1016/j.ebiom.2016.03.040; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qi YJ, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P307, DOI 10.1007/978-1-4419-9326-7_11; SEGUCHI T, 1992, J UROLOGY, V148, P791, DOI 10.1016/S0022-5347(17)36721-6; Suskind AM, 2013, J UROLOGY, V189, P141, DOI 10.1016/j.juro.2012.08.088; Tamaki M, 2004, J UROLOGY, V172, P945, DOI 10.1097/01.ju.0000135009.55905.cb; Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034; Zhang Chen-Ou, 2005, BMC Urol, V5, P7, DOI 10.1186/1471-2490-5-7	33	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0185686	10.1371/journal.pone.0185686	http://dx.doi.org/10.1371/journal.pone.0185686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088231	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900004
J	Barrett, AN; Xiong, L; Tana, TZ; Advani, HV; Hua, R; Laureano-Asibal, C; Soong, R; Biswas, A; Nagarajan, N; Choolani, M				Barrett, Angela N.; Xiong, Li; Tana, Tuan Z.; Advani, Henna V.; Hua, Rui; Laureano-Asibal, Cecille; Soong, Richie; Biswas, Arijit; Nagarajan, Niranjan; Choolani, Mahesh			Measurement of fetal fraction in cell-free DNA from maternal plasma using a panel of insertion/deletion polymorphisms	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; DIGITAL PCR; MONOGENIC DISEASES; ANEUPLOIDY; MUTATIONS; REVEALS; MARKER	Objective Cell-free DNA from maternal plasma can be used for non-invasive prenatal testing for aneuploidies and single gene disorders, and also has applications as a biomarker for monitoring high-risk pregnancies, such as those at risk of pre-eclampsia. On average, the fractional cell-free fetal DNA concentration in plasma is approximately 15%, but can vary from less than 4% to greater than 30%. Although quantification of cell-free fetal DNA is straightforward in the case of a male fetus, there is no universal fetal marker; in a female fetus measurement is more challenging. We have developed a panel of multiplexed insertion/deletion polymorphisms that can measure fetal fraction in all pregnancies in a simple, targeted sequencing reaction. Methods A multiplex panel of primers was designed for 35 indels plus a ZFX/ZFY amplicon. cfDNA was extracted from plasma from 157 pregnant women, and maternal genomic DNA was extracted for 20 of these samples for panel validation. Sixty-one samples from pregnancies with a male fetus were subjected to whole genome sequencing on the Ion Proton sequencing platform, and fetal fraction derived from Y chromosome counts was compared to fetal fraction measured using the indel panel. A total of 157 cell-free DNA samples were sequenced using the indel panel, and informativity was assessed, along with the proportion of fetal DNA. Results Using gDNA we optimised the indel panel, removing amplicons giving rise to PCR bias. Good correlation was found between fetal fraction using indels and using whole genome sequencing of the Y chromosome (Spearmans r = 0.69). A median of 12 indels were informative per sample. The indel panel was informative in 157/157 cases (mean fetal fraction 14.4% (+/- 0.58%)). Conclusions Using our targeted next generation sequencing panel we can readily assess the fetal DNA percentage in male and female pregnancies.	[Barrett, Angela N.; Xiong, Li; Advani, Henna V.; Hua, Rui; Laureano-Asibal, Cecille; Biswas, Arijit; Choolani, Mahesh] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore; [Xiong, Li; Hua, Rui] Soothern Med Univ, Nanfang Hosp, Dept Gynecol & Obstet, Guangzhou, Guangdong, Peoples R China; [Tana, Tuan Z.; Soong, Richie] Natl Univ Singapore, Canc Sci Inst, Singapore, Singapore; [Nagarajan, Niranjan] Genome Inst Singapore, Singapore, Singapore	National University of Singapore; Southern Medical University - China; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Barrett, AN; Choolani, M (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore.	obganb@nus.edu.sg; obgmac@nus.edu.sg		Nagarajan, Niranjan/0000-0003-0850-5604	National Medical Research Council/Clinician Scientist Award [NMRC/CSA/0059/2014]	National Medical Research Council/Clinician Scientist Award	We acknowledge the National Medical Research Council/Clinician Scientist Award (NMRC/CSA/0059/2014) for supporting our work. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry MS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.063; Barrett AN, 2012, CLIN CHEM, V58, P1026, DOI 10.1373/clinchem.2011.178939; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Canick JA, 2013, PRENATAL DIAG, V33, P667, DOI 10.1002/pd.4126; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chan KCA, 2016, P NATL ACAD SCI USA, V113, pE8159, DOI 10.1073/pnas.1615800113; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; De Vlaminck I, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007803; Dugoff L, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.009; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Hidestrand M, 2012, FETAL DIAGN THER, V31, P122, DOI 10.1159/000335020; Hudecova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088484; Jiang PY, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.13; Jiang PY, 2012, BIOINFORMATICS, V28, P2883, DOI 10.1093/bioinformatics/bts549; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim SK, 2015, PRENATAL DIAG, V35, P810, DOI 10.1002/pd.4615; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Lam KWG, 2012, CLIN CHEM, V58, P1467, DOI 10.1373/clinchem.2012.189589; Lench N, 2013, PRENATAL DIAG, V33, P555, DOI 10.1002/pd.4124; Lo KK, 2014, BIOINFORMATICS, V30, P2965, DOI 10.1093/bioinformatics/btu419; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Lun FMF, 2013, CLIN CHEM, V59, P1583, DOI 10.1373/clinchem.2013.212274; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Martin A, 2014, PRENATAL DIAG, V34, P685, DOI 10.1002/pd.4416; Miura K, 2006, CLIN CHEM, V52, P2121, DOI 10.1373/clinchem.2006.075697; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Peng XL, INT J MOL SCI, V18, pE453; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rozen S, 2000, Methods Mol Biol, V132, P365; Samango-Sprouse C, 2013, PRENATAL DIAG, V33, P643, DOI 10.1002/pd.4159; Shih DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016090; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; Sparks AB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.030; Straver R, 2016, PRENATAL DIAG, V36, P614, DOI 10.1002/pd.4816; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Takoudes T, 2015, ULTRASOUND OBST GYN, V45, P112, DOI 10.1002/uog.14715; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; van Beek DM, 2017, PRENATAL DIAG, V37, P769, DOI 10.1002/pd.5079; Wataganara T, 2016, BJOG-INT J OBSTET GY, V123, P31, DOI 10.1111/1471-0528.14197; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Yu SCY, 2014, P NATL ACAD SCI USA, V111, P8583, DOI 10.1073/pnas.1406103111; Zhong Q, 2011, LAB CHIP, V11, P2167, DOI 10.1039/c1lc20126c; Zimmermann B, 2012, PRENATAL DIAG, V32, P1233, DOI 10.1002/pd.3993	46	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186771	10.1371/journal.pone.0186771	http://dx.doi.org/10.1371/journal.pone.0186771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084245	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200011
J	Sato, T; Usui, M; Konishi, N; Kai, A; Matsui, H; Hanaki, H; Tamura, Y				Sato, Tomomi; Usui, Masaru; Konishi, Noriko; Kai, Akemi; Matsui, Hidehito; Hanaki, Hideaki; Tamura, Yutaka			Closely related methicillin-resistant Staphylococcus aureus isolates from retail meat, cows with mastitis, and humans in Japan	PLOS ONE			English	Article							MULTIPLEX PCR; STRAINS; EPIDEMIOLOGY; IDENTIFICATION; OUTBREAK; SEQUENCE; MILK; INFECTIONS; PRODUCTS; PATTERNS	Methicillin-resistant Staphylococcus aureus (MRSA) is a pervasive healthcare-acquired (HA) pathogen with recent emergence as a community-acquired (CA) pathogen. To elucidate whether meat mediates MRSA transmission between animals and humans in Japan, this study examined MRSA isolates from retail meat (n = 8), cows with mastitis (n = 7), and humans (HA-MRSA = 46 and CA-MRSA = 54) by molecular typing, virulence gene analyses, and antimicrobial susceptibility testing. MRSA isolates from retail meat were classified into sequence type (ST) 8/spa type t1767 (n = 4), ST8/t4133 (n = 1), ST59/t3385 (n = 1), ST88/t375 (n = 1), and ST509/t375 (n = 1). All seven MRSA isolates from cows with mastitis were ST8/t1767. 46 HA-MRSA were clonal complex (CC) 5, divided into t002 (n = 30), t045 (n = 12), and t7455 (n = 4). 54 CA-MRSA were classified into 6 different CCs: CC1 (n = 14), CC5 (n = 7), CC8 (n = 29), CC45 (n = 1), CC89 (n = 1), CC509 (n = 1), and into 16 different spa types including newly identified t17177, t17193, and t17194. The majority were CC8/t1767 (n = 16). CC of one CA-MRSA isolate (spa type t1767) was not classified. Among 41 CC8 MRSA (five from meat, seven from cows with mastitis, and 29 CA-MRSA), 14 ST8/SCCmec IVl isolates (three from meat, one from a cow with mastitis, and 10 CA-MRSA) had identical pulsed-field gel electrophoresis patterns and similar spa type (t1767, t4133, and t17177), and were typed as CA-MRSA/J (ST8/SCCmec IVl, positive for sec + sel + tst but negative for Panton-Valentine leukocidin and the arginine catabolic mobile element). These results suggest that there is a transmission cycle of CA-MRSA/J among meat, cows, and humans in Japan, although it is unclear whether the origin is cow.	[Sato, Tomomi; Usui, Masaru; Tamura, Yutaka] Rakuno Gakuen Univ, Sch Vet Med, Dept Hlth & Environm Sci, Lab Food Microbiol & Food Safety, Ebetsu, Hokkaido, Japan; [Konishi, Noriko] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Shinjuku Ku, Tokyo, Japan; [Kai, Akemi] Tokyo Med Univ, Dept Microbiol, Shinjuku Ku, Tokyo, Japan; [Matsui, Hidehito; Hanaki, Hideaki] Kitasato Univ, Infect Control Res Ctr, Minato Ku, Tokyo, Japan	Rakuno Gakuen University; Tokyo Medical University; Kitasato University	Tamura, Y (corresponding author), Rakuno Gakuen Univ, Sch Vet Med, Dept Hlth & Environm Sci, Lab Food Microbiol & Food Safety, Ebetsu, Hokkaido, Japan.	tamuray@rakuno.ac.jp						Al-Talib H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-113; Asao T, 2003, EPIDEMIOL INFECT, V130, P33, DOI 10.1017/S0950268802007951; Baba K, 2010, INT J ANTIMICROB AG, V36, P352, DOI 10.1016/j.ijantimicag.2010.06.040; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Chuang YY, 2015, INT J ANTIMICROB AG, V45, P334, DOI 10.1016/j.ijantimicag.2014.12.007; Cremonesi P, 2005, MOL CELL PROBE, V19, P299, DOI 10.1016/j.mcp.2005.03.002; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Deiters C, 2015, INT J MED MICROBIOL, V305, P110, DOI 10.1016/j.ijmm.2014.11.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Hata E, 2016, J VET DIAGN INVEST, V28, P291, DOI 10.1177/1040638716643126; Hata E, 2010, J CLIN MICROBIOL, V48, P2130, DOI 10.1128/JCM.01940-09; Hennekinne JA, 2012, FEMS MICROBIOL REV, V36, P815, DOI 10.1111/j.1574-6976.2011.00311.x; Iwaki M, 2011, YAKUGAKU ZASSHI, V131, P1653, DOI 10.1248/yakushi.131.1653; Iwao Y, 2012, J INFECT CHEMOTHER, V18, P96, DOI 10.1007/s10156-011-0348-5; Juhasz-kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P3; Kitai S, 2005, J VET MED SCI, V67, P107, DOI 10.1292/jvms.67.107; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2010, CLIN MICROBIOL INFEC, V16, P11, DOI 10.1111/j.1469-0691.2009.03110.x; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Molla B, 2012, J CLIN MICROBIOL, V50, P3687, DOI 10.1128/JCM.01971-12; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Murakami K, 2002, JAPANESE J FOOD MICR, V19, P127; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; Ogata K, 2012, APPL ENVIRON MICROB, V78, P2797, DOI 10.1128/AEM.07470-11; Pantosti A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00127; Rodriguez-Lazaro D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01344; Sato T, 2015, J GLOB ANTIMICROB RE, V3, P283, DOI 10.1016/j.jgar.2015.07.009; Sheng WH, 2009, DIAGN MICR INFEC DIS, V63, P309, DOI 10.1016/j.diagmicrobio.2008.11.014; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Suzuki M, 2009, J APPL MICROBIOL, V107, P1367, DOI 10.1111/j.1365-2672.2009.04321.x; Verhegghe M., 2015, International Journal of Food Contamination, V2, DOI 10.1186/s40550-015-0013-3; Wayne P, 2014, M100S24 CLIN LAB S S; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9	38	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187319	10.1371/journal.pone.0187319	http://dx.doi.org/10.1371/journal.pone.0187319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084288	Green Submitted, Green Published, gold			2022-12-27	WOS:000413910200049
J	Abatangelo, V; Bacci, NP; Boncompain, CA; Amadio, AF; Carrasco, S; Suarez, CA; Morbidoni, HR				Abatangelo, Virginia; Bacci, Natalia Peressutti; Boncompain, Carina A.; Amadio, Ariel F.; Carrasco, Soledad; Suarez, Cristian A.; Morbidoni, Hector R.			Broad-range lytic bacteriophages that kill Staphylococcus aureus local field strains (vol 12, e0181671, 2017)	PLOS ONE			English	Correction														Carrasco, Soledad Telma/0000-0003-2515-1932; Amadio, Ariel Fernando/0000-0002-1147-4485				Abatangelo V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181671	1	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187387	10.1371/journal.pone.0187387	http://dx.doi.org/10.1371/journal.pone.0187387			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077755	Green Submitted, gold, Green Published			2022-12-27	WOS:000413861200062
J	Kim, DH; Park, J; Kahng, B				Kim, Do-Hyun; Park, Jinha; Kahng, Byungnam			Enhanced storage capacity with errors in scale-free Hopfield neural networks: An analytical study	PLOS ONE			English	Article							SMALL-WORLD; CONNECTIVITY; MODEL; HUBS	The Hopfield model is a pioneering neural network model with associative memory retrieval. The analytical solution of the model in mean field limit revealed that memories can be retrieved without any error up to a finite storage capacity of O( N), where N is the system size. Beyond the threshold, they are completely lost. Since the introduction of the Hopfield model, the theory of neural networks has been further developed toward realistic neural networks using analog neurons, spiking neurons, etc. Nevertheless, those advances are based on fully connected networks, which are inconsistent with recent experimental discovery that the number of connections of each neuron seems to be heterogeneous, following a heavytailed distribution. Motivated by this observation, we consider the Hopfield model onscalefree networks and obtain a different pattern of associative memory retrieval from that obtained on the fully connected network: the storage capacity becomes tremendously enhanced but with some error in the memory retrieval, which appears as the heterogeneity of the connections is increased. Moreover, the error rates are also obtained on several real neural networks and are indeed similar to that on scale-free model networks.	[Kim, Do-Hyun] Sogang Univ, Dept Phys, Seoul, South Korea; [Park, Jinha; Kahng, Byungnam] Seoul Natl Univ, CCSS, CTP, Seoul, South Korea; [Park, Jinha; Kahng, Byungnam] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea	Sogang University; Seoul National University (SNU); Seoul National University (SNU)	Kim, DH (corresponding author), Sogang Univ, Dept Phys, Seoul, South Korea.; Kahng, B (corresponding author), Seoul Natl Univ, CCSS, CTP, Seoul, South Korea.; Kahng, B (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea.	dohyunkim@sogang.ac.kr; bkahng@snu.ac.kr		Kim, Do-Hyun/0000-0002-8384-668X	National Research Foundation of Korea [2014R1A3A2069005, 2015R1A5A7037676]; Sogang University [201610033.01, 201710066.01]; NRF of Korea [2014R1A3A2069005, 2015R1A5A7037676]	National Research Foundation of Korea(National Research Foundation of Korea); Sogang University; NRF of Korea	This work was supported by the National Research Foundation of Korea (http://www.nrf.re.kr): Grant Nos. 2014R1A3A2069005 and 2015R1A5A7037676 to B. Kahng and by Sogang University (http://www.sogang.ac.kr): Grant No. 201610033.01 and 201710066.01 to D.-H. Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the NRF of Korea (Grant Nos. 2014R1A3A2069005 and 2015R1A5A7037676) and Sogang University (Grant Nos. 201610033.01 and 201710066.01). We would like to express our appreciation toward S.-H. Lee and Joonwon Lee.	Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; AMIT DJ, 1987, ANN PHYS-NEW YORK, V173, P30, DOI 10.1016/0003-4916(87)90092-3; Amit DJ, 1989, MODELING BRAIN FUNCT; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartol TM, 2015, ELIFE, V4, DOI 10.7554/eLife.10778; BOLLOBAS B., 2001, RANDOM GRAPHS, V73, DOI 10.1017/CBO9780511814068.008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Castillo IP, 2004, J PHYS A-MATH GEN, V37, P8789, DOI 10.1088/0305-4470/37/37/002; Cho YS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.135702; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; ERDOS P, 1960, B INT STATIST INST, V38, P343; Erdos P., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kandel ER, 2013, PRINCIPLES NEURAL SC, V5; Kim DH, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056115; Kim DH, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022803; Lee JS, 2006, EUR PHYS J B, V49, P231, DOI 10.1140/epjb/e2006-00051-y; Mezard M., 1987, WORLD SCI LECT NOT P, V9; Nishimori H., 2001, STAT PHYS SPIN GLASS; Rubinov Mikail, 2013, Dialogues Clin Neurosci, V15, P339; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stauffer D, 2003, EUR PHYS J B, V32, P395, DOI 10.1140/epjb/e2003-00114-7; Steullet P, 2014, SCHIZOPHR RES; Torres JJ, 2004, NEUROCOMPUTING, V58, P229, DOI 10.1016/j.neucom.2004.01.048; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012	32	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0184683	10.1371/journal.pone.0184683	http://dx.doi.org/10.1371/journal.pone.0184683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077721	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200001
J	Marot, A; Henrion, J; Knebel, JF; Moreno, C; Deltenre, P				Marot, Astrid; Henrion, Jean; Knebel, Jean-Francois; Moreno, Christophe; Deltenre, Pierre			Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HEPATITIS-C; CLINICAL-COURSE; COMPETING RISK; MODEL; STEATOHEPATITIS; SURVIVAL; OUTCOMES; MORTALITY; CANCER	Background Cirrhosis is a heterogeneous clinical condition that includes patients at wide-ranging stages of severity. The role of the underlying liver disease on patient prognosis remains unclear. Aim To assess the impact of the underlying liver disease on the occurrence of hepatocellular carcinoma (HCC) and death. Methods Data related to the occurrence of HCC and death were collected during a 21-year period among patients with cirrhosis related to alcoholic liver disease (ALD) (n = 529), chronic hepatitis C virus (HCV) infection (n = 145) or non-alcoholic fatty liver disease (NAFLD) (n = 78). Results At inclusion, ALD patients were younger than HCV and NAFLD patients (56 vs. 67 vs. 63 years; p<0.001) and had worse liver function (percent of patients with Child-Pugh stages B or C: 48% vs. 8% vs. 17%; p<0.001). During follow-up, 85 patients developed HCC and 379 died. The 10-year cumulative incidence rate of HCC was lower in ALD patients than in HCV and NAFLD patients (8.4% vs. 22.0% vs. 23.7%; p<0.001). The 10-year cumulative incidence rates of mortality were not statistically different between ALD, HCV and NAFLD patients (58.1% vs. 47.7% vs. 49.9%; p = 0.078). Alcohol abstinence and viral eradication were associated with reduced mortality among ALD and HCV patients, respectively. In multivariate analyses, ALD was associated with a reduced risk of HCC (0.39; 95% CI, 0.20-0.76; p = 0.005) but with a higher risk of mortality (1.53; 95% CI, 1.20-1.95; p<0.001). ALD patients died more frequently from decompensation of cirrhosis. Conclusion Despite a lower incidence of HCC, patients with ALD-related cirrhosis have a worse outcome than those with chronic HCV infection or NAFLD-related cirrhosis.	[Marot, Astrid; Deltenre, Pierre] Univ Lausanne, Div Gastroenterol & Hepatol, CHU Vaudois, Lausanne, Switzerland; [Henrion, Jean] Ctr Hosp Jolimont, Div Gastroenterol & Hepatol, Haine St Paul, Belgium; [Knebel, Jean-Francois] Univ Hosp Ctr, Dept Radiol, Lab Investigat Neurophysiol LINE, Lausanne, Switzerland; [Knebel, Jean-Francois] Univ Hosp Ctr, Dept Clin Neurosci, Lausanne, Switzerland; [Knebel, Jean-Francois] Univ Lausanne, Lausanne, Switzerland; [Knebel, Jean-Francois] Ctr Biomed Imaging CIBM, EEG Brain Mapping Core, Lausanne, Switzerland; [Moreno, Christophe; Deltenre, Pierre] Univ Libre Bruxelles, CUB Hop Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Groupe Jolimont; University of Lausanne; Universite Libre de Bruxelles	Deltenre, P (corresponding author), Univ Lausanne, Div Gastroenterol & Hepatol, CHU Vaudois, Lausanne, Switzerland.; Deltenre, P (corresponding author), Univ Libre Bruxelles, CUB Hop Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium.	pierre.deltenre01@gmail.com		Deltenre, Pierre/0000-0002-4253-6028; Knebel, Jean-Francois/0000-0003-1665-1724				Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Bartosch B, 2009, J HEPATOL, V51, P810, DOI 10.1016/j.jhep.2009.05.008; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cholongitas E, 2005, ALIMENT PHARM THERAP, V22, P1079, DOI 10.1111/j.1365-2036.2005.02691.x; Deuffic-Burban S, 2012, GASTROENTEROLOGY, V143, P974, DOI 10.1053/j.gastro.2012.05.054; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Giannini EG, 2012, HEPATOLOGY, V56, P1371, DOI 10.1002/hep.25814; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Ioannou GN, 2007, CLIN GASTROENTEROL H, V5, P938, DOI 10.1016/j.cgh.2007.02.039; Jepsen P, 2015, HEPATOLOGY, V62, P292, DOI 10.1002/hep.27598; Jepsen P, 2010, HEPATOLOGY, V51, P1675, DOI 10.1002/hep.23500; Kuk D, 2013, STAT MED, V32, P3077, DOI 10.1002/sim.5762; Louvet A, 2007, HEPATOLOGY, V45, P1348, DOI 10.1002/hep.21607; Mancebo A, 2013, CLIN GASTROENTEROL H, V11, P95, DOI 10.1016/j.cgh.2012.09.007; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; Mazzaferro V, 2011, LIVER TRANSPLANT, V17, pS44, DOI 10.1002/lt.22365; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Nilsson E, 2016, ALIMENT PHARM THER, V43, P1330, DOI 10.1111/apt.13635; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Sola R, 2006, LIVER INT, V26, P62, DOI 10.1111/j.1478-3231.2005.01181.x; Sorensen HT, 2003, J CLIN EPIDEMIOL, V56, P88, DOI 10.1016/S0895-4356(02)00531-0; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; Toshikuni N, 2009, J GASTROEN HEPATOL, V24, P1276, DOI 10.1111/j.1440-1746.2009.05851.x; Vandenbulcke H, 2016, J HEPATOLOGY; Volinsky CT, 2000, BIOMETRICS, V56, P256, DOI 10.1111/j.0006-341X.2000.00256.x; Yatsuji S, 2009, J GASTROEN HEPATOL, V24, P248, DOI 10.1111/j.1440-1746.2008.05640.x	30	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186715	10.1371/journal.pone.0186715	http://dx.doi.org/10.1371/journal.pone.0186715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077714	Green Submitted, Green Published, gold			2022-12-27	WOS:000413861200018
J	Rao, A; Padhy, D; Sahay, P; Pradhan, A; Sarangi, S; Das, G; Raj, N				Rao, Aparna; Padhy, Debananda; Sahay, Prity; Pradhan, Amiya; Sarangi, Sarada; Das, Gopinath; Raj, Niranjan			Clinical spectrum of pseudoexfoliation syndrome-An electronic records audit	PLOS ONE			English	Article							SOUTH INDIAN POPULATION; EXFOLIATION SYNDROME; GLAUCOMA; PREVALENCE; PATHOGENESIS; EYE	Purpose To evaluate different clinical variants of pseudoexfoliation syndrome and their risk of developing ocular hypertension (OHT) or glaucoma (PXG) Design Cross sectional hospital based study. Setting All patients seen at glaucoma services of a tertiary eye care center in east India. Methods Electronic medical records search of hospital database including consecutive new and old cases seen during April 2013 to March 2015 was done to retrieve case sensitive words including pseudoexfoliation, PXF, PEX, PXG and pseudoexfoliative glaucoma over any part of the clinical electronic sheet of the patient. All demographic and clinical details including laterality, the pattern of deposits, need for medicines and disc damage at presentation was compared in eyes with radial pigmentary, classical or combined forms of PXF phenotypes. Results Of 110313 PXF patients seen during the period of 2013-2015, a total of 2297 eyes of 1150 PXF patients were identified including 525 unilateral PXF (meaning a total of 1775 PXF eyes with 625 patients having bilateral disease, n = 1250 eyes, other clinically normal eye, n = 522) at presentation. Of 525 unilateral PXF eyes, 105 had OHT and 131 had glaucoma while bilateral cases had more > 50% (675 eyes of 1250 eyes) with glaucoma. Glaucoma with significant changes in IOP with or without disc damage was seen in 32% of pigmentary and 39% of classical PXF forms with eyes with combined forms of PXF having around 50% with glaucoma at presentation compared to other forms, p< 0.001. Conclusion Different phenotypic variants of PXF in this Indian cohort was associated with 30-50% risk of OHT or glaucoma respectively. Adequate care is required while examining the pattern of PXF in each case to prognosticate each patient/eye.	[Rao, Aparna; Padhy, Debananda; Sahay, Prity; Pradhan, Amiya; Sarangi, Sarada; Das, Gopinath; Raj, Niranjan] LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Odisha, India	L. V. Prasad Eye Institute	Rao, A (corresponding author), LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Odisha, India.	aparna@lvpei.org		rao, Aparna/0000-0001-8120-8740	DBT Wellcome Trust grant [IA/CPHI/15/1/502031]	DBT Wellcome Trust grant(Wellcome Trust DBT India Alliance)	This work was funded in part by the DBT Wellcome Trust grant, ref no IA/CPHI/15/1/502031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobakar IF, 2017, EXP EYE RES, V154, P88, DOI 10.1016/j.exer.2016.11.011; Al-Saleh SA, 2015, SAUDI MED J, V36, P108, DOI 10.15537/smj.2015.1.9121; Anastasopoulos E, 2015, CURR OPIN OPHTHALMOL, V26, P82, DOI 10.1097/ICU.0000000000000132; Anastasopoulos E, 2011, J GLAUCOMA, V20, P160, DOI 10.1097/IJG.0b013e3181d9d8bd; Arnarsson A, 2009, AM J OPHTHALMOL, V148, P291, DOI 10.1016/j.ajo.2009.03.021; Founti P, 2015, ANN HUM GENET, V79, P431, DOI 10.1111/ahg.12128; Gunes A, 2016, SEMINOPHTHALMOL, V21, P1; HENKE V, 1987, KLIN MONATSBL AUGENH, V190, P173, DOI 10.1055/s-2008-1050350; Konstas Anastasios G P, 2006, Compr Ophthalmol Update, V7, P131; Landers J, 2012, CLIN EXP OPHTHALMOL, V40, P454, DOI 10.1111/j.1442-9071.2011.02696.x; LAYDEN WE, 1974, AM J OPHTHALMOL, V78, P835, DOI 10.1016/0002-9394(74)90307-9; Miglior S, 2015, PROG BRAIN RES, V221, P233, DOI 10.1016/bs.pbr.2015.06.007; Mitchell P, 1999, ARCH OPHTHALMOL-CHIC, V117, P1319, DOI 10.1001/archopht.117.10.1319; Naumann GOH, 1998, OPHTHALMOLOGY, V105, P951, DOI 10.1016/S0161-6420(98)96020-1; Olawoye OO, 2014, INT OPHTHALMOL, V34, P1165, DOI 10.1007/s10792-014-9953-5; OSTENFELDAKERBLOM A, 1988, ACTA OPHTHALMOL, V66, P467; Padhy B, 2014, EXP EYE RES, V127, P69, DOI 10.1016/j.exer.2014.07.005; Parrish RK, 2009, AM J OPHTHALMOL, V148, P482, DOI 10.1016/j.ajo.2009.07.005; Puska PM, 2002, J GLAUCOMA, V11, P517, DOI 10.1097/00061198-200212000-00012; Rao A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113329; Rao V, 2015, ASIA-PAC J OPHTHALMO, V4, P121, DOI 10.1097/APO.0b013e3182a0af43; Ren RJ, 2015, ASIA-PAC J OPHTHALMO, V4, P86, DOI 10.1097/APO.0000000000000106; Schlotzer-Schrehardt U, 2012, OPHTHALMOLOGE, V109, P944, DOI 10.1007/s00347-012-2531-1; SOOD NN, 1968, ACTA OPHTHALMOL, V46, P211; Vazquez Luis E, 2014, Int Ophthalmol Clin, V54, P1, DOI 10.1097/IIO.0000000000000047; Vesti E, 2000, PROG RETIN EYE RES, V19, P345, DOI 10.1016/S1350-9462(99)00019-1; Vijaya L, 2016, J GLAUCOMA, V25, pE596, DOI 10.1097/IJG.0000000000000276; Vijaya L, 2015, OPHTHALMOLOGY, V122, P1158, DOI 10.1016/j.ophtha.2015.02.007	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0185373	10.1371/journal.pone.0185373	http://dx.doi.org/10.1371/journal.pone.0185373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077713	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200003
J	Wall, EC; Mukaka, M; Denis, B; Mlozowa, VS; Msukwa, M; Kasambala, K; Nyrienda, M; Allain, TJ; Faragher, B; Heyderman, RS; Lalloo, DG				Wall, Emma C.; Mukaka, Mavuto; Denis, Brigitte; Mlozowa, Veronica S.; Msukwa, Malango; Kasambala, Khumbo; Nyrienda, Mulinda; Allain, Theresa J.; Faragher, Brian; Heyderman, Robert S.; Lalloo, David G.			Goal directed therapy for suspected acute bacterial meningitis in adults and adolescents in sub-Saharan Africa	PLOS ONE			English	Article							SURVIVING SEPSIS CAMPAIGN; MENINGOCOCCAL DISEASE; SEPTIC SHOCK; INTERNATIONAL GUIDELINES; COMPLEX INTERVENTIONS; MANAGEMENT; CHILDREN; DIAGNOSIS; CARE; RESUSCITATION	Background Mortality from acute bacterial meningitis (ABM) in sub-Saharan African adults and adolescents exceeds 50%. We tested if Goal Directed Therapy (GDT) was feasible for adults and adolescents with clinically suspected ABM in Malawi. Materials and methods Sequential patient cohorts of adults and adolescents with clinically suspected ABM were recruited in the emergency department of a teaching hospital in Malawi using a before/after design. Routine care was monitored in year one (P1). In year two (P2), nurses delivered protocolised GDT (rapid antibiotics, airway support, oxygenation, seizure control and fluid resuscitation) to a second cohort. The primary endpoint was composite mean number of clinical goals attained. Secondary endpoints were individual goals attained and death or disability from proven or probable ABM at day 40. Results 563 patients with suspected ABM were enrolled in the study; 273 were monitored in P1; 290 patients with suspected ABM received GDT in P2. 61% were male, median age 33 years and 90% were HIV co-infected. ABM was proven or probable in 132 (23%) patients. GDT attained more clinical goals compared to routine care: composite mean number of goals in P1 was 0.55 vs. 1.57 in P2 GDT (p<0.001); Death or disability by day 40 from proven or probable ABM occurred in 29/57 (51%) in P1 and 38/60 (63%) in P2 (p = 0.19). Conclusion Nurse-led GDT in a resource-constrained setting was associated with improved delivery of protocolised care. Outcome was unaffected.	[Wall, Emma C.; Mukaka, Mavuto; Denis, Brigitte; Mlozowa, Veronica S.; Msukwa, Malango; Kasambala, Khumbo; Heyderman, Robert S.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Wall, Emma C.; Faragher, Brian; Lalloo, David G.] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England; [Wall, Emma C.; Heyderman, Robert S.] UCL, Div Infect & Immun, London, England; [Mukaka, Mavuto] Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand; [Mukaka, Mavuto] Univ Oxford, Nuffield Dept Med Res Bldg, Oxford Ctr Trop Med & Global Hlth, Oxford, England; [Nyrienda, Mulinda] Minist Hlth, Adult Emergency & Trauma Ctr, Queen Elizabeth Cent Hosp, Blantyre, Malawi; [Allain, Theresa J.] Coll Med, Dept Med, Blantyre, Malawi	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of London; University College London; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; University of Malawi; University of Malawi	Wall, EC (corresponding author), Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.; Wall, EC (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England.; Wall, EC (corresponding author), UCL, Div Infect & Immun, London, England.	emma.wall@doctors.org.uk		Heyderman, Robert/0000-0003-4573-449X; Lalloo, David/0000-0001-7680-2200; Wall, Emma/0000-0003-2732-4497	Wellcome Trust [086971/B/09/Z]; Academy of Medical Sciences (AMS) [SGL016\\1009] Funding Source: researchfish; National Institute for Health Research [CL-2014-18-002] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by The Wellcome Trust in a personal Clinical PhD Fellowship in Global Health EW #086971/B/09/Z. The funding body had no role in study design, data collection, analysis of data, manuscript preparation or the decision to publish. The corresponding author takes full responsibility for the integrity of the data.	Ajdukiewicz KMB, 2011, LANCET INFECT DIS, V11, P293, DOI 10.1016/S1473-3099(10)70317-0; Andrews B, 2014, CRIT CARE MED, V42, P2315, DOI 10.1097/CCM.0000000000000541; Arnold RC, 2008, SHOCK; Baker T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144801; Barochia AV, 2010, CRIT CARE MED, V38, P668, DOI 10.1097/CCM.0b013e3181cb0ddf; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Council MR., 2008, DEV EVALUATING COMPL; Council UR, 2010, ADV LIF SUPP GUID 20; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Fitch MT, 2007, LANCET INFECT DIS, V7, P191, DOI 10.1016/S1473-3099(07)70050-6; Gans J. de, 2002, New England Journal of Medicine, V347, P1549, DOI 10.1056/NEJMoa021334; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; Harnden A, 2006, BRIT MED J, V332, P1295, DOI 10.1136/bmj.38789.723611.55; Heyderman RS, 2005, J INFECTION, V50, P373, DOI 10.1016/j.jinf.2005.04.002; Jacob ST, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-107; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Kalil AC, 2017, CRIT CARE MED, V45, P607, DOI 10.1097/CCM.0000000000002235; Lee WK, 2016, YONSEI MED J, V57, P1260, DOI 10.3349/ymj.2016.57.5.1260; Lepur D, 2007, INFECTION, V35, P225, DOI 10.1007/s15010-007-6202-0; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Maitland K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-90; McGill F, 2016, J INFECTION, V72, P405, DOI 10.1016/j.jinf.2016.01.007; Molyneux AJ, 2006, CLIN NEUROL NEUROSUR, V108, P115, DOI 10.1016/j.clineuro.2005.10.015; Molyneux EM, 2014, PEDIATR INFECT DIS J, V33, P214, DOI 10.1097/INF.0000000000000122; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Nguyen HB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1288-3; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; party BSoACBw, BSAC DISC DIFF METH; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Peltola H, 2001, CLIN INFECT DIS, V32, P64, DOI 10.1086/317534; RANKIN J, 1957, Scott Med J, V2, P254; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Townsend SR, 2008, CLIN CHEST MED, V29, P721, DOI 10.1016/j.ccm.2008.06.011; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Wall EC, 2016, CLIN INFECT DIS OFFI; Wall EC, 2017, CLIN INFECT DIS, V64, P413, DOI 10.1093/cid/ciw779; Wall EC, 2014, J INFECTION, V69, P440, DOI 10.1016/j.jinf.2014.06.011; Wall EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069783; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Yu H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008330	52	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186687	10.1371/journal.pone.0186687	http://dx.doi.org/10.1371/journal.pone.0186687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077720	Green Published, Green Accepted, gold			2022-12-27	WOS:000413861200017
J	Baer, A; Colon-Moran, W; Xiang, JH; Stapleton, JT; Bhattarai, N				Baer, Alan; Colon-Moran, Winston; Xiang, Jinhua; Stapleton, Jack T.; Bhattarai, Nirjal			Src-family kinases negatively regulate NFAT signaling in resting human T cells	PLOS ONE			English	Article							LIPID RAFTS; ACTIVATION; LCK; RECEPTOR; FYN; HOMEOSTASIS; INHIBITION; TOLERANCE; INSIGHTS; STIMULATION	T cell signaling is required for activation of both natural and therapeutic T cells including chimeric antigen receptor (CAR) T cells. Identification of novel factors and pathways regulating T cell signaling may aid in development of effective T cell therapies. In resting human T cells, the majority of Src-family of tyrosine kinases (SFKs) are inactive due to phosphorylation of a conserved carboxy-terminal tyrosine residue. Recently, a pool of enzymatically active SFKs has been identified in resting T cells; however, the significance of these is incompletely understood. Here, we characterized the role of active SFKs in resting human T cells. Pharmacologic inhibition of active SFKs enhanced distal TCR signaling as measured by IL-2 release and CD25 surface expression following TCR-independent activation. Mechanistically, inhibition of the active pool of SFKs induced nuclear translocation of NFAT1, and enhanced NFAT1-dependent signaling in resting T cells. The negative regulation of NFAT1 signaling was in part mediated by the Src-kinase Lck as human T cells lacking Lck had increased levels of nuclear NFAT1 and demonstrated enhanced NFAT1-dependent gene expression. Inhibition of active SFKs in resting primary human T cells also increased nuclear NFAT1 and enhanced NFAT1-dependent signaling. Finally, the calcineurin inhibitor FK506 and Cyclosporin A reversed the effect of SFKs inhibition on NFAT1. Together, these data identified a novel role of SFKs in preventing aberrant NFAT1 activation in resting T cells, and suggest that maintaining this pool of active SFKs in therapeutic T cells may increase the efficacy of T cell therapies.	[Baer, Alan; Colon-Moran, Winston; Bhattarai, Nirjal] US FDA, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Xiang, Jinhua; Stapleton, Jack T.] Iowa City Vet Affairs Med Ctr, Res Serv, Iowa City, IA USA; [Xiang, Jinhua; Stapleton, Jack T.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	US Food & Drug Administration (FDA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Bhattarai, N (corresponding author), US FDA, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	nirjal.bhattarai@fda.hhs.gov		Stapleton, Jack/0000-0002-2302-9055; Bhattarai, Nirjal/0000-0003-1798-8863	Intramural Research Program of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration; Research Participation Program at CBER; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000207] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration; Research Participation Program at CBER; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Intramural Research Program of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration. This project was supported in part by Dr. Alan Baer's appointment to the Research Participation Program at CBER administered by the Oak Ridge Institute for Science and Education through US Department of Education and U.S. Food and Drug Administration.	Arakaki R, 2014, CRIT REV IMMUNOL, V34, P301, DOI 10.1615/CritRevImmunol.2014009988; Austin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036327; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balagopalan L, 2011, P NATL ACAD SCI USA, V108, P2885, DOI 10.1073/pnas.1007098108; Ballek O, 2015, IMMUNOL CELL BIOL, V93, P384, DOI 10.1038/icb.2014.100; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; Bhattarai N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005183; Bhattarai N, 2013, J IMMUNOL, V190, P6351, DOI 10.4049/jimmunol.1300589; Brandvold KR, 2012, ACS CHEM BIOL, V7, P1393, DOI 10.1021/cb300172e; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Cencioni MT, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.164; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Criado G, 2004, J IMMUNOL, V172, P222, DOI 10.4049/jimmunol.172.1.222; Davis SJ, 2011, TRENDS IMMUNOL, V32, P1, DOI 10.1016/j.it.2010.11.003; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Dong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015114; Dutta D, 2017, NAT IMMUNOL, V18, P196, DOI 10.1038/ni.3640; Filipp D, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00155; GAJEWSKI TF, 1995, EUR J IMMUNOL, V25, P1836, DOI 10.1002/eji.1830250707; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Jang IK, 2003, CURR OPIN IMMUNOL, V15, P315, DOI 10.1016/S0952-7915(03)00048-7; KATAGIRI T, 1989, P NATL ACAD SCI USA, V86, P10064, DOI 10.1073/pnas.86.24.10064; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lovatt M, 2006, MOL CELL BIOL, V26, P8655, DOI 10.1128/MCB.00168-06; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Methi T, 2005, J IMMUNOL, V175, P7398, DOI 10.4049/jimmunol.175.11.7398; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nabbi Arash, 2015, Cold Spring Harb Protoc, V2015, P769, DOI 10.1101/pdb.prot083733; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Papatriantafyllou M, 2013, NAT REV IMMUNOL, V13, P222, DOI 10.1038/nri3429; Posevitz V, 2008, J IMMUNOL, V180, P1634, DOI 10.4049/jimmunol.180.3.1634; ROSSY J, 2012, FRONT IMMUNOL, V3; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Sabat M, 2006, BIOORG MED CHEM LETT, V16, P5973, DOI 10.1016/j.bmcl.2006.08.132; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stanford SM, 2012, IMMUNOLOGY, V137, P1, DOI 10.1111/j.1365-2567.2012.03591.x; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Stirnweiss A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003607; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wittmann M, 2006, J LEUKOCYTE BIOL, V80, P75, DOI 10.1189/jlb.0605328; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813	55	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187123	10.1371/journal.pone.0187123	http://dx.doi.org/10.1371/journal.pone.0187123			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073235	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400116
J	del Rio, VC; Mostaza, J; Lahoz, C; Sanchez-Arroyo, V; Sabin, C; Lopez, S; Patron, P; Fernandez-Garcia, P; Fernandez-Puntero, B; Vicent, D; Montesano-Sanchez, L; Garcia-Iglesias, F; Gonzalez-Alegre, T; Estirado, E; Laguna, F; de Burgos-Lunar, C; Gomez-Campelo, P; Abanades-Herranz, JC; de Miguel-Yanes, JM; Salinero-Fort, MA				Cornejo del Rio, V.; Mostaza, J.; Lahoz, C.; Sanchez-Arroyo, V.; Sabin, C.; Lopez, S.; Patron, P.; Fernandez-Garcia, P.; Fernandez-Puntero, B.; Vicent, D.; Montesano-Sanchez, L.; Garcia-Iglesias, F.; Gonzalez-Alegre, T.; Estirado, E.; Laguna, F.; de Burgos-Lunar, C.; Gomez-Campelo, P.; Abanades-Herranz, J. C.; de Miguel-Yanes, J. M.; Salinero-Fort, M. A.		SPREDIA-2 Grp	Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; SERUM URIC-ACID; RESTING HEART-RATE; PULSE PRESSURE; CARDIOVASCULAR-DISEASE; MEDITERRANEAN DIET; LOWER-EXTREMITY; RISK-FACTORS; MORTALITY; ATHEROSCLEROSIS	Aim To describe the prevalence of Peripheral Artery Disease (PAD) in a random population sample and to evaluate its relationship with Mediterranean diet and with other potential cardiovascular risk factors such as serum uric acid and pulse pressure in individuals ranged 45 to 74 years. Methods Cross-sectional analysis of 1568 subjects (mean age 6.5 years, 43% males), randomly selected from the population. A fasting blood sample was obtained to determine glucose, lipids, and HbA1C levels. An oral glucose tolerance test was performed in non-diabetic subjects. PAD was evaluated by ankle-brachial index and/or having a prior diagnosis. Results PAD prevalence was 3.81% (95% CI, 2.97-4.87) for all participants. In men, PAD prevalence was significantly higher than in women [5.17% (95% CI, 3.74-7.11) vs. 2.78% (95% CI, 1.89-4.07); p = 0.014]. Serum uric acid in the upper quartile was associated with the highest odds ratio (OR) of PAD (for uric acid > 6.1 mg/dl, OR = 4.31; 95% CI, 1.49-12.44). The remaining variables more strongly associated with PAD were: Heart rate > 90 bpm (OR = 4.16; 95% CI, 1.62-10.65), pulse pressure in the upper quartile (>= 54 mmHg) (OR = 3.82; 95% CI, 1.50-9.71), adherence to Mediterranean diet (OR = 2.73; 95% CI, 1.48-5.04), and former smoker status (OR = 2.04; 95% CI, 1.00-4.16). Conclusions Our results show the existence of a low prevalence of peripheral artery disease in a population aged 45-74 years. Serum uric acid, pulse pressure and heart rate > 90 bpm were strongly associated with peripheral artery disease. The direct association between Mediterranean diet and peripheral artery disease that we have found should be evaluated through a follow-up study under clinical practice conditions.	[Cornejo del Rio, V.; Mostaza, J.; Lahoz, C.; Sanchez-Arroyo, V.; Sabin, C.; Lopez, S.; Patron, P.; Fernandez-Garcia, P.; Fernandez-Puntero, B.; Vicent, D.; Garcia-Iglesias, F.; Gonzalez-Alegre, T.; Estirado, E.; Laguna, F.] Hosp Carlos III, Madrid, Spain; [Cornejo del Rio, V.] Hosp La Paz, Grp Invest Cuidados IdIPAZ, Madrid, Spain; [Vicent, D.; Gomez-Campelo, P.] Hosp Univ La Paz IdiPAZ, Inst Invest Sanitaria, Madrid, Spain; [Montesano-Sanchez, L.] Hosp Fuenlabrada, Madrid, Spain; [de Burgos-Lunar, C.] Consejeria Sanidad, Direcc Gen Salud Publ, Subdirecc Promoc Prevenc & Educ Salud, Madrid, Spain; [de Burgos-Lunar, C.; Salinero-Fort, M. A.] Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain; [Gomez-Campelo, P.] IdiPAZ, Plataforma Apoyo Investigador Novel, Madrid, Spain; [Abanades-Herranz, J. C.] Ctr Salud Monovar, Madrid, Spain; [de Miguel-Yanes, J. M.] Hosp Gregorio Maranon, Madrid, Spain; [Salinero-Fort, M. A.] Consejeria Sanidad, Subdirecc Gen Invest Sanitaria, Madrid, Spain	Hospital Carlos III; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario Fuenlabrada; General University Gregorio Maranon Hospital	Salinero-Fort, MA (corresponding author), Red Invest Serv Salud Enfermedades Cron REDISSEC, Madrid, Spain.; Salinero-Fort, MA (corresponding author), Consejeria Sanidad, Subdirecc Gen Invest Sanitaria, Madrid, Spain.	miguel.salinero@salud.madrid.org	SALINERO-FORT, MIGUEL A./GOP-2536-2022	SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; de Miguel-Yanes, Jose M./0000-0003-2802-033X; Lahoz, Carlos/0000-0001-5690-7558	Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid) [RS_AP10/6]; FIS (Fondo de Investigaciones Sanitarias, Instituto de la Salud Carlos III) [12/01806, 15/00259]; European Union through the Fondo Europeo de Desarrollo Regional (FEDER, Una manera de hacer Europa)	Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid); FIS (Fondo de Investigaciones Sanitarias, Instituto de la Salud Carlos III); European Union through the Fondo Europeo de Desarrollo Regional (FEDER, Una manera de hacer Europa)	This work was funded by the Agencia Lain Entralgo (Consejeria de Sanidad de la Comunidad de Madrid) Grant RS_AP10/6 and by FIS (Fondo de Investigaciones Sanitarias, Instituto de la Salud Carlos III) grants no. 12/01806 and 15/00259 and co-financied by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, Una manera de hacer Europa). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman JA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110680; Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Aboyans V, 2011, ATHEROSCLEROSIS, V214, P169, DOI 10.1016/j.atherosclerosis.2010.10.011; Alderman M H, 2001, Curr Hypertens Rep, V3, P184, DOI 10.1007/s11906-001-0036-4; Martinez-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043134; Salinero-Fort MA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007195; Benetos A, 1998, HYPERTENSION, V32, P560, DOI 10.1161/01.HYP.32.3.560; Benetos A, 1997, HYPERTENSION, V30, P1410, DOI 10.1161/01.HYP.30.6.1410; Blanes JI, 2009, INT ANGIOL, V28, P20; Bonaccio M, 2014, NUTR METAB CARDIOVAS, V24, P853, DOI 10.1016/j.numecd.2014.02.014; Bundo M, 1998, Aten Primaria, V22, P5; Cambou JP, 2010, EUR J VASC ENDOVASC, V39, P577, DOI 10.1016/j.ejvs.2010.02.009; Carbayo JA, 2007, NUTR METAB CARDIOVAS, V17, P41, DOI 10.1016/j.numecd.2005.08.009; Chen J, 2012, AM J CARDIOL, V110, P136, DOI 10.1016/j.amjcard.2012.02.061; Chrysohoou C, 2015, ANGIOLOGY, V66, P708, DOI 10.1177/0003319714556651; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Doobay AV, 2005, ARTERIOSCL THROM VAS, V25, P1463, DOI 10.1161/01.ATV.0000168911.78624.b7; Downer MK, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0394-6; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fan Li-Chi, 2013, Biomed J, V36, P282, DOI 10.4103/2319-4170.113371; Feig DI, 2009, CURR OPIN NEPHROL HY, V18, P526, DOI 10.1097/MNH.0b013e328330d9d0; Felix-Redondo FJ, 2012, REV ESP CARDIOL, V65, P726, DOI [10.1016/j.rec.2012.03.007, 10.1016/j.recesp.2012.03.008]; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; Greenland P, 1999, AM J EPIDEMIOL, V149, P853; Greenland P, 2000, CIRCULATION, V101, P723; HALE WE, 1988, AGE AGEING, V17, P57, DOI 10.1093/ageing/17.1.57; Hiramoto JS, 2014, VASCULAR, V22, P142, DOI 10.1177/1708538113476023; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Ho WJ, 2010, RHEUMATOLOGY, V49, P1929, DOI 10.1093/rheumatology/keq184; Korhonen P, 2014, J HUM HYPERTENS, V28, P242, DOI 10.1038/jhh.2013.99; Kristal-Boneh E, 2000, EUR HEART J, V21, P116, DOI 10.1053/euhj.1999.1741; Kullo IJ, 2003, VASC MED, V8, P237, DOI 10.1191/1358863x03vm511oa; MADHAVAN S, 1994, HYPERTENSION, V23, P395, DOI 10.1161/01.HYP.23.3.395; Manzano L, 2007, MED CLIN-BARCELONA, V128, P241, DOI 10.1157/13099239; Mosca L, 1997, CIRCULATION, V96, P2468; Murabito JM, 2002, AM HEART J, V143, P961, DOI 10.1067/mhj.2002.122871; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Planas A, 2002, J VASC SURG, V35, P506, DOI 10.1067/mva.2002.120030; Ramos R, 2009, EUR J VASC ENDOVASC, V38, P305, DOI 10.1016/j.ejvs.2009.04.013; Ramos R, 2011, ATHEROSCLEROSIS, V214, P474, DOI 10.1016/j.atherosclerosis.2010.11.015; Ramsay SE, 2015, HEART, V101, P616, DOI 10.1136/heartjnl-2014-306472; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Ruiz-Canela M, 2014, JAMA-J AM MED ASSOC, V311, P415, DOI 10.1001/jama.2013.280618; Sanchez-Lozada LG, 2006, CURR OPIN NEPHROL HY, V15, P30, DOI 10.1097/01.mnh.0000199010.33929.7f; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Selvaraj S, 2016, J AM COLL CARDIOL, V67, P392, DOI 10.1016/j.jacc.2015.10.084; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shankar A, 2008, ATHEROSCLEROSIS, V196, P749, DOI 10.1016/j.atherosclerosis.2006.12.029; Sigvant B, 2007, J VASC SURG, V45, P1185, DOI 10.1016/j.jvs.2007.02.004; Soriguer F, 2013, MED HYPOTHESES, V80, P150, DOI 10.1016/j.mehy.2012.11.015; Tangri N, 2010, AM J KIDNEY DIS, V56, P247, DOI 10.1053/j.ajkd.2010.06.004; Alzamora MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-38; Tseng CH, 2004, DIABETIC MED, V21, P724, DOI 10.1111/j.1464-5491.2004.01239.x; VOGT MT, 1993, AM J EPIDEMIOL, V137, P559, DOI 10.1093/oxfordjournals.aje.a116709; Wilkins JT, 2012, AM J HYPERTENS, V25, P535, DOI 10.1038/ajh.2012.13; Xu DC, 2013, CAN J CARDIOL, V29, P492, DOI 10.1016/j.cjca.2012.06.014; Zhan YQ, 2016, VASA, V45, P31, DOI 10.1024/0301-1526/a000492; Zhan YQ, 2015, ANGIOLOGY, V66, P687, DOI 10.1177/0003319714566228; Zhan YQ, 2012, J EPIDEMIOL, V22, P454, DOI 10.2188/jea.JE20110140; ZHANG Y, 2016, MEDICINE, V0095; Zheng ZJ, 2005, AM J PREV MED, V29, P42, DOI 10.1016/j.amepre.2005.07.019	64	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186220	10.1371/journal.pone.0186220	http://dx.doi.org/10.1371/journal.pone.0186220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073236	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400016
J	Niccoli, S; Boreham, DR; Phenix, CP; Lees, SJ				Niccoli, Sarah; Boreham, Douglas R.; Phenix, Christopher P.; Lees, Simon J.			Non-radioactive 2-deoxy-2-fluoro-D-glucose inhibits glucose uptake in xenograft tumours and sensitizes HeLa cells to doxorubicin in vitro	PLOS ONE			English	Article							CANCER-CELLS; OXIDATIVE STRESS; AEROBIC GLYCOLYSIS; ANTITUMOR-ACTIVITY; DOSE-ESCALATION; 2-DEOXY-D-GLUCOSE; METABOLISM; ADRIAMYCIN; EFFICACY; 2-DEOXYGLUCOSE	A glucose analog called 2-deoxy-D-glucose (2DG) has been successfully used to sensitize cancer cells to ROS-inducing cancer treatments such as ionizing radiation, through the inhibition of glycolysis. However, the use of 2DG can be limited by several factors such as availability, non-specific cytotoxicity, and chemoresistance under hypoxic conditions. The purpose of this study was to investigate the use of non-radioactive 2-deoxy-2-fluoro-D-glucose ((19)FDG), a drug that potentially addresses current limitations of 2DG. The effectiveness of using either 2DG or (19)FDG in combination with doxorubicin (Dox) in HeLa cells was determined in both normoxia and hypoxia. We have also shown that under both oxygen conditions, (19)FDG-treated cells produce less lactate than 2DG-treated cells, an important finding that suggests improved inhibition of glycolysis, the preferential pathway for cancerous cells. When used in combination with Dox, we have demonstrated a significant decrease in the number of viable cells, with the effect of (19)FDG remaining stable across both normoxic and hypoxic conditions. Moreover, the assessment of apoptosis and necrosis revealed that (19)FDG maintained its ability to sensitize HeLa cells to Dox in hypoxia, but 2DG was only effective under normoxic conditions. The retained effectiveness of (19)FDG in combination with Dox under hypoxic conditions, suggests that (19)FDG may be efficacious for sensitizing hypoxic regions of solid tumour masses. Importantly, the ability of (19)FDG to inhibit glucose uptake in vivo was also confirmed using positron emission tomography (PET) of xenograft tumours. The results displayed here suggest (19)FDG is a promising combination therapy, which may lead to decreased ROS scavenging via glycolysis, and enhanced treatment success.	[Niccoli, Sarah; Lees, Simon J.] Lakehead Univ, Fac Med, Med Sci, Thunder Bay, ON, Canada; [Boreham, Douglas R.; Lees, Simon J.] Northern Ontario Sch Med, Med Sci Div, Thunder Bay, ON, Canada; [Phenix, Christopher P.] Univ Saskatchewan, Chem, Saskatoon, SK, Canada; [Phenix, Christopher P.] Thunder Bay Reg Hlth Res Inst, Thunder Bay, ON, Canada; [Lees, Simon J.] Lakehead Univ, Biol, Thunder Bay, ON, Canada	Lakehead University; Northern Ontario School of Medicine; University of Saskatchewan; Northern Ontario School of Medicine; Lakehead University	Lees, SJ (corresponding author), Lakehead Univ, Fac Med, Med Sci, Thunder Bay, ON, Canada.; Lees, SJ (corresponding author), Northern Ontario Sch Med, Med Sci Div, Thunder Bay, ON, Canada.; Lees, SJ (corresponding author), Lakehead Univ, Biol, Thunder Bay, ON, Canada.	simon.lees@nosm.ca	Phenix, Christopher P/O-5028-2018	Phenix, Christopher P/0000-0001-8392-5268	Northern Ontario Academic Medicine Association [A-15-02]; Northern Ontario School of Medicine Research Development Fund	Northern Ontario Academic Medicine Association; Northern Ontario School of Medicine Research Development Fund	This work was supported by the Northern Ontario Academic Medicine Association (A-15-02) SJL, (http://www.noama.ca/site/) and the Northern Ontario School of Medicine Research Development Fund SJL, (http://www.nosm.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloj L, 1999, CANCER RES, V59, P4709; BALCH CM, 1990, CANCER, V65, P604, DOI 10.1002/1097-0142(19900201)65:3+<604::AID-CNCR2820651303>3.0.CO;2-8; Baselga J, 1998, CANCER RES, V58, P2825; Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858; BROWN J, 1962, METABOLISM, V11, P1098; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Desagher S, 1997, J NEUROSCI, V17, P9060; Dwarukanath BS, 2004, CANCER BIOL THER, V3, P864, DOI 10.4161/cbt.3.9.1040; FLORIDI A, 1981, J NATL CANCER I, V66, P497; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Goldberg L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.24; Gonzalez-Lima F, 1992, ADV METABOLIC MAPPIN, Vxxiv; Gorovits N, 2003, BIOCHEM MOL BIOL EDU, V31, P163, DOI 10.1002/bmb.2003.494031030227; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Gupta S, 2005, CANCER BIOL THER, V4, P87; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kostakoglu L, 2003, RADIOGRAPHICS, V23, P315, DOI 10.1148/rg.232025705; KOVAC P, 1986, CARBOHYD RES, V153, P168, DOI 10.1016/S0008-6215(00)90209-X; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lampidis TJ, 2006, CANCER CHEMOTH PHARM, V58, P725, DOI 10.1007/s00280-006-0207-8; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Maher JC, 2007, MOL CANCER THER, V6, P732, DOI 10.1158/1535-7163.MCT-06-0407; Malm SW, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0147-4; Manning G, 2014, MUTAT RES-FUND MOL M, V770, P29, DOI 10.1016/j.mrfmmm.2014.09.002; Marin-Hernandez A, 2017, J CELL PHYSIOL, V232, P1346, DOI 10.1002/jcp.25617; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; May MS, 2012, EUR J NUCL MED MOL I, V39, P1712, DOI 10.1007/s00259-012-2201-1; Moreno-Sanchez R, 2014, INT J BIOCHEM CELL B, V50, P10, DOI 10.1016/j.biocel.2014.01.025; Muggia FM, 1997, J CLIN ONCOL, V15, P987, DOI 10.1200/JCO.1997.15.3.987; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Purohit BS, 2014, INSIGHTS IMAGING, V5, P585, DOI 10.1007/s13244-014-0349-x; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Rempel A, 1996, CANCER RES, V56, P2468; Rodriguez-Enriquez S, 2010, INT J BIOCHEM CELL B, V42, P1744, DOI 10.1016/j.biocel.2010.07.010; Schwarzer R, 1969, Zentralbl Chir, V94, P1259; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043; Takeuchi R, 2015, BIOORG MED CHEM LETT, V25, P5500, DOI 10.1016/j.bmcl.2015.10.068; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; WICK AN, 1957, J BIOL CHEM, V224, P963; WILS JA, 1991, J CLIN ONCOL, V9, P827, DOI 10.1200/JCO.1991.9.5.827; Xu RH, 2005, CANCER RES, V65, P613; Zhang FJ, 2009, J CANCER RES THER, V5, P41, DOI 10.4103/0973-1482.55140; Zhu AZ, 2011, SEMIN ONCOL, V38, P55, DOI 10.1053/j.seminoncol.2010.11.012; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	57	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187584	10.1371/journal.pone.0187584	http://dx.doi.org/10.1371/journal.pone.0187584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095925	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200121
J	Zhang, JM; Wang, JK; An, TT; Wei, D; Chi, FQ; Zhou, BK				Zhang, Jiuming; Wang, Jingkuan; An, Tingting; Wei, Dan; Chi, Fengqin; Zhou, Baoku			Effects of long-term fertilization on soil humic acid composition and structure in Black Soil	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; FLUORESCENCE; SUBSTANCES; SPECTROSCOPY; FRACTIONS; COMPOSTS	The composition and structure of humic acid (HA) can be affected by fertilization, but the short-term effects are difficult to detect using traditional analysis methods. Using a 35-year long-term experiment in Black Soil, the molecular structure of HA was analyzed with Fourier transform infrared spectroscopy (FTIR), C-13 nuclear magnetic resonance spectroscopy (NMR), and fluorescence spectroscopy. Variation in HA was analyzed after long-term fertilization, including fertilization with manure (M), inorganic N, P and K fertilizer (NPK), manure combined with inorganic N, P, and K fertilizer (MNPK), and a no-fertilizer control (CK). The application of each fertilizer treatment increased crop yields compared with the CK treatment, and the MNPK treatment increased crop yield the most. The ratio of main IR absorption peak of HA at 2,920 cm(-1) compared with the peak at 2,850 cm(-1) (2920/2850) was higher in the NPK and MNPK treatments compared with the CK treatment. The application of manure (MNPK and M treatments) increased the ratio of hydrogen to carbon (H/C) in HA, and raised the ratio of the main IR absorption peak of HA at 2920 cm(-1) to that at 1720 cm(-1) (2920/1720). Manure treatments also raised the ratio of aliphatic carbon (C) to aromatic C, alkyl C to alkoxy C and hydrophobic C to hydrophilic C and the fluorescence index (f 450/500), but decreased the degree of aromatization of HA, when compared with the CK treatment. The ratio between each type of C in HA was similar among all the fertilizer treatments, but NPK had a lower ratio of H/C and a lower content of aliphatic C compared with the CK treatment. These results indicated that the molecular structure of HA in Black Soil tends to be aliphatic, simpler, and younger after the application of manure. While the application of inorganic fertilizers increased in the degree of condensation of HA and made HA structure complicated. The application of manure alone or combined with inorganic fertilizers may be an effective way to increase crop yield and improve the structure of soil organic matter.	[Zhang, Jiuming; Wang, Jingkuan; An, Tingting] Shenyang Agr Univ, Coll Land & Environm, Shenyang, Liaoning, Peoples R China; [Zhang, Jiuming; Wei, Dan; Chi, Fengqin; Zhou, Baoku] Heilongjiang Acad Agr Sci, Soil Fertilizer & Environm Resources Inst, Key Lab Soil Environm & Plant Nutr Harbin, Harbin, Heilongjiang, Peoples R China	Shenyang Agricultural University; Heilongjiang Academy of Agricultural Sciences	Wang, JK; An, TT (corresponding author), Shenyang Agr Univ, Coll Land & Environm, Shenyang, Liaoning, Peoples R China.	j-kwang@163.com; atting@126.com	An, Tingting/V-9666-2017	An, Tingting/0000-0002-5263-7375	Youth Fund of Heilongjiang Province [QC2014C042]; National Science and Technology Support Program [2013BAD07B01]; National Natural Science Foundation of China [41771284]; Public Welfare Industry (agriculture) Research Project [201303126]	Youth Fund of Heilongjiang Province; National Science and Technology Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Industry (agriculture) Research Project	The study was supported by the Youth Fund of Heilongjiang Province (Grant No. QC2014C042), National Science and Technology Support Program (Grant No. 2013BAD07B01), National Natural Science Foundation of China (41771284), and the Public Welfare Industry (agriculture) Research Project (Grant No. 201303126) supported this study.r The study was supported by the Youth Fund of Heilongjiang Province (Grant No. QC2014C042), National Science and Technology Support Program (Grant No. 2013BAD07B01), the Public Welfare Industry (agriculture) Research Project (Grant No. 201303126), and National Natural Science Foundation of China (41771284) supported this study.	Amir S, 2010, J HAZARD MATER, V177, P524, DOI 10.1016/j.jhazmat.2009.12.064; Baldock J., 2000, SOIL ORGANIC MATTER; Bertoncini EI, 2008, BIORESOURCE TECHNOL, V99, P4972, DOI 10.1016/j.biortech.2007.09.024; Chien SWC, 2006, J AGR FOOD CHEM, V54, P6790, DOI 10.1021/jf061275m; Dou S, 2008, EUR J SOIL SCI, V59, P532, DOI 10.1111/j.1365-2389.2007.01012.x; Dou S., 2010, SOIL ORGANIC MATTERS; Dou Sen, 1999, Journal of Jilin Agricultural University, V21, P43; Ellerbrock RH, 2016, SOIL TILL RES, V156, P209, DOI 10.1016/j.still.2015.08.014; Galantini J, 2006, SOIL TILL RES, V87, P72, DOI 10.1016/j.still.2005.02.032; HALL KJ, 1974, WATER RES, V8, P239, DOI 10.1016/0043-1354(74)90161-4; [姜杰 Jiang Jie], 2012, [环境化学, Environmental Chemistry], V31, P2002; LEVESQUE M, 1972, SOIL SCI, V113, P346, DOI 10.1097/00010694-197205000-00008; Li L, 2002, CHINESE J ANAL CHEM, V30, P1303; Luce MS, 2014, GEODERMA, P232; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Mylotte R, 2016, ORG GEOCHEM, V98, P155, DOI 10.1016/j.orggeochem.2016.05.011; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Plaza C, 2002, J AGR FOOD CHEM, V50, P4867, DOI 10.1021/jf020195p; Rezacova V, 2007, FOLIA MICROBIOL, V52, P415, DOI 10.1007/BF02932097; Sanchez-Monedero MA, 2002, BIODEGRADATION, V13, P361, DOI 10.1023/A:1022888231982; SENESI N, 1991, SOIL SCI, V152, P259, DOI 10.1097/00010694-199110000-00004; Tan KH, 2014, BOOKS SOIL PLANT ENV, P1, DOI 10.1201/b17037; Wei ZM, 2016, INT BIODETER BIODEGR, V113, P187, DOI 10.1016/j.ibiod.2016.03.010; Wei ZM, 2014, CHEMOSPHERE, V95, P261, DOI 10.1016/j.chemosphere.2013.08.087; Wen B, 2007, ENVIRON SCI TECHNOL, V41, P3165, DOI 10.1021/es062262s; Wolfe AP, 2002, ENVIRON SCI TECHNOL, V36, P3217, DOI 10.1021/es011215r; Wu JG, 1998, SPECTROSC SPECT ANAL, V18, P52; Zhang JJ, 2009, CHINESE AGR SCI, V42, P2223; Zhao Y, 2017, ECOL INDIC, V72, P473, DOI 10.1016/j.ecolind.2016.08.051; Zhuo SN, 1994, ADV SOIL SCI, V22, P6	30	26	28	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186918	10.1371/journal.pone.0186918	http://dx.doi.org/10.1371/journal.pone.0186918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095840	Green Submitted, gold, Green Published			2022-12-27	WOS:000414340200031
J	Zheteyeva, Y; Rainey, JJ; Gao, HJ; Jacobson, EU; Adhikari, BB; Shi, JR; Mpofu, JJ; Bhavnani, D; Dobbs, T; Uzicanin, A				Zheteyeva, Yenlik; Rainey, Jeanette J.; Gao, Hongjiang; Jacobson, Evin U.; Adhikari, Bishwa B.; Shi, Jianrong; Mpofu, Jonetta J.; Bhavnani, Darlene; Dobbs, Thomas; Uzicanin, Amra			Unintended costs and consequences of school closures implemented in preparation for Hurricane Isaac in Harrison County School District, Mississippi, August-September 2012	PLOS ONE			English	Article							PANDEMIC INFLUENZA	Introduction School closures, while an effective measure against the spread of disease during a pandemic, may carry unintended social and economic consequences for students and families. We evaluated these costs and consequences following a 4-day school closure in Mississippi's Harrison County School District (HCSD). Methods In a survey of all households with students enrolled in HCSD, we collected information on difficulties related to the school closure, including interruption of employment and pay, loss of access to subsidized school meals, and arrangement of alternative childcare. We analyzed this information in the context of certain demographic characteristics of the survey respondents and households, such as race, level of education, and income. We also estimated the average number of lost work days and documented the childcare alternatives chosen by households affected by the school closure. Results We received 2,229 (28.4%) completed surveys from an estimated 7,851 households eligible to participate. About half (1,082 [48.5%]) of the households experienced at least some difficulty during the closure, primarily in three areas: uncertainty about duration of the closure, lost income, and the effort of arranging alternate childcare. Adults working outside the home, particularly the major wage earner in the household, were more likely to suffer lost income while schools were closed, an effect mitigated by paid leave benefits. Difficulty arranging childcare was reported most frequently by respondents with lower levels of education and households with younger children. Beyond the top three concerns expressed by households in HCSD, the survey also shed light on the issue of food insecurity when subsidized school meals are not available. Reported by 17.9% of households participating in the subsidized school lunch program, difficulty providing meals during the closure was associated with higher numbers of dependent children, selection of "other" as the race of the household respondent, and lower levels of education. Conclusion To help prevent undue financial hardship in families of school children, public health authorities and school administrators should provide recommendations for childcare alternatives and paid leave or remote work options during prolonged school closures, particularly to households in which all adults work outside of the home.	[Zheteyeva, Yenlik; Rainey, Jeanette J.; Gao, Hongjiang; Shi, Jianrong; Bhavnani, Darlene; Uzicanin, Amra] US Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA; [Jacobson, Evin U.] US Ctr Dis Control & Prevent, Off Publ Hlth Preparedness & Response, Atlanta, GA USA; [Adhikari, Bishwa B.] US Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Mpofu, Jonetta J.] US Ctr Dis Control & Prevent, Div Reprod Hlth Chron Dis Prevent & Promot, Atlanta, GA USA; [Mpofu, Jonetta J.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA USA; [Bhavnani, Darlene] Council State & Terr Epidemiologists Appl, Atlanta, GA USA; [Dobbs, Thomas] Mississippi Dept Hlth, Jackson, MS USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Zheteyeva, Y (corresponding author), US Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.	igg0@cdc.gov		Dobbs, Thomas/0000-0001-6199-5337	United States Centers for Disease Control and Prevention	United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the United States Centers for Disease Control and Prevention (http://www.cdc.gov). Karna, LLC provided support in the form of a salary for Jianrong Shi, but did not have any other role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	[Anonymous], 2008, AM COMM SURV 5 YEAR; Berg R., 2012, TROPICAL CYCLONE REP; Berkman BE, 2008, J PUBLIC HEALTH MAN, V14, P372, DOI 10.1097/01.PHH.0000324566.72533.0b; Blendon RJ, 2008, EMERG INFECT DIS, V14, P778, DOI 10.3201/eid1405.071437; Centers for Disease Control and Prevention, 2012, GUID COMM PREV SERV; Jarquin VG, 2011, EMERG INFECT DIS, V17, P751, DOI [10.3201/eid1704.100906, 10.3201/eid1706.100906]; Johnson AJ, 2008, EMERG INFECT DIS, V14, P1024, DOI 10.3201/eid1407.080096; Laughlin L., 2011, CHILD CARE ARRANGEME; Qualls N, 2017, MMWR RECOMM REP, V66, P1, DOI 10.15585/mmwr.rr6601a1; Steelfisher GK, 2010, MMWR-MORBID MORTAL W, V59, P2000; Timperio C. G., 2009, Morbidity and Mortality Weekly Report, V58, P1405; United States Department of Agriculture, FOOD NUTR SERV SCH M; United States Department of Agriculture, 2009, PAND SUPPL NUTR ASS; United States Department of Labor, 2012, EMPL CHAR FAM; Wong KK, 2014, PLOS ONE, V9, P2011, DOI DOI 10.1371/J0URNAL.P0NE.0113755	15	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0184326	10.1371/journal.pone.0184326	http://dx.doi.org/10.1371/journal.pone.0184326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091717	gold, Green Published			2022-12-27	WOS:000414229700002
J	Huang, SH; Hart, MA; Wade, M; Cozart, MR; McGrath, SL; Kobryn, K				Huang, Shu Hui; Hart, Madison A.; Wade, Matthew; Cozart, McKayla R.; McGrath, Siobhan L.; Kobryn, Kerri			Biochemical characterization of Borrelia burgdorferi's RecA protein	PLOS ONE			English	Article							ESCHERICHIA-COLI RECA; SINGLE-STRANDED-DNA; LYME-DISEASE SPIROCHETE; BINDING PROTEIN; YEAST RAD51; ANTIGENIC VARIATION; TELOMERE RESOLVASE; ATP HYDROLYSIS; SSB PROTEIN; RECOMBINATION	RecA plays key roles in DNA recombination, replication and repair. Mutation of recA in the Lyme disease spirochete, Borrelia burgdorferi, fails to produce some of the phenotypes expected from study of recA mutation in other organisms. 'Missing' recA phenotypes include a lack of growth or viability effects, including in the presence of DNA damage, and a lack of a role in vlsE antigenic variation and infectivity. We present a purification and biochemical characterization of recombinant B. burgdorferi RecA protein. We find that B. burgdorferi RecA displays the expected properties of being a DNA-dependent ATPase, of having an intrinsic binding preference for ssDNA over dsDNA enhanced by ATP binding, of promoting DNA pairing and strand exchange reactions and of having a detectable coprotease activity with E. coli LexA repressor. DNA pairing and strand exchange reactions promoted by B. burgdorferi RecA show an unusually strong dependence upon the presence of the cognate ssDNA binding protein (SSB) but are very sensitive to inhibition by SSB when the ssDNA was prebound by SSB. This indicates B. burgdorferi RecA may have an enhanced requirement for recombinational mediators to promote RecA-SSB exchange, despite the absence of homologues of the RecF pathway proteins that normally play this role in eubacteria. Finally, we do not find any unusual, intrinsic properties of B. burgdorferi's RecA protein to explain the unusual phenotype of recA mutation and suggest that there may be alternative recombinase functions that could explain the 'missing' phenotypes.	[Huang, Shu Hui; Hart, Madison A.; Wade, Matthew; Cozart, McKayla R.; McGrath, Siobhan L.; Kobryn, Kerri] Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Acad Hlth Sci Bldg, Saskatoon, SK, Canada; [Wade, Matthew] CHUL, Quebec City, PQ, Canada	University of Saskatchewan; Laval University	Kobryn, K (corresponding author), Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Acad Hlth Sci Bldg, Saskatoon, SK, Canada.	kerri.kobryn@usask.ca			Natural Sciences and Engineering Council of Canada [RGPIN 04382-2017]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by grant #RGPIN 04382-2017 from the Natural Sciences and Engineering Council of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco P R, 1998, Front Biosci, V3, pD570; Black CG, 1998, GENE, V208, P61, DOI 10.1016/S0378-1119(97)00653-7; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Chenail AM, 2012, J BACTERIOL, V194, P4570, DOI 10.1128/JB.00661-12; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Dresser AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000680; Eggers CH, 1999, J BACTERIOL, V181, P7308, DOI 10.1128/JB.181.23.7308-7313.1999; Eggers CH, 2001, J BACTERIOL, V183, P4771, DOI 10.1128/JB.183.16.4771-4778.2001; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Hardy PO, 2013, J BACTERIOL, V195, P2220, DOI 10.1128/JB.00043-13; HOWARDFLANDERS P, 1984, COLD SPRING HARB SYM, V49, P571, DOI 10.1101/SQB.1984.049.01.064; Huang SH, 2016, NUCLEIC ACIDS RES, V44, P5288, DOI 10.1093/nar/gkw344; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; Lin T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000679; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; Liu J, 2006, J BIOL CHEM, V281, P26308, DOI 10.1074/jbc.M604349200; Liu J, 2011, CRIT REV BIOCHEM MOL, V46, P240, DOI 10.3109/10409238.2011.576007; Liveris D, 2004, J BACTERIOL, V186, P2275, DOI 10.1128/JB.186.8.2275-2280.2004; Liveris D, 2008, INFECT IMMUN, V76, P4009, DOI 10.1128/IAI.00027-08; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mazin AV, 1996, P NATL ACAD SCI USA, V93, P10673, DOI 10.1073/pnas.93.20.10673; Mazin AV, 1998, EMBO J, V17, P1161, DOI 10.1093/emboj/17.4.1161; McIlwraith MJ, 2001, J MOL BIOL, V305, P23, DOI 10.1006/jmbi.2000.4268; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Mir T, 2013, NUCLEIC ACIDS RES, V41, P10438, DOI 10.1093/nar/gkt832; MUNIYAPPA K, 1984, P NATL ACAD SCI-BIOL, V81, P2757, DOI 10.1073/pnas.81.9.2757; Norris SJ, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0038-2014; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; PUGH BF, 1988, J BIOL CHEM, V263, P76; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Putteet-Driver AD, 2004, J BACTERIOL, V186, P2266, DOI 10.1128/JB.186.8.2266-2274.2004; Rehrauer WM, 1996, J BIOL CHEM, V271, P11996, DOI 10.1074/jbc.271.20.11996; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Rice KP, 2001, J BIOL CHEM, V276, P38570, DOI 10.1074/jbc.M105678200; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; Solinger JA, 2001, P NATL ACAD SCI USA, V98, P8447, DOI 10.1073/pnas.121009898; Solinger JA, 2001, J MOL BIOL, V307, P1207, DOI 10.1006/jmbi.2001.4555; Steffen SE, 2002, J BIOL CHEM, V277, P14493, DOI 10.1074/jbc.M112444200; Stohl EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017101; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8	54	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187382	10.1371/journal.pone.0187382	http://dx.doi.org/10.1371/journal.pone.0187382			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088268	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900080
J	Kind, M; Klukowska-Rotzler, J; Berezowska, S; Arcaro, A; Charles, RP				Kind, Marcus; Klukowska-Rotzler, Jolanta; Berezowska, Sabina; Arcaro, Alexandre; Charles, Roch-Philippe			Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE C2-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT MECHANISM; THERAPEUTIC TARGET; C2 DOMAIN; SURVIVAL; PI3K; CARCINOMAS; MIGRATION; IDENTIFICATION	PI3K signaling is frequently dysregulated in NSCLC-SQCC. In contrast to well characterized components of the PI3K signaling network contributing to the formation of SQCC, potential oncogenic effects of alterations in PIK3C2B are poorly understood. Here, a large cohort (n = 362) of NSCLC-SQCC was selectively screened for four reported somatic mutations in PIK3C2B via Sanger sequencing. In addition, two mutations leading to an amino acid exchange in the kinase domain (C1181, H1208R) were examined on a functional level. None of the mutations were identified in the cohort while well characterized hotspot PIK3CA mutations were observed at the expected frequency. Ultimately, kinase domain mutations in PI3KC2 beta were found to have no altering effect on downstream signaling. A set of SQCC tumors sequenced by The Cancer Genome Atlas (TCGA) equally indicates a lack of oncogenic potential of the kinase domain mutations or PIK3C2B in general. Taken together, this study suggests that PIK3C2B might only have a minor role in SQCC oncogenesis.	[Kind, Marcus; Klukowska-Rotzler, Jolanta; Arcaro, Alexandre] Univ Childrens Hosp Bern, Freiburgstr 31, Bern, Switzerland; [Klukowska-Rotzler, Jolanta] Univ Hosp Bern, Dept Emergency Med, Freiburgstr 16c, Bern, Switzerland; [Berezowska, Sabina] Univ Bern, Inst Pathol, Murtenstr 31, Bern, Switzerland; [Charles, Roch-Philippe] Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, Bern, Switzerland; [Charles, Roch-Philippe] Univ Bern, Swiss Natl Ctr Res NCCR TransCure, Buhlstr 28, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern	Charles, RP (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, Bern, Switzerland.; Charles, RP (corresponding author), Univ Bern, Swiss Natl Ctr Res NCCR TransCure, Buhlstr 28, Bern, Switzerland.	roch-philippe.charles@ibmm.unibe.ch	Berezowska, Sabina/AAJ-4557-2021	Berezowska, Sabina/0000-0001-5442-9791; Charles, Roch-Philippe/0000-0002-5243-3866	Swiss National Science Foundation [146464]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation grant (146464). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliouachene S, 2015, CELL REP, V13, P1881, DOI 10.1016/j.celrep.2015.10.052; Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Boller D, 2012, ANTICANCER RES, V32, P3015; Brown RA, 1997, BIOCHEM BIOPH RES CO, V233, P537, DOI 10.1006/bbrc.1997.6495; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Domin J, 2005, J CELL PHYSIOL, V205, P452, DOI 10.1002/jcp.20478; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harada K, 2005, MOL CELL BIOL, V25, P11122, DOI 10.1128/MCB.25.24.11122-11130.2005; Ikeda H, 2010, BLOOD, V116, P1460, DOI 10.1182/blood-2009-06-222943; Iorns E, 2009, BIOCHEM J, V417, P361, DOI 10.1042/BJ20081682; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Koutros S, 2010, CANCER RES, V70, P2389, DOI 10.1158/0008-5472.CAN-09-3575; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Liu Z, 2011, J INT MED RES, V39, P1319, DOI 10.1177/147323001103900419; Pesch B, 2012, INT J CANCER, V131, P1210, DOI 10.1002/ijc.27339; Piddock RE, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.16; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Russo A, 2015, CANCER LETT, V359, P262, DOI 10.1016/j.canlet.2015.01.026; Sadhu C, 2003, J IMMUNOL, P170; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sumihito N, 2010, BRAIN PATHOL, V20, P936; Wheeler M, 2006, J CELL PHYSIOL, V206, P586, DOI 10.1002/jcp.20507; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	41	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187308	10.1371/journal.pone.0187308	http://dx.doi.org/10.1371/journal.pone.0187308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088297	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900064
J	Pedersen, MO; Gang, AO; Brown, P; Pedersen, M; Knudsen, H; Nielsen, SL; Poulsen, T; Klausen, TW; Hogdall, E; Norgaard, P				Pedersen, Mette Olgod; Gang, Anne Ortved; Brown, Peter; Pedersen, Michael; Knudsen, Helle; Nielsen, Signe Ledou; Poulsen, Tim; Klausen, Tobias Wirenfeldt; Hogdall, Estrid; Norgaard, Peter			Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers	PLOS ONE			English	Article							RITUXIMAB PLUS CYCLOPHOSPHAMIDE; SINGLE CENTERS EXPERIENCE; NON-HODGKINS-LYMPHOMA; POOR-PROGNOSIS; CLINICAL-FEATURES; GERMINAL CENTER; PHASE-II; TRANSLOCATIONS; REARRANGEMENTS; EXPRESSION	Background Double expression of MYC and BCL2 proteins (DE) and double-hit MYC+BCL2/BCL6 translocations (DH) were established as important biomarkers in patients with diffuse large B-cell lymphoma (DLBCL) by the 2016 revision of the World Health Organization classification of lymphoid neoplasms. Whether this applies to the subgroup of young patients with high risk DLBCL is not known. We previously found that in a uniform retrospective population-based cohort of patients aged 18-60 years with high-risk DLBCL, the addition of etoposide to R-CHOP chemotherapy (R-CHOEP) resulted in improved survival mainly in patients with germinal center B-cell like (GCB) immunophenotype. The aim of this study was to investigate the prognostic and predictive value of DE and DH in this patient cohort. Methods Data on all young Danish patients diagnosed with de novo high-risk DLBCL 2004-2008 and treated with R-CHOP or R-CHOEP were obtained from the Danish Lymphoma database (n = 159). Tumor samples were available from 103 patients. MYC and BCL2 proteins were analyzed with quantitative immunohistochemistry (IHC) using different cut off values. MYC-, BCL2-and BCL6-translocations were examined with fluorescent in situ hybridization (FISH). Results DE with MYC > 75% and BCL2 > 85% was an independent negative prognostic marker of progression free survival (PFS) in patients treated with R-CHOP but not R-CHOEP (p < 0.001), also after exclusion of patients with DH. A predictive effect of DE for response (PFS) to R-CHOEP vs. R-CHOP was almost significant (p = 0.07). DH was not prognostic in this patient cohort. Conclusion In young patients with high-risk DLBCL, treatment with R-CHOEP may overcome the negative prognostic impact of DE observed in patients treated with R-CHOP.	[Pedersen, Mette Olgod; Knudsen, Helle; Nielsen, Signe Ledou; Poulsen, Tim; Hogdall, Estrid; Norgaard, Peter] Herlev & Gentofte Hosp, Dept Pathol, Herlev, Denmark; [Gang, Anne Ortved; Klausen, Tobias Wirenfeldt] Herlev & Gentofte Hosp, Dept Hematol, Herlev, Denmark; [Brown, Peter; Pedersen, Michael] Rigshosp, Dept Hematol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Pedersen, MO (corresponding author), Herlev & Gentofte Hosp, Dept Pathol, Herlev, Denmark.	Mette-pedersen@dadlnet.dk		Hogdall, Estrid/0000-0003-4689-5658; Brown, Peter de Nully/0000-0002-6522-4086; Poulsen, Tim/0000-0001-9781-0541	Department of Pathology, Herlev Hospital; Dansk Kraeftforsknings Fond and Roche NS	Department of Pathology, Herlev Hospital; Dansk Kraeftforsknings Fond and Roche NS	This work was supported by the Department of Pathology, Herlev Hospital; Dansk Kraeftforsknings Fond and Roche NS (unrestricted grant).	Akyurek N, 2012, CANCER-AM CANCER SOC, V118, P4173, DOI 10.1002/cncr.27396; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Arboe B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157999; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Ballman KV, 2015, J CLIN ONCOL, V33, P3968, DOI 10.1200/JCO.2015.63.3651; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Dunleavy K, 2014, BLOOD, V124, P395; Foot NJ, 2011, J CLIN PATHOL, V64, P802, DOI 10.1136/jclinpath-2011-200015; Gang AO, 2012, ANN ONCOL, V23, P147, DOI 10.1093/annonc/mdr058; Gang AO, 2014, LEUKEMIA LYMPHOMA, P1; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Holte H, 2013, ANN ONCOL, V24, P1385, DOI 10.1093/annonc/mds621; Horn H, 2015, LEUKEMIA, V29, P1564, DOI 10.1038/leu.2015.43; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Johnson NA, 2009, BLOOD, V114, P2273, DOI 10.1182/blood-2009-03-212191; Kanungo A, 2006, MODERN PATHOL, V19, P25, DOI 10.1038/modpathol.3800500; Klapper W, 2008, LEUKEMIA, V22, P2226, DOI 10.1038/leu.2008.230; Kluk MJ, 2016, AM J CLIN PATHOL, V145, P166, DOI 10.1093/ajcp/aqv028; Kramer MH, 1998, BLOOD, P92; Kuhnl A, 2017, ANN ONCOL; Le Gouill S, 2007, HAEMATOLOGICA, V92, P1335, DOI 10.3324/haematol.11305; Li S., 2011, MODERN PATHOL, V25, P145; Li SY, 2012, MODERN PATHOL, V25, P145, DOI 10.1038/modpathol.2011.147; Lin P, 2007, HAEMATOLOGICA, V92, P1297, DOI 10.3324/haematol.11263; Mahmoud AZ, 2015, MODERN PATHOL, V28, P545, DOI 10.1038/modpathol.2014.140; Melen CM, 2016, BRIT J HAEMATOL, V175, P614, DOI 10.1111/bjh.14399; Niitsu N, 2009, LEUKEMIA, V23, P777, DOI 10.1038/leu.2008.344; Pedersen MO, 2014, EUR J HAEMATOL, V92, P42, DOI 10.1111/ejh.12212; Pedersen MO, 2012, EUR J HAEMATOL, V89, P63, DOI 10.1111/j.1600-0609.2012.01787.x; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Schmitz N, 2012, LANCET ONCOL, V13, P1250, DOI 10.1016/S1470-2045(12)70481-3; Slack GW, 2011, ADV ANAT PATHOL, V18, P219, DOI 10.1097/PAP.0b013e3182169948; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Swerdlow SH, 2008, WHO CLASSIFICATION T; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Tibiletti MG, 2009, HUM PATHOL, V40, P645, DOI 10.1016/j.humpath.2008.06.032; Tomita N, 2009, HAEMATOL-HEMATOL J, V94, P935, DOI 10.3324/haematol.2008.005355; Vyberg M, 2016, VIRCHOWS ARCH, V468, P19, DOI 10.1007/s00428-015-1829-1; Wasterlid T, 2017, HEMATOL ONCOL, V35, P151, DOI 10.1002/hon.2256; Wilson WH, 2008, J CLIN ONCOL, V26, P2717, DOI 10.1200/JCO.2007.13.1391; Wilson WH, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.469.469; Wilson WH, 2012, HAEMATOL-HEMATOL J, V97, P758, DOI 10.3324/haematol.2011.056531; Xu-Monette ZY, 2015, MODERN PATHOL, V28, P1555, DOI 10.1038/modpathol.2015.118	47	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186983	10.1371/journal.pone.0186983	http://dx.doi.org/10.1371/journal.pone.0186983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088292	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900034
J	Teymouri, M; Halabchi, F; Mirshahi, M; Mansournia, MA; Ahranjani, AM; Sadeghi, A				Teymouri, Meghdad; Halabchi, Farzin; Mirshahi, Maryam; Mansournia, Mohammad Ali; Ahranjani, Ali Mousavi; Sadeghi, Amir			Comparison of plantar pressure distribution between three different shoes and three common movements in futsal	PLOS ONE			English	Article							FOOT; INJURIES; PATTERNS; PLAYERS; WALKING; RISK	Introduction Analysis of in-shoe pressure distribution during sport-specific movements may provide a clue to improve shoe design and prevent injuries. This study compared the mean and the peak pressures over the whole foot and ten separate areas of the foot, wearing different shoes during specific movements. Methods Nine male adult recreational futsal players performed three trials of three sport-specific movements (shuffle, sprint and penalty kick), while they were wearing three brands of futsal shoes (Adidas, Lotto and Tiger). Plantar pressures on dominant feet were collected using the F-SCAN system. Peak and mean pressures for whole foot and each separate area were extracted. For statistical analysis, the mean differences in outcome variables between different shoes and movements were estimated using random-effects regression model using STATA ver. 10. Results In the average calculation of the three movements, the peak pressure on the whole foot in Adidas shoe was less than Lotto [8.8% (CI95%: 4.1-13.6%)] and Tiger shoes [11.8% (CI95%: 7-16.7%)], (P<0.001). Also, the recorded peak pressure on the whole foot in penalty kick was 61.1% (CI95%: 56.3-65.9%) and 57.6% (CI95%: 52.8-62.3%) less than Shuffle and Sprint tests, respectively (P<0.001). Conclusion Areas with the highest peak pressure during all 3 movements were not different between all shoes. This area was medial forefoot in cases of shuffle and sprint movements and medial heel in case of penalty kick.	[Teymouri, Meghdad] PNU, Dept Phys Educ, Shahrood, Iran; [Halabchi, Farzin; Mirshahi, Maryam] Univ Tehran Med Sci, Sports Med Res Ctr, Tehran, Iran; [Halabchi, Farzin] Univ Tehran Med Sci, Imam Khomeini Hosp Complex, Dept Sports & Exercise Med, Tehran, Iran; [Mirshahi, Maryam] Univ Tehran Med Sci, Sina Hosp, Tehran, Iran; [Mansournia, Mohammad Ali] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran; [Ahranjani, Ali Mousavi] Islamic Azad Univ, South Tehran Branch, Fac Engn, Tehran, Iran; [Sadeghi, Amir] Rozbahan Univ, Fac Engn, Sari, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Islamic Azad University	Halabchi, F (corresponding author), Univ Tehran Med Sci, Sports Med Res Ctr, Tehran, Iran.; Halabchi, F (corresponding author), Univ Tehran Med Sci, Imam Khomeini Hosp Complex, Dept Sports & Exercise Med, Tehran, Iran.	fhalabchi@tums.ac.ir	Mirshahi, Maryam/J-2683-2018; Halabchi, Farzin/A-3191-2019	Mirshahi, Maryam/0000-0002-8754-4937; Halabchi, Farzin/0000-0002-3005-6190	Tehran University of Medical Sciences (TUMS) [89-01-53-10421]	Tehran University of Medical Sciences (TUMS)(Tehran University of Medical Sciences)	This study is being funded by the grant No. 89-01-53-10421 from Vice-Chancellor for Research of Tehran University of Medical Sciences (TUMS) (vcr.tums.ac.ir).	Abate M, 2012, J SPORT SCI MED, V11, P180; Althoff K., 2011, FOOTWEAR SCI, V3, pS1; Angoorani H, 2014, ASIAN J SPORTS MED, V5; Arnold JB, 2010, DIABET FOOT ANKLE, V1, DOI 10.3402/dfa.v1i0.5518; Barbero-Alvarez JC, 2008, J SPORT SCI, V26, P63, DOI 10.1080/02640410701287289; Bastos LF, 2004, LECT NOTES COMPUT SC, V3179, P39; Burnfield JM, 2004, CLIN BIOMECH, V19, P78, DOI 10.1016/j.clinbiomech.2003.09.007; Bus SA, 2005, CLIN BIOMECH, V20, P892, DOI 10.1016/j.clinbiomech.2005.05.004; Cain LE, 2007, J SCI MED SPORT, V10, P311, DOI 10.1016/j.jsams.2006.07.012; Carl HD, 2014, CLIN J SPORT MED, V24, P58, DOI 10.1097/01.jsm.0000432857.79305.6c; Castagna C, 2009, J SCI MED SPORT, V12, P490, DOI 10.1016/j.jsams.2008.02.001; Cavanagh P., 1992, FOOT, V2, P185, DOI DOI 10.1016/0958-2592(92)90047-S; CHEN H, 1994, CLIN BIOMECH, V9, P335, DOI 10.1016/0268-0033(94)90062-0; Dogramaci NS, 2006, INT J PERF ANAL SPOR, V6, P73, DOI [10.1080/24748668.2006.11868356, DOI 10.1080/24748668.2006.11868356]; Dvorak J, 2000, AM J SPORT MED, V28, pS69; Eils E, 2004, AM J SPORT MED, V32, P140, DOI 10.1177/0363546503258932; FIFA, 2006, FIFA BIG COUNT STAT; Fourchet F, 2012, GAIT POSTURE, V35, P685, DOI 10.1016/j.gaitpost.2011.12.004; Halabchi F., 2016, ASIAN J SPORTS MED, V7, DOI [10.5812/asjsm.35287, DOI 10.5812/ASJSM.35287]; Halabchi Farzin, 2013, Asian J Sports Med, V4, P85, DOI 10.5812/asjsm.34488; HENNIG EM, 1995, J APPL BIOMECH, V11, P299, DOI 10.1123/jab.11.3.299; Hughes J, 1993, Foot Ankle, V14, P514; Junge A, 2004, AM J SPORT MED, V32, p80S, DOI 10.1177/0363546503261245; Junge A, 2010, BRIT J SPORT MED, V44, P1089, DOI 10.1136/bjsm.2010.076752; Keijsers NLW, 2009, J BIOMECH, V42, P87, DOI 10.1016/j.jbiomech.2008.09.038; Knapp TP, 1998, CLIN SPORT MED, V17, P835, DOI 10.1016/S0278-5919(05)70123-X; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; Rosenbaum D., 1997, FOOT ANKLE SURG, V3, P1, DOI [10.1046/J.1460-9584.1997.00043.X, DOI 10.1046/J.1460-9584.1997.00043.X]; Santos D., 2001, FOOT, V11, P10, DOI [10.1054/foot.2000.0640, DOI 10.1054/FOOT.2000.0640, DOI 10.1054/F00T.2000.0640]; Tessutti V, 2010, J SCI MED SPORT, V13, P151, DOI 10.1016/j.jsams.2008.07.008; Titianova EB, 2004, J ELECTROMYOGR KINES, V14, P275, DOI 10.1016/S1050-6411(03)00077-4; Weist R, 2004, AM J SPORT MED, V32, P1893, DOI 10.1177/0363546504265191; Weist R, 2002, EM SCI M KAN CAN; Wong PL, 2007, BRIT J SPORT MED, V41, P93, DOI 10.1136/bjsm.2006.030668; ZHU HS, 1991, ARCH PHYS MED REHAB, V72, P390	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187359	10.1371/journal.pone.0187359	http://dx.doi.org/10.1371/journal.pone.0187359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088278	Green Submitted, gold, Green Published			2022-12-27	WOS:000414088900073
J	Angelo, PH; Varella, LRD; de Oliveira, MCE; Matias, MGL; de Azevedo, MAR; de Almeida, LM; de Azevedo, PRM; Micussi, MT				Angelo, Priscylla Helouyse; Dantas Varella, Larissa Ramalho; Eugenia de Oliveira, Maria Clara; Leite Matias, Monayane Grazielly; Ribeiro de Azevedo, Maria Aneilma; de Almeida, Luzinete Medeiros; Medeiros de Azevedo, Paulo Roberto; Micussi, Maria Thereza			A manometry classification to assess pelvic floor muscle function in women	PLOS ONE			English	Article							VAGINAL SQUEEZE PRESSURE; STRESS URINARY-INCONTINENCE; STRENGTH; PERINEOMETER; DELIVERY; PALPATION; PARITY; RELIABILITY; VOLUNTARY	Objective To develop a classification scale for manometry of pelvic floor muscles (PFM) in Brazilian women, according to the modified Oxford scale. Methods A cross sectional study, with 288 women enrolled in the Maternity, Natal, Brazil. Manometry and PFM strength data were collected and classified according to the modified Oxford scale. A simple linear regression was performed to determine the classification scale of manometry using the modified Oxford scale as the explanatory variable and the arithmetic mean of the manometry measurements as the response variable. Results The average age was 52.80 (+/- 8.78; CI: 51.67-53.93) years. Manometry showed an average of 35.1 (+/- 22.7; CI: 32.1-38.0) cmH(2)O and most women (29.7%) scored grade 3 on the modified Oxford scale. According to the proposed scale, values between 7.5 to 14.5 cmH(2)O correspond to very weak pressure; 14.6 to 26.5 cmH(2)O represent weak pressure; 26.6 to 41.5 cmH(2)O represent moderate pressure; 41.6 to 60.5 cmH(2)O represent good pressure, and values above 60.6 cmH(2)O correspond to strong pressure. Conclusion Manometry values were rated on a five-point scale. It is possible to rank the pressure levels performed by voluntary contraction of PFM with this new scale.	[Angelo, Priscylla Helouyse; Dantas Varella, Larissa Ramalho; Eugenia de Oliveira, Maria Clara; Leite Matias, Monayane Grazielly; Ribeiro de Azevedo, Maria Aneilma; de Almeida, Luzinete Medeiros; Micussi, Maria Thereza] Univ Fed Rio Grande do Norte, Physiotherapy Dept, Natal, RN, Brazil; [Medeiros de Azevedo, Paulo Roberto] Univ Fed Rio Grande do Norte, Stat Dept, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Angelo, PH (corresponding author), Univ Fed Rio Grande do Norte, Physiotherapy Dept, Natal, RN, Brazil.	priscyllahmangelo@gmail.com		Angelo, Priscylla/0000-0002-2238-1866				Barbosa PB, 2009, CLINICS, V64, P527, DOI 10.1590/S1807-59322009000600007; Batista EM, 2011, GYNECOL ENDOCRINOL, V27, P910, DOI 10.3109/09513590.2011.569603; Beuttenmüller Leila, 2011, Fisioter. Pesqui., V18, P210; Bo K, 2005, PHYS THER, V85, P269; Bo K, 2001, ACTA OBSTET GYN SCAN, V80, P883, DOI 10.1034/j.1600-0412.2001.801003.x; Brazales B, 2017, NEUROUROL, P1; Chehrehrazi M, 2009, INT UROGYNECOL J, V20, P1491, DOI 10.1007/s00192-009-0977-8; Chevalier F, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0143-4; Varella LRD, 2016, J PHYS THER SCI, V28, P824, DOI 10.1589/jpts.28.824; de Assis LC, 2015, REV BRAS GINECOL OBS, V37, P460, DOI 10.1590/SO100-720320150005361; de Oliveira MCE, 2016, DIABET METAB SYND OB, V9, P207, DOI 10.2147/DMSO.S106221; Fistonic N, 2016, LASER MED SCI, V31, P635, DOI 10.1007/s10103-016-1884-0; Gameiro MO, 2011, CLINICS, V66, P1389, DOI 10.1590/S1807-59322011000800014; Hundley AF, 2005, AM J OBSTET GYNECOL, V192, P1583, DOI 10.1016/j.ajog.2004.11.015; Isherwood PJ, 2000, BRIT J OBSTET GYNAEC, V107, P1007, DOI 10.1111/j.1471-0528.2000.tb10404.x; Ferreira CHJ, 2011, PHYSIOTHERAPY, V97, P132, DOI 10.1016/j.physio.2010.06.007; Kerschan-Schindl K, 2002, NEUROUROL URODYNAM, V21, P42, DOI 10.1002/nau.2099; Laycock J., 2001, PHYSIOTHERAPY, V87, P631, DOI [10.1016/s0031-9406(05)61108-x, DOI 10.1016/S0031-9406(05)61108-X]; Lee HN, 2013, INT UROGYNECOL J, V24, P831, DOI 10.1007/s00192-012-1943-4; LEVITT EE, 1979, ARCH SEX BEHAV, V8, P425, DOI 10.1007/BF01541198; Messelink B, 2005, NEUROUROL URODYNAM, V24, P374, DOI 10.1002/nau.20144; Oversand SH, 2015, INT UROGYNECOL J, V26, P1777, DOI 10.1007/s00192-015-2793-7; Ozdemir OC, 2015, J PHYS THER SCI, V27, P2133, DOI 10.1589/jpts.27.2133; Barbosa AMP, 2005, REV BRAS GINECOL OBS, V27, P677, DOI 10.1590/S0100-72032005001100008; Pereira VS, 2014, BRAZ J PHYS THER, V18, P428, DOI 10.1590/bjpt-rbf.2014.0038; Rahmani N, 2011, J BODYW MOV THER, V15, P209, DOI 10.1016/j.jbmt.2009.07.007; Sartore A, 2003, J REPROD MED, V48, P171; Slieker-ten Hove MCP, 2009, INT UROGYNECOL J, V20, P1497, DOI 10.1007/s00192-009-0978-7; Thompson JA, 2006, INT UROGYNECOL J, V17, P624, DOI 10.1007/s00192-006-0081-2; Unger CA, 2011, OBSTET GYN CLIN N AM, V38, P23, DOI 10.1016/j.ogc.2011.02.002; Volloyhaug I, 2016, ULTRASOUND OBST GYN, V47, P768, DOI 10.1002/uog.15731; World Health Organization, 1997, OB PREV MAN GLOB EP	32	8	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187045	10.1371/journal.pone.0187045	http://dx.doi.org/10.1371/journal.pone.0187045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084229	gold, Green Published, Green Submitted			2022-12-27	WOS:000413910200026
J	Lai, YF; Lum, AYW; Ho, ETL; Lim, YW				Lai, Yi Feng; Lum, Andrew Yew Wai; Ho, Emily Tse Lin; Lim, Yee Wei			Patient-provider disconnect: A qualitative exploration of understanding and perceptions to care integration	PLOS ONE			English	Article							HEALTH-CARE	Background Integrated care has been well-recognized as a solution to improve quality of care for patients with complex needs. As Singapore increasingly develops and promotes integrated models of care, it is unclear if providers, patients, and caregivers share similar understanding of changes in the healthcare system. Objectives This study aims at exploring three dimensions of care integration: a) understanding of integration; b) challenges and c) changes perceived as essential among three distinct stake-holder groups: providers, patients and caregivers. Methods This qualitative study was conducted among 41 care providers (clinicians and administrators) and care consumers (patients and caregivers) in Singapore utilizing 29 semi-structured interviews and 2 focus group discussions. Study participants were selected by purposive, snowball sampling from various clinical settings. Data were transcribed, familiarized, coded and analyzed using a conceptual framework. Results Understanding of care integration was generally lacking among patient and caregivers. Most of them focused on healthcare costs and accessibility of services. Providers characterized care integration in clinical process terms and had a more systems view of the concept. Most participants viewed resource constraints as a key challenge in integrating care. Additionally, providers expressed the need for patients and their families to play a greater role in managing their health. Individuals and the community are key components of an integrated care system in the future. Reliance on the healthcare system alone is not sustainable. Conclusions Patients, caregivers and providers have varying degrees of understanding towards care integration. The success of engaging stakeholders on the ground to be active participants in the healthcare system integration process requires policymakers and healthcare leaders to increase patient engagement efforts and to better appreciate the challenges faced by the healthcare workers in the rapidly changing national and global healthcare landscape.	[Lai, Yi Feng] Sengkang Hlth, Dept Pharm, Singapore, Singapore; [Lum, Andrew Yew Wai] Raffles Hosp, Dept Pharm, Singapore, Singapore; [Ho, Emily Tse Lin] Singapore Hlth Serv, Reg Hlth Syst, Singapore, Singapore; [Lim, Yee Wei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	Raffles Hospital; National University of Singapore	Lai, YF (corresponding author), Sengkang Hlth, Dept Pharm, Singapore, Singapore.	laiyifeng@gmail.com		Lai, Yi Feng/0000-0002-1318-3032				Agency for Healthcare Research and Quality, 2012, AHRQ PUBLICATION, V12-05154, P71; Allen J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-346; [Anonymous], 2013, STRAITS TIMES; [Anonymous], 2014, TODAY ONLINE    0304; [Anonymous], 2014, STRAITS TIMES; [Anonymous], 2016, TODAY ONLINE    0901; [Anonymous], 2016, CHANNEL NEWS ASIA; [Anonymous], 2016, STRAITS TIMES O 0709; Armitage Gail D, 2009, Int J Integr Care, V9, pe82; Aysola J, 2015, J GEN INTERN MED, V30, P1461, DOI 10.1007/s11606-015-3312-8; Benzer JK, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1079-6; Bonney A, 2009, EDUC PRIM CARE, V20, P371, DOI 10.1080/14739879.2009.11493812; Commonwealth Fund, 2012, 2012 COMM FUND INT S; Ehrlich C, 2009, HEALTH SOC CARE COMM, V17, P619, DOI 10.1111/j.1365-2524.2009.00863.x; Evans JM, 2013, ADV HEALTH CARE MANA, V15, P125, DOI 10.1108/S1474-8231(2013)0000015011; Hartgerink JM, 2013, INT J INTEGR CARE, P14; Iliffe S, 2006, FAM PRACT, V23, P353, DOI 10.1093/fampra/cmi116; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; King's Fund, 2013, MAK INT CAR HAPP SCA; Kodner D L, 2000, Int J Integr Care, V1, pe08; Kodner Dennis L, 2002, Int J Integr Care, V2, pe12; Kodner Dennis L, 2009, Healthc Q, V13 Spec No, P6; Kreindler SA, 2012, MILBANK Q, V90, P457, DOI 10.1111/j.1468-0009.2012.00671.x; Lafortune C, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0052-x; Leutz WN, 1999, MILBANK Q, V77, P77, DOI 10.1111/1468-0009.00125; Leydon GM, 2013, BMJ SUPPORT PALLIAT, V3, P412, DOI 10.1136/bmjspcare-2012-000266; Ling T, 2012, INT J INTEGR CARE, P14; Lloyd J, 2005, INTEGRATED CARE GUID; Low CO, CHALLENGES TRANSFORM; Luijks HD, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652373; Ministry of Health Singapore, REORG HEALTHC SYST 3; Naylor C, 2015, ACUTE HOSP INTEGRATE; Parsons S, PICKER I EUROPE QUAL; Pate Judy, 2010, J Health Organ Manag, V24, P200; Saw PS, 2015, PATIENT PREFER ADHER, V9, P467, DOI 10.2147/PPA.S73953; Schoen C, 2012, HEALTH AFFAIR, V31, P2805, DOI 10.1377/hlthaff.2012.0884; Shaw S., 2011, OVERVIEW INTEGRATED; Singapore Government, 1950, REP REG BIRTHS DEATH; Strandberg-Larsen Martin, 2011, Dan Med Bull, V58, pB4245; Suter Esther, 2009, Healthc Q, V13 Spec No, P16; Uijen AA, 2012, FAM PRACT, V29, P264, DOI 10.1093/fampra/cmr104; United Nations, 2002, WORLD POPULATION AGE; Valentijn PP, 2013, INT J INTEGR CARE, V13; Williams P, 2009, INT J INTEGR CARE, V14	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187372	10.1371/journal.pone.0187372	http://dx.doi.org/10.1371/journal.pone.0187372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077758	Green Submitted, gold, Green Published			2022-12-27	WOS:000413861200060
J	Rozera, G; Fabbri, G; Lorenzini, P; Mastrorosa, I; Timelli, L; Zaccarelli, M; Amendola, A; Vergori, A; Plazzi, MM; Cicalini, S; Antinori, A; Capobianchi, MR; Abbate, I; Ammassari, A				Rozera, Gabriella; Fabbri, Gabriele; Lorenzini, Patrizia; Mastrorosa, Ilaria; Timelli, Laura; Zaccarelli, Mauro; Amendola, Alessandra; Vergori, Alessandra; Plazzi, Maria Maddalena; Cicalini, Stefania; Antinori, Andrea; Capobianchi, Maria Rosaria; Abbate, Isabella; Ammassari, Adriana			Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals	PLOS ONE			English	Article							CD4(+) T-CELLS; INTERFERON-ALPHA; HIV-1-INFECTED PATIENTS; VIRUS-INFECTION; THERAPY; REPLICATION; PERSISTENCE; RESERVOIR; RALTEGRAVIR; DECAY	Background Aim was to determine the dynamics of peripheral blood mononuclear cells (PBMC)-associated total HIV-1 DNA in successfully ART-treated HIV/HCV co-infected patients receiving DAA treatment and to explore possible virological hypotheses underlying the phenomenon. Methods Longitudinal, single-centre study measuring total HIV-1 DNA before the start of DAA, at the end of treatment (EOT), and 3 months after treatment. Univariable and multivariable analyses were used to assess factors associated with HIV-1 DNA increase >= 0.5 Log copies/million PBMC. Episomal 2-LTR forms, residual HIV-1 viremia and proviral DNA quasispecies evolution were also investigated. Results 119 successfully ART-treated HIV/HCV co-infected patients were included. Median baseline HIV-1 DNA was 3.84 Log copies/million PBMC (95% CI 3.49-4.05), and no significant variation with respect to baseline was found at EOT and after 3 months of DAA termination. In 17% of cases an increase >= 0.5 Log copies/million PBMC was observed at EOT compared to baseline. HIV-1 DNA increase was independently associated with lower baseline HIV-1 DNA, longer HIV suppression, raltegravir-based ART and previous exposure to interferon/ribavirin for HCV treatment. In none of the patients with HIV-1 DNA increase, 2-LTR forms were detected at baseline, while in 2 cases 2-LTR forms were found at EOT, without association with residual HIV-1 RNA viremia. No evidence of viral evolution was observed. Conclusions In successfully ART-treated HIV/HCV co-infected patients receiving DAA, PBMC-associated total HIV-1 DNA was quite stable over time, but some patients showed a considerable increase at EOT when compared to baseline. A significantly higher risk of HIV DNA increase was found, in presence of lower cellular HIV reservoir at baseline. Activation of replicative-competent virus generating new rounds of viral replication seems unlikely, while mobilization of cell-associated HIV from tissue reservoirs could be hypothesized.	[Rozera, Gabriella; Amendola, Alessandra; Capobianchi, Maria Rosaria; Abbate, Isabella] IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Virol, Rome, Italy; [Fabbri, Gabriele; Lorenzini, Patrizia; Mastrorosa, Ilaria; Timelli, Laura; Zaccarelli, Mauro; Vergori, Alessandra; Plazzi, Maria Maddalena; Cicalini, Stefania; Antinori, Andrea; Ammassari, Adriana] IRCCS, Natl Inst Infect Dis L Spallanzani, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Abbate, I (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Virol, Rome, Italy.; Ammassari, A (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Clin Dept, Rome, Italy.	isabella.abbate@inmi.it; adriana.ammassari@inmi.it	Amendola, Alessandra/K-8835-2016; Abbate, Isabella/K-6434-2016; Amendola, Alessandra/ABC-2753-2021; Vergori, Alessandra/AAC-1171-2019; Rozera, Gabriella/B-6874-2017; Antinori, Andrea/K-7125-2016; Zaccarelli, Mauro/GYV-1093-2022	Amendola, Alessandra/0000-0002-7063-0222; Amendola, Alessandra/0000-0002-7063-0222; Vergori, Alessandra/0000-0001-6944-0686; Antinori, Andrea/0000-0003-2121-4684; Ammassari, Adriana/0000-0002-0284-0340; Timelli, Laura/0000-0003-2306-0260	HIV infection; Italian Ministry of Health	HIV infection; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the SIMIT 2015 Scholarship for HIV infection (G. Fabbri) and the INMI "L. Spallanzani" Ricerca Corrente grant from the Italian Ministry of Health. The funders were external to our organization and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola A, 2011, J CLIN VIROL, V52, P17, DOI 10.1016/j.jcv.2011.04.012; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Besson GJ, 2014, CLIN INFECT DIS, V59, P1312, DOI 10.1093/cid/ciu585; Bianco C, 2014, J INT AIDS SOC, V17, P197; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Cope R, 2015, AIDS PATIENT CARE ST, V29, P379, DOI 10.1089/apc.2015.0004; Correll T, 2008, PHARMACOTHERAPY, V28, P90, DOI 10.1592/phco.28.1.90; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; Curran R, 2002, J GEN VIROL, V83, P11, DOI 10.1099/0022-1317-83-1-11; Cuzin L, 2015, AIDS, V29, P1665, DOI 10.1097/QAD.0000000000000723; Dianzani F, 2008, J INTERF CYTOK RES, V28, P1, DOI 10.1089/jir.2007.0076; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Gandhi RT, 2012, JAIDS-J ACQ IMM DEF, V59, P229, DOI 10.1097/QAI.0b013e31823fd1f2; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH, V68, P1169, DOI 10.1093/jac/dks533; Izopet J, 1998, J ACQ IMMUN DEF SYND, V19, P478, DOI 10.1097/00042560-199812150-00006; Jiao YM, 2015, ANTIVIR RES, V118, P118, DOI 10.1016/j.antiviral.2015.03.011; Kiselinova M, 2015, J ANTIMICROB CHEMOTH, V70, P3311, DOI 10.1093/jac/dkv250; Laanani M, 2015, CLIN INFECT DIS, V60, P1715, DOI 10.1093/cid/civ171; Lafeuillade A, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-33; Lam YMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031990; Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Mexas AM, 2012, AIDS, V26, P2295, DOI 10.1097/QAD.0b013e32835a5c2f; Moron-Lopez S, 2016, J INFECT DIS, V213, P1008, DOI 10.1093/infdis/jiv521; Murray JM, 2014, J VIROL, V88, P3516, DOI 10.1128/JVI.03331-13; Nicastri E, 2011, ANTIVIR THER, V16, P797, DOI 10.3851/IMP1833; Parisi SG, 2017, MED MICROBIOL IMMUNO; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Poizot-Martin I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141164; Schaefer CJ, 2011, ANTIMICROB AGENTS CH, V55, P3125, DOI 10.1128/AAC.00131-11; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Sun H, 2014, J INFECT DIS, V209, P1315, DOI 10.1093/infdis/jit628; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005	36	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187095	10.1371/journal.pone.0187095	http://dx.doi.org/10.1371/journal.pone.0187095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077766	Green Submitted, Green Published, gold			2022-12-27	WOS:000413861200042
J	Samarasekera, N; Rodrigues, MA; Toh, PS; Salman, RA				Samarasekera, Neshika; Rodrigues, Mark Alexander; Toh, Pheng Shiew; Salman, Rustam Al-Shahi			Imaging features of intracerebral hemorrhage with cerebral amyloid angiopathy: Systematic review and meta-analysis (vol 12, e0180923, 2017)	PLOS ONE			English	Correction													Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Samarasekera, Neshika/0000-0001-6840-0199; Rodrigues, Mark/0000-0002-4507-6872; Al-Shahi Salman, Rustam/0000-0002-2108-9222	Medical Research Council [G108/613, G1002605] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Samarasekera N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180923	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187386	10.1371/journal.pone.0187386	http://dx.doi.org/10.1371/journal.pone.0187386			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077753	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200061
J	Haiden, N; Pimpel, B; Kreissl, A; Jilma, B; Berger, A				Haiden, Nadja; Pimpel, Birgit; Kreissl, Alexandra; Jilma, Bernd; Berger, Angelika			Does Visceral Osteopathic Treatment Accelerate Meconium Passage in Very Low Birth Weight Infants?- A Prospective Randomized Controlled Trial (vol 10, e0123530, 2015)	PLOS ONE			English	Correction													Haiden, Nadja/L-3775-2019	Haiden, Nadja/0000-0003-4806-0312; Berger, Angelika/0000-0001-8775-2405; Jilma, Bernd/0000-0001-5652-7977				Haiden N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123530	1	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187784	10.1371/journal.pone.0187784	http://dx.doi.org/10.1371/journal.pone.0187784			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095914	Green Published, gold			2022-12-27	WOS:000414340200132
J	Huang, YS; Koo, M; Chen, JC; Hwang, JH				Huang, Yung-Sung; Koo, Malcolm; Chen, Jin-Cherng; Hwang, Juen-Haur			The association between tinnitus and the risk of ischemic cerebrovascular disease in young and middle-aged patients: A secondary case-control analysis of a nationwide, population-based health claims database	PLOS ONE			English	Article							SALICYLATE-INDUCED TINNITUS; HEARING-LOSS; STROKE; DIAGNOSIS; STIFFNESS; JAPANESE; GENES; BRAIN	Background Tinnitus and ischemic cerebrovascular disease (ICVD) may share common pathophysiologic mechanisms. Nevertheless, no studies have investigated whether tinnitus is associated with a higher risk of ICVD. The aim of this study was to evaluate the risk of ICVD among young and middle-aged patients with tinnitus. Methods Using the Taiwan's National Health Insurance Research Database, we identified 3,474 patients 20-45 years old with incident ICVD diagnosed between January 1, 2000 and December 31, 2010 and 17,370 controls, frequency matched on age interval, sex, and year of the index date. Risk of ICVD associated with tinnitus was assessed using multiple logistic regression analyses. Results Tinnitus was significantly associated with a higher risk of incident ICVD among young and middle-aged patients (adjusted odds ratio [OR] 1.66, 95% confidence interval [CI] 1.34-2.04), adjusting for sex, age, and comorbidities. In addition, sex-stratified analysis showed that the associations were significant in both male (adjusted OR 1.55, 95% CI 1.16-2.07) and female patients (adjusted OR 1.77, 95% CI 1.30-2.41). Furthermore, tinnitus was significantly associated with a higher risk of ICVD in the 20.0-29.9 years (adjusted OR 4.11, 95% CI 1.98-8.52) and 30.0-39.9 years (adjusted OR 2.19, 95% CI 1.57-3.05) age groups, but for this work. Competing interests: The authors have declared that no competing interests exist. not in the 40.0-45.0 years age group. Conclusions Tinnitus could be a novel risk factor or clinical indicator for young ischemic stroke, and further investigations are warranted.	[Huang, Yung-Sung] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurol, Chiayi, Taiwan; [Koo, Malcolm] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Res, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chen, Jin-Cherng] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurosurg, Chiayi, Taiwan; [Chen, Jin-Cherng; Hwang, Juen-Haur] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hwang, Juen-Haur] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Hwang, JH (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Hwang, JH (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan.	juenhaur@ms96.url.com.tw	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Abanoz Y, 2017, NEUROL SCI; Arnold M, 2009, J NEUROL NEUROSUR PS, V80, P171, DOI 10.1136/jnnp.2008.155226; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; Bayraktar C, 2017, EUR ARCH OTO-RHINO-L, V274, P2125, DOI 10.1007/s00405-016-4440-4; Benjaminsen E, 2016, CASE REP NEUROL MED, V2016, DOI 10.1155/2016/8736248; Biller J, 2014, STROKE, V45, P3155, DOI 10.1161/STR.0000000000000016; Borghi C, 2005, CURR THER RES CLIN E, V66, P420, DOI 10.1016/j.curtheres.2005.10.001; Chiang CY, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0109-x; Choi EJ, 2013, EVID-BASED COMPL ALT, V2013; Cohen JE, 2010, NEUROL RES, V32, P1027, DOI 10.1179/016164110X12767786356273; Ding X, 2014, INT J NEUROSCI, V124, P834, DOI 10.3109/00207454.2013.879580; Gaspar L, 2011, BRATISL MED J, V112, P63; Gopinath B, 2009, STROKE, V40, P1496, DOI 10.1161/STROKEAHA.108.535682; Hughes JW, 2016, J DIABETES COMPLICAT, V30, P1640, DOI 10.1016/j.jdiacomp.2016.08.004; Hwang JJ, 2017, DENTOMAXILLOFAC RAD, V46, DOI 10.1259/dmfr.20170006; Hwang JH, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0682-4; Hwang JH, 2015, AUDIOL NEURO-OTOL, V20, P322, DOI 10.1159/000381934; Hwang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058215; Hwang JH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-30; Hwang JH, 2011, LARYNGOSCOPE, V121, P361, DOI 10.1002/lary.21283; Ikegami-Takada T, 2012, AURIS NASUS LARYNX, V39, P244, DOI 10.1016/j.anl.2011.07.015; Karadas Omer, 2011, Kulak Burun Bogaz Ihtis Derg, V21, P237, DOI 10.5606/kbbihtisas.2011.034; Kazmierczak H, 2001, Int Tinnitus J, V7, P54; Kefi A, 2017, INT J NEUROSCI, V127, P314, DOI 10.1080/00207454.2016.1214131; Kehrle HM, 2016, ANN OTO RHINOL LARYN, V125, P185, DOI 10.1177/0003489415606445; Kim HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127578; Kim JS, 2012, STROKE, V43, P3313, DOI 10.1161/STROKEAHA.112.658500; Koo M, 2016, LARYNGOSCOPE; Lee TH, 2002, STROKE, V33, P1950, DOI 10.1161/01.STR.0000021409.16314.16; Li Y, 2017, NEUROL RES, V39, P30, DOI 10.1080/01616412.2016.1250856; Malm J, 1999, CEREBROVASC DIS, V9, P282, DOI 10.1159/000015979; Mazurek B, 2006, MED HYPOTHESES, V67, P892, DOI 10.1016/j.mehy.2006.03.040; Michikawa T, 2013, PREV MED, V56, P333, DOI 10.1016/j.ypmed.2013.01.016; Patel RR, 2012, CARDIOL REV, V20, P145, DOI 10.1097/CRD.0b013e318247cd15; Pinto PCL, 2014, J LARYNGOL OTOL, V128, P660, DOI 10.1017/S0022215114001030; Renna R, 2014, J STROKE CEREBROVASC, V23, pE221, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.008; Schecklmann M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/461090; Smajlovic D, 2015, VASC HEALTH RISK MAN, V11, P157, DOI 10.2147/VHRM.S53203; Sugiura S, 2008, ACTA OTO-LARYNGOL, V128, P525, DOI 10.1080/00016480701558930; van Sloten TT, 2015, J AM COLL CARDIOL, V66, P2116, DOI 10.1016/j.jacc.2015.08.888	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187474	10.1371/journal.pone.0187474	http://dx.doi.org/10.1371/journal.pone.0187474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095920	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200098
J	Kruse, KE; Batten, J; Constantine, ML; Kache, S; Magnus, D				Kruse, Katherine E.; Batten, Jason; Constantine, Melissa L.; Kache, Saraswati; Magnus, David			Challenges to code status discussions for pediatric patients	PLOS ONE			English	Article							OF-LIFE CARE; PALLIATIVE CARE; FAMILY PERSPECTIVES; RESUSCITATE ORDERS; INTENSIVE-CARE; ATTITUDES; CHILDREN; COMMUNICATION; PHYSICIANS; QUALITY	Objectives In the context of serious or life-limiting illness, pediatric patients and their families are faced with difficult decisions surrounding appropriate resuscitation efforts in the event of a cardiopulmonary arrest. Code status orders are one way to inform end-of-life medical decision making. The objectives of this study are to evaluate the extent to which pediatric providers have knowledge of code status options and explore the association of provider role with (1) knowledge of code status options, (2) perception of timing of code status discussions, (3) perception of family receptivity to code status discussions, and (4) comfort carrying out code status discussions. Design Nurses, trainees (residents and fellows), and attending physicians from pediatric units where code status discussions typically occur completed a short survey questionnaire regarding their knowledge of code status options and perceptions surrounding code status discussions. Setting Single center, quaternary care children's hospital. Measurements and main results 203 nurses, 31 trainees, and 29 attending physicians in 4 high-acuity pediatric units responded to the survey (N = 263, 90% response rate). Based on an objective knowledge measure, providers demonstrate poor understanding of available code status options, with only 22% of providers able to enumerate more than two of four available code status options. In contrast, provider groups self-report high levels of familiarity with available code status options, with attending physicians reporting significantly higher levels than nurses and trainees (p = 0.0125). Nurses and attending physicians show significantly different perception of code status discussion timing, with majority of nurses (63.4%) perceiving discussions as occurring "too late" or "much too late" and majority of attending physicians (55.6%) perceiving the timing as "about right" (p<0.0001). Attending physicians report significantly higher comfort having code status discussions with families than do nurses or trainees (p<0.0001). Attending physicians and trainees perceive families as more receptive to code status discussions than nurses (p<0.0001 and p = 0.0018, respectively). Conclusions Providers have poor understanding of code status options and differ significantly in their comfort having code status discussions and their perceptions of these discussions. These findings may reflect inherent differences among providers, but may also reflect discordant visions of appropriate care and function as a potential source of moral distress. Lack of knowledge of code status options and differences in provider perceptions are likely barriers to quality communication surrounding end-of-life options.	[Kruse, Katherine E.; Batten, Jason; Magnus, David] Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Stanford, CA 94305 USA; [Kruse, Katherine E.; Kache, Saraswati] Stanford Univ, Dept Pediat, Sch Med, Div Pediat Crit Care Med, Stanford, CA 94305 USA; [Constantine, Melissa L.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA	Stanford University; Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Kruse, KE (corresponding author), Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Stanford, CA 94305 USA.; Kruse, KE (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Pediat Crit Care Med, Stanford, CA 94305 USA.	kruse575@gmail.com			Jackson Vaughan Critical Care Research Award	Jackson Vaughan Critical Care Research Award	Dr. Kruse received grant support from the Jackson Vaughan Critical Care Research Award. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Anderson WG, 2011, J GEN INTERN MED, V26, P359, DOI 10.1007/s11606-010-1568-6; Auerbach AD, 2008, J HOSP MED, V3, P437, DOI 10.1002/jhm.369; Austin W, 2005, HEC FORUM, V17, P33, DOI 10.1007/s10730-005-4949-1; Contro N, 2002, ARCH PEDIAT ADOL MED, V156, P14, DOI 10.1001/archpedi.156.1.14; Contro NA, 2004, PEDIATRICS, V114, P1248, DOI 10.1542/peds.2003-0857-L; Dellon EP, 2010, J PAIN SYMPTOM MANAG, V40, P821, DOI 10.1016/j.jpainsymman.2010.03.021; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Dube CE, 2003, AMBUL PEDIATR, V3, P137, DOI 10.1367/1539-4409(2003)003<0137:SOCSPA>2.0.CO;2; Hakim RB, 1996, ANN INTERN MED, V125, P284, DOI 10.7326/0003-4819-125-4-199608150-00005; Hamric AB, 2012, AJOB PRIM RES, V3, P1, DOI [10.1080/21507716.2011.652337, DOI 10.1080/21507716.2011.652337]; Henrich NJ, 2016, J CRIT CARE, V35, P57, DOI 10.1016/j.jcrc.2016.04.033; Heyland DK, 2006, CHEST, V130, P419, DOI 10.1378/chest.130.2.419; Hilden JM, 2001, J CLIN ONCOL, V19, P205, DOI 10.1200/JCO.2001.19.1.205; Hinds Pamela S, 2005, J Palliat Med, V8 Suppl 1, pS70, DOI 10.1089/jpm.2005.8.s-70; JARRETT N, 1995, J ADV NURS, V22, P72, DOI 10.1046/j.1365-2648.1995.22010072.x; Khaneja S, 1998, ARCH PEDIAT ADOL MED, V152, P909; Kolarik RC, 2006, PEDIATRICS, V117, P1949, DOI 10.1542/peds.2005-1111; Kraemer HC, 1987, MANY SUBJECTS STAT P; Mack JW, 2007, J CLIN ONCOL, V25, P5636, DOI 10.1200/JCO.2007.12.6110; McCallum DE, 2000, J PAIN SYMPTOM MANAG, V20, P417, DOI 10.1016/S0885-3924(00)00212-8; Michelson KN, 2013, PEDIATR CRIT CARE ME, V14, pE34, DOI 10.1097/PCC.0b013e31826e7408; Mirza Ayoub, 2005, Am J Hosp Palliat Care, V22, P20, DOI 10.1177/104990910502200107; Sanderson A, 2013, JAMA PEDIATR, V167, P954, DOI 10.1001/jamapediatrics.2013.2204; Serwint JR, 2004, J PEDIATR-US, V145, P229, DOI 10.1016/j.jpeds.2004.04.055; Solomon MZ, 2005, PEDIATRICS, V116, P872, DOI 10.1542/peds.2004-0905; Sulmasy DP, 2008, CRIT CARE MED, V36, P1817, DOI 10.1097/CCM.0b013e31817c79fe; Vazirani RM, 2000, CRIT CARE MED, V28, P3740, DOI 10.1097/00003246-200011000-00036; WEBSTER GC, 1991, CAN J ANAESTH, V38, P553, DOI 10.1007/BF03008184; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469	29	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187375	10.1371/journal.pone.0187375	http://dx.doi.org/10.1371/journal.pone.0187375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095938	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200079
J	Kucharova, K; Stallcup, WB				Kucharova, Karolina; Stallcup, William B.			Distinct NG2 proteoglycan-dependent roles of resident microglia and bone marrow-derived macrophages during myelin damage and repair	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; OLIGODENDROCYTE PROGENITORS; CNS REMYELINATION; HL-60 CELLS; EXPRESSION; RECEPTOR; DIFFERENTIATION; PROLIFERATION; PERICYTES; AXONS	We used a bone marrow transplantation approach to distinguish the activities of bone marrow-derived macrophages from the activities of central nervous system-resident microglia in phenomena associated with axon demyelination and remyelination. We transplanted wild type or germline NG2 null beta-actin-EGFP expressing bone marrow into irradiated wild type or NG2 null recipient mice, followed by analysis of lysolecithin-induced spinal cord demyelination and remyelination and quantification of lba-1(+)/F4/80(+)/EGFP(+)macrophages and lba-1 (+)/F4/80(+)/EGFP(-) microglia. One week after microinjection of 1 % lysolecithin into the spinal cord, wild type recipients receiving NG2 null bone marrow exhibit greatly reduced infiltration of macrophages into lesions, compared to wild type recipients receiving wild type bone marrow. Wild type bone marrow recipients also exhibit larger numbers of demyelinated axons than NG2 null recipients, indicative of macrophage participation in the initial myelin damage. However, wild type bone marrow recipients also exhibit superior myelin repair at 6 weeks post-injury, compared to NG2 null bone marrow recipients, demonstrating the additional importance of macrophages in remyelination. Incompletely repaired lesions in NG2 null bone marrow recipients at 6 weeks post-injury retain elevated numbers of macrophages, in contrast to lower numbers of macrophages in more completely repaired lesions in wild type bone marrow recipients. This suggests that NG2 expression renders macrophages more effective in myelin repair and less likely to promote chronic inflammation. Effective macrophage involvement in myelin repair is due in part to effects on the proliferation and/or recruitment of oligodendrocyte progenitor cells. Reduced numbers of oligodendrocyte progenitors are seen in lesions in NG2 null bone marrow recipients, likely due to deficits in macrophage production of oligodendrocyte progenitor-relevant mitogens and in phagocytosis of inhibitory myelin debris. Microglia also appear to be important for clearance of myelin debris, as indicated by reduced phagocytosis in NG2 null recipients receiving wild type bone marrow.	[Kucharova, Karolina; Stallcup, William B.] Sanford Burnham Prebys Med Discovery Inst, Tumor Microenvironm & Canc Immunol Program, Canc Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Stallcup, WB (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Tumor Microenvironm & Canc Immunol Program, Canc Ctr, La Jolla, CA 92037 USA.	stallcup@SBPDiscovery.org		Kucharova, Karolina/0000-0002-3196-748X	National Institutes of Health, National Cancer Institute [R01 CA095287]; Sanford Burnham Prebys Medical Discovery Institute, Lab Funding Initiative; NIH [R01 CA095287]; Sanford Burnham Prebys Lab Funding Initiative; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sanford Burnham Prebys Medical Discovery Institute, Lab Funding Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford Burnham Prebys Lab Funding Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health, National Cancer Institute, R01 CA095287 (WBS); and Sanford Burnham Prebys Medical Discovery Institute, Lab Funding Initiative (WBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Ms. Regina Kapono for her help in preparing the manuscript, Ms. Adriana Char-bono for assistance with animal care, and Dr. Pilar Cejudo-Martin for expertise with flow cytometric determination of bone marrow engraftment efficiency. This work was supported by NIH grant R01 CA095287 and by Sanford Burnham Prebys Lab Funding Initiative to WBS.	Atkins HL, 2016, LANCET, V388, P576, DOI 10.1016/S0140-6736(16)30169-6; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Cejudo-Martin Pilar, 2016, Trends Cell Mol Biol, V11, P55; de Castro R, 2005, EXP NEUROL, V192, P299, DOI 10.1016/j.expneurol.2004.11.027; Gao Q, 2010, NEUROSCIENCE, V165, P386, DOI 10.1016/j.neuroscience.2009.10.022; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gibby K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3174; Grako KA, 1999, J CELL SCI, V112, P905; Hinks GL, 1999, MOL CELL NEUROSCI, V14, P153, DOI 10.1006/mcne.1999.0771; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Keirstead HS, 1999, ADV EXP MED BIOL, V468, P183; Kirk S, 2004, J NEUROL SCI, V217, P125, DOI 10.1016/j.jns.2003.10.016; Kitic M, 2017, ACTA NEUROPATHOL, V134, P325, DOI 10.1007/s00401-017-1735-5; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Kucharova K, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0385-6; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Mensah-Brown EP, 2011, J NEUROIMMUNOL, V232, P68, DOI 10.1016/j.jneuroim.2010.10.010; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Reiterer G, 2008, FEBS LETT, V582, P2508, DOI 10.1016/j.febslet.2008.06.016; Reiterer G, 2007, CANCER RES, V67, P7765, DOI 10.1158/0008-5472.CAN-07-0014; Stallcup WB, 2016, MICROCIRCULATION, V23, P122, DOI 10.1111/micc.12251; Tigges U, 2008, DEVELOPMENT, V135, P523, DOI 10.1242/dev.002071; Trebst C, 2008, MULT SCLER, V14, P728, DOI 10.1177/1352458508089359; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Yotsumoto F, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.1001204	29	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187530	10.1371/journal.pone.0187530	http://dx.doi.org/10.1371/journal.pone.0187530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095924	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200112
J	Lai, HW; Liu, LC; Ouyang, F; Yao, CC; Jan, HC; Chang, YH; Tu, CW; Chen, DR; Cheng, TF; Tzeng, YD; Hsu, HM; Yeh, MH; Wu, YC; Yang, PS; Lam, HB; Hou, MF; Chen, FM				Lai, Hung-Wen; Liu, Liang-Chih; Ouyang, Fu; Yao, Chung-Chin; Jan, Hsiang-Chun; Chang, Ya-Herng; Tu, Chi-Wen; Chen, Dar-Ren; Cheng, Tsui-Fen; Tzeng, Yen-Dun; Hsu, Huan-Ming; Yeh, Ming-Hsin; Wu, Yao-Chung; Yang, Po-Sheng; Lam, Hung-Bun; Hou, Ming-Feng; Chen, Fang-Ming			Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent (R) eBx (R) System for the management of early stage breast cancer in Taiwan	PLOS ONE			English	Article							20-YEAR FOLLOW-UP; CONSERVING SURGERY; BRACHYTHERAPY; IRRADIATION; MASTECTOMY; CONSENSUS; THERAPY; PHASE-3; TRIAL; CARE	Background In this multi-center study, we report the patient selection criteria for and preliminary oncologic outcomes associated with intraoperative radiotherapy (IORT) delivered by the Xoft Axxent (R) eBx (R) system for early-stage breast cancer in Taiwan. Methods Patients with early breast cancer in Taiwan received breast conserving surgery and received IORT with Xoft Axxent (R) eBx (R) System during 2013-2015 was search from database of Taiwan IORT study cooperative group (T-IORTSCG). Patients' clinicopathologic characteristics and early post-operative results were collected and reported. Results During the study period, 26 hospitals in Taiwan performed a total of 261 Xoft IORT procedures for breast cancer. The mean age of them was 52.9 +/- 9.8 years (37-72), and tumor size was 1.5 +/- 0.8 cm (0.1-4.2 cm) for invasive cancer and 1.2 +/- 0.8 cm (range, 0.2-3.0 cm) for ductal carcinoma in situ (DCIS) lesions. Lymph node metastasis was found in 6 (2.3%) patients. The patients received IORT in Taiwan differed markedly from those used in the ELIOT and TARGIT-A studies. Specifically, patients selected for IORT in Taiwan tended to be younger, their tumors tended to be larger and the prevalence of lymph node metastasis tended to be lower. Among these 261 patients, 8 (3.1 %) patients required whole breast radiotherapy. During a mean follow up of 15.6 months, locoregional recurrence was observed in 2 (0.8%) patients. Conclusion In real world experience, patients received IORT differed quite significantly with criteria formulated by trials. The preliminary results of IORT in Taiwan showed it is well acceptable by patients and clinicians.	[Lai, Hung-Wen] Changhua Christian Hosp, Endoscopy & Oncoplast Breast Surg Ctr, Changhua, Taiwan; [Lai, Hung-Wen; Chen, Dar-Ren] Changhua Christian Hosp, Comprehens Breast Canc Ctr, Changhua, Taiwan; [Lai, Hung-Wen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Liu, Liang-Chih; Wu, Yao-Chung] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Liu, Liang-Chih; Wu, Yao-Chung] China Med Univ, Coll Med, Taichung, Taiwan; [Ouyang, Fu; Chen, Fang-Ming] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan; [Ouyang, Fu; Hou, Ming-Feng; Chen, Fang-Ming] Kaohsiung Med Univ Hosp, Breast Div, Dept Surg, Kaohsiung, Taiwan; [Ouyang, Fu; Hou, Ming-Feng; Chen, Fang-Ming] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Yao, Chung-Chin; Yeh, Ming-Hsin] Chung Shan Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yao, Chung-Chin; Chen, Dar-Ren; Yeh, Ming-Hsin] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Jan, Hsiang-Chun; Chang, Ya-Herng] Cardinal Tien Hosp, Taipei, Taiwan; [Tu, Chi-Wen] Ditmanson Med Fdn Chia Yi Christian Hosp, Dept Gen Surg, Chiayi, Taiwan; [Cheng, Tsui-Fen] Shin Kong Wu Ho Su Mem Hosp, Taipei, Taiwan; [Tzeng, Yen-Dun] Kaohsiung Vet Gen Hosp, Div Gen Surg, Dept Surg, Kaohsiung, Taiwan; [Hsu, Huan-Ming] Triserv Gen Hosp, Songshan Branch, Dept Surg, Taipei, Taiwan; [Yang, Po-Sheng; Lam, Hung-Bun] Mackay Mem Hosp, Dept Surg, Taipei, Taiwan; [Yang, Po-Sheng; Lam, Hung-Bun] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Hou, Ming-Feng] Kaohsiung Municipal Hsiaokang Hosp, Dept Surg, Kaohsiung, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Shin Kong Wu Ho Su Memorial Hospital; Kaohsiung Veterans General Hospital; Tri-Service General Hospital; Mackay Memorial Hospital; Mackay Medical College; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Chen, FM (corresponding author), Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan.; Hou, MF; Chen, FM (corresponding author), Kaohsiung Med Univ Hosp, Breast Div, Dept Surg, Kaohsiung, Taiwan.; Hou, MF; Chen, FM (corresponding author), Kaohsiung Med Univ, Kaohsiung, Taiwan.; Hou, MF (corresponding author), Kaohsiung Municipal Hsiaokang Hosp, Dept Surg, Kaohsiung, Taiwan.	mifeho@kmu.edu.tw; fchen@kmu.edu.tw		Tzeng, Yen-Dun/0000-0003-1502-0840; Hou, Ming-Feng/0000-0001-6030-9702	Ministry of Science and Technology of Taiwan [104-2314-B-371-006-MY3]; Changhua Christian Hospital [104-CCH-ICO-006]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital	This study was funded by the Ministry of Science and Technology of Taiwan, and the number of this funding was 104-2314-B-371-006-MY3. This study was also sponsored by research provided by the Changhua Christian Hospital 104-CCH-ICO-006.	Abe O, 2005, LANCET, V366, P2087; Anderson BO, 2005, LANCET ONCOL, V6, P145, DOI 10.1016/S1470-2045(05)01765-1; Budach W, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0568-4; Christgen M, 2016, PATHOL RES PRACT, V212, P583, DOI 10.1016/j.prp.2016.05.002; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Derias M, 2016, BREAST J, V22, P384, DOI 10.1111/tbj.12594; Dolan JT, 1999, AM J SURG, V178, P470, DOI 10.1016/S0002-9610(99)00226-3; FARROW DC, 1992, NEW ENGL J MED, V326, P1097, DOI 10.1056/NEJM199204233261701; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Guedea F, 2010, RADIOTHER ONCOL, V97, P514, DOI 10.1016/j.radonc.2010.09.009; Hahn CA, 2003, INT J RADIAT ONCOL, V55, P1196, DOI 10.1016/S0360-3016(02)04475-9; Holmes DR, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/303879; Ivanov O, 2011, ANN SURG ONCOL, V18, P453, DOI 10.1245/s10434-010-1283-x; Lai HW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003810; Mehta VK, 2010, AM J CLIN ONCOL-CANC, V33, P327, DOI 10.1097/COC.0b013e3181d79d9e; Network NCC, 2014, NCCN CLIN PRACT GUID; Smith BD, 2009, INT J RADIAT ONCOL, V74, P987, DOI 10.1016/j.ijrobp.2009.02.031; Strnad V, 2016, LANCET, V387, P229, DOI 10.1016/S0140-6736(15)00471-7; Vaidya JS, 2014, LANCET, V383, P603, DOI 10.1016/S0140-6736(13)61950-9; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Veronesi U, 2013, LANCET ONCOL, V14, P1269, DOI 10.1016/S1470-2045(13)70497-2; Veronesi U, 2010, BREAST CANCER RES TR, V124, P141, DOI 10.1007/s10549-010-1115-5	25	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0185876	10.1371/journal.pone.0185876	http://dx.doi.org/10.1371/journal.pone.0185876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095832	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200010
J	Nedoszytko, B; Sieminska, A; Strapagiel, D; Dabrowski, S; Slomka, M; Sobalska-Kwapis, M; Marciniak, B; Wierzba, J; Skokowski, J; Fijalkowski, M; Nowicki, R; Kalinowski, L				Nedoszytko, Boguslaw; Sieminska, Alicja; Strapagiel, Dominik; Dabrowski, Slawomir; Slomka, Marcin; Sobalska-Kwapis, Marta; Marciniak, Blazej; Wierzba, Jolanta; Skokowski, Jaroslaw; Fijalkowski, Marcin; Nowicki, Roman; Kalinowski, Leszek			High prevalence of carriers of variant c.1528G > C of HADHA gene causing long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) in the population of adult Kashubians from North Poland	PLOS ONE			English	Article							MITOCHONDRIAL TRIFUNCTIONAL PROTEIN; ACUTE FATTY LIVER; MUTATIONAL ANALYSIS; POLISH PATIENTS; PREGNANCY; IDENTIFICATION; METAANALYSIS; ASSOCIATION; SMOKING	Background/Objectives The mitochondrial (5-oxidation of fatty acids is a complex catabolic pathway. One of the enzymes of this pathway is the heterooctameric mitochondrial trifunctional protein (MTP), composed of four a-and (5-subunits. Mutations in MTP genes (HADHA and HADHB), both located on chromosome 2p23, cause MTP deficiency, a rare autosomal recessive metabolic disorder characterized by decreased activity of MTP. The most common MTP mutation is long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency caused by the c.1528G>C (rs137852769, p.Glu510Gln) substitution in exon 15 of the HADHA gene. Subjects/Methods We analyzed the frequency of genetic variants in the HADHA gene in the adults of Kashubian origin from North Poland and compared this data in other Polish provinces. Results We found a significantly higher frequency of HDHA c.1528G>C(rs137852769, p.Glu510Gln) carriers among Kashubians (1/57) compared to subjects from other regions of Poland (1/187). We found higher frequency of c.652G>C (rs71441018, pVal218Leu) polymorphism in the HADHA gene within population of Silesia, southern Poland (1/107) compared to other regions. Conclusion Our study indicate described high frequency of c.1528G>C variant of HADHAgene in Kashubian population, suggesting the founder effect. For the first time we have found high frequency of rs71441018 in the South Poland Silesian population.	[Nedoszytko, Boguslaw; Nowicki, Roman] Med Univ Gdansk, Dept Dermatol Venereol & Allergol, Gdansk, Poland; [Sieminska, Alicja] Med Univ Gdansk, Dept Pneumonol & Allergol, Gdansk, Poland; [Strapagiel, Dominik; Slomka, Marcin; Sobalska-Kwapis, Marta; Marciniak, Blazej] Univ Lodz, Fac Biol & Environm Protect, Dept Mol Biophys, Biobank Lab, Lodz, Poland; [Strapagiel, Dominik; Slomka, Marcin; Sobalska-Kwapis, Marta; Marciniak, Blazej; Skokowski, Jaroslaw; Kalinowski, Leszek] BBMRI Pl Consortium, Wroclaw, Poland; [Dabrowski, Slawomir] A&A Biotechnol Sc, Gdynia, Poland; [Wierzba, Jolanta] Med Univ Gdansk, Dept Pediat Hematol & Oncol, Gdansk, Poland; [Skokowski, Jaroslaw] Med Univ Gdansk, Dept Surg Oncol, Gdansk, Poland; [Fijalkowski, Marcin] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland; [Kalinowski, Leszek] Med Univ Gdansk, Cent Bank Frozen Tissues & Genet Specimens, Dept Med Lab Diagnost, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Lodz; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Nedoszytko, B (corresponding author), Med Univ Gdansk, Dept Dermatol Venereol & Allergol, Gdansk, Poland.; Strapagiel, D (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Mol Biophys, Biobank Lab, Lodz, Poland.; Strapagiel, D (corresponding author), BBMRI Pl Consortium, Wroclaw, Poland.	bned@gumed.edu.pl; dominik.strapagiel@biol.uni.lodz.pl	Kalinowski, Leszek/N-3076-2019; Nedoszytko, Boguslaw/AAY-5079-2020; Nowicki, Roman J./U-3148-2018; Strapagiel, Dominik/AAD-4351-2020; Sieminska, Alicja/S-9604-2018	Kalinowski, Leszek/0000-0001-7270-1592; Nowicki, Roman J./0000-0003-4768-1387; Strapagiel, Dominik/0000-0001-9752-4270; Marciniak, Blazej/0000-0003-1571-1473; Sobalska-Kwapis, Marta/0000-0003-1982-2621; Fijalkowski, Marcin/0000-0002-2913-5457; Skokowski, Jaroslaw/0000-0002-3079-3502; Sieminska, Alicja/0000-0002-4415-7566; Wierzba, Jolanta/0000-0003-0290-1243; Nedoszytko, Boguslaw/0000-0002-6286-0693; Slomka, Marcin/0000-0002-7906-5549	Polish Ministry of Science and Higher Education [02-0066/07/253, DIR/WK/2017/01]; Polish POIG Grant from European Regional Development Fund [01.01.02-10-005/08]; A&A Biotechnology s.c.	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish POIG Grant from European Regional Development Fund; A&A Biotechnology s.c.	The study is financed by Polish Ministry of Science and Higher Education grant 02-0066/07/253 and DIR/WK/2017/01. POPULOUS collection was financed by the Polish POIG Grant 01.01.02-10-005/08 TESTOPLEK from the European Regional Development Fund. Stawomir Dabrowski received salaries from A&A Biotechnology s.c. The funder provided support in the form of salaries for Stawomir Dabrowski, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The study was approved by the local research ethics committee of the Medical University of Gdansk and local research ethics committee of the University of Lodz. The study was financed by the Polish Ministry of Science and Higher Education grant 02-0066/07/253 and DIR/WK/2017/01. The POPULOUS collection was financed by the Polish POIG Grant 01.01.02-10-005/08 TESTOPLEK from the European Regional Development Fund. Slawomir Dabrowski received salaries from A&A Biotechnology s.c. The funder provided support in the form of salaries for SD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BAS INF REL SOC POL; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Boutron A, 2011, MOL GENET METAB, V103, P341, DOI 10.1016/j.ymgme.2011.04.006; Chen LS, 2012, GENET EPIDEMIOL, V36, P340, DOI 10.1002/gepi.21627; Chmara M, 2010, J APPL GENET, V51, P95, DOI 10.1007/BF03195716; Choi JH, 2007, INT J MOL MED, V19, P81; Das AM, 2006, CLIN CHEM, V52, P530, DOI 10.1373/clinchem.2005.062000; den Boer MEJ, 2002, PEDIATRICS, V109, P99, DOI 10.1542/peds.109.1.99; Den Boer MEJ, 2000, PEDIATR RES, V48, P151, DOI 10.1203/00006450-200008000-00006; Gregersen N, 2010, J INHERIT METAB DIS, V33, P547, DOI 10.1007/s10545-010-9046-1; HAGENFELDT L, 1995, J INHERIT METAB DIS, V18, P245, DOI 10.1007/BF00711779; Ibdah JA, 1999, J INHERIT METAB DIS, V22, P811, DOI 10.1023/A:1005506024055; Ijlst L, 1996, J CLIN INVEST, V98, P1028, DOI 10.1172/JCI118863; Janik M., 2015, INVENTORMETHOD DETER; Joost K, 2012, JIMD REP, V2, P79, DOI 10.1007/8904_2011_51; KAMIJO T, 1994, BIOCHEM BIOPH RES CO, V199, P818, DOI 10.1006/bbrc.1994.1302; Kita-Milczarska K, 2016, MED SCI MONITOR, V22, P1442, DOI 10.12659/MSM.895907; Kushniarevich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135820; Lindner M, 2010, J INHERIT METAB DIS, V33, P521, DOI 10.1007/s10545-010-9076-8; Lipska-Zietkiewicz BS, 2013, J APPL GENET, V54, P327, DOI 10.1007/s13353-013-0147-z; Mielnik-Sikorska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054360; Orii KE, 1997, HUM MOL GENET, V6, P1215, DOI 10.1093/hmg/6.8.1215; Pastinen T, 2001, HUM MOL GENET, V10, P2961, DOI 10.1093/hmg/10.26.2961; Piekutowska-Abramczuk D, 2010, J INHERIT METAB DIS, V33, pS373, DOI 10.1007/s10545-010-9190-7; Purevsuren J, 2009, MOL GENET METAB, V98, P372, DOI 10.1016/j.ymgme.2009.07.011; Rebala K, 2013, EUR J HUM GENET, V21, P415, DOI 10.1038/ejhg.2012.190; Sander J, 2005, MOL GENET METAB, V85, P108, DOI 10.1016/j.ymgme.2005.02.002; Shahrokhi M, 2017, ARCH IRAN MED, V20, P22, DOI 0172001/AIM.006; Sieminska A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1455-5; SIMS HF, 1995, P NATL ACAD SCI USA, V92, P841, DOI 10.1073/pnas.92.3.841; Sobalska-Kwapis M, PLOS ONE, V12; Specjalski K, 2013, RHEUMATOL INT, V33, P3043, DOI 10.1007/s00296-012-2575-1; Spiekerkoetter U, 2003, HUM MUTAT, V21, P598, DOI 10.1002/humu.10211; Strapagiel D., 2016, POLAND OPEN J BIORES, V3, pe6, DOI DOI 10.5334/OJB.22; TREEM WR, 1994, HEPATOLOGY, V19, P339; Tyni T, 1999, ACTA PAEDIATR, V88, P237, DOI 10.1080/08035259950169954; WANDERS RJA, 1989, LANCET, V2, P52, DOI 10.1016/S0140-6736(89)90300-0; Ware JJ, 2011, NICOTINE TOB RES, V13, P1167, DOI 10.1093/ntr/ntr118; WILCKEN B, 1993, LANCET, V341, P407, DOI 10.1016/0140-6736(93)92993-4; Witon M, 2017, BIOPRESERV BIOBANK; Wozniak M, 2010, AM J PHYS ANTHROPOL, V142, P540, DOI 10.1002/ajpa.21253; Zhu Jin-ming, 2005, Beijing Da Xue Xue Bao Yi Xue Ban, V37, P72	42	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187365	10.1371/journal.pone.0187365	http://dx.doi.org/10.1371/journal.pone.0187365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095929	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200077
J	Heimann, AS; Gupta, A; Gomes, I; Rayees, R; Schlessinger, A; Ferro, ES; Unterwald, EM; Devi, LA				Heimann, Andrea S.; Gupta, Achla; Gomes, Ivone; Rayees, Rahman; Schlessinger, Avner; Ferro, Emer S.; Unterwald, Ellen M.; Devi, Lakshmi A.			Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states	PLOS ONE			English	Article								The N-terminal region of G protein-coupled receptors can be efficiently targeted for the generation of receptor-selective antibodies. These antibodies are useful for the biochemical characterization of the receptors. In this study, we developed a set of criteria to select the optimal epitope and applied them to generate antibodies to the N-terminal region of 34 different G protein-coupled receptors. The antibody characterization revealed that a subset of antibodies exhibited increased recognition of the receptor following agonist treatment and this increase could be blocked by treatment with the receptor antagonist. An analysis of the epitopes showed that those antibodies that exhibit increased recognition are on average twelve residues long, have an overall net negative charge and are enriched in aspartic and glutamic acids. These antibodies are useful since they facilitate studies examining dose dependent increases in recognition of receptors in heterologous cells as well as in native tissue. Another interesting use of these antibodies is that they facilitate measuring changes in receptor recognition in brain following peripheral drug administration; for example, systemic administration of cocaine, a blocker of dopamine transporter that increases local dopamine levels at the synapse, was found to lead to increases in antibody recognition of dopamine receptors in the brain. Taken together these studies, in addition to describing novel tools to study native receptors, provide a framework for the generation of antibodies to G protein coupled receptors that can detect ligand-induced conformational changes.	[Heimann, Andrea S.] Proteimax Biotechnol LTDA, Av Corifeu Azevedo Marques, Sao Paulo, SP, Brazil; [Gupta, Achla; Gomes, Ivone; Rayees, Rahman; Schlessinger, Avner; Devi, Lakshmi A.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Ferro, Emer S.] Univ Sao Paulo, Biomed Sci Inst, Dept Pharmacol, Sao Paulo, SP, Brazil; [Unterwald, Ellen M.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA	Icahn School of Medicine at Mount Sinai; Universidade de Sao Paulo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Heimann, AS (corresponding author), Proteimax Biotechnol LTDA, Av Corifeu Azevedo Marques, Sao Paulo, SP, Brazil.; Devi, LA (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.	andrea@proteimaxnet.com.br; lakshmi.devi@mssm.edu	Ferro, Emer S/D-3908-2012; Devi P, Lakshmi/GXM-5982-2022	Ferro, Emer S/0000-0003-1651-9192; Devi P, Lakshmi/0000-0001-9274-4776	National Institutes of Health [DA008863, NS026880, DA013429, DA018326, GM108911];  [T32 GM062754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108911, T32GM062754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008863, R37DA008863, R01DA018326, R56DA008863, P30DA013429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health awards DA008863 and NS026880 to LAD, DA013429 and DA018326 to EMU, GM108911 to AS; RR was supported by T32 GM062754.	Ferreira DN, 2010, J NUTR, V140, P1742, DOI 10.3945/jn.109.117473; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Gomes I, 2003, METH MOLEC MED, V84, P157; Gomes I, 2013, NEUROPEPTIDE RECEPTO, P1; Gupta A, 2015, BRIT J PHARMACOL, V172, P704, DOI 10.1111/bph.12833; Gupta A, 2008, J BIOL CHEM, V283, P10735, DOI 10.1074/jbc.M709454200; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Gupta A, 2006, MT SINAI J MED, V73, P673; Hinkle Patricia M., 2003, V237, P127; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jiang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047016; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Machado FC, 2014, BRIT J PHARMACOL, V171, P961, DOI 10.1111/bph.12488; Mika S, 2003, NUCLEIC ACIDS RES, V31, P3789, DOI 10.1093/nar/gkg620; Milligan G, 1999, BRIT J PHARMACOL, V128, P501, DOI 10.1038/sj.bjp.0702824; Rozenfeld R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029239; Schlessinger A, 2005, PROTEINS, V61, P115, DOI 10.1002/prot.20587; Unterwald EM, 2001, BRAIN RES, V900, P103, DOI 10.1016/S0006-8993(01)02269-7; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187306	10.1371/journal.pone.0187306	http://dx.doi.org/10.1371/journal.pone.0187306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091950	gold, Green Published, Green Submitted			2022-12-27	WOS:000414229700053
J	Rios, M; Sanchez, IM; Morales, J				Rios, Maria; Sanchez, Israel M.; Morales, Jorge			A new giraffid (Mammalia, Ruminantia, Pecora) from the late Miocene of Spain, and the evolution of the sivathere-samothere lineage	PLOS ONE			English	Article							MIDDLE MIOCENE; PHYLOGENY; MOSCHIDAE; ARTIODACTYLA; CHARACTERS	Giraffids include the only living giraffomorph ruminants and are diagnosed by the presence of bi-lobed canines and a special type of epiphyseal cranial appendages called ossicones. The family Giraffidae ranges from the latest early Miocene until today. However they are currently extant relics with only two living representatives, the African genera Okapia and Giraffa. Giraffids were much more diverse and widespread in the past, with more than 30 fossil species described. For the past decades a number of studies intended to resolve the phylogenetic relationships of the family, but due to the lack of really good cranial material no clear consensus was reached regarding the phylogenetic relationships amongst the different members of the group. The exceptionally complete remains of a new large giraffid from the late Miocene of Spain, Decennatherium rexsp. nov., allows us to improve and reassess giraffid systematics, offering a lot of new data, both anatomic and phylogenetic, on the large late Miocene giraffids of Eurasia. The results of our cladistic analysis show Decennatherium as a basal offshoot of a Glade containing the gigantic samotheres and sivatheres, characterized by the presence of a Sivatherium-like ossicone-plan among other features. Decennatherium thus offers the most ancient evidence of this Sivatherium-plan and firmly establishes the early morphological patterns of evolution of a sivathere / samothere-clade that is defined as the less inclusive Glade that contains Decennatherium and Sivatherium. Finally, this large group of four-ossiconed giraffids evolutionarily links Miocene Europe and Africa indicating vicariance / migration processes among the giraffid genetic pools separated by the Mediterranean Sea.	[Rios, Maria; Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Madrid, Spain; [Sanchez, Israel M.] Inst Catala Paleontol Miguel Crusafont, Dept Faunas Neogeno & Cuaternario, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Institut Catala de Paleontologia Miquel Crusafont (ICP)	Rios, M (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Madrid, Spain.	maria.rios.iba@gmail.com		Sanchez, Israel M./0000-0003-2151-7693; Rios, Maria/0000-0001-7242-1259	FPI predoctoral grant (Spanish Government MINECO) [BES-2012-052589, EEBB-I-14-07947, EEBB-I-15-09349, EEBB-I-16-10617]; EEBB-FPI grant program; Spanish Ministerio de Economia y Competitividad [CGL2016-76431-P, CGL2011-25754, CGL2015-68333-P]	FPI predoctoral grant (Spanish Government MINECO); EEBB-FPI grant program; Spanish Ministerio de Economia y Competitividad(Spanish Government)	MR acknowledges a FPI predoctoral grant (2012-2016) (Spanish Government MINECO http://www.mineco.gob.es/ codes: BES-2012-052589, EEBB-I-14-07947, EEBB-I-15-09349, EEBB-I-16-10617) as well as the EEBB-FPI grant program 2013, 2014 and 2015. IMS acknowledges the CERCA Program (Generalitat de Catalunya) and the CGL2016-76431-P research project by the Spanish Ministerio de Economia y Competitividad (http://www.mineco.gob.es/). This study was supported by the Spanish Ministerio de Economia y Competitividad (research projects CGL2011-25754 (2012-2015) and CGL2015-68333-P (2016-2019), http://www.mineco.gob.esi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala A L, 1994, MACROMAMIFEROS NEOGE; Alcala L., 1994, Estudios Geologicos (Madrid), V50, P127; [Anonymous], 1942, PALAEONTOGR ABT A, V94, P43; [Anonymous], 1994, B MUS NAT HIST NAT C, V16, P159; [Anonymous], 1856, CR HEBD ACAD SCI; Azanza Asensio Beatriz, 2000, Memorias del Museo Paleontologico de la Universidad de Zaragoza, V8, P1; Basu C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0940; Bohlin B., 1926, Palaeontologia Sinica Series C, V4, P1; Bohlin B., 1935, Bulletin of the Geological Society of China, V14, P83; BRUNET M, 1983, PALAEOGEOGR PALAEOCL, V44, P283, DOI 10.1016/0031-0182(83)90107-4; BUBENIK AB, 1975, 1 INT REIND CAR S CO, P9; Calvo JP, 2013, SEDIMENTOLOGY, V60, P1681, DOI 10.1111/sed.12048; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Cantalapiedra JL, 2015, EVOLUTION, V69, P2941, DOI 10.1111/evo.12787; Cautley, 1836, J ASIATIC SOC BENGAL, V5, P38; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Churcher C.S., 1978, P509; Churcher C.S., 1990, P180; Churcher C.S., 1970, FOSSIL VERTEBRATES A, V2, P1; Clauss M, 2014, ANN ZOOL FENN, V51, P80, DOI 10.5735/086.051.0210; Crusafont M., 1952, JIRAFIDOS FOSILES DI; Crusafont-Pairo M., 1966, Notas y Comunicaciones del Instituto Geologico y Minero de Espana, V85, P61; Damian A., 2013, VET MED-US, V58, P90; Danowitz M, 2016, PALAEOGEOGR PALAEOCL, V449, P194, DOI 10.1016/j.palaeo.2016.02.026; Danowitz M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150521; Danowitz M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150393; Danowitz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136552; De Mecquenem R, 1924, ANN PALEONTOL, V13-14, P135; deBonis L, 1997, PALAEONTOLOGY, V40, P121; Dietrich W.O., 1937, WISSENSCHAFTLICHE ER, V1913, P106; Domingo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063739; DURANTHON F, 1995, CR ACAD SCI II A, V321, P339; ESTES RD, 1991, APPL ANIM BEHAV SCI, V29, P403, DOI 10.1016/0168-1591(91)90264-X; Falconer, 1845, Q J GEOL SOC LOND, V1, P356, DOI DOI 10.1144/GSL.JGS.1845.001.01.80; Fennessy J, 2016, CURR BIOL, V26, P2543, DOI 10.1016/j.cub.2016.07.036; Gaudry, 1861, CR HEBD ACAD SCI, V51, P802; Gentry A.W., 1994, Historical Biology, V7, P115; GERAADS D, 1985, Palaeontologische Zeitschrift, V59, P311; GERAADS D, 1986, GEOBIOS-LYON, V19, P465, DOI 10.1016/S0016-6995(86)80004-3; Geraads D, 1978, GEOLOGIE MEDITERRANE, V5, P269; Geraads D, 2009, GEODIVERSITAS, V31, P893, DOI 10.5252/g2009n4a893; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P297; Grossman Ari, 2013, Zitteliana Reihe B, V31, P24; Groves C, 2011, UNGULATE TAXONOMY; HAMILTON W R, 1973, Bulletin of the British Museum (Natural History) Geology, V21, P73; HAMILTON WR, 1978, PHILOS T R SOC B, V283, P165, DOI 10.1098/rstb.1978.0019; HARRIS J M, 1974, Annals of the South African Museum, V65, P189; HARRIS J M, 1976, Annals of the South African Museum, V69, P325; Harris J.M., 1976, P264; HARRIS JM, 1991, KOOBI FORA RES PROJE, V3; HEINTZ E, 1981, CR ACAD SCI II, V292, P423; HENDEY Q B, 1970, Annals of the South African Museum, V56, P75; Hopwood A. T., 1934, Annals & Magazine of Natural History Series 10, V14, P546; Hou Sukuan, 2014, Zitteliana Reihe B, V32, P91; Janis C.M., 1987, Journal of Vertebrate Paleontology, V7, P200; Killgus H., 1923, Palaeontologische Zeitschrift Berlin, V5, P251; Kohler Meike, 1993, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V25, P1; Kostopoulos Dimitris S., 1996, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V239, P61; Kostopoulos Dimitris S., 2009, Beitraege zur Palaeontologie, V31, P345; Leakey L. S. B., 1965, OLDUVAI GORGE 1951 1; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Linnaeus C, 1758, HOLMIAE LAUR SALVIUS, V10, P424; Lopez-Antonanzas R, 2010, ZOOL J LINN SOC-LOND, V160, P725, DOI 10.1111/j.1096-3642.2010.00618.x; Lydekker BA, 1876, MEM GEOL SURV INDIA, V1, P19; Major CF, 1888, GISEMENT OSSEMENTS F; Melentis IK, 1974, SCI EPETIRIS ISSUED, V14, P65; Montgelard C, 1997, MOL BIOL EVOL, V14, P550, DOI 10.1093/oxfordjournals.molbev.a025792; MONTOYA P, 1991, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V13, P177; Montoya P., 1994, THESIS; MORALES J, 1987, GEOBIOS-LYON, V20, P441, DOI 10.1016/S0016-6995(87)80080-3; Morales J., 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P41; O'Brien HD, 2016, PEERJ, V4, DOI 10.7717/peerj.1696; O'Gara B.W., 1990, P231; Paraskevaidis I., 1940, NEUES JB MINERALOGIE, V83, P363; Pilgrim G.E., 1911, MEM GEOL SURV INDIA, V4, P1; Pomel, 1892, CR HEBD ACAD SCI, V115, P100; Pozo M., 2004, CUENCA MADRID GEOGAC, V35, P143; QIU ZX, 1985, VERTEBRAT PALASIATIC, V23, P173; Quiralte MV, 2011, THESIS; Rios M, 2016, PAL ELECT, V19, P1, DOI [10.26879/653, DOI 10.26879/653]; Rios M, 2016, J VERTEBR PALEONTOL; Robinson CA, 2011, VERTEBR PALEOBIOL PA, P339, DOI 10.1007/978-90-481-9962-4_14; Rodler A, 1890, DENKSCHRIFTEN KAISER, V57, P753; Sanchez IM, 2008, J VERTEBR PALEONTOL, V28, P873, DOI 10.1671/0272-4634(2008)28[873:MASNRM]2.0.CO;2; Sanchez IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143034; Sanchez IM, 2010, PALAEONTOLOGY, V53, P1023, DOI 10.1111/j.1475-4983.2010.00992.x; Sanchez IM, 2010, J VERTEBR PALEONTOL, V30, P1306, DOI 10.1080/02724634.2010.483555; Sanchez IM, 2009, J VERTEBR PALEONTOL, V29, P567, DOI 10.1671/039.029.0223; Savy, 1873, ANIMAUX FOSSILES MON, P5; Schlosser M., 1903, ABHANDLUNGEN BAYERIS, V2, P1; Sclater P. L., 1901, Proceedings of the Zoological Society of London, Vi, P50; Scopoli G.A., 1777, INTRO HIST NATURALEM; SINGER RONALD, 1960, ANN S AFRICAN MUS, V45, P375; Domingo MS, 2011, PALAIOS, V26, P55, DOI 10.2110/palo.2010.p10-047r; SOLOUNIAS N, 1993, J MAMMAL, V74, P1059, DOI 10.2307/1382445; SOLOUNIAS N, 1988, PALAEOGEOGR PALAEOCL, V65, P149, DOI 10.1016/0031-0182(88)90021-1; Solounias N., 1988, PALEOBIOLOGY, V69, P845; Solounias N, 2016, PALAEOBIO PALAEOENV, V96, P489, DOI 10.1007/s12549-016-0230-7; Solounias Nikos, 2000, P84; Solounias Nikos, 2007, P257; Valenciano A, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.934570; WEBB S D, 1980, Bulletin of the American Museum of Natural History, V167, P117	103	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185378	10.1371/journal.pone.0185378	http://dx.doi.org/10.1371/journal.pone.0185378			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091914	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700006
J	Chiu, PY; Hsu, MH; Wang, CW; Tsai, CT; Pai, MC				Chiu, Pai-Yi; Hsu, Min-Hsien; Wang, Chein-Wei; Tsai, Chun-Tang; Pai, Ming-Chyi			Visual hallucinations in Alzheimer's disease is significantly associated with clinical diagnostic features of dementia with Lewy bodies	PLOS ONE			English	Article							NEUROPSYCHIATRIC SYMPTOMS; PSYCHOSIS; GUIDELINES; CONSORTIUM; MORTALITY; AUTOPSY; DECLINE	Visual hallucinations (VHs) are among the most striking features of dementia with Lewy bodies (DLB). Given that Lewy body pathology is frequently observed in the brains of patients with AD, we aimed to study factors associated with VHs in AD and examine their association with DLB features. This cross-sectional study enrolled a consecutive series of AD patients who visited the dementia clinic of a regional hospital. Clinically diagnosed possible or probable DLB cases were excluded. VH frequency and associated factors including age, sex, education, disease severity, DLB features, vascular risk factors, cognitive function, and neuropsychiatric symptoms were compared between AD patients with VHs (VH+) and those without VHs (VH-). Among a total of 295 patients analyzed, 42 (14.2%) had VHs. After adjusting for age, sex, and disease severity, DLB features including fluctuations in cognition scores, rapid-eye-movement behavioral disorder (RBD), and severe neuroleptic sensitivity were more frequent in the VH+ group. Furthermore, depression score, total Neuropsychiatric Inventory (NPI) score, and total caregiver burden score as assessed by the NPI were higher in the VH+ group. Among neuropsychiatric symptoms, delusions, hallucinations in the non-visual domains, anxiety, and disinhibition were more frequent in the VH+ group. Conversely, none of the vascular risk factors (VRFs) or cognitive domains of the Cognitive Abilities Screening Instrument (CASI) was associated with VHs in AD. In summary, VHs, albeit occurring at a low rate, had a high impact on AD. Diagnostic features of DLB, including fluctuations, RBD, and severe neuroleptic sensitivity were significantly associated with VHs in AD. AD patients with VHs tended to have more severe neuropsychiatric symptoms and greater caregiver burden.	[Chiu, Pai-Yi; Hsu, Min-Hsien] Show Chwan Mem Hosp, Dept Neurol, Changhua, Taiwan; [Wang, Chein-Wei] Lin Shin Hosp, Dept Neurol, Taichung, Taiwan; [Tsai, Chun-Tang] Natl Changhua Univ Educ, Dept Guidance & Counseling, Changhua, Taiwan; [Pai, Ming-Chyi] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Div Behav Neurol,Dept Neurol, Tainan, Taiwan; [Pai, Ming-Chyi] Natl Cheng Kung Univ Hosp, Alzheimers Dis Res Ctr, Tainan, Taiwan; [Pai, Ming-Chyi] Natl Cheng Kung Univ, Coll Med, Inst Gerontol, Tainan, Taiwan	Show Chwan Memorial Hospital; National Changhua University of Education; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Pai, MC (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Div Behav Neurol,Dept Neurol, Tainan, Taiwan.; Pai, MC (corresponding author), Natl Cheng Kung Univ Hosp, Alzheimers Dis Res Ctr, Tainan, Taiwan.; Pai, MC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Gerontol, Tainan, Taiwan.	pair@mail.ncku.edu.tw		Pai, Ming-Chyi/0000-0003-0475-4515				American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Ballard C, 1997, Int Psychogeriatr, V9, P381, DOI 10.1017/S1041610297004523; Ballard C, 1999, AM J PSYCHIAT, V156, P1039; Ballard CG, 2004, AM J PSYCHIAT, V161, P843, DOI 10.1176/appi.ajp.161.5.843; Bjoerke-Bertheussen J, 2012, DEMENT GERIATR COGN, V34, P1, DOI 10.1159/000339590; Caputo M, 2008, ACTA PSYCHIAT SCAND, V117, P455, DOI 10.1111/j.1600-0447.2008.01175.x; Chapman FM, 1999, AM J PSYCHIAT, V156, P1983; Chiu Pai-Yi, 2006, Acta Neurol Taiwan, V15, P21; Chiu PY, 2015, TAIWANESE J PSYCHIAT, V29, P29; Christie D, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-62; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; El Haj M, 2015, COGN NEUROPSYCHIATRY, V20, P281, DOI 10.1080/13546805.2015.1023392; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galvin JE, 2007, NEUROLOGY, V68, P1895, DOI 10.1212/01.wnl.0000263131.80945.ad; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOLROYD S, 1995, AM J GERIAT PSYCHIAT, V3, P198, DOI 10.1097/00019442-199522330-00003; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Lee DR, 2013, INT J GERIATR PSYCH, V28, P135, DOI 10.1002/gps.3799; Leroi I, 2003, AM J GERIAT PSYCHIAT, V11, P83, DOI 10.1176/appi.ajgp.11.1.83; Lin SH, 2006, CLIN IMAG, V30, P388, DOI 10.1016/j.clinimag.2006.09.025; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Schneider JA, 2012, BRAIN, V135, P3005, DOI 10.1093/brain/aws234; Sinforiani E, 2007, NEUROL SCI, V28, P96, DOI 10.1007/s10072-007-0794-0; Suarez-Gonzalez A, 2014, INT PSYCHOGERIATR, V26, P453, DOI 10.1017/S1041610213002068; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Tsuang D, 2009, AM J GERIAT PSYCHIAT, V17, P317, DOI 10.1097/JGP.0b013e3181953b9a; Vilalta-Franch J, 2013, AM J GERIAT PSYCHIAT, V21, P1135, DOI 10.1016/j.jagp.2013.01.051; Wilson RS, 2005, AM J GERIAT PSYCHIAT, V13, P984, DOI 10.1176/appi.ajgp.13.11.984; Wilson RS, 2000, J NEUROL NEUROSUR PS, V69, P172, DOI 10.1136/jnnp.69.2.172	34	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186886	10.1371/journal.pone.0186886	http://dx.doi.org/10.1371/journal.pone.0186886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088240	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900029
J	Marcos-Vadillo, E; Garcia-Sanchez, A; Sanz, C; Davila, I; Isidoro-Garcia, M				Marcos-Vadillo, Elena; Garcia-Sanchez, Asuncio; Sanz, Catalina; Davila, Ignacio; Isidoro-Garcia, Maria			PTGDR gene expression and response to dexamethasone treatment in an in vitro model	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ETS TRANSCRIPTION FACTORS; GLUCOCORTICOID-RECEPTOR; INHALED CORTICOSTEROIDS; ASTHMATIC-CHILDREN; ALLERGIC RHINITIS; POLYMORPHISM; PROMOTER; LUNG; INFLAMMATION	Asthma is a multifactorial pathology influenced by environmental and genetic factors. Glucocorticoid treatment decreases symptoms by regulating genes involved in the inflammatory process through binding to specific DNA sequences. Polymorphisms located in the promoter region of the Prostaglandin D Receptor (PTGDR) gene have been related to asthma. We aimed to analyze the effect of PTGDR promoter haplotypes on gene expression and response to corticosteroid therapy. A549 lung epithelial cells were transfected with vectors carrying four different PTGDR haplotypes (CTCT, CCCC, CCCT and TCCT), and treated with dexamethasone. Different approaches to study the promoter activity (Dual Luciferase Reporter System), gene expression levels (qPCR) and cytokine secretion (Multiplexed Bead-based Flow Cytometric) were used. In addition, in silico analysis was also performed. Cells carrying the TCCT haplotype showed the lowest promoter activity (p-value < 0.05) and mRNA expression levels in basal conditions. After dexamethasone treatment, cells carrying the wild-type variant CTCT showed the highest response, and those carrying the TCCT variant the lowest (p-value < 0.05) in luciferase assays. Different transcription factor binding patterns were identified in silico. Moreover, differences in cytokine secretion were also found among different promoter haplotypes. Polymorphisms of PTGDR gene influence basal promoter activity and gene expression, as well as the cytokine secretory pattern. Furthermore, an association between these positions and response to corticoid treatment was observed.	[Marcos-Vadillo, Elena; Garcia-Sanchez, Asuncio; Sanz, Catalina; Davila, Ignacio; Isidoro-Garcia, Maria] IBSAL, Inst Biomed Res, Salamanca, Spain; [Garcia-Sanchez, Asuncio; Davila, Ignacio] Univ Salamanca, Dept Biomed & Diagnost Sci, Salamanca, Spain; [Sanz, Catalina] Univ Salamanca, Dept Genet & Microbiol, Salamanca, Spain; [Davila, Ignacio] Univ Hosp Salamanca, Dept Allergy, Salamanca, Spain; [Isidoro-Garcia, Maria] Univ Hosp Salamanca, Dept Clin Biochem, Salamanca, Spain; [Isidoro-Garcia, Maria] Univ Salamanca, Dept Med, Salamanca, Spain	University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca	Davila, I (corresponding author), IBSAL, Inst Biomed Res, Salamanca, Spain.; Davila, I (corresponding author), Univ Salamanca, Dept Biomed & Diagnost Sci, Salamanca, Spain.; Davila, I (corresponding author), Univ Hosp Salamanca, Dept Allergy, Salamanca, Spain.	idg@usal.es	Garcia-Sanchez, Asuncion/AAE-8611-2019; Dávila, Ignacio/K-4453-2012; Sanz Lozano, Catalina S/H-6759-2015	Garcia-Sanchez, Asuncion/0000-0002-9655-4918; Dávila, Ignacio/0000-0001-8485-5513; ISIDORO-GARCIA, MARIA/0000-0002-9013-9422; Sanz Lozano, Catalina S/0000-0003-2974-0873; Marcos-Vadillo, Elena/0000-0003-1016-8395	Institute de Salud Carlos III [PI13/00564]; Institute de Salud Carlos III (RETICS ARADyAL) [RD16/0006/0019]	Institute de Salud Carlos III(Instituto de Salud Carlos III); Institute de Salud Carlos III (RETICS ARADyAL)	This work was supported by the Institute de Salud Carlos III (grant PI13/00564 and RETICS ARADyAL RD16/0006/0019) to ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Instituto de Salud Carlos III (grant PI13/00564 and RETICS ARADyAL RD16/0006/0019).	Almawi WY, 2002, J MOL ENDOCRINOL, V28, P69, DOI 10.1677/jme.0.0280069; Arima Masafumi, 2011, Korean Journal of Internal Medicine, V26, P8, DOI 10.3904/kjim.2011.26.1.8; Awasthi S, 2015, INDIAN J PEDIATR, V82, P781, DOI 10.1007/s12098-015-1702-x; Badorrek P, 2015, ANN ALLERG ASTHMA IM, V115, P325, DOI 10.1016/j.anai.2015.07.016; Baiula M, 2014, DRUG DES DEV THER, V8, P745, DOI 10.2147/DDDT.S62659; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Berce V, 2013, PHARMACOGENOMICS J, V13, P523, DOI 10.1038/tpj.2012.36; Berce V, 2010, BIOMARKERS, V15, P158, DOI 10.3109/13547500903384318; Berger WE, 2015, ANN ALLERG ASTHMA IM, V115, P130, DOI 10.1016/j.anai.2015.05.012; Chihara J, 1997, J ALLERGY CLIN IMMUN, V100, pS52, DOI 10.1016/S0091-6749(97)70005-8; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Corrigan CJ, 1999, CLIN EXP IMMUNOL, V116, P1; DeKoter RP, 2007, J BIOL CHEM, V282, P14194, DOI 10.1074/jbc.M700377200; Dijkstra A, 2011, EUR RESPIR J, V38, P1036, DOI 10.1183/09031936.00182410; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Garcia-Sanchez A, 2016, J INVEST ALLERG CLIN, V26, P249, DOI 10.18176/jiaci.0042; Garcia-Solaesa V, 2014, ALLERGOL IMMUNOPATH, V42, P64, DOI 10.1016/j.aller.2012.12.002; Gong XM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181466; Grenningloh R, 2006, J IMMUNOL, V176, P5161, DOI 10.4049/jimmunol.176.9.5161; Hakonarson H, 2005, P NATL ACAD SCI USA, V102, P14789, DOI 10.1073/pnas.0409904102; Hakonarson H, 2002, AM J HUM GENET, V71, P483, DOI 10.1086/342205; Hejazi ME, 2016, J RES PHARM PRACT, V5, P7, DOI 10.4103/2279-042X.176542; Hosoki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126035; Huang GX, 2016, J CELL MOL MED, V20, P1276, DOI 10.1111/jcmm.12809; Isidoro-Garcia M, 2011, ALLERGY, V66, P1553, DOI 10.1111/j.1398-9995.2011.02685.x; Jin HL, 2017, MOL BIOL REP, V44, P243, DOI 10.1007/s11033-017-4106-3; Keranen T, 2017, INFLAMM RES, V66, P441, DOI 10.1007/s00011-017-1028-4; Kim MH, 2013, KOREAN J INTERN MED, V28, P708, DOI 10.3904/kjim.2013.28.6.708; Kim V, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0103-2; Krystel-Whittemore M, 2016, FRONT IMMUNOL, P6; Lee SH, 2009, J STEROID BIOCHEM, V115, P30, DOI 10.1016/j.jsbmb.2009.02.013; Livak K, 2004, APPL BIOSYSTEMS; Lopert A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02915; Luhadia S K, 2014, J Assoc Physicians India, V62, P38; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Mansur AH, 2004, THORAX, V59, P876, DOI 10.1136/thx.2003.014092; Marcos-Vadillo E, 2016, METHODS MOL BIOL, V1434, P169, DOI 10.1007/978-1-4939-3652-6_12; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Oguma T, 2004, NEW ENGL J MED, V351, P1752, DOI 10.1056/NEJMoa031785; Pascussi JM, 2000, MOL PHARMACOL, V58, P1441, DOI 10.1124/mol.58.6.1441; Pascussi JM, 2003, MOL ENDOCRINOL, V17, P42, DOI 10.1210/me.2002-0244; Pease James E., 2001, Current Opinion in Pharmacology, V1, P248, DOI 10.1016/S1471-4892(01)00044-3; Roberts JK, 2013, F1000RESEARCH, P2; Sanz C, 2006, ALLERGY, V61, P543, DOI 10.1111/j.1398-9995.2006.01025.x; Sanz C, 2009, PEDIAT ALLERG IMM-UK, V20, P151, DOI 10.1111/j.1399-3038.2008.00772.x; Sato M, 2011, RESPIROLOGY, V16, P124, DOI 10.1111/j.1440-1843.2010.01886.x; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Thu Kelsie L, 2014, Oncoscience, V1, P326; Ungvari I, 2012, PLOS ONE, P7; van Aalderen WMC, 2011, EUR J PEDIATR, V170, P709, DOI 10.1007/s00431-010-1319-z; Vijverberg SJH, 2015, CLIN EXP ALLERGY, V45, P1051, DOI 10.1111/cea.12492; Wu JH, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-28; Yang H, 2014, PROTEIN CELL, V5, P113, DOI 10.1007/s13238-013-0013-0; Zhang J, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-4	56	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186957	10.1371/journal.pone.0186957	http://dx.doi.org/10.1371/journal.pone.0186957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088248	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900033
J	Zaggia, L; Lorenzetti, G; Manfe, G; Scarpa, GM; Molinaroli, E; Parnell, KE; Rapaglia, JP; Gionta, M; Soomere, T				Zaggia, Luca; Lorenzetti, Giuliano; Manfe, Giorgia; Scarpa, Gian Marco; Molinaroli, Emanuela; Parnell, Kevin Ellis; Rapaglia, John Paul; Gionta, Maria; Soomere, Tarmo			Fast shoreline erosion induced by ship wakes in a coastal lagoon: Field evidence and remote sensing analysis	PLOS ONE			English	Article							SEA-LEVEL RISE; VENICE LAGOON; OF-VENICE; HEAVY-METALS; NEW-ZEALAND; CHANGING STATE; RIEMANN WAVES; CONTAMINATION; DEPRESSION; FISH	An investigation based on in-situ surveys combined with remote sensing and GIS analysis revealed fast shoreline retreat on the side of a major waterway, the Malamocco Marghera Channel, in the Lagoon of Venice, Italy. Monthly and long-term regression rates caused by ship wakes in a reclaimed industrial area were considered. The short-term analysis, based on field surveys carried out between April 2014 and January 2015, revealed that the speed of shoreline regression was insignificantly dependent on the distance from the navigation channel, but was not constant through time. Periods of high water levels due to tidal forcing or storm surges, more common in the winter season, are characterized by faster regression rates. The retreat is a discontinuous process in time and space depending on the morphostratigraphy and the vegetation cover of the artificial deposits. A GIS analysis performed with the available imagery shows an average retreat of 3-4 m/yr in the period between 1974 and 2015. Digitization of historical maps and bathymetric surveys made in April 2015 enabled the construction of two digital terrain models for both past and present situations. The two models have been used to calculate the total volume of sediment lost during the period 1968-2015 (1.19x10(6) m(3)). The results show that in the presence of heavy ship traffic, ship-channel interactions can dominate the morphodynamics of a waterway and its margins. The analysis enables a better understanding of how shallow-water systems react to the human activities in the post-industrial period. An adequate evaluation of the temporal and spatial variation of shoreline position is also crucial for the development of future scenarios and for the sustainable management port traffic worldwide.	[Zaggia, Luca; Lorenzetti, Giuliano; Manfe, Giorgia] CNR, Ist Sci Marine, Venice, Italy; [Scarpa, Gian Marco; Molinaroli, Emanuela; Gionta, Maria] Univ Ca Foscari, Dipartimento Sci Ambientali Informat & Stat, Venice, Italy; [Parnell, Kevin Ellis] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Brisbane, Qld, Australia; [Rapaglia, John Paul] Sacred Heart Univ, Dept Biol, Fairfield, CT USA; [Soomere, Tarmo] Tallinn Univ Technol, Sch Sci, Dept Cybernet, Tallinn, Estonia	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Universita Ca Foscari Venezia; James Cook University; Sacred Heart University; Tallinn University of Technology	Zaggia, L (corresponding author), CNR, Ist Sci Marine, Venice, Italy.	l.zaggia@ismar.cnr.it	Lorenzetti, Giuliano/P-6841-2018; Parnell, Kevin E/E-6546-2013; Soomere, Tarmo/E-4393-2016; Zaggia, Luca/C-4478-2012; Manfè, Giorgia/P-7870-2018; Scarpa, Gian Marco/AAZ-8104-2021; Zaggia, Luca/AAV-9558-2020	Parnell, Kevin E/0000-0001-9473-5267; Soomere, Tarmo/0000-0003-2900-0840; Manfè, Giorgia/0000-0001-6953-3874; Scarpa, Gian Marco/0000-0002-5061-5607; 	Ritmare Italian Flagship Project; Estonian Research Council [IUT333]; Scuola Dottorale Ca Foscari, Venezia, PhD in Environmental Sciences, 31 Ciclo	Ritmare Italian Flagship Project; Estonian Research Council; Scuola Dottorale Ca Foscari, Venezia, PhD in Environmental Sciences, 31 Ciclo	This study was supported by Ritmare Italian Flagship Project, Sub-Project 3, Work Package 3, Action AZ1 (SP3-WP3-AZ1), www.ritmare.it; Scuola Dottorale Ca Foscari, Venezia, PhD in Environmental Sciences, 31 Ciclo; Estonian Research Council, institutional support IUT333. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aage C., 2003, GUIDELINES MANAGING; [Anonymous], 2015, STAT; Bellucci LG, 2002, SCI TOTAL ENVIRON, V295, P35, DOI 10.1016/S0048-9697(02)00040-2; Bernardello M, 2006, CHEMOSPHERE, V64, P1334, DOI 10.1016/j.chemosphere.2005.12.033; Bloundi MK, 2009, ENVIRON GEOL, V56, P833, DOI 10.1007/s00254-007-1184-x; Bondesan A, 2004, CARTOGR, V5, P4; Bosello F, 2014, ENERG ECON, V46, P593, DOI 10.1016/j.eneco.2013.09.002; Castillo J. M., 2000, Journal of Coastal Conservation, V6, P89, DOI 10.1007/BF02730472; Cazenave A, 2014, EARTHS FUTURE, V2, P15, DOI 10.1002/2013EF000188; Chaussard E, 2013, REMOTE SENS ENVIRON, V128, P150, DOI 10.1016/j.rse.2012.10.015; Cochran JK, 1998, MAR CHEM, V62, P15, DOI 10.1016/S0304-4203(98)00017-6; D'Alpaos L, 2010, IST VENETO SCI LETT, P1; Eriksson BK, 2004, ESTUAR COAST SHELF S, V61, P339, DOI 10.1016/j.ecss.2004.05.009; Erm Ants, 2004, Proceedings of the Estonian Academy of Sciences Biology Ecology, V53, P161; Ferrarin C, 2016, STATO AMBIENTALE LAG; Gelinas M, 2013, J COASTAL RES, V29, P8, DOI 10.2112/JCOASTRES-D-11-00213.1; Goransson G, 2014, J WATERW PORT COAST, V140, DOI 10.1061/(ASCE)WW.1943-5460.0000224; Handmer J, MANAGING RISKS EXTRE, P231; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; Hoeke RK, 2001, GIS BASED TOOL EXTRA, P1; Hu RL, 2004, ENG GEOL, V76, P65, DOI 10.1016/j.enggeo.2004.06.006; Institute of Marine Sciences National Research Council Venice, 2002, INT GEOGR NOD PLATF; Istituzione Centro Previsione e Segnalazione Maree Comune di Venezia, DAT E STAT; Kelpsaite L, 2009, J COASTAL RES, P812; Kucera-Hirzinger V, 2009, AQUAT SCI, V71, P94, DOI 10.1007/s00027-008-8110-5; Masselink G., 2013, MCCIP SCI REV, V2013, P71, DOI [DOI 10.14465/2013.ARC09.071-086, 10.14465/2013.arc09.071-08]; Molinaroli E., 2013, Journal of Environmental Protection, V4, P37; Molinaroli E, 2009, MAR GEOL, V258, P115, DOI 10.1016/j.margeo.2008.12.001; National Institute for Coastal and Marine Management of the Netherlands (RIKZ), 2004, LIV COAST ER EUR SED; Neuman DG, 2001, CAN J REMOTE SENS, V27, P361, DOI 10.1080/07038992.2001.10854878; Osborne PD, 1999, J COASTAL RES, V15, P388; Parnell KE, 2007, J COASTAL RES, P502; Parnell KE, 2001, COAST MANAGE, V29, P217; Parnell KE, 2016, J COASTAL RES, P907, DOI 10.2112/SI75-182.1; Parnell KE, 2015, PHYS LETT A, V379, P555, DOI 10.1016/j.physleta.2014.12.004; Pethiyagoda R, 2014, J FLUID MECH, V758, P468, DOI 10.1017/jfm.2014.530; Pettibone GW, 1996, WATER RES, V30, P2517, DOI 10.1016/0043-1354(96)00135-2; Rapaglia J, 2015, OCEAN COAST MANAGE, V110, P1, DOI 10.1016/j.ocecoaman.2015.03.002; Rapaglia J, 2011, J MARINE SYST, V85, P45, DOI 10.1016/j.jmarsys.2010.11.005; Ravens TM, 2008, J WATERW PORT COAST, V134, P21, DOI 10.1061/(ASCE)0733-950X(2008)134:1(21); Regione Veneto, INFR DAT TERR VEN CA; Rodin A, 2015, P EST ACAD SCI, V64, P22, DOI 10.3176/proc.2015.1.04; Rodrigue JP., 2013, GEOGRAPHY TRANSPORT, DOI DOI 10.4324/9781315618159-2; Rosati JD, 2011, MYSTERY HIST CHANNEL; Sarretta A, 2010, CONT SHELF RES, V30, P934, DOI 10.1016/j.csr.2009.07.002; Secco T, 2005, CHEMOSPHERE, V58, P279, DOI 10.1016/j.chemosphere.2004.06.030; Soomere T, 2006, OCEANOLOGIA, V48, P185; Soomere T, 2011, J MARINE SYST, V88, P74, DOI 10.1016/j.jmarsys.2011.02.011; Syvitski JPM, 2011, PHILOS T R SOC A, V369, P957, DOI 10.1098/rsta.2010.0329; Tate JN, 2008, ERDCCHLTR088 VICKSB; Townsend K., 2014, TERRA AQUA, V136, P20; Trincardi F, 2016, OCEANOGRAPHY, V29, P178, DOI 10.5670/oceanog.2016.87; Walling DE, 2006, GEOMORPHOLOGY, V79, P192, DOI 10.1016/j.geomorph.2006.06.019; Wolter C, 2003, REV FISH BIOL FISHER, V13, P63, DOI 10.1023/A:1026350223459; Wolter C, 2004, ENVIRON MANAGE, V34, P656, DOI 10.1007/s00267-004-0201-z; Zecchin M, 2014, HOLOCENE, V24, P646, DOI 10.1177/0959683614526903; Zhang KQ, 2004, CLIMATIC CHANGE, V64, P41, DOI 10.1023/B:CLIM.0000024690.32682.48; Zonta R, 2007, MAR POLLUT BULL, V55, P529, DOI 10.1016/j.marpolbul.2007.09.024	58	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187210	10.1371/journal.pone.0187210	http://dx.doi.org/10.1371/journal.pone.0187210			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088244	Green Published, gold, Green Accepted			2022-12-27	WOS:000414088900048
J	Roswall, N; Bidstrup, PE; Reaschou-Nielsen, O; Jensen, SS; Overvad, K; Halkjaer, J; Sorensen, M				Roswall, Nina; Bidstrup, Pernille Envold; Reaschou-Nielsen, Ole; Jensen, Steen Solvang; Overvad, Kim; Halkjaer, Jytte; Sorensen, Mette			Residential road traffic noise exposure and colorectal cancer survival - A Danish cohort study	PLOS ONE			English	Article							CIRCADIAN-RHYTHM; BREAST-CANCER; EXPRESSION; MELATONIN; GENES; PREDICTOR; MORTALITY; DISEASE; QUALITY; SLEEP	Background Residential traffic noise exposure may entail sleep disruption and compromised circadian functioning; two factors which have been associated with a poor colorectal cancer (CRC) prognosis. Hence, the aim of the present study was to investigate the association between residential road traffic noise and CRC survival. Methods and materials Road traffic noise was calculated for all residential addresses from 1987 to February 2012 for incident CRC cases (n = 1,234) in a cohort of 57,053 Danes. We used Cox Proportional Hazard Models to investigate the association between residential road traffic noise at different time-windows, and overall and CRC-specific mortality. Furthermore, we investigated interaction with sex, age, prognostic factors, and comorbidity. Mortality Rate Ratios (MRR) were calculated in unadjusted models, and adjusted for railway noise, lifestyle factors, and socioeconomic variables. Results During a median follow-up of 4 years, 594 patients died; 447 from CRC. We found no association between road traffic noise exposure and overall (MRR 1.00 (0.88-1.13) per 10 dB) or CRC-specific mortality (MRR 0.98 (0.85-1.13) per 10 dB) over the entire follow-up period, or 1 year preceding death. Results did not differ when examining colon and rectal cancer separately. Interaction analyses suggested that patients with less clinically advanced disease could be more susceptible to harmful effects of traffic noise. Conclusion The present study suggests no overall association between residential road traffic noise and concurrent mortality in CRC patients. As it is the first study of its kind, with relatively limited power, further studies are warranted.	[Roswall, Nina; Bidstrup, Pernille Envold; Reaschou-Nielsen, Ole; Halkjaer, Jytte; Sorensen, Mette] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Jensen, Steen Solvang] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Overvad, Kim] Aarhus Univ, Sect Epidemiol, Dept Publ Hlth, Aarhus, Denmark	Danish Cancer Society; Aarhus University; Aarhus University	Roswall, N (corresponding author), Danish Canc Soc, Res Ctr, Copenhagen, Denmark.	roswall@cancer.dk	Jensen, Steen Solvang/AAM-2945-2021; Raaschou-Nielsen, Ole/GOK-0338-2022; Roswall, Nina/AAJ-6700-2020	Raaschou-Nielsen, Ole/0000-0002-1223-0909; Roswall, Nina/0000-0003-3071-1658; Sorensen, Mette/0000-0002-7302-4789; Overvad, Kim/0000-0001-6429-7921; Bidstrup, Pernille/0000-0002-9704-6800; Jensen, Steen Solvang/0000-0001-5923-8441	European Research Council [281760]	European Research Council(European Research Council (ERC)European Commission)	This work received support from the European Research Council, grant number 281760, https://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Bendtsen H, 1999, SCI TOTAL ENVIRON, V235, P331, DOI 10.1016/S0048-9697(99)00216-8; Boyle T, 2013, BRIT J CANCER, V109, P814, DOI 10.1038/bjc.2013.310; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleeland CS, 2012, NAT REV CLIN ONCOL, V9, P471, DOI 10.1038/nrclinonc.2012.99; Cos S, 1998, CANCER RES, V58, P4383; Danish Colorectal Cancer Group, 2016, NAT ARS RAPP 2014; Davies JM, 2011, SEMIN ONCOL, V38, P552, DOI 10.1053/j.seminoncol.2011.05.009; Egeberg R, 2008, EUR J CANCER, V44, P1978, DOI 10.1016/j.ejca.2008.06.020; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Frederiksen BL, 2009, EUR J CANCER, V45, P1248, DOI 10.1016/j.ejca.2008.11.035; Goines L, 2007, SOUTH MED J, V100, P287, DOI 10.1097/SMJ.0b013e3180318be5; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hanninen O, 2014, ENVIRON HEALTH PERSP, V122, P439, DOI 10.1289/ehp.1206154; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Ingeholm P, 2016, CLIN EPIDEMIOL, V8, P465, DOI 10.2147/CLEP.S99481; Innominato PF, 2015, SLEEP MED, V16, P391, DOI 10.1016/j.sleep.2014.10.022; Innominato PF, 2012, INT J CANCER, V131, P2684, DOI 10.1002/ijc.27574; Innominato PF, 2009, CANCER RES, V69, P4700, DOI 10.1158/0008-5472.CAN-08-4747; Jensen SS, 2009, GIS BASED NATL ROAD; Karantanos T, 2014, WORLD J GASTROENTERO, V20, P1986, DOI 10.3748/wjg.v20.i8.1986; Karantanos T, 2013, INT J BIOL MARKER, V28, P280, DOI [10.5301/JBM.5000033, 10.5301/jbm.5000033]; Kelleher FC, 2014, CANCER LETT, V342, P9, DOI 10.1016/j.canlet.2013.09.040; Kerkhof GA, 2010, PROG BRAIN RES, V185, P181, DOI 10.1016/B978-0-444-53702-7.00011-7; Kim SE, 2015, WORLD J GASTROENTERO, V21, P5167, DOI 10.3748/wjg.v21.i17.5167; Larsen SB, 2012, EUR J EPIDEMIOL, V27, P837, DOI 10.1007/s10654-012-9739-x; Levi F, 2014, CHRONOBIOL INT, V31, P891, DOI 10.3109/07420528.2014.924523; Liu R, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-1; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mazzoccoli G, 2011, CHRONOBIOL INT, V28, P841, DOI 10.3109/07420528.2011.615182; Miedema Henk M E, 2007, Behav Sleep Med, V5, P1, DOI 10.1207/s15402010bsm0501_1; Oshima T, 2011, ONCOL REP, V25, P1439, DOI 10.3892/or.2011.1207; Palesh O, 2012, NAT SCI SLEEP, V4, P151, DOI 10.2147/NSS.S18895; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Roosli M, 2014, NOISE HEALTH, V16, P197, DOI 10.4103/1463-1741.137036; Roswall N, 2017, CANC CAUSES IN PRESS; Roswall N, 2016, ENVIRON RES, V151, P814, DOI 10.1016/j.envres.2016.09.016; Schoenberg MH, 2016, VISC MED, V32, P199, DOI 10.1159/000446492; Sephton S, 2003, BRAIN BEHAV IMMUN, V17, P321, DOI 10.1016/S0889-1591(03)00078-3; Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503; Storm HH, 1997, DAN MED BULL, V44, P535; Tamas K, 2015, CANCER TREAT REV, V41, P671, DOI 10.1016/j.ctrv.2015.06.007; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vienneau D, 2015, ENVIRON RES, V138, P372, DOI 10.1016/j.envres.2015.02.023; World Cancer Research Fund / American Institute for Cancer Research, 2011, CONT UPD PROJ REP FO; World Health Organization, 2009, NOGHT NOIS GUID EUR; Zeman M, 2008, MOL MED REP, V1, P599; Zhou F, 2012, CANCER-AM CANCER SOC, V118, P937, DOI 10.1002/cncr.26348	51	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187161	10.1371/journal.pone.0187161	http://dx.doi.org/10.1371/journal.pone.0187161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084272	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200036
J	Eckl, J; Sima, S; Marcus, K; Lindemann, C; Richter, K				Eckl, Julia; Sima, Siyuan; Marcus, Katrin; Lindemann, Claudia; Richter, Klaus			Hsp90-downregulation influences the heat-shock response, innate immune response and onset of oocyte development in nematodes	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; QUANTITATIVE-ANALYSIS; TRANSCRIPTION FACTOR; C. ELEGANS; HSP90; INFECTION; PROTEINS; PATHWAY	Hsp90 is a molecular chaperone involved in the regulation and maturation of kinases and transcription factors. In Caenorhabditis elegans, it contributes to the development of fertility, maintenance of muscle structure, the regulation of heat-shock response and dauer state. To understand the consequences of Hsp90-depletion, we studied Hsp90 RNAi-treated nematodes by DNA microarrays and mass spectrometry. We find that upon development of phenotypes the levels of chaperones and Hsp90 cofactors are increased, while specific proteins related to the innate immune response are depleted. In microarrays, we further find many differentially expressed genes related to gonad and larval development. These genes form an expression cluster that is regulated independently from the immune response implying separate pathways of Hsp90-involvement. Using fluorescent reporter strains for the differentially expressed immune response genes skr-5, dod-24 and clec-60 we observe that their activity in intestinal tissues is influenced by Hsp90-depletion. Instead, effects on the development are evident in both gonad arms. After Hsp90-depletion, changes can be observed in early embryos and adults containing fluorescence-tagged versions of SEPA-1, CAV-1 or PUD-1, all of which are downregulated after Hsp90-depletion. Our observations identify molecular events for Hsp90-RNAi induced phenotypes during development and immune responses, which may help to separately investigate independent Hsp90-influenced processes that are relevant during the nematode's life and development.	[Eckl, Julia; Sima, Siyuan; Richter, Klaus] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Lichtenbergstr, Garching, Germany; [Marcus, Katrin; Lindemann, Claudia] Ruhr Univers Bochum, Med Proteom Ctr, Funct Prote, Univ Str, Bochum, Germany	Technical University of Munich; Ruhr University Bochum	Richter, K (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Lichtenbergstr, Garching, Germany.	klaus.richter@tum.de	Richter, Klaus/A-2673-2010	Richter, Klaus/0000-0002-8952-9642	P.U.R.E. (Protein Unit for Research in Europe - German federal state North Rhine-Westphalia); DFG [RI1873/1-3]; German Research Foundation (DFG); Technical University of Munich within the funding programme Open Access Publishing	P.U.R.E. (Protein Unit for Research in Europe - German federal state North Rhine-Westphalia); DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich within the funding programme Open Access Publishing	The work was supported by P.U.R.E. (Protein Unit for Research in Europe, funded by the German federal state North Rhine-Westphalia). Klaus Richter is funded by the research grant DFG grant RI1873/1-3. This work was supported by the German Research Foundation (DFG) and the Technical University of Munich within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bar-Lavan Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006531; Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487; Beers M, 2006, DEVELOPMENT, V133, P3745, DOI 10.1242/dev.02544; Birnby DA, 2000, GENETICS, V155, P85; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Ceron J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-30; Clough E, 2016, METHODS MOL BIOL, V1418, P93, DOI 10.1007/978-1-4939-3578-9_5; Dehner A, 2003, CHEMBIOCHEM, V4, P870, DOI 10.1002/cbic.200300658; Devaney E, 2005, INT J PARASITOL, V35, P627, DOI 10.1016/j.ijpara.2005.01.007; Ding W, 2015, CELL METAB, V22, P633, DOI 10.1016/j.cmet.2015.07.013; Ding YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067158; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Ermolaeva MA, 2013, NATURE, V501, P416, DOI 10.1038/nature12452; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Geillinger KE, 2012, J PROTEOME RES, V11, P4594, DOI 10.1021/pr300385v; Gillan V, 2009, INT J PARASITOL, V39, P1071, DOI 10.1016/j.ijpara.2009.02.024; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Hall JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177432; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Haslbeck V, 2013, J MOL BIOL, V425, P2922, DOI 10.1016/j.jmb.2013.05.019; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; JebaMercy G, 2013, MICROBES INFECT, V15, P550, DOI 10.1016/j.micinf.2013.03.009; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Marudhupandiyan S, 2017, IMMUNOL RES, V65, P609, DOI 10.1007/s12026-016-8879-6; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Obayashi T, 2013, NUCLEIC ACIDS RES, V41, pD1014, DOI 10.1093/nar/gks1014; Papsdorf K, 2016, MICROBIAL CELL; Papsdorf K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1831-7; Safra M, 2014, CELL METAB, V20, P870, DOI 10.1016/j.cmet.2014.09.006; Sahu SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038200; Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Singh V, 2009, J BIOL CHEM, V284, P35580, DOI 10.1074/jbc.M109.060905; Sivamaruthi BS, 2014, INDIAN J MICROBIOL, V54, P52, DOI 10.1007/s12088-013-0424-x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stiernagle Theresa, 2006, WormBook, P1; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Tenge VR, 2015, EUKARYOT CELL, V14, P55, DOI 10.1128/EC.00170-14; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; THOMAS JH, 1993, GENETICS, V134, P1105; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; VENOLIA L, 1990, GENETICS, V126, P345; VOWELS JJ, 1994, GENETICS, V138, P303; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Yamanaka A, 2002, CURR BIOL, V12, P267, DOI 10.1016/S0960-9822(02)00657-7; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Yunger E, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006577; Zhang Y, 2016, MOL CELL BIOL, V36, P2374, DOI 10.1128/MCB.00131-16; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zhu Q, 2015, NAT METHODS, V12, P211, DOI [10.1038/NMETH.3249, 10.1038/nmeth.3249]	69	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186386	10.1371/journal.pone.0186386	http://dx.doi.org/10.1371/journal.pone.0186386			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29078207	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200011
J	Chaturvedi, S; Rao, ALN				Chaturvedi, Sonali; Rao, A. L. N.			Riboproteomics: A versatile approach for the identification of host protein interaction network in plant pathogenic noncoding RNAs	PLOS ONE			English	Article							CUCUMBER-MOSAIC-VIRUS; SATELLITE RNA; CAPSID PROTEIN; REPLICATION; BROMODOMAIN	Pathogenic or non-pathogenic small (17 to 30 nt) and long (>200 nt) non-coding RNAs (ncRNAs) have been implicated in the regulation of gene expression at transcriptional, post-transcriptional and epigenetic level by interacting with host proteins. However, lack of suitable experimental system precludes the identification and evaluation of the functional significance of host proteins interacting with ncRNAs. In this study, we present a first report on the application of riboproteomics to identify host proteins interacting with small, highly pathogenic, noncoding satellite RNA (sat-RNA) associated with Cucumber mosaic virus, the helper virus (HV). RNA affinity beads containing sat-RNA transcripts of (+) or (-)-sense covalently coupled to cyanogen bromide activated sepharose beads were incubated with total protein extracts from either healthy or HV-infected Nicotiana benthamiana leaves. RNA-protein complexes bound to the beads were eluted and subjected to MudPIT analysis. Bioinformatics programs PANTHER classification and WoLF-PSORT were used to further classify the identified host proteins in each case based on their functionality and subcellular distribution. Finally, we observed that the host protein network interacting with plus and minus-strand transcripts of sat-RNA, in the presence or absence of HV is distinct, and the global interactome of host proteins interacting with satRNA in either of the orientations is very different.	[Chaturvedi, Sonali; Rao, A. L. N.] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA; [Chaturvedi, Sonali] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California Riverside; University of California System; University of California San Francisco; The J David Gladstone Institutes	Rao, ALN (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.	arao@ucr.edu		Chaturvedi, Sonali/0000-0002-9175-8110	University of California Agricultural Experimental Station Mission Funding Program [19900]	University of California Agricultural Experimental Station Mission Funding Program	This study was partly funded by a grant from University of California Agricultural Experimental Station Mission Funding Program (19900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by a grant from University of California Agricultural Experimental Station Mission Funding Program (19900).	Annamalai P., 2006, CURRENT PROTOCOLS MI; Bamunusinghe D, 2013, J VIROL, V87, P8982, DOI 10.1128/JVI.01253-13; Chaturvedi S, 2016, VIROLOGY, V494, P47, DOI 10.1016/j.virol.2016.04.001; Chaturvedi S, 2016, J PROTEOMICS, V131, P1, DOI 10.1016/j.jprot.2015.09.030; Chaturvedi S, 2014, VIROLOGY, V464, P67, DOI 10.1016/j.virol.2014.06.030; Chaturvedi S, 2014, J VIROL, V88, P1890, DOI 10.1128/JVI.03082-13; Chaturvedi S, 2012, JOVE-J VIS EXP, DOI 10.3791/3645; Choi SH, 2012, J VIROL, V86, P4823, DOI 10.1128/JVI.00018-12; de Wispelaere M, 2009, VIROLOGY, V384, P179, DOI 10.1016/j.virol.2008.10.023; de Wispelaere M, 2011, VIROLOGY, V419, P17, DOI 10.1016/j.virol.2011.07.016; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu CC, 2009, VIRUSES-BASEL, V1, P1325, DOI 10.3390/v1031325; Kwon SJ, 2014, VIROLOGY, V450, P222, DOI 10.1016/j.virol.2013.12.008; MARSH LE, 1991, VIROLOGY, V182, P76, DOI 10.1016/0042-6822(91)90650-Z; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Nagy PD, 2006, VIROLOGY, V344, P211, DOI 10.1016/j.virol.2005.09.017; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; PIAZZOLLA P, 1982, VIROLOGY, V122, P147, DOI 10.1016/0042-6822(82)90384-1; Rao ALN, 2015, VIROLOGY, V479, P627, DOI 10.1016/j.virol.2015.02.018; Rao ALN, 2014, CURR OPIN VIROL, V9, P61, DOI 10.1016/j.coviro.2014.09.008; Rao A.L.N., 2015, VIRUS RES; Seo JK, 2013, VIROLOGY, V435, P214, DOI 10.1016/j.virol.2012.10.031; Seo JK, 2009, VIROLOGY, V383, P248, DOI 10.1016/j.virol.2008.10.033; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vashist S, 2012, J VIROL, V86, P11977, DOI 10.1128/JVI.00432-12; Wang AM, 2015, ANNU REV PHYTOPATHOL, V53, P45, DOI 10.1146/annurev-phyto-080614-120001	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186703	10.1371/journal.pone.0186703	http://dx.doi.org/10.1371/journal.pone.0186703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073276	Green Published, gold			2022-12-27	WOS:000413845400042
J	Logan, JM; Bean, SB; Myers, AE				Logan, John M.; Bean, Sarah B.; Myers, Andrew E.			Author contributions to ecological publications: What does it mean to be an author in modern ecological research? (vol 12, e0179956, 2017)	PLOS ONE			English	Correction																		Logan JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179956	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187321	10.1371/journal.pone.0187321	http://dx.doi.org/10.1371/journal.pone.0187321			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073225	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400136
J	Theeuwes, HP; van der Ende, B; Potters, JW; Kerver, AJ; Bessems, JHJM; Kleinrensink, GJ				Theeuwes, H. P.; van der Ende, B.; Potters, J. W.; Kerver, A. J.; Bessems, J. H. J. M.; Kleinrensink, G-J.			The course of the radial nerve in the distal humerus: A novel, anatomy based, radiographic assessment	PLOS ONE			English	Article							SURGICAL ANATOMY; SHAFT FRACTURE; PALSY; MANAGEMENT; INJURY	Iatrogenic nerve injury during fracture surgery of the upper arm is a well-known complication. Prevention of this type of injuries would be of great value. The literature describes several methods to reduce this type of injury, but no perfect solution is at hand. In this study we introduce a new radiographic evaluation of the course and variation of the radial nerve in the distal part of the humerus in relation to bony landmarks as observed on a plain (trauma) radiographs. Aim of this new approach is to reduce the chance of iatrogenic nerve injury by defining of a danger zone in the distal upper arm regarding the radial nerve and hence give an advise for future implant fabrication. Methods and findings Measurements were done on both arms of ten specially embalmed specimens. Arms were dissected and radiopaque wires attached to the radial nerve in the distal part of the upper arm. Digital radiographs were obtained to determine the course of the radial nerve in the distal 20 cm of the humerus in relation to bony landmarks; medial epicondyle and capitellum-trochlea projection (CCT). Analysis was done with ImageJ and Microsoft Excel software. We also compared humeral nail specifications from different companies with the course of the radial nerve to predict possible radial nerve damage. Results The distance from the medial epicondyle to point where the radial nerve bends from posterior to lateral was 142 mm on AP radiographs and 152 mm measured on the lateral radiographs. The average distance from the medial epicondyle to point where the radial nerve bends from lateral to anterior on AP radiographs was 66 mm. On the lateral radiographs where the nerve moves away from the anterior cortex 83 mm to the center of capitellum and trochlea (CCT). The distance from the bifurcation of the radial nerve into the posterior interosseous nerve (PIN) and superficial radial nerve was 21 mm on AP radiographs and 42 mm on the lateral radiographs (CCT). Conclusions The course of the radial nerve in the distal part of the upper arm has great variety. Lateral fixation is relatively safe in a zone between the center of capitellum-trochlea and 48 mm proximal to this point. The danger zone in lateral fixation is in-between 48-122 mm proximal from CCT. In anteroposterior direction; distal fixation is dangerous between 21-101 mm measured from the medial epicondyle. The more distal, the more medial the nerve courses making it more valuable to iatrogenic damage. The IMN we compared with our data all show potential risk in case of (blind) distal locking, especially from lateral to medial direction.	[Theeuwes, H. P.; van der Ende, B.; Potters, J. W.; Kleinrensink, G-J.] Erasmus MC, Univ Med Ctr, Dept Neurosci Anat, Rotterdam, Netherlands; [Theeuwes, H. P.; van der Ende, B.; Potters, J. W.; Kleinrensink, G-J.] Erasmus MC, Univ Med Ctr, Erasmus MC Anat Res Project EARP, Rotterdam, Netherlands; [Theeuwes, H. P.] VieCuri Med Ctr, Dept Surg, Tegelseweg Bl Venlo, Netherlands; [van der Ende, B.] Reinier de Graafweg AD Delft, Dept Orthoped Surg, Reinier de Graaf Gasthuis, Delft, Netherlands; [Potters, J. W.] Erasmus MC, Dept Anesthesiol, Univ Med Ctr, Rotterdam, Netherlands; [Kerver, A. J.] Franciscus Gasthuis & Vlietland, Dept Surg, Rotterdam, Netherlands; [Bessems, J. H. J. M.] Erasmus MC, Univ Med Ctr, Dept Orthoped Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; VieCuri Medical Center; Reinier de Graaf Hospital; Erasmus University Rotterdam; Erasmus MC; Franciscus Gasthuis; Erasmus University Rotterdam; Erasmus MC	Theeuwes, HP (corresponding author), Erasmus MC, Univ Med Ctr, Dept Neurosci Anat, Rotterdam, Netherlands.; Theeuwes, HP (corresponding author), Erasmus MC, Univ Med Ctr, Erasmus MC Anat Res Project EARP, Rotterdam, Netherlands.; Theeuwes, HP (corresponding author), VieCuri Med Ctr, Dept Surg, Tegelseweg Bl Venlo, Netherlands.	hilcotheeuwes@gmail.com		Theeuwes, Hilco/0000-0003-4900-3539				Apergis E, 1998, J TRAUMA, V45, P825, DOI 10.1097/00005373-199810000-00040; Arora S, 2011, CLIN ORTHOP RELAT R, V469, P2638, DOI 10.1007/s11999-011-1791-4; Bishop J, 2009, J HAND SURG-AM, V34A, P991, DOI 10.1016/j.jhsa.2008.12.029; Bono CM, 2000, CLIN ORTHOP RELAT R, P259; Chaudhry T, 2010, CLIN ANAT, V23, P222, DOI 10.1002/ca.20903; Chou PH, 2008, CLIN ORTHOP RELAT R, V466, P135, DOI 10.1007/s11999-007-0019-0; Cox CL, 2010, CLIN ANAT, V23, P420, DOI 10.1002/ca.20951; Fleming P, 2004, CLIN ANAT, V17, P26, DOI 10.1002/ca.10181; GUSE TR, 1995, CLIN ORTHOP RELAT R, P149; Hems TEJ, 2012, J BONE JOINT SURG BR, V94B, P799, DOI 10.1302/0301-620X.94B6.28286; Kim SH, 2008, ARTHRIT CARE RES, V64, P407, DOI DOI 10.1002/ACR.21563; Klitsie PJ, 2017, SURG ENDOSC, V31, P1754, DOI 10.1007/s00464-016-5168-3; Kurup H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005959.pub2; Noger M, 2007, INJURY, V38, P954, DOI 10.1016/j.injury.2007.04.014; Putti Amit B, 2009, J Orthop Surg (Hong Kong), V17, P139; Schemitsch EH, 1997, ANN PLAS SURG, V38, P623, DOI 10.1097/00000637-199706000-00010; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slieker JC, 2012, SURG ENDOSC, V26, P2189, DOI 10.1007/s00464-012-2158-y; Stahl S, 1998, J ORTHOP TRAUMA, V12, P363, DOI 10.1097/00005131-199806000-00013; Theeuwes H., 2018, ANAT PHYSL BIOCH INT, V3, DOI [10.19080/apbij.2017.03.555604, DOI 10.19080/APBIJ.2017.03.555604]; Venouziou AI, 2011, INJURY, V42, P1289, DOI 10.1016/j.injury.2011.01.020; Wang Xun, 2014, Eur J Orthop Surg Traumatol, V24, P331, DOI 10.1007/s00590-013-1197-y	22	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186890	10.1371/journal.pone.0186890	http://dx.doi.org/10.1371/journal.pone.0186890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073240	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400069
J	Mitra, S; Banerjee, S; Hayashi, Y				Mitra, Somosmita; Banerjee, Subhashis; Hayashi, Yoichi			Volumetric brain tumour detection from MRI using visual saliency	PLOS ONE			English	Article							ATTENTION	Medical image processing has become a major player in the world of automatic tumour region detection and is tantamount to the incipient stages of computer aided design. Saliency detection is a crucial application of medical image processing, and serves in its potential aid to medical practitioners by making the affected area stand out in the foreground from the rest of the background image. The algorithm developed here is a new approach to the detection of saliency in a three dimensional multi channel MR image sequence for the glioblastoma multiforme (a form of malignant brain tumour). First we enhance the three channels, FLAIR (Fluid Attenuated Inversion Recovery), T2 and T1C (contrast enhanced with gadolinium) to generate a pseudo coloured RGB image. This is then converted to the CIE L*a*b* color space. Processing on cubes of sizes k= 4, 8,16, the L*a*b* 3D image is then compressed into volumetric units; each representing the neighbourhood information of the surrounding 64 voxels for k = 4, 512 voxels for k = 8 and 4096 voxels for k = 16, respectively. The spatial distance of these voxels are then compared along the three major axes to generate the novel 3D saliency map of a 3D image, which unambiguously highlights the tumour region. The algorithm operates along the three major axes to maximise the computation efficiency while minimising loss of valuable 3D information. Thus the 3D multichannel MR image saliency detection algorithm is useful in generating a uniform and logistically correct 3D saliency map with pragmatic applicability in Computer Aided Detection (CADe). Assignment of uniform importance to all three axes proves to be an important factor in volumetric processing, which helps in noise reduction and reduces the possibility of compromising essential information. The effectiveness of the algorithm was evaluated over the BRATS MICCAI 2015 dataset having 274 glioma cases, consisting both of high grade and low grade GBM. The results were compared with that of the 2D saliency detection algorithm taken over the entire sequence of brain data. For all comparisons, the Area Under the receiver operator characteristic (ROC) Curve (AUC) has been found to be more than 0.99 +/- 0.01 over various tumour types, structures and locations.	[Mitra, Somosmita] Inst Engn & Management, Dept Comp Sci & Engn, Kolkata 700091, W Bengal, India; [Banerjee, Subhashis] Indian Stat Inst, Machine Intelligence Unit, Kolkata 700108, W Bengal, India; [Banerjee, Subhashis] Univ Calcutta, Dept Comp Sci & Engn, Kolkata 700106, W Bengal, India; [Hayashi, Yoichi] Meiji Univ, Dept Comp Sci, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Institute of Engineering & Management (IEM), Kolkata; Indian Statistical Institute; Indian Statistical Institute Kolkata; University of Calcutta; Meiji University	Mitra, S (corresponding author), Inst Engn & Management, Dept Comp Sci & Engn, Kolkata 700091, W Bengal, India.	somosmita.mitra@gmail.com		Banerjee, Subhashis/0000-0002-2358-2096; Mitra, Somosmita/0000-0001-6573-9285	Ministry of Electronics & Information Technology(MeitY), Government of India	Ministry of Electronics & Information Technology(MeitY), Government of India	S. Banerjee acknowledges Visvesvaraya PhD Scheme by Ministry of Electronics & Information Technology(MeitY), Government of India.	Achanta R, 2008, LECT NOTES COMPUT SC, V5008, P66; Alpert S., 2014, SPIE MED IMAGING; Banerjee T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154666; Bian P, 2009, LECT NOTES COMPUT SC, V5506, P251, DOI 10.1007/978-3-642-02490-0_31; Erdem E, 2013, J VISION, V13, DOI 10.1167/13.4.11; Erihov M, 2015, LECT NOTES COMPUT SC, V9351, P636, DOI 10.1007/978-3-319-24574-4_76; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jampani V., 2012, P 8 IND C COMP VIS G, P80; Kistler M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2930; Ma Y.-F, 2003, P 11 ACM INT C MULTI, P374; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Quellec G, 2011, IEEE T MED IMAGING, V30, P523, DOI 10.1109/TMI.2010.2089383; Rosin PL, 2009, PATTERN RECOGN, V42, P2363, DOI 10.1016/j.patcog.2009.04.021; Ujjwal, 2013, I S BIOMED IMAGING, P1436; Ullman S., 1988, P 2 INT C COMP VIS, P321, DOI DOI 10.1109/CCV.1988.590008; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32; Zinn PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041522	23	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187209	10.1371/journal.pone.0187209	http://dx.doi.org/10.1371/journal.pone.0187209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095877	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200058
J	Nam, K; Maruyama, CL; Wang, CS; Trump, BG; Lei, P; Andreadis, ST; Baker, OJ				Nam, Kihoon; Maruyama, Christina L.; Wang, Ching-Shuen; Trump, Bryan G.; Lei, Pedro; Andreadis, Stelios T.; Baker, Olga J.			Laminin-111-derived peptide conjugated fibrin hydrogel restores salivary gland function	PLOS ONE			English	Article							GENE DELIVERY; INTEGRIN; CHANNEL; CANCER; TUMORIGENESIS; AQUAPORIN-5; XEROSTOMIA; COLLAGEN; BINDING	Hyposalivation reduces the patient quality of life, as saliva is important for maintaining oral health. Current treatments for hyposalivation are limited to medications such as the muscarinic receptor agonists, pilocarpine and cevimeline. However, these therapies only provide temporary relief. Therefore, alternative therapies are essential to restore salivary gland function. An option is to use bioengineered scaffolds to promote functional salivary gland regeneration. Previous studies demonstrated that the laminin-111 protein is critical for intact salivary gland cell cluster formation and organization. However, laminin-111 protein as a whole is not suitable for clinical applications as some protein domains may contribute to unwanted side effects such as degradation, tumorigenesis and immune responses. Conversely, the use of synthetic laminin-111 peptides makes it possible to minimize the immune reactivity or pathogen transfer. In addition, it is relatively simple and inexpensive as compared to animal-derived proteins. Therefore, the goal of this study was to demonstrate whether a 20 day treatment with laminin-111-derived peptide conjugated fibrin hydrogel promotes tissue regeneration in submandibular glands of a wound healing mouse model. In this study, laminin-111-derived peptide conjugated fibrin hydrogel significantly accelerated formation of salivary gland tissue. The regenerated gland tissues displayed not only structural but also functional restoration.	[Nam, Kihoon; Maruyama, Christina L.; Wang, Ching-Shuen; Trump, Bryan G.; Baker, Olga J.] Univ Utah, Sch Dent, Salt Lake City, UT 84112 USA; [Lei, Pedro; Andreadis, Stelios T.] Univ Buffalo State Univ New York, Dept Chem & Biol Engn, Buffalo, NY USA; [Andreadis, Stelios T.] Univ Buffalo State Univ New York, Sch Engn & Appl Sci, Dept Biomed Engn, Buffalo, NY USA; [Andreadis, Stelios T.] Univ Buffalo State Univ New York, Ctr Bioinformat & Life Sci, Buffalo, NY USA	Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Baker, OJ (corresponding author), Univ Utah, Sch Dent, Salt Lake City, UT 84112 USA.	olga.baker@hsc.utah.edu	Lei, Pedro/U-1027-2019		National Institutes of Health-National Institute of Dental and Craniofacial Research [R01DE022971, R01DE021697]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022971, R56DE021697] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study is supported by the National Institutes of Health-National Institute of Dental and Craniofacial Research Grants R01DE022971 (to 0.B. and S.A.) and R01DE021697 (to O.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KM, 2015, CANCER GROWTH METAST, V8, P1, DOI 10.4137/CGM.S11286; Asakura S, 1997, J BIOL CHEM, V272, P8824, DOI 10.1074/jbc.272.13.8824; Brett D, 2008, WOUNDS, V20, P347; Carlson E. R., 2015, TRAUMA INJURIES SALI, P409; Del Bufalo F, 2016, BIOMATERIALS, V84, P76, DOI 10.1016/j.biomaterials.2016.01.030; des Rieux A, 2009, J CONTROL RELEASE, V136, P148, DOI 10.1016/j.jconrel.2009.02.004; Dijkema T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-91; Ehrlich HP, 2012, ADV WOUND CARE, V1, P3, DOI 10.1089/wound.2011.0311; Frith JE, 2012, STEM CELLS DEV, V21, P2442, DOI 10.1089/scd.2011.0615; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jeong J, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.121; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kesimer M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-163; Kidd ME, 2012, J CONTROL RELEASE, V157, P80, DOI 10.1016/j.jconrel.2011.08.036; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Lei P, 2009, BIOMATERIALS, V30, P3790, DOI 10.1016/j.biomaterials.2009.03.049; Liang MS, 2013, BIOMATERIALS, V34, P7281, DOI 10.1016/j.biomaterials.2013.05.073; Liang MS, 2011, BIOMATERIALS, V32, P8684, DOI 10.1016/j.biomaterials.2011.07.079; Litvinov RI, 2005, BIOPHYS J, V89, P2824, DOI 10.1529/biophysj.105.061887; Maruyama CL, 2015, J DENT RES; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; Matsuzaki T, 2012, ACTA HISTOCHEM CYTOC, V45, P251, DOI 10.1267/ahc.12018; Nam K, 2017, J DENT RES, V96, P798, DOI 10.1177/0022034517695496; Nam K, 2016, BIOMACROMOLECULES, V17, P2293, DOI 10.1021/acs.biomac.6b00588; O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; Ogawa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3498; Padmashali RM, 2011, BIOMATERIALS, V32, P3330, DOI 10.1016/j.biomaterials.2011.01.035; Parveen S, 2006, J STEM CELLS REGEN, V1, P8; Patel VN, 2014, SEMIN CELL DEV BIOL, V25, P52, DOI 10.1016/j.semcdb.2013.12.001; Pinna R, 2015, THER CLIN RISK MANAG, V11, P171, DOI 10.2147/TCRM.S70652; Pook M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138346; Rajasekaran SA, 2008, BBA-BIOMEMBRANES, V1778, P757, DOI 10.1016/j.bbamem.2007.11.007; RAO CN, 1991, CONNECT TISSUE RES, V25, P321, DOI 10.3109/03008209109029167; Rasmussen CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145389; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Sonesson M, 2008, ARCH ORAL BIOL, V53, P523, DOI 10.1016/j.archoralbio.2008.01.002; Soon ASC, 2011, BIOMATERIALS, V32, P4406, DOI 10.1016/j.biomaterials.2011.02.050; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Suehiro K, 2000, J BIOCHEM, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804; Villa A, 2015, THER CLIN RISK MANAG, V11, P45, DOI 10.2147/TCRM.S76282; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; WEISFOGH US, 1988, EUR SURG RES, V20, P381, DOI 10.1159/000128789; Wiener RC, 2010, J AM DENT ASSOC, V141, P279, DOI 10.14219/jada.archive.2010.0161; Wilson M, 2015, MACROMOLECULES, V48, P6313, DOI 10.1021/acs.macromol.5b00885; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yuan X, 2016, TISSUE ENG PT A, V22, P928, DOI [10.1089/ten.tea.2016.0052, 10.1089/ten.TEA.2016.0052]	48	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187069	10.1371/journal.pone.0187069	http://dx.doi.org/10.1371/journal.pone.0187069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095857	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200043
J	Wu, JC; Crawford, FW; Raag, M; Heimer, R; Uuskula, A				Wu, Jiacheng; Crawford, Forrest W.; Raag, Mait; Heimer, Robert; Uuskula, Anneli			Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Jarve region of Estonia	PLOS ONE			English	Article							POPULATION-SIZE; CAPTURE-RECAPTURE; ST-PETERSBURG; HIV; PREVALENCE; USERS; PREVENTION; EPIDEMIC; RUSSIA; MEN	Estimating the size of key risk populations is essential for determining the resources needed to implement effective public health intervention programs. Several standard methods for population size estimation exist, but the statistical and practical assumptions required for their use may not be met when applied to HIV risk groups. We apply three approaches to estimate the number of people who inject drugs (PWID) in the Kohtla-Jarve region of Estonia using data from a respondent-driven sampling (RDS) study: the standard "multiplier" estimate gives 654 people (95% CI 509-804), the "successive sampling" method gives estimates between 600 and 2500 people, and a network-based estimate that uses the RDS recruitment chain gives between 700 and 2800 people. We critically assess the strengths and weaknesses of these statistical approaches for estimating the size of hidden or hard-to-reach HIV risk groups.	[Wu, Jiacheng] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Crawford, Forrest W.] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA; [Crawford, Forrest W.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Crawford, Forrest W.] Yale Sch Management, New Haven, CT 06511 USA; [Raag, Mait; Uuskula, Anneli] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia; [Heimer, Robert] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Heimer, Robert] Yale Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT USA	University of Washington; University of Washington Seattle; Yale University; Yale University; Yale University; University of Tartu; Yale University; Yale University	Crawford, FW (corresponding author), Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA.; Crawford, FW (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.; Crawford, FW (corresponding author), Yale Sch Management, New Haven, CT 06511 USA.	forrest.crawford@yale.edu	Uusküla, Anneli/H-3303-2015	Uusküla, Anneli/0000-0002-4036-3856; Crawford, Forrest/0000-0002-0046-0547	National Institutes of Health grants from Eunice Kennedy Shriver National Institute of Child Health and Human Development [DP2OD022614]; National Center for Advancing Translational Sciences [KL2 TR000140]; National Institute of Mental Health [P30MH062294]; Yale Center for Clinical Investigation; Yale Center for Interdisciplinary Research on AIDS; Estonian Ministry of Education and Research [TARTH15017I]; National Institute on Drug Abuse [1R01DA029888]; NICHD [DP2 OD022614]; NIH/NCATS [KL2 TR000140]; NIMH [P30MH062294]; NIH/NIDA [1R01DA029888]	National Institutes of Health grants from Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Yale Center for Clinical Investigation; Yale Center for Interdisciplinary Research on AIDS; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	FWC was supported by National Institutes of Health grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development DP2OD022614, National Center for Advancing Translational Sciences grant KL2 TR000140, National Institute of Mental Health P30MH062294, the Yale Center for Clinical Investigation, and the Yale Center for Interdisciplinary Research on AIDS. The Estonian Ministry of Education and Research under grant #TARTH15017I to AU. RH was also supported by the National Institute of Mental Health P30MH062294. The RDS study was funded by the National Institute on Drug Abuse grant 1R01DA029888 to RH/AU (Co-PIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r FWC was supported by NICHD DP2 OD022614, NIH/NCATS grant KL2 TR000140, NIMH grant P30MH062294, the Yale Center for Clinical Investigation, and the Yale Center for Interdisciplinary Research on AIDS. Estonian Ministry of Education and Research under grant #TARTH15017I. The RDS study was funded by NIH/NIDA grant 1R01DA029888 to Heimer/Uuskula (Co-PIs).	Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; Burke SE, 2015, SOC SCI MED, V130, P154, DOI 10.1016/j.socscimed.2015.02.018; CHEN Yan, 2009, J ORDNANCE ENG COLL, V21, P10; Crawford FW, 2017, J AM STAT A IN PRESS; Des Jarlais D. C., 2013, ADV PREVENTIVE MED, V2013; Development NIfH, 2014, HIV EST SIT PREV TRE; Drew R., 2008, EVALUATION FIGHTING; Gile KJ, 2015, J R STAT SOC A STAT, V178, P241, DOI 10.1111/rssa.12059; Handcock M, 2015, SSPSE ESTIMATING HID; Handcock MS, 2015, BIOMETRICS, V71, P258, DOI 10.1111/biom.12255; Handcock MS, 2014, ELECTRON J STAT, V8, P1491, DOI 10.1214/14-EJS923; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heimer R, 2010, DRUG ALCOHOL DEPEN, V109, P79, DOI 10.1016/j.drugalcdep.2009.12.010; Johnston L, 2011, INT J DRUG POLICY, V22, P252, DOI 10.1016/j.drugpo.2011.05.007; Khalid FJ, 2014, AIDS BEHAV, V18, pS25, DOI 10.1007/s10461-013-0517-x; Laisaar K-T, 2016, EUROSURVEILLANCE, V21; Laisaar KT, 2013, AIDS CARE, V25, P863, DOI 10.1080/09540121.2013.764393; Lemsalu L, 2013, REPORT HIV INFECTED; Lewis M, 2013, WHY EUROPES HEALTHIE; Luan RS, 2005, EUR J EPIDEMIOL, V20, P581, DOI 10.1007/s10654-005-4305-4; Paz-Bailey G, 2011, SEX TRANSM INFECT, V87, P279, DOI 10.1136/sti.2010.045633; Population and Housing Census, EST POP CONC MAJ CIT; Quaye S, 2015, AIDS BEHAV, V19, pS16, DOI 10.1007/s10461-014-0943-4; Raben D, 2014, HIV AIDS TREATMENT C; Robins G, 2001, SOC NETWORKS, V23, P1, DOI 10.1016/S0378-8733(01)00029-6; Ruiz MS, 2015, AIDS BEHAV, P1; Tilling K, 2001, INT J EPIDEMIOL, V30, P12, DOI 10.1093/ije/30.1.12; Uuskula A, 2015, AIDS CARE, V27, P105, DOI 10.1080/09540121.2014.940271; Uuskula A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-517; Uuskula A, 2008, J PUBLIC HEALTH-UK, V30, P119, DOI 10.1093/pubmed/fdn014; Uuskula A, 2007, ADDICT RES THEORY, V15, P411, DOI 10.1080/16066350701417533; Uuskula A, 2013, INT J DRUG POLICY, V24, P312, DOI 10.1016/j.drugpo.2012.11.002; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wesson P, 2017, AIDS BEHAV, P1; World Health Organization, 2013, HIV AIDS SURV EUR; World Health Organization, 2010, EST SIZ POP MOST RIS; Zhao Y., 2011, WORLD J AIDS, V01, P88	38	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0185711	10.1371/journal.pone.0185711	http://dx.doi.org/10.1371/journal.pone.0185711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095866	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200006
J	Hernandez, PR; Bloodhart, B; Barnes, RT; Adams, AS; Clinton, SM; Pollack, I; Godfrey, E; Burt, M; Fischer, EV				Hernandez, Paul R.; Bloodhart, Brittany; Barnes, Rebecca T.; Adams, Amanda S.; Clinton, Sandra M.; Pollack, Ilana; Godfrey, Elaine; Burt, Melissa; Fischer, Emily V.			Promoting professional identity, motivation, and persistence: Benefits of an informal mentoring program for female undergraduate students	PLOS ONE			English	Article							COLLEGE-STUDENTS; ROLE-MODELS; SCIENCE IDENTITY; ACADEMIC-SUCCESS; GENDER; WOMEN; PARTICIPATION; METAANALYSIS; PERFORMANCE; EXPERIENCES	Women are underrepresented in a number of science, technology, engineering, and mathematics (STEM) disciplines. Limited diversity in the development of the STEM workforce has negative implications for scientific innovation, creativity, and social relevance. The current study reports the first-year results of the PROmoting Geoscience Research, Education, and SuccesS (PROGRESS) program, a novel theory-driven informal mentoring program aimed at supporting first- and second-year female STEM majors. Using a prospective, longitudinal, multi-site (i.e., 7 universities in Colorado/Wyoming Front Range & Carolinas), propensity score matched design, we compare mentoring and persistence outcomes for women in and out of PROGRESS (N = 116). Women in PROGRESS attended an off-site weekend workshop and gained access to a network of volunteer female scientific mentors from on- and off-campus (i.e., university faculty, graduate students, and outside scientific professionals). The results indicate that women in PROGRESS had larger networks of developmental mentoring relationships and were more likely to be mentored by faculty members and peers than matched controls. Mentoring support from a faculty member benefited early-undergraduate women by strengthening their scientific identity and their interest in earth and environmental science career pathways. Further, support from a faculty mentor had a positive indirect impact on women's scientific persistence intentions, through strengthened scientific identity development. These results imply that first- and second- year undergraduate women's mentoring support networks can be enhanced through provision of protege training and access to more senior women in the sciences willing to provide mentoring support.	[Hernandez, Paul R.] West Virginia Univ, Dept Learning Sci & Human Dev, Morgantown, WV 26506 USA; [Bloodhart, Brittany; Pollack, Ilana; Burt, Melissa; Fischer, Emily V.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Barnes, Rebecca T.] Colorado Coll, Environm Program, Colorado Springs, CO 80903 USA; [Adams, Amanda S.; Clinton, Sandra M.; Godfrey, Elaine] Univ North Carolina Charlotte, Dept Geog & Earth Sci, Charlotte, NC USA	West Virginia University; Colorado State University; Colorado College; University of North Carolina; University of North Carolina Charlotte	Hernandez, PR (corresponding author), West Virginia Univ, Dept Learning Sci & Human Dev, Morgantown, WV 26506 USA.	prhermandez@mail.wvu.edu	Fischer, Emily/K-7330-2015; Barnes, Rebecca T/A-2659-2011; Barnes, Rebecca T/U-9595-2019; Pollack, Ilana B/F-9875-2012; Clinton, Sandra/V-8925-2019; Hernandez, Paul/AAY-8970-2020	Fischer, Emily/0000-0001-8298-3669; Barnes, Rebecca T/0000-0001-6385-1062; Barnes, Rebecca T/0000-0001-6385-1062; Pollack, Ilana B/0000-0001-7151-9756; Clinton, Sandra/0000-0002-8042-6671; Hernandez, Paul/0000-0002-4063-357X	National Science Foundation [DUE-1431795, DUE-1431823, DUE-1460229]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (https.//www.nsf.govidivi index.isp?divr,DUE) grant# DUE-1431795, DUE-1431823, DUE-1460229. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2016, B AM METEOROL SOC, V97, P345, DOI 10.1175/BAMS-D-15-00040.1; [Anonymous], COCHRANE HDB SYSTEMA; Bai, 2015, PROPENSITY SCORE ANA, DOI 10.1108/S1474-7863(2012)0000013012; Blake-Beard S, 2011, J SOC ISSUES, V67, P622, DOI 10.1111/j.1540-4560.2011.01717; Campbell TA, 2007, MENTOR TUTOR, V15, P135, DOI 10.1080/13611260601086287; Campos CM, 2009, J HISPANIC HIGHER ED, V8, P158, DOI DOI 10.1177/1538192708317621; Carlone HB, 2007, J RES SCI TEACH, V44, P1187, DOI 10.1002/tea.20237; CHAO GT, 1992, PERS PSYCHOL, V45, P619, DOI 10.1111/j.1744-6570.1992.tb00863.x; Chemers MM, 2011, J SOC ISSUES, V67, P469, DOI 10.1111/j.1540-4560.2011.01710.x; Cheryan S, 2013, PSYCHOL WOMEN QUART, V37, P72, DOI 10.1177/0361684312459328; Cohen J., 2002, APPL MULTIPLE REGRES, V3rd, DOI 10.4324/9780203774441; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; COOK RD, 1979, J AM STAT ASSOC, V74, P169, DOI 10.2307/2286747; COSGROVE TJ, 1986, J COLL STUDENT DEV, V27, P119; Crisp G, 2009, RES HIGH EDUC, V50, P525, DOI 10.1007/s11162-009-9130-2; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dasgupta N, 2004, J EXP SOC PSYCHOL, V40, P642, DOI 10.1016/j.jesp.2004.02.003; Downing RA, 2005, PSYCHOL WOMEN QUART, V29, P419, DOI 10.1111/j.1471-6402.2005.00242.x; Eby L.T., 2007, BLACKWELL HDB MENTOR, P211, DOI DOI 10.1111/B.9781405133739.2007.00002.X; Eby LT, 2008, J VOCAT BEHAV, V72, P254, DOI 10.1016/j.jvb.2007.04.005; Eby LTD, 2013, PSYCHOL BULL, V139, P441, DOI 10.1037/a0029279; Estrada M, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-01-0038; Estrada M, 2011, J EDUC PSYCHOL, V103, P206, DOI 10.1037/a0020743; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Freedland KE, 2011, PSYCHOSOM MED, V73, P323, DOI 10.1097/PSY.0b013e318218e1fb; Glessmer M.S., 2012, EOS T AM GEOPHYS UN, V93, P406, DOI [10.1029/2012EO410011, DOI 10.1029/2012EO410011, DOI 10.1029/2012E0410011]; Gonzales L., 2011, STATUS GEOSCIENCE WO; Graham MJ, 2013, SCIENCE, V341, P1455, DOI 10.1126/science.1240487; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hernandez PR, 2013, J EDUC PSYCHOL, V105, P89, DOI 10.1037/a0029691; Hernandez PR, 2016, J EXPT ED; Hidi S, 2006, EDUC PSYCHOL-US, V41, P111, DOI 10.1207/s15326985ep4102_4; Higgins M.C., 2000, J MANAGEMENT DEV, V19, P277, DOI [DOI 10.1108/02621710010322634, 10.1108/02621710010322634]; Higgins MC, 2001, J ORGAN BEHAV, V22, P223, DOI 10.1002/job.66; Hill C., 2010, WOMEN SCI TECHNOLOGY, DOI [10.1002/sce.21007, DOI 10.1002/SCE.21007]; Hulleman CS, 2010, J EDUC PSYCHOL, V102, P880, DOI 10.1037/a0019506; Hulleman CS, 2009, SCIENCE, V326, P1410, DOI 10.1126/science.1177067; Hunter AB, 2007, SCI EDUC, V91, P36, DOI 10.1002/sce.20173; JACOBI M, 1991, REV EDUC RES, V61, P505, DOI 10.3102/00346543061004505; Judd CM, 2009, DATA ANAL MODEL COMP, P328; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Linn MC, 2015, SCIENCE, V347, DOI 10.1126/science.1261757; Lockwood P, 2006, PSYCHOL WOMEN QUART, V30, P36, DOI 10.1111/j.1471-6402.2006.00260.x; Lockwood P, 1997, J PERS SOC PSYCHOL, V73, P91, DOI 10.1037/0022-3514.73.1.91; Maton KI, 2004, AM PSYCHOL, V59, P547, DOI 10.1037/0003-066X.59.6.547; Merolla DM, 2013, SOC PSYCHOL EDUC, V16, P575, DOI 10.1007/s11218-013-9233-7; National Academies of Sciences, 2017, ENG MED UND RES EXP; NSF, 2015, STAT NCFSAE; Packard B. W.-L., 2004, MENTORING TUTORING P, V12, P71, DOI [10.1080/1361126042000183039, DOI 10.1080/1361126042000183039]; Packard B.W.L., 2003, MENTORING TUTORING, V11, P53, DOI DOI 10.1080/1361126032000054808; Paglis LL, 2006, RES HIGH EDUC, V47, P451, DOI 10.1007/s11162-005-9003-2; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Perez T, 2014, J EDUC PSYCHOL, V106, P315, DOI 10.1037/a0034027; Pfund C, 2006, SCIENCE, V311, P473, DOI 10.1126/science.1123806; Phinney JS, 2011, J SOC ISSUES, V67, P599, DOI 10.1111/j.1540-4560.2011.01716.x; Rodger, 2003, CANADIAN JOURNAL OF, V33, P1; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; San Miguel AM, 2015, J CAREER DEV, V42, P133, DOI 10.1177/0894845314542248; Schultz PW, 2011, EDUC EVAL POLICY AN, V33, P95, DOI 10.3102/0162373710392371; Shields SA, 2011, J DIVERS HIGH EDUC, V4, P120, DOI 10.1037/a0022953; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Smith J, 2015, SOC PSYCHOL EDUC, P1; Stets JE, 2016, SOCIAL SCI RES; Stokes Philip J., 2015, J GEOSCIENCE ED, V63, P250, DOI [10.5408/14-038.1, DOI 10.5408/14-038.1]; Stout JG, 2011, J PERS SOC PSYCHOL, V100, P255, DOI 10.1037/a0021385; Summers MF, 2011, PROTEIN SCI, V20, P1796, DOI 10.1002/pro.733; Syed M, 2011, J SOC ISSUES, V67, P442, DOI 10.1111/j.1540-4560.2011.01709.x; Tabachnick BG., 2007, USING MULTIVARIATE S, V5, P481; Tan-Wilson A, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.14-11-0210; Thiry H, 2011, J HIGH EDUC-UK, V82, P357, DOI 10.1080/00221546.2011.11777209; West SG, 2008, AM J PUBLIC HEALTH, V98, P1359, DOI 10.2105/AJPH.2007.124446; Wilson C, 2019, US FEMALE GEOSCIENCE; Wilson ZS, 2012, J SCI EDUC TECHNOL, V21, P148, DOI 10.1007/s10956-011-9292-5; Woodcock A, 2016, SOC PSYCHOL PERS SCI, V7, P184, DOI 10.1177/1948550615608401; Young DM, 2013, PSYCHOL WOMEN QUART, V37, P283, DOI 10.1177/0361684313482109	75	41	41	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187531	10.1371/journal.pone.0187531	http://dx.doi.org/10.1371/journal.pone.0187531			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091969	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700072
J	Kim, SY; Sim, S; Choi, HG				Kim, So Young; Sim, Songyong; Choi, Hyo Geun			Atopic dermatitis is associated with active and passive cigarette smoking in adolescents	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ALLERGIC SENSITIZATION; EXPOSURE; MARKERS; ECZEMA; RISK	Objective The relationship between passive smoking and atopic dermatitis has previously been reported, but few studies have simultaneously evaluated the association of atopic dermatitis with active and passive smoking. Methods The relationships between atopic dermatitis and active and passive smoking were evaluated in Korean adolescents. We used a large, representative, population-based survey (The Korea Youth Risk Behavior Web-based Survey) conducted in 2011 and 2012. Active smoking was classified into 3 groups (0 days, 1-19 days, and > 20 days/month). Passive smoking was categorized into 3 groups (0 days, 1-4 days, and > 5 days/week). Atopic dermatitis diagnosed by a medical doctor either during the past 1 month or during the participant's lifetime was surveyed. Age, sex, obesity status, region of residence, economic level, and parental educational level of the participants were adjusted as confounders. Adjusted odds ratios (AORs) and 95% confidence intervals (CI) were calculated using multiple logistic regression analysis with complex sampling. Results A total of 6.8% (10,020/135,682) of the participants reported atopic dermatitis during the last 12 months. Active smoking was significantly associated with atopic dermatitis (previous 12 months) (AOR [95% CI] of smoking >= 20 days/month =1.18 [1.07-1.29]; 1-19 days/month = 1.11 [0.99-1.23], P = 0.002). Passive smoking was also related to atopic dermatitis (previous 12 months) (AOR [95% CI] of smoking > 5 days/week = 1.12 [1.05-1.20]; 1-4 days/week = 1.08 [1.03-1.13], P < 0.001). Conclusion Atopic dermatitis was significantly associated with active and passive smoking in Korean adolescents.	[Kim, So Young] CHA Univ, Dept Otorhinolaryngol Head & Neck Surg, CHA Bundang Med Ctr, Seongnam, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860]; Hallym University Sacred Heart Hospital [HURF-2016-38]; Korea Ministry of Environment (MOE) as "The Environmental Health Action Program" [2016001360009]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital; Korea Ministry of Environment (MOE) as "The Environmental Health Action Program"	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea, a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38), and a Korea Ministry of Environment (MOE) as "The Environmental Health Action Program"(2016001360009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, RELIABILITY VALIDITY; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Centers for Disease Control and Prevention, BMI CHILDR TEENS; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Edwards K, 1999, HUM EXP TOXICOL, V18, P233, DOI 10.1191/096032799678839978; FERSON M, 1979, INT J CANCER, V23, P603, DOI 10.1002/ijc.2910230504; FORASTIERE F, 1993, ARCH ENVIRON HEALTH, V48, P230, DOI 10.1080/00039896.1993.9940364; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; Graif Y, 2013, DERMATOLOGY, V226, P195, DOI 10.1159/000348333; Hancox RJ, 2008, J ALLERGY CLIN IMMUN, V121, P38, DOI 10.1016/j.jaci.2007.09.052; Jarvis D, 1999, J ALLERGY CLIN IMMUN, V104, P934, DOI 10.1016/S0091-6749(99)70071-0; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135753; Kramer U, 2004, BRIT J DERMATOL, V150, P111, DOI 10.1111/j.1365-2133.2004.05710.x; Lee CH, 2011, BRIT J DERMATOL, V164, P483, DOI 10.1111/j.1365-2133.2010.10116.x; Leow YH, 1998, CLIN DERMATOL, V16, P579, DOI 10.1016/S0738-081X(98)00042-X; Linneberg A, 2006, J ALLERGY CLIN IMMUN, V117, P184, DOI 10.1016/j.jaci.2005.09.042; MATHEWS JD, 1973, LANCET, V2, P754; Seymour BWP, 1997, J IMMUNOL, V159, P6169; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Tae B., 2016, ENV TOXICOL; Tanaka K, 2008, J ASTHMA, V45, P833, DOI 10.1080/02770900802339742; Wuthrich B, 1996, INT ARCH ALLERGY IMM, V111, P396, DOI 10.1159/000237398; Yi O, 2012, ENVIRON RES, V113, P40, DOI 10.1016/j.envres.2011.12.012	24	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187453	10.1371/journal.pone.0187453	http://dx.doi.org/10.1371/journal.pone.0187453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091936	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700068
J	Lee, Y; Kwon, DJ; Kim, YH; Ra, M; Heo, SI; Ahn, WG; Park, JR; Lee, SR; Kim, KH; Kim, SY				Lee, Yongjun; Kwon, Dong-Joo; Kim, Young Han; Ra, Moonjin; Heo, Seong Il; Ahn, Won Gyeong; Park, Jeong-Ran; Lee, Seoung Rak; Kim, Ki Hyun; Kim, Sun Young			HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice	PLOS ONE			English	Article							ACER-TEGMENTOSUM MAXIM; ALCOHOL; DISEASE; PATHOGENESIS; RATS	Chronic alcohol consumption causes alcohol-induced lipogenesis and promotes hepatic injury by preventing the oxidation of hepatocellular fatty acids through the suppression of the activation of AMP-activated protein kinase (AMPK). HIMH0021, an active flavonoid compound, which is a component of the Acer tegmentosum extract, has been shown to protect against liver damage caused by alcohol consumption. Therefore, in this study, we aimed to determine whether HIMH0021 could regulate alcoholic fatty liver and liver injury in mice. Oral administration of 10 days of Lieber-DeCarli ethanol plus a single binge of 30% ethanol (chronic-plus-binge model) induced steatosis and liver injury and inflammation in mice, which appears similar to the condition observed in human patients with alcohol-related diseases. HIMH0021, which was isolated from the active methanol extract of A. tegmentosum, inhibited alcohol-induced steatosis and attenuated the serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) during hepatocellular alcohol metabolism, both of which promote lipogenesis as well as liver inflammation. Treatment with HIMH0021 conferred protection against lipogenesis and liver injury, inhibited the expression of cytochrome P4502E1, and increased serum adiponectin levels in the mice subjected to chronic-plus-binge feeding. Furthermore, in hepatocytes, HIMH0021 activated fatty acid oxidation by activating pAMPK, which comprises pACC and CPT1 alpha. These findings suggested that HIMH0021 could be used to target a TNF alpha-related pathway for treating patients with alcoholic hepatitis.	[Lee, Yongjun; Kwon, Dong-Joo; Kim, Young Han; Ra, Moonjin; Heo, Seong Il; Ahn, Won Gyeong; Park, Jeong-Ran; Kim, Sun Young] Hongcheon Inst Med Herb, 101 Yeonbongri, Hongcheon, South Korea; [Lee, Seoung Rak; Kim, Ki Hyun] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea	Sungkyunkwan University (SKKU)	Kim, SY (corresponding author), Hongcheon Inst Med Herb, 101 Yeonbongri, Hongcheon, South Korea.	wiscsyk@naver.com	ra, moonjin/AAK-3816-2021; Kim, Sun/GSN-4867-2022		'R&D program for Forest Science Technology' - Korea Forest Service (Korea Forestry Promotion Institute) [S121415L020110]	'R&D program for Forest Science Technology' - Korea Forest Service (Korea Forestry Promotion Institute)	This study was carried out with the support of 'R&D program for Forest Science Technology' (Project No. S121415L020110) provided by Korea Forest Service (Korea Forestry Promotion Institute).	Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Casanova J, 2014, GASTROENT HEPAT-BARC, V37, P262, DOI 10.1016/j.gastrohep.2014.02.001; Crabb D W, 1993, Recent Dev Alcohol, V11, P207; Crabb DW, 2006, J GASTROEN HEPATOL, V21, pS56, DOI 10.1111/j.1440-1746.2006.04582.x; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GRUNNET N, 1986, ALCOHOL CLIN EXP RES, V10, pS64, DOI 10.1111/j.1530-0277.1986.tb05182.x; Hasin D, 2003, ALCOHOL RES HEALTH, V27, P5; Hwang YH, 2013, J ETHNOPHARMACOL, V148, P99, DOI 10.1016/j.jep.2013.03.074; Kiselica AM, 2015, ADDICT DISORD TREAT, V14, DOI 10.1097/ADT.0000000000000036; Li Z, 2016, BIOMED CHROMATOGR, V30, P1124, DOI 10.1002/bmc.3660; Lieber Charles S, 2004, Curr Gastroenterol Rep, V6, P60, DOI 10.1007/s11894-004-0027-0; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; Liu Q, 2012, NAT PROD RES, V26, P1750, DOI 10.1080/14786419.2011.608676; Mathurin P, 2000, HEPATOLOGY, V32, P1008, DOI 10.1053/jhep.2000.19621; Mueller S, 2014, WORLD J GASTROENTERO, V20, P14626, DOI 10.3748/wjg.v20.i40.14626; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Park KM, 2006, ARCH PHARM RES, V29, P1086, DOI 10.1007/BF02969296; Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929; Ronis MJ, 2010, ALCOHOL, V44, P157, DOI 10.1016/j.alcohol.2009.11.002; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; SY Kim GP, 2015, Patent KR, Patent No. [20160079622A, 20160079622]; Tung NH, 2008, J AGR FOOD CHEM, V56, P10510, DOI 10.1021/jf8020283; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6	27	8	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185134	10.1371/journal.pone.0185134	http://dx.doi.org/10.1371/journal.pone.0185134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091708	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700004
J	Philip, J; Ryman, TK; Hopkins, SE; O'Brien, DM; Bersamin, A; Pomeroy, J; Thummel, KE; Austin, MA; Boyer, BB; Dombrowski, K				Philip, Jacques; Ryman, Tove K.; Hopkins, Scarlett E.; O'Brien, Diane M.; Bersamin, Andrea; Pomeroy, Jeremy; Thummel, Kenneth E.; Austin, Melissa A.; Boyer, Bert B.; Dombrowski, Kirk			Bi-cultural dynamics for risk and protective factors for cardiometabolic health in an Alaska Native (Yup'ik) population	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; YUKON-KUSKOKWIM DELTA; MARINE FOOD-INTAKE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MENTAL-HEALTH; INUIT YOUTH; ALCOHOL-USE; EICOSAPENTAENOIC ACID	Alaska Native people experience disparities in mortality from heart disease and stroke. This work attempts to better understand the relationships between socioeconomic, behavioral, and cardiometabolic risk factors among Yup'ik people of southwestern Alaska, with a focus on the role of the socioeconomic, and cultural components. Using a cross-sectional sample of 486 Yup'ik adults, we fitted a Partial Least Squares Path Model (PLS-PM) to assess the associations between components, including demographic factors [age and gender], socioeconomic factors [education, economic status, Yup'ik culture, and Western culture], behavioral factors [diet, cigarette smoking and smokeless tobacco use, and physical activity], and cardiometabolic risk factors [adiposity, triglyceride-HDL and LDL lipids, glycemia, and blood pressure]. We found relatively mild associations of education and economic status with cardiometabolic risk factors, in contrast with studies in other populations. The socioeconomic factor and participation in Yup'ik culture had potentially protective associations with adiposity, triglyceride-HDL lipids, and blood pressure, whereas participation in Western culture had a protective association with blood pressure. We also found a moderating effect of participation in Western culture on the relationships between Yup'ik culture participation and both blood pressure and LDL lipids, indicating a potentially beneficial additional effect of biculturalism. Our results suggest that reinforcing protective effects of both Yup'ik and Western cultures could be useful for interventions aimed at reducing cardiometabolic health disparities.	[Philip, Jacques; Hopkins, Scarlett E.; O'Brien, Diane M.; Bersamin, Andrea; Boyer, Bert B.] Univ Alaska Fairbanks, Ctr Alaska Native Hlth Res, Fairbanks, AK 99775 USA; [Ryman, Tove K.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Pomeroy, Jeremy] Marshfield Clin Fdn Med Res & Educ, Res Inst, Marshfield, WI USA; [Thummel, Kenneth E.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Austin, Melissa A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Dombrowski, Kirk] Univ Nebraska, Dept Sociol, Lincoln, NE 68588 USA	University of Alaska System; University of Alaska Fairbanks; Bill & Melinda Gates Foundation; Marshfield Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nebraska System; University of Nebraska Lincoln	Philip, J (corresponding author), Univ Alaska Fairbanks, Ctr Alaska Native Hlth Res, Fairbanks, AK 99775 USA.	jphilip@alaska.edu	O'Brien, Diane/B-2919-2010	O'Brien, Diane/0000-0001-5807-9661	National Institute of Health [P20RR016430, P30GM103325, R01DK074842, U01GM092676, U54GM115371, U54GM104944]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103325, U54GM104944, U54GM115371, U01GM092676] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the following grants from the National Institute of Health: P20RR016430, P30GM103325, R01DK074842, U01GM092676, U54GM115371, U54GM104944.	Abel T, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.066159; Abel T, 2012, SOC SCI MED, V74, P236, DOI 10.1016/j.socscimed.2011.10.028; Albert MA, 2006, CIRCULATION, V114, P2619, DOI 10.1161/CIRCULATIONAHA.106.660043; Allen J., 2014, AM J COMMUNITY PSYCH; Allen J, 2014, AM J COMMUN PSYCHOL, V54, P100, DOI 10.1007/s10464-014-9647-1; Arias E, 2014, AM J PUBLIC HEALTH, V104, pS312; Ayunerak Paula, 2014, Am J Community Psychol, V54, P91, DOI 10.1007/s10464-014-9652-4; Bauer KW, 2012, AM J PUBLIC HEALTH, V102, P1346, DOI 10.2105/AJPH.2011.300522; Beaulieu-Jones BR, 2015, J NUTR, V145, P931, DOI 10.3945/jn.114.209619; Berger T. R, 1985, VILLAGE JOURNEY REPO; Bersamin A, 2014, ETHNIC HEALTH, V19, P255, DOI 10.1080/13557858.2012.758691; Boden-Albala B, 2013, ETHNIC DIS, V23, P484; Boyer BB, 2007, OBESITY, V15, P2535, DOI 10.1038/oby.2007.302; Boyer Bert B, 2005, Int J Circumpolar Health, V64, P281; Brabec M, 2007, AM J HUM BIOL, V19, P459, DOI 10.1002/ajhb.20606; Brice-Bennett C., 1994, DISPOSSESSED EVICTIO; BurnSilver S, 2016, AM ANTHROPOL, V118, P121, DOI 10.1111/aman.12447; Chandler M. J., 2003, MONOGR SOC RES CHILD, P138, DOI DOI 10.2307/1166217; Chandler M. J., 1998, TRANSCULT PSYCHIATRY, V35, P191, DOI DOI 10.1177/136346159803500202; Cheadle JE, 2011, J HEALTH SOC BEHAV, V52, P228, DOI 10.1177/0022146510393973; Chen D, 2017, REV PANAM SALUD PUBL, V41; Currie CL, 2013, SOC SCI MED, V88, P1, DOI 10.1016/j.socscimed.2013.03.032; Dombrowski K., 2013, J ANTHR, V2013, DOI [10.1155/2013/185048, DOI 10.1155/2013/185048]; Dombrowski K., 2014, CULTURE POLITICS STO; Dombrowski K, 2014, IDENTITIES-GLOB STUD, V21, P134, DOI 10.1080/1070289X.2013.854718; Dombrowski K, 2013, ARCTIC ANTHROPOL, V50, P89, DOI 10.3368/aa.50.1.89; Douglas V. K., 2013, INTRO ABORIGINAL HLT; Dressler WW, 2000, AM ANTHROPOL, V102, P244, DOI 10.1525/aa.2000.102.2.244; Duran E., 1995, NATIVE AM POSTCOLONI; Edwards KL, 1998, AM J EPIDEMIOL, V147, P441, DOI 10.1093/oxfordjournals.aje.a009469; Espey DK, 2014, AM J PUBLIC HEALTH, V104, pS303, DOI 10.2105/AJPH.2013.301798; Fraser SL, 2015, SUICIDE LIFE-THREAT, V45, P141, DOI 10.1111/sltb.12122; Garroutte EM, 2003, SOC SCI MED, V56, P1571, DOI 10.1016/S0277-9536(02)00157-0; GERHARD GT, 1991, AM J CLIN NUTR, V54, P334, DOI 10.1093/ajcn/54.2.334; Gone JP, 2007, AM J COMMUN PSYCHOL, V40, P290, DOI 10.1007/s10464-007-9136-x; Gone JP, 2012, ANNU REV CLIN PSYCHO, V8, P131, DOI 10.1146/annurev-clinpsy-032511-143127; Gone JP, 2011, J PSYCHOACTIVE DRUGS, V43, P291, DOI 10.1080/02791072.2011.628915; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hallett D, 2007, COGNITIVE DEV, V22, P392, DOI 10.1016/j.cogdev.2007.02.001; Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120; Hautala DS, 2015, YOUTH VIOLENCE JUV J; Henseler J, 2012, ELGAR ORIG REF, P252; Jacobson TA, 2012, J CLIN LIPIDOL, V6, P5, DOI 10.1016/j.jacl.2011.10.018; Jernigan VBB, 2017, AM J PUBLIC HEALTH, V107, P441, DOI 10.2105/AJPH.2016.303605; Jernigan VBB, 2015, AM J PUBLIC HEALTH, V105, pS376, DOI 10.2105/AJPH.2014.302447; Joe JR, 2014, AM INDIAN CULT RES J, V38, P123, DOI 10.17953/aicr.38.1.qj47130n435njl34; Joe JR, 2014, AM INDIAN CULT RES J, V38, P11, DOI 10.17953/aicr.38.1.w753453k6h67061m; Jorgensen ME, 2006, EUR J EPIDEMIOL, V21, P741, DOI 10.1007/s10654-006-9063-4; Kaholokula JK, 2008, DIABETES CARE, V31, P698, DOI 10.2337/dc07-1560; Kaufman CE, 2013, J CONSULT CLIN PSYCH, V81, P1040, DOI 10.1037/a0034342; Kawagley AO, 1998, J RES SCI TEACH, V35, P133, DOI 10.1002/(SICI)1098-2736(199802)35:2<133::AID-TEA4>3.3.CO;2-C; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Kirmayer L., 2003, AUSTRALAS PSYCHIATRY, V11, pS15, DOI DOI 10.1046/J.1038-5282.2003.02010.X; Kirmayer LJ, 1998, CAN J PSYCHIAT, V43, P816, DOI 10.1177/070674379804300806; Koller KR, 2015, DIABETES RES CLIN PR, V108, P423, DOI 10.1016/j.diabres.2015.03.001; Lara M, 2005, ANNU REV PUBL HEALTH, V26, P367, DOI 10.1146/annurev.publhealth.26.021304.144615; Larimore JA, 2005, SERVING NATIVE AM ST, V2005, P17, DOI DOI 10.1002/SS.150; Lazrus H, 2015, HUM ORGAN, V74, P52, DOI 10.17730/humo.74.1.q0667716284749m8; Lehti V, 2009, SOC SCI MED, V69, P1194, DOI 10.1016/j.socscimed.2009.07.045; MacDonald JP, 2015, SOC SCI MED, V141, P133, DOI 10.1016/j.socscimed.2015.07.017; MacDonald Joanna Petrasek, 2013, Int J Circumpolar Health, V72, P21775, DOI 10.3402/ijch.v72i0.21775; McIntosh CN, 2014, ORGAN RES METHODS, V17, P210, DOI 10.1177/1094428114529165; McIvor O, 2009, INT J INDIG HEALTH, V5, P6; Mendelsohn ME, 2002, AM J CARDIOL, V89, p12E; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mitchell FM, 2012, HEALTH SOC WORK, V37, P71, DOI 10.1093/hsw/hls013; Mitrou F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-201; Mohatt GV, 2007, INT J CIRCUMPOL HEAL, V66, P8, DOI 10.3402/ijch.v66i1.18219; Moore K, 2014, AM J PUBLIC HEALTH, V104, pE158, DOI 10.2105/AJPH.2014.302108; Morgan M., 1992, HIST ECONOMETRIC IDE; Moses J, 2017, HUM ORGAN, V76, P171, DOI 10.17730/0018-7259.76.2.171; Napoleon H, 1991, ALASKA NATIVE KNOWLE; Nash SH, 2012, J NUTR, V142, P84, DOI 10.3945/jn.111.147595; O'Brien DM, 2017, PUBLIC HEALTH NUTR, V20, P1738, DOI 10.1017/S1368980016001853; O'Brien DM, 2014, J NUTR, V144, P706, DOI 10.3945/jn.113.189381; O'Brien DM, 2009, AM J CLIN NUTR, V89, P913, DOI 10.3945/ajcn.2008.27054; OETTING ER, 1991, INT J ADDICT, V25, P655, DOI 10.3109/10826089109077265; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; ONell TD, 1996, SOC SCI MED, V42, P565, DOI 10.1016/0277-9536(95)00157-3; Pappas RS, 2008, J ANAL TOXICOL, V32, P281, DOI 10.1093/jat/32.4.281; Parlee Brenda, 2005, EcoHealth, V2, P127, DOI 10.1007/s10393-005-3870-z; Philip J, 2016, PSYCHOSOC INTERV, V25, P45, DOI 10.1016/j.psi.2015.08.002; Piano MR, 2010, CIRCULATION, V122, P1520, DOI 10.1161/CIR.0b013e3181f432c3; R Development Core Team, 2009, R LANG ENV STAT COMP; Rasmus SM, 2014, AM J COMMUN PSYCHOL, V54, P140, DOI 10.1007/s10464-014-9651-5; Reeve R, 2014, AUST NZ J PUBL HEAL, V38, P459, DOI 10.1111/1753-6405.12211; Renner CC, 2005, AM J HEALTH BEHAV, V29, P588, DOI 10.5993/AJHB.29.6.13; Roh S, 2015, AGING MENT HEALTH, V19, P371, DOI 10.1080/13607863.2014.938603; Ryman TK, 2015, NUTR METAB CARDIOVAS, V25, P1140, DOI 10.1016/j.numecd.2015.08.003; Ryman TK, 2017, ETHN HLTH, P1; Ryman TK, 2015, BRIT J NUTR, V113, P634, DOI 10.1017/S0007114514003596; Ryman TK, 2014, PUBLIC HEALTH NUTR, V17, P510, DOI 10.1017/S1368980012005411; Sanchez G., 2013, PLS PATH MODELING R; Sider Gerald, 2014, SKIN SKIN DEATH LIFE; Silviken A, 2007, J ADOLESCENCE, V30, P613, DOI 10.1016/j.adolescence.2006.06.004; Singer MK, 2012, PREV MED, V55, P356, DOI 10.1016/j.ypmed.2012.02.011; Spicer P, 2001, SOC SCI MED, V53, P227, DOI 10.1016/S0277-9536(00)00333-6; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Stone RAT, 2006, J STUD ALCOHOL, V67, P236, DOI 10.15288/jsa.2006.67.236; Sutton Peter, 2011, POLITICS SUFFERING I; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Tester F.J., 1994, TAMMARNIIT MISTAKES; US Census Bureau, 2016, AM FACTFINDER; Valeggia CR, 2015, ANNU REV ANTHROPOL, V44, P117, DOI 10.1146/annurev-anthro-102214-013831; Veenstra G, 2014, SOCIOL HLTH ILLN MON, P31; Veenstra G, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0167-x; Vinzi V.E., 2010, HDB PARTIAL LEAST SQ, P47, DOI [10.1007/978-3-540-32827-8_3, DOI 10.1007/978-3-540-32827-8]; Wetzels M, 2009, MIS QUART, V33, P177, DOI 10.2307/20650284; Wexler L, 2013, HEALTH PROMOT PRACT, V14, P617, DOI 10.1177/1524839912462390; Wexler LM, 2006, SOC SCI MED, V63, P2938, DOI 10.1016/j.socscimed.2006.07.022; Whitbeck LB, 2009, COMMUNITY MENT HLT J, V45, P62, DOI 10.1007/s10597-008-9172-5; Wijndaele K, 2006, DIABETES CARE, V29, P2329, DOI 10.2337/dc06-1341; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Wolsko C, 2007, INT J CIRCUMPOL HEAL, V66, P51, DOI 10.3402/ijch.v66i1.18226; Wolsko C, 2006, ETHNIC HEALTH, V11, P345, DOI 10.1080/13557850600824005; Wolsko C, 2009, CULT DIVERS ETHN MIN, V15, P165, DOI 10.1037/a0015323; Zimmet P., 2005, DIABETES VOICE, V50, P31	117	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e018345	10.1371/journal.pone.0183451	http://dx.doi.org/10.1371/journal.pone.0183451			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091709	Green Published, gold			2022-12-27	WOS:000414229700001
J	Kouwaye, B; Rossi, F; Fonton, N; Garcia, A; Dossou-Gbete, S; Hounkonnou, MN; Cottrell, G				Kouwaye, Bienvenue; Rossi, Fabrice; Fonton, Noel; Garcia, Andre; Dossou-Gbete, Simplice; Hounkonnou, Mahouton Norbert; Cottrell, Gilles			Predicting local malaria exposure using a Lasso-based two-level cross validation algorithm	PLOS ONE			English	Article							VARIABLE SELECTION; REGULARIZATION	Recent studies have highlighted the importance of local environmental factors to determine the fine-scale heterogeneity of malaria transmission and exposure to the vector. In this work, we compare a classical GLM model with backward selection with different versions of an automatic LASSO-based algorithm with 2-level cross-validation aiming to build a predictive model of the space and time dependent individual exposure to the malaria vector, using entomological and environmental data from a cohort study in Benin. Although the GLM can outperform the LASSO model with appropriate engineering, the best model in terms of predictive power was found to be the LASSO-based model. Our approach can be adapted to different topics and may therefore be helpful to address prediction issues in other health sciences domains.	[Kouwaye, Bienvenue; Rossi, Fabrice] Univ Paris 1 Pantheon Sorbonne, Lab SAMM, EA 4543, Paris, France; [Kouwaye, Bienvenue; Fonton, Noel; Hounkonnou, Mahouton Norbert] Univ Abomey Calavi, 072 BP 50, Cotonou, Benin; [Kouwaye, Bienvenue; Fonton, Noel] Univ Abomey Calavi, LERSAB, Cotonou, Benin; [Garcia, Andre; Cottrell, Gilles] Inst Rech Dev, MERIT UMR216, Mere & Enfant Face Infect Trop, F-75006 Paris, France; [Garcia, Andre; Cottrell, Gilles] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, Paris, France; [Garcia, Andre; Cottrell, Gilles] CERPAGE, IRD, UMR 216, Fac Sci Sante, Cotonou, Benin; [Dossou-Gbete, Simplice] Univ Pau & Pays Adour, CNRS, Lab Math & Leurs Applicat Pau Fed IPRA, UMR 5142, F-64012 Pau, France	University of Abomey Calavi; University of Abomey Calavi; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Pau et des Pays de l'Adour	Kouwaye, B (corresponding author), Univ Paris 1 Pantheon Sorbonne, Lab SAMM, EA 4543, Paris, France.; Kouwaye, B (corresponding author), Univ Abomey Calavi, 072 BP 50, Cotonou, Benin.; Kouwaye, B (corresponding author), Univ Abomey Calavi, LERSAB, Cotonou, Benin.	Kouwaye2000@yahoo.fr	Garcia, Andre/S-2959-2016; Rossi, Fabrice/H-5335-2019; Hounkonnou, Mahouton Norbert/AAF-4695-2019; Garcia, Andre/ABA-1820-2020	Garcia, Andre/0000-0002-1808-472X; Rossi, Fabrice/0000-0003-4638-1286; Hounkonnou, Mahouton Norbert/0000-0002-6231-4975; Garcia, Andre/0000-0002-1808-472X; Cottrell, Gilles/0000-0002-7964-8963				Biau G, 2008, J MACHINE LEARNING R; Bontempi G., 2005, ESANN 2005, P405; Campbell JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025661; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Fonton N, 2015, SELECTION VARIABLES; Friedman J, 2015, LASSO ELASTI NET REG; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gillies D, 1987, PUB S AFR I MED RES; Gillies D, 1968, PUB S AFR I MED RES; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Gu WD, 2005, AM J TROP MED HYG, V73, P546, DOI 10.4269/ajtmh.2005.73.546; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Keerthi S, 2007, EFFICIENT METHOD GRA; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kouwaye B, 2015, LASSO BASED FEATURE; Li H, 2014, BMC BIOINFORMATICS, P12; Li S, 2016, BMC BIOINFORMATICS, P13; Miller A., 1990, SUBSET SELECTION REG, P235; Oermann EK, 2016, SCI REPORTS, V13, P12; Pierrat C, 2012, PLOS ONE, V7, P8; Ratner B., 2010, J TARGET MEAS ANAL M, V18, P65, DOI [10.1057/jt.2009.26, DOI 10.1057/JT.2009.26]; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tutz G, 2011, VARIABLES SELECTION; van der Ploeg T, 2016, BMC RES NOTES, P7; Wang H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8949835; Weiss JC, 2012, MACHINE LEARNING PER, P13; WHO, 2013, WORLD MAL REP 2013, P248; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	37	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187234	10.1371/journal.pone.0187234	http://dx.doi.org/10.1371/journal.pone.0187234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088280	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900052
J	Meng, XW; Murakami, T; Hashiya, K				Meng, Xianwei; Murakami, Taro; Hashiya, Kazuhide			Phonological loop affects children's interpretations of explicit but not ambiguous questions: Research on links between working memory and referent assignment	PLOS ONE			English	Article							EXECUTIVE CONTROL; SERIAL-ORDER; MIND; EXPERIENCE; CONTEXT; CHINESE; MODEL	Understanding the referent of other's utterance by referring the contextual information helps in smooth communication. Although this pragmatic referential process can be observed even in infants, its underlying mechanism and relative abilities remain unclear. This study aimed to comprehend the background of the referential process by investigating whether the phonological loop affected the referent assignment. A total of 76 children (43 girls) aged 3-5 years participated in a reference assignment task in which an experimenter asked them to answer explicit (e.g., "What color is this?") and ambiguous (e.g., "What about this?") questions about colorful objects. The phonological loop capacity was measured by using the forward digit span task in which children were required to repeat the numbers as an experimenter uttered them. The results showed that the scores of the forward digit span task positively predicted correct response to explicit questions and part of the ambiguous questions. That is, the phonological loop capacity did not have effects on referent assignment in response to ambiguous questions that were asked after a topic shift of the explicit questions and thus required a backward reference to the preceding explicit questions to detect the intent of the current ambiguous questions. These results suggest that although the phonological loop capacity could overtly enhance the storage of verbal information, it does not seem to directly contribute to the pragmatic referential process, which might require further social cognitive processes.	[Meng, Xianwei] Kyushu Univ, Grad Sch Human Environm Studies, Fukuoka, Fukuoka, Japan; [Meng, Xianwei] Japan Soc Promot Sci, Tokyo, Japan; [Murakami, Taro] Kyushu Womens Univ, Fac Humanities, Dept Educ & Psychol, Kitakyushu, Fukuoka, Japan; [Hashiya, Kazuhide] Kyushu Univ, Fac Human Environm Studies, Fukuoka, Fukuoka, Japan	Kyushu University; Japan Society for the Promotion of Science; Kyushu University	Meng, XW (corresponding author), Kyushu Univ, Grad Sch Human Environm Studies, Fukuoka, Fukuoka, Japan.; Meng, XW (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	mokeni1211@gmail.com		Meng, Xianwei/0000-0002-7873-7518	JSPS grant of Program for Leading Graduate Schools P02;  [JP15J02341]; Grants-in-Aid for Scientific Research [17KT0139, 25118003] Funding Source: KAKEN	JSPS grant of Program for Leading Graduate Schools P02; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science Research Fellow (JP15J02341), and is partly supported by the JSPS grant of Program for Leading Graduate Schools P02 (http://ketsudan.kyushu-u.ac.jp/?lng=e&lng=e).	ALTMANN G, 1988, COGNITION, V30, P191, DOI 10.1016/0010-0277(88)90020-0; ANDERSON RC, 1977, J EXP PSYCHOL-HUM L, V3, P142, DOI 10.1037/0278-7393.3.2.142; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Burgess N, 1999, PSYCHOL REV, V106, P551, DOI 10.1037/0033-295X.106.3.551; Clark HerbertH., 1981, ELEMENTS DISCOURSE U, P10; CLARK HH, 1979, MEM COGNITION, V7, P35, DOI 10.3758/BF03196932; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; CRAIN S, 1985, NATURAL LANGUAGE PAR, P320, DOI DOI 10.1017/CBO9780511597855.011; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Frank MC, 2012, SCIENCE, V336, P998, DOI 10.1126/science.1218633; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; GATHERCOLE SE, 1995, BRIT J EDUC PSYCHOL, V65, P155, DOI 10.1111/j.2044-8279.1995.tb01139.x; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; Geoffrey L., 1983, PRINCIPLES PRAGMATIC, P13; Grodner D, 2005, COGNITION, V95, P275, DOI 10.1016/j.cognition.2004.01.007; HAVILAND SE, 1974, J VERB LEARN VERB BE, V13, P512, DOI 10.1016/S0022-5371(74)80003-4; Henson RNA, 1996, Q J EXP PSYCHOL-A, V49, P80, DOI 10.1080/027249896392810; Johns CL, 2014, LANG COGN NEUROSCI, V29, P60, DOI 10.1080/01690965.2012.733014; Kirkham NZ, 2003, DEVELOPMENTAL SCI, V6, P449, DOI 10.1111/1467-7687.00300; Kobayashi C, 2007, BRAIN RES, V1164, P95, DOI 10.1016/j.brainres.2007.06.022; LANDAU B, 1988, COGNITIVE DEV, V3, P299, DOI 10.1016/0885-2014(88)90014-7; Liebal K, 2009, DEVELOPMENTAL SCI, V12, P264, DOI 10.1111/j.1467-7687.2008.00758.x; Liu D, 2008, DEV PSYCHOL, V44, P523, DOI 10.1037/0012-1649.44.2.523; Luciana M, 2005, CHILD DEV, V76, P697, DOI 10.1111/j.1467-8624.2005.00872.x; Mazuka R, 2009, LANG LINGUIST COMPAS, V3, P59, DOI 10.1111/j.1749-818x.2008.00102.x; MCKOON G, 1980, J VERB LEARN VERB BE, V19, P668, DOI 10.1016/S0022-5371(80)90355-2; Meng XW, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02065; Meng XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107579; MITCHELL DC, 1992, J EXP PSYCHOL LEARN, V18, P69, DOI 10.1037/0278-7393.18.1.69; Moll H, 2007, DEVELOPMENTAL SCI, V10, P826, DOI 10.1111/j.1467-7687.2007.00615.x; Moriguchi Y, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00388; Murakami T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00523; MURDOCK BB, 1993, PSYCHOL REV, V100, P183, DOI 10.1037/0033-295X.100.2.183; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; PAPAGNO C, 1991, J MEM LANG, V30, P331, DOI 10.1016/0749-596X(91)90040-Q; Rasmussen C, 2005, J EXP CHILD PSYCHOL, V91, P137, DOI 10.1016/j.jecp.2005.01.004; Rasmussen C, 2003, J EXP CHILD PSYCHOL, V85, P89, DOI 10.1016/S0022-0965(03)00031-6; Ravizza SM, 2008, NEUROPSYCHOLOGIA, V46, P2924, DOI 10.1016/j.neuropsychologia.2008.06.006; Rothman KJ., 2012, EPIDEMIOLOGY INTRO; Sabbagh MA, 2006, PSYCHOL SCI, V17, P74, DOI 10.1111/j.1467-9280.2005.01667.x; Saylor MM, 2007, DEV PSYCHOL, V43, P696, DOI 10.1037/0012-1649.43.3.696; Senzaki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147199; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Sperber D, 1986, RELEVANCE COMMUNICAT, P15; Tomasello M, 2003, DEV PSYCHOL, V39, P906, DOI 10.1037/0012-1649.39.5.906; Vallar G, 2008, NEUROPSYCHOLOGICAL RESEARCH: A REVIEW, P307; Van Dijk T.A., 1983, STRATEGIES DISCOURSE; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	53	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187368	10.1371/journal.pone.0187368	http://dx.doi.org/10.1371/journal.pone.0187368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088282	Green Submitted, Green Published, gold			2022-12-27	WOS:000414088900075
J	Vazquez-Marrufo, M; Galvao-Carmona, A; Lugo, MLB; Ruiz-Pena, JL; Guerra, MB; Ayuso, GI				Vazquez-Marrufo, Manuel; Galvao-Carmona, Alejandro; Benitez Lugo, Maria Luisa; Luis Ruiz-Pena, Juan; Borges Guerra, Monica; Izquierdo Ayuso, Guillermo			Retest reliability of individual alpha ERD topography assessed by human electroencephalography	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; SYNCHRONIZATION; P300; EEG; STIMULATION; CONSISTENCY; POTENTIALS; STABILITY	Background Despite the immense literature related to diverse human electroencephalographic (EEG) parameters, very few studies have focused on the reliability of these measures. Some of the most studied components (i.e., P3 or MMN) have received more attention regarding the stability of their main parameters, such as latency, amplitude or topography. However, spectral modulations have not been as extensively evaluated considering that different analysis methods are available. The main aim of the present study is to assess the reliability of the latency, amplitude and topography of event-related desynchronization (ERD) for the alpha band (10-14 Hz) observed in a cognitive task (visual oddball). Topography reliability was analysed at different levels (for the group, within-subjects individually and between-subjects individually). Results The latency for alpha ERD showed stable behaviour between two sessions, and the amplitude exhibited an increment (more negative) in the second session. Alpha ERD topography exhibited a high correlation score between sessions at the group level (r = 0.903, p<0.001). The mean value for within-subject correlations was 0.750 (with a range from 0.391 to 0.954). Regarding between-subject topography comparisons, some subjects showed a highly specific topography, whereas other subjects showed topographies that were more similar to those of other subjects. Conclusion ERD was mainly stable between the two sessions with the exception of amplitude, which exhibited an increment in the second session. Topography exhibits excellent reliability at the group level; however, it exhibits highly heterogeneous behaviour at the individual level. Considering that the P3 was previously evaluated for this group of subjects, a direct comparison of the correlation scores was possible, and it showed that the ERD component is less reliable in individual topography than in the ERP component (P3).	[Vazquez-Marrufo, Manuel] Univ Seville, Fac Psychol, Expt Psychol Dept, Seville, Spain; [Galvao-Carmona, Alejandro] Univ Loyola Andalucia, Dept Psychol, Seville, Spain; [Benitez Lugo, Maria Luisa] Univ Seville, Physiotherapy Dept, Fac Nursing Physiotherapy & Chiropody, Seville, Spain; [Luis Ruiz-Pena, Juan; Borges Guerra, Monica; Izquierdo Ayuso, Guillermo] Virgen Macarena Hosp, Multiple Sclerosis Unit, Seville, Spain	University of Sevilla; Universidad Loyola Andalucia; University of Sevilla; Hospital Universitario Virgen Macarena	Vazquez-Marrufo, M (corresponding author), Univ Seville, Fac Psychol, Expt Psychol Dept, Seville, Spain.	marrufo@us.es	Marrufo, Manuel Vazquez/Y-8460-2019; Benítez-Lugo, María-Luisa/J-7487-2018; Galvao-Carmona, Alejandro/A-1725-2015; peña, juan luis ruiz/Z-6168-2019	Marrufo, Manuel Vazquez/0000-0002-0456-7165; Benítez-Lugo, María-Luisa/0000-0003-2058-8799; Galvao-Carmona, Alejandro/0000-0002-5126-1273; peña, juan luis ruiz/0000-0003-3956-1131; Borges Guerra, Monica/0000-0002-4258-2390	Plan Nacional I+D+i (Ministerio de Economia y Competitividad, Government of Spain) [PSI2016-78133-P]; Asociacion Sanitaria Virgen Macarena	Plan Nacional I+D+i (Ministerio de Economia y Competitividad, Government of Spain); Asociacion Sanitaria Virgen Macarena	This study was supported by Plan Nacional I+D+i (Ministerio de Economia y Competitividad, Government of Spain, PSI2016-78133-P) and Asociacion Sanitaria Virgen Macarena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basar E, 2014, COGN NEURODYNAMICS, V8, P437, DOI 10.1007/s11571-014-9301-5; Burgess AP, 1996, INT J PSYCHOPHYSIOL, V23, P163, DOI 10.1016/S0167-8760(96)00046-3; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Friedrich EVC, 2013, CLIN NEUROPHYSIOL, V124, P61, DOI 10.1016/j.clinph.2012.05.020; Friesen CL, 2017, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00692; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hidalgo-Munoz AR, 2014, MED BIOL ENG COMPUT, V52, P149, DOI 10.1007/s11517-013-1126-6; Karrasch M, 1998, ELECTROEN CLIN NEURO, V107, P112, DOI 10.1016/S0013-4694(98)00047-9; KILENY PR, 1987, EAR HEARING, V8, P110, DOI 10.1097/00003446-198704000-00008; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 2003, EUR J NEUROSCI, V17, P1129, DOI 10.1046/j.1460-9568.2003.02517.x; Kline P., 2000, HDB PSYCHOL TESTING; Krause CM, 2001, CLIN NEUROPHYSIOL, V112, P750, DOI 10.1016/S1388-2457(01)00501-6; Krause CM, 1996, ELECTROEN CLIN NEURO, V98, P319, DOI 10.1016/0013-4694(96)00283-0; Li MF, 2014, INT J NEUROSCI, V124, P403, DOI 10.3109/00207454.2013.850082; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; Neuper C, 2005, CLIN NEUROPHYSIOL, V116, P1681, DOI 10.1016/j.clinph.2005.03.013; Notturno F, 2014, HUM BRAIN MAPP, V35, P2220, DOI 10.1002/hbm.22322; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V43, P757, DOI 10.1016/0013-4694(77)90092-X; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V47, P21, DOI 10.1016/0013-4694(79)90029-4; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; POLICH J, 1986, PSYCHOPHYSIOLOGY, V23, P590, DOI 10.1111/j.1469-8986.1986.tb00677.x; POLICH J, 1986, ELECTROEN CLIN NEURO, V65, P236, DOI 10.1016/0168-5597(86)90059-6; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Sanei S, 2007, EEG SIGNAL PROCESSIN; Schabus M, 2011, FUNCT NEUROL, V26, P31; Sutoh T, 2000, CLIN NEUROPHYSIOL, V111, P858, DOI 10.1016/S1388-2457(99)00321-1; VANWINSUM W, 1984, ELECTROEN CLIN NEURO, V58, P519, DOI 10.1016/0013-4694(84)90042-7; Vazquez-Marrufo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062523; Walhovd KB, 2002, INT J PSYCHOPHYSIOL, V46, P29, DOI 10.1016/S0167-8760(02)00039-9; Wright D, 2015, PSYCHOPHYSIOLOGY, V52, P638, DOI 10.1111/psyp.12399	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187244	10.1371/journal.pone.0187244	http://dx.doi.org/10.1371/journal.pone.0187244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088307	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900053
J	Han, YJ; Kim, YS; Hwang, OJ; Roh, J; Ganguly, K; Kim, SK; Hwang, I; Kim, JI				Han, Yun-Jeong; Kim, Young Soon; Hwang, Ok-Jin; Roh, Jeehee; Ganguly, Keya; Kim, Seong-Ki; Hwang, Ildoo; Kim, Jeong-Il			Overexpression of Arabidopsis thaliana brassinosteroid-related acyltransferase 1 gene induces brassinosteroid-deficient phenotypes in creeping bentgrass	PLOS ONE			English	Article							PUTATIVE ACYLTRANSFERASE; DROUGHT TOLERANCE; BIOSYNTHESIS; HOMEOSTASIS; MUTANT; CYTOCHROME-P450; CYP72C1; PROTEIN; INACTIVATION; ACTIVATION	Brassinosteroids (BRs) are naturally occurring steroidal hormones that play diverse roles in various processes during plant growth and development. Thus, genetic manipulation of endogenous BR levels might offer a way of improving the agronomic traits of crops, including plant architecture and stress tolerance. In this study, we produced transgenic creeping bentgrass (Agrostis stolonifera L.) overexpressing a BR-inactivating enzyme, Arabidopsis thaliana BR-related acyltransferase 1 (AtBAT1), which is known to catalyze the conversion of BR intermediates to inactive acylated conjugates. After putative transgenic plants were selected using herbicide resistance assay, genomic integration of the AtBAT1 gene was confirmed by genomic PCR and Southern blot analysis, and transgene expression was validated by northern blot analysis. The transgenic creeping bentgrass plants exhibited BR-deficient phenotypes, including reduced plant height with shortened internodes (i.e., semi-dwarf), reduced leaf growth rates with short, wide, and thick architecture, high chlorophyll contents, decreased numbers of vascular bundles, and large lamina joint bending angles (i.e., erect leaves). Subsequent analyses showed that the transgenic plants had significantly reduced amounts of endogenous BR intermediates, including typhasterol, 6-deoxocastasterone, and castasterone. Moreover, the AtBAT1 transgenic plants displayed drought tolerance as well as delayed senescence. Therefore, the results of the present study demonstrate that overexpression of an Arabidopsis BR-inactivating enzyme can reduce the endogenous levels of BRs in creeping bentgrass resulting in BR-deficient phenotypes, indicating that the AtBAT1 gene from a dicot plant is also functional in the monocot crop.	[Han, Yun-Jeong; Kim, Young Soon; Hwang, Ok-Jin; Ganguly, Keya; Kim, Jeong-Il] Chonnam Natl Univ, Dept Biotechnol, Gwangju, South Korea; [Han, Yun-Jeong; Kim, Young Soon; Hwang, Ok-Jin; Ganguly, Keya; Kim, Jeong-Il] Chonnam Natl Univ, Kumho Life Sci Lab, Gwangju, South Korea; [Roh, Jeehee; Kim, Seong-Ki] Chung Ang Univ, Dept Life Sci, Seoul, South Korea; [Hwang, Ildoo] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Hwang, Ildoo] Pohang Univ Sci & Technol, Biotechnol Res Ctr, Pohang, South Korea	Chonnam National University; Chonnam National University; Chung Ang University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, JI (corresponding author), Chonnam Natl Univ, Dept Biotechnol, Gwangju, South Korea.; Kim, JI (corresponding author), Chonnam Natl Univ, Kumho Life Sci Lab, Gwangju, South Korea.	kimji@jnu.ac.kr		Kim, Jeong-Il/0000-0003-4177-4048; Ganguly, Keya/0000-0002-0235-6313	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01104001, PJ011132, PJ01184402]; Chonnam National University	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Chonnam National University	This work was supported by Next-Generation BioGreen 21 Program (http://ssac.gnu.ac.kr), Rural Development Administration, Republic of Korea (Grant nos. PJ01104001 to J.-I. Kim; PJ011132 to S.-K. Kim; PJ01184402 to I. Hwang). In addition, this study was financially supported by Chonnam National University, 2016-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; Belkhadir Y, 2015, NEW PHYTOL, V206, P522, DOI 10.1111/nph.13269; Bishop GJ, 2002, PLANT CELL, V14, pS97, DOI 10.1105/tpc.001461; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Cho KC, 2011, PLANT PATHOL, V60, P631, DOI 10.1111/j.1365-3059.2011.02433.x; Choi S, 2013, PLANT J, V73, P380, DOI 10.1111/tpj.12036; Choi YS, 2013, PLANT BIOTECHNOL REP, V7, P165, DOI 10.1007/s11816-012-0245-0; Choudhary SP, 2012, TRENDS PLANT SCI, V17, P594, DOI 10.1016/j.tplants.2012.05.012; Chung Y, 2013, CRIT REV PLANT SCI, V32, P396, DOI 10.1080/07352689.2013.797856; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Divi UK, 2016, PLANT BIOTECHNOL J, V14, P419, DOI 10.1111/pbi.12396; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Feng ZM, 2016, J EXP BOT, V67, P4241, DOI 10.1093/jxb/erw204; Ferrero-Serrano A, 2016, J EXP BOT, V67, P3433, DOI 10.1093/jxb/erw183; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Ganesan M, 2012, PLANTA, V236, P1135, DOI 10.1007/s00425-012-1662-6; Han YJ, 2015, PLANT CELL REP, V34, P265, DOI 10.1007/s00299-014-1705-5; Han YJ, 2012, PLANT CELL REP, V31, P1677, DOI 10.1007/s00299-012-1280-6; Han YJ, 2009, PLANT CELL REP, V28, P397, DOI 10.1007/s00299-008-0648-0; Husar S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-51; Kagale S, 2007, PLANTA, V225, P353, DOI 10.1007/s00425-006-0361-6; Kim BK, 2008, BIOCHEM BIOPH RES CO, V374, P614, DOI 10.1016/j.bbrc.2008.07.073; Kim SJ, 2007, J PLANT BIOL, V50, P577, DOI 10.1007/BF03030712; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; Kutschera U, 2012, J EXP BOT, V63, P3511, DOI 10.1093/jxb/ers065; Marsolais F, 2007, PLANTA, V225, P1233, DOI 10.1007/s00425-006-0413-y; Matsumoto Tadashi, 2013, Plants-Basel, V2, P521, DOI 10.3390/plants2030521; Mussig C, 2005, PLANT BIOLOGY, V7, P110, DOI 10.1055/s-2005-837493; Nakamura M, 2005, J EXP BOT, V56, P833, DOI 10.1093/jxb/eri073; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Northey JGB, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.114, 10.1038/nplants.2016.114]; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Roh H, 2012, PLANT PHYSIOL, V159, P696, DOI 10.1104/pp.112.197202; Rouleau M, 1999, J BIOL CHEM, V274, P20925, DOI 10.1074/jbc.274.30.20925; Sade D, 2014, PLANT PHYSIOL, V165, P1684, DOI 10.1104/pp.114.243402; Saini S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00950; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sakamoto T, 2004, CURR OPIN BIOTECH, V15, P144, DOI 10.1016/j.copbio.2004.02.003; Schneider K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046805; Schroder F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0309-0; Singh AP, 2015, J EXP BOT, V66, P1123, DOI 10.1093/jxb/erv026; Symons GM, 2004, PLANT PHYSIOL, V135, P2196, DOI 10.1104/pp.104.043034; Takahashi N, 2005, PLANT J, V42, P13, DOI 10.1111/j.1365-313X.2005.02357.x; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Thornton LE, 2010, PLANT MOL BIOL, V74, P167, DOI 10.1007/s11103-010-9663-y; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; Vriet C, 2012, PLANT CELL, V24, P842, DOI 10.1105/tpc.111.094912; WADA K, 1981, PLANT CELL PHYSIOL, V22, P323; Wang MJ, 2012, J EXP BOT, V63, P5787, DOI 10.1093/jxb/ers227; Warnke S., 2003, TURFGRASS BIOL GENET, P175; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Yang CJ, 2011, MOL PLANT, V4, P588, DOI 10.1093/mp/ssr020; Yu XH, 2009, PLANT MOL BIOL, V70, P421, DOI 10.1007/s11103-009-9482-1; Zhang C, 2014, PLANT CELL REP, V33, P683, DOI 10.1007/s00299-014-1578-7; Zhao BL, 2012, J INTEGR PLANT BIOL, V54, P746, DOI 10.1111/j.1744-7909.2012.01168.x; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702; Zhu JY, 2013, DEVELOPMENT, V140, P1615, DOI 10.1242/dev.060590; Zhu WJ, 2013, MOL PLANT, V6, P546, DOI 10.1093/mp/sss144	61	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187378	10.1371/journal.pone.0187378	http://dx.doi.org/10.1371/journal.pone.0187378			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084267	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200054
J	Wang, JL; Xu, D; Zhou, H; Bai, AN; Lu, W				Wang, Jianlin; Xu, Dan; Zhou, Huan; Bai, Anning; Lu, Wei			High-performance fractional order terminal sliding mode control strategy for DC-DC Buck converter	PLOS ONE			English	Article							LYAPUNOV FUNCTIONS; SYSTEMS	This paper presents an adaption of the fractional order terminal sliding mode control (AFTSMC) strategy for DC-DC Buck converter. The following strategy aims to design a novel nonlinear sliding surface function, with a double closed-loop structure of voltage and current. This strategy is a fusion of two characteristics: terminal sliding mode control (TSMC) and fractional order calculation (FOC). In addition, the influence of "the controller parameters" on the "performance of double closed-loop system" is investigated. It is observed that the value of terminal power has to be chosen to make a compromise between start-up and transient response of the converter. Therefore the AFTSMC strategy chooses the value of the terminal power adaptively, and this strategy can lead to the appropriate number of fractional order as well. Furthermore, through the fractional order analysis, the system can reach the sliding mode surface in a finite time. And the theoretical considerations are verified by numerical simulation. The performance of the AFTSMC and TSMC strategies is tested by computer simulations. And the comparison simulation results show that the AFTSMC exhibits a considerable improvement in terms of a faster output voltage response during load changes. Moreover, AFTSMC obtains a faster dynamical response, smaller steady-state error rate and lower overshoot.	[Wang, Jianlin; Xu, Dan; Zhou, Huan; Lu, Wei] Xi An Jiao Tong Univ, Dept Mech Elect Engn, Xian, Shanxi, Peoples R China; [Wang, Jianlin; Bai, Anning] Ningxia Med Univ, Dept Coll Sci, Ningxia, Peoples R China	Xi'an Jiaotong University; Ningxia Medical University	Xu, D (corresponding author), Xi An Jiao Tong Univ, Dept Mech Elect Engn, Xian, Shanxi, Peoples R China.	xudan@xjtu.edu.cn		wang, jianlin/0000-0002-5372-0381	National Natural Science Foundation of China [51275379]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been funded by the National Natural Science Foundation of China (grant no. 51275379), http://www.nsfc.gov.cn.	Aguila-Camacho N, 2014, COMMUN NONLINEAR SCI, V19, P2951, DOI 10.1016/j.cnsns.2014.01.022; Delavari H, 2010, COMMUN NONLINEAR SCI, V15, P963, DOI 10.1016/j.cnsns.2009.05.025; Delghavi MB, 2016, IEEE T SUSTAIN ENERG, V7, P1482, DOI 10.1109/TSTE.2016.2564105; Gallegos JA, 2016, APPL MATH COMPUT, V287, P161, DOI 10.1016/j.amc.2016.04.039; Hosseinnia SH, 2012, SIGNAL IMAGE VIDEO P, V6, P445, DOI 10.1007/s11760-012-0318-0; Komurcugil H, 2012, ISA T, V51, P673, DOI 10.1016/j.isatra.2012.07.005; Li HY, 2017, IEEE T CYBERNETICS, V47, P1041, DOI 10.1109/TCYB.2016.2536750; Li Y, 2010, COMPUT MATH APPL, V59, P1810, DOI 10.1016/j.camwa.2009.08.019; Lorentz VRH, 2010, ANALOG INTEGR CIRC S, V62, P333, DOI 10.1007/s10470-009-9365-z; Ningning Yang, 2016, Mathematical Problems in Engineering, V2016, DOI 10.1155/2016/6835910; Oldham KB., 1974, FRACTIONAL CALCULUS; Ramos R, 2013, CONTROL ENG PRACT, V21, P737, DOI 10.1016/j.conengprac.2012.09.005; Ren GD, 2017, NONLINEAR DYNAM, V88, P893, DOI 10.1007/s11071-016-3283-2; Tan S., 2012, IEEE IND ELECT MAG, V38, P203; Tan SC, 2005, IEEE T POWER ELECTR, V20, P425, DOI 10.1109/TPEL.2004.842977; Wang CN, 2015, COMPLEXITY, V21, P370, DOI 10.1002/cplx.21572; Wang JX, 2015, IET CONTROL THEORY A, V9, P579, DOI 10.1049/iet-cta.2014.0220; Wang Yan-min, 2016, Electric Machines and Control, V20, P92, DOI 10.15938/j.emc.2016.08.012; Wu CJ, 2015, NONLINEAR DYNAM, V79, P689, DOI 10.1007/s11071-014-1695-4; Wu GC, 2017, APPL MATH COMPUT, V314, P228, DOI 10.1016/j.amc.2017.06.019; Wu GC, 2016, PHYSICA A, V460, P374, DOI 10.1016/j.physa.2016.05.045; Wu KC, 2015, IEEE T CIRCUITS-II, V62, P1194, DOI 10.1109/TCSII.2015.2469032	22	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187152	10.1371/journal.pone.0187152	http://dx.doi.org/10.1371/journal.pone.0187152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084255	gold, Green Published, Green Submitted			2022-12-27	WOS:000413910200035
J	Kerekes, A; Hoffmann, OI; Iski, G; Liptak, N; Gocza, E; Kues, WA; Bosze, Z; Hiripi, L				Kerekes, Andrea; Hoffmann, Orsolya Ivett; Iski, Gergely; Liptak, Nandor; Gocza, Elen; Kues, Wilfried A.; Bosze, Zsuzsanna; Hiripi, Laszlo			Secretion of a recombinant protein without a signal peptide by the exocrine glands of transgenic rabbits	PLOS ONE			English	Article							NONSPECIFIC ALKALINE-PHOSPHATASE; CLOTTING FACTOR-VIII; MAMMARY-GLAND; PROMOTER DIRECTS; EXPRESSION; MILK; MICE; PIGS; SHEEP; ACID	Transgenic rabbits carrying mammary gland specific gene constructs are extensively used for excreting recombinant proteins into the milk. Here, we report refined phenotyping of previously generated Venus transposon-carrying transgenic rabbits with particular emphasis on the secretion of the reporter protein by exocrine glands, such as mammary, salivary, tear and seminal glands. The Sleeping Beauty (SB) transposon transgenic construct contains the Venus fluorophore cDNA, but without a signal peptide for the secretory pathway, driven by the ubiquitous CAGGS (CAG) promoter. Despite the absence of a signal peptide, the fluorophore protein was readily detected in milk, tear, saliva and seminal fluids. The expression pattern was verified by Western blot analysis. Mammary gland epithelial cells of SBCAG-Venus transgenic lactating does also showed Venus-specific expression by tissue histology and fluorescence microscopy. In summary, the SB-CAG-Venus transgenic rabbits secrete the recombinant protein by different glands. This finding has relevance not only for the understanding of the biological function of exocrine glands, but also for the design of constructs for expression of recombinant proteins in dairy animals.	[Kerekes, Andrea; Hoffmann, Orsolya Ivett; Iski, Gergely; Liptak, Nandor; Gocza, Elen; Bosze, Zsuzsanna; Hiripi, Laszlo] NARIC Agr Biotechnol Inst, Dept Anim Biotechnol, Godollo, Hungary; [Kues, Wilfried A.] Friedrich Loeffler Inst, Inst Nutztiergenet, Dept Biotechnol, Neustadt, Germany	Friedrich Loeffler Institute	Hiripi, L (corresponding author), NARIC Agr Biotechnol Inst, Dept Anim Biotechnol, Godollo, Hungary.	hiripi1@gmail.com	Hiripi, Laszlo/AAL-8243-2021; Bosze, Zsuzsanna/N-9689-2019; Lipták, Nándor/ABD-1954-2021; Gocza, Elen/C-9883-2014; Gocza, Elen/A-8838-2012	Hiripi, Laszlo/0000-0002-1023-0112; Gocza, Elen/0000-0001-7720-4720; Gocza, Elen/0000-0001-7720-4720; Liptak, Nandor/0000-0002-9406-1482; Kues, Wilfried/0000-0002-0850-8103	(OTKA) National Research, Development and Innovation Office (NKFIH) NN grant [108921, PD 120870, NN 113162]	(OTKA) National Research, Development and Innovation Office (NKFIH) NN grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by (OTKA) National Research, Development and Innovation Office (NKFIH) NN grant no. 108921 to ZB, grant no. PD 120870 to LN and grant no. NN 113162 to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranyi M, 2007, J BIOTECHNOL, V128, P383, DOI 10.1016/j.jbiotec.2006.10.016; Bender B, 2015, PHYSIOL RES, V64, P731, DOI 10.33549/physiolres.932946; Bodrogi L, 2006, TRANSGENIC RES, V15, P627, DOI 10.1007/s11248-006-9015-5; Boutinaud M, 2002, REPROD NUTR DEV, V42, P133, DOI 10.1051/rnd:2002013; BUHLER TA, 1990, BIO-TECHNOL, V8, P140, DOI 10.1038/nbt0290-140; Dyck MK, 1999, NAT BIOTECHNOL, V17, P1087, DOI 10.1038/15067; Franscini N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000071; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023573; Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788; Gordon K, 1992, Biotechnology, V24, P425; Guan LZ, 2015, TRANSGENIC RES, V24, P489, DOI 10.1007/s11248-015-9863-y; Guan LZ, 2013, TRANSGENIC RES, V22, P805, DOI 10.1007/s11248-012-9682-3; Hiripi L, 2003, DNA CELL BIOL, V22, P41, DOI 10.1089/104454903321112488; Hoffmann OI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154489; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Ivics Z, 2014, NAT PROTOC, V9, P794, DOI 10.1038/nprot.2014.009; Katter K, 2013, FASEB J, V27, P930, DOI 10.1096/fj.12-205526; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; LeJan C, 1996, VET RES, V27, P403; MIKKELSEN TR, 1992, NUCLEIC ACIDS RES, V20, P2249, DOI 10.1093/nar/20.9.2249; MIRCHEFF AK, 1994, INT OPHTHALMOL CLIN, V34, P1, DOI 10.1097/00004397-199403410-00003; MUKHERJEE A, 2016, SCI REP, V6, P31140; Niemann H, 1999, TRANSGENIC RES, V8, P237, DOI 10.1023/A:1008999622117; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OWERBACH D, 1980, GENETICS, V95, P129; PITTIUS CW, 1988, P NATL ACAD SCI USA, V85, P5874, DOI 10.1073/pnas.85.16.5874; SIMONS JP, 1987, NATURE, V328, P530, DOI 10.1038/328530a0; Trousdale Melvin D, 2005, J Autoimmune Dis, V2, P6, DOI 10.1186/1740-2557-2-6; Van Cott KE, 1999, GENET ANAL-BIOMOL E, V15, P155, DOI 10.1016/S1050-3862(99)00020-0; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wells GAH, 2003, J GEN VIROL, V84, P1021, DOI 10.1099/vir.0.18788-0; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Zhou Q, 2005, J BIOTECHNOL, V117, P57, DOI 10.1016/j.jbiotec.2005.01.001	33	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187214	10.1371/journal.pone.0187214	http://dx.doi.org/10.1371/journal.pone.0187214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077768	Green Submitted, Green Published, gold			2022-12-27	WOS:000413861200053
J	Reiger, S; Jardim, TV; Abrahams-Gessel, S; Crowther, NJ; Wade, A; Gomez-Olive, FX; Salomon, J; Tollman, S; Gaziano, TA				Reiger, Sheridan; Jardim, Thiago Veiga; Abrahams-Gessel, Shafika; Crowther, Nigel J.; Wade, Alisha; Gomez-Olive, F. Xavier; Salomon, Joshua; Tollman, Stephen; Gaziano, Thomas A.			Awareness, treatment, and control of dyslipidemia in rural South Africa: The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) study	PLOS ONE			English	Article							RISK; COUNTRIES; DISEASES	Dyslipidemia is a primary driver for chronic cardiovascular conditions and there is no comprehensive literature about its management in South Africa. The objective of this study was to assess the prevalence, awareness, treatment, and control of dyslipidemia in rural South Africa and how they are impacted by different behaviors and non-modifiable factors. To fulfill this objective we recruited for this cohort study adults aged >= 40 years residing in the Agin-court sub-district of Mpumalanga Province. Data collection included socioeconomic and clinical data, anthropometric measures, blood pressure (BP), HIV-status, point-of-care glucose and lipid levels. Framingham CVD Risk Score was ascribed to patients based upon categories for 10 year cardiovascular risk of low (<3%), moderate (>= 3% and <15%), high (>= 15% and <30%), and very high (>= 30%).LDL cholesterol control by risk category was defined according to South African Guidelines. Multivariable logistic regression models were built to identify factors that were significantly associated with dyslipidemia and awareness of dyslipidemia From 5,059 respondents a total of 4247 subjects (83.9%) had their cholesterol levels measured and were included in our analysis. Overall, 67.3% (2860) of these met criteria for dyslipidemia, only 30 (1.05%) were aware of their condition, and only 21 subjects (0.73%) were on treatment. The majority have abnormalities in triglycerides (59.3%). As cardiovascular risk increased the rates of lipid control according to LDL level dropped. Multivariate logistic regression analyses showed that being overweight was predictive of dyslipidemia (OR 1.76; 95% CI 1.51-2.05, p<0.001) and dyslipidemia awareness (OR 2.58; 95% CI 1.19-5.58; p = 0.017). In conclusion, the very low awareness and treatment of dyslipidemia in this cohort indicate a greater need for systematic screening and education within the population and demonstrate that there are multiple opportunities to allay this burden.	[Reiger, Sheridan; Jardim, Thiago Veiga; Gaziano, Thomas A.] Brigham & Womens Hosp, Dept Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Jardim, Thiago Veiga; Abrahams-Gessel, Shafika; Gaziano, Thomas A.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA; [Crowther, Nigel J.] Univ Witwatersrand, Natl Hlth Lab Serv, Johannesburg, South Africa; [Crowther, Nigel J.] Univ Witwatersrand, Dept Chem Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Wade, Alisha; Gomez-Olive, F. Xavier; Tollman, Stephen] Univ Witwatersrand, Med Res Council, Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth,Fac Hlth Sci, Johannesburg, South Africa; [Salomon, Joshua] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; South African Medical Research Council; University of Witwatersrand; Harvard University; Harvard T.H. Chan School of Public Health	Jardim, TV; Gaziano, TA (corresponding author), Brigham & Womens Hosp, Dept Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.; Jardim, TV; Gaziano, TA (corresponding author), Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA.	tdesouzaveigajardim@bwh.harvard.edu; tgaziano@bwh.harvard.edu	Gómez-Olivé, Francesc Xavier/AAP-7673-2021; Salomon, Joshua/S-1929-2019; Jardim, Thiago V/I-9095-2018	Gómez-Olivé, Francesc Xavier/0000-0002-4876-0848; Salomon, Joshua/0000-0003-3929-5515; Jardim, Thiago V/0000-0002-7750-2792; Wade, Alisha/0000-0002-1158-2523; Crowther, Nigel/0000-0002-5766-1745; Tollman, Stephen/0000-0003-0744-7588	National Institute on Aging within Agincourt Health and Demographic Surveillance System [P01 AG041710]; University of the Witwatersrand and Medical Research Council, South Africa; Wellcome Trust, UK [058893/A/99A, 069683/Z/02/Z, 085477/Z08/Z]; Fogarty International Center of the National Institutes of Health [K43TW010698]; FOGARTY INTERNATIONAL CENTER [K43TW010698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG041710] Funding Source: NIH RePORTER	National Institute on Aging within Agincourt Health and Demographic Surveillance System; University of the Witwatersrand and Medical Research Council, South Africa; Wellcome Trust, UK(Wellcome Trust); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The HAALSI study, funded by the National Institute on Aging (P01 AG041710), is nested within the Agincourt Health and Demographic Surveillance System site, funded by the University of the Witwatersrand and Medical Research Council, South Africa, and the Wellcome Trust, UK (058893/A/99A; 069683/Z/02/Z; 085477/Z08/Z). The HAALSI study has been carried out through a collaboration between the Harvard Center for Population and Development Studies from the Harvard T.H. Chan School of Public Health, the MRC/Wits Rural Public Health and Health Transitions Research Unit from the School of Public Health at the University of the Witwatersrand in South Africa, and the INDEPTH Network in Accra, Ghana. AW is supported by the Fogarty International Center of the National Institutes of Health under Award Number K43TW010698. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achterberg S, 2012, EUR J PREV CARDIOL, V19, P5, DOI 10.1177/1741826710391117; Barquera S, 2015, ARCH MED RES, V46, P328, DOI 10.1016/j.arcmed.2015.06.006; Church K, 2015, B WORLD HEALTH ORGAN, V93, P457, DOI 10.2471/BLT.14.147215; Cohen M, 2006, DIABETES RES CLIN PR, V71, P113, DOI 10.1016/j.diabres.2005.05.013; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Ferreira CED, 2015, CLIN CHIM ACTA, V446, P263, DOI 10.1016/j.cca.2015.04.036; Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Gaziano TA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4117-y; Grover SA, 2005, AM J CARDIOL, V95, P586, DOI 10.1016/j.amjcard.2004.11.004; Jardim TV, 2017, J HYPERTENS, V35, P1283, DOI 10.1097/HJH.0000000000001312; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Klug EQ, 2015, S AFR FAM PRACT, V57, P22; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023; Maimela E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147926; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Manning K, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i1.913; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Park PH, 2016, TROP MED INT HEALTH, V21, P437, DOI 10.1111/tmi.12653; Rutstein S. O., 2004, DHS WEALTH INDEX; Rutstein SO, 2014, STEPS TO CONSTRUCTIN; Shisana O, 2013, S AFRICAN NATL HLTH; Sundvall J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-63; The uses of epidemiology in the study of the elderly, 1984, WHO TECH REP SER, V706, P1; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Toth P P, 2003, J CLIN LIPI, V6, P325; WHO, 2015, CONSOLIDATED GUIDELI; World Health Organization, 2014, POL BRIEF CONS GUID; 2000, WHO TECHNICAL REPORT, V894	32	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187347	10.1371/journal.pone.0187347	http://dx.doi.org/10.1371/journal.pone.0187347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077762	gold, Green Published, Green Submitted			2022-12-27	WOS:000413861200059
J	Schmidt, LH; Heitkotter, B; Schulze, AB; Schliemann, C; Steinestel, K; Trautmann, M; Marra, A; Hillejan, L; Mohr, M; Evers, G; Wardelmann, E; Rahbar, K; Gorlich, D; Lenz, G; Berdel, WE; Hartmann, W; Wiewrodt, R; Huss, S				Schmidt, Lars Henning; Heitkoetter, Birthe; Schulze, Arik B.; Schliemann, Christoph; Steinestel, Konrad; Trautmann, Marcel; Marra, Alessandro; Hillejan, Ludger; Mohr, Michael; Evers, Georg; Wardelmann, Eva; Rahbar, Kambiz; Gorlich, Dennis; Lenz, Georg; Berdel, Wolfgang E.; Hartmann, Wolfgang; Wiewrodt, Rainer; Huss, Sebastian			Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED NEOVASCULATURE; MONOCLONAL-ANTIBODY J591; ADVANCED SOLID TUMORS; ENDOTHELIAL-CELLS; CD34; HYDROLASE; THERAPY; TARGET	Objectives PSMA (prostate-specific membrane antigen) is overexpressed in prostate cancer cells and is reported to be a promising target for antibody-based radioligand therapy in patients with metastasized prostate cancer. Since PSMA expression is not restricted to prostate cancer, the underlying study investigates PSMA expression in non-small cell lung cancer (NSCLC). Material and methods Immunohistochemistry was used to identify PSMA expression in n = 275 samples of NSCLC tissue specimens. By means of CD34 co-expression, the level of PSMA expression in tumor associated neovasculature was investigated. The impact of PSMA expression on clinicopathologic parameters and prognosis was evaluated. Results PSMA tumor cell expression in NSCLC is as low as 6% and was predominantly found in squamous cell carcinoma (p = 0.002). Neovascular PSMA expression was found in 49% of NSCLC. High neovascular PSMA expression was associated with higher tumor grading (G3/G4) (p < 0.001). Neither for PSMA tumor cell expression, nor for PSMA neovascular cell expression prognostic effects were found for the investigated NSCLC cases. Conclusion Here, we report on the expression of PSMA in NSCLC tissue samples. Against the background of a potential treatment with radiolabeled PSMA ligands, our data might serve for the future identification of patients who could benefit from this therapeutic option.	[Schmidt, Lars Henning; Schulze, Arik B.; Schliemann, Christoph; Mohr, Michael; Evers, Georg; Lenz, Georg; Berdel, Wolfgang E.; Wiewrodt, Rainer] Univ Hosp Muenster, Dept Med Hematol Oncol & Resp Med A, Munster, Germany; [Heitkoetter, Birthe; Steinestel, Konrad; Trautmann, Marcel; Wardelmann, Eva; Hartmann, Wolfgang; Huss, Sebastian] Univ Munster, Gerhard Domagk Inst Pathol, Munster, Germany; [Steinestel, Konrad] Bundeswehrkrankenhaus Ulm, Inst Pathol & Mol Pathol, Ulm, Germany; [Marra, Alessandro] Klinikum Bremen Ost, Dept Thorac Surg, Bremen, Germany; [Hillejan, Ludger] Niels Stensen Kliniken, Dept Thorac Surg, Ostercappeln, Germany; [Rahbar, Kambiz] Univ Hosp Munster, Dept Nucl Med, Munster, Germany; [Gorlich, Dennis] Westfaelische Wilhelms Univ Muenster, Inst Biostat & Clin Res, Munster, Germany; [Lenz, Georg] Univ Hosp Muenster, Translat Oncol, Munster, Germany; [Lenz, Georg] Cells Mot, Cluster Excellence EXC 1003, Munster, Germany	University of Munster; University of Munster; Ulm University; Military Hospital Ulm; Klinikum Bremen-Ost; University of Munster; University of Munster	Schmidt, LH (corresponding author), Univ Hosp Muenster, Dept Med Hematol Oncol & Resp Med A, Munster, Germany.	larshenning.sohmidt@ukmuenster.de	Trautmann, Marcel/B-4627-2015; Görlich, Dennis/C-8950-2012; Hartmann, Wolfgang/G-1893-2017	Trautmann, Marcel/0000-0002-5842-1196; Görlich, Dennis/0000-0002-2574-9419; Hartmann, Wolfgang/0000-0002-7609-5021; Schulze, Arik B/0000-0002-1644-3573; Steinestel, Konrad/0000-0002-6549-9848; Rahbar, Kambiz/0000-0002-4591-4055	Deutsche Forschungsgemeinschaft (Cluster of Excellence "Cells in Motion") [DFG EXC1003]	Deutsche Forschungsgemeinschaft (Cluster of Excellence "Cells in Motion")	The laboratories of W.E.B. and G.L. are supported by Deutsche Forschungsgemeinschaft (DFG EXC1003, Cluster of Excellence "Cells in Motion").	Ahmadzadehfar H, 2015, EJNMMI RES, V5, P1, DOI 10.1186/s13550-015-0114-2; Bander NH, 2003, J UROLOGY, V170, P1717, DOI 10.1097/01.ju.0000091655.77601.0c; Bostwick DG, 1998, CANCER-AM CANCER SOC, V82, P2256, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S; Carter RE, 1996, P NATL ACAD SCI USA, V93, P749, DOI 10.1073/pnas.93.2.749; Chang Sam S, 2004, Rev Urol, V6 Suppl 10, pS13; Chang SS, 1999, CLIN CANCER RES, V5, P2674; Chang SS, 1999, CANCER RES, V59, P3192; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; Evangelista L, 2016, EUROPEAN UROLOGY; FINA L, 1990, BLOOD, V75, P2417; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Foss CA, 2012, CURR MED CHEM, V19, P1346; Ghosh A, 2004, J CELL BIOCHEM, V91, P528, DOI 10.1002/jcb.10661; Godeiro Katyanne Dantas, 2006, J Carcinog, V5, P21, DOI 10.1186/1477-3163-5-21; Haberkorn U, 2016, CLIN CANCER RES, V22, P9, DOI 10.1158/1078-0432.CCR-15-0820; Heitkotter B, 2016, ONCOTARGET; Kratochwil C, 2016, J NUCL MED OFFICIAL; Milowsky MI, 2007, J CLIN ONCOL, V25, P540, DOI 10.1200/JCO.2006.07.8097; Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012; Pinto JT, 1996, CLIN CANCER RES, V2, P1445; Rahbar K, 2016, J NUCL MED, V57, P563, DOI 10.2967/jnumed.115.169243; Rajasekaran SA, 2003, MOL BIOL CELL, V14, P4835, DOI 10.1091/mbc.E02-11-0731; Schildhaus HU, 2011, HUM PATHOL, V42, P1667, DOI 10.1016/j.humpath.2010.12.025; SCHLINGEMANN RO, 1990, LAB INVEST, V62, P690; Siemerink MJ, 2012, ANGIOGENESIS, V15, P151, DOI 10.1007/s10456-011-9251-z; Von Hoff DD, 2016, CLIN CANCER RES, V22, P3157, DOI 10.1158/1078-0432.CCR-15-2548; Wang H, 2015, ADVANCES IN ENERGY SCIENCE AND EQUIPMENT ENGINEERING, P1371; Wernicke AG, 2011, ARCH PATHOL LAB MED, V135, P1486, DOI 10.5858/arpa.2010-0740-OA	28	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186280	10.1371/journal.pone.0186280	http://dx.doi.org/10.1371/journal.pone.0186280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077706	Green Published, gold			2022-12-27	WOS:000413861200010
J	Urban, J; Kuzu, G; Bowman, S; Scruggs, B; Henriques, T; Kingston, R; Adelmae, K; Tolstorukov, M; Larschan, E				Urban, Jennifer; Kuzu, Guray; Bowman, Sarah; Scruggs, Benjamin; Henriques, Telmo; Kingston, Robert; Adelmae, Karen; Tolstorukov, Michael; Larschan, Erica			Enhanced chromatin accessibility of the dosage compensated Drosophila mleale X-chromosome requires the CLAMP zinc finger protein	PLOS ONE			English	Article							MSL COMPLEX; GAGA FACTOR; GENE-EXPRESSION; POL-II; BINDING; TRANSCRIPTION; ORGANIZATION; REVEALS; NELF; ELONGATION	The essential process of dosage compensation is required to equalize gene expression of X-chromosome genes between males (XY) and females (XX). In Drosophila, the conserved Male-specific lethal (MSL) histone acetyltransferase complex mediates dosage compensation by increasing transcript levels from genes on the single male X-chromosome approximately two-fold. Consistent with its increased levels of transcription, the male X-chromosome has enhanced chromatin accessibility, distinguishing it from the autosomes. Here, we demonstrate that the non-sex-specific CLAMP (Chromatin-linked adaptor for MSL proteins) zinc finger protein that recognizes GA-rich sequences genome-wide promotes the specialized chromatin environment on the male X-chromosome and can act over long genomic distances (similar to 14 kb). Although MSL complex is required for increasing transcript levels of X-linked genes, it is not required for enhancing global male X-chromosome chromatin accessibility, and instead works cooperatively with CLAMP to facilitate an accessible chromatin configuration at its sites of highest occupancy. Furthermore, CLAMP regulates chromatin structure at strong MSL complex binding sites through promoting recruitment of the Nucleosome Remodeling Factor (NURF) complex. In contrast to the X-chromosome, CLAMP regulates chromatin and gene expression on autosomes through a distinct mechanism that does not involve NURF recruitment. Overall, our results support a model where synergy between a non-sex-specific transcription factor (CLAMP) and a sex-specific cofactor (MSL) creates a specialized chromatin domain on the male X-chromosome.	[Urban, Jennifer; Larschan, Erica] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Kuzu, Guray; Bowman, Sarah; Kingston, Robert; Tolstorukov, Michael] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Scruggs, Benjamin; Henriques, Telmo; Adelmae, Karen] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, Durham, NC USA; [Kingston, Robert] Harvard Med Sch, Dept Genet, Boston, MA USA; [Adelmae, Karen] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA	Brown University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Larschan, E (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.; Tolstorukov, M (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	tolstorukov@molbio.mgh.harvard.edu; Erica_Larschan@brown.edu		Urban, Jennifer/0000-0002-6621-8358; Adelman, Karen/0000-0001-5364-334X	NIH (NIGMS) [R01GM098461-1, F31GM108423]; American Cancer Society [123682-RSG-13-040-01-DMC]; Pew Biomedical Scholar Grant; NIH, National Institute of Environmental Health Sciences [Z01 ES101987]	NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); Pew Biomedical Scholar Grant; NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant numbers (NIGMS): https://www.nigms.nih.gov/Pages/defaultaspx, R01 to EL: R01GM098461-1 and F31 to JAU: F31GM108423; American Cancer Society: https://donate3.cancer.org/?campaign= search&gclid=CKK-hbDTIldMCFVOBswodqtcOKQ, Research Scholar Grant to EL: 123682-RSG-13-040-01-DMC; Pew Biomedical Scholar Grant, www.pewtrusts.org, Pew Scholars Grant to EL; Intramural Research Program of NIH, National Institute of Environmental Health Sciences to KA: Z01 ES101987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Alekeyenko AA, 2012, PLOS GENET, V8, P351, DOI 10.1371/journal.pgen.1002646; Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Bai X, 2007, GENETICS, V176, P1491, DOI 10.1534/genetics.107.071571; Bai XY, 2004, EMBO J, V23, P2853, DOI 10.1038/sj.emboj.7600299; BELOTE JM, 1980, GENETICS, V96, P165; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chereji RV, 2016, NUCLEIC ACIDS RES, V44, P1036, DOI 10.1093/nar/gkv978; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Disteche CM, 2012, ANNU REV GENET, V46, P537, DOI 10.1146/annurev-genet-110711-155454; Eeckhoute J, 2009, J CELL SCI, P122; Ellison CE, 2013, SCIENCE, V342, P846, DOI 10.1126/science.1239552; Emmert, 2013, FLYBASE HIGH THROUGH; Ferrari F, 2013, CELL REP, V5, P629, DOI 10.1016/j.celrep.2013.09.037; Fry CJ, 1999, J BIOL CHEM, V274, P29583, DOI 10.1074/jbc.274.42.29583; Fuda NJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005108; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Iwafuchi-Doi M, 2016, MOL CELL, V62, P79, DOI 10.1016/j.molcel.2016.03.001; Kaye EG, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00253-17; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Knight B, 2014, GENE DEV, V28, P1695, DOI 10.1101/gad.244434.114; Kuzu G, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006120; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larschan E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002830; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li J, 2013, MOL CELL, V50, P711, DOI 10.1016/j.molcel.2013.05.016; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Lomaev D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173602; Lott SE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000590; LUCCHESI JC, 1978, SCIENCE, V202, P711, DOI 10.1126/science.715437; Matzat LH, 2014, BBA-GENE REGUL MECH, V1839, P203, DOI 10.1016/j.bbagrm.2013.10.007; Melnikova L, 2004, P NATL ACAD SCI USA, V101, P14806, DOI 10.1073/pnas.0403959101; Mieczkowski J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11485; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Ramirez F, 2015, MOL CELL, V60, P146, DOI 10.1016/j.molcel.2015.08.024; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Soruco MML, 2013, GENE DEV, V27, P1551, DOI 10.1101/gad.214585.113; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Teif VB, 2014, GENOME RES, V24, P1285, DOI 10.1101/gr.164418.113; Tsai SY, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0082-4; Tsompana M, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-33; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Urban JA, 2016, CHROMOSOME RES, P1; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Vicoso B, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002078; Villa R, 2016, NATURE, V537, P244, DOI 10.1038/nature19338; Wang CI, 2013, NAT STRUCT MOL BIOL, V20, P202, DOI 10.1038/nsmb.2477; Wells MB, 2012, GENET RES INT, V2012, DOI 10.1155/2012/795069; Wolle D, 2016, MOL CELL BIOL; Wolle D, 2015, MOL CELL BIOL, V35, P3739, DOI 10.1128/MCB.00456-15; Xi YX, 2011, GENOME RES, V21, P718, DOI 10.1101/gr.117101.110; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8	61	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186855	10.1371/journal.pone.0186855	http://dx.doi.org/10.1371/journal.pone.0186855			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077765	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200026
J	Lambert, AS; Rothenbuhler, A; Charles, P; Brailly-Tabard, S; Trabado, S; Celestine, E; Durand, E; Fontaine, I; Miladi, L; Wicart, P; Bahi-Buisson, N; Linglart, A				Lambert, Anne-Sophie; Rothenbuhler, Anya; Charles, Perrine; Brailly-Tabard, Sylvie; Trabado, Severine; Celestine, Elisabeth; Durand, Emmanuel; Fontaine, Isabelle; Miladi, Lotfi; Wicart, Philippe; Bahi-Buisson, Nadia; Linglart, Agnes			Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility	PLOS ONE			English	Article							CEREBRAL-PALSY; TREAT OSTEOPENIA; CHILDREN; OSTEOPOROSIS; PAMIDRONATE; POPULATION; MANAGEMENT; MUTATIONS; MECP2; MASS	Background Classic Rett Syndrome (RS) is a disabling condition mainly caused by MECP2 mutations. Girls with RS are at risk of developing bone fragility and fractures at a young age which results in pain and may seriously impair quality of life. Objective To retrospectively assess the safety and efficacy of IV bisphosphonates on fracture, bone mineral density (BMD) and bone markers in RS girls with bone fragility. Methods RS girls received either IV pamidronate (n = 19) or IV zoledronate (n = 1) for 2 years. Results Of 20 patients studied (age: 12.5 years [6; 39]), 14 were non-ambulatory. The incidence of fracture decreased from 37 fractures in 20 patients, to 1 fracture during or after treatment (follow-up: 3.1 years [1.5; 5]). The spine BMD Z-score improved from -3.2 [-5.6; -0.1] to -2.2 [-3.8; 0.0], p = 0.0006. Most parents reported decreases in chronic pain and 2 patients started to walk. Urinary calcium excretion decreased from 0.7 [0.18; 1.5] to 0.2 [0.03; 0.67] mM/mM of creatinine (p = 0.0001). Pamidronate was well tolerated. Conclusion RS girls should be screened for impaired bone mineralization and preventive measures should be taken. In girls experiencing fractures, IV bisphosphonates constitute a beneficial adjuvant treatment to diminish the risk of fracture and restore bone density.	[Lambert, Anne-Sophie; Rothenbuhler, Anya; Linglart, Agnes] AP HP, Dept Pediat Endocrinol & Diabetol Children, Bicetre Paris Sud, Le Kremlin Bicetre, France; [Lambert, Anne-Sophie; Rothenbuhler, Anya; Linglart, Agnes] AP HP, Filiere OSCAR, Reference Ctr Rare Disorders Calcium & Phosphate, Le Kremlin Bicetre, France; [Lambert, Anne-Sophie; Rothenbuhler, Anya; Linglart, Agnes] Plateforme Expertise Malad Rares Paris Sud, Bicetre Paris Sud, Le Kremlin Bicetre, France; [Charles, Perrine] AP HP, Reference Ctr Intellectual Disabil, Dept Genet, Pitie Salpetriere Paris, Paris, France; [Brailly-Tabard, Sylvie; Trabado, Severine] AP HP, Dept Genet & Hormonol, Bicetre Paris Sud, Le Kremlin Bicetre, France; [Celestine, Elisabeth; Bahi-Buisson, Nadia] Necker Enfants Malad, AP HP, Rett Ctr, Paris, France; [Durand, Emmanuel] Univ Paris Saclay, CNRS, AP HP, Unit IR4M, Orsay, France; [Fontaine, Isabelle] IMP Marie Auxiliatrice, Draveil, France; [Miladi, Lotfi; Wicart, Philippe] Univ Paris 05, Sorbonne Paris Cite, Sch Med, Necker Enfants Malad,AP HP,Dept Pediat Orthoped, Paris, France; [Miladi, Lotfi; Wicart, Philippe] Necker Enfants Malad, AP HP, Reference Ctr Rare Disorders Calcium & Phosphate, Filiere OSCAR, Paris, France; [Bahi-Buisson, Nadia] Necker Enfants Malad, AP HP, Dept Pediat Neurol, Paris, France; [Bahi-Buisson, Nadia] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Lab Embryol & Genet Congenital Malformat, INSERM,UMR 1163, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lambert, AS (corresponding author), AP HP, Dept Pediat Endocrinol & Diabetol Children, Bicetre Paris Sud, Le Kremlin Bicetre, France.; Lambert, AS (corresponding author), AP HP, Filiere OSCAR, Reference Ctr Rare Disorders Calcium & Phosphate, Le Kremlin Bicetre, France.; Lambert, AS (corresponding author), Plateforme Expertise Malad Rares Paris Sud, Bicetre Paris Sud, Le Kremlin Bicetre, France.	anne-sophie.lambert@aphp.fr	Linglart, Agnès/A-8047-2016; Bahi-Buisson, Nadia/H-5207-2017	Linglart, Agnès/0000-0003-3455-002X; ANNE SOPHIE, LAMBERT/0000-0002-4232-3882; Bahi-Buisson, Nadia/0000-0002-5352-0929; Trabado, Severine/0000-0002-1925-1999				Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anderson A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-87; Bachrach LK, 2009, J CLIN ENDOCR METAB, V94, P400, DOI 10.1210/jc.2008-1531; Bahi-Buisson N, 2013, HAND CLINIC, V111, P281, DOI 10.1016/B978-0-444-52891-9.00031-2; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Boyce AM, 2014, PM&R, V6, P427, DOI 10.1016/j.pmrj.2013.10.009; Bronson WH, 2014, CURR OSTEOPOROS REP, V12, P446, DOI 10.1007/s11914-014-0239-7; Downs J, 2008, PEDIATRICS, V121, P540, DOI 10.1542/peds.2007-1641; Downs J, 2009, SPINE, V34, pE607, DOI 10.1097/BRS.0b013e3181a95ca4; Eladl A, 2011, PEDIATR RES, V70, P313, DOI 10.1038/pr.2011.538; Glaze DG, 2010, NEUROLOGY, V74, P909, DOI 10.1212/WNL.0b013e3181d6b852; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Henderson RC, 2002, J PEDIATR-US, V141, P644, DOI 10.1067/mpd.2002.128207; Jefferson A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146824; Lotan M, 2013, OSTEOPOROSIS INT, V24, P3059, DOI 10.1007/s00198-013-2423-5; Nakamura A, 2010, J DIABETES INVEST, V1, P208, DOI 10.1111/j.2040-1124.2010.00046.x; Oddy WH, 2007, J PEDIATR GASTR NUTR, V45, P582, DOI 10.1097/MPG.0b013e318073cbf7; Plotkin H, 2006, DEV MED CHILD NEUROL, V48, P709, DOI 10.1017/S0012162206001526; Roende G, 2011, J BONE MINER RES, V26, P2280, DOI 10.1002/jbmr.423; Roende G, 2011, PEDIATR RES, V69, P359, DOI 10.1203/PDR.0b013e31820bc6d3; Shapiro JR, 2010, PEDIATR RES, V68, P446, DOI 10.1203/PDR.0b013e3181f2edd2; Society of osteodensitometry, 2013, OSTEOPOROSIS; STEWART AF, 1982, NEW ENGL J MED, V306, P1136, DOI 10.1056/NEJM198205133061903; Tarquinio DC, 2012, NEUROLOGY, V79, P1653, DOI 10.1212/WNL.0b013e31826e9a70; Ward L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005324.pub2; Wort UU, 2013, DEV MED CHILD NEUROL, V55, P821, DOI 10.1111/dmcn.12178	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186941	10.1371/journal.pone.0186941	http://dx.doi.org/10.1371/journal.pone.0186941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073271	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400078
J	Baede, VO; Broens, EM; Spaninks, MP; Timmerman, AJ; Graveland, H; Wagenaar, JA; Duim, B; Hordijk, J				Baede, Valerie O.; Broens, Els M.; Spaninks, Mirlin P.; Timmerman, Arjen J.; Graveland, Haitske; Wagenaar, Jaap A.; Duim, Birgitta; Hordijk, Joost			Raw pet food as a risk factor for shedding of extended-spectrum beta-lactamase-producing Enterobacteriaceae in household cats	PLOS ONE			English	Article							AMPC-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; ANTIMICROBIAL SUSCEPTIBILITY; COMPANION ANIMALS; DOGS PREVALENCE; CTX-M; RESISTANCE; RELATEDNESS; CARRIAGE; PATTERNS	Background Close contact between pets and owners provides the opportunity for transmission of antimicrobial resistant organisms like extended-spectrum beta-lactamase (ESBL)/AmpC beta-lactamase (AmpC)-producing Enterobacteriaceae, posing a risk to public health. Objectives To investigate whether raw feed is a risk factor for household cats to shed ESBL-producing Enterobacteriaceae, a cohort study was designed. Additionally, raw and non-raw commercial pet food products were screened for the presence of ESBL-producing Enterobacteriaceae. Methods Weekly fecal samples of 17 cats in the control group and 19 cats in the exposed group were collected for three weeks and analyzed for the presence of ESBL-producing Enterobacteriaceae. Questionnaires were obtained to determine additional risk factors. Fecal samples were cultured on MacConkey agar supplemented with 1 mg/L cefotaxime. PCR and sequence analysis was used for screening for ESBL genes in suspected isolates. Pet food samples were cultured in LB broth supplemented with 1 mg/L cefotaxime and processed as described above. Results In the cohort study, ESBL-producing bacteria were isolated from 3 of 51 (5.9%) samples in the control group compared to 37 of 57 (89.5%) samples in the exposed group. A significant association was found between ESBL shedding and feeding raw pet food products (OR = 31.5). No other risk factors were identified in this study. ESBL-producing Enterobacteriaceae were isolated from 14 of 18 (77.8%) raw pet food products and 0 of 35 that no competing interests exist. non-raw pet food products. Conclusions This study shows a strong association between shedding of ESBL-producing bacteria in household cats and feeding raw pet food. Raw pet food was often contaminated with ESBL-producing Enterobacteriaceae.	[Baede, Valerie O.; Broens, Els M.; Spaninks, Mirlin P.; Timmerman, Arjen J.; Graveland, Haitske; Wagenaar, Jaap A.; Duim, Birgitta; Hordijk, Joost] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands; [Wagenaar, Jaap A.] Wageningen Biovet Res, Lelystad, Netherlands; [Baede, Valerie O.] Univ Med Ctr, Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Utrecht University; Wageningen University & Research; Erasmus University Rotterdam; Erasmus MC	Hordijk, J (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands.	j.hordijk@uu.nl		Baede, Valerie/0000-0002-0702-8263	animal production sectors, as part of the ESBL attribution project (ESBLAT) [TKI-AF-12067]; Dutch Ministry of Economic Affairs	animal production sectors, as part of the ESBL attribution project (ESBLAT); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This project was funded by the Dutch Ministry of Economic Affairs and the animal production sectors, as part of the ESBL attribution project (ESBLAT), grant number TKI-AF-12067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baede VO, 2015, ANTIMICROB AGENTS CH, V59, P3117, DOI 10.1128/AAC.04576-14; Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007; Blaak H, 2014, INT J FOOD MICROBIOL, V168, P8, DOI 10.1016/j.ijfoodmicro.2013.10.006; Carvalho AC, 2016, BRAZ J MICROBIOL, V47, P150, DOI 10.1016/j.bjm.2015.11.005; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Dahmen S, 2013, J ANTIMICROB CHEMOTH, V68, P2797, DOI 10.1093/jac/dkt291; Damborg P, 2012, VET MICROBIOL, V154, P298, DOI 10.1016/j.vetmic.2011.07.005; Damborg P, 2011, VET MICROBIOL, V151, P404, DOI 10.1016/j.vetmic.2011.03.015; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Hansen KH, 2013, APPL ENVIRON MICROB, V79, P794, DOI 10.1128/AEM.02399-12; Hordijk J, 2013, J ANTIMICROB CHEMOTH, V68, P2468, DOI 10.1093/jac/dkt219; Hordijk J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00242; Huber H, 2013, VET MICROBIOL, V162, P992, DOI 10.1016/j.vetmic.2012.10.029; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Johnson JR, 2008, J INFECT DIS, V197, P218, DOI 10.1086/524844; Korzeniewska E, 2013, J ENVIRON MANAGE, V128, P904, DOI 10.1016/j.jenvman.2013.06.051; Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008; Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13; Ljungquist Oskar, 2016, Infection Ecology & Epidemiology, V6, P31514, DOI 10.3402/iee.v6.31514; Maddox TW, 2012, EQUINE VET J, V44, P297, DOI 10.1111/j.2042-3306.2011.00440.x; Nijsse R, 2015, PARASITOL RES, V114, P561, DOI 10.1007/s00436-014-4218-9; Nilsson Oskar, 2015, Infection Ecology & Epidemiology, V5, P28758, DOI 10.3402/iee.v5.28758; Poeta P, 2009, J BASIC MICROB, V49, P584, DOI 10.1002/jobm.200900066; Schmidt VM, 2015, PREV VET MED, V119, P31, DOI 10.1016/j.prevetmed.2015.01.013; Schwarz S, 2010, J ANTIMICROB CHEMOTH, V65, P601, DOI 10.1093/jac/dkq037; Shaheen BW, 2011, ANTIMICROB AGENTS CH, V55, P5666, DOI 10.1128/AAC.00656-11; Stenske KA, 2009, AM J VET RES, V70, P1108, DOI 10.2460/ajvr.70.9.1108; Strohmeyer RA, 2006, JAVMA-J AM VET MED A, V228, P537, DOI 10.2460/javma.228.4.537; Sun Y, 2010, CLIN MICROBIOL INFEC, V16, P1475, DOI 10.1111/j.1469-0691.2010.03127.x; Wedley AL, 2017, VET MICROBIOL, V199, P23, DOI 10.1016/j.vetmic.2016.11.017; Weese JS, 2005, CAN VET J, V46, P513; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	33	39	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187239	10.1371/journal.pone.0187239	http://dx.doi.org/10.1371/journal.pone.0187239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095871	Green Published, Green Submitted			2022-12-27	WOS:000414340200060
J	Chen, YC; Ho, CC; Yi, CH; Liu, XZ; Cheng, TT; Lam, CF				Chen, Yen-Cheng; Ho, Ching-Chun; Yi, Chih-Hsun; Liu, Xiu-Zhu; Cheng, Tzu-Ting; Lam, Chen-Fuh			Exendin-4, a glucagon-like peptide-1 analogue accelerates healing of chronic gastric ulcer in diabetic rats	PLOS ONE			English	Article							ACETIC-ACID ULCER; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; MELLITUS; PROTEIN; MATRIX	Background Diabetes mellitus is an independent risk factor for impaired healing of peptic ulcers, and there are currently no supplementary therapeutics other than the standard antipeptic medicine to improve the ulcer healing in diabetes. This study examined the potential pleiotropic effect of a glucagon-like peptide (Glp)-1 analogue exendin (Ex)-4 on the regeneration of gastric ulcer in streptozotocin-induced diabetic rats. Methods and results Chronic ulcer was created in rat stomach by submucosal injection of acetic acid and peri-ulcer tissues were analyzed 7 days after operation. Ulcer wound healing was impaired in diabetic rats with suppressed tissue expression of eNOS and enhanced levels of pro-inflammatory reactions. Treatment with intraperitoneal injection of Ex4 (0.5 mu g/kg/d) significantly reduced the area of gastric ulcer without changing blood glucose level. Ex-4 restored the expression of pro-angiogenic factors, and attenuated the generation of regional inflammation and superoxide anions. The improvement of ulcer healing was associated with increased expression of MMP-2 and formation of granulation tissue in the peri-ulcer area. Conclusion Administration of Ex4 may induce pro-angiogenic, anti-inflammatory and anti-oxidative reactions in the peri-ulcer tissue of diabetic rats that eventually enhances tissue granulation and closure of ulcerative wounds. Our results support the potential clinical application of Glp-1 analogues as supplementary hypoglycemic agents in the antipeptic ulcer medication in diabetes.	[Chen, Yen-Cheng; Ho, Ching-Chun] Buddhist Tzu Chi Gen Hosp, Dept Surg, Hualien, Taiwan; [Yi, Chih-Hsun] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Liu, Xiu-Zhu; Lam, Chen-Fuh] Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Hualien, Taiwan; [Cheng, Tzu-Ting; Lam, Chen-Fuh] I Shou Univ, Dept Anesthesiol, E Da Hosp, E Da Canc Hosp, Kaohsiung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; E-Da Hospital; I Shou University	Lam, CF (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Hualien, Taiwan.; Lam, CF (corresponding author), I Shou Univ, Dept Anesthesiol, E Da Hosp, E Da Canc Hosp, Kaohsiung, Taiwan.	ed110208@edah.org.tw			Ministry of Science and Technology, Taiwan [MOST 105-2314-B-303-007-MY2]; Hualien Buddhist Tzu Chi General Hospital, Taiwan [TCRD105-07, TCRD105-06]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Hualien Buddhist Tzu Chi General Hospital, Taiwan	This work was supported, in part, by research grants obtained from the Ministry of Science and Technology, Taiwan (grant number MOST 105-2314-B-303-007-MY2 to C.F.L) and the Hualien Buddhist Tzu Chi General Hospital, Taiwan (grant numbers TCRD105-07 to Y.C.C and TCRD105-06 to C.F.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation ofthe manuscript.r This work was supported by research grants obtained from the Ministry of Science and Technology, Taiwan (grant number MOST 105-2314-B-303-007-MY2 to C.F.L) and the Hualien Buddhist Tzu Chi General Hospital, Taiwan (grant numbers TCRD105-07 to Y.C.C and TCRD105-06 to C.F.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122417; Arakawa T, 2012, WORLD J GASTROENTERO, V18, P4811, DOI 10.3748/wjg.v18.i35.4811; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1301, DOI 10.1016/j.freeradbiomed.2004.07.009; Bacci S, 2015, EUR J PHARMACOL, V764, P346, DOI 10.1016/j.ejphar.2015.06.056; Baraka AM, 2010, BIOCHEM PHARMACOL, V79, P1634, DOI 10.1016/j.bcp.2010.02.001; Berlanga-Acosta J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/256043; Boehme MWJ, 2007, HEPATO-GASTROENTEROL, V54, P643; Broide E, 2014, J CLIN ENDOCR METAB, V99, pE1691, DOI 10.1210/jc.2014-1114; Brzozowska I, 2004, J PHYSIOL PHARMACOL, V55, P773; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Fang SY, 2014, J VASC RES, V51, P81, DOI 10.1159/000357619; Fouad AA, 2010, EUR J PHARMACOL, V637, P162, DOI 10.1016/j.ejphar.2010.04.007; Gallwitz B, 2016, ENDOCR DEV, V31, P43, DOI 10.1159/000439372; Guha P, 2010, BRIT J PHARMACOL, V159, P726, DOI 10.1111/j.1476-5381.2009.00572.x; Harsch IA, 2003, EUR J PHARMACOL, V481, P249, DOI 10.1016/j.ejphar.2003.09.019; Kangwan Napapan, 2014, World J Gastrointest Pathophysiol, V5, P40, DOI 10.4291/wjgp.v5.i1.40; Kissow H, 2013, GUT, V62, P1724, DOI 10.1136/gutjnl-2012-303280; Kobayashi T, 2001, ATHEROSCLEROSIS, V155, P313, DOI 10.1016/S0021-9150(00)00583-9; Lempinen M, 2000, EUR SURG RES, V32, P169, DOI 10.1159/000008759; Lim JH, 2015, SURG ENDOSC, V29, P3666, DOI 10.1007/s00464-015-4123-z; Maity B, 2009, INT IMMUNOPHARMACOL, V9, P491, DOI 10.1016/j.intimp.2009.01.028; Mimura S, 2013, SCAND J GASTROENTERO, V48, P1152, DOI 10.3109/00365521.2013.832366; Newsholme P, 2016, BIOCHEM J, V473, P4527, DOI 10.1042/BCJ20160503C; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Okabe S, 2005, BIOL PHARM BULL, V28, P1321, DOI 10.1248/bpb.28.1321; OKABE S, 1972, AM J DIG DIS, V17, P619, DOI 10.1007/BF02231748; Peng YL, 2013, J GASTROEN HEPATOL, V28, P1295, DOI 10.1111/jgh.12190; Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945; Rao XQ, 2014, LIFE SCI, V116, P59, DOI 10.1016/j.lfs.2014.09.015; Rashed L, 2016, TISSUE CELL, V48, P644, DOI 10.1016/j.tice.2016.09.006; Roan JN, 2017, J SURG RES, V208, P93, DOI 10.1016/j.jss.2016.09.024; Scheen AJ, 2015, DIABETES METAB, V41, P183, DOI 10.1016/j.diabet.2015.02.003; Shahin M, 2001, MICROSC RES TECHNIQ, V53, P396, DOI 10.1002/jemt.1108; Smits MM, 2016, GUT, V65, P702, DOI 10.1136/gutjnl-2015-310572; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; Tseng PH, 2012, DIABETES CARE, V35, P1053, DOI 10.2337/dc11-1596	38	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187434	10.1371/journal.pone.0187434	http://dx.doi.org/10.1371/journal.pone.0187434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095895	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200089
J	Hwang, HJ; Hahne, JM; Muller, KR				Hwang, Han-Jeong; Hahne, Janne Mathias; Mueller, Klaus-Robert			Real-time robustness evaluation of regression based myoelectric control against arm position change and donning/doffing	PLOS ONE			English	Article							PATTERN-RECOGNITION; SURFACE EMG; CLASSIFICATION; ONLINE; FORCE; INFORMATION; KINEMATICS; MOVEMENTS; SIGNALS	There are some practical factors, such as arm position change and donning/doffing, which prevent robust myoelectric control. The objective of this study is to precisely characterize the impacts of the two representative factors on myoelectric controllability in practical control situations, thereby providing useful references that can be potentially used to find better solutions for clinically reliable myoelectric control. To this end, a real-time target acquisition task was performed by fourteen subjects including one individual with congenital upper-limb deficiency, where the impacts of arm position change, donning/doffing and a combination of both factors on control performance was systematically evaluated. The changes in online performance were examined with seven different performance metrics to comprehensively evaluate various aspects of myoelectric controllability. As a result, arm position change significantly affects offline prediction accuracy, but not online control performance due to real-time feedback, thereby showing no significant correlation between offline and online performance. Donning/doffing was still problematic in online control conditions. It was further observed that no benefit was attained when using a control model trained with multiple position data in terms of arm position change, and the degree of electrode shift caused by donning/doffing was not severely associated with the degree of performance loss under practical conditions (around 1 cm electrode shift). Since this study is the first to concurrently investigate the impacts of arm position change and donning/doffing in practical myoelectric control situations, all findings of this study provide new insights into robust myoelectric control with respect to arm position change and donning/doffing.	[Hwang, Han-Jeong] Kumoh Natl Inst Technol, Dept Med IT Convergence Engn, Gyeongbuk Do, Gumi, South Korea; [Hahne, Janne Mathias] Univ Med Ctr Goettingen, Dept Trauma Surg Orthoped Surg & Hand Surg, Neurorehabil Syst Res Grp, Gottingen, Germany; [Mueller, Klaus-Robert] TU Berlin, Berlin Inst Technol, Machine Learning Grp, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mueller, Klaus-Robert] Max Planck Inst Informat, Saarbrucken, Germany	Kumoh National University Technology; University of Gottingen; Technical University of Berlin; Korea University; Max Planck Society	Hwang, HJ (corresponding author), Kumoh Natl Inst Technol, Dept Med IT Convergence Engn, Gyeongbuk Do, Gumi, South Korea.; Muller, KR (corresponding author), TU Berlin, Berlin Inst Technol, Machine Learning Grp, Berlin, Germany.; Muller, KR (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.; Muller, KR (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	h2j@kumoh.ac.kr; klaus-robert.mueller@tu-berlin.de	Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685; Hwang, Han-Jeong/0000-0002-1183-1219	European Marie Currie IAPP grant 'AMYO' [251555]; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government [2017-0-00451]; Brain Korea 21 Plus Program; SGER through National Research Foundation of Korea (NRF) - Ministry of Education [2014055911]; DFG [DFG SPP 1527, MU 987/14-1)]	European Marie Currie IAPP grant 'AMYO'; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea); Brain Korea 21 Plus Program; SGER through National Research Foundation of Korea (NRF) - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); DFG(German Research Foundation (DFG))	This work was supported by the European Marie Currie IAPP grant 'AMYO' (project number 251555), and also supported by Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korea government (No. 2017-0-00451), the Brain Korea 21 Plus Program, and SGER Grant 2014055911 through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, and the DFG (DFG SPP 1527, MU 987/14-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuyi AA, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0246-x; Adewuyi AA, 2016, FRONT NEUROROBOTICS, V10, DOI 10.3389/fnbot.2016.00015; Adewuyi AA, 2016, IEEE T NEUR SYS REH, V24, P485, DOI 10.1109/TNSRE.2015.2424371; Ameri A, 2014, IEEE T NEUR SYS REH, V22, P1198, DOI 10.1109/TNSRE.2014.2323576; Ameri A, 2014, BIOMED SIGNAL PROCES, V13, P8, DOI 10.1016/j.bspc.2014.03.006; Ameri A, 2014, IEEE T BIO-MED ENG, V61, P279, DOI 10.1109/TBME.2013.2281595; Blair A, 2016, TRENT INT PROSTH S; Brantly NW, 2017, SIMULTANEOUS 2 DOF P; Castellini C, 2009, BIOL CYBERN, V100, P35, DOI 10.1007/s00422-008-0278-1; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Engelhart K, 1999, MED ENG PHYS, V21, P431, DOI 10.1016/S1350-4533(99)00066-1; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Farina D, 2014, IEEE T NEUR SYS REH, V22, P797, DOI 10.1109/TNSRE.2014.2305111; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fougner A, 2011, IEEE T NEUR SYS REH, V19, P644, DOI 10.1109/TNSRE.2011.2163529; Gauravkumar KP, 2016, J NEURAL ENG, V13; Geng YJ, 2012, IEEE ENG MED BIO, P2772, DOI 10.1109/EMBC.2012.6346539; Geng YJ, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-74; Hahne JM, 2014, IEEE T NEUR SYS REH, V22, P269, DOI 10.1109/TNSRE.2014.2305520; Hahne JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04255-x; Hahne JM, 2015, IEEE T NEUR SYS REH, V23, P618, DOI 10.1109/TNSRE.2015.2401134; Hahne JM, 2012, IEEE T BIO-MED ENG, V59, P1436, DOI 10.1109/TBME.2012.2188799; Hahne JM, 2016, THESIS; Hargrove L, 2008, BIOMED SIGNAL PROCES, V3, P175, DOI 10.1016/j.bspc.2007.11.005; Hargrove LJ, 2010, IEEE T NEUR SYS REH, V18, P49, DOI 10.1109/TNSRE.2009.2039590; Hofmann D, 2016, IEEE T NEUR SYS REH, V24, P1333, DOI 10.1109/TNSRE.2015.2501979; Hwang HJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056008; Jiang NF, 2013, IEEE ENG MED BIO, P1603, DOI 10.1109/EMBC.2013.6609822; Jiang N, 2014, IEEE T NEUR SYS REH, V22, P549, DOI 10.1109/TNSRE.2013.2287383; Jiang N, 2014, IEEE T NEUR SYS REH, V22, P501, DOI 10.1109/TNSRE.2013.2278411; Jiang N, 2013, MED BIOL ENG COMPUT, V51, P143, DOI 10.1007/s11517-012-0979-4; Jiang N, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-42; Jiang N, 2012, IEEE SIGNAL PROC MAG, V29, P147, DOI 10.1109/MSP.2012.2203480; Jiang N, 2009, IEEE T BIO-MED ENG, V56, P1070, DOI 10.1109/TBME.2008.2007967; Khushaba RN, 2014, NEURAL NETWORKS, V55, P42, DOI 10.1016/j.neunet.2014.03.010; Kuiken T, 2014, P MYOEL CONTR S MEC, P117; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lobo-Prat J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-68; Muceli S, 2014, IEEE T NEUR SYS REH, V22, P623, DOI 10.1109/TNSRE.2013.2282898; Muceli S, 2012, IEEE T NEUR SYS REH, V20, P371, DOI 10.1109/TNSRE.2011.2178039; Nielsen JLG, 2011, IEEE T BIO-MED ENG, V58, P681, DOI 10.1109/TBME.2010.2068298; Ortiz-Catalan M, 2013, IEEE ENG MED BIO, P6651, DOI 10.1109/EMBC.2013.6611081; Rehbaum H, 2012, IEEE ENG MED BIO, P1346, DOI 10.1109/EMBC.2012.6346187; Rickard B, 2013, P 34 INT C ART NEUR; Scheme E, 2011, IEEE ENG MED BIO, P4828, DOI 10.1109/IEMBS.2011.6091196; Scheme E, 2014, IEEE T NEUR SYS REH, V22, P149, DOI 10.1109/TNSRE.2013.2247421; Scheme E, 2011, J REHABIL RES DEV, V48, P643, DOI 10.1682/JRRD.2010.09.0177; Sebelius F., 2006, Journal of Medical Engineering & Technology, V30, P2, DOI 10.1080/03091900512331332546; Smith LH, 2011, IEEE T NEUR SYS REH, V19, P186, DOI 10.1109/TNSRE.2010.2100828; Sogaard K, 2006, J PHYSIOL-LONDON, V573, P511, DOI 10.1113/jphysiol.2005.103598; Stokes IAF, 2005, CLIN BIOMECH, V20, P9, DOI 10.1016/j.clinbiomech.2004.08.010; Sugiyama M, 2012, ADAPT COMPUT MACH LE, P1; Vidovic MMC, 2016, IEEE T NEUR SYS REH, V24, P961, DOI 10.1109/TNSRE.2015.2492619; von Bunau P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.214101; Wurth SM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-91; Young AJ, 2013, IEEE T BIO-MED ENG, V60, P1250, DOI 10.1109/TBME.2012.2232293; Young AJ, 2012, IEEE T BIO-MED ENG, V59, P645, DOI 10.1109/TBME.2011.2177662; Young AJ, 2011, IEEE T BIO-MED ENG, V58, P2537, DOI 10.1109/TBME.2011.2159216	58	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186318	10.1371/journal.pone.0186318	http://dx.doi.org/10.1371/journal.pone.0186318			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095846	gold, Green Published			2022-12-27	WOS:000414340200015
J	Fernandes, JR; Berthoud, TK; Kornai, A; Angel, JB				Fernandes, Jason R.; Berthoud, Tamara K.; Kornai, Ashok; Angel, Jonathan B.			IL-23 signaling in Th17 cells is inhibited by HIV infection and is not restored by HAART: Implications for persistent immune activation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERIC IG RECEPTOR; T-CELLS; PERIPHERAL-BLOOD; ROR-ALPHA; DIFFERENTIATION; EXPRESSION; INTERLEUKIN-17; RESPONSES; INDUCTION	Objectives HIV infection causes a profound depletion of gut derived Th17 cells, contributing to loss of mucosal barrier function and an increase in microbial translocation, thus driving systemic immune activation. Despite normalization of circulating CD4+ T cell counts with highly active antiretroviral therapy (HAART), Th17 frequency and function often remain impaired. Given the importance of interleukin (IL)-23 in the generation and stabilization of Th17 cells we hypothesized that impaired IL-23 signaling causes persistent Th17 dysfunction in HIV infection. Methods The effects of in vitro HIV infection on responses to IL-23 in Th17 cells were examined. These included the production of IL-17, phosphorylated STAT3 (pSTAT3) and the transcription of retinoic acid orphan receptor C (RORC) gene. Blood derived Th17 cells from untreated and HAART-treated HIV-infected individuals were also examined for the IL-23 induced production of phosphorylated STAT3 (pSTAT3) and the expression of the IL-23 receptors. Results In vitro HIV infection significantly inhibited IL-17 production and IL-23 induced pSTAT3 while expression of RORC RNA was unaffected. Th17 cells isolated from untreated and HAARTtreated HIV-infected individuals showed complete loss of IL-23 induced pSTAT3 without a decrease in the expression of the IL-23 receptors. Conclusions This study is the first to demonstrate an effect of HIV on the IL-23 signaling pathway in Th17 cells. We show that in vitro and in vivo HIV infection results in impaired IL-23 signaling which is not reversed by HAART nor is it a result of reduced receptor expression, suggesting that HIV interferes with IL-23-activated signaling pathways. These findings may explain the inability of HAART to restore Th17 frequency and function and the resulting persistent chronic immune activation observed in HIV infected individuals.	[Fernandes, Jason R.; Berthoud, Tamara K.; Angel, Jonathan B.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Fernandes, Jason R.; Berthoud, Tamara K.; Kornai, Ashok; Angel, Jonathan B.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Kornai, Ashok] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Angel, Jonathan B.] Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute	Angel, JB (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Angel, JB (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Angel, JB (corresponding author), Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada.	jangel@ohri.ca		Angel, Jonathan B/0000-0003-3102-4462	Canadian Institutes of Health Research Grant [HOP-98830]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant HOP-98830 to JBA and AK, http://wm.cihr-irsc.gc.cate/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Alvarez Y, 2013, J VIROL, V87, P10843, DOI 10.1128/JVI.01838-13; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Cao AT, 2012, J IMMUNOL, V189, P4666, DOI 10.4049/jimmunol.1200955; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Chege D, 2011, AIDS, V25, P741, DOI 10.1097/QAD.0b013e328344cefb; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cheng SM, 2009, BLOOD, V113, P5192, DOI 10.1182/blood-2008-10-183525; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Crome SQ, 1950, J IMMUNOL BALTIM MD, V185; Dandekar S, 2010, CURR OPIN HIV AIDS, V5, P173, DOI 10.1097/COH.0b013e328335eda3; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Duan MC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/898053; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Gordon SN, 2010, J IMMUNOL, V185, P5169, DOI 10.4049/jimmunol.1001801; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; He Y, 2012, AIDS RES HUM RETROV, V28, P339, DOI [10.1089/aid.2011.0140, 10.1089/AID.2011.0140]; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Honda M, 1950, J IMMUNOL BALTIM MD, V148; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Kim CJ, 2013, J IMMUNOL, V191, P2164, DOI 10.4049/jimmunol.1300829; Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Le Saout C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003976; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lurati A, 2015, OPEN ACCESS RHEUMATO, V7, P63, DOI 10.2147/OARRR.S81905; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Mat NFC, 2011, J INTERF CYTOK RES, V31, P363, DOI 10.1089/jir.2010.0083; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Miller RC, 2011, EUR J IMMUNOL, V41, P1058, DOI 10.1002/eji.201041198; Monteleone I, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/297645; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Morrison PJ, 2011, IMMUNOLOGY, V133, P397, DOI 10.1111/j.1365-2567.2011.03454.x; Nakayama K, 2012, AIDS RES HUM RETROV, V28, P702, DOI [10.1089/aid.2011.0073, 10.1089/AID.2011.0073]; Ndhlovu LC, 2008, AIDS, V22, P990, DOI 10.1097/QAD.0b013e3282ff884e; Neri F, 2011, VIROLOGY, V410, P316, DOI 10.1016/j.virol.2010.11.018; Ness-Schwickerath KJ, 2011, CELL MOL LIFE SCI, V68, P2371, DOI 10.1007/s00018-011-0700-z; Pallikkuth S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003471; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Peck A, 2010, IMMUNOLOGY, V129, P147, DOI 10.1111/j.1365-2567.2009.03189.x; Popik W, 1998, J VIROL, V72, P6406, DOI 10.1128/JVI.72.8.6406-6413.1998; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Rozmyslowicz T, 2010, EXP HEMATOL, V38, P1157, DOI 10.1016/j.exphem.2010.08.009; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; Singh A, 2012, CYTOKINE, V60, P55, DOI 10.1016/j.cyto.2012.06.288; Sohn SJ, 2013, J IMMUNOL, V191, P2205, DOI 10.4049/jimmunol.1202859; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	68	19	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186823	http://dx.doi.org/10.1371/journal.pone.0186823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091911	gold, Green Submitted, Green Published			2022-12-27	WOS:000414229700031
J	Oliverl, MD; Dattal, S; Baldwin, DR				Oliverl, Michael D.; Dattal, Subimal; Baldwin, Debora R.			A sympathetic nervous system evaluation of obesity stigma	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; PSYCHOSOCIAL STRESS; WEIGHT STIGMA; SELF-ESTEEM; CORTISOL REACTIVITY; CHILDHOOD OBESITY; PUBLIC-HEALTH; DISCRIMINATION; RESPONSES; STIGMATIZATION	The portrayal of obesity in the media is often one of negativity. Consequently, it may generate an increase in stigma. Obesity stigma, a form of social discrimination, is responsible for many of the negative psychological and physiological effects on individual wellness. These effects not only impact individual health, but also affect the economy, and ultimately, societal wellness. In an attempt to examine the influence of the media on obesity stigma, this study tested the hypothesis that positive priming would lead to a reduction in obesity stigma. To further our understanding of this relationship, we: 1) examined the role of priming on physiological measures (e.g. salivary alpha amylase and skin conductance) in 70 college students by introducing positive and negative media images of individuals with obesity, and 2) assessed psychological measures (e.g. perceived stress, need to belong, and selfesteem, and Body Mass Index). After the priming manipulation, participants read a vignette depicting the discrimination of an individual with obesity and answered subsequent questions assessing participants' attributional blame of obesity. Results of this study revealed that priming affects physiological responding to obesity stigmatization. In conclusion, these findings suggest that incorporating positive media images of individuals with obesity may be an effective tool for reducing stigma and the various physiological consequences associated with it, which in turn, can enhance societal health and wellness.	[Oliverl, Michael D.; Dattal, Subimal; Baldwin, Debora R.] Univ Tennessee, Dept Psychol, Coll Arts & Sci, Knoxville, TN 37996 USA; [Dattal, Subimal] Univ Tennessee, Dept Anesthesiol, Grad Sch Med, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center	Oliverl, MD (corresponding author), Univ Tennessee, Dept Psychol, Coll Arts & Sci, Knoxville, TN 37996 USA.	moliver8@utk.edu			National Institutes of Health Research Grant [MH59839]; Research Fund of the University of Tennessee; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059839] Funding Source: NIH RePORTER	National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Fund of the University of Tennessee; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study is supported by National Institutes of Health Research Grant (MH59839). The aforementioned content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Research Fund of the University of Tennessee and the National Institutes of Health Research Grant (MH59839). MO is a doctoral student in the Department of Psychology at the University of Tennessee-Knoxville. This research is part of MO's graduate thesis. The authors would also like to acknowledge Drs. Matthew Cooper and Michael Olson for their suggestions in the earlier version of this manuscript.	Ahern J, 2007, DRUG ALCOHOL DEPEN, V88, P188, DOI 10.1016/j.drugalcdep.2006.10.014; Almela M, 2011, BIOL PSYCHOL, V87, P421, DOI 10.1016/j.biopsycho.2011.05.008; Arthur C Guyton, TXB MED PHYSL; Bach DR, 2010, INT J PSYCHOPHYSIOL, V75, P349, DOI 10.1016/j.ijpsycho.2010.01.005; Bacon JG, 2001, INT J OBESITY, V25, P252, DOI 10.1038/sj.ijo.0801537; Carroll D, 2011, BEHAV HLTH COROLLARI, P243; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Crocker J, 2003, PSYCHOL INQ, V14, P232, DOI 10.1207/S15327965PLI1403&4_9; Davison KK, 2002, DEV PSYCHOL, V38, P735, DOI 10.1037//0012-1649.38.5.735; Dutton GR, 2013, INT J OBESITY, V37, P1282, DOI 10.1038/ijo.2012.224; Ehlert U, 2006, J CLIN ENDOCR METAB, V91, P5130, DOI 10.1210/jc.2006-0461; Engert V, 2011, PSYCHONEUROENDOCRINO, V36, P1294, DOI 10.1016/j.psyneuen.2011.02.018; Farag NH, 2008, J WOMENS HEALTH, V17, P1647, DOI 10.1089/jwh.2008.0866; Gee GC, 2008, AM J PUBLIC HEALTH, V98, P493, DOI 10.2105/AJPH.2007.114025; Graves RE, 2005, SCHIZOPHR RES, V76, P317, DOI 10.1016/j.schres.2005.02.003; Hayran Osman, 2013, J Allied Health, V42, P147; Hebl MR, 2005, BASIC APPL SOC PSYCH, V27, P267, DOI 10.1207/s15324834basp2703_8; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Himmelstein MS, 2015, OBESITY, V23, P368, DOI 10.1002/oby.20959; Jackson SE, 2016, OBESITY, V24, P2515, DOI 10.1002/oby.21657; Kim SH, 2007, J HEALTH COMMUN, V12, P359, DOI 10.1080/10810730701326051; Kurzban R, 2001, PSYCHOL BULL, V127, P187, DOI 10.1037//0033-2909.127.2.187; Latner JD, 2007, BODY IMAGE, V4, P147, DOI 10.1016/j.bodyim.2007.03.002; Leary MR, 2013, J PERS ASSESS, V95, P610, DOI 10.1080/00223891.2013.819511; Lewis TT, 2009, J GERONTOL A-BIOL; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Mellor D, 2008, PERS INDIV DIFFER, V45, P213, DOI 10.1016/j.paid.2008.03.020; Myers A, 1999, INT J OBESITY, V23, P221, DOI 10.1038/sj.ijo.0800765; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Olson MA, 2003, PSYCHOL SCI, V14, P636, DOI 10.1046/j.0956-7976.2003.psci_1477.x; Olson MA, 2001, PSYCHOL SCI, V12, P413, DOI 10.1111/1467-9280.00376; Papadopoulos S, 2015, OBESITY, V23, P1743, DOI 10.1002/oby.21187; Perala CH, 2007, GALVANIC SKIN RESPON; Prelow HM, 2006, J BLACK PSYCHOL, V32, P442, DOI 10.1177/0095798406292677; Puhl R M, 2003, Obes Rev, V4, P213, DOI 10.1046/j.1467-789X.2003.00122.x; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI DOI 10.1515/9781400876136; Salimetrics, 2016, SALVIOBIO ORAL SWAB; Sapolsky R, 2003, SCI AM, V289, P86, DOI 10.1038/scientificamerican0903-86; Sawyer PJ, 2012, AM J PUBLIC HEALTH, V102, P1020, DOI 10.2105/AJPH.2011.300620; Schvey NA, 2014, PSYCHOSOM MED, V76, P156, DOI 10.1097/PSY.0000000000000031; Sharma Ratna, 2006, Indian J Physiol Pharmacol, V50, P367; Sira N, 2011, FAMILY SCI REV, V16, P57; STEPHAN CW, 1992, INT J INTERCULT REL, V16, P89, DOI 10.1016/0147-1767(92)90007-H; Storm H, 2002, ACTA ANAESTH SCAND, V46, P887, DOI 10.1034/j.1399-6576.2002.460721.x; Strauss RS, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e15; Stuart H, 2006, CNS DRUGS, V20, P99, DOI 10.2165/00023210-200620020-00002; Tajfel H, PSYCHOL INTERGROUP R; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Tomiyama AJ, 2014, APPETITE, V82, P8, DOI 10.1016/j.appet.2014.06.108; Torres L, 2010, CULT DIVERS ETHN MIN, V16, P561, DOI 10.1037/a0020652; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; Vartanian LR, 2013, J BIOETHIC INQ, V10, P49, DOI 10.1007/s11673-012-9412-9; Verkuyten M, 1998, J SOC PSYCHOL, V138, P479, DOI 10.1080/00224549809600402; White S. E., 1999, COMMUNICATION RES RE, V16, P386, DOI DOI 10.1080/08824099909388740; Zeiders KH, 2014, PSYCHONEUROENDOCRINO, V50, P280, DOI 10.1016/j.psyneuen.2014.08.023	64	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0185703	10.1371/journal.pone.0185703	http://dx.doi.org/10.1371/journal.pone.0185703			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL0OH	29084240	gold, Green Published, Green Submitted			2022-12-27	WOS:000413910200003
J	Xu, Y; Zhao, WL; Li, T; Zhao, Y; Bu, HE; Song, SL				Xu, Yang; Zhao, Wenli; Li, Te; Zhao, Ye; Bu, Huaien; Song, Shilin			Effects of acupuncture for the treatment of endometriosis-related pain: A systematic review and meta-analysis	PLOS ONE			English	Review							PELVIC PAIN; CA-125; WOMEN; SURGERY; QUALITY; CANCER; LIFE	Background Endometriosis is a multifactorial, oestrogen-dependent, inflammatory, gynaecological condition that can result in long-lasting visceral pelvic pain and infertility. Acupuncture could be an effective treatment for endometriosis and may relieve pain. Our aim in the present study was to determine the effectiveness of acupuncture as a treatment for endometriosis-related pain. Methods In December 2016, six databases were searched for randomised controlled trials that determined the effectiveness of acupuncture in the treatment of endometriosis-related pain. Ultimately, 10 studies involving 589 patients were included. The main outcomes assessed were variation in pain level, variation in peripheral blood CA-125 level, and clinical effective rate. All analyses were performed using comprehensive meta-analysis statistical software. Results Of the 10 studies included, only one pilot study used a placebo control and assessed blinding; the rest used various controls (medications and herbs), which were impossible to blind. The sample sizes were small in all studies, ranging from 8 to 36 patients per arm. The mean difference (MD) in pain reduction (pre-minus post-interventional pain level D measured on a 0-10-point scale) between the acupuncture and control groups was 1.36 (95% confidence intervals [ CI] = 1.01-1.72, P<0.0001). Acupuncture had a positive effect on peripheral blood CA-125 levels, as compared with the control groups (MD = 5.9, 95% CI = 1.56-10.25, P = 0.008). Similarly, the effect of acupuncture on clinical effective rate was positive, as compared with the control groups (odds ratio = 2.07; 95% CI = 1.24-3.44, P = 0.005). Conclusions Few randomised, blinded clinical trials have addressed the efficacy of acupuncture in treating endometriosis-related pain. Nonetheless, the current literature suggests that acupuncture reduces pain and serum CA-125 levels, regardless of the control intervention used. To confirm these findings, additional, blinded studies with proper controls and adequate sample sizes are needed.	[Xu, Yang] Tianjin Acad Integrat Med, Nankai Hosp, Dept Gynecol & Obstet, Tianjin, Peoples R China; [Zhao, Wenli] Tianjin Univ Tradit Chinese Med, Grad Sch, Tianjin, Peoples R China; [Zhao, Wenli] Tianjin Acad Integrat Med, Nankai Hosp, Dept Neurol, Tianjin, Peoples R China; [Li, Te] Tianjin Hearing Impairment Specialist Hosp, Dept Chinese Med, Tianjin, Peoples R China; [Zhao, Ye] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA; [Bu, Huaien] Tianjin Univ Tradit Chinese Med, Sch Tradit Chinese Med, Dept Publ Hlth, Tianjin, Peoples R China; [Song, Shilin] Tianjin Univ Tradit Chinese Med, Sch Integrat Med, Lab Anat, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; State University System of Florida; University of Florida; Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Bu, HE (corresponding author), Tianjin Univ Tradit Chinese Med, Sch Tradit Chinese Med, Dept Publ Hlth, Tianjin, Peoples R China.; Song, SL (corresponding author), Tianjin Univ Tradit Chinese Med, Sch Integrat Med, Lab Anat, Tianjin, Peoples R China.	buhuaien@163.com; haiguagua@163.com						Abbott JA, 2003, HUM REPROD, V18, P1922, DOI 10.1093/humrep/deg275; Ahn SH, 2016, FERTIL STERIL, V106, P1420, DOI 10.1016/j.fertnstert.2016.07.005; Amaral Vivian Ferreira do, 2006, Sao Paulo Med. J., V124, P223; Amer Saad, 2008, OBSTET GYNECOL REPRO, V18, P126; ANDERSSON S, 1995, MED HYPOTHESES, V45, P271, DOI 10.1016/0306-9877(95)90117-5; BARBIERI RL, 1986, FERTIL STERIL, V45, P630; Brawn J, 2014, HUM REPROD UPDATE, V20, P737, DOI 10.1093/humupd/dmu025; Chen GX., 2014, THESIS, P16; Chen Ming, 2010, Zhongguo Zhen Jiu, V30, P725; Chen QX, 2015, THESIS, P16; Chen S, 2014, EVID-BASED COMPL ALT, V2014; Cheng YM, 2002, OBSTET GYNECOL, V99, P375, DOI 10.1016/S0029-7844(01)01731-8; DIZEREGA GS, 1980, FERTIL STERIL, V33, P649; EISERMANN J, 1988, FERTIL STERIL, V50, P573; Fedele L, 2004, AM J OBSTET GYNECOL, V190, P1020, DOI 10.1016/j.ajog.2003.10.698; Ferrero S, 2005, FERTIL STERIL, V83, P573, DOI 10.1016/j.fertnstert.2004.07.973; Gao CY., 2015, THESIS, P16; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hui KK, 2006, INTEGR CANCER THER, V5, P56, DOI 10.1177/1534735405286109; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; JACOBS I, 1988, LANCET, V1, P889; Jin YB, 2009, ACUPUNCTURE RES, V26, P188; Johnston MF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep236; Kaludjerovic J, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/837901; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Liu YX, 2003, XIN ZHONG YI, V35, P55; Liu YY, 2009, HU BEI ZHONG YI ZA Z, V31, P53; Lund I, 2016, J PAIN RES, V9, P157, DOI 10.2147/JPR.S55580; Ma Jie, 2008, Zhen Ci Yan Jiu, V33, P235; Miller JD, 2000, AM J OBSTET GYNECOL, V182, P1483, DOI 10.1067/mob.2000.106846; Scheerer C, 2016, ARCH GYNECOL OBSTET, V294, P657, DOI 10.1007/s00404-016-4142-6; Staud R, 2006, EXPERT REV NEUROTHER, V6, P661, DOI 10.1586/14737175.6.5.661; Sun Yuan-Zheng, 2006, Zhongguo Zhen Jiu, V26, P863; Tian LY, 2016, CLIN J TRAD CHIN MED, P670; Tian X, 2014, ALTERN THER HEALTH M, V20, P33; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Vercellini P, 2009, HUM REPROD UPDATE, V15, P177, DOI 10.1093/humupd/dmn062; Wang M, 1991, ZHONGGUO ZHONG XI YI, V11; Wayne PM, 2008, J PEDIATR ADOL GYNEC, V21, P247, DOI 10.1016/j.jpag.2007.07.008; Wieser F, 2007, HUM REPROD UPDATE, V13, P487, DOI 10.1093/humupd/dmm015; Wu JX, 2013, J EMERG TRADIT CHIN, P1947; Xiang Dong-Fang, 2011, Zhongguo Zhen Jiu, V31, P113; Yan Hong, 2008, Zhongguo Zhen Jiu, V28, P579; Zhang Xinxin, 2015, Zhongguo Zhen Jiu, V35, P323; Zhen R, 2009, YI XUE LI LUN YU SHI, V22, P571; Zhu XS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007864.pub2	46	29	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186616	10.1371/journal.pone.0186616	http://dx.doi.org/10.1371/journal.pone.0186616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077705	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200014
J	Isakov, M; Tripathy, A				Isakov, Michael; Tripathy, Arnav			Behavioral correlates of cheating: Environmental specificity and reward expectation	PLOS ONE			English	Article							ACADEMIC DISHONESTY; PREVALENCE; SIDE	Academic dishonesty has been and continues to be a major problem in America's schools and universities. Such dishonesty is especially important in high schools, where grades earned directly impact the academic careers of students for many years to come. The rising pressure to get the best grades in school, get into the best college, and land the best paying job is a cycle that has made academic dishonesty increase exponentially. Thus, finding the widespread roots of cheating is more important now than ever. In this study, we focus on how societal norms and interactions with peers influence lying about scores in order to obtain a benefit in a high school population. We show that (1) the societal norms that go hand in hand with test-taking in school, as administered by a teacher, significantly dampen small-scale dishonesty, perhaps suggesting that context-dependent rewards offset cheating; (2) providing reminders of societal norms via pre-reported average scores leads to more truthful self-reporting of honesty; (3) the matrix search task was shown to not depend on class difficulty, confirming its effectiveness as an appropriate method for this study; (4) males seem to cheat more than females; and (5) teenagers are more dishonest earlier in the day. We suggest that students understand that cheating is wrong, an idea backed up by the literature, and that an environment which clearly does not condone dishonesty helps dampen widespread cheating in certain instances. This dampening effect seems to be dependent on the reward that students thought they would get for exaggerating their performance.	[Isakov, Michael] Lincoln Sudbury Reg High Sch, Sudbury, MA 01776 USA; [Tripathy, Arnav] Stanford Univ, Dept Math, Stanford, CA 94305 USA	Stanford University	Isakov, M (corresponding author), Lincoln Sudbury Reg High Sch, Sudbury, MA 01776 USA.	michael.isakov.11@gmail.com						ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; BAIRD JS, 1980, PSYCHOL SCHOOLS, V17, P515, DOI 10.1002/1520-6807(198010)17:4<515::AID-PITS2310170417>3.0.CO;2-3; Bucciol A, 2011, J ECON PSYCHOL, V32, P73, DOI 10.1016/j.joep.2010.12.001; Callahan D., 2007, CHEATING CULTURE WHY; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Coskan C., THESIS; DAVIS SF, 1992, TEACH PSYCHOL, V19, P16, DOI 10.1207/s15328023top1901_3; Dawidowicz PM, 2003, J MORAL EDUC, V32, P275, DOI 10.1080/0305724032000136707; Gino F, 2012, J PERS SOC PSYCHOL, V102, P445, DOI 10.1037/a0026406; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Grolleau G, CHEATING LOSS AVERSI; Harding TS, 2004, SCI ENG ETHICS, V10, P311; Isakov A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148314; Isakov A, 2012, DYN GAMES APPL, V2, P97, DOI 10.1007/s13235-011-0020-9; Jensen LA, 2002, CONTEMP EDUC PSYCHOL, V27, P209, DOI 10.1006/ceps.2001.1088; Martinelli CA, CHEATING INCENTIVES; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; McCabe DL, 1994, J COLL STUDENT DEV; McCabe DL, 2006, ACAD MANAG LEARN EDU, V5, P294, DOI 10.5465/AMLE.2006.22697018; Pulvers K, 1999, RES HIGH EDUC, V40, P487, DOI 10.1023/A:1018792210076; Rand D. G., 2014, NATURE COMMUNICATION, P5; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Sims R. L., 1993, J EDUC BUS, V68, P207, DOI DOI 10.1080/08832323.1993.10117614; Sun-GeunBaek, 2002, Asia Pacific Education Review, V3, P125; Wenzel M, 2004, LAW HUMAN BEHAV, V28, P547, DOI 10.1023/B:LAHU.0000046433.57588.71; West MD., 2005, LAW EVERYDAY JAPAN S	26	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186054	10.1371/journal.pone.0186054	http://dx.doi.org/10.1371/journal.pone.0186054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9QH	29073226	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400013
J	Rivadeneira, MM; Nielsen, SN				Rivadeneira, Marcelo M.; Nielsen, Sven N.			Diversification dynamics, species sorting, and changes in the functional diversity of marine benthic gastropods during the Pliocene-Quaternary at temperate western South America	PLOS ONE			English	Article							SEA-LEVEL CHANGES; MOLLUSCAN ASSEMBLAGES; MASS EXTINCTION; MURICIDAE; SELECTIVITY; END; PLIOPLEISTOCENE; BIODIVERSITY; TURNOVER; ECOLOGY	Functional diversity based on species traits is a powerful tool to investigate how changes in species richness and composition affect ecosystem functioning. However, studies aimed at understanding changes in functional diversity over large temporal and spatial scales are still scant. Here we evaluate the combined effect of diversification and species sorting on functional diversity of fossil marine gastropods during the Pliocene-Quaternary transition in the Pacific coast of South America. We analyzed a total of 172 species in 29 Pliocene and 97 Quaternary sites. Each species was characterized according to six functional traits: body size, feeding type, mobility, attachment, life-habit, and larval mode. Functional diversity was estimated according to four indexes (functional richness, evenness, divergence and dispersion) based on functional traits measured. Extrapolated species richness showed a slight yet not significant decrease from the Pliocene to the Quaternary despite the fact that a large faunal turnover took place; furthermore, a large extinction of Pliocene species (61-76%) was followed by a high pulse of appearances (49-56%) during the Quaternary. Three out of four indices of functional diversity (evenness, divergence and dispersion) increased significantly towards the Quaternary which is more than expected under a random turnover of species. The increase in functional diversity is associated with a loss of large-sized carnivore forms, which tended to be replaced by small-sized grazers. Hence, this trait-selective species turnover, even in the absence of significant changes in species richness, likely had a large effect and has shaped the functional diversity of present-day assemblages.	[Rivadeneira, Marcelo M.] CEAZA, Lab Paleobiol, Av Bernardo Ossandon, Coquimbo, Chile; [Rivadeneira, Marcelo M.] Univ Catolica Norte, Dept Biol Marina, Larrondo, Coquimbo, Chile; [Nielsen, Sven N.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Tierra, Isla Teja S-N, Valdivia, Chile	Universidad Catolica del Norte; Universidad Austral de Chile	Rivadeneira, MM (corresponding author), CEAZA, Lab Paleobiol, Av Bernardo Ossandon, Coquimbo, Chile.; Rivadeneira, MM (corresponding author), Univ Catolica Norte, Dept Biol Marina, Larrondo, Coquimbo, Chile.	marcelo.rivadeneira@ceaza.cl	Nielsen, Sven N/A-2187-2009	Nielsen, Sven N/0000-0003-2064-8050; Rivadeneira, Marcelo/0000-0002-1681-416X	FONDECYT [1140841, 1150664, INACH G_05-11]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by FONDECYT projects 1140841,1150664 and INACH G_05-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Paleolab CEAZA, Alex Alballay, Jaime Villafana, and Pablo Oyanadel, for their help collecting the information used. Geraat Vermeij and Nicole Webster provided very constructive comments that improved the manuscript. This work was funded by FONDECYT projects 1140841, 1150664 and INACH G_05-11.	Aberhan M, 2015, P NATL ACAD SCI USA, V112, P7207, DOI 10.1073/pnas.1422248112; Allmon W.D., 1989, Historical Biology, V3, P141; Berke SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101494; Boyer AG, 2014, GLOBAL ECOL BIOGEOGR, V23, P679, DOI 10.1111/geb.12147; Bush AM, 2011, ANNU REV EARTH PL SC, V39, P241, DOI 10.1146/annurev-earth-040809-152556; Cardenas J, 2009, ANDEAN GEOL, V36, P81, DOI 10.4067/S0718-71062009000100007; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Dekens PS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001394; DeVries TJ, 2008, VELIGER, V50, P129; DeVries TJ, 2007, NAUTILUS, V121, P163; DeVries TJ, 2007, J PALEONTOL, V81, P331, DOI 10.1666/0022-3360(2007)81[331:CTGFSP]2.0.CO;2; DeVries TJ, 2007, VELIGER, V48, P247; DeVries TJ, 2006, NAUTILUS, V120, P139; DeVries TJ, 2005, NAUTILUS, V119, P164; DeVries TJ, 2005, VELIGER, V47, P277; DeVries TJ, 2005, VELIGER, V47, P259; DeVries TJ, 2004, VELIGER, V47, P6; DeVries TJ, 2003, VELIGER, V46, P332; DEVRIES TJ, 1995, VELIGER, V38, P284; DeVries TJ, 1997, J PALEONTOL, V71, P610, DOI 10.1017/S0022336000040099; DeVriesi TJ, 2008, VELIGER, V50, P274; Dineen AA, 2015, GLOBAL PLANET CHANGE, V133, P79, DOI 10.1016/j.gloplacha.2015.08.001; Dineen AA, 2014, EARTH-SCI REV, V136, P339, DOI 10.1016/j.earscirev.2014.06.002; Dowsett HJ, 2009, CLIM PAST, V5, P769, DOI 10.5194/cp-5-769-2009; Dowsett HJ, 2009, PHILOS T R SOC A, V367, P109, DOI 10.1098/rsta.2008.0206; Foster WJ, 2014, NAT GEOSCI, V7, P233, DOI [10.1038/ngeo2079, 10.1038/NGEO2079]; Garreaud RD, 2010, EARTH PLANET SC LETT, V292, P39, DOI 10.1016/j.epsl.2010.01.017; Gonzalez-Wevar CA, 2010, MOL PHYLOGEN EVOL, V56; Guzman N, 2000, C GEOL GIC CHIL; Herm D., 1969, Zitteliana, V2, P1; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hopkins MJ, 2014, ECOL LETT, V17, P314, DOI 10.1111/ele.12232; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; JACKSON JBC, 1993, SCIENCE, V260, P1624, DOI 10.1126/science.260.5114.1624; JOHNSON KG, 1995, PALEOBIOLOGY, V21, P52, DOI 10.1017/S0094837300013075; Johnson KG, 2001, PALAEOGEOGR PALAEOCL, V172, P39, DOI 10.1016/S0031-0182(01)00267-X; Keller G, 2009, PALAEOGEOGR PALAEOCL, V284, P47, DOI 10.1016/j.palaeo.2009.08.029; Kiel S, 2010, GEOLOGY, V38, P955, DOI 10.1130/G31282.1; Kowalewski M, 2006, PALEOBIOLOGY, V32, P533, DOI 10.1666/05074.1; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Le Roux JP, 2006, SEDIMENT GEOL, V184, P133, DOI 10.1016/j.sedgeo.2005.09.023; Le Roux JP, 2005, J S AM EARTH SCI, V19, P83, DOI 10.1016/j.jsames.2003.11.003; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Madin JS, 2006, SCIENCE, V312, P897, DOI 10.1126/science.1123591; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; MORICKE W, 1896, BEILAGE BAND, V10, P548; Mouillot D, 2014, P NATL ACAD SCI USA, V111, P13757, DOI 10.1073/pnas.1317625111; Nielsen SN, 2009, PALAEOGEOGR PALAEOCL, V280, P480, DOI 10.1016/j.palaeo.2009.06.035; Nielsen SN, 2008, NAUTILUS, V122, P201; Ortlieb L, 1996, QUATERNARY SCI REV, V15, P857, DOI 10.1016/S0277-3791(96)00062-5; Ortlieb L, 1995, AN M INT GEOL CORR P; Ortlieb L., 1994, ESTUDIOS OCEANOL GIC, V13, P57; Ortlieb Luc, 1990, Boletin de la Sociedad Geologica del Peru, V81, P127; Paskoff R, 1995, AN M INT GEOL CORR P; Petchey OL, 2002, P ROY SOC B-BIOL SCI, V269, P1721, DOI 10.1098/rspb.2002.2073; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Philippi RA, 1887, FO SILES TERCIARIOS; Poos MS, 2009, ECOLOGY, V90, P341, DOI 10.1890/08-1638.1; R Core Team, R LANG ENV STAT COMP; Rivadeneira MM, 2008, REV GEOL CHILE, V35, P163; Rivadeneira MM, 2007, PALEOBIOLOGY, V33, P455, DOI 10.1666/06042.1; Schmera D, 2009, AQUAT ECOL, V43, P157, DOI 10.1007/s10452-007-9152-9; Smith AB, 1998, NATURE, V392, P69, DOI 10.1038/32155; Smith JT, 2006, PALEOBIOLOGY, V32, P408, DOI 10.1666/05078.1; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; STANLEY SM, 1981, NATURE, V293, P457, DOI 10.1038/293457a0; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Todd JA, 2002, P ROY SOC B-BIOL SCI, V269, P571, DOI 10.1098/rspb.2001.1923; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Valentine JW, 2002, MAR ECOL PROG SER, V228, P153, DOI 10.3354/meps228153; Valenzuela-Toro AM, 2013, J VERTEBR PALEONTOL, V33, P216, DOI 10.1080/02724634.2012.710282; Vermeij GJ, 2012, BIOL J LINN SOC, V106, P776, DOI 10.1111/j.1095-8312.2012.01897.x; Villafana JA, 2014, PALEOBIOLOGY, V40, P659, DOI 10.1666/13069; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2011, ECOL LETT, V14, P561, DOI 10.1111/j.1461-0248.2011.01618.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	83	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187140	10.1371/journal.pone.0187140	http://dx.doi.org/10.1371/journal.pone.0187140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073224	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400121
J	Valkovic, L; Dragonu, I; Almujayyaz, S; Batzakis, A; Young, LAJ; Purvis, LAB; Clarke, WT; Wichmann, T; Lanz, T; Neubauer, S; Robson, MD; Klomp, DWJ; Rodgers, CT				Valkovic, Ladislav; Dragonu, Iulius; Almujayyaz, Salam; Batzakis, Alex; Young, Liam A. J.; Purvis, Lucian A. B.; Clarke, William T.; Wichmann, Tobias; Lanz, Titus; Neubauer, Stefan; Robson, Matthew D.; Klomp, Dennis W. J.; Rodgers, Christopher T.			Using a whole-body P-31 birdcage transmit coil and 16-element receive array for human cardiac metabolic imaging at 7T	PLOS ONE			English	Article							SKELETAL-MUSCLE; DILATED CARDIOMYOPATHY; SPECTROSCOPY; SUPPRESSION	Purpose Cardiac phosphorus magnetic resonance spectroscopy (P-31-MRS) provides unique insight into the mechanisms of heart failure. Yet, clinical applications have been hindered by the restricted sensitivity of the surface radiofrequency-coils normally used. These permit the analysis of spectra only from the interventricular septum, or large volumes of myocardium, which may not be meaningful in focal disease. Loring et al. recently presented a prototype whole-body (52 cm diameter) transmit/receive birdcage coil for P-31 at 7T. We now present a new, easily-removable, whole-body P-31 transmit radiofrequency-coil built into a patient-bed extension combined with a 16-element receive array for cardiac P-31-MRS. Materials and methods A fully-removable (55 cm diameter) birdcage transmit coil was combined with a 16-element receive array on a Magnetom 7T scanner (Siemens, Germany). Electro-magnetic field simulations and phantom tests of the setup were performed. In vivo maps of B1(+), metabolite signals, and saturation-band efficiency were acquired across the torsos of eight volunteers. Results The combined (volume-transmit, local receive array) setup increased signal-to-noise ratio 2.6-fold 10 cm below the array (depth of the interventricular septum) compared to using the birdcage coil in transceiver mode. The simulated coefficient of variation for B1(+) of the whole-body coil across the heart was 46.7% (surface coil 129.0%); and the in vivo measured value was 38.4%. Metabolite images of 2,3-diphosphoglycerate clearly resolved the ventricular blood pools, and muscle tissue was visible in phosphocreatine (PCr) maps. Amplitude-modulated saturation bands achieved 71 +/- 4% suppression of phosphocreatine PCr in chest-wall muscles. Subjects reported they were comfortable. Conclusion This easy-to-assemble, volume-transmit, local receive array coil combination significantly improves the homogeneity and field-of-view for metabolic imaging of the human heart at 7T.	[Valkovic, Ladislav; Young, Liam A. J.; Purvis, Lucian A. B.; Clarke, William T.; Neubauer, Stefan; Robson, Matthew D.; Rodgers, Christopher T.] Univ Oxford, Oxford Ctr Clin Magnet Resonance Res OCMR, BHF Ctr Res Excellence, Oxford, England; [Valkovic, Ladislav] Slovak Acad Sci, Inst Measurement Sci, Dept Imaging Methods, Bratislava, Slovakia; [Dragonu, Iulius] Siemens Healthcare Ltd, Frimley, Surrey, England; [Almujayyaz, Salam; Batzakis, Alex; Klomp, Dennis W. J.] MR Coils BV, Zaltbommel, Netherlands; [Wichmann, Tobias; Lanz, Titus] Rapid Biomed GmbH, Rimpar, Germany; [Klomp, Dennis W. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	University of Oxford; Slovak Academy of Sciences; Institute of Measurement Science, SAS; Siemens AG; Utrecht University; Utrecht University Medical Center	Valkovic, L (corresponding author), Univ Oxford, Oxford Ctr Clin Magnet Resonance Res OCMR, BHF Ctr Res Excellence, Oxford, England.; Valkovic, L (corresponding author), Slovak Acad Sci, Inst Measurement Sci, Dept Imaging Methods, Bratislava, Slovakia.	ladislav.valkovic@cardiov.ox.ac.uk	Rodgers, Christopher T./AAD-3344-2019; Valkovič, Ladislav/J-5731-2019	Rodgers, Christopher T./0000-0003-1275-1197; Valkovič, Ladislav/0000-0003-2567-3642; Neubauer, Stefan/0000-0001-9017-5645; Young, Liam/0000-0003-0720-421X	Wellcome Trust; Royal Society [098436/Z/12/Z]; Wellcome Trust Science Enhancement [098436/Z/12/A]; EPA Cephalosporin Fund [CF 284]; BHF Centre of Research Excellence, Oxford [RE/13/1/30181]; Austrian National Bank Annual Fund [15455]; Grant Agency of the Slovak Ministry of Education, Science, Research and Sport and Slovak Academy of Sciences VEGA [2/0001/17]; Slovak Research and Development Agency [15-0029]; MRC [G0900883, 1966877] Funding Source: UKRI; Medical Research Council [G0900883, 1515231] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Wellcome Trust Science Enhancement(Wellcome Trust); EPA Cephalosporin Fund; BHF Centre of Research Excellence, Oxford; Austrian National Bank Annual Fund; Grant Agency of the Slovak Ministry of Education, Science, Research and Sport and Slovak Academy of Sciences VEGA(Slovak Academy of Sciences); Slovak Research and Development Agency(Slovak Research and Development Agency); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by: Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society (Grant No. 098436/Z/12/Z, https://wellcome.ac.uk/) to C.T.R.; Wellcome Trust Science Enhancement (Grant No. 098436/Z/12/A, https:/wellcome.ac.uk./) to C.T.R.; EPA Cephalosporin Fund (Grant No. CF 284, http//opencharities.org/charities/309698) to S.N.; BHF Centre of Research Excellence, Oxford (Grant No. RE/13/1/30181, https://www.bhf.org.uk/) to C.T.R.; Austrian National Bank Annual Fund (Grant No. 15455, https.//www.oenb.at/) to L.V.; Grant Agency of the Slovak Ministry of Education, Science, Research and Sport and Slovak Academy of Sciences VEGA (Grant No. 2/0001/17, https://www.minedu.skivedecka-grantova-agentura-rnsvvas-sr-a-sav-vega/); and Slovak Research and Development Agency (Grant No. 15-0029, ham://www.apvv.sk/?lang=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTTOMLEY PA, 1988, MAGN RESON MED, V7, P319, DOI 10.1002/mrm.1910070309; Bottomley PA, 2009, ENCY MAGNETIC RESONA; Chmelik M, 2014, J MAGN RESON IMAGING, V40, P391, DOI 10.1002/jmri.24401; Levelt E, 2016, EUR HEART J, V37, P3461, DOI 10.1093/eurheartj/ehv442; Loring J, 2016, NMR BIOMED, V29, P709, DOI 10.1002/nbm.3517; Luo Y, 2001, MAGNET RESON MED, V45, P1095, DOI 10.1002/mrm.1144; Neubauer S, 1997, CIRCULATION, V96, P2190; Purvis LAB, 2017, MAGNETIC RESONANCE M; Purvis LAB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185356; Rider OJ, 2012, CIRCULATION, V125, P1511, DOI 10.1161/CIRCULATIONAHA.111.069518; Robson MD, 2005, MAGNET RESON MED, V53, P267, DOI 10.1002/mrm.20344; Rodgers CT, 2016, MAGN RESON MED, V75, P473, DOI 10.1002/mrm.25618; Rodgers CT, 2014, MAGN RESON MED, V72, P304, DOI 10.1002/mrm.24922; Rodgers CT, 2014, 22 JOINT ANN M ISMRM; Schaller B, 2016, MAGN RESON MED, V75, P962, DOI 10.1002/mrm.25755; Sedivy P, 2015, MED PHYS, V42, P1678, DOI 10.1118/1.4914448; Stoll VM, 2016, RADIOLOGY, V281, P409, DOI 10.1148/radiol.2016152629; Valkovic L, 2016, MAGNETIC RESONANCE M; Valkovic L, 2017, ANAL BIOCHEM, V529, P193, DOI 10.1016/j.ab.2017.01.018; Valkovic L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20087; van der Kemp WJM, 2013, NMR BIOMED, V26, P1299, DOI 10.1002/nbm.2952	21	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187153	10.1371/journal.pone.0187153	http://dx.doi.org/10.1371/journal.pone.0187153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073228	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400124
J	Choi, JY; Jung, JH; Shin, S; Kim, YH; Han, DJ				Choi, Ji Yoon; Jung, Joo Hee; Shin, Sung; Kim, Young Hoon; Han, Duck Jong			Association between the pancreas transplantation and survival of patients with diabetes: A single center experience	PLOS ONE			English	Article							MORTALITY	Pancreas transplantation is considered a therapeutic option for patients with complicated diabetes mellitus. In this study, we compared survival rate between patients on the waiting list for pancreas transplant alone(PTA), simultaneous pancreas-kidney(SPK) transplant, and pancreas after kidney(PAK) transplant and transplant recipients. A total of 503 patients (PTA:n = 116; SPK:n = 303; PAK:n = 84) and 280 PT recipients (PTA:n = 89; SPK:n = 155; PAK:n = 36) were retrospectively analyzed at our center between February 2000 and December 2015; 11.9%(60/503) of the patients on the waiting list and 4.3%(12/280) of the PT recipients died. The overall survival rate was higher in the waiting list group for the first year (99.3% vs. 97.8%), after which it was significantly higher in PT group (p = 0.039). The overall relative risk of all-cause mortality for transplant recipients was 2.145(p = 0.285) for PTA, 0.688(p = 0.735) for PAK, however,0.361 (p = 0.012) for SPK compared with that for the waiting list patients. SPK transplant recipients had considerable higher survival benefits, despite the relatively long waiting period, especially after 1 year. In addition, PTA and PAK can also be considered as a treatment option as patient survival was not poor.	[Han, Duck Jong] Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea; Asan Med Ctr, Seoul, South Korea	University of Ulsan	Han, DJ (corresponding author), Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea.	djhan@amc.seoul.kr						Choi JY, 2016, AM J TRANSPLANT, V16, P2413, DOI 10.1111/ajt.13738; Gruessner RWG, 2004, AM J TRANSPLANT, V4, P2018, DOI 10.1111/j.1600-6143.2004.00667.x; Han DJ, 2010, GUT LIVER, V4, P450, DOI 10.5009/gnl.2010.4.4.450; Kandaswamy R, 2016, AM J TRANSPLANT, V16, P47, DOI 10.1111/ajt.13667; Kandaswamy R, 2015, Am J Transplant, V15 Suppl 2, P1, DOI 10.1111/ajt.13196; Park JB, 2012, TRANSPL P, V44, P925, DOI 10.1016/j.transproceed.2012.03.035; Reynoso JF, 2010, J HEPATO-BIL-PAN SCI, V17, P92, DOI 10.1007/s00534-009-0147-x; Stratta RJ, 2016, AM J TRANSPLANT, V16, P2556, DOI 10.1111/ajt.13890; Stratta RJ, 2016, CURR OPIN ORGAN TRAN, V21, P386, DOI 10.1097/MOT.0000000000000319; van Dellen D, 2013, NEPHROL DIAL TRANSPL, V28, P1315, DOI 10.1093/ndt/gfs613; Venstrom JM, 2003, JAMA-J AM MED ASSOC, V290, P2817, DOI 10.1001/jama.290.21.2817; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	12	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186827	10.1371/journal.pone.0186827	http://dx.doi.org/10.1371/journal.pone.0186827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095903	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200024
J	Lorca, V; Rueda, D; Martin-Morales, L; Poves, C; Fernandez-Acenero, MJ; Ruiz-Ponte, C; Llovet, P; Marrupe, D; Garcia-Barberan, V; Garcia-Paredes, B; Perez-Segura, P; de la Hoya, M; Diaz-Rubio, E; Caldes, T; Garre, P				Lorca, Victor; Rueda, Daniel; Martin-Morales, Lorena; Poves, Carmen; Jesus Fernandez-Acenero, Maria; Ruiz-Ponte, Clara; Llovet, Patricia; Marrupe, David; Garcia-Barberan, Vanesa; Garcia-Paredes, Beatriz; Perez-Segura, Pedro; de la Hoya, Miguel; Diaz-Rubio, Eduardo; Caldes, Trinidad; Garre, Pilar			Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome	PLOS ONE			English	Article							COLORECTAL-CANCER; GERMLINE MUTATIONS; HUMAN COLON; VARIANTS; AGE	The involvement of GALNT12 in colorectal carcinogenesis has been demonstrated but it is not clear to what extent it is implicated in familial CRC susceptibility. Partially inactivating variant, NM_024642.4:c.907G>A, p.(D303N), has been previously detected in familial CRC and proposed as the causative risk allele. Since phenotypes of the described carrier families showed not only CRC but also a polyp history, we hypothesized that GALNT12 could be involved in adenoma predisposition and consequently, in hereditary polyposis CRC syndromes. For that purpose, we have screened the GALNT12 gene in germline DNA from 183 unrelated attenuated polyposis patients. c.907G>A, p.(D303N) was detected in 4 cases (MAF = 1.1%) and no other candidate variants were found. After segregation studies, LOH analyses, glycosylation pattern tests and case-control studies, our results did not support the role of c.907G>A, p.(D303N) as a high-penetrance risk allele for polyposis CRC.	[Lorca, Victor; Martin-Morales, Lorena; Llovet, Patricia; Garcia-Barberan, Vanesa; de la Hoya, Miguel; Caldes, Trinidad; Garre, Pilar] Hosp Clin San Carlos, IdISSC, CIBERONC, Lab Oncol Mol, Madrid, Spain; [Rueda, Daniel] Hosp 12 Octubre, Serv Bioquim i 12, Lab Canc Hereditario, Madrid, Spain; [Poves, Carmen] Hosp Clin San Carlos, Serv Aparato Digest, Madrid, Spain; [Jesus Fernandez-Acenero, Maria] Hosp Clin San Carlos, Serv Anat Patol, Madrid, Spain; [Ruiz-Ponte, Clara] IDIS, Grp Med Xenom USC, FPGMX, SERGAS, Santiago De Compostela, Spain; [Marrupe, David] Hosp Mostoles, Serv Oncol Med, Madrid, Spain; [Garcia-Paredes, Beatriz; Perez-Segura, Pedro; Diaz-Rubio, Eduardo] Hosp Clin San Carlos, CIBERONC, Serv Oncol Med, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Clinico San Carlos; Hospital Universitario 12 de Octubre; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Clinico San Carlos	Garre, P (corresponding author), Hosp Clin San Carlos, IdISSC, CIBERONC, Lab Oncol Mol, Madrid, Spain.	pilar_garre@hotmail.com	Rueda, Daniel/I-1176-2015; Marrupe, David/CAI-0370-2022; de la Hoya, MIguel/Z-2911-2019; Aceñero, M Jesús Fernández/ABC-5904-2020	Rueda, Daniel/0000-0002-5377-8890; Marrupe, David/0000-0002-7986-2783; Aceñero, M Jesús Fernández/0000-0002-2439-3553; Llovet, Patricia/0000-0003-0190-2105; de la Hoya, Miguel/0000-0002-8113-1410; Garcia-Barberan, Vanesa/0000-0002-2531-0203; Martin-Morales, Lorena/0000-0002-1970-8872; LORCA CASTELLANOS, VICTOR/0000-0002-3681-4319; Garre Rubio, Pilar/0000-0001-8285-4138	Instituto de Salud Carlos III, Spain; European Regional Development FEDER funds [PI14/00929, PI16/01292, PI14/00230]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); European Regional Development FEDER funds	The present study was supported by grants from the Instituto de Salud Carlos III, Spain (www.isciii.es) and European Regional Development FEDER funds: PI14/00929 to Pilar Garre, PI16/01292 to Trinidad Caldes and PI14/00230 to Clara Ruiz-Ponte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscnpt.	Adam R, 2016, AM J HUM GENET, V99, P337, DOI 10.1016/j.ajhg.2016.06.015; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Clarke E, 2012, HUM MUTAT, V33, P1056, DOI 10.1002/humu.22088; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Exome Variant Server, NHLBI GO EX SEQ PROJ; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Guo JM, 2002, FEBS LETT, V524, P211, DOI 10.1016/S0014-5793(02)03007-7; Guo JM, 2004, ONCOLOGY-BASEL, V67, P271, DOI 10.1159/000081328; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pendergrass CJ, 2008, CLIN GASTROENTEROL H, V6, P1011, DOI 10.1016/j.cgh.2008.03.022; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Segui N, 2014, HUM MUTAT, V35, P50, DOI 10.1002/humu.22454; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287	20	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187312	10.1371/journal.pone.0187312	http://dx.doi.org/10.1371/journal.pone.0187312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095867	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200070
J	Qiao, JX; Xu, J; Bo, T; Wang, W				Qiao, Juxia; Xu, Jing; Bo, Tao; Wang, Wei			Micronucleus-specific histone H1 is required for micronuclear chromosome integrity in Tetrahymena thermophila	PLOS ONE			English	Article							LINKER HISTONE; IN-VIVO; VARIANT OVEREXPRESSION; GENE-EXPRESSION; CORE PARTICLE; DNA-DAMAGE; CHROMATIN; IDENTIFICATION; NUCLEOSOME; SEQUENCE	Histone H1 molecules play a key role in establishing and maintaining higher order chromatin structures. They can bind to linker DNA entering and exiting the nucleosome and regulate transcriptional activity. Tetrahymena thermophila has two histone H1, namely, macronuclear histone H1 and micronuclear histone H1 (Mlh1). Mlh1 is specifically localized at micro-nuclei during growth and starvation stages. Moreover, Mlh1 is localized around micronuclei and forms a specific structure during the conjugation stage. It co-localizes partially with spindle apparatus during micronuclear meiosis. Analysis of MLH1 knock-out revealed that Mlh1 was required for the micronuclear integrity and development during conjugation stage. Overexpression of Mlh1 led to abnormal conjugation progression. RT-PCR analysis indicated that the expression level of HMGB3 increased in delta MLH1 strains, while the expression level of MLH1 increased in delta HMGB3 cells during conjugation. These results indicate that micronuclear integrity and sexual development require normal expression level of Mlh1 and that HmgB3 and Mlh1 may functionally compensate each other in regulating micronuclear structure in T. thermophila.	[Qiao, Juxia; Xu, Jing; Bo, Tao; Wang, Wei] Shanxi Univ, Inst Biotechnol, Minist Educ, Key Lab Chem Biol & Mol Engn, Taiyuan, Shanxi, Peoples R China; [Xu, Jing] Shanxi Univ, Coll Life Sci, Taiyuan, Shanxi, Peoples R China; [Xu, Jing] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Shandong, Peoples R China	Shanxi University; Shanxi University; Ocean University of China	Wang, W (corresponding author), Shanxi Univ, Inst Biotechnol, Minist Educ, Key Lab Chem Biol & Mol Engn, Taiyuan, Shanxi, Peoples R China.	gene@sxu.edu.cn			National Natural Scientific Foundation of China [31471999, 31572253]; International cooperation project of Shanxi Province [2015081032]; Shanxi Scholarship Council of China [2015-008]; Natural Science Foundation of Shanxi Province [2015011078]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); International cooperation project of Shanxi Province; Shanxi Scholarship Council of China; Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province)	This study was supported by grants from the National Natural Scientific Foundation of China (No.31471999), International cooperation project of Shanxi Province (2015081032), and Shanxi Scholarship Council of China(2015-008) to WW, National Natural Scientific Foundation of China (31572253) and Natural Science Foundation of Shanxi Province (2015011078) to JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by grants from the National Natural Scientific Foundation of China (No.31471999, 31572253), International cooperation project of Shanxi Province (2015081032), Natural Science Foundation of Shanxi Province (2015011078), Shanxi Scholarship Council of China (2015-008).	Ali T, 2004, J MOL BIOL, V337, P1123, DOI 10.1016/j.jmb.2004.02.029; ALLIS CD, 1979, P NATL ACAD SCI USA, V76, P4857, DOI 10.1073/pnas.76.10.4857; ALLIS CD, 1984, J CELL BIOL, V99, P1669, DOI 10.1083/jcb.99.5.1669; ALLIS CD, 1982, DEV BIOL, V93, P519, DOI 10.1016/0012-1606(82)90139-7; Bednar J, 2016, BBA-GENE REGUL MECH, V1859, P436, DOI 10.1016/j.bbagrm.2015.10.012; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; CassidyHanley D, 1997, GENETICS, V146, P135; CASSIDYHANLEY D, 1994, GENETICS, V137, P95; CHAPMAN GE, 1976, EUR J BIOCHEM, V61, P69, DOI 10.1111/j.1432-1033.1976.tb09998.x; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; Gunjan A, 1999, J BIOL CHEM, V274, P37950, DOI 10.1074/jbc.274.53.37950; Hamilton E, 2005, GENETICS, V170, P1611, DOI 10.1534/genetics.104.031401; Hashimoto H, 2007, DNA REPAIR, V6, P1584, DOI 10.1016/j.dnarep.2007.05.003; HAYASHI T, 1987, J BIOCHEM-TOKYO, V102, P369, DOI 10.1093/oxfordjournals.jbchem.a122063; Hergeth SP, 2015, EMBO REP, V16, P1439, DOI 10.15252/embr.201540749; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mayor R, 2015, J BIOL CHEM, V290, P7474, DOI 10.1074/jbc.M114.617324; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Nagel S, 2000, J MOL EVOL, V51, P286, DOI 10.1007/s002390010090; Ragab A, 2003, NUCLEIC ACIDS RES, V31, P7083, DOI 10.1093/nar/gkg923; ROTH SY, 1991, EMBO J, V10, P2069, DOI 10.1002/j.1460-2075.1991.tb07738.x; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Song XY, 2007, MOL CELL BIOL, V27, P2648, DOI 10.1128/MCB.01910-06; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; WU M, 1994, MOL CELL BIOL, V14, P10, DOI 10.1128/MCB.14.1.10; WU M, 1986, P NATL ACAD SCI USA, V83, P8674, DOI 10.1073/pnas.83.22.8674; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030630; Xu Jiaxing, 2012, Shengwu Jiagong Guocheng, V10, P7, DOI 10.3969/j.issn.1672-3678.2012.06.002; Xu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10243; Xu J, 2013, GENE, V526, P87, DOI 10.1016/j.gene.2013.05.006; YASUDA H, 1986, J BIOL CHEM, V261, P2349; Zhou YB, 1998, NATURE, V395, P402, DOI 10.1038/26521	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187475	10.1371/journal.pone.0187475	http://dx.doi.org/10.1371/journal.pone.0187475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095884	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200099
J	Sasaki, M; Kato, Y; Fujinami, K; Hirakata, T; Tsunoda, K; Watanabe, K; Akiyama, K; Noda, T				Sasaki, Mariko; Kato, Yu; Fujinami, Kaoru; Hirakata, Toshiaki; Tsunoda, Kazushige; Watanabe, Ken; Akiyama, Kunihiko; Noda, Toru			Advanced quantitative analysis of the sub-retinal pigment epithelial space in recurrent neovascular age-related macular degeneration	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; THERAPY; RANIBIZUMAB	To quantitatively evaluate changes in the sub-retinal pigment epithelial (RPE) space and determine the association with recurrent neovascular age-related macular degeneration (AMD). Twenty-two eyes treated with intravitreal aflibercept for treatment-naive neovascular AMD were studied retrospectively. The sub-RPE area, volume, and central retinal thickness (CRT) were evaluated 1 and 2 months after the loading phase using spectral-domain optical coherence tomography. Recurrence was defined as newly detected neovascular activity during the 6 months after the loading phase. In eyes with recurrent AMD, the sub-RPE area increased significantly (P = 0.036) from 1 to 2 months after the loading phase and the sub-RPE volume increased marginally (P = 0.06). Subgroup analysis showed significant (P = 0.008 and P = 0.016, respectively) increases in the sub-RPE area and volume in typical AMD. In eyes with no recurrence, no significant changes occurred in the two parameters. No significant CRT changes occurred in eyes with or without a recurrence. A quantitative analysis demonstrated an increased likelihood of the sub-RPE space shortly after the loading phase in eyes with recurrent AMD; no changes occurred in eyes without a recurrence. These early changes in the sub-RPE space could indicate disease activity and are valuable for predicting recurrences of neovascular AMD.	[Sasaki, Mariko; Kato, Yu; Fujinami, Kaoru; Hirakata, Toshiaki; Tsunoda, Kazushige; Watanabe, Ken; Akiyama, Kunihiko; Noda, Toru] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Dept Ophthalmol, Tokyo, Japan; [Sasaki, Mariko] Tachikawa Hosp, Dept Ophthalmol, Tokyo, Japan; [Sasaki, Mariko; Fujinami, Kaoru] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Kato, Yu] Metropolitan Komagome Hosp, Dept Ophthalmol, Tokyo, Japan; [Fujinami, Kaoru] UCL Inst Ophthalmol, Genet, London, England	Tachikawa Hospital; Keio University; University of London; University College London	Sasaki, M (corresponding author), Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Dept Ophthalmol, Tokyo, Japan.; Sasaki, M (corresponding author), Tachikawa Hosp, Dept Ophthalmol, Tokyo, Japan.; Sasaki, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	mariko.sasaki@a2.keio.jp	Akiyama, Kunihiko/AAF-6894-2020	Akiyama, Kunihiko/0000-0003-3935-5434; Kato, YU/0000-0003-2568-0084; Sasaki, Mariko/0000-0001-5608-0546	Japan Society for the Promotion of Science, Japan (JSPS KAKENHI) [17K09150]; Grants-in-Aid for Scientific Research [17K09150] Funding Source: KAKEN	Japan Society for the Promotion of Science, Japan (JSPS KAKENHI); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Japan (JSPS KAKENHI, 17K09150)to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbazetto I, 2003, ARCH OPHTHALMOL-CHIC, V121, P1253; Campbell JP, 2012, ARCH OPHTHALMOL-CHIC, V130, P794, DOI 10.1001/archophthalmol.2011.2480; Gregori G, 2011, OPHTHALMOLOGY, V118, P1373, DOI 10.1016/j.ophtha.2010.11.013; Holz FG, 2011, OPHTHALMOLOGY, V118, P663, DOI 10.1016/j.ophtha.2010.12.019; Lalwani GA, 2009, AM J OPHTHALMOL, V148, P43, DOI 10.1016/j.ajo.2009.01.024; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Penha FM, 2013, RETINA-J RET VIT DIS, V33, P459, DOI 10.1097/IAE.0b013e31827d2657; RAYESS N, 2015, AM J OPHTHALMOL, V159, pE1, DOI DOI 10.1016/j.ajo.2014.09.033; Schmidt-Erfurth U, 2016, PROG RETIN EYE RES, V50, P1, DOI 10.1016/j.preteyeres.2015.07.007; Schmidt-Erfurth U, 2015, OPHTHALMOLOGY, V122, P822, DOI 10.1016/j.ophtha.2014.11.017; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Terasaki H, 2002, BRIT J OPHTHALMOL, V86, P321, DOI 10.1136/bjo.86.3.321; Wykoff CC, 2015, OPHTHALMOLOGY, V122, P2514, DOI 10.1016/j.ophtha.2015.08.009; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yasukawa T, 2015, EXPERT REV OPHTHALMO, V10, P105, DOI 10.1586/17469899.2015.1019473	19	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186955	10.1371/journal.pone.0186955	http://dx.doi.org/10.1371/journal.pone.0186955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095879	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200034
J	Henle, AM; Nassar, A; Puglisi-Knutson, D; Youssef, B; Knutson, KL				Henle, Andrea M.; Nassar, Aziza; Puglisi-Knutson, Danell; Youssef, Bahaaeldin; Knutson, Keith L.			Downregulation of TAP1 and TAP2 in early stage breast cancer	PLOS ONE			English	Article							MHC CLASS-I; MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN PRESENTATION; PROTEASOME SUBUNITS; TISSUE MICROARRAYS; INTERFERON-GAMMA; LUNG-CANCER; CELL LINE; TRANSPORTER; EXPRESSION	TAP1-TAP2 heterodimeric complexes are recognized as the transporter associated with antigen processing of major histocompatibility complex class I peptides for recognition by tumor-specific cytotoxic T lymphocytes. In this study, we investigated the immunohistochemical expression of TAP1 and TAP2 in 160 patients with breast cancer and correlated their expression levels with clinicopathologic parameters. The median age of the patient cohort was 52.5 years (range, 30-86 years). Both TAP1 and TAP2 immunohistochemical expression levels correlated significantly with breast cancer characteristics (P <.001). TAP1 expression levels were low to negative in stage I breast tumors. TAP1 and TAP2 levels were significantly higher in grade 3 tumors than low-grade (grade 1 and 2) tumors. TAP1 and TAP2 expression levels were not significantly different among different levels of HER2expressing tumors and did not vary by estrogen and progesterone receptor status or patient age. Both TAP1 and TAP2 overexpression in breast cancer might be an indicator of an aggressive breast tumor.	[Henle, Andrea M.] Carthage Coll, Dept Biol, Kenosha, WI 53140 USA; [Nassar, Aziza] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Puglisi-Knutson, Danell; Youssef, Bahaaeldin; Knutson, Keith L.] Mayo Clin, Dept Immunol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic	Henle, AM (corresponding author), Carthage Coll, Dept Biol, Kenosha, WI 53140 USA.	ahenle@carthage.com			National Institutes of Health [P50-CA116201, R01-CA113861, UL1-TR000135]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health Grants: P50-CA116201, R01-CA113861, and UL1-TR000135, https://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Alimonti J, 2000, NAT BIOTECHNOL, V18, P515, DOI 10.1038/75373; Ambagala APN, 2000, J IMMUNOL, V164, P93, DOI 10.4049/jimmunol.164.1.93; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; CROMME FV, 1994, BRIT J CANCER, V69, P1176, DOI 10.1038/bjc.1994.231; CROMME FV, 1994, J EXP MED, V179, P335, DOI 10.1084/jem.179.1.335; Dovhey SE, 2000, CANCER RES, V60, P5789; Durgeau A, 2011, J IMMUNOL, V187, P5532, DOI 10.4049/jimmunol.1102060; Einstein MH, 2009, CLIN CANCER RES, V15, P1019, DOI 10.1158/1078-0432.CCR-08-1207; El Hage F, 2013, ANN NY ACAD SCI, V1283, P75, DOI 10.1111/j.1749-6632.2012.06777.x; Georgopoulos NT, 2000, ONCOGENE, V19, P4930, DOI 10.1038/sj.onc.1203860; Hicklin DJ, 1996, TISSUE ANTIGENS, V48, P38, DOI 10.1111/j.1399-0039.1996.tb02603.x; Johnsen A, 1998, CANCER RES, V58, P3660; KAKLAMANIS L, 1995, CANCER RES, V55, P5191; KAKLAMANIS L, 1994, AM J PATHOL, V145, P505; Koppers-Lalic D, 2003, ARCH VIROL, V148, P2023, DOI 10.1007/s00705-003-0142-5; Korkolopoulou P, 1996, BRIT J CANCER, V73, P148, DOI 10.1038/bjc.1996.28; Kutsch O, 2002, AIDS RES HUM RETROV, V18, P1319, DOI 10.1089/088922202320886361; Lampen MH, 2011, CURR OPIN IMMUNOL, V23, P293, DOI 10.1016/j.coi.2010.12.005; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Leibowitz MS, 2011, CANCER IMMUNOL IMMUN, V60, P525, DOI 10.1007/s00262-010-0961-7; Liu Y, 2012, CANCER IMMUNOL IMMUN, V61, P789, DOI 10.1007/s00262-011-1137-9; Lou YM, 2005, CANCER RES, V65, P7926, DOI 10.1158/0008-5472.CAN-04-3977; Lou Y, 2008, CLIN CANCER RES, V14, P1494, DOI 10.1158/1078-0432.CCR-07-1066; Lou YM, 2007, VACCINE, V25, P2331, DOI 10.1016/j.vaccine.2006.11.064; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Matsui M, 2002, J GASTROEN HEPATOL, V17, P897, DOI 10.1046/j.1440-1746.2002.02837.x; Moch H, 2001, ADV ANAT PATHOL, V8, P14, DOI 10.1097/00125480-200101000-00002; Setiadi AF, 2007, MOL CELL BIOL, V27, P7886, DOI 10.1128/MCB.01547-07; Simon Ronald, 2004, Drug Discov Today Technol, V1, P41, DOI 10.1016/j.ddtec.2004.08.003; Tao J, 2008, J INVEST DERMATOL, V128, P1991, DOI 10.1038/jid.2008.10; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; van de Rijn M, 2004, HISTOPATHOLOGY, V44, P97, DOI 10.1111/j.1365-2559.2004.01766.x; Vitale M, 1998, CANCER RES, V58, P737; Vitalis TZ, 2005, PLOS PATHOG, V1, P289, DOI 10.1371/journal.ppat.0010036; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Yang TY, 2003, J BIOL CHEM, V278, P15291, DOI 10.1074/jbc.M300954200; Zhang H, 2015, BREAST CANCER RES TR, V151, P555, DOI 10.1007/s10549-015-3443-y; Zhang QJ, 2007, INT J CANCER, V120, P1935, DOI 10.1002/ijc.22371	40	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187323	10.1371/journal.pone.0187323	http://dx.doi.org/10.1371/journal.pone.0187323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091951	Green Submitted, Green Published, gold			2022-12-27	WOS:000414229700056
J	Mei, L; Xu, S; Lu, P; Lin, HP; Guo, YB; Wang, YJ				Mei, Li; Xu, Sanger; Lu, Peng; Lin, Haiping; Guo, Yanbin; Wang, Yongjun			CsrB, a noncoding regulatory RNA, is required for BarA-dependent expression of biocontrol traits in Rahnella aquatilis HX2	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; ESCHERICHIA-COLI; GENES; SYSTEM; METABOLISM; SEQUENCE; STRAINS; VECTORS; PROTEIN; FAMILY	Background Rahnella aquatilis is ubiquitous and its certain strains have the applicative potent as a plant growthpromoting rhizobacteria. R. aquatilis HX2 is a biocontrol agent to produce antibacterial substance (ABS) and showed efficient biocontrol against crown gall caused by Agrobacterium vitis on sunflower and grapevine plants. The regulatory network of the ABS production and biocontrol activity is still limited known. Methodology/Principal findings In this study, a transposon-mediated mutagenesis strategy was used to investigate the regulators that involved in the biocontrol activity of R. aquatilis HX2. A 366-nt noncoding RNA CsrB was identified in vitro and in vivo, which regulated ABS production and biocontrol activity against crown gall on sunflower plants, respectively. The predicted product of noncoding RNA CsrB contains 14 stemloop structures and an additional pindependent terminator harpin, with 23 characteristic GGA motifs in the loops and other unpaired regions. CsrB is required for ABS production and biocontrol activity in the biocontrol regulation by a twocomponent regulatory system BarA/UvrY in R. aquatilis HX2. Conclusion/Significance The noncoding RNA CsrB regulates BarA-dependent ABS production and biocontrol activity in R. aquatilis HX2. To the best of our knowledge, this is the first report of noncoding RNA as a regulator for biocontrol function in R. aquatilis.	[Mei, Li; Xu, Sanger; Lu, Peng; Lin, Haiping; Wang, Yongjun] Zhejiang A&F Univ, Coll Forestry & Biotechnol, Linan, Peoples R China; [Guo, Yanbin] China Agr Univ, Dept Ecol Sci & Engn, Coll Resources & Environm Sci, Beijing, Peoples R China; [Wang, Yongjun] Natl & Prov Joint Engn Lab Biopesticide Preparat, Linan, Peoples R China	Zhejiang A&F University; China Agricultural University	Wang, YJ (corresponding author), Zhejiang A&F Univ, Coll Forestry & Biotechnol, Linan, Peoples R China.; Wang, YJ (corresponding author), Natl & Prov Joint Engn Lab Biopesticide Preparat, Linan, Peoples R China.	wangyj@zafu.edu.cn		Wang, Yongjun/0000-0002-8488-3423	National Natural Science Foundation of China [31200386]; Zhejiang Provincial Natural Science Foundation of China [LY12C14006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China (31200386) and Zhejiang Provincial Natural Science Foundation of China (LY12C14006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons S, 2000, J BACTERIOL, V182, P3913, DOI 10.1128/JB.182.14.3913-3919.2000; Altier C, 2000, MOL MICROBIOL, V35, P635, DOI 10.1046/j.1365-2958.2000.01734.x; Andrews HL, 1998, INFECT IMMUN, V66, P950, DOI 10.1128/IAI.66.3.950-958.1998; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Calvo J, 2007, INT J FOOD MICROBIOL, V113, P251, DOI 10.1016/j.ijfoodmicro.2006.07.003; Chen F, 2007, PLANT DIS, V91, P957, DOI 10.1094/PDIS-91-8-0957; Chen F, 2009, EUR J PLANT PATHOL, V124, P427, DOI 10.1007/s10658-009-9429-z; Cui Y, 2001, MOL PLANT MICROBE IN, V14, P516, DOI 10.1094/MPMI.2001.14.4.516; Dubey AK, 2005, RNA, V11, P1579, DOI 10.1261/rna.2990205; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; El-Hendawy HH, 2005, MICROBIOL RES, V160, P343, DOI 10.1016/j.micres.2005.02.008; El-Hendawy HH, 2003, FOLIA MICROBIOL, V48, P799, DOI 10.1007/BF02931517; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Guigueno A, 2001, J BACTERIOL, V183, P1147, DOI 10.1128/JB.183.4.1147-1158.2001; Guo YB, 2009, APPL ENVIRON MICROB, V75, P6792, DOI 10.1128/AEM.00902-09; Guo YB, 2012, J BACTERIOL, V194, P6646, DOI 10.1128/JB.01769-12; Harfouche L, 2015, NEW PHYTOL, V206, P98, DOI 10.1111/nph.13195; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Iimura K, 1996, INT J FOOD MICROBIOL, V30, P243, DOI 10.1016/0168-1605(96)00949-X; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; LABES M, 1990, GENE, V89, P37, DOI 10.1016/0378-1119(90)90203-4; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115010; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Ma WL, 2001, J BACTERIOL, V183, P1870, DOI 10.1128/JB.183.6.1870-1880.2001; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Sambrook J., 2001, MOL CLONING LAB MANU; Tillett D, 2000, BIOTECHNIQUES, V28, P448, DOI 10.2144/00283st01; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; VERVLIET G, 1975, J GEN VIROL, V26, P33, DOI 10.1099/0022-1317-26-1-33; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Xiao FengHu, 2015, Journal of Zhejiang University (Agriculture and Life Sciences), V41, P56; Yan Q, 2009, MICROBIOL-SGM, V155, P124, DOI 10.1099/mic.0.020750-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187492	10.1371/journal.pone.0187492	http://dx.doi.org/10.1371/journal.pone.0187492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091941	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700069
J	Mitchell, N; Triska, M; Liberatore, A; Ashcroft, L; Weatherill, R; Longnecker, N				Mitchell, Nicola; Triska, Maggie; Liberatore, Andrea; Ashcroft, Linden; Weatherill, Richard; Longnecker, Nancy			Benefits and challenges of incorporating citizen science into university education	PLOS ONE			English	Article							KNOWLEDGE; TOOL	A common feature of many citizen science projects is the collection of data by unpaid contributors with the expectation that the data will be used in research. Here we report a teaching strategy that combined citizen science with inquiry-based learning to offer first year university students an authentic research experience. A six-year partnership with the Australian phenology citizen science program Climate Watch has enabled biology students from the University of Western Australia to contribute phenological data on plants and animals, and to conduct the first research on unvalidated species datasets contributed by public and university participants. Students wrote scientific articles on their findings, peer-reviewed each other's work and the best articles were published online in a student journal. Surveys of more than 1500 students showed that their environmental engagement increased significantly after participating in data collection and data analysis. However, only 31% of students agreed with the statement that "data collected by citizen scientists are reliable" at the end of the project, whereas the rate of agreement was initially 79%. This change in perception was likely due to students discovering erroneous records when they mapped data points and analysed submitted photographs. A positive consequence was that students subsequently reported being more careful to avoid errors in their own data collection, and making greater efforts to contribute records that were useful for future scientific research. Evaluation of our project has shown that by embedding a research process within citizen science participation, university students are given cause to improve their contributions to environmental datasets. If true for citizen scientists in general, enabling participants as well as scientists to analyse data could enhance data quality, and so address a key constraint of broad-scale citizen science programs.	[Mitchell, Nicola; Triska, Maggie; Longnecker, Nancy] Univ Western Australia, Sch Biol Sci, Crawley, WA, Australia; [Liberatore, Andrea; Longnecker, Nancy] Univ Otago, Ctr Sci Commun, Dunedin, New Zealand; [Ashcroft, Linden; Weatherill, Richard] Earthwatch Inst, Melbourne, Vic, Australia; [Ashcroft, Linden] Univ Rovira & Virgili, Ctr Climate Change, Tarragona, Spain; [Weatherill, Richard] Fiona Stanley Hosp, South Metropolitan Hlth Serv, Murdoch, WA, Australia	University of Western Australia; University of Otago; Universitat Rovira i Virgili	Mitchell, N (corresponding author), Univ Western Australia, Sch Biol Sci, Crawley, WA, Australia.	nicola.mitchell@uwa.edu.au	Mitchell, Nicola/AAE-4132-2020; Mitchell, Nicola/K-5277-2012	Longnecker, Nancy/0000-0002-2798-6389; Mitchell, Nicola/0000-0003-0744-984X	University of Western Australia; UWA	University of Western Australia; UWA	The author(s) received no specific funding for this study, but the development of the Journal Project in first year biology teaching was supported by a 'Improving student learning' grant from the University of Western Australia to NM. Further, the project has been supported in-kind by Earthwatch Australia since its inception in 2011.; We thank the 2300+ UWA biology students who have participated in this project and who provided feedback and inspiration for its continual improvement. ClimateWatch staff Kristine Nga, Yue Chin Chew, and Science Director Justin Foster have provided outstanding support to UWA students and teaching staff across various years. We are grateful to unit co-coordinators Susan Barker (2011-2014) and Tim Colmer (2015-2016) for their help with article editing, and teaching support staff Trina Jorre de St Jorre, Mary Webberley, Yvonne Button, Joshua Brown and Jamie Tedeschi for assistance with project organisation. We also commend the efforts of the subject editors of each edition of Cygnus to providing feedback to students on data analysis and scientific writing. This project was initiated with an Improving Student Learning Grant from UWA to NM, and evaluated as part of a UWA teaching internship to MT.	Berkowitz A., 2005, ENV ED ADVOCACY CHAN, P227; Bohn C., 2008, SCI EDIT, V17, P36; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dittrich R, 2007, STAT MODEL, V7, P3, DOI 10.1177/1471082X0600700102; Fukami T, 2013, SCIENCE, V339, P1536, DOI 10.1126/science.1229850; Harnik P. G., 2003, J GEOSCIENCE ED, V51, P76; Hoskins SG, 2011, CBE-LIFE SCI EDUC, V10, P368, DOI 10.1187/cbe.11-03-0027; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Jenkins EW, 1999, INT J SCI EDUC, V21, P703, DOI 10.1080/095006999290363; Jordan R, 2009, FRONT ECOL ENVIRON, V7, P495, DOI 10.1890/070113; Jordan RC, 2011, CONSERV BIOL, V25, P1148, DOI 10.1111/j.1523-1739.2011.01745.x; Karlin M, 2015, SOUTHWEST NAT, V60, P171, DOI 10.1894/SWNAT-D-14-00005.1; Kobori H, 2016, ECOL RES, V31, P1, DOI 10.1007/s11284-015-1314-y; Krasny M., 2005, ENV ED ADVOCACY CHAN, P292; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Krippendorff K, 2012, ENCY RES DESIGN, P669; Kullenberg C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147152; Lederman NG, 1999, ELEC J SCI ED, V3; Martin VY, 2016, BIOSCIENCE, V66, P683, DOI 10.1093/biosci/biw070; Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oberhauser K, 2012, FRONT ECOL ENVIRON, V10, P318, DOI 10.1890/110274; Priest S., 2013, B SCI TECHNOL SOC, V33, P138, DOI [10.1177/0270467614529707, DOI 10.1177/0270467614529707]; R Core Team, 2016, R LANG ENV STAT COMP; Rossiter DG, 2015, GEODERMA, V259, P71, DOI 10.1016/j.geoderma.2015.05.006; Roy HE, UNDERSTANDING CITIZE; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Weller R., 2009, BOOMTOWN 2050 SCENAR	34	33	35	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186285	10.1371/journal.pone.0186285	http://dx.doi.org/10.1371/journal.pone.0186285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091933	Green Published, gold			2022-12-27	WOS:000414229700015
J	Dultz, G; Graubard, BI; Martin, P; Welker, MW; Vermehren, J; Zeuzem, S; McGlynn, KA; Welzel, TM				Dultz, Georg; Graubard, Barry I.; Martin, Paul; Welker, Martin-Walter; Vermehren, Johannes; Zeuzem, Stefan; McGlynn, Katherine A.; Welzel, Tania M.			Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry	PLOS ONE			English	Article							ACTING ANTIVIRAL THERAPY; HEPATOCELLULAR-CARCINOMA; FIBROSIS PROGRESSION; RACIAL-DIFFERENCES; GENDER-DIFFERENCE; CIRRHOSIS; DISEASE; OUTCOMES; RISK; DISPARITIES	Chronic hepatitis C virus (HCV) infection is a leading cause for orthotopic liver transplantation (OLT) in the U.S. We investigated characteristics of HCV-infected patients registered for OLT, and explored factors associated with mortality. Data were obtained from the United Network for Organ Sharing and Organ Procurement and Transplantation network (UNOS/OPTN) registry. Analyses included 41,157 HCV-mono-infected patients >= 18 years of age listed for cadaveric OLT between February 2002 and June 2014. Characteristics associated with pre- and post-transplant survival and time trends over the study period were determined by logistic and Cox proportional hazard regression analyses and Poisson regressions. Most patients were white (69.1%) and male (70.8%). At waitlist registration, mean age was 54.6 years and mean MELD was 16. HCC was recorded in 26.9% of the records. A total of 51.2% of the patients received an OLT, 21.0% died or were too sick; 15.6% were delisted and 10.4% were still waiting. Factors associated with increased waitlist mortality were older age, female gender, blood type 0, diabetes, no HCC and transplant region (p<0.001). OLT recipient characteristics associated with increased risk for post OLT mortality were female gender, age, diabetes, race (p<0.0001), and allocation MELD (p = 0.005). Donor characteristics associated with waitlist mortality included age, ethnicity (p<0.0001) and diabetes (p<0.03). Waitlist registrations and OLTs for HCC significantly increased from 14.4% to 37.3% and 27.8% to 38.5%, respectively (p<0.0001). Pre- and post-transplant survival depended on a variety of patient-, donor-, and allocation-characteristics of which most remain relevant in the DAA-era. Still, intensified HCV screening strategies and timely and effective treatment of HCV are highly relevant to reduce the burden of HCV-related OLTs in the U.S.	[Dultz, Georg; Welker, Martin-Walter; Vermehren, Johannes; Zeuzem, Stefan; Welzel, Tania M.] Univ Hosp Frankfurt, Frankfurt, Germany; [Graubard, Barry I.] NCI, Div Canc Epidemiol & Genet, Biostat Branch, Bethesda, MD 20892 USA; [Martin, Paul] Univ Miami, Hepatol Div, Miami, FL USA; [McGlynn, Katherine A.] NCI, Div Canc Epidemiol & Genet, HREB, Bethesda, MD 20892 USA	Goethe University Frankfurt; Goethe University Frankfurt Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Welzel, TM (corresponding author), Univ Hosp Frankfurt, Frankfurt, Germany.	tania.welzel@kgu.de	Dultz, Georg/AAE-2986-2019; Zeuzem, Stefan/AAE-7435-2019	Dultz, Georg/0000-0003-0775-0907; 	NATIONAL CANCER INSTITUTE [ZIACP010158] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilar M, 2016, LIVER INT OFFICIAL J; Ahn J, 2017, DIGEST DIS SCI, V62, P1051, DOI 10.1007/s10620-017-4469-2; Ananthakrishnan AN, 2008, AM J GASTROENTEROL, V103, P901, DOI 10.1111/j.1572-0241.2008.01809.x; Armstrong GL, 2006, ANN INTERN MED, V144; Asrani SK, 2010, LIVER TRANSPLANT, V16, P1009, DOI 10.1002/lt.22123; Barone M, 2008, TRANSPLANTATION, V85, P844, DOI 10.1097/TP.0b013e318166cc38; Belli LS, 2007, LIVER TRANSPLANT, V13, P733, DOI 10.1002/lt.21093; Beste LA, 2015, GASTROENTEROLOGY, V149, P1471, DOI 10.1053/j.gastro.2015.07.056; Biggins SW, 2012, LIVER TRANSPLANT, V18, P1471, DOI 10.1002/lt.23551; Cheung MCM, 2016, J HEPATOL, V65, P741, DOI 10.1016/j.jhep.2016.06.019; Chhatwal J, 2016, HEPATOLOGY, V64, P1442, DOI 10.1002/hep.28571; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Dyal HK, 2015, DIGEST DIS SCI, V60, P2813, DOI 10.1007/s10620-015-3760-3; Flemming JA, 2017, HEPATOLOGY, V65, P804, DOI 10.1002/hep.28923; Gentry SE, 2013, AM J TRANSPLANT, V13, P2052, DOI 10.1111/ajt.12301; Goldberg D, 2012, LIVER TRANSPLANT, V18, P434, DOI 10.1002/lt.23394; Huo SC, 2007, TRANSPLANTATION, V84, P1406, DOI 10.1097/01.tp.0000282867.92367.d0; Kim WR, 2016, AM J TRANSPLANT, V16, P69, DOI 10.1111/ajt.13668; Lai JC, 2010, AM J TRANSPLANT, V10, P2658, DOI 10.1111/j.1600-6143.2010.03326.x; Lai JC, 2016, AM J TRANSPLANTATION; Lai JC, 2011, HEPATOLOGY, V54, P418, DOI 10.1002/hep.24390; Layden JE, 2012, TRANSPLANTATION, V94, P178, DOI 10.1097/TP.0b013e318253f7fa; Lue A, 2016, WORLD J GASTROENTERO, V22, P4966, DOI 10.3748/wjg.v22.i21.4966; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; McTaggart RA, 2004, LIVER TRANSPLANT, V10, P975, DOI 10.1002/lt.20213; Moylan CA, 2008, JAMA-J AM MED ASSOC, V300, P2371, DOI 10.1001/jama.2008.720; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Myers RP, 2011, J HEPATOL, V54, P462, DOI 10.1016/j.jhep.2010.07.015; Pang PS, 2009, LIVER TRANSPLANT, V15, P1126, DOI 10.1002/lt.21835; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Roche B, 2012, LIVER INT, V32, P120, DOI 10.1111/j.1478-3231.2011.02714.x; Sarkar M, 2015, J HEPATOL, V62, P946, DOI 10.1016/j.jhep.2014.11.023; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Su F, 2016, GASTROENTEROLOGY, V150, P441, DOI 10.1053/j.gastro.2015.10.043; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Trooskin SB, 2007, WORLD J GASTROENTERO, V13, P1074, DOI 10.3748/wjg.v13.i7.1074; Udompap P, 2016, J HEPATOL, V64, P1027, DOI 10.1016/j.jhep.2016.01.009; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yeh HD, 2011, TRANSPLANTATION, V91, P479, DOI 10.1097/TP.0b013e3182066275; Younossi ZM, 2014, ALIMENT PHARM THER, V39, P518, DOI 10.1111/apt.12625; 2016, J HEPATOLOGY, V65, P734	44	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186898	10.1371/journal.pone.0186898	http://dx.doi.org/10.1371/journal.pone.0186898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088255	Green Submitted, gold, Green Published			2022-12-27	WOS:000414088900030
J	Harfouche, M; Chemaitelly, H; Kouyoumjian, SP; Mahmud, S; Chaabna, K; Al-Kanaani, Z; Abu-Raddad, LJ				Harfouche, Manale; Chemaitelly, Hiam; Kouyoumjian, Silva P.; Mahmud, Sarwat; Chaabna, Karima; Al-Kanaani, Zaina; Abu-Raddad, Laith J.			Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC LIVER-DISEASE; HEALTH-CARE WORKERS; RISK-FACTORS; HEMODIALYSIS-PATIENTS; VIRAL-HEPATITIS; DIALYSIS PATIENTS; HIGH PREVALENCE; HCV INFECTION; SEROLOGICAL DIAGNOSIS	Objectives To estimate hepatitis C virus (HCV) viremic rate, defined as the proportion of HCV chronically infected individuals out of all ever infected individuals, in the Middle East and North Africa (MENA). Methods Sources of data were systematically-gathered and standardized databases of the MENA HCV Epidemiology Synthesis Project. Meta-analyses were conducted using DerSimonian Laird random-effects models to determine pooled HCV viremic rate by risk population or subpopulation, country/subregion, sex, and study sampling method. Random-effects meta-regressions were conducted to identify predictors of higher viremic rate. Results Analyses were conducted on 178 measures for HCV viremic rate among 19,593 HCV antibody positive individuals. In the MENA region, the overall pooled mean viremic rate was 67.6% (95% CI: 64.9-70.3%). Across risk populations, the pooled mean rate ranged between 57.4% (95% CI: 49.4-65.2%) in people who inject drugs, and 75.5% (95% CI: 61.0-87.6%) in populations with liver-related conditions. Across countries/subregions, the pooled mean rate ranged between 62.1% (95% CI: 50.0-72.7%) and 70.4% (95% CI: 65.5-75.1%). Similar pooled estimates were further observed by risk subpopulation, sex, and sampling method. None of the hypothesized population-level predictors of higher viremic rate were statistically significant. Conclusions Two-thirds of HCV antibody positive individuals in MENA are chronically infected. Though there is extensive variation in study-specific measures of HCV viremic rate, pooled mean estimates are similar regardless of risk population or subpopulation, country/subregion,HCV antibody prevalence in the background population, or sex. HCV viremic rate is a useful indicator to track the progress in (and coverage of) HCV treatment programs towards the set target of HCV elimination by 2030.	[Harfouche, Manale; Chemaitelly, Hiam; Kouyoumjian, Silva P.; Mahmud, Sarwat; Chaabna, Karima; Al-Kanaani, Zaina; Abu-Raddad, Laith J.] Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar; [Chaabna, Karima; Abu-Raddad, Laith J.] Cornell Univ, Dept Healthcare Policy & Res, Weill Cornell Med, New York, NY 10021 USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University	Abu-Raddad, LJ (corresponding author), Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar.; Abu-Raddad, LJ (corresponding author), Cornell Univ, Dept Healthcare Policy & Res, Weill Cornell Med, New York, NY 10021 USA.	lja2002@qatar-med.cornell.edu	Kouyoumjian, Silva/AEQ-8876-2022; Kouyoumjian, Silva/AAG-9767-2022; Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Chemaitelly, Hiam/0000-0002-8756-6968; Kouyoumjian, Silva/0000-0003-1675-6067	NPRP from Qatar National Research Fund (a member of Qatar Foundation) [9-040-3-008]	NPRP from Qatar National Research Fund (a member of Qatar Foundation)	This publication was made possible by NPRP grant number 9-040-3-008 from the Qatar National Research Fund (a member of Qatar Foundation). The findings achieved herein are solely the responsibility of the authors. The authors are also grateful for infrastructure support provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine-Qatar.; This publication was made possible by NPRP grant number 9-040-3-008 from the Qatar National Research Fund (a member of Qatar Foundation). The findings achieved herein are solely the responsibility of the authors. The authors are also grateful for infrastructure support provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine-Qatar.	Abdel-Aziz F, 2000, HEPATOLOGY, V32, P111, DOI 10.1053/jhep.2000.8438; Abdelnour GE, 1997, EUR J EPIDEMIOL, V13, P863, DOI 10.1023/A:1007468322940; Abdelwahab MS, 2012, ANN SAUDI MED, V32, P200, DOI 10.5144/0256-4947.2012.200; Abdelwahab S, 2012, T ROY SOC TROP MED H, V106, P98, DOI 10.1016/j.trstmh.2011.10.003; Abdollahi A, 2008, IRAN J PATHOL, V3, P119; Abdulkarim AS, 1998, AM J TROP MED HYG, V59, P571, DOI 10.4269/ajtmh.1998.59.571; Abdullah AM, 2012, DIYALA J MED, V3, P9; AbdulQawi K, 2010, CROAT MED J, V51, P219, DOI 10.3325/cmj.2010.51.219; Abu-Raddad LJ, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000386729.56683.33; AbuRaddad LJ, 2010, CHARACTERIZING THE HIV/AIDS EPIDEMIC IN THE MIDDLE EAST AND NORTH AFRICA: TIME FOR STRATEGIC ACTION, P1, DOI 10.1596/978-0-8213-8137-3; Agha S, 1998, RES VIROLOGY, V149, P229, DOI 10.1016/S0923-2516(98)80004-6; Aguilar CE, 2008, J GASTROEN HEPATOL, V23, pE137, DOI 10.1111/j.1440-1746.2007.04949.x; Al-Kanaani Z MS, 2017, EPIDEMIOLOG IN PRESS; Al-Kubaisy W. A., 2006, Eastern Mediterranean Health Journal, V12, P264; Al-Kubaisy WA, 2014, ASIAN PAC J CANCER P, V15, P7725, DOI 10.7314/APJCP.2014.15.18.7725; Al-Naamani Khalid, 2015, Sultan Qaboos Univ Med J, V15, pe46; Al-Sweedan SA, 2011, TURK J HEMATOL, V28, P47, DOI 10.5152/tjh.2011.05; Alvai S, 2005, PEJOUHESH, V29, P213; Amin J, 2007, EPIDEMIOL INFECT, V135, P144, DOI 10.1017/S0950268806006388; Angelico M, 1997, J HEPATOL, V26, P236, DOI 10.1016/S0168-8278(97)80036-0; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Arafa N, 2005, J HEPATOL, V43, P418, DOI 10.1016/j.jhep.2005.03.021; Assarehzadegan MA, 2012, IRAN RED CRESCENT ME, V14, P470; Ayed K, 2003, TRANSPL P, V35, P2573, DOI 10.1016/j.transproceed.2003.09.005; Ayoub H, 2017, HEPATITIS C VI UNPUB; Azarkeivan A, 2011, SCI J IRAN BLOOD TRA, V8, P32; Aziz S, 2011, HEPATOL INT, V5, P677, DOI 10.1007/s12072-010-9229-8; Baha W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-50; Bahri O, 2011, WORLD J HEPATOL, V3, P24, DOI 10.4254/wjh.v3.i1.24; Barakat S, 2009, J PEDIAT GASTROENTER, V48, pE64; Bdour S, 2002, J MED MICROBIOL, V51, P700, DOI 10.1099/0022-1317-51-8-700; Ben Othman S, 2004, PATHOL BIOL, V52, P323, DOI 10.1016/j.patbio.2003.07.001; Benani A, 1997, J MED VIROL, V52, P396, DOI 10.1002/(SICI)1096-9071(199708)52:4&lt;396::AID-JMV9&gt;3.0.CO;2-X; Benouda A, 2009, PATHOL BIOL, V57, P368, DOI 10.1016/j.patbio.2008.07.006; Bensalem A, 2016, J MED VIROL, V88, P1394, DOI 10.1002/jmv.24491; Borenstein M., 2009, INTRO METAANALYSIS; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Broumand Behrooz, 2002, Saudi J Kidney Dis Transpl, V13, P467; Cacoub P, 2000, GASTROEN CLIN BIOL, V24, P169; Chaabna K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149966; Chaabna K, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-146; Chehadeh Wassim, 2011, J Infect Public Health, V4, P200, DOI 10.1016/j.jiph.2011.05.004; Chemaitelly H, 2015, INT J INFECT DIS, V40, P54, DOI 10.1016/j.ijid.2015.09.011; Chemaitelly H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135281; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Colin C, 2001, J VIRAL HEPATITIS, V8, P87, DOI 10.1046/j.1365-2893.2001.00280.x; Cowgill KD, 2004, INT J EPIDEMIOL, V33, P1034, DOI 10.1093/ije/dyh183; Darwish N M, 1995, J Egypt Public Health Assoc, V70, P397; Derbala M, 2014, CLIN EXP GASTROENTER, V7, P427, DOI 10.2147/CEG.S65369; Doblali T, 2014, MED SANTE TROP, V24, P375, DOI 10.1684/mst.2014.0333; Doosti A, 2009, NEW MICROBIOL, V32, P193; El Garf A, 2012, RHEUMATOL INT, V32, P2691, DOI 10.1007/s00296-011-2014-8; El-Kamary SS, 2015, J INFECTION, V70, P512, DOI 10.1016/j.jinf.2015.01.009; El-Karaksy H, 2010, CURR DIABETES REV, V6, P388, DOI 10.2174/157339910793499137; El-Ottol AEY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-210; el-Sadawy Mahmoud, 2004, J Egypt Soc Parasitol, V34, P367; El-Sherbini A, 2003, J TROP PEDIATRICS, V49, P384, DOI 10.1093/tropej/49.6.384; El-Zanaty F., 2009, EGYPT DEMOGRAPHIC HL, DOI DOI 10.1177/0049475514561330; Elzouki AN, 2014, J INFECT PUBLIC HEAL, V7, P534, DOI 10.1016/j.jiph.2014.07.006; ELZOUKI ANY, 1995, NEPHROL DIAL TRANSPL, V10, P475, DOI 10.1093/ndt/10.4.475; Fadlalla FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121873; Faranoush M, 2006, MED J HORMOZGAN U, V10, P77; Farghaly Hekma Saad, 2014, Indian J Endocrinol Metab, V18, P197, DOI 10.4103/2230-8210.129111; Farshadpour F, 2010, INDIAN J MED MICROBI, V28, P54, DOI 10.4103/0255-0857.58731; Flamm S L., 2015, GASTROENTEROL HEPATO, V11, P1; Foullous A., 2015, Journal of Biology, Agriculture and Healthcare, V5, P99; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Ghane Masood, 2012, Pak J Biol Sci, V15, P748, DOI 10.3923/pjbs.2012.748.753; Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639; Gupta Ekta, 2014, Asian J Transfus Sci, V8, P19, DOI 10.4103/0973-6247.126683; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Halawani M, 2012, GENET TEST MOL BIOMA, V16, P46, DOI 10.1089/gtmb.2011.0064; Halawani Mona, 2010, Saudi Pharm J, V18, P35, DOI 10.1016/j.jsps.2009.12.003; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Harfouche M, 2017, EPIDEMIOLOG IN PRESS; Hassane FM, 1998, ALEXANDRIA J PEDIAT, V12, P209; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hmaied F, 2006, J MED VIROL, V78, P185, DOI 10.1002/jmv.20526; Hussein E, 2014, ANN CLIN LAB SCI, V44, P62; HUSSEIN MM, 1994, NEPHROL DIAL TRANSPL, V9, P1072, DOI 10.1093/ndt/9.8.1072; Idrees M, 2008, J DIGEST DIS, V9, P95, DOI 10.1111/j.1751-2980.2008.00329.x; Jhaveri R, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv089; Joukar F, 2011, HEPAT MON, V11, P178; Kalantari H., 2011, Iranian Journal of Clinical Infectious Diseases, V6, P82; Kalil K. A., 2010, Eastern Mediterranean Health Journal, V16, P356; Karim Fawad, 2016, Asian Pac J Cancer Prev, V17, P235; Kassem AS, 2000, J TROP PEDIATRICS, V46, P231, DOI 10.1093/tropej/46.4.231; Khaled M. D., 2014, Journal of Biotechnology Research Center, V8, P11; Khamis HH, 2014, TROPICAL DOCTOR, V46, P21; Khokhar N., 2004, JPMA Journal of the Pakistan Medical Association, V54, P135; Kouyoumjian SP, 2017, CHARACTERIZ IN PRESS; Kumar RM, 1997, EUR J OBSTET GYN R B, V75, P177, DOI 10.1016/S0301-2115(97)00130-9; Lakhouda Gorgi Y, 2010, TUNIS MED, V88, P902; Lioussfi Z, 2014, SAUDI J KIDNEY DIS T, V25, P672, DOI 10.4103/1319-2442.132236; Madwar M A, 1999, J Egypt Public Health Assoc, V74, P313; Mahboob Atiya, 2003, J Coll Physicians Surg Pak, V13, P248; Mahfoud Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-96; Mahfoud Z, 2010, J INFECT DEV COUNTR, V4, P144, DOI 10.3855/jidc.517; Mahmoud GA, 2011, EGYPT RHEUMATOL, V33, P139, DOI 10.1016/j.ejr.2011.05.003; Mahmud S, 2017, EPIDEMIOLOG IN PRESS; Mahmud S, 2017, J MED VIROLOGY; Makhlough A, 2008, SINGAP MED J, V49, P921; Mansouri SD., 2003, ARCH IRAN MED, V6, P5; Mejri S, 2005, J MED VIROL, V76, P185, DOI 10.1002/jmv.20342; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Ministry of Health and Population [Egypt] El-Zanaty and Associates [Egypt] ICF International, 2015, EG HLTH ISS SURV 201; Mohamed HI, 2013, J INFECT PUBLIC HEAL, V6, P186, DOI 10.1016/j.jiph.2012.12.003; Mohamoud YA, 2016, INT J INFECT DIS, V46, P116, DOI 10.1016/j.ijid.2016.03.012; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mostafa A, 2003, J EGYPTIAN NAT CANC, V15, P33; Mouffok NA, 2013, J CLIN EXPT HEPATOLO, V3, pS38; Mousavi F, 2002, A IFN TREATMENT HEPA, V7, P21; Munier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057835; Nafeh MA, 2000, AM J TROP MED HYG, V63, P236, DOI 10.4269/ajtmh.2000.63.236; Nasir A, 2011, INT J DRUG POLICY, V22, P145, DOI 10.1016/j.drugpo.2010.10.006; Obied H. M., 2014, INT J ADV RES, V2, P295; Omar N, 2011, BLOOD COAGUL FIBRIN, V22, P280, DOI 10.1097/MBC.0b013e3283451255; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Quinti I, 1997, DIGEST DIS SCI, V42, P2017, DOI 10.1023/A:1018897813268; Qureshi Huma, 2007, J Pak Med Assoc, V57, P175; Ramia S, 2002, ANN TROP MED PARASIT, V96, P197, DOI 10.1179/000349802125000439; Rashdan A., 2008, Jordan Medical Journal, V42, P179; Rauf A, 2011, EUR J PUBLIC HEALTH, V21, P638, DOI 10.1093/eurpub/ckq084; Rebbani K, 2013, CLIN MICROBIOL INFEC, V19, pE454, DOI 10.1111/1469-0691.12252; Rstudio Team, 2015, RSTUDIO INT DEV R; Sabry A, 2005, VIROLOGY, V334, P10, DOI 10.1016/j.virol.2005.01.013; Said F, 2013, J TROP PEDIATRICS, V59, P309, DOI 10.1093/tropej/fmt017; Salama Khaled M, 2015, Open Access Maced J Med Sci, V3, P287, DOI 10.3889/oamjms.2015.059; SALEH MG, 1994, T ROY SOC TROP MED H, V88, P292, DOI 10.1016/0035-9203(94)90082-5; Samimi-rad K, 2008, IRAN J PUBLIC HEALTH, V37, P146; Samimi-Rad K, 2007, HAEMOPHILIA, V13, P156, DOI 10.1111/j.1365-2516.2006.01415.x; Sassi F, 2000, Saudi J Kidney Dis Transpl, V11, P218; Schwarzer G., 2007, R NEWS, V7, P40; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shalaby S., 2010, Eastern Mediterranean Health Journal, V16, P10; Sharaf-Eldeen S., 2007, Journal of Medical Sciences (Pakistan), V7, P1003; Shemer-Avni Y, 1998, J MED VIROL, V56, P230, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;230::AID-JMV9&gt;3.0.CO;2-8; Shihab SS, 2014, EUR J EXP BIOL, V4, P106; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; StataCorp, 2015, STAT STAT SOFTW REL, V14; Strickland GT, 2002, AM J TROP MED HYG, V67, P436, DOI 10.4269/ajtmh.2002.67.436; Sundus A, 2013, J PAK MED ASSOC, V63, P1566; Tanaka Y, 2004, J MOL EVOL, V58, P191, DOI 10.1007/s00239-003-2541-3; Tawfeeq WF, 2013, MED J BABYLON, V10, P25; Tayeb Z, 2012, CLIN CHEM LAB MED, V50; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; WHO, GLOB HLTH SECT STRAT; World Health Organization, COMB HEP B C REACH E; World Health Organization, GLOB VIR HEP REP LIC; World Health Organization-Regional Office for the Eastern Mediterranean, 2020, EP HEP C VIR WHO E M; Yazaji W, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.046; Youssef A, 2009, INTERVIROLOGY, V52, P123, DOI 10.1159/000219385; Ziaee M, 2005, FAQ KNOWLEDGE, V11, P54; Ziaee M, 2007, HEPAT MON, V7, P11; Zuberi BF, 2009, PAK J MED SCI, V25, P766; Zuure FR, 2013, LIVER INT, V33, P727, DOI 10.1111/liv.12131	158	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187177	10.1371/journal.pone.0187177	http://dx.doi.org/10.1371/journal.pone.0187177			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088252	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900045
J	Sachs, M; Kaplan, J; Sarkissian, AD; Habibi, A				Sachs, Matthew; Kaplan, Jonas; Sarkissian, Alissa Der; Habibi, Assal			Increased engagement of the cognitive control network associated with music training in children during an fMRI Stroop task	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL-CORTEX; RESPONSE-INHIBITION; WORKING-MEMORY; AEROBIC FITNESS; FUNCTIONAL MRI; DEVELOPMENTAL FMRI; EXECUTIVE FUNCTION; MOTOR AREA	Playing a musical instrument engages various sensorimotor processes and draws on cognitive capacities collectively termed executive functions. However, while music training is believed to associated with enhancements in certain cognitive and language abilities, studies that have explored the specific relationship between music and executive function have yielded conflicting results. As part of an ongoing longitudinal study, we investigated the effects of music training on executive function using fMRI and several behavioral tasks, including the Color-Word Stroop task. Children involved in ongoing music training (N = 14, mean age = 8.67) were compared with two groups of comparable general cognitive abilities and socioeconomic status, one involved in sports ("sports" group, N = 13, mean age = 8.85) and another not involved in music or sports ("control" group, N = 17, mean age = 9.05). During the Color-Word Stroop task, children with music training showed significantly greater bilateral activation in the pre-SMA/SMA, ACC, IFG, and insula in trials that required cognitive control compared to the control group, despite no differences in performance on behavioral measures of executive function. No significant differences in brain activation or in task performance were found between the music and sports groups. The results suggest that systematic extracurricular training, particularly music-based training, is associated with changes in the cognitive control network in the brain even in the absence of changes in behavioral performance.	[Sachs, Matthew; Kaplan, Jonas; Sarkissian, Alissa Der; Habibi, Assal] Univ Southern Calif, Brain & Creat Inst, Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90007 USA	University of Southern California	Habibi, A (corresponding author), Univ Southern Calif, Brain & Creat Inst, Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90007 USA.	assal.habibi@usc.edu			USC's Brain & Creativity Institute	USC's Brain & Creativity Institute	This research was funded in part by an anonymous donor and by the USC's Brain & Creativity Institute. None of the research costs or authors' salaries were funded by a tobacco company.; We are also grateful to the Los Angeles Philharmonic, Youth Orchestra of Los Angeles, Heart of Los Angeles, Brotherhood Crusade and their Soccer for Success Program as well as the following elementary schools and community programs in the Los Angeles area: Vermont Avenue Elementary School, Saint Vincent School and Macarthur Park Recreation Center. This research was funded in part by an anonymous donor and by the USC's Brain & Creativity Institute.	Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Aleman X, 2016, PREV SCI, V18; Amer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071630; Anguera JA, 2013, NATURE, P501; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2010, BIOL PSYCHIAT; Bahlmann J, 2015, J NEUROSCI, V35, P3207, DOI 10.1523/JNEUROSCI.2389-14.2015; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; Boebinger D, 2015, J ACOUST SOC AM, V137, P378, DOI 10.1121/1.4904537; Boehler CN, 2010, NEUROIMAGE, V52, P1621, DOI 10.1016/j.neuroimage.2010.04.276; Booth E, 2011, TEACH ARTIST J, V9, P16, DOI 10.1080/15411796.2011.531634; Booth JR, 2005, J CHILD PSYCHOL PSYC, V46, P94, DOI 10.1111/j.1469-7610.2004.00337.x; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown JW, 2005, SCIENCE, P307; Bugos JA, 2007, AGING MENT HEALTH, V11, P464, DOI 10.1080/13607860601086504; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Cai WD, 2014, J NEUROSCI, V34, P14652, DOI 10.1523/JNEUROSCI.3048-14.2014; Chaddock L, 2012, BIOL PSYCHOL, V89, P260, DOI 10.1016/j.biopsycho.2011.10.017; Chaddock-Heyman L, 2014, MONOGR SOC RES CHILD, V79, P25, DOI 10.1111/mono.12129; Chang YK, 2013, EXP BRAIN RES, V225, P187, DOI 10.1007/s00221-012-3360-9; Chao HHA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-75; Clayton KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157638; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Davis CL, 2011, HEALTH PSYCHOL, V30, P91, DOI 10.1037/a0021766; Dege F, 2011, MUSIC PERCEPT, V29, P195, DOI 10.1525/MP.2011.29.2.195; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Diamond A, 2016, DEV COGN NEUROS-NETH, V18, P34, DOI 10.1016/j.dcn.2015.11.005; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fan LY, 2014, PSYCHOL MED, V44, P2661, DOI 10.1017/S0033291714000038; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Flook L, 2010, J APPL SCH PSYCHOL, V26, P70, DOI 10.1080/15377900903379125; Forstmann BU, 2008, J NEUROSCI, V28, P9790, DOI 10.1523/JNEUROSCI.1465-08.2008; Golden C.J., 1978, STROOP COLOR WORD TE; Habibi A., 2014, FRONT HUM NEUROSCI, V8, P1; Hansen M, 2013, PSYCHOL MUSIC, V41, P779, DOI 10.1177/0305735612452186; Hart H, 2012, NEUROSCI BIOBEHAV R, V36, P2248, DOI 10.1016/j.neubiorev.2012.08.003; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Holochwost SJ, 2017, PSYCHOL AESTHET CREA, V11, P147, DOI 10.1037/aca0000112; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Keller K, 2009, NEUROIMAGE, V47, P342, DOI 10.1016/j.neuroimage.2009.04.042; Kleiner M, 2007, PERCEPTION, V36, P14; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Lakes KD, 2004, J APPL DEV PSYCHOL, V25, P283, DOI 10.1016/j.appdev.2004.04.002; Langenecker SA, 2004, NEUROIMAGE, V21, P192, DOI 10.1016/j.neuroimage.2003.08.027; Lee YS, 2007, LEARN INSTR, V17, P336, DOI 10.1016/j.learninstruc.2007.02.010; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Lieberman MD, 2015, P NATL ACAD SCI USA, V112, P15250, DOI 10.1073/pnas.1515083112; Luijten M, 2015, PSYCHIAT RES-NEUROIM, V231, P262, DOI 10.1016/j.pscychresns.2015.01.004; Luna B, 2010, BRAIN COGNITION, V72, P1; Luna B, 2009, ADV CHILD DEV BEHAV, V37, P233, DOI 10.1016/S0065-2407(09)03706-9; Majno M, 2012, ANN NY ACAD SCI, V1252, P56, DOI 10.1111/j.1749-6632.2012.06498.x; Manza P, 2016, NEUROIMAGE, V134, P466, DOI 10.1016/j.neuroimage.2016.04.055; Marsh R, 2006, HUM BRAIN MAPP, V27, P848, DOI 10.1002/hbm.20225; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Moffitt TE, 2011, PNAS, V108; Moreno S, 2014, MUSIC TRAINING INHIB, P9; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nutley SB, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00926; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Peterson BS, 2009, AM J PSYCHIAT, V166, P1286, DOI 10.1176/appi.ajp.2009.08050724; Peterson BS, 2002, COGNITIVE BRAIN RES, V13, P427, DOI 10.1016/S0926-6410(02)00054-X; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ramautar JR, 2006, BRAIN RES; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Roden I, 2014, PSYCHOL MUSIC, V42, P284, DOI 10.1177/0305735612471239; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Schellenberg EG, 2011, BRIT J PSYCHOL, V102, P283, DOI 10.1111/j.2044-8295.2010.02000.x; Schellenberg EG, 2005, CURR DIR PSYCHOL SCI, V14, P317, DOI 10.1111/j.0963-7214.2005.00389.x; Shackman AJ, 2011, NATURE, V12, P29; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Slevc LR, 2016, COGNITION, V152, P199, DOI 10.1016/j.cognition.2016.03.017; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Suskauer SJ, 2008, J COGNITIVE NEUROSCI, V20, P478, DOI 10.1162/jocn.2008.20032; Tamm L., 2004, J AM ACAD CHILD ADOL, V43, P11; Tang YY, 2012, CHILD DEV PERSPECT, V6, P361, DOI 10.1111/j.1750-8606.2012.00250.x; Thorell L.B., 2008, DEVELOPMENTAL SCI, V11, P969, DOI DOI 10.1111/J.1467-7687.2008.00745.X; Travis F, 2011, CONSCIOUS COGN, V20, P1256, DOI 10.1016/j.concog.2011.03.020; Uy M. S., 2012, MUSIC ARTS ACT, V4, P5; Vara AS, 2014, DEV COGN NEUROS-NETH, V10, P129, DOI 10.1016/j.dcn.2014.08.009; Vassena E, 2017, FRONT NEUROSCI, V11, P1; Vassena E, 2016, SCI REP, V6, P1; Verguts T, 2009, TRENDS COGN SCI, P1; Veroude K, 2013, TRENDS NEUROSCI EDUC, V2, P100, DOI 10.1016/j.tine.2013.10.001; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2011, NEUROSCIENCE, V199, P166, DOI 10.1016/j.neuroscience.2011.10.009; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Wagner G, 2006, BIOL PSYCHIAT, V59, P958, DOI 10.1016/j.biopsych.2005.10.025; Watanabe T, 2015, J NEUROSCI, V35, P4813, DOI 10.1523/JNEUROSCI.3761-14.2015; Weschler D, 1999, WECHSLER ABBREVIATED; Wright Andy, 2014, Front Psychol, V5, P213, DOI 10.3389/fpsyg.2014.00213; ZUK J, 2014, PLOS ONE, V9	112	50	50	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187254	10.1371/journal.pone.0187254	http://dx.doi.org/10.1371/journal.pone.0187254			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084283	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200040
J	Koyanagi, A; Stubbs, B; Smith, L; Gardner, B; Vancampfort, D				Koyanagi, Ai; Stubbs, Brendon; Smith, Lee; Gardner, Benjamin; Vancampfort, Davy			Correlates of physical activity among community-dwelling adults aged 50 or over in six low-and middle-income countries	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; OLDER-ADULTS; NONCOMMUNICABLE DISEASES; BACK-PAIN; HEALTH; ASSOCIATION; PEOPLE; DEPRESSION; EXERCISE; ANXIETY	Background Considering that physical activity is associated with healthy ageing and helps to delay, prevent, or manage a plethora of non-communicable diseases in older adults, there is a need to investigate the factors that influence physical activity participation in this population. Thus, we investigated physical activity correlates among community-dwelling older adults (aged >= 50 years) in six low-and middle-income countries. Methods Cross-sectional data were analyzed from the World Health Organization's Study on Global Ageing and Adult Health. Physical activity was assessed by the Global Physical Activity Questionnaire. Participants were dichotomized into low (i.e., not meeting 150 minutes of moderate physical activity per week) and moderate-to-high physically active groups. Associations between physical activity and a range of correlates were examined using multivariable logistic regressions. Results The overall prevalence (95%CI) of people not meeting recommended physical activity levels in 34,129 participants (mean age 62.4 years, 52.1% female) was 23.5% (22.3%-24.8%). In the multivariable analysis, older age and unemployment were significant sociodemographic correlates of low physical activity. Individuals with low body mass index (< 18.5kg/m(2)), bodily pain, asthma, chronic back pain, chronic obstructive pulmonary disease, hearing problems, stroke, visual impairment, slow gait, and weak grip strength were less likely to meet physical activity targets in the overall sample (P < 0.05). The associations varied widely between countries. Conclusion Our data illustrates that a multitude of factors influence physical activity target achievement in older adults, which can inform future interventions across low- and middle-income countries to assist people of this age group to engage in regular physical activity. Future prospective cohort studies are also required to investigate the directionality and mediators of the relationships observed.	[Koyanagi, Ai] Univ Barcelona, Res & Dev Unit, Fundacio St Joan de Deu, Parc Sanitari Sant Joan de Deu, Barcelona, Spain; [Koyanagi, Ai] Inst Salud Carlos III, CIBERSAM, Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Stubbs, Brendon] South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, Denmark Hill, London, England; [Stubbs, Brendon] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, De Crespigny Pk, London, England; [Stubbs, Brendon] Anglia Ruskin Univ, Fac Hlth Social Care & Educ, Chelmsford, England; [Smith, Lee] Anglia Ruskin Univ, Dept Life Sci, Cambridge Ctr Sport & Exercise Sci, Cambridge, England; [Gardner, Benjamin] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, De Crespigny Pk, London, England; [Vancampfort, Davy] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Vancampfort, Davy] Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of London; King's College London; Anglia Ruskin University; Anglia Ruskin University; University of London; King's College London; KU Leuven; KU Leuven	Koyanagi, A (corresponding author), Univ Barcelona, Res & Dev Unit, Fundacio St Joan de Deu, Parc Sanitari Sant Joan de Deu, Barcelona, Spain.; Koyanagi, A (corresponding author), Inst Salud Carlos III, CIBERSAM, Ctr Invest Biomed Red Salud Mental, Madrid, Spain.	a.koyanagi@pssjd.org	Vancampfort, Davy/AAD-1987-2019; Gardner, Benjamin/C-1565-2008; Koyanagi, Ai/D-3833-2018; Stubbs, Brendon/X-1904-2018	Gardner, Benjamin/0000-0003-1223-5934; Koyanagi, Ai/0000-0002-9565-5004; Stubbs, Brendon/0000-0001-7387-3791	Miguel Servet contract [CP13/00150, PI15/00862]; ISCIII - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER); National Institute for Health Research	Miguel Servet contract; ISCIII - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER)(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Ai Koyanagi's work is supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII - General Branch Evaluation and Promotion of Health Research - and the European Regional Development Fund (ERDF-FEDER). Brendon Stubbs receives funding from the National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care Funding scheme. The funders had no role in: design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abubakari AR, 2008, PUBLIC HEALTH, V122, P173, DOI 10.1016/j.puhe.2007.06.012; Arokiasamy P, 2017, AM J EPIDEMIOL, V185, P414, DOI 10.1093/aje/kww125; Atkinson Kaitlin, 2016, Prev Med Rep, V3, P40, DOI 10.1016/j.pmedr.2015.11.009; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Birdee GS, 2013, J ALTERN COMPLEM MED, V19, P550, DOI 10.1089/acm.2012.0223; Blakely T, 2005, B WORLD HEALTH ORGAN, V83, P118; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Cohen-Mansfield J, 2016, INT PSYCHOGERIATR, V28, P557, DOI 10.1017/S1041610215001532; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Daskalopoulou C, 2017, AGEING RES REV, V38, P6, DOI 10.1016/j.arr.2017.06.003; Doi T, 2015, GERIATR GERONTOL INT, V15, P1073, DOI 10.1111/ggi.12407; Endrighi R, 2016, BRIT J PSYCHIAT, V208, P245, DOI 10.1192/bjp.bp.114.150755; Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063315; French MT, 2009, AM J HEALTH PROMOT, V24, P2, DOI 10.4278/ajhp.0801104; Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128; Joint FAO/WHO Expert Consultation, 2003, JOINT WHO FAO EXP CO; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Koyanagi A, 2015, SLEEP, V38, P1875, DOI 10.5665/sleep.5232; Koyanagi A, 2015, J PSYCHIATR RES, V69, P19, DOI 10.1016/j.jpsychires.2015.07.020; Koyanagi A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1362-9; Kravitz AV, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00514; Kumar A, 2016, AGE AGEING, V45, P345, DOI 10.1093/ageing/afw036; Kwak L, 2016, J SCI MED SPORT, V19, P482, DOI 10.1016/j.jsams.2015.05.008; Leach LS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-621; Leasure JL, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00156; Sosa AL, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-48; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; O'Donoghue G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2841-3; Pengpid S, 2015, INT J PUBLIC HEALTH, V60, P539, DOI 10.1007/s00038-015-0680-0; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rubin KH, 2001, DEV PSYCHOPATHOLOGY; Ruegsegger GN, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00109; Sallis JF, 2016, LANCET, V388, P1325, DOI 10.1016/S0140-6736(16)30581-5; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Salmon J, 2000, INT J OBESITY, V24, P600, DOI 10.1038/sj.ijo.0801203; Sazlina SG, 2012, J NUTR HEALTH AGING, V16, P498, DOI 10.1007/s12603-012-0038-8; Smit W, 2016, HEALTH PLACE, V39, P196, DOI 10.1016/j.healthplace.2016.04.006; Smith L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007423; Soundy A, 2014, ARCH PSYCHIAT NURS, V28, P135, DOI 10.1016/j.apnu.2013.12.002; Stewart Williams Jennifer, 2015, BMC Med, V13, P147, DOI 10.1186/s12916-015-0390-8; Stubbs B, 2017, J AFFECT DISORDERS, V208, P545, DOI 10.1016/j.jad.2016.10.028; Stubbs B, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0734-z; Stubbs B, 2016, GEN HOSP PSYCHIAT, V43, P63, DOI 10.1016/j.genhosppsych.2016.09.008; Stubbs B, 2014, PAIN MED, V15, P1861, DOI 10.1111/pme.12570; Tandon A, 2001, STAT METHODS ENHANCI; Teychenne M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1843-x; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Tyrovolas S, 2015, EXPT GERONTOLOGY, V15, P123; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Vancampfort D, 2015, PSYCHIAT DANUBINA, V27; Vancampfort D, 2016, DISABIL REHABIL, V38, P2047, DOI [10.3109/09638288.2015.1114037, 10.1080/09638288.2016.1260645]; Vancampfort D, 2015, ARCH PSYCHIAT NURS, V29, P196, DOI 10.1016/j.apnu.2014.08.006; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Viswanath K, 2006, AM J PUBLIC HEALTH, V96, P1456, DOI 10.2105/AJPH.2003.029793; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wirth K, 2017, AGEING RES REV, V35, P87, DOI 10.1016/j.arr.2016.12.002; World Health Organization, 2010, Global recommendations on physical activity for health; Zamora-Macorra M, 2017, ARCH GERONTOL GERIAT, V68, P113, DOI 10.1016/j.archger.2016.10.005	64	22	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186992	10.1371/journal.pone.0186992	http://dx.doi.org/10.1371/journal.pone.0186992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077744	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000413861200034
J	Passow, CN; Arias-Rodriguez, L; Tobler, M				Passow, Courtney N.; Arias-Rodriguez, Lenin; Tobler, Michael			Convergent evolution of reduced energy demands in extremophile fish	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; WATER-BUG BELOSTOMA; BODY-SIZE; POECILIA-MEXICANA; METABOLIC-RATE; SULFIDE; PREDATION; HYPOXIA; OXYGEN; CAVE	Convergent evolution in organismal function can arise from nonconvergent changes in traits that contribute to that function. Theory predicts that low resource availability and high maintenance costs in extreme environments select for reductions in organismal energy demands, which could be attained through modifications of body size or metabolic rate. We tested for convergence in energy demands and underlying traits by investigating livebearing fish (genus Poecilia) that have repeatedly colonized toxic, hydrogen sulphide-rich springs. We quantified variation in body size and routine metabolism across replicated sulphidic and non-sulphidic populations in nature, modelled total organismal energy demands, and conducted a common-garden experiment to test whether population differences had a genetic basis. Sulphidic populations generally exhibited smaller body sizes and lower routine metabolic rates compared to non-sulphidic populations, which together caused significant reductions in total organismal energy demands in extremophile populations. Although both mechanisms contributed to variation in organismal energy demands, variance partitioning indicated reductions of body size overall had a greater effect than reductions of routine metabolism. Finally, population differences in routine metabolism documented in natural populations were maintained in common-garden reared individuals, indicating evolved differences. In combination with other studies, these results suggest that reductions in energy demands may represent a common theme in adaptation to physiochemical stressors. Selection for reduced energy demand may particularly affect body size, which has implications for life history evolution in extreme environments.	[Passow, Courtney N.; Tobler, Michael] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Arias-Rodriguez, Lenin] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Biol, Villahermosa, Tabasco, Mexico; [Passow, Courtney N.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Kansas State University; Universidad Juarez Autonoma de Tabasco; University of Minnesota System; University of Minnesota Twin Cities	Passow, CN (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.; Passow, CN (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	cpassow@umn.edu	Arias Rodriguez, Lenin/AAE-5577-2022	Tobler, Michael/0000-0002-0326-0890; ARIAS RODRIGUEZ, LENIN/0000-0002-8025-5569	American Livebearing Association; NSF [IOS-1463720, IOS-1557860]; Army Research Office [W911NF-15-1-0175]; Defense University of the U.S. Office of Naval Research [W911NF-16-1-0225]; Kansas State University; Centro de Investigacion e Innovacion para la Ensenanza y el Aprendizaje in Teapa; Direct For Biological Sciences [1557860] Funding Source: National Science Foundation	American Livebearing Association; NSF(National Science Foundation (NSF)); Army Research Office; Defense University of the U.S. Office of Naval Research(Office of Naval Research); Kansas State University; Centro de Investigacion e Innovacion para la Ensenanza y el Aprendizaje in Teapa; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by the American Livebearing Association (http://www. livebearers.org; to CNP), NSF (https://www.nsf. gov; IOS-1463720, and IOS-1557860 to MT), Army Research Office (http://www.ari.army.mil/; W911NF-15-1-0175) and Defense University Research Instrumentation Program of the U.S. Office of Naval Research (https://www.onr.navy. mil., W911NF-16-1-0225 to MT). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. No funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Centro de Investigacion e Innovacion para la Ensenanza y el Aprendizaje in Teapa for their support. We also thank R. Greenway, T. Doumas, C. Keith, and C. Saylor for help in the field and laboratory.	ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Bierbach David, 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/148745; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Burggren WW, 2014, J EXP BIOL, V217, P682, DOI 10.1242/jeb.086132; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; Constantz G.D., 1989, P33; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Council NR, 2010, GUIDE CARE USE LAB A, DOI 10.17226/5140; Culumber ZW, 2016, AQUAT CONSERV, V26, P1155, DOI 10.1002/aqc.2640; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Eifert C, 2015, J ZOOL, V295, P143, DOI 10.1111/jzo.12190; Endler J. A., 1986, NATURAL SELECTION WI; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Greenway R, 2016, EVOLUTION, V70, P2809, DOI 10.1111/evo.13087; Greenway Ryan, 2014, Diversity-Basel, V6, P597; Haney DC, 1997, PHYSIOL ZOOL, V70, P511, DOI 10.1086/515867; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Huppop K., 1985, Bulletin of the National Speleological Society, V47, P136; Huppop K, 2000, ECOSY WORLD, V30, P159; Ip YK, 2004, PHYSIOL BIOCHEM ZOOL, V77, P824, DOI 10.1086/423746; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; ITAZAWA Y, 1986, EXPERIENTIA, V42, P152, DOI 10.1007/BF01952441; Jahn A, 1997, MAR ECOL PROG SER, V154, P175, DOI 10.3354/meps154175; Jeyasingh PD, 2007, ECOL LETT, V10, P282, DOI 10.1111/j.1461-0248.2007.01023.x; Jourdan J, 2014, PEERJ, V2, DOI 10.7717/peerj.490; Kaeuffer R, 2012, EVOLUTION, V66, P402, DOI 10.1111/j.1558-5646.2011.01440.x; Kelley JL, 2016, MOL BIOL EVOL, V33, P1419, DOI 10.1093/molbev/msw020; Klok CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003876; Kohler A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1513, DOI 10.1007/s00265-011-1161-y; Koslow JA, 1996, J FISH BIOL, V49, P54, DOI 10.1111/j.1095-8649.1996.tb06067.x; Landry L, 2010, J EVOLUTION BIOL, V23, P2602, DOI 10.1111/j.1420-9101.2010.02121.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; McClain CR, 2006, J BIOGEOGR, V33, P1578, DOI 10.1111/j.1365-2699.2006.01545.x; Oksanen J., 2019, R PACKAGE VERSION, DOI DOI 10.4135/9781412971874.N145; Palacios M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071069; Parsons PA, 2005, BIOL REV, V80, P589, DOI 10.1017/S1464793105006822; Passow CN, 2017, MOL ECOL, V26, P4211, DOI 10.1111/mec.14198; Passow CN, 2015, PHYSIOL BIOCHEM ZOOL, V88, P371, DOI 10.1086/681053; Pfenninger M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4873; Pichavant K, 2001, J FISH BIOL, V59, P875, DOI [10.1006/jfbi.2001.1702, 10.1111/j.1095-8649.2001.tb00158.x]; Pirozzi I, 2009, COMP BIOCHEM PHYS A, V152, P586, DOI 10.1016/j.cbpa.2009.01.008; Plath M, 2008, BEHAVIOUR, V145, P73, DOI 10.1163/156853908782687241; Plath M, 2007, NATURWISSENSCHAFTEN, V94, P991, DOI 10.1007/s00114-007-0279-2; Plath M, 2013, EVOLUTION, V67, P2647, DOI 10.1111/evo.12133; Plath M, 2011, EVOL ECOL RES, V13, P133; POWELL E, 1989, J MAR RES, V47, P887, DOI 10.1357/002224089785076082; Reznick DN, 1996, AM NAT, V147, P319, DOI 10.1086/285854; Riesch R., 2015, EXTREMOPHILE FISHES, P137; Riesch R, 2014, ECOL LETT, V17, P65, DOI 10.1111/ele.12209; Riesch R, 2010, BIOL J LINN SOC, V101, P417, DOI 10.1111/j.1095-8312.2010.01522.x; Riesch R, 2010, NATURWISSENSCHAFTEN, V97, P133, DOI 10.1007/s00114-009-0613-y; Riesch R, 2009, BEHAV ECOL SOCIOBIOL, V63, P1515, DOI 10.1007/s00265-009-0780-z; Rosenfeld J, 2015, J ANIM ECOL, V84, P4, DOI 10.1111/1365-2656.12260; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schulz-Mirbach T, 2016, J ZOOL, V300, P163, DOI 10.1111/jzo.12366; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; Tieleman BI, 2000, PHYSIOL BIOCHEM ZOOL, V73, P461, DOI 10.1086/317740; Timmerman CM, 2004, J FISH BIOL, V65, P635, DOI 10.1111/j.0022-1112.2004.00474.x; Tobler M, 2008, BIOL LETTERS, V4, P452, DOI 10.1098/rsbl.2008.0259; Tobler M, 2007, ECOL ENTOMOL, V32, P492, DOI 10.1111/j.1365-2311.2007.00892.x; Tobler M, 2006, EXTREMOPHILES, V10, P577, DOI 10.1007/s00792-006-0531-2; Tobler M, 2016, ANNU REV ECOL EVOL S, V47, P239, DOI 10.1146/annurev-ecolsys-121415-032418; Tobler M, 2016, FRESHWATER BIOL, V61, P158, DOI 10.1111/fwb.12691; Tobler M, 2015, FRESHWATER BIOL, V60, P768, DOI 10.1111/fwb.12530; Tobler Michael, 2011, P120; Tobler M, 2011, EVOLUTION, V65, P2213, DOI 10.1111/j.1558-5646.2011.01298.x; Tobler M, 2009, EVOL ECOL RES, V11, P935; Tsuboi M, 2015, EVOLUTION, V69, P190, DOI 10.1111/evo.12556; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Welch JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008776	82	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186935	10.1371/journal.pone.0186935	http://dx.doi.org/10.1371/journal.pone.0186935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077740	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200027
J	Yu, DJ; Wang, WR; Zhang, S; Zhang, WY; Liu, RY				Yu, Dejian; Wang, Wanru; Zhang, Shuai; Zhang, Wenyu; Liu, Rongyu			Hybrid self-optimized clustering model based on citation links and textual features to detect research topics	PLOS ONE			English	Article							COMBINED COCITATION; CORE DOCUMENTS; WORD ANALYSIS; SCIENCE; BIBLIOMETRICS; SIMILARITIES; NETWORKS; 1ST	The challenge of detecting research topics in a specific research field has attracted attention from researchers in the bibliometrics community. In this study, to solve two problems of clustering papers, i.e., the influence of different distributions of citation links and involved textual features on similarity computation, the authors propose a hybrid self-optimized clustering model to detect research topics by extending the hybrid clustering model to identify "core documents". First, the Amsler network, consisting of bibliographic coupling and co-citation links, is created to calculate the citation-based similarity based on the cosine angle of papers. Second, the cosine similarity is also used to compute the text-based similarity, which consists of the textual statistical and topological features. Then, the cosine angle of the linear combination of citation-and text-based similarity is considered as the hybrid similarity. Finally, the Louvain method is applied to cluster papers, and the terms based on term frequency are used to label clusters. To test the performance of the proposed model, a data-set related to the data envelopment analysis field is used for comparison and analysis of clustering results. Based on the benchmark built, different clustering methods with different citation links or textual features are compared according to evaluation measures. The results show that the proposed model can obtain reasonable and effective clustering results, and the research topics of data envelopment analysis field are also analyzed based on the proposed model. As different features are considered in the proposed model compared with previous hybrid clustering models, the proposed clustering model can provide inspiration for further studies on topic identification by other researchers.	[Yu, Dejian; Wang, Wanru; Zhang, Shuai; Zhang, Wenyu; Liu, Rongyu] Zhejiang Univ Finance & Econ, Sch Informat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Finance & Economics	Wang, WR (corresponding author), Zhejiang Univ Finance & Econ, Sch Informat, Hangzhou, Zhejiang, Peoples R China.	wanruwang0401@163.com	Wang, Ruby W/M-7965-2017	Wang, Ruby W/0000-0001-6544-3660; Yu, Dejian/0000-0003-2796-9148	National Natural Science Foundation of China [51375429, 51475410]; Natural Science Foundation of Zhejiang Province [LY17E050010, LY17G010007]; Zhejiang Science & Technology Plan of China [2015C33024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Science & Technology Plan of China	This work has been supported by National Natural Science Foundation of China (nos. 51375429, and 51475410), URL of the funder: http://www.nsfc.gov.cn/; Natural Science Foundation of Zhejiang Province (nos. LY17E050010, and LY17G010007), URL of the funder: http://www.zjnsf.gov.cn/; Zhejiang Science & Technology Plan of China (no. 2015C33024), URL of the funder: http://www.zjsti.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren P, 2009, J INFORMETR, V3, P49, DOI 10.1016/j.joi.2008.11.003; Amancio DR, 2012, PHYSICA A, V391, P1855, DOI 10.1016/j.physa.2011.10.015; Amancio DR, 2015, SCIENTOMETRICS, V105, P1763, DOI 10.1007/s11192-015-1637-z; Amancio DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136076; Amsler R.A., 1972, APPL CITATION BASED; [Anonymous], [No title captured], DOI DOI 10.1103/PhysRevE.69.066133; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyack K, 2017, SCIENTOMETRICS, V111, P1223, DOI 10.1007/s11192-017-2307-0; Boyack KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018029; BRAAM RR, 1991, J AM SOC INFORM SCI, V42, P233, DOI 10.1002/(SICI)1097-4571(199105)42:4<233::AID-ASI1>3.0.CO;2-I; BRAAM RR, 1991, J AM SOC INFORM SCI, V42, P252, DOI 10.1002/(SICI)1097-4571(199105)42:4<252::AID-ASI2>3.0.CO;2-G; Calado P, 2006, J AM SOC INF SCI TEC, V57, P208, DOI 10.1002/asi.20266; CALLON M, 1983, SOC SCI INFORM, V22, P191, DOI 10.1177/053901883022002003; Chen G, 2016, J INFORMETR, V10, P212, DOI 10.1016/j.joi.2016.01.006; Colliander C, 2012, SCIENTOMETRICS, V90, P675, DOI 10.1007/s11192-011-0491-x; Couto T, 2010, INFORM RETRIEVAL, V13, P315, DOI 10.1007/s10791-009-9119-7; Deng ZH, 2010, PATTERN RECOGN, V43, P767, DOI 10.1016/j.patcog.2009.09.010; DILLON M, 1983, INFORM PROCESS MANAG, V19, P402, DOI 10.1016/0306-4573(83)90062-6; Glanzel W, 2011, SCIENTOMETRICS, V88, P297, DOI 10.1007/s11192-011-0347-4; Glanzel W, 1996, SCIENTOMETRICS, V37, P195, DOI 10.1007/BF02093621; Glanzel W, 2017, SCIENTOMETRICS, V111, P1071, DOI 10.1007/s11192-017-2301-6; Glanzel W, 2012, SCIENTOMETRICS, V91, P399, DOI 10.1007/s11192-011-0591-7; Janssens F, 2008, SCIENTOMETRICS, V75, P607, DOI 10.1007/s11192-007-2002-7; Janssens F, 2009, INFORM PROCESS MANAG, V45, P683, DOI 10.1016/j.ipm.2009.06.003; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P688, DOI 10.1109/TCYB.2014.2334595; Jing L, 2007, IEEE T KNOWL DATA EN, V19, P1026, DOI 10.1109/TKDE.2007.1048; KESSLER MM, 1963, AM DOC, V14, P10, DOI 10.1002/asi.5090140103; Kim J, 2016, J ASSOC INF SCI TECH, V67, P1446, DOI 10.1002/asi.23489; Liu RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139245; Liu XH, 2012, SCIENTOMETRICS, V91, P473, DOI 10.1007/s11192-011-0600-x; Liu XH, 2010, J AM SOC INF SCI TEC, V61, P1105, DOI 10.1002/asi.21312; Meng XF, 2015, SCIENTOMETRICS, V105, P1527, DOI 10.1007/s11192-015-1682-7; Merigo JM, 2016, SCIENTOMETRICS, V108, P559, DOI 10.1007/s11192-016-1984-4; Merigo JM, 2016, J BUS ECON MANAG, V17, P397, DOI 10.3846/16111699.2013.807868; Meyer-Brotz F, 2017, SCIENTOMETRICS, V111, P1307, DOI 10.1007/s11192-017-2366-2; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Olson D.L., 2008, TECHNIQUES, DOI [10.1007/978-3-540-76917-0, DOI 10.1007/978-3-540-76917-0]; Qian PJ, 2017, KNOWL-BASED SYST, V130, P33, DOI 10.1016/j.knosys.2017.05.018; Radhakrishnan S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172778; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Salles T, 2016, J ASSOC INF SCI TECH, V67, P1639, DOI 10.1002/asi.23452; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; Silva FN, 2016, J INFORMETR, V10, P487, DOI 10.1016/j.joi.2016.03.008; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Travencolo BAN, 2008, PHYS LETT A, V373, P89, DOI 10.1016/j.physleta.2008.10.069; Wang J, 2013, INFORM SCIENCES, V246, P133, DOI 10.1016/j.ins.2013.05.029; Yu DJ, 2017, INFORM SCIENCES, V418, P619, DOI 10.1016/j.ins.2017.08.031; Yu DJ, 2017, SCIENTOMETRICS, V111, P521, DOI 10.1007/s11192-017-2262-9; Yu DJ, 2016, J INTELL FUZZY SYST, V30, P2727, DOI 10.3233/IFS-152026; Yu DJ, 2015, APPL SOFT COMPUT, V32, P189, DOI 10.1016/j.asoc.2015.03.027; Zhang L, 2016, SCIENTOMETRICS, V106, P369, DOI 10.1007/s11192-015-1705-4	52	20	20	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187164	10.1371/journal.pone.0187164	http://dx.doi.org/10.1371/journal.pone.0187164			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077747	Green Submitted, Green Published, gold			2022-12-27	WOS:000413861200050
J	Geng, XC; Liu, YY; Diersch, S; Kotzsch, M; Grill, S; Weichert, W; Kiechle, M; Magdolen, V; Dorn, J				Geng, Xiaocong; Liu, Yueyang; Diersch, Sandra; Kotzsch, Matthias; Grill, Sabine; Weichert, Wilko; Kiechle, Marion; Magdolen, Viktor; Dorn, Julia			Clinical relevance of kallikrein-related peptidase 9,10,11, and 15 mRNA expression in advanced high-grade serous ovarian cancer	PLOS ONE			English	Article							FAVORABLE PROGNOSTIC MARKER; CELL LUNG-CANCER; BREAST-CANCER; GENE-EXPRESSION; POOR-PROGNOSIS; GASTRIC-CANCER; MULTIPLE KALLIKREINS; MOLECULAR-CLONING; PROSTATE-CANCER; 10 KLK10	KLK9, 10, 11, and 15 may represent potential cancer biomarkers for evaluating ovarian cancer prognosis. In the present study, we selected a homogeneous cohort including 139 patients of advanced high-grade serous ovarian cancer (FIGO stage III/IV) and assessed the mRNA levels of KLK9,10,11, and 15 in tumor tissue by quantitative PCR. No significant associations of KLK9, 10, 11, and 15 mRNA with established clinical parameters (residual tumor mass, ascitic fluid volume) were found. Pronounced correlations between KLK10/KLK11 (r(s)= 0.647) and between KLK9/KLK15 (r(s)= 0.716) mRNA, but not between other combinations, indicate coordinate expression of distinct pairs of peptidases. In univariate Cox regression analysis, elevated KLK11 mRNA levels were significantly linked with prolonged overall survival (OS; p = 0.021) and progression-free survival (PFS; p = 0.008). KLK15 mRNA levels showed a trend towards significance in case of OS (p = 0.06); KLK9 and KLK10 mRNA expression levels were not associated with patients' outcome. In multi-variable Cox analysis, KLK11 mRNA expression levels, apart from residual tumor mass, remained an independent predictive marker for OS (p = 0.007) and PFS (p = 0.015). Here, elevated KLK15 mRNA expression levels turned out to be significantly related to prolonged OS (p = 0.025) as well. High KLK11 but not the other KLK mRNA levels can be considered as strong independent favorable prognostic factor in this major ovarian cancer subtype.	[Geng, Xiaocong; Liu, Yueyang; Diersch, Sandra; Grill, Sabine; Kiechle, Marion; Magdolen, Viktor; Dorn, Julia] Tech Univ Munich, Dept Obstet & Gynecol, Clin Res Unit, Munich, Germany; [Kotzsch, Matthias] Med Lab Ostsachsen, Dresden, Germany; [Weichert, Wilko] Tech Univ Munich, Inst Pathol, Munich, Germany	Technical University of Munich; Technical University of Munich	Magdolen, V (corresponding author), Tech Univ Munich, Dept Obstet & Gynecol, Clin Res Unit, Munich, Germany.	viktor.magdolen@tum.de	Grill, Sabine/AAM-3978-2020		Wilhelm Sander-Stiftung [2016-024.1]; Deutsche Forschungsgemeinschaft [AV 109/74-1, D0 1772/1-1]	Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Wilhelm Sander-Stiftung, grant 2016-024.1, http://wihelm-sander-stiftung.de, (VM); Deutsche Forschungsgemeinschaft, grant AV 109/74-1, http://www.dfg.de (WW); and Deutsche Forschungsgemeinschaft, grant D0 1772/1-1, http://www.dfg.de (JD).	Ahmed N, 2016, BIOL CHEM, V397, P1265, DOI 10.1515/hsz-2016-0177; Alexopoulou DK, 2013, CLIN BIOCHEM, V46, P1453, DOI 10.1016/j.clinbiochem.2013.03.002; Bharaj BB, 2002, PROSTATE, V51, P35, DOI 10.1002/pros.10076; Borgono CA, 2003, INT J CANCER, V106, P605, DOI 10.1002/ijc.11296; Bustin SA, 2013, REAL-TIME PCR: ADVANCED TECHNOLOGIES AND APPLICATIONS, P51; Diamandis EP, 2004, CLIN BIOCHEM, V37, P823, DOI 10.1016/j.clinbiochem.2004.04.009; Diamandis EP, 2002, CANCER RES, V62, P295; Dorn J, 2016, AM J CANCER RES, V6, P61; Drucker KL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1566-5; El Sherbini MAH, 2011, INT J GYNECOL CANCER, V21, P625, DOI 10.1097/IGC.0b013e31821283c3; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Hu JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17426; Jiao X, 2013, WORLD J GASTROENTERO, V19, P9425, DOI 10.3748/wjg.v19.i48.9425; Kioulafa M, 2009, ANN ONCOL, V20, P1020, DOI 10.1093/annonc/mdn733; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Koh SCL, 2011, ARCH GYNECOL OBSTET, V284, P183, DOI 10.1007/s00404-010-1605-z; Kolin DL, 2016, TUMOR BIOL, V37, P437, DOI 10.1007/s13277-015-3802-7; Kroon Evert, 1997, Genes and Function, V1, P309; Kryza T, 2016, BIOCHIMIE, V122, P283, DOI 10.1016/j.biochi.2015.09.002; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Li L, 2015, ONCOL REP, V34, P2325, DOI 10.3892/or.2015.4211; Luo LY, 2003, CANCER RES, V63, P807; Luo LY, 2001, CLIN CANCER RES, V7, P2372; Mavridis K, 2013, PROSTATE, V73, P1191, DOI 10.1002/pros.22667; McIntosh MW, 2007, CLIN CANCER RES, V13, P4422, DOI 10.1158/1078-0432.CCR-06-2224; Paliouras M, 2008, TUMOR BIOL, V29, P63, DOI 10.1159/000135686; Paliouras M, 2007, BREAST CANCER RES TR, V102, P7, DOI 10.1007/s10549-006-9312-y; Petraki CD, 2002, J HISTOCHEM CYTOCHEM, V50, P1247, DOI 10.1177/002215540205000912; Pfaffl MW, 2012, QUANTITATIVE REAL-TIME PCR IN APPLIED MICROBIOLOGY, P53; Planque C, 2006, BIOL CHEM, V387, P783, DOI 10.1515/BC.2006.098; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; Santin AD, 2006, AM J OBSTET GYNECOL, V194, P1296, DOI 10.1016/j.ajog.2005.10.794; Sasaki H, 2006, CLIN LUNG CANCER, V8, P45, DOI 10.3816/CLC.2006.n.032; Seiz L, 2012, BIOL CHEM, V393, P391, DOI 10.1515/hsz-2011-0264; Shigemasa K, 2004, CLIN CANCER RES, V10, P2766, DOI 10.1158/1078-0432.CCR-03-0269; Stephan C, 2003, J UROLOGY, V169, P361, DOI 10.1016/S0022-5347(05)64127-4; Unal D, 2016, CANCER RES TREAT, V48, P98, DOI 10.4143/crt.2014.364; Wen YG, 2011, J SURG ONCOL, V104, P516, DOI 10.1002/jso.21981; White NMA, 2010, BRIT J CANCER, V102, P1244, DOI 10.1038/sj.bjc.6605634; Xu CH, 2014, TUMOR BIOL, V35, P5199, DOI 10.1007/s13277-014-1674-x; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; Yousef GM, 2000, GENOMICS, V65, P184, DOI 10.1006/geno.2000.6159; Yousef GM, 2004, BRIT J CANCER, V90, P167, DOI 10.1038/sj.bjc.6601451; Yousef GM, 2003, BREAST CANCER RES TR, V78, P149, DOI 10.1023/A:1022931403825; Yousef GM, 2003, J CLIN ONCOL, V21, P3119, DOI 10.1200/JCO.2003.09.111; Yousef GM, 2003, CANCER RES, V63, P2223; Yousef GM, 2002, BRIT J CANCER, V87, P1294, DOI 10.1038/sj.bjc.6600590; Yousef GM, 2001, CANCER RES, V61, P7811; Yousef GM, 2001, J BIOL CHEM, V276, P53, DOI 10.1074/jbc.M005432200	50	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186847	10.1371/journal.pone.0186847	http://dx.doi.org/10.1371/journal.pone.0186847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095848	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200025
J	Madbouni, MAZ; Samih, MA; Qureshi, JA; Biondi, A; Namvar, P				Madbouni, Mohammad Ali Ziaei; Samih, Mohammad Amin; Qureshi, Jawwad A.; Biondi, Antonio; Namvar, Peyman			Compatibility of insecticides and fungicides with the zoophytophagous mirid predator Nesidiocoris tenuis	PLOS ONE			English	Article							TUTA-ABSOLUTA; BIOLOGICAL-CONTROL; BEMISIA-TABACI; LIFE-HISTORY; HYMENOPTERA-APHELINIDAE; ERETMOCERUS-EREMICUS; NATURAL ENEMIES; HOST-PLANT; PESTICIDES; TOMATO	Nesidiocoris tenuis (Reuter) (Hemiptera: Miridae) is an effective predator of multiple pests of vegetable crops, such as thrips, mites, aphids, whiteflies, leafminers. It is mass-reared and released for augmentative biocontrol programs mainly aimed at controlling whiteflies and Tuta absoluta (Meyrick) (Lepidoptera: Gelechiidae) in greenhouses and open field. We evaluated the lethal and sublethal toxicity upon N. tenuis adults of label doses of three insecticides (pyriproxyfen, spirotetramat, cypermethrin) and seven fungicides (benomyl, chlor-othalonil, copper oxychloride, cyazofamid, fluopicolide + propamocarb hydrochloride (FPH), penconazol, trifloxystrobin) commonly used in various crops. Two exposure routes were tested: (i) contact with dry residues of insecticides or fungicides on tomato sprouts and (ii) multiple exposure to these chemicals via topical sprays on adults which foraged on treated sprouts; and fed on treated eggs of Ephestia kuehniella (Zeller) (Lepidoptera: Pyralidae) simultaneously. Mortality and reproductive capacity were investigated as indicators of lethal and sublethal effects on N. tenius. The tested insecticides and fungicides were all classified as harmless when predator was exposed only to the dry residues of each. However, the multiple exposure to either cypermethrin, benomyl, chlorothalonil, copper oxychloride or trifloxystrobin caused significant mortality of N. tenuis adults. Cypermethrin also significantly reduced its reproductive capacity. Interestingly, N. tenuis produced a higher number of progeny when exposed to fungicides penconazol and FPH in both exposure scenarios. Overall, findings suggest that the two insecticides, pyriproxyfen and spirotetramat but not cypermethrin, and all tested fungicides can be considered compatible with N. tenuis.	[Madbouni, Mohammad Ali Ziaei; Samih, Mohammad Amin] Vali e Asr Univ Rafsanjan, Coll Agr, Dept Plant Protect, Rafsanjan, Iran; [Qureshi, Jawwad A.] Univ Florida, IFAS, Indian River Res & Educ Ctr, Dept Entomol & Nematol, Ft Pierce, FL USA; [Biondi, Antonio] Univ Catania, Dept Agr Food & Environm, Via Santa Sofia, Catania, Italy; [Namvar, Peyman] AREEO, South Kerman Agr & Nat Resources Res & Educ Ctr, Plant Protect Res Dept, Jiroft, Iran	State University System of Florida; University of Florida; University of Catania	Qureshi, JA (corresponding author), Univ Florida, IFAS, Indian River Res & Educ Ctr, Dept Entomol & Nematol, Ft Pierce, FL USA.	jawwadq@ufl.edu	BIONDI, Antonio/I-6381-2012	BIONDI, Antonio/0000-0002-1982-7716; Qureshi, Jawwad/0000-0001-9076-4079	department of plant protection at Vali-e Asr University of Rafsanjani (Rafsanjani, Iran); department of plant protection in Agricultural and Natural Resources Research Center of Southern Kerman (Jiroft, Iran); Italian Ministry of Education, University and Research (SIR project) [RBSI14I02A]; EU FP7 [618127]	department of plant protection at Vali-e Asr University of Rafsanjani (Rafsanjani, Iran); department of plant protection in Agricultural and Natural Resources Research Center of Southern Kerman (Jiroft, Iran); Italian Ministry of Education, University and Research (SIR project); EU FP7(European Commission)	We are grateful to the department of plant protection at Vali-e Asr University of Rafsanjani (Rafsanjani, Iran) and the department of plant protection in Agricultural and Natural Resources Research Center of Southern Kerman (Jiroft, Iran) for providing financial support for this research to Mohammad Amin Samih. Antonio Biondi was founded by EU FP7 no. 618127 ARIMNet2 (Stomp project) and the Italian Ministry of Education, University and Research (SIR project, RBSI14I02A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to the department of plant protection at Vali-e Asr University of Rafsanjani (Rafsanjani, Iran) and the department of plant protection in Agricultural and Natural Resources Research Center of Southern Kerman (Jiroft, Iran) for providing financial support for this research to Mohammad Amin Samih. Antonio Biondi was founded by EU FP7 no. 618127 ARIMNet2 (Stomp project) and the Italian Ministry of Education, University and Research (SIR project, RBSI14I02A).	Abbes K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138411; Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Alomar O, 2006, BIOL CONTROL, V36, P154, DOI 10.1016/j.biocontrol.2005.08.010; Arie T, 2007, PLANT BIOTECHNOL-NAR, V24, P135, DOI 10.5511/plantbiotechnology.24.135; Bengochea P, 2014, BIOCONTROL SCI TECHN, V24, P625, DOI 10.1080/09583157.2014.884212; Bernard MB, 2010, J ECON ENTOMOL, V103, P2061, DOI 10.1603/EC09357; Biondi A, 2015, J ECON ENTOMOL, V108, P1191, DOI 10.1093/jee/tov045; Biondi A, 2018, ANNU REV ENTOMOL, V63, P239, DOI 10.1146/annurev-ento-031616-034933; Biondi A, 2016, BIOCONTROL, V61, P79, DOI 10.1007/s10526-015-9700-5; Biondi A, 2015, CHEMOSPHERE, V128, P142, DOI 10.1016/j.chemosphere.2015.01.034; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Bozsik A, 2006, PEST MANAG SCI, V62, P651, DOI 10.1002/ps.1221; Broughton S, 2014, PEST MANAG SCI, V70, P389, DOI 10.1002/ps.3565; Calvo FJ, 2012, BIOCONTROL, V57, P809, DOI 10.1007/s10526-012-9455-1; Calvo J, 2009, BIOCONTROL, V54, P237, DOI 10.1007/s10526-008-9164-y; Campos MR, 2017, J PEST SCI, V90, P787, DOI 10.1007/s10340-017-0867-7; Carvalho Geraldo A., 2006, IOBC-WPRS Bulletin, V29, P349; Carvalho Geraldo A., 2006, IOBC-WPRS Bulletin, V29, P355; Castane C, 1996, ENTOMOPHAGA, V41, P211, DOI 10.1007/BF02764246; Chailleux A, 2013, J ECON ENTOMOL, V106, P2310, DOI 10.1603/EC13092; Velasco-Hernandez MC, 2015, PEST MANAG SCI, V71, P1346, DOI 10.1002/ps.3938; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Drobnjakovic T, 2016, ENTOMOL GEN, V35, P281, DOI 10.1127/entomologia/2016/0183; El-Arnaouty SA, 2014, AFR ENTOMOL, V22, P801, DOI 10.4001/003.022.0410; Francesena N, 2012, Commun Agric Appl Biol Sci, V77, P727; Garcera C, 2013, J ECON ENTOMOL, V106, P2126, DOI 10.1603/EC12510; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Hall DG, 2010, BIOCONTROL, V55, P601, DOI 10.1007/s10526-010-9283-0; Hassan S. A., 1994, Bulletin OILB/SROP, V17, P1; Hoddle MS, 2001, BIOL CONTROL, V20, P122, DOI 10.1006/bcon.2000.0885; Jansen JP, 1996, ENTOMOPHAGA, V41, P37, DOI 10.1007/BF02893290; Martinou AF, 2014, CHEMOSPHERE, V96, P167, DOI 10.1016/j.chemosphere.2013.10.024; Michaud J. P., 2001, Journal of Insect Science (Tucson), V1, P1; Mills NJ, 2016, BIOL CONTROL, V102, P17, DOI 10.1016/j.biocontrol.2015.05.006; Molla O, 2014, BIOCONTROL, V59, P175, DOI 10.1007/s10526-013-9553-8; Nauen R., 2008, Bayer CropScience Journal, V61, P245; OOMEN P A, 1991, Bulletin OEPP, V21, P701, DOI 10.1111/j.1365-2338.1991.tb01304.x; Perdikis D, 2016, ENTOMOL GEN, V35, P297, DOI 10.1127/entomologia/2016/0219; Planes L, 2013, J PEST SCI, V86, P321, DOI 10.1007/s10340-012-0440-3; Pratissoli D, 2010, CHIL J AGR RES, V70, P323; Qureshi JA, PLOS ONE, V9; Rimoldi F, 2008, ENVIRON ENTOMOL, V37, P1252, DOI 10.1603/0046-225X(2008)37[1252:SOCEEN]2.0.CO;2; Roditakis E, 2014, PEST MANAG SCI, V70, P1460, DOI 10.1002/ps.3723; Salehi Z, 2016, ENTOMOL GEN, V36, P127, DOI 10.1127/entomologia/2016/0339; Sanchez JA, 2009, J APPL ENTOMOL, V133, P125, DOI 10.1111/j.1439-0418.2008.01342.x; SARODE SV, 1999, STEPH PESTICIDE RES, V11, P97; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Urbaneja A, 2005, BIOCONTROL SCI TECHN, V15, P513, DOI 10.1080/09583150500088777; Urbaneja A, 2008, PEST MANAG SCI, V64, P834, DOI 10.1002/ps.1572; Urbaneja-Bernat P, 2013, BIOCONTROL, V58, P57, DOI 10.1007/s10526-012-9466-y; Vanaclocha P, 2013, J PEST SCI, V86, P329, DOI 10.1007/s10340-012-0448-8; Vos CM, 2014, BIOL CONTROL, V74, P65, DOI 10.1016/j.biocontrol.2014.04.004; Wanumen AC, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew084; Yardim EN, 1998, AGR ECOSYST ENVIRON, V70, P31, DOI 10.1016/S0167-8809(97)00160-6; Zappala L, 2012, J APPL ENTOMOL, V136, P401, DOI 10.1111/j.1439-0418.2011.01662.x; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9	56	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187439	10.1371/journal.pone.0187439	http://dx.doi.org/10.1371/journal.pone.0187439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095873	gold, Green Submitted, Green Published			2022-12-27	WOS:000414340200091
J	Frison, S; Kerac, M; Checchi, F; Nicholas, J				Frison, Severine; Kerac, Marko; Checchi, Francesco; Nicholas, Jennifer			A novel, efficient method for estimating the prevalence of acute malnutrition in resource-constrained and crisis-affected settings: A simulation study	PLOS ONE			English	Article							UPPER ARM CIRCUMFERENCE; WEIGHT-FOR-HEIGHT; LOW-INCOME; HIGH-RISK; NUTRITION; CHILDREN; DEATH	Introduction The assessment of the prevalence of acute malnutrition in children under five is widely used for the detection of emergencies, planning interventions, advocacy, and monitoring and evaluation. This study examined PROBIT Methods which convert parameters (mean and standard deviation (SD)) of a normally distributed variable to a cumulative probability below any cut-off to estimate acute malnutrition in children under five using Middle-Upper Arm Circumference (MUAC). Methods We assessed the performance of: PROBIT Method I, with mean MUAC from the survey sample and MUAC SD from a database of previous surveys; and PROBIT Method II, with mean and SD of MUAC observed in the survey sample. Specifically, we generated sub samples from 852 survey datasets, simulating 100 surveys for eight sample sizes. Overall the methods were tested on 681 600 simulated surveys. Results PROBIT methods relying on sample sizes as small as 50 had better performance than the classic method for estimating and classifying the prevalence of acute malnutrition. They had better precision in the estimation of acute malnutrition for all sample sizes and better coverage for smaller sample sizes, while having relatively little bias. They classified situations accurately for a threshold of 5% acute malnutrition. Both PROBIT methods had similar outcomes. Conclusions PROBIT Methods have a clear advantage in the assessment of acute malnutrition prevalence based on MUAC, compared to the classic method. Their use would require much lower sample sizes, thus enable great time and resource savings and permit timely and/or locally relevant prevalence estimates of acute malnutrition for a swift and well-targeted response.	[Frison, Severine; Kerac, Marko; Checchi, Francesco; Nicholas, Jennifer] LSHTM, Dept Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine	Frison, S (corresponding author), LSHTM, Dept Populat Hlth, London, England.	severine.frison@gmail.com	Kerac, Marko/G-1777-2010; Kerac, Marko/GQR-1136-2022	Kerac, Marko/0000-0002-3745-7317; Frison, Severine/0000-0002-1586-9564; Checchi, Francesco/0000-0001-9030-5382	OFDA [ITDCZD07]; WFP [ITDCZD07]; National Institute for Health Research [ACF-2008-18-010, CL-2012-18-005] Funding Source: researchfish	OFDA; WFP; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by OFDA and WFP, grant number ITDCZD07.	ALAM N, 1989, AM J CLIN NUTR, V49, P884, DOI 10.1093/ajcn/49.5.884; Ale FGB, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0149-5; [Anonymous], 1995, PHYS STAT UINT ANT; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; BINKIN N, 1992, DISASTERS, V16, P97, DOI 10.1111/j.1467-7717.1992.tb00383.x; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blackwell N, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0074-z; Blanton CJ, PROBIT APPROACH ESTI; BRIEND A, 1986, BRIT MED J, V293, P373, DOI 10.1136/bmj.293.6543.373; BRIEND A, 1989, EUR J CLIN NUTR, V43, P715; BRIEND A, 1987, LANCET, V2, P725; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Dale NM, 2013, PUBLIC HEALTH NUTR, V16, P858, DOI 10.1017/S1368980012003345; Darcy J, ACCORDING NEED BRITA; Frison S, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0048-9; Frison S, 2015, AM J CLIN NUTR, V102, P1176, DOI 10.3945/ajcn.115.108282; Shoham J, 2001, USE NUTR INDICATORS; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; Tuffrey V., 2016, BMC NUTR, V2; Tuffrey V., 2016, NUTR SURVEILLANCE SY; Tuffrey V, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0045-z; United Nations' Children's Fund (UNICEF), 2015, STAT WORLDS CHILDR 2; Vella V, PUBLIC HEAL BRIEFS; Young H, 2004, LANCET, V364, P1899, DOI 10.1016/S0140-6736(04)17447-3; Young H., 2006, HUMANITARIAN PRACTIC, V44, P1; Young H., 2009, REV NUTR MORTALITY I, P78	26	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186328	10.1371/journal.pone.0186328	http://dx.doi.org/10.1371/journal.pone.0186328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091927	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000414229700016
J	Hung, SK; Ng, CJ; Kuo, CF; Goh, ZNL; Huang, LH; Li, CH; Chan, YL; Weng, YM; Seak, JCY; Seak, CK; Seak, CJ				Hung, Shang-Kai; Ng, Chip-Jin; Kuo, Chang-Fu; Goh, Zhong Ning Leonard; Huang, Lu-Hsiang; Li, Chih-Huang; Chan, Yi-Ling; Weng, Yi-Ming; Seak, Joanna Chen-Yeen; Seak, Chen-Ken; Seak, Chen-June			Comparison of the Mortality in Emergency Department Sepsis Score, Modified Early Warning Score, Rapid Emergency Medicine Score and Rapid Acute Physiology Score for predicting the outcomes of adult splenic abscess patients in the emergency department	PLOS ONE			English	Article							APACHE-II; MULTICENTER; INFECTION; SEVERITY; TAIWAN	Background Splenic abscess is rare but has mortality rates as high as 14% even with recent improvements in management. Early and appropriate intervention may improve patient outcomes, yet at present there is no identified method that can predict mortality risk rapidly and accurately for emergency physicians, surgeons, and intensivists to decide on the ideal course of action. Objective This study aims to evaluate the performance of Mortality in Emergency Department Sepsis Score (MEDS), Modified Early Warning Score (MEWS), Rapid Emergency Medicine Score (REMS) and Rapid Acute Physiology Score (RAPS) for predicting the mortality risk of adult splenic abscess patients. This will expedite decision making in the emergency department (ED) to increase survival rates and help avoid unnecessary splenectomies. Methods Data of 114 adult patients admitted to the EDs of 4 research and training hospitals who had undergone an abdominal contrast CT scan and diagnosed with splenic abscess between Jan 2000 and April 2015 were analyzed. The MEDS, MEWS, REMS, and RAPS and their corresponding mortality risks were calculated, with their abilities to predict patient mortality assessed through receiver operating characteristic curve analysis and calibration analysis. Results MEDS was found to be the best performing scoring system across all indicators, with sensitivity, specificity, and accuracy of 92.86%, 88.00%, and 88.60% respectively; its area under curve for AUROC analysis was 0.92. With a cutoff value of 8, negative predictive value of MEDS was 98.88%. Conclusion Our series is the largest multicenter study in adult ED patients with splenic abscess. The results from the present study show that MEDS is superior to MEWS, REMS and RAPS in predicting mortality, thus allowing earlier detection of critically ill adult ED splenic abscess patients. Therefore, we recommend that MEDS be used for predicting severity of illness and risk stratification in these patients.	[Hung, Shang-Kai; Ng, Chip-Jin; Li, Chih-Huang; Chan, Yi-Ling; Weng, Yi-Ming; Seak, Chen-June] Chang Gung Mem Hosp, Dept Emergency Med, Lin Kou Med Ctr, Taoyuan, Taiwan; [Ng, Chip-Jin; Li, Chih-Huang; Chan, Yi-Ling; Weng, Yi-Ming; Seak, Chen-June] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Kuo, Chang-Fu; Huang, Lu-Hsiang] Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Kuo, Chang-Fu] Univ Nottingham, Sch Med, Div Rheumatol Orthoped & Dermatol, Nottingham, England; [Goh, Zhong Ning Leonard] Int Med Univ, Sch Med, Kuala Lumpur, Malaysia; [Seak, Joanna Chen-Yeen; Seak, Chen-Ken] Sarawak Gen Hosp, Kuching, Sarawak, Malaysia; [Seak, Chen-June] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; University of Nottingham; International Medical University Malaysia; National Taiwan University	Seak, CJ (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, Lin Kou Med Ctr, Taoyuan, Taiwan.; Seak, CJ (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Seak, CJ (corresponding author), Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan.	julianseak@hotmail.com	Smith, Gary B/A-8235-2013; bulut, mehtap/AAX-5571-2021	Goh, Zhong Ning Leonard/0000-0002-9252-0323; SEAK, CHEN-JUNE/0000-0003-0984-8385	Chang Gung Memorial Hospital in Taiwan [CORPG3F0931]; Maintenance Project for Center for Big Data Analytics and Statistics from Chang Gung Memorial Hospital for Statistical Analysis [CLRPG3D0043]	Chang Gung Memorial Hospital in Taiwan(Chang Gung Memorial Hospital); Maintenance Project for Center for Big Data Analytics and Statistics from Chang Gung Memorial Hospital for Statistical Analysis	The current study was supported by Chang Gung Memorial Hospital in Taiwan (CORPG3F0931). The authors also wish to acknowledge the support of the Maintenance Project for Center for Big Data Analytics and Statistics (Grant CLRPG3D0043) from Chang Gung Memorial Hospital for Statistical Analysis. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulut M, 2014, EMERG MED J, V31, P476, DOI 10.1136/emermed-2013-202444; Chang KC, 2006, WORLD J GASTROENTERO, V12, P460, DOI 10.3748/wjg.v12.i3.460; Chen CC, 2006, EMERG MED J, V23, P281, DOI 10.1136/emj.2004.020933; CHUN CH, 1980, MEDICINE, V59, P50, DOI 10.1097/00005792-198001000-00003; Goodacre S, 2006, EMERG MED J, V23, P372, DOI 10.1136/emj.2005.028522; Hargrove J, 2005, CRIT CARE, V9, P376, DOI 10.1186/cc3518; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kuo SH, 2013, AM J EMERG MED, V31, P916, DOI 10.1016/j.ajem.2013.02.045; Lee CC, 2008, SHOCK, V29, P322, DOI 10.1097/SHK.0b013e31815077ca; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Liu YH, 2014, J MICROBIOL IMMUNOL, V47, P104, DOI 10.1016/j.jmii.2012.08.027; NELKEN N, 1987, AM J SURG, V154, P27, DOI 10.1016/0002-9610(87)90285-6; Olsson T, 2004, J INTERN MED, V255, P579, DOI 10.1111/j.1365-2796.2004.01321.x; Olsson T, 2003, ACAD EMERG MED, V10, P1040, DOI 10.1197/S1069-6563(03)00342-7; Ooi LLPJ, 1997, AM J SURG, V174, P87; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Vanderschueren S, 2000, CRIT CARE MED, V28, P1871, DOI 10.1097/00003246-200006000-00031; Wang JY, 2016, AM J EMERG MED, V34, P1788, DOI 10.1016/j.ajem.2016.06.015; Williams JM, 2016, CRIT CARE MED, V44, P539, DOI 10.1097/CCM.0000000000001427	19	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187495	10.1371/journal.pone.0187495	http://dx.doi.org/10.1371/journal.pone.0187495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091954	gold, Green Submitted, Green Published			2022-12-27	WOS:000414229700070
J	Boiko, N; Medrano, G; Montano, E; Jiang, N; Williams, CR; Madungwe, NB; Bopassa, JC; Kim, CC; Parrish, JZ; Hargreaves, KM; Stockand, JD; Eaton, BA				Boiko, Nina; Medrano, Geraldo; Montano, Elizabeth; Jiang, Nan; Williams, Claire R.; Madungwe, Ngonidzashe B.; Bopassa, Jean C.; Kim, Charles C.; Parrish, Jay Z.; Hargreaves, Kenneth M.; Stockand, James D.; Eaton, Benjamin A.			TrpA1 activation in peripheral sensory neurons underlies the ionic basis of pain hypersensitivity in response to vinca alkaloids	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; POTENTIAL ANKYRIN 1; ACETYL-L-CARNITINE; NEUROPATHIC PAIN; NERVE HYPEREXCITABILITY; MECHANOSENSORY NEURONS; NOCICEPTIVE NEURONS; DROSOPHILA LARVAL; COLD HYPERALGESIA; PACLITAXEL	Chemotherapy induced peripheral neuropathy (CIPN), a side effect of many anti-cancer drugs including the vinca alkaloids, is characterized by a severe pain syndrome that compromises treatment in many patients. Currently there are no effective treatments for this pain syndrome except for the reduction of anti-cancer drug dose. Existing data supports the model that the pain associated with CIPN is the result of anti-cancer drugs augmenting the function of the peripheral sensory nociceptors but the cellular mechanisms underlying the effects of anti-cancer drugs on sensory neuron function are not well described. Studies from animal models have suggested a number of disease etiologies including mitotoxicity, axonal degeneration, immune signaling, and reduced sensory innervations but these outcomes are the result of prolonged treatment paradigms and do not necessarily represent the early formative events associated with CIPN. Here we show that acute exposure to vinca alkaloids results in an immediate pain syndrome in both flies and mice. Furthermore, we demonstrate that exposure of isolated sensory neurons to vinca alkaloids results in the generation of an inward sodium current capable of depolarizing these neurons to threshold resulting in neuronal firing. These neuronal effects of vinca alkaloids require the transient receptor potential ankyrin-1 (TrpA1) channel, and the hypersensitization to painful stimuli in response to the acute exposure to vinca alkaloids is reduced in TrpA1 mutant flies and mice. These findings demonstrate the direct excitation of sensory neurons by CIPN-causing chemotherapy drugs, and identify TrpA1 as an important target during the pathogenesis of CIPN.	[Boiko, Nina; Medrano, Geraldo; Montano, Elizabeth; Madungwe, Ngonidzashe B.; Bopassa, Jean C.; Stockand, James D.; Eaton, Benjamin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Jiang, Nan; Williams, Claire R.; Parrish, Jay Z.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Kim, Charles C.] Verily, San Francisco, CA USA; [Hargreaves, Kenneth M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health San Antonio	Eaton, BA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA.	eatonb@uthscsa.edu	Jiang, Nan/AAJ-7102-2021	Jiang, Nan/0000-0003-4174-0657; Madungwe, Ngonidzashe/0000-0002-2975-1487; Williams, Claire/0000-0001-5467-149X; Stockand, James/0000-0002-3817-4319	CPRIT IIRG [RP150408]; NIH/NCI [CA194138]; NATIONAL CANCER INSTITUTE [R21CA194138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076614, R25NS080684] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	CPRIT IIRG; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a CPRIT IIRG grant (RP150408) and a NIH/NCI R21 grant (CA194138) to JDS and BAE. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Barriere DA, 2012, PAIN, V153, P553, DOI 10.1016/j.pain.2011.11.019; Bhattacharya MRC, 2012, J NEUROSCI, V32, P5054, DOI 10.1523/JNEUROSCI.4951-11.2012; Boiko N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411736; Boyette-Davis JA, 2015, PAIN MANAG, V5, P285, DOI [10.2217/pmt.15.19, 10.2217/PMT.15.19]; Chen Y, 2011, NEUROSCIENCE, V193, P440, DOI 10.1016/j.neuroscience.2011.06.085; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; [李永洙 Li Yongzhu], 2015, [生态学报, Acta Ecologica Sinica], V35, P1601; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du EJ, 2016, ELIFE, V5, DOI 10.7554/eLife.18425; Du EJ, 2015, MOL CELLS, V38, P911, DOI 10.14348/molcells.2015.0215; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Flatters SJL, 2006, NEUROSCI LETT, V397, P219, DOI 10.1016/j.neulet.2005.12.013; Fowler MA, 2013, LIFE SCI, V92, P394, DOI 10.1016/j.lfs.2012.07.029; Gibbs JL, 2006, PAIN, V124, P167, DOI 10.1016/j.pain.2006.04.013; Green DP, 2016, MOL PAIN, V12, DOI 10.1177/1744806916661725; Grueber W B JA LYJ YN, 2002, TILING DROSOPHILA EP, P1; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Guntur AR, 2015, P NATL ACAD SCI USA, V112, pE5753, DOI 10.1073/pnas.1514862112; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hill A, 2010, BMC CANCER, V10, P573; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Hynkova A, 2016, N TERMINAL TETRAPEPT, P1; Ibarra Y, 2013, MOL PHARMACOL, V83, P1120, DOI 10.1124/mol.112.084194; Im SH, 2012, DEV DYNAM, V241, P16, DOI 10.1002/dvdy.22737; Jabba S, 2014, NEURON, V82, P1017, DOI 10.1016/j.neuron.2014.04.016; Jaggi AS, 2012, TOXICOLOGY, V291, P1, DOI 10.1016/j.tox.2011.10.019; Jiang N, 2014, DEVELOPMENT, V141, P2657, DOI 10.1242/dev.107573; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kremeyer B, 2016, CLIN STUDY, P1; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Kucher Volodymyr, 2013, Methods Mol Biol, V998, P385, DOI 10.1007/978-1-62703-351-0_30; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Lucchetta M, 2012, CANCER CHEMOTH PHARM, V70, P899, DOI 10.1007/s00280-012-2006-8; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Malik B, 2008, CURR NEUROL NEUROSCI, V8, P56, DOI 10.1007/s11910-008-0010-5; Materazzi S, 2012, PFLUG ARCH EUR J PHY, V463, P561, DOI 10.1007/s00424-011-1071-x; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Meotti FC, 2013, CHEM-BIOL INTERACT, V203, P440, DOI 10.1016/j.cbi.2013.03.008; Mogos S., 2013, P ASME 2013 PRESS VE, P1; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Morota S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067747; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Neely GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024343; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Patwardhan AM, 2006, PAIN, V125, P114, DOI 10.1016/j.pain.2006.05.007; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Petruska JC, 2002, NEUROSCIENCE, V115, P15, DOI 10.1016/S0306-4522(02)00409-8; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Prager-Khoutorsky M, 2014, NEURON, V83, P866, DOI 10.1016/j.neuron.2014.07.023; Nieto FR, 2008, PAIN, V137, P520, DOI 10.1016/j.pain.2007.10.012; Rau KK, 2005, J NEUROPHYSIOL, V93, P1358, DOI 10.1152/jn.00591.2004; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; STEWART DJ, 1984, J NEURO-ONCOL, V2, P133; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Trevisan G, 2013, CANCER RES, V73, P3120, DOI 10.1158/0008-5472.CAN-12-4370; Venkatachalam K, 2014, HANDB EXP PHARMACOL, V223, P937, DOI 10.1007/978-3-319-05161-1_9; Williams CR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1457-z; Williams CR, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0956-2; Wilson RH, 2002, J CLIN ONCOL, V20, P1767, DOI 10.1200/JCO.2002.07.056; Wu D, 2012, NATURE, V484, P214, DOI [10.1038/nature10931, 10.1038/nature11685]; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023; Xiao WH, 2011, NEUROSCIENCE, V199, P461, DOI 10.1016/j.neuroscience.2011.10.010; Xiao WH, 2008, PAIN, V135, P262, DOI 10.1016/j.pain.2007.06.001; Xiao WH, 2012, PAIN, V153, P704, DOI 10.1016/j.pain.2011.12.011; Yan Z, 2012, ACTA PHARMACOL SIN, V33, P852, DOI 10.1038/aps.2012.44; Zhang HJ, 2014, ANESTHESIOLOGY, V120, P1463, DOI 10.1097/ALN.0000000000000176; Zhang W, 2015, CELL, V162, P1391, DOI 10.1016/j.cell.2015.08.024; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	86	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186888	10.1371/journal.pone.0186888	http://dx.doi.org/10.1371/journal.pone.0186888			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084244	Green Submitted, Green Published, gold			2022-12-27	WOS:000413910200016
J	Moschetti, K; Zabrodina, V; Stadelmann, P; Wangmo, T; Holly, A; Wassertallen, JB; Elger, BS; Gravier, B				Moschetti, Karine; Zabrodina, Vera; Stadelmann, Pierre; Wangmo, Tenzin; Holly, Alberto; Wassertallen, Jean-Blaise; Elger, Bernice S.; Gravier, Bruno			Exploring differences in healthcare utilization of prisoners in the Canton of Vaud, Switzerland	PLOS ONE			English	Article							AGING PRISONERS; REMAND PRISON; SERVICES; INMATES; US; POPULATION; INSOMNIA; ILLNESS; GENEVA; ABUSE	Prison healthcare is an important public health concern given the increasing healthcare needs of a growing and aging prison population, which accumulates vulnerability factors and suffers from higher disease prevalence than the general population. This study identifies the key factors associated with outpatient general practitioner (GP), nursing or psychiatric healthcare utilization (HCU) within prisons. Cross-sectional data systematically collected by the prison medical staff were obtained for a sample of 1664 adult prisoners of the Canton of Vaud, Switzerland, for the year 2011. They contain detailed information on demographics (predisposing factors), diagnosed chronic somatic and psychiatric disorders (needs factors), as well as prison stay characteristics (contextual factors). For GP, nurse and psychiatric care, two-part regressions are used to model separately the probability and the volume of HCU. Predisposing factors are generally not associated with the probability to use healthcare services after controlling for needs factors. However, female inmates use higher volumes of care, and the volume of GP consultations increases with age. Chronic somatic and psychiatric conditions are the most important predictors of the probability of HCU, but associations with volumes differ in their magnitude and significance across disease groups. Infectious, musculoskeletal, nervous and circulatory diseases actively mobilize GP and nursing staff. Schizophrenia, illicit drug and pharmaceuticals abuse are strongly positively associated with psychiatric and nurse HCU. The occupancy rate displays positive associations among contextual factors. Prison healthcare systems face increasingly complex organizational, budgetary and ethical challenges. This study provides relevant insights into the HCU patterns of a marginalized and understudied population.	[Moschetti, Karine; Zabrodina, Vera; Stadelmann, Pierre] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Moschetti, Karine; Zabrodina, Vera; Stadelmann, Pierre] Univ Hosp Lausanne CHUV, Lausanne, Switzerland; [Moschetti, Karine; Wassertallen, Jean-Blaise] Univ Hosp Lausanne CHUV, Technol Assessment Unit, Lausanne, Switzerland; [Zabrodina, Vera; Wangmo, Tenzin; Elger, Bernice S.] Univ Basel, Inst Biomed Eth, Basel, Switzerland; [Stadelmann, Pierre; Holly, Alberto] Univ Lausanne, Inst Hlth Econ & Management, HEC Lausanne, Lausanne, Switzerland; [Elger, Bernice S.] Univ Geneva, Univ Ctr Legal Med, Geneva, Switzerland; [Gravier, Bruno] Univ Hosp Lausanne CHUV, Serv Correct Med & Psychiat, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; University of Lausanne; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Moschetti, K (corresponding author), Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland.; Moschetti, K (corresponding author), Univ Hosp Lausanne CHUV, Lausanne, Switzerland.; Moschetti, K (corresponding author), Univ Hosp Lausanne CHUV, Technol Assessment Unit, Lausanne, Switzerland.	karine.moscheffi@chuv.ch; bruno.gravier@chuv.ch	Elger, Bernice Simone/V-7265-2017; Holly, Alberto/GOK-0872-2022	Elger, Bernice Simone/0000-0002-4249-7399; Holly, Alberto/0000-0003-0748-7977; Wangmo, Tenzin/0000-0003-0857-0510	Swiss National Science Foundation (SNF); SNF [CR13I1_135035/1]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF	This research was undertaken as part of a larger project funded by the Swiss National Science Foundation (SNF) and thus the authors acknowledge the financial support received from the SNF (grant CR13I1_135035/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday L A, 1974, Health Serv Res, V9, P208; Barry LC, 2015, SGIM FORUM, V38; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Bretschneider W, 2014, J BIOETHIC INQ, V11, P319, DOI 10.1007/s11673-014-9547-y; Cameron A. C., 1986, J APPL ECONOMET, V1, P29, DOI DOI 10.1002/JAE.3950010104; Cameron Colin A., 2013, REGRESSION ANAL COUN; Douglas N, 2009, J EPIDEMIOL COMMUN H, V63, P749, DOI 10.1136/jech.2008.080713; Elger BS, 2008, J PUBLIC HEALTH POL, V29, P192, DOI 10.1057/jphp.2008.6; Elger BS, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13273; Elger BS, 2009, INT J LAW PSYCHIAT, V32, P74, DOI 10.1016/j.ijlp.2009.01.001; Elger BS, 2004, EUR J EPIDEMIOL, V19, P665, DOI 10.1023/B:EJEP.0000036805.58237.e3; Elger BS, 2002, SOZ PRAVENTIV MED, V47, P39, DOI 10.1007/BF01318404; Fazel S., 2012, British Journal of Psychiatry, V200, P364, DOI 10.1192/bjp.bp.111.096370; Fazel S, 2001, AGE AGEING, V30, P403, DOI 10.1093/ageing/30.5.403; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Federal Statistical Office, 2015, PRIS DET DAT IND; Feron JM, 2005, J EPIDEMIOL COMMUN H, V59, P651, DOI 10.1136/jech.2004.022269; Garrity TF, 2002, PRISON J, V82, P295, DOI 10.1177/003288550208200301; Goncalves LC, 2014, CRIMINAL JUSTICE BEH; GOURIEROUX C, 1984, ECONOMETRICA, V52, P681, DOI 10.2307/1913471; Jones AM, 2000, HANDB ECON, V17, P265; Jotterand F, 2014, AM J BIOETHICS, V14, P4, DOI 10.1080/15265161.2014.919365; Lindquist CH, 1999, J COMMUN HEALTH, V24, P285, DOI 10.1023/A:1018794305843; Marshall T, 2001, J EPIDEMIOL COMMUN H, V55, P364, DOI 10.1136/jech.55.5.364; Moschetti K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2211-6; Nesset MB, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-301; Nobile CGA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-529; Nowotny KM, 2016, J CORRECT HEALTH CAR, V22, P129, DOI 10.1177/1078345816633701; Prison Reform Trust, 2016, PRIS FACTS; Ritter C, 2011, J PUBLIC HEALTH POL, V32, P32, DOI 10.1057/jphp.2010.47; Rutherford M, 2009, PUBLIC HEALTH, V123, P415, DOI 10.1016/j.puhe.2009.04.006; Sheps S B, 1987, J Community Health, V12, P4, DOI 10.1007/BF01321393; Swiss Academy of Medical Sciences:, 2015, MED PRACT RESP DET P; Thomas Emily H, 2016, Health Justice, V4, P4; TWADDLE AC, 1976, J HEALTH SOC BEHAV, V17, P236, DOI 10.2307/2136545; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; Walmsley R., 2015, WORLD PRISON POPULAT; Wandeler G, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14093; Wangmo T, 2016, J AGING HEALTH, V28, P481, DOI 10.1177/0898264315594137; Williams BA, 2012, J AM GERIATR SOC, V60, P1150, DOI 10.1111/j.1532-5415.2012.03962.x; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279; Wolff H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-245	42	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187255	10.1371/journal.pone.0187255	http://dx.doi.org/10.1371/journal.pone.0187255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL0OH	29084290	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200041
J	Zeune, L; van Dalum, G; Decraene, C; Proudhon, C; Fehm, T; Neubauer, H; Rack, B; Alunni-Fabbroni, M; Terstappen, LWMM; van Gils, SA; Brune, C				Zeune, Leonie; van Dalum, Guus; Decraene, Charles; Proudhon, Charlotte; Fehm, Tanja; Neubauer, Hans; Rack, Brigitte; Alunni-Fabbroni, Marianna; Terstappen, Leon W. M. M.; van Gils, Stephan A.; Brune, Christoph			Quantifying HER-2 expression on circulating tumor cells by ACCEPT	PLOS ONE			English	Article							GENE STATUS; CANCER; BLOOD	Circulating tumor cells (CTCs) isolated from blood can be probed for the expression of treatment targets. Immunofluorescence is often used for both the enumeration of CTC and the determination of protein expression levels related to treatment targets. Accurate and reproducible assessment of such treatment target expression levels is essential for their use in the clinic. To enable this, an open source image analysis program named ACCEPT was developed in the EU-FP7 CTCTrap and CANCER-ID programs. Here its application is shown on a retrospective cohort of 132 metastatic breast cancer patients from which blood samples were processed by CellSearch (R) and stained for HER-2 expression as additional marker. Images were digitally stored and reviewers identified a total of 4084 CTCs. CTC's HER-2 expression was determined in the thumbnail images by ACCEPT. 150 of these images were selected and sent to six independent investigators to score the HER-2 expression with and without ACCEPT. Concordance rate of the operators' scoring results for HER2 on CTCs was 30% and could be increased using the ACCEPT tool to 51%. Automated assessment of HER-2 expression by ACCEPT on 4084 CTCs of 132 patients showed 8 (6.1%) patients with all CTCs expressing HER-2, 14 (10.6%) patients with no CTC expressing HER-2 and 110 (83.3%) patients with CTCs showing a varying HER-2 expression level. In total 1576 CTCs were determined HER-2 positive. We conclude that the use of image analysis enables a more reproducible quantification of treatment targets on CTCs and leads the way to fully automated and reproducible approaches.	[Zeune, Leonie; van Gils, Stephan A.; Brune, Christoph] Univ Twente, MIRA Inst, Dept Appl Math, Enschede, Netherlands; [Zeune, Leonie; van Dalum, Guus; Terstappen, Leon W. M. M.] Univ Twente, MIRA Inst, Dept Med Cell BioPhys, Enschede, Netherlands; [Decraene, Charles] PSL Res Univ, Inst Curie, Translat Res Dept, Circulating Tumor Biomarkers Lab,SiRIC, Paris, France; [Decraene, Charles; Proudhon, Charlotte] PSL Res Univ, Inst Curie, CNRS, UMR144, Paris, France; [Fehm, Tanja; Neubauer, Hans] Univ Dusseldorf, Dept Gynecol & Obstet, Dusseldorf, Germany; [Rack, Brigitte; Alunni-Fabbroni, Marianna] Univ Munich, Dept Gynecol & Obstet, Munich, Germany	University of Twente; University of Twente; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Heinrich Heine University Dusseldorf; University of Munich	Zeune, L (corresponding author), Univ Twente, MIRA Inst, Dept Appl Math, Enschede, Netherlands.; Zeune, L (corresponding author), Univ Twente, MIRA Inst, Dept Med Cell BioPhys, Enschede, Netherlands.	l.l.zeune@utwente.nl	terstappen, leon/O-4923-2018; Neubauer, Hans/C-4467-2016; Brune, Christoph/C-1700-2013	terstappen, leon/0000-0001-5944-3787; Neubauer, Hans/0000-0002-3467-4105; Brune, Christoph/0000-0003-0145-5069; Proudhon, Charlotte/0000-0002-4649-4574; Fehm, Tanja/0000-0002-4926-0108	EUFP7 [305341 CTCTrap]; EU I MI [115749-1 CANCER-ID]	EUFP7(European Commission); EU I MI(European Commission)	This work was supported by EUFP7 # 305341 CTCTrap; EU I MI # 115749-1 CANCER-ID.	Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Allard WJ, 2015, CLIN CANCER RES, V21, P2883, DOI 10.1158/1078-0432.CCR-14-2559; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Barradas Ana M C, 2013, Cancers (Basel), V5, P1619, DOI 10.3390/cancers5041619; Benning M, 2013, J SCI COMPUT, V54, P269, DOI 10.1007/s10915-012-9650-3; Brune C, 2011, INT J COMPUT VISION, V92, P211, DOI 10.1007/s11263-010-0339-5; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; Hayes DF, 2002, INT J ONCOL, V21, P1111; Hiltermann TJN, 2012, ANN ONCOL, V23, P2937, DOI 10.1093/annonc/mds138; Ignatiadis M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3647; Janni WJ, 2016, CLIN CANCER RES, V22, P2583, DOI 10.1158/1078-0432.CCR-15-1603; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Ligthart ST, 2013, ANN ONCOL, V24, P1231, DOI 10.1093/annonc/mds625; Ligthart ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067148; Ligthart ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027419; Mazel M, 2015, MOL ONCOL, V9, P1773, DOI 10.1016/j.molonc.2015.05.009; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Myung JH, 2015, LAB CHIP, V15, P4500, DOI 10.1039/c5lc00947b; Rao CG, 2005, INT J ONCOL, V27, P49; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; Smerage JB, 2013, MOL ONCOL, V7, P680, DOI 10.1016/j.molonc.2013.02.013; Van Dalum G, 2015, INT J ONCOL, V46, P1361, DOI 10.3892/ijo.2015.2824; Zeune L, 2017, SIAM J IMAGING SCI, V10, P111, DOI 10.1137/16M1074503	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186562	10.1371/journal.pone.0186562	http://dx.doi.org/10.1371/journal.pone.0186562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084234	Green Submitted, Green Published, gold			2022-12-27	WOS:000413910200009
J	Li, P; Guo, W; Yue, HM; Li, CJ; Du, H; Qiao, XM; Liu, ZG; Zhou, Q; Wei, QW				Li, Ping; Guo, Wei; Yue, Huamei; Li, Chuangju; Du, Hao; Qiao, Xinmei; Liu, Zhigang; Zhou, Qiong; Wei, Qiwei			Variability in the protein profiles in spermatozoa of two sturgeon species	PLOS ONE			English	Article							PLASMA-MEMBRANE INTEGRITY; LIPID-PEROXIDATION LEVELS; SPERM MOTILITY; AMINO-ACIDS; OXIDATIVE-PHOSPHORYLATION; ONCORHYNCHUS-MYKISS; UBIQUITIN SYSTEM; SEMINAL PLASMA; SEMEN; FERTILITY	Conventional sperm analysis (i.e., motility and fertility) has been used to evaluate sperm quality. Understanding the quality of sperm on the molecular level in the sturgeons, Acipenser baerii and A. schrenckii, is essential for the improvement of the conservation of genetic resources and farming performance. In this study, we used the iTRAQ proteomics approach to perform proteomic profiling of spermatozoa associated with sperm quality in sturgeons (Data are available via ProteomeXchange with identifier PXD006108). The results showed 291 and 359 differentially expressed proteins in A. baerii and A. schrenckii, respectively, of which 72 were common to both species and all were upregulated in high quality compared with low quality samples. The differentially expressed proteins were mainly categorized into the generation of precursor metabolites and energy and oxidation, and they were localized to the mitochondria. Three distinguishing pathways, Arginine and proline metabolism, Pyruvate metabolism and the Citrate cycle (TCA cycle) were found to play an important role in energy metabolism, and some substrates could be used in the sperm medium for storage and cryopreservation. The quantity levels of two proteins, CKMT1 and LDHB, were verified by western blot analysis. Moreover, other potential biomarkers involved in oxidation reduction, ubiquitin-proteasome-dependent proteolysis, chaperones and binding activity were also discussed. Our study is the first to use the iTRAQ-based proteomics approach to analyse the sturgeon spermatozoa proteome, and the results that we obtained are valuable for the prediction of sperm quality and reproduction management in these threatened species.	[Li, Ping; Yue, Huamei; Li, Chuangju; Du, Hao; Qiao, Xinmei; Liu, Zhigang; Zhou, Qiong; Wei, Qiwei] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Minist Agr China, Key Lab Freshwater Biodivers Conservat, Wuhan, Hubei, Peoples R China; [Li, Ping; Guo, Wei; Yue, Huamei; Li, Chuangju; Du, Hao; Qiao, Xinmei; Liu, Zhigang; Zhou, Qiong; Wei, Qiwei] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Sinoczech Joint Lab Fish Conservat & Biotechnol, Wuhan, Hubei, Peoples R China; [Li, Ping; Guo, Wei] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Res Inst Fish Culture & Hydrobiol, Zatisi, Vodnany, Czech Republic	Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; University of South Bohemia Ceske Budejovice	Wei, QW (corresponding author), Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Minist Agr China, Key Lab Freshwater Biodivers Conservat, Wuhan, Hubei, Peoples R China.; Wei, QW (corresponding author), Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Sinoczech Joint Lab Fish Conservat & Biotechnol, Wuhan, Hubei, Peoples R China.	weiqw@yfi.ac.cn	Wei, Qiwei/B-6928-2014	Wei, Qiwei/0000-0002-6366-1020	National Natural Science Foundation of China [31402301]; National Program on Key Basic Research Project (973 Program) [2015CB150702]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Special Scientific Research Fund for Central Non-profit Institutes, Chinese Academy of Fishery Sciences [2015B02YQ01, 2016GH04]; Ministry of Education, Youth and Sports of the Czech Republic-projects CENAKVA [CZ.1.05/2.1.00/01.0024]; CENAKVA II (NPU I program) [LO1205]; Czech Science Foundation [16-02407Y]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; Special Scientific Research Fund for Central Non-profit Institutes, Chinese Academy of Fishery Sciences; Ministry of Education, Youth and Sports of the Czech Republic-projects CENAKVA; CENAKVA II (NPU I program); Czech Science Foundation(Grant Agency of the Czech Republic)	This study was financially supported by the National Natural Science Foundation of China (31402301, Ping Li received the funding), the National Program on Key Basic Research Project (973 Program, 2015CB150702, Qiwei Wei received the funding), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086, Qiwei Wei received the funding), the Special Scientific Research Fund for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2015B02YQ01, Ping Li received the funding; 2016GH04, Chuangju Li received the funding), the Ministry of Education, Youth and Sports of the Czech Republic-projects CENAKVA (CZ.1.05/2.1.00/01.0024, Otomar Linhart received the funding), CENAKVA II (LO1205 under the NPU I program, Otomar Linhart received the funding), and the Czech Science Foundation (16-02407Y, Ping Li received the funding).	Adams SH, 1998, BIOL REPROD, V59, P1399, DOI 10.1095/biolreprod59.6.1399; Aitken RJ, 2008, INT J ANDROL, V31, P295, DOI 10.1111/j.1365-2605.2007.00851.x; Alavi SMH, 2007, THERIOGENOLOGY, V68, P276, DOI 10.1016/j.theriogenology.2007.05.045; Arangasamy A, 2011, THERIOGENOLOGY, V76, P570, DOI 10.1016/j.theriogenology.2011.03.009; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; Baarends WM, 1999, MOL CELL ENDOCRINOL, V151, P5, DOI 10.1016/S0303-7207(99)00060-X; BARETT GC, 1985, CHEM BIOCH AMINO ACI; Baska K. M., 2005, New impact on protein modifications in the regulation of reproductive system, P83; Bebington C, 2001, HUM REPROD UPDATE, V7, P102, DOI 10.1093/humupd/7.1.102; Birstein VJ, 1997, ENVIRON BIOL FISH, V48, P427, DOI 10.1023/A:1007382724251; Crowe J.H., 1986, P188; D'Amours O, 2010, REPRODUCTION, V139, P545, DOI 10.1530/REP-09-0375; Darr CR, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140707; Dietrich MA, 2016, J PROTEOMICS, V138, P124, DOI 10.1016/j.jprot.2016.02.029; du Plessis SS, 2015, ASIAN J ANDROL, V17, P230, DOI 10.4103/1008-682X.135123; Eggert-Kruse W, 2002, HUM REPROD, V17, P726, DOI 10.1093/humrep/17.3.726; Erikson DW, 2007, REPRODUCTION, V133, P909, DOI 10.1530/REP-06-0228; Ferramosca A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/902953; Fujii J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-43; Gamboa S, 2005, THERIOGENOLOGY, V64, P275, DOI 10.1016/j.theriogenology.2004.11.021; Griveau JF, 1997, INT J ANDROL, V20, P61, DOI 10.1046/j.1365-2605.1997.00044.x; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOSHI K, 1991, TOHOKU J EXP MED, V165, P99, DOI 10.1620/tjem.165.99; INAZU N, 1992, BIOCHIM BIOPHYS ACTA, V1116, P50, DOI 10.1016/0304-4165(92)90127-G; Karp G., 2008, CELL MOL BIOL; KELLER DW, 1975, BIOL REPROD, V13, P154, DOI 10.1095/biolreprod13.2.154; Lahnsteiner F, 1999, J EXP ZOOL, V284, P454, DOI 10.1002/(SICI)1097-010X(19990901)284:4&lt;454::AID-JEZ12&gt;3.0.CO;2-O; Lahnsteiner F, 2009, J FISH BIOL, V75, P816, DOI 10.1111/j.1095-8649.2009.02317.x; Li P, 2008, J APPL ICHTHYOL, V24, P121, DOI 10.1111/j.1439-0426.2007.01025.x; Li P, 2009, FISH PHYSIOL BIOCHEM, V35, P567, DOI 10.1007/s10695-008-9261-y; McCauley TC, 1999, MOL REPROD DEV, V54, P145, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;145::AID-MRD6&gt;3.0.CO;2-6; Meyers SA, 2012, OXID STRESS APPL BAS, P41, DOI 10.1007/978-1-61779-776-7_3; Morita M, 2011, J EXP BIOL, V214, P2096, DOI 10.1242/jeb.053405; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Novak S, 2010, J ANDROL, V31, P188, DOI 10.2164/jandrol.109.007583; O'Flaherty C, 2004, BBA-GEN SUBJECTS, V1674, P215, DOI 10.1016/j.bbagen.2004.06.020; Oliva R, 2009, PROTEOMICS, V9, P1004, DOI 10.1002/pmic.200800588; Patel AB, 1998, BIOPHYS J, V75, P1522, DOI 10.1016/S0006-3495(98)74071-8; Peeker R, 1997, MOL HUM REPROD, V3, P1061, DOI 10.1093/molehr/3.12.1061; Pesch S., 2007, J REPRODUKTIONSMEDIZ, V4, P101; Qiu JH, 2016, THERIOGENOLOGY, V86, P839, DOI 10.1016/j.theriogenology.2016.03.005; RADANY EW, 1981, ARCH ANDROLOGY, V7, P351, DOI 10.3109/01485018108999330; Ruiz-Pesini E, 2007, CURR TOP DEV BIOL, V77, P3, DOI 10.1016/S0070-2153(06)77001-6; Sanchez-Partida LG, 1998, REPROD FERT DEVELOP, V10, P347, DOI 10.1071/R98053; Sangeeta S, 2015, ANIM REPROD SCI, V161, P82, DOI 10.1016/j.anireprosci.2015.08.008; Sangeeta S, 2015, INDIAN J ANIM SCI, V85, P729; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Srivastava S, 2010, ANDROLOGIA, V42, P76, DOI 10.1111/j.1439-0272.2009.00959.x; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Sun SY, 2009, J ENDOCRINOL, V202, P327, DOI 10.1677/JOE-09-0041; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; Tomar AK, 2010, BIOMARK MED, V4, P905, DOI 10.2217/BMM.10.100; Tubb B, 2002, EXP CELL RES, V275, P92, DOI 10.1006/excr.2002.5486; Walsh A, 2008, BIOL REPROD, V78, P983, DOI 10.1095/biolreprod.107.066860; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; Williams AC, 2001, J ANDROL, V22, P680; Yi YJ, 2007, BIOL REPROD, V77, P780, DOI 10.1095/biolreprod.107.061275	57	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186003	10.1371/journal.pone.0186003	http://dx.doi.org/10.1371/journal.pone.0186003			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077704	Green Submitted, Green Published, gold			2022-12-27	WOS:000413861200008
J	Olafsdottir, GA; Petursdottir, G; Bardarson, H; Edvardsson, R				Olafsdottir, Gudbjorg Asta; Petursdottir, Groa; Bardarson, Hlynur; Edvardsson, Ragnar			A millennium of north-east Atlantic cod juvenile growth trajectories inferred from archaeological otoliths	PLOS ONE			English	Article							GADUS-MORHUA L.; LIFE-HISTORY; MARINE FISH; SIZE; TEMPERATURE; AGE; VARIABILITY; FISHERIES; RECRUITMENT; PERSPECTIVE	Archaeological excavations of historical fishing sites across the North Atlantic have recovered high quantities of Atlantic cod (Gadus morhua) bones. In the current study we use Atlantic cod otoliths from archaeological excavations of a historical fishing sites in northwest Iceland, dated to AD 970 -AD 1910 to examine historical growth trajectories of cod. No large scale growth variations or shifts in growth patterns were observed in the current chronologies, supporting the stability of historical Atlantic cod growth trajectories. The most significant variation in growth patterns was consistent with those that have been observed in recent times, for example, reduced early juvenile growth during periods of colder ocean temperature. The current results represent a high resolution chronological record of north-east Atlantic cod growth, greatly increasing the prior temporal range of such data, thereby providing a valuable baseline for a broad range of studies on Atlantic cod growth.	[Olafsdottir, Gudbjorg Asta; Edvardsson, Ragnar] Univ Iceland, Res Ctr Westfjords, Adalstraeti Bolungarvik, Iceland; [Petursdottir, Groa; Bardarson, Hlynur] Marine & Freshwater Res Inst, Skulagata Reykjavik, Iceland	University of Iceland; Marine & Freshwater Research Institute (MFRI)	Olafsdottir, GA (corresponding author), Univ Iceland, Res Ctr Westfjords, Adalstraeti Bolungarvik, Iceland.	gaol@hi.is	Edvardsson, Ragnar/M-2632-2015; Olafsdottir, Gudbjorg Asta/M-2722-2015	Olafsdottir, Gudbjorg Asta/0000-0002-2814-9160; Edvardsson, Ragnar/0000-0002-3663-1205	Icelandic Research Fund	Icelandic Research Fund	This study was partly funded by a grant to GAO from the Icelandic Research Fund. Other cost was covered by the University of Iceland and the Marine Research Institute through salaries of the authors. There was no additional external funding received for this study. The funders had no role in the subsequent work.	AMOROSI T, 1994, ICES MAR SC, V198, P31; Andersen KH, 2007, ECOL MODEL, V204, P246, DOI 10.1016/j.ecolmodel.2007.01.002; Astthorsson OS, 2007, DEEP-SEA RES PT II, V54, P2456, DOI 10.1016/j.dsr2.2007.07.030; ASTTHORSSON OS, 1994, ICES MAR SC, V198, P529; Barrett JH, 2011, J ARCHAEOL SCI, V38, P1516, DOI 10.1016/j.jas.2011.02.017; Barrett JH, 2004, P ROY SOC B-BIOL SCI, V271, P2417, DOI 10.1098/rspb.2004.2885; Barrett JH, 1997, ANTIQUITY, V71, P616, DOI 10.1017/S0003598X00085367; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Bianchi G, 2000, ICES J MAR SCI, V57, P558, DOI 10.1006/jmsc.2000.0727; Bjornsson B, 2002, CAN J FISH AQUAT SCI, V59, P494, DOI [10.1139/f02-028, 10.1139/F02-028]; BRANDER KM, 1995, ICES J MAR SCI, V52, P1, DOI 10.1016/1054-3139(95)80010-7; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Campana SE, 1996, MAR ECOL PROG SER, V135, P21, DOI 10.3354/meps135021; CAMPANA SE, 1993, CAN J FISH AQUAT SCI, V50, P1062, DOI 10.1139/f93-123; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/cjfas-58-1-30; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Dalley EL, 1997, CAN J FISH AQUAT SCI, V54, P168, DOI 10.1139/cjfas-54-S1-168; Disspain MCF, 2016, J ARCHAEOL SCI-REP, V6, P623, DOI 10.1016/j.jasrep.2015.05.012; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Edvardsson R., 2010, THESIS; Freitas C, 2015, ECOL EVOL, V5, P2070, DOI 10.1002/ece3.1496; Geffen AJ, 2011, ICES J MAR SCI; Gibb FM, 2007, MAR BIOL, V151, P1185, DOI 10.1007/s00227-006-0565-0; Haddon M., 2011, MODELLING QUANTITATI; Hufthammer AK, 2010, J ARCHAEOL SCI, V37, P78, DOI 10.1016/j.jas.2009.09.001; Hutchings JA, 2005, PHILOS T R SOC B, V360, P315, DOI 10.1098/rstb.2004.1586; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jonsdottir IG, 2008, MAR BIOL, V154, P867, DOI 10.1007/s00227-008-0979-y; Jonsdottir ODB, 2002, FISH RES, V55, P37, DOI 10.1016/S0165-7836(01)00296-X; Jorgensen C, 2009, EVOL APPL, V2, P356, DOI 10.1111/j.1752-4571.2009.00075.x; JORGENSEN T, 1992, ICES J MAR SCI, V49, P263, DOI 10.1093/icesjms/49.3.263; Kristiansen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017456; Li L, 2008, CAN J FISH AQUAT SCI, V65, P2496, DOI 10.1139/F08-157; Limburg KE, 2008, P ROY SOC B-BIOL SCI, V275, P2659, DOI 10.1098/rspb.2008.0711; Limburg KE, 1994, AQUAC INT, V2, P75; MacKenzie BR, 2007, FISH RES, V87, P106, DOI 10.1016/j.fishres.2007.07.003; Mirman D., 2014, GROWTH CURVE ANAL VI; Ogilvie AEJ, 2001, CLIMATIC CHANGE, V48, P9, DOI 10.1023/A:1005625729889; Ogle D., 2016, FSA FISHERIES STOCK; Ogle D., 2016, INTRO FISHERIES ANAL; Olafsdottir GA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2976; Opdal AF, 2015, GLOBAL CHANGE BIOL, V21, P1521, DOI 10.1111/gcb.12773; Orton DC, 2016, PERSPECTIVES OCEANS, P47; Patterson WP, 2010, P NATL ACAD SCI USA, V107, P5306, DOI 10.1073/pnas.0902522107; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Perdikaris S., 2009, CATCH FISHERIES N AT, V41, P61; Petersen MF, 2003, J EXP BIOL, V206, P359, DOI 10.1242/jeb.00111; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; Poulsen B, 2007, FISH RES, V87, P181, DOI 10.1016/j.fishres.2007.07.014; R Development Core Team, 2009, R LANG ENV STAT COMP; Ratz HJ, 2003, FISH RES, V60, P369, DOI 10.1016/S0165-7836(02)00132-7; Reibisch J., 1899, WISSENSCHAFTLICHE ME, V4, P233; Rochet MJ, 1998, ICES J MAR SCI, V55, P371, DOI 10.1006/jmsc.1997.0324; Rowell K, 2010, ENVIRON BIOL FISH, V89, P415, DOI 10.1007/s10641-010-9687-9; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rspb.2006.0275; TAYLOR C. C., 1958, JOUR CONS PERM INTERNATL EXPLOR MER, V23, P366; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; Van Neer W, 1999, INT J OSTEOARCHAEOL, V9, P116, DOI 10.1002/(SICI)1099-1212(199903/04)9:2<116::AID-OA465>3.3.CO;2-8; Van Neer Wim, 2002, Environmental Archaeology, V7, P61	62	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187134	10.1371/journal.pone.0187134	http://dx.doi.org/10.1371/journal.pone.0187134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077736	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200047
J	dos Santos, SP; Benda, RN; Couto, CR; Campos, CE; Andrade, AGP; Lage, GM; Ugrinowitsch, H				dos Santos, Suziane Peixoto; Benda, Rodolfo N.; Couto, Crislaine Rangel; Campos, Carlos Eduardo; Pereira Andrade, Andre Gustavo; Lage, Guilherme M.; Ugrinowitsch, Herbert			The level of performance stabilization influences motor adaptation on an isometric force control task	PLOS ONE			English	Article							ARM MOVEMENTS; STABILITY; JOINT; PERTURBATIONS; COACTIVATION; COORDINATION; VARIABILITY; STIFFNESS; DYNAMICS; IMPROVES	This study compared the effects of two levels of performance stabilization on the adaptation to unpredictable perturbations in an isometric control force task with the goal of controlling 40% of the maximum force. The experiment consisted of pre-exposure and exposure phases. In the pre-exposure two levels of performance stabilization were manipulated: a stabilization group (SG) performed three trials in a row while maintaining 40% of the maximum force for three seconds and an absolute error less than or equal to 5% (i.e., the criteria of performance), and a superstabilization group (SSG) performed six blocks of the same criteria. During the exposure phase, the task was the same as that in the pre-exposure phase; however, it was inserted 9 trials of perturbations when the task goal changed to 60% of the maximum force. We measured the % RMSE, RMS from the biceps and triceps brachii and co-contraction. In the pre-exposure phase, both groups showed similar performance and muscle activity. When exposed to the perturbations, SSG performance more quickly returned to the previous level of accuracy, showed lower muscle activation and demonstrated a greater muscle co-contraction than did SG. The results give support to the adaptive process model on motor learning.	[dos Santos, Suziane Peixoto] Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil; [Benda, Rodolfo N.; Pereira Andrade, Andre Gustavo; Lage, Guilherme M.; Ugrinowitsch, Herbert] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Couto, Crislaine Rangel] Ctr Univ Izabela Hendrix, Belo Horizonte, MG, Brazil; [Campos, Carlos Eduardo] Univ Itauna, Itauna, MG, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal de Minas Gerais; Universidade de Itauna	dos Santos, SP (corresponding author), Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil.	suziane.naves@uftm.edu.br	Ugrinowitsch, Herbert/G-8859-2012; Lage, Guilherme/F-4355-2011; ANDRADE, A G P/GLR-3846-2022	Ugrinowitsch, Herbert/0000-0003-0317-1940; Lage, Guilherme/0000-0001-8296-3676; ANDRADE, A G P/0000-0003-3406-4558	FAPEMIG	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The author(s) received specific funding for this work at FAPEMIG.	Anwar MN, 2011, BRAIN RES, V1395, P21, DOI 10.1016/j.brainres.2011.04.030; BARATTA R, 1988, AM J SPORT MED, V16, P113, DOI 10.1177/036354658801600205; BENECKE R, 1986, EXP BRAIN RES, V63, P585, DOI 10.1007/BF00237481; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Brownstone RM, 2015, CURR OPIN NEUROBIOL, V33, P166, DOI 10.1016/j.conb.2015.04.007; Carvalho MFSP, 2012, J SPORT EXERCISE PSY, V34, pS74; Carvalho MFS., 2013, HUMAN MOVEMENT, V14, P20, DOI DOI 10.2478/V10038-012-0050-1; Coca Ugrinowitsch A. A., 2014, PERCEPT MOTOR SKILL, V118, P1; Diedrichsen J, 2007, CURR BIOL, V17, P1675, DOI 10.1016/j.cub.2007.08.051; Fitts PM, 1967, HUM PERFORM; Fonseca FD, 2012, NEUROSCI LETT, V517, P123, DOI 10.1016/j.neulet.2012.04.041; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Gabriel DA, 2002, J ELECTROMYOGR KINES, V12, P407, DOI 10.1016/S1050-6411(02)00026-3; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Granata KP, 2001, J BIOMECH, V34, P1117, DOI 10.1016/S0021-9290(01)00081-1; Guthrie E. R., 1952, PSYCHOL LEARNING; Haith AM, 2013, ADV EXP MED BIOL, V782, P1, DOI 10.1007/978-1-4614-5465-6_1; HAMMOND MC, 1988, ARCH PHYS MED REHAB, V69, P348; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hewett TE, 1999, AM J SPORT MED, V27, P699, DOI 10.1177/03635465990270060301; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; JOHANSSON H, 1991, CRIT REV BIOMED ENG, V18, P341; KEARNEY RE, 1990, CRIT REV BIOMED ENG, V18, P55; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Laidlaw DH, 1999, J APPL PHYSIOL, V87, P1786, DOI 10.1152/jappl.1999.87.5.1786; Latash ML, 2003, HUM MOVEMENT SCI, V22, P153, DOI 10.1016/S0167-9457(02)00157-4; Levin MF, 2000, BRAIN RES, V853, P352, DOI 10.1016/S0006-8993(99)02298-2; Li L, 2005, HUM MOVEMENT SCI, V24, P257, DOI 10.1016/j.humov.2005.03.003; Maestu J, 2006, J STRENGTH COND RES, V20, P824; Novakovic V, 2011, EXP BRAIN RES, V209, P425, DOI 10.1007/s00221-011-2573-7; OSTERNIG LR, 1995, MED SCI SPORT EXER, V27, P805; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Pinter IJ, 2011, J ELECTROMYOGR KINES, V21, P960, DOI 10.1016/j.jelekin.2011.08.001; Proteau L., 1992, VISION MOTOR CONTROL, V85, P67, DOI DOI 10.1016/S0166-4115(08)62011-7; Rand MK, 2004, EXP BRAIN RES, V154, P50, DOI 10.1007/s00221-003-1637-8; Richter S, 2004, PSYCHOL RES-PSYCH FO, V68, P245, DOI 10.1007/s00426-003-0140-y; Rieger M, 2005, EXP BRAIN RES, V163, P487, DOI 10.1007/s00221-004-2203-8; Santos-Naves S. P., 2012, J SPORT EXERCISE PSY, V34, P114; Shemmell J, 2010, CLIN NEUROPHYSIOL, V121, P1680, DOI 10.1016/j.clinph.2010.02.166; Torre K, 2011, J EXP PSYCHOL HUMAN, V37, P539, DOI 10.1037/a0020556; TURKER KS, 1993, PHYS THER, V73, P698; Turvey M.T., 1982, HUMAN MOTOR BEHAV IN, P239; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; Ugrinowitsch H., 2014, AM J LIFE SCI, V2, P90, DOI DOI 10.11648/J.AJLS.20140202.19; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0185939	10.1371/journal.pone.0185939	http://dx.doi.org/10.1371/journal.pone.0185939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073273	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400009
J	Fang, XM; Zhang, XL; Zong, YY; Zhang, Y; Wan, SZ; Bu, WS; Chen, FS				Fang, Xiang-Min; Zhang, Xiu-Lan; Zong, Ying-Ying; Zhang, Yang; Wan, Song-Ze; Bu, Wen-Sheng; Chen, Fu-Sheng			Soil phosphorus functional fractions and tree tissue nutrient concentrations influenced by stand density in subtropical Chinese fir plantation forests	PLOS ONE			English	Article							LOWLAND TROPICAL FOREST; HEDLEY FRACTIONATION; SPECIES-DIVERSITY; SOUTHERN CHINA; NITROGEN; RHIZOSPHERE; LIMITATION; RESORPTION; PINE; PRODUCTIVITY	Stand density regulation is an important measure of plantation forest management, and phosphorus (P) is often the limiting factor of tree productivity, especially in the subtropics and tropics. However, the stand density influence on ecosystem P cycling is unclear in Chinese fir (Cunninghamia lanceolata) plantations of subtropical China. We collected rhizosphere and bulk soils, leaves and twigs with different ages and roots with different orders to measure P and nitrogen (N) variables in Chinese fir plantations with low density (LDCF) and high density (HDCF) at Fujian and Hunan provinces of subtropical China. Rhizosphere soil labile P, slow P, occluded P and extractable P were higher in LDCF than HDCF at two sites. Meanwhile, P and N concentrations of 1-year-old leaves and twigs were higher in LDCF than HDCF and leaf N/P ratio generally increased with increasing leaf age at two sites. Rhizosphere vs. bulk soil labile P and occluded P were greater in LDCF than HDCF at Fujian. Nitrogen resorption efficiencies (NRE) of leaves and twigs were higher in LDCF than HDCF at Fujian, while their P resorption efficiencies (PRE) were not different between two densities at two sites. The average NRE of leaves (41.7%) and twigs (65.6%) were lower than the corresponding PRE (67.8% and 78.0%, respectively). Our results suggest that reducing stem density in Chinese fir plantations might be helpful to increase soil active P supplies and meet tree nutrient requirements.	[Fang, Xiang-Min; Zhang, Xiu-Lan; Zong, Ying-Ying; Zhang, Yang; Wan, Song-Ze; Bu, Wen-Sheng; Chen, Fu-Sheng] Jiangxi Agr Univ, Coll Forestry, Jiangxi Prov Key Lab Silviculture, Nanchang, Jiangxi, Peoples R China; [Fang, Xiang-Min; Bu, Wen-Sheng; Chen, Fu-Sheng] Jiangxi Agr Univ, Jiulianshan Natl Observat & Res Stn Chinese Fores, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University	Chen, FS (corresponding author), Jiangxi Agr Univ, Coll Forestry, Jiangxi Prov Key Lab Silviculture, Nanchang, Jiangxi, Peoples R China.; Chen, FS (corresponding author), Jiangxi Agr Univ, Jiulianshan Natl Observat & Res Stn Chinese Fores, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang, Jiangxi, Peoples R China.	chenfush@yahoo.com		Chen, Fu-Sheng/0000-0001-5126-3298	National Key Research and Development Program of China [2016YFD0600202-2]; National Natural Science Foundation of China [31360179]; Jiangxi Provincial Department of Science and Technology [20153BCB22008, 20151BAB214020, 20165BCB19006]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Department of Science and Technology	This work was supported by the National Key Research and Development Program of China (2016YFD0600202-2), the National Natural Science Foundation of China (31360179) and Jiangxi Provincial Department of Science and Technology (20153BCB22008, 20151BAB214020 and 20165BCB19006).	Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Allen SE, 1989, CHEM ANAL ECOLOGICAL; Ares A, 2010, FOREST ECOL MANAG, V260, P1104, DOI 10.1016/j.foreco.2010.06.023; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Blanco JA, 2009, ECOL APPL, V19, P682, DOI 10.1890/1051-0761-19.3.682; Blevins DP, 2005, CAN J FOREST RES, V35, P2851, DOI 10.1139/X05-204; BORMANN BT, 1984, ECOLOGY, V65, P394, DOI 10.2307/1941402; Braakhekke WG, 1999, J VEG SCI, V10, P187, DOI 10.2307/3237140; Cameron AD, 2002, FORESTRY, V75, P25, DOI 10.1093/forestry/75.1.25; Carey AB, 2003, FORESTRY, V76, P127, DOI 10.1093/forestry/76.2.127; CARLYLE JC, 1995, CAN J FOREST RES, V25, P1278, DOI 10.1139/x95-141; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; Chen FS, 2015, TREE PHYSIOL, V35, P1106, DOI 10.1093/treephys/tpv076; Chen Fu-sheng, 2010, Journal of Forestry Research (Harbin), V21, P39, DOI 10.1007/s11676-010-0006-2; Chen HJ, 2003, FOREST ECOL MANAG, V178, P301, DOI 10.1016/S0378-1127(02)00478-4; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; Davis MR, 2004, CAN J FOREST RES, V34, P2037, DOI [10.1139/x04-067, 10.1139/X04-067]; Ding JingYi, 2016, Acta Ecologica Sinica - International Journal, V36, P377, DOI 10.1016/j.chnaes.2016.05.004; Fan J, 2014, URBAN FOR URBAN GREE, V13, P576, DOI 10.1016/j.ufug.2014.03.002; Feller IC, 2003, BIOGEOCHEMISTRY, V62, P145, DOI 10.1023/A:1021166010892; Fu XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128894; Giuggiola A, 2013, FOREST ECOL MANAG, V310, P827, DOI 10.1016/j.foreco.2013.09.030; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Hinsinger P, 1998, ADV AGRON, V64, P225, DOI 10.1016/S0065-2113(08)60506-4; HIROSE T, 1988, OECOLOGIA, V77, P145, DOI 10.1007/BF00379180; Horner GJ, 2010, FOREST ECOL MANAG, V259, P286, DOI 10.1016/j.foreco.2009.10.015; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Liu Yu, 2013, Yingyong Shengtai Xuebao, V24, P1501; Lopez BC, 2003, TREE PHYSIOL, V23, P1217, DOI 10.1093/treephys/23.17.1217; Mayor JR, 2014, J ECOL, V102, P36, DOI 10.1111/1365-2745.12190; Mirabello MJ, 2013, SOIL RES, V51, P215, DOI 10.1071/SR12188; Motavalli PP, 2002, BIOL FERT SOILS, V36, P35, DOI 10.1007/s00374-002-0500-6; Negassa W, 2009, J PLANT NUTR SOIL SC, V172, P305, DOI 10.1002/jpln.200800223; Phillips RP, 2008, SOIL SCI SOC AM J, V72, P453, DOI 10.2136/sssaj2006.0389; Phillips RP, 2006, ECOLOGY, V87, P1302, DOI 10.1890/0012-9658(2006)87[1302:TSAMAI]2.0.CO;2; SPSS Inc, 2007, SPSS WIND 16 0; TATE RL, 1991, SOIL SCI SOC AM J, V55, P998, DOI 10.2136/sssaj1991.03615995005500040018x; Tian YuMing, 2011, Scientia Silvae Sinicae, V47, P102; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; Yang X, 2011, BIOGEOSCIENCES, V8, P2907, DOI 10.5194/bg-8-2907-2011; Zhang YanJie, 2011, Scientia Silvae Sinicae, V47, P75; Zhao DH, 2012, CAN J FOREST RES, V42, P111, DOI [10.1139/x11-166, 10.1139/X11-166]; Zhu FF, 2014, J PLANT ECOL, V7, P526, DOI 10.1093/jpe/rtu001	45	25	34	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186905	10.1371/journal.pone.0186905	http://dx.doi.org/10.1371/journal.pone.0186905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073278	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400073
J	Tan, YF; Zhang, W; Jiang, L; Yang, JY; Yan, LN				Tan, Yifei; Zhang, Wei; Jiang, Li; Yang, Jiayin; Yan, Lunan			Efficacy and safety of anatomic resection versus nonanatomic resection in patients with hepatocellular carcinoma: A systemic review and meta-analysis	PLOS ONE			English	Review							LIVER RESECTION; CIRRHOTIC-PATIENTS; RISK-FACTORS; INTRAHEPATIC RECURRENCE; HEPATIC RESECTION; 5 CM; HEPATECTOMY; SURVIVAL; MORTALITY; OUTCOMES	Background The surgical decision of performing anatomic resection (AR) or nonanatomic resection (NAR) in patients with hepatocellular carcinoma remains controversial. The aim of the current study is to conduct a meta-analysis on published results to compare surgical outcomes after AR and NAR. Methods A comprehensive search of the Pubmed, Ovid-Medline, Embase, Cochrane library, and Science Citation indexes was performed. Overall and disease free survival (DFS), perioperative mortality and morbidity were the main outcomes. The meta-analysis was performed using Revman 5.3 statistical software, and the results are expressed as the relative risk (RR) or weighted mean differences with 95% of confidence intervals. Results After application of the exclusion and inclusion criteria, 25 studies published between 1996-2015 that compared outcomes after AR and NAR in patients with HCC were identified. A total of 10216 patients were included in the meta-analysis, 4576 in the AR group and 5640 in the NAR group. Liver cirrhosis was found in 54.8% (range from 18.8% to 100%) of patients in the AR group and 67.8% (range from 34.3% to 100%) of patients in the NAR group, resulting in a RR of 0.45 (I2 = 18%, fixed model, 95% CI 0.39-0.52; Z = 10.31; P = < 0.00001). The meta-analysis revealed a statistically significant 5-year survival (RR of 1.10, 95% CI 1.03-1.17; Z = 2.92, P = 0.004) and DFS (RR: 1.33, 95% CI 1.18-1.51; Z = 4.46, P < 0.00001) advantage for patients undergoing AR resection compared to NAR. In regards to safety, no statistical significance was found in mortality and morbidity between the two groups. Eight studies including 1812 patients with small (< 5 cm) solitary HCC indicated a better 5-year DFS in the AR group (41.4%) than in the NAR group (28.6%), with a RR of 1.32 (I2 = 42, fixed model, 95% CI: 1.15-1.52, Z = 3.86, P = 0.0001). Conclusion The current study demonstrates better surgical outcomes after AR than NAR in patients with HCC. Therefore, AR is recommended in resectable HCC, especially with small (< 5 cm) solitary tumours.	[Tan, Yifei; Zhang, Wei; Jiang, Li; Yang, Jiayin; Yan, Lunan] Sichuan Univ, West China Hosp, Dept Liver Surg, Liver Transplantat Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University	Yan, LN (corresponding author), Sichuan Univ, West China Hosp, Dept Liver Surg, Liver Transplantat Ctr, Chengdu, Sichuan, Peoples R China.	yanlunan688@163.com						Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Capussotti L, 2005, EJSO-EUR J SURG ONC, V31, P986, DOI 10.1016/j.ejso.2005.04.002; Cho YB, 2007, HEPATO-GASTROENTEROL, V54, P1766; Cucchetti A, 2014, SURGERY, V155, P512, DOI 10.1016/j.surg.2013.10.009; Cucchetti A, 2012, ANN SURG ONCOL, V19, P3697, DOI 10.1245/s10434-012-2450-z; Dahiya D, 2010, SURGERY, V147, P676, DOI 10.1016/j.surg.2009.10.043; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhir M, 2012, HPB, V14, P635, DOI 10.1111/j.1477-2574.2012.00500.x; Dong J, 2010, HPB, V12, P83; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Fan LF, 2013, HEPATO-GASTROENTEROL, V60, P825, DOI 10.5754/hge121039; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Hirokawa F, 2015, SURGERY, V157, P27, DOI 10.1016/j.surg.2014.06.080; Hsia CY, 2000, J AM COLL SURGEONS, V190, P574, DOI 10.1016/S1072-7515(00)00259-3; Ikai I, 2005, HEPATOL RES, V32, P163, DOI 10.1016/j.hepres.2005.04.005; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Itoh S, 2014, AM SURGEON, V80, P166; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaibori M, 2006, SURGERY, V139, P385, DOI 10.1016/j.surg.2005.08.035; Kamiyama T, 2010, J SURG ONCOL, V101, P54, DOI 10.1002/jso.21414; Kang CM, 2010, J SURG RES, V160, P81, DOI 10.1016/j.jss.2009.01.021; Kim YK, 2015, J LAPAROENDOSC ADV S, V25, P375, DOI 10.1089/lap.2014.0443; Kobayashi Akira, 2008, J Hepatobiliary Pancreat Surg, V15, P515, DOI 10.1007/s00534-007-1293-7; Kudo A, 2014, AM J SURG, V207, P863, DOI 10.1016/j.amjsurg.2013.06.009; Makuuchi M, 2002, ONCOLOGY-BASEL, V62, P74, DOI 10.1159/000048280; Matsuda M, 2014, HPB, V16, P452; Nanashima A, 2008, ACTA CHIR BELG, V108, P532; Njei B, 2015, HEPATOLOGY, V61, P191, DOI 10.1002/hep.27388; Nusbaum JD, 2015, J CLIN GASTROENTEROL, V49, pE91, DOI 10.1097/MCG.0000000000000306; Okamura Y, 2014, J GASTROINTEST SURG, V18, P1994, DOI 10.1007/s11605-014-2646-6; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Popescu I, 2009, CHIRURGIA-BUCHAREST, V104, P7; Regimbeau JM, 2002, SURGERY, V131, P311, DOI 10.1067/msy.2002.121892; Sasaki K, 2013, AM SURGEON, V79, P1163; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Tanaka K, 2008, SURGERY, V143, P607, DOI 10.1016/j.surg.2008.01.006; Tang YH, 2013, HEPATO-GASTROENTEROL, V60, P2019, DOI 10.5754/hge.11235; Thuan N, 2014, HPB, V16, P466; Tomimaru Y, 2012, DIGEST DIS SCI, V57, P1942, DOI 10.1007/s10620-012-2114-7; Ueno S, 2008, J HEPATO-BILIARY-PAN, V15, P493, DOI 10.1007/s00534-007-1312-8; Wakai T, 2007, ANN SURG ONCOL, V14, P1356, DOI 10.1245/s10434-006-9318-z; Wells GA, NEWCASTLE D SCALE AS; Yamamoto M, 2001, SURGERY, V130, P443, DOI 10.1067/msy.2001.116406; YAMANAKA N, 1993, HEPATOLOGY, V18, P79, DOI 10.1016/0270-9139(93)90510-T; Yamashita Y, 2007, J AM COLL SURGEONS, V205, P19, DOI 10.1016/j.jamcollsurg.2007.01.069; Yamazaki O, 2010, J HEPATO-BIL-PAN SCI, V17, P349, DOI 10.1007/s00534-009-0253-9; Ye JZ, 2012, ASIAN PAC J CANCER P, V13, P1771, DOI 10.7314/APJCP.2012.13.5.1771; Ziparo V, 2002, EUR J SURG ONCOL, V28, P723, DOI 10.1053/ejso.2002.1299	49	26	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186930	10.1371/journal.pone.0186930	http://dx.doi.org/10.1371/journal.pone.0186930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073257	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400076
J	Voigt, J; Carpenter, L; Leuchter, A				Voigt, Jeffrey; Carpenter, Linda; Leuchter, Andrew			Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis	PLOS ONE			English	Article							TREATMENT-RESISTANT; ELECTROCONVULSIVE-THERAPY; CLINICAL-RESPONSE; DOUBLE-BLIND; EFFICACY; SAFETY; METAANALYSIS; MORTALITY; RTMS	Objective Repetitive Transcranial Magnetic Stimulation (rTMS) commonly is used for the treatment of Major Depressive Disorder (MDD) after patients have failed to benefit from trials of multiple antidepressant medications. No analysis to date has examined the cost-effectiveness of rTMS used earlier in the course of treatment and over a patients' lifetime. Methods We used lifetime Markov simulation modeling to compare the direct costs and quality adjusted life years (QALYs) of rTMS and medication therapy in patients with newly diagnosed MDD (ages 20-59) who had failed to benefit from one pharmacotherapy trial. Patients' life expectancies, rates of response and remission, and quality of life outcomes were derived from the literature, and treatment costs were based upon published Medicare reimbursement data. Baseline costs, aggregate per year quality of life assessments (QALYs), Monte Carlo simulation, tornado analysis, assessment of dominance, and one way sensitivity analysis were also performed. The discount rate applied was 3%. Results Lifetime direct treatment costs, and QALYs identified rTMS as the dominant therapy compared to antidepressant medications (i. e., lower costs with better outcomes) in all age ranges, with costs/improved QALYs ranging from $2,952/0.32 (older patients) to $11,140/ 0.43 (younger patients). One-way sensitivity analysis demonstrated that the model was most sensitive to the input variables of cost per rTMS session, monthly prescription drug cost, and the number of rTMS sessions per year. Conclusion rTMS was identified as the dominant therapy compared to antidepressant medication trials over the life of the patient across the lifespan of adults with MDD, given current costs of treatment. These models support the use of rTMS after a single failed antidepressant medication trial versus further attempts at medication treatment in adults with MDD.	[Voigt, Jeffrey] Med Device Consultants Ridgewood LLC, Ridgewood, NJ 07450 USA; [Carpenter, Linda] Brown Univ, Dept Psychiat & Human Behav, Brown Inst Brain Sci, Providence, RI 02912 USA; [Leuchter, Andrew] Univ Calif Los Angeles, Neuromodulat Div, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA	Brown University; University of California System; University of California Los Angeles	Voigt, J (corresponding author), Med Device Consultants Ridgewood LLC, Ridgewood, NJ 07450 USA.	meddevconsultant@aol.com		Voigt, Jeffrey/0000-0002-1755-8612	Magstim; Neuronetics; NeoSync; Jannssen	Magstim; Neuronetics; NeoSync; Jannssen	The funder (Magstim) provided an unrestricted grant to Medical Device Consultants of Ridgewood (commercial company) for the research, analysis, and preparation of the manuscript. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Linda Carpenter, MD, has received consulting income from Magstim, Inc (<$5,000/year). Additionally, Dr. Carpenter has received clinical trial research support from Neuronetics, NeoSync, and Jannssen; and equipment support from NeoSync and Neuronetics.	Berlim MT, 2013, PSYCHOL MED, V43, P2245, DOI 10.1017/S0033291712002802; Brakemeier EL, 2007, J PSYCHIATR RES, V41, P395, DOI 10.1016/j.jpsychires.2006.01.013; Buikema A, 2015, AM J PHARM BENEFIST, V7, P135; Dunner DL, 2014, J CLIN PSYCHIAT, V75, P1394, DOI 10.4088/JCP.13m08977; Gallo JJ, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f2570; George MS, 2010, ARCH GEN PSYCHIAT, V67, P507, DOI 10.1001/archgenpsychiatry.2010.46; Gold MR, 1996, COST EFFECTIVENESS H, P285; Greenberg PE, 2015, J CLIN PSYCHIAT, P76; Health Quality Ontario, 2016, Ont Health Technol Assess Ser, V16, P1; Huang X, 2017, MOL PSYCHIATR, V22, P1274, DOI 10.1038/mp.2017.143; Janicak PG, 2008, J CLIN PSYCHIAT, V69, P222, DOI 10.4088/JCP.v69n0208; Kedzior KK, 2015, DEPRESS ANXIETY, V32, P193, DOI 10.1002/da.22339; Kozel FA, 2004, CNS SPECTRUMS, V9, P476; Leuchter AF, 2015, BRAIN STIMUL, V8, P787, DOI 10.1016/j.brs.2015.05.005; Levkovitz Y, 2015, WORLD PSYCHIATRY, V14, P64, DOI 10.1002/wps.20199; Liu BS, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0342-4; MedPAC, 2017, HOSP INP OUTP SERV A; Miller LW, 2013, CIRCULATION, V127, P743, DOI 10.1161/CIRCULATIONAHA.112.139824; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Nguyen KH, 2015, VALUE HEALTH, V18, P597, DOI 10.1016/j.jval.2015.04.004; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Perera T, 2016, BRAIN STIMUL, V9, P336, DOI 10.1016/j.brs.2016.03.010; Philip NS, 2016, BRAIN STIMUL, V9, P251, DOI 10.1016/j.brs.2015.11.007; Piatt EE, 2010, PSYCHIAT SERV, V61, P663, DOI 10.1176/ps.2010.61.7.663; PRUDIC J, 1990, PSYCHIAT RES, V31, P287, DOI 10.1016/0165-1781(90)90098-P; Prudic J, 1996, AM J PSYCHIAT, V153, P985; Rasanen P, 1999, J AFFECT DISORDERS, V55, P67, DOI 10.1016/S0165-0327(99)00002-6; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; SACKEIM HA, 1990, J CLIN PSYCHOPHARM, V10, P96, DOI 10.1097/00004714-199004000-00004; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Schousboe JT, 2007, JAMA-J AM MED ASSOC, V298, P629, DOI 10.1001/jama.298.6.629; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Simpson KN, 2009, ADV THER, V26, P346, DOI 10.1007/s12325-009-0013-x; Sinyor M, 2010, CAN J PSYCHIAT, V55, P126, DOI 10.1177/070674371005500303; Tosteson ANA, 2008, ANN INTERN MED, V149, P845, DOI 10.7326/0003-4819-149-12-200812160-00003; Udupa K, 2007, J AFFECT DISORDERS, V104, P231, DOI 10.1016/j.jad.2007.04.002; Vallejo-Torres L, 2015, PSYCHOL MED, V45, P1459, DOI 10.1017/S0033291714002554; Zivin K, 2012, PSYCHIAT SERV, V63, P823, DOI 10.1176/appi.ps.201100317	40	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186950	10.1371/journal.pone.0186950	http://dx.doi.org/10.1371/journal.pone.0186950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073256	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400079
J	Huh, MS; Young, KG; Yan, KQ; Price-O'Dea, T; Picketts, DJ				Huh, Michael S.; Young, Kevin G.; Yan, Keqin; Price-O'Dea, Tina; Picketts, David J.			Recovery from impaired muscle growth arises from prolonged postnatal accretion of myonuclei in Atrx mutant mice	PLOS ONE			English	Article							X SYNDROME PROTEIN; SKELETAL-MUSCLE; STEM-CELLS; HISTONE CHAPERONE; SELF-RENEWAL; HYPERTROPHY; EXPRESSION; DAXX; DYSFUNCTION; SURVIVAL	Reduced muscle mass due to pathological development can occur through several mechanisms, including the loss or reduced proliferation of muscle stem cells. Muscle-specific ablation of the alpha-thalassemia mental retardation syndrome mutant protein, Atrx, in transgenic mice results in animals with a severely reduced muscle mass at three weeks of age; yet this muscle mass reduction resolves by adult age. Here, we explore the cellular mechanism underlying this effect. Analysis of Atrx mutant mice included testing for grip strength and rotorod performance. Muscle fiber length, fiber volume and numbers of myofiber-associated nuclei were determined from individual EDL or soleus myofibers isolated at three, five, or eight weeks. Myofibers from three week old Atrx mutant mice are smaller with fewer myofiber-associated nuclei and reduced volume compared to control animals, despite similar fiber numbers. Nonetheless, the grip strength of/tomutant mice was comparable to control mice when adjusted for body weight. Myofiber volume remained smaller at five weeks, becoming comparable to controls by 8 weeks of age. Concomitantly, increased numbers of myofiber-associated nuclei and Ki67(+) myoblasts indicated that the recovery of muscle mass likely arises from the prolonged accretion of new myonuclei. This suggests that under disease conditions the muscle satellite stem cell niche can remain in a prolonged active state, allowing for the addition of a minimum number of myonuclei required to achieve a normal muscle size.	[Huh, Michael S.; Young, Kevin G.; Yan, Keqin; Price-O'Dea, Tina; Picketts, David J.] Ottawa Hosp Res Inst, Regenerat Med Program, 501 Smyth Rd, Ottawa, ON, Canada; [Picketts, David J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Picketts, David J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Picketts, DJ (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, 501 Smyth Rd, Ottawa, ON, Canada.; Picketts, DJ (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Picketts, DJ (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	dpicketts@ohri.ca			Canadian Institutes of Health Research [MOP-133586]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/37788.html), MOP-133586 (DJP).	Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Egner IM, 2016, DEVELOPMENT, V143, P2898, DOI 10.1242/dev.134411; Ferdousi LV, 2014, STEM CELL RES, V13, P492, DOI 10.1016/j.scr.2014.08.005; Frese S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132099; Fujimaki S, 2014, J BIOL CHEM, V289, P7399, DOI 10.1074/jbc.M113.539247; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; Goh Q, 2017, ELIFE, V6, DOI 10.7554/eLife.20007; Huh MS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.121; Huh MS, 2012, J CLIN INVEST, V122, P4412, DOI 10.1172/JCI63765; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lagali PS, 2016, HUM MOL GENET, V25, P4787, DOI 10.1093/hmg/ddw306; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lee SJ, 2012, P NATL ACAD SCI USA, V109, pE2353, DOI 10.1073/pnas.1206410109; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Nogami T, 2011, HIPPOCAMPUS, V21, P678, DOI 10.1002/hipo.20782; Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Servian-Morilla E, 2016, EMBO MOL MED, V8, P1289, DOI 10.15252/emmm.201505815; Sharples AP, 2016, BIOGERONTOLOGY, V17, P603, DOI 10.1007/s10522-015-9604-x; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Watson LA, 2013, J CLIN INVEST, V123, P2049, DOI 10.1172/JCI65634; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Zalc A, 2014, DEVELOPMENT, V141, P2780, DOI 10.1242/dev.110155	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186989	10.1371/journal.pone.0186989	http://dx.doi.org/10.1371/journal.pone.0186989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095838	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200037
J	Park, JH; Kim, CS; Won, KS; Oh, JS; Kim, JS; Kim, HW				Park, Jae Hyun; Kim, Chun Soo; Won, Kyoung Sook; Oh, Jungsu S.; Kim, Jae Seung; Kim, Hae Won			Asymmetry of cerebral glucose metabolism in very low-birth-weight infants without structural abnormalities	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PRETERM INFANTS; WHITE-MATTER; NEURODEVELOPMENTAL OUTCOMES; FDG-PET; PALSY; PREMATURITY; PREDICT; BRAIN; MRI	Even when structural abnormalities are not observed on the brain magnetic resonance images (MRI) of very low-birth-weight (VLBW) infants, such infants are at increased risk for poor neurodevelopment. The aim of the present study was to evaluate cerebral glucose metabolism in VLBW infants without apparent structural abnormalities on MRI. Methods Thirty-six VLBW infants who underwent F-18 fluorodeoxyglucose (F-18 FDG) brain PET and MRI were prospectively enrolled, while infants with evidence of parenchymal brain injury on MRI were excluded. The regional glucose metabolic ratio and asymmetry index were calculated. The asymmetry index more than 10% (right > left asymmetry) or less than-10% (left > right asymmetry) were defined as abnormal. Regional cerebral glucose metabolism were compared between right and left cerebral hemispheres, and between the following subgroups: multiple gestations, premature rupture of membrane, bronchopulmonary dysplasia, and low-grade intraventricular hemorrhage. Results In the individual analysis, 21 (58.3%) of 36 VLBW infants exhibited asymmetric cerebral glucose metabolism. Fifteen infants (41.7%) exhibited right > left asymmetry, while six (16.7%) exhibited left > right asymmetry. In the regional analysis, right > left asymmetry was more extensive than left > right asymmetry. The metabolic ratio in the right frontal, temporal, and occipital cortices and right thalamus were significantly higher than those in the corresponding left regions. In the subgroup analyses, the cerebral glucose metabolism in infants with multiple gestations, premature rupture of membrane, bronchopulmonary dysplasia, or low-grade intraventricular hemorrhage were significantly lower than those in infants without these. Conclusion VLBW infants without structural abnormalities have asymmetry of cerebral glucose metabolism. Decreased cerebral glucose metabolism are noted in infants with neurodevelopmental risk factors. F-18 FDG PET could show microstructural abnormalities not detected by MRI in VLBW infants.	[Park, Jae Hyun; Kim, Chun Soo] Keimyung Univ, Dongsan Med Ctr, Dept Pediat, Daegu, South Korea; [Won, Kyoung Sook; Kim, Hae Won] Keimyung Univ, Dongsan Med Ctr, Dept Nucl Med, Daegu, South Korea; [Oh, Jungsu S.; Kim, Jae Seung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea	Keimyung University; Keimyung University; University of Ulsan; Asan Medical Center	Kim, HW (corresponding author), Keimyung Univ, Dongsan Med Ctr, Dept Nucl Med, Daegu, South Korea.	hwkim.nm@gmail.com			Keimyung University Dongsan Medical Center; National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2014R1A5A2010008]	Keimyung University Dongsan Medical Center; National Research Foundation of Korea (NRF) - Korea Government (MSIP)	This work was supported by a research promoting grant from the Keimyung University Dongsan Medical Center in 2014 and by a National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (no. 2014R1A5A2010008).	AHNSJO S, 1955, Nord Med, V54, P1657; ALTMAN DI, 1991, CLIN PERINATOL, V18, P549, DOI 10.1016/S0095-5108(18)30512-8; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behrman RE, 2007, I MED COMMITTEE UNDE; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; CHUGANI HT, 1993, CLIN PERINATOL, V20, P395, DOI 10.1016/S0095-5108(18)30400-7; Degani S, 2008, GYNECOL OBSTET INVES, V66, P184, DOI 10.1159/000143157; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hayakawa M, 2014, PEDIATR INT, V56, P215, DOI 10.1111/ped.12233; Higuchi Y, 1997, EUR J PEDIATR, V156, P236, DOI 10.1007/s004310050591; Ivancevic V, 2000, CLIN NUCL MED, V25, P596; KERRIGAN JF, 1991, PEDIATR NEUROL, V7, P415, DOI 10.1016/0887-8994(91)90024-F; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Korzeniewski SJ, 2008, J CHILD NEUROL, V23, P216, DOI 10.1177/0883073807307983; Leitner Y, 2014, NEURORADIOLOGY, V56, P669, DOI 10.1007/s00234-014-1373-8; Linsell L, 2015, JAMA PEDIATR, V169, P1162, DOI 10.1001/jamapediatrics.2015.2175; Lodha A, 2009, DEV MED CHILD NEUROL, V51, P895, DOI 10.1111/j.1469-8749.2009.03284.x; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; McClure MM, 2008, J CEREBR BLOOD F MET, V28, P995, DOI 10.1038/sj.jcbfm.9600597; Mikolajczyk K, 1998, MED INFORM, V23, P207, DOI 10.3109/14639239809001400; Msall ME, 2008, SEMIN PERINATOL, V32, P42, DOI 10.1053/j.semperi.2007.12.006; Nelson KB, 2015, NEW ENGL J MED, V373, P946, DOI 10.1056/NEJMra1505261; Ruotsalainen U, 1996, J NUCL MED, V37, P387; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Shen XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039256; Shi Y, 2009, EARLY HUM DEV, V85, P429, DOI 10.1016/j.earlhumdev.2009.02.002; Silverman DHS, 2004, J NUCL MED, V45, P594; Son SM, 2007, NEUROSCI LETT, V420, P34, DOI 10.1016/j.neulet.2007.04.054; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volpe JJ, 2005, PEDIATRICS, V116, P221, DOI 10.1542/peds.2005-0191; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Xia T, 2012, PHYS MED BIOL, V57, P309, DOI 10.1088/0031-9155/57/2/309; Xiong T, 2012, WORLD J PEDIATR, V8, P293, DOI 10.1007/s12519-012-0372-2; Zeng Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023621	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186976	10.1371/journal.pone.0186976	http://dx.doi.org/10.1371/journal.pone.0186976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095842	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200035
J	Wang, ST; Feng, Q; Zeng, YP; Mao, XX; Chen, YH; Xu, H				Wang, Shutao; Feng, Qian; Zeng, Yapeng; Mao, Xiaoxi; Chen, Yaheng; Xu, Hao			Dynamic changes in water and salinity in saline-alkali soils after simulated irrigation and leaching	PLOS ONE			English	Article								Soil salinization is a global problem that limits agricultural development and impacts human life. This study aimed to understand the dynamic changes in water and salinity in saline alkali soil based on an indoor soil column simulation. We studied the changes in the water and salt contents of soils with different degrees of salinization under various irrigation conditions. The results showed that after seven irrigations, the pH, conductivity and total soluble salt content of the percolation samples after irrigation generally increased initially then decreased with repeated irrigation. The soil moisture did not change significantly after irrigation. The pH, conductivity, and total soluble salt content of each layer of the soil profile exhibited general declining trends. In the soil profile from Changguo Township (CG), the pH decreased from 8.21-8.35 to 7.71-7.88, the conductivity decreased from 0.95-1.14 ms/cm to 0.45-0.68 ms/cm, and the total soluble salt content decreased from 2.63-2.81 g/kg to 2.28-2.51 g/kg. In the soil profile from Zhongjie Industrial Park (ZJ), the pH decreased from 8.36-8.54 to 7.73-7.96, the conductivity decreased from 1.58-1.68 ms/cm to 1.45-1.54 ms/cm, and the total soluble salt decreased from 2.81-4.03 g/kg to 2.56-3.28 g/kg. The transported salt ions were primarily K+, Na+ and Cl-. After several irrigations, a representative desalination effect was achieved. The results of this study can provide technical guidance for the comprehensive management of saline-alkali soils.	[Wang, Shutao; Feng, Qian; Zeng, Yapeng; Chen, Yaheng; Xu, Hao] Hebei Agr Univ, Land & Resources Coll, Baoding, Peoples R China; [Wang, Shutao] Key Lab Hebei Agr Environm, Baoding, Peoples R China; [Wang, Shutao] Minist Land & Resources, Cangzhou Field Res Stn, Land Use Circum Bohai Sea, Baoding, Peoples R China; [Mao, Xiaoxi] Hebei Acad Agr & Forestry Sci, Plant Protect Inst, Baoding, Peoples R China	Hebei Agricultural University; Ministry of Natural Resources of the People's Republic of China; Hebei Academy of Agricultural & Forestry Sciences	Chen, YH (corresponding author), Hebei Agr Univ, Land & Resources Coll, Baoding, Peoples R China.	chenyaheng@126.com	Mao, Xiaoxi/GQP-8460-2022					Ala MS, 2016, GEODERMA, V264, P132, DOI 10.1016/j.geoderma.2015.10.008; [Anonymous], 2012, YELLOW RIVER; Benduhn F, 2004, J MARINE SYST, V47, P35, DOI 10.1016/j.jmarsys.2003.12.007; Bing H, 2015, ENVIRON EARTH SCI, V74, P675, DOI 10.1007/s12665-015-4072-9; Du M., 2012, THESIS U MINNESOTA; Gao Hui, 2015, Yingyong Shengtai Xuebao, V26, P1016; Gap YH, 2011, THESIS; Garre S, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0129; Gu XB, 2009, THESIS; Guan BY, 2012, THESIS; Hansson K, 2006, COLD REG SCI TECHNOL, V44, P20, DOI 10.1016/j.coldregions.2005.06.004; [胡安焱 Hu Anyan], 2002, [水科学进展, Advances in Water Science], V13, P726; [李宝富 Li Baofu], 2013, [地理科学, Scientia Geographica Sinica], V33, P763; Li ST, 2011, THESIS; Li W. W., 2011, THESIS; Li WJ, 2014, WATER SAVING IRRIGAT, V4, P7; Liang CJ, 2014, THESIS; Lv ZW, 2005, THESIS; Phogat V, 2012, IRRIGATION SCI, V30, P315, DOI 10.1007/s00271-011-0284-2; Selim T, 2013, IRRIG DRAIN, V62, P352, DOI 10.1002/ird.1739; Siyal AA, 2013, AGR WATER MANAGE, V121, P73, DOI 10.1016/j.agwat.2013.01.005; Wang Y., 2015, THESIS; [余根坚 Yu Genjian], 2013, [水利学报, Journal of Hydraulic Engineering], V44, P826; [岳耀杰 YUE Yaojie], 2010, [资源科学, Resources Science], V32, P423; [张珂萌 Zhang Kemeng], 2015, [灌溉排水学报, Journal of Irrigation and Drainage], V34, P11	25	6	9	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187536	10.1371/journal.pone.0187536	http://dx.doi.org/10.1371/journal.pone.0187536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091963	Green Submitted, gold, Green Published			2022-12-27	WOS:000414229700073
J	Wollenman, LC; Ploeg, MRV; Miller, ML; Zhang, YZ; Bazil, JN				Wollenman, Lucas C.; Ploeg, Matthew R. Vander; Miller, Mackinzie L.; Zhang, Yizhu; Bazil, Jason N.			The effect of respiration buffer composition on mitochondrial metabolism and function	PLOS ONE			English	Article							RAT-HEART MITOCHONDRIA; SKELETAL-MUSCLE MITOCHONDRIA; HYDROGEN-PEROXIDE PRODUCTION; ISOLATED LIVER-MITOCHONDRIA; CITRIC-ACID CYCLE; OXIDATIVE-PHOSPHORYLATION; DEHYDROGENASE COMPLEX; CARDIAC MITOCHONDRIA; ADENINE-NUCLEOTIDES; ADP/ATP CARRIER	Functional studies on isolated mitochondria critically rely on the right choice of respiration buffer. Differences in buffer composition can lead to dramatically different respiration rates leading to difficulties in comparing prior studies. The ideal buffer facilities high ADP-stimulated respiratory rates and minimizes substrate transport effects so that the ability to distinguish between various treatments and conditions is maximal. In this study, we analyzed a variety of respiration buffers and substrate combinations to determine the optimal conditions to support mitochondrial function through ADP-stimulated respiration and uncoupled respiration using FCCP. The buffers consisted of a standard KCI based buffer (B1) and three modified buffers with chloride replaced by the K-lactobionate, sucrose, and the antioxidant taurine (B2) or K-gluconate (B3). The fourth buffer (B4) was identical to B2 except that K-lactobionate was replaced with K-gluconate. The substrate combinations consisted of metabolites that utilize different pathways of mitochondrial metabolism. To test mitochondrial function, we used isolated cardiac guinea pig mitochondria and measured oxygen consumption for three respiratory states using an Oroboros Oxygraph-2k. These states were the leak state (energized mitochondria in the absence of adenylates), ADP-stimulated state (energized mitochondria in the presence of saturating ADP concentrations), and uncoupled state (energized mitochondria in the presence of FCCP). On average across all substrate combinations, buffers B2, B3, and B4 had an increase of 16%, 26%, and 35% for the leak state, ADP-simulated state, and uncoupled state, respectively, relative to rates using B1. The common feature distinguishing these buffers from B1 is the notable lack of high chloride concentrations. Based on the respiratory rate metrics obtained with the substrate combinations, we conclude that the adenine nucleotide translocase, the dicarboxylate carrier, and the alpha-ketoglutarate exchanger are partially inhibited by chloride. Therefore, when the goal is to maximize ADP-stimulated respiration, buffers containing K-lactobionate or K-gluconate are superior choices compared to the standard KCI-based buffers.	[Wollenman, Lucas C.; Ploeg, Matthew R. Vander; Zhang, Yizhu; Bazil, Jason N.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Wollenman, Lucas C.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Miller, Mackinzie L.] Michigan State Univ, Biomed Lab Diagnost, E Lansing, MI 48824 USA; [Miller, Mackinzie L.] Henry Ford Hosp, Nephrol & Hypertens, Detroit, MI 48202 USA	Michigan State University; Vanderbilt University; Michigan State University; Henry Ford Health System; Henry Ford Hospital	Bazil, JN (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	jnbazil@msu.edu			NIH ROOHL121160; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL121160] Funding Source: NIH RePORTER	NIH ROOHL121160; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH ROOHL121160 (to JB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar JG, 2003, CIRCULATION, V107, P1810, DOI 10.1161/01.CIR.0000058462.23347.93; Aldakkak M, 2010, AM J PHYSIOL-CELL PH, V298, pC530, DOI 10.1152/ajpcell.00468.2009; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P71, DOI 10.1016/j.bbabio.2009.08.002; Bazil JN, 2013, J BIOENERG BIOMEMBR, V45, P177, DOI 10.1007/s10863-012-9488-2; Beadle RM, 2015, JACC-HEART FAIL, V3, P202, DOI 10.1016/j.jchf.2014.09.009; BISHOP PD, 1984, ARCH BIOCHEM BIOPHYS, V230, P335, DOI 10.1016/0003-9861(84)90116-4; Blomeyer CA, 2016, J BIOENERG BIOMEMBR, V48, P175, DOI 10.1007/s10863-016-9644-1; Boelens AD, 2013, J BIOENERG BIOMEMBR, V45, P203, DOI 10.1007/s10863-013-9500-5; Bombicino SS, 2016, INT J BIOCHEM CELL B, V81, P335, DOI 10.1016/j.biocel.2016.09.018; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BURGMANN H, 1992, TRANSPLANTATION, V54, P1106; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CARMELIE.EE, 1965, ARCH INT PHYS BIOCH, V73, P174; Coleman HW, 1999, EXPT UNCERTAINTY ANA, Vxvii; Coll O, 2003, HEPATOLOGY, V38, P692, DOI 10.1053/jhep.2003.50351; Contreras L, 2007, J BIOL CHEM, V282, P7098, DOI 10.1074/jbc.M610491200; Cortassa S, 2014, BBA-BIOENERGETICS, V1837, P287, DOI 10.1016/j.bbabio.2013.11.007; Csaba K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039839; Dabkowski ER, 2010, AM J PHYSIOL-HEART C, V299, pH529, DOI 10.1152/ajpheart.00267.2010; DEMELLO WC, 1960, AM J PHYSIOL, V199, P1125, DOI 10.1152/ajplegacy.1960.199.6.1125; Denton RM, 1996, ADV ENZYME REGUL, V36, P183, DOI 10.1016/0065-2571(95)00020-8; Devin A, 1997, BBA-BIOENERGETICS, V1319, P293, DOI 10.1016/S0005-2728(96)00172-7; Devin A, 1997, J BIOENERG BIOMEMBR, V29, P579, DOI 10.1023/A:1022435102552; Dueregger A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135704; Fink BD, 2017, AM J PHYSIOL-CELL PH, V313, pC146, DOI 10.1152/ajpcell.00086.2017; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Gnaiger E, 2000, LIFE IN THE COLD; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Gropp T, 1999, BIOPHYS J, V77, P714, DOI 10.1016/S0006-3495(99)76926-2; Gutierrez-Aguilar M, 2014, J MOL CELL CARDIOL, V72, P316, DOI 10.1016/j.yjmcc.2014.04.008; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; HANSFORD RG, 1982, J BIOENERG BIOMEMBR, V14, P361, DOI 10.1007/BF00743064; Harrison DK, 2015, J APPL PHYSIOL, V119, P1210, DOI 10.1152/japplphysiol.00146.2015; HUCHO F, 1972, Archives of Biochemistry and Biophysics, V151, P328, DOI 10.1016/0003-9861(72)90504-8; HUTTER OF, 1961, J PHYSIOL-LONDON, V157, P335, DOI 10.1113/jphysiol.1961.sp006726; Kawamata H, 2010, ANAL BIOCHEM, V407, P52, DOI 10.1016/j.ab.2010.07.031; Kiss G, 2013, FASEB J, V27, P2392, DOI 10.1096/fj.12-220202; Krammer EM, 2009, BIOPHYS J, V97, pL25, DOI 10.1016/j.bpj.2009.08.047; Kristian T, 2007, J NEUROCHEM, V102, P1346, DOI 10.1111/j.1471-4159.2007.04626.x; Lacerda L, 2010, BASIC RES CARDIOL, V105, P751, DOI 10.1007/s00395-010-0113-4; LAMB JF, 1961, J PHYSIOL-LONDON, V157, P415, DOI 10.1113/jphysiol.1961.sp006733; LANOUE K, 1970, J BIOL CHEM, V245, P102; Lionetti L, 1996, MOL CELL BIOCHEM, V158, P133; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533; MCKEAN TA, 1990, COMP BIOCHEM PHYS B, V97, P109, DOI 10.1016/0305-0491(90)90186-W; MILNERWH.EJ, 1971, BIOCHEM J, V122, P727, DOI 10.1042/bj1220727; Monteiro JP, 2011, J BIOENERG BIOMEMBR, V43, P287, DOI 10.1007/s10863-011-9359-2; MORENOSANCHEZ R, 1988, BIOCHEM J, V256, P403, DOI 10.1042/bj2560403; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicholls DG, 2013, BIOENERGETICS 4, P1; NICHOLLS DG, 1978, BIOCHEM J, V176, P463, DOI 10.1042/bj1760463; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Schmidt CW, 2010, ENVIRON HEALTH PERSP, V118, pA292, DOI 10.1289/ehp.118-a292; Schopf B, 2016, FEBS J, V283, P2181, DOI 10.1111/febs.13733; Southard JH, 1993, TRANSPLANT REV-ORLAN, V7, P176; STRINGHAM JC, 1994, J THORAC CARDIOV SUR, V107, P764; TAEGTMEYER H, 1980, BIOCHEM J, V186, P701, DOI 10.1042/bj1860701; TAEGTMEYER H, 1994, CURR PROB CARDIOLOGY, V19, P61, DOI 10.1016/0146-2806(94)90008-6; Territo PR, 2001, CELL CALCIUM, V30, P19, DOI 10.1054/ceca.2001.0211; Tomaskova Z, 2010, FEBS LETT, V584, P2085, DOI 10.1016/j.febslet.2010.01.035; VAUGHANJONES RD, 1979, J PHYSIOL-LONDON, V295, P83, DOI 10.1113/jphysiol.1979.sp012956; Vavrusova M, 2014, J AGR FOOD CHEM, V62, P5675, DOI 10.1021/jf501453c; Vavrusova M, 2013, J AGR FOOD CHEM, V61, P8207, DOI 10.1021/jf402124n; Vinnakota KC, 2016, BIOPHYS J, V110, P972, DOI 10.1016/j.bpj.2016.01.003; Vinnakota KC, 2011, J BIOL CHEM, V286, P30816, DOI 10.1074/jbc.M111.242529; WAN B, 1989, J BIOL CHEM, V264, P13430; Wang XM, 2005, CELL PHYSIOL BIOCHEM, V16, P147, DOI 10.1159/000089840; Wang ZV, 2015, CIRCULATION, V131, P771, DOI 10.1161/CIRCULATIONAHA.115.015357; Wei AC, 2011, BIOPHYS J, V100, P2894, DOI 10.1016/j.bpj.2011.05.027; Xu Yan-Jun, 2008, Exp Clin Cardiol, V13, P57	72	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187523	10.1371/journal.pone.0187523	http://dx.doi.org/10.1371/journal.pone.0187523			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091971	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700071
J	Rainard, P; Reperant-Ferter, M; Gitton, C; Gilbert, FB; Germon, P				Rainard, Pascal; Reperant-Ferter, Maryline; Gitton, Christophe; Gilbert, Florence B.; Germon, Pierre			Cellular and humoral immune response to recombinant Escherichia coli OmpA in cows	PLOS ONE			English	Article							MEMBRANE PROTEIN-A; MAMMARY-GLAND; INFECTION; BOVINE; SURFACE; MICE; K-12; EFFECTOR; BACTERIA; ANTIGEN	The outer membrane protein (Omp) A is a major constituent of the outer membrane of Escherichia coli. This protein has been used in several vaccine development studies, but seldom with a view to vaccinating against mastitis. The objective of this study was to investigate the immunogenicity of E. coli OmpA and its vaccine potential for cows. Both the humoral and cellular immune responses were investigated. The gene for OmpA of the mastitis- causing strain P4 was cloned and expressed, and the recombinant protein (rEcOmpA) purified. Cows were immunized twice with rEcOmpA with adjuvant one month apart by the systemic route. Before immunization, few antibodies to rEcOmpA were detected, and there was little production of IL-17A in a whole blood stimulation assay (WBA) with rEcOmpA. Antibodies to rEcOmpA were induced by immunization. These antibodies were not able to react with E. coli P4, but reacted with a rough P4 mutant prepared by inactivating the rfb locus. This suggests that the complete LPS O-chain precluded the accessibility of antibodies to their target at the outer membrane. The cellular immune response appeared to be biased towards a Th17-type, as more IL-17A than IFN-gamma was produced in the OmpA-specific WBA. There was a good correlation between antibody titers and the production of IL-17A in the WBA. The intramammary instillation of rEcOmpA elicited a slight local inflammatory response which was not related to the WBA. Overall, the interest of OmpA as vaccine immunogen was not established, although other experimental conditions (dose, adjuvant, route) need to be investigated to conclude definitively. The study pointed to several important issues such as the accessibility of OmpA to antibodies and the weakness of Th1-type response induced by OmpA.	[Rainard, Pascal; Reperant-Ferter, Maryline; Gitton, Christophe; Gilbert, Florence B.; Germon, Pierre] Univ Tours, UMR 1282, Infectiol & Sante Publ, INRA, Nouzilly, France	INRAE; Universite de Tours	Rainard, P (corresponding author), Univ Tours, UMR 1282, Infectiol & Sante Publ, INRA, Nouzilly, France.	pascal.rainard@inra.fr	GERMON, Pierre/AAC-9111-2019; GERMON, Pierre/M-5264-2019	GERMON, Pierre/0000-0003-3078-876X; Rainard, Pascal/0000-0002-5477-2626	Institut National de la Recherche Agronomique; Region Centre Val de Loire [201200073634]	Institut National de la Recherche Agronomique; Region Centre Val de Loire(Region Centre-Val de Loire)	This work was funded by the Institut National de la Recherche Agronomique (www.inra.fr) and by the Region Centre Val de Loire (Project convention 201200073634, www.regioncentre.fr). There was no additional external funding received for this study. The funders had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 2013, TRENDS IMMUNOL, V34, P299, DOI 10.1016/j.it.2013.03.003; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; CRAVEN N, 1985, VET IMMUNOL IMMUNOP, V10, P71, DOI 10.1016/0165-2427(85)90039-X; Dabo SM, 2008, VACCINE, V26, P4345, DOI 10.1016/j.vaccine.2008.06.029; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FREUDL R, 1986, J MOL BIOL, V188, P491, DOI 10.1016/0022-2836(86)90171-3; Guan QF, 2015, APPL MICROBIOL BIOT, V99, P5451, DOI 10.1007/s00253-014-6339-6; Herry V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03724-7; HILL AW, 1983, VET MICROBIOL, V8, P293, DOI 10.1016/0378-1135(83)90081-0; Hounsome JDA, 2011, INFECT IMMUN, V79, P4332, DOI 10.1128/IAI.05469-11; Hu R, 2013, ISR J VET MED, V68, P48; Jeannin P, 2002, VACCINE, V20, pA23, DOI 10.1016/S0264-410X(02)00383-3; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Krishnan S, 2012, FEBS J, V279, P919, DOI 10.1111/j.1742-4658.2012.08482.x; Lee JS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-263; Lu QY, 2011, SOFT MATTER, V7, P9366, DOI 10.1039/c1sm05554b; McConnell MJ, 2011, PROTEIN EXPRES PURIF, V77, P98, DOI 10.1016/j.pep.2010.11.019; Perez-Toledo Marisol, 2017, Front Immunol, V8, P230, DOI 10.3389/fimmu.2017.00230; Porcherie A, 2016, J IMMUNOL, V196, P803, DOI 10.4049/jimmunol.1500705; Rainard P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154172; Rainard P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137755; ROCQUE WJ, 1987, J BACTERIOL, V169, P4003, DOI 10.1128/jb.169.9.4003-4010.1987; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; Singh SP, 2003, INFECT IMMUN, V71, P3937, DOI 10.1128/IAI.71.7.3937-3946.2003; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; TSANG VCW, 1991, J IMMUNOL METHODS, V138, P291, DOI 10.1016/0022-1759(91)90178-I; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; WILLIAMS MR, 1982, RES VET SCI, V33, P47, DOI 10.1016/S0034-5288(18)32358-0; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187369	10.1371/journal.pone.0187369	http://dx.doi.org/10.1371/journal.pone.0187369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088296	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900076
J	Birch, JL; Walsh, NG; Cantrill, DJ; Holmes, GD; Murphy, DJ				Birch, Joanne L.; Walsh, Neville G.; Cantrill, David J.; Holmes, Gareth D.; Murphy, Daniel J.			Testing efficacy of distance and tree-based methods for DNA barcoding of grasses (Poaceae tribe Poeae) in Australia	PLOS ONE			English	Article							SPECIES DELIMITATION; GENUS; IDENTIFICATION; DIVERGENCE; TAXONOMY; LOCI	In Australia, Poaceae tribe Poeae are represented by 19 genera and 99 species, including economically and environmentally important native and introduced pasture grasses [e.g.Poa (Tussock-grasses) and Lolium (Ryegrasses)]. We used this tribe, which are well characterised in regards to morphological diversity and evolutionary relationships, to test the efficacy of DNA barcoding methods. A reference library was generated that included 93.9% of species in Australia (408 individuals, (x) over bar = 3.7 individuals per species). Molecular data were generated for official plant barcoding markers (rbcL, matK) and the nuclear ribosomal internal transcribed spacer (ITS) region. We investigated accuracy of specimen identifications using distance-(nearest neighbour, best-close match, and threshold identification) and treebased (maximum likelihood, Bayesian inference) methods and applied species discovery methods (automatic barcode gap discovery, Poisson tree processes) based on molecular data to assess congruence with recognised species. Across all methods, success rate for specimen identification of genera was high (87.5-99.5%) and of species was low (25.6-44.6%). Distance-and tree-based methods were equally ineffective in providing accurate identifications for specimens to species rank (26.1-44.6% and 25.6-31.3%, respectively). The ITS marker achieved the highest success rate for specimen identification at both generic and species ranks across the majority of methods. For distance-based analyses the best-close match method provided the greatest accuracy for identification of individuals with a high percentage of "correct" (97.6%) and a low percentage of "incorrect" (0.3%) generic identifications, based on the ITS marker. For tribe Poeae, and likely for other grass lineages, sequence data in the standard DNA barcode markers are not variable enough for accurate identification of specimens to species rank. For recently diverged grass species similar challenges are encountered in the application of genetic and morphological data to species delimitations, with taxonomic signal limited by extensive infra-specific variation and shared polymorphisms among species in both data types.	[Birch, Joanne L.; Walsh, Neville G.; Cantrill, David J.; Holmes, Gareth D.; Murphy, Daniel J.] Royal Bot Gardens Victoria, Melbourne, Vic, Australia		Birch, JL (corresponding author), Royal Bot Gardens Victoria, Melbourne, Vic, Australia.	Joanne.Birch@unimelb.edu.au	Cantrill, David/R-1415-2019; Murphy, Daniel/C-3781-2008	Cantrill, David/0000-0002-1185-4015; Murphy, Daniel/0000-0002-8358-363X; Birch, Joanne/0000-0002-8226-6085	Australian Biological Resources Study [BB210-46]	Australian Biological Resources Study	This work was supported by the Australian Biological Resources Study (http://www. environment.gov.au/science/abrs) Bush Blitz Strategic Taxonomy Grants Scheme (BB210-46) funding to DJM, NGW, and DJC.	Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Bayon ND, 1998, CLADISTICS, V14, P287, DOI 10.1111/j.1096-0031.1998.tb00339.x; Birch JL, 2014, AUST SYST BOT, V27, P333, DOI 10.1071/SB14028; Birch JL, 2014, BOT J LINN SOC, V175, P523, DOI 10.1111/boj.12185; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; CORNISHBOWDEN A, 1985, EUR J BIOCHEM, V150, P1; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Griffin PC, 2014, ANN BOT-LONDON, V113, P953, DOI 10.1093/aob/mcu017; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hernandez-Leon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070501; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Holmes GD, 2014, AUST SYST BOT, V27, P56, DOI 10.1071/SB13045; Inda LA, 2008, MOL PHYLOGENET EVOL, V46, P932, DOI 10.1016/j.ympev.2007.11.022; Jeanson ML, 2011, ANN BOT-LONDON, V108, P1445, DOI 10.1093/aob/mcr158; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; McClenaghan B, 2015, ECOL EVOL, V5, P3046, DOI 10.1002/ece3.1585; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moore R. M., 1970, AUSTR GRASSLANDS, P169; Padial JM, 2010, BIOL J LINN SOC, V101, P747, DOI 10.1111/j.1095-8312.2010.01528.x; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterson Paul M., 2014, Webbia, V69, P1, DOI 10.1080/00837792.2014.927555; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2013, R COR TEAM R LANG EN; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Saarela JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077982; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Schwarzfeld MD, 2015, MOL PHYLOGENET EVOL, V93, P234, DOI 10.1016/j.ympev.2015.08.003; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Syme AE, 2012, DNA BARCODES, P19; Thiers B., INDEX HERBARIORUM GL; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; VICKERY J W, 1970, Contributions from the New South Wales National Herbarium, V4, P145; Wang AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175338; Ward J, 2009, J FORENSIC SCI, V54, P1254, DOI 10.1111/j.1556-4029.2009.01196.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson A, 2009, FLORA OF AUSTR A, V44A; Wyler SC, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0678-0; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	56	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186259	10.1371/journal.pone.0186259	http://dx.doi.org/10.1371/journal.pone.0186259			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084279	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200005
J	Hu, XJ; Xu, JW; Wu, CY; Deng, JB; Liao, WW; Ling, YX; Yang, YX; Zhao, YN; Zhao, YL; Hu, X; Wang, H; Liu, YG				Hu, Xinjiang; Xu, Jiawen; Wu, Cuiyu; Deng, Jianbin; Liao, Wenwei; Ling, Yuxiang; Yang, Yuanxiu; Zhao, Yina; Zhao, Yunlin; Hu, Xi; Wang, Hui; Liu, Yunguo			Ethylenediamine grafted to graphene oxide@Fe3O4 for chromium(VI) decontamination: Performance, modelling, and fractional factorial design	PLOS ONE			English	Article							ACIDIC AQUEOUS-SOLUTION; ADSORPTION BEHAVIOR; BETA-CYCLODEXTRIN; ACTIVATED CARBON; CR(VI) REMOVAL; OXIDE; CU(II); IONS; PARAMETERS; ALGINATE	A method for grafting ethylenediamine to a magnetic graphene oxide composite (EDAGO@Fe3O4) was developed for Cr(VI) decontamination. The physicochemical properties of EDA-GO@Fe3O4 were characterized using HRTEM, EDS, FT-IR, TG-DSC, and XPS. The effects of pH, sorbent dose, foreign anions, time, Cr(VI) concentration, and temperature on decontamination process were studied. The solution pH can largely affect the decontamination process. The pseudo-second-order model is suitable for being applied to fit the adsorption processes of Cr(VI) with GO@Fe3O4 and EDA-GO@Fe3O4. The intra-particle diffusion is not the rate-controlling step. Isotherm experimental data can be described using the Freundlich model. The effects of multiple factors on the Cr(VI) decontamination was investigated by a 2 5-1 fractional factorial design (FFD). The adsorption process can significantly be affected by the main effects of A (pH), B (Cr(VI) concentration), and E (Adsorbent dose). The combined factors of AB (pH x Cr(VI) concentration), AE (pH x Adsorbent dose), and BC (Cr(VI) concentration x Temperature) had larger effects than other factors on Cr(VI) removal. These results indicated that EDA-GO@Fe3O4 is a potential and suitable candidate for treatment of heavy metal wastewater.	[Hu, Xinjiang; Zhao, Yunlin; Hu, Xi] Cent South Univ Forestry & Technol, Coll Environm Sci & Engn, Changsha, Hunan, Peoples R China; [Hu, Xinjiang; Zhao, Yunlin] Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha, Hunan, Peoples R China; [Hu, Xinjiang; Xu, Jiawen; Wu, Cuiyu; Deng, Jianbin; Liao, Wenwei; Ling, Yuxiang; Yang, Yuanxiu; Zhao, Yina] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Wang, Hui] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China; [Liu, Yunguo] Hunan Univ, Coll Environm Sci & Engn, Changsha, Hunan, Peoples R China; [Liu, Yunguo] Hunan Univ, Minist Educ, Key Lab Environm Biol & Pollut Control, Changsha, Hunan, Peoples R China	Central South University of Forestry & Technology; Central South University of Forestry & Technology; South China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; Hunan University; Hunan University	Hu, XJ; Zhao, YL; Hu, X (corresponding author), Cent South Univ Forestry & Technol, Coll Environm Sci & Engn, Changsha, Hunan, Peoples R China.; Hu, XJ; Zhao, YL (corresponding author), Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha, Hunan, Peoples R China.; Hu, XJ (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China.	huxinjiang@126.com; zyl8291290@163.com; liam.ho@live.cn	xu, jia/GSD-6347-2022	Hu, Xi/0000-0001-8809-6921; Hu, Xinjiang/0000-0001-8509-3290; Wang, Hui/0000-0002-5000-2069	National Natural Science Foundation of China [5160820]; China Postdoctoral Science Foundation [2017M610513]; Research Foundation of Education Department of Hunan Province, China [17K105]; Natural Science Foundation of Guangdong Province [2016A030310246, 2016A030310456]; Science and Technology Planning Project of Hunan Province [2016TP2007, 2016TP1014]; Scientific Research Staring Foundation for the attracted talent of Central South University of Forestry and Technology [2016YJ001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Foundation of Education Department of Hunan Province, China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Hunan Province; Scientific Research Staring Foundation for the attracted talent of Central South University of Forestry and Technology	This study was financially supported by the National Natural Science Foundation of China (Grant No. 5160820 to Xinjiang Hu), the Project funded by China Postdoctoral Science Foundation (Grant No. 2017M610513 Xinjiang Hu), the Research Foundation of Education Department of Hunan Province, China (Grant No. 17K105 to Xinjiang Hu), the Natural Science Foundation of Guangdong Province (grant numbers 2016A030310246 and 2016A030310456 to Xinjiang Hu), the Science and Technology Planning Project of Hunan Province (grant numbers 2016TP2007 and 2016TP1014 to Yunlin Zhao), and the Scientific Research Staring Foundation for the attracted talent of Central South University of Forestry and Technology (grant number 2016YJ001 to Xinjiang Hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu Z, 2002, PROCESS BIOCHEM, V38, P89, DOI 10.1016/S0032-9592(02)00051-1; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Chang SH, 2011, J ENVIRON MANAGE, V92, P2580, DOI 10.1016/j.jenvman.2011.05.025; Chen Z, 2008, J HAZARD MATER, V155, P327, DOI 10.1016/j.jhazmat.2007.11.064; Dinda D, 2013, J MATER CHEM A, V1, P11221, DOI 10.1039/c3ta12504a; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Hu X., 2015, ALTERN MED, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0142351; Hu XJ, 2015, CHEM ENG RES DES, V93, P675, DOI 10.1016/j.cherd.2014.06.002; Hu XJ, 2013, SEP PURIF TECHNOL, V108, P189, DOI 10.1016/j.seppur.2013.02.011; Hu XJ, 2011, J HAZARD MATER, V185, P306, DOI 10.1016/j.jhazmat.2010.09.034; Hu XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34378; Huang BY, 2015, RSC ADV, V5, P106339, DOI 10.1039/c5ra22862j; Huang DL, 2008, ENVIRON SCI TECHNOL, V42, P4946, DOI 10.1021/es800072c; Jiang LH, 2017, ENVIRON SCI TECHNOL, V51, P6352, DOI 10.1021/acs.est.7b00073; Jiang LH, 2017, CHEM ENG J, V308, P597, DOI 10.1016/j.cej.2016.09.067; Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007; Lawrie G, 2007, BIOMACROMOLECULES, V8, P2533, DOI 10.1021/bm070014y; Lei YL, 2014, J MATER SCI, V49, P4236, DOI 10.1007/s10853-014-8118-2; Li LL, 2013, COLLOID SURFACE B, V107, P76, DOI 10.1016/j.colsurfb.2013.01.074; Liang J, 2015, CARBOHYD POLYM, V132, P472, DOI 10.1016/j.carbpol.2015.06.067; Liu L, 2013, J CHEM ENG DATA, V58, P209, DOI 10.1021/je300551c; Liu YG, 2013, CHEM ENG J, V226, P131, DOI 10.1016/j.cej.2013.04.048; Lu M, 2013, J CENT SOUTH UNIV, V20, P2478, DOI 10.1007/s11771-013-1760-z; Ma HL, 2012, J MATER CHEM, V22, P5914, DOI 10.1039/c2jm00145d; Madadrang CJ, 2012, ACS APPL MATER INTER, V4, P1186, DOI 10.1021/am201645g; Myers R.H., 2008, RESPONSE SURFACE MET; Phuong NTK, 2016, CHEMOSPHERE, V146, P51, DOI 10.1016/j.chemosphere.2015.12.008; Panic S, 2015, CHEMOSPHERE, V141, P87, DOI 10.1016/j.chemosphere.2015.06.042; Parida K, 2012, IND ENG CHEM RES, V51, P2235, DOI 10.1021/ie200109h; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Tripathi KM, 2016, ACS SUSTAIN CHEM ENG, V4, P6399, DOI 10.1021/acssuschemeng.6b01045; Tripathi KM, 2016, RSC ADV, V6, P29545, DOI 10.1039/c5ra27432j; Tyagi A, 2016, RSC ADV, V6, P72423, DOI 10.1039/c6ra10488f; Wang H, 2013, APPL SURF SCI, V279, P432, DOI 10.1016/j.apsusc.2013.04.133; Wang H, 2014, CARBOHYD POLYM, V113, P166, DOI 10.1016/j.carbpol.2014.07.014; Wang J, 2015, CHEM ENG J, V281, P379, DOI 10.1016/j.cej.2015.06.102; Wang XS, 2007, J HAZARD MATER, V142, P468, DOI 10.1016/j.jhazmat.2006.08.047; Yang CH, 1998, J COLLOID INTERF SCI, V208, P379, DOI 10.1006/jcis.1998.5843; Zeng W, 2016, RSC ADV, V6, P19298, DOI 10.1039/c5ra27657h; Zhang YK, 2014, J MOL LIQ, V191, P177, DOI 10.1016/j.molliq.2013.12.015	40	20	22	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187166	10.1371/journal.pone.0187166	http://dx.doi.org/10.1371/journal.pone.0187166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084287	gold, Green Submitted, Green Published			2022-12-27	WOS:000413910200037
J	Grenier, JK; Foureman, PA; Sloma, EA; Miller, AD				Grenier, Jennifer K.; Foureman, Polly A.; Sloma, Erica A.; Miller, Andrew D.			RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; GENE-EXPRESSION; INTRACRANIAL-MENINGIOMAS; DIFFERENTIAL EXPRESSION; QUANTITATIVE PCR; BRAIN-TUMORS; PROGRESSION; CELL; NEOPLASIA; GROWTH	Meningiomas are the most commonly reported primary intracranial tumor in dogs and humans and between the two species there are similarities in histology and biologic behavior. Due to these similarities, dogs have been proposed as models for meningioma pathobiology. However, little is known about specific pathways and individual genes that are involved in the development and progression of canine meningioma. In addition, studies are lacking that utilize RNAseq to characterize gene expression in clinical cases of canine meningioma. The primary objective of this study was to develop a technique for which high quality RNA can be extracted from formalin-fixed, paraffin embedded tissue and then used for transcriptome analysis to determine patterns of gene expression. RNA was extracted from thirteen canine meningiomas-eleven from formalin fixed and two flash-frozen. These represented six grade I and seven grade II meningiomas based on the World Health Organization classification system for human meningioma. RNA was also extracted from fresh frozen leptomeninges from three control dogs for comparison. RNAseq libraries made from formalin fixed tissue were of sufficient quality to successfully identify 125 significantly differentially expressed genes, the majority of which were related to oncogenic processes. Twelve genes (AQP1, BMPER, FBLN2, FRZB, MEDAG, MYC, PAMR1, PDGFRL, PDPN, PECAM1, PERP, ZC2HC1C) were validated using qPCR. Among the differentially expressed genes were oncogenes, tumor suppressors, transcription factors, VEGF-related genes, and members of the WNT pathway. Our work demonstrates that RNA of sufficient quality can be extracted from FFPE canine meningioma samples to provide biologically relevant transcriptome analyses using a next-generation sequencing technique, such as RNAseq.	[Grenier, Jennifer K.; Foureman, Polly A.; Sloma, Erica A.; Miller, Andrew D.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Foureman, Polly A.] Chandler Gilbert Community Coll, Div Biol Sci, Chandler, AZ USA	Cornell University	Miller, AD (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	adm10@cornell.edu		Foureman, Polly/0000-0003-4802-969X				Aarhus M, 2011, ACTA NEUROCHIR, V153, P447, DOI 10.1007/s00701-010-0906-0; Antonescu CR, 2014, GENE CHROMOSOME CANC, V53, P951, DOI 10.1002/gcc.22206; Barrett CSX, 2016, PROSTATE, V77, P2016; Bo HJ, 2016, MOL MED REP, V13, P1163, DOI 10.3892/mmr.2015.4642; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Callari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086511; de Vicente JC, 2015, VIRCHOWS ARCH, V466, P549, DOI 10.1007/s00428-015-1746-3; Chang X, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.10.FOCUS13326; Clarke VE, 2016, NAT GENET, V48, P1253, DOI 10.1038/ng.3651; Courtay-Cahen C, 2008, VET COMP ONCOL, V6, P182, DOI 10.1111/j.1476-5829.2008.00159.x; Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902; Dai K, 2016, ONCOTARGET, V7, P4770, DOI 10.18632/oncotarget.6613; DETTA A, 1993, NEUROSURGERY, V33, P1065; Dickinson PJ, 2009, VET PATHOL, V46, P884, DOI 10.1354/vp.08-VP-0251-D-FL; Domingues P, 2015, ONCOTARGET, V6, P10671, DOI 10.18632/oncotarget.3870; Eikrem O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149743; Esser JS, 2015, ARTERIOSCL THROM VAS, V35, P358, DOI 10.1161/ATVBAHA.114.304345; Fevre-Montange M, 2009, INT J ONCOL, V35, P1395, DOI 10.3892/ijo_00000457; Florkowska M, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-8; Guo FJ, 2010, WORLD J GASTROENTERO, V16, P1465, DOI 10.3748/wjg.v16.i12.1465; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; Heinke J, 2012, ONCOGENE, V31, P2919, DOI 10.1038/onc.2011.473; Hicks J, 2017, VET COMP ONCOL, V15, P252, DOI 10.1111/vco.12152; Hofman I, 2014, APPL IMMUNOHISTO M M, V22, P46; Howng SL, 2002, CANCER LETT, V183, P95, DOI 10.1016/S0304-3835(02)00085-X; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Jeanne A, 2015, FRONT PHARMACOL, V6, DOI [10.3389/tphar2115.00257, 10.3389/fphar.2015.00252]; Kalamarides M, 2011, ONCOGENE, V30, P2333, DOI 10.1038/onc.2010.609; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim YJ, 2006, VIRCHOWS ARCH, V449, P529, DOI 10.1007/s00428-006-0285-3; Koestner A, 1999, HIST CLASSIFICATION; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeBlanc AK, 2016, NEURO-ONCOLOGY, V18, P1209, DOI 10.1093/neuonc/now051; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Millman R.E., 2014, J INTERPROF CARE, P1; Muller P, 1999, CLIN CANCER RES, V5, P3569; Murovic JA, 2014, WORLD NEUROSURG, V81, P714, DOI [10.1016/J.WNEU.2013.08.048, 10.1016/j.wneu.2013.08.048]; Niedermayer I, 1997, J NEUROPATH EXP NEUR, V56, P879, DOI 10.1097/00005072-199708000-00006; Ongaratti BR, 2016, BRAZ J MED BIOL RES, V49, P4; Ortiz A, 2015, FASEB J, V29, P1080, DOI 10.1096/fj.14-261594; PATNAIK AK, 1986, VET PATHOL, V23, P369, DOI 10.1177/030098588602300404; Perez-Magan E, 2012, J NEUROPATH EXP NEUR, V71, P882, DOI 10.1097/NEN.0b013e31826bf704; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rigau V, 2011, BRAIN PATHOL, V21, P633, DOI 10.1111/j.1750-3639.2011.00491.x; Saraf S, 2011, ONCOLOGIST, V16, P1604, DOI 10.1634/theoncologist.2011-0193; Schiffman JD, 2015, PHILOS T R SOC LON B, V370, P1065; Schulten HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153681; Shintaku M, 2010, BRAIN TUMOR PATHOL, V27, P23, DOI 10.1007/s10014-009-0262-z; Snyder JM, 2006, J VET INTERN MED, V20, P669, DOI 10.1892/0891-6640(2006)20[669:CIPNC]2.0.CO;2; Song RB, 2013, J VET INTERN MED, V27, P1143, DOI 10.1111/jvim.12136; Stassen Quirine E M, 2015, BMC Res Notes, V8, P761, DOI 10.1186/s13104-015-1628-4; Sturges BK, 2008, J VET INTERN MED, V22, P586, DOI 10.1111/j.1939-1676.2008.00042.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas R, 2009, J NEURO-ONCOL, V94, P333, DOI 10.1007/s11060-009-9877-5; Thomson SAM, 2005, VET PATHOL, V42, P550, DOI 10.1354/vp.42-5-550; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Troxel MT, 2003, J VET INTERN MED, V17, P850, DOI 10.1892/0891-6640(2003)017&lt;0850:FINRRO&gt;2.3.CO;2; Ucar T, 2003, BRIT J NEUROSURG, V17, P525, DOI 10.1080/02688690310001627759; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Yang M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-219; Zengin T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132757; Zhang Y, 2016, ONCOL REP, V36, P3619, DOI 10.3892/or.2016.5194; Zhao PL, 2015, INT J CLIN EXP MED, V8, P3291; Zheng B, 2016, MOL CARCINOGEN, V55, P1560, DOI 10.1002/mc.22409; Zouaoui S, 2012, NEUROCHIRURGIE, V58, P4, DOI 10.1016/j.neuchi.2012.01.004	70	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187150	10.1371/journal.pone.0187150	http://dx.doi.org/10.1371/journal.pone.0187150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073243	Green Submitted, gold, Green Published			2022-12-27	WOS:000413845400123
J	Chung, EJ; Jun, DR; Kim, DW; Han, MJ; Kwon, TK; Choi, SW; Kwon, SK				Chung, Eun-Jae; Jun, Dae-Ryong; Kim, Dong-Wook; Han, Mi-Jung; Kwon, Tack-Kyun; Choi, Sung-Wook; Kwon, Seong Keun			Prevention of polydimethylsiloxane microsphere migration using a mussel-inspired polydopamine coating for potential application in injection therapy	PLOS ONE			English	Article							URINARY-INCONTINENCE; VESICOURETERAL REFLUX; DERMAL FILLER; SILICONE; POLY(DIMETHYLSILOXANE); PHAGOCYTOSIS; MACROPHAGES; SUBSTANCES; IMPLANTS; WRINKLES	The use of injectable bulking agents is a feasible alternative procedure for conventional surgical therapy. In this study, poly(dimethylsiloxane) (PDMS) microspheres coated with polydopamine (PDA) were developed as a potential injection agent to prevent migration in vocal fold. Uniform PDMS microspheres are fabricated using a simple fluidic device and then coated with PDA. Cell attachment test reveals that the PDA-coated PDMS (PDA-PDMS) substrate favors cell adhesion and attachment. The injected PDA-PDMS microspheres persist without migration on reconstructed axial CT images, whereas, pristine PDMS locally migrates over a period of 12 weeks. The gross appearance of the implants retrieved at 4, 8, 12 and 34 weeks indicates that the PDA-PDMS group maintained their original position without significant migration until 34 weeks after injection. By contrast, there is diffuse local migration of the pristine PDMS group from 4 weeks after injection. The PDA-coated PDMS microspheres can potentially be used as easily injectable, non-absorbable filler without migration.	[Chung, Eun-Jae; Kim, Dong-Wook; Han, Mi-Jung; Kwon, Tack-Kyun; Kwon, Seong Keun] Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Jun, Dae-Ryong; Choi, Sung-Wook] Catholica Univ Korea, Dept Biotechnol, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea	Kwon, SK (corresponding author), Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.; Choi, SW (corresponding author), Catholica Univ Korea, Dept Biotechnol, Gyeonggi Do, South Korea.	choisw@catholic.ac.kr; otolarynx@snuh.org			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2017M3A9B4032446]; "GRRC" Project of the Gyeonggi Provincial Government, Korea	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; "GRRC" Project of the Gyeonggi Provincial Government, Korea	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3A9B4032446), and a grant from the "GRRC" Project of the Gyeonggi Provincial Government, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation ofthe manuscript.r This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3A9B4032446), and a grant from the "GRRC" Project of the Gyeonggi Provincial Government, Korea.	Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043; Bondurant S, 2005, SAFETY SILICONE BREA, P1; BOYKIN W, 1989, J UROLOGY, V141, P1199, DOI 10.1016/S0022-5347(17)41213-4; BRANDWOOD A, 1992, BIOMATERIALS, V13, P646, DOI 10.1016/0142-9612(92)90035-M; Chuah YJ, 2015, BIOMATER SCI-UK, V3, P383, DOI 10.1039/c4bm00268g; Conrad K, 1996, ARCH OTOLARYNGOL, V122, P664; DEHEER DH, 1995, J HAND SURG-AM, V20A, pS101, DOI 10.1016/S0363-5023(95)80180-4; Delor-Jestin F, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/0031-8949/9/2/024406; Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004; Grunebaum LD, 2010, DERMATOL SURG, V36, P760, DOI 10.1111/j.1524-4725.2010.01555.x; HENLY DR, 1995, J UROLOGY, V153, P2039, DOI 10.1016/S0022-5347(01)67398-1; Hexsel DM, 2003, SEMIN CUTAN MED SURG, V22, P107, DOI 10.1053/sder.2003.50010; Joyner BD, 1997, UROLOGY, V50, P489, DOI 10.1016/S0090-4295(97)00261-6; Jun DR, 2014, COLLOID SURFACE B, V121, P395, DOI 10.1016/j.colsurfb.2014.06.027; Keegan PE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003881.pub2; Kershen RT, 2000, WORLD J UROL, V18, P51, DOI 10.1007/PL00007072; Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+; Lemperle G, 1998, AESTHET PLAST SURG, V22, P356, DOI 10.1007/s002669900217; MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277; MITTLEMAN RE, 1983, ARCH PATHOL LAB MED, V107, P611; Morhenn VB, 2002, DERMATOL SURG, V28, P484, DOI 10.1046/j.1524-4725.2002.01273.x; Pannek J, 2001, J UROLOGY, V166, P1350, DOI 10.1016/S0022-5347(05)65767-9; POLLACK SV, 1999, J CUTAN MED SURG S4, V3, P27; Sclafani AP, 2002, ANN PLAS SURG, V49, P181, DOI 10.1097/00000637-200208000-00011; Shin YM, 2012, BIOMACROMOLECULES, V13, P2020, DOI 10.1021/bm300194b; Yanagihara M, 2000, J CUTAN PATHOL, V27, P301, DOI 10.1034/j.1600-0560.2000.027006301.x	28	5	6	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186877	10.1371/journal.pone.0186877	http://dx.doi.org/10.1371/journal.pone.0186877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095854	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200028
J	Han, RW; Li, SL; Wang, J; Yu, ZN; Wang, JQ; Zheng, N				Han, Rongwei; Li, Songli; Wang, Jun; Yu, Zhongna; Wang, Jiaqi; Zheng, Nan			Elimination kinetics of ceftiofur hydrochloride in milk after an 8-day extended intramammary administration in healthy and infected cows	PLOS ONE			English	Article							LACTATING DAIRY-COWS; RANDOMIZED CLINICAL-TRIAL; STAPHYLOCOCCUS-AUREUS; SUBCLINICAL MASTITIS; CEPHAPIRIN SODIUM; THERAPY PROGRAM; EFFICACY; INFUSION; PHARMACOKINETICS; PIRLIMYCIN	Ceftiofur hydrochloride (CEF) is occasionally used for the intramammary (IMM) treatment of mastitis. This extralabel manner could result in a drug-residue violation of the milk. The objective of this study was to determine the elimination kinetics of IMM CEF in lactating dairy cattle. The pharmacokinetic profile of CEF after repeated IMM administration in nine healthy cows and nine Staphylococcus aureus infected cows was investigated, alongside determining the MICs of Staph, aureus field strains. The MIC 90 value for CEF in Staph, aureus field strains (n = 31) was 0.25 mu g/mL. The t>MIC CEF values for low-production quarters were longer than those for high- and mid- production quarters. The results showed that ceftiofur was detected in milk up to 108 h after the last infusion in both healthy and infected cows. Cows with low milk production eliminate IMM drugs more slowly than cows with higher production. Our findings suggest that this extralabel use is not encouraged and a prudent use is recommended for mastitis therapy. The use of CEF should be reserved for infections where susceptibility tests indicate its efficacy and when alternatives are not available.	[Han, Rongwei; Wang, Jun] Qingdao Agr Univ, Coll Food Sci & Technol, Qingdao, Peoples R China; [Li, Songli; Wang, Jiaqi; Zheng, Nan] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China; [Yu, Zhongna] Qingdao Agr Univ, Haidu Coll, Laiyang, Peoples R China	Qingdao Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Qingdao Agricultural University	Zheng, N (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China.	zhengnan_1980@126.com	Wang, Jun/H-4803-2011	Wang, Jun/0000-0001-7676-0493	Special Fund for Agro-scientific Research in the Public Interest [201403071]; Natural Science Foundation of Shandong Province of the PR China [ZR2015CQ020]; Key Research Program of Shandong Province [2016GSF120010]; Scientific Research Foundation of the Higher Education Institutions of Shandong Province [J17KA131]	Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Shandong Province of the PR China; Key Research Program of Shandong Province; Scientific Research Foundation of the Higher Education Institutions of Shandong Province	The authors gratefully acknowledge the Special Fund for Agro-scientific Research in the Public Interest (201403071) to Rongwei Han, Natural Science Foundation of Shandong Province of the PR China (ZR2015CQ020) to Rongwei Han, Key Research Program of Shandong Province (2016GSF120010) to Jun Wang and Scientific Research Foundation of the Higher Education Institutions of Shandong Province (J17KA131) to Zhongna Yu for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Cagnardi P, 2010, J DAIRY SCI, V93, P4105, DOI 10.3168/jds.2010-3379; Committee for Medicinal Products for Veterinary Use (CVMP), 2009, EMEACVMPSAGAM8173020; Constable PD, 2003, VET CLIN N AM-FOOD A, V19, P139, DOI 10.1016/S0749-0720(02)00068-3; Deluyker HA, 2005, J DAIRY SCI, V88, P604, DOI 10.3168/jds.S0022-0302(05)72724-7; Gehring R, 2006, J VET PHARMACOL THER, V29, P237, DOI 10.1111/j.1365-2885.2006.00750.x; Gibaldi M, 1982, NONCOMPARTMENTAL ANA, P409; Gorden PJ, 2013, J DAIRY SCI, V96, P4455, DOI 10.3168/jds.2012-6487; Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165; Kromker V, 2010, BERL MUNCH TIERARZTL, V123, P147, DOI 10.2376/0005-9366-123-147; Mckellar OA, 2004, J VET PHARMACOL THER, V27, P503, DOI 10.1111/j.1365-2885.2004.00603.x; MOA, 2012, B MIN AGR PEOPL REP, V235; Oliver SP, 2004, J DAIRY SCI, V87, P2393, DOI 10.3168/jds.S0022-0302(04)73361-5; OWENS WE, 1990, J DAIRY SCI, V73, P3449, DOI 10.3168/jds.S0022-0302(90)79043-1; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Roy JP, 2012, VET CLIN N AM-FOOD A, V28, P39, DOI 10.1016/j.cvfa.2011.12.004; Roy JP, 2009, CAN VET J, V50, P1257; Schukken YH, 2011, J DAIRY SCI, V94, P6203, DOI 10.3168/jds.2011-4290; Smith GW, 2005, JAVMA-J AM VET MED A, V226, P1994, DOI 10.2460/javma.2005.226.1994; Smith GW, 2004, JAVMA-J AM VET MED A, V224, P1827, DOI 10.2460/javma.2004.224.1827; Stockler RM, 2009, J DAIRY SCI, V92, P4262, DOI 10.3168/jds.2008-1916; Truchetti G, 2014, CAN J VET RES, V78, P31; US FDA CfVM, 2013, ANN REP 2012; USDA, 2009, DAIR 2007 5; Whittem T, 1999, J VET PHARMACOL THER, V22, P41, DOI 10.1046/j.1365-2885.1999.00187.x; Zonca A, 2011, J DAIRY SCI, V94, P3455, DOI 10.3168/jds.2010-4109	26	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187261	10.1371/journal.pone.0187261	http://dx.doi.org/10.1371/journal.pone.0187261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095869	gold, Green Submitted, Green Published			2022-12-27	WOS:000414340200063
J	Moon, SJ; Lee, WY; Hwang, JS; Hong, YP; Morisky, DE				Moon, Sun Jae; Lee, Weon-Young; Hwang, Jin Seub; Hong, Yeon Pyo; Morisky, Donald E.			Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8	PLOS ONE			English	Review							TYPE-2 DIABETES PATIENTS; PREDICTIVE-VALIDITY; NONADHERENCE; INTERVENTION; VALIDATION; QUADAS-2; VERSION	Background This systematic review examined the reliability and validity of the Morisky Medication Adherence Scale-8 (MMAS-8), which has been widely used to assess patient medication adherence in clinical research and medical practice. Methods Of 418 studies identified through searching 4 electronic databases, we finally analyzed 28 studies meeting the selection criteria of this study regarding the reliability and validity of MMAS-8 including sensitivity and specificity. Meta-analysis for Cronbach's alpha, intraclass correlation coefficient (ICC), sensitivity and specificity to detect a patient with nonadherence to medication were performed. The pooled estimates for Cronbach's a and ICC were calculated using the random-effects weighted T transformation. A bivariate random-effects model was used to estimate pooled sensitivity and specificity. Findings The pooled Cronbach's a estimate for type 2 diabetes group in 7 studies and osteoporosis group in 3 studies were 0.67 (95% Confidence Interval(CI), 0.65 to 0.69) and 0.77 (95% CI, 0.72 to 0.83), respectively. With regard to test-retest, the pooled ICC for type 2 diabetes group in 3 studies and osteoporosis group in 2 studies were 0.81 (95% CI, 0.75 to 0.85) and 0.80 (95% CI, 0.74 to 0.85). For a cut-off value of 6, the pooled sensitivity and specificity in 12 studies were 0.43 (95% CI, 0.33 to 0.53) and 0.73 (95% CI, 0.68 to 0.78), respectively. Conclusions The MMAS-8 had acceptable internal consistency and reproducibility in a few diseases like type 2 diabetes. Using the cut-off value of 6, criterion validity was not enough good to validly screen a patient with nonadherence to medication. However, this study did not calculated a pooled estimate for criterion validity using the higher values than 6 as a cut-off value since most of included individual studies did not report criterion validity based on those values.	[Moon, Sun Jae; Lee, Weon-Young; Hong, Yeon Pyo] Chung Ang Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hwang, Jin Seub] Daegu Univ, Dept Comp Sci & Stat, Gyongsan, Gyeongsangbuk D, South Korea; [Morisky, Donald E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90024 USA	Chung Ang University; Chung Ang University Hospital; Daegu University; University of California System; University of California Los Angeles	Lee, WY (corresponding author), Chung Ang Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	wylee@cau.ac.kr	Morisky, Donald/AAU-4679-2021	Moon, Sun Jae/0000-0003-3786-6935				Alcoba M, 2003, JAIDS-J ACQ IMM DEF, V33, P253, DOI 10.1097/00126334-200306010-00022; AlGhurair SA, 2012, J CLIN HYPERTENS, V14, P877, DOI 10.1111/j.1751-7176.2012.00699.x; [Anonymous], 2013, ADV COMM PHARM PRACT; [Anonymous], 2013, PRIM CAR PHYS FEEL R, P20; Arora S, 2014, ANN EMERG MED, V63, P745, DOI 10.1016/j.annemergmed.2013.10.012; Ashur ST, 2015, E MEDITERR HEALTH J, V21, P722, DOI 10.26719/2015.21.10.722; Berry DL, 2015, PATIENT PREFER ADHER, V9, P1587, DOI 10.2147/PPA.S91534; Bramlage P, 2014, CLIN DRUG INVEST, V34, P403, DOI 10.1007/s40261-014-0188-z; Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575; Chan HK, 2014, INT J CLIN PHARM-NET, V36, P904, DOI 10.1007/s11096-014-0003-1; Cohen Robin A, 2013, NCHS Data Brief, P1; Crutzen R, 2017, HEALTH PSYCHOL REV, V11, P242, DOI 10.1080/17437199.2015.1124240; Cummings DM, 2014, ANN PHARMACOTHER, V48, P970, DOI 10.1177/1060028014536532; DiBonaventura M, 2014, PATIENT PREFER ADHER, V8, P873, DOI 10.2147/PPA.S55550; Garfield S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-149; Goodhand JR, 2013, ALIMENT PHARM THER, V38, P1097, DOI 10.1111/apt.12476; Granger BB, 2015, AM HEART J, V169, P539, DOI 10.1016/j.ahj.2015.01.006; Guo XH, 2014, J DIABETES, V6, P290, DOI 10.1111/1753-0407.12100; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; Kamran A, 2014, ANN MED HEALTH SCI R, V4, P922, DOI 10.4103/2141-9248.144914; Kassab Y, 2013, INT J CLIN PHARM-NET, V35, P275, DOI 10.1007/s11096-012-9735-y; Katalenich B, 2015, CLIN THER, V37, P1216, DOI 10.1016/j.clinthera.2015.03.022; MACASKILL P, 2010, ANAL PRESENTING RESU; Marcum ZA, 2013, JAMA-J AM MED ASSOC, V309, P2105, DOI 10.1001/jama.2013.4638; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Park LG, 2014, PATIENT EDUC COUNS, V94, P261, DOI 10.1016/j.pec.2013.10.027; Parthan Anju, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P325, DOI 10.1586/14737167.6.3.325; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rodriguez MC, 2006, PSYCHOL METHODS, V11, P306, DOI 10.1037/1082-989X.11.3.306; Schueler S, 2012, ANN INTERN MED, V156, P323, DOI 10.7326/0003-4819-156-4-201202210-00018; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Tabasi HK, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0113-2; Tandon S, 2015, DIABETES RES CLIN PR, V110, P129, DOI 10.1016/j.diabres.2015.10.001; Tepie MF, 2013, VALUE HEALTH, V16, pA568; Trikalinos TA, 2012, METHODS GUIDE MED TE; Vinluan CM, 2015, J PHARM HEALTH SERV, V6, P103, DOI 10.1111/jphs.12093; Viswanathan Meera, 2012, Evid Rep Technol Assess (Full Rep), P1; Wagner JH, 2001, J CLIN EPIDEMIOL, V54, pS91, DOI 10.1016/S0895-4356(01)00450-4; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	42	45	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187139	10.1371/journal.pone.0187139	http://dx.doi.org/10.1371/journal.pone.0187139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095870	gold, Green Published			2022-12-27	WOS:000414340200049
J	Poczai, P; Hyvonen, J				Poczai, Peter; Hyvonen, Jaakko			The complete chloroplast genome sequence of the CAM epiphyte Spanish moss (Tillandsia usneoides,Bromeliaceae) and its comparative analysis	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; ACETYL-COA CARBOXYLASE; PHYLOGENETIC-RELATIONSHIPS; EVOLUTIONARY RATE; PLASTID GENOMES; DNA; IDENTIFICATION; GRASSES; GENE; AMPLIFICATION	Spanish moss (Tillandsia usneoides) is an epiphytic bromeliad widely distributed throughout tropical and warm temperate America. This plant is highly adapted to extreme environmental conditions. Striking features of this species include specialized trichomes (scales) covering the surface of its shoots aiding the absorption of water and nutrients directly from the atmosphere and a specific photosynthesis using crassulacean acid metabolism (CAM). Here we report the plastid genome of Spanish moss and present the comparison of genome organization and sequence evolution within Poales. The plastome of Spanish moss has a quadripartite structure consisting of a large single copy (LSC, 87,439 bp), two inverted regions (IRa and IRb, 26,803 bp) and short single copy (SSC, 18,612 bp) region. The plastid genome had 37.2% GC content and 134 genes with 88 being unique protein-coding genes and 20 of these are duplicated in the IR, similar to other reported bromeliads. Our study shows that early diverging lineages of Poales do not have high substitution rates as compared to grasses, and plastid genomes of bromeliads show structural features considered to be ancestral in graminids. These include the loss of the introns in the c/pP and rpoC1 genes and the complete loss or partial degradation of accD and ycf genes in the Graminid clade. Further structural rearrangements appeared in the graminids lacking in Spanish moss, which include a 28-kb inversion between the tmG-UCC-rps14 region and 6-kb in the tmG-UCC-psbD, followed by a third<1kb inversion in the trnT sequence.	[Poczai, Peter; Hyvonen, Jaakko] Univ Helsinki, Finnish Museum Nat Hist Bot, Helsinki, Finland; [Hyvonen, Jaakko] Univ Helsinki, Dept Biosci Plant Biol, Helsinki, Finland	University of Helsinki; University of Helsinki	Poczai, P (corresponding author), Univ Helsinki, Finnish Museum Nat Hist Bot, Helsinki, Finland.	peter.poczai@gmail.com	Hyvonen, Jaakko T/H-5120-2012					Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; Barfuss MHJ, 2005, AM J BOT, V92, P337, DOI 10.3732/ajb.92.2.337; Barrett CF, 2013, CLADISTICS, V29, P65, DOI 10.1111/j.1096-0031.2012.00418.x; BENZING DH, 2000, BROMELIACEAE PROFILE; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bouchenak-Khelladi Y, 2014, BOT J LINN SOC, V175, P4, DOI 10.1111/boj.12160; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; Bungard RA, 2004, BIOESSAYS, V26, P235, DOI 10.1002/bies.10405; Bushnell B., 2017, BBTOOLS SOFTWARE PAC; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chodova A D, 2004, PLANT PROTECT SCI, V40, P151; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Donadio S, 2015, PLANT SYST EVOL, V301, P387, DOI 10.1007/s00606-014-1081-1; Elnitski L, 2002, GENOMICS, V80, P681, DOI 10.1006/geno.2002.7018; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; Givnish TJ, 2011, AM J BOT, V98, P872, DOI 10.3732/ajb.1000059; Goloboff P, 1994, NONA TREE SEARCHING; GRAY MW, 1989, TRENDS GENET, V5, P294, DOI 10.1016/0168-9525(89)90111-X; Gross E., 1985, J BROM SOC, V35, P202; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Guo XW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-228; Harris ME, 2013, PLANT MOL BIOL REP, V31, P21, DOI 10.1007/s11105-012-0461-3; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jansen RK, 2012, GENOMICS CHLOROPLAST, P103, DOI [DOI 10.1007/978-94-007-2920-9_5, 10.1007/978-94-007-2920-9_5]; Katayama H, 1996, CURR GENET, V29, P572, DOI 10.1007/BF02426962; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Linder HP, 2005, ANNU REV ECOL EVOL S, V36, P107, DOI 10.1146/annurev.ecolsys.36.102403.135635; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lovmar L, 2006, HUM MUTAT, V27, P603, DOI 10.1002/humu.20341; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marchant A. D., 2007, Telopea, V11, P437; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Michelangeli FA, 2003, AM J BOT, V90, P93, DOI 10.3732/ajb.90.1.93; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Murrell B, 2015, MOL BIOL EVOL, V32, P1365, DOI 10.1093/molbev/msv035; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Nixon K.C, 2002, WINCLADA 1 00 08; Oldenburg DJ, 2016, CURR GENET, V62, P431, DOI 10.1007/s00294-015-0548-0; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Redwan RM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0587-1; Saarela JM, 2015, AOB PLANTS, V7, DOI [10.1093/aobpla/plv046, 10.10]; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059620; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wertheim JO, 2015, MOL BIOL EVOL, V32, P820, DOI 10.1093/molbev/msu400; Wicke S, 2016, P NATL ACAD SCI USA, V113, P9045, DOI 10.1073/pnas.1607576113; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Wysocki WP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0321-5; Xu XZ, 2008, J ZHEJIANG UNIV-SC B, V9, P667, DOI 10.1631/jzus.B0820005; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110656; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yohe LR, 2017, EVOLUTION, V71, P923, DOI 10.1111/evo.13187; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	84	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187199	10.1371/journal.pone.0187199	http://dx.doi.org/10.1371/journal.pone.0187199			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095905	Green Published, gold, Green Submitted			2022-12-27	WOS:000414340200054
J	Zanlungo, F; Yucel, Z; Brscic, D; Kanda, T; Hagita, N				Zanlungo, Francesco; Yucel, Zeynep; Brscic, Drazen; Kanda, Takayuki; Hagita, Norihiro			Intrinsic group behaviour: Dependence of pedestrian dyad dynamics on principal social and personal features	PLOS ONE			English	Article							EYE-CONTACT; DENSITY; SPACES	Being determined by human social behaviour, pedestrian group dynamics may depend on "intrinsic properties" such as the purpose of the pedestrians, their personal relation, gender, age, and body size. In this work we investigate the dynamical properties of pedestrian dyads (distance, spatial formation and velocity) by analysing a large data set of automatically tracked pedestrian trajectories in an unconstrained "ecological" setting (a shopping mall), whose apparent physical and social group properties have been analysed by three different human coders. We observed that females walk slower and closer than males, that workers walk faster, at a larger distance and more abreast than leisure oriented people, and that inter-group relation has a strong effect on group structure, with couples walking very close and abreast, colleagues walking at a larger distance, and friends walking more abreast than family members. Pedestrian height (obtained automatically through our tracking system) influences velocity and abreast distance, both growing functions of the average group height. Results regarding pedestrian age show that elderly people walk slowly, while active age adults walk at the maximum velocity. Groups with children have a strong tendency to walk in a non-abreast formation, with a large distance (despite a low abreast distance). A cross-analysis of the interplay between these intrinsic features, taking in account also the effect of an "extrinsic property" such as crowd density, confirms these major results but reveals also a richer structure. An interesting and unexpected result, for example, is that the velocity of groups with children increases with density, at least in the low-medium density range found under normal conditions in shopping malls. Children also appear to behave differently according to the gender of the parent.	[Zanlungo, Francesco; Yucel, Zeynep; Kanda, Takayuki; Hagita, Norihiro] ATR Int, Kyoto, Japan; [Yucel, Zeynep] Okayama Univ, Okayama, Japan; [Brscic, Drazen] Univ Rijeka, Fac Engn, Rijeka, Croatia	Okayama University; University of Rijeka	Zanlungo, F (corresponding author), ATR Int, Kyoto, Japan.	zanlungo@atr.jp	Brščić, Dražen/Q-7952-2018; Yucel, Zeynep/V-9340-2019; Yucel, Zeynep/AAW-8179-2021; Yucel, Zeynep/E-7906-2015; Kanda, Takayuki/I-5843-2016	Brščić, Dražen/0000-0001-8477-6460; Yucel, Zeynep/0000-0003-3404-4485; Kanda, Takayuki/0000-0002-9546-5825	Ministry of Internal Affairs and Communications of Japan quot;Research and development project on autonomous personal mobility including robotsquot;; JST, CREST; JSPS KAKENHI RDP grant [16J40223]; ATR	Ministry of Internal Affairs and Communications of Japan quot;Research and development project on autonomous personal mobility including robotsquot;; JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI RDP grant; ATR	This work was supported by the Ministry of Internal Affairs and Communications of Japan "Research and development project on autonomous personal mobility including robots" (http://www.soumu.go.jp/english/), JST, CREST (http://www.jst.go.jp/kisoken/crest/en/) project webpage http://www.irc.atr.jp/crest2010 HRI/index.html, and JSPS KAKENHI (https://www.jsps.go.jp/english/index.html) RDP grant https://www.jsps.go.jp/j-pd/rpd_gaiyo.html) grant number 16J40223. ATR provides the salary of two of the authors, TK and NH, and at the time of the first submission provided also the salary of the corresponding author, FZ. At the moment, FZ and ZY are affiliated to ATR as visiting researchers to facilitate their collaboration with former colleagues, but do not receive a salary from this company. Nevertheless, the company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There will be no patent application or other commercial interest directly related to the results of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research is partly supported by the Ministry of Internal Affairs and Communications (MIC), Japan, Research and development project on autonomous personal mobility including robots, by CREST, JST and JSPS KAKENHI Grant Number 16J40223.	ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Bandini Stefania, 2016, Cross-Cultural Design. 8th International Conference, CCD 2016, held as part of HCI International 2016. Proceedings: LNCS 9741, P491, DOI 10.1007/978-3-319-40093-8_49; Bandini S, 2014, 2014 IEEE 17TH INTERNATIONAL CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS (ITSC), P572, DOI 10.1109/ITSC.2014.6957751; Bode N, P 2016 PED EV DYN C; Bode N, PLOS ONE; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Brscic D, 2017, 2017 40TH INTERNATIONAL CONVENTION ON INFORMATION AND COMMUNICATION TECHNOLOGY, ELECTRONICS AND MICROELECTRONICS (MIPRO), P564, DOI 10.23919/MIPRO.2017.7973489; Brscic D, 2014, TRANSP RES PROC, V2, P77, DOI 10.1016/j.trpro.2014.09.011; Brscic D, 2013, IEEE T HUM-MACH SYST, V43, P522, DOI 10.1109/THMS.2013.2283945; CORBETTA A, P 2016 PED EV DYN C; Corbetta A, 2014, TRANSP RES PROC, V2, P96, DOI 10.1016/j.trpro.2014.09.013; Costa M, 2010, J NONVERBAL BEHAV, V34, P15, DOI 10.1007/s10919-009-0077-y; Faria JJ, 2010, ANIM BEHAV, V79, P895, DOI 10.1016/j.anbehav.2009.12.039; Feng Y, P 2016 PED EV DYN C; Gorrini A, P 2016 PED EV DYN C; Gorrini A, 2015, 11 C INT TRAFF GRAN; He L, 2016, IEEE INT CONF ROBOT, P292, DOI 10.1109/ICRA.2016.7487147; HENDERSON LF, 1972, NATURE, V240, P353, DOI 10.1038/240353a0; Huang J, P 2016 PED EV DYN C; Kachroo P, 2008, UNDERST COMPLEX SYST, P1; Kanda T., 2009, 2009 4th ACM/IEEE International Conference on Human-Robot Interaction (HRI), P173; Karamouzas I, P 2010 17 ACM S VIRT, P183; Kim Sujeong, 2012, P ACM SIGGRAPH S INT; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Knapp M., 2012, NONVERBAL COMMUNICAT; Koster G, 2011, CONTEMP SOC SCI, V6, P397, DOI 10.1080/21582041.2011.619867; Koster G., 2014, PEDESTRIAN EVACUATIO, P1051, DOI [10.1007/978-3-319-02447-9_87, DOI 10.1007/978-3-319-02447-9_87]; Kumagai K, P 2016 PED EV DYN C; Levine RV, 1999, J CROSS CULT PSYCHOL, V30, P178, DOI 10.1177/0022022199030002003; Manfredi M, 2014, PATTERN RECOGN LETT, V44, P39, DOI 10.1016/j.patrec.2013.11.001; Mawson A. R., 2012, MASS PANIC SOCIAL AT; Morales Y, 2013 IEEE RSJ INT C; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Muller F, 2016, TRAFFIC GRANULAR FLO; Muller F, 2016, TRAFFIC GRANULAR FLO; Murakami R, P 2014 ACM IEEE INT, P471; Reicher SD, 2001, BLACKWELL HDB SOCIAL, V44; Robinson, 2009, UNDERSTANDING CROWD, P11; Schultz M, 2014, PEDESTR EVAC DYN, V2012, P1097; Seer S, 2014, TRANSPORT RES C-EMER, V48, P212, DOI 10.1016/j.trc.2014.08.012; Seitz MJ, 2017, REV GEN PSYCHOL, V21, P95, DOI 10.1037/gpr0000092; Shiomi M, 2014, INT J SOC ROBOT, V6, P443, DOI 10.1007/s12369-014-0238-y; Templeton A, 2015, REV GEN PSYCHOL, V19, P215, DOI 10.1037/gpr0000032; TURCHETTI G, EPL-EUROPHYS LETT, V78, P58003, DOI DOI 10.1016/J.ANBEHAV.2009.12.039; von Kruchten C, 2017, PHYSICA A, V475, P129, DOI 10.1016/j.physa.2017.02.004; VONSIVERS I, P 2016 PED EV DYN C; Wang W, P 2016 PED EV DYN C; Wei XG, 2015, COMPLEXITY, V20, P87, DOI 10.1002/cplx.21633; Yijiang Zhang, 2011, 2011 12th International Conference on Computer-Aided Design and Computer Graphics, P275, DOI 10.1109/CAD/Graphics.2011.48; Yucel Z, 2013, SENSORS-BASEL, V13, P875, DOI 10.3390/s130100875; Zanlungo F, 2015, EPL-EUROPHYS LETT, V111, DOI 10.1209/0295-5075/111/38007; Zanlungo F, 2013, COGSCI13 2013 COGN S; Zanlungo F, P 2016 PED EV DYN C; Zanlungo F, 2014, TRANSP RES PROC, V2, P149, DOI 10.1016/j.trpro.2014.09.020; Zanlungo F, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.062810; Zanlungo F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012811; Zhang J, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/06/P06004; Zhao P, P 2016 PED EV DYN C	58	29	29	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187253	10.1371/journal.pone.0187253	http://dx.doi.org/10.1371/journal.pone.0187253			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095913	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200062
J	da Silva, WQA; Fontes, EB; Forti, RM; Lima, ZL; Machado, DGD; Deslandes, AC; Hussey, E; Ward, N; Mesquita, RC; Okano, AH; Elsangedy, HM				Alves da Silva, Weslley Quirino; Fontes, Eduardo Bodnariuc; Forti, Rodrigo Menezes; Lima, Zayonara Larissa; da Silva Machado, Daniel Gomes; Deslandes, Andrea Camaz; Hussey, Erika; Ward, Nathan; Mesquita, Rickson Coelho; Okano, Alexandre Hideki; Elsangedy, Hassan Mohamed			Affect during incremental exercise: The role of inhibitory cognition, autonomic cardiac function, and cerebral oxygenation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PUBLIC-HEALTH PROBLEM; PHYSICAL INACTIVITY; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; PERFORMANCE; INTENSITY; EVOLUTIONARY; DISPLEASURE; TOLERANCE	Background Pleasure is a key factor for physical activity behavior in sedentary individuals. Inhibitory cognitive control may play an important role in pleasure perception while exercising, especially at high intensities. In addition, separate work suggests that autonomic regulation and cerebral hemodynamics influence the affective and cognitive responses during exercise. Purpose We investigated the effects of exercise intensity on affect, inhibitory control, cardiac autonomic function, and prefrontal cortex (PFC) oxygenation. Methods Thirty-seven sedentary young adults performed two experimental conditions (exercise and control) in separate sessions in a repeated-measures design. In the exercise condition, participants performed a maximum graded exercise test on a cycle ergometer as we continuously measured oxygen consumption, heart rate variability (HRV), and PFC oxygenation. At each of 8 intensity levels we also measured inhibitory control (Stroop test), associative and dissociative thoughts (ADT), and affective/pleasure ratings. In the control condition, participants sat motionless on a cycle ergometer without active pedaling, and we collected the same measures at the same points in time as the exercise condition. We evaluated the main effects and interactions of exercise condition and intensity level for each measure using two-way repeated measures ANOVAs. Additionally, we evaluated the relationship between affect and inhibitory control, ADT, HRV, and PFC oxygenation using Pearson's correlation coefficients. Results For exercise intensities below and at the ventilatory threshold (VT), participants reported feeling neutral, with preservation of inhibitory control, while intensities above the VT were associated with displeasure (p<0.001), decreased inhibitory control and HRV (p<0.001), and increased PFC oxygenation (p<0.001). At the highest exercise intensity, pleasure was correlated with the low-frequency index of HRV (r =-0.34; p<0.05) and the low-frequency/high-frequency HRV ratio (r =-0.33; p<0.05). PFC deoxyhemoglobin was correlated with pleasure two stages above the VT (r =-0.37; p<0.05). Conclusion Our results support the notion that exercise at high intensities influences inhibitory control and one's perception of pleasure, which are linked to changes in cardiac autonomic control and cerebral hemodynamics. These findings strengthen the existence of an integrated brain-heart-body system and highlight the importance of exercise intensity in exercise related behavior in sedentary individuals.	[Alves da Silva, Weslley Quirino; Fontes, Eduardo Bodnariuc; Lima, Zayonara Larissa; da Silva Machado, Daniel Gomes; Okano, Alexandre Hideki; Elsangedy, Hassan Mohamed] Univ Fed Rio Grande do Norte, Dept Phys Educ, Natal, RN, Brazil; [Alves da Silva, Weslley Quirino; Lima, Zayonara Larissa] Natalense Fac Educ & Culture, Grad Program Phys Educ, Natal, RN, Brazil; [Forti, Rodrigo Menezes; Mesquita, Rickson Coelho] Univ Estadual Campinas, Inst Phys Gleb Wataghin, Campinas, SP, Brazil; [Forti, Rodrigo Menezes; Mesquita, Rickson Coelho] Brazilian Inst Neurosci & Neurotechnol BRAINN, Campinas, SP, Brazil; [da Silva Machado, Daniel Gomes; Okano, Alexandre Hideki] Univ Estadual Londrina, Ctr Phys Educ & Sport, Londrina, PR, Brazil; [Deslandes, Andrea Camaz] Univ Estado Rio De Janeiro, Inst Phys Educ & Sport, Rio De Janeiro, RJ, Brazil; [Hussey, Erika] Tufts Univ, Ctr Appl Brain & Cognit Sci, Medford, MA 02155 USA; [Hussey, Erika] Natick Soldier Res Dev & Engn Ctr, Cognit Sci Team, Natick, MA USA; [Ward, Nathan] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Universidade Federal do Rio Grande do Norte; Universidade Estadual de Campinas; Universidade Estadual de Londrina; Universidade do Estado do Rio de Janeiro; Tufts University; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); Tufts University	da Silva, WQA (corresponding author), Univ Fed Rio Grande do Norte, Dept Phys Educ, Natal, RN, Brazil.; da Silva, WQA (corresponding author), Natalense Fac Educ & Culture, Grad Program Phys Educ, Natal, RN, Brazil.	weslleyqurino@gmail.com	Elsangedy, Hassan M/L-6919-2013; Machado, Daniel Gomes da Silva/GQQ-1775-2022; Fontes, Eduardo B/D-7241-2013; da Silva, Weslley/E-5266-2019; Deslandes, Andrea C/F-3545-2010; Ward, Nathan/AAB-5713-2021; Forti, Rodrigo Menezes/K-2285-2017; Deslandes, Andrea/AAF-4525-2021; Okano, Alexandre Hideki/C-2757-2013; da Silva Machado, Daniel Gomes/F-8065-2017	Machado, Daniel Gomes da Silva/0000-0002-8426-0488; da Silva, Weslley/0000-0001-9332-4001; Deslandes, Andrea C/0000-0001-5941-9111; Forti, Rodrigo Menezes/0000-0002-8978-2525; Deslandes, Andrea/0000-0001-5941-9111; Okano, Alexandre Hideki/0000-0002-8995-1392; da Silva Machado, Daniel Gomes/0000-0002-8426-0488	Coordination for the Improvement of Higher Education Personnel (CAPES)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We thank the Coordination for the Improvement of Higher Education Personnel (CAPES) for providing a scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricola P. M. D., 2016, SLOW DOWN ENJOY EFFE; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; BALKE B, 1959, U S Armed Forces Med J, V10, P675; Binder RK, 2008, EUR J CARDIOV PREV R, V15, P726, DOI 10.1097/HJR.0b013e328304fed4; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Brewer BW, 2006, KINESIOL SLOVEN, V12, P82; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH133, DOI 10.1152/ajpheart.00062.2007; Camm AJ, 1996, CIRCULATION, V93, P1043; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Comte M., 2014, DISSOCIATING BOTTOM; Critchley Hugo D, 2013, Handb Clin Neurol, V117, P59, DOI 10.1016/B978-0-444-53491-0.00006-7; Damasio A, 2013, NAT REV NEUROSCI, V14, P143, DOI 10.1038/nrn3403; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Dietrich A, 2006, PSYCHIAT RES, V145, P79, DOI 10.1016/j.psychres.2005.07.033; Ekkekakis P, 2005, J SPORT SCI, V23, P477, DOI 10.1080/02640410400021492; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P., 2006, PSYCHOBIOLOGY PHYS A, P91; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Gibson AS, 2018, EUR J SPORT SCI, V18, P25, DOI 10.1080/17461391.2017.1321688; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hardy CJ, 1989, NOT WHAT ONE FEELS M, V11; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Hughes MM, 2014, BEHAV RES METHODS, V46, P702, DOI 10.3758/s13428-013-0411-5; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Hureau TJ, 2018, EUR J SPORT SCI, V18, P13, DOI 10.1080/17461391.2016.1252428; Hutchinson JC, 2007, PSYCHOL SPORT EXERC, V8, P233, DOI 10.1016/j.psychsport.2006.03.006; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Jones CM, 2017, SPORTS MED, V47, P943, DOI 10.1007/s40279-016-0619-5; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Labelle V., 2012, FITNESS LEVEL MODERA; Labelle V, 2013, BRAIN COGNITION, V81, P10, DOI 10.1016/j.bandc.2012.10.001; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Loprinzi PD, 2016, HEALTH PROMOT PERSPE, V6, P180, DOI 10.15171/hpp.2016.29; Martin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159907; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Mekari S., 2015, EUR J APPL PHYSL; Morgan W P, 1977, Ann N Y Acad Sci, V301, P382, DOI 10.1111/j.1749-6632.1977.tb38215.x; N?brega OT., 2008, NEUROCIENCIAS, V4, P75; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; RAGLIN JS, 1994, INT J SPORTS MED, V15, P84, DOI 10.1055/s-2007-1021025; Rhodes RE, 2015, ANN BEHAV MED, V49, P715, DOI 10.1007/s12160-015-9704-5; Rivera-Brown AM, 2012, PM&R, V4, P797, DOI 10.1016/j.pmrj.2012.10.007; Robertson CV, 2016, J APPL PHYSIOL, V120, P464, DOI 10.1152/japplphysiol.00363.2015; Rooks CR, 2010, PROG NEUROBIOL, V92, P134, DOI 10.1016/j.pneurobio.2010.06.002; Ross D., 1973, BRIT J SURG, P227; Sakaki M, 2016, NEUROIMAGE, V139, P44, DOI 10.1016/j.neuroimage.2016.05.076; Sarmiento S, 2013, J SYST SCI COMPLEX, V26, P104, DOI 10.1007/s11424-013-2287-y; Silvers JA, 2015, SOC COGN AFFECT NEUR, V10, P10, DOI 10.1093/scan/nsu016; Smith M, 2016, J HUM KINET, V51, P27, DOI 10.1515/hukin-2015-0167; Subudhi AW, 2011, J APPL PHYSIOL, V111, P1727, DOI 10.1152/japplphysiol.00569.2011; Tammen VV, 1996, J APPL SPORT PSYCHOL, V8, P1, DOI 10.1080/10413209608406304; Tempest G., 2015, COGN AFFECT BEHAV NE; Tempest GD, 2017, BRAIN COGNITION, V113, P133, DOI 10.1016/j.bandc.2017.02.001; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Trost SG, 2014, BRIT J SPORT MED, V48, P169, DOI 10.1136/bjsports-2013-093372	59	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186926	http://dx.doi.org/10.1371/journal.pone.0186926			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091915	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700034
J	Jordi, M; Marty, J; Mordasini, V; Lunemann, A; McComb, S; Bernasconi, M; Nadal, D				Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David			IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt's lymphoma cells	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; NF-KAPPA-B; LYTIC CYCLE; HISTONE MODIFICATION; SIGNAL-TRANSDUCTION; CROSS-LINKING; LATENCY; EBV; REACTIVATION; ACTIVATION	Burkitt's lymphoma (BL) is the most common childhood cancer in equatorial Africa, and is endemic to areas where people are chronically co-infected with Epstein-Barr virus (EBV) and the malaria pathogen Plasmodium falciparum. The contribution of these pathogens in the oncogenic process remains poorly understood. We showed earlier that the activation of Toll-like receptor (TLR) 9 by hemozoin, a disposal product formed from the digestion of blood by P. falciparum, suppresses the lytic reactivation of EBV in BL cells. EBV lytic reactivation is regulated by the expression of transcription factor Zta (ZEBRA), encoded by the EBV gene BZLF1. Here, we explore in the BL cell line Akata, the mechanism involved in repression by TLR9 of expression of BZLF1. We show that BZLF1 repression is mediated upon TLR9 engagement by a mechanism that is largely independent of de novo protein synthesis. By CRISPR/Cas9-induced inactivation of TLR9, MyD88, IRAK4 and IRAK1 we confirm that BZLF1 repression is dependent on functional TLR9 and MyD88 signaling, and identify IRAK4 as an essential element for TLR9-induced repression of BZLF1 expression upon BCR cross-linking. Our results unprecedentedly show that TLR9-mediated inhibition of lytic EBV is largely independent of new protein synthesis and demonstrate the central roles of MyD88 and IRAK4 in this process contributing to EBV's persistence in the host's B-cell pool.	[Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Lab Expt Infect Dis & Canc Res, Div Infect Dis, Zurich, Switzerland; [Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Hosp Epidemiol, Zurich, Switzerland; [Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Div Oncol, Zurich, Switzerland; [Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Nadal, David] Univ Childrens Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich	Nadal, D (corresponding author), Univ Zurich, Univ Childrens Hosp Zurich, Lab Expt Infect Dis & Canc Res, Div Infect Dis, Zurich, Switzerland.; Nadal, D (corresponding author), Univ Zurich, Univ Childrens Hosp Zurich, Hosp Epidemiol, Zurich, Switzerland.; Nadal, D (corresponding author), Univ Zurich, Univ Childrens Hosp Zurich, Div Oncol, Zurich, Switzerland.; Nadal, D (corresponding author), Univ Zurich, Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland.; Nadal, D (corresponding author), Univ Childrens Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	david.nadal@kispi.uzh.ch	Bernasconi, Michele/C-6734-2008; Bernasconi, Michele/GOH-1815-2022; Bernasconi, Michele/CAG-2492-2022	Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806	Swiss National Foundation [310040-568 114118]; Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation; OPO Foundation; Wolfermann-Nageli Foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation; OPO Foundation; Wolfermann-Nageli Foundation	This work was supported by grants from the Swiss National Foundation (#310040-568 114118), Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation, OPO Foundation, and Wolfermann-Nageli Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYA T, 1991, LANCET, V337, P1190, DOI 10.1016/0140-6736(91)92861-U; Brady G, 2008, POSTGRAD MED J, V84, P372, DOI 10.1136/jcp.2007.047977; Bryant H, 2002, J VIROL, V76, P10290, DOI 10.1128/JVI.76.20.10290-10298.2002; Callan MFC, 2004, MICROBES INFECT, V6, P937, DOI 10.1016/j.micinf.2004.04.014; Chene A, 2007, PLOS PATHOG, V3, P826, DOI 10.1371/journal.ppat.0030080; COUNTRYMAN J, 1987, J VIROL, V61, P3672, DOI 10.1128/JVI.61.12.3672-3679.1987; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; DIRENZO L, 1994, INT J CANCER, V57, P914, DOI 10.1002/ijc.2910570623; Duellman SJ, 2009, J GEN VIROL, V90, P2251, DOI 10.1099/vir.0.012260-0; FLEMINGTON EK, 1991, J VIROL, V65, P7073, DOI 10.1128/JVI.65.12.7073-7077.1991; Haas F, 2014, J VIROL, V88, P10002, DOI 10.1128/JVI.01486-14; Heeg K, 2008, INT J MED MICROBIOL, V298, P33, DOI 10.1016/j.ijmm.2007.07.007; Hislop AD, 2015, CURR TOP MICROBIOL, V391, P325, DOI 10.1007/978-3-319-22834-1_11; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Jenkins PJ, 2000, J VIROL, V74, P710, DOI 10.1128/JVI.74.2.710-720.2000; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KLEIN G, 1994, CELL, V77, P791, DOI 10.1016/0092-8674(94)90125-2; Ladell K, 2007, CELL MICROBIOL, V9, P2055, DOI 10.1111/j.1462-5822.2007.00937.x; Lunemann A, 2015, CURR TOP MICROBIOL, V391, P265, DOI 10.1007/978-3-319-22834-1_9; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Middeldorp JM, 2015, CURR TOP MICROBIOL, V391, P289, DOI 10.1007/978-3-319-22834-1_10; Murata T, 2012, J VIROL, V86, P4752, DOI 10.1128/JVI.06768-11; NEMEROW GR, 1987, J VIROL, V61, P1416, DOI 10.1128/JVI.61.5.1416-1420.1987; Ramasubramanyan S, 2012, J VIROL, V86, P1809, DOI 10.1128/JVI.06334-11; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rechsteiner MP, 2008, J VIROL, V82, P1739, DOI 10.1128/JVI.01723-07; ROWE DT, 1986, EMBO J, V5, P2599, DOI 10.1002/j.1460-2075.1986.tb04540.x; Rowe M, 2009, SEMIN CANCER BIOL, V19, P377, DOI 10.1016/j.semcancer.2009.07.004; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TOVEY MG, 1978, NATURE, V276, P270, DOI 10.1038/276270a0; Ye JJ, 2010, J VIROL, V84, P12405, DOI 10.1128/JVI.01415-10; Yin QY, 2004, VIROLOGY, V327, P134, DOI 10.1016/j.virol.2004.06.026; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zauner L, 2010, ONCOGENE, V29, P4588, DOI 10.1038/onc.2010.203; ZURHAUSEN H, 1978, NATURE, V272, P373	38	7	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186614	10.1371/journal.pone.0186614	http://dx.doi.org/10.1371/journal.pone.0186614			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088270	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000414088900018
J	Mogire, RM; Akala, HM; Macharia, RW; Juma, DW; Cheruiyot, AC; Andagalu, B; Brown, ML; El-Shemy, HA; Nyanjom, SG				Mogire, Reagan M.; Akala, Hoseah M.; Macharia, Rosaline W.; Juma, Dennis W.; Cheruiyot, Agnes C.; Andagalu, Ben; Brown, Mathew L.; El-Shemy, Hany A.; Nyanjom, Steven G.			Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets	PLOS ONE			English	Article							CIS-TRANS ISOMERASE; IN-VITRO ACTIVITY; DASATINIB BMS-354825; KINASE INHIBITOR; DNA TOPOISOMERASES; ACID METABOLISM; HDAC INHIBITORS; MOSQUITO-STAGE; RESISTANCE; DISCOVERY	Malaria causes about half a million deaths annually, with Plasmodium falciparum being responsible for 90% of all the cases. Recent reports on artemisinin resistance in Southeast Asia warrant urgent discovery of novel drugs for the treatment of malaria. However, most bioactive compounds fail to progress to treatments due to safety concerns. Drug repositioning offers an alternative strategy where drugs that have already been approved as safe for other diseases could be used to treat malaria. This study screened approved drugs for antimalarial activity using an in silico chemogenomics approach prior to in vitro verification. All the P. falciparum proteins sequences available in NCBI RefSeq were mined and used to perform a similarity search against DrugBank, TTD and STITCH databases to identify similar putative drug targets. Druggability indices of the potential P. falciparum drug targets were obtained from TDR targets database. Functional amino acid residues of the drug targets were determined using ConSurf server which was used to fine tune the similarity search. This study predicted 133 approved drugs that could target 34 P. falciparum proteins. A literature search done at PubMed and Google Scholar showed 105 out of the 133 drugs to have been previously tested against malaria, with most showing activity. For further validation, drug susceptibility assays using SYBR Green I method were done on a representative group of 10 predicted drugs, eight of which did show activity against P. falciparum 3D7 clone. Seven had IC50 values ranging from 1 mu M to 50 mu M. This study also suggests drug-target association and hence possible mechanisms of action of drugs that did show anti-plasmodial activity. The study results validate the use of proteome-wide target similarity approach in identifying approved drugs with activity against P. falciparum and could be adapted for other pathogens.	[Mogire, Reagan M.] Pan African Univ Inst Sci Technol & Innovat, Dept Mol Biol & Biotechnol, Nairobi, Kenya; [Akala, Hoseah M.; Juma, Dennis W.; Cheruiyot, Agnes C.; Andagalu, Ben; Brown, Mathew L.] Kenya Med Res Inst KEMRI, Walter Reed Project, DEID, USAMRD K, Kisumu, Kenya; [Macharia, Rosaline W.] Univ Nairobi, Ctr Biotechnol & Bioinformat, Nairobi, Kenya; [El-Shemy, Hany A.] Cairo Univ, Dept Biochem, Fac Agr, Giza, Egypt; [Nyanjom, Steven G.] Jomo Kenyatta Univ Agr & Technol, Dept Biochem, Nairobi, Kenya	Kenya Medical Research Institute; University of Nairobi; Egyptian Knowledge Bank (EKB); Cairo University; Jomo Kenyatta University of Agriculture & Technology	Mogire, RM (corresponding author), Pan African Univ Inst Sci Technol & Innovat, Dept Mol Biol & Biotechnol, Nairobi, Kenya.	reaganmoseti@gmail.com	El-Shemy, Hany A./A-6367-2008	Akala, Hoseah/0000-0001-8584-2706; Mogire, Reagan/0000-0001-6454-1613; Nyanjom, Steven/0000-0002-6290-991X	Japan International Cooperation Agency (AFRICA-ai-JAPAN Research Fund) [JKU/ADM/10B]; JICA [iCMOB/05/16]	Japan International Cooperation Agency (AFRICA-ai-JAPAN Research Fund); JICA	This work was supported by the Japan International Cooperation Agency (AFRICA-ai-JAPAN Research Fund), grant no; JKU/ADM/10B, (url: https//wwwJica.go.jp/keriya/english/). The grant number for financial support I received from JICA to facilitate part of this study is iCMOB/05/16 to RMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaki M, 2002, PARASITOL RES, V88, P1044, DOI 10.1007/s00436-002-0690-8; Akala HM, 2011, AM J TROP MED HYG, V85, P34, DOI 10.4269/ajtmh.2011.10-0674; Alam A, 2014, HINDAWI PUBLISHING C, V2014; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrews KT, 2012, IMMUNOL CELL BIOL, V90, P66, DOI 10.1038/icb.2011.97; Andrews KT, 2009, CURR TOP MED CHEM, V9, P292, DOI 10.2174/156802609788085313; Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; Andrews KT, 2000, INT J PARASITOL, V30, P761, DOI 10.1016/S0020-7519(00)00043-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bajsa J, 2010, BIOORGANIC MED CHEM; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BELL A, 1994, BIOCHEM PHARMACOL, V48, P495, DOI 10.1016/0006-2952(94)90279-8; Bentley R, 2000, CHEM REV, V100, P3801, DOI 10.1021/cr990097b; Bispo NA, 2013, PLOS ONE, P8; Bobbala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-102; Bodley AL, 1998, BIOCHEM PHARMACOL, V55, P709, DOI 10.1016/S0006-2952(97)00556-X; Boruah L, 2013, IJPBR, V1, P60; Buchholz K, 2011, J INFECT DIS, V203, P1445, DOI 10.1093/infdis/jir037; Burchard GD, 2014, INTERNIST, V55, P165, DOI 10.1007/s00108-013-3390-9; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen LQ, 2007, CURR OPIN DRUG DISC, V10, P403; Chen ZM, 2006, MOL PHARMACOL, V69, P1527, DOI 10.1124/mol.105.020172; Cheruiyot AC, 2016, ANTIMICROB AGENTS CH, V60, P2417, DOI 10.1128/AAC.00527-15; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; DarkinRattray SJ, 1996, P NATL ACAD SCI USA, V93, P13143, DOI 10.1073/pnas.93.23.13143; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; DAVIS R, 1994, DRUGS, V47, P677, DOI 10.2165/00003495-199447040-00008; Dechamps S, 2010, MOL BIOCHEM PARASIT, V173, P69, DOI 10.1016/j.molbiopara.2010.05.006; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; Derbyshire ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002178; Doerig C, 2004, BBA-PROTEINS PROTEOM, V1697, P155, DOI 10.1016/j.bbapap.2003.11.021; Doerig C, 2002, TRENDS PARASITOL, V18, P366, DOI 10.1016/S1471-4922(02)02321-8; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; Dohse M, 2010, DRUG METAB DISPOS, V38, P1371, DOI 10.1124/dmd.109.031302; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Ekins S, 2011, PHARM RES-DORDR, V28, P1785, DOI 10.1007/s11095-011-0486-6; Engel JA, 2015, INT J PARASITOL-DRUG, V5, P117, DOI 10.1016/j.ijpddr.2015.05.004; FIGGITT D, 1992, ANTIMICROB AGENTS CH, V36, P1644, DOI 10.1128/AAC.36.8.1644; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Fiskus W, 2006, CLIN CANCER RES, V12, P5869, DOI 10.1158/1078-0432.CCR-06-0980; Flannery EL, 2013, NAT REV MICROBIOL, V11, P849, DOI 10.1038/nrmicro3138; Gandhi V, 2003, CLIN CANCER RES, V9, P6335; Garcia-Estrada C, 2010, P ROY SOC B-BIOL SCI, V277, P1777, DOI 10.1098/rspb.2009.2176; Gardner MJ, 2013, GENOME SEQUENCE HUMA, V419, P3; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gego A, 2006, ANTIMICROB AGENTS CH, V50, P1586, DOI 10.1128/AAC.50.4.1586-1589.2006; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; goston A V, 2005, TRENDS PHARMACOL SCI, V26, P178; Graewe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002224; Hampton T, 2004, JAMA-J AM MED ASSOC, V292, P419, DOI 10.1001/jama.292.4.419; Hamzah J, 2000, ACTA TROP, V74, P39, DOI 10.1016/S0001-706X(99)00051-0; Hedstrom L, 2011, CURR MED CHEM, V18, P1909, DOI 10.2174/092986711795590129; HERLEKAR I, 2014, CURR SCI INDIA, V106, P345, DOI DOI 10.1038/NATURE12876; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jirage Dayadevi, 2010, Infectious Disorders - Drug Targets, V10, P134; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Kamath AV, 2008, CANCER CHEMOTH PHARM, V61, P365, DOI 10.1007/s00280-007-0478-8; Ke HJ, 2015, CELL REP, V11, P164, DOI 10.1016/j.celrep.2015.03.011; Ke HJ, 2014, J BIOL CHEM, V289, P34827, DOI 10.1074/jbc.M114.615831; Kesely KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164895; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Koenderink JB, 2010, TRENDS PARASITOL, V26, P440, DOI 10.1016/j.pt.2010.05.002; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Bao LQ, 2017, IMMUNOLOGY, V150, P155, DOI 10.1111/imm.12661; Lee BJ, 2003, ANTIMICROB AGENTS CH, V47, P3810, DOI 10.1128/AAC.47.12.3810-3814.2003; Leprohon P, 2011, ESSAYS BIOCHEM, V50, P121, DOI [10.1042/BSE0500121, 10.1042/bse0500121]; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Li QL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-353; Liao CZ, 2011, FUTURE MED CHEM, V3, P1057, DOI [10.4155/fmc.11.63, 10.4155/FMC.11.63]; Lotharius J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-143; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Ma Y, 2010, PHYTOTHER RES, V24, P146, DOI 10.1002/ptr.2860; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Magarinos MP, 2012, NUCLEIC ACIDS RES, V40, pD1118, DOI 10.1093/nar/gkr1053; Mahmoudi N, 2003, ANTIMICROB AGENTS CH, V47, P2636, DOI 10.1128/AAC.47.8.2636-2639.2003; Matthews H., 2013, ACCELERATING ANTIMAL; Menezes CMS, 2002, MEM I OSWALDO CRUZ F, P97; Meshnick Sr, 2001, INFEC DIS S, P15; Metz J, 2007, FOOD NUTR BULL, V28, pS540, DOI 10.1177/15648265070284S407; Monaghan P, 2005, MOL BIOCHEM PARASIT, V139, P185, DOI 10.1016/j.molbiopara.2004.10.007; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002; NAIR L, 1994, JPN J MED SCI BIOL, V47, P241, DOI 10.7883/yoken1952.47.241; Nasveld Peter, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P552; Neves BJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003435; Nezami A, 2003, BIOCHEMISTRY-US, V42, P8459, DOI 10.1021/bi034131z; Nsanzabana C, 2011, ANTIMICROB AGENTS CH, V55, P5073, DOI 10.1128/AAC.05130-11; Owens J, 2007, NAT REV DRUG DISCOV, V6, P187, DOI 10.1038/nrd2275; Pradines B, 2007, ANTIMICROB AGENTS CH, V51, P2654, DOI 10.1128/AAC.01330-06; Preuss J, 2012, IUBMB LIFE, V64, P603, DOI 10.1002/iub.1047; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quintas-Cardama Alfonso, 2006, Future Oncol, V2, P655, DOI 10.2217/14796694.2.6.655; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Rijpma SR, 2016, MOL MICROBIOL, V101, P78, DOI 10.1111/mmi.13373; Sekhon B.S., 2013, J PHARM ED RES, V4, P1; Serrels A, 2006, MOL CANCER THER, V5, P3014, DOI 10.1158/1535-7163.MCT-06-0382; Sinou V, 1996, ANTIMICROB AGENTS CH, V40, P358, DOI 10.1128/AAC.40.2.358; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Sriram S, 2009, ANTIMALARIAL DRUG DE, P13; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; T D R Targets, 2015, TDR TARG DAT, P1; Talele TT, 2010, CURR TOP MED CHEM, V10, P127, DOI 10.2174/156802610790232251; Tam RC, 2001, ANTIVIR CHEM CHEMOTH, V12, P261, DOI 10.1177/095632020101200501; Tang YQ, 2004, MED RES REV, V24, P425, DOI 10.1002/med.10066; Team RDC, 2004, R LANG ENV STAT COMP; THOMSON AW, 1995, THER DRUG MONIT, V17, P584, DOI 10.1097/00007691-199512000-00007; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; Tyler PC, 2007, J AM CHEM SOC, V129, P6872, DOI 10.1021/ja0708363; van Erp NP, 2009, CANCER TREAT REV, V35, P692, DOI 10.1016/j.ctrv.2009.08.004; van Niekerk DD, 2016, PLASMODIUM FALCIPARU, V283, P634; van Schaijk BCL, 2014, EUKARYOT CELL, V13, P550, DOI 10.1128/EC.00264-13; Velankar S, 2012, NUCLEIC ACIDS RES, V40, pD445, DOI 10.1093/nar/gkr998; Veletzky L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-476; Wang LF, 2008, DRUG METAB DISPOS, V36, P1828, DOI 10.1124/dmd.107.020255; Wang Yufeng, 2004, Current Drug Targets - Infectious Disorders, V4, P25, DOI 10.2174/1568005043480952; WATT G, 1991, J INFECT DIS, V164, P602, DOI 10.1093/infdis/164.3.602; Wegscheid-Gerlach C, 2010, CURR TOP MED CHEM, V10, P346, DOI 10.2174/156802610790725461; White Nicholas J, 2008, Malar J, V7 Suppl 1, pS8, DOI 10.1186/1475-2875-7-S1-S8; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; World Health Organization, 2016, WORLD MALARIA REPORT; Wu ZK, 2013, MOL BIOSYST, V9, P1268, DOI 10.1039/c3mb25382a; Yeh I, 2006, MINI-REV MED CHEM, V6, P177, DOI 10.2174/138955706775475957; Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; Zvegy-Laczka C, 2009, BRIT J PHARMACOL, P1153	131	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186364	10.1371/journal.pone.0186364	http://dx.doi.org/10.1371/journal.pone.0186364			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088219	Green Submitted, gold, Green Published			2022-12-27	WOS:000414088900009
J	Oka, S; Furukawa, H; Yasunami, M; Kawasaki, A; Nakamura, H; Nakamura, M; Komori, A; Abiru, S; Nagaoka, S; Hashimoto, S; Naganuma, A; Naeshiro, N; Yoshizawa, K; Yamashita, H; Ario, K; Ohta, H; Sakai, H; Yabuuchi, I; Takahashi, A; Abe, K; Yatsuhashi, H; Tohma, S; Ohira, H; Tsuchiya, N; Migita, K				Oka, Shomi; Furukawa, Hiroshi; Yasunami, Michio; Kawasaki, Aya; Nakamura, Hitomi; Nakamura, Minoru; Komori, Atsumasa; Abiru, Seigo; Nagaoka, Shinya; Hashimoto, Satoru; Naganuma, Atsushi; Naeshiro, Noriaki; Yoshizawa, Kaname; Yamashita, Haruhiro; Ario, Keisuke; Ohta, Hajime; Sakai, Hironori; Yabuuchi, Iwao; Takahashi, Atsushi; Abe, Kazumichi; Yatsuhashi, Hiroshi; Tohma, Shigeto; Ohira, Hiromasa; Tsuchiya, Naoyuki; Migita, Kiyoshi			HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype	PLOS ONE			English	Article							HLA-DR; SUSCEPTIBILITY; HAPLOTYPES; ASSOCIATION; PROTECTION; MECHANISMS; SEQUENCES; ANTIGENS; REGION	Objective Autoimmune hepatitis (AIH) is a chronic progressive liver disease. AIH is composed predominantly of type 1 in Japanese populations. The genetic and environmental factors are associated with the pathogenesis of AIH. HLA-DRB1* 03: 01 and * 04: 01 are associated with type 1 AIH in European and * 04: 05 in Japanese populations. Here, we conducted an HLA association study in order to find HLA alleles or haplotypes predisposing or protective for Japanese AIH. Methods HLA-DRB1 and DQB1 genotyping of 360 type 1 AIH patients and 1026 healthy controls was performed. Results The predisposing association of DRB1*04: 01 (P = 0.0006, corrected P [Pc] = 0.0193, odds ratio [OR] 2.97, 95% confidence interval [CI] 1.62-5.43), DRB1*04: 05 (P = 1.89x10(-21), Pc = 5.86x10(-20), OR 3.41, 95% CI 2.65-4.38), and DQB1*04: 01 (P = 4.66x10(-18), Pc = 6.99x10(-17), OR 3.89, 95% CI 2.84-5.33) and the protective association of DRB1*13: 02 (P = 0.0003, Pc = 0.0080, OR 0.48, 95% CI 0.32-0.72) with Japanese type 1 AIH were observed. An association of the DR4/DR8 heterozygous genotype with Japanese AIH was identified for the first time (P = 3.12x10(-9), OR 3.52, 95% CI 2.34-5.29). Susceptible diplotypes were DRB1*04: 05-DQB1*04: 01/DRB1*08: 02-DQB1*03: 02 (P = 0.0004, OR 24.77, 95% CI 1.45-424.31) and DRB1*04: 05-DQB1*04: 01/DRB1*08: 03-DQB1*06: 01 (P = 1.18x10(-6), OR 10.64, 95% CI 3.19-35.46). Serum levels of Immunoglobulin G and Immunoglobulin M, International Autoimmune Hepatitis Group score, positive rate of anti-smooth muscle antibodies, and the rate of definite AIH were higher in AIH patients with DRB1*04: 05 than without. Conclusions The important roles of specific combinations of DRB1 and DQB1 alleles or haplotypes in the pathogenesis of type 1 AIH were suggested. The association of DR4/DR8 heterozygous genotype suggested the pathologic importance of trans-complementing DQ alpha-beta heterodimer molecules encoded by DQA1 allele of one haplotype and the DQB1 allele of the other haplotype, as it was proposed in the HLA association studies of Type 1 diabetes.	[Oka, Shomi; Furukawa, Hiroshi; Kawasaki, Aya; Tsuchiya, Naoyuki] Univ Tsukuba, Mol & Genet Epidemiol Lab, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Oka, Shomi; Furukawa, Hiroshi; Tohma, Shigeto] Sagamihara Natl Hosp, Natl Hosp Org, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan; [Yasunami, Michio] Saga Ken Med Ctr Koseikan, Inst Life Sci, Dept Med Gen, 400 Kasemachi Nakabaru, Saga, Japan; [Yasunami, Michio; Nakamura, Hitomi] Nagasaki Univ, Dept Clin Med, Inst Trop Med, 1-12-4 Sakamoto, Nagasaki, Japan; [Nakamura, Minoru] Nagasaki Univ, Dept Hepatol, Grad Sch Biomed Sci, 1-12-4 Sakamoto, Nagasaki, Japan; [Nakamura, Minoru; Komori, Atsumasa; Yatsuhashi, Hiroshi; Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, 2-1001-1 Kubara, Omura, Japan; [Nakamura, Minoru; Komori, Atsumasa; Abiru, Seigo; Nagaoka, Shinya; Hashimoto, Satoru; Naganuma, Atsushi; Naeshiro, Noriaki; Yoshizawa, Kaname; Yamashita, Haruhiro; Ario, Keisuke; Ohta, Hajime; Sakai, Hironori; Yabuuchi, Iwao; Yatsuhashi, Hiroshi; Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, NHO AIH study Grp, 2-1001-1 Kubara, Omura, Japan; [Takahashi, Atsushi; Abe, Kazumichi; Ohira, Hiromasa; Migita, Kiyoshi] Fukushima Med Univ, Sch Med, Dept Gastroenterol & Rheumatol, 1 Hikarigaoka, Fukushima, Japan	University of Tsukuba; Nagasaki University; Nagasaki University; Fukushima Medical University	Furukawa, H (corresponding author), Univ Tsukuba, Mol & Genet Epidemiol Lab, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.; Furukawa, H (corresponding author), Sagamihara Natl Hosp, Natl Hosp Org, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan.	furukawa-tky@umin.org	Tsuchiya, Naoyuki/CAA-4545-2022	Tsuchiya, Naoyuki/0000-0002-6776-5580; Naganuma, Atsushi/0000-0003-0663-0102	Japan Society for the Promotion of Science [26293076]; Grants-in-Aid for Scientific Research [17H04169] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by Grants-in-Aid for Clinical Research from National Hospital Organization and Grants-in-Aid for Scientific Research (B) (26293076) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparing the manuscript.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Baharlou R, 2016, HUM IMMUNOL, V77, P330, DOI 10.1016/j.humimm.2016.01.007; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; de Boer YS, 2014, GASTROENTEROLOGY, V147, P443, DOI 10.1053/j.gastro.2014.04.022; Duarte-Rey C, 2009, AUTOIMMUN REV, V8, P325, DOI 10.1016/j.autrev.2008.11.005; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Fortes MD, 2007, LIVER INT, V27, P1409, DOI 10.1111/j.1478-3231.2007.01581.x; Furukawa H, 2017, GENES IMMUN IN PRESS, V2017; Furukawa H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154255; Furumoto Y, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0360-9; Goldberg AC, 2001, HUM IMMUNOL, V62, P165, DOI 10.1016/S0198-8859(00)00234-2; Hassan N, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.13598; Kamatani N, 2004, TISSUE CULTURE RES C, V23, P71; Kaur N, 2014, J CLIN EXP HEPATOL, V4, P14, DOI 10.1016/j.jceh.2013.12.002; Kawabata Y, 2002, DIABETES, V51, P545, DOI 10.2337/diabetes.51.2.545; Koning F, 2015, NAT REV RHEUMATOL, V11, P450, DOI 10.1038/nrrheum.2015.59; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; Lim YS, 2008, J HEPATOL, V48, P133, DOI 10.1016/j.jhep.2007.08.019; Maeda Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146048; Manns MP, 2006, HEPATOLOGY, V43, pS132, DOI 10.1002/hep.21059; Migita K, 2012, LIVER INT, V32, P837, DOI 10.1111/j.1478-3231.2011.02734.x; Miyadera H, 2015, J CLIN INVEST, V125, P275, DOI 10.1172/JCI74961; Nakajima F, 2001, MHC, V8, P1; Oka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099453; Pando M, 1999, HEPATOLOGY, V30, P1374, DOI 10.1002/hep.510300611; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; Strettell MDJ, 1997, GASTROENTEROLOGY, V112, P2028, DOI 10.1053/gast.1997.v112.pm9178696; Umemura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100565; Vazquez-Garcia MN, 1998, J HEPATOL, V28, P985, DOI 10.1016/S0168-8278(98)80347-4; Yoshizawa K, 2005, J HEPATOL, V42, P578, DOI 10.1016/j.jhep.2004.12.019	30	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187325	10.1371/journal.pone.0187325	http://dx.doi.org/10.1371/journal.pone.0187325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088299	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900066
J	Bernabe-Ortiz, A; Ruiz-Alejos, A; Miranda, JJ; Mathur, R; Perel, P; Smeeth, L				Bernabe-Ortiz, Antonio; Ruiz-Alejos, Andrea; Jaime Miranda, J.; Mathur, Rohini; Perel, Pablo; Smeeth, Liam			EZSCAN for undiagnosed type 2 diabetes mellitus: A systematic review and meta-analysis	PLOS ONE			English	Review							GLUCOSE; PREVALENCE; DIAGNOSIS; TOOL	Objectives The EZSCAN is a non-invasive device that, by evaluating sweat gland function, may detect subjects with type 2 diabetes mellitus (T2DM). The aim of the study was to conduct a systematic review and meta-analysis including studies assessing the performance of the EZSCAN for detecting cases of undiagnosed T2DM. Methodology/Principal findings We searched for observational studies including diagnostic accuracy and performance results assessing EZSCAN for detecting cases of undiagnosed T2DM. OVID (Medline, Embase, Global Health), CINAHL and SCOPUS databases, plus secondary resources, were searched until March 29, 2017. The following keywords were utilized for the systematic searching: type 2 diabetes mellitus, hyperglycemia, EZSCAN, SUDOSCAN, and sudomotor function. Two investigators extracted the information for meta-analysis and assessed the quality of the data using the Revised Version of the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) checklist. Pooled estimates were obtained by fitting the logistic-normal random-effects model without covariates but random intercepts and using the Freeman-Tukey Arcsine Transformation to stabilize variances. Heterogeneity was also assessed using the I 2 measure. Four studies (n = 7,720) were included, three of them used oral glucose tolerance test as the gold standard. Using Hierarchical Summary Receiver Operating Characteristic model, summary sensitivity was 72.0% (95% CI: 60.0%-83.0%), whereas specificity was 56.0% (95% CI: 38.0%-74.0%). Studies were very heterogeneous (I 2 for sensitivity: 79.2% and for specificity: 99.1%) regarding the inclusion criteria and bias was present mainly due to participants selection. Conclusions The sensitivity of EZSCAN for detecting cases of undiagnosed T2DM seems to be acceptable, but evidence of high heterogeneity and participant selection bias was detected in most of the studies included. More studies are needed to evaluate the performance of the EZS-CAN for undiagnosed T2DM screening, especially at the population level.	[Bernabe-Ortiz, Antonio; Ruiz-Alejos, Andrea; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Bernabe-Ortiz, Antonio; Mathur, Rohini; Perel, Pablo; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Bernabe-Ortiz, Antonio] Univ Peruana Ciencias Aplicadas UPC, Escuela Med, Lima, Peru; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru	Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Peruana Cayetano Heredia	Bernabe-Ortiz, A (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.; Bernabe-Ortiz, A (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.; Bernabe-Ortiz, A (corresponding author), Univ Peruana Ciencias Aplicadas UPC, Escuela Med, Lima, Peru.	Antonio.Bernabe@upch.pe	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; /0000-0002-2342-301X; Bernabe-Ortiz, Antonio/0000-0002-6834-1376; Ruiz-Alejos, Andrea/0000-0003-3484-9742	Research Training Fellowship in Public Health and Tropical Medicine - Wellcome Trust [103994/Z/14/Z]; Senior Research Fellowship in Clinical Science - Wellcome Trust [098504/Z/12/Z]; FOGARTY INTERNATIONAL CENTER [D43TW009343] Funding Source: NIH RePORTER	Research Training Fellowship in Public Health and Tropical Medicine - Wellcome Trust; Senior Research Fellowship in Clinical Science - Wellcome Trust; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	AB-O is supported by a Research Training Fellowship in Public Health and Tropical Medicine (103994/Z/14/Z) and LS is supported by a Senior Research Fellowship in Clinical Science (098504/Z/12/Z), both funded by Wellcome Trust (ww.welcome.ac.uk). The funders had no role in study design, data collection, data analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Calvet J. H., 2011, BR J DIABETES VASC D, V11, P204, DOI DOI 10.1177/1474651411402629; Chen LZ, 2013, DIABETES RES CLIN PR, V100, P210, DOI 10.1016/j.diabres.2013.03.001; Chen XL, 2015, EXP THER MED, V9, P1688, DOI 10.3892/etm.2015.2358; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Danaei G, 2015, LANCET DIABETES ENDO, V3, P624, DOI 10.1016/S2213-8587(15)00129-1; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Federation ID, 2013, IDF DIABETES ATLAS; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Hardbord RM, 2009, STATA J, V9, P211; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Impeto Medical, 2016, COMPL STUD EZSCAN PA; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Lin YH, 2017, MED CLIN-BARCELONA, V148, P444, DOI [10.1016/j.medcli.2016.11.037, 10.1016/j.medcle.2017.04.029]; Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183; Mao F, 2016, J DIABETES INVESTIG; Maskarinec G, 2009, ETHNIC DIS, V19, P49; Muller G, 2015, EXP CLIN ENDOCR DIAB, V123, P34, DOI 10.1055/s-0033-1357128; Mueller G, 2013, PRIM CARE DIABETES, V7, P269, DOI 10.1016/j.pcd.2013.08.001; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Ozaki R, 2011, DIABETES TECHNOL THE, V13, P937, DOI 10.1089/dia.2011.0023; Ramachandran A, 2010, DIABETES RES CLIN PR, V88, P302, DOI 10.1016/j.diabres.2010.01.023; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Riedel A, 1999, MUSCLE NERVE, V22, P1257, DOI 10.1002/(SICI)1097-4598(199909)22:9<1257::AID-MUS14>3.0.CO;2-J; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Sanchez-Hernadez OE, 2015, J DIABETES METAB, V6; Selph S, 2015, ANN INTERN MED, V162, P765, DOI 10.7326/M14-2221; Selvarajah D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138224; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Sun JC, 2014, J DIABETES, V6, P409, DOI 10.1111/1753-0407.12135; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043449; The Cochrane Collaboration, 2016, HDB DIAGN TESTS ACC; Vinik AI, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00094; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; World Health Organization, 2014, GLOB HLTH EST DEATHS, DOI 10.1371/journal.pgen.1004412.20; World Health Organization, 2011, US GLYC HAEM HB A1C; Yang Z, 2013, OXID MED CELL LONGEV, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0056480; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	47	3	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187297	10.1371/journal.pone.0187297	http://dx.doi.org/10.1371/journal.pone.0187297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084286	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000413910200047
J	Kompaniyets, L; Evans, MA				Kompaniyets, Lyudmyla; Evans, Marc A.			Modeling the relationship between wolf control and cattle depredation	PLOS ONE			English	Article							NORTHWESTERN UNITED-STATES; LIVESTOCK DEPREDATION	Wolf control to reduce cattle depredation is an important issue to ecology and agriculture in the United States. Two recent papers use the same dataset having wolf population characteristics and cattle depredation, but come to opposing conclusions concerning the link between wolf control and cattle depredation. Our paper aims to resolve this issue by using the same dataset and developing a model based on a causal association that would explain the nature of the relationship between wolf control and cattle depredation. We use the data on wolf population, number of cattle, number of wolves killed and number of cattle killed, from the U.S. Fish and Wildlife Services Interagency Annual Wolf Reports over the period of 1987-2012. We find a positive link between wolf control and cattle depredation. However, it would be incorrect to infer that wolf control has a positive effect on the number of cattle depredated. We maintain that this link comes from a growing wolf population, which increases cattle depredation, and in turn, causes an increase in the number of wolves killed. While the wolf population is growing, we see both wolf removal and cattle depredation simultaneously grow. It is not until the wolf population growth nears the steady state, that removal of wolves has a sufficient negative effect to reduce or stabilize the number of cattle depredated.	[Kompaniyets, Lyudmyla] Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA; [Evans, Marc A.] Washington State Univ, Dept Math & Stat, Pullman, WA 99164 USA	Washington State University; Washington State University	Kompaniyets, L (corresponding author), Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA.; Evans, MA (corresponding author), Washington State Univ, Dept Math & Stat, Pullman, WA 99164 USA.	l.kompaniyets@wsu.edu; marcevan@wsu.edu						[Anonymous], 2015, NO ROCK MOUNT GRAY W; [Anonymous], 1996, CATEGORICAL DATA ANA; [Anonymous], 2016, GRAY WOLV NO ROCK MO; Bangs EE, 2005, CONSERV BIOL SER, V9, P340; Blejwas KM, 2002, J WILDLIFE MANAGE, V66, P451, DOI 10.2307/3803178; Bradley EH, 2005, CONSERV BIOL, V19, P1498, DOI 10.1111/j.1523-1739.2005.00102.x; Bradley EH, 2015, J WILDLIFE MANAGE, V79, P1337, DOI 10.1002/jwmg.948; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; Kutner M., 2004, APPL LINEAR STAT MOD; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Mech LD, 2010, J WILDLIFE MANAGE, V74, P1421, DOI 10.2193/2009-540; Muhly TB, 2009, ECOL ECON, V68, P2439, DOI 10.1016/j.ecolecon.2009.04.008; Murray DL, 2010, BIOL CONSERV, V143, P2514, DOI 10.1016/j.biocon.2010.06.018; Musiani M, 2005, WILDLIFE SOC B, V33, P876, DOI 10.2193/0091-7648(2005)33[876:SARODA]2.0.CO;2; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Parsons DR, 1998, WILDLIFE SOC B, V26, P799; Poudyal N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148743; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Wielgus RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113505	20	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187264	10.1371/journal.pone.0187264	http://dx.doi.org/10.1371/journal.pone.0187264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084261	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200045
J	Shafaie, S; Hotter, V; Brown, MB; Cook, MT; Chau, DYS				Shafaie, Sara; Hotter, Victoria; Brown, Marc B.; Cook, Michael T.; Chau, David Y. S.			Influence of surface geometry on the culture of human cell lines: A comparative study using flat, round-bottom and v-shaped 96 well plates	PLOS ONE			English	Article							SUBSTRATE; 3RD-DIMENSION; BEHAVIOR	In vitro cell based models have been invaluable tools for studying cell behaviour and for investigating drug disposition, toxicity and potential adverse effects of administered drugs. Within this drug discovery pipeline, the ability to assess and prioritise candidate compounds as soon as possible offers a distinct advantage. However, the ability to apply this approach to a cell culture study is limited by the need to provide an accurate, in vitro-like, microenvironment in conjunction with a low cost and high-throughput screening (HTS) methodology. Although the geometry and/or alignment of cells has been reported to have a profound influence on cell growth and differentiation, only a handful of studies have directly compared the growth of a single cell line on different shaped multiwell plates the most commonly used substrate for HTS, in vitro, studies. Herein, the impact of various surface geometries (flat, round and v-shaped 96 well plates), as well as fixed volume growth media and fixed growth surface area have been investigated on the characteristics of three commonly used human cell lines in biopharmaceutical research and development, namely ARPE-19 (retinal epithelial), A549 (alveolar epithelial) and Malme-3M (dermal fibroblastic) cells. The effect of the surface curvature on cells was characterised using a combination of a metabolic activity assay (Cell-Titer AQ/MTS), LDH release profiles (CytoTox ONE) and absolute cell counts (Guava Via-Count), respectively. In addition, cell differentiation and expression of specific marker proteins were determined using flow cytometry. These in vitro results confirmed that surface topography had a significant effect (p < 0.05) on cell activity and morphology. However, although specific marker proteins were expressed on day 1 and 5 of the experiment, no significant differences were seen between the different plate geometries (p < 0.05) at the later time point. Accordingly, these results highlight the impact of substrate geometry on the culture of a cell line and the influence it has on the cells' correct growth and differentiation characteristics. As such, these results provide important implications in many aspects of cell biology the development of a HTS, in vitro, cell based systems to further investigate different aspects of toxicity testing and drug delivery.	[Shafaie, Sara; Hotter, Victoria; Brown, Marc B.; Cook, Michael T.; Chau, David Y. S.] Univ Hertfordshire, Res Ctr Top Drug Delivery & Toxicol, Dept Pharm Pharmacol & Postgrad Med, Sch Life & Med Sci, Coll Lane, Hatfield, Herts, England; [Brown, Marc B.] MedPharm Ltd, Unit Chancellor Court 3, Guildford, Surrey, England	University of Hertfordshire	Chau, DYS (corresponding author), Univ Hertfordshire, Res Ctr Top Drug Delivery & Toxicol, Dept Pharm Pharmacol & Postgrad Med, Sch Life & Med Sci, Coll Lane, Hatfield, Herts, England.	d.chau@herts.ac.uk	Cook, Michael T./U-2208-2019; Chau, David YS/U-2911-2019	Cook, Michael T./0000-0002-0772-682X; Chau, David/0000-0001-9200-6749; Brown, Marc/0000-0001-8327-2252	University of Hertfordshire	University of Hertfordshire	This work was supported by a University of Hertfordshire PhD student scholarship award. The funder provided support in the form of salaries for authors [SS, VH, MBB, MTC, DYSC] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No funding arrangements or academic contributions were made or provided by MedPharm Ltd. for this study.	Adcock AF, 2015, J ANAL BIOANALYTICA, V2015; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Bokhari M, 2007, BIOCHEM BIOPH RES CO, V354, P1095, DOI 10.1016/j.bbrc.2007.01.105; Clement RA, 1993, INTRO VISION SCI; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Deshpande P, 2009, TISSUE ENG PT A, V15, P2889, DOI [10.1089/ten.tea.2008.0528, 10.1089/ten.TEA.2008.0528]; Folkman J, 1978, ROLE CELL SHAPE GROW; Fronk AH, 2015, METHODS GROWING RETI; Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024; Huang Hui-Pei, 2013, J Tradit Complement Med, V3, P7, DOI 10.4103/2225-4110.106535; Jeanes AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018144; Kaufman PL, 2011, ADLERS PHYSL EYE; Kim MH, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-13; LAIFOOK SJ, 1993, ANNU REV PHYSIOL, V55, P155, DOI 10.1146/annurev.physiol.55.1.155; Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Perche F, 2012, CANCER BIOL THER, V13, P1205, DOI 10.4161/cbt.21353; Postnikoff CK, 2014, DEV CURVED STRATIFIE; Rivera AL, 2015, MICROMACHINES-BASEL, V6, P330, DOI 10.3390/mi6030330; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Shafaie S, 2016, BIORESEARCH OPEN ACC, V5, DOI 10.1089/biores.2016.0008; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Wang L., 2011, ADV BIOMIMETICS, DOI [10.5772/14383, DOI 10.5772/14383]; Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4; Witte RP, 2005, BIOMATERIALS, V26, P3673, DOI 10.1016/j.biomaterials.2004.09.054	31	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186799	10.1371/journal.pone.0186799	http://dx.doi.org/10.1371/journal.pone.0186799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084285	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200014
J	Bates, K; Leone, T; Ghandour, R; Mitwalli, S; Nasr, S; Coast, E; Giacaman, R				Bates, Katie; Leone, Tiziana; Ghandour, Rula; Mitwalli, Suzan; Nasr, Shiraz; Coast, Ernestina; Giacaman, Rita			Women's health in the occupied Palestinian territories: Contextual influences on subjective and objective health measures	PLOS ONE			English	Article							SELF-RATED HEALTH; AGE; MORTALITY	The links between two commonly used measures of health D self-rated health (SRH) and self-reported illness (SRI)-and socio-economic and contextual factors are poorly understood in Low and Middle Income Countries (LMICs) and more specifically among women in conflict areas. This study assesses the socioeconomic determinants of three self-reported measures of health among women in the occupied Palestinian territories; self-reported self-rated health (SRH) and two self-reported illness indicators (acute and chronic diseases). Data were obtained from the 2010 Palestinian Family Health Survey (PFHS), providing a sample of 14,819 women aged 15-54. Data were used to construct three binary dependent variable D SRH (poor or otherwise), and reporting two SRI indicators D general illness and chronic illness (yes or otherwise). Multilevel logistic regression models for each dependent variable were estimated, with individual level socioeconomic and sociodemographic predictors and random intercepts at the governorate and community level included, to explore the determinants of inequalities in health. Consistent socioeconomic inequalities in women's reports of both SRH and SRI are found. Better educated, wealthier women are significantly less likely to report an SRI and poor SRH. However, intra-oPt regional disparities are not consistent across SRH and SRI. Women from the Gaza Strip are less likely to report poor SRH compared to women from all other regions in the West Bank. Geographic and residential factors, together with socioeconomic status, are key to understanding differences between women's reports of SRI and SRH in the oPt. More evidence is needed on the health of women in the oPt beyond the ages currently included in surveys. The results for SRH show discrepancies which can often occur in conflict affected settings where a combination of ill-health and poor access to health services impact on women's health. These results indicate that future policies should be developed in a holistic manner by targeting physical and mental health and well-being in programmes addressing the health needs of women, especially those in conflict affected zones.	[Bates, Katie; Leone, Tiziana] LSE, Dept Social Policy, London, England; [Ghandour, Rula; Coast, Ernestina] LSE, Dept Int Dev, London, England; [Mitwalli, Suzan; Nasr, Shiraz; Giacaman, Rita] Birzeit Univ Ramallah, Inst Community & Publ Hlth, West Bank, Palestine	University of London; London School Economics & Political Science; University of London; London School Economics & Political Science; Birzeit University	Leone, T (corresponding author), LSE, Dept Social Policy, London, England.	t.leone@lse.ac.uk	Leone, Tiziana/Q-2169-2016	Leone, Tiziana/0000-0001-9671-5382; Bates, Katie/0000-0002-3118-4637; coast, ernestina/0000-0002-8703-307X	Emirates Foundation granny	Emirates Foundation granny	Gandhour, Nasr and Mitwalli salaries were partially funded by the Emirates Foundation granny. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Al-Adili N, 2008, REPROD HEALTH MATTER, V16, P112, DOI 10.1016/S0968-8080(08)31340-8; Azaiza F, 2011, BREAST CANCER RES TR, V128, P219, DOI 10.1007/s10549-010-1321-1; Baker M, 2004, J HUM RESOUR, V39, P1067, DOI 10.2307/3559039; Baron-Epel O, 2001, SOC SCI MED, V53, P1373, DOI 10.1016/S0277-9536(00)00426-3; Bovet P, 2012, PUB HLTH REV, V33, P397, DOI DOI 10.1007/BF03391643; Burgard SA, 2014, SOC SCI MED, V106, P143, DOI 10.1016/j.socscimed.2014.01.045; Bustreo F, 2013, B WORLD HEALTH ORGAN, V91, P712, DOI 10.2471/BLT.12.109785; Dabbagh Nadia Taysir, 2005, SUICIDE PALESTINE NA; Eljedi A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-268; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Giacaman R, 2007, EUR J PUBLIC HEALTH, V17, P86, DOI 10.1093/eurpub/ckl089; Grundy E, 2000, SOC SCI MED, V51, P1061, DOI 10.1016/S0277-9536(00)00023-X; Hammoudeh D, 2017, SOC SCI MED, V184, P108, DOI 10.1016/j.socscimed.2017.05.028; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Johnston DW, 2009, J HEALTH ECON, V28, P540, DOI 10.1016/j.jhealeco.2009.02.010; Jurges H, 2007, HEALTH ECON, V16, P163, DOI 10.1002/hec.1134; Kaleta D, 2008, INT J OCCUP MED ENV, V21, P227, DOI 10.2478/v10001-008-0023-y; Kaplan G, 2003, SOC SCI MED, V56, P1669, DOI 10.1016/S0277-9536(02)00179-X; Layes A, 2012, SOC SCI MED, V75, P1, DOI 10.1016/j.socscimed.2011.10.030; Leone T, 2016, AGEING SOC, V36, P968, DOI 10.1017/S0144686X15000148; LUND E, 1990, J EPIDEMIOL COMMUN H, V44, P237, DOI 10.1136/jech.44.3.237; Majaj L, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-26; Malmusi D, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23189; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; Maurer TJ, 1998, J APPL PSYCHOL, V83, P324, DOI 10.1037/0021-9010.83.2.324; McNeely C, 2013, LANCET S4, V382, pS25; Newton-Levinson A, 2014, CULT HEALTH SEX, V16, P916, DOI 10.1080/13691058.2014.921838; Nolan LB, 2016, SURV RES METHODS-GER, V10, P65, DOI 10.18148/srm/2016.v1012.6711; Palestinian Ministry of Health, 2010, PAL NAT HLTH STRAT 2; Panter-Brick C, 2011, J AM ACAD CHILD PSY, V50, P349, DOI 10.1016/j.jaac.2010.12.001; PCBS. Palestinian Family Health Survey (PAPFAM), 2011, PAL FAM HLTH SURV PA; Peteet J., 2015, J REFUGEE STUDIES; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; Saca-Hazboun H, 2011, CLIN J ONCOL NURS, V15, P281, DOI 10.1188/11.CJON.281-286; Senanayake P, 2000, INT J GYNECOL OBSTET, V70, P59, DOI 10.1016/S0020-7292(00)00224-1; Seth D., 2011, HARVARD INT REV, V32, P11; Shahin Y., 2012, LANCET S1, V380, pS4; Singh-Manoux A, 2006, J EPIDEMIOL COMMUN H, V60, P364, DOI 10.1136/jech.2005.039883; Sonkusare S, 2007, Med J Malaysia, V62, P402; StataCorp, 2013, STATA STAT SOFTW REL; World Health Organisation, 2013, RIGHT HLTH CROSS BAR; Ziadni Maisa, 2011, J HUMAN SECURITY, V7	42	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186610	10.1371/journal.pone.0186610	http://dx.doi.org/10.1371/journal.pone.0186610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077709	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000413861200013
J	Figueroa, A; Gulati, RK; Rainey, JJ				Figueroa, Argelia; Gulati, Reena K.; Rainey, Jeanette J.			Estimating the frequency and characteristics of respiratory disease outbreaks at mass gatherings in the United States: Findings from a state and local health department assessment	PLOS ONE			English	Article							PANDEMIC INFLUENZA; INFECTIOUS-DISEASE; VIRUS; RISK	Mass gatherings create environments conducive to the transmission of infectious diseases. Thousands of mass gatherings are held annually in the United States; however, information on the frequency and characteristics of respiratory disease outbreaks and on the use of non-pharmaceutical interventions at these gatherings is scarce. We administered an online assessment to the 50 state health departments and 31 large local health departments in the United States to gather information about mass gathering-related respiratory disease outbreaks occurring between 2009 and 2014. The assessment also captured information on the use of nonpharmaceutical interventions to slow disease transmission in these settings. We downloaded respondent data into a SAS dataset for descriptive analyses. We received responses from 43 (53%) of the 81 health jurisdictions. Among these, 8 reported 18 mass gathering outbreaks. More than half (n = 11) of the outbreaks involved zoonotic transmission of influenza A (H3N2v) at county and state fairs. Other outbreaks occurred at camps (influenza A (H1N1) pdm09 [n = 2] and A (H3) [n = 1]), religious gatherings (influenza A (H1N1) pdm09 [n = 1] and unspecified respiratory virus [n = 1]), at a conference (influenza A (H1N1) pdm09), and a sporting event (influenza A). Outbreaks ranged from 5 to 150 reported cases. Of the 43 respondents, 9 jurisdictions used nonpharmaceutical interventions to slow or prevent disease transmission. Although respiratory disease outbreaks with a large number of cases occur at many types of mass gatherings, our assessment suggests that such outbreaks may be uncommon, even during the 2009 influenza A (H1N1) pandemic, which partially explains the reported, but limited, use of nonpharmaceutical interventions. More research on the characteristics of mass gatherings with respiratory disease outbreaks and effectiveness of nonpharmaceutical interventions would likely be beneficial for decision makers at state and local health departments when responding to future outbreaks and pandemics.	[Figueroa, Argelia; Gulati, Reena K.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; [Rainey, Jeanette J.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Rainey, JJ (corresponding author), Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA 30333 USA.	jkr7@cdc.gov						Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; American Camp Association, 2017, ACA SIT FAC PROGR RE; Blyth CC, 2010, EMERG INFECT DIS, V16, P809, DOI 10.3201/eid1605.091136; Botelho-Nevers E, 2010, J TRAVEL MED, V17, P197, DOI 10.1111/j.1708-8305.2010.00410.x; Centers for Disease Control and Prevention, THE FLU SEAS; Centers for Disease Control and Prevention (CDC), FLU PREV MASS GATH; Centers for Disease Control and Prevention (CDC), 2009, CDC HLTH UPD SCH K 1; Centers for Disease Control and Prevention (CDC), FLU ACT 2012 2013 SE; Chowell G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-159; Coletta M., 2006, Morbidity and Mortality Weekly Report, V55, P71; Glatman-Freedman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050228; Gundlapalli AV, 2006, EMERG INFECT DIS, V12, P144, DOI 10.3201/eid1201.050645; Gutierrez I, 2009, EUROSURVEILLANCE, V2009, P14; Ishola DA, 2011, J EPIDEMIOL GLOB HEA, V1, P33, DOI 10.1016/j.jegh.2011.06.004; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Jhung MA, 2013, CLIN INFECT DIS, V57, P1703, DOI 10.1093/cid/cit649; Johansson A, 2012, LANCET INFECT DIS, V12, P150, DOI 10.1016/S1473-3099(11)70287-0; Khan K, 2012, LANCET INFECT DIS, V12, P222, DOI 10.1016/S1473-3099(11)70313-9; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Michael J A, 1997, Prehosp Disaster Med, V12, P305; PricewaterhouseCoopers, 2014, EC SIGN M US EC INT; Qualls N, 2017, MMWR RECOMM REP, V66, P1, DOI 10.15585/mmwr.rr6601a1; Rainey JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160378; Rashid H, 2008, LANCET INFECT DIS, V8, P526, DOI 10.1016/S1473-3099(08)70186-5; Robinson S, 2012, PEDIATR INFECT DIS J, V31, P547, DOI 10.1097/INF.0b013e31824f8124; SAENZ AC, 1969, LANCET, V1, P91; Selig B, 2013, J EMERG NURS, V39, pE39, DOI 10.1016/j.jen.2011.10.002; Shi PY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-778; Tsalik EL, 2011, J AM COLL HEALTH, V59, P419, DOI 10.1080/07448481.2010.534215; Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Zielinski Andrzej, 2009, Przegl Epidemiol, V63, P343	33	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186730	10.1371/journal.pone.0186730	http://dx.doi.org/10.1371/journal.pone.0186730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077750	Green Submitted, gold, Green Published			2022-12-27	WOS:000413861200019
J	Kramer, DB; Stevens, K; Williams, NE; Sistla, SA; Roddy, AB; Urquhart, GR				Kramer, Daniel B.; Stevens, Kara; Williams, Nicholas E.; Sistla, Seeta A.; Roddy, Adam B.; Urquhart, Gerald R.			Coastal livelihood transitions under globalization with implications for trans-ecosystem interactions	PLOS ONE			English	Article							COVER CHANGE; CONSERVATION; POVERTY	Anthropogenic threats to natural systems can be exacerbated due to connectivity between marine, freshwater, and terrestrial ecosystems, complicating the already daunting task of governance across the land-sea interface. Globalization, including new access to markets, can change social-ecological, land-sea linkages via livelihood responses and adaptations by local people. As a first step in understanding these trans-ecosystem effects, we examined exit and entry decisions of artisanal fishers and smallholder farmers on the rapidly globalizing Caribbean coast of Nicaragua. We found that exit and entry decisions demonstrated clear temporal and spatial patterns and that these decisions differed by livelihood. In addition to household characteristics, livelihood exit and entry decisions were strongly affected by new access to regional and global markets. The natural resource implications of these livelihood decisions are potentially profound as they provide novel linkages and spatially explicit feedbacks between terrestrial and marine ecosystems. Our findings support the need for more scientific inquiry in understanding trans-ecosystem tradeoffs due to linked-livelihood transitions as well as the need for a trans-ecosystem approach to natural resource management and development policy in rapidly changing coastal regions.	[Kramer, Daniel B.] Michigan State Univ, James Madison Coll, E Lansing, MI 48824 USA; [Stevens, Kara] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Stevens, Kara] NOAA, 1315 East West Highway, Silver Spring, MD USA; [Williams, Nicholas E.] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA; [Sistla, Seeta A.] Hampshire Coll, Amherst, MA 01002 USA; [Roddy, Adam B.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT USA; [Urquhart, Gerald R.] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA; [Urquhart, Gerald R.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; Yale University; Michigan State University; Michigan State University	Kramer, DB (corresponding author), Michigan State Univ, James Madison Coll, E Lansing, MI 48824 USA.	dbk@msu.edu	Roddy, Adam/M-4523-2013	Roddy, Adam/0000-0002-4423-8729	U.S. National Science Foundation [CNH-0815966]; U.S. National Socio-Environmental Synthesis Center (SESYNC); German Center for Integrative Biodiversity Research (iDIV)	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Socio-Environmental Synthesis Center (SESYNC)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); German Center for Integrative Biodiversity Research (iDIV)	This work was supported by U.S. National Science Foundation CNH-0815966, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13681; U.S. National Socio-Environmental Synthesis Center (SESYNC), https://www.sesync.org/; and the German Center for Integrative Biodiversity Research (iDIV), https://www.idiv.de/sdiv.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2002, AMBIO, V31, P358, DOI 10.1639/0044-7447(2002)031[0358:MRLTAS]2.0.CO;2; Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Alvarez-Romero JG, 2015, BIOL CONSERV, V191, P799, DOI 10.1016/j.biocon.2015.07.003; Alvarez-Romero JG, 2011, ANNU REV ECOL EVOL S, V42, P381, DOI 10.1146/annurev-ecolsys-102209-144702; [Anonymous], 2011, REEFS RISK REVISITED; Auguie B, 2017, GRIDEXTRA MISCELLANE; Barrett CB, 2001, FOOD POLICY, V26, P367, DOI 10.1016/S0306-9192(01)00017-3; Barton K., 2013, MUMIN MULTIMODEL INT; Bebbington A, 1999, CAPITALS CAPABILITIE; Bene C, 2011, PROG DEV STUD, V11, P119, DOI 10.1177/146499341001100203; Bhandari PB, 2013, J RURAL STUD, V32, P126, DOI 10.1016/j.jrurstud.2013.05.001; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; CGIAR Research Program on Aquatic Agricultural Systems, 2012, RES LIV FOOD SEC COA; Christie, 2000, TAKING CARE WHAT WE; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Convention on the International Trade of Endagered Species, 2014, CITES EXT LEG CONTR; Daw TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031460; Ferrol-Schulte D, 2013, MAR POLICY, V42, P253, DOI 10.1016/j.marpol.2013.03.007; Food and Agricultural Organization of the United Nations, 2017, SMALL SAL FISH; Garland K.A., 2010, CONSERV SOC, V8, P55, DOI 10.4103/0972-4923.62675; Glaeser B, 2010, HUM ECOL REV, V17, P135; Hviding E, 1998, OCEAN COAST MANAGE, V40, P253, DOI 10.1016/S0964-5691(98)00042-8; International Fund for Agricultural Development & United Nations Development Programme, 2013, SMALL HOLD FOOD SEC; Ivarez-romero JG, 2013, CONSERV LETT, P1; Ivarez-romero JG, 2015, PLOS ONE, V10; Jamieson M, 2011, NATL INTEGRATION CON, P283; Jordan CA, 2010, TAPIR CONSERV, V19; Kramer DB, 2009, ECOL ECON, V68, P2897, DOI 10.1016/j.ecolecon.2009.06.026; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; MacNeil MA, 2010, PHILOS T R SOC B, V365, P3753, DOI 10.1098/rstb.2010.0289; McCauley DJ, 2013, BIOL CONSERV, V165, P139, DOI 10.1016/j.biocon.2013.05.026; Mcneely J. A, 2003, ECOAGRICULTURE STRAT; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Muallil RN, 2011, FISH RES, V111, P74, DOI 10.1016/j.fishres.2011.06.013; Nakazawa M, 2015, PACKAGE FMSB; Nations F& AO of the U, 2014, STAT FOOD AGR; Olsoy PJ, 2016, BIOL CONSERV, V203, P8, DOI 10.1016/j.biocon.2016.08.037; Reuter K, 2016, ENVIRON CONSERV, P1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Schmitt KM, 2009, ENVIRON CONSERV, V36, P289, DOI 10.1017/S0376892910000159; Sistla SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162529; Stevens K, 2014, MAR POLICY, V50, P46, DOI 10.1016/j.marpol.2014.05.007; Sunderlin WD, 2000, ENVIRON CONSERV, V27, P284, DOI 10.1017/S0376892900000321; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams, 2015, DYNAMIC INTERRELATIO; Williams NE, 2016, J POLIT ECOL, V23, P223, DOI 10.2458/v23i1.20210; Witt CM, 2015, SCIENCE, V347, pS50	49	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186683	10.1371/journal.pone.0186683	http://dx.doi.org/10.1371/journal.pone.0186683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077748	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200016
J	Nowak, I; Bylinska, A; Wilczynska, K; Wisniewski, A; Malinowski, A; Wilczynski, JR; Radwan, P; Radwan, M; Barcz, E; Ploski, R; Motak-Pochrzest, H; Banasik, M; Sobczynski, M; Kusnierczyk, P				Nowak, Izabela; Bylinska, Aleksandra; Wilczynska, Karolina; Wisniewski, Andrzej; Malinowski, Andrzej; Wilczynski, Jacek R.; Radwan, Pawel; Radwan, Michel; Barcz, Ewa; Ploski, Rafal; Motak-Pochrzest, Hanna; Banasik, Malgorzata; Sobczynski, Maciej; Kusnierczyk, Piotr			The methylenetetrahydrofolate reductase c.c.677 C > T and c.c.1298 A > C polymorphisms in reproductive failures: Experience from an RSA and RIF study on a Polish population	PLOS ONE			English	Article							MALE-INFERTILITY; GENETIC-POLYMORPHISM; C677T POLYMORPHISM; MTHFR; THROMBOPHILIA; ASSOCIATION; RISK; MISCARRIAGE; DEFINITION; EXPRESSION	Almost 1600 individuals from the Polish population were recruited to this study. Among them 319 were fertile couples, 289 were recurrent spontaneous abortion (RSA) couples, and 131 were in the group of recurrent implantation failure (RIF) following in vitro fertilization. The aim of this study was to evaluate the MTHFR c.c.677 C > T and c.c.1298 A > C polymorphisms' association with RSA and RIF. We used PCR-RFLP with HinfI (677 C > T) and MboII (1298 A > C) digestion. We observed a protective effect of the female AC genotype (OR = 0.64, p = 0.01) and the C allele (AC+CC genotypes; OR = 0.65, p = 0.009) against RSA. Moreover, 1298 AA/677 CT women were more frequent in RSA (31.14%) and RIF (25.20%) groups in comparison to fertile women (22.88%), although this difference was significant only in the case of RSA (p = 0.022, OR = 1.52). Male combined genotype analysis revealed no association with reproductive failure of their partners. Nevertheless, the female/male combination AA/AC of the 1298 polymorphism was more frequent in RSA couples (p = 0.049, OR = 1.49). However, the significant results became insignificant after Bonferroni correction. In addition, analysis of haplotypes showed significantly higher frequency of the C/C haplotype (1298 C/677 C) in the female control group than in the female RSA group (p = 0.03, OR = 0.77). Moreover, the association between elevated homocysteine (Hcy) level in plasma of RSA and RIF women and MTHFR polymorphisms was investigated but did not reveal significant differences. In conclusion, for clinical practice, it is better to check the homocysteine level in plasma and, if the Hcy level is increased, to recommend patients to take folic acid supplements rather than undergo screening of MTHFR for 1298 A > C and 677 C > T polymorphisms.	[Nowak, Izabela; Bylinska, Aleksandra; Wilczynska, Karolina; Wisniewski, Andrzej; Kusnierczyk, Piotr] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Clin Immunol, Lab Immunogenet & Tissue Immunol, Wroclaw, Poland; [Malinowski, Andrzej] Polish Mothers Mem Hosp, Res Inst, Dept Surg Endoscop & Oncol Gynecol, Lodz, Poland; [Wilczynski, Jacek R.] Polish Mothers Mem Hosp, Res Inst, Dept Gynecol & Gynecol Oncol, Lodz, Poland; [Radwan, Pawel; Radwan, Michel] Gameta Hosp, Dept Reprod Med, Rzgow, Poland; [Radwan, Pawel] Biogenoreg Sci Technol Ctr, Podzamcze, Poland; [Barcz, Ewa] Med Univ Warsaw, Chair 1, Warsaw, Poland; [Barcz, Ewa] Med Univ Warsaw, Clin Obstet & Gynecol, Warsaw, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Ctr Biostruct Res, Warsaw, Poland; [Motak-Pochrzest, Hanna] Opole Univ Technol, Fac Phys Educ & Physiotherapy, Opole, Poland; [Motak-Pochrzest, Hanna] Dist Hosp Strzelce Opolskie, Obstet Gynecol Dept, Strzelce Opolskie, Poland; [Banasik, Malgorzata] APC Med Anal, Lodz, Poland; [Sobczynski, Maciej] Univ Wroclaw, Fac Biotechnol, Dept Genom, Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; Opole University of Technology; University of Wroclaw	Nowak, I (corresponding author), Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Clin Immunol, Lab Immunogenet & Tissue Immunol, Wroclaw, Poland.	izan@iitd.pan.wroc.pl	Kusnierczyk, Piotr/ABB-6734-2020; Barcz, Ewa/AAS-7533-2020; Radwan, Pawel/ABC-4159-2020; Radwan, Paweł/D-1360-2013	Radwan, Pawel/0000-0002-9724-8517; Malinowski, Andrzej/0000-0002-3129-1504; Piekarska, Karolina/0000-0002-4175-965X; Wisniewski, Andrzej/0000-0002-1919-2298; Wilczynski, Jacek R/0000-0002-2072-6533; Kusnierczyk, Piotr/0000-0002-9224-8921; Ploski, Rafal/0000-0001-6286-5526; Sobczynski, Maciej/0000-0003-2428-0927; Nowak, Izabela/0000-0002-9127-1089	National Science Centre, Poland [2014/13/B/NZ5/00273, N N401 588340]; Dr. Izabela Nowak and Wroclaw Centre of Biotechnology; Leading National Research Centre (KNOW)	National Science Centre, Poland(National Science Centre, Poland); Dr. Izabela Nowak and Wroclaw Centre of Biotechnology; Leading National Research Centre (KNOW)	This work was supported by National Science Centre, Poland, 2014/13/B/NZ5/00273 and N N401 588340, Dr. Izabela Nowak and Wroclaw Centre of Biotechnology, the programme The Leading National Research Centre (KNOW) for years 2014-2018 (to I. Nowak, Ph.D.).	Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS60, DOI 10.1016/j.fertnstert.2008.08.065; Ata B, 2016, J ASSIST REPROD GEN, V33, P1305, DOI 10.1007/s10815-016-0771-8; Azem F, 2004, HUM REPROD, V19, P368, DOI 10.1093/humrep/deh069; Burda P, 2017, J INHERIT METAB DIS, V40, P297, DOI 10.1007/s10545-016-9987-0; Cakmak H, 2011, HUM REPROD UPDATE, V17, P242, DOI 10.1093/humupd/dmq037; Choi Y, 2016, PLOS ONE, V25; Coughlan C, 2014, REPROD BIOMED ONLINE, V28, P14, DOI 10.1016/j.rbmo.2013.08.011; Di Nisio M, 2011, BLOOD, V118, P2670, DOI 10.1182/blood-2011-03-340216; Diejomaoh MFE, 2015, MED PRIN PRACT, V24, P38, DOI 10.1159/000365973; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Heby O, 1995, INT J DEV BIOL, V39, P737; Hekmatdoost A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143569; Karimian M, 2016, REPROD FERT DEVELOP, V28, P785, DOI 10.1071/RD14186; Koot YEM, 2012, BBA-MOL BASIS DIS, V1822, P1943, DOI 10.1016/j.bbadis.2012.05.017; Levin BL, 2016, J GENET COUNS, V25, P901, DOI 10.1007/s10897-016-9956-7; Mfady DS, 2014, GENE, V536, P40, DOI 10.1016/j.gene.2013.12.001; Montjean D, 2011, FERTIL STERIL, V95, P635, DOI 10.1016/j.fertnstert.2010.08.054; Nair RR, 2013, FERTIL STERIL, V99, P1311, DOI 10.1016/j.fertnstert.2012.12.027; Nikzad H, 2015, REPROD BIOMED ONLINE, V31, P668, DOI 10.1016/j.rbmo.2015.07.015; Nowak I, 2015, TISSUE ANTIGENS, V85, P450, DOI 10.1111/tan.12544; Nowak I, 2016, ARCH IMMUNOL THER EX, V64, P505, DOI 10.1007/s00005-016-0389-7; Pereza N, 2017, FERTIL STERIL, V107, P150, DOI 10.1016/j.fertnstert.2016.10.007; Qublan HS, 2006, HUM REPROD, V21, P2694, DOI 10.1093/humrep/del203; Shi X, 2017, CLIN GENET, V91, P265, DOI 10.1111/cge.12910; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simur A, 2009, GYNECOL OBSTET INVES, V67, P109, DOI 10.1159/000165776; Sugiura-Ogasawara M, 2014, J OBSTET GYNAECOL RE, V40, P1174, DOI 10.1111/jog.12388; Tan XF, 2016, J ASSIST REPROD GEN, V33, P1093, DOI 10.1007/s10815-016-0726-0; Tara Somayeh-Sadat, 2015, J Reprod Infertil, V16, P193; Timeva Tanya, 2014, J Reprod Infertil, V15, P173; Unfried G, 2002, OBSTET GYNECOL, V99, P614, DOI 10.1016/S0029-7844(01)01789-6; Vlachadis N, 2014, REPROD BIOMED ONLINE, V29, P144, DOI 10.1016/j.rbmo.2014.03.003; Weiner AS, 2014, FERTIL STERIL, V101, P87, DOI 10.1016/j.fertnstert.2013.09.014; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; Wolski H, GINEKOL POL; Wu W, 2012, INT J ANDROL, V35, P18, DOI 10.1111/j.1365-2605.2011.01147.x	37	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186022	10.1371/journal.pone.0186022	http://dx.doi.org/10.1371/journal.pone.0186022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073227	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400012
J	Li, XD; Wan, JF; Zhang, S; Lin, P; Zhang, YS; Yang, GH; Wang, MK; Duan, WS; Sun, JA; Yang, L				Li, Xiaodong; Wan, Jiangfeng; Zhang, Sheng; Lin, Ping; Zhang, Yanshi; Yang, Guanghui; Wang, Mengke; Duan, Wenshan; Sun, Jian'an; Yang, Lei			Preliminary research on flow rate and free surface of the accelerator driven subcritical system gravity-driven dense granular-flow target	PLOS ONE			English	Article							SPALLATION TARGET; DISCHARGE RATE; HOPPER FLOWS; ORIFICE; SIMULATION; DESIGN; SILO	A spallation target is one of the three core parts of the accelerator driven subcritical system (ADS), which has already been investigated for decades. Recently, a gravity-driven Dense Granular-flow Target (DGT) is proposed, which consists of a cylindrical hopper and an internal coaxial cylindrical beam pipe. The research on the flow rate and free surface are important for the design of the target whether in Heavy Liquid Metal (HLM) targets or the DGT. In this paper, the relations of flow rate and the geometry of the DGT are investigated. Simulations based on the discrete element method (DEM) implementing on Graphics Processing Units (GPUs) and experiments are both performed. It is found that the existence of an internal pipe doesn't influence the flow rate when the distance from the bottom of the pipe to orifice is large enough even in a larger system. Meanwhile, snapshots of the free surface formed just below the beam pipe are given. It is observed that the free surface is stable over time. The entire research is meaningful for the design of DGT.	[Li, Xiaodong; Duan, Wenshan; Sun, Jian'an] NWNU, Coll Phys & Elect Engn, Lanzhou, Gansu, Peoples R China; [Li, Xiaodong; Duan, Wenshan; Sun, Jian'an] NWNU, Joint Lab Atom & Mol Phys, Lanzhou, Gansu, Peoples R China; [Li, Xiaodong; Wan, Jiangfeng; Zhang, Sheng; Lin, Ping; Zhang, Yanshi; Yang, Guanghui; Wang, Mengke; Yang, Lei] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Gansu, Peoples R China; [Wan, Jiangfeng; Yang, Guanghui; Wang, Mengke] Univ Chinese Acad Sci, Sch Phys Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, L (corresponding author), Chinese Acad Sci, Inst Modern Phys, Lanzhou, Gansu, Peoples R China.	lyang@impcas.ac.cn	林, ping/AGE-1236-2022	wan, Jiangfeng/0000-0002-9632-9139; Lin, Ping/0000-0002-3317-5793	National Magnetic Confinement Fusion Science Program of China [2014GB104002]; National Natural Science Foundation of P.R. China [11647313]	National Magnetic Confinement Fusion Science Program of China; National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Magnetic Confinement Fusion Science Program of China [grant number 2014GB104002; url:http://www.most.gov.cn] and National Natural Science Foundation of P.R. China [grant number 11647313; url:http://wmv.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the National Magnetic Confinement Fusion Science Program of China [grant number 2014GB104002] to Lei Yang and National Natural Science Foundation of P.R. China [grant number 11647313] to Wenshan Duan.	Ahn HJ, 2008, POWDER TECHNOL, V186, P65, DOI 10.1016/j.powtec.2007.11.001; Balevicius R, 2011, POWDER TECHNOL, V214, P322, DOI 10.1016/j.powtec.2011.08.042; Batta A, 2015, NUCL ENG DES, V290, P107, DOI 10.1016/j.nucengdes.2014.11.009; Batta A, 2009, HYDRAULIC ANAL HEAVY; Batta A, 2009, HELIMERT 2009, P115; Batta A., 2008, P 2008 INT C ADV NUC; Bauer GS, 2010, J NUCL MATER, V398, P19, DOI 10.1016/j.jnucmat.2009.10.005; BEVERLOO WA, 1961, CHEM ENG SCI, V15, P260, DOI 10.1016/0009-2509(61)85030-6; BOWMAN CD, 1992, NUCL INSTRUM METH A, V320, P336, DOI 10.1016/0168-9002(92)90795-6; Carminati F, 1993, ENERGY AMPLIFIER CLE; Class AG, 2014, J NUCL MATER, V450, P204, DOI 10.1016/j.jnucmat.2013.09.005; Class AG, 2011, J NUCL MATER, V415, P378, DOI 10.1016/j.jnucmat.2011.04.050; Dierckx M., 2009, TARGET AREA DESIGN O; Furukawa K., 1985, JAP US SEM THOR FUEL, P271; Guertin A, 2010, 1 INT WORKSH TECHN C; Jeanmart H, 2011, J NUCL MATER, V415, P385, DOI 10.1016/j.jnucmat.2011.04.046; Lin P, 2015, PHYSICA A, V417, P29, DOI 10.1016/j.physa.2014.09.032; Litfin K, 2015, J RADIOANAL NUCL CH, V305, P795, DOI 10.1007/s10967-015-4002-z; Mankoc C, 2007, GRANUL MATTER, V9, P407, DOI 10.1007/s10035-007-0062-2; NEDDERMAN RM, 1982, CHEM ENG SCI, V37, P1597, DOI 10.1016/0009-2509(82)80029-8; Nedderman RM, 2005, STATICS KINEMATICS G; Nifenecker H, 2001, NUCL INSTRUM METH A, V463, P428, DOI 10.1016/S0168-9002(01)00160-7; Profir M, LEADING CFD MODELS I; Riemer B, 2016, SPALLATION TARGET DE, P273; Su GY, 2012, ANN NUCL ENERGY, V43, P142, DOI 10.1016/j.anucene.2012.01.010; Tian Y, 2013, AW SCI TECHN UB MED; Tian Y, 2017, COMPUT CHEM ENG, V104, P231, DOI 10.1016/j.compchemeng.2017.04.019; Unac RO, 2012, POWDER TECHNOL, V225, P214, DOI 10.1016/j.powtec.2012.04.013; Wan J. -F., 2016, J NUCL SCI TECHNOL, P1; Yang L, 2015, SCI CHINA TECHNOL SC, V58, P1705, DOI 10.1007/s11431-015-5894-0; Zatloukal Z, 2012, PARTICUL SCI TECHNOL, V30, P316, DOI 10.1080/02726351.2011.573839; Zhang S, 2014, GRANUL MATTER, V16, P857, DOI 10.1007/s10035-014-0533-1; Zhu HP, 2008, CHEM ENG SCI, V63, P5728, DOI 10.1016/j.ces.2008.08.006; Zuriguel I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.030301	34	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187435	10.1371/journal.pone.0187435	http://dx.doi.org/10.1371/journal.pone.0187435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095910	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200090
J	Lopes, VG; Branco, CWC; Kozlowsky-Suzuki, B; Sousa, IF; Souza, LCE; Bini, LM				Lopes, Vanessa Guimaraes; Castelo Branco, Christina W.; Kozlowsky-Suzuki, Betina; Sousa-Filho, Izidro F.; e Souza, Leonardo Coimbra; Bini, Luis Mauricio			Predicting temporal variation in zooplankton beta diversity is challenging	PLOS ONE			English	Article							ENVIRONMENTAL HETEROGENEITY; BIOTIC HOMOGENIZATION; BIODIVERSITY; COMMUNITIES; TURNOVER; SIMILARITY; HABITAT; CLIMATE; IMPACT; INFORM	Beta diversity, the spatial variation in species composition, has been related to different explanatory variables, including environmental heterogeneity, productivity and connectivity. Using a long-term time series of zooplankton data collected over 62 months in a tropical reservoir (Ribeirao das Lajes Reservoir, Rio de Janeiro State, Brazil), we tested whether beta diversity (as measured across six sites distributed along the main axis of the reservoir) was correlated with environmental heterogeneity (spatial environmental variation in a given month), chlorophyll-a concentration (a surrogate for productivity) and water level. We did not found evidence for the role of these predictors, suggesting the need to reevaluate predictions or at least to search for better surrogates of the processes that hypothetically control beta diversity variation. However, beta diversity declined over time, which is consistent with the process of biotic homogenization, a worldwide cause of concern.	[Lopes, Vanessa Guimaraes; Bini, Luis Mauricio] Univ Fed Goias, Dept Ecol, Goias, Brazil; [Castelo Branco, Christina W.; e Souza, Leonardo Coimbra] Univ Fed Estado Rio de Janeiro, Dept Zool, Rio De Janeiro, Brazil; [Kozlowsky-Suzuki, Betina] Univ Fed Estado Rio de Janeiro, Dept Ecol & Recursos Marinhos, Rio De Janeiro, Brazil; [Sousa-Filho, Izidro F.] Univ Fed Rio de Janeiro, Lab Radioisotopos Eduardo Penna Franca IBCCF CCS, Rio De Janeiro, Brazil	Universidade Federal de Goias; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Lopes, VG (corresponding author), Univ Fed Goias, Dept Ecol, Goias, Brazil.	vglopes@gmail.com	Bini, Luis Mauricio/D-5865-2013	Bini, Luis Mauricio/0000-0003-3398-9399; Sousa-Filho, Izidro/0000-0001-9210-0399; Castelo Branco, Christina W/0000-0002-0509-171X	Light Energia CORP. (Projects of research and development-Light/ANEEL/UNIRIO); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); MCTIC/CNpq [465610/2014-5]; FAPEG; CNPq Productivity Grants	Light Energia CORP. (Projects of research and development-Light/ANEEL/UNIRIO); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCTIC/CNpq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); CNPq Productivity Grants	The authors received logistic and financial support for this work from Light Energia CORP. (Projects of research and development-Light/ANEEL/UNIRIO), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). This work was also developed in the context of National Institutes for Science and Technology (INCT) in Ecology, Evolution and Biodiversity Conservation, supported by MCTIC/CNpq(proc. 465610/2014-5) and FAPEG". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors wish to thank Light Energia CORP. for logistic support in carrying out this study (Projects of research and development?Light/ANEEL/UNIRIO). We are also thankful to anonymous reviewers for excellent comments that improved this paper. This work was developed in the context of National Institutes for Science and Technology (INCT) in Ecology, Evolution and Biodiversity Conservation, supported by MCTIC/CNpq (proc. 465610/2014-5) and FAPEG. Research by LMB has been continuously supported by CNPq Productivity Grants.	Adamczuk M, 2015, ENVIRON EARTH SCI, V73, P8189, DOI 10.1007/s12665-014-3977-z; Akasaka M, 2012, ECOLOGY, V93, P967, DOI 10.1890/11-0879.1; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; APHA, 2005, STAND METH EX WAT WA, V20th; Astorga A, 2014, ECOL EVOL, V4, P2693, DOI 10.1002/ece3.1124; Baselga A, 2007, BIOLOGY LETT, V3, P642, DOI 10.1098/rsbl.2007.0449; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bini LM, 2014, ECOLOGY, V95, P1569, DOI 10.1890/13-0656.1; Bledzki L.A., 2016, FRESHWATER CRUSTACEA, DOI [DOI 10.1007/978-3-319-29871-9, 10.1007/978-3-319-29871-9]; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Boyer JN, 2009, ECOL INDIC, V9, pS56, DOI 10.1016/j.ecolind.2008.11.013; Bozelli RL, 2015, HYDROBIOLOGIA, V753, P233, DOI 10.1007/s10750-015-2209-1; Branco Christina W. C., 2009, Lakes & Reservoirs Research and Management, V14, P175, DOI 10.1111/j.1440-1770.2009.00403.x; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Chick JH, 2010, LIMNOL OCEANOGR-METH, V8, P79, DOI 10.4319/lom.2010.8.0079; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; Deflandre G., 1928, ARCHIV PROTISTENKUND, V64, P152; Deflandre G, 1929, ARCH PROTISTENKD, V67, P323; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Ellis LE, 2013, ENVIRON REV, V21, P136, DOI 10.1139/er-2012-0064; Elmoor-Loureiro L.M.A., 1997, MANUAL IDENTIFICACAO; Forbes AE, 2002, OIKOS, V96, P433, DOI 10.1034/j.1600-0706.2002.960305.x; Ford DE, 1990, RESERVOIR LIMNOLOGY; Gianuca AT, 2017, ECOGRAPHY COP, P1; Ginders MA, 2016, RIVER RES APPL, V32, P1675, DOI 10.1002/rra.3008; Guarino AWS., 2005, ACTA LIMNOL BRAS, V17, P129; Heino J, 2015, ECOL EVOL, V5, P1235, DOI 10.1002/ece3.1439; Heino J, 2015, FRESHWATER BIOL, V60, P223, DOI 10.1111/fwb.12502; Heino J, 2013, FRESHW SCI, V32, P142, DOI 10.1899/12-083.1; Jyrkankallio-Mikkola J, 2016, FRESHWATER BIOL, V61, P239, DOI 10.1111/fwb.12697; Kimmel B.L., 1990, RESERVOIR LIMNOLOGY, P133; Koste W., 1978, RADERTIERE MITTLEURO; Langenheder S, 2012, ISME J, V6, P1107, DOI 10.1038/ismej.2011.177; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Lopes PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109581; Magurran AE, 2010, PHILOS T R SOC B, V365, P3611, DOI 10.1098/rstb.2010.0285; Marzolf G.R., 1990, P195; McGarvey DJ, 2014, FRESHW SCI, V33, P18, DOI 10.1086/674967; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Mello Nelson Azevedo S.T., 2011, Oecologia Australis, V15, P559; Nogrady T, 1995, RIOTIFERA, V3, P1; NOGRADY T, 2002, GUIDES IDENTIFICATIO; Nusch E., 1975, GAS WASSERFACH WASSE, V116; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olden JD, 2004, ECOLOGY, V85, P1867, DOI 10.1890/03-3131; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Passy SI, 2007, DIVERS DISTRIB, V13, P670, DOI 10.1111/j.1472-4642.2007.00361.x; Pennisi E, 2005, SCIENCE, V309, P90, DOI 10.1126/science.309.5731.90; Pinheiro J., 2020, PACKAGE NLME LINEAR, DOI DOI 10.1016/S0006-3207(01)00201-4; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Sartori LP, 2009, BRAZ J BIOL, V69, P1, DOI 10.1590/S1519-69842009000100002; Seda J, 2000, J PLANKTON RES, V22, P1829, DOI 10.1093/plankt/22.10.1829; Segers H., 1995, ROTIFERA LECANIDAE M; Siqueira T, 2015, HYDROBIOLOGIA, V750, P5, DOI 10.1007/s10750-014-2071-6; Soares CEA, 2015, NAT CONSERVACAO, V13, P74, DOI 10.1016/j.ncon.2015.04.002; Soares MCS, 2012, LIMNOLOGICA, V42, P197, DOI 10.1016/j.limno.2011.11.002; Soares Maria Carolina S., 2008, Lakes & Reservoirs Research and Management, V13, P257, DOI 10.1111/j.1440-1770.2008.00379.x; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; VELHO L.F.M., 1996, STUDIES NEOTROPOICAL, V31, P174; Vellend M, 2014, OIKOS, V123, P1420, DOI 10.1111/oik.01493; Vucetich MC, 1973, REV MUS PLATA, VXI; Zorzal-Almeida S, HYDROBIOLOG IN PRESS; Zuur A.F., 2009, MIXED EFFECTS MODELS, P574	80	13	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187499	10.1371/journal.pone.0187499	http://dx.doi.org/10.1371/journal.pone.0187499			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095892	gold, Green Submitted, Green Published			2022-12-27	WOS:000414340200104
J	Campione, GC; Mansi, G; Fumagalli, A; Fumagalli, B; Sottocornola, S; Molteni, M; Micali, N				Campione, Giovanna Cristina; Mansi, Gianluigi; Fumagalli, Alessandra; Fumagalli, Beatrice; Sottocornola, Simona; Molteni, Massimo; Micali, Nadia			Motor-based bodily self is selectively impaired in eating disorders	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BODY-SIZE ESTIMATION; ANOREXIA-NERVOSA; BULIMIA-NERVOSA; MENTAL REPRESENTATIONS; NEURAL MECHANISMS; RISK-FACTORS; SCHEMA; IMAGE; OWNERSHIP	Background Body representation disturbances in body schema (i.e. unconscious sensorimotor body representations for action) have been frequently reported in eating disorders. Recently, it has been proposed that body schema relies on adequate functioning of the motor system, which is strongly implicated in discriminating between one's own and someone else's body. The present study aimed to investigate the motor-based bodily self in eating disorders and controls, in order to examine the role of the motor system in body representation disturbances at the body schema level. Method Female outpatients diagnosed with eating disorders (N = 15), and healthy controls (N = 18) underwent a hand laterality task, in which their own (self-stimuli) and someone else's hands (other-stimuli) were displayed at different orientations. Participants had to mentally rotate their own hand in order to provide a laterality judgement. Group differences in motor-based bodily self-recognition i.e. whether a general advantage occurred when implicitly processing self- vs. other-stimuli- were evaluated, by analyzing response times and accuracy by means of mixed ANOVAs. Results Patients with eating disorders did not show a temporal advantage when mentally rotating self-stimuli compared to other-stimuli, as opposed to controls (F(1, 31) = 5.6, p = 0.02; eating disorders-other = 1092 256 msec, eating disorders-self = 1097 +/- 254 msec; healthy controls-other = 1239 +/- 233 msec, healthy controls-self = 1192 +/- 232 msec). Conclusion This study provides initial indication that high-level motor functions might be compromised as part of body schema disturbances in eating disorders. Further larger investigations are required to test motor system abnormalities in the context of body schema disturbance in eating disorders.	[Campione, Giovanna Cristina; Mansi, Gianluigi; Fumagalli, Alessandra; Fumagalli, Beatrice; Sottocornola, Simona; Molteni, Massimo] IRCCS Eugenio Medea, Sci Inst, Child Psychopathol Unit, Bosisio Parini, Italy; [Campione, Giovanna Cristina; Micali, Nadia] Icahn Sch Med Mt Sinai, Dept Psychiat, Eating & Weight Disorders Program, New York, NY 10029 USA; [Micali, Nadia] UCL, Inst Child Hlth, London, England	IRCCS Eugenio Medea; Icahn School of Medicine at Mount Sinai; University of London; University College London	Campione, GC (corresponding author), IRCCS Eugenio Medea, Sci Inst, Child Psychopathol Unit, Bosisio Parini, Italy.; Campione, GC (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, Eating & Weight Disorders Program, New York, NY 10029 USA.	cristina.campione@bp.lnf.it	Micali, Nadia/E-6829-2010; Molteni, Massimo/AHD-4792-2022	Micali, Nadia/0000-0001-5571-2273; Molteni, Massimo/0000-0001-6268-5883; Campione, Giovanna Cristina/0000-0003-0410-5400	Cariplo Foundation-Lombardy Region [2014-2247]; Italian Ministry of Health, "Ricerca Corrente" [2612765 02.04]	Cariplo Foundation-Lombardy Region; Italian Ministry of Health, "Ricerca Corrente"(Ministry of Health, Italy)	This study was supported by Cariplo Foundation-Lombardy Region, grant no 2014-2247 to GCC (http://matondazionecariplo.itIen/index.html). Development of the paradigm was previously supported by Italian Ministry of Health, "Ricerca Corrente 2015" - Work-Flow Project Code 2612765 02.04 (http://www.salute.govit/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Arzy S, 2006, ARCH NEUROL-CHICAGO, V63, P1022, DOI 10.1001/archneur.63.7.1022; Beato-Fernandez L, 2004, EUR CHILD ADOLES PSY, V13, P287, DOI 10.1007/s00787-004-0407-x; Beato-Fernandez L, 2009, PSYCHIAT RES-NEUROIM, V171, P129, DOI 10.1016/j.pscychresns.2008.01.001; Berlucchi G, 2010, EXP BRAIN RES, V200, P25, DOI 10.1007/s00221-009-1970-7; Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Candini M, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00405; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Coslett HB, 1998, BRAIN COGNITION, V37, P527, DOI 10.1006/brcg.1998.1011; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; De Vignemont F, 2007, MIND LANG, V22, P427, DOI 10.1111/j.1468-0017.2007.00315.x; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Ferri F, 2012, J COGNITIVE NEUROSCI, V24, P1584, DOI 10.1162/jocn_a_00230; Ferri F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017927; First MB, 2002, STRUCTURED CLIN INTE; Frassinetti F, 2008, J COGNITIVE NEUROSCI, V20, P1507, DOI 10.1162/jocn.2008.20067; Frassinetti F, 2009, NEUROPSYCHOLOGIA, V47, P1988, DOI 10.1016/j.neuropsychologia.2009.03.012; Gallagher, 1995, BODY SELF, P225; GALLAGHER S, 1986, J MIND BEHAV, V7, P541; Gallagher S., 1995, BODY SELF, P225, DOI [10.2307/1576384, DOI 10.2307/1576384]; Gallagher S., 2005, BODY SHAPES MIND; Gallese V, 2014, PSYCHOPATHOLOGY, V47, P357, DOI 10.1159/000365638; Gallese V, 2010, NEUROPSYCHOLOGIA, V48, P746, DOI 10.1016/j.neuropsychologia.2009.09.038; Garner D. M., 2004, PROFESSIONAL MANUAL; Gaudio S, 2012, NEUROSCI BIOBEHAV R, V36, P1839, DOI 10.1016/j.neubiorev.2012.05.003; Giummarra MJ, 2008, NEUROSCI BIOBEHAV R, V32, P143, DOI 10.1016/j.neubiorev.2007.07.001; Guardia D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043241; Guardia D, 2010, NEUROPSYCHOLOGIA, V48, P3961, DOI 10.1016/j.neuropsychologia.2010.09.004; Jacobi C, 2004, PSYCHOL BULL, V130, P19, DOI 10.1037/0033-2909.130.1.19; Jeannerod M, 2004, NAT NEUROSCI, V7, P422, DOI 10.1038/nn0504-422; Keel PK, 2005, AM J PSYCHIAT, V162, P2263, DOI 10.1176/appi.ajp.162.12.2263; Keizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064602; KEULS M., 1952, Euphytica, V1, P112, DOI 10.1007/BF01908269; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Merleau-Ponty M., 1962, PHENOMENOLOGY PERCEP; Metral Morgane, 2014, BMC Res Notes, V7, P707, DOI 10.1186/1756-0500-7-707; Miyake Y, 2010, PSYCHIAT RES-NEUROIM, V181, P183, DOI 10.1016/j.pscychresns.2009.09.001; Mussap AJ, 2006, J HEALTH PSYCHOL, V11, P627, DOI 10.1177/1359105306065022; Neisser U., 1993, PERCEIVED SELF ECOLO; Newman D, 1939, BIOMETRIKA, V31, P20, DOI 10.1093/biomet/31.1-2.20; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paillard J., 1999, MOTOR CONTROL TODAY, P197; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; Peterson M, 2004, AM J HEALTH BEHAV, V28, P437; Porro CA, 1996, J NEUROSCI, V16, P7688; Probst M., 1995, EAT DISORD, V3, P133, DOI [10.1080/10640269508249156, DOI 10.1080/10640269508249156]; Sachdev P, 2008, NEUROPSYCHOLOGIA, V46, P2161, DOI 10.1016/j.neuropsychologia.2008.02.031; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; Schwoebel J, 2002, BRAIN COGNITION, V50, P1, DOI 10.1016/S0278-2626(02)00005-2; Schwoebel J, 2002, NEUROLOGY, V59, P775, DOI 10.1212/WNL.59.5.775; Schwoebel J, 2001, BRAIN, V124, P2098, DOI 10.1093/brain/124.10.2098; Skrzypek S, 2001, EUR CHILD ADOLES PSY, V10, P215, DOI 10.1007/s007870170010; Smeets MAM, 1997, EUR EAT DISORD REV, V5, P75; Takeda K, 2010, LATERALITY, V15, P415, DOI 10.1080/13576500902938105; Tchanturia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020462; Treasure J, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.74; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Urgesi C, 2014, BRIT J PSYCHOL, V105, P486, DOI 10.1111/bjop.12057; Urgesi C, 2012, INT J EAT DISORDER, V45, P501, DOI 10.1002/eat.20982; Urgesi C, 2011, INT J EAT DISORDER, V44, P238, DOI 10.1002/eat.20816; Van den Eynde F, 2011, ACTA PSYCHIAT SCAND, V124, P120, DOI 10.1111/j.1600-0447.2011.01701.x; Vocks S, 2010, J PSYCHIATR NEUROSCI, V35, P163, DOI 10.1503/jpn.090048	72	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187342	10.1371/journal.pone.0187342	http://dx.doi.org/10.1371/journal.pone.0187342			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091967	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700059
J	Ribak, G; Barkan, S; Soroker, V				Ribak, Gal; Barkan, Shay; Soroker, Victoria			The aerodynamics of flight in an insect flight mill	PLOS ONE			English	Article							STALK-EYED FLIES; COLEOPTERA BUPRESTIDAE; LOCUST FLIGHT; PERFORMANCE; MANEUVERS; BIOLOGY; PHYSICS; LIFT	Predicting the dispersal of pest insects is important for pest management schemes. Flight mills provide a simple way to evaluate the flight potential of insects, but there are several complications in relating tethered-flight to natural flight. We used high-speed video to evaluate the effect of flight-mill design on flight of the red palm weevil (Rynchophorous ferruginneus) in four variants of a flight-mill. Two variants had the rotating radial arm pivoted on the main shaft of the rotation axis, allowing freedom to elevate the arm as the insect applied lift force. Two other variants had the pivot point fixed, restricting the radial arm to horizontal motion. Beetles were tethered with their lateral axis horizontal or rotated by 40, as in a banked turn. Flight-mill type did not affect flight speed or wing-beat frequency, but did affect flapping kinematics. The wingtip internal to the circular trajectory was always moved faster relative to air, suggesting that the beetles were attempting to steer in the opposite direction to the curved trajectory forced by the flight-mill. However, banked beetles had lower flapping asymmetry, generated higher lift forces and lost more of their body mass per time and distance flown during prolonged flight compared to beetles flying level. The results indicate, that flapping asymmetry and low lift can be rectified by tethering the beetle in a banked orientation, but the flight still does not correspond directly to free-flight. This should be recognized and taken into account when designing flight-mills and interoperating their data.	[Ribak, Gal] Tel Aviv Univ, Sch Zool, Fac Life Sci, Tel Aviv, Israel; [Ribak, Gal] Steinhardt Museum Nat Hist, Tel Aviv, Israel; [Ribak, Gal] Israel Natl Ctr Biodivers Studies, Tel Aviv, Israel; [Barkan, Shay; Soroker, Victoria] Agr Res Org, Dept Entomol, Volcani Ctr, Rishon Leziyyon, Israel	Tel Aviv University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Ribak, G (corresponding author), Tel Aviv Univ, Sch Zool, Fac Life Sci, Tel Aviv, Israel.; Ribak, G (corresponding author), Steinhardt Museum Nat Hist, Tel Aviv, Israel.; Ribak, G (corresponding author), Israel Natl Ctr Biodivers Studies, Tel Aviv, Israel.	gribak@post.tau.ac.il	Soroker, Victoria/AAO-1632-2020	Ribak, Gal/0000-0002-6267-5471	ISRAEL SCIENCE FOUNDATION [1625/15, 849/15]	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation)	This research was supported in part by THE ISRAEL SCIENCE FOUNDATION grant no. 1625/15 and 849/15 to GR.	Axenfeld D, 1911, B ACCAD MED ROMA, V37, P123; CHAMBERS DL, 1976, BEHAV RES METH INSTR, V8, P352, DOI 10.3758/BF03201790; CHANCE M A, 1971, Quaestiones Entomologicae, V7, P253; David G, 2014, J APPL ENTOMOL, V138, P566, DOI 10.1111/jen.12110; Dickson WB, 2004, J EXP BIOL, V207, P4269, DOI 10.1242/jeb.01266; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; ELLINGTON CP, 1990, NATURE, V347, P472, DOI 10.1038/347472a0; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P17, DOI 10.1098/rstb.1984.0050; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P41, DOI 10.1098/rstb.1984.0051; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P145, DOI 10.1098/rstb.1984.0054; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; HEINRICH B, 1971, J EXP BIOL, V54, P141; HEINRICH B, 1974, SCIENCE, V185, P747, DOI 10.1126/science.185.4153.747; Hocking B., 1953, T ROY ENT SOC LONDON, V104, P223; Hoddle MS, 2015, J ECON ENTOMOL, V108, P2599, DOI 10.1093/jee/tov240; JENSEN M, 1956, PHILOS T ROY SOC B, V239, P511, DOI 10.1098/rstb.1956.0009; KENNEDY J. S., 1948, Anti-Locust Bull.; KROGH A, 1952, J EXP BIOL, V29, P211; Lopez VM, 2014, J ECON ENTOMOL, V107, P1127, DOI 10.1603/EC13525; Maes S, 2014, BIOCONTROL, V59, P415, DOI 10.1007/s10526-014-9576-9; Miller TA., 2012, INSECT NEUROPHYSIOLO; RAYNER JMV, 1985, J EXP BIOL, V118, P247; Ribak G, 2007, J COMP PHYSIOL A, V193, P1065, DOI 10.1007/s00359-007-0259-1; Ribak G, 2009, BIOL J LINN SOC, V98, P860, DOI 10.1111/j.1095-8312.2009.01326.x; Riley JR, 1997, ENTOMOL EXP APPL, V83, P317, DOI 10.1023/A:1003034517752; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Schumacher P, 1997, PHYSIOL ENTOMOL, V22, P149, DOI 10.1111/j.1365-3032.1997.tb01152.x; Taylor RAJ, 2010, J INSECT BEHAV, V23, P128, DOI 10.1007/s10905-010-9202-3; Tsunoda T, 2008, APPL ENTOMOL ZOOL, V43, P451, DOI 10.1303/aez.2008.451; valos J.A., 2014, B ENTOMOL RES, V104, P462; Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435; Weihs D, 1979, H7917 SW FISH CTR AD; WEISFOGH T, 1964, J EXP BIOL, V41, P257	35	25	25	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186441	10.1371/journal.pone.0186441	http://dx.doi.org/10.1371/journal.pone.0186441			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091924	Green Submitted, Green Published, gold			2022-12-27	WOS:000414229700018
J	Levin, E; Ballester, AR; Raphael, G; Feigenberg, O; Liu, YS; Norelli, J; Gonzalez-Candelas, L; Mao, J; Dardick, C; Wisniewski, M; Droby, S				Levin, Elena; Rosa Ballester, Ana; Raphael, Ginat; Feigenberg, Oleg; Liu, Yongsheng; Norelli, John; Gonzalez-Candelas, Luis; Mao, Jing; Dardick, Christopher; Wisniewski, Michael; Droby, Samir			Identification and characterization of LysM effectors in Penicillium expansum	PLOS ONE			English	Article							CHITIN-TRIGGERED IMMUNITY; MAGNAPORTHE-ORYZAE; PROTEINS; VIRULENCE; GENE; SEQUENCE; BINDING; PLANTS; TRANSCRIPTOME; SUPPRESSION	P. expansum is regarded as one of the most important postharvest rots of apple fruit and is also of great concern to fruit processing industries. Elucidating the pathogenicity mechanism of this pathogen is of utmost importance for the development of effective and safe management strategies. Although, many studies on modification of the host environment by the pathogen were done, its interactions with fruit during the early stages of infection and the virulence factors that mediate pathogenicity have not been fully defined. Effectors carrying LysM domain have been identified in numerous pathogenic fungi and their role in the first stages of infection has been established. In this study, we identified 18 LysM genes in the P. expansum genome. Amino acid sequence analysis indicated that P. expansum LysM proteins belong to a clade of fungal-specific LysM. Eleven of the discovered LysM genes were found to have secretory pathway signal peptide, among them, 4 (PeLysM1 PeLysM2, PeLysM3 and PeLysM4) were found to be highly expressed during the infection and development of decay of apple fruit. Effect of targeted deletion of the four putative PeLysM effectors on the growth and pathogenicity was studied. Possible interactions of PeLysM with host proteins was investigated using the yeast-two-hybrid system.	[Levin, Elena; Raphael, Ginat; Feigenberg, Oleg; Droby, Samir] ARO, Dept Postharvest Sci, Volcani Ctr, Bet Dagan, Israel; [Rosa Ballester, Ana; Gonzalez-Candelas, Luis] CSIC, IATA, Avda Agustin Escardino, Valencia, Spain; [Liu, Yongsheng] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Norelli, John; Mao, Jing; Dardick, Christopher; Wisniewski, Michael] USDA ARS, Appalachian Fruit Res Stn, 45 Wiltshire Rd, Kearneysville, WV 25430 USA	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Hefei University of Technology; United States Department of Agriculture (USDA)	Droby, S (corresponding author), ARO, Dept Postharvest Sci, Volcani Ctr, Bet Dagan, Israel.	samird@volcani.agri.gov.il	Ballester, Ana-Rosa/D-9677-2011; Gonzalez-Candelas, Luis/B-7998-2008	Ballester, Ana-Rosa/0000-0002-7688-7838; Gonzalez-Candelas, Luis/0000-0002-2579-6880; Levin, Elena/0000-0001-6398-9651; Wisniewski, Michael/0000-0002-7481-5590	Israel Binational Agricultural Research and Development Fund (BARD) [US-4774-14C]; Israel Science Foundation (ISF); National Natural Science Foundation of China (NSFC) [1936/14]	Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation); Israel Science Foundation (ISF)(Israel Science Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Israel Binational Agricultural Research and Development Fund (BARD), US-4774-14C, Prof. Samir Droby and Dr. Michael Wisniewski; Israel Science Foundation (ISF) and National Natural Science Foundation of China (NSFC), 1936/14, Prof. Samir Droby and Prof. Yongsheng Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcapinar GB, 2015, CURR GENET, V61, P103, DOI 10.1007/s00294-014-0471-9; Akimitsu K, 2004, PHYSIOL MOL PLANT P, V65, P271, DOI 10.1016/j.pmpp.2005.03.001; Ballester AR, 2015, MOL PLANT MICROBE IN, V28, P232, DOI 10.1094/MPMI-09-14-0261-FI; Beck J, 1990, EUROPEAN J BIOCH; Berry MD, 2000, J NEUROSCI RES, V60, P150, DOI 10.1002/(SICI)1097-4547(20000415)60:2<150::AID-JNR3>3.0.CO;2-4; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Buron-Moles G, 2012, INT J FOOD MICROBIOL, V160, P162, DOI 10.1016/j.ijfoodmicro.2012.10.005; CAPPELLINI RA, 1987, PLANT DIS, V71, P852; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Constabel C. Peter, 2008, P253, DOI 10.1007/978-1-4020-8182-8_12; Crespo-Sempere A, 2013, FOOD RES INT, V54, P697, DOI 10.1016/j.foodres.2013.08.008; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Deak M, 1999, NAT BIOTECHNOL, V17, P192, DOI 10.1038/6198; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; DEMONT N, 1993, J BIOL CHEM, V268, P20134; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Doong H, CANC LETT S, V1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Farrow SC, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00524; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Frandsen RJN, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-70; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Frith MC, 2008, PLOS COMPUTATIONAL B; GARVEY KJ, 1986, NUCLEIC ACIDS RES, V14, P10001, DOI 10.1093/nar/14.24.10001; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Jain S., 2015, ADV PLANTS AGR RES, V2, DOI DOI 10.15406/APAR.2015.02.00077; Jurick II WM, 2011, PLANT BREEDING; Kombrink A, 2017, MOL PLANT PATHOL, V18, P596, DOI 10.1111/mpp.12520; Kombrink A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003769; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Leatherwood J, 1998, CURR OPIN CELL BIOL, V10, P742, DOI 10.1016/S0955-0674(98)80117-8; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Liu ZH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000581; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; McCallum JL, 2002, J FOOD PROTECT, V65, P1937, DOI 10.4315/0362-028X-65.12.1937; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Mitchell A, 2015, NUCL ACIDS RES; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Mukamolova GV, 2002, MOL MICROBIOL, V46, P611, DOI 10.1046/j.1365-2958.2002.03183.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oliver RP, 2004, TRENDS PLANT SCI, V9, P472, DOI 10.1016/j.tplants.2004.08.006; PELSER PDT, 1977, PHYTOPATHOLOGY, V67, P747; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIERSON CH, 1971, AGR HDB, V376; Potrykus J, 2013, PLOS PATHOG, V9, P10, DOI DOI 10.1371/J0URNAL.PPAT.1003676; Prusky D, 2003, MOL PLANT PATHOL, V4, P509, DOI [10.1046/j.1364-3703.2003.00196.x, 10.1046/J.1364-3703.2003.00196.X]; Prusky D, 2001, MOL PLANT MICROBE IN, V14, P1105, DOI 10.1094/MPMI.2001.14.9.1105; Prusky DB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01306; Ravagnani A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-39; Richau KH, 2012, PLANT PHYSIOL, V158, P1583, DOI 10.1104/pp.112.194001; Sanzani SM, 2009, EUR J PLANT PATHOL, V125, P223, DOI 10.1007/s10658-009-9475-6; Seidl-Seiboth V, 2013, FEBS J, V280, P1226, DOI 10.1111/febs.12113; Sperschneider J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004806; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Takahara H, 2016, NEW PHYTOL, V211, P1323, DOI 10.1111/nph.13994; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Pijkeren JP, 2006, APPL ENVIRON MICROB, V72, P4143, DOI 10.1128/AEM.03023-05; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Werck-Reichhart D, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-6-REVIEWS3003; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Wouters M.F.A., 1996, WHO FOOD ADDIT SER, V35, P377	74	18	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186023	10.1371/journal.pone.0186023	http://dx.doi.org/10.1371/journal.pone.0186023			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084256	Green Submitted, gold, Green Published			2022-12-27	WOS:000413910200004
J	Sun, YJ; Chen, JJ; Li, J; Xu, YW; Jin, H; Xu, N; Yin, R; Hu, GH				Sun, Yajuan; Chen, Jiajun; Li, Jia; Xu, Yawei; Jin, Hui; Xu, Na; Yin, Rui; Hu, Guohua			Novel approach based on one-tube nested PCR and a lateral flow strip for highly sensitive diagnosis of tuberculous meningitis	PLOS ONE			English	Article							REAL-TIME PCR; MYCOBACTERIUM-TUBERCULOSIS; CEREBROSPINAL-FLUID; DNA; ASSAY	Rapid and sensitive detection of Mycobacterium tuberculosis (M. Tb) in cerebrospinal fluid is crucial in the diagnosis of tuberculous meningitis (TBM), but conventional diagnostic technologies have limited sensitivity and specificity or are time-consuming. In this work, a novel, highly sensitive molecular diagnostic method, one-tube nested PCR-lateral flow strip test (OTNPCR-LFST), was developed for detecting M. tuberculosis. This one-tube nested PCR maintains the sensitivity of conventional two-step nested PCR and reduces both the chance of cross-contamination and the time required for analysis. The PCR product was detected by a lateral flow strip assay, which provided a basis for migration of the test to a point-of-care (POC) microfluidic format. The developed assay had an improved sensitivity compared with traditional PCR, and the limit of detection was up to 1 fg DNA isolated from M. tuberculosis. The assay was also specific for M. tuberculosis, and no cross-reactions were found in other non-target bacteria. The application of this technique to clinical samples was successfully evaluated, and OTNPCR-LFST showed 89% overall sensitivity and 100% specificity for TBM patients. This one-tube nested PCR-lateral flow strip assay is useful for detecting M. tuberculosis in TBM due to its rapidity, high sensitivity and simple manipulation.	[Sun, Yajuan; Hu, Guohua] Jilin Univ, Dept Neurol, Hosp 2, Changchun, Jilin, Peoples R China; [Sun, Yajuan; Chen, Jiajun; Li, Jia; Jin, Hui] Jilin Univ, Dept Neurol, China Japan Union Hosp, Changchun, Jilin, Peoples R China; [Xu, Yawei; Xu, Na; Yin, Rui] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Yin, Rui] Jilin Coll Agr Sci & Technol, Coll Biol Engn, Jilin, Jilin, Peoples R China	Jilin University; Jilin University; Jilin Agricultural University	Hu, GH (corresponding author), Jilin Univ, Dept Neurol, Hosp 2, Changchun, Jilin, Peoples R China.; Yin, R (corresponding author), Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China.; Yin, R (corresponding author), Jilin Coll Agr Sci & Technol, Coll Biol Engn, Jilin, Jilin, Peoples R China.	542977965@qq.com; guohuahu2017@163.com			Province of Jilin Science and Technology Development Plan [20160204030YY]; Jilin College of Agricultural Science and Technology [2015X012]	Province of Jilin Science and Technology Development Plan; Jilin College of Agricultural Science and Technology	This work was financially supported by the Province of Jilin Science and Technology Development Plan (20160204030YY), http://kjt.jl.gov.cn/; and Research Project of Jilin College of Agricultural Science and Technology (2015X012), http://www.jlnku.com/.	Atkinson C, 2014, J VIROL METHODS, V196, P40, DOI 10.1016/j.jviromet.2013.10.029; Bonington A, 2000, TUBERCLE LUNG DIS, V80, P191, DOI 10.1054/tuld.2000.0246; Boyle DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103091; Caws M, 2000, J CLIN MICROBIOL, V38, P3150, DOI 10.1128/JCM.38.9.3150-3155.2000; Chaidir L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052001; Choi Y, 2014, DIAGN MICR INFEC DIS, V80, P299, DOI 10.1016/j.diagmicrobio.2014.08.009; Costa J, 2013, FOOD RES INT, V51, P228, DOI 10.1016/j.foodres.2012.12.006; Costa J, 2012, J AGR FOOD CHEM, V60, P8103, DOI 10.1021/jf302898z; Dil-Afroze, 2008, BRAZ J MICROBIOL, V39, P209, DOI 10.1590/S1517-83822008000200002; Grobler A, 2012, CHEM ENG SCI, V81, P311, DOI 10.1016/j.ces.2012.07.009; Haldar S, 2009, J MED MICROBIOL, V58, P616, DOI 10.1099/jmm.0.006015-0; Kositcharoenkul N, 2011, PLANT PATHOL, V60, P436, DOI 10.1111/j.1365-3059.2010.02390.x; Kusum S, 2011, J NEUROL, V258, P1781, DOI 10.1007/s00415-011-6010-4; Park JY, 2013, AQUACULTURE, V410, P225, DOI 10.1016/j.aquaculture.2013.06.036; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Pitz AD, 2013, REV SOC BRAS MED TRO, V46, P783, DOI 10.1590/0037-8682-1625-2013; Quan C, 2006, J CLIN MICROBIOL, V44, P3160, DOI 10.1128/JCM.00333-06; Rafi W, 2007, J NEUROL SCI, V252, P163, DOI 10.1016/j.jns.2006.11.001; Rios-Sarabia N, 2016, INT J MOL MED, V38, P1289, DOI 10.3892/ijmm.2016.2698; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Roskos K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069355; Takahashi S, 2004, NIHON JINZO GAKKAI S, V47, P113; Takahashi T, 2007, J NEUROL SCI, V255, P69, DOI 10.1016/j.jns.2007.01.071; Thongsri Y, 2013, MYCOPATHOLOGIA, V176, P369, DOI 10.1007/s11046-013-9695-3; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tiwari V, 2003, INDIAN J MED RES, V118, P224; Yin R, 2016, FOOD CONTROL, V60, P146, DOI 10.1016/j.foodcont.2015.07.030	27	11	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186985	10.1371/journal.pone.0186985	http://dx.doi.org/10.1371/journal.pone.0186985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084241	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200022
J	Wolsk, HM; Chawes, BL; Litonjua, AA; Hollis, BW; Waage, J; Stokholm, J; Bonnelykke, K; Bisgaard, H; Weiss, ST				Wolsk, Helene M.; Chawes, Bo L.; Litonjua, Augusto A.; Hollis, Bruce W.; Waage, Johannes; Stokholm, Jakob; Bonnelykke, Klaus; Bisgaard, Hans; Weiss, Scott T.			Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheeze in early childhood: A combined analysis of two randomized controlled trials	PLOS ONE			English	Article							CLINICAL-TRIAL; PREGNANCY; ASTHMA; ASSAY; CHILDREN; DESIGN	Background We recently published two independent randomized controlled trials of vitamin D supplementation during pregnancy, both indicating a >20% reduced risk of asthma/recurrent wheeze in the offspring by 3 years of age. However, neither reached statistical significance. Objective To perform a combined analysis of the two trials and investigate whether maternal 25-hydroxy-vitamin D (25(OH) D) level at trial entry modified the intervention effect. Methods VDAART (N = 806) and COPSAC2010. (N = 581) randomized pregnant women to daily high-dose vitamin D-3 (4,000 IU/d and 2,400 IU/d, respectively) or placebo. All women also received a prenatal vitamin containing 400 IU/d vitamin D3. The primary outcome was asthma/recurrent wheeze from 0-3yrs. Secondary end-points were specific IgE, total IgE, eczema and lower respiratory tract infections (LRTI). We conducted random effects combined analyses of the treatment effect, individual patient data (IPD) meta-analyses, and analyses stratified by 25(OH) D level at study entry. Results The analysis showed a 25% reduced risk of asthma/recurrent wheeze at 0-3yrs: adjusted odds ratio (aOR) = 0.74 (95% CI, 0.57-0.96), p = 0.02. The effect was strongest among women with 25(OH) D level >= 30ng/ml at study entry: aOR = 0.54 (0.33-0.88), p = 0.01, whereas no significant effect was observed among women with 25( OH) D level <30ng/ml at study entry: aOR = 0.84 (0.62-1.15), p = 0.25. The IPD meta-analyses showed similar results. There was no effect on the secondary end-points. Conclusions This combined analysis shows that vitamin D supplementation during pregnancy results in a significant reduced risk of asthma/recurrent wheeze in the offspring, especially among women with 25(OH) D level >= 30 ng/ml at randomization, where the risk was almost halved. Future studies should examine the possibility of raising 25(OH) D levels to at least 30 ng/ml early in pregnancy or using higher doses than used in our studies.	[Wolsk, Helene M.; Chawes, Bo L.; Waage, Johannes; Stokholm, Jakob; Bonnelykke, Klaus; Bisgaard, Hans] Copenhagen Prospect Studies Asthma Childhood, COPSAC, Herlev, Denmark; [Wolsk, Helene M.; Chawes, Bo L.; Waage, Johannes; Stokholm, Jakob; Bonnelykke, Klaus; Bisgaard, Hans] Univ Copenhagen, Gentofte Hosp, Copenhagen, Denmark; [Wolsk, Helene M.; Chawes, Bo L.; Litonjua, Augusto A.; Weiss, Scott T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Litonjua, Augusto A.; Weiss, Scott T.] Harvard Med Sch, Boston, MA USA; [Hollis, Bruce W.] Med Univ South Carolina, Dept Pediat, Charleston, SC USA	University of Copenhagen; Herlev & Gentofte Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Medical University of South Carolina	Weiss, ST (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Weiss, ST (corresponding author), Harvard Med Sch, Boston, MA USA.	scott.weiss@channing.harvard.edu	; Bisgaard, Hans/N-4761-2016	Chawes, Bo/0000-0001-6846-6243; Stokholm, Jakob/0000-0003-4989-9769; Weiss, Scott/0000-0001-7196-303X; Bisgaard, Hans/0000-0003-4131-7592; Bonnelykke, Klaus/0000-0003-2003-1018	National Heart, Lung, and Blood Institute [U01HL091528, 5 R01 HL091528]; National Centers for Advancing Translational Sciences (NCATS) [U54TR001012]; Lundbeck Foundation [R16-A1694, R191-2015.1571]; Danish Ministry of Health [903516]; Danish Council for Strategic Research [0603-00280B]; Capital Region Research Foundation; European Respiratory Society fellowship, LTRF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091528] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Centers for Advancing Translational Sciences (NCATS); Lundbeck Foundation(Lundbeckfonden); Danish Ministry of Health; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Capital Region Research Foundation; European Respiratory Society fellowship, LTRF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	VDAART was supported by U01HL091528 and 5 R01 HL091528 from the National Heart, Lung, and Blood Institute. Additional support was provided by U54TR001012 from the National Centers for Advancing Translational Sciences (NCATS) for participant visits at Boston Medical Center. COPSAC is funded by private and public research funds all listed on www.copsac.com. The Lundbeck Foundation Grant (no. R16-A1694); The Danish Ministry of Health (Grant no. 903516); Danish Council for Strategic Research (Grant no. 0603-00280B) and The Capital Region Research Foundation (no grant no.) have provided core support for COPSAC. HMW was supported by an unrestricted grant from the Lundbeck Foundation (R191-2015.1571). BC was supported by a European Respiratory Society fellowship, LTRF, 2016. No pharmaceutical company was involved in the study. The funding agencies did not have any role in design and conduct of the study; collection, management, and interpretation of the data; or preparation, review, or approval of the manuscript.	Abadia L, 2016, AM J CLIN NUTR, V104, P729, DOI 10.3945/ajcn.115.126359; Agarwal S, 2016, CRIT REV FOOD SCI NU, V24; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; Bisgaard H, 2013, CLIN EXP ALLERGY, V43, P1384, DOI 10.1111/cea.12213; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Bisgaard H, 2009, AM J RESP CRIT CARE, V179, P179, DOI 10.1164/rccm.200809-1436OC; Chawes BL, 2016, JAMA-J AM MED ASSOC, V315, P353, DOI 10.1001/jama.2015.18318; Chawes BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099856; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Feng H, 2016, J ALLERGY CLIN IMMUN; Goldring ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066627; Grant CC, 2016, ALLERGY, V71, P1325, DOI 10.1111/all.12909; Guido Schwarzer, 2015, MET GEN PACK MET R P; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hansen L, 2016, J STEROID BIOCH MOL; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; Hojskov CS, 2010, CLIN CHIM ACTA, V411, P114, DOI 10.1016/j.cca.2009.10.010; Kho AT, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-47; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Litonjua AA, 2014, CONTEMP CLIN TRIALS, V38, P37, DOI 10.1016/j.cct.2014.02.006; Litonjua AA, 2009, CURR OPIN ALLERGY CL, V9, P202, DOI 10.1097/ACI.0b013e32832b36cd; Magnus MC, 2013, PAEDIATR PERINAT EP, V27, P532, DOI 10.1111/ppe.12080; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Raby BA, 2004, AM J RESP CRIT CARE, V170, P1057, DOI 10.1164/rccm.200404-447OC; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sorensen IM, 2012, DIABETES, V61, P175, DOI 10.2337/db11-0875; Stokholm J, 2016, LANCET RESP MED, V4, P19, DOI [10.1016/S2213-2600(15)00500-7, 10.1016/S2213-2600(16)00050-3]; Team RC., 2013, R LANG ENV STAT COMP; Vahdaninia M, 2016, J ALLERGY CLIN IMMUN; Wegienka G, 2012, CLIN EXP ALLERGY, V42, P909, DOI 10.1111/j.1365-2222.2011.03946.x; Wolsk H, 2017, J ALLERGY CLIN IMMUN; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	34	112	113	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186657	10.1371/journal.pone.0186657	http://dx.doi.org/10.1371/journal.pone.0186657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077711	Green Submitted, Green Published, gold			2022-12-27	WOS:000413861200015
J	Lin, CC; Hung, YY; Tsai, MC; Huang, TL				Lin, Chin-Chuen; Hung, Yi-Yung; Tsai, Meng-Chang; Huang, Tiao-Lai			Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia	PLOS ONE			English	Article							NMDA-RECEPTOR; ALCOHOL-WITHDRAWAL; SUBUNIT NR1; 1ST EPISODE; SCHIZOPHRENIA; AUTOANTIBODIES; ENCEPHALITIS; PREVALENCE; LORAZEPAM; DIAGNOSIS	Objective Anti-N-methyl-D-aspartate receptor (NMDAR) antibody was thought to be the cause of anti-NMDAR encephalitis, with manifestations similar to catatonia and schizophrenia. Anti-NMDAR antibody in neuropsychiatric patients who had catatonia before were investigated in a follow-up evaluation. The intensity of antibody immunofluorescence was quantified and compared with healthy controls. Method Nineteen patients (eight males and eleven females) agreed to be followed-up. Thirteen had the diagnosis of schizophrenia, two had the diagnosis of major depressive disorder, two had bipolar disorder, one had postpartum depression, and one had herpes simplex encephalitis. No patient had catatonia during the follow-up. Nineteen sex-matched healthy controls were recruited. Results Using Mann-Whitney U test, patients had greater intensity of anti-NMDAR antibody immunofluorescence than the healthy controls (121,979 +/- 86,526 vs. 47,692 +/- 26,102, p = 0.003). No correlation was found between immunofluorescence intensity and catatonia scales or symptom severity scores. Neuropsychiatric patients with past catatonia showed greater anti-NMDAR antibody response than the healthy controls. Conclusion NMDAR dysfunction might play a role in the mechanism underlying catatonia. Further studies are needed to confirm this finding.	[Huang, Tiao-Lai] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Huang, TL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan.	a540520@adm.cgmh.org.tw			Kaohsiung Chang Gung Memorial Hospital in Taiwan [CMRPG8D0571]	Kaohsiung Chang Gung Memorial Hospital in Taiwan	This work was supported by a clinical research grant, No. CMRPG8D0571, from Kaohsiung Chang Gung Memorial Hospital in Taiwan (www.cgmh.org.tw).; This work was supported by a clinical research grant, No. CMRPG8D0571, from Kaohsiung Chang Gung Memorial Hospital in Taiwan.	Basu A, 2014, J PHARMACOL PHARMACO, V5, P261, DOI 10.4103/0976-500X.142449; Busse S, 2014, EUR ARCH PSY CLIN N, V264, P545, DOI 10.1007/s00406-014-0493-9; Castillo-Gomez E., 2016, MOL PSYCHIAT; Castillo-Gomez E, 2016, ANN NEUROL, V79, P144, DOI 10.1002/ana.24545; Chen CH, 2017, SCHIZOPHR RES; CHONG MY, 1989, PSYCHOL MED, V19, P495, DOI 10.1017/S0033291700012526; Dahm L, 2014, ANN NEUROL, V76, P82, DOI 10.1002/ana.24189; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Dauvilliers Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep25230; Ezeoke A, 2013, SCHIZOPHR RES, V150, P245, DOI 10.1016/j.schres.2013.07.029; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Geoffroy PA, 2012, ALCOHOL ALCOHOLISM, V47, P288, DOI 10.1093/alcalc/agr170; Gleichman AJ, 2012, J NEUROSCI, V32, P11082, DOI 10.1523/JNEUROSCI.0064-12.2012; Gresa-Arribas N, 2014, LANCET NEUROL, V13, P167, DOI 10.1016/S1474-4422(13)70282-5; Grover S, 2011, GEN HOSP PSYCHIAT, V33, DOI 10.1016/j.genhosppsych.2010.06.006; Hammer C, 2014, MOL PSYCHIATR, V19, P1143, DOI 10.1038/mp.2013.110; Haussleiter IS, 2012, SCHIZOPHR RES, V140, P258, DOI 10.1016/j.schres.2012.05.006; Hsieh MH, 2011, PSYCHOSOMATICS, V52, P475, DOI 10.1016/j.psym.2011.01.024; Huang TL, 2005, PSYCHIAT CLIN NEUROS, V59, P52, DOI 10.1111/j.1440-1819.2005.01331.x; Huang Yu-Chi, 2013, Biomed J, V36, P35, DOI 10.4103/2319-4170.107162; Hung YY, 2006, CLIN NEUROPHARMACOL, V29, P144, DOI 10.1097/01.WNF.0000221908.56361.C7; Inta D, 2015, SCHIZOPHR RES, V168, P581, DOI 10.1016/j.schres.2015.07.029; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Kiani R, 2015, BJPSYCH BULL, V39, P32, DOI 10.1192/pb.bp.112.041954; Kolli Venkata, 2013, Innov Clin Neurosci, V10, P11; Komori T, 1997, ACTA PSYCHIAT SCAND, V96, P155, DOI 10.1111/j.1600-0447.1997.tb09921.x; Kreye J, 2016, BRAIN, V139, P2641, DOI 10.1093/brain/aww208; Lai JY, 2004, PSYCHIAT CLIN NEUROS, V58, P157, DOI 10.1111/j.1440-1819.2003.01210.x; Lin CC, 2016, COMPR PSYCHIAT, V66, P157, DOI 10.1016/j.comppsych.2016.01.011; Lin CC, 2013, COMPR PSYCHIAT, V54, P1210, DOI 10.1016/j.comppsych.2013.06.003; Masdeu JC, 2012, AM J PSYCHIAT, V169, P1120, DOI 10.1176/appi.ajp.2012.12050646; Masopust J, 2015, NEUROPSYCH DIS TREAT, V11, P619, DOI 10.2147/NDT.S80746; Narayanaswamy JC, 2011, PSYCHOPATHOLOGY, V44, P136, DOI 10.1159/000319849; Parenti A, 2016, PSYCHOSOMATICS, V57, P336, DOI 10.1016/j.psym.2016.01.007; Pearlman DM, 2014, SCHIZOPHR RES, V157, P249, DOI 10.1016/j.schres.2014.05.001; Pollak TA, 2014, PSYCHOL MED, V44, P2475, DOI 10.1017/S003329171300295X; Rhoads J, 2011, SCHIZOPHR RES, V129, P213, DOI 10.1016/j.schres.2010.12.018; Rosebush PI, 2006, CUR CLIN NEUROL, P81; Steiner J, 2015, SCHIZOPHR RES, V162, P291, DOI 10.1016/j.schres.2015.01.009; Steiner J, 2014, JAMA PSYCHIAT, V71, P838, DOI 10.1001/jamapsychiatry.2014.469; Steiner J, 2013, JAMA PSYCHIAT, V70, P271, DOI 10.1001/2013.jamapsychiatry.86; Timucin D, 2016, NEUROPSYCH DIS TREAT, V12, P2327, DOI 10.2147/NDT.S113872; Tsutsui K, 2017, NEUROPSYCH DIS TREAT, V13, P339, DOI 10.2147/NDT.S125800; Tsutsui K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-37; Wilson JE, 2013, PSYCHOSOMATICS; Zandi MS, 2011, J NEUROL, V258, P686, DOI 10.1007/s00415-010-5788-9; Zerche M, 2015, STROKE, V46, P1180, DOI 10.1161/STROKEAHA.114.008323	49	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187156	10.1371/journal.pone.0187156	http://dx.doi.org/10.1371/journal.pone.0187156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073246	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400125
J	Cheng, YC; Zhang, Y; Ma, J; Zhan, SY				Cheng, Yinchu; Zhang, Yang; Ma, Jun; Zhan, Siyan			Food safety knowledge, attitude and self-reported practice of secondary school students in Beijing, China: A cross-sectional study	PLOS ONE			English	Article							HANDLING BEHAVIORS; YOUNG-ADULTS; SOUTH-INDIA; IMPLEMENTATION; COGNITIONS; ADDITIVES	In China, food safety problems have occurred frequently in the past ten years, causing great concern for the public. Adolescents, with higher exposure to problematic food, represent a unique target for interventions aimed at risk reduction. To understand their food safety knowledge, attitude and practice, a cross-sectional survey using paper questionnaire was carried out among 4,220 students (median age of 14 years, 50.3% females) from nine secondary schools in 3 districts of Beijing. The findings showed that the majority of respondents (42.0%) had a high knowledge level. Significant association was found between food safety knowledge score (median = 11, IQR:9-13) and demographic characteristics of region, school type, residence type, habit of smoking and alcohol use, academic record and parents' education background. In terms of attitude and practice, only 17% of those surveyed regarded China's food safety situation as good, 53.6% regarded it as worrying; almost all students (96.5%) did pay attention to food safety; 95.3% of the students had worried about the safety of the food provided by the small restaurants and street peddlers, but in reality, as many as 69.4% often or occasionally bought food from peddlers around their campuses and nearly half continued the consumption of such food in spite of worrying about its safety problems. Overall, the food safety knowledge among Beijing secondary school students was relatively good. They did not show much confidence in the country's food safety situation, but many aware of the safety issues did not bother to change or take action. The study suggests that more systematic and targeted education on food safety is necessary for this age group.	[Cheng, Yinchu; Zhang, Yang; Zhan, Siyan] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Ma, Jun] Peking Univ, Inst Child & Adolescent Hlth, Beijing, Peoples R China	Peking University; Peking University	Zhan, SY (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China.	siyan-zhan@bjmu.edu.cn		Cheng, Yinchu/0000-0001-6084-0384; Zhan, Siyan/0000-0001-7252-5349	Beijing Food and Drug Administration [89300-432104014]	Beijing Food and Drug Administration	This study was supported by the Beijing Food and Drug Administration (No. 89300-432104014). SZ received the funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot JM, 2009, EUR J CLIN NUTR, V63, P572, DOI 10.1038/sj.ejcn.1602961; Abdullahi A, 2016, IJGM, V79; Administration office State Council of China, 2016, KEY TASK ARR FOOD SA; Albrecht JA, 2014, J ACAD NUTR DIET, V114, pA57; Byrd-Bredbenner C, 2007, J FOOD PROTECT, V70, P1917, DOI 10.4315/0362-028X-70.8.1917; Chen L, 2015, CHINA FOOD SAFE 1127, V30, P57; Cheng JM, 2011, CHINESE J SCH HLTH, V32, P707; Chinese Ministry of Education, 2008, GUID HLTH ED PRIM SE; Coulson NS, 2002, APPETITE, V38, P199, DOI 10.1006/appe.2001.0479; Cusato S, 2014, QUAL ASSUR SAF CROP, V6, P135, DOI 10.3920/QAS2012.0195; Cusato S, 2013, FOODBORNE PATHOG DIS, V10, P6, DOI 10.1089/fpd.2012.1286; Felicio TL, 2013, APPETITE, V66, P84, DOI 10.1016/j.appet.2013.03.002; Food safety Committee of the State Council of China, 2011, GUID FOOD SAF POP ED; Gao J, 2016, CAPITAL MED     0617, V23, P40; Gavaravarapu SRM, 2009, J NUTR EDUC BEHAV, V41, P340, DOI 10.1016/j.jneb.2008.12.003; Gomes CCB, 2014, J FOOD SAFETY, V34, P218, DOI 10.1111/jfs.12116; Kang NE, 2010, NUTR RES PRACT, V4, P535, DOI 10.4162/nrp.2010.4.6.535; Knight PG, 2003, INT J FOOD SCI NUTR, V54, P309, DOI [10.1080/09637480120092107, 10.1080/096374803766666184]; Lam HM, 2013, LANCET, V381, P2044, DOI 10.1016/S0140-6736(13)60776-X; Li ST, 2012, J BEIJING I TECHNOL, V14, P1; Lin Y, 2013, JIANGSU AGR SCI, V41, P299; Lu FQ, 2014, FOOD CONTROL, V41, P134, DOI 10.1016/j.foodcont.2014.01.019; Majowicz SE, 2015, CAN J PUBLIC HEALTH, V106, pE520, DOI [10.17269/CJPH.106.5213, 10.17269/cjph.106.5213]; Mepham B, 2011, BRIT MED BULL, V99, P7, DOI 10.1093/bmb/ldr024; Mitchell RE, 2007, INT J ENVIRON HEAL R, V17, P9, DOI 10.1080/09603120601124371; Pontual I, 2017, FOOD RES INT, V94, P1, DOI 10.1016/j.foodres.2017.01.018; Rao GMS, 2007, APPETITE, V49, P441, DOI 10.1016/j.appet.2007.02.011; Ren Ci, 2015, Occupation and Health, V31, P2501; Research group of food safety awareness investigation, 2012, QUALITY STANDARDIZAT, V12, P33; Saltmarsh M, 2015, J SCI FOOD AGR, V95, P649, DOI 10.1002/jsfa.6715; Shen Li, 2010, Modern Preventive Medicine, V37, P294; Shen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123418; Shi YJ, 2008, OCCUPATION HLTH, V24, P2455; State Council of China, 2012, STAT COUNC DEC STREN; Su Hsun-Pi, 2005, Journal of Infection and Chemotherapy, V11, P146, DOI 10.1007/s10156-005-0383-1; Takeda S, 2011, J NUTR EDUC BEHAV, V43, P449, DOI 10.1016/j.jneb.2010.08.009; Wang J, 2012, GEOD GEODYN, V3, P7, DOI 10.3724/SP.J.1246.2012.0008; Wang JX, 2013, COAL MINE MACHINERY, V34, P272; Xie XW, 2014, CHINESE J HLTH ED, V30, P1094; Yin SJ, 2017, CHINESE DEV REPORT F; Yin SJ, 2016, CHINESE DEV REPORT F; Zhang JB, 2014, BIOMED ENVIRON SCI, V27, P147, DOI 10.3967/bes2014.032; Zhu BY, 2013, SCI TECHNOLOGY INFOR, V35, P108	43	11	11	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187208	10.1371/journal.pone.0187208	http://dx.doi.org/10.1371/journal.pone.0187208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095878	gold, Green Submitted, Green Published			2022-12-27	WOS:000414340200057
J	Protiere, C; Spire, B; Mora, M; Poizot-Martin, I; Preau, M; Doumergue, M; Morlat, P; Zucman, D; Goujard, C; Raffi, F; Lambotte, O; Suzan-Monti, M				Protiere, Christel; Spire, Bruno; Mora, Marion; Poizot-Martin, Isabelle; Preau, Marie; Doumergue, Marjolaine; Morlat, Philippe; Zucman, David; Goujard, Cecile; Raffi, Franceois; Lambotte, Olivier; Suzan-Monti, Marie			Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC)	PLOS ONE			English	Article							QUALITATIVE RESEARCH; LIFE; COUNTRIES; DISEASE; VIEWS; TIME	Context Despite huge advances in the fight against HIV concerning diagnosis, clinical efficacy of antiretroviral treatments (ART), patient survival and quality of life, there is still no cure. Recent developments in HIV cure research have opened the way for clinical trials which could lead to a temporary or definitive end to ART. However, ethical questions exist about related trial-participation risks. The main goal of the ANRS-APSEC survey was, using Q-methodology, to investigate the viewpoints of people living with HIV (PLWH) and HIV healthcare providers (HHP) regarding motivations for and barriers to participation in HIV Cure-related clinical trials (HCRCT). Materials and methods Thirty-three statements were defined encompassing seven dimensions: treatment and follow-up; risks; benefits; patient-physician relationship; beliefs and attitudes; information; target population. Forty-one PLWH and 41 HHP from five French HIV services were asked to rank-order the statements. Results Five main viewpoints were elicited from "the most motivated" to "the most reluctant" vis-a-vis HCRCT participation. All placed importance on the wish to participate in HIV research. This result is inline with the HIV-specific culture of joint mobilization. For some viewpoints, the motivation to participate in/propose HCRCT was primarily conditioned by side-effects and/or by constraints, which overall were more accepted by PLWH than HHP. Some viewpoints placed particular importance on HCRCT recruitment strategies. Finally, some expressed a high acceptance of risks and constraints but emphasized the need for information. Conclusion HIV cure research clinical trials (HCRCT) constitute a risky yet unavoidable step towards the goal of finding a cure. To improve future HCRCT and informed consent designs, based on PLWH and HHP preferences and expectations, we need greater knowledge about how these populations perceive the risks and the benefits of HCRCT. Our results confirmed the importance of careful, studied HCRCT design, management and communication, to ensure PLWH and HHP acceptability and convergence of their expectations.	[Protiere, Christel; Spire, Bruno; Mora, Marion; Poizot-Martin, Isabelle; Preau, Marie; Suzan-Monti, Marie] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France; [Protiere, Christel; Spire, Bruno; Mora, Marion; Suzan-Monti, Marie] ORS PACA, Observ Reg Sante Provence Alpes Cote Azur, Marseille, France; [Poizot-Martin, Isabelle] Aix Marseille Univ, Hop St Marguerite, AP HM, CISIH, Marseille, France; [Preau, Marie; Doumergue, Marjolaine] Lyon 2 Univ, GRePS, Bron, France; [Morlat, Philippe] Univ Bordeaux, INSERM, CHU Bordeaux,U 1219, Hop St Andre,Serv Med Interne & Malad Infect, Bordeaux, France; [Zucman, David] Hop Foch, Serv Med Interne, Suresnes, France; [Goujard, Cecile; Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne & Immunol Clin, Le Kremlin Bicetre, France; [Goujard, Cecile] Univ Paris Sud, AP HP, Serv Sante Publ, Villejuif, France; [Goujard, Cecile] Univ Paris Sud, INSERM 1018, Ctr Rech Epidemiol & Sante Populat CESP, Villejuif, France; [Raffi, Franceois] Univ Hosp, Dept Infect Dis, Nantes, France; [Lambotte, Olivier] INSERM, U1184, Immunol Viral Infect & Autoimmune Dis, Le Kremlin Bicetre, France; [Lambotte, Olivier] Univ Paris Sud, UMR 1184, Le Kremlin Bicetre, France; [Lambotte, Olivier] CEA, DSV IMETI, IDMIT, Fontenay Aux Roses, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CEA	Protiere, C (corresponding author), Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France.; Protiere, C (corresponding author), ORS PACA, Observ Reg Sante Provence Alpes Cote Azur, Marseille, France.	christel.protiere@inserm.fr	Protière, Christel/D-5687-2017; Lambotte, Olivier/GRT-0160-2022; Spire, Bruno/F-5546-2013	Protière, Christel/0000-0002-5602-9617; Spire, Bruno/0000-0002-3546-8020; Poizot-Martin, Isabelle/0000-0002-5676-5411	France REcherche Nord & Sud Sida-hiv Hepatites [14697]	France REcherche Nord & Sud Sida-hiv Hepatites	This work was supported by France REcherche Nord & Sud Sida-hiv Hepatites, convention number 14697, http://www.anrs.fr/, to MSM.	Aldrich S, 2000, SOC SCI MED, V50, P1631, DOI 10.1016/S0277-9536(99)00391-3; [Anonymous], 2017, J MED ETHICS, V43; Arnold MP, 2015, J VIRUS ERAD, V1, P43; Baker R, 2013, HLTH EC; Baker R.M., 2010, OPERANT SUBJECTIVITY, V34, P38; Baker Rachel, 2006, J Health Serv Res Policy, V11, P38, DOI 10.1258/135581906775094217; Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Brouwer M, 1999, J ADVERTISING RES, V39, P35; Brown S.R., 1980, POLITICAL SUBJECTIVI; Brown SR, 1996, QUAL HEALTH RES, V6, P561, DOI 10.1177/104973239600600408; Chanel O, 2004, REV EC, V55, P923; Chu CE, 2015, AIDS RES HUM RETROV, V31, P78, DOI [10.1089/aid.2014.0200, 10.1089/AID.2014.0200]; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Deeks SG, 2012, NATURE, V487, P293, DOI 10.1038/487293a; Dube K, 2017, AIDS RES HUM RETROVI; Dube K, 2017, J VIRUS ERAD, V3, P40; EPSTEIN S, 1995, SCI TECHNOL HUM VAL, V20, P408, DOI 10.1177/016224399502000402; Fishbein M.A., 1975, PHILOS RHETORIC; Grossman CI, 2016, TRENDS MICROBIOL, V24, P5, DOI 10.1016/j.tim.2015.10.011; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Henderson GE, 2015, AIDS RES HUM RETROV, V31, P56, DOI [10.1089/aid.2014.0219, 10.1089/AID.2014.0219]; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Johnston R, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-16; Ma QY, 2016, J VIRUS ERAD, V2, P170; Mason H, 2016, SOC SCI MED, V166, P205, DOI 10.1016/j.socscimed.2016.08.036; Mazanderani F, 2015, SOC SCI MED, V131, P66, DOI 10.1016/j.socscimed.2015.02.041; McGrath JW, 2014, MED ANTHROPOL, V33, P303, DOI 10.1080/01459740.2014.892483; Morecroft C, 2006, PATIENT EDUC COUNS, V61, P354, DOI 10.1016/j.pec.2005.04.011; Moyer E, 2014, MED ANTHROPOL, V33, P263, DOI 10.1080/01459740.2014.890618; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Pierret J, 2007, SOC SCI MED, V65, P1595, DOI 10.1016/j.socscimed.2007.06.017; Preau M, 2015, KEYST S MOL CELL BIO; Protiere C, 2000, ANN ONCOL, V11, P39, DOI 10.1023/A:1008390027720; Protiere C, 2017, HIV MED; Protiere C, 2017, MED DECIS MAKING; Protiere C, 2017, HIV CLIN TRIALS, P1; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Sax PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113031; Simmons R, 2017, HIV MED, V18, P73, DOI 10.1111/hiv.12391; Stenner PHD, 2003, SOC SCI MED, V57, P2161, DOI 10.1016/S0277-9536(03)00070-4; Stephenson W., 1953, STUDY BEHAV Q TECHNI; Tucker JD, 2014, AIDS, V28, P1247, DOI 10.1097/QAD.0000000000000210; van Exel J, 2007, HEALTH POLICY, V83, P332, DOI 10.1016/j.healthpol.2007.02.002; van Exel J, 2015, SOC SCI MED, V126, P128, DOI 10.1016/j.socscimed.2014.12.023; Watts S., 2012, DOING Q METHODOLOGIC; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347	49	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187489	10.1371/journal.pone.0187489	http://dx.doi.org/10.1371/journal.pone.0187489			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095883	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200101
J	Rhee, SJ; Kwon, T; Seo, M; Jang, YJ; Sim, TY; Cho, S; Han, SW; Lee, GP				Rhee, Sun-Ju; Kwon, Taehyung; Seo, Minseok; Jang, Yoon Jeong; Sim, Tae Yong; Cho, Seoae; Han, Sang-Wook; Lee, Gung Pyo			De novo-based transcriptome profiling of male-sterile and fertile watermelon lines	PLOS ONE			English	Article							RNA-SEQ; GENE-EXPRESSION; CITRULLUS-LANATUS; GENERATION; POLLEN; GENOME; IDENTIFICATION; PROTEINS; NUCLEAR	The whole-genome sequence of watermelon (Citrullus lanatus (Thunb.) Matsum. & Nakai), a valuable horticultural crop worldwide, was released in 2013. Here, we compared a de novo-based approach (DBA) to a reference-based approach (RBA) using RNA-seq data, to aid in efforts to improve the annotation of the watermelon reference genome and to obtain biological insight into male-sterility in watermelon. We applied these techniques to available data from two watermelon lines: the male-sterile line DAH3615-MS and the male-fertile line DAH3615. Using DBA, we newly annotated 855 watermelon transcripts, and found gene functional clusters predicted to be related to stimulus responses, nucleic acid binding, transmembrane transport, homeostasis, and Golgi/vesicles. Among the DBA-annotated transcripts, 138 de novo-exclusive differentially-expressed genes (DEDEGs) related to male sterility were detected. Out of 33 randomly selected newly annotated transcripts and DEDEGs, 32 were validated by RT-qPCR. This study demonstrates the usefulness and reliability of the de novo transcriptome assembly in watermelon, and provides new insights for researchers exploring transcriptional blueprints with regard to the male sterility.	[Rhee, Sun-Ju; Jang, Yoon Jeong; Sim, Tae Yong; Han, Sang-Wook; Lee, Gung Pyo] Chung Ang Univ, Dept Integrat Plant Sci, Ansung, South Korea; [Kwon, Taehyung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kwon, Taehyung] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Seo, Minseok] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Seo, Minseok; Cho, Seoae] CHO&KIM Genom, C-1008,H Business Pk,26,Beobwon Ro 9 Gil, Seoul, South Korea	Chung Ang University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Han, SW; Lee, GP (corresponding author), Chung Ang Univ, Dept Integrat Plant Sci, Ansung, South Korea.	swhan@cau.ac.kr; gplee@cau.ac.kr	Rhee, Sun-Ju/ABC-6570-2021	Kwon, Taehyung/0000-0002-5668-059X; Rhee, Sun-Ju/0000-0002-4911-539X	Golden Seed Project [213006051SBV20]; Ministry of Agriculture, Food, and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korean Forest Service (KFS) of the Republic of Korea	Golden Seed Project; Ministry of Agriculture, Food, and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korean Forest Service (KFS) of the Republic of Korea	This study was supported by the Golden Seed Project (213006051SBV20); the Ministry of Agriculture, Food, and Rural Affairs (MAFRA); the Ministry of Oceans and Fisheries (MOF); the Rural Development Administration (RDA); and the Korean Forest Service (KFS) of the Republic of Korea to GPL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the Golden Seed Project (213006051SBV20); the Ministry of Agriculture, Food, and Rural Affairs (MAFRA); the Ministry of Oceans and Fisheries (MOF); the Rural Development Administration (RDA); and the Korean Forest Service (KFS) of the Republic of Korea.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altunoglu YC, 2017, PHYSIOL MOL BIOL PLA, V23, P5, DOI 10.1007/s12298-016-0405-8; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bang HaeJeen, 2005, Cucurbit Genetics Cooperative, P47; Bock KW, 2006, PLANT PHYSIOL, V140, P1151, DOI 10.1104/pp.105.074708; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Chang ZY, 2016, P NATL ACAD SCI USA, V113, P14145, DOI 10.1073/pnas.1613792113; Chen G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-590; Choi D, 2006, PHYSIOL PLANTARUM, V126, P511, DOI 10.1111/j.1399-3054.2005.00612.x; Coimbra S, 2007, J EXP BOT, V58, P4027, DOI 10.1093/jxb/erm259; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Dai S, 2006, PROTEOMICS, V6, P2504, DOI 10.1002/pmic.200401351; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Doukhanina EV, 2006, J BIOL CHEM, V281, P18793, DOI 10.1074/jbc.M511794200; Du K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01313; DYUTIN K E, 1990, Tsitologiya i Genetika, V24, P56; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Fan ML, 2014, PLANTA, V239, P397, DOI 10.1007/s00425-013-1976-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grassi S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-781; Guo SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130267; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HX, 1998, SCI HORTIC-AMSTERDAM, V74, P175, DOI 10.1016/S0304-4238(97)00102-7; Kang JG, 2008, PLANT MOL BIOL, V66, P177, DOI 10.1007/s11103-007-9261-9; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kinsella M, 2011, BIOINFORMATICS, V27, P1068, DOI 10.1093/bioinformatics/btr085; Kobayashi M, 2012, MOL BIOL REP, V39, P4367, DOI 10.1007/s11033-011-1224-1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; LI YQ, 1995, SEX PLANT REPROD, V8, P123, DOI 10.1007/BF00242254; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Loraine AE, 2013, PLANT PHYSIOL, V162, P1092, DOI 10.1104/pp.112.211441; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Omidvar V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170715; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; RAY DT, 1988, J HERED, V79, P397, DOI 10.1093/oxfordjournals.jhered.a110537; Rhee SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2186-9; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VEDEL F, 1994, PLANT PHYSIOL BIOCH, V32, P601; Vidal EA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-701; Wagner D, 2002, CURR BIOL, V12, P85, DOI 10.1016/S0960-9822(01)00651-0; Wang W, 2004, SEX PLANT REPROD, V17, P41, DOI 10.1007/s00497-004-0207-y; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watts V, 1962, P AM SOC HORT SCI; Watts V, 1962, P AM SOC HORTICULTUR; Watts V, 1967, P AM SOC HORTICULTUR; Yang YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166314; Zhang X. P., 1990, Report - Cucurbit Genetics Cooperative, P45; Zhu QL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3442-3	59	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187147	10.1371/journal.pone.0187147	http://dx.doi.org/10.1371/journal.pone.0187147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095876	gold, Green Submitted, Green Published			2022-12-27	WOS:000414340200051
J	Ristic, N; Milovanovic, I; Radusinovic, M; Stevic, M; Ristic, M; Ristic, M; Tepavcevic, DK; Alempijevic, T				Ristic, Nina; Milovanovic, Ivan; Radusinovic, Milica; Stevic, Marija; Ristic, Milos; Ristic, Maja; Tepavcevic, Darija Kisic; Alempijevic, Tamara			The comparative analyses of different diagnostic approaches in detection of gastroesophageal reflux disease in children	PLOS ONE			English	Article							MULTICHANNEL INTRALUMINAL IMPEDANCE; GASTRO-ESOPHAGEAL REFLUX; EOSINOPHILIC ESOPHAGITIS; ASSOCIATION ANALYSIS; PH; INFANTS; ACID; CONSENSUS; SYMPTOMS; RECOMMENDATIONS	Objectives The aim of this study was to compare the different diagnostic approaches in detection of gastroesophageal reflux disease in children presented with symptoms suggesting gastroesophageal reflux disease. Methods The study design was cross sectional. The study retrospectively included all children who underwent combined multiple intraluminal impedance and pH (pH-MII) monitoring due to gastrointestinal and/or extraesophageal symptoms suggesting gastroesophageal reflux disease at University Children's Hospital in Belgrade, from July 2012 to July 2016. Results A total of 218 (117 boys/101 girls), mean age 6.7 years (range 0.06-18.0 years), met the inclusion criteria. Gastroesophageal reflux disease was found in 128 of 218 children (57.4%) by pH-MII and in 76 (34.1%) children by pH metry alone. Using pH-MII monitoring as gold standard, sensitivity of pH-metry was lowest in infants (22.9%), with tendency to increase in older age groups (reaching 76.4% in children >9 years). The sensitivity of pH-metry alone in children with extraesophageal symptoms was 38.1 %, while the sensitivity of pH-metry in children with gastrointestinal symptoms was 63.8%. Reflux esophagitis was identified in 31 (26.1%) of 119 children who underwent endoscopy. Logistic regression analysis showed that best predictors of endoscopic reflux esophagitis are the longest acid episode (OR = 1.52, p<0.05) and DeMeester reflux composite score (OR = 3.31, p<0.05). The significant cutoff values included DeMeester reflux composite score >29 (AUC 0.786, Cl 0.695-0.877, p<0.01) and duration of longest acid reflux >18 minutes (AUC 0.784, Cl 0.692-0.875, p<0.01). Conclusions The results of our study suggested that compared with pH-metry alone, pH-MII had significantly higher detection rate of gastroesophageal reflux disease, especially in infants. Our findings also showed that pH-MII parameters correlated significantly with the endoscopically confirmed erosive esophagitis.	[Ristic, Nina; Milovanovic, Ivan; Radusinovic, Milica] Univ Childrens Hosp, Dept Gastroenterol Hepatol & GI Endoscopy, Belgrade, Serbia; [Stevic, Marija] Univ Childrens Hosp, Dept Anesthesia, Belgrade, Serbia; [Ristic, Milos] Clin Ctr Serbia, Emergency Ctr, Emergency Surg, Belgrade, Serbia; [Ristic, Maja] Inst Publ Hlth Belgrade, Dept Nutr & Food Safety Control, Belgrade, Serbia; [Tepavcevic, Darija Kisic] Inst Epidemiol, Belgrade, Serbia; [Tepavcevic, Darija Kisic; Alempijevic, Tamara] Univ Belgrade, Fac Med, Belgrade, Serbia; [Alempijevic, Tamara] Clin Ctr Serbia, Clin Gastroenterol & Hepatol, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia; University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Ristic, N (corresponding author), Univ Childrens Hosp, Dept Gastroenterol Hepatol & GI Endoscopy, Belgrade, Serbia.	nina.ristic13@gmail.com						BOIXOCHOA J, 1980, J PEDIATR SURG, V15, P74, DOI 10.1016/S0022-3468(80)80407-6; Bredenoord AJ, 2009, NEUROGASTROENT MOTIL, V21, P807, DOI 10.1111/j.1365-2982.2009.01306.x; Dent J, 1999, GUT, V44, pS1, DOI 10.1136/gut.44.2008.S1; El-Serag HB, 2001, GASTROENTEROLOGY, V121, P1294, DOI 10.1053/gast.2001.29545; Francavilla R, 2010, J PEDIATR GASTR NUTR, V50, P154, DOI 10.1097/MPG.0b013e3181a4c1d8; Frazzoni M, 2003, ALIMENT PHARM THERAP, V18, P1091, DOI 10.1046/j.1365-2036.2003.01768.x; Genevay M, 2010, ARCH PATHOL LAB MED, V134, P815, DOI 10.1043/1543-2165-134.6.815; Gilger MA, 2008, J PEDIATR GASTR NUTR, V47, P141, DOI 10.1097/MPG.0b013e31815eeabe; Goldani HAS, 2012, WORLD J GASTRO ENDOS, V4, P339, DOI 10.4253/wjge.v4.i8.339; Hassall E, 2012, J PEDIATR-US, V160, P193, DOI 10.1016/j.jpeds.2011.08.067; Hojsak I, 2016, NEUROGASTROENT MOTIL, V28, P1488, DOI 10.1111/nmo.12846; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Liu YW, 2016, PEDIATR NEONATOL, V57, P385, DOI 10.1016/j.pedneo.2015.09.008; Loots CM, 2009, J PEDIATR-US, V154, P248, DOI 10.1016/j.jpeds.2008.08.019; Loots CM, 2011, GASTROESOPHAGEAL REF; Luthold SC, 2010, WORLD J GASTROENTERO, V16, P2401, DOI 10.3748/wjg.v16.i19.2401; Lupu VV, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003804; Orenstein SR, 1996, CLIN PEDIATR, V35, P607, DOI 10.1177/000992289603501201; Orenstein Susan R, 2010, Curr Gastroenterol Rep, V12, P431, DOI 10.1007/s11894-010-0140-1; Pilic D, 2013, SCAND J GASTROENTERO, V48, P785, DOI 10.3109/00365521.2013.793388; Pilic D, 2011, J PEDIATR-US, V158, P650, DOI 10.1016/j.jpeds.2010.09.033; Richter JE, 2003, AM J MED SCI, V326, P300, DOI 10.1097/00000441-200311000-00006; Salvatore S, 2005, J PEDIATR GASTR NUTR, V40, P210, DOI 10.1097/00005176-200502000-00024; Salvatore S, 2002, PEDIATRICS, V110, P972, DOI 10.1542/peds.110.5.972; Salvatore S, 2009, J PEDIATR GASTR NUTR, V49, P566, DOI 10.1097/MPG.0b013e3181a23dac; Sherman PM, 2009, AM J GASTROENTEROL, V104, P1278, DOI 10.1038/ajg.2009.129; Shin MS, 2012, J MATERN-FETAL NEO M, V25, P2406, DOI 10.3109/14767058.2012.697944; Sifrim D, 2004, GUT, V53, P1024, DOI 10.1136/gut.2003.033290; Stein MR, 2003, AM J MED, V115, p55S, DOI 10.1016/S0002-9343(03)00194-3; Stordal K, 2005, SCAND J GASTROENTERO, V40, P636, DOI 10.1080/00365520510015502; VANDENPLAS Y, 1991, PEDIATRICS, V88, P834; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; Wenzl TG, 2001, PEDIATR PULM, V31, P144, DOI 10.1002/1099-0496(200102)31:2<144::AID-PPUL1023>3.0.CO;2-Z; Wenzl TG, 2012, J PEDIATR GASTR NUTR, V55, P230, DOI 10.1097/MPG.0b013e3182592b65; Zentilin P, 2005, AM J GASTROENTEROL, V100, P2299, DOI 10.1111/j.1572-0241.2005.50209.x	35	4	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187081	10.1371/journal.pone.0187081	http://dx.doi.org/10.1371/journal.pone.0187081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095882	Green Submitted, Green Published, gold			2022-12-27	WOS:000414340200044
J	Mihailovic, PM; Lio, WM; Yano, J; Zhao, XN; Zhou, JC; Chyu, KY; Shah, PK; Cercek, B; Dimayuga, PC				Mihailovic, Peter M.; Lio, Wai Man; Yano, Juliana; Zhao, Xiaoning; Zhou, Jianchang; Chyu, Kuang-Yuh; Shah, Prediman K.; Cercek, Bojan; Dimayuga, Paul C.			The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; ANTIMICROBIAL PEPTIDE LL-37; CD8 T-CELLS; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; HLA PEPTIDOME; INFLAMMATION; AUTOIMMUNITY; DEFICIENCY; EXPRESSION	Auto-immunity is believed to contribute to inflammation in atherosclerosis. The antimicrobial peptide LL-37, a fragment of the cathelicidin protein precursor hCAP18, was previously identified as an autoantigen in psoriasis. Given the reported link between psoriasis and coronary artery disease, the biological relevance of the autoantigen to atherosclerosis was tested in vitro using a truncated (t) form of the mouse homolog of hCAP18, CRAMP, on splenocytes from athero-prone ApoE(-/-) mice. Stimulation with tCRAMP resulted in increased CD8+ T cells with Central Memory and Effector Memory phenotypes in ApoE(-/-) mice, differentially activated by feeding with normal chow or high fat diet. Immunization of ApoE(-/-) with different doses of the shortened peptide (Cramp) resulted in differential outcomes with a lower dose reducing atherosclerosis whereas a higher dose exacerbating the disease with increased neutrophil infiltration of the atherosclerotic plaques. Low dose Cramp immunization also resulted in increased splenic CD8+ T cell degranulation and reduced CD11b+ CD11c+ conventional dendritic cells (cDCs), whereas high dose increased CD11b+CD11c+ cDCs. Our results identified CRAMP, the mouse homolog of hCAP-18, as a potential self antigen involved in the immune response to atherosclerosis in the ApoE(-/-) mouse model.	[Mihailovic, Peter M.; Lio, Wai Man; Yano, Juliana; Zhao, Xiaoning; Zhou, Jianchang; Chyu, Kuang-Yuh; Shah, Prediman K.; Cercek, Bojan; Dimayuga, Paul C.] Cedars Sinai Heart Inst, Oppenheimer Atherosclerosis Res Ctr, Div Cardiol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Dimayuga, PC (corresponding author), Cedars Sinai Heart Inst, Oppenheimer Atherosclerosis Res Ctr, Div Cardiol, Los Angeles, CA 90048 USA.	dimayugap@cshs.org	Mihailovic, Peter Marko/ABG-5713-2020		Eleanor and Harold Foonberg Endowed Chair in Cardiac Intensive Care Fund; Joe Weider Foundation; Heart Foundation; Petersen Foundation	Eleanor and Harold Foonberg Endowed Chair in Cardiac Intensive Care Fund; Joe Weider Foundation; Heart Foundation; Petersen Foundation	Funding was provided by the Eleanor and Harold Foonberg Endowed Chair in Cardiac Intensive Care Fund (PMM). This work was also supported by the Joe Weider Foundation, Heart Foundation, and the Petersen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlehoff O, 2011, J INTERN MED, V270, P237, DOI 10.1111/j.1365-2796.2011.02368.x; Almanzar G, 2012, J AUTOIMMUN, V39, P441, DOI 10.1016/j.jaut.2012.07.006; Bassani-Sternberg M, 2010, P NATL ACAD SCI USA, V107, P18769, DOI 10.1073/pnas.1008501107; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bourdetsky D, 2014, P NATL ACAD SCI USA, V111, pE1591, DOI 10.1073/pnas.1321902111; Chen M, 2012, BLOOD, V119, P127, DOI 10.1182/blood-2011-06-363994; Chyu KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030780; Ciornei Cristina D, 2006, BMC Cardiovasc Disord, V6, P49, DOI 10.1186/1471-2261-6-49; Daissormont ITMN, 2011, CIRC RES, V109, P1387, DOI 10.1161/CIRCRESAHA.111.256529; Dhanji S, 2006, J IMMUNOL, V177, P138, DOI 10.4049/jimmunol.177.1.138; Dimayuga PC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005318; DiSpirito JR, 2010, CELL RES, V20, P13, DOI 10.1038/cr.2009.140; Doring Y, 2012, CIRC RES, V110, P1052, DOI 10.1161/CIRCRESAHA.112.265868; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Edfeldt K, 2006, ARTERIOSCL THROM VAS, V26, P1551, DOI 10.1161/01.ATV.0000223901.08459.57; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hickman HD, 2010, P NATL ACAD SCI USA, V107, P18747, DOI 10.1073/pnas.1013851107; Kahlenberg JM, 2013, J IMMUNOL, V191, P4895, DOI 10.4049/jimmunol.1302005; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Lande R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6621; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Legein B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15414; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; MacRitchie N, 2012, ARTERIOSCL THROM VAS, V32, P2569, DOI 10.1161/ATVBAHA.112.251314; Mangold A, 2015, CIRC RES, V116, P1182, DOI 10.1161/CIRCRESAHA.116.304944; Martinic MM, 2010, J AUTOIMMUN, V35, P404, DOI 10.1016/j.jaut.2010.08.006; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Nilsson J, 2012, CURR OPIN LIPIDOL, V23, P422, DOI 10.1097/MOL.0b013e328356ec7c; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Picard D, 2014, BRIT J DERMATOL, V171, P580, DOI 10.1111/bjd.13155; Rombouts M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6467375; Sage AP, 2014, CIRCULATION, V130, P1363, DOI 10.1161/CIRCULATIONAHA.114.011090; Santilli S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0947-0; Shaw MK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00095; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Swee LK, 2014, EUR J IMMUNOL, V44, P1299, DOI 10.1002/eji.201343840; Terrell CE, 2013, BLOOD, V121, P5184, DOI 10.1182/blood-2013-04-495309; Tse K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00493; Turner MJ, 2008, J EXP MED, V205, P1859, DOI 10.1084/jem.20072390; Van Brussel I, 2015, J IMMUNOL METHODS, V417, P76, DOI 10.1016/j.jim.2014.12.010; Van Vre EA, 2006, CORONARY ARTERY DIS, V17, P243, DOI 10.1097/00019501-200605000-00007; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2; Wu HZ, 2004, J IMMUNOL, V173, P297, DOI 10.4049/jimmunol.173.1.297; Yun TJ, 2016, CELL METAB, V23, P852, DOI 10.1016/j.cmet.2016.04.010; Zhang ZY, 2015, IMMUNITY, V43, P1137, DOI 10.1016/j.immuni.2015.10.018; Zhao HJ, 2012, J ATHEROSCLER THROMB, V19, P357, DOI 10.5551/jat.10108; Zhou JC, 2014, BIOCHEM BIOPH RES CO, V443, P864, DOI 10.1016/j.bbrc.2013.12.057	49	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187432	10.1371/journal.pone.0187432	http://dx.doi.org/10.1371/journal.pone.0187432			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091929	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700064
J	Neto, AF; Rocha, PRD; Perez, EC; Xavier, JG; Peres, GB; Spadacci-Morena, DD; Alvares-Saraiva, AM; Lallo, MA				Neto, Aldo Francisco; Dell'Armelina Rocha, Paulo Ricardo; Perez, Elizabeth Christina; Xavier, Jose Guilherme; Peres, Giovani Bravin; Spadacci-Morena, Diva Denelle; Alvares-Saraiva, Anuska Marcelino; Lallo, Maria Anete			Diabetes mellitus increases the susceptibility to encephalitozoonosis in mice	PLOS ONE			English	Article							CUNICULI INFECTION; IMMUNOSUPPRESSED MICE; IMMUNE-RESPONSE; URINARY-TRACT; ENTEROCYTOZOON-BIENEUSI; POSTMENOPAUSAL WOMEN; COMMON INFECTIONS; RISK; CYCLOPHOSPHAMIDE; MICROSPORIDIOSIS	Microsporidiosis are diseases caused by opportunistic intracellular fungi in immunosuppressed individuals, as well as in transplanted patients, the elderly and children, among others. Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia and decreased T cell response, neutrophil function, humoral immunity failure, increasing the susceptibility to infections. Here, we investigated the susceptibility of streptozotocin (STZ)induced type I diabetic and/or immunosuppressed mice to encephalitozoonosis by Encephalitozoon cuniculi. Microscopically, granulomatous hepatitis, interstitial pneumonia and pielonephritis were observed in all infected groups. STZ treatment induced an immunossupressor effect in the populations of B (B-1 and B2) and CD4(+) T lymphocytes. Moreover, infection decreased CD4(+) and CD8(+) T lymphocytes and macrophages of DM mice. Furthermore, infection induced a significant increase of IL-6 and TNF-alpha cytokine serum levels in DM mice. IFN-y, the most important cytokine for the resolution of encephalitozoonosis, increased only in infected mice. In addition to the decreased immune response, DM mice were more susceptible to encephalitozoonosis, associated with increased fungal burden, and symptoms. Additionally, cyclophosphamide immunosuppression in DM mice further increased the susceptibility to encephalitozoonosis. Thus, microsporidiosis should be considered in the differential diagnosis of comorbidities in diabetics.	[Neto, Aldo Francisco; Dell'Armelina Rocha, Paulo Ricardo; Perez, Elizabeth Christina; Xavier, Jose Guilherme; Peres, Giovani Bravin; Alvares-Saraiva, Anuska Marcelino; Lallo, Maria Anete] Univ Paulista UNIP, Programa Patol Ambiental & Expt, Sao Paulo, Brazil; [Spadacci-Morena, Diva Denelle] Inst Butantan, Dept Fisiopatol, Sao Paulo, Brazil	Universidade Paulista; Instituto Butantan	Lallo, MA (corresponding author), Univ Paulista UNIP, Programa Patol Ambiental & Expt, Sao Paulo, Brazil.	anetelallo@hotmail.com	Spadacci-Morena, Diva Denelle/P-6390-2015; Alvares-Saraiva, Anuska M/J-1128-2016; Pérez, Elizabeth C/E-8057-2012; Rocha, Paulo Ricardo Dell'Armelina/AAW-3255-2020; Lallo, Maria Anete/D-5976-2012; Peres, Giovani B/D-4553-2013	Spadacci-Morena, Diva Denelle/0000-0003-1225-1715; Alvares-Saraiva, Anuska M/0000-0001-8899-4182; Pérez, Elizabeth C/0000-0003-3038-9902; Rocha, Paulo Ricardo Dell'Armelina/0000-0002-3086-2301; Peres, Giovani B/0000-0003-3890-5334; Lallo, Maria Anete/0000-0003-3578-3087	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Brazil [2012/51727-5]	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Brazil	This work was supported by Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Brazil, (Process number 2012/51727-5), to Dr Maria Anete Lallo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares-Saraiva AM, 2015, EUR J IMMUNOL, V45, P1452, DOI 10.1002/eji.201445409; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Boyko EJ, 2002, DIABETES CARE, V25, P1778, DOI 10.2337/diacare.25.10.1778; Braunfuchsova P, 2001, INT J PARASITOL, V31, P681, DOI 10.1016/S0020-7519(01)00134-5; Brode S, 2008, CRIT REV IMMUNOL, V28, P109, DOI 10.1615/CritRevImmunol.v28.i2.20; Brodsky RA, 2010, IMMUNOL RES, V47, P179, DOI 10.1007/s12026-009-8149-y; Calvet HM, 2001, INFECT DIS CLIN N AM, V15, P407, DOI 10.1016/S0891-5520(05)70153-7; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Chaudhry ZZ, 2013, LAB ANIM-UK, V47, P257, DOI 10.1177/0023677213489548; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Didier ES, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P307; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Ditrich O, 2011, J CLIN MICROBIOL, V49, P2769, DOI 10.1128/JCM.00620-11; Elnadi Nada A, 2015, J Egypt Soc Parasitol, V45, P443; Emadi A, 2009, NAT REV CLIN ONCOL, V6, P638, DOI 10.1038/nrclinonc.2009.146; Farnsworth CW, 2015, INFECT IMMUN, V83, P2264, DOI 10.1128/IAI.03074-14; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1111/j.1574-695X.1999.tb01397.x; Geerlings SE, 2000, EUR J CLIN INVEST, V30, P995, DOI 10.1046/j.1365-2362.2000.00745.x; Gill SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27636; Hinney B, 2016, INT J PARASITOL-PAR, V5, P76, DOI 10.1016/j.ijppaw.2016.01.001; Hu KK, 2004, ARCH INTERN MED, V164, P989, DOI 10.1001/archinte.164.9.989; Khan IA, 1999, INFECT IMMUN, V67, P1887; Khan IA, 2001, MICROBES INFECT, V3, P401, DOI 10.1016/S1286-4579(01)01397-1; Kicia M, 2014, J CLIN MICROBIOL, V52, P1780, DOI 10.1128/JCM.03328-13; Kowalewska B, 2016, PATIENT PREFER ADHER, V10, P591, DOI 10.2147/PPA.S97852; Lallo MA, 2005, ARQ NEURO-PSIQUIAT, V63, P246, DOI 10.1590/S0004-282X2005000200010; Lallo MA, 2002, REV SAUDE PUBL, V36, P621, DOI 10.1590/S0034-89102002000600012; Lallo MA, 2012, EXP PARASITOL, V131, P339, DOI 10.1016/j.exppara.2012.04.019; Lawlor EM, 2010, INFECT IMMUN, V78, P3097, DOI 10.1128/IAI.00181-10; Lores B, 2002, CLIN INFECT DIS, V34, P918, DOI 10.1086/339205; Martinez N, 2016, MICROBES INFECT, V18, P649, DOI 10.1016/j.micinf.2016.05.007; Metenier G, 2001, MICROBES INFECT, V3, P407, DOI 10.1016/S1286-4579(01)01398-3; Mohammad MK, 2006, INT IMMUNOL, V18, P1101, DOI 10.1093/intimm/dxl045; Moretto M, 2004, J IMMUNOL, V172, P4402, DOI 10.4049/jimmunol.172.7.4402; Muller A, 2001, J CLIN MICROBIOL, V39, P1630, DOI 10.1128/JCM.39.4.1630-1632.2001; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nagib PRA, 2010, IMMUNOBIOLOGY, V215, P971, DOI 10.1016/j.imbio.2010.02.001; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Price CL, 2010, J CELL MOL MED, V14, P1806, DOI 10.1111/j.1582-4934.2009.00803.x; Salat J, 2004, FOLIA PARASIT, V51, P275, DOI 10.14411/fp.2004.033; Salat J, 2006, PARASITOL RES, V99, P682, DOI 10.1007/s00436-006-0208-x; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Valencakova A, 2012, COMP IMMUNOL MICROB, V35, P1, DOI 10.1016/j.cimid.2011.11.004; da Costa LFV, 2017, IMMUNOBIOLOGY, V222, P218, DOI 10.1016/j.imbio.2016.09.018; Weidner E, 1999, J MED ENTOMOL, V36, P522, DOI 10.1093/jmedent/36.4.522; Weiss LM, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P371	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186954	http://dx.doi.org/10.1371/journal.pone.0186954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091912	Green Submitted, gold, Green Published			2022-12-27	WOS:000414229700036
J	Nunez, IA; Carlock, MA; Allen, JD; Owino, SO; Moehling, KK; Nowalk, P; Susick, M; Diagle, K; Sweeney, K; Mundle, S; Vogel, TU; Delagrave, S; Ramgopal, M; Zimmerman, RK; Kleanthous, H; Ross, TM				Nunez, Ivette A.; Carlock, Michael A.; Allen, James D.; Owino, Simon O.; Moehling, Krissy K.; Nowalk, Patricia; Susick, Michael; Diagle, Kensington; Sweeney, Kristen; Mundle, Sophia; Vogel, Thorsten U.; Delagrave, Simon; Ramgopal, Moti; Zimmerman, Richard K.; Kleanthous, Harry; Ross, Ted M.			Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains	PLOS ONE			English	Article							SEASONAL INFLUENZA; INTRINSIC DEFECTS; RANDOMIZED-TRIAL; B-CELLS; VIRUS; PROTECTION; INFECTION; EFFICACY; PEOPLE; NAIVE	Most humans have pre-existing immunity to influenza viruses. In this study, volunteers (ages of 18-85 years) were vaccinated with split, inactivated Fluzone TM influenza vaccine in four consecutive influenza seasons from 2013 to 2016 seasons. The impact of repeated vaccination on breadth and durability of antibodies was assessed as a result of vaccine strain changes. Total IgG anti-hemagglutinin (HA) binding antibodies and hemagglutinationinhibition (HAI) activity increased in all age groups against both influenza A HA components in the vaccine post-vaccination(day 21). However, younger subjects maintained seroprotective titers to the vaccine strains, which resulted in higher seroconversion rates in the elderly, since the HAI titers in elderly subjects were more likely to decline prior to the next season. Young subjects had significant HAI activity against historical, as well as contemporary H1 and H3 vaccine strains from the mid-1980s to present. In contrast, elderly subjects had HAI activity to H1 strains from all years, but were more likely to have HAI activity to older strains from 1918-1950s. They also had a more restricted HAI profile against H3 viruses compared to young subjects recognizing H3N2 influenza viruses from the mid-2000s to present. Vaccine recipients were then categorized by whether subjects seroconverted from a seronegative or seropositive pre-vaccination state. Regardless of age, immunological recall or 'back boosting' to antigenically related strains were associated with seroconversion to the vaccine strain. Overall, both younger and older people have the ability to mount a breadth of immune responses following influenza vaccination. This report describes how imprinting exposure differs across age groups, influences antibody cross-reactivity to past hemagglutinin antigenic variants, and shapes immune responses elicited by current split inactivated influenza vaccines. Understanding how current influenza vaccines are influenced by pre-existing immunity in people of different ages is critical for designing the next-generation of 'universal' or broadly-protective influenza vaccines.	[Nunez, Ivette A.; Carlock, Michael A.; Allen, James D.; Owino, Simon O.; Ross, Ted M.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA; [Moehling, Krissy K.; Nowalk, Patricia; Susick, Michael] Univ Pittsburgh, Dept Family Med, Pittsburgh, PA USA; [Diagle, Kensington; Sweeney, Kristen; Ramgopal, Moti; Kleanthous, Harry] Martin Hlth Syst, Clin Res Div, Stuart, FL USA; [Mundle, Sophia; Vogel, Thorsten U.; Delagrave, Simon] Sanofi Pasteur Inc, Res North Amer, Cambridge, MA USA; [Zimmerman, Richard K.; Ross, Ted M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; University of Georgia	Ross, TM (corresponding author), Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.; Ross, TM (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	tedross@uga.edu		Nunez, Ivette/0000-0003-3213-3628; Ross, Ted/0000-0003-1947-7469	Sanofi Pasteur, Inc.; Merck Co, Inc.; Pfizer Inc.; Georgia Research Alliance	Sanofi Pasteur, Inc.; Merck Co, Inc.(Merck & Company); Pfizer Inc.(Pfizer); Georgia Research Alliance	TMR and RKZ have research funding from Sanofi Pasteur, Inc. RKZ and MPN have additional support from Merck & Co, Inc., Pfizer Inc. TMR is also supported, in part, by the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Agency EM Use CfMPfH], 2014, EMACHMPVWP4572592014; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Andrews SF, 2015, J VIROL, V89, P3308, DOI 10.1128/JVI.02871-14; Blomberg BB, 2011, J CLIN INVEST, V121, P2981, DOI 10.1172/JCI58406; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; deBruijn IA, 1997, VACCINE, V15, P1323, DOI 10.1016/S0264-410X(97)00019-4; Deenick EK, 2013, J EXP MED, V210, P2739, DOI 10.1084/jem.20130323; Flannery B, 2017, MMWR-MORBID MORTAL W, V66, P167, DOI 10.15585/mmwr.mm6606a3; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Frasca D, 2012, INT IMMUNOL, V24, P175, DOI 10.1093/intimm/dxr123; Frasca D, 2010, VACCINE, V28, P8077, DOI 10.1016/j.vaccine.2010.10.023; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Hensley SE, 2014, CURR OPIN VIROL, V8, P85, DOI 10.1016/j.coviro.2014.07.007; Huang KYA, 2015, J CLIN INVEST, V125, P2631, DOI 10.1172/JCI81104; Jiang J, 2013, EXP GERONTOL, V48, P579, DOI 10.1016/j.exger.2013.02.027; Kaml M, 2006, VACCINE, V24, P6808, DOI 10.1016/j.vaccine.2006.06.037; Kim JH, 2016, VACCINE, V34, P4594, DOI 10.1016/j.vaccine.2016.07.018; Lee J, 2016, NAT MED, V22, P1023, DOI 10.1038/nm.4145; Lefebvre JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25051; McElhaney JE, 2013, LANCET INFECT DIS, V13, P485, DOI 10.1016/S1473-3099(13)70046-X; Miller MS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006637; Moens L, 2016, IMMUNOL CELL BIOL, V94, P774, DOI 10.1038/icb.2016.41; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pera A, 2015, MATURITAS, V82, P50, DOI 10.1016/j.maturitas.2015.05.004; Plant EP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05579-4; Pritz T, 2015, EUR J IMMUNOL, V45, P738, DOI 10.1002/eji.201444878; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Ross TM, 2014, HUM VACC IMMUNOTHER, V10, P1195, DOI 10.4161/hv.28313; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Shinde V, 2009, NEW ENGL J MED, V360, P2616; Skowronski DM, 2017, J INFECT DIS, V215, P1059, DOI 10.1093/infdis/jix074; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Souty C, 2015, HUM VACC IMMUNOTHER, V11, P1621, DOI 10.1080/21645515.2015.1046661; Valero-Pacheco N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150146; van Essen GA, 2014, INFLUENZA OTHER RESP, V8, P452, DOI 10.1111/irv.12245; Wong TM, 2017, J VIROL IN PRESS; World Health Organization, 2011, MAN LAB DIAGN VIR SU	46	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185666	10.1371/journal.pone.0185666	http://dx.doi.org/10.1371/journal.pone.0185666			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091724	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700009
J	Garbarino, S; Magnavita, N; Guglielmi, O; Maestri, M; Dini, G; Bersi, FM; Toletone, A; Chiorri, C; Durando, P				Garbarino, Sergio; Magnavita, Nicola; Guglielmi, Ottavia; Maestri, Michelangelo; Dini, Guglielmo; Bersi, Francesca Maria; Toletone, Alessandra; Chiorri, Carlo; Durando, Paolo			Insomnia is associated with road accidents. Further evidence from a study on truck drivers	PLOS ONE			English	Article							SLEEP DISORDERS; SHIFT WORK; IMPACT; RISK; INJURIES; DURATION; FATIGUE; HABITS; HEALTH; ADULTS	Background Sleep-related problems are known risk factors for road accidents. However, very few studies have investigated the role played by insomnia and its components, and no data are available for a population of occupational drivers at risk, such as the truck driver category. Objective To measure the prevalence and impact of insomnia on motor vehicle accidents (MVAs) and near-miss accidents (NMAs) in 949 truck drivers. Design Cross-sectional survey. Results Insomnia affected 27.5% of the sample. Compared to other drivers, in the 3 years prior to the study, truck drivers with insomnia had reported a significantly higher number of MVAs; they had also reported a greater number of NMAs in the previous 6 months. After correction for the presence of obstructive sleep apnea, excessive daytime sleepiness, short sleep duration, and other concurrent diseases, insomniac truck drivers had an almost two-fold risk of driving accidents (OR: 1.82, CI 95%: 1.33-2.49) and a more than three-fold increased risk of near-miss accidents (OR: 3.35, CI95%: 2.06-5.45) compared to non-insomniac drivers. Conclusion Insomnia emerged as an independent risk factor for MVAs and NMAs. We strongly advise screening commercial drivers for signs and symptoms of insomnia in order to improve health and safety on the road.	[Garbarino, Sergio; Guglielmi, Ottavia] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy; [Garbarino, Sergio; Dini, Guglielmo; Bersi, Francesca Maria; Toletone, Alessandra; Durando, Paolo] Univ Genoa, Postgrad Sch Occupat Med, Dept Hlth Sci, Genoa, Italy; [Magnavita, Nicola] Univ Cattolica Sacro Cuore, Inst Publ Hlth, Occupat Hlth Unit, Rome, Italy; [Maestri, Michelangelo] Univ Pisa, Dept Clin & Expt Med, Neurol Unit, Pisa, Italy; [Dini, Guglielmo; Bersi, Francesca Maria; Durando, Paolo] Osped Policlin San Martino, Occupat Med Unit, Genoa, Italy; [Chiorri, Carlo] Univ Genoa, Dept Educ Sci, Genoa, Italy	University of Genoa; University of Genoa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Pisa; University of Genoa	Magnavita, N (corresponding author), Univ Cattolica Sacro Cuore, Inst Publ Hlth, Occupat Hlth Unit, Rome, Italy.	nicolamagnavita@gmail.com	Garbarino, Sergio/X-5368-2018; Maestri, Michelangelo/AAJ-2879-2020; Magnavita, Nicola/J-6074-2014; Garbarino, Sergio/AAV-4629-2021	Garbarino, Sergio/0000-0002-8508-552X; Maestri, Michelangelo/0000-0003-0960-4938; Magnavita, Nicola/0000-0002-0988-7344; Garbarino, Sergio/0000-0002-8508-552X	CNH Iveco Industrial Corporation [25171877]	CNH Iveco Industrial Corporation	Medical examinations were funded by CNH Iveco Industrial Corporation, Grant n.25171877. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Printing expenses were covered with University funds (D1, 2015) of the Corresponding Author (NM).	Adams RJ, 2017, SLEEP HEALTH, V3, P35, DOI 10.1016/j.sleh.2016.11.005; Akerstedt T, 2002, J SLEEP RES, V11, P69, DOI 10.1046/j.1365-2869.2002.00287.x; American Academy of Sleep Medicine, 2005, INT CLASSLEEP DIS; American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S, V3; American Psychiatric Association, 2013, DSM 5 DIAGN STAT MAN, V5th; Arnold PK, 1997, ACCIDENT ANAL PREV, V29, P471, DOI 10.1016/S0001-4575(97)00026-2; CDC-Centers for Disease Control and Prevention. Short sleep duration among workers D United States, 2010, MMWR-MORBID MORTAL W, V61, P281; Dembe AE, 2005, OCCUP ENVIRON MED, V62, P588, DOI 10.1136/oem.2004.016667; Folkard S, 2003, OCCUP MED-OXFORD, V53, P95, DOI 10.1093/occmed/kqg047; Fragoso CAV, 2010, J AM GERIATR SOC, V58, P1878, DOI 10.1111/j.1532-5415.2010.03083.x; Garbarino S, 2001, SLEEP, V24, P203; Garbarino S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166262; James L, 2017, AM J IND MED, V60, P449, DOI 10.1002/ajim.22714; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kessler RC, 2012, SLEEP, V35, P825, DOI 10.5665/sleep.1884; Kumar S, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030037; Laraqui O, 2008, ARCH MAL PROF ENVIRO, V69, P574, DOI 10.1016/j.admp.2008.02.018; Laugsand LE, 2014, SLEEP, V37, P1776, DOI 10.5665/sleep.4170; Leger D, 2002, SLEEP, V25, P625; Leger D, 2006, SLEEP, V29, P171; Leger D, 2014, J SLEEP RES, V23, P143, DOI 10.1111/jsr.12104; Lerman SE, 2012, J OCCUP ENVIRON MED, V54, P231, DOI 10.1097/JOM.0b013e318247a3b0; Lian YL, 2015, J PSYCHOSOM RES, V78, P45, DOI 10.1016/j.jpsychores.2014.09.009; Mohebbi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031790; Moradifar Razmik, 2014, Electron Physician, V6, P827, DOI 10.14661/2014.932-827-831; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; NSF, 2009, SLEEP AM POLL; O'Mahony S, 2017, AM J HOSP PALLIAT CA; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Patel SR, 2007, SLEEP, V30, P1077, DOI 10.1093/sleep/30.9.1077; Perez-Chada D, 2005, SLEEP, V28, P1103, DOI 10.1093/sleep/28.9.1103; Perrier J, 2014, SLEEP, V37, P1565, DOI 10.5665/sleep.4012; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Sateia MJ, 2017, J CLIN SLEEP MED, V13, P307, DOI 10.5664/jcsm.6470; Shahly V, 2012, ARCH GEN PSYCHIAT, V69, P1054, DOI 10.1001/archgenpsychiatry.2011.2188; Smolensky MH, 2011, ACCIDENT ANAL PREV, V43, P533, DOI 10.1016/j.aap.2009.12.004; Souza JC, 2005, ARQ NEURO-PSIQUIAT, V63, P925, DOI 10.1590/S0004-282X2005000600004; Swanson LM, 2011, J SLEEP RES, V20, P487, DOI 10.1111/j.1365-2869.2010.00890.x; Sweetman AM, 2017, SLEEP MED REV, V33, P28, DOI 10.1016/j.smrv.2016.04.004; Tahghighi M, 2017, J ADV NURS, V73, P2065, DOI 10.1111/jan.13283; Talmage JB, 2008, J OCCUP ENVIRON MED, V50, P324, DOI 10.1097/JOM.0b013e3181617ab8; Uehli K, 2014, SLEEP MED REV, V18, P61, DOI 10.1016/j.smrv.2013.01.004; Van Dongen HPA, 2009, IND HEALTH, V47, P518, DOI 10.2486/indhealth.47.518; Wong CKH, 2012, J OCCUP ENVIRON MED, V54, P989, DOI 10.1097/JOM.0b013e3182535d7d	44	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187256	10.1371/journal.pone.0187256	http://dx.doi.org/10.1371/journal.pone.0187256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088276	Green Published, Green Submitted, gold			2022-12-27	WOS:000414088900055
J	Johnsenl, A; Kearns, AM; Omland, KE; Anmarkrud, JA				Johnsenl, Arild; Kearns, Anna M.; Omland, Kevin E.; Anmarkrud, Jarl Andreas			Sequencing of the complete mitochondrial genome of the common raven Corvus corax (Aves: Corvidae) confirms mitogenome-wide deep lineages and a paraphyletic relationship with the Chihuahuan raven C. cryptoleucus	PLOS ONE			English	Article							PASSERIFORMES CORVIDAE; GENE ORDER; CROW; PHYLOGENETICS; EVOLUTION; HISTORY; DNA	Previous studies based on single mitochondrial markers have shown that the common raven (Corvus corax) consists of two highly diverged lineages that are hypothesised to have undergone speciation reversal upon secondary contact. Furthermore, common ravens are paraphyletic with respect to the Chihuahuan raven (C. cryptoleucus) based on mitochondrial DNA (mtDNA). Here we explore the causes of mtDNA paraphyly by sequencing whole mitochondrial genomes of 12 common ravens from across the Northern Hemisphere, in addition to three Chihuahuan ravens and one closely related brown-necked raven (C. ruficollis) using a long-range PCR protocol. Our raven mitogenomes ranged between 16925-16928 bp in length. GC content varied from 43.3% to 43.8% and the 13 protein coding genes, two rRNAs and 22 tRNAs followed a standard avian mitochondrial arrangement. The overall divergence between the two common raven clades was 3% (range 0.3-5.8% in 16 regions including the protein coding genes, rRNAs and the control region). Phylogenies constructed from whole mitogenomes recovered the previously found mitochondrial sister relationship between the common raven California clade and the Chihuahuan raven (overall divergence 1.1%), which strengthens the hypothesis that mtDNA paraphyly in the common raven results from speciation reversal of previously distinct Holarctic and California lineages.	[Johnsenl, Arild; Kearns, Anna M.; Anmarkrud, Jarl Andreas] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Kearns, Anna M.; Omland, Kevin E.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA; [Kearns, Anna M.] Smithsonian Conservat Biol Inst, Ctr Conservat Gen, Natl Zool Pk, Washington, DC USA	University of Oslo; University System of Maryland; University of Maryland Baltimore County; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Johnsenl, A (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	arild.johnsen@nhm.uio.no	Anmarkrud, Jarl Andreas/R-1822-2019; Anmarkrud, Jarl Andreas/G-2651-2015; Kearns, Anna M/H-5812-2019	Anmarkrud, Jarl Andreas/0000-0002-7496-4430; Anmarkrud, Jarl Andreas/0000-0002-7496-4430; Kearns, Anna M/0000-0002-8502-7442; Johnsen, Arild/0000-0003-4864-6284	Norwegian Research Council [213592]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was financed by a grant to AJ from the Norwegian Research Council, https://www.forskningsradet.no/en/Home_page/1177315753906 (grant no 213592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 2011, ZOOL J LINN SOC-LOND, V161, P573, DOI 10.1111/j.1096-3642.2010.00656.x; Anmarkrud JA, 2017, MOL ECOL RESOUR, V17, P334, DOI 10.1111/1755-0998.12600; Baker JM, 2006, IBIS, V148, P174, DOI 10.1111/j.1474-919X.2006.00493.x; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; del Hoyo J, 2009, HDB BIRDS WORLD, V14; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Ekblom R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-467; Feldman CR, 2005, ZOOL SCR, V34, P145, DOI 10.1111/j.1463-6409.2005.00182.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fleischer RC, 2008, MOL ECOL, V17, P464, DOI 10.1111/j.1365-294X.2007.03532.x; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Gibb GC, 2015, GENOME BIOL EVOL, V7, P2983, DOI 10.1093/gbe/evv196; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Haran J, 2013, MOL PHYLOGENET EVOL, V67, P156, DOI 10.1016/j.ympev.2012.12.022; Haring E, 2012, J ZOOL SYST EVOL RES, V50, P230, DOI 10.1111/j.1439-0469.2012.00664.x; Irwin DE, 2009, BIOL J LINN SOC, V98, P422, DOI 10.1111/j.1095-8312.2009.01282.x; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Jonsson KA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-72; Krzeminska U, 2016, MITOCHONDRIAL DNA A, V27, P974, DOI 10.3109/19401736.2014.926512; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li XF, 2016, MITOCHONDRIAL DNA A, V27, P4213, DOI 10.3109/19401736.2015.1022745; Lifjeld JT, 2016, BMC ZOOL, V1, DOI 10.1186/s40850-016-0008-4; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Miya M, 2015, ICHTHYOL RES, V62, P29, DOI 10.1007/s10228-014-0440-9; Moray C, 2014, GENOME BIOL EVOL, V6, P161, DOI 10.1093/gbe/evu005; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; Omland KE, 2006, MOL ECOL, V15, P795, DOI 10.1111/j.1365-294X.2005.02827.x; Omland KE, 2000, P ROY SOC B-BIOL SCI, V267, P2475, DOI 10.1098/rspb.2000.1308; Rutz C, 2016, NATURE, V537, P403, DOI 10.1038/nature19103; Scofield RP, 2017, MOL PHYLOGENET EVOL, V106, P136, DOI 10.1016/j.ympev.2016.09.022; Singh TR, 2008, MOL BIOL EVOL, V25, P475, DOI 10.1093/molbev/msn003; Sloan DB, 2017, MOL ECOL, V26, P2212, DOI 10.1111/mec.13959; Smith DR, 2016, BRIEF FUNCT GENOMICS, V15, P47, DOI 10.1093/bfgp/elv027; Smith DR, 2015, P NATL ACAD SCI USA, V112, P10177, DOI 10.1073/pnas.1422049112; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Talavera G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-315; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Webb WC, 2011, MOL ECOL, V20, P2390, DOI 10.1111/j.1365-294X.2011.05095.x; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615	43	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187316	10.1371/journal.pone.0187316	http://dx.doi.org/10.1371/journal.pone.0187316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084259	Green Published, Green Submitted, gold			2022-12-27	WOS:000413910200048
J	Ranak, MSAN; Azad, S; Nor, NNHBM; Zamli, KZ				Ranak, M. S. A. Noman; Azad, Saiful; Nor, Nur Nadiah Hanim Binti Mohd; Zamli, Kamal Z.			Press touch code: A finger press based screen size independent authentication scheme for smart devices	PLOS ONE			English	Article							RESISTANT; ATTACKS	Due to recent advancements and appealing applications, the purchase rate of smart devices is increasing at a higher rate. Parallely, the security related threats and attacks are also increasing at a greater ratio on these devices. As a result, a considerable number of attacks have been noted in the recent past. To resist these attacks, many password-based authentication schemes are proposed. However, most of these schemes are not screen size independent; whereas, smart devices come in different sizes. Specifically, they are not suitable for miniature smart devices due to the small screen size and/or lack of full sized keyboards. In this paper, we propose a new screen size independent password-based authentication scheme, which also offers an affordable defense against shoulder surfing, brute force, and smudge attacks. In the proposed scheme, the Press Touch (PT)-a.k.a., Force Touch in Apple's MacBook, Apple Watch, ZTE's Axon 7 phone; 3D Touch in iPhone 6 and 7; and so on-is transformed into a new type of code, named Press Touch Code (PTC). We design and implement three variants of it, namely mono-PTC, multi-PTC, and multi-PTC with Grid, on the Android Operating System. An in-lab experiment and a comprehensive survey have been conducted on 105 participants to demonstrate the effectiveness of the proposed scheme.	[Ranak, M. S. A. Noman; Azad, Saiful; Nor, Nur Nadiah Hanim Binti Mohd; Zamli, Kamal Z.] Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Gambang, Kuantan, Malaysia; [Azad, Saiful; Zamli, Kamal Z.] UMP, IBM Ctr Excellence, Gambang, Kuantan, Malaysia	Universiti Malaysia Pahang; Universiti Malaysia Pahang	Azad, S (corresponding author), Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Gambang, Kuantan, Malaysia.; Azad, S (corresponding author), UMP, IBM Ctr Excellence, Gambang, Kuantan, Malaysia.	saifulazad@ump.edu.my	Zamli, Kamal Z./F-6437-2010	Zamli, Kamal Z./0000-0003-4626-0513; Azad, Saiful/0000-0002-6234-7267	RDU - University Malaysia Pahang (UMP), Malaysia [RDU160353, RDU160107]; IBM Center of Excellence (IBMCoE)	RDU - University Malaysia Pahang (UMP), Malaysia; IBM Center of Excellence (IBMCoE)	This work is supported by the RDU grants RDU160353 and RDU160107, which are funded by the University Malaysia Pahang (UMP), Malaysia. IBM Center of Excellence (IBMCoE) supported authors Saiful Azad and Kamal Z. Zamli in the form of honorary fellowships. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; This work is supported by the RDU grants RDU160353 and RDU160107, which are funded by the University Malaysia Pahang (UMP), Malaysia. IBM Center of Excellence (IBMCoE) supported authors Saiful Azad and Kamal Z. Zamli in the form of honorary fellowships. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed N., 2012, ORTHOGONAL TRANSFORM; [Anonymous], [No title captured]; Aviv AJ, 2010, P USENIX 4 WORKSH OF; Azad S, 2017, COMPUT ELECTR ENG, V59, P99, DOI 10.1016/j.compeleceng.2016.12.007; Biddle R, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2333112.2333114; Blasco J, 2016, ACM COMPUT SURV, V49, DOI 10.1145/2968215; Blonder GE, 1996, uS Patent, Patent No. [US 5559961, 5559961, 5,559,961]; Chakraborty N, 2016, PROCEDIA COMPUT SCI, V93, P854, DOI 10.1016/j.procs.2016.07.256; Chang TY, 2012, J SYST SOFTWARE, V85, P1157, DOI 10.1016/j.jss.2011.12.044; Debnath A, 2014, J KING SAUD UNIV-COM, V26, P228, DOI 10.1016/j.jksuci.2013.12.006; Dirik A. E., 2007, P 3 S US PRIV SEC SO, P20, DOI DOI 10.1145/1280680.1280684; eMarketer, 2017, SMARTPH US WORLDW WI; Gokhale AS, 2016, PROCEDIA COMPUT SCI, V79, P490, DOI 10.1016/j.procs.2016.03.063; Guo JM, 2012, EXPERT SYST APPL, V39, P11728, DOI 10.1016/j.eswa.2012.04.081; Harbach M, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P4806, DOI 10.1145/2858036.2858267; Krombholz K, 2015, J INF SECUR APPL, V22, P113, DOI 10.1016/j.jisa.2014.09.005; Kwon T, 2014, COMPUT SECUR, V42, P137, DOI 10.1016/j.cose.2013.12.001; Leyk D, 2006, EUR J APPL PHYSIOL, V96, P593, DOI 10.1007/s00421-005-0126-0; Murdoch SJ, 2011, P IEEE S SEC PRIV OA; Nayak A, 2016, PROCEDIA COMPUT SCI, V79, P553, DOI 10.1016/j.procs.2016.03.070; Passfaces Corporation, PASSF 2 FACT ATH ENT; Pawar M., 2017, INT J ADV RES COMPUT, V6, P265; Por L. Y., 2008, WSEAS Transactions on Information Science and Applications, V5, P943; Reddy AG, 2017, IEEE ACCESS, V5, P3622, DOI 10.1109/ACCESS.2017.2666258; Saito S., 2016, J INF PROCESS, V24, P217; Samangouei P, 2017, IMAGE VISION COMPUT, V58, P181, DOI 10.1016/j.imavis.2016.05.004; Shahzad A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010037; Siek KA, 2005, LECT NOTES COMPUT SC, V3585, P267, DOI 10.1007/11555261_24; Snell B, 2017, MOBILE THREAT REPORT; Thomas H. Cormen, 2014, INTRO ALGORITHMS; Tsai PW, 2014, IEEE SYST J, V8, P395, DOI 10.1109/JSYST.2012.2208153; Wright N, 2012, P 8 S US PRIV SEC	33	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186940	10.1371/journal.pone.0186940	http://dx.doi.org/10.1371/journal.pone.0186940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084262	gold, Green Published, Green Submitted			2022-12-27	WOS:000413910200020
J	Campbell, DC; Piller, KR				Campbell, D. Cooper; Piller, Kyle R.			Let's jump in: A phylogenetic study of the great basin springfishes and poolfishes, Crenichthys and Empetrichthys (Cyprinodontiformes: Goodeidae)	PLOS ONE			English	Article							AMERICAN FRESH-WATER; BAYESIAN-INFERENCE; CRYPTIC DIVERSITY; GENE; CONSERVATION; TELEOSTEI; SEQUENCE; FISHES; PHYLOGEOGRAPHY; PERCIDAE	North America's Great Basin has long been of interest to biologists due to its high level of organismal endemicity throughout its endorheic watersheds. One example of such a group is the subfamily Empetricthyinae. In this paper, we analyzed the relationships of the Empetrichtyinae and assessed the validity of the subspecies designations given by Williams and Wilde within the group using concatenated phylogenetic tree estimation and species tree estimation. Samples from 19 populations were included covering the entire distribution of the three extant species of Empetricthyinae-Crenichthys nevadae, Crenichthys baileyi and Empetricthys latos. Three nuclear introns (S8 intron 4, S7 intron 1, and P0 intron 1) and one mitochondrial gene (Cytb) were sequenced for phylogenetic analysis. Using these sequences, we generated two separate hypotheses of the evolutionary relationships of Empetrichtyinae-one based on the mitochondrial data and one based on the nuclear data using Bayesian phylogenetics. Haplotype networks were also generated to look at the relationships of the populations within Empetrichthyinae. After comparing the two phylogenetic hypotheses, species trees were generated using *BEAST with the nuclear data to further test the validity of the subspecies within Empetrichthyinae. The mitochondrial analyses supported four lineages within C. baileyi and 2 within C. nevadae. The concatenated nuclear tree was more conserved, supporting one clade and an unresolved polytomy in both species. The species tree analysis supported the presence of two species within both C. baileyi and C. nevadae. Based on the results of these analyses, the subspecies designations of Williams and Wilde are not valid, rather a conservative approach suggests there are two species within C. nevadae and two species within C. baileyi. No structure was found for E. latos or the populations of Empetricthyinae. This study represents one of many demonstrating the invalidity of subspecies and their detriment to species identification, conservation, and understanding.	[Campbell, D. Cooper; Piller, Kyle R.] Southeastern Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA	University of Louisiana System; Southeastern Louisiana University	Piller, KR (corresponding author), Southeastern Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA.	kyle.piller@selu.edu			Division Of Environmental Biology [1354930] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		BALL RM, 1992, AUK, V109, P626; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Braby MF, 2012, BIOL J LINN SOC, V106, P699, DOI 10.1111/j.1095-8312.2012.01909.x; Burbrink FT, 2009, SOC STUDY EVOLUTION, V54, P2107; Burkhead NM, 2012, BIOSCIENCE, V62, P798, DOI 10.1525/bio.2012.62.9.5; Chow S, 1999, MOL ECOL, V8, P513; Chow Seinen, 2016, International Aquatic Research, V8, P29, DOI 10.1007/s40071-016-0122-5; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Deacon JE, 2010, WEST N AM NATURALIST, V70, P425, DOI 10.3398/064.070.0401; Doadrio I, 2004, MOL PHYLOGENET EVOL, V31, P416, DOI 10.1016/j.ympev.2003.08.022; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Escobar-Camacho D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135569; FROST DR, 1994, CLADISTICS, V10, P259, DOI 10.1111/j.1096-0031.1994.tb00178.x; FROST DR, 1990, HERPETOLOGICA, V46, P87; GHISELIN MT, 1974, SYST ZOOL, V23, P536, DOI 10.2307/2412471; Gilbert C. H., 1893, North American Fauna, VNo. 7, P229, DOI 10.3996/nafa.7.0003; GRANT EC, 1995, COPEIA, P209; Guadalupe K, 2012, NEVADA DEP WILDLIFE, V2, P81; Halas D, 2014, MOL PHYLOGENET EVOL, V70, P13, DOI 10.1016/j.ympev.2013.08.014; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hundt PJ, 2016, ZOOLOGICAL J LINNEAN; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Jorgensen MC, 2013, ZOOL SCR, V42, P317, DOI 10.1111/zsc.12003; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; La Rivers I, 1994, FISHES FISHERIES NEV; La Voie A, 2004, FED REGISTER, V69, P17383; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Manier MK, 2004, BIOL J LINN SOC, V83, P65, DOI 10.1111/j.1095-8312.2004.00373.x; Mayden RL, 2002, FISH FISH, V3, P171, DOI 10.1046/j.1467-2979.2002.00086.x; Mayr E., 1942, P1; MAYR E, 1982, AUK, V99, P593; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; McMahan CD, 2013, J BIOGEOGR, V40, P894, DOI 10.1111/jbi.12036; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; MILLER RR, 1989, FISHERIES, V14, P22, DOI 10.1577/1548-8446(1989)014<0022:EONAFD>2.0.CO;2; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Piller KR, 2008, MOL PHYLOGENET EVOL, V46, P974, DOI 10.1016/j.ympev.2007.11.023; Piller Kyle R., 2001, Copeia, V2001, P802, DOI 10.1643/0045-8511(2001)001[0802:MVOTRD]2.0.CO;2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; SCHMIDT TR, 1993, COPEIA, P880; Scoppettone GG, 2004, WEST N AM NATURALIST, V64, P45; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; US Fish and Wildlife Service, 1996, RAILR VALL SPRINGF C; Wiley E.O., 1981, PHYLOGENETICS THEORY; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; WILLIAMS J E, 1981, Southwestern Naturalist, V25, P485, DOI 10.2307/3670848; Williams JE, 1996, ENVIRON BIOL FISH, V45, P272, DOI 10.1007/BF00003095; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	59	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0185425	10.1371/journal.pone.0185425	http://dx.doi.org/10.1371/journal.pone.0185425			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077708	gold, Green Submitted, Green Published			2022-12-27	WOS:000413861200004
J	Ghodsalavi, B; Svenningsen, NB; Hao, XL; Olsson, S; Nicolaisen, MH; Abu Al-Soud, W; Sorensen, SJ; Nybroe, O				Ghodsalavi, Behnoushsadat; Svenningsen, Nanna Bygvraa; Hao, Xiuli; Olsson, Stefan; Nicolaisen, Mette Haubjerg; Abu Al-Soud, Waleed; Sorensen, Soren J.; Nybroe, Ole			A novel baiting microcosm approach used to identify the bacterial community associated with Penicillium bilaii hyphae in soil	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGUS; RHIZOSPHERE BACTERIA; SELECTION; POPULATIONS; MYCOSPHERE; DIVERSITY	It is important to identify and recover bacteria associating with fungi under natural soil conditions to enable eco-physiological studies, and to facilitate the use of bacterial-fungal consortia in environmental biotechnology. We have developed a novel type of baiting microcosm, where fungal hyphae interact with bacteria under close-to-natural soil conditions; an advantage compared to model systems that determine fungal influences on bacterial communities in laboratory media. In the current approach, the hyphae are placed on a solid support, which enables the recovery of hyphae with associated bacteria in contrast to model systems that compare bulk soil and mycosphere soil. We used the baiting microcosm approach to determine, for the first time, the composition of the bacterial community associating in the soil with hyphae of the phosphate-solubilizer, Penicillium bilaii. By applying a cultivation-independent 16S rRNA gene-targeted amplicon sequencing approach, we found a hypha-associated bacterial community with low diversity compared to the bulk soil community and exhibiting massive dominance of Burkholderia OTUs. Burkholderia is known be abundant in soil environments affected by fungi, but the discovery of this massive dominance among bacteria firmly associating with hyphae in soil is novel and made possible by the current bait approach.	[Ghodsalavi, Behnoushsadat; Svenningsen, Nanna Bygvraa; Hao, Xiuli; Olsson, Stefan; Nicolaisen, Mette Haubjerg; Nybroe, Ole] Univ Copenhagen, Sect Microbial Ecol & Biotechnol, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Olsson, Stefan] Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China; [Abu Al-Soud, Waleed; Sorensen, Soren J.] Univ Copenhagen, Sect Microbiol, Dept Biol, Copenhagen, Denmark	University of Copenhagen; Fujian Agriculture & Forestry University; University of Copenhagen	Nybroe, O (corresponding author), Univ Copenhagen, Sect Microbial Ecol & Biotechnol, Dept Plant & Environm Sci, Frederiksberg C, Denmark.	oln@plen.ku.dk	Olsson, Stefan/I-5889-2019; Sørensen, Søren Johannes/N-2120-2019; Abu Al-Soud, Waleed/AAH-3477-2021; Nybroe, Ole/G-2421-2014; Sørensen, Søren J/J-5015-2014; Abu Al-Soud, Waleed/K-4408-2014; Olsson, Stefan/H-2617-2014; Nicolaisen, Mette/H-1853-2014	Olsson, Stefan/0000-0003-1931-9081; Sørensen, Søren Johannes/0000-0001-6227-9906; Abu Al-Soud, Waleed/0000-0002-1143-9233; Nybroe, Ole/0000-0001-7354-0188; Sørensen, Søren J/0000-0001-6227-9906; Abu Al-Soud, Waleed/0000-0002-1143-9233; Olsson, Stefan/0000-0003-1931-9081; Nicolaisen, Mette/0000-0002-0983-2466	Innovation Fund Denmark from the Council for Strategic Research [1308-00016B]	Innovation Fund Denmark from the Council for Strategic Research	This study was funded by Innovation Fund Denmark (https://innovationsfonden.dk/en) through grant number 1308-00016B from the Council for Strategic Research to Ole Nybroe. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; This work was supported by Innovation Fund Denmark by grant number 1308-00016B from the Council for Strategic Research.	Ballhausen MB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01416; Boersma FGH, 2010, SOIL BIOL BIOCHEM, V42, P2137, DOI 10.1016/j.soilbio.2010.08.009; Cruz Andre Freire, 2004, Acta Bot. Bras., V18, P473, DOI 10.1590/S0102-33062004000300007; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Eberl L, 2016, F1000; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Furuno S, 2012, MICROB BIOTECHNOL, V5, P142, DOI 10.1111/j.1751-7915.2011.00309.x; Halsey JA, 2016, ANTON LEEUW INT J G, V109, P1353, DOI 10.1007/s10482-016-0734-1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrington BJ, 2003, LAB MED, V34, P361, DOI 10.1309/EPH2TDT8335GH0R3; Ipcho S, 2016, G3-GENES GENOM GENET, V6, P1585, DOI 10.1534/g3.116.027987; Johansson JF, 2004, FEMS MICROBIOL ECOL, V48, P1, DOI 10.1016/j.femsec.2003.11.012; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Kost T, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00421; Lumini E, 2007, CELL MICROBIOL, V9, P1716, DOI 10.1111/j.1462-5822.2007.00907.x; Nazir R., 2013, MICROB DISCOV, V10, P1; Nazir R, 2010, FEMS MICROBIOL ECOL, V71, P169, DOI 10.1111/j.1574-6941.2009.00807.x; Cuong ND, 2011, MICROB ECOL, V62, P425, DOI 10.1007/s00248-011-9823-x; Nuccio EE, 2013, ENVIRON MICROBIOL, V15, P1870, DOI 10.1111/1462-2920.12081; Ravnskov S, 1999, NEW PHYTOL, V142, P113, DOI 10.1046/j.1469-8137.1999.00374.x; Ritz K., 2004, Mycologist, V18, P52, DOI 10.1017/S0269915X04002010; Rudnick MB, 2015, SOIL BIOL BIOCHEM, V88, P73, DOI 10.1016/j.soilbio.2015.04.015; Sahin N, 2003, RES MICROBIOL, V154, P399, DOI 10.1016/S0923-2508(03)00112-8; Scheublin TR, 2010, ISME J, V4, P752, DOI 10.1038/ismej.2010.5; Simon A, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv116; Stopnisek N, 2016, ISME J, V10, P253, DOI 10.1038/ismej.2015.73; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Takeda M, 2006, CAN J MICROBIOL, V52, P1121, DOI 10.1139/W06-074; Taktek S, 2015, SOIL BIOL BIOCHEM, V90, P1, DOI 10.1016/j.soilbio.2015.07.016; Timonen S, 2006, CAN J MICROBIOL, V52, P769, DOI 10.1139/W06-016; Toljander JF, 2006, FEMS MICROBIOL LETT, V254, P34, DOI 10.1111/j.1574-6968.2005.00003.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Ul Haq I, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw164; van der Bom F, 2017, EUR J AGRON, V86, P12, DOI 10.1016/j.eja.2017.02.006; Warmink JA, 2008, ISME J, V2, P887, DOI 10.1038/ismej.2008.41	35	16	16	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187116	10.1371/journal.pone.0187116	http://dx.doi.org/10.1371/journal.pone.0187116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077733	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200046
J	Sun, H; Kalakoti, P; Sharma, K; Thakur, JD; Dossani, RH; Patra, DP; Phan, K; Akbarian-Tefaghi, H; Farokhi, F; Notarianni, C; Guthikonda, B; Nanda, A				Sun, Hai; Kalakoti, Piyush; Sharma, Kanika; Thakur, Jai Deep; Dossani, Rimal H.; Patra, Devi Prasad; Phan, Kevin; Akbarian-Tefaghi, Hesam; Farokhi, Frank; Notarianni, Christina; Guthikonda, Bharat; Nanda, Anil			Proposing a validated clinical app predicting hospitalization cost for extracranial-intracranial bypass surgery	PLOS ONE			English	Article							INTERNATIONAL RANDOMIZED-TRIAL; OCCLUSIVE CEREBROVASCULAR-DISEASE; NATIONWIDE INPATIENT SAMPLE; UNITED-STATES; ARTERIAL BYPASS; NEVER EVENTS; SUBARACHNOID HEMORRHAGE; ENDOVASCULAR TREATMENT; MOYAMOYA-DISEASE; CASE VOLUME	Object United States healthcare reforms are focused on curtailing rising expenditures. In neurosurgical domain, limited or no data exists identifying potential modifiable targets associated with high-hospitalization cost for cerebrovascular procedures such as extracranial-intracranial (ECIC) bypass. Our study objective was to develop a predictive model of initial cost for patients undergoing bypass surgery. Methods In an observational cohort study, we analyzed patients registered in the Nationwide Inpatient Sample (2002-2011) that underwent ECIC bypass. Split-sample 1:1 randomization of the study cohort was performed. Hospital cost data was modelled using ordinary least square to identity potential drivers impacting initial hospitalization cost. Subsequently, a validated clinical app for estimated hospitalization cost is proposed (https://www. neurosurgerycost. com/calc/ec-ic-by-pass). Results Overall, 1533 patients [mean age: 45.18 +/- 19.51 years; 58% female] underwent ECIC bypass for moyamoya disease [45.1%], cerebro-occlusive disease (COD) [23% without infarction; 12% with infarction], unruptured [12%] and ruptured [4%] aneurysms. Median hospitalization cost was $37,525 (IQR: $16,225-$58,825). Common drivers impacting cost include Asian race, private payer, elective admission, hyponatremia, neurological and respiratory complications, acute renal failure, bypass for moyamoya disease, COD without infarction, medium and high volume centers, hospitals located in Midwest, Northeast, and West region, total number of diagnosis and procedures, days to bypass and post-procedural LOS. Our model was validated in an independent cohort and using 1000-bootstrapped replacement samples. Conclusions Identified drivers of hospital cost after ECIC bypass could potentially be used as an adjunct for creation of data driven policies, impact reimbursement criteria, aid in-hospital auditing, and in the cost containment debate.	[Sun, Hai; Kalakoti, Piyush; Sharma, Kanika; Thakur, Jai Deep; Dossani, Rimal H.; Patra, Devi Prasad; Akbarian-Tefaghi, Hesam; Farokhi, Frank; Notarianni, Christina; Guthikonda, Bharat; Nanda, Anil] Louisiana State Univ, Hlth Sci Ctr, Neurosurg, Shreveport, LA 71105 USA; [Phan, Kevin] Prince Wales Private Hosp, NeuroSpine Surg Res Grp NSURG, Barker St Randwick, Sydney, NSW, Australia	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Nanda, A (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosurg, Shreveport, LA 71105 USA.	ananda@lsuhsc.edu	Sharma, Kanika/S-2467-2019; Sun, Hai/Z-3229-2019; Kalakoti, Piyush/J-5269-2015	Sharma, Kanika/0000-0003-1376-3720; Sun, Hai/0000-0001-8878-8776; Kalakoti, Piyush/0000-0002-9169-7418	Malcolm Feist Seed Funding; CSNS/CNS	Malcolm Feist Seed Funding; CSNS/CNS	This study was supported by Malcolm Feist Seed Funding to HS (LSUHSC) and partly by the CSNS/CNS Medical Student Fellowship in Socioeconomic Research to HAT.	Akbarian-Tefaghi H, 2017, WORLD NEUROSURG; Amin-Hanjani S, 2005, J NEUROSURG, V103, P794, DOI 10.3171/jns.2005.103.5.0794; AWAD IA, 1986, NEUROSURGERY, V19, P655, DOI 10.1227/00006123-198610000-00028; Baaj AA, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.01.FOCUS08293; Bambakidis NC, 2010, J NEUROINTERV SURG, V2, P229, DOI 10.1136/jnis.2010.002808; Bang OY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130663; Barker FG, 2004, NEUROSURGERY, V54, P18, DOI 10.1227/01.NEU.0000097195.48840.C4; BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191, DOI 10.1056/nejm198511073131904; BARNETT HJM, 1986, SURG NEUROL, V26, P227, DOI 10.1016/0090-3019(86)90154-0; BEARDEN D, 1994, J AM GERIATR SOC, V42, P1143, DOI 10.1111/j.1532-5415.1994.tb06979.x; Bekelis K, 2016, J NEUROINTERV SURG, V8, P316, DOI 10.1136/neurintsurg-2014-011575; Bekelis K, 2015, J NEUROINTERV SURG, V7, P543, DOI 10.1136/neurintsurg-2014-011222; DAY AL, 1986, SURG NEUROL, V26, P222, DOI 10.1016/0090-3019(86)90153-9; Donaghy R M, 1968, Prog Brain Res, V30, P263; Familiari P, 2015, NEUROSURGERY, V77, P733, DOI 10.1227/NEU.0000000000000917; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; FIELDS WS, 1976, JAMA-J AM MED ASSOC, V235, P2734, DOI 10.1001/jama.235.25.2734; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442; Gobble RM, 2012, J VASC SURG, V56, P1303, DOI 10.1016/j.jvs.2012.03.281; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Jeng JS, 2010, EXPERT REV CARDIOVAS, V8, P1423, DOI 10.1586/ERC.10.129; Kalakoti P, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.5.FOCUS15157; Kalakoti P, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.3.FOCUS1547; Kalani MYS, 2015, WORLD NEUROSURG, V83, P345, DOI 10.1016/j.wneu.2014.10.013; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Klebanoff MA, 2008, AM J EPIDEMIOL, V168, P355, DOI 10.1093/aje/kwn071; Liu HM, 1996, STROKE, V27, P650, DOI 10.1161/01.STR.27.4.650; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Mathiesen T, 2015, J NEUROSURG, V123, P629, DOI 10.3171/2014.12.JNS142758; Milstein A, 2009, NEW ENGL J MED, V360, P2388, DOI 10.1056/NEJMp0809125; Missios S, 2015, J CLIN NEUROSCI, V22, P1632, DOI 10.1016/j.jocn.2015.05.005; Missios S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0742-2; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Morse BC, 2010, AM SURGEON, V76, P841; Pandey AS, 2015, NEUROSURGERY, V77, P462, DOI 10.1227/NEU.0000000000000850; Park EK, 2008, J KOREAN NEUROSURG S, V44, P228, DOI 10.3340/jkns.2008.44.4.228; Powers WJ, 2011, JAMA-J AM MED ASSOC, V306, P1983, DOI 10.1001/jama.2011.1610; Prabhakaran S, 2014, NEUROSURGERY, V75, P500, DOI 10.1227/NEU.0000000000000475; Reichman OH, 2009, J STROKE CEREBROVASC, V18, P389, DOI 10.1016/j.jstrokecerebrovasdis.2009.03.004; Shrive Fiona M, 2006, BMC Med Res Methodol, V6, P57, DOI 10.1186/1471-2288-6-57; Starke RM, 2012, NEUROSURGERY, V71, P93, DOI 10.1227/NEU.0b013e318253ab8e; SUNDT TM, 1987, NEW ENGL J MED, V316, P814, DOI 10.1056/NEJM198703263161318; Suri MFK, 2009, J NEUROIMAGING, V19, p11S, DOI 10.1111/j.1552-6569.2009.00415.x; Titsworth WL, 2016, STROKE, V47, P1303, DOI 10.1161/STROKEAHA.115.012168; Titsworth WL, 2016, STROKE S1, V47; WELCH K, 1956, J NEUROSURG, V13, P73, DOI 10.3171/jns.1956.13.1.0073; Wen T, 2014, J NEUROSURG, V121, P580, DOI 10.3171/2014.4.JNS131253; Wu ZG, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/896458	49	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186758	10.1371/journal.pone.0186758	http://dx.doi.org/10.1371/journal.pone.0186758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077743	Green Published, Green Submitted, gold			2022-12-27	WOS:000413861200021
J	Yamada, Y; Shimada, T; Motomura, Y; Sato, F				Yamada, Yasuyuki; Shimada, Tomoe; Motomura, Yukiya; Sato, Fumihiko			Modulation of benzylisoquinoline alkaloid biosynthesis by heterologous expression of CjWRKY1 in Eschscholzia californica cells	PLOS ONE			English	Article							OPIUM POPPY; MOLECULAR-CLONING; COPTIS-JAPONICA; SANGUINARINE BIOSYNTHESIS; TRANSCRIPTION FACTORS; ENZYME; PLANTS; BERBERINE; PATHWAY; PROTEIN	Transcription factors control many processes in plants and have high potentials to manipulate specialized metabolic pathways. Transcriptional regulation of the biosynthesis of mono-terpenoid indole alkaloids (MIAs), nicotine alkaloids, and benzylisoquinoline alkaloids (BIAs) has been characterized using Catharanthus roseus, Nicotiana and Coptis plants. However, metabolic engineering in which specific transcription factors are used in alkaloid biosynthesis is limited. In this study, we characterized the effects of ectopic expression of CjWRKY1, which is a transcriptional activator with many targets in BIA biosynthesis in Coptis japonica (Ranunculaceae) and Eschscholzia californica (California poppy, Papaveraceae). Heterologous expression of CjWRKY1 in cultured California poppy cells induced increases in transcripts of several genes encoding BIA biosynthetic enzymes. Metabolite analyses indicated that the overexpression of the CjWRKY1 gene also induced increases in the accumulation of BIAs such as sanguinarine, chelerythrine, chelirubine, protopine, allocryptopine, and 10-hydroxychelerythrine in the culture medium. Previous characterization of EcbHLH1 and current results indicated that both transcription factors, WRKY1 and bHLH1, are substantially involved in the regulation of BIA biosynthesis. We discuss the function of CjWRKY1 in E. californica cells and its potential for metabolic engineering in BIA biosynthesis.	[Yamada, Yasuyuki; Shimada, Tomoe; Motomura, Yukiya; Sato, Fumihiko] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Dept Plant Gene & Totipotency, Kyoto, Japan; [Yamada, Yasuyuki] Kobe Pharmaceut Univ, Lab Med Cell Biol, Kobe, Hyogo, Japan	Kyoto University; Kobe Pharmaceutical University	Yamada, Y; Sato, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Dept Plant Gene & Totipotency, Kyoto, Japan.; Yamada, Y (corresponding author), Kobe Pharmaceut Univ, Lab Med Cell Biol, Kobe, Hyogo, Japan.	yyamada.m08@lif.kyoto-u.ac.jp; fsato@lif.kyoto-u.ac.jp	Sato, Fumihiko/C-1078-2011; Yamada, Yasuyuki/AAG-7576-2020	Sato, Fumihiko/0000-0001-9497-4452; Yamada, Yasuyuki/0000-0003-4699-9799	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [26221201]	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [Grant-in-Aid for Scientific Research (S); 26221201 to F.S.]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagoz Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30910; Apuya NR, 2008, PLANT BIOTECHNOL J, V6, P160, DOI 10.1111/j.1467-7652.2007.00302.x; Beaudoin GAW, 2013, BIOCHEM BIOPH RES CO, V431, P597, DOI 10.1016/j.bbrc.2012.12.129; Boke H, 2015, PLANT BIOTECHNOL J, V13, P409, DOI 10.1111/pbi.12346; Dewey RE, 2013, PHYTOCHEMISTRY, V94, P10, DOI 10.1016/j.phytochem.2013.06.002; DITTRICH H, 1991, P NATL ACAD SCI USA, V88, P9969, DOI 10.1073/pnas.88.22.9969; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Facchini PJ, 2008, PLANT J, V54, P763, DOI 10.1111/j.1365-313X.2008.03438.x; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2012, J BIOL CHEM, V287, P42972, DOI 10.1074/jbc.M112.420414; Heinze M, 2015, PLANT CELL, V27, P448, DOI 10.1105/tpc.114.135343; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; Inui T, 2007, PLANT CELL PHYSIOL, V48, P252, DOI 10.1093/pcp/pcl062; Kato N, 2007, PLANT CELL PHYSIOL, V48, P8, DOI 10.1093/pcp/pcl041; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Mishra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052784; Purwanto R, 2017, PLANT CELL PHYSIOL, V58, P1528, DOI 10.1093/pcp/pcx093; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sato F, 2013, BIOSCI BIOTECH BIOCH, V77, P1, DOI 10.1271/bbb.120759; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; Takemura T, 2010, PLANT CELL PHYSIOL, V51, P949, DOI 10.1093/pcp/pcq063; Yamada Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01352; Yamada Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31988; Yamada Y, 2015, PLANT CELL PHYSIOL, V56, P1019, DOI 10.1093/pcp/pcv027; Yamada Y, 2011, PLANT CELL PHYSIOL, V52, P1131, DOI 10.1093/pcp/pcr062; Zhou M, 2016, BIOTECHNOL ADV; Zhu XX, 2014, FRONT MED-PRC, V8, P285, DOI 10.1007/s11684-014-0350-2	33	10	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186953	10.1371/journal.pone.0186953	http://dx.doi.org/10.1371/journal.pone.0186953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077729	Green Published, gold, Green Submitted			2022-12-27	WOS:000413861200029
J	Eroshenko, GA; Nosov, NY; Krasnov, YM; Oglodin, YG; Kukleva, LM; Guseva, NP; Kuznetsov, AA; Abdikarimov, ST; Dzhaparova, AK; Kutyrev, VV				Eroshenko, Galina A.; Nosov, Nikita Yu; Krasnov, Yaroslav M.; Oglodin, Yevgeny G.; Kukleva, Lyubov M.; Guseva, Natalia P.; Kuznetsov, Alexander A.; Abdikarimov, Sabyrzhan T.; Dzhaparova, Aigul K.; Kutyrev, Vladimir V.			Yersinia pestis strains of ancient phylogenetic branch 0. ANT are widely spread in the high-mountain plague foci of Kyrgyzstan	PLOS ONE			English	Article								Fifty six Yersinia pestis strains, isolated over the period of more than 50 years in three high-mountain foci of Kyrgyzstan (Tien Shan, Alai, and Talas), have been characterized by means of PCR and single nucleotide polymorphism (SNP) typing methods. Seven of these strains were also characterized by means of whole genome sequencing and genome-wide SNP phylogenetic analysis. It was found that forty two strains belong to 0.ANT2, 0.ANT3 and 0.ANT5 phylogenetic branches. From these, strains of 0.ANT2 and 0.ANT3 branches were earlier detected in China only, whereas 0.ANT5 phylogenetic branch was identified for Y. pestis phylogeny for the first time. According to the results of genome-wide SNP analysis, 0.ANT5 strains are ones of the most closely related to Y. pestis strain responsible for the Justinianic Plague. We have also found out that four of the studied strains belong to the phylogenetic branch 2.MED1, and ten strains from Talas high-mountain focus belong to the phylogenetic branch 0.PE4 (sub-branch 0.PE4t). Established diversity of Y. pestis strains and extensive dissemination of the strains pertaining to the 0.ANT branch confirm the antiquity of the mentioned above plague foci and suggest that strains of the 0.ANT branch, which serve as precursors for all highly virulent Y. pestis strains, had their origin in the Tien Shan mountains.	[Eroshenko, Galina A.; Nosov, Nikita Yu; Krasnov, Yaroslav M.; Oglodin, Yevgeny G.; Kukleva, Lyubov M.; Guseva, Natalia P.; Kuznetsov, Alexander A.; Kutyrev, Vladimir V.] Fed Serv Surveillance Sphere Consumers Rights Pro, Russian Res Antiplague Inst Microbe, Saratov, Russia; [Abdikarimov, Sabyrzhan T.; Dzhaparova, Aigul K.] Minist Hlth Kyrgyz Republ, Dept Dis Prevent, Ctr Quarantine & Particularly Dangerous Infect, Bishkek, Kyrgyzstan	Ministry of Health - Kyrgyzstan	Eroshenko, GA (corresponding author), Fed Serv Surveillance Sphere Consumers Rights Pro, Russian Res Antiplague Inst Microbe, Saratov, Russia.	geroshenko@yandex.ru	Nosov, Nikita/ABH-2045-2021; Eroshenko, Galina/AAL-1818-2020	Krasnov, Aroslav/0000-0002-4909-2394; Eroshenko, Galina/0000-0001-5403-989X				Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Bos KI, 2016, ELIFE, V5, DOI 10.7554/eLife.12994; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Devignat R, 1951, B WORLD HEALTH ORGAN, V4, P241; Eroshenko G. A., 2012, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P25; Eroshenko GA, 2012, ADV EXP MED BIOL, V954, P45, DOI 10.1007/978-1-4614-3561-7_6; Feldman M, 2016, MOL BIOL EVOL, V33, P2911, DOI 10.1093/molbev/msw170; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Motin VL, 2002, J BACTERIOL, V184, P1019, DOI 10.1128/jb.184.4.1019-1027.2002; Nikiforov K. A., 2015, INVENTIONS USEFUL MO, V29; Odinokov GN, 2013, PROBLEMY OSOBO OPASN, V3, P49; Onishchenko GG, 2004, NATURAL PLAGUE FOCI; Onishchenko GG., 2013, PRACTICE GUIDELINES; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Spyrou MA, 2016, CELL HOST MICROBE, V19, P874, DOI 10.1016/j.chom.2016.05.012; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2	16	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187230	10.1371/journal.pone.0187230	http://dx.doi.org/10.1371/journal.pone.0187230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073248	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400134
J	Sugiyama, A; Sone, D; Sato, N; Kimura, Y; Ota, M; Maikusa, N; Maekawa, T; Enokizono, M; Mori-Yoshimura, M; Ohya, Y; Kuwabara, S; Matsuda, H				Sugiyama, Atsuhiko; Sone, Daichi; Sato, Noriko; Kimura, Yukio; Ota, Miho; Maikusa, Norihide; Maekawa, Tomoko; Enokizono, Mikako; Mori-Yoshimura, Madoka; Ohya, Yasushi; Kuwabara, Satoshi; Matsuda, Hiroshi			Brain gray matter structural network in myotonic dystrophy type 1	PLOS ONE			English	Article							FACIAL EMOTION RECOGNITION; COGNITIVE IMPAIRMENT; ORBITOFRONTAL CORTEX; ODOR RECOGNITION; EXPANSION SIZE; CTG REPEAT; WHITE; DISEASE; LATERALIZATION; PERSONALITY	This study aimed to investigate abnormalities in structural covariance network constructed from gray matter volume in myotonic dystrophy type 1 (DM1) patients by using graph theoretical analysis for further clarification of the underlying mechanisms of central nervous system involvement. Twenty-eight DM1 patients (4 childhood onset, 10 juvenile onset, 14 adult onset), excluding three cases from 31 consecutive patients who underwent magnetic resonance imaging in a certain period, and 28 age-and sex-matched healthy control subjects were included in this study. The normalized gray matter images of both groups were subjected to voxel based morphometry (VBM) and Graph Analysis Toolbox for graph theoretical analysis. VBM revealed extensive gray matter atrophy in DM1 patients, including cortical and subcortical structures. On graph theoretical analysis, there were no significant differences between DM1 and control groups in terms of the global measures of connectivity. Betweenness centrality was increased in several regions including the left fusiform gyrus, whereas it was decreased in the right striatum. The absence of significant differences between the groups in global network measurements on graph theoretical analysis is consistent with the fact that the general cognitive function is preserved in DM1 patients. In DM1 patients, increased connectivity in the left fusiform gyrus and decreased connectivity in the right striatum might be associated with impairment in face perception and theory of mind, and schizotypal-paranoid personality traits, respectively.	[Sugiyama, Atsuhiko; Sato, Noriko; Kimura, Yukio; Maekawa, Tomoko; Enokizono, Mikako] Natl Ctr Neurol & Psychiat, Dept Radiol, Tokyo, Japan; [Sugiyama, Atsuhiko; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan; [Sone, Daichi; Maikusa, Norihide; Matsuda, Hiroshi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan; [Ota, Miho] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Mori-Yoshimura, Madoka; Ohya, Yasushi] Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; Chiba University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Sato, N (corresponding author), Natl Ctr Neurol & Psychiat, Dept Radiol, Tokyo, Japan.	snoriko@ncnp.go.jp	Sone, Daichi/J-7634-2019	Sone, Daichi/0000-0001-9617-706X; Kuwabara, Satoshi/0000-0002-4716-8578				Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Antonini G, 2004, J NEUROL NEUROSUR PS, V75, P1611, DOI 10.1136/jnnp.2003.032417; Baldanzi S, 2016, NEUROIMAGE-CLIN, V12, P190, DOI 10.1016/j.nicl.2016.06.011; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caso F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104697; Dai ZJ, 2014, NEUROSCI BULL, V30, P217, DOI 10.1007/s12264-013-1421-0; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Filippi M, 2013, LANCET NEUROL, V12, P1189, DOI 10.1016/S1474-4422(13)70144-3; Frassle S, 2016, NEUROIMAGE, V124, P977, DOI 10.1016/j.neuroimage.2015.09.055; Gourdon G, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00101; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Kleberg JL, 2014, ACTA NEUROL SCAND, V130, P312, DOI 10.1111/ane.12228; Kobayakawa M, 2012, NEUROSCI RES, V72, P341, DOI 10.1016/j.neures.2012.01.005; Kobayakawa M, 2010, J NEUROL SCI, V290, P48, DOI 10.1016/j.jns.2009.11.011; Masaoka Y, 2007, NEUROSCI LETT, V412, P45, DOI 10.1016/j.neulet.2006.10.055; Masaoka Y, 2011, NEUROSCI LETT, V503, P163, DOI 10.1016/j.neulet.2011.08.006; Meng M, 2012, P ROY SOC B-BIOL SCI, V279, P2052, DOI 10.1098/rspb.2011.1784; Meola G, 2007, MUSCLE NERVE, V36, P294, DOI 10.1002/mus.20800; Minnerop M, 2011, BRAIN, V134, P3527, DOI 10.1093/brain/awr299; Modoni A, 2008, J NEUROL, V255, P1737, DOI 10.1007/s00415-008-0017-5; Okkersen K, 2017, NEUROLOGY, V89, P960, DOI 10.1212/WNL.0000000000004300; Ota M, 2006, NEUROSCI LETT, V407, P234, DOI 10.1016/j.neulet.2006.08.077; Rolls ET, 2001, CHEM SENSES, V26, P595, DOI 10.1093/chemse/26.5.595; Romeo V, 2010, NEUROL SCI, V31, P757, DOI 10.1007/s10072-010-0406-2; Romeo V, 2010, J NEUROL, V257, P1246, DOI 10.1007/s00415-010-5498-3; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Sansone V, 2007, NEUROL SCI, V28, P9, DOI 10.1007/s10072-007-0742-z; Schneider-Gold C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130352; Serra L, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2696085; Serra L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156901; Serra L, 2015, FUNCT NEUROL, V30, P21; Serra L, 2014, JAMA NEUROL, V71, P603, DOI 10.1001/jamaneurol.2014.130; Sistiaga A, 2010, PSYCHOL MED, V40, P487, DOI 10.1017/S0033291709990602; Sone D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158728; Sporns O., 2011, NETWORKS BRAIN; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Weber YG, 2010, NEUROLOGY, V74, P1108, DOI 10.1212/WNL.0b013e3181d8c35f; Winblad S, 2006, J NEUROL NEUROSUR PS, V77, P219, DOI 10.1136/jnnp.2005.070763; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yoo WK, 2017, YONSEI MED J, V58, P807, DOI 10.3349/ymj.2017.58.4.807; Zanigni S, 2016, NEUROIMAGE-CLIN, V11, P678, DOI 10.1016/j.nicl.2016.04.012	43	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187343	10.1371/journal.pone.0187343	http://dx.doi.org/10.1371/journal.pone.0187343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095898	gold, Green Published, Green Submitted			2022-12-27	WOS:000414340200076
J	Minato, T; Maeda, T; Fujisawa, Y; Tsuji, H; Nomoto, K; Ohno, K; Hirayama, M				Minato, Tomomi; Maeda, Tetsuya; Fujisawa, Yoshiro; Tsuji, Hirokazu; Nomoto, Koji; Ohno, Kinji; Hirayama, Masaaki			Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; INTESTINAL MICROFLORA; COGNITIVE IMPAIRMENT; FECAL MICROBIOTA; LACTOBACILLUS; PCR; BIFIDOBACTERIA; METAANALYSIS; CHILDREN; BACTERIA	Background We previously reported gut dysbiosis in patients with Parkinson's disease (PD). Objective The aim of this study is to examine whether gut dysbiosis correlates with the progression of PD. Methods We examined changes in gut microbiota and demographic features in 2 years in 36 PD patients. Results A change of total UPDRS scores in 2 years was predicted by the counts of Bifidobacterium and Atopobium cluster at year 0 with a correlation coefficient of 0.52. Correlation analysis additionally revealed that low counts of Bifidobacterium and Bacteroides fragilis at year 0 were associated with worsening of UPDRS I scores in 2 years. In addition, low counts of Bifidobacterium at year 0 were associated with worsening of hallucinations/delusions in 2 years. Similarly, low counts of B. fragilis at year 0 were associated with worsening of motivation/initiative in 2 years. The patients were evenly divided into the deteriorated and stable groups based on the degree of worsening of total UPDRS scores. The deteriorated group had lower counts of Bifidobacterium, B. fragilis, and Clostridium leptium than the stable group at year 0 but not at year 2, suggesting that the deteriorated group may demonstrate accelerated lowering of these bacteria at year 0. Conclusions The total counts of intestinal bacterial decrease in the course of PD progression. Temporal profiles of lowering of bacterial counts are likely to be different from bacteria to bacteria, and also between the deteriorating and stable groups, which may be able to be exploited to differentiate patients with rapidly and slowly progressive PD pathology.	[Minato, Tomomi; Fujisawa, Yoshiro; Hirayama, Masaaki] Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Aichi, Japan; [Maeda, Tetsuya] Iwate Med Univ, Sch Med, Div Neurol & Gerontol, Dept Internal Med, Morioka, Iwate, Japan; [Tsuji, Hirokazu; Nomoto, Koji] Yakult Cent Inst, Tokyo, Japan; [Ohno, Kinji] Nagoya Univ, Grad Sch Med, Div Neurogenet, Ctr Neurol Dis & Canc, Nagoya, Aichi, Japan	Nagoya University; Iwate Medical University; Yakult Honsha Company, Limited; Nagoya University	Hirayama, M (corresponding author), Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Aichi, Japan.; Ohno, K (corresponding author), Nagoya Univ, Grad Sch Med, Div Neurogenet, Ctr Neurol Dis & Canc, Nagoya, Aichi, Japan.	ohnok@med.nagoya-u.ac.jp; hirasan@met.nagoya-u.ac.jp	Hirayama, Masaaki/I-9341-2018; Ohno, Kinji/ABD-5787-2020; Ohno, Kinji/H-4020-2012; Hirayama, Masaaki/ABH-2669-2020	Hirayama, Masaaki/0000-0003-0092-7837; Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; Hirokazu, Tsuji/0000-0003-2856-6447; Maeda, Tetsuya/0000-0002-6207-8343	Japan Society for the Promotion of Science [24500458, 15H04840]; Japan Agency for Medical Research and Development [17gm1010002h0002]; Smoking Research Foundation; Grants-in-Aid for Scientific Research [15H04840] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors acknowledge funding by the Japan Society for the Promotion of Science (JP) (24500458, 15H04840) (http://www.jsps.go.ip/), the Japan Agency for Medical Research and Development (JP) (17gm1010002h0002) (http://www.amed.go.jp/); and Smoking Research Foundation (JP) (http://www.srf.or.jp/). The Yakult Central Institute provided support in the form of salaries for HT and KN, but did not play any further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HT and KN blindly quantified intestinal microbiota, and were not involved in the data analysis. HT and KN provided essential experimental information, but did not affect the results and interpretation of our study.	Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Akbari E, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00256; Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; BRAEKHUS A, 1992, J AM GERIATR SOC, V40, P1139, DOI 10.1111/j.1532-5415.1992.tb01804.x; Ding PH, 2014, J PERIODONTAL RES, V49, P1, DOI 10.1111/jre.12081; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Fujiwara Y, 2010, GERIATR GERONTOL INT, V10, P225, DOI 10.1111/j.1447-0594.2010.00585.x; Goetze O, 2005, NEUROSCI LETT, V375, P170, DOI 10.1016/j.neulet.2004.11.007; Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Hill-Burns EM, 2017, MOV DISORD; HIRAYAMA M, 1995, J AUTONOM NERV SYST, V53, P230, DOI 10.1016/0165-1838(95)00002-F; Hirayama M, 2011, PARKINSONISM RELAT D, V17, P46, DOI 10.1016/j.parkreldis.2010.11.004; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hopfner F, 2017, BRAIN RES, V1667, P41, DOI 10.1016/j.brainres.2017.04.019; Jeong JJ, 2016, BENEF MICROBES, V7, P707, DOI 10.3920/BM2016.0016; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Kelly LP, 2014, MOVEMENT DISORD, V29, P999, DOI 10.1002/mds.25736; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Li W., 2017, SCI CHINA LIFE SCI; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; MITSUOKA T, 1992, NUTR REV, V50, P438, DOI 10.1111/j.1753-4887.1992.tb02499.x; Mountzouris KC, 2002, BRIT J NUTR, V87, P405, DOI 10.1079/BJN2002563; Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397; Noh SY, 2015, MOL IMMUNOL, V64, P183, DOI 10.1016/j.molimm.2014.11.014; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5; Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4; Petrov VA, 2017, B EXP BIOL MED+, V162, P734, DOI 10.1007/s10517-017-3700-7; Pompei A, 2007, APPL ENVIRON MICROB, V73, P179, DOI 10.1128/AEM.01763-06; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Saito S, 2006, CHEM SENSES, V31, P379, DOI 10.1093/chemse/bjj042; Sakaguchi S, 2010, J CLIN MICROBIOL, V48, P1624, DOI 10.1128/JCM.01724-09; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838; Sinha R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0841-8; Ueno N, 2011, INFLAMM BOWEL DIS, V17, P2235, DOI 10.1002/ibd.21597; Unger MM, 2016, PARKINSONISM RELAT D; Ventura M, 2014, J SCI FOOD AGR, V94, P163, DOI 10.1002/jsfa.6356	51	138	144	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187307	10.1371/journal.pone.0187307	http://dx.doi.org/10.1371/journal.pone.0187307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091972	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700054
J	Gopalam, R; Rupwate, SD; Tumaney, AW				Gopalam, Rahul; Rupwate, Sunny D.; Tumaney, Ajay W.			Selection and validation of appropriate reference genes for quantitative real-time PCR analysis in Salvia hispanica	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENOME-WIDE IDENTIFICATION; RT-PCR; HOUSEKEEPING GENES; TRANSCRIPT NORMALIZATION; EXPRESSION ANALYSIS; INTERNAL CONTROL; ABIOTIC STRESS; ARABIDOPSIS; ACCUMULATION	Quantitative real-time polymerase chain reaction (qRT-PCR) has become the most popular choice for gene expression studies. For accurate expression analysis, it is pertinent to select a stable reference gene to normalize the data. It is now known that the expression of internal reference genes varies considerably during developmental stages and under different experimental conditions. For Salvia hispanica, an economically important oilseed crop, there are no reports of stable reference genes till date. In this study, we chose 13 candidate reference genes viz. Actinl 1 (ACT), Elongation factor 1-alpha (EF1-alpha), Eukaryotic translation initiation factor 3E (ETIF3E), alpha tubulin (alpha-TUB), beta tubulin ((3-TUB), Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), Cyclophilin (CYP), Clathrin adaptor complex (CAC), Serine/threonine-protein phosphatase 2A (PP2A), FtsH protease (FtsH), 18S ribosomal RNA (18S rRNA), S-adenosyl methionine decarboxylase (SAMDC) and Rubisco activase (RCA) and the expression levels of these genes were assessed in a diverse set of tissue samples representing vegetative stages, reproductive stages and various abiotic stress treatments. Two of the widely used softwares, geNorm and Normfinder were used to evaluate the expression stabilities of these 13 candidate reference genes under different conditions. Results showed that GAPDH and CYP expression remain stable throughout in the different abiotic stress treatments, CAC and PP2A expression were relatively stable under reproductive stages and alpha-TUB, PP2A and ETIF3E were found to be stably expressed in vegetative stages. Further, the expression levels of Diacylglycerol acyltransferase (DGAT1), a key enzyme in triacylglycerol synthesis was analyzed to confirm the validity of reference genes identified in the study. This is the first systematic study of selection of reference genes in S. hispanica, and will benefit future expression studies in this crop.	[Gopalam, Rahul; Rupwate, Sunny D.; Tumaney, Ajay W.] CSIR CFTRI, Dept Lipid Sci, Mysore, Karnataka, India; [Gopalam, Rahul; Tumaney, Ajay W.] CSIR CFTRI, Acad Sci & Innovat Res AcSIR, Mysore, Karnataka, India; [Rupwate, Sunny D.] Ahmednagar Coll, Dr John Barnabas Post Grad Sch Biol Studies, Dept Chem, Ahmednagar, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Tumaney, AW (corresponding author), CSIR CFTRI, Dept Lipid Sci, Mysore, Karnataka, India.; Tumaney, AW (corresponding author), CSIR CFTRI, Acad Sci & Innovat Res AcSIR, Mysore, Karnataka, India.	ajay@cftri.res.in		Tumaney, Ajay W./0000-0003-3708-0123	Council of Scientific and Industrial Research, New Delhi, India; Council of Scientific and Industrial Research and Science and Engineering Research Board Department of Science and Technology, New Delhi fo [EEO/2016/000531]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research and Science and Engineering Research Board Department of Science and Technology, New Delhi fo	RG is thankful to Council of Scientific and Industrial Research, New Delhi, India, for fellowship. AWT acknowledges the financial support received from Council of Scientific and Industrial Research and Science and Engineering Research Board Department of Science and Technology (EEO/2016/000531), New Delhi for the current work.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; Ayerza R, 2011, IND CROP PROD, V34, P1366, DOI 10.1016/j.indcrop.2010.12.007; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fernandez-Aparicio M, 2013, MOL BIOL REP, V40, P3395, DOI 10.1007/s11033-012-2417-y; Gadkar VJ, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0952-4; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Ji YX, 2014, ACTA BIOCH BIOPH SIN, V46, P305, DOI 10.1093/abbs/gmu002; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Li J, 2016, FRONT PLANT SCI, P7; Li W, 2014, GENE, V547, P55, DOI 10.1016/j.gene.2014.06.015; Lin F, 2014, PLANT MOL BIOL, V86, P543, DOI 10.1007/s11103-014-0246-1; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Ma R, 2016, FRONT PLANT SCI, P7; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Munoz LA, 2013, FOOD REV INT, V29, P394, DOI 10.1080/87559129.2013.818014; Nakayama TJ, 2014, GENET MOL RES, V13, P860, DOI 10.4238/2014.February.13.4; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Niu XP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00848; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Reddy PS, 2016, FRONT HEAT MASS TRAN, P7; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sinha P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122847; Sreedhar RV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123580; Taylor DC, 2009, BOTANY, V87, P533, DOI 10.1139/B08-101; Tian C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117569; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Weselake RJ, 2005, BIOL SCI SER, P162; Wu ZJ, 2016, SCI REPORTS, P6, DOI DOI 10.1038/SREP19748; Yang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119569; Yim AKY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136343; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Zhuang H, 2015, FRONT PLANT SCI, P6	55	16	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186978	http://dx.doi.org/10.1371/journal.pone.0186978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091948	Green Published, gold, Green Submitted			2022-12-27	WOS:000414229700039
J	Mazza, A; Cavallin, F; Cappellari, A; Divisic, A; Grbin, I; Akakpo, J; Moukaila, AR; Trevisanuto, D				Mazza, Alessandro; Cavallin, Francesco; Cappellari, Anita; Divisic, Antuan; Grbin, Ivana; Akakpo, Jean; Moukaila, Abdou Razak; Trevisanuto, Daniele			Effect of a short training on neonatal face-mask ventilation performance in a low resource setting	PLOS ONE			English	Article							RESUSCITATION; GUIDELINES; MORTALITY; BABIES	Background We assessed whether a short training, effective in a high resource country, was able to improve the quality of face-mask ventilation (FMV) in a low resource setting. Methods Local healthcare providers at the Centre Me A dico-Social, Kouve, Togo were asked to ventilate a neonatal leak-free manikin before (time-t(1)) and after (t(2)) a two-minute training session. Immediately after this section, a further two-minute training with participants aware of the data monitor was offered. Finally, a third 1-minute FMV round (t(3)) was performed by each participant. Ventilatory parameters were recorded using a computerized system. Primary outcome was the percentage of breaths with relevant mask leak (>25%). Secondary outcomes were percentages of breaths with a low peak inspiratory pressure (PIP<20 cm H2O), within the recommended PIP (20-35 cm H2O) and with a high PIP (>35 cm H2O). Results Twenty-six subjects participated in the study. The percentage of relevant mask leak significantly decreased (p<0.0001; beta = -0.76, SE = 0.10) from 89.7% (SD 21.5%) at t(1) to 45.4% (SD 27.2%) at t(2) and to 18.3% (SD 20.1%) at t(3). The percentage of breaths within the recommended PIP significantly increased (p<0.0001; beta = +0.54, SE = 0.12). The percentage of breaths with PIP>35 cm H2O was 19.5% (SD 32.8%) at t(1) and 39.2% (SD 37.7%) at t(2) (padj = 0.27; beta = +0.61, SE = 0.36) and significantly decreased (padj = 0.01; beta = -1.61, SE = 0.55) to 6.0% (SD 15.4%) at t(3). Conclusions A 2-minute training on FMV, effective in a high resource country, had a positive effect also in a low resource setting. FMV performance further improved after an extra 2-minute verbal recall plus real time feedback. Although the training was extended, it still does not cost much time and effort. Further studies are needed to establish if these basic skills are transferred in real patients and if they are maintained over time.	[Mazza, Alessandro; Cappellari, Anita; Divisic, Antuan; Grbin, Ivana; Trevisanuto, Daniele] Univ Padua, Azienda Osped Padova, Dept Womens & Childrens Hlth, Padua, Italy; [Akakpo, Jean; Moukaila, Abdou Razak] Ctr Med Social, Maternite, Marie Mere Providence, Kouve, Togo	University of Padua; Azienda Ospedaliera - Universita di Padova	Trevisanuto, D (corresponding author), Univ Padua, Azienda Osped Padova, Dept Womens & Childrens Hlth, Padua, Italy.	daniele.trevisanuto@gmail.com	Divisic, Antuan/AAG-2819-2022; Divisic, Antuan/AFK-4023-2022	Trevisanuto, Daniele/0000-0002-7126-5298	Autonomous Province of Trento; Autonomous Region Trentino-Alto Adige, Italy	Autonomous Province of Trento(Autonomous Province of Trento); Autonomous Region Trentino-Alto Adige, Italy	Autonomous Province of Trento and Autonomous Region Trentino-Alto Adige, Italy, supported the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Autonomous Province of Trento and Autonomous Region Trentino-Alto Adige, Italy that supported the project.	[Anonymous], 2019, R LANG ENV STAT COMP; Kelm M, 2012, J PERINAT MED, V40, P583, DOI 10.1515/jpm-2012-0023; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Mduma E, 2015, RESUSCITATION, V93, P1, DOI 10.1016/j.resuscitation.2015.04.019; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Newton O, 2006, T ROY SOC TROP MED H, V100, P899, DOI 10.1016/j.trstmh.2006.02.012; Singhal N, 2006, CLIN PERINATOL, V33, P219, DOI 10.1016/j.clp.2005.11.009; Trevisanuto D, 2015, PLOS ONE, V11, P10; Unicef Levels & Trends in Child Mortality, 2013, LEV TRENDS CHILD MOR; van Vonderen JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109049; WHO, 2014, WORLD HLTH STAT; Wood FE, 2008, ARCH DIS CHILD-FETAL, V93, pF230, DOI 10.1136/adc.2007.117788; Wyckoff MH, 2015, CIRCULATION, V132, pS543, DOI 10.1161/CIR.0000000000000267; Wyllie J, 2015, RESUSCITATION, V95, P249, DOI 10.1016/j.resuscitation.2015.07.029	15	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186731	10.1371/journal.pone.0186731	http://dx.doi.org/10.1371/journal.pone.0186731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073266	Green Submitted, gold, Green Published			2022-12-27	WOS:000413845400046
J	Mandaviya, PR; Joehanes, R; Aissi, D; Kuhnel, B; Marioni, RE; Truong, V; Stolk, L; Beekman, M; Bonder, MJ; Franke, L; Gieger, C; Huan, TX; Ikram, MA; Kunze, S; Liang, LM; Lindemann, J; Liu, CY; Mcrae, AF; Mendelson, MM; Muller-Nurasyid, M; Peters, A; Slagboom, PE; Starr, JM; Tregouet, DA; Uitterlinden, AG; van Greevenbroek, MMJ; van Heemst, D; van Iterson, M; Wells, PS; Yao, C; Deary, IJ; Gagnon, F; Heijmans, BT; Levy, D; Morange, PE; Waldenberger, M; Heil, SG; van Meurs, JBJ				Mandaviya, Pooja R.; Joehanes, Roby; Aissi, Dylan; Kuehnel, Brigitte; Marioni, Riccardo E.; Truong, Vinh; Stolk, Lisette; Beekman, Marian; Bonder, Marc Jan; Franke, Lude; Gieger, Christian; Huan, Tianxiao; Ikram, M. Arfan; Kunze, Sonja; Liang, Liming; Lindemann, Jan; Liu, Chunyu; McRae, Allan F.; Mendelson, Michael M.; Muller-Nurasyid, Martina; Peters, Annette; Slagboom, P. Eline; Starr, John M.; Tregouet, David -Alexandre; Uitterlinden, Andre G.; van Greevenbroek, Marleen M. J.; van Heemst, Diana; van Iterson, Maarten; Wells, Philip S.; Yao, Chen; Deary, Ian J.; Gagnon, France; Heijmans, Bastiaan T.; Levy, Daniel; Morange, Pierre-Emmanuel; Waldenberger, Melanie; Heil, Sandra G.; van Meurs, Joyce B. J.		Charge Consortium Epigenetics Grp	Genetically defined elevated homocysteine levels do not result in widespread changes of DNA methylation in leukocytes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION; FOLATE STATUS; INSTRUMENTAL VARIABLES; GENE-EXPRESSION; CANCER; METAANALYSIS; VARIANTS; REGION; RISK	Background DNA methylation is affected by the activities of the key enzymes and intermediate metabolites of the one-carbon pathway, one of which involves homocysteine. We investigated the effect of the well-known genetic variant associated with mildly elevated homocysteine: MTHFR 677C>T independently and in combination with other homocysteine-associated variants, on genome-wide leukocyte DNA-methylation. Methods Methylation levels were assessed using Illumina 450k arrays on 9,894 individuals of European ancestry from 12 cohort studies. Linear-mixed-models were used to study the association of additive MTHFR 677C> T and genetic-risk score (GRS) based on 18 homocysteineassociated SNPs, with genome-wide methylation. Results Meta-analysis revealed that the MTHFR 677C> T variant was associated with 35 CpG sites in cis, and the GRS showed association with 113 CpG sites near the homocysteine-associated variants. Genome-wide analysis revealed that the MTHFR 677C> T variant was associated with 1 trans-CpG (nearest gene ZNF184), while the GRS model showed association with 5 significant trans-CpGs annotated to nearest genes PTF1A, MRPL55, CTDSP2, CRYM and FKBP5. Conclusions Our results do not show widespread changes in DNA-methylation across the genome, and therefore do not support the hypothesis that mildly elevated homocysteine is associated with widespread methylation changes in leukocytes.	[Mandaviya, Pooja R.; Lindemann, Jan; Heil, Sandra G.] Erasmus Univ, Dept Clin Chem, Med Ctr, Rotterdam, Netherlands; [Mandaviya, Pooja R.; Stolk, Lisette; Uitterlinden, Andre G.; van Meurs, Joyce B. J.] Erasmus Univ, Dept Internal Med, Med Ctr, Rotterdam, Netherlands; [Joehanes, Roby] Harvard Med Sch, Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Aissi, Dylan; Tregouet, David -Alexandre] UPMC Univ Paris 06, Sorbonne Univ, Team Genom & Pathophysiol Cardiovasc Dis, INSERM,UMR S 1166, Paris, France; [Aissi, Dylan; Tregouet, David -Alexandre] ICAN Inst Cardiometab & Nutr, Paris, France; [Kuehnel, Brigitte; Gieger, Christian; Kunze, Sonja; Peters, Annette; Waldenberger, Melanie] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Kuehnel, Brigitte; Gieger, Christian; Kunze, Sonja; Peters, Annette; Waldenberger, Melanie] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Marioni, Riccardo E.; McRae, Allan F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Marioni, Riccardo E.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Marioni, Riccardo E.] Univ Edinburgh, Inst Genet & Mol Med, Med Genet Sect, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Truong, Vinh; Gagnon, France] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Beekman, Marian; Slagboom, P. Eline; van Iterson, Maarten; Heijmans, Bastiaan T.] Leiden Univ, Mol Epidemiol Sect, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Bonder, Marc Jan; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Huan, Tianxiao; Liu, Chunyu; Mendelson, Michael M.; Yao, Chen; Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Huan, Tianxiao; Liu, Chunyu; Mendelson, Michael M.; Yao, Chen; Levy, Daniel] NHLBI, Populat Studies Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Liang, Liming] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Mendelson, Michael M.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Muller-Nurasyid, Martina; Peters, Annette] Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany; [Muller-Nurasyid, Martina] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Muller-Nurasyid, Martina] Univ Munich, Univ Hosp Munich, Dept Med 1, Campus Grosshadern, Munich, Germany; [van Greevenbroek, Marleen M. J.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [van Greevenbroek, Marleen M. J.] Maastricht Univ, Med Ctr, Sch Cardiovasc Dis CARIM, Maastricht, Netherlands; [van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr Sect, Leiden, Netherlands; [Wells, Philip S.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wells, Philip S.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Morange, Pierre-Emmanuel] La Timone Hosp, Lab Haematol, Marseille, France; [Morange, Pierre-Emmanuel] Aix Marseille Univ, INSERM, Inra UMR 1260, UMR S 1062, Marseille, France	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard Medical School; Hebrew SeniorLife; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Queensland; University of Edinburgh; University of Edinburgh; University of Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; German Centre for Cardiovascular Research; Munich Heart Alliance; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Maastricht University; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Edinburgh; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	van Meurs, JBJ (corresponding author), Erasmus Univ, Dept Internal Med, Med Ctr, Rotterdam, Netherlands.	j.vanmeurs@erasmusroc.nl	Heil, Sandra/AAM-8104-2020; Aïssi, Dylan/AAH-1499-2019; Morange, Pierre/T-9070-2019; Fox, Laura J/C-6249-2016; Peters, Annette/A-6117-2011; Trégouët, David-Alexandre/P-9210-2019; Tregouet, David-Alexandre/E-3961-2016; Ikram, M. Arfan/AAM-5225-2021; Deary, Ian J/C-6297-2009; Levy, Daniel/ABB-2752-2021; Timpson, Nicholas John/O-7548-2015; Mendelson, Michael/I-2874-2014; Levy, Daniel/ABF-6873-2021; Huan, Tianxiao/AAF-3577-2021; Müller-Nurasyid, Martina/I-8735-2018; Waldenberger, Melanie/B-5355-2014; Attrill, Lauren/V-1688-2018; McRae, Allan/J-2644-2014	Aïssi, Dylan/0000-0002-5858-6468; Morange, Pierre/0000-0002-9065-722X; Peters, Annette/0000-0001-6645-0985; Trégouët, David-Alexandre/0000-0001-9084-7800; Deary, Ian J/0000-0002-1733-263X; Timpson, Nicholas John/0000-0002-7141-9189; Mendelson, Michael/0000-0001-7590-3958; Levy, Daniel/0000-0003-1843-8724; Müller-Nurasyid, Martina/0000-0003-3793-5910; Waldenberger, Melanie/0000-0003-0583-5093; Kunze, Sonja/0000-0002-9685-2675; Bonder, Marc Jan/0000-0002-8431-3180; McRae, Allan/0000-0001-5286-5485; van Meurs, Joyce/0000-0001-6245-2123; van Greevenbroek, Marleen/0000-0002-2989-1631; Huan, Tianxiao/0000-0001-5840-9413; Marioni, Riccardo/0000-0003-4430-4260	Genetic Laboratory of the Department of Internal Medicine, Erasmus MC; Netherlands Organization for Scientific Research (NWO) [184021007]; Rainbow Project (RP3) (BIOS) of the Biobanking and Biomolecular Research Infrastructure Netherlands (BBMRI-NL); Erasmus Medical Center; Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands CardioVascular Research Initiative (the Dutch Heart Foundation); Netherlands CardioVascular Research Initiative (Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development); Netherlands CardioVascular Research Initiative (Royal Netherlands Academy of Sciences) [CVON2011-19]; BBMRI-NL; Dutch government [NWO 184.021.007]; Region Ile de France (CORDDIM); Region Ile de France; Pierre and Marie Curie University; ICAN Institute for Cardiometabolism and Nutrition [ANR-10-IAHU-05]; National Institutes of Health [N01-HC-25195]; Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health; Division of Intramural Research, National Heart, Lung, and Blood Institute Bethesda, MD; Helmholtz Zentrum Munchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ; European Union Seventh Framework Programme [603288]; UK's Biotechnology and Biological Sciences Research Council (BBSRC) [1921]; Royal Society; Chief Scientist Office of the Scottish Government; Age UK (The Disconnected Mind project) [1936]; Centre for Cognitive Ageing and Cognitive Epidemiology (Pilot Fund award); Age UK; Wellcome Trust Institutional Strategic Support Fund; University of Edinburgh; University of Queensland; BBSRC; Medical Research Council (MRC); University of Edinburgh as part of the cross council Lifelong Health and Wellbeing initiative [MR/K026992/1]; Canadian Institutes of Health Research [MOP 86466]; Heart and Stroke Foundation of Canada [T6484]; Canada Research Chair; BBSRC [BB/F019394/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0700704B, MR/K026992/1] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL136875] Funding Source: NIH RePORTER	Genetic Laboratory of the Department of Internal Medicine, Erasmus MC; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Rainbow Project (RP3) (BIOS) of the Biobanking and Biomolecular Research Infrastructure Netherlands (BBMRI-NL); Erasmus Medical Center; Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands CardioVascular Research Initiative (the Dutch Heart Foundation); Netherlands CardioVascular Research Initiative (Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development); Netherlands CardioVascular Research Initiative (Royal Netherlands Academy of Sciences); BBMRI-NL; Dutch government; Region Ile de France (CORDDIM)(Region Ile-de-France); Region Ile de France(Region Ile-de-France); Pierre and Marie Curie University; ICAN Institute for Cardiometabolism and Nutrition; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of Intramural Research, National Heart, Lung, and Blood Institute Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ; European Union Seventh Framework Programme(European Commission); UK's Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Chief Scientist Office of the Scottish Government; Age UK (The Disconnected Mind project); Centre for Cognitive Ageing and Cognitive Epidemiology (Pilot Fund award); Age UK; Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); University of Edinburgh; University of Queensland(University of Queensland); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh as part of the cross council Lifelong Health and Wellbeing initiative; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Rotterdam Study: The generation and management of the Illumina 450K methylation array data (EWAS data) for the Rotterdam Study was executed by the Human Genotyping Facility of the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, the Netherlands. The EWAS data was funded by the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, and by the Netherlands Organization for Scientific Research (NWO; project number 184021007) and made available as a Rainbow Project (RP3; BIOS) of the Biobanking and Biomolecular Research Infrastructure Netherlands (BBMRI-NL). We thank Mr. Michael Verbiest, Ms. Mila Jhamai, Ms. Sarah Higgins, Mr. Marijn Verkerk, and Lisette Stolk PhD for their help in creating the methylation database. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. Biobank-Based Integrative Omics Studies (BIOS) Consortium Samples were contributed by LifeLines (http://lifelines.research/general), the Leiden Longevity Study (http://www.leidenlangleven.nl), the Netherlands Twin Registry (littp://www.tweelingenregister.org), the Rotterdam studies (http://www.erasmus-epidemiology.nl/research/ergo.htm), the CODAM study (http://www.carimmaastricht.nl/), and the PAN study (http://www.alsonderzoek.nl/). We thank the participants of all aforementioned biobanks and acknowledge the contributions of the investigators to this study, especially Aaron Isaacs, Rene Pool, Marian Beekman, P. Mila Jhamai, Michael Verbiest, H. Eka D. Suchiman, Marijn Verkerk, Ruud van der Breggen, Jeroen van Rooij, Nico Lakenberg, Jan Bot, Patrick Deelen, Irene Nooren, Martijn Vermaat, Dasha V. Zhernakova, Rene Luijk, Freerk van Dijk, Wibowo Arindrarto, Szymon M. Kielbasa, and Morris A. Swertz (S1_File-BIOSconsortium MembershipList). This work was carried out on the Dutch national e-infrastructure with the support of SURF Cooperative. We acknowledge the support from the Netherlands CardioVascular Research Initiative (the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development, and the Royal Netherlands Academy of Sciences) for the GENIUS project "Generating the best evidence-based pharmaceutical targets for atherosclerosis" (CVON2011-19). This work was performed within the framework of the BiobankBased Integrative Omics Studies (BIOS) Consortium funded by BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184.021.007). MARseille THrombosis Association Study (MARTHA) D.A. was supported by a PhD grant from the Region Ile de France (CORDDIM). Statistical analyses of the MARTHA were performed using the C2BIG computing cluster, funded by the Region Ile de France, Pierre and Marie Curie University, and the ICAN Institute for Cardiometabolism and Nutrition (ANR-10-IAHU-05). Framingham Heart Study (FHS): The Framingham Heart Study is funded by National Institutes of Health contract N01-HC-25195. The laboratory work for this investigation was funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health.; r The analytical component of this project was funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute Bethesda, MD. Cooperative health research in the Region of Augsburg (KORA) The KORA study was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research has been supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ. The research leading to these results has received funding fromthe European Union Seventh Framework Programme under grant agreement [no 603288] (Systems Biology to Identify Molecular Targets for Vascular Disease Treatment - SysVasc; http://www.sysvasc.eu/). Lothian Birth Cohort (LBC): Phenotype collection in the Lothian Birth Cohort 1921 was supported by the UK's Biotechnology and Biological Sciences Research Council (BBSRC), The Royal Society and The Chief Scientist Office of the Scottish Government. Phenotype collection in the Lothian Birth Cohort 1936 was supported by Age UK (The Disconnected Mind project). Methylation typing was supported by the Centre for Cognitive Ageing and Cognitive Epidemiology (Pilot Fund award), Age UK, The Wellcome Trust Institutional Strategic Support Fund, The University of Edinburgh, and The University of Queensland. REM, JMS, and IJD are members of the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE). CCACE is supported by funding from the BBSRC, the Medical Research Council (MRC), and the University of Edinburgh as part of the cross council Lifelong Health and Wellbeing initiative (MR/K026992/1). French-Canadian Family Study on Factor V Leiden (F5L) Thrombophilia (F5L Family Study) The F5L Family Study was supported by the Canadian Institutes of Health Research (Grant MOP 86466) and by the Heart and Stroke Foundation of Canada (Grant T6484). F. Gagnon is recipient of a Canada Research Chair.r We acknowledge the support from the Netherlands CardioVascular Research Initiative (the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development, and the Royal Netherlands Academy of Sciences) for the GENIUS project "Generating the best evidence -based pharmaceutical targets for atherosclerosis" (CVON2011-19). This work was performed within the framework of the Biobank-Based Integrative Omics Studies (BIOS) Consortium funded by BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184.021.007).	Amarasekera M, 2014, FASEB J, V28, P4068, DOI 10.1096/fj.13-249029; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; Bonder M. J., 2015, BIORXIV; Bonder MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-860; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Borges MC, 2016, AM J CLIN NUTR, V103, P39, DOI 10.3945/ajcn.115.116038; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; Dekkers KF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1000-6; Devlin AM, 2005, J BIOL CHEM, V280, P25506, DOI 10.1074/jbc.M504815200; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gassen NC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac7695; Glier MB, 2013, EPIGENETICS-US, V8, P44, DOI 10.4161/epi.23063; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Hanks J, 2013, AM J CLIN NUTR, V98, P1564, DOI 10.3945/ajcn.113.061432; Hegele RA, 2000, ARTERIOSCL THROM VAS, V20, P217, DOI 10.1161/01.ATV.20.1.217; Heil SG, 2007, MOL GENET METAB, V91, P55, DOI 10.1016/j.ymgme.2007.01.008; Joubert BR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10577; Klutstein M, 2016, CANCER RES, V76, P3446, DOI 10.1158/0008-5472.CAN-15-3278; Lauc G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001256; Ligthart S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118859; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Mandaviya PR, 2014, MOL GENET METAB, V113, P243, DOI 10.1016/j.ymgme.2014.10.006; Martens EP, 2006, EPIDEMIOLOGY, V17, P260, DOI 10.1097/01.ede.0000215160.88317.cb; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mevik B.-H., 2007, J STAT SOFTWARE, V18; Narayanan S, 2004, CANCER EPIDEM BIOMAR, V13, P1436; Palmer TM, 2012, STAT METHODS MED RES, V21, P223, DOI 10.1177/0962280210394459; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Pierce BL, 2011, CANCER RES, V71, P4352, DOI 10.1158/0008-5472.CAN-11-0124; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Pufulete M, 2005, BRIT J CANCER, V92, P838, DOI 10.1038/sj.bjc.6602439; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Swanson SA, 2013, EPIDEMIOLOGY, V24, P370, DOI 10.1097/EDE.0b013e31828d0590; Tsepilov YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081431; van Meurs JBJ, 2013, AM J CLIN NUTR, V98, P668, DOI 10.3945/ajcn.112.044545; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	43	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0182472	10.1371/journal.pone.0182472	http://dx.doi.org/10.1371/journal.pone.0182472			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084233	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200001
J	Schadler, D; Pausch, C; Heise, D; Meier-Hellmann, A; Brederlau, J; Weiler, N; Marx, G; Putensen, C; Spies, C; Jorres, A; Quintel, M; Engel, C; Kellum, JA; Kuhlmann, MK				Schaedler, Dirk; Pausch, Christine; Heise, Daniel; Meier-Hellmann, Andreas; Brederlau, Joerg; Weiler, Norbert; Marx, Gernot; Putensen, Christian; Spies, Claudia; Joerres, Achim; Quintel, Michael; Engel, Christoph; Kellum, John A.; Kuhlmann, Martin K.			The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial	PLOS ONE			English	Article							B-IMMOBILIZED FIBER; CONTINUOUS VENOVENOUS HEMOFILTRATION; SHORT-TERM SURVIVAL; ACUTE-RENAL-FAILURE; CONTINUOUS HEMODIAFILTRATION; SEPSIS SYNDROME; VOLUME HEMOFILTRATION; BLOOD PURIFICATION; NECROSIS-FACTOR; SHOCK PATIENTS	Objective We report on the effect of hemoadsorption therapy to reduce cytokines in septic patients with respiratory failure. Methods This was a randomized, controlled, open-label, multicenter trial. Mechanically ventilated patients with severe sepsis or septic shock and acute lung injury or acute respiratory distress syndrome were eligible for study inclusion. Patients were randomly assigned to either therapy with CytoSorb hemoperfusion for 6 hours per day for up to 7 consecutive days (treatment), or no hemoperfusion (control). Primary outcome was change in normalized IL-6-serum concentrations during study day 1 and 7. Results 97 of the 100 randomized patients were analyzed. We were not able to detect differences in systemic plasma IL-6 levels between the two groups (n = 75; p = 0.15). Significant IL-6 elimination, averaging between 5 and 18% per blood pass throughout the entire treatment period was recorded. In the unadjusted analysis, 60-day-mortality was significantly higher in the treatment group (44.7%) compared to the control group (26.0%; p = 0.039). The proportion of patients receiving renal replacement therapy at the time of enrollment was higher in the treatment group (31.9%) when compared to the control group (16.3%). After adjustment for patient morbidity and baseline imbalances, no association of hemoperfusion with mortality was found (p = 0.19). Conclusions In this patient population with predominantly septic shock and multiple organ failure, hemoadsorption removed IL-6 but this did not lead to lower plasma IL-6-levels. We did not detect statistically significant differences in the secondary outcomes multiple organ dysfunction score, ventilation time and time course of oxygenation.	[Schaedler, Dirk; Weiler, Norbert] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany; [Pausch, Christine; Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Heise, Daniel; Quintel, Michael] Univ Hosp Gottingen, Ctr Anaesthesiol Emergency & Intens Care Med, Gottingen, Germany; [Meier-Hellmann, Andreas] HELIOS Klin, Dept Intens Care Med, Erfurt, Germany; [Brederlau, Joerg] Helios Hosp Berlin Buch, Dept Intens Care Med, Berlin, Germany; [Marx, Gernot] RWTH Univ Hosp Aachen, Dept Intens Care & Intermediate Care, Aachen, Germany; [Putensen, Christian] Univ Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany; [Spies, Claudia] Charite Univ Med Berlin, Anaesthesiol & Intens Care Med, Campus Charite Mitte, Berlin, Germany; [Spies, Claudia] Charite Univ Med Berlin, Campus Charite VirchowKlinikum, Berlin, Germany; [Joerres, Achim] Univ Witten Herdecke, Dept Med Nephrol Transplantat & Med Intens Care 1, Med Ctr Cologne Merheim, Cologne, Germany; [Kellum, John A.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Kuhlmann, Martin K.] Vivantes Klinikum Friedrichshain, Dept Nephrol, Berlin, Germany	University of Kiel; Schleswig Holstein University Hospital; Leipzig University; University of Gottingen; Helios Kliniken; RWTH Aachen University; RWTH Aachen University Hospital; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Witten Herdecke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schadler, D (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.	dirk.schaedler@uksh.de	Kellum, John A/HCH-2944-2022; Spies, Claudia/AAJ-5412-2020; Schädler, Dirk/A-7253-2012; Kellum, John/AAP-3072-2020	Kellum, John A/0000-0003-1995-2653; Spies, Claudia/0000-0002-1062-0495; Schädler, Dirk/0000-0002-5745-4797; Kellum, John/0000-0003-1995-2653; Engel, Christoph/0000-0002-7247-282X	Cytosorbents Corporation, New Jersey, United States	Cytosorbents Corporation, New Jersey, United States	The study was supported by Cytosorbents Corporation, New Jersey, United States. Cytosorbents was involved in study design and data collection. Cytosorbents had no role in analysis, decision to publish or preparation of the manuscript.	BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Cruz DN, 2009, JAMA-J AM MED ASSOC, V301, P2445, DOI 10.1001/jama.2009.856; De Vriese AS, 1999, J AM SOC NEPHROL, V10, P846; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Ghani RA, 2006, NEPHROLOGY, V11, P386, DOI 10.1111/j.1440-1797.2006.00600.x; Haase M, 2007, INT J ARTIF ORGANS, V30, P108, DOI 10.1177/039139880703000205; Honore PM, 2004, CRIT CARE MED, V32, P896, DOI 10.1097/01.CCM.0000115262.31804.46; Huang Z, 2010, THER APHER DIAL, V14, P596, DOI 10.1111/j.1744-9987.2010.00825.x; Joannes-Boyau O, 2013, INTENS CARE MED, V39, P1535, DOI 10.1007/s00134-013-2967-z; Kellum JA, 2004, CRIT CARE MED, V32, P801, DOI 10.1097/01.CCM.0000114997.39857.69; Kellum JA, 2008, CRIT CARE MED, V36, P268, DOI 10.1097/01.CCM.0000291646.34815.BB; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kobe Y, 2007, BLOOD PURIFICAT, V25, P446, DOI 10.1159/000111568; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Morgera S, 2006, CRIT CARE MED, V34, P2099, DOI 10.1097/01.CCM.0000229147.50592.F9; Nakada T, 2008, MOL MED, V14, P257, DOI 10.2119/2007-00108.Nakada; Nakamura T, 1999, INFLAMM RES, V48, P171, DOI 10.1007/s000110050442; Nakamura T, 2007, AM J MED SCI, V334, P244, DOI 10.1097/MAJ.0b013e3180a5e8d8; Namas RA, 2012, MOL MED, V18, P1366, DOI 10.2119/molmed.2012.00106; Nemoto H, 2001, BLOOD PURIFICAT, V19, P361, DOI 10.1159/000046966; Panacek EA, 2004, CRIT CARE MED, V32, P2173, DOI 10.1097/01.CCM.0000145229.59014.6c; Payen D, 2009, CRIT CARE MED, V37, P803, DOI 10.1097/CCM.0b013e3181962316; Payen DM, 2015, INTENS CARE MED, V41, P975, DOI 10.1007/s00134-015-3751-z; Peng ZY, 2008, CRIT CARE MED, V36, P1573, DOI 10.1097/CCM.0b013e318170b9a7; Peng ZY, 2012, KIDNEY INT, V81, P363, DOI 10.1038/ki.2011.320; R Developpment Core Team, 2014, R LANG ENV STAT COMP, P602; Reinhart K, 2004, CRIT CARE MED, V32, P1662, DOI 10.1097/01.CCM.0000132902.54925.B5; Shiga H, 2014, BLOOD PURIFICAT, V38, P211, DOI 10.1159/000369377; Shoji H, 2003, THER APHER DIAL, V7, P108, DOI 10.1046/j.1526-0968.2003.00005.x; Suzuki H, 2002, THER APHER, V6, P234, DOI 10.1046/j.1526-0968.2002.00416.x; Vincent JL, 2005, SHOCK, V23, P400, DOI 10.1097/01.shk.0000159930.87737.8a; Zhou FH, 2013, CRIT CARE MED, V41, P2209, DOI 10.1097/CCM.0b013e31828cf412	35	157	158	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187015	10.1371/journal.pone.0187015	http://dx.doi.org/10.1371/journal.pone.0187015			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084247	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200025
J	Huang, HR; Xu, ZZ; Shao, XH; Wismeijer, D; Sun, P; Wang, JX; Wu, G				Huang, Hairong; Xu, Zanzan; Shao, Xianhong; Wismeijer, Daniel; Sun, Ping; Wang, Jingxiao; Wu, Gang			Multivariate linear regression analysis to identify general factors for quantitative predictions of implant stability quotient values	PLOS ONE			English	Article							RESONANCE-FREQUENCY-ANALYSIS; LOADED IMPLANTS; DESIGN	Objectives This study identified potential general influencing factors for a mathematical prediction of implant stability quotient (ISQ) values in clinical practice. Methods We collected the ISQ values of 557 implants from 2 different brands (SICace and Osstem) placed by 2 surgeons in 336 patients. Surgeon 1 placed 329 SICace implants, and surgeon 2 placed 113 SICace implants and 115 Osstem implants. ISQ measurements were taken at T1 (immediately after implant placement) and T2 (before dental restoration). A multivariate linear regression model was used to analyze the influence of the following 11 candidate factors for stability prediction: sex, age, maxillary/mandibular location, bone type, immediate/delayed implantation, bone grafting, insertion torque, I-stage or II-stage healing pattern, implant diameter, implant length and T1-T2 time interval. Results The need for bone grafting as a predictor significantly influenced ISQ values in all three groups at T1 (weight coefficients ranging from -4 to -5). In contrast, implant diameter consistently influenced the ISQ values in all three groups at T2 (weight coefficients ranging from 3.4 to 4.2). Other factors, such as sex, age, I/II-stage implantation and bone type, did not significantly influence ISQ values at T2, and implant length did not significantly influence ISQ values at T1 or T2. Conclusions These findings provide a rational basis for mathematical models to quantitatively predict the ISQ values of implants in clinical practice.	[Huang, Hairong; Wismeijer, Daniel; Wu, Gang] Univ Amsterdam, Dept Oral Implantol & Prosthet Dent, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Nord Holland, Netherlands; [Huang, Hairong; Wismeijer, Daniel; Wu, Gang] Vrije Univ Amsterdam, Amsterdam, Nord Holland, Netherlands; [Xu, Zanzan] Goethe Univ Frankfurt, Dept Prosthodont Dent, Frankfurt, Hessen, Germany; [Shao, Xianhong] Best & Easy Dent Clin, Hangzhou, Zhejiang, Peoples R China; [Sun, Ping] Zhejiang Univ, Affiliated Stomatol Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Jingxiao] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Goethe University Frankfurt; Zhejiang University; Wenzhou Medical University	Sun, P (corresponding author), Zhejiang Univ, Affiliated Stomatol Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Wang, JX (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China.	doctorsp@163.com; wangjingxiao@zju.edu.cn	wu, gang/C-5072-2012	wu, gang/0000-0001-8941-2500	China Scholarship Council; National Natural Science Foundation of China [81400475, 81470724]; Zhejiang Provincial Natural Science Foundation of China [LY14H140002, LY17H140010]	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by: China Scholarship Council, www.csc.edu.cn; National Natural Science Foundation of China (Grant No. 81400475 and No. 81470724), http://www.nsfc.gov.cn/; and Zhejiang Provincial Natural Science Foundation of China (Grant No. LY14H140002 and No. LY17H140010), www.zjnsf.gov.cn.	Atsumi M, 2007, INT J ORAL MAX IMPL, V22, P743; Barikani Hamidreza, 2013, J Dent (Tehran), V10, P449; Bataineh Anwar B, 2017, J Clin Exp Dent, V9, pe1, DOI 10.4317/jced.53302; Bischof M, 2004, CLIN ORAL IMPLAN RES, V15, P529, DOI 10.1111/j.1600-0501.2004.01042.x; Brizuela-Velasco A, 2015, IMPLANT DENT, V24, P607, DOI 10.1097/ID.0000000000000318; Brochu JF, 2005, INT J PROSTHODONT, V18, P506; Degidi M, 2013, IMPLANT DENT, V22, P530, DOI 10.1097/ID.0b013e31829f1ef2; Dias DR, 2016, CLIN ORAL IMPLAN RES, V27, P1212, DOI 10.1111/clr.12728; Dottore AM, 2014, CLIN IMPLANT DENT R, V16, P330, DOI 10.1111/cid.12010; Gehrke SA, 2016, CLIN ORAL IMPLANTS R; Gehrke SA, 2015, J ORAL IMPLANTOL, V41, pE281, DOI 10.1563/aaid-joi-D-13-00294; Gehrke SA, 2014, J CRANIOFAC SURG, V25, P2117, DOI 10.1097/SCS.0000000000001067; Guo CY, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/381535; Hagi TT, 2010, CLIN ORAL IMPLAN RES, V21, P1214, DOI 10.1111/j.1600-0501.2010.01916.x; Han J, 2010, CLIN ORAL IMPLAN RES, V21, P605, DOI 10.1111/j.1600-0501.2009.01909.x; Huang HR, 2016, THER CLIN RISK MANAG, V12, P1525, DOI 10.2147/TCRM.S113764; Huang HL, 2013, OR SURG OR MED OR PA, V116, pE356, DOI 10.1016/j.oooo.2012.01.037; Liaje A, 2012, INT J ORAL MAX IMPL, V27, P162; Lozano-Carrascal N, 2016, MED ORAL PATOL ORAL, V21, pE214, DOI 10.4317/medoral.21024; Morris Harold F, 2004, J Oral Implantol, V30, P162, DOI 10.1563/1548-1336(2004)30<162:APVFII>2.0.CO;2; Ostman PO, 2006, INT J PROSTHODONT, V19, P77; Park IP, 2011, J ADV PROSTHODONT, V3, P76, DOI 10.4047/jap.2011.3.2.76; Quesada-Garcia MP, 2009, MED ORAL PATOL ORAL, V14, pE538; Raghavendra S, 2005, INT J ORAL MAX IMPL, V20, P425; Rastelli C, 2014, Oral Implantol (Rome), V7, P33; Romanos GE, 2016, CLIN ORAL IMPLANTS R; T A, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X; Tsolaki IN, 2016, J ORAL IMPLANTOL; Valiyaparambil JV, 2012, INT J ORAL MAX IMPL, V27, P1271; Wada M, 2015, INT J IMPLANT DENT, V1, DOI 10.1186/s40729-014-0003-x; Zix J, 2005, INT J ORAL MAX IMPL, V20, P747	31	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187010	10.1371/journal.pone.0187010	http://dx.doi.org/10.1371/journal.pone.0187010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084260	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200024
J	Belo, VS; Struchiner, CJ; Werneck, GL; Neto, RGT; Tonelli, GB; de Carvalho, CG; Ribeiro, RAN; da Silva, ES				Belo, Vinicius Silva; Struchiner, Claudio Jose; Werneck, Guilherme Loureiro; Teixeira Neto, Rafael Goncalves; Tonelli, Gabriel Barbosa; de Carvalho Junior, Clovis Gomes; Nascimento Ribeiro, Renata Aparecida; da Silva, Eduardo Sergio			Abundance, survival, recruitment and effectiveness of sterilization of free-roaming dogs: A capture and recapture study in Brazil	PLOS ONE			English	Article							POPULATION-DYNAMICS; VISCERAL LEISHMANIASIS; STRAY DOG; MODEL SELECTION; DOMESTIC DOGS; URBAN AREAS; SOAY SHEEP; MANAGEMENT; ECOLOGY; DISEASE	The existence of free-roaming dogs raises important issues in animal welfare and in public health. A proper understanding of these animals' ecology is useful as a necessary input to plan strategies to control these populations. The present study addresses the population dynamics and the effectiveness of the sterilization of unrestricted dogs using capture and recapture procedures suitable for open animal populations. Every two months, over a period of 14 months, we captured, tagged, released and recaptured dogs in two regions in a city in the southeast region of Brazil. In one of these regions the animals were also sterilized. Both regions had similar social, environmental and demographic features. We estimated the presence of 148 females and 227 males during the period of study. The average dog:man ratio was 1 dog for each 42 and 51 human beings, in the areas without and with sterilization, respectively. The animal population size increased in both regions, due mainly to the abandonment of domestic dogs. Mortality rate decreased throughout the study period. Survival probabilities did not differ between genders, but males entered the population in higher numbers. There were no differences in abundance, survival and recruitment between the regions, indicating that sterilization did not affect the population dynamics. Our findings indicate that the observed animal dynamics were influenced by density-independent factors, and that sterilization might not be a viable and effective strategy in regions where availability of resources is low and animal abandonment rates are high. Furthermore, the high demographic turnover rates observed render the canine free-roaming population younger, thus more susceptible to diseases, especially to rabies and leishmaniasis. We conclude by stressing the importance of implementing educational programs to promote responsible animal ownership and effective strategies against abandonment practices.	[Belo, Vinicius Silva; Teixeira Neto, Rafael Goncalves; de Carvalho Junior, Clovis Gomes; Nascimento Ribeiro, Renata Aparecida; da Silva, Eduardo Sergio] Univ Fed Sao Joao del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil; [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Dept Endemias Samuel Pessoa, Rio De Janeiro, RJ, Brazil; [Werneck, Guilherme Loureiro] Univ Estado Rio de Janeiro, Dept Epidemiol, Inst Med Social, Rio De Janeiro, Brazil; [Tonelli, Gabriel Barbosa] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil	Universidade Federal de Sao Joao del-Rei; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz	Belo, VS; da Silva, ES (corresponding author), Univ Fed Sao Joao del Rei, Campus Ctr Oeste Dona Lindu, Divinopolis, MG, Brazil.; Struchiner, CJ (corresponding author), Fundacao Oswaldo Cruz, Dept Endemias Samuel Pessoa, Rio De Janeiro, RJ, Brazil.; Werneck, GL (corresponding author), Univ Estado Rio de Janeiro, Dept Epidemiol, Inst Med Social, Rio De Janeiro, Brazil.	viniciusbelo4@hotmail.com; struprocco@gmail.com; gwerneck@iesc.ufrj.br; silvaedu@ufsj.edu.br	Silva, Eduardo Sergio/B-3777-2018; Struchiner, Claudio Jose/HGB-9492-2022; Belo, Vinícius Silva/AAP-6532-2020; Werneck, Guilherme/A-2841-2013; Struchiner, Claudio J/M-9360-2013; Silva, Eduardo/N-7254-2019	Belo, Vinícius Silva/0000-0003-0183-1175; Werneck, Guilherme/0000-0003-1169-1436; Struchiner, Claudio J/0000-0003-2114-847X; Silva, Eduardo/0000-0001-7409-9216; Barbosa Tonelli, Gabriel/0000-0002-8415-3199	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-02612-16, APQ-00371-10]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (http://www.fapemig.br/pt-br/), Grant number: APQ-00371-10; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) Grant number: APQ-02612-16; and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). Support to publication: (http://www.fapemig.br/visualizacao-de-divulgacao-cienfifica/ler/361/pagamento-de-publicacao-em-periodcos-indexados). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062636; Acosta-Jamett G, 2010, PREV VET MED, V94, P272, DOI 10.1016/j.prevetmed.2010.01.002; Albon SD, 2000, J ANIM ECOL, V69, P1099, DOI 10.1046/j.1365-2656.2000.00485.x; Alonso RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123032; Amaku M, 2010, MATH POPUL STUD, V17, P69, DOI 10.1080/08898481003689452; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Beck A.M., 1973, ECOLOGY STRAY DOGS S; Belo VS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144830; Belo VS, 2013, VET PARASITOL, V195, P1, DOI 10.1016/j.vetpar.2013.03.010; Belsare AV, 2013, PREV VET MED, V111, P139, DOI 10.1016/j.prevetmed.2013.04.003; Beran G. W., 1991, The natural history of rabies. 2nd Edition.., P427; Bonenfant C, 2002, ECOGRAPHY, V25, P446, DOI 10.1034/j.1600-0587.2002.250407.x; Brasil. Ministerio da Saude, 2011, NORM TECN PROF RAIV; Brasil Ministerio da Saude, 2006, MAN VIG CONTR LEISHM; Burnham K, 2002, MODEL SELECTION MULT, DOI [10.1016/i.prevetmed.2013.04.003, DOI 10.1016/I.PREVETMED.2013.04.003]; Buzatto BA, 2007, J ANIM ECOL, V76, P937, DOI 10.1111/j.1365-2656.2007.01273.x; Caceres LPN, 2004, THESIS; Castillo-Neyra Ricardo, 2016, Rev Peru Med Exp Salud Publica, V33, P772, DOI 10.17843/rpmesp.2016.334.2564; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C; CLUTTONBROCK TH, 1991, J ANIM ECOL, V60, P593, DOI 10.2307/5300; Conan A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004177; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Cozzi A., 2007, Annali della Facolta di Medicina Veterinaria di Pisa, V60, P241; Crespin L, 2008, POPUL ECOL, V50, P247, DOI 10.1007/s10144-008-0090-8; Crone EE, 2001, EVOLUTION, V55, P2611; Dalla Villa P, 2010, PREV VET MED, V97, P58, DOI 10.1016/j.prevetmed.2010.07.001; Dantas-Torres F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-22; de Little Siobhan C., 2007, BMC Ecology, V7, P3, DOI 10.1186/1472-6785-7-3; Dias RA, 2015, PREV VET MED, V122, P154, DOI 10.1016/j.prevetmed.2015.10.004; Dias RA, 2013, PREV VET MED, V110, P263, DOI 10.1016/j.prevetmed.2012.12.002; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; Eccard Jana A., 2011, BMC Ecology, V11, P16, DOI 10.1186/1472-6785-11-16; Faleke O. O., 2003, Nigerian Journal of Animal Production, V30, P242; Fernandez FAS, 1995, OECOLAGIAS BRASILIEN, V2; FONT E, 1987, APPL ANIM BEHAV SCI, V17, P319, DOI 10.1016/0168-1591(87)90155-9; Frank J, 2004, HUM ECOL, V32, P107, DOI 10.1023/B:HUEC.0000015213.66094.06; Frank JM, 2007, ECOL ECON, V62, P740, DOI 10.1016/j.ecolecon.2006.09.011; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Garde E, 2016, PREV VET MED, V123, P106, DOI 10.1016/j.prevetmed.2015.11.011; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P1; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hodgson K, 2011, CAN VET J, V52, P189; Hogasen HR, 2013, PREV VET MED, V112, P401, DOI 10.1016/j.prevetmed.2013.07.010; Hossain M, 2013, PREV VET MED, V111, P134, DOI 10.1016/j.prevetmed.2013.03.008; Hudson EG, 2017, PREV VET MED, V146, P52, DOI 10.1016/j.prevetmed.2017.07.010; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kachani M, 2014, ACTA TROP, V139, P99, DOI 10.1016/j.actatropica.2014.05.011; Kalati K, 2010, STREET DOG POPULATIO; Lambert K, 2015, PREV VET MED, V118, P148, DOI 10.1016/j.prevetmed.2014.11.002; Lele SR, 2010, J AM STAT ASSOC, V105, P1617, DOI 10.1198/jasa.2010.tm09757; Lindsey JK, 1998, STAT MED, V17, P59, DOI 10.1002/(SICI)1097-0258(19980115)17:1<59::AID-SIM733>3.3.CO;2-Z; Lunney M, 2011, PREV VET MED, V102, P315, DOI 10.1016/j.prevetmed.2011.07.017; Macpherson CNL, 2013, DOGS, ZOONOSES AND PUBLIC HEALTH, 2ND EDITION, P1, DOI 10.1079/9781845938352.0000; Garcia RDM, 2012, REV PANAM SALUD PUBL, V32, P140, DOI 10.1590/S1020-49892012000800008; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; Morters MK, 2014, J APPL ECOL, V51, P1096, DOI 10.1111/1365-2664.12279; Natoli E, 2006, PREV VET MED, V77, P180, DOI 10.1016/j.prevetmed.2006.06.005; Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005; O'Neill Dan G, 2014, Canine Genet Epidemiol, V1, P2, DOI 10.1186/2052-6687-1-2; Ohlberger J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098940; Pal SK, 2001, ACTA THERIOL, V46, P69, DOI 10.1007/BF03192418; Paula PMC, 2010, THESIS; Penaforte KM, 2013, REV BRAS PARASITOL V, V22, P592, DOI 10.1590/S1984-29612013000400022; Reece JF, 2006, VET REC, V159, P379, DOI 10.1136/vr.159.12.379; Reece JF, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-6; Rinzim K., 2007, THESIS; Romero GAS, 2009, PLOSNEGLTROPDIS, V4, pe584; Baquero OS, 2016, PREV VET MED, V123, P121, DOI 10.1016/j.prevetmed.2015.11.009; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Speed CW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-2; Stanley TR, 1998, BIOMETRICAL J, V40, P475, DOI 10.1002/(SICI)1521-4036(199808)40:4<475::AID-BIMJ475>3.3.CO;2-R; Stavisky J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-163; Tenzin, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001391; Tenzin T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003784; Udell MAR, 2008, J EXP ANAL BEHAV, V89, P247, DOI 10.1901/jeab.2008.89-247; Ugbomoiko Uade Samuel, 2008, BMC Vet Res, V4, P49, DOI 10.1186/1746-6148-4-49; van de Kerk M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070354; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vas J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144583; Voslarova E, 2012, ANN I SUPER SANITA, V48, P97, DOI 10.4415/ANN_12_01_16; White SC, 2010, J APPL ANIM WELF SCI, V13, P191, DOI 10.1080/10888700903579903; Willians BK, 2002, ANAL MANAGEMENT ANIM; Wolff JO, 1997, J ANIM ECOL, V66, P1, DOI 10.2307/5959; Zinsstag J, 2009, P NATL ACAD SCI USA, V106, P14996, DOI 10.1073/pnas.0904740106; Zivicnjak T, 2005, VET PARASITOL, V131, P35, DOI 10.1016/j.vetpar.2005.04.036; Zubillaga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115307	90	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187233	10.1371/Journal.pone.0187233	http://dx.doi.org/10.1371/Journal.pone.0187233			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091961	gold, Green Published, Green Submitted			2022-12-27	WOS:000414229700048
J	Zhou, SJ; Wang, P; Su, XL; Chen, JX; Chen, HF; Yang, HB; Fang, AP; Xie, LS; Yao, YQ; Yang, JL				Zhou, Shijie; Wang, Ping; Su, Xiaolan; Chen, Jingxia; Chen, Hongfen; Yang, Hanbing; Fang, Aiping; Xie, Linshen; Yao, Yuqin; Yang, Jinliang			High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma	PLOS ONE			English	Article							CARCINOMA; 3Q; OVEREXPRESSION; AMPLIFICATION; RESISTANT	Different subtypes of non-small cell lung cancer (NSCLC) have distinct sites of origin, histologies, genetic and epigenetic changes. In this study, we explored the mechanisms of ECT2 dysregulation and compared its prognostic value in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). In addition, we also investigated the enrichment of ECT2 co-expressed genes in KEGG pathways in LUAD and LUSC. Bioinformatic analysis was performed based on data from the Cancer Genome Atlas (TCGA)-LUAD and TCGA-LUSC. Results showed that ECT2 expression was significantly upregulated in both LUAD and LUSC compared with normal lung tissues. ECT2 expression was considerably higher in LUSC than in LUAD. The level of ECT2 DNA methylation was significantly lower in LUSC than in LUAD. ECT2 mutation was observed in 5% of LUAD and in 51% of LUSC cases. Amplification was the predominant alteration. LUAD patients with ECT2 amplification had significantly worse disease-free survival (p = 0.022). High ECT2 expression was associated with unfavorable overall survival (OS) (p<0.0001) and recurrence-free survival (RFS) (p = 0.001) in LUAD patients. Nevertheless, these associations were not observed in patients with LUSC. The following univariate and multivariate analysis showed that the high ECT2 expression was an independent prognostic factor for poor OS (HR: 2.039, 95% CI: 1.457-2.852, p<0.001) and RFS (HR: 1.715, 95% CI: 1.210-2.432, p = 0.002) in LUAD patients, but not in LUSC patients. Among 518 genes co-expressed with ECT2 in LUAD and 386 genes co-expressed with ECT2 in LUSC, there were only 98 genes in the overlapping cluster. Some of the genes related KEGG pathways in LUAD were not observed in LUSC. These differences might help to explain the different prognostic value of ECT2 in LUAD and LUSC, which are also worthy of further studies.	[Zhou, Shijie; Wang, Ping; Fang, Aiping; Xie, Linshen; Yao, Yuqin] Sichuan Univ, West China Teaching Hosp 4, West China Sch Publ Health, Res Ctr Publ Hlth & Prevent Med, Chengdu, Sichuan, Peoples R China; [Zhou, Shijie; Wang, Ping; Su, Xiaolan; Fang, Aiping; Yang, Jinliang] Sichuan Univ, West China Hosp, West China Med Sch, Canc Ctr, Chengdu, Sichuan, Peoples R China; [Chen, Jingxia; Chen, Hongfen; Yang, Hanbing] Weifang Med Univ, Affiliated Hosp, Dept Emergency Med, Weifang, Shandong, Peoples R China	Sichuan University; Sichuan University; Weifang Medical University	Yao, YQ (corresponding author), Sichuan Univ, West China Teaching Hosp 4, West China Sch Publ Health, Res Ctr Publ Hlth & Prevent Med, Chengdu, Sichuan, Peoples R China.	yuqin_yao@scu.edu.cn	Yao, Yuqin/AAG-3879-2020; Yao, Yuqin/W-9673-2018	Yao, Yuqin/0000-0003-2097-6978; Zhou, Shijie/0000-0002-7787-8722	National Science Foundation of China [81402564]; National Natural Science Foundation of China [81773375]; National High Technology Research and Development Program of China [2015AA020904]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Science Foundation of China, grant 81402564 to Yuqing Yao; National Natural Science Foundation of China, grant 81773375 to Yuqing Yao; and National High Technology Research and Development Program of China, grant 2015AA020904 to Yuqing Yao.	Balsara BR, 1997, CANCER RES, V57, P2116; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Fields Alan P., 2015, Advances in Biological Regulation, V60, P47, DOI 10.1016/j.jbior.2015.10.009; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hirata D, 2009, CLIN CANCER RES, V15, P256, DOI 10.1158/1078-0432.CCR-08-1672; Huff Lauren P, 2013, Genes Cancer, V4, P460, DOI 10.1177/1947601913514851; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Luo Y, 2015, BIOMED PHARMACOTHER, V73, P135, DOI 10.1016/j.biopha.2015.06.007; Mendez P, 2013, TRANSL LUNG CANCER R, V2, P101, DOI 10.3978/j.issn.2218-6751.2013.03.05; Murata Y, 2014, CANCER SCI, V105, P490, DOI 10.1111/cas.12363; Pasini A, 2012, TRANSL ONCOL, V5, P461, DOI 10.1593/tlo.12256; Pierceall WE, 2012, ANN ONCOL, V23, P2245, DOI 10.1093/annonc/mdr624; Qian J, 2015, GENOM DATA, V5, P272, DOI 10.1016/j.gdata.2015.06.014; Saghaeian Jazi M, 2016, TUMOUR BIOL J INT SO; Schmid-Bindert G, 2013, TARGET ONCOL, V8, P15, DOI 10.1007/s11523-013-0261-1; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sun RF, 2015, TUMOR BIOL, V36, P7195, DOI 10.1007/s13277-015-3361-y; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921	23	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187356	10.1371/journal.pone.0187356	http://dx.doi.org/10.1371/journal.pone.0187356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088286	gold, Green Published, Green Submitted			2022-12-27	WOS:000414088900072
J	Fawzy, MS; Toraih, EA; Ibrahiem, A; Abdeldayem, H; Mohamed, AO; Abdel-Daim, MM				Fawzy, Manal S.; Toraih, Eman A.; Ibrahiem, Afaf; Abdeldayem, Hala; Mohamed, Amany O.; Abdel-Daim, Mohamed M.			Evaluation of miRNA-196a2 and apoptosis-related target genes: ANX41, DFFA and PDCD4 expression in gastrointestinal cancer patients: A pilot study	PLOS ONE			English	Article							CASPASE-ACTIVATED DNASE; ANNEXIN A1; DOWN-REGULATION; CIRCULATING MICRORNAS; COLORECTAL-CANCER; DECREASED EXPRESSION; BREAST-CANCER; UP-REGULATION; ESOPHAGEAL; CARCINOMA	Previous reports have suggested the significant association of miRNAs aberrant expression with tumor initiation, progression and metastasis in cancer, including gastrointestinal (GI) cancers. The current preliminary study aimed to evaluate the relative expression levels of miR-196a2 and three of its selected apoptosis-related targets; ANXA1, DFFA and PDCD4 in a sample of GI cancer patients. Quantitative real-time PCR for miR-196a2 and its selected mRNA targets, as well as immunohistochemical assay for annexin Al protein expression were detected in 58 tissues with different GI cancer samples. In addition, correlation with the clinicopathological features and in silico network analysis of the selected molecular markers were analyzed. Stratified analyses by cancer site revealed elevated levels of miR-196a2 and low expression of the selected target genes. Annexin protein expression was positively correlated with its gene expression profile. In colorectal cancer, miR-196a over-expression was negatively correlated with annexin Al protein expression (r =-0.738, p < 0.001), and both were indicators of unfavorable prognosis in terms of poor differentiation, larger tumor size, and advanced clinical stage. Taken together, aberrant expression of miR-196a2 and the selected apoptosis-related biomarkers might be involved in GI cancer development and progression and could have potential diagnostic and prognostic roles in these types of cancer; particularly colorectal cancer, provided the results experimentally validated and confirmed in larger multi-center studies.	[Fawzy, Manal S.] Suez Canal Univ, Dept Med Biochem, Fac Med, Ismailia, Egypt; [Fawzy, Manal S.] Northern Border Univ, Dept Biochem, Fac Med, Ar Ar, Saudi Arabia; [Toraih, Eman A.] Suez Canal Univ, Dept Histol & Cell Biol, Genet Unit, Fac Med, Ismailia, Egypt; [Ibrahiem, Afaf] Mansoura Univ, Dept Pathol, Fac Med, Mansoura, Egypt; [Abdeldayem, Hala] Suez Canal Univ, Dept Pathol, Fac Med, Ismailia, Egypt; [Mohamed, Amany O.] Assiut Univ, Dept Med Biochem, Fac Med, Assiut, Egypt; [Abdel-Daim, Mohamed M.] Suez Canal Univ, Dept Pharmacol, Fac Vet Med, Ismailia, Egypt; [Abdel-Daim, Mohamed M.] Yokohama City Univ, Dept Ophthalmol & Microtechnol, Yokohama, Kanagawa, Japan	Egyptian Knowledge Bank (EKB); Suez Canal University; Northern Borders University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Suez Canal University; Yokohama City University	Fawzy, MS (corresponding author), Suez Canal Univ, Dept Med Biochem, Fac Med, Ismailia, Egypt.; Fawzy, MS (corresponding author), Northern Border Univ, Dept Biochem, Fac Med, Ar Ar, Saudi Arabia.; Toraih, EA (corresponding author), Suez Canal Univ, Dept Histol & Cell Biol, Genet Unit, Fac Med, Ismailia, Egypt.	manal2_khashana@ymail.com; emantoraih@gmail.com	Toraih, Eman/I-3024-2019; Fawzy, Manal S./L-1516-2016; Ibrahiem, Afaf Taha/AEJ-2582-2022; Abdel-Daim, Mohamed M./B-2545-2013	Toraih, Eman/0000-0001-9267-3787; Fawzy, Manal S./0000-0003-1252-8403; Abdel-Daim, Mohamed M./0000-0002-4341-2713; Mohamed, Amany/0000-0003-3131-3846; abdeldayem, hala/0000-0001-9215-1575				Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; Aravalli RN, 2015, TRANSL RES, V166, P219, DOI 10.1016/j.trsl.2015.04.007; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Belvedere R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-961; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Brustmann H, 2006, PATHOL RES PRACT, V202, P713, DOI 10.1016/j.prp.2006.06.003; Charrier L, 2002, CANCER RES, V62, P2169; Chen B, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20155020; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Da J, 2001, Zhonghua Bing Li Xue Za Zhi, V30, P256; Ding XL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002729; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Errami Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057871; Fawzy MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152834; Fischer N, 2012, BIOCHEM BIOPH RES CO, V417, P29, DOI 10.1016/j.bbrc.2011.11.035; Gao YS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-520; Garman KS, 2013, DIGEST DIS SCI, V58, P3178, DOI 10.1007/s10620-013-2806-7; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Ge J, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0128-2; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hamilton SR, 2000, WHO CLASSIFICATION T; Hao YX, 2015, BIOMED PHARMACOTHER, V72, P1, DOI 10.1016/j.biopha.2014.10.032; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hou T, 2014, BRIT J CANCER, V110, P1260, DOI 10.1038/bjc.2013.829; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Hu N, 2004, CLIN CANCER RES, V10, P6013, DOI 10.1158/1078-0432.CCR-04-0317; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Huang F, 2014, PLOS ONE, V92; Inokuchi J, 2009, CARCINOGENESIS, V30, P1082, DOI 10.1093/carcin/bgp078; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jansen AP, 2004, MOL CANCER THER, V3, P103; Jiang Y, 2010, BIOMED PHARMACOTHER, V64, P424, DOI 10.1016/j.biopha.2010.01.015; Jorge YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152860; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Konishi S, 2002, CANCER-AM CANCER SOC, V95, P2473, DOI 10.1002/cncr.10987; Lankat-Buttgereit B, 2004, MOL CELL ENDOCRINOL, V214, P149, DOI 10.1016/j.mce.2003.10.058; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lee S, 2006, ONCOL REP, V16, P747; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Li Hai-Long, 2015, Asian Pac J Cancer Prev, V16, P1781; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Liu Qing-Hua, 2015, Asian Pac J Cancer Prev, V16, P2719; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Ma G, 2013, TUMOR BIOL, V34, P3879, DOI 10.1007/s13277-013-0975-9; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Moqadam FA, 2013, LEUKEMIA, V27, P16, DOI 10.1038/leu.2012.179; Omata K, 2008, APOPTOSIS, V13, P929, DOI 10.1007/s10495-008-0223-8; Park JJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.32; Paweletz CP, 2000, CANCER RES, V60, P6293; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Petrella A, 2006, CANCER BIOL THER, V5, P643, DOI 10.4161/cbt.5.6.2700; Pin AL, 2012, J BIOL CHEM, V287, P30541, DOI 10.1074/jbc.M112.393561; Ramdas L, 2009, HEAD NECK-J SCI SPEC, V31, P642, DOI 10.1002/hed.21017; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rokkas T, 2015, EUR J GASTROEN HEPAT, V27, P819, DOI 10.1097/MEG.0000000000000363; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Spain SL, 2012, HUM MOL GENET, V21, P934, DOI 10.1093/hmg/ddr523; Suh YE, 2015, INT J CANCER, V137, P1021, DOI 10.1002/ijc.29397; Sun M, 2012, MOL CANCER THER, V11, P842, DOI 10.1158/1535-7163.MCT-11-1015; Symonds ME, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00283; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tazawa H, 2015, TRANSL GASTROIN CANC, V4, P219, DOI 10.3978/j.issn.2224-4778.2015.04.01; Toraih EA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3269379; Toraih EA, 2016, MOL DIAGN THER, V20, P559, DOI 10.1007/s40291-016-0223-2; Toraih EA, 2015, MOL DIAGN THER, V19, P179, DOI 10.1007/s40291-015-0143-6; Tsai KW, 2012, GENE CHROMOSOME CANC, V51, P394, DOI 10.1002/gcc.21924; Vishwanatha JK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-8; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang F, 2013, MOL BIOL REP, V40, P109, DOI 10.1007/s11033-012-2039-4; Wang J, 2015, INT J MOL SCI, V16, P19886, DOI 10.3390/ijms160819886; Wang KL, 2006, CLIN CANCER RES, V12, P4598, DOI 10.1158/1078-0432.CCR-06-0483; Wang LD, 2008, J INT MED RES, V36, P665, DOI 10.1177/147323000803600407; Wei N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030311; Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Winnepenninckx B, 2001, GENE SCREEN, V1, P131; Wu CM, 2006, ONCOL REP, V15, P57; Wu HH, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2013.16; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yu GZ, 2008, CLIN EXP METASTAS, V25, P695, DOI 10.1007/s10585-008-9178-y; Yu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105306; Zeng JH, 2017, ONCOTARGET, V8, P35681, DOI 10.18632/oncotarget.16051; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211; Zhang J, 2013, BIOCHEM BIOPH RES CO, V440, P582, DOI 10.1016/j.bbrc.2013.09.142; Zhang Q, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-103; Zhang SH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-71; Zhao HH, 2016, DNA CELL BIOL, V35, P81, DOI 10.1089/dna.2014.2785; Zhu FJ, 2010, ANAT REC, V293, P1310, DOI 10.1002/ar.21176; Zhu XY, 2014, DIGEST DIS SCI, V59, P911, DOI 10.1007/s10620-013-2970-9	99	30	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187310	10.1371/journal.pone.0187310	http://dx.doi.org/10.1371/journal.pone.0187310			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091952	Green Submitted, gold, Green Published			2022-12-27	WOS:000414229700055
J	Choi, JY; Yoo, TK; Seo, JG; Kwak, J; Um, TT; Rim, TH				Choi, Joon Yul; Yoo, Tae Keun; Seo, Jeong Gi; Kwak, Jiyong; Um, Terry Taewoong; Rim, Tyler Hyungtaek			Multi-categorical deep learning neural network to classify retinal images: A pilot study employing small database	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; MACULAR DEGENERATION; AUTOMATED DETECTION; MULTICATEGORY CLASSIFICATION; PREVALENCE; GLAUCOMA; DISCRIMINATION; MACHINE; CANCER	Deep learning emerges as a powerful tool for analyzing medical images. Retinal disease detection by using computer-aided diagnosis from fundus image has emerged as a new method. We applied deep learning convolutional neural network by using MatConvNet for an automated detection of multiple retinal diseases with fundus photographs involved in STructured Analysis of the REtina (STARE) database. Dataset was built by expanding data on 10 categories, including normal retina and nine retinal diseases. The optimal outcomes were acquired by using a random forest transfer learning based on VGG-19 architecture. The classification results depended greatly on the number of categories. As the number of categories increased, the performance of deep learning models was diminished. When all 10 categories were included, we obtained results with an accuracy of 30.5%, relative classifier information (RCI) of 0.052, and Cohen's kappa of 0.224. Considering three integrated normal, background diabetic retinopathy, and dry age-related macular degeneration, the multi-categorical classifier showed accuracy of 72.8%, 0.283 RCI, and 0.577 kappa. In addition, several ensemble classifiers enhanced the multi-categorical classification performance. The transfer learning incorporated with ensemble classifier of clustering and voting approach presented the best performance with accuracy of 36.7%, 0.053 RCI, and 0.225 kappa in the 10 retinal diseases classification problem. First, due to the small size of data-sets, the deep learning techniques in this study were ineffective to be applied in clinics where numerous patients suffering from various types of retinal disorders visit for diagnosis and treatment. Second, we found that the transfer learning incorporated with ensemble classifiers can improve the classification performance in order to detect multi-categorical retinal diseases. Further studies should confirm the effectiveness of algorithms with large datasets obtained from hospitals.	[Choi, Joon Yul] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea; [Yoo, Tae Keun; Seo, Jeong Gi; Kwak, Jiyong; Rim, Tyler Hyungtaek] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea; [Um, Terry Taewoong] Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON, Canada	Seoul National University (SNU); Yonsei University; Yonsei University Health System; University of Waterloo	Yoo, TK; Rim, TH (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea.	fawoo2@yuhs.ac; awaitingyourfeedback@gmail.com	Yoo, Tae Keun/Q-3620-2019	Yoo, Tae Keun/0000-0003-0890-8614; Kwak, Jay Jiyong/0000-0002-7738-9136	faculty research grant of Yonsei University College of Medicine [6-2017-0089]	faculty research grant of Yonsei University College of Medicine	This study was supported by a faculty research grant of Yonsei University College of Medicine for 2017 (6-2017-0089).	Abramoff MD, 2010, EXPERT REV MED DEVIC, V7, P287, DOI 10.1586/ERD.09.76; Abramoff MD, 2016, INVEST OPHTH VIS SCI, V57, P5200, DOI 10.1167/iovs.16-19964; Acharya UR, 2016, COMPUT BIOL MED, V73, P131, DOI 10.1016/j.compbiomed.2016.04.009; Adarsh P, 2013, 2013 INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND SIGNAL PROCESSING (ICCSP), P206, DOI 10.1109/iccsp.2013.6577044; Asaoka R, 2016, OPHTHALMOLOGY, V123, P1974, DOI 10.1016/j.ophtha.2016.05.029; Ben-David A, 2008, EXPERT SYST APPL, V34, P825, DOI 10.1016/j.eswa.2006.10.022; Burlina P, 2016, I S BIOMED IMAGING, P184, DOI 10.1109/ISBI.2016.7493240; Caixinha M, 2017, CURR EYE RES, V42, P1, DOI 10.1080/02713683.2016.1175019; Casanova R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098587; Chan CKW, 2015, OPHTHALMOLOGY, V122, P2278, DOI 10.1016/j.ophtha.2015.06.050; Chen XY, 2015, IEEE ENG MED BIO, P715, DOI 10.1109/EMBC.2015.7318462; Chen XW, 2014, IEEE ACCESS, V2, P514, DOI 10.1109/ACCESS.2014.2325029; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Choi SB, 2014, IEEE ENG MED BIO, P3460, DOI 10.1109/EMBC.2014.6944367; Deng J, 2010, LECT NOTES COMPUT SC, V6315, P71, DOI 10.1007/978-3-642-15555-0_6; Dosovitskiy A, 2015, IEEE I CONF COMP VIS, P2758, DOI 10.1109/ICCV.2015.316; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Ganesan K, 2014, MED BIOL ENG COMPUT, V52, P663, DOI 10.1007/s11517-014-1167-5; Gao XT, 2015, IEEE T BIO-MED ENG, V62, P2693, DOI 10.1109/TBME.2015.2444389; GOLDBAUM MH, 1990, INVEST OPHTH VIS SCI, V31, P617; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jain S, 2006, EYE, V20, P471, DOI 10.1038/sj.eye.6701916; Kanagasingam Y, 2014, PROG RETIN EYE RES, V38, P20, DOI 10.1016/j.preteyeres.2013.10.002; Kijsirikul B, 2002, IEEE IJCNN, P980, DOI 10.1109/IJCNN.2002.1005608; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee CS, OPHTHALMOL RETINA; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Liu B, 2017, MOL THER-NUCL ACIDS, V7, P267, DOI 10.1016/j.omtn.2017.04.008; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu M, 2013, SENSOR ACTUAT B-CHEM, V177, P970, DOI 10.1016/j.snb.2012.11.071; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Oh E, 2015, INVEST OPHTH VIS SCI, V56, P3957, DOI 10.1167/iovs.15-16805; Oh E, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-106; Oquab M, 2014, PROC CVPR IEEE, P1717, DOI 10.1109/CVPR.2014.222; Paul R, 2016, TOMOGRAPHY, V2, P388, DOI 10.18383/j.tom.2016.00211; Pratt H, 2016, PROCEDIA COMPUT SCI, V90, P200, DOI 10.1016/j.procs.2016.07.014; Qi ZQ, 2016, KNOWL-BASED SYST, V107, P54, DOI 10.1016/j.knosys.2016.05.055; Ramani RG, 2012, 2012 INTERNATIONAL CONFERENCE ON MACHINE VISION AND IMAGE PROCESSING (MVIP), P149, DOI 10.1109/MVIP.2012.6428782; Ribeiro E, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/6584725; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sandhu SS, 2005, BRIT J OPHTHALMOL, V89, P967, DOI 10.1136/bjo.2004.060863; Sindhwani V., 2001, SIAM, P1; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; SZEGEDY C, 2016, PROC CVPR IEEE, P2818, DOI DOI 10.1109/CVPR.2016.308; Phan TV, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/5893601; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Welikala RA, 2014, COMPUT METH PROG BIO, V114, P247, DOI 10.1016/j.cmpb.2014.02.010; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Worrall DE, 2016, LECT NOTES COMPUT SC, V10008, P68, DOI 10.1007/978-3-319-46976-8_8; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123	59	107	109	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187336	10.1371/journal.pone.0187338	http://dx.doi.org/10.1371/journal.pone.0187338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095872	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200075
J	Fiess, A; Schuster, AK; Pfeiffer, N; Nickels, S				Fiess, Achim; Schuster, Alexander K.; Pfeiffer, Norbert; Nickels, Stefan			Association of birth weight with corneal power in early adolescence: Results from the National Health and Nutrition Examination Survey (NHANES) 1999-2008	PLOS ONE			English	Article							PREMATURELY BORN CHILDREN; TERM-FOLLOW-UP; 1ST 10 YEARS; REFRACTIVE ERROR; MATERNAL RECALL; OPTICAL-COMPONENTS; EXTREMELY PRETERM; VISUAL FUNCTION; INFANTS; RETINOPATHY	Purpose To analyze the effect of birth weight on ocular morphology, refraction and visual function in early adolescents aged 12-15 years. Material and methods We conducted a secondary data analysis using the public use files from the National Health and Nutrition Examination Survey of the period from 1999 to 2008. Study participants aged 12 to 15 years were included with data on birth weight and ophthalmic parameters including presenting distance visual acuity, objective refraction and keratometry. Visual acuity, sphere, astigmatism in power vectors J(0) and J(45), corneal power and corneal astigmatism were evaluated for an association with birth weight. Linear and logistic regression with adjustment for age, sex, ethnicity, survey cycle and birth weight as independent variable were calculated. Results Linear regression analysis revealed an association between corneal power and birth weight (per 100g: beta = -0.04, p<0.001) in the univariate analysis, and in the model adjusted for age, sex, ethnicity and NHANES survey cycle (per 100g: beta = -0.04, p<0.001). A lower birth weight was associated with higher corneal power. We found no evidence for an association of visual acuity, sphere, spherical equivalent, J(0)-vector and J(45)-vector of astigmatism, corneal J(0)- or corneal J(45)-vector with birth weight. Conclusion Our data demonstrate that low BW is linked to alterations in keratometric power even in early adolescents aged 12-15 years whereas visual acuity and refractive error showed no association.	[Fiess, Achim; Schuster, Alexander K.; Pfeiffer, Norbert; Nickels, Stefan] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany	Johannes Gutenberg University of Mainz	Fiess, A (corresponding author), Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany.	Achim.Fiess@gmail.com	Pfeiffer, Norbert/AAO-7586-2020					Adegboye ARA, 2008, BJOG-INT J OBSTET GY, V115, P886, DOI 10.1111/j.1471-0528.2008.01717.x; ALUMRAN KU, 1992, BRIT J OPHTHALMOL, V76, P292, DOI 10.1136/bjo.76.5.292; AUTZEN T, 1991, ACTA OPHTHALMOL, V69, P251; Catov JM, 2006, ANN EPIDEMIOL, V16, P429, DOI 10.1016/j.annepidem.2005.09.004; Cook A, 2003, INVEST OPHTH VIS SCI, V44, P953, DOI 10.1167/iovs.02-0124; Davitt BV, 2009, OPHTHALMOLOGY, V116, P332, DOI 10.1016/j.ophtha.2008.09.035; DONZIS PB, 1985, AM J OPHTHALMOL, V99, P213, DOI 10.1016/0002-9394(85)90240-5; Ecsedy M, 2014, J PEDIAT OPHTH STRAB, V51, P235, DOI 10.3928/01913913-20140521-04; FIELDER AR, 1986, DEV MED CHILD NEUROL, V28, P279; Fiess A, 2017, BR J OPHTHALMOL; Fiess A, 2017, GRAEFES ARCH CLIN EX; Fiess A, 2017, CORNEA; Friling R, 2004, BRIT J OPHTHALMOL, V88, P8, DOI 10.1136/bjo.88.1.8; Haugen OH, 2012, ACTA OPHTHALMOL, V90, P422, DOI 10.1111/j.1755-3768.2010.02020.x; Holladay JT, 1997, J REFRACT SURG, V13, P388; Holmstrom G, 1998, BRIT J OPHTHALMOL, V82, P1265, DOI 10.1136/bjo.82.11.1265; Holmstrom GE, 2005, ARCH OPHTHALMOL-CHIC, V123, P1404, DOI 10.1001/archopht.123.10.1404; Holmstrom G, 2008, J AAPOS, V12, P157, DOI 10.1016/j.jaapos.2007.08.012; Holmstrom GE, 2014, JAMA OPHTHALMOL, V132, P182, DOI 10.1001/jamaophthalmol.2013.5812; INAGAKI Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1026; Johnson CL, 2013, VITAL HLTH STAT, V2, P1; Kirwan C, 2005, ACTA OPHTHALMOL SCAN, V83, P751, DOI 10.1111/j.1600-0420.2005.00559.x; Larsson EK, 2006, ARCH OPHTHALMOL-CHIC, V124, P1608, DOI 10.1001/archopht.124.11.1608; LUMEY LH, 1994, INT J EPIDEMIOL, V23, P1006, DOI 10.1093/ije/23.5.1006; Molloy CS, 2013, PEDIATRICS, V132, pE704, DOI 10.1542/peds.2013-0040; O'Connor AR, 2006, BRIT J OPHTHALMOL, V90, P456, DOI 10.1136/bjo.2005.083535; O'Connor AR, 2004, BRIT J OPHTHALMOL, V88, P1149, DOI 10.1136/bjo.2003.035154; PORTELLINHA W, 1991, ACTA OPHTHALMOL, V69, P247; Saw SM, 2004, BRIT J OPHTHALMOL, V88, P538, DOI 10.1136/bjo.2003.025411; Tate AR, 2005, INT J EPIDEMIOL, V34, P688, DOI 10.1093/ije/dyi029; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Wu WC, 2012, OPHTHALMOLOGY, V119, P1907, DOI 10.1016/j.ophtha.2012.02.040	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186723	10.1371/journal.pone.0186723	http://dx.doi.org/10.1371/journal.pone.0186723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073249	Green Submitted, Green Published, gold			2022-12-27	WOS:000413845400045
J	Goldberg, SB; Tucker, RP; Greene, PA; Simpson, TL; Kearney, DJ; Davidson, RJ				Goldberg, Simon B.; Tucker, Raymond P.; Greene, Preston A.; Simpson, Tracy L.; Kearney, David J.; Davidson, Richard J.			Is mindfulness research methodology improving over time? A systematic review	PLOS ONE			English	Review							PSYCHOLOGICAL-RESEARCH; STATISTICAL POWER; CHRONIC PAIN; STRESS; INTERVENTION; MEDITATION; THERAPY; FAILURE	Background Despite an exponential growth in research on mindfulness-based interventions, the body of scientific evidence supporting these treatments has been criticized for being of poor methodological quality. Objectives The current systematic review examined the extent to which mindfulness research demonstrated increased rigor over the past 16 years regarding six methodological features that have been highlighted as areas for improvement. These feature included using active control conditions, larger sample sizes, longer follow-up assessment, treatment fidelity assessment, and reporting of instructor training and intent-to-treat (ITT) analyses. Data sources We searched PubMed, PsychInfo, Scopus, and Web of Science in addition to a publically available repository of mindfulness studies. Study eligibility criteria Randomized clinical trials of mindfulness-based interventions for samples with a clinical disorder or elevated symptoms of a clinical disorder listed on the American Psychological Association's list of disorders with recognized evidence-based treatment. Study appraisal and synthesis methods Independent raters screened 9,067 titles and abstracts, with 303 full text reviews. Of these, 171 were included, representing 142 non-overlapping samples. Results Across the 142 studies published between 2000 and 2016, there was no evidence for increases in any study quality indicator, although changes were generally in the direction of improved quality. When restricting the sample to those conducted in Europe and North America (continents with the longest history of scientific research in this area), an increase in reporting of ITT analyses was found. When excluding an early, high-quality study, improvements were seen in sample size, treatment fidelity assessment, and reporting of ITT analyses. Conclusions and implications of key findings Taken together, the findings suggest modest adoption of the recommendations for methodological improvement voiced repeatedly in the literature. Possible explanations for this and implications for interpreting this body of research and conducting future studies are discussed.	[Goldberg, Simon B.; Greene, Preston A.; Simpson, Tracy L.; Kearney, David J.] VA Puget Sound Hlth Care Syst, Seattle Div, Seattle, WA USA; [Goldberg, Simon B.; Davidson, Richard J.] Univ Wisconsin, Ctr Healthy Minds, Madison, WI 53706 USA; [Goldberg, Simon B.] Univ Wisconsin, Dept Counseling Psychol, Madison, WI 53706 USA; [Tucker, Raymond P.] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; [Simpson, Tracy L.] VA Puget Sound Hlth Care Syst, Seattle Div, Ctr Excellence Subst Abuse Treatment & Educ, Seattle, WA USA; [Davidson, Richard J.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Louisiana State University System; Louisiana State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Wisconsin System; University of Wisconsin Madison	Goldberg, SB (corresponding author), VA Puget Sound Hlth Care Syst, Seattle Div, Seattle, WA USA.; Goldberg, SB (corresponding author), Univ Wisconsin, Ctr Healthy Minds, Madison, WI 53706 USA.; Goldberg, SB (corresponding author), Univ Wisconsin, Dept Counseling Psychol, Madison, WI 53706 USA.	simon.goldberg@va.gov	Goldberg, Simon/AAQ-5173-2021; Tucker, Raymond/AAJ-8458-2021; Greene, Preston/P-5255-2014	Goldberg, Simon/0000-0002-6888-0126; Greene, Preston/0000-0002-7897-3019; Davidson, Richard/0000-0002-8506-4964	National Center for Complementary and Alternative Medicine (NCCAM) [P01AT004952]; Mind and Life Institute Varela Award; National Center for Complementary & Integrative Health [P01AT004952] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Mind and Life Institute Varela Award; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Center for Complementary and Alternative Medicine (NCCAM) P01AT004952 to RD and Mind and Life Institute Varela Award to SG. The NCCAM and Mind and Life Institute were not directly involved in study design; collection, analysis, or interpretation of data; in writing of the report; or in the decision to submit the article for publication. Any views, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect those of the Mind & Life Institute.	American Psychological Association, 2017, RES SUPP PSYCH TREAT, V1, P2; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bishop SR, 2002, PSYCHOSOM MED, V64, P71, DOI 10.1097/00006842-200201000-00010; Black David S, 2010, Mindfulness (N Y), V1, P174; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2002, APPL MULTIPLE REGRES, V3rd, DOI 10.4324/9780203774441; Coronado-Montoya S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153220; Davidson RJ, 2015, AM PSYCHOL, V70, P581, DOI 10.1037/a0039512; Davis JM, 2014, SUBST USE MISUSE, V49, P571, DOI 10.3109/10826084.2013.770025; Davis JM, 2017, MINDFULNESS; Dimidjian S, 2015, AM PSYCHOL, V70, P593, DOI 10.1037/a0039589; Farias M, 2016, LANCET PSYCHIAT, V3, P1012, DOI 10.1016/S2215-0366(16)30211-5; Garland EL, 2014, J CONSULT CLIN PSYCH, V82, P448, DOI 10.1037/a0035798; Goldberg SB, 2017, COUNSELLING PSYCHOL; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Kabat-Zinn J, 2011, CONTEMP BUDDHISM, V12, P281, DOI 10.1080/14639947.2011.564844; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005; Kristeller Jean L, 2011, Eat Disord, V19, P49, DOI 10.1080/10640266.2011.533605; Kuyken W, 2016, JAMA PSYCHIAT, V73, P565, DOI 10.1001/jamapsychiatry.2016.0076; Lachin JM, 2000, CONTROL CLIN TRIALS, V21, P167, DOI 10.1016/S0197-2456(00)00046-5; Liebherz S, 2016, PSYCHOTHER RES, V26, P573, DOI 10.1080/10503307.2015.1044763; Linehan M., 1993, COGNITIVE BEHAV TREA; MacCoon DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097551; MacCoon DG, 2012, BEHAV RES THER, V50, P3, DOI 10.1016/j.brat.2011.10.011; Maxwell SE, 2015, AM PSYCHOL, V70, P487, DOI 10.1037/a0039400; McHugh RK, 2009, BEHAV RES THER, V47, P946, DOI 10.1016/j.brat.2009.07.005; ROSSI JS, 1990, J CONSULT CLIN PSYCH, V58, P646, DOI 10.1037/0022-006X.58.5.646; Segal Z. V., 2002, MINDFULNESS BASED CO; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Tijdink JK, 2014, J EMPIR RES HUM RES, V9, P64, DOI 10.1177/1556264614552421; Wampold BE, 1997, PSYCHOL BULL, V122, P203, DOI 10.1037/0033-2909.122.3.203; Zoogman S, 2015, MINDFULNESS, V6, P290, DOI 10.1007/s12671-013-0260-4	40	34	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187298	10.1371/journal.pone.0187298	http://dx.doi.org/10.1371/journal.pone.0187298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088283	Green Published, gold, Green Submitted			2022-12-27	WOS:000414088900062
J	Huang, JB; Zhou, YB; Wan, B; Wang, QS; Wan, XC				Huang, Jinbao; Zhou, Yibin; Wan, Bei; Wang, Qiushi; Wan, Xiaochun			Green tea polyphenols alter lipid metabolism in the livers of broiler chickens through increased phosphorylation of AMP-activated protein kinase	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; HEPATIC STELLATE CELLS; RECEPTOR-ALPHA; ENERGY-METABOLISM; GENE-EXPRESSION; ADIPOSE-TISSUE; X-RECEPTOR; BLACK TEA; MICE; RATS	Our previous results showed that green tea polyphenols (GTPs) significantly altered the expression of lipid-metabolizing genes in the liver of chickens. However, the underlying mechanism was not elucidated. In this study, we further characterized how GTPs influence AMP-activated protein kinase (AMPK) in the regulation of hepatic fat metabolism. Thirty-six male chickens were fed GTPs at a daily dose of 0, 80 or 160 mg/kg of body weight for 4 weeks. The results demonstrated that oral administration of GTPs significantly reduced hepatic lipid content and abdominal fat mass, enhanced the phosphorylation levels of AMPK alpha and ACACA, and altered the mRNA levels and enzymatic activities of lipid-metabolizing enzymes in the liver. These results suggested that the activation of AMPK is a potential mechanism by which GTPs regulate hepatic lipid metabolism in such a way that lipid synthesis is reduced and fat oxidation is stimulated.	[Huang, Jinbao; Zhou, Yibin; Wan, Bei; Wang, Qiushi; Wan, Xiaochun] Anhui Agr Univ, Sch Tea & Food Sci & Technol, State Key Lab Tea Plant Biol & Utilizat, Hefei, Anhui, Peoples R China; [Huang, Jinbao; Wan, Xiaochun] Anhui Agr Univ, Int Joint Res Lab Tea Chem & Hlth Effects, Hefei, Anhui, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Wan, XC (corresponding author), Anhui Agr Univ, Sch Tea & Food Sci & Technol, State Key Lab Tea Plant Biol & Utilizat, Hefei, Anhui, Peoples R China.; Wan, XC (corresponding author), Anhui Agr Univ, Int Joint Res Lab Tea Chem & Hlth Effects, Hefei, Anhui, Peoples R China.	xcwan@ahau.edu.cn	Huang, Jinbao/N-3391-2018	Huang, Jinbao/0000-0003-2272-933X	Anhui Major Demonstration Project for Leading Talent Team on Tea Chemistry and Health; Natural Science Foundation of Anhui province, China [1608085MC54]; Natural Science Foundation of the Anhui Higher Education Institutions of China [KJ2015A060]; Youth Science Foundation of Anhui Agricultural University [2014zr009]; Talent Foundation of Anhui Agricultural University [yj2015-19]	Anhui Major Demonstration Project for Leading Talent Team on Tea Chemistry and Health; Natural Science Foundation of Anhui province, China(Natural Science Foundation of Anhui Province); Natural Science Foundation of the Anhui Higher Education Institutions of China; Youth Science Foundation of Anhui Agricultural University; Talent Foundation of Anhui Agricultural University	This work was supported, in whole or in part, by Anhui Major Demonstration Project for Leading Talent Team on Tea Chemistry and Health (www.ahedu.gov.cn); the Natural Science Foundation of Anhui province, China (Grant No. 1608085MC54, www.ahkjt.gov.cn); the Natural Science Foundation of the Anhui Higher Education Institutions of China (Key project, Grant No. KJ2015A060, www.ahedu.gov.cn), Youth Science Foundation of Anhui Agricultural University (Grant No. 2014zr009, www.ahau.edu.cn), Talent Foundation of Anhui Agricultural University (Grant No. yj2015-19, www.ahau.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameen C, 2004, AM J PHYSIOL-ENDOC M, V287, pE1039, DOI 10.1152/ajpendo.00059.2004; Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003; Diot C, 1999, POULTRY SCI, V78, P1198, DOI 10.1093/ps/78.8.1198; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gondret F, 2001, J LIPID RES, V42, P106; Hardie DG, 2011, BIOCHEM SOC T, V39, P1, DOI 10.1042/BST0390001; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Huang HC, 2012, FOOD FUNCT, V3, P170, DOI 10.1039/c1fo10157a; Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143; Huang JB, 2013, J AGR FOOD CHEM, V61, P8565, DOI 10.1021/jf402004x; Kandhro A, 2008, FOOD CHEM, V109, P207, DOI 10.1016/j.foodchem.2007.12.029; Kim SB, 2000, NUTR CANCER, V37, P41, DOI 10.1207/S15327914NC3701_5; Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926; Kohjima M, 2008, INT J MOL MED, V21, P507; Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021; Ni Q, 2014, BIOCHEM BIOPH RES CO, V446, P574, DOI 10.1016/j.bbrc.2014.03.001; Nogalska A, 2005, METABOLISM, V54, P1041, DOI 10.1016/j.metabol.2005.03.007; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Pollak M, 2014, NAT MED, V20, P591, DOI 10.1038/nm.3596; Sa C, 2015, EVID-BASED COMPL ALT, V2015, DOI DOI 10.1155/2015/647832; Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Yan KF, 2012, MOL MED, V18, P10, DOI 10.2119/molmed.2011.00243; Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717; Zhai XG, 2013, BRIT J PHARMACOL, V169, P197, DOI 10.1111/bph.12114; Zhang C, 2012, TOXICOL LETT, V212, P229, DOI 10.1016/j.toxlet.2012.06.002	35	15	18	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187061	10.1371/journal.pone.0187061	http://dx.doi.org/10.1371/journal.pone.0187061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073281	gold, Green Published, Green Submitted			2022-12-27	WOS:000413845400105
J	Friedrich-Rust, M; Schoelzel, F; Maier, S; Seeger, F; Rey, J; Fichtlscherer, S; Herrmann, E; Zeuzem, S; Bojunga, J				Friedrich-Rust, Mireen; Schoelzel, Fabian; Maier, Sebastian; Seeger, Florian; Rey, Julia; Fichtlscherer, Stephan; Herrmann, Eva; Zeuzem, Stefan; Bojunga, Joerg			Severity of coronary artery disease is associated with non-alcoholic fatty liver disease: A single-blinded prospective mono-center study	PLOS ONE			English	Article							CONTROLLED ATTENUATION PARAMETER; CENTRAL VENOUS-PRESSURE; TRANSIENT ELASTOGRAPHY; HEART-FAILURE; NONINVASIVE ASSESSMENT; STIFFNESS MEASUREMENT; HEPATIC STEATOSIS; OBESE-PATIENTS; FIBROSIS; CRITERIA	Background and aims Liver steatosis has shown to be associated with coronary artery disease (CAD). The aim of our study was to evaluate the association between the presence and severity of CAD and Non-alcoholic fatty liver disease (NAFLD) assessed by transient elastography (TE) and controlled attenuation parameter (CAP). Methods 576 Patients undergoing coronary angiography were enrolled in this prospective study, receiving at least 10 TE and CAP measurements using the FibroScan (R) M-probe. Clinically relevant CAD (CAD 3) was defined as stenosis with >= 75% reduction of the luminal diameter. NAFLD was determined by CAP >= 234 dB/m. NAFLD with advanced fibrosiswas determined by TE-values >= 7.9 kPain the presence of NAFLD and absence of congestive or right-sided heart failure. Rates and 95% confidence intervals are shown. Results 505 patients were available for analysis of NAFLD. However, only 392 patients were available for analysis of NAFLD with advanced fibrosis, since 24 patients had to be excluded due to non valid TE-measurements and 89 patients due to congestive or right-sided heart failure or suspected concomitant liver disease, respectively. 70.5% (66.3%-74.4%) of patients had CAD 3, 71.5% (67.3%-75.4%) were diagnosed with NAFLD, and 11.2% (8.3%-14.8%) with NAFLD with advanced fibrosis. Patients with CAD 3 had higher median CAP-values (273 +/- 61 vs. 260 +/- 66 dB/m; p = 0.038) and higher degrees of steatosis as compared to patients without CAD 3. While NAFLD was significantly more often diagnosed in patients with CAD 3 (75.0% vs. 63.1%, p = 0.0068), no significant difference was found for NAFLD with advanced fibrosis (10.7% vs. 12.5%, p = 0.60). Conclusions Clinically relevant CAD is frequently associated with the presence of NAFLD, but not NAFLD with advanced fibrosis.	[Friedrich-Rust, Mireen; Schoelzel, Fabian; Maier, Sebastian; Zeuzem, Stefan; Bojunga, Joerg] Hosp Goethe Univ, Dept Internal Med 1, Frankfurt, Germany; [Seeger, Florian; Fichtlscherer, Stephan] Hosp Goethe Univ, Dept Internal Med 3, Frankfurt, Germany; [Rey, Julia; Herrmann, Eva] Goethe Univ Frankfurt, Dept Med, Inst Biostat & Math Modelling, Frankfurt, Germany; [Herrmann, Eva] DZHK, German Ctr Cardiovasc Res, Partner Site Frankfurt Rhine Main, Berlin, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; German Centre for Cardiovascular Research	Friedrich-Rust, M (corresponding author), Hosp Goethe Univ, Dept Internal Med 1, Frankfurt, Germany.	Mireen.Friedrich-Rust@kgu.de	Zeuzem, Stefan/AAE-7435-2019		FibroScan(R) M-probe	FibroScan(R) M-probe	The commercial company, Echosens, provided material support by lending the FibroScan (R) M-probe used in this study to the authors (http://www.echosens.us/). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agac MT, 2013, ANGIOLOGY, V64, P604, DOI 10.1177/0003319713479155; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Arena U, 2013, HEPATOLOGY, V58, P65, DOI 10.1002/hep.26343; Bang Ki Bae, 2015, J Lifestyle Med, V5, P7, DOI 10.15280/jlm.2015.5.1.7; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Chan WK, 2014, J GASTROEN HEPATOL, V29, P1470, DOI 10.1111/jgh.12557; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; de Ledinghen V, 2012, J HEPATOL, V56, P833, DOI 10.1016/j.jhep.2011.10.017; Fraquelli M, 2011, J HEPATOL, V54, P621, DOI 10.1016/j.jhep.2010.07.017; Friedrich-Rust M, 2012, EUR J RADIOL, V81, pE325, DOI 10.1016/j.ejrad.2011.10.029; Friedrich-Rust M, 2010, EUR RADIOL, V20, P2390, DOI 10.1007/s00330-010-1820-9; Goertz RS, 2012, ULTRASCHALL MED, V33, P380, DOI 10.1055/s-0032-1312816; Jalal Z, 2015, HEART, V101, P1499, DOI 10.1136/heartjnl-2014-307385; Karlas T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091987; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee SS, 2010, J HEPATOL, V52, P579, DOI 10.1016/j.jhep.2010.01.008; Mikolasevic I, 2016, WORLD J GASTROENTERO, V22, P7236, DOI 10.3748/wjg.v22.i32.7236; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Mueller S, 2010, WORLD J GASTROENTERO, V16, P966, DOI 10.3748/wjg.v16.i8.966; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Myers RP, 2012, HEPATOLOGY, V55, P199, DOI 10.1002/hep.24624; Patel MR, 2009, CIRCULATION, V119, P1330, DOI 10.1161/CIRCULATIONAHA.108.191768; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sasso M, 2016, ULTRASOUND MED BIOL, V42, P92, DOI 10.1016/j.ultrasmedbio.2015.08.008; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Taniguchi T, 2014, AM J CARDIOL, V113, P552, DOI 10.1016/j.amjcard.2013.10.018; Wong VWS, 2017, J HEPATOL, V67, P577, DOI 10.1016/j.jhep.2017.05.005; Wong VWS, 2016, HEPATOLOGY, V63, P754, DOI 10.1002/hep.28253; Wong VWS, 2011, GUT, V60, P1721, DOI 10.1136/gut.2011.242016; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Yoshitani T, 2016, CIRC J, V80, P1187, DOI 10.1253/circj.CJ-15-1200	34	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186720	10.1371/journal.pone.0186720	http://dx.doi.org/10.1371/journal.pone.0186720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073252	Green Submitted, Green Published, gold			2022-12-27	WOS:000413845400044
J	Sun, DD; Liu, JL; Xiao, L; Liu, Y; Wang, ZG; Li, C; Jin, YX; Zhao, Q; Wen, SJ				Sun, Dongdong; Liu, Jielin; Xiao, Lei; Liu, Ya; Wang, Zuoguang; Li, Chuang; Jin, Yongxin; Zhao, Qiong; Wen, Shaojun			Recent development of risk-prediction models for incident hypertension: An updated systematic review	PLOS ONE			English	Review							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; KOREAN GENOME; CHINESE POPULATION; SCORE; WOMEN	Background Hypertension is a leading global health threat and a major cardiovascular disease. Since clinical interventions are effective in delaying the disease progression from prehypertension to hypertension, diagnostic prediction models to identify patient populations at high risk for hypertension are imperative. Methods Both PubMed and Embase databases were searched for eligible reports of either prediction models or risk scores of hypertension. The study data were collected, including risk factors, statistic methods, characteristics of study design and participants, performance measurement, etc. Results From the searched literature, 26 studies reporting 48 prediction models were selected. Among them, 20 reports studied the established models using traditional risk factors, such as body mass index (BMI), age, smoking, blood pressure (BP) level, parental history of hypertension, and biochemical factors, whereas 6 reports used genetic risk score (GRS) as the prediction factor. AUC ranged from 0.64 to 0.97, and C-statistic ranged from 60% to 90%. Conclusions The traditional models are still the predominant risk prediction models for hypertension, but recently, more models have begun to incorporate genetic factors as part of their model predictors. However, these genetic predictors need to be well selected. The current reported models have acceptable to good discrimination and calibration ability, but whether the models can be applied in clinical practice still needs more validation and adjustment.	[Sun, Dongdong; Liu, Jielin; Liu, Ya; Wang, Zuoguang; Li, Chuang; Jin, Yongxin; Wen, Shaojun] Capital Med Univ, Beijing Anzhen Hosp, Dept Hypertens Res, Beijing, Peoples R China; [Sun, Dongdong; Liu, Jielin; Liu, Ya; Wang, Zuoguang; Li, Chuang; Jin, Yongxin; Wen, Shaojun] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Sun, Dongdong; Liu, Jielin; Liu, Ya; Wang, Zuoguang; Li, Chuang; Jin, Yongxin; Wen, Shaojun] Beijing Lab Cardiovasc Precis Med PXM2017 014226, Beijing, Peoples R China; [Xiao, Lei] NHLBI, Lung Cell & Vasc Biol Program, Bldg 10, Bethesda, MD 20892 USA; [Zhao, Qiong] Virginia Commonwealth Univ, Sch Med, Dept Med, Div Cardiol, Inova Campus, Falls Church, VA 22042 USA	Capital Medical University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Virginia Commonwealth University	Wen, SJ (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Hypertens Res, Beijing, Peoples R China.; Wen, SJ (corresponding author), Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China.; Wen, SJ (corresponding author), Beijing Lab Cardiovasc Precis Med PXM2017 014226, Beijing, Peoples R China.; Zhao, Q (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Med, Div Cardiol, Inova Campus, Falls Church, VA 22042 USA.	qiong.zhao@inova.org; wenshaojun@aliyun.com		Wang, Zuoguang/0000-0002-0230-1611; Liu, Ya/0000-0002-7816-684X	Beijing Natural Science Foundation [7120001]; National Institutes of Health (NIH) [7R01 HL083218-06, 3R01 HL083218-01A2S1]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from Beijing Natural Science Foundation [grant number 7120001] (S.W.). This work was supported in part by the National Institutes of Health (NIH) grants 7R01 HL083218-06 (Q.Z.) and 3R01 HL083218-01A2S1 (L.X.).	Asgari S, 2015, BLOOD PRESSURE, P1; Bozorgmanesh M, 2011, J HYPERTENS, V29, P1486, DOI 10.1097/HJH.0b013e328348fdb2; Carson AP, 2013, HYPERTENSION, V62, P1015, DOI 10.1161/HYPERTENSIONAHA.113.01539; Chen Y, 2016, CELL ADHES MIGR, V1, P7, DOI DOI 10.1016/J.JNUTBI0.2016.01.007; Chien KL, 2011, J HUM HYPERTENS, V25, P294, DOI 10.1038/jhh.2010.63; Choi Yun-Hee, 2014, BMC Proc, V8, pS78, DOI 10.1186/1753-6561-8-S1-S78; Devereux RB, 2000, AM J CARDIOL, V85, P1265, DOI 10.1016/S0002-9149(00)00744-X; Echouffo-Tcheugui Justin B, 2013, PLoS One, V8, pe67370, DOI 10.1371/journal.pone.0067370; Fava C, 2013, HYPERTENSION, V61, P319, DOI 10.1161/HYPERTENSIONAHA.112.202655; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kivimaki M, 2010, HYPERTENSION, V55, P1058, DOI 10.1161/HYPERTENSIONAHA.109.144220; Kivimaki M, 2009, HYPERTENSION, V54, P496, DOI 10.1161/HYPERTENSIONAHA.109.132373; Kshirsagar AV, 2010, J CLIN HYPERTENS, V12, P800, DOI 10.1111/j.1751-7176.2010.00343.x; Lee BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084897; Lee JW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1471-5; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li Guoqi, 2014, Zhonghua Nei Ke Za Zhi, V53, P265; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lim NK, 2016, CIRC J, V80, P1578, DOI 10.1253/circj.CJ-15-1334; Lim NK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131603; Lim NK, 2013, J CLIN HYPERTENS, V15, P344, DOI 10.1111/jch.12080; Lu XF, 2015, HYPERTENSION, V66, P786, DOI 10.1161/HYPERTENSIONAHA.115.05961; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Muntner P, 2010, HYPERTENSION, V55, P1339, DOI 10.1161/HYPERTENSIONAHA.109.149609; Niiranen TJ, 2016, J CLIN HYPERTENS, V18, P181, DOI 10.1111/jch.12702; Otsuka T, 2015, HYPERTENS RES, V38, P445, DOI 10.1038/hr.2015.41; Padmanabhan S, 2013, HYPERTENSION, V61, P961, DOI 10.1161/HYPERTENSIONAHA.113.00948; Parikh NI, 2008, ANN INTERN MED, V148, P102, DOI 10.7326/0003-4819-148-2-200801150-00005; Paynter NP, 2009, AM J MED, V122, P464, DOI 10.1016/j.amjmed.2008.10.034; Pearson T A, 1990, Am J Prev Med, V6, P23; Qi Y, 2014, HYPERTENS RES, V37, P134, DOI 10.1038/hr.2013.132; Sathish T, 2016, ASIA-PAC J PUBLIC HE, V28, p26S, DOI 10.1177/1010539515604701; Sun Ning-Ling, 2013, Zhonghua Xin Xue Guan Bing Za Zhi, V41, P333; Volzke H, 2013, J HYPERTENS, V31, P2142, DOI 10.1097/HJH.0b013e328364a16d; Yamakado M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11918; Yeh CJ, 2001, J FORMOS MED ASSOC, V100, P668; Zhang WC, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150192; Zheng LQ, 2014, AM J HYPERTENS, V27, P409, DOI 10.1093/ajh/hpt229	38	40	41	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187240	10.1371/journal.pone.0187240	http://dx.doi.org/10.1371/journal.pone.0187240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084293	Green Published, gold, Green Submitted			2022-12-27	WOS:000413910200039
J	Belloir, C; Savistchenko, J; Neiers, F; Taylor, AJ; McGrane, S; Briand, L				Belloir, Christine; Savistchenko, Jimmy; Neiers, Fabrice; Taylor, Andrew J.; McGrane, Scott; Briand, Loic			Biophysical and functional characterization of the N-terminal domain of the cat T1R1 umami taste receptor expressed in Escherichia coli	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; GLOSSOPHARYNGEAL NERVE; EXTRACELLULAR DOMAIN; MOLECULAR-MECHANISM; CHORDA TYMPANI; DOMESTIC DOGS; SWEET; RESPONSES; MICE; SUBUNITS	Umami taste perception is mediated by the heterodimeric G-protein coupled receptors (GPCRs), formed by the assembly of T1R1 and T1R3 subunits. T1R1 and T1R3 subunits are class C GPCRs whose members share common structural homologies including a long N-terminal domain (NTD) linked to a seven transmembrane domain by a short cysteine-rich region. The NTD of the T1R1 subunit contains the primary binding site for umami stimuli, such as L-glutamate (L-Glu) for humans. Inosine-5'-monophosphate (IMP) binds at a location close to the opening of the T1R1-NTD "flytrap", thus creating the observed synergistic response between L-Glu and IMP. T1R1/T1R3 binding studies have revealed species-dependent differences. While human T1R1/T1R3 is activated specifically by L-Glu, the T1R1/T1R3 in other species is a broadly tuned receptor, sensitive to a range of L-amino acids. Because domestic cats are obligate carnivores, they display strong preferences for some specific amino acids. To better understand the structural basis of umami stimuli recognition by non-human taste receptors, we measured the binding of selected amino acids to cat T1R1/T1R3 (cT1R1/cT1R3) umami taste receptor. For this purpose, we expressed cT1R1-NTD in bacteria as inclusion bodies. After purification, refolding of the protein was achieved. Circular dichroism spectroscopic studies revealed that cT1R1-NTD was well renatured with evidence of secondary structures. Using size-exclusion chromatography coupled to light scattering, we found that the cT1R1-NTD behaves as a monomer. Ligand binding quantified by intrinsic tryptophan fluorescence showed that cT1R1-NTD is capable of binding L-amino acids with K-d values in the micromolar range. We demonstrated that IMP potentiates L-amino acid binding onto renatured cT1R1-NTD. Interestingly, our results revealed that IMP binds the extracellular domain in the absence of L-amino acids. Thus, this study demonstrates that the feasibility to produce milligram quantities of cT1R1-NTD for functional and structural studies.	[Belloir, Christine; Savistchenko, Jimmy; Neiers, Fabrice; Briand, Loic] Bourgogne Franche Comte Univ, Ctr Sci Gout & Alimentat, INRA, CNRS,AgroSup Dijon, Dijon, France; [Taylor, Andrew J.; McGrane, Scott] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Mars; WALTHAM Petcare Science Institute	Briand, L (corresponding author), Bourgogne Franche Comte Univ, Ctr Sci Gout & Alimentat, INRA, CNRS,AgroSup Dijon, Dijon, France.	loic.briand@inra.fr	Neiers, Fabrice/AAM-1637-2021	Neiers, Fabrice/0000-0002-8965-4929; Briand, Loic/0000-0002-8175-5936	WALTHAM Centre for Pet Nutrition	WALTHAM Centre for Pet Nutrition	This work was supported by a grant from the WALTHAM Centre for Pet Nutrition, which is part of Mars Petcare UK, to LB. There was no additional internal or external funding received for this study. WALTHAM Centre for Pet Nutrition provided support in the form of salaries for authors Andrew J. Taylor and Scott McGrane but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ariyasu T, 2003, IN VITRO CELL DEV-AN, V39, P80; Bachmanov AA, 2014, CURR PHARM DESIGN, V20, P2669, DOI 10.2174/13816128113199990566; Baldwin MW, 2014, SCIENCE, V345, P929, DOI 10.1126/science.1255097; Beauchamp GK, 2009, AM J CLIN NUTR, V90, p723S, DOI 10.3945/ajcn.2009.27462E; Bradshaw JWS, 2006, J NUTR, V136, p1927S, DOI 10.1093/jn/136.7.1927S; BRADSHAW JWS, 1991, P NUTR SOC, V50, P99, DOI 10.1079/PNS19910015; Chaudhari N, 2009, AM J CLIN NUTR, V90, p738S, DOI 10.3945/ajcn.2009.27462H; Choudhuri SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130088; Danilova V, 1999, CHEM SENSES, V24, P301, DOI 10.1093/chemse/24.3.301; Delay ER, 2015, CHEM SENSES, V40, P125, DOI 10.1093/chemse/bju067; Geng Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13662; Geng Y, 2012, NAT NEUROSCI, V15, P970, DOI 10.1038/nn.3133; Hellekant G, 1997, J NEUROPHYSIOL, V77, P978, DOI 10.1152/jn.1997.77.2.978; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Kendig DM, 2014, AM J PHYSIOL-GASTR L, V307, pG1100, DOI 10.1152/ajpgi.00251.2014; Kuninaka A, 1960, J AGR CHEM SOC JPN, V34, P487; Kuninaka A., 1964, S FLAV POT CAMBR MA, P4; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Kusuhara Y, 2013, J PHYSIOL-LONDON, V591, P1967, DOI 10.1113/jphysiol.2012.236604; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lei WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139670; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Maitrepierre E, 2013, BIOENGINEERED, V4, P25, DOI 10.4161/bioe.21877; Maitrepierre E, 2012, PROTEIN EXPRES PURIF, V83, P75, DOI 10.1016/j.pep.2012.03.006; Maruyama Y, 2006, J NEUROSCI, V26, P2227, DOI 10.1523/JNEUROSCI.4329-05.2006; McGrane S., 2014, CURR TOP FLAV CHEM B, P35; McGrane S, 2014, Patent application, Patent No. [WO 2014/068043., 2014068043]; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Nie YL, 2006, CHEM SENSES, V31, P505, DOI 10.1093/chemse/bjj053; NINOMIYA Y, 1989, COMP BIOCHEM PHYS A, V92, P365; Nuemket N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15530; Raliou M, 2011, CHEM SENSES, V36, P527, DOI 10.1093/chemse/bjr014; Roura E, 2011, FLAVOUR FRAG J, V26, P282, DOI 10.1002/ffj.2057; Saites LN, 2015, CHEM SENSES, V40, P295, DOI 10.1093/chemse/bjv010; Sandau MM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0170-6; SATO M, 1965, JPN J PHYSIOL, V15, P53; Stapleton JR, 2002, CHEM SENSES, V27, P375, DOI 10.1093/chemse/27.4.375; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Toda Y, 2013, J BIOL CHEM, V288, P36863, DOI 10.1074/jbc.M113.494443; WHITE TD, 1975, PHYSIOL PSYCHOL, V3, P405; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; YAMAGUCHI S, 1991, PHYSIOL BEHAV, V49, P833, DOI 10.1016/0031-9384(91)90192-Q; YOSHII K, 1986, BRAIN RES, V367, P45, DOI 10.1016/0006-8993(86)91577-5; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106	52	15	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187051	10.1371/journal.pone.0187051	http://dx.doi.org/10.1371/journal.pone.0187051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084235	gold, Green Published, Green Submitted			2022-12-27	WOS:000413910200027
J	van Rosmalen, BV; Alldinger, I; Cieslak, KP; Wennink, R; Clarke, M; Ali, UA; Besselink, MGH				van Rosmalen, Belle V.; Alldinger, Ingo; Cieslak, Kasia P.; Wennink, Roos; Clarke, Mike; Ali, Usama Ahmed; Besselink, Marc G. H.			Worldwide trends in volume and quality of published protocols of randomized controlled trials (vol 12, e0173042, 2017)	PLOS ONE			English	Correction													Besselink, Marc G/R-4268-2019	Besselink, Marc G/0000-0003-2650-9350				van Rosmalen BV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173042	1	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187389	10.1371/journal.pone.0187389	http://dx.doi.org/10.1371/journal.pone.0187389			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073285	Green Published, Green Submitted, gold			2022-12-27	WOS:000413845400138
J	Ayanore, MA; Pavlova, M; Biesma, R; Groot, W				Ayanore, Martin Amogre; Pavlova, Milena; Biesma, Regien; Groot, Wim			Stakeholder's experiences, expectations and decision making on reproductive care: An ethnographic study of three districts in northern Ghana	PLOS ONE			English	Article							CONTRACEPTIVE USE; UNSAFE ABORTION; HEALTH; COUPLES; AFRICA; PATTERNS; SERVICES; BEHAVIOR; NIGERIA; TRENDS	Background In Ghana, priority-setting for reproductive health service interventions is known to be rudimentary with little wider stakeholder involvement. In recognizing the need for broad stakeholder engagement to advance reproductive care provision and utilization, it is necessary to jointly study the varied stakeholder views on reproductive care services. Methods We applied an ethnographic study approach where field data was collected between March May 2015 in three rural districts of northern Ghana. Data was collected among women with recent births experiences (n = 90), health care providers (n = 16) and policy actors (n = 6). In-depth interviews and focus group discussions was applied to collect all data. Each stakeholder participant's audio file was transcribed, and repeatedly read through to identify similar and divergent views in data. A coding scheme guided coding processes. All transcripts were then imported into QSR NVivo 11 for further analysis. Results Four themes emerged. Women participants accentuated that sex and sexuality values of men have changed over time, and drives gender roles, parity levels and decision making on reproductive care needs at community levels. Sexual stigma on reproductive care reduces the willingness of women to voice poor experiences related to their previous reproductive experiences. All stakeholders' highlighted clinical treatments for post-abortion care are minimally covered under the fee exemption policy for antenatal and postnatal care. Policy processes on service delivery protocols still is top-down in Ghana. Conclusions Health teams working to improve sexual and reproductive health care must find suitable context strategies that effectively work to improve women reproductive care needs at their operational levels. Private sector participation and informal community support clutches are encouraged to advance the delivery of reproductive care services.	[Ayanore, Martin Amogre] Univ Hlth & Allied Sci, Dept Family & Community Hlth, Sch Publ Hlth, Hohoe, Ghana; [Ayanore, Martin Amogre; Pavlova, Milena; Groot, Wim] Maastricht Univ, Dept Hlth Serv Res, CAPHRI, Med Ctr,Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Ayanore, Martin Amogre] Ctr Hlth Policy Advocacy Innovat & Res Africa CHP, Accra, Ghana; [Biesma, Regien] Royal Coll Surgeons Ireland, Dept Epidemiol & Publ Hlth Med, Div Populat Hlth Sci, Dublin, Ireland; [Groot, Wim] Maastricht Univ, Top Inst Evidence Based Educ Res TIER, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Royal College of Surgeons - Ireland; Maastricht University	Ayanore, MA (corresponding author), Univ Hlth & Allied Sci, Dept Family & Community Hlth, Sch Publ Hlth, Hohoe, Ghana.; Ayanore, MA (corresponding author), Maastricht Univ, Dept Hlth Serv Res, CAPHRI, Med Ctr,Fac Hlth Med & Life Sci, Maastricht, Netherlands.; Ayanore, MA (corresponding author), Ctr Hlth Policy Advocacy Innovat & Res Africa CHP, Accra, Ghana.	mayanore@uhas.edu.gh	Dangal, Ganesh/O-1989-2017; Pavlova, Milena/B-4778-2011; Biesma, Regien/D-8803-2017	Dangal, Ganesh/0000-0002-5834-5525; Pavlova, Milena/0000-0002-6082-8446; Ayanore, Martin/0000-0002-4095-3047; Biesma, Regien/0000-0002-5532-0242				Abekah-Nkrumah G, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0085-7; Ahman E, 2011, INT J GYNECOL OBSTET, V115, P121, DOI 10.1016/j.ijgo.2011.05.027; Allen M, 2011, QUAL RES, V11, P23, DOI 10.1177/1468794110384452; [Anonymous], J FAM WELFARE; Ashford, 2007, REPROD HLTH, V14, P8; ATKINSON P, 1988, REV EDUC RES, V58, P231, DOI 10.3102/00346543058002231; Ayanore MA, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-015-0104-x; Baiden F, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0310-x; Baschieri A, 2013, J BIOSOC SCI, V45, P145, DOI 10.1017/S0021932012000569; Bawah AA, 1999, STUD FAM PLANN, V30; Beegle K, 2001, STUD FAMILY PLANN, V32, P130, DOI 10.1111/j.1728-4465.2001.00130.x; Biddlecom AE, 1998, STUD FAM PLANN, V29; Binka FN, 1995, STUD FAM PLANN, V26; Blackstone SR, 2017, J BIOSOC SCI, V49, P423, DOI 10.1017/S0021932016000377; Blanc AK, 2001, STUD FAM PLANN, V32; BOYLE JS, 1994, CRITICAL ISSUES IN QUALITATIVE RESEARCH METHODS, P159; Burt R.S., 2005, BROKERAGE CLOSURE IN; Corroon M, 2014, MATERN CHILD HLTH J, V18, P307, DOI 10.1007/s10995-013-1266-1; Creswell JW, 2013, RES DESIGN QUALITATI; Crissman Halley P, 2013, Afr J Reprod Health, V17, P15; Dalaba MA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1325-6; Dehne K, 1999, INTEGRATING STI MANA; Domar AD, 2004, FERTIL STERIL, V81, P271, DOI 10.1016/j.fertnstert.2003.08.013; Doyle AM, 2012, TROP MED INT HEALTH, V17, P796, DOI 10.1111/j.1365-3156.2012.03005.x; Dudgeon MR, 2004, SOC SCI MED, V59, P1379, DOI 10.1016/j.socscimed.2003.11.035; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Feyisetan BJ, 2000, POPUL RES POLICY REV, V19, P29, DOI 10.1023/A:1006388011947; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; GOG, 2000, GHAN AD REPR HLTH PO; GSS GHS ICF, 2014, GHAN DEM HLTH SURV; Hall KS, 2016, J ADOLESCENT HEALTH, V58, pS4, DOI 10.1016/j.jadohealth.2015.10.024; Hanschmidt F, 2016, ABORTION STIGMA SYST; Kiapi-Iwa L, 2004, AIDS CARE, V16, P339, DOI 10.1080/09540120410001665349; Maharaj P, 2005, HEALTH POLICY PLANN, V20, P310, DOI 10.1093/heapol/czi038; Mayhew SH, 2004, HEALTH POLICY PLANN, V19, pI50, DOI 10.1093/heapol/czh045; MILLER WB, 1995, J APPL SOC PSYCHOL, V25, P530, DOI 10.1111/j.1559-1816.1995.tb01766.x; MoH, 2008, NAT CONS M RED MAT M; MoH, 2014, HOL ASS HLTH SECT PR; MOH, 2011, IND REV HLTH SECT PR; MUECKE MA, 1994, CRITICAL ISSUES IN QUALITATIVE RESEARCH METHODS, P187; Mutemwa R, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-18; OlaOlorun F, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0118-z; Opit LJ, 1987, SHOULD INFORM HLTH C; Phillips JF, 2006, B WORLD HEALTH ORGAN, V84, P949, DOI 10.2471/BLT.06.030064; Rifkin S, 1986, HLTH PLANNING COMMUN; Seddoh A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S10; Slade P, 2007, HUM REPROD, V22, P2309, DOI 10.1093/humrep/dem115; van der Geugten J, 2015, SEX EDUC-SEX SOC LEA, V15, P113, DOI 10.1080/14681811.2014.968771; Vlassoff M, 2009, INT PERSPECT SEX R H, V35, P114, DOI 10.1363/ipsrh.35.114.09; Walsh D, 1999, MIDWIFERY, V15, P165, DOI 10.1016/S0266-6138(99)90061-X; Welsh E., 2002, FOR QUAL SOZ FOR QUA; Witter S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1881; Zabin LS, 1998, STUD FAMILY PLANN, V29, P210, DOI 10.2307/172160	53	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186908	http://dx.doi.org/10.1371/journal.pone.0186908			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091916	Green Published, Green Submitted, gold			2022-12-27	WOS:000414229700033
J	Islam, S; Rahman, IA; Islam, T; Ghosh, A				Islam, Shiful; Rahman, Iffat Ara; Islam, Tahmina; Ghosh, Ajit			Genome-wide identification and expression analysis of glutathione S-transferase gene family in tomato: Gaining an insight to their physiological and stress-specific roles	PLOS ONE			English	Article							SUPERGENE FAMILY; SEGMENTAL DUPLICATIONS; ARABIDOPSIS; DETOXIFICATION; TOLERANCE; EVOLUTION; GST; INDUCTION; DATABASE	Glutathione S-transferase (GST) refers to one of the major detoxifying enzymes that plays an important role in different abiotic and biotic stress modulation pathways of plant. The present study aimed to a comprehensive genome-wide functional characterization of GST genes and proteins in tomato (Solarium lycopersicum L). The whole genome sequence analysis revealed the presence of 90 GSTgenes in tomato, the largest GSTgene family reported till date. Eight segmental duplicated gene pairs might contribute significantly to the expansion of S/GSTgene family. Based on phylogenetic analysis of tomato, rice, and Arabidopsis GST proteins, GST family members could be further divided into ten classes. Members of each orthologous class showed high conservancy among themselves. Tau and lambda are the major classes of tomato; while tau and phi are the major classes for rice and Arabidopsis. Chromosomal localization revealed highly uneven distribution of S/GSTgenes in 13 different chromosomes, where chromosome 9 possessed the highest number of genes. Based on publicly available microarray data, expression analysis of 30 available S/GSTgenes exhibited a differential pattern in all the analyzed tissues and developmental stages. Moreover, most of the members showed highly induced expression in response to multiple biotic and abiotic stress inducers that could be harmonized with the increase in total GST enzyme activity under several stress conditions. Activity of tomato GST could be enhanced further by using some positive modulators (safeners) that have been predicted through molecular docking of SIGSTU5 and ligands. Moreover, tomato GST proteins are predicted to interact with a lot of other glutathione synthesizing and utilizing enzymes such as glutathione peroxidase, glutathione reductase, glutathione synthetase and gamma-glutamyl-transferase. This comprehensive genome-wide analysis and expression profiling would provide a rational platform and possibility to explore the versatile role of GSTgenes in crop engineering.	[Islam, Shiful; Ghosh, Ajit] Shahjalal Univ Sci & Technol, Dept Biochem & Mol Biol, Sylhet, Bangladesh; [Rahman, Iffat Ara; Islam, Tahmina] Univ Dhaka, Dept Bot, Plant Breeding & Biotechnol Lab, Dhaka, Bangladesh	Shahjalal University of Science & Technology (SUST); University of Dhaka	Ghosh, A (corresponding author), Shahjalal Univ Sci & Technol, Dept Biochem & Mol Biol, Sylhet, Bangladesh.	ajitghoshbd@gmail.com	Islam, Tahmina/AAU-9539-2021; Islam, Shiful/AAX-7442-2021; Ghosh, Ajit/AAC-5914-2022	Islam, Tahmina/0000-0002-0542-0050; Islam, Shiful/0000-0002-1826-6777; Ghosh, Ajit/0000-0001-9045-3916				Bagaria A, 2012, PROTEIN SCI, V21, P229, DOI 10.1002/pro.2007; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Biovia DS., DISCOVERY STUDIO MOD; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Csiszar J, 2014, PLANT PHYSIOL BIOCH, V78, P15, DOI 10.1016/j.plaphy.2014.02.010; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; DeRidder BP, 2002, PLANT PHYSIOL, V130, P1497, DOI 10.1104/pp.010066; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dixon DP, 1998, PLANT MOL BIOL, V36, P75, DOI 10.1023/A:1005958711207; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frova C, 2003, PHYSIOL PLANTARUM, V119, P469, DOI 10.1046/j.1399-3054.2003.00183.x; Ghosh A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00836; Ghosh A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0773-9; Ghosh A, 2014, PLANT J, V80, P93, DOI 10.1111/tpj.12621; HATZIOS KK, 1986, CAN J PLANT SCI, V66, P353, DOI 10.4141/cjps86-050; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; He G, 2016, FRONT PLANT SCI, P7; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Ji W, 2010, BIOTECHNOL LETT, V32, P1173, DOI 10.1007/s10529-010-0269-x; Jiang HW, 2010, PLANT PHYSIOL, V154, P1646, DOI 10.1104/pp.110.159152; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kearney PC, 1975, HERBICIDES CHEM DEGR; Kerwin SM, 2010, J AM CHEM SOC, V132, P2466, DOI 10.1021/ja1005306; Kilili KG, 2004, J BIOL CHEM, V279, P24540, DOI 10.1074/jbc.M309882200; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kumar S, 2013, PLANT MOL BIOL REP, V31, P569, DOI 10.1007/s11105-012-0524-5; Kumar S, 2013, J HAZARD MATER, V248, P228, DOI 10.1016/j.jhazmat.2013.01.004; Lallement PA, 2014, FRONT PHARMACOL, P5; Lallement PA, 2015, FEBS LETT, V589, P37, DOI 10.1016/j.febslet.2014.11.021; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Licciardello C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-39; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Mohsenzadeh S, 2011, AFR J BIOTECHNOL, V10, P8160; Mysore KS, 2001, GENOME BIOL, V2; Nianiou-Obeidat I, 2017, PLANT CELL REP, V36, P791, DOI 10.1007/s00299-017-2139-7; Nishida M, 1998, J MOL BIOL, V281, P135, DOI 10.1006/jmbi.1998.1927; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Pascal S, 1999, PHYSIOL PLANTARUM, V106, P17, DOI 10.1034/j.1399-3054.1999.106103.x; Patel BP, 2002, NEOPLASMA, V49, P260; Ramsay EE, 2015, CHANGING FACES GLUTA, P125; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rezaei MK, 2013, J PLANT PHYSIOL, V170, P1277, DOI 10.1016/j.jplph.2013.04.005; Riechers DE, 2010, PLANT PHYSIOL, V153, P3, DOI 10.1104/pp.110.153601; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092900; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Steinberg CE, 2012, STRESS ECOLOGY ENV S, P75; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Xu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122216; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang Q, 2014, PLANT PHYSIOL BIOCH, V77, P99, DOI 10.1016/j.plaphy.2014.02.003; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018	69	57	59	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187504	10.1371/journal.pone.0187504	http://dx.doi.org/10.1371/journal.pone.0187504			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095889	Green Published, Green Submitted, gold			2022-12-27	WOS:000414340200105
J	Kulaeva, OA; Zhernakov, AI; Afonin, AM; Boikov, SS; Sulima, AS; Tikhonovich, IA; Zhukov, VA				Kulaeva, Olga A.; Zhernakov, Aleksandr I.; Afonin, Alexey M.; Boikov, Sergei S.; Sulima, Anton S.; Tikhonovich, Igor A.; Zhukov, Vladimir A.			Pea Marker Database (PMD) - A new online database combining known pea (Pisum sativum L.) gene-based markers	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; INEFFECTIVE NODULATION; NITROGEN-FIXATION; CANDIDATE GENES; LINKAGE MAPS; POLYMORPHISM; NODULES; GENOME; IDENTIFICATION; CONSERVATION	Pea (Pisum sativum L.) is the oldest model object of plant genetics and one of the most agriculturally important legumes in the world. Since the pea genome has not been sequenced yet, identification of genes responsible for mutant phenotypes or desirable agricultural traits is usually performed via genetic mapping followed by candidate gene search. Such mapping is best carried out using gene-based molecular markers, as it opens the possibility for exploiting genome synteny between pea and its close relative Medicago truncatula Gaertn., possessing sequenced and annotated genome. In the last 5 years, a large number of pea gene-based molecular markers have been designed and mapped owing to the rapid evolution of "next-generation sequencing" technologies. However, the access to the complete set of markers designed worldwide is limited because the data are not uniformed and therefore hard to use. The Pea Marker Database was designed to combine the information about pea markers in a form of user-friendly and practical online tool. Version 1 (PMD1) comprises information about 2484 genic markers, including their locations in linkage groups, the sequences of corresponding pea transcripts and the names of related genes in M. truncatula. Version 2 (PMD2) is an updated version comprising 15944 pea markers in the same format with several advanced features. To test the performance of the PMD, fine mapping of pea symbiotic genes Sym13 and Sym27 in linkage groups VII and V, respectively, was carried out. The results of mapping allowed us to propose the Sen1 gene (a homologue of SEN1 gene of Lotus japonicus (Regel) K. Larsen) as the best candidate gene for Sym13, and to narrow the list of possible candidate genes for Sym27 to ten, thus proving PMD to be useful for pea gene mapping and cloning.	[Kulaeva, Olga A.; Zhernakov, Aleksandr I.; Afonin, Alexey M.; Boikov, Sergei S.; Sulima, Anton S.; Tikhonovich, Igor A.; Zhukov, Vladimir A.] All Russia Res Inst Agr Microbiol, St Petersburg, Russia; [Tikhonovich, Igor A.] St Petersburg State Univ, Univ Skaya Embankment, St Petersburg, Russia	Saint Petersburg State University	Zhukov, VA (corresponding author), All Russia Res Inst Agr Microbiol, St Petersburg, Russia.	VZhukov@arriam.ru	Afonin, Alexey m./K-4186-2017; Zhernakov, Aleksandr/AAB-7596-2020; Tikhonovich, Igor A./C-1744-2014; Sulima, Anton/AAB-7597-2020; Zhukov, Vladimir/A-4781-2014	Afonin, Alexey m./0000-0002-8530-0226; Tikhonovich, Igor A./0000-0001-8968-854X; Zhukov, Vladimir/0000-0002-2411-9191; Sulima, Anton/0000-0002-2300-857X; Zhernakov, Aleksandr/0000-0001-8961-9317	Russian Science Foundation [14-24-00135, 16-16-00118]; Russian Foundation for Basic Research [16-34-60132]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The work of AMA and IAT on development of PMD1 and localization of the Sym27 gene was supported by the Russian Science Foundation (http://www.rscf.ru/en) (Grant # 14-24-00135). The work of OAK on development of PMD2 was supported by the Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng) (Grant # 16-34-60132). The work of AIZ, ASS and VAZ on localization of the Sym13 gene and Sen1 sequencing was supported by the Russian Science Foundation (http://www.rscf.ru/en) (Grant # 16-16-00118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonin A, 2017, GENOM DATA, V11, P85, DOI 10.1016/j.gdata.2016.12.003; Alves-Carvalho S, 2015, PLANT J, V84, P1, DOI 10.1111/tpj.12967; Armstead I, 2007, SCIENCE, V315, P73, DOI 10.1126/science.1132912; Aubert G, 2006, THEOR APPL GENET, V112, P1024, DOI 10.1007/s00122-005-0205-y; Bohra A, 2014, THEOR APPL GENET, V127, P1263, DOI 10.1007/s00122-014-2301-3; Bordat A, 2011, G3-GENES GENOM GENET, V1, P93, DOI 10.1534/g3.111.000349; Borisov AY, 2007, APPL BIOCHEM MICRO+, V43, P237, DOI 10.1134/S0003683807030027; Borisov AY, 1997, MOL GEN GENET, V254, P592, DOI 10.1007/s004380050456; Bourgeois M, 2011, PROTEOMICS, V11, P1581, DOI 10.1002/pmic.201000687; Boutet G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2447-2; Burstin J, 2001, PLANT BREEDING, V120, P311, DOI 10.1046/j.1439-0523.2001.00608.x; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Demason D. A., 2006, Pisum Genetics, V38, P3; Deulvot C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-468; Duarte J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-126; Ellis THN, 2002, NEW PHYTOL, V153, P17, DOI 10.1046/j.0028-646X.2001.00302.x; ENGVILD KC, 1987, THEOR APPL GENET, V74, P711, DOI 10.1007/BF00247546; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Gilpin BJ, 1997, THEOR APPL GENET, V95, P1289, DOI 10.1007/s001220050695; Hakoyama T, 2012, PLANT CELL PHYSIOL, V53, P225, DOI 10.1093/pcp/pcr167; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Ivanova KA, 2015, PROTOPLASMA, V252, P1505, DOI 10.1007/s00709-015-0780-y; Jing R, 2007, GENETICS, V177, P2263, DOI 10.1534/genetics.107.081323; Kalo P, 2004, MOL GENET GENOMICS, V272, P235, DOI 10.1007/s00438-004-1055-z; Kaur S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-104; KNEEN BE, 1990, PLANT PHYSIOL, V94, P899, DOI 10.1104/pp.94.3.899; KNEEN BE, 1988, PLANT SCI, V58, P177, DOI 10.1016/0168-9452(88)90007-6; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laucou V, 1998, THEOR APPL GENET, V97, P905, DOI 10.1007/s001220050971; Lejeune-Henaut I, 2008, THEOR APPL GENET, V116, P1105, DOI 10.1007/s00122-008-0739-x; Leonforte A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-161; Loridon K, 2005, THEOR APPL GENET, V111, P1022, DOI 10.1007/s00122-005-0014-3; Ma Y, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0956-4; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Morzhina EV, 2000, PLANT SCI, V155, P75, DOI 10.1016/S0168-9452(00)00207-7; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Page D, 2002, MOL GENET GENOMICS, V267, P359, DOI 10.1007/s00438-002-0667-4; Platten JD, 2005, PLANT PHYSIOL, V139, P1472, DOI 10.1104/pp.105.067462; Prioul-Gervais S, 2007, THEOR APPL GENET, V114, P971, DOI 10.1007/s00122-006-0492-y; Rameau C, 1998, THEOR APPL GENET, V97, P916, DOI 10.1007/s001220050972; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Royal Botanic Gardens, KEW PLANT DNA C VAL; Serova TA, 2017, J PLANT PHYSIOL, V212, P29, DOI 10.1016/j.jplph.2017.01.012; Sindhu A, 2014, THEOR APPL GENET, V127, P2225, DOI 10.1007/s00122-014-2375-y; Smykal P, 2012, AGRONOMY-BASEL, V2, P74, DOI 10.3390/agronomy2020074; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Sudheesh S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1815-7; Tang HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-312; Tayeh N, 2015, PLANT J, V84, P1257, DOI 10.1111/tpj.13070; Tayeh N, 2013, MOL BREEDING, V32, P279, DOI 10.1007/s11032-013-9869-1; Varshney RK, 2010, MOLECULAR TECHNIQUES IN CROP IMPROVEMENT, SECOND EDITION, P119, DOI 10.1007/978-90-481-2967-6_5; Verdier J, 2008, PLANT MOL BIOL, V67, P567, DOI 10.1007/s11103-008-9320-x; Vilmorin PD, 1911, P ROY SOC LOND B BIO, V84, P9; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Weeden NF, 1998, PISUM GENET, V30, P4; Wellensiek SJ, 1925, GENETIC MONOGRAPH PI; Yang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139775; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhernakov A, 2017, GENOM DATA, V11, P75, DOI 10.1016/j.gdata.2016.12.004; Zhukov V. A., 2007, Pisum Genetics, V39, P19; Zhukov VA, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/695947	64	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186713	10.1371/journal.pone.0186713	http://dx.doi.org/10.1371/journal.pone.0186713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073280	Green Published, gold, Green Submitted			2022-12-27	WOS:000413845400043
